PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Li, J; Parlak, M; Mukai, H; Matsuo, M; Buckwalter, JF				Li, Jun; Parlak, Mehmet; Mukai, Hirohito; Matsuo, Michiaki; Buckwalter, James F.			A Reconfigurable 50-Mb/s-1 Gb/s Pulse Compression Radar Signal Processor With Offset Calibration in 90-nm CMOS	IEEE TRANSACTIONS ON MICROWAVE THEORY AND TECHNIQUES			English	Article						Analog correlation; Barker code; dc-offset calibration; delay-locked loop (DLL); flash analog-to-digital converter (ADC); pulse compression radar (PCR)	VARIABLE-GAIN AMPLIFIER; TRANSCEIVER; TECHNOLOGY; SYSTEM; DLL	This paper presents a reconfigurable mixed-signal-processing circuit for high-speed pulse compression radar (PCR). Mixed-signal design techniques incorporate calibration and adaptation to improve the performance of a PCR receiver. Adaptive bandwidth PCR is an important feature for maximizing the dynamic range of a low-power radar system. The baseband signal processor includes a variable gain amplifier, 4-bit digital-to-analog converter, high-speed analog correlator, passive integrator, a 4-bit flash analog-to-digital converter, and a multi-range delay-locked loop. This proposed system is fabricated in 90-nm CMOS and can be configured to work from 50 Mb/s to 1 Gb/s with 2/3/5/7-bit Barker codes. The proposed calibration techniques improve the sidelobe reduction to 15.6 dB at 1 Gb/s. The total power consumption is 42 mW at the peak rate of 1 Gb/s for 15-cm range resolution.	[Li, Jun; Parlak, Mehmet; Buckwalter, James F.] Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA; [Mukai, Hirohito] Panasonic Corp, Tokyo 1538687, Japan; [Matsuo, Michiaki] Panasonic Corp, Yokohama, Kanagawa 1538687, Japan	Li, J (reprint author), Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA.	j6li@ucsd.edu; mparlak@ucsd.edu; buckwalter@ece.ucsd.edu					Godoy P, 2008, IEEE J SOLID-ST CIRC, V43, P2311, DOI 10.1109/JSSC.2008.2004328; Lee J, 2010, IEEE J SOLID-ST CIRC, V45, P2746, DOI 10.1109/JSSC.2010.2075250; Lee HD, 2007, IEEE T MICROW THEORY, V55, P1363, DOI 10.1109/YMTT.2007.896787; Mincica M, 2011, IEEE T CIRCUITS-II, V58, P570, DOI 10.1109/TCSII.2011.2161175; Kumar TB, 2013, IEEE T MICROW THEORY, V61, P2648, DOI 10.1109/TMTT.2013.2261086; [Anonymous], 2012, IEEE T MICROW THEORY, V60, P743; Bryllert T, 2013, IEEE T MICROW THEORY, V61, P3808, DOI 10.1109/TMTT.2013.2279359; Vahidi A, 2003, IEEE T INTELL TRANSP, V4, P143, DOI 10.1109/TITS.2003.821292; Yeh HC, 2013, IEEE T MICROW THEORY, V61, P902, DOI 10.1109/TMTT.2012.2233211; Xu R, 2006, IEEE T MICROW THEORY, V54, P3271, DOI 10.1109/TMTT.2006.877830; Mitomo T, 2010, IEEE J SOLID-ST CIRC, V45, P928, DOI 10.1109/JSSC.2010.2040234; Parlak M, 2012, IEEE T MICROW THEORY, V60, P3810, DOI 10.1109/TMTT.2012.2222433; Chien G, 2000, IEEE J SOLID-ST CIRC, V35, P1996, DOI 10.1109/4.890315; Li JY, 2013, INT CONF MEAS, P1, DOI 10.1109/ICMTMA.2013.11; Belloni M, 2010, IEEE J SOLID-ST CIRC, V45, P2521, DOI 10.1109/JSSC.2010.2076430; Kim SY, 2012, IEEE J SOLID-ST CIRC, V47, P359, DOI 10.1109/JSSC.2011.2170769; van de Beek RCH, 2002, IEEE T CIRCUITS-II, V49, P555, DOI 10.1109/TCSII.2002.806248; Chien JC, 2007, IEEE J SOLID-ST CIRC, V42, P1906, DOI 10.1109/JSSC.2007.903058; Crain E., 2005, IEEE INT SOL STAT CI, V1, P232; Deguchi K., 2007, IEEE S VLSI CIRC JUN, P64; Figueiredo PM, 2004, IEEE T CIRCUITS-I, V51, P233, DOI 10.1109/TCSI.2003.822415; Ismail A, 2008, IEEE J SOLID-ST CIRC, V43, P1982, DOI 10.1109/JSSC.2008.2001936; Jain Vipul H. P., 2012, AUTOMOTIVE RADAR SEN; Kang SY, 2012, IEEE T MICROW THEORY, V60, P2843, DOI 10.1109/TMTT.2012.2203928; Kumar TB, 2012, IEEE T MICROW THEORY, V60, P3482, DOI 10.1109/TMTT.2012.2217151; Kuo C., 2008, IEEE AS SOL STAT CIR, P441; Lee SM, 2010, IEEE T MICROW THEORY, V58, P747, DOI 10.1109/TMTT.2010.2042641; Li Jonathan J, 2011, Horm Cancer, V2, P1, DOI 10.1007/s12672-010-0064-0; Liao FR, 2012, IEEE T MICROW THEORY, V60, P1086, DOI 10.1109/TMTT.2012.2183379; Liao FR, 2010, IEEE T CIRCUITS-II, V57, P946, DOI 10.1109/TCSII.2010.2087992; Sun Y., 2012, IEEE RAD FREQ INT CI, P181; Xia LL, 2011, IEEE T MICROW THEORY, V59, P1147, DOI 10.1109/TMTT.2011.2114193; Zhou L, 2011, IEEE T MICROW THEORY, V59, P1117, DOI 10.1109/TMTT.2011.2114190	33	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9480	1557-9670		IEEE T MICROW THEORY	IEEE Trans. Microw. Theory Tech.	JAN	2015	63	1					266	278		10.1109/TMTT.2014.2375177		13	Engineering, Electrical & Electronic	Engineering	AY4CB	WOS:000347524700026		
J	Shimizu, T; Kojima, S; Kogami, Y				Shimizu, Takashi; Kojima, Shunsuke; Kogami, Yoshinori			Accurate Evaluation Technique of Complex Permittivity for Low-Permittivity Dielectric Films Using a Cavity Resonator Method in 60-GHz Band	IEEE TRANSACTIONS ON MICROWAVE THEORY AND TECHNIQUES			English	Article						Cavity resonator method; complex permittivity; low-loss dielectric materials; millimeter wave	WAVE-GUIDE METHOD; MILLIMETER-WAVE	In order to realize modern millimeter-wave applications, the accurate value of complex permittivity of low-permittivity dielectric films with excellent characteristics are needed by circuit designers and material developers. However, there are few accurate measurement methods for dielectric films in the millimeter-wave region. In this paper, an accurate evaluation technique for thin dielectric films using a novel V-band cavity in the 60-GHz band is proposed on the basis of a cavity resonator method. The novel V-band cavity with small excitation holes, which does not affect the resonant electromagnetic fields, is designed and fabricated. The six kinds of thin dielectric film were measured by the proposed technique using the novel cavity. The measured results and the uncertainty analysis validate the accuracy and the usefulness of the proposed method. Moreover, it was verified that this technique can evaluate thin samples with thicknesses of 10 mu m or more.	[Shimizu, Takashi; Kojima, Shunsuke; Kogami, Yoshinori] Utsunomiya Univ, Grad Sch Engn, Utsunomiya, Tochigi 3218585, Japan	Shimizu, T (reprint author), Utsunomiya Univ, Grad Sch Engn, Utsunomiya, Tochigi 3218585, Japan.	tshimizu@cc.utsunomiya-u.ac.jp; mt136211@cc.utsunomiya-u.ac.jp; kogami@cc.utsunomiya-u.ac.jp					Afsar M.N., 1989, P 1989 EUR MICR C, P820; Appleby R, 2007, P IEEE, V95, P1683, DOI 10.1109/JPROC.2007.898832; Janezic MD, 1999, IEEE T MICROW THEORY, V47, P2014, DOI 10.1109/22.795077; Shimizu T, 2004, IEICE T ELECTRON, VE87C, P672; Ern A., 2004, THEORY PRACTICE FINI; Fisher R., 2007, P INT S SIGN SYST EL, P103; Janezic M. D., 2004, IEEE MTT S INT MICR, V3, P1817; KAJFEZ D, 1984, IEEE T MICROW THEORY, V32, P941, DOI 10.1109/TMTT.1984.1132803; Kobayashi Y., 1987, MW8753 IEICE, P41; Kobayashi Y., 1988, IEICE TOK JAP NOV, P43; KOBAYASHI Y, 1985, IEEE T MICROW THEORY, V33, P1361, DOI 10.1109/TMTT.1985.1133226; Kobayashi Y., 1988, PREC EL MEAS C JUN, P147; Kogami Y., 2001, IEICE T ELECT AUG, VJ84-C, P703; Shimizu T., 2002, P 32 EUR MICR C SEP, P825; Shimizu T., 2014, IEEE MTT S INT MICR; Shimizu T, 2001, IEEE MTT S INT MICR, P2195, DOI 10.1109/MWSYM.2001.967351; Shimizu T., 2002, P AS PAC MICR C NOV, P1019; Suga R, 2010, IEEE MTT S INT MICR, P449, DOI 10.1109/MWSYM.2010.5518210	18	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9480	1557-9670		IEEE T MICROW THEORY	IEEE Trans. Microw. Theory Tech.	JAN	2015	63	1					279	286		10.1109/TMTT.2014.2375830		8	Engineering, Electrical & Electronic	Engineering	AY4CB	WOS:000347524700027		
J	Tanimoto, A; Ogawa, Y; Oki, C; Kimoto, Y; Nozawa, K; Amano, W; Noji, S; Shiozaki, M; Matsuo, A; Shinozaki, Y; Matsushita, M				Tanimoto, Atsuo; Ogawa, Yoshihiro; Oki, Chika; Kimoto, Yukari; Nozawa, Keisuke; Amano, Wataru; Noji, Satoru; Shiozaki, Makoto; Matsuo, Akira; Shinozaki, Yuichi; Matsushita, Mutsuyoshi			Pharmacological properties of JTE-052: a novel potent JAK inhibitor that suppresses various inflammatory responses in vitro and in vivo	INFLAMMATION RESEARCH			English	Article						JTE-052; Janus kinase; Cytokine signaling; Collagen-induced arthritis	TOFACITINIB CP-690,550; RHEUMATOID-ARTHRITIS; INADEQUATE RESPONSE; KINASE INHIBITOR; METHOTREXATE; EFFICACY; DISEASE; PLACEBO; SAFETY; CELLS	To evaluate the pharmacological properties of JTE-052, a novel Janus kinase (JAK) inhibitor. The JAK inhibitory activity of JTE-052 was evaluated using recombinant human enzymes. The inhibitory effects on cytokine signaling pathways were evaluated using primary human inflammatory cells. The in vivo efficacy and potency of JTE-052 were examined in a mouse interleukin (IL)-2-induced interferon (IFN)-gamma production model and a rat collagen-induced arthritis model. JTE-052 inhibited the JAK1, JAK2, JAK3, and tyrosine kinase (Tyk)2 enzymes in an adenosine triphosphate (ATP)-competitive manner and inhibited cytokine signaling evoked by IL-2, IL-6, IL-23, granulocyte/macrophage colony-stimulating factor, and IFN-alpha. JTE-052 inhibited the activation of inflammatory cells, such as T cells, B cells, monocytes, and mast cells, in vitro. Oral dosing of JTE-052 resulted in potent suppression of the IL-2-induced IFN-gamma production in mice with an ED50 value of 0.24 mg/kg, which was more potent than that of tofacitinib (ED50 = 1.1 mg/kg). In the collagen-induced arthritis model, JTE-052 ameliorated articular inflammation and joint destruction even in therapeutic treatments where methotrexate was ineffective. The present results indicate that JTE-052 is a highly potent JAK inhibitor, and represents a candidate anti-inflammatory agent for suppressing various types of inflammation.	[Tanimoto, Atsuo; Ogawa, Yoshihiro; Oki, Chika; Kimoto, Yukari; Nozawa, Keisuke; Amano, Wataru; Noji, Satoru; Shiozaki, Makoto; Matsuo, Akira; Shinozaki, Yuichi; Matsushita, Mutsuyoshi] Japan Tobacco Inc, Cent Pharmaceut Res Inst, Takatsuki, Osaka 5691125, Japan	Tanimoto, A (reprint author), Japan Tobacco Inc, Cent Pharmaceut Res Inst, 1-1 Murasaki Cho, Takatsuki, Osaka 5691125, Japan.	atsuo.tanimoto@jt.com					Fleischmann R, 2012, ARTHRITIS RHEUM-US, V64, P617, DOI 10.1002/art.33383; Quintas-Cardama A, 2010, BLOOD, V115, P3109, DOI 10.1182/blood-2009-04-214957; Sasakawa T, 2005, INT IMMUNOPHARMACOL, V5, P503, DOI 10.1016/j.intimp.2004.10.012; Boy MG, 2009, J INVEST DERMATOL, V129, P2299, DOI 10.1038/jid.2009.25; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Changelian PS, 2003, SCIENCE, V302, P875, DOI 10.1126/science.1087061; Yamaoka K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-253; Boulay JL, 2003, IMMUNITY, V19, P159, DOI 10.1016/S1074-7613(03)00211-5; Cornish AL, 2009, NAT REV RHEUMATOL, V5, P554, DOI 10.1038/nrrheum.2009.178; Swinney DC, 2006, CURR TOP MED CHEM, V6, P461, DOI 10.2174/156802606776743093; Tanaka Y, 2011, ARTHRIT CARE RES, V63, P1150, DOI 10.1002/acr.20494; Konforte D, 2009, J IMMUNOL, V182, P1781, DOI 10.4049/jimmunol.0803009; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Nielsen CH, 2007, CLIN EXP IMMUNOL, V148, P288, DOI 10.1111/j.1365-2249.2007.03335.x; Vincenti F, 2012, AM J TRANSPLANT, V12, P2446, DOI 10.1111/j.1600-6143.2012.04127.x; Cohen S, 2014, ARTHRITIS RHEUM; Dinh M, 2007, J BIOL CHEM, V282, P8768, DOI 10.1074/jbc.M609920200; Maeshima K, 2012, ARTHRITIS RHEUM-US, V64, P1790, DOI 10.1002/art.34329; Meyer DM, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-41; Sandborn WJ, 2012, NEW ENGL J MED, V367, P616, DOI 10.1056/NEJMoa1112168; Toru H, 1998, J ALLERGY CLIN IMMUN, V102, P491, DOI 10.1016/S0091-6749(98)70140-X	21	3	3	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1023-3830	1420-908X		INFLAMM RES	Inflamm. Res.	JAN	2015	64	1					41	51		10.1007/s00011-014-0782-9		11	Cell Biology; Immunology	Cell Biology; Immunology	AY4MS	WOS:000347553300005		
J	Kurisu, S; Kihara, Y				Kurisu, Satoshi; Kihara, Yasuki			Diagnosis and Management of Takotsubo Cardiomyopathy	INTERNAL MEDICINE			English	Editorial Material						prognosis; complication; treatment	ACUTE MYOCARDIAL-INFARCTION; TAKO-TSUBO CARDIOMYOPATHY; ST-SEGMENT ELEVATION; CARDIAC RUPTURE		[Kurisu, Satoshi; Kihara, Yasuki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cardiovasc Med, Hiroshima 730, Japan	Kurisu, S (reprint author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cardiovasc Med, Hiroshima 730, Japan.	skurisu@nifty.com					Sharkey SW, 2010, J AM COLL CARDIOL, V55, P333, DOI 10.1016/j.jacc.2009.08.057; Ogura R, 2003, CIRC J, V67, P687; Kurisu S, 2002, AM HEART J, V143, P448, DOI 10.1067/mhj.2002.120403; Kumar S, 2011, CLIN CARDIOL, V34, P672, DOI 10.1002/clc.20957; Kosuge M, 2010, J AM COLL CARDIOL, V55, P2514, DOI 10.1016/j.jacc.2009.12.059; Kamada T, 2015, INTERNAL MED, V54, P31, DOI 10.2169/internalmedicine.54.3239; Kurisu S, 2012, INT J CARDIOL, V158, pE5, DOI 10.1016/j.ijcard.2011.10.059; Sato H, 1990, CLIN ASPECT MYOCARDI, P56	8	1	1	JAPAN SOC INTERNAL MEDICINE	TOKYO	34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN	0918-2918	1349-7235		INTERNAL MED	Intern. Med.		2015	54	1					1	2		10.2169/internalmedicine.54.3454		2	Medicine, General & Internal	General & Internal Medicine	AY2YI	WOS:000347451600001		
J	Matsuoka, S; Tamura, A; Moriyama, M; Fujikawa, H; Mimatsu, K; Oida, T; Sugitani, M				Matsuoka, Shunichi; Tamura, Akinori; Moriyama, Mitsuhiko; Fujikawa, Hirotoshi; Mimatsu, Kenji; Oida, Takatsugu; Sugitani, Masahiko			Pathological Evidence of the Cause of Spontaneous Regression in a Case of Resected Hepatocellular Carcinoma	INTERNAL MEDICINE			English	Article						hepatocellular carcinoma (HCC); spontaneous regression; arterio-portal thrombi; non-alcoholic steatohepatitis (NASH)	FATTY LIVER-DISEASE; IRREGULAR REGENERATION; HEPATOCYTES; NECROSIS	A 67-year-old man presented for an evaluation after experiencing right hypochondrial pain lasting for two months. Abdominal ultrasonography showed a hepatic tumor in the right liver and extremely mild hepatic steatosis. The imaging findings indicated that the tumor (43 mm in size) was ischemic, and the lesion was surgically resected and examined. The histopathological findings demonstrated 95% necrosis with moderately differentiated hepatocellular carcinoma (HCC). The diagnosis was HCC with spontaneous regression. There was also pathological evidence of thrombus formation in the peripheral arteries and portal veins. In addition, the non-cancerous regions of the liver were diagnosed as exhibiting non-alcoholic steatohepatitis. The pathological findings obtained after resection of the HCC lesion showed spontaneous regression.	[Matsuoka, Shunichi; Tamura, Akinori; Moriyama, Mitsuhiko] Nihon Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Tokyo 102, Japan; [Fujikawa, Hirotoshi] Social Insurance Yokohama Cent Hosp, Dept Gastroenterol & Hepatol, Yokohama, Kanagawa, Japan; [Mimatsu, Kenji; Oida, Takatsugu] Social Insurance Yokohama Cent Hosp, Dept Surg, Yokohama, Kanagawa, Japan; [Sugitani, Masahiko] Nihon Univ, Sch Med, Dept Pathol, Tokyo 102, Japan	Matsuoka, S (reprint author), Nihon Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Tokyo 102, Japan.	matsuoka.shunichi@nihon-u.ac.jp					Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Heianna J, 2007, HEPATO-GASTROENTEROL, V54, P1560; IMAOKA S, 1994, HEPATO-GASTROENTEROL, V41, P359; Morimoto Y, 2002, DIGEST SURG, V19, P413, DOI 10.1159/000065822; Shibata M, 1998, LANCET, V351, P1773, DOI 10.1016/S0140-6736(97)08002-1; Ueno Y, 2001, HEPATOLOGY, V33, P357, DOI 10.1053/jhep.2001.21902; Yano Yoichi, 2005, Kurume Medical Journal, V52, P97, DOI 10.2739/kurumemedj.52.97; Yatsuji S, 2007, HEPATOL INT, V1, P22	10	0	0	JAPAN SOC INTERNAL MEDICINE	TOKYO	34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN	0918-2918	1349-7235		INTERNAL MED	Intern. Med.		2015	54	1					25	30		10.2169/internalmedicine.54.2981		6	Medicine, General & Internal	General & Internal Medicine	AY2YI	WOS:000347451600005		
J	Kamada, T; Hayashi, M; Yokoi, H; Fujiwara, W; Yoshikawa, D; Mukaide, D; Sugishita, Y; Yoshinaga, M; Ito, T; Ozaki, Y; Izawa, H				Kamada, Tomohito; Hayashi, Mutsuharu; Yokoi, Hiroatsu; Fujiwara, Wakaya; Yoshikawa, Daiji; Mukaide, Daisuke; Sugishita, Yoshinori; Yoshinaga, Masataka; Ito, Takehiro; Ozaki, Yukio; Izawa, Hideo			Takotsubo Cardiomyopathy with Involvement of Delayed-onset Rhabdomyolysis and Acute Kidney Injury after Rosuvastatin Treatment	INTERNAL MEDICINE			English	Article						Takotsubo cardiomyopathy; statin; rhabdomyolysis; ST elevated myocardial infarction (STEMI)	MYOCARDIAL-INFARCTION; STATIN THERAPY	Takotsubo cardiomyopathy is a disorder characterized by left ventricular apical ballooning with preceding emotional and/or physical stressors. This condition is also an important differential diagnosis of acute coronary syndrome. We herein describe a case of Takotsubo cardiomyopathy, a significant clinical phenomenon, triggered by delayed-onset rhabdomyolysis following the administration of long-term statin treatment, without any preceding stressors or changes in the patient's medical condition, in association with complaints of nonspecific muscle-related symptoms. Although an electrocardiogram showed remarkable ST-segment elevation, a careful reading of the electrocardiogram findings revealed the features of Takotsubo cardiomyopathy. Withdrawing the statin therapy improved the patient's cardiac function.	[Kamada, Tomohito; Hayashi, Mutsuharu; Yokoi, Hiroatsu; Fujiwara, Wakaya; Yoshikawa, Daiji; Mukaide, Daisuke; Sugishita, Yoshinori; Yoshinaga, Masataka; Ito, Takehiro; Izawa, Hideo] Fujita Hlth Univ, Hosp 2, Div Cardiol, Toyoake, Aichi, Japan; [Ozaki, Yukio] Fujita Hlth Univ Hosp, Dept Cardiol, Toyoake, Aichi, Japan	Hayashi, M (reprint author), Fujita Hlth Univ, Hosp 2, Div Cardiol, Toyoake, Aichi, Japan.	muhayasi@fujita-hu.ac.jp					Silva MA, 2006, CLIN THER, V28, P26, DOI 10.1016/j.clinthera.2006.01.005; Bruckert E, 2005, CARDIOVASC DRUG THER, V19, P403, DOI 10.1007/s10557-005-5686-z; Dib C, 2009, AM HEART J, V157, P933, DOI 10.1016/j.ahj.2008.12.023; Kashani A, 2006, CIRCULATION, V114, P2788, DOI 10.1161/CIRCULATIONAHA.106.624890; Kosuge M, 2010, J AM COLL CARDIOL, V55, P2514, DOI 10.1016/j.jacc.2009.12.059; Bybee KA, 2004, ANN INTERN MED, V141, P858; Bybee KA, 2007, J ELECTROCARDIOL, V40; Ireland JH, 2005, ANN INTERN MED, V142, P949	8	2	2	JAPAN SOC INTERNAL MEDICINE	TOKYO	34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN	0918-2918	1349-7235		INTERNAL MED	Intern. Med.		2015	54	1					31	35		10.2169/internalmedicine.54.3239		5	Medicine, General & Internal	General & Internal Medicine	AY2YI	WOS:000347451600006		
J	Aikawa, T; Sakakibara, M; Takahashi, M; Asakawa, K; Dannoura, Y; Makino, T; Koya, T; Tsutsui, H				Aikawa, Tadao; Sakakibara, Mamoru; Takahashi, Masayuki; Asakawa, Kyoko; Dannoura, Yutaka; Makino, Takao; Koya, Tetsuro; Tsutsui, Hiroyuki			Critical Takotsubo Cardiomyopathy Complicated by Ventricular Septal Perforation	INTERNAL MEDICINE			English	Article						Takotsubo cardiomyopathy; apical ballooning; ventricular septal perforation; prolonged QT interval; ventricular fibrillation	TAKO-TSUBO CARDIOMYOPATHY; ACUTE MYOCARDIAL-INFARCTION; STRESS CARDIOMYOPATHY; MORTALITY	An 81-year-old woman was admitted with chest pain. An electrocardiogram demonstrated ST segment elevation in leads II, III and aVF, and echocardiography revealed left ventricular apical asynergy with a left-toright ventricular shunt. Meanwhile, emergent coronary angiography showed no significant coronary artery stenosis, whereas left ventriculography indicated apical ballooning and a left-to-right ventricular shunt. We therefore diagnosed the patient with Takotsubo cardiomyopathy complicated by ventricular septal perforation and cardiogenic shock. An electrocardiogram disclosed a prolonged QT interval over time, and the patient became hemodynamically stable under treatment with inotropes; however, she suddenly developed fatal ventricular fibrillation three days after hospitalization. Takotsubo cardiomyopathy complicated by ventricular septal perforation is a critical condition that requires careful monitoring.	[Aikawa, Tadao; Sakakibara, Mamoru; Tsutsui, Hiroyuki] Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Med, Sapporo, Hokkaido 060, Japan; [Takahashi, Masayuki; Asakawa, Kyoko; Dannoura, Yutaka; Makino, Takao; Koya, Tetsuro] Sapporo City Gen Hosp, Dept Cardiovasc Med, Sapporo, Hokkaido, Japan	Aikawa, T (reprint author), Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Med, Sapporo, Hokkaido 060, Japan.	aikawatadao@med.hokudai.ac.jp					Ahmed Saeed, 2013, N Am J Med Sci, V5, P77, DOI 10.4103/1947-2714.107520; Kosuge M, 2014, J ELECTROCARDIOL, V47, P684, DOI 10.1016/j.jelectrocard.2014.03.004; Rotondi F, 2013, EUR REV MED PHARMACO, V17, P105; Madias C, 2011, HEART RHYTHM, V8, P555, DOI 10.1016/j.hrthm.2010.12.012; Arnaoutakis GJ, 2012, ANN THORAC SURG, V94, P436, DOI 10.1016/j.athoracsur.2012.04.020; Wittstein IS, 2005, NEW ENGL J MED, V352, P539, DOI 10.1056/NEJMoa043046; Singh K, 2014, AM J CARDIOL, V113, P1420, DOI 10.1016/j.amjcard.2014.01.419; Kurisu S, 2012, J CARDIOL, V60, P429, DOI 10.1016/j.jjcc.2012.06.015; O'Gara PT, 2013, CIRCULATION, V127, pE362, DOI 10.1161/CIR.0b013e3182742cf6; Brinjikji W, 2012, AM HEART J, V164, P215, DOI 10.1016/j.ahj.2012.04.010; Prasad A, 2008, AM HEART J, V155, P408, DOI 10.1016/j.ahj.2007.11.008; Kumar S, 2011, CLIN CARDIOL, V34, P672, DOI 10.1002/clc.20957; Previtali M, 2009, INT J CARDIOL, V134, P91, DOI 10.1016/j.ijcard.2008.01.037; Izumi K, 2008, CIRC J, V72, P1540, DOI 10.1253/circj.CJ-07-0907; Kurowski V, 2007, CHEST, V132, P809, DOI 10.1378/chest.07-0608; Kosuge M, 2012, CIRC J, V76, P462, DOI 10.1253/circj.CJ-11-1036; Marra MP, 2013, HEART RHYTHM, V10, P70, DOI 10.1016/j.hrthm.2012.09.004; Kosuge M, 2010, J AM COLL CARDIOL, V55, P2514, DOI 10.1016/j.jacc.2009.12.059; Akashi YJ, 2008, CIRCULATION, V118, P2754, DOI 10.1161/CIRCULATIONAHA.108.767012; Abraham J, 2009, J AM COLL CARDIOL, V53, P1320, DOI 10.1016/j.jacc.2009.02.020; Behr ER, 2009, EUROPACE, V11, P697, DOI 10.1093/europace/eup081; Mariscalco G, 2010, HEART VESSELS, V25, P73, DOI 10.1007/s00380-009-1167-9; Prasad A, 2014, CATHETER CARDIO INTE, V83, P343, DOI 10.1002/ccd.23441; Sakai K, 2005, CIRC J, V69, P365, DOI 10.1253/circj.69.365; Showkathali R, 2014, EUR J INTERN MED, V25, P132, DOI 10.1016/j.ejim.2013.09.004	25	0	0	JAPAN SOC INTERNAL MEDICINE	TOKYO	34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN	0918-2918	1349-7235		INTERNAL MED	Intern. Med.		2015	54	1					37	41		10.2169/internalmedicine.54.3475		5	Medicine, General & Internal	General & Internal Medicine	AY2YI	WOS:000347451600007		
J	Ashinuma, H; Shingyoji, M; Yoshida, Y; Itakura, M; Ishibashi, F; Tamura, H; Moriya, Y; Itami, M; Tatsumi, K; Iizasa, T				Ashinuma, Hironori; Shingyoji, Masato; Yoshida, Yasushi; Itakura, Meiji; Ishibashi, Fumihiro; Tamura, Hajime; Moriya, Yasumitsu; Itami, Makiko; Tatsumi, Koichiro; Iizasa, Toshihiko			Endobronchial Ultrasound-guided Transbronchial Needle Aspiration in a Patient with Pericardial Mesothelioma	INTERNAL MEDICINE			English	Article						endobronchial ultrasonography; mesothelioma; pericardium	HEART	Pericardial mesothelioma is a very rare pericardial tumor. Diagnosing pericardial disease can be challenging, and obtaining an antemortem diagnosis of pericardial mesothelioma is particularly difficult. We herein report the case of a 60-year-old man with pericardial mesothelioma diagnosed on endobronchial ultrasoundguided transbronchial needle aspiration (EBUS-TBNA). Chest computed tomography showed a mass surrounding the pericardium, and EBUS-TBNA of the right inferior paratracheal and subcarinal stations was consequently performed. No uptake was noted on F-18-fluorodeoxy glucose positron emission tomography, other than in the pericardial mass. The results of histological and immunohistochemical examinations indicated the features of malignant mesothelioma. We therefore diagnosed the patient with pericardial mesothelioma, which was subsequently confirmed at autopsy.	[Ashinuma, Hironori; Shingyoji, Masato; Yoshida, Yasushi; Itakura, Meiji; Ishibashi, Fumihiro; Tamura, Hajime; Moriya, Yasumitsu; Iizasa, Toshihiko] Chiba Canc Ctr, Dept Thorac Dis, Kashiwa, Chiba, Japan; [Itami, Makiko] Chiba Canc Ctr, Dept Clin Pathol, Kashiwa, Chiba, Japan; [Tatsumi, Koichiro] Chiba Univ, Grad Sch Med, Dept Respirol, Chiba, Japan	Ashinuma, H (reprint author), Chiba Canc Ctr, Dept Thorac Dis, Kashiwa, Chiba, Japan.	hashinuma@chiba-cc.jp					ANDERSEN JA, 1974, DAN MED BULL, V21, P195; Rice DC, 2009, ANN THORAC SURG, V88, P862, DOI 10.1016/j.athoracsur.2009.05.022; Reynen K, 1996, AM J CARDIOL, V77, P107, DOI 10.1016/S0002-9149(97)89149-7; Gemba K, 2012, CANCER SCI, V103, P483, DOI 10.1111/j.1349-7006.2011.02165.x; Yasufuku K, 2006, CHEST, V130, P710, DOI 10.1378/chest.130.3.710; Nilsson A, 2009, CASE REP ONCOL, V2, P125; Papi M, 2005, TUMORI, V91, P276; Reardon Kelli A, 2010, Rare Tumors, V2, pe51, DOI 10.4081/rt.2010.e51; Rice DC, 2009, ANN THORAC SURG, V88, P868; Rizzardi C, 2010, ANTICANCER RES, V30, P1323; Sardar MR, 2012, TEX HEART I J, V39, P261	11	1	1	JAPAN SOC INTERNAL MEDICINE	TOKYO	34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN	0918-2918	1349-7235		INTERNAL MED	Intern. Med.		2015	54	1					43	48		10.2169/internalmedicine.54.3216		6	Medicine, General & Internal	General & Internal Medicine	AY2YI	WOS:000347451600008		
J	Ihara, K; Naito, S; Okado, T; Rai, T; Mori, Y; Toda, T; Uchida, S; Sasaki, S; Matsui, N				Ihara, Katsuhito; Naito, Shotaro; Okado, Tomokazu; Rai, Tatemitu; Mori, Yutaro; Toda, Takayuki; Uchida, Shinichi; Sasaki, Sei; Matsui, Noriaki			Successful Recovery from an Acute Kidney Injury due to Amniotic Fluid Embolism	INTERNAL MEDICINE			English	Article						acute kidney injury; amniotic fluid embolism; multiple organ failure; renal replacement therapy; acute tubular necrosis; bilateral renal cortical necrosis	CONTINUOUS HEMODIAFILTRATION; SHOCK	A 33-year-old Japanese woman at 40 weeks gestation visited the maternity hospital after imminent labor had begun. After the delivery, persistent bleeding developed resulting in hemorrhagic shock. Although the hemorrhage was eventually controlled, hepatic and renal dysfunction occurred, leading to acute kidney injury (AKI). The patient's clinical presentation was suggestive of amniotic fluid embolism (AFE). We subsequently initiated continuous renal replacement therapy (RRT) for AKI. The patient's condition improved, she discontinued RRT, and her renal function recovered. We herein report a patient who successfully recovered from AKI caused by AFE.	[Ihara, Katsuhito; Naito, Shotaro; Mori, Yutaro; Toda, Takayuki; Matsui, Noriaki] Tsuchiura Kyodo Gen Hosp, Dept Nephrol, Ibaraki, Japan; [Okado, Tomokazu; Rai, Tatemitu; Uchida, Shinichi; Sasaki, Sei] Tokyo Med & Dent Univ, Dept Nephrol, Tokyo, Japan	Ihara, K (reprint author), Tsuchiura Kyodo Gen Hosp, Dept Nephrol, Ibaraki, Japan.	ctngt512@yahoo.co.jp					MATLIN RA, 1974, AM J MED, V56, P110, DOI 10.1016/0002-9343(74)90756-6; Reade MC, 2014, NEW ENGL J MED, V370, P444, DOI 10.1056/NEJMra1208705; Kaneko Y, 2001, INTERNAL MED, V40, P945, DOI 10.2169/internalmedicine.40.945; Ostermann M, 2012, NEPHROL DIAL TRANSPL, V27, P2242, DOI 10.1093/ndt/gfr707; KANAYAMA N, 1992, CLIN CHEM, V38, P526; Gando S, 2010, CRIT CARE MED, V38, pS35, DOI 10.1097/CCM.0b013e3181c9e31d; Aziz ES, 2000, EUR J ANAESTH, V17, P712; BUSING CM, 1979, PATHOL RES PRACT, V165, P253; Colvin RB, 2011, DIAGNOSTIC PATHOLOGY; Jennette JC, 2007, HEPTINSTALLS PATHOLO, P1178; Knight M, 2012, LIT THEOL, V26, P1, DOI 10.1093/litthe/frr058; Lee Jung Hyang, 2010, Korean J Anesthesiol, V59 Suppl, pS158, DOI 10.4097/kjae.2010.59.S.S158; Ogihara T, 2012, THER APHER DIAL, V16, P195, DOI 10.1111/j.1744-9987.2011.01033.x; Oi H, 1998, SEMIN THROMB HEMOST, V24, P479, DOI 10.1055/s-2007-996043; Price T M, 1985, Obstet Gynecol Surv, V40, P462, DOI 10.1097/00006254-198507000-00007; The Japanese Society of Obstetrical, GYN NEON HEM	16	0	0	JAPAN SOC INTERNAL MEDICINE	TOKYO	34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN	0918-2918	1349-7235		INTERNAL MED	Intern. Med.		2015	54	1					49	54		10.2169/internalmedicine.54.2348		6	Medicine, General & Internal	General & Internal Medicine	AY2YI	WOS:000347451600009		
J	Miura, S; Kagamu, H; Sakai, T; Nozaki, K; Asakawa, K; Moro, H; Okajima, M; Watanabe, S; Yamamoto, S; Iino, N; Goto, S; Kazama, JJ; Yoshizawa, H; Narita, I				Miura, Satoru; Kagamu, Hiroshi; Sakai, Takehito; Nozaki, Koichiro; Asakawa, Katsuaki; Moro, Hiroshi; Okajima, Masaaki; Watanabe, Satoshi; Yamamoto, Suguru; Iino, Noriaki; Goto, Shin; Kazama, Junichiro James; Yoshizawa, Hirohisa; Narita, Ichiei			Advanced Thymic Cancer Treated with Carboplatin and Paclitaxel in a Patient Undergoing Hemodialysis	INTERNAL MEDICINE			English	Article						thymic cancer; hemodialysis; carboplatin; paclitaxel	ADVANCED OVARIAN-CANCER; CELL LUNG-CANCER; COMBINATION CHEMOTHERAPY; PHARMACOKINETIC ANALYSIS; CARCINOMA; DIALYSIS; THYMOMA; DOSAGE	A 53-year-old man with an asymptomatic anterior mediastinal tumor undergoing hemodialysis was referred to our institution. He was diagnosed with thymic basaloid carcinoma based on the findings of a chest tomography-guided biopsy and successfully treated with carboplatin (300 mg/m(2)/day) and paclitaxel (200 mg/ m2/day) on day 1 for six three-week cycles. To our knowledge, this is the first report regarding the efficiency of a carboplatin dose-definition method based on the body surface area with paclitaxel in a hemodialysis patient. This report may therefore be useful for treating hemodialysis patients who are candidates for carboplatin and paclitaxel therapy.	[Miura, Satoru; Kagamu, Hiroshi; Nozaki, Koichiro; Asakawa, Katsuaki; Moro, Hiroshi; Okajima, Masaaki; Yamamoto, Suguru; Iino, Noriaki; Goto, Shin; Kazama, Junichiro James; Narita, Ichiei] Niigata Univ, Med & Dent Hosp, Dept Med 2, Niigata 95021, Japan; [Sakai, Takehito] Saiseikai Niigata Daini Hosp, Dept Internal Med, Niigata, Japan; [Watanabe, Satoshi; Yoshizawa, Hirohisa] Niigata Univ, Med & Dent Hosp, Biosci Med Res Ctr, Niigata 95021, Japan	Kagamu, H (reprint author), Niigata Univ, Med & Dent Hosp, Dept Med 2, Niigata 95021, Japan.	hkagamu@med.niigata-u.ac.jp					Oguri T, 2010, CANCER CHEMOTH PHARM, V66, P813, DOI 10.1007/s00280-010-1366-1; Hiraike M, 2012, CANCER CHEMOTH PHARM, V69, P845, DOI 10.1007/s00280-011-1802-x; Brown JG, 2009, AM J SURG PATHOL, V33, P1113, DOI 10.1097/PAS.0b013e3181a2443b; Lemma GL, 2011, J CLIN ONCOL, V29, P2060, DOI 10.1200/JCO.2010.32.9607; Nakai S, 2013, THER APHER DIAL, V17, P567, DOI 10.1111/1744-9987.12147; Engels EA, 2003, INT J CANCER, V105, P546, DOI 10.1002/ijc.11099; CALVERT AH, 1989, J CLIN ONCOL, V7, P1748; Inoue A, 2004, ANN ONCOL, V15, P51, DOI 10.1093/annonc/mdh008; Janus N, 2010, ANN ONCOL, V21, P1395, DOI 10.1093/annonc/mdp598; Kodama J, 2010, ONCOL LETT, V1, P511, DOI 10.3892/ol_00000090; LINDNER A, 1981, NEPHRON, V27, P292, DOI 10.1159/000182073; Watanabe M, 2002, GYNECOL ONCOL, V84, P335, DOI 10.1006/gyno.2001.6527; Woo MH, 1999, CANCER CHEMOTH PHARM, V43, P92, DOI 10.1007/s002800050868; Yokoyama Y, 2006, EUR J GYNAECOL ONCOL, V27, P437; Yoshida H, 2009, EUR J GYNAECOL ONCOL, V30, P583	15	0	0	JAPAN SOC INTERNAL MEDICINE	TOKYO	34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN	0918-2918	1349-7235		INTERNAL MED	Intern. Med.		2015	54	1					55	58		10.2169/internalmedicine.54.3484		4	Medicine, General & Internal	General & Internal Medicine	AY2YI	WOS:000347451600010		
J	Numanami, H; Takahashi, D; Takahashi, E; Katsuda, E; Kamei, S; Naruse, K; Baba, K; Haniuda, M; Yokoi, T; Yamaguchi, E; Kubo, A				Numanami, Hiroki; Takahashi, Daisuke; Takahashi, Emiko; Katsuda, Eisuke; Kamei, Seiji; Naruse, Katsuya; Baba, Kenji; Haniuda, Masayuki; Yokoi, Toyoharu; Yamaguchi, Etsuro; Kubo, Akihito			Metastatic Embryonal Carcinoma Mimicking Locally Advanced Non-small Cell Lung Cancer	INTERNAL MEDICINE			English	Article						embryonal carcinoma; non-small cell lung cancer; positron emission tomography (PET)	TUMORS	A 50-year-old man with a history of smoking of 45 pack-years underwent right lower lobectomy after neoadjuvant chemoradiotherapy for locally advanced non-small cell lung cancer diagnosed on a bronchial biopsy and standard imaging examinations, including chest-abdominal contrast-enhanced computed tomography (CT) and whole-body F-18 fluorodeoxyglucose positron emission tomography/CT. Left orchiectomy was performed simultaneously to treat the slightly swollen left testis, which had remained unchanged for over five years. The thoracic tumor was proven to be in pathological complete remission and the testicular lesion was pathologically diagnosed as an embryonal carcinoma. Furthermore, a pathological reevaluation of the preoperative bronchial biopsy specimen revealed the lung tumor to be a metastatic embryonal carcinoma.	[Numanami, Hiroki; Haniuda, Masayuki] Aichi Med Univ, Sch Med, Dept Surg, Div Chest Surg, Nagakute, Aichi, Japan; [Takahashi, Daisuke; Baba, Kenji; Yamaguchi, Etsuro; Kubo, Akihito] Aichi Med Univ, Sch Med, Dept Internal Med, Div Resp Med & Allergol, Nagakute, Aichi, Japan; [Takahashi, Emiko; Yokoi, Toyoharu] Aichi Med Univ, Sch Med, Dept Pathol, Div Pathol, Nagakute, Aichi, Japan; [Katsuda, Eisuke; Kamei, Seiji] Aichi Med Univ, Sch Med, Dept Radiol, Div Radiol, Nagakute, Aichi, Japan; [Naruse, Katsuya] Aichi Med Univ, Sch Med, Dept Surg, Div Urol, Nagakute, Aichi, Japan	Kubo, A (reprint author), Aichi Med Univ, Sch Med, Dept Internal Med, Div Resp Med & Allergol, Nagakute, Aichi, Japan.	kuboa@aichi-med-u.ac.jp					Krege S, 2008, EUR UROL, V53, P478, DOI 10.1016/j.eururo.2007.12.024; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Basu S, 2008, MINERVA ENDOCRINOL, V33, P229; Fraser RS, 1999, DIAGNOSIS DIS CHEST, P1381; Hain SF, 2000, BRIT J CANCER, V83, P863, DOI 10.1054/bjoc.2000.1389; Lewis DeQuincy A, 2006, J Clin Oncol, V24, pe54, DOI 10.1200/JCO.2006.08.1737; Woodward PJ, 2004, WHO CLASSIFICATION T, P217	7	0	0	JAPAN SOC INTERNAL MEDICINE	TOKYO	34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN	0918-2918	1349-7235		INTERNAL MED	Intern. Med.		2015	54	1					59	61		10.2169/internalmedicine.54.2884		3	Medicine, General & Internal	General & Internal Medicine	AY2YI	WOS:000347451600011		
J	Saraya, T; Sada, M; Ohkuma, K; Sakuma, S; Tsujimoto, N; Yoshida, S; Fujiwara, M; Tsukahara, Y; Kurai, D; Ishii, H; Takizawa, H; Goto, H				Saraya, Takeshi; Sada, Mitsuru; Ohkuma, Kosuke; Sakuma, Sho; Tsujimoto, Naoki; Yoshida, Shigehiko; Fujiwara, Masachika; Tsukahara, Yayoi; Kurai, Daisuke; Ishii, Haruyuki; Takizawa, Hajime; Goto, Hajime			Evidence of Unilateral Metastatic Pulmonary Calcification with a Prolonged Fever and Arthralgia Caused by Acute Lymphoblastic Leukemia in a Chronic Dialysis Patient	INTERNAL MEDICINE			English	Article						end-stage renal disease; metastatic pulmonary calcification; secondary hyperparathyroidism; acute lymphoblastic leukemia	RENAL-FAILURE; HYPERCALCEMIA	A 55-year-old man was transferred to our hospital with unilateral lung lesions, a persistent fever and vague chest pain with arthralgia lasting for three months. He had been treated for end-stage renal disease with hemodialysis for 15 years and had a medical history of recurrent subcutaneous calciphylaxis due to secondary hyperparathyroidism. Transbronchial biopsied specimens demonstrated metastatic pulmonary calcification, and a bone marrow biopsy showed Philadelphia chromosome-positive acute lymphoblastic leukemia. Although metastatic calcification often lacks specific symptoms, the lungs is a primary site for deposition. This is the first report of unilateral metastatic pulmonary calcification associated with secondary hyperparathyroidism.	[Saraya, Takeshi; Sada, Mitsuru; Ohkuma, Kosuke; Sakuma, Sho; Tsujimoto, Naoki; Kurai, Daisuke; Ishii, Haruyuki; Takizawa, Hajime; Goto, Hajime] Kyorin Univ, Dept Resp Med, Sch Med, Mitaka, Tokyo, Japan; [Yoshida, Shigehiko] Inokashira Clin, Mitaka, Tokyo, Japan; [Fujiwara, Masachika] Kyorin Univ, Dept Pathol, Sch Med, Mitaka, Tokyo, Japan; [Tsukahara, Yayoi] Kyorin Univ, Dept Radiol, Sch Med, Mitaka, Tokyo, Japan	Saraya, T (reprint author), Kyorin Univ, Dept Resp Med, Sch Med, Mitaka, Tokyo, Japan.	sara@yd5.so-net.ne.jp					Young EW, 2005, KIDNEY INT, V67, P1179, DOI 10.1111/j.1523-1755.2005.00185.x; Redaelli A, 2005, EUR J CANCER CARE, V14, P53, DOI 10.1111/j.1365-2354.2005.00513.x; AUERBACH JM, 1981, AM J ROENTGENOL, V136, P605; Cadavid JC, 2011, CHEST, V139, P1503, DOI 10.1378/chest.10-1322; CONGER JD, 1975, ANN INTERN MED, V83, P330; Cotellese Roberto, 2004, Chir Ital, V56, P47; DAVIDSON RM, 1990, CLIN NUCL MED, V15, P692, DOI 10.1097/00003072-199015100-00007; Dhanjal TS, 2009, BMJ CASE REP, V2009; Fukasawa H, 2001, AM J MED SCI, V322, P109, DOI 10.1097/00000441-200108000-00009; HARTMAN TE, 1994, AM J ROENTGENOL, V162, P799; Lingam RK, 2002, BRIT J RADIOL, V75, P74; Madhusudhan KS, 2012, INT UROL NEPHROL, V44, P1285, DOI 10.1007/s11255-011-0035-6; National Kidney Foundation, 2003, AM J KIDNEY DIS S, V42, pS1, DOI DOI 10.1016/S0272-6386(03)00905-3; RICCI J, 1984, CAN MED ASSOC J, V131, P459; Ullmer E, 2001, CHEST, V120, P1394, DOI 10.1378/chest.120.4.1394	15	0	0	JAPAN SOC INTERNAL MEDICINE	TOKYO	34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN	0918-2918	1349-7235		INTERNAL MED	Intern. Med.		2015	54	1					63	67		10.2169/internalmedicine.54.2840		5	Medicine, General & Internal	General & Internal Medicine	AY2YI	WOS:000347451600012		
J	Hattori, T; Arai, A; Yokota, T; Imadome, KI; Tomimitsu, H; Miura, O; Mizusawa, H				Hattori, Takaaki; Arai, Ayako; Yokota, Takanori; Imadome, Ken-Ichi; Tomimitsu, Hiroyuki; Miura, Osamu; Mizusawa, Hidehiro			Immune-mediated Neuropathy with Epstein-Barr virus-positive T-cell Lymphoproliferative Disease	INTERNAL MEDICINE			English	Article						neuropathy; EBV-T/NK-LPD; CAEBV; immune-mediated; Guillain-Barre syndrome	INFECTION; TRANSPLANTATION; GUIDELINES	A 47-year-old man with Epstein-Barr virus (EBV)-positive T/NK-cell lymphoproliferative disease (EBVT/NK-LPD) developed acute-onset weakness. A nerve conduction study showed a conduction block in both the proximal and most distal segments. Although the patient's neuropathy transiently responded to intravenous immunoglobulin, it was progressive for at least 25 days until the start of prednisolone (PSL) administration, after which it remarkably improved. The neuropathy further improved after allogeneic bone marrow transplantation (BMT). The present patient's clinical course is not consistent with that of typical Guillain-Barre syndrome. This case suggests that EBV-T/NK-LPD can cause progressive immune-mediated neuropathy as a result of chronic EBV antigen presentation and can be treated with PSL and BMT.	[Hattori, Takaaki; Yokota, Takanori; Tomimitsu, Hiroyuki; Mizusawa, Hidehiro] Tokyo Med & Dent Univ, Grad Sch, Dept Neurol & Neurol Sci, Tokyo, Japan; [Arai, Ayako; Miura, Osamu] Tokyo Med & Dent Univ, Dept Hematol, Tokyo, Japan; [Imadome, Ken-Ichi] Natl Res Inst Child Hlth & Dev, Dept Infect Dis, Tokyo, Japan	Hattori, T (reprint author), Tokyo Med & Dent Univ, Grad Sch, Dept Neurol & Neurol Sci, Tokyo, Japan.	takaaki-hattori@umin.ac.jp					Sato E, 2008, AM J HEMATOL, V83, P721, DOI 10.1002/ajh.21247; Okano M, 2005, AM J HEMATOL, V80, P64, DOI 10.1002/ajh.20398; Kimura H, 2001, BLOOD, V98, P280, DOI 10.1182/blood.V98.2.280; Arai A, 2011, INT J HEMATOL, V93, P602, DOI 10.1007/s12185-011-0831-x; Uncini A, 2012, CLIN NEUROPHYSIOL, V123, P1487, DOI 10.1016/j.clinph.2012.01.025; Takahashi K, 2005, CLIN NEUROL NEUROSUR, V108, P80, DOI 10.1016/j.clineuro.2004.11.009; Kimura H, 2012, BLOOD, V119, P673, DOI 10.1182/blood-2011-10-381921; Kimura H, 1999, J CLIN MICROBIOL, V37, P132; Jacobs BC, 1998, NEUROLOGY, V51, P1110; Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003; Fujii N, 2000, BONE MARROW TRANSPL, V26, P805, DOI 10.1038/sj.bmt.1702600; Hadden RDM, 2001, NEUROLOGY, V56, P758; Hughes RAC, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001446.pub2; Kanai K, 2003, MUSCLE NERVE, V27, P113, DOI 10.1002/mus.10287; KIMURA J, 1978, ANN NEUROL, V3, P344, DOI 10.1002/ana.410030412; Kobayashi Z, 2008, J NEUROL SCI, V275, P170, DOI 10.1016/j.jns.2008.07.035	16	0	0	JAPAN SOC INTERNAL MEDICINE	TOKYO	34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN	0918-2918	1349-7235		INTERNAL MED	Intern. Med.		2015	54	1					69	73				5	Medicine, General & Internal	General & Internal Medicine	AY2YI	WOS:000347451600013		
J	Nagamine, Y; Hayashi, T; Kato, Y; Horiuchi, Y; Tanahashi, N				Nagamine, Yuito; Hayashi, Takeshi; Kato, Yuji; Horiuchi, Yohsuke; Tanahashi, Norio			Human T Lymphotropic Virus Type-1-associated Myelopathy Manifesting Shortly after Living-donor Renal Transplantation	INTERNAL MEDICINE			English	Article						HAM; renal transplantation	I-ASSOCIATED MYELOPATHY; HTLV-I; SPASTIC PARAPARESIS; PROVIRAL LOAD; INFECTION; TRANSFUSION; LYMPHOCYTES; THERAPY; PATIENT; TYPE-1	A 38-year-old woman experienced numbness in both lower extremities and spastic paralysis a few months after undergoing living-donor renal transplantation. The patient was negative for human T lymphotropic virus type-1 (HTLV-1) antibodies prior to the procedure; however, she was diagnosed with HTLV-1-associated myelopathy (HAM) based on positive serum and cerebrospinal fluid antibody titers after the surgery. Because the donor was also positive for HTLV-1 antibodies, the infection likely originated from the transplanted kidney. Clinical and imaging improvements were noted following the administration of interferon-a. HAM has been reported to occur after living-donor renal transplantation; however, there are no previous reports of onset within such a short period.	[Nagamine, Yuito; Hayashi, Takeshi; Kato, Yuji; Horiuchi, Yohsuke; Tanahashi, Norio] Saitama Med Univ, Int Med Ctr, Dept Neurol, Moroyama, Saitama, Japan	Nagamine, Y (reprint author), Saitama Med Univ, Int Med Ctr, Dept Neurol, Moroyama, Saitama, Japan.	yuiton@saitama-med.ac.jp					Verdonck K, 2007, LANCET INFECT DIS, V7, P266, DOI 10.1016/S1473-3099(07)70081-6; Kawano N, 2006, TRANSPLANTATION, V82, P840, DOI 10.1097/01.tp.0000235186.30113.c7; Nakatsuji Y, 2000, J NEUROL SCI, V177, P154, DOI 10.1016/S0022-510X(00)00332-4; Matsuzaki T, 2001, J NEUROVIROL, V7, P228; Igakura T, 2003, SCIENCE, V299, P1713, DOI 10.1126/science.1080115; Hlela C, 2009, AIDS REV, V11, P205; Watanabe T, 2011, INT J HEMATOL, V94, P430, DOI 10.1007/s12185-011-0934-4; Bangham CRM, 2003, J GEN VIROL, V84, P3177, DOI 10.1099/vir.0.19334-0; Manns A, 1999, LANCET, V353, P1951, DOI 10.1016/S0140-6736(98)09460-4; OSAME M, 1986, LANCET, V1, P1031; Jeffery KJM, 1999, P NATL ACAD SCI USA, V96, P3848, DOI 10.1073/pnas.96.7.3848; Caillard S, 2005, TRANSPLANTATION, V80, P1233, DOI 10.1097/01.tp.0000179639.98338.39; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Nakamura N, 2005, TRANSPLANT P, V37, P1779, DOI 10.1016/j.transproceed.2005.03.132; Casseb J, 2008, CLIN INFECT DIS, V47, P728, DOI 10.1086/590969; Croda MG, 2008, J NEUROL SCI, V269, P133, DOI 10.1016/j.jns.2008.01.004; DUNCAN J, 1990, J NEUROL NEUROSUR PS, V53, P173, DOI 10.1136/jnnp.53.2.173-a; GOUT O, 1990, NEW ENGL J MED, V322, P383, DOI 10.1056/NEJM199002083220607; Inose Y, 2010, CLIN NEUROL, V50, P241; KURODA Y, 1992, J NEUROL SCI, V109, P196, DOI 10.1016/0022-510X(92)90168-K; Naghibi Orode, 2011, Saudi J Kidney Dis Transpl, V22, P670; Nakagawa M, 1996, J NEUROVIROL, V2, P345, DOI 10.3109/13550289609146899; Shinntani Y, 2002, ISHOKU JAPANESE J TR, V37, P85; Taylor G, 1999, AIDS REV, V1, P195; Zarranz Imirizaldu J. J., 2003, Journal of Neurology Neurosurgery & Psychiatry, V74, P1080	25	1	1	JAPAN SOC INTERNAL MEDICINE	TOKYO	34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN	0918-2918	1349-7235		INTERNAL MED	Intern. Med.		2015	54	1					75	78		10.2169/internalmedicine.54.2950		4	Medicine, General & Internal	General & Internal Medicine	AY2YI	WOS:000347451600014		
J	Matsuzono, K; Morihara, R; Sato, K; Hishikawa, N; Yamashita, T; Deguchi, K; Abe, K				Matsuzono, Kosuke; Morihara, Ryuta; Sato, Kota; Hishikawa, Nozomi; Yamashita, Toru; Deguchi, Kentaro; Abe, Koji			Single Photon Emission Computed Tomography (SPECT) Findings of a Patient with a Novel Prion Mutation	INTERNAL MEDICINE			English	Article						prion disease; SPECT; MRI; sensory neuropathy; autonomic disease	CREUTZFELDT-JAKOB-DISEASE; DIFFUSION-WEIGHTED MRI; DIAGNOSIS; ABNORMALITIES	We experienced a unique case of familial prion disease with a prion gene mutation that caused panautonomic failure, sensory neuropathy and mild cognitive impairment. No abnormal sites of intensity were observed on diffusion-weighted magnetic resonance image (MRI) over six to 11 years or fluid attenuated inversion recovery MRI at six or nine years. However, (99)mTc-ethylcysteinate dimer single photon emission computed tomography (SPECT) showed a decreased cerebral blood flow in the bilateral parietal and occipital lobes at nine years, which then expanded at 11 years, corresponding to mild atrophy in these areas on MRI. In some cases of prion mutations, particularly the slowly progressive type, SPECT may show abnormalities, while MRI does not.	[Matsuzono, Kosuke; Morihara, Ryuta; Sato, Kota; Hishikawa, Nozomi; Yamashita, Toru; Deguchi, Kentaro; Abe, Koji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurol, Okayama 7008530, Japan	Abe, K (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurol, Okayama 7008530, Japan.	kmatsuzono51@gmail.com			Ministry of Education, Science, Culture and Sports of Japan [21390267]; Research Committee on CNS Degenerative Diseases; Ministry of Health, Labour and Welfare of Japan	We appreciate the cooperation of the patient. This work was partly supported by a Grant-in-Aid for Scientific Research (B) 21390267 from the Ministry of Education, Science, Culture and Sports of Japan, Grants-in-Aid from the Research Committee on CNS Degenerative Diseases (Nakano I.) and grants (Mizusawa H., Nishizawa M., Sasaki H., Sobue G.) from the Ministry of Health, Labour and Welfare of Japan.	Shiga Y, 2004, NEUROLOGY, V63, P443; Collins S, 2000, J CLIN NEUROSCI, V7, P195, DOI 10.1054/jocn.1999.0191; Demaerel P, 2003, J NEUROL, V250, P222, DOI 10.1007/s00415-003-0983-6; Haik S, 2002, ANN NEUROL, V51, P797, DOI 10.1002/ana.10195; Knight R, 2001, CONTRIB MICROBIOL, V7, P68; Kono S, 2011, J NEUROL SCI, V301, P100, DOI 10.1016/j.jns.2010.10.032; Mathews D, 2001, CLIN NUCL MED, V26, P770, DOI 10.1097/00003072-200109000-00006; Matsuda M, 2001, J NEUROL SCI, V183, P5, DOI 10.1016/S0022-510X(00)00468-8; Matsuzono K, 2013, EUR J NEUROL, V20, pe67, DOI 10.1111/ene.12089	9	0	0	JAPAN SOC INTERNAL MEDICINE	TOKYO	34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN	0918-2918	1349-7235		INTERNAL MED	Intern. Med.		2015	54	1					79	82		10.2169/internalmedicine.54.3378		4	Medicine, General & Internal	General & Internal Medicine	AY2YI	WOS:000347451600015		
J	Kinjo, T; Nabeya, D; Nakamura, H; Haranaga, S; Hirata, T; Nakamoto, T; Atsumi, E; Fuchigami, T; Aoki, Y; Fujita, J				Kinjo, Takeshi; Nabeya, Daijiro; Nakamura, Hideta; Haranaga, Shusaku; Hirata, Tetsuo; Nakamoto, Tomoko; Atsumi, Eriko; Fuchigami, Tatsuya; Aoki, Yoichi; Fujita, Jiro			Acute Respiratory Distress Syndrome due to Strongyloides stercoralis Infection in a Patient with Cervical Cancer	INTERNAL MEDICINE			English	Article						Strongyloides stercoralis; strongyloides hyperinfection syndrome; acute respiratory distress syndrome; human T-cell lymphotropic virus-1; corticosteroid; ivermectin	HYPERINFECTION SYNDROME	A 62-year-old woman complained of diarrhea and vomiting after receiving chemotherapy for cervical cancer in association with high doses of corticosteroids. Two months later, the patient developed acute respiratory distress syndrome, and numerous Strongyloides stercoralis parasites were found in the intrabronchial discharge. Ivermectin was administered daily until nematodes were no longer detected in the sputum, and the patient's condition was successfully rescued. Antibodies for human T-cell lymphotropic virus-1 (HTLV-1) were positive. HTLV-1 infection and the administration of corticosteroids are known risk factors for strongyloides hyperinfection syndrome. Therefore, physicians should consider this disease in the differential diagnosis of patients from endemic areas who present with gastrointestinal symptoms under these risk factors.	[Kinjo, Takeshi; Nabeya, Daijiro; Nakamura, Hideta; Haranaga, Shusaku; Hirata, Tetsuo; Atsumi, Eriko; Fujita, Jiro] Univ Ryukyus, Fac Med, Dept Infect Dis Resp & Digest Med, Nishihara, Okinawa 90301, Japan; [Nakamoto, Tomoko; Aoki, Yoichi] Univ Ryukyus, Fac Med, Dept Obstet & Gynecol, Nishihara, Okinawa 90301, Japan; [Atsumi, Eriko] Univ Ryukyus, Fac Med, Dept Pathol & Oncol, Nishihara, Okinawa 90301, Japan; [Fuchigami, Tatsuya] Univ Ryukyus, Fac Med, Dept Anesthesiol, Nishihara, Okinawa 90301, Japan	Kinjo, T (reprint author), Univ Ryukyus, Fac Med, Dept Infect Dis Resp & Digest Med, Nishihara, Okinawa 90301, Japan.	kumanomis6@yahoo.co.jp					Verdonck K, 2007, LANCET INFECT DIS, V7, P266, DOI 10.1016/S1473-3099(07)70081-6; Mejia R, 2012, CURR OPIN INFECT DIS, V25, P458, DOI 10.1097/QCO.0b013e3283551dbd; Aoyama H, 2007, AM J TROP MED HYG, V76, P972; COOK GA, 1987, CHEST, V92, P1115, DOI 10.1378/chest.92.6.1115; Greaves D, 2012, BRIT J HAEMATOL, V158, P2, DOI 10.1111/j.1365-2141.2012.09183.x; Greaves D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4610; Haubner HP, 2005, INFECTION, V33, P383, DOI 10.1007/s15010-005-5060-x; Hirata T, 2006, AM J TROP MED HYG, V74, P246; LIVNEH A, 1988, ARTHRITIS RHEUM, V31, P930, DOI 10.1002/art.1780310719; Montes M, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000456; Setoyama M, 1997, SCAN J RHEUMATOL, V26, P635; THOMPSON JR, 1991, CHEST, V99, P772, DOI 10.1378/chest.99.3.772; Valerio L, 2013, T ROY SOC TROP MED H, V107, P465, DOI 10.1093/trstmh/trt053; Zaha O, 2000, INTERNAL MED, V39, P695, DOI 10.2169/internalmedicine.39.695	14	0	0	JAPAN SOC INTERNAL MEDICINE	TOKYO	34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN	0918-2918	1349-7235		INTERNAL MED	Intern. Med.		2015	54	1					83	87		10.2169/internalmedicine.54.3284		5	Medicine, General & Internal	General & Internal Medicine	AY2YI	WOS:000347451600016		
J	Kimura, M; Kato, T; Miyamoto, S; Inoko, M				Kimura, Masahiro; Kato, Takao; Miyamoto, Shoichi; Inoko, Moriaki			Remission and Worsening of Claudication on MRI	INTERNAL MEDICINE			English	Editorial Material						cystic adventitial disease; peripheral artery disease; MRI			[Kimura, Masahiro; Kato, Takao; Miyamoto, Shoichi; Inoko, Moriaki] Kitano Hosp, Tazuke Kofukai Med Res Inst, Ctr Cardiovasc, Osaka, Japan	Kato, T (reprint author), Kitano Hosp, Tazuke Kofukai Med Res Inst, Ctr Cardiovasc, Osaka, Japan.	takao-kato@kitano-hp.or.jp					Pursell R, 2004, J ROY SOC MED, V97, P77, DOI 10.1258/jrsm.97.2.77; Shimizu T, 1997, INTERNAL MED, V36, P524, DOI 10.2169/internalmedicine.36.524	2	0	0	JAPAN SOC INTERNAL MEDICINE	TOKYO	34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN	0918-2918	1349-7235		INTERNAL MED	Intern. Med.		2015	54	1					89	90		10.2169/internalmedicine.54.3105		2	Medicine, General & Internal	General & Internal Medicine	AY2YI	WOS:000347451600017		
J	Hanada, S; Wada, S; Ohno, T; Sawaguchi, H; Muraki, M; Tohda, Y				Hanada, Soichiro; Wada, Shota; Ohno, Takeshi; Sawaguchi, Hirochiyo; Muraki, Masato; Tohda, Yuji			Questionnaire on switching from the tiotropium HandiHaler to the Respimat inhaler in patients with chronic obstructive pulmonary disease: changes in handling and preferences immediately and several years after the switch	INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE			English	Article						chronic obstructive pulmonary disease; tiotropium; HandiHaler; Respimat; questionnaire; pulmonary function	SOFT MIST(TM) INHALER; METERED-DOSE INHALER; COPD PATIENTS; UPLIFT(R) TRIAL; HEALTH OUTCOMES; PERFORMANCE; EFFICACY; POWDER; DEVICES; ASTHMA	Background: Tiotropium (Spiriva) is an inhaled muscarinic antagonist for patients with chronic obstructive pulmonary disease (COPD), and is available in two forms: the HandiHaler and the Respimat inhaler. The aim of this study was to investigate the handling of and preference for each device immediately after switching from the HandiHaler to the Respimat and 2-3 years after the switch. Materials and methods: The study comprised two surveys. A questionnaire was first administered to 57 patients with COPD (male: female 52: 5, mean age 73.6 +/- 7.1 years) 8 weeks after switching from the HandiHaler (18 mu g) to the Respimat (5 mu g). A second similar but simplified questionnaire was administered to 39 of these patients who continued to use the Respimat and were available for follow-up after more than 2 years. Pulmonary function was also measured during each period. Results: In the first survey, 17.5% of patients preferred the HandiHaler, and 45.6% preferred the Respimat. There were no significant changes in pulmonary function or in the incidence of adverse events after the switch. In the second survey, performed 2-3 years later, the self-assessed handling of the Respimat had significantly improved, and the number of patients who preferred the Respimat had increased to 79.5%. Conclusion: The efficacy of the Respimat was similar to that of the HandiHaler. This was clear immediately after the switch, even in elderly patients with COPD who were long-term users of the HandiHaler. The preference for the Respimat increased with continued use.	[Hanada, Soichiro; Wada, Shota; Ohno, Takeshi; Sawaguchi, Hirochiyo; Muraki, Masato] Kinki Univ, Fac Med, Nara Hosp, Dept Resp Med & Allergol, Ikoma, Nara 6300298, Japan; [Tohda, Yuji] Kinki Univ, Fac Med, Dept Resp Med & Allergol, Osakasayama, Japan	Muraki, M (reprint author), Kinki Univ, Fac Med, Nara Hosp, Dept Resp Med & Allergol, 1248-1 Otoda Cho, Ikoma, Nara 6300298, Japan.	muraki@nara.med.kindai.ac.jp			Department of Respiratory Medicine and Allergology, Nara Hospital, Kinki University Faculty of Medicine	This study was funded by the Department of Respiratory Medicine and Allergology, Nara Hospital, Kinki University Faculty of Medicine.	Ambrosino Nicolino, 2008, Int J Chron Obstruct Pulmon Dis, V3, P771; Chorao P, 2014, RESP MED, V108, P968, DOI 10.1016/j.rmed.2014.04.019; Vincken W, 2002, EUR RESPIR J, V19, P209, DOI 10.1183/09031936.02.00238702; Fukuchi Y, 2004, RESPIROLOGY, V9, P458, DOI 10.1111/j.1440-1843.2004.00637.x; van Noord JA, 2009, RESP MED, V103, P22, DOI 10.1016/j.rmed.2008.10.002; Wise RA, 2013, NEW ENGL J MED, V369, P1491, DOI 10.1056/NEJMoa1303342; Vogelmeier C, 2011, NEW ENGL J MED, V364, P1093, DOI 10.1056/NEJMoa1008378; van Noord JA, 2000, THORAX, V55, P289, DOI 10.1136/thorax.55.4.289; Makela MJ, 2013, RESP MED, V107, P1481, DOI 10.1016/j.rmed.2013.04.005; Casaburi R, 2002, EUR RESPIR J, V19, P217, DOI 10.1183/09031936.02.00269802; Troosters T, 2010, EUR RESPIR J, V36, P65, DOI 10.1183/09031936.00127809; Hohlfeld JM, 2014, J CLIN PHARMACOL, V54, P405, DOI 10.1002/jcph.215; Pitcairn G, 2005, J AEROSOL MED, V18, P264, DOI 10.1089/jam.2005.18.264; Taffet GE, 2014, CLIN INTERV AGING, V9, P23, DOI 10.2147/CIA.S52999; Disse B, 1999, LIFE SCI, V64, P457, DOI 10.1016/S0024-3205(98)00588-8; Ichinose M, 2010, RESP MED, V104, P228, DOI 10.1016/j.rmed.2009.11.011; Tashkin DP, 2012, COPD, V9, P289, DOI 10.3109/15412555.2012.656211; Chodosh S, 2001, J AEROSOL MED, V14, P309, DOI 10.1089/089426801316970268; Morice AH, 2010, RESP MED, V104, P1659, DOI 10.1016/j.rmed.2010.07.016; Maltais F, 2005, CHEST, V128, P1168, DOI 10.1378/chest.128.3.1168; Loke Yoon K, 2012, Ther Adv Drug Saf, V3, P123, DOI 10.1177/2042098612438388; Celli B, 2009, AM J RESP CRIT CARE, V180, P948, DOI 10.1164/rccm.200906-0876OC; Bateman ED, 2010, RESP MED, V104, P1460, DOI 10.1016/j.rmed.2010.06.004; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Decramer M, 2009, LANCET, V374, P1171, DOI 10.1016/S0140-6736(09)61298-8; Asakura Y, 2013, J AEROSOL MED PULM D, V26, P41, DOI 10.1089/jamp.2011.0941; Barrons R, 2011, AM J HEALTH-SYST PH, V68, P1221, DOI 10.2146/ajhp100452; Caillaud Denis, 2007, Int J Chron Obstruct Pulmon Dis, V2, P559; Dahl R, 2003, RESP MED, V97, P1126, DOI 10.1016/S0954-6111(03)00162-8; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2014, GLOB STRAT DIAGN MAN; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2006, GLOB STRAT DIAGN MAN; Hodder Richard, 2009, Int J Chron Obstruct Pulmon Dis, V4, P381; Karner C, 2012, COCHRANE DB SYST REV, V7, DOI DOI 10.1002/14651858.CD009285.PUB2; Newman SP, 2005, EUR RESPIR REV, V14, P102, DOI 10.1183/09059180.05.00009605; Rau-Berger Heike, 2010, Int J Chron Obstruct Pulmon Dis, V5, P367; Singh S, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3215; Zierenberg B, 1999, J AEROSOL MED, V12, pS19	37	1	1	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-2005			INT J CHRONIC OBSTR	Int. J. Chronic Obstr. Pulm. Dis.		2015	10						69	77		10.2147/COPD.S73521		9	Respiratory System	Respiratory System	AY2CL	WOS:000347396000002		
J	Enchi, Y; Imai, K; Ikeda, M; Takase, I; Yamauchi-Kawaura, C; Mori, M				Enchi, Yukihiro; Imai, Kuniharu; Ikeda, Mitsuru; Takase, Ikuko; Yamauchi-Kawaura, Chiyo; Mori, Masaki			Arterial contour detectability in head CT angiography	INTERNATIONAL JOURNAL OF COMPUTER ASSISTED RADIOLOGY AND SURGERY			English	Article						CT angiography; Arterial contour detectability; Phase information; Fourier transform	STATISTICAL ITERATIVE RECONSTRUCTION; RADIATION-DOSE REDUCTION; PHASE-ONLY CORRELATION; IMAGE QUALITY; SUBARACHNOID HEMORRHAGE; CEREBRAL ANEURYSM; STREAK ARTIFACTS; CURRENT SETTINGS	Arterial contour extraction is essential for visualization and analysis of vasculature in CT angiography (CTA). A means for evaluating the detectability of artery contours CTA images is required. We developed and tested a new method for this purpose based on phase information from two-dimensional Fourier transforms of CTA images. The relationship between arterial contour detectability and a patient's ocular lens dose was evaluated in CTA images obtained with various tube voltages and currents. A head phantom was designed for use as a target object containing a simulated vascular tree, filled with dilute contrast medium (10 mg iodine/ml). The head phantom was scanned using a 64-multidetector CT scanner with tube voltages of 80-140 kV and tube currents corresponding to volume CT dose index ranging from 24.4 to 72.8 mGy. Lens doses were measured using the planar silicon PIN-photodiode system. The quality of artery contours in the CTA source images was assessed using a computed detectability index. Lens dose increased proportionally with tube voltage and current. The use of 80 kV provided the highest contour detectability. However, for each tube voltage, the detectability of artery contours was almost constant across the values. These results were mostly consistent with the subjective recognition of artery contours on CTA images. A CTA protocol using 80 kV and 420 mA can reduce the radiation exposure to ocular lens by approximately 40 %, and improve the artery contour detectability compared with a routine protocol.	[Enchi, Yukihiro] Osaka Univ Hosp, Dept Med Technol, Div Radiol, Suita, Osaka 5650871, Japan; [Enchi, Yukihiro; Imai, Kuniharu; Ikeda, Mitsuru; Takase, Ikuko; Yamauchi-Kawaura, Chiyo] Nagoya Univ, Dept Radiol Technol, Sch Hlth Sci, Higashi Ku, Nagoya, Aichi 4618673, Japan; [Mori, Masaki] Nagoya Univ Hosp, Showa Ku, Nagoya, Aichi 4668560, Japan	Enchi, Y (reprint author), Osaka Univ Hosp, Dept Med Technol, Div Radiol, 2-15 Yamadaoka, Suita, Osaka 5650871, Japan.	yenchi@hp-rad.med.osaka-u.ac.jp; imai@met.nagoya-u.ac.jp; mikeda@nagoya-u.jp; takase.ikuko@h.mbox.nagoya-u.ac.jp; kawaura@met.nagoya-u.ac.jp; mmori-ngy@umin.ac.jp	Ikeda, Mitsuru/B-5163-2010	Ikeda, Mitsuru/0000-0002-5695-3527	Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [23591814]	This work was supported in part by a Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT Grant), Grant number: 23591814.	Takita K, 2003, IEICE T FUND ELECTR, VE86A, P1925; Imai K, 2012, BRIT J RADIOL, V85, pE673, DOI 10.1259/bjr/63268088; Waaijer A, 2007, RADIOLOGY, V242, P832, DOI 10.1148/radiol.2423051191; Cloft HJ, 1999, STROKE, V30, P317; Agid R, 2006, NEURORADIOLOGY, V48, P787, DOI 10.1007/s00234-006-0129-5; McKinney AM, 2008, AM J NEURORADIOL, V29, P594, DOI 10.3174/ajnr.A0848; Sagara Y, 2010, AM J ROENTGENOL, V195, P713, DOI 10.2214/AJR.09.2989; Karamessini MT, 2004, EUR J RADIOL, V49, P212, DOI 10.1016/S0720-048X(03)00173-6; Prakash P, 2010, J COMPUT ASSIST TOMO, V34, P40, DOI 10.1097/RCT.0b013e3181b26c67; RINKEL GJE, 1993, STROKE, V24, P1403; Rapalino O, 2012, AM J NEURORADIOL, V33, P609, DOI 10.3174/ajnr.A2826; Bahner ML, 2005, INVEST RADIOL, V40, P229, DOI 10.1097/01.rli.0000155281.32319.52; Aoyama T, 2002, MED PHYS, V29, P1504, DOI 10.1118/1.1489042; Ert-Wagner BB, 2004, RADIOLOGY, V231, P528; Gumbel E. J, 1958, STAT EXTREMES; Hagiwara M, 2004, TECH REP IEICE; Huda W, 2004, MED PHYS, V31, P595, DOI 10.1118/1.1646233; Imai K, 2007, BRIT J RADIOL, V80, P911, DOI 10.1259/bjr/93741044; Imai K, 2009, MED PHYS, V36, P492, DOI 10.1118/1.3056554; Ito K, 2004, IEICE T FUND ELECTR, VE87A, P682; Suzuki S, 2010, AM J NEURORADIOL, V31, P822, DOI 10.3174/ajnr.A1946	21	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1861-6410	1861-6429		INT J COMPUT ASS RAD	Int. J. Comput. Assist. Radiol. Surg.	JAN	2015	10	1					1	10		10.1007/s11548-014-0999-7		10	Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging; Surgery	Engineering; Radiology, Nuclear Medicine & Medical Imaging; Surgery	AY2IU	WOS:000347413500001		
J	Gomi, T; Nakajima, M; Umeda, T				Gomi, Tsutomu; Nakajima, Masahiro; Umeda, Tokuo			Wavelet denoising for quantum noise removal in chest digital tomosynthesis	INTERNATIONAL JOURNAL OF COMPUTER ASSISTED RADIOLOGY AND SURGERY			English	Article						Digital tomosynthesis; Wavelet; Denoising; Quantum noise; Chest imaging	RADIOGRAPHIC RECONSTRUCTION METHOD; BASIC IMAGING PROPERTIES; OF-PLANE STRUCTURES; DOSE REDUCTION; SYSTEMS; ECTOMOGRAPHY; PERFORMANCE; SIMULATION; SHRINKAGE; DENSITY	Quantum noise impairs image quality in chest digital tomosynthesis (DT). A wavelet denoising processing algorithm for selectively removing quantum noise was developed and tested. A wavelet denoising technique was implemented on a DT system and experimentally evaluated using chest phantom measurements including spatial resolution. Comparison was made with an existing post-reconstruction wavelet denoising processing algorithm reported by Badea et al. (Comput Med Imaging Graph 22:309-315, 1998). The potential DT quantum noise decrease was evaluated using different exposures with our technique (pre-reconstruction and post-reconstruction wavelet denoising processing via the balance sparsity-norm method) and the existing wavelet denoising processing algorithm. Wavelet denoising processing algorithms such as the contrast-to-noise ratio (CNR), root mean square error (RMSE) were compared with and without wavelet denoising processing. Modulation transfer functions (MTF) were evaluated for the in-focus plane. We performed a statistical analysis (multi-way analysis of variance) using the CNR and RMSE values. Our wavelet denoising processing algorithm significantly decreased the quantum noise and improved the contrast resolution in the reconstructed images (CNR and RMSE: pre-balance sparsity-norm wavelet denoising processing versus existing wavelet denoising processing, ; post-balance sparsity-norm wavelet denoising processing versus existing wavelet denoising processing, ; CNR: with versus without wavelet denoising processing, ). The results showed that although MTF did not vary (thus preserving spatial resolution), the existing wavelet denoising processing algorithm caused MTF deterioration. A balance sparsity-norm wavelet denoising processing algorithm for removing quantum noise in DT was demonstrated to be effective for certain classes of structures with high-frequency component features. This denoising approach may be useful for a variety of clinical applications for chest digital tomosynthesis when quantum noise is present.	[Gomi, Tsutomu; Umeda, Tokuo] Kitasato Univ, Sch Allied Hlth Sci, Sagamihara, Kanagawa 2520373, Japan; [Nakajima, Masahiro] Hosoda Clin, Tokyo, Japan	Gomi, T (reprint author), Kitasato Univ, Sch Allied Hlth Sci, 1-15-1 Minami Ku, Sagamihara, Kanagawa 2520373, Japan.	gomi@kitasato-u.ac.jp					Hall P, 1997, STAT COMPUT, V7, P115, DOI 10.1023/A:1018569615247; Lee G, 2013, CLIN RADIOL, V68, P376, DOI 10.1016/j.crad.2012.05.022; Yamada Y, 2011, INVEST RADIOL, V46, P471, DOI 10.1097/RLI.0b013e318217b838; Kasap S, 2011, SENSORS-BASEL, V11, P5112, DOI 10.3390/s110505112; Bath M, 2005, RADIAT PROT DOSIM, V114, P253, DOI 10.1093/rpd/nch540; Sabol JM, 2009, MED PHYS, V36, P5480, DOI 10.1118/1.3250907; Vikgren J, 2008, RADIOLOGY, V249, P1034, DOI 10.1148/radiol.2492080304; Antoniadis A, 1999, J ROY STAT SOC B, V61, P63, DOI 10.1111/1467-9868.00163; Donoho DL, 1996, ANN STAT, V24, P508; Svalkvist A, 2010, MED PHYS, V37, P258, DOI 10.1118/1.3273064; MALLAT S, 1992, IEEE T PATTERN ANAL, V14, P710, DOI 10.1109/34.142909; DONOHO DL, 1994, BIOMETRIKA, V81, P425, DOI 10.1093/biomet/81.3.425; Badea C, 1998, COMPUT MED IMAG GRAP, V22, P309, DOI 10.1016/S0895-6111(98)00037-8; CHAKRABORTY DP, 1984, RADIOLOGY, V150, P225; DAUBECHIES I, 1988, COMMUN PUR APPL MATH, V41, P909, DOI 10.1002/cpa.3160410705; Dobbins JT, 2008, MED PHYS, V35, P2554, DOI 10.1118/1.2937277; GIGER ML, 1986, MED PHYS, V13, P312, DOI 10.1118/1.595919; Kak AC, 2001, CLASSICS APPL MATH, V33; KNUTSSON HE, 1980, IEEE T BIO-MED ENG, V27, P640, DOI 10.1109/TBME.1980.326704; Kolaczyk ED, 1996, J AM STAT ASSOC, V91, P1079, DOI 10.2307/2291727; KOLITSI Z, 1993, MED PHYS, V20, P47, DOI 10.1118/1.597060; KUME Y, 1986, MED PHYS, V13, P843, DOI 10.1118/1.595808; Mathworks Inc, 2011, WAV TOOLB; MATSUO H, 1993, IEEE T MED IMAGING, V12, P307, DOI 10.1109/42.232260; Michael U, 1996, P IEEE, V84, P626; Nitkzen M, 2012, P IEEE INT S BIOM IM, P462; NITZKEN M, 2013, J BIOMED SCI ENG, V6, P1; PETERSSON CU, 1980, IEEE T BIO-MED ENG, V27, P649, DOI 10.1109/TBME.1980.326705; Quaia E, 2010, ACAD RADIOL, V17, P1267, DOI 10.1016/j.acra.2010.05.009; ROSSMANN K, 1969, RADIOLOGY, V93, P257; ROY DNG, 1985, MED PHYS, V12, P65; Ruttimann U E, 1984, IEEE Trans Med Imaging, V3, P141, DOI 10.1109/TMI.1984.4307670; Siiskonen T., 2008, STUKA231; SONE S, 1995, EUR RADIOL, V5, P96; SONE S, 1991, RADIOGRAPHICS, V11, P807; SONE S, 1993, ACTA RADIOL, V34, P346; Ullman G, 2010, RADIAT PROT DOSIM, V139, P159, DOI 10.1093/rpd/ncq079	37	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1861-6410	1861-6429		INT J COMPUT ASS RAD	Int. J. Comput. Assist. Radiol. Surg.	JAN	2015	10	1					75	86		10.1007/s11548-014-1003-2		12	Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging; Surgery	Engineering; Radiology, Nuclear Medicine & Medical Imaging; Surgery	AY2IU	WOS:000347413500008		
J	Crisan, D; Otobe, Y; Peszat, S				Crisan, Dan; Otobe, Yoshiki; Peszat, Szymon			Inverse problems for stochastic transport equations	INVERSE PROBLEMS			English	Article						stochastic transport equations; partial observations; inverse problem		Inverse problems for stochastic linear transport equations driven by a temporal or spatial white noise are discussed. We analyse stochastic linear transport equations which depend on an unknown potential and have either additive noise or multiplicative noise. We show that one can approximate the potential with arbitrary small error when the solution of the stochastic linear transport equation is observed over time at some fixed point in the state space.	[Crisan, Dan] Univ London Imperial Coll Sci Technol & Med, Dept Math, London SW7 2AZ, England; [Otobe, Yoshiki] Shinshu Univ, Dept Math Sci, Matsumoto, Nagano 3908621, Japan; [Peszat, Szymon] Polish Acad Sci, Inst Math, PL-31027 Krakow, Poland; [Peszat, Szymon] Jagiellonian Univ, Inst Math, PL-30348 Krakow, Poland	Crisan, D (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Math, 180 Queens Gate, London SW7 2AZ, England.	d.crisan@imperial.ac.uk			Isaac Newton Institute for Mathematical Sciences in Cambridge	The authors are grateful for the financial support from the Isaac Newton Institute for Mathematical Sciences in Cambridge. A part of the study was done during our stay there. The second author thanks Professor M Yamamoto of the University of Tokyo and J-S Choi to arise his interest in the stability of the inverse problems and lead him to this direction with many valuable discussions and comments when he was a student. He also thanks Professor J Zabczyk for the discussions during his stay at the University of Warwick.	ALBEVERIO S, 1989, J STAT PHYS, V57, P347, DOI 10.1007/BF01023648; Stuart AM, 2010, ACTA NUMER, V19, P451, DOI 10.1017/S0962492910000061; Blagovescenskii A S, 1979, ZAP NAUCH SEM LOMI, V89, P63; Chow PL, 1997, COMMUN MATH PHYS, V189, P521, DOI 10.1007/s002200050215; CHOW PL, 1978, SIAM J APPL MATH, V35, P665, DOI 10.1137/0135055; Galubev G K, 1999, PROBL INFORM TRANSM, V35, P136; Kazimierczyk P., 1988, Reports on Mathematical Physics, V26, DOI 10.1016/0034-4877(88)90027-4; PESZAT S., 2007, STOCHASTIC PARTIAL D; Ton BA, 2004, STOCH ANAL APPL, V22, P19, DOI 10.1081/SAP-120028021	9	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0266-5611	1361-6420		INVERSE PROBL	Inverse Probl.	JAN	2015	31	1							015005	10.1088/0266-5611/31/1/015005		20	Mathematics, Applied; Physics, Mathematical	Mathematics; Physics	AY2KD	WOS:000347417900006		
J	Verdonschot, RG; Tamaoka, K				Verdonschot, Rinus G.; Tamaoka, Katsuo			Editorial: The production of speech sounds across languages	JAPANESE PSYCHOLOGICAL RESEARCH			English	Editorial Material							FUNCTIONAL UNIT; TIME COURSE; WORD		[Verdonschot, Rinus G.] Nagoya Univ, Nagoya, Aichi 4648601, Japan; [Tamaoka, Katsuo] Nagoya Univ, Grad Sch Languages & Cultures, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Verdonschot, RG (reprint author), Nagoya Univ, Grad Sch Languages & Cultures, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	rinusverdonschot@gmail.com					O'Seaghdha PG, 2010, COGNITION, V115, P282, DOI 10.1016/j.cognition.2010.01.001; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; O'Seaghdha PG, 2014, J EXP PSYCHOL LEARN, V40, P797, DOI 10.1037/a0035576; Chen JY, 2002, J MEM LANG, V46, P751, DOI 10.1006/jmla.2001.2825; Verdonschot RG, 2015, JPN PSYCHOL RES, V57, P61, DOI 10.1111/jpr.12064; MEYER AS, 1990, J MEM LANG, V29, P524, DOI 10.1016/0749-596X(90)90050-A; MEYER AS, 1991, J MEM LANG, V30, P69, DOI 10.1016/0749-596X(91)90011-8; Chen TM, 2015, JPN PSYCHOL RES, V57, P81, DOI 10.1111/jpr.12059; Ida K, 2015, JPN PSYCHOL RES, V57, P38, DOI 10.1111/jpr.12066; Jacobs C. L., 2012, ANN M PSYCH SOC MINN; Kureta Y, 2015, JPN PSYCHOL RES, V57, P50, DOI 10.1111/jpr.12067; Kureta Y, 2006, J EXP PSYCHOL LEARN, V32, P1102, DOI 10.1037/0278-7393.32.5.1102; O'Seaghdha PG, 2015, JPN PSYCHOL RES, V57, P4, DOI 10.1111/jpr.12074; Roelofs A, 1998, J EXP PSYCHOL LEARN, V24, P904, DOI 10.1037/0278-7393.24.4.904; Roelofs A, 2015, JPN PSYCHOL RES, V57, P22, DOI 10.1111/jpr.12050; Tamaoka K., 2013, LEXICON FORUM, V6, P327; Verdonschot RG, 2011, J EXP PSYCHOL LEARN, V37, P1458, DOI 10.1037/a0024491; Verdonschot RG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061454, 10.1037/journal.pone.0061454]; Wong AWK, 2015, JPN PSYCHOL RES, V57, P69, DOI 10.1111/jpr.12054	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-5368	1468-5884		JPN PSYCHOL RES	Jpn. Psychol. Res.	JAN	2015	57	1			SI		1	3		10.1111/jpr.12073		3	Psychology, Multidisciplinary	Psychology	AY0XA	WOS:000347316400001		
J	Ida, K; Nakayama, M; Lupker, SJ				Ida, Keisuke; Nakayama, Mariko; Lupker, Stephen J.			The functional phonological unit of Japanese-English bilinguals is language dependent: Evidence from masked onset and mora priming effects	JAPANESE PSYCHOLOGICAL RESEARCH			English	Article						masked onset and mora priming effect; Japanese-English bilinguals; phonological unit-size; speech production; phonological encoding	READING ALOUD; ORTHOGRAPHY; ACCURACY; SPEAKERS; PROGRAM; TIME; TASK	Speech production research has shown that Japanese monolingual speakers use mora-sized phonological units, not phoneme-sized units, when phonologically encoding Japanese words. Recent bilingual research has indicated that proficient Japanese-English bilinguals nevertheless use phoneme-sized units when phonologically encoding English words, suggesting that use of a phonological unit that is smaller than that of their L1 develops with increasing proficiency in English. The purpose of the present research was to determine whether proficient Japanese-English bilinguals also begin to use the smaller, phoneme-sized units when producing Japanese words. In a masked priming naming task, proficient Japanese-English bilinguals produced a significant masked onset priming effect for English words, confirming that they do use phoneme-sized units when phonologically encoding in English (L2). These bilinguals, however, showed only mora-based facilitation for Japanese words in an experiment involving only Japanese words. These results suggest that proficient bilinguals use different unit sizes depending on the language being produced, and that for bilinguals whose L1 and L2 have different unit sizes, the phonological encoding process is at least somewhat different in their two languages.	[Ida, Keisuke; Nakayama, Mariko] Waseda Univ, Tokyo 1628644, Japan; [Lupker, Stephen J.] Univ Western Ontario, London, ON N6A 3K7, Canada	Nakayama, M (reprint author), Waseda Univ, Fac Letters Arts & Sci, Shinjuku Ku, Tokyo 1628644, Japan.	mariko_nakayama@aoni.waseda.jp					Amano N., 2003, NIHONGO NO GOI TOKUS, V7; Protopapas A, 2007, BEHAV RES METHODS, V39, P859, DOI 10.3758/BF03192979; Dimitropoulou M, 2010, Q J EXP PSYCHOL, V63, P1813, DOI 10.1080/17470210903540763; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; O'Seaghdha PG, 2010, COGNITION, V115, P282, DOI 10.1016/j.cognition.2010.01.001; Schiller NO, 2004, J MEM LANG, V50, P477, DOI 10.1016/j.jml.2004.02.004; Chen TM, 2013, PSYCHON B REV, V20, P154, DOI 10.3758/s13423-012-0326-7; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Chen JY, 2002, J MEM LANG, V46, P751, DOI 10.1006/jmla.2001.2825; MEYER AS, 1991, J MEM LANG, V30, P69, DOI 10.1016/0749-596X(91)90011-8; FORSTER KI, 1991, J MEM LANG, V30, P1, DOI 10.1016/0749-596X(91)90008-8; Kinoshita S, 2002, MEM COGNITION, V30, P237, DOI 10.3758/BF03195284; Schiller NO, 2007, PSYCHON B REV, V14, P460, DOI 10.3758/BF03194089; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Bates D., 2012, LME4 LINEAR MIXED EF; Kinoshita S, 2000, AUSTR J PSYCHOL S, V52, P37; Kinoshita S, 2000, PSYCHON B REV, V7, P133, DOI 10.3758/BF03210732; Kinoshita S, 2003, MASKED PRIMING STATE, P223; Kuera H., 1967, COMPUTATIONAL ANAL P; Kureta Y, 2006, J EXP PSYCHOL LEARN, V32, P1102, DOI 10.1037/0278-7393.32.5.1102; Malouf T., 2007, Q J EXPT PSYCHOL, V60, P1156; Nakayama M., 2014, 55 ANN M PSYCH SOC L; Roelofs A, 2003, LANG COGNITIVE PROC, V18, P175, DOI 10.1080/01690960143000515; Timmer K, 2012, BRAIN RES, V1483, P39, DOI 10.1016/j.brainres.2012.09.004; Verdonschot RG, 2011, J EXP PSYCHOL LEARN, V37, P1458, DOI 10.1037/a0024491; Verdonschot RG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061454, 10.1037/journal.pone.0061454]	26	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-5368	1468-5884		JPN PSYCHOL RES	Jpn. Psychol. Res.	JAN	2015	57	1			SI		38	49		10.1111/jpr.12066		12	Psychology, Multidisciplinary	Psychology	AY0XA	WOS:000347316400004		
J	Kureta, Y; Fushimi, T; Sakuma, N; Tatsumi, IF				Kureta, Yoichi; Fushimi, Takao; Sakuma, Naoko; Tatsumi, Itaru F.			Orthographic influences on the word-onset phoneme preparation effect in native Japanese speakers: Evidence from the word-form preparation paradigm	JAPANESE PSYCHOLOGICAL RESEARCH			English	Article						word production; preparation effects; phonemes; orthography; romanized script; Japanese	SPEECH PRODUCTION; LANGUAGE PRODUCTION; MANDARIN CHINESE; FUNCTIONAL UNIT; TIME COURSE; SYLLABLES; AWARENESS; TASK; MORA	A central issue in recent psycholinguistic research is whether phonological planning units in word production are language-specific. Evidence from some Indo-European language speakers contrasts with recent studies of native Chinese and Japanese speakers, who did not exploit word-onset phonemes in the word-form preparation paradigm. In the present study, we first replicated our earlier finding that no preparation effect for word-onset phonemes occurred when target responses were learned from commonly used Japanese orthographies, including kanji and kana. We then asked participants to learn target responses presented in romanized Japanese, known as romaji, and found a significant phoneme preparation effect. However, we failed to find a similar effect for auditory presentations of the target responses during the learning phase. These results suggest that Japanese speakers, who do not essentially base their speech planning on phonemes, can prepare phonemic segments in special circumstances in which the orthographic representation of romanized Japanese is first activated.	[Kureta, Yoichi] Showa Univ, Fujiyoshida, Yamanashi 4030005, Japan; [Fushimi, Takao] Kitasato Univ, Tokyo, Japan; [Sakuma, Naoko] Tokyo Metropolitan Inst Gerontol, Tokyo, Japan	Kureta, Y (reprint author), Showa Univ, Dept Educ, Fujiyoshida, Yamanashi 4030005, Japan.	ykureta@gmail.com					Amano N., 1999, NIHONGO NO GOI TOKUS; READ C, 1986, COGNITION, V24, P31, DOI 10.1016/0010-0277(86)90003-X; Roelofs A, 1997, COGNITION, V64, P249, DOI 10.1016/S0010-0277(97)00027-9; Wong AWK, 2008, J EXP PSYCHOL LEARN, V34, P1172, DOI 10.1037/a0013000; Forster KI, 1998, J PSYCHOLINGUIST RES, V27, P203, DOI 10.1023/A:1023202116609; O'Seaghdha PG, 2010, COGNITION, V115, P282, DOI 10.1016/j.cognition.2010.01.001; Alario FX, 2007, COGNITION, V102, P464, DOI 10.1016/j.cognition.2006.02.002; Chen TM, 2013, PSYCHON B REV, V20, P154, DOI 10.3758/s13423-012-0326-7; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; O'Seaghdha PG, 2014, J EXP PSYCHOL LEARN, V40, P797, DOI 10.1037/a0035576; Kawamoto AH, 1998, J EXP PSYCHOL LEARN, V24, P862, DOI 10.1037/0278-7393.24.4.862; CLARK HH, 1973, J VERB LEARN VERB BE, V12, P335, DOI 10.1016/S0022-5371(73)80014-3; Cholin J, 2004, J MEM LANG, V50, P47, DOI 10.1016/j.jml.2003.08.003; OTAKE T, 1993, J MEM LANG, V32, P258; Roelofs A, 1998, J EXP PSYCHOL LEARN, V24, P922, DOI 10.1037//0278-7393.24.4.922; Kello CT, 2000, J EXP PSYCHOL GEN, V129, P340, DOI 10.1037//0096-3445.129.3.340; Chen JY, 2002, J MEM LANG, V46, P751, DOI 10.1006/jmla.2001.2825; MEYER AS, 1990, J MEM LANG, V29, P524, DOI 10.1016/0749-596X(90)90050-A; MEYER AS, 1991, J MEM LANG, V30, P69, DOI 10.1016/0749-596X(91)90011-8; MORAIS J, 1979, COGNITION, V7, P323, DOI 10.1016/0010-0277(79)90020-9; Roelofs A, 1999, LANG COGNITIVE PROC, V14, P173, DOI 10.1080/016909699386338; Damian MF, 2003, J MEM LANG, V49, P119, DOI 10.1016/S0749-596X(03)00008-1; Bi YC, 2009, PSYCHON B REV, V16, P555, DOI 10.3758/PBR.16.3.555; KUBOZONO H, 1989, LANG SPEECH, V32, P249; Kureta Y, 2006, J EXP PSYCHOL LEARN, V32, P1102, DOI 10.1037/0278-7393.32.5.1102; Levelt William J. M., 1989, SPEAKING INTENTION A; MANN VA, 1986, COGNITION, V24, P65, DOI 10.1016/0010-0277(86)90005-3; Roelofs A, 1998, J EXP PSYCHOL LEARN, V24, P904, DOI 10.1037/0278-7393.24.4.904; Roelofs A, 2002, Q J EXP PSYCHOL-A, V55, P465, DOI 10.1080/02724980143000488; Roelofs A, 2006, PSYCHON B REV, V13, P33, DOI 10.3758/BF03193809; Roelofs A, 1996, J MEM LANG, V35, P854, DOI 10.1006/jmla.1996.0044; Santiago J., 2000, PSICOLOGICA, V21, P39; Verdonschot RG, 2011, J EXP PSYCHOL LEARN, V37, P1458, DOI 10.1037/a0024491; Verdonschot RG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061454, 10.1037/journal.pone.0061454]	34	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-5368	1468-5884		JPN PSYCHOL RES	Jpn. Psychol. Res.	JAN	2015	57	1			SI		50	60		10.1111/jpr.12067		11	Psychology, Multidisciplinary	Psychology	AY0XA	WOS:000347316400005		
J	Verdonschot, RG; Lai, J; Chen, F; Tamaoka, K; Schiller, NO				Verdonschot, Rinus G.; Lai, Jun; Chen, Feng; Tamaoka, Katsuo; Schiller, Niels O.			Constructing initial phonology in Mandarin Chinese: Syllabic or subsyllabic? A masked priming investigation	JAPANESE PSYCHOLOGICAL RESEARCH			English	Article						fundamental unit; proximate unit; masked priming; language production; Chinese; psycholinguistics	LANGUAGE PRODUCTION; FUNCTIONAL UNIT; TIME COURSE; WORD; SPEAKERS	Recent research has put forward the idea that Chinese speech production is governed by the syllable as the fundamental phonological unit. However, it may be that onset priming might be more difficult to obtain in Mandarin Chinese. Therefore, in this study, the degree of overlap between prime and target was increased from C to CV (i.e., extending beyond the phoneme) as well as whether primes and targets had an overlapping structure (CV vs. CVN). Subsyllabic priming effects were found (i.e., onset+vowel overlap but not purely onset overlap), contrasting with the claim that the syllable is the compulsory building block in the initial construction of Mandarin Chinese phonology.	[Verdonschot, Rinus G.; Tamaoka, Katsuo] Nagoya Univ, Nagoya, Aichi 4648601, Japan; [Lai, Jun] Tilburg Univ, NL-5000 LE Tilburg, Netherlands; [Chen, Feng] Chinese Acad Sci, Beijing 100864, Peoples R China; [Schiller, Niels O.] Leiden Univ, NL-2300 RA Leiden, Netherlands	Verdonschot, RG (reprint author), Nagoya Univ, Grad Sch Languages & Cultures, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	rinusverdonschot@gmail.com	Schiller, Niels/A-9481-2008	Schiller, Niels/0000-0002-0392-7608			O'Seaghdha PG, 2010, COGNITION, V115, P282, DOI 10.1016/j.cognition.2010.01.001; Schiller NO, 2004, J MEM LANG, V50, P477, DOI 10.1016/j.jml.2004.02.004; Chen TM, 2013, PSYCHON B REV, V20, P154, DOI 10.3758/s13423-012-0326-7; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; [Anonymous], 2003, CHINESE J PSYCHOL; Ferrand L, 1996, J MEM LANG, V35, P708, DOI 10.1006/jmla.1996.0037; Schiller NO, 1998, J MEM LANG, V39, P484, DOI 10.1006/jmla.1998.2577; Chen JY, 2002, J MEM LANG, V46, P751, DOI 10.1006/jmla.2001.2825; Qu QQ, 2012, P NATL ACAD SCI USA, V109, P14265, DOI 10.1073/pnas.1200632109; MEYER AS, 1990, J MEM LANG, V29, P524, DOI 10.1016/0749-596X(90)90050-A; MEYER AS, 1991, J MEM LANG, V30, P69, DOI 10.1016/0749-596X(91)90011-8; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Brand M, 2003, J MEM LANG, V48, P435, DOI 10.1016/S0749-596X(02)00522-3; Chinese Linguistic Data Consortium, 2003, CLDCLAC200301 TSINGH; Kureta Y, 2006, J EXP PSYCHOL LEARN, V32, P1102, DOI 10.1037/0278-7393.32.5.1102; Verdonschot RG, 2011, J EXP PSYCHOL LEARN, V37, P1458, DOI 10.1037/a0024491; Verdonschot RG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061454, 10.1037/journal.pone.0061454]; Wong AWK, 2009, PSYCHON B REV, V16, P888, DOI 10.3758/PBR.16.5.888; You WP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046595	19	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-5368	1468-5884		JPN PSYCHOL RES	Jpn. Psychol. Res.	JAN	2015	57	1			SI		61	68		10.1111/jpr.12064		8	Psychology, Multidisciplinary	Psychology	AY0XA	WOS:000347316400006		
J	West, CE; Renz, H; Jenmalm, MC; Kozyrskyj, AL; Allen, KJ; Vuillermin, P; Prescott, SL; MacKay, C; Salminen, S; Wong, G; Sinn, J; Stokholm, J; Bisgaard, H; Pawankar, R; Noakes, P; Kesper, D; Tulic, M				West, Christina E.; Renz, Harald; Jenmalm, Maria C.; Kozyrskyj, Anita L.; Allen, Katrina J.; Vuillermin, Peter; Prescott, Susan L.; MacKay, Charles; Salminen, Seppo; Wong, Gary; Sinn, John; Stokholm, Jakob; Bisgaard, Hans; Pawankar, Ruby; Noakes, Paul; Kesper, Doerthe; Tulic, Meri		In-FLAME Microbiome Interest Grp	The gut microbiota and inflammatory noncommunicable diseases: Associations and potentials for gut microbiota therapies	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Fecal microbiota transplantation; gut microbiome; inflammation; noncommunicable diseases; prebiotics; probiotics; short-chain fatty acids	CLOSTRIDIUM-DIFFICILE INFECTION; RANDOMIZED CONTROLLED-TRIAL; FECAL MICROBIOTA; INTESTINAL MICROBIOTA; EARLY-LIFE; ALLERGIC DISEASE; FOLLOW-UP; PROBIOTIC SUPPLEMENTATION; ATOPIC SENSITIZATION; HEALTHY-CHILDREN	Rapid environmental transition and modern lifestyles are likely driving changes in the biodiversity of the human gut microbiota. With clear effects on physiologic, immunologic, and metabolic processes in human health, aberrations in the gut microbiome and intestinal homeostasis have the capacity for multisystem effects. Changes in microbial composition are implicated in the increasing propensity for a broad range of inflammatory diseases, such as allergic disease, asthma, inflammatory bowel disease (IBD), obesity, and associated noncommunicable diseases (NCDs). There are also suggestive implications for neurodevelopment and mental health. These diverse multisystem influences have sparked interest in strategies that might favorably modulate the gut microbiota to reduce the risk of many NCDs. For example, specific prebiotics promote favorable intestinal colonization, and their fermented products have anti-inflammatory properties. Specific probiotics also have immunomodulatory and metabolic effects. However, when evaluated in clinical trials, the effects are variable, preliminary, or limited in magnitude. Fecal microbiota transplantation is another emerging therapy that regulates inflammation in experimental models. In human subjects it has been successfully used in cases of Clostridium difficile infection and IBD, although controlled trials are lacking for IBD. Here we discuss relationships between gut colonization and inflammatory NCDs and gut microbiota modulation strategies for their treatment and prevention.	[West, Christina E.] Umea Univ, Dept Clin Sci, SE-90185 Umea, Sweden; [Renz, Harald; Kesper, Doerthe] Univ Marburg, Dept Clin Chem & Mol Diagnost, Marburg, Germany; [Jenmalm, Maria C.] Linkoping Univ, Dept Clin & Expt Med, S-58183 Linkoping, Sweden; [Kozyrskyj, Anita L.] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Allen, Katrina J.] Univ Melbourne, Murdoch Childrens Res Inst, Melbourne, Vic 3010, Australia; [Allen, Katrina J.] Univ Melbourne, Dept Pediat, Melbourne, Vic 3010, Australia; [Vuillermin, Peter] Barwon Hlth, Child Hlth Res Unit, Geelong, Vic, Australia; [Prescott, Susan L.; Noakes, Paul] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia; [MacKay, Charles] Monash Univ, Fac Med, Clayton, Vic, Australia; [Salminen, Seppo] Univ Turku, Funct Foods Forum, SF-20500 Turku, Finland; [Wong, Gary] Chinese Univ Hong Kong, Dept Paediat, Hong Kong, Hong Kong, Peoples R China; [Wong, Gary] Chinese Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Sinn, John] Univ Sydney, Dept Neonatol, Sydney, NSW 2006, Australia; [Stokholm, Jakob; Bisgaard, Hans] Univ Copenhagen, Copenhagen Prospect Studies Asthma Childhood Hlth, DK-1168 Copenhagen, Denmark; [Pawankar, Ruby] Nippon Med Sch, Dept Pediat, Div Allergy, Tokyo 113, Japan; [Tulic, Meri] Univ Nice Sophia Antipolis, F-06189 Nice, France	West, CE (reprint author), Umea Univ, Dept Clin Sci, SE-90185 Umea, Sweden.	christina.west@umu.se		Allen, Katrina/0000-0002-1921-4493; Bisgaard, Hans/0000-0003-4131-7592			Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Wang X, 2013, DIABETES CARE, V36, P166, DOI 10.2337/dc12-0702; Fraher MH, 2012, NAT REV GASTRO HEPAT, V9, P312, DOI 10.1038/nrgastro.2012.44; Ege MJ, 2006, J ALLERGY CLIN IMMUN, V117, P817, DOI 10.1016/j.jaci.2005.12.1307; Morgan XC, 2014, GASTROENTEROLOGY, V146, P1437, DOI 10.1053/j.gastro.2014.01.049; Aagaard K, 2013, FASEB J, V27, P1012, DOI 10.1096/fj.12-220806; Thorburn AN, 2014, IMMUNITY, V40, P833, DOI 10.1016/j.immuni.2014.05.014; Kalliomaki M, 2007, J ALLERGY CLIN IMMUN, V119, P1019, DOI 10.1016/j.jaci.2006.12.608; Wickens K, 2013, CLIN EXP ALLERGY, V43, P1048, DOI 10.1111/cea.12154; Sudo N, 1997, J IMMUNOL, V159, P1739; Wold AE, 1998, ALLERGY, V53, P20; Prescott SL, 2013, J ALLERGY CLIN IMMUN, V131, P23, DOI 10.1016/j.jaci.2012.11.019; Sjogren YM, 2009, CLIN EXP ALLERGY, V39, P1842, DOI 10.1111/j.1365-2222.2009.03326.x; Abrahamsson TR, 2013, PEDIAT ALLERG IMM-UK, V24, P556, DOI 10.1111/pai.12104; Ke XY, 2012, AM J HUM GENET, V91, P185, DOI 10.1016/j.ajhg.2012.05.020; Postigo R, 2012, INFECTION, V40, P643, DOI 10.1007/s15010-012-0307-9; West CE, 2014, CURR OPIN CLIN NUTR, V17, P261, DOI 10.1097/MCO.0000000000000044; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ellwood P, 2013, THORAX, V68, P351, DOI 10.1136/thoraxjnl-2012-202285; Rook GA, 2013, P NATL ACAD SCI USA, V110, P18360, DOI 10.1073/pnas.1313731110; van Nimwegen FA, 2011, J ALLERGY CLIN IMMUN, V128, P948, DOI 10.1016/j.jaci.2011.07.027; Huang RC, 2009, DIABETES CARE, V32, P695, DOI 10.2337/dc08-1917; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Kalliomaki M, 2008, AM J CLIN NUTR, V87, P534; de Goffau MC, 2013, DIABETES, V62, P1238, DOI 10.2337/db12-0526; Cahenzli J, 2013, CELL HOST MICROBE, V14, P559, DOI 10.1016/j.chom.2013.10.004; Renz H, 2012, NAT REV IMMUNOL, V12, P9, DOI 10.1038/nri3112; Gosalbes MJ, 2013, CLIN EXP ALLERGY, V43, P198, DOI 10.1111/cea.12063; Yousuf O, 2013, J AM COLL CARDIOL, V62, P397, DOI 10.1016/j.jacc.2013.05.016; STRACHAN DP, 1989, BRIT MED J, V299, P1259; Smits LP, 2013, GASTROENTEROLOGY, V145, P946, DOI 10.1053/j.gastro.2013.08.058; Vulevic J, 2013, J NUTR, V143, P324, DOI 10.3945/jn.112.166132; Jenny NS, 2007, AM J EPIDEMIOL, V165, P684, DOI 10.1093/aje/kwk057; Goodrich JK, 2014, CELL, V158, P250, DOI 10.1016/j.cell.2014.06.037; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Ismail IH, 2012, PEDIAT ALLERG IMM-UK, V23, P674, DOI 10.1111/j.1399-3038.2012.01328.x; Stene LC, 2013, DIABETOLOGIA, V56, P1888, DOI 10.1007/s00125-013-2929-6; Vaarala O, 2012, IMMUNOL CELL BIOL, V90, P271, DOI 10.1038/icb.2011.115; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Kuitunen M, 2009, J ALLERGY CLIN IMMUN, V123, P335, DOI 10.1016/j.jaci.2008.11.019; Kassam Z, 2013, AM J GASTROENTEROL, V108, P500, DOI 10.1038/ajg.2013.59; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Kadooka Y, 2010, EUR J CLIN NUTR, V64, P636, DOI 10.1038/ejcn.2010.19; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Abrahamsson TR, 2014, CLIN EXP ALLERGY, V44, P842, DOI 10.1111/cea.12253; McDade TW, 2012, P NATL ACAD SCI USA, V109, P17281, DOI 10.1073/pnas.1202244109; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Kumar M, 2012, EXP DIABETES RES, DOI 10.1155/2012/902917; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Rautava S, 2012, NAT REV GASTRO HEPAT, V9, P565, DOI 10.1038/nrgastro.2012.144; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Karlsson CLJ, 2012, OBESITY, V20, P2257, DOI 10.1038/oby.2012.110; Hanson M, 2011, PROG BIOPHYS MOL BIO, V106, P272, DOI 10.1016/j.pbiomolbio.2010.12.008; Penders J, 2013, J ALLERGY CLIN IMMUN, V132, P601, DOI 10.1016/j.jaci.2013.05.043; Azad MB, 2013, CAN MED ASSOC J, V185, P385, DOI 10.1503/cmaj.121189; Stefka AT, 2014, P NATL ACAD SCI USA, V111, P13145, DOI 10.1073/pnas.1412008111; Jakobsson HE, 2014, GUT, V63, P559, DOI 10.1136/gutjnl-2012-303249; Bisgaard H, 2011, J ALLERGY CLIN IMMUN, V128, P646, DOI 10.1016/j.jaci.2011.04.060; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; Abrahamsson TR, 2012, J ALLERGY CLIN IMMUN, V129, P434, DOI 10.1016/j.jaci.2011.10.025; Jeffery IB, 2012, NAT REV MICROBIOL, V10, P591, DOI 10.1038/nrmicro2859; Garn H, 2013, J ALLERGY CLIN IMMUN, V131, P1465, DOI 10.1016/j.jaci.2013.04.031; Azad MB, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6471; Bertelsen RJ, 2014, J ALLERGY CLIN IMMUN, V133, P165, DOI 10.1016/j.jaci.2013.07.032; Borre YE, 2014, TRENDS MOL MED, V20, P509, DOI 10.1016/j.molmed.2014.05.002; Cheng J, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-113; Chorell E, 2013, BRIT J NUTR, V110, P116, DOI 10.1017/S0007114512004618; Doll HM, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-259; Fiocchi Alessandro, 2012, World Allergy Organ J, V5, P148, DOI 10.1097/WOX.0b013e3182784ee0; Food and Agriculture Organization/World Health Organization (FAO/ WHO), 2002, GUID EV PROB FOOD RE; Fouhy Fiona, 2012, Gut Microbes, V3, P203, DOI 10.4161/gmic.20169; Gevers D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001377; Haahtela Tari, 2013, World Allergy Organ J, V6, P3, DOI 10.1186/1939-4551-6-3; Hamilton Matthew J, 2013, Gut Microbes, V4, P125, DOI 10.4161/gmic.23571; Heintze K, 2013, EUR J CLIN PHARMACOL, V69, P1197, DOI 10.1007/s00228-012-1463-7; Jensen MP, 2012, J ALLERGY CLIN IMMUN, V130, P1209, DOI 10.1016/j.jaci.2012.07.018; Jumpstart Consortium Human Microbiome Project Data Generation Working Group, 2012, PLOS ONE, V7; Karlstrom A, 2013, BJOG-INT J OBSTET GY, V120, P479, DOI 10.1111/1471-0528.12129; Kolokotroni O, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-179; Koren O, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002863; Korpela K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090702; Lee CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044224; Li H, 2014, PEDIATR OBES, V9, P10, DOI 10.1111/j.2047-6310.2013.00151.x; Loo EXL, 2014, INT ARCH ALLERGY IMM, V163, P25, DOI 10.1159/000356338; Luoto R, 2010, BRIT J NUTR, V103, P1792, DOI 10.1017/S0007114509993898; Merras-Salmio Laura, 2014, Clin Transl Allergy, V4, P8, DOI 10.1186/2045-7022-4-8; Murri M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-46; Nylund L, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-12; Osborn DA, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006474.pub3; Reiprich M, 2013, ALLERGY, V68, P481, DOI 10.1111/all.12121; Wang SG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097523; Wang J, 2014, ISME J; West CE, 2014, CLIN EXP ALLERGY; West CE, 2013, ALLERGY, V68, P1015, DOI 10.1111/all.12191	99	18	18	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2015	135	1					3	14		10.1016/j.jaci.2014.11.012		12	Allergy; Immunology	Allergy; Immunology	AY0PG	WOS:000347298200001		
J	McClure, R; Yanagisawa, D; Stec, D; Abdollahian, D; Koktysh, D; Xhillari, D; Jaeger, R; Stanwood, G; Chekmenev, E; Tooyama, I; Gore, JC; Pham, W				McClure, Richard; Yanagisawa, Daijiro; Stec, Donald; Abdollahian, Dave; Koktysh, Dmitry; Xhillari, Dritan; Jaeger, Rudolph; Stanwood, Gregg; Chekmenev, Eduard; Tooyama, Ikuo; Gore, John C.; Pham, Wellington			Inhalable Curcumin: Offering the Potential for Translation to Imaging and Treatment of Alzheimer's Disease	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Aerosol; Alzheimer's disease; amyloid imaging; amyloid plaques; atomization; inhalation exposure; clinical translation; curcumin	BLOOD-BRAIN-BARRIER; IN-VIVO; ULTRAFINE PARTICLES; DOUBLE-BLIND; LOADED PLGA; MOUSE MODEL; BIOAVAILABILITY; NANOPARTICLES; MICE; DELIVERY	Curcumin is a promising compound that can be used as a theranostic agent to aid research in Alzheimer's disease. Beyond its ability to bind to amyloid plaques, the compound can also cross the blood-brain barrier. Presently, curcumin can be applied only to animal models, as the formulation needed for iv injection renders it unfit for human use. Here, we describe a novel technique to aerosolize a curcumin derivative, FMeC1, and facilitate its safe delivery to the brain. Aside from the translational applicability of this approach, a study in the 5XFAD mouse model suggested that inhalation exposure to an aerosolized FMeC1 modestly improved the distribution of the compound in the brain. Additionally, immunohistochemistry data confirms that following aerosol delivery, FMeC1 binds amyloid plaques expressed in the hippocampal areas and cortex.	[McClure, Richard; Abdollahian, Dave; Chekmenev, Eduard; Gore, John C.; Pham, Wellington] Vanderbilt Univ, Inst Imaging Sci, Nashville, TN 37212 USA; [McClure, Richard; Abdollahian, Dave; Chekmenev, Eduard; Gore, John C.; Pham, Wellington] Vanderbilt Univ, Sch Med, Dept Radiol & Radiol Sci, Nashville, TN 37212 USA; [McClure, Richard; Yanagisawa, Daijiro; Gore, John C.; Pham, Wellington] Vanderbilt Univ, Vanderbilt Brain Inst, Nashville, TN 37235 USA; [Yanagisawa, Daijiro; Tooyama, Ikuo] Shiga Univ Med Sci, Otsu, Shiga, Japan; [Tooyama, Ikuo] Shiga Univ Med Sci, Mol Neurosci Res Ctr, Otsu, Shiga 52021, Japan; [Stec, Donald; Koktysh, Dmitry] Vanderbilt Univ, Dept Chem, Nashville, TN USA; [Koktysh, Dmitry] Vanderbilt Inst Nanoscale Sci & Engn, Nashville, TN USA; [Xhillari, Dritan; Jaeger, Rudolph] CH Technol USA Inc, Westwood, NJ USA; [Stanwood, Gregg; Chekmenev, Eduard; Gore, John C.; Pham, Wellington] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Nashville, TN 37235 USA; [Stanwood, Gregg] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA; [Chekmenev, Eduard; Gore, John C.; Pham, Wellington] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Gore, John C.] Vanderbilt Univ, Nashville, TN 37235 USA; [Pham, Wellington] Vanderbilt Inst Chem Biol, Nashville, TN USA	Pham, W (reprint author), Vanderbilt Univ, Sch Med, Inst Imaging Sci, 1161 21st Ave South, Nashville, TN 37212 USA.	wellington.pham@vanderbilt.edu			National Institutes of Health [R01CA16700, T32 EB014841]; VICC Cancer Center Support grant	The work described was partially funded by grants, R01CA16700 (W.P.), T32 EB014841 (J.C.G.) from the National Institutes of Health, and the VICC Cancer Center Support grant (W.P.). The authors thank Meying Zhu for excellent assistance during the course of work.	Abbott A, 2008, NATURE, V456, P161, DOI 10.1038/456161a; Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003; Oberdorster G, 2004, INHAL TOXICOL, V16, P437, DOI 10.1080/08958370490439597; Pan MH, 1999, DRUG METAB DISPOS, V27, P486; Kumagai H, 2013, INT J CANCER, V132, P2107, DOI 10.1002/ijc.27903; Anand P, 2007, MOL PHARM, V4, P807, DOI 10.1021/mp700113r; Baum L, 2008, J CLIN PSYCHOPHARM, V28, P110, DOI 10.1097/jcp.0b013e318160862c; Anand P, 2010, BIOCHEM PHARMACOL, V79, P330, DOI 10.1016/j.bcp.2009.09.003; Nemmar A, 2001, AM J RESP CRIT CARE, V164, P1665; Donaldson K, 2004, OCCUP ENVIRON MED, V61, P727, DOI 10.1136/oem.2004.013243; Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016; Wang PW, 2014, J NEUROSCI RES, V92, P218, DOI 10.1002/jnr.23322; Hoppe JB, 2013, TOXICOL IN VITRO, V27, P2325, DOI 10.1016/j.tiv.2013.10.002; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Pham W, 2004, CHEMBIOCHEM, V5, P1148, DOI 10.1002/cbic.200400063; Ringman JM, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt146; Pardridge WM, 2002, NEURON, V36, P555, DOI 10.1016/S0896-6273(02)01054-1; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Ray B, 2011, J ALZHEIMERS DIS, V23, P61, DOI 10.3233/JAD-2010-101374; Mistry A, 2009, J DRUG TARGET, V17, P543, DOI 10.1080/10611860903055470; Yanagisawa D, 2011, NEUROSCIENCE, V184, P120, DOI 10.1016/j.neuroscience.2011.03.071; Garbuzenko OB, 2010, P NATL ACAD SCI USA, V107, P10737, DOI 10.1073/pnas.1004604107; Khalil NM, 2013, COLLOID SURFACE B, V101, P353, DOI 10.1016/j.colsurfb.2012.06.024; Ryu EK, 2006, J MED CHEM, V49, P6111, DOI 10.1021/jm0607193; Garcia-Alloza M, 2007, J NEUROCHEM, V102, P1095, DOI 10.1111/j.1471-4159.2007.04613.x; Ireson CR, 2002, CANCER EPIDEM BIOMAR, V11, P105; Sasaki H, 2011, BIOL PHARM BULL, V34, P660, DOI 10.1248/bpb.34.660; Cheng KK, 2013, AAPS J, V15, P324, DOI 10.1208/s12248-012-9444-4; Geiser M, 2005, ENVIRON HEALTH PERSP, V113, P1555, DOI 10.1289/ehp.8006; Brondino N, 2014, SCI WORLD J, DOI 10.1155/2014/174282; Marchiani A, 2014, CURR MED CHEM, V21, P204; Aggarwal BB, 2007, ADV EXP MED BIOL, V595, P1; Subhashini, 2013, INT IMMUNOPHARMACOL, V17, P733, DOI 10.1016/j.intimp.2013.08.008; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Hoppe JB, 2013, NEUROBIOL LEARN MEM, V106, P134, DOI 10.1016/j.nlm.2013.08.001; Rahman I, 2006, BIOCHEM PHARMACOL, V72, P1439, DOI 10.1016/j.bcp.2006.07.004; Chiu SS, 2011, ANTICANCER RES, V31, P907; Kumaraswamy P, 2013, J AGR FOOD CHEM, V61, P3278, DOI 10.1021/jf4000709; Corona-Rivera A, 2007, J APPL GENET, V48, P389, DOI 10.1007/BF03195238; Gandapu U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023388; goindi S, 2011, ALTERNAT MED SCI, V1, P49; Hoppe JB, 2013, NEUROL RES, V35, P857, DOI 10.1179/1743132813Y.0000000225; McClure RA, 2013, NEUROIMAGE-CLIN, V2, P620, DOI 10.1016/j.nicl.2013.04.015; Pham W, 2005, NEUROIMAGE, V28, P287, DOI 10.1016/j.neuroimage.2005.06.007; PHIPPS PR, 1990, CHEST, V97, P1327, DOI 10.1378/chest.97.6.1327; Prasad S, 2014, CANCER RES TREAT, V46, P2, DOI 10.4143/crt.2014.46.1.2; Rothen-Rutishauser BM, 2006, ENVIRON SCI TECHNOL, V40, P4353, DOI 10.1021/es0522635; Tirkey Naveen, 2005, BMC Pharmacology, V5, P15, DOI 10.1186/1471-2210-5-15; Yanagisawa D, 2014, J ALZHEIMERS DIS, V39, P617, DOI 10.3233/JAD-131025	49	2	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2015	44	1					283	295		10.3233/JAD-140798		13	Neurosciences	Neurosciences & Neurology	AY3AQ	WOS:000347457400027		
J	Kim, H; Tabata, A; Tomoyasu, T; Ueno, T; Uchiyama, S; Yuasa, K; Tsuji, A; Nagamune, H				Kim, Hyejin; Tabata, Atsushi; Tomoyasu, Toshifumi; Ueno, Tomomi; Uchiyama, Shigeto; Yuasa, Keizo; Tsuji, Akihiko; Nagamune, Hideaki			Estrogen stimuli promote osteoblastic differentiation via the subtilisin-like proprotein convertase PACE4 in MC3T3-E1 cells	JOURNAL OF BONE AND MINERAL METABOLISM			English	Article						Osteoblast; PACE4; Estrogen; Soybean isoflavone	BONE MORPHOGENETIC PROTEINS; RECEPTOR-ALPHA; SEX STEROIDS; BETA; FURIN; EQUOL; SOY; PHYTOESTROGENS; ISOFLAVONES; METABOLITE	Estrogenic compounds include endogenous estrogens such as estradiol as well as soybean isoflavones, such as daidzein and its metabolite equol, which are known phytoestrogens that prevent osteoporosis in postmenopausal women. Indeed, mineralization of MC3T3-E1 cells, a murine osteoblastic cell line, was significantly decreased in medium containing fetal bovine serum treated with charcoal-dextran to deplete endogenous estrogens, but estradiol and these soybean isoflavones dose-dependently restored the differentiation of MC3T3-E1 cells; equol was tenfold more effective than daidzein. These differentiation-promoting effects were inhibited by the addition of fulvestrant, which is a selective downregulator of estrogen receptors. Analysis of the expression pattern of bone-related genes by reverse transcription PCR (RT-PCR)/quantitative real-time PCR (qRT-PCR), which focused on responsiveness to the estrogen stimuli, revealed that the transcription of PACE4, a subtilisin-like proprotein convertase, was tightly linked with the differentiation of MC3T3-E1 cells induced by estrogen stimuli. Moreover, treatment with RNAi of PACE4 in MC3T3-E1 cells resulted in a drastic decrease of mineralization in the presence of estrogen stimuli. These results strongly suggest that PACE4 participates in bone formation at least in osteoblast differentiation, and estrogen receptor-mediated stimuli induce osteoblast differentiation through the upregulation of PACE4 expression.	[Kim, Hyejin; Tabata, Atsushi; Tomoyasu, Toshifumi; Yuasa, Keizo; Tsuji, Akihiko; Nagamune, Hideaki] Univ Tokushima, Grad Sch, Inst Sci & Technol, Dept Biol Sci & Technol, Tokushima 7708506, Japan; [Ueno, Tomomi; Uchiyama, Shigeto] Otsuka Pharmaceut Co Ltd, Saga Nutraceut Res Inst, Saga, Japan	Nagamune, H (reprint author), Univ Tokushima, Grad Sch, Inst Sci & Technol, Dept Biol Sci & Technol, 2-1 Minami Josanjima, Tokushima 7708506, Japan.	nagamune@bio.tokushima-u.ac.jp			Tokushima Shinbun Co.	The authors are grateful to Dr. H. Ohkuni for the measurement of E2 concentration in sera. This work was partly supported by a Grant-in-Aid for Life Science Research from Tokushima Shinbun Co.	Akamatsu T, 1999, DEV DYNAM, V216, P481, DOI 10.1002/(SICI)1097-0177(199912)216:4/5<481::AID-DVDY16>3.0.CO;2-M; ALBRIGHT FULLER, 1940, TRANS ASSOC AMER PHYSICIANS, V55, P298; Tremblay GB, 1997, MOL ENDOCRINOL, V11, P353, DOI 10.1210/me.11.3.353; Zhou SH, 2003, MOL ENDOCRINOL, V17, P56, DOI 10.1210/me.2002-0210; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Kanis JA, 2004, OSTEOPOROSIS INT, V15, P20, DOI 10.1007/s00198-003-1463-7; Setchell KDR, 2002, J NUTR, V132, P3577; Muthyala RS, 2004, BIOORGAN MED CHEM, V12, P1559, DOI 10.1016/j.bmc.2003.11.035; Viegas CSB, 2013, J BIOL CHEM, V288, P27801, DOI 10.1074/jbc.M113.450213; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; Kameda T, 1997, J EXP MED, V186, P489, DOI 10.1084/jem.186.4.489; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Morito K, 2001, BIOL PHARM BULL, V24, P351, DOI 10.1248/bpb.24.351; Yuasa K, 2009, J BIOCHEM, V146, P407, DOI 10.1093/jb/mvp090; Kanno S, 2004, TOXICOLOGY, V196, P137, DOI 10.1016/j.tox.2003.12.002; Wu J, 2007, MENOPAUSE, V14, P866, DOI 10.1097/gme.0b013e3180305299; Armstrong VJ, 2007, J BIOL CHEM, V282, P20715, DOI 10.1074/jbc.M703224200; Marchesi C, 2011, J MOL MED, V89, P1103, DOI 10.1007/s00109-011-0776-9; Kousteni S, 2002, SCIENCE, V298, P843, DOI 10.1126/science.1074935; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; Constam DB, 1999, J CELL BIOL, V144, P139, DOI 10.1083/jcb.144.1.139; Yuasa K, 2012, FEBS J, V279, P3997, DOI 10.1111/j.1742-4658.2012.08758.x; Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; Cui YZ, 1998, EMBO J, V17, P4735, DOI 10.1093/emboj/17.16.4735; Cheng M, 1997, INT J CANCER, V71, P966, DOI 10.1002/(SICI)1097-0215(19970611)71:6<966::AID-IJC10>3.0.CO;2-4; Felin JE, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-20; Hwang EM, 2006, BIOCHEM BIOPH RES CO, V349, P654, DOI 10.1016/j.bbrc.2006.08.077; JASANI C, 1965, P ROY SOC MED, V58, P441; Ma DF, 2008, EUR J CLIN NUTR, V62, P155, DOI 10.1038/sj.ejcn.1602748; Mori K, 1999, J BIOCHEM-TOKYO, V125, P627; Paige LA, 1999, P NATL ACAD SCI USA, V96, P3999, DOI 10.1073/pnas.96.7.3999; Scammell BE, 1996, J BONE MINER RES, V11, P737; Uchiyama S, 2004, US patent, Patent No. [6,716,424 B1, 6716424]; Usui T, 2006, SOY PROTEIN RES JPN, V9, P153	34	4	4	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0914-8779	1435-5604		J BONE MINER METAB	J. Bone Miner. Metab.	JAN	2015	33	1					30	39		10.1007/s00774-014-0567-9		10	Endocrinology & Metabolism; Medicine, Research & Experimental	Endocrinology & Metabolism; Research & Experimental Medicine	AY2GX	WOS:000347407900005		
J	Ota, M; Yanagisawa, M; Tachibana, H; Yokota, K; Araki, Y; Sato, K; Mimura, T				Ota, Muneo; Yanagisawa, Maiko; Tachibana, Hideyuki; Yokota, Kazuhiro; Araki, Yasuto; Sato, Kojiro; Mimura, Toshihide			A significant induction of neutrophilic chemoattractants but not RANKL in synoviocytes stimulated with interleukin 17	JOURNAL OF BONE AND MINERAL METABOLISM			English	Article						Interleukin 17; Osteoclast; Synoviocytes; Rheumatoid arthritis	T-CELLS; RHEUMATOID-ARTHRITIS; OSTEOCLAST DIFFERENTIATION; OSTEOPROTEGERIN LIGAND; ANTIBODY; RECEPTOR; LINEAGE; DESTRUCTION; ACTIVATION; PSORIASIS	Interleukin 17 (IL-17) is a cytokine implicated in the promotion of osteoclastogenesis. Its effect has been believed not to be directly exerted on osteoclast precursors, but rather indirectly carried out via an induction of receptor activator of NF-kappa B ligand (RANKL), the osteoclast differentiation factor, on osteoclast-supporting cells, which in turn exert an effect on osteoclast precursors. The mechanistic details, however, remain unclear. In this study, we first performed a transcriptome analysis of synoviocytes derived from a patient with rheumatoid arthritis cultured in the presence or absence of IL-17. We discovered that most of the genes significantly induced by IL-17 were chemokines with a chemotactic effect on neutrophils. We confirmed these results by quantitative RT-PCR and ELISA. Unexpectedly, the stimulation with IL-17 alone did not induce the expression of RANKL either at the mRNA or the protein level. The induction of RANKL was observed when IL-17 was added in combination with 1,25-dihydroxyvitamin D-3 and prostaglandin E-2, well-known inducers of RANKL, although the exact mechanism of this synergistic effect remains unclear. IL-6 and monocyte chemoattractant protein-1 were also significantly induced by IL-17 at both the mRNA and protein levels. Thus, it appears that IL-17 induces the migration of neutrophils and monocytes/macrophages through the activation of synoviocytes, and enhances a positive feedback loop composed of proinflammatory cytokines IL-6 and IL-17.	[Ota, Muneo; Yanagisawa, Maiko; Tachibana, Hideyuki; Yokota, Kazuhiro; Araki, Yasuto; Sato, Kojiro; Mimura, Toshihide] Saitama Med Univ, Dept Rheumatol & Appl Immunol, Fac Med, Moroyama, Saitama 3500495, Japan	Sato, K (reprint author), Saitama Med Univ, Dept Rheumatol & Appl Immunol, Fac Med, Morohongo 38, Moroyama, Saitama 3500495, Japan.	satok@saitama-med.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [23591467, 25462379, 22591083]; Naito Foundation; Uehara Memorial Foundation; Kato Memorial Bioscience Foundation; Japan Intractable Diseases Research Foundation; Japan Rheumatism Foundation; Saitama Medical University [12B-01]; Daiichi-Sankyo Foundation of Life Science	We are grateful to N. Shiraishi, N. Koga, Y. Yamada, N. Kurosawa, Y. Aizaki, and T. Ishibashi for their technical assistance. This work was supported in part by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Numbers 23591467, 25462379 and 22591083 and grants from the Naito Foundation, Uehara Memorial Foundation, Kato Memorial Bioscience Foundation, Japan Intractable Diseases Research Foundation, Japan Rheumatism Foundation, Saitama Medical University Internal Grant 12B-01, and Daiichi-Sankyo Foundation of Life Science.	Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Nishimoto N, 2006, NAT CLIN PRACT RHEUM, V2, P619, DOI 10.1038/ncprheurn0338; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Hueber AJ, 2010, J IMMUNOL, V184, P3336, DOI 10.4049/jimmunol.0903566; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600; Ogura H, 2008, IMMUNITY, V29, P628, DOI 10.1016/j.immuni.2008.07.018; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Hashizume M, 2008, RHEUMATOLOGY, V47, P1635, DOI 10.1093/rheumatology/ken363; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Takayanagi H, 2000, NATURE, V408, P600; Kong YY, 1999, NATURE, V402, P304; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Ha J, 2010, J IMMUNOL, V184, P4717, DOI 10.4049/jimmunol.0902444; Onan D, 2009, ENDOCRINOLOGY, V150, P2244, DOI 10.1210/en.2008-1597; Singh JA, 2011, J RHEUMATOL, V38, P10, DOI 10.3899/jrheum.100717; Suurmond J, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3466; Yokota K, 2008, J RHEUMATOL, V35, P193	24	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0914-8779	1435-5604		J BONE MINER METAB	J. Bone Miner. Metab.	JAN	2015	33	1					40	47		10.1007/s00774-014-0565-y		8	Endocrinology & Metabolism; Medicine, Research & Experimental	Endocrinology & Metabolism; Research & Experimental Medicine	AY2GX	WOS:000347407900006		
J	Ezura, Y; Nagata, J; Nagao, M; Hemmi, H; Hayata, T; Rittling, S; Denhardt, DT; Noda, M				Ezura, Yoichi; Nagata, Junji; Nagao, Masashi; Hemmi, Hiroaki; Hayata, Tadayoshi; Rittling, Susan; Denhardt, David T.; Noda, Masaki			Hindlimb-unloading suppresses B cell population in the bone marrow and peripheral circulation associated with OPN expression in circulating blood cells	JOURNAL OF BONE AND MINERAL METABOLISM			English	Article						Osteopontin; Tail-suspension; Hindlimb unloading; PBMC; Lymphocyte fraction	SYMPATHETIC-NERVOUS-SYSTEM; STEM-CELLS; OSTEOPONTIN; STRESS; MECHANISMS; RESORPTION; ANTIBODY; ATROPHY; THYMUS; GENE	Rodent hindlimb unloading (HU) by tail-suspension is a model to investigate disuse-induced bone loss in vivo. Previously, we have shown that osteopontin (OPN, also known as Spp1) is required for unloading-induced bone loss. However, how unloading affects OPN expression in the body is not fully understood. Here, we examined OPN expression in peripheral blood of mice subjected to HU. Real-time RT-PCR analysis indicated that OPN expression is increased in circulating peripheral blood cells. This HU-induced increase in OPN mRNA expression was specific in circulating peripheral blood cells, as OPN was not increased in the blood cells in bone marrow. HU-induced enhancement in OPN expression in peripheral blood cells was associated with an increase in the fraction of monocyte/macrophage lineage cells in the peripheral blood. In contrast, HU decreased the fraction size of B-lymphocytes in the peripheral blood. We further examined if B-lymphogenesis is affected in the mice deficient for osteopontin subjected to HU. In bone marrow, HU decreased the population of the B-lymphocyte lineage cells significantly, whereas it did not alter the population of monocyte/macrophage lineage cells. HU also increased the cells in T-lymphocyte lineage in bone marrow. Interestingly, these changes were observed similarly both in OPN-deficient and wild-type mice. These results indicate for the first time that HU increases OPN expression in circulating cells and suppresses bone marrow B-lymphogenesis.	[Ezura, Yoichi; Nagata, Junji; Nagao, Masashi; Hemmi, Hiroaki; Hayata, Tadayoshi; Noda, Masaki] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Pharmacol, Bunkyo Ku, Tokyo 1138510, Japan; [Ezura, Yoichi; Noda, Masaki] TMDU, Hard Tissue Genome Res Ctr, Tokyo, Japan; [Hemmi, Hiroaki] TMDU, Med Top Track Fellow Program MTT, Tokyo, Japan; [Rittling, Susan] Forsyth Inst, Boston, MA 02115 USA; [Denhardt, David T.] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA; [Noda, Masaki] Int Res Ctr Mol Sci Tooth & Bone Dis, Global Ctr Excellence GCOE Program, Tokyo, Japan; [Noda, Masaki] JSPS Core Core Program, Integrated Act Initiat, Tokyo, Japan	Ezura, Y (reprint author), Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Pharmacol, Bunkyo Ku, 5-45 Yushima 1 Chome, Tokyo 1138510, Japan.	ezura.mph@mri.tmd.ac.jp			Japanese Ministry of Education, Global Center of Excellence (GCOE) Program, "International Research Center for Molecular Science in Tooth and Bone Diseases"; Japan Space forum, NASDA, Japan Society for Promotion of Science (JSPS Core to Core Program, "Research for the Future Program"); Japan Science and Technology Agency (JST) [3K019]	This work was supported by a grant from the Japanese Ministry of Education, Global Center of Excellence (GCOE) Program, "International Research Center for Molecular Science in Tooth and Bone Diseases", and grants from the Japan Space forum, NASDA, Japan Society for Promotion of Science (JSPS Core to Core Program, "Research for the Future Program"), and Japan Science and Technology Agency (JST) 3K019.	Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Ulrich D, 1999, BONE, V25, P55, DOI 10.1016/S8756-3282(99)00098-8; Fukuda T, 2013, NATURE, V497, P490, DOI 10.1038/nature12115; Ishijima M, 2006, EXP CELL RES, V312, P3075, DOI 10.1016/j.yexcr.2006.06.003; PATARCA R, 1989, J EXP MED, V170, P145, DOI 10.1084/jem.170.1.145; Kondo H, 2005, J BIOL CHEM, V280, P30192, DOI 10.1074/jbc.M504179200; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Ishijima M, 2001, J EXP MED, V193, P399, DOI 10.1084/jem.193.3.399; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Yumoto K, 2002, P NATL ACAD SCI USA, V99, P4556, DOI 10.1073/pnas.052523599; Morey-Holton ER, 2002, J APPL PHYSIOL, V92, P1367, DOI 10.1152/japplphysiol.00969.2001; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; DHABHAR FS, 1995, J IMMUNOL, V154, P5511; Bertola A, 2009, DIABETES, V58, P125, DOI 10.2337/db08-0400; Kuznetsov SA, 2004, J CELL BIOL, V167, P1113, DOI 10.1083/jcb.200408079; Nagao M, 2011, P NATL ACAD SCI USA, V108, P17767, DOI 10.1073/pnas.1109402108; Wang KX, 2007, P NATL ACAD SCI USA, V104, P14777, DOI 10.1073/pnas.0703236104; Wang KX, 2009, J IMMUNOL, V182, P2485, DOI 10.4049/jimmunol.0803023; Wei LX, 2003, CELL RES, V13, P465, DOI 10.1038/sj.cr.7290189	19	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0914-8779	1435-5604		J BONE MINER METAB	J. Bone Miner. Metab.	JAN	2015	33	1					48	54		10.1007/s00774-014-0568-8		7	Endocrinology & Metabolism; Medicine, Research & Experimental	Endocrinology & Metabolism; Research & Experimental Medicine	AY2GX	WOS:000347407900007		
J	Makita, K; Okano, H; Furuya, T; Urano, T; Hirabayashi, H; Kumakubo, T; Iwamoto, J				Makita, Kazuya; Okano, Hiroya; Furuya, Takefumi; Urano, Tomohiko; Hirabayashi, Hisashi; Kumakubo, Takami; Iwamoto, Jun			Survey of the utility of once-monthly bisphosphonate treatment for improvement of medication adherence in osteoporosis patients in Japan	JOURNAL OF BONE AND MINERAL METABOLISM			English	Article						Osteoporosis; Bisphosphonate; Monthly dosing; Medication adherence	POSTMENOPAUSAL OSTEOPOROSIS; ELDERLY-WOMEN; PERSISTENCE; ALENDRONATE; RISEDRONATE	Prescription of a bisphosphonate (BP) with monthly dosing has recently been approved in Japan. The value of this approach for improvement of medication adherence was investigated in patients undergoing drug therapy for osteoporosis. A questionnaire was distributed to patients receiving treatment for osteoporosis at 8 medical facilities (5 orthopedic, 2 gynecology, and one internal medicine). Responses were collected from 1,300 patients. After exclusion of those who missed an item on the questionnaire or took drugs other than oral drugs, responses from 1,151 patients were analyzed. The most frequently used drug for treatment of osteoporosis was a once-weekly BP. Of the 1,151 patients, 38.4 % reported forgetting to take their current drug. The most frequent concern was 'I cannot feel an effect', but 73.2 % answered 'I have no concerns'. Regarding the most appropriate dosing regimen for long-term treatment, 60.3 % selected once-weekly and 24 % selected once every 4 weeks. Based on a recommendation by a physician of a drug to be taken monthly, 32.5 % wanted to switch, 31.8 % were undecided, and 35.7 % wanted to continue with their current drug. The desire for a change was higher among patients currently taking a once-weekly BP (52.3 %) than among patients taking a daily BP (29.5 %) or a SERM (19.4 %). This survey revealed patients' preferences in osteoporosis drug therapy. It is important to select a drug for osteoporosis based on the efficacy and the drug regimen preferred by the individual patient.	[Makita, Kazuya] Makita Obstet & Gynecol Clin, Niiza, Saitama 3520021, Japan; [Okano, Hiroya] Iidabashi Ladiess Clin, Tokyo 1020072, Japan; [Furuya, Takefumi] Tokyo Womens Med Univ, Inst Rheumatol, Tokyo 1620054, Japan; [Urano, Tomohiko] Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Tokyo 1130033, Japan; [Hirabayashi, Hisashi] Tokyo Adventist Hosp, Dept Orthoped, Tokyo 1678507, Japan; [Kumakubo, Takami] Kumakubo Orthoped Clin, Tokyo 1650025, Japan; [Iwamoto, Jun] Keio Univ, Inst Integrated Sports Med, Sch Med, Tokyo 1608582, Japan; [Iwamoto, Jun] Keiyu Orthopaed Hosp, Dept Orthopaed Surg, Gunma 3740011, Japan	Makita, K (reprint author), Makita Obstet & Gynecol Clin, 3-3-17 Atago, Niiza, Saitama 3520021, Japan.	y-makita@titan.ocn.ne.jp	Okano, Hideyuki/J-5973-2013				Adachi I, 2007, BMC MUSCULOSKEL DIS, V8, P97; Cotte FE, 2010, OSTEOPOROSIS INT, V21, P145, DOI 10.1007/s00198-009-0930-1; Papaioannou A, 2007, DRUG AGING, V24, P37, DOI 10.2165/00002512-200724010-00003; Emkey R, 2005, CURR MED RES OPIN, V21, P1895, DOI 10.1185/030079905X74862; Cramer JA, 2006, CLIN THER, V28, P1686, DOI 10.1016/j.clinthera.2006.10.013; Cranney A, 2002, ENDOCR REV, V23, P570, DOI 10.1210/er.2001-9002; Okazaki R, 2012, OSTEOPOROSIS INT, V23, P1737, DOI 10.1007/s00198-011-1782-z; Blouin J, 2008, BRIT J CLIN PHARMACO, V66, P117, DOI 10.1111/j.1365-2125.2008.03178.x; Cramer JA, 2005, CURR MED RES OPIN, V21, P1453, DOI 10.1185/030079905X61875; Solomon DH, 2005, ARCH INTERN MED, V165, P2414, DOI 10.1001/archinte.165.20.2414; Berecki-Gisolf J, 2008, MENOPAUSE, V15, P984, DOI 10.1097/gme.0b013e31816be98a; Cranney A, 2002, ENDOCR REV, V23, P517, DOI 10.1210/er.2001-3002; Orimo H, 2007, OSTEOPOROS JPN, V15, P351; Tsurukami H, 2012, J NEW REMED CLIN, V61, P552	14	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0914-8779	1435-5604		J BONE MINER METAB	J. Bone Miner. Metab.	JAN	2015	33	1					55	60		10.1007/s00774-013-0553-7		6	Endocrinology & Metabolism; Medicine, Research & Experimental	Endocrinology & Metabolism; Research & Experimental Medicine	AY2GX	WOS:000347407900008		
J	Itabashi, A; Yoh, K; Chines, AA; Miki, T; Takada, M; Sato, H; Gorai, I; Sugimoto, T; Mizunuma, H; Ochi, H; Constantine, GD; Ohta, H				Itabashi, Akira; Yoh, Kousei; Chines, Arkadi A.; Miki, Takami; Takada, Masahiko; Sato, Hiroshi; Gorai, Itsuo; Sugimoto, Toshitsugu; Mizunuma, Hideki; Ochi, Hiroshi; Constantine, Ginger D.; Ohta, Hiroaki			Bridging analysis of the efficacy and safety of bazedoxifene in Japanese and global populations of postmenopausal women with osteoporosis	JOURNAL OF BONE AND MINERAL METABOLISM			English	Article						Bazedoxifene; Postmenopausal osteoporosis; Treatment; Selective estrogen receptor modulator; Bone mineral density	VERTEBRAL FRACTURE RISK; BONE-MINERAL DENSITY; CLINICAL-TRIAL; TURNOVER; REDUCTION; PERSPECTIVE; RALOXIFENE; MANAGEMENT; PLACEBO; 3-YEAR	This study examined whether the global clinical data for bazedoxifene could be extrapolated to a Japanese population by evaluating the results of a phase 2 study in postmenopausal Japanese women with osteoporosis as compared to those of a pivotal, phase 3 study. The efficacy of bazedoxifene 20 and 40 mg versus placebo on lumbar spine bone mineral density (BMD), bone turnover markers, lipid profile, incidence of fractures, and safety parameters was compared between the Japanese phase 2 study (N = 429) and the global phase 3 study (N = 7,492) during a 2-year period. In the primary population for assessment of bridging, differences in the mean percent change from baseline in lumbar spine BMD at 2 years relative to placebo were greater for women treated with bazedoxifene 20 and 40 mg in the phase 2 study than in the phase 3 study. BMD changes in the bazedoxifene groups were confirmed to be similar between the phase 2 study population and a subset of the phase 3 study population with similar baseline characteristics. The effects of bazedoxifene on incidence of fractures, bone turnover markers, and lipid metabolism were similar between studies. There were no major differences in safety parameters between studies. The greater improvement in lumbar spine BMD and similar results in bone turnover markers, fracture incidence, and safety profile observed with bazedoxifene in the phase 2 study compared with the phase 3 study confirmed the feasibility of extrapolating the global clinical data to a Japanese population.	[Itabashi, Akira] Saitama Ctr Bone Res, Kubojima Clin, Kumagaya, Saitama 3600831, Japan; [Yoh, Kousei] Hyogo Coll Med, Sasayama Med Ctr, Sasayama, Hyogo, Japan; [Chines, Arkadi A.; Constantine, Ginger D.] Pfizer Inc, Collegeville, PA USA; [Miki, Takami] Osaka City Univ, Sch Med, Osaka 545, Japan; [Takada, Masahiko] Shiga Univ Med Sci, Otsu, Shiga 52021, Japan; [Sato, Hiroshi] Niigata Univ Hlth & Welf, Niigata, Japan; [Gorai, Itsuo] Int Univ Hlth & Welf, Atami Hosp, Atami, Shizuoka, Japan; [Gorai, Itsuo] Hori Hosp, Yokohama, Kanagawa, Japan; [Sugimoto, Toshitsugu] Shimane Univ, Fac Med, Izumo, Shimane, Japan; [Mizunuma, Hideki] Hirosaki Univ, Sch Med, Hirosaki, Aomori 036, Japan; [Ochi, Hiroshi] Pfizer Inc, Tokyo, Japan; [Ohta, Hiroaki] Int Univ Hlth & Welf, Sanno Med Ctr, Tokyo, Japan	Itabashi, A (reprint author), Saitama Ctr Bone Res, Kubojima Clin, 1785-2 Kubojima, Kumagaya, Saitama 3600831, Japan.	itabashi@amail.plala.or.jp			Wyeth Research, Collegeville, PA, USA; Wyeth K. K., Tokyo, Japan; Pfizer Inc.	These studies and analysis were sponsored by Wyeth Research, Collegeville, PA, USA, and Wyeth K. K., Tokyo, Japan, which were acquired by Pfizer Inc in October 2009. Medical writing support was provided by Katie Gersh, PhD, of MedErgy and was funded by Pfizer Inc.	Eastell R, 2003, J BONE MINER RES, V18, P1051, DOI 10.1359/jbmr.2003.18.6.1051; Papaioannou A, 2007, DRUG AGING, V24, P37, DOI 10.2165/00002512-200724010-00003; Itabashi A, 2011, J BONE MINER RES, V26, P519, DOI 10.1002/jbmr.252; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Silverman SL, 2008, J BONE MINER RES, V23, P1923, DOI [10.1359/jbmr.080710, 10.1359/JBMR.080710]; Bischoff-Ferrari HA, 2004, AM J MED, V116, P634, DOI 10.1016/j.amjmed.2003.12.029; Bauer DC, 2004, J BONE MINER RES, V19, P1250, DOI 10.1359/JBMR.040512; Orimo H, 1998, J BONE MINER METAB, V16, P139, DOI 10.1007/s007740050038; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Bonnick SL, 2010, MENOPAUSE, V17, P25, DOI 10.1097/gme.0b013e3181e617e6; Kuchuk NO, 2009, J BONE MINER RES, V24, P693, DOI [10.1359/jbmr.081209, 10.1359/JBMR.081209]; Miller PD, 2008, J BONE MINER RES, V23, P525, DOI 10.1359/JBMR.071206; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Bjarnason NH, 2001, OSTEOPOROSIS INT, V12, P922, DOI 10.1007/s001980170020; Chandran M, 2010, ENDOCR PRACT, V17, P226; Finkelstein JS, 2008, J CLIN ENDOCR METAB, V93, P861, DOI 10.1210/jc.2007-1876; Hagino H, 2009, OSTEOPOROSIS INT, V20, P543, DOI 10.1007/s00198-008-0685-0; International Osteoporosis Foundation, 2009, AS AUD EP COSTS BURD; Ito M, 2001, Semin Musculoskelet Radiol, V5, P121, DOI 10.1055/s-2001-15664; Koh LKH, 2002, ANN ACAD MED SINGAP, V31, P26; Lau EM, 2009, IBMS BONEKEY, V6, P190; Mizuno S, 2005, CLIN TRIALS, V2, P174, DOI 10.1191/1740774505cn077oa; National Osteoporosis Foundation, 2010, CLIN GUID PREV TREAT; National Osteoporosis Foundation, 2010, FAST FACTS OST; Sarkar S, 2002, DRUG INF J, V36, P349; Xu L, 2011, OSTEOPOROSIS INT, V22, P559, DOI 10.1007/s00198-010-1259-5	26	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0914-8779	1435-5604		J BONE MINER METAB	J. Bone Miner. Metab.	JAN	2015	33	1					61	72		10.1007/s00774-013-0554-6		12	Endocrinology & Metabolism; Medicine, Research & Experimental	Endocrinology & Metabolism; Research & Experimental Medicine	AY2GX	WOS:000347407900009		
J	Honma, M; Ikebuchi, Y; Kariya, Y; Suzuki, H				Honma, Masashi; Ikebuchi, Yuki; Kariya, Yoshiaki; Suzuki, Hiroshi			Establishment of optimized in vitro assay methods for evaluating osteocyte functions	JOURNAL OF BONE AND MINERAL METABOLISM			English	Article						Osteocyte; Differentiation; Culture method; Osteoclastogenesis; Co-culture system	BONE-FORMATION; MATRIX; SCLEROSTIN; RANKL; WNT; HOMEOSTASIS; EXPRESSION; PROTEIN; MLO-Y4; CELLS	Recent studies have revealed that osteocytes play multiple important physiological roles. To analyze osteocyte functions in detail, an in vitro experimental system for primary osteocytes would be useful. Unfortunately, osteocytes tend to dedifferentiate and acquire osteoblast-like features even when the cells are cultured in three-dimensional (3D) collagen gel. Therefore, it is desirable to establish osteocyte culture conditions that prevent dedifferentiation over longer periods. In this study, we obtained systematic information about the influence of culture conditions on osteocyte differentiation states. Fetal bovine serum (FBS) concentrations from 0.1 to 0.5 % in 3D culture matrix did not significantly influence the expression of osteocyte markers. On the other hand, addition of Matrigel to the culture matrix significantly enhanced the expression of Rankl and late osteocyte markers such as Sost and Fgf23. Matrigel addition also inhibited upregulation of Opg and early osteocyte markers such as Dmp1 and Gp38. These effects on osteocyte properties were maximal at a Matrigel culture matrix content of 50 %. Matrigel addition to the matrix also increased dendritic process extension by osteocytes. In addition, Matrigel addition significantly stimulated tartrate-resistant acid phosphatase activity in co-culture with bone marrow macrophages. Among the conditions tested, 50 % Matrigel and 0.2 % FBS in type I collagen matrix were optimal for culture of primary osteocytes.	[Honma, Masashi; Ikebuchi, Yuki; Kariya, Yoshiaki; Suzuki, Hiroshi] Univ Tokyo, Fac Med, Tokyo Univ Hosp, Dept Pharm,Bunkyo Ku, Tokyo 1138655, Japan	Honma, M (reprint author), Univ Tokyo, Fac Med, Tokyo Univ Hosp, Dept Pharm,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	mhonma-tky@umin.ac.jp			Japan Society for the Promotion of Science [24390349, 25670632, 24890048]; Ministry of Education, Culture, Sports, Science, and Technology [22136015]	We would like to thank the University of Tokyo and Leica Microsystems Imaging Center for their help with acquisition of imaging data. This work was supported in part by Grant-in-Aid for Scientific Research (B) 24390349, Grant-in-Aid for Challenging Exploratory Research 25670632 and Grant-in-Aid for Young Scientists (Start-up) 24890048 from the Japan Society for the Promotion of Science, and by Grant-in-Aid for Scientific Research on Innovative Areas "HD-physiology" 22136015 from the Ministry of Education, Culture, Sports, Science, and Technology.	Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; McNamara LM, 2009, ANAT REC, V292, P355, DOI 10.1002/ar.20869; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Mulcahy LE, 2011, BONE, V48, P182, DOI 10.1016/j.bone.2010.09.014; van Bezooijen RL, 2007, J BONE MINER RES, V22, P19, DOI 10.1359/JBMR.061002; Kato Y, 1997, J BONE MINER RES, V12, P2014, DOI 10.1359/jbmr.1997.12.12.2014; Li XT, 2003, ENDOCRINOLOGY, V144, P4999, DOI 10.1210/en.2003-0166; Moester MJC, 2010, CALCIFIED TISSUE INT, V87, P99, DOI 10.1007/s00223-010-9372-1; Karsdal MA, 2002, J BIOL CHEM, V277, P44061, DOI 10.1074/jbc.M207205200; Liu SG, 2007, CURR OPIN NEPHROL HY, V16, P329, DOI 10.1097/MNH.0b013e3281ca6ffd; Cheng F, 2010, MATURITAS, V67, P327, DOI 10.1016/j.maturitas.2010.08.011; Dewitt DD, 2009, TISSUE ENG PT A, V15, P2785, DOI 10.1089/ten.TEA.2008.0406; Fukunaga T, 2008, J BIOMECH SCI ENG, V3, P13, DOI 10.1299/jbse.3.13; Gu GL, 2006, CELL TISSUE RES, V323, P263, DOI 10.1007/s00441-005-0066-3; HAUSCHKA PV, 1988, CIBA F SYMP, V136, P207; Honma M, 2013, J BONE MINER RES, V28, P1936, DOI 10.1002/jbmr.1941; KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025; Kurata K, 2007, INT J FATIGUE, V29, P1010, DOI 10.1016/j.ijfatigue.2006.06.011; Lind M, 1996, ACTA ORTHOP SCAND, V67, P407; ten Dijke P, 2008, J BONE JOINT SURG AM, V90A, P31, DOI 10.2106/JBJS.G.01183; Torreggiani E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075204; Yang WC, 2009, BONE, V44, P32, DOI 10.1016/j.bone.2008.08.133	24	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0914-8779	1435-5604		J BONE MINER METAB	J. Bone Miner. Metab.	JAN	2015	33	1					73	84		10.1007/s00774-013-0555-5		12	Endocrinology & Metabolism; Medicine, Research & Experimental	Endocrinology & Metabolism; Research & Experimental Medicine	AY2GX	WOS:000347407900010		
J	Nagase, S; Ohyama, M; Hashimoto, Y; Small, M; Sharpe, J; Manako, J; Kuwayama, T; Deacon, S				Nagase, Shinichi; Ohyama, Michiyo; Hashimoto, Yoshitaka; Small, Maria; Sharpe, John; Manako, Junichiro; Kuwayama, Tomohiro; Deacon, Steve			Bone turnover markers and pharmacokinetics of a new sustained-release formulation of the cathepsin K inhibitor, ONO-5334, in healthy post-menopausal women	JOURNAL OF BONE AND MINERAL METABOLISM			English	Article						Cathepsin K inhibitor; Osteoporosis; Sustained-release formulation; CTX-I; ONO-5334	MATRIX DEGRADATION; PYCNODYSOSTOSIS; OSTEOPETROSIS; DEFICIENCY; RESORPTION; MICE	A sustained-release tablet (SRT) of ONO-5334 was compared to the immediate-release tablet (IRT) dose, which demonstrated effects on bone mineral density (BMD) comparable to those of therapy with alendronate. The single-dose phase was a randomized, partial single-blind, crossover study where 50-, 100-, and 300-mg SRTs and 300-mg IRTs were administered to nine post-menopausal women. The multiple-dose phase was a randomized, double-blind, placebo-controlled, parallel-group study where 100- and 300-mg SRTs, or placebo were administered to 24 women. After a single administration of a 300-mg SRT, mean C (max) was 3.3-fold lower, mean AUC(inf) was 0.83-fold lower and mean C (24h) was 5.4-fold higher compared to the 300-mg IRT. Repeated SRT dosing did not significantly affect PK, although C (24h) increased slightly. After a single ONO-5334 dose, serum CTX-I was suppressed by 50 % within 1 h, reaching maximum suppression 6 h post-dose. Greater suppression was maintained longer by the 300-mg SRT vs. the 300-mg IRT. Second morning void and cumulative urine CTX-I showed clear dose-response effects at/over 24 h for SRT, with maximum suppression occurring at/over 24 h (except 50- and 300-mg cumulative urine). Repeated dosing suggested greater suppression of urine CTX-I. Compared with the IRT, the SRT showed reduced C (max), greater C (24h), and slightly reduced AUC(inf) dose for dose. The SRT showed clear dose-response suppression on bone resorption and greater efficacy dose for dose vs. the IRT.	[Nagase, Shinichi; Small, Maria; Sharpe, John; Kuwayama, Tomohiro; Deacon, Steve] ONO PHARMA UK LTD, Drug Dev, London WC1V 6EA, England; [Ohyama, Michiyo; Manako, Junichiro] Ono Pharmaceut Co Ltd, Clin Dev Planning, Chuo Ku, Osaka 5418564, Japan; [Hashimoto, Yoshitaka] Ono Pharmaceut Co Ltd, Pharmacokinet Res Grp, Tsukuba, Ibaraki 3004247, Japan	Nagase, S (reprint author), ONO PHARMA UK LTD, Drug Dev, 71 High Holborn, London WC1V 6EA, England.	s.nagase@ono.co.jp			Ono Pharmaceutical Co., Ltd.	This study was sponsored by Ono Pharmaceutical Co., Ltd. We would like to thank Dr. Gillian Pover for medical support provided to this study, as well as Dr. med. Kathrin Reseski (Principal Investigator) and the staff at PAREXEL International GmbH for their help with this study.	[Anonymous], DAT FIL INV ON COMP; [Anonymous], DAT FIL INH EFF ONO; Eastell R, 2011, J BONE MINER RES, V26, P1303, DOI 10.1002/jbmr.341; Nishi Y, 1999, J BONE MINER RES, V14, P1902, DOI 10.1359/jbmr.1999.14.11.1902; Ochi Y, 2011, BONE, V49, P1351, DOI 10.1016/j.bone.2011.09.041; Gowen M, 1999, J BONE MINER RES, V14, P1654, DOI 10.1359/jbmr.1999.14.10.1654; Gelb BD, 1996, SCIENCE, V273, P1236, DOI 10.1126/science.273.5279.1236; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; Bjarnason NH, 2002, BONE, V30, P307, DOI 10.1016/S8756-3282(01)00662-7; BERTI PJ, 1995, J MOL BIOL, V246, P273, DOI 10.1006/jmbi.1994.0083; Nagase S, 2012, J CLIN PHARMACOL, V52, P306, DOI 10.1177/0091270011399080; Eastell R, 2014, J BONE MINER RES, V29, P458, DOI 10.1002/jbmr.2047; Engelke K, 2012, IOF ECCEO12 EUR C OS; SCHLEMMER A, 1992, J CLIN ENDOCR METAB, V74, P476, DOI 10.1210/jc.74.3.476; Small M, 2012, J BONE MINER RES S1, V27; Yamada H, 2009, AM SOC BON MIN RES	16	3	3	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0914-8779	1435-5604		J BONE MINER METAB	J. Bone Miner. Metab.	JAN	2015	33	1					93	100		10.1007/s00774-013-0558-2		8	Endocrinology & Metabolism; Medicine, Research & Experimental	Endocrinology & Metabolism; Research & Experimental Medicine	AY2GX	WOS:000347407900012		
J	Kurobe, M; Kawai, K; Oikawa, T; Ichioka, D; Kandori, S; Takaoka, E; Kojima, T; Joraku, A; Suetomi, T; Miyazaki, J; Nishiyama, H				Kurobe, Masahiro; Kawai, Koji; Oikawa, Takehiro; Ichioka, Daishi; Kandori, Shuya; Takaoka, Ei-ichirou; Kojima, Takahiro; Joraku, Akira; Suetomi, Takahiro; Miyazaki, Jun; Nishiyama, Hiroyuki			Paclitaxel, ifosfamide, and cisplatin (TIP) as salvage and consolidation chemotherapy for advanced germ cell tumor	JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY			English	Article						TIP; Salvage; Chemotherapy; Germ cell tumor	HIGH-DOSE CHEMOTHERAPY; TESTICULAR-CANCER; 2ND-LINE THERAPY; PLUS IFOSFAMIDE; PHASE-II; ETOPOSIDE; BLEOMYCIN; CARBOPLATIN; COMBINATION; BEP	The purpose of the study was to assess the efficacy of TIP as salvage chemotherapy for germ cell tumor (GCT) patients with relapsed disease or cisplatin (CDDP)-refractory disease and consolidation chemotherapy for patients who responded unfavorably to first-line chemotherapy. Forty-three patients with advanced GCT were treated with TIP. Eleven with relapsed disease and five with CDDP-refractory disease received TIP as salvage chemotherapy. The remaining 27 received TIP as consolidation chemotherapy following initial induction chemotherapy. All patients received prophylactic granulocyte colony-stimulating factor. In total, 116 cycles of TIP were administered with a median of three cycles (range 1-4 cycles) per patient. Before TIP, 33 patients showed elevated tumor marker and 23 patients (70 %) achieved marker normalization with the chemotherapy. One of six (17 %) patients with refractory disease and 5 of 10 (50 %) patients with relapsed disease achieved durable complete response (CR) after TIP with or without surgery. Eighteen of 27 (67 %) patients receiving TIP as consolidation chemotherapy achieved durable CR. Five additional patients were given further chemotherapy and achieved durable CR. Grade 4 leukocytopenia and thrombocytopenia were observed in 91 and 42 % of patients, respectively; all were managed with routine supportive care. Grade 2 and grade 3 sensory neuropathy was observed in 37 and 2 % of patients, respectively. The TIP was effective for relapsed patients with favorable risk features and selected CDDP-refractory GCT patients. Results of TIP as consolidation for patients with unfavorable response to the initial chemotherapy were also encouraging. The toxicities were mainly myelosuppression and sensory neuropathy.	[Kurobe, Masahiro; Kawai, Koji; Ichioka, Daishi; Kandori, Shuya; Takaoka, Ei-ichirou; Kojima, Takahiro; Joraku, Akira; Suetomi, Takahiro; Miyazaki, Jun; Nishiyama, Hiroyuki] Univ Tsukuba, Inst Clin Med, Fac Med, Dept Urol, Tsukuba, Ibaraki 3058575, Japan; [Oikawa, Takehiro] Tsukuba Med Ctr Hosp, Dept Urol, Tsukuba, Ibaraki, Japan	Kurobe, M (reprint author), Univ Tsukuba, Inst Clin Med, Fac Med, Dept Urol, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	gdechirico1982-igaku@yahoo.co.jp; nishiuro@md.tsukuba.ac.jp					Lorch A, 2011, J CLIN ONCOL, V29, P2178, DOI 10.1200/JCO.2010.32.6678; Kondagunta GV, 2007, J CLIN ONCOL, V25, P85, DOI 10.1200/JCO.2006.06.9401; Kondagunta GV, 2005, J CLIN ONCOL, V23, P6549, DOI 10.1200/JCO.2005.19.638; Nichols CR, 1998, J CLIN ONCOL, V16, P1287; Einhorn LH, 2007, NEW ENGL J MED, V357, P340, DOI 10.1056/NEJMoa067749; McCaffrey JA, 1997, J CLIN ONCOL, V15, P2559; Motzer RJ, 2000, J CLIN ONCOL, V18, P2413; de Wit R, 2012, J CLIN ONCOL, V30, P792, DOI 10.1200/JCO.2011.37.0171; WILLIAMS SD, 1987, NEW ENGL J MED, V316, P1435, DOI 10.1056/NEJM198706043162302; Kawai K, 2003, JPN J CLIN ONCOL, V33, P127, DOI 10.1093/jjco/hyg029; Kollmannsberger C, 2004, J CLIN ONCOL, V22, P108, DOI 10.1200/JCO.2004.06.068; Mardiak J, 2005, NEOPLASMA, V52, P497; Mead GM, 2005, BRIT J CANCER, V93, P178, DOI 10.1038/sj.bjc.6602682; Mead GM, 1997, J CLIN ONCOL, V15, P594; Miki T, 2007, INT J UROL, V14, P54, DOI 10.1111/j.1442-2042.2006.01655.x; Miyazaki J, 2000, INT J UROL, V7, P258, DOI 10.1046/j.1442-2042.2000.00187.x; Park S, 2011, ONKOLOGIE, V34, P416, DOI 10.1159/000331129; Voss MH, 2011, ONKOLOGIE, V34, P410, DOI 10.1159/000331699	18	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0171-5216	1432-1335		J CANCER RES CLIN	J. Cancer Res. Clin. Oncol.	JAN	2015	141	1					127	133		10.1007/s00432-014-1760-x		7	Oncology	Oncology	AY0LY	WOS:000347289100015		
J	Yasui, H; Muro, K; Shimada, Y; Tsuji, A; Sameshima, S; Baba, H; Satoh, T; Denda, T; Ina, K; Nishina, T; Yamaguchi, K; Esaki, T; Tokunaga, S; Kuwano, H; Boku, N; Komatsu, Y; Watanabe, M; Hyodo, I; Morita, S; Sugihara, K				Yasui, Hirofumi; Muro, Kei; Shimada, Yasuhiro; Tsuji, Akihito; Sameshima, Shinichi; Baba, Hideo; Satoh, Taroh; Denda, Tadamichi; Ina, Kenji; Nishina, Tomohiro; Yamaguchi, Kensei; Esaki, Taito; Tokunaga, Shinya; Kuwano, Hiroyuki; Boku, Narikazu; Komatsu, Yoshito; Watanabe, Masahiko; Hyodo, Ichinosuke; Morita, Satoshi; Sugihara, Kenichi			A phase 3 non-inferiority study of 5-FU/l-leucovorin/irinotecan (FOLFIRI) versus irinotecan/S-1 (IRIS) as second-line chemotherapy for metastatic colorectal cancer: updated results of the FIRIS study	JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY			English	Article						Colorectal cancer; FIRIS; Irinotecan; IRIS; S-1	S-1 IRIS; TRIALS	The FIRIS study previously demonstrated non-inferiority of IRIS (irinotecan plus S-1) to FOLFIRI (5-fluorouracil/leucovorin with irinotecan) for progression-free survival as the second-line chemotherapy for metastatic colorectal cancer (mCRC) as the primary endpoint. The overall survival (OS) data were immature at the time of the primary analysis. Between 30 January 2006 and 29 January 2008, 426 patients with mCRC who failed in first-line chemotherapy were randomly assigned to receive either FOLFIRI or IRIS. After the primary analysis, the follow-up survey was cut off on 29 July 2010, and the final OS data were analysed. With a median follow-up of 39.2 months, the median OS was 17.4 months in the FOLFIRI group and 17.8 months in the IRIS group [hazard ratio (HR) 0.900; 95 % confidence interval (CI) 0.728-1.112]. In the pre-planned subgroup of patients who received prior chemotherapy containing oxaliplatin, the median OS was 12.7 months in the FOLFIRI group and 15.3 months in the IRIS group (HR 0.755; 95 % CI 0.580-0.983). IRIS is non-inferior to FOLFIRI for OS as second-line chemotherapy for mCRC. IRIS can be an option for second-line chemotherapy of mCRC. (ClinicalTrials.gov Number: NCT00284258).	[Yasui, Hirofumi] Shizuoka Canc Ctr, Div Gastrointestinal Oncol, Nagaizumi, Shizuoka 4118777, Japan; [Muro, Kei] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi 464, Japan; [Shimada, Yasuhiro] Natl Canc Ctr, Div Gastrointestinal Oncol, Tokyo, Japan; [Tsuji, Akihito] Kobe City Med Ctr Gen Hosp, Dept Med Oncol, Kobe, Hyogo, Japan; [Sameshima, Shinichi] Dokkyo Med Univ, Koshigaya Hosp, Dept Surg, Koshigaya, Japan; [Baba, Hideo] Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto, Japan; [Satoh, Taroh] Osaka Univ, Grad Sch Med, Dept Frontier Sci Canc & Chemotherapy, Suita, Osaka, Japan; [Denda, Tadamichi] Chiba Canc Ctr, Dept Gastroenterol, Chiba, Japan; [Ina, Kenji] Nagoya Mem Hosp, Dept Med Oncol, Nagoya, Aichi, Japan; [Nishina, Tomohiro] Natl Hosp Org, Shikoku Canc Ctr, Dept Med Oncol, Matsuyama, Ehime, Japan; [Yamaguchi, Kensei] Saitama Canc Ctr, Dept Gastroenterol, Ina, Saitama, Japan; [Esaki, Taito] Kyushu Natl Canc Ctr, Dept Gastrointestinal & Med Oncol, Fukuoka, Japan; [Tokunaga, Shinya] Osaka City Gen Hosp, Dept Clin Oncol, Osaka, Japan; [Kuwano, Hiroyuki] Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, Maebashi, Gumma 371, Japan; [Boku, Narikazu] St Marianna Univ, Sch Med, Dept Clin Oncol, Kawasaki, Kanagawa, Japan; [Komatsu, Yoshito] Hokkaido Univ Hosp, Ctr Canc, Dept Canc Chemotherapy, Sapporo, Hokkaido 060, Japan; [Watanabe, Masahiko] Kitasato Univ, Sch Med, Dept Surg, Sagamihara, Kanagawa 228, Japan; [Hyodo, Ichinosuke] Tsukuba Univ Hosp, Div Gastroenterol, Tsukuba, Ibaraki, Japan; [Morita, Satoshi] Yokohama City Univ, Med Ctr, Dept Biostat & Epidemiol, Yokohama, Kanagawa 232, Japan; [Sugihara, Kenichi] Tokyo Med & Dent Univ, Grad Sch, Dept Surg Oncol, Tokyo, Japan	Yasui, H (reprint author), Shizuoka Canc Ctr, Div Gastrointestinal Oncol, 1007 Shimonagakubo, Nagaizumi, Shizuoka 4118777, Japan.	h.yasui@scchr.jp			Taiho Pharmaceutical Co. Ltd., Japan; Daiichi Sankyo Co. Ltd., Japan	We thank all of the patients, their families, and the institutions involved in this study (see "Appendix"). The authors also thank Yuh Sakata, Yasuo Ohashi, and Nobuyuki Yamamoto for the Independent Data Monitoring Committee, and Atsushi Ohtsu, Yasuaki Arai, and Junji Tanaka for the Independent Central Review Committee for their contributions to this report. The authors dedicate this article to the memory of Prof. Hiroya Takiuchi, who contributed to the conception and design of this study. The senior academic authors designed the trial in cooperation with the study sponsors. The sponsors provided funding and organisational support, collected data, and performed analyses, but did not undertake any data interpretation. This report was written by the corresponding author (with additional input from the other authors), who had unrestricted access to the raw study data, gives assurance for the accuracy and completeness of the reported analyses, and had final responsibility for the decision to submit for publication. This work was funded by Taiho Pharmaceutical Co. Ltd., Japan, and Daiichi Sankyo Co. Ltd., Japan.	SPIEGELHALTER DJ, 1994, J R STAT SOC A STAT, V157, P357, DOI 10.2307/2983527; Peeters M, 2010, J CLIN ONCOL, V28, P4706, DOI 10.1200/JCO.2009.27.6055; Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113; Schmoll HJ, 2012, ANN ONCOL, V23, P2479, DOI 10.1093/annonc/mds236; O'Neil BH, 2008, ONCOLOGIST, V13, P1074, DOI 10.1634/theoncologist.2008-0083; Baba H, 2012, BRIT J CANCER, V107, P1950, DOI 10.1038/bjc.2012.502; Muro K, 2010, LANCET ONCOL, V11, P853, DOI 10.1016/S1470-2045(10)70181-9; Sobrero AF, 2008, J CLIN ONCOL, V26, P2311, DOI 10.1200/JCO.2007.13.1193; BROOKMEYER R, 1982, BIOMETRICS, V38, P29, DOI 10.2307/2530286; Fuse N, 2008, INT J CLIN ONCOL, V13, P144, DOI 10.1007/s10147-007-0737-z; Goto A, 2006, ANN ONCOL, V17, P968, DOI 10.1093/annonc/mdl066; Komatsu Y, 2010, ADV THER, V27, P483, DOI 10.1007/s12325-010-0037-2; Komatsu Y, 2011, ONCOLOGY-BASEL, V80, P70, DOI 10.1159/000328739; National Comprehensive Cancer Network Inc, 2014, NCCN CLIN PRACT GUID; NCCN, 2014, NCCN CLIN PRACT GUID; Shiozawa M, 2010, CANCER CHEMOTH PHARM, V66, P987, DOI 10.1007/s00280-010-1278-0; Tsunoda A, 2009, ONCOLOGY-BASEL, V77, P192, DOI 10.1159/000236017	17	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0171-5216	1432-1335		J CANCER RES CLIN	J. Cancer Res. Clin. Oncol.	JAN	2015	141	1					153	160		10.1007/s00432-014-1783-3		8	Oncology	Oncology	AY0LY	WOS:000347289100018		
J	Ofude, M; Kitagawa, Y; Yaegashi, H; Izumi, K; Ueno, S; Kadono, Y; Konaka, H; Mizokami, A; Namiki, M				Ofude, Mitsuo; Kitagawa, Yasuhide; Yaegashi, Hiroshi; Izumi, Kouji; Ueno, Satoru; Kadono, Yoshifumi; Konaka, Hiroyuki; Mizokami, Atsushi; Namiki, Mikio			Selection of adjuvant intravesical therapies using the European Organization for Research and Treatment of Cancer scoring system in patients at intermediate risk of non-muscle-invasive bladder cancer	JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY			English	Article						Bacillus Calmette-Guerin; European Organization for Research and Treatment of Cancer scoring system; Non-muscle-invasive bladder cancer; Recurrence risk predictor	BACILLUS-CALMETTE-GUERIN; STAGE TA; PREDICTING RECURRENCE; UROTHELIAL CARCINOMA; MITOMYCIN-C; PROGRESSION; EORTC; METAANALYSIS; GUIDELINES; CHEMOTHERAPY	We investigated whether the European Organization for Research and Treatment of Cancer (EORTC) scoring system can be used for the selection of adjuvant intravesical therapies for individual patients who undergo transurethral resection (TURB) for non-muscle-invasive bladder cancer (NMIBC). We retrospectively analyzed the data of 469 TURB cases for NMIBC. Clinical and pathological variables were compared using univariate and multivariate Cox proportional hazards regression analyses. The recurrence-free survival (RFS) rate was estimated by the Kaplan-Meier method, and the log-rank test was used to compare groups divided according to EORTC score or type of adjuvant therapy. The overall RFS rate at 1 and 3 years was 59.1 and 40.3 %, respectively. Of the total, 424 TURB cases (90.4 %) had an EORTC score of 1-9. Tumor number, size, and grade were significant predictors of time to recurrence. The EORTC score was a significant predictor of RFS according to multivariate analysis, and the hazard ratios increased according to each EORTC score in multivariate analysis of a combination of EORTC score and adjuvant therapies. In groups with intermediate recurrence risk as defined by the European Association of Urology guidelines, the recurrence prevention effects in patients with an EORTC score of a parts per thousand yen5 were significantly greater with intravesical Bacillus Calmette-Gu,rin therapy than with weekly intravesical chemotherapy. The EORTC scoring system provides useful information for the selection of adjuvant therapies for patients at intermediate risk of NMIBC recurrence.	[Ofude, Mitsuo; Kitagawa, Yasuhide; Yaegashi, Hiroshi; Izumi, Kouji; Ueno, Satoru; Kadono, Yoshifumi; Konaka, Hiroyuki; Mizokami, Atsushi; Namiki, Mikio] Kanazawa Univ, Grad Sch Med Sci, Dept Integrat Canc Therapy & Urol, Kanazawa, Ishikawa 9208640, Japan	Kitagawa, Y (reprint author), Kanazawa Univ, Grad Sch Med Sci, Dept Integrat Canc Therapy & Urol, Takaramachi 13-1, Kanazawa, Ishikawa 9208640, Japan.	yasukita@med.kanazawa-u.ac.jp	IZUMI, KOUJI/C-5973-2015				Sylvester RJ, 2004, J UROLOGY, V171, P2186, DOI 10.1097/01.ju.0000125486.92260.b2; Hernandez V, 2011, WORLD J UROL, V29, P409, DOI 10.1007/s00345-010-0635-2; Faba OR, 2012, WORLD J UROL, V30, P833, DOI 10.1007/s00345-012-0967-1; van Rhijn BWG, 2009, EUR UROL, V56, P430, DOI 10.1016/j.eururo.2009.06.028; Brausi M, 2011, J UROLOGY, V186, P2158, DOI 10.1016/j.juro.2011.07.076; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; Sylvester RJ, 2010, EUR UROL, V57, P766, DOI 10.1016/j.eururo.2009.12.024; Kikuchi E, 2009, INT J UROL, V16, P279, DOI 10.1111/j.1442-2042.2008.02235.x; Gudjonsson S, 2009, EUR UROL, V55, P773, DOI 10.1016/j.eururo.2009.01.006; Bohle A, 2003, J UROLOGY, V169, P90, DOI 10.1097/01.ju.0000039680.90768.b3; Malmstrom PU, 2009, EUR UROL, V56, P247, DOI 10.1016/j.eururo.2009.04.038; Babjuk M, 2013, EUR UROL, V64, P639, DOI 10.1016/j.eururo.2013.06.003; Ehdaie B, 2013, EUR UROL, V64, P579, DOI 10.1016/j.eururo.2013.05.027; Friedrich MG, 2007, EUR UROL, V52, P1123, DOI 10.1016/j.eururo.2007.02.063; Hisataki T, 2001, UROLOGY, V58, P935, DOI 10.1016/S0090-4295(01)01435-2; Mostofi F. K., 1973, HISTOLOGICAL TYPING; Pillai R, 2011, THESCIENTIFICWORLDJO, V11, P751, DOI 10.1100/tsw.2011.77; Sakano S, 2011, BJU INT, V107, P1598, DOI 10.1111/j.1464-410X.2010.09850.x; Sobin LH, 1997, TNM CLASSIFICATION M; Xu TY, 2013, UROLOGY, V82, P387, DOI 10.1016/j.urology.2013.04.007	20	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0171-5216	1432-1335		J CANCER RES CLIN	J. Cancer Res. Clin. Oncol.	JAN	2015	141	1					161	168		10.1007/s00432-014-1795-z		8	Oncology	Oncology	AY0LY	WOS:000347289100019		
J	Murakami, N; Yoshimoto, S; Matsumoto, F; Ueno, T; Ito, Y; Watanabe, S; Kobayashi, K; Harada, K; Kitaguchi, M; Sekii, S; Takahashi, K; Yoshio, K; Inaba, K; Morota, M; Sumi, M; Saito, Y; Itami, J				Murakami, Naoya; Yoshimoto, Seiichi; Matsumoto, Fumihiko; Ueno, Takao; Ito, Yoshinori; Watanabe, Satoru; Kobayashi, Kazuma; Harada, Ken; Kitaguchi, Mayuka; Sekii, Shuhei; Takahashi, Kana; Yoshio, Kotaro; Inaba, Koji; Morota, Madoka; Sumi, Minako; Saito, Yutaka; Itami, Jun			Severe gastrointestinal bleeding in patients with locally advanced head and neck squamous cell carcinoma treated by concurrent radiotherapy and Cetuximab	JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY			English	Article						EGFR inhibitor; Cetuximab; Radiation therapy; Gastrointestinal bleeding; Adverse effect; Head and neck squamous cell carcinoma	CANCER-PATIENTS; CLINICAL-PRACTICE; DRUG-THERAPY; MANAGEMENT; BEVACIZUMAB; GUIDELINES; TOXICITIES; TRIAL	Concurrent administration of Cetuximab with radiotherapy (Cetuximab-radiation) has been accepted as an alternative option for locally advanced head and neck squamous cell carcinoma (HNSCC). The purpose of this study was to retrospectively compare complications of Cetuximab-radiation with those of concurrent chemoradiation (cCRT) with a special concern on gastrointestinal (GI) hemorrhage associated with Cetuximab-radiation. Indication of Cetuximab-radiation/cCRT for locally advanced HNSCC was primary, postoperative adjuvant, or salvage after recurrence. Our first choice for patients with advanced HNSCC was cCRT; however, if patients did not have enough organ function but with a favorable performance status, Cetuximab-radiation was applied. From April 2013 to March 2014, 30 patients were identified who were treated with Cetuximab-radiation or cCRT and each cohort consisted of 15 patients. Patients in Cetuximab-radiation cohort suffered from a statistically higher rate of G3/4 dermatitis compared with cCRT cohort (80 vs. 13.3 %, respectively, p < 0.001). More patients required unexpected hospitalization due to deterioration of their general condition and total parenteral nutrition in Cetuximab-radiation cohort (p = 0.011 and p = 0.025, respectively). While none experienced GI bleeding in cCRT cohort, four patients experienced GI bleeding including two grade 4 bleeding in Cetuximab-radiation cohort (p = 0.05). It is probable that there exists a group of patients who are susceptible for Cetuximab-radiation not only in terms of well-known dermatitis and mucositis but also of gastrointestinal complications.	[Murakami, Naoya; Ito, Yoshinori; Watanabe, Satoru; Kobayashi, Kazuma; Harada, Ken; Kitaguchi, Mayuka; Sekii, Shuhei; Takahashi, Kana; Yoshio, Kotaro; Inaba, Koji; Morota, Madoka; Sumi, Minako; Itami, Jun] Natl Canc Ctr, Dept Radiat Oncol, Chuo Ku, Tokyo 1040045, Japan; [Yoshimoto, Seiichi; Matsumoto, Fumihiko] Natl Canc Ctr, Dept Head & Neck Surg, Chuo Ku, Tokyo 1040045, Japan; [Ueno, Takao] Natl Canc Ctr, Dept Oral Hlth & Diagnost Sci, Chuo Ku, Tokyo 1040045, Japan; [Saito, Yutaka] Natl Canc Ctr, Endoscopy Div, Chuo Ku, Tokyo 1040045, Japan	Murakami, N (reprint author), Natl Canc Ctr, Dept Radiat Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	ore-murakami@hotmail.co.jp			Cancer Research and Development Fund of National Cancer Center [23-A-13]	Part of this study was financially supported by Cancer Research and Development Fund 23-A-13 of National Cancer Center.	Aapro M, 2000, ANN ONCOL, V11, P223, DOI 10.1023/A:1011156805700; ALISON MR, 1994, CELL BIOL INT, V18, P1, DOI 10.1006/cbir.1994.1001; Bernier J, 2011, ANN ONCOL, V22, P2191, DOI 10.1093/annonc/mdr139; Budach W, 2007, NEW ENGL J MED, V357, P514, DOI 10.1056/NEJMc071075; Scope A, 2007, J CLIN ONCOL, V25, P5390, DOI 10.1200/JCO.2007.12.6987; Studer G, 2011, INT J RADIAT ONCOL, V81, P110, DOI 10.1016/j.ijrobp.2010.05.018; Maloney DG, 2012, NEW ENGL J MED, V366, P2008, DOI 10.1056/NEJMct1114348; Eilers RE, 2010, JNCI-J NATL CANCER I, V102, P47, DOI 10.1093/jnci/djp439; Hitt R, 2005, EUR J CANCER, V41, P453, DOI 10.1016/j.ejca.2004.10.014; Curran D, 2007, J CLIN ONCOL, V25, P2191, DOI 10.1200/JCO.2006.08.8005; Saif MW, 2006, EXPERT OPIN DRUG SAF, V5, P553, DOI 10.1517/14740338.5.4.553; Lansdown ABG, 2007, WOUND REPAIR REGEN, V15, P2, DOI 10.1111/j.1524-475X.2006.00179.x; Ranpura V, 2011, JAMA-J AM MED ASSOC, V305, P487, DOI 10.1001/jama.2011.51; Ang KK, 2002, CANCER RES, V62, P7350; Bonner JA, 2010, LANCET ONCOL, V11, P21, DOI 10.1016/S1470-2045(09)70311-0; Bölke Edwin, 2008, Strahlenther Onkol, V184, P105, DOI 10.1007/s00066-008-1829-z; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Brockstein Bruce, 2008, J Natl Compr Canc Netw, V6, P696; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Lacouture ME, 2006, NAT REV CANCER, V6, P803, DOI 10.1038/nrc1970; Lord HK, 2008, CLIN ONCOL-UK, V20, P96, DOI 10.1016/j.clon.2007.09.003; Peterson DE, 2010, ANN ONCOL, V21, pv261, DOI 10.1093/annonc/mdq197; Pfister DG, 2006, J CLIN ONCOL, V24, P1072, DOI 10.1200/JCO.2004.00.1792; Thomas Melodie, 2005, Clin J Oncol Nurs, V9, P332, DOI 10.1188/05.CJON.332-338; Valeriani M, 2012, RADIOL MED, V117, P125, DOI 10.1007/s11547-011-0716-3	26	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0171-5216	1432-1335		J CANCER RES CLIN	J. Cancer Res. Clin. Oncol.	JAN	2015	141	1					177	184		10.1007/s00432-014-1801-5		8	Oncology	Oncology	AY0LY	WOS:000347289100021		
J	Nakano, R; Takanashi, T; Surlykke, A				Nakano, Ryo; Takanashi, Takuma; Surlykke, Annemarie			Moth hearing and sound communication	JOURNAL OF COMPARATIVE PHYSIOLOGY A-NEUROETHOLOGY SENSORY NEURAL AND BEHAVIORAL PHYSIOLOGY			English	Review						Co-evolution; Sensory exploitation; Ultrasound; Echolocating bats; Predator-prey	ULTRASONIC COURTSHIP SONGS; AUSTRALIAN WHISTLING MOTH; BAT ECHOLOCATION; NOCTUID MOTH; TIGER MOTH; AUDITORY-SENSITIVITY; LASIURUS-CINEREUS; SEXUAL SELECTION; RECEIVER BIASES; ARCTIID MOTHS	Active echolocation enables bats to orient and hunt the night sky for insects. As a counter-measure against the severe predation pressure many nocturnal insects have evolved ears sensitive to ultrasonic bat calls. In moths bat-detection was the principal purpose of hearing, as evidenced by comparable hearing physiology with best sensitivity in the bat echolocation range, 20-60 kHz, across moths in spite of diverse ear morphology. Some eared moths subsequently developed sound-producing organs to warn/startle/jam attacking bats and/or to communicate intraspecifically with sound. Not only the sounds for interaction with bats, but also mating signals are within the frequency range where bats echolocate, indicating that sound communication developed after hearing by "sensory exploitation". Recent findings on moth sound communication reveal that close-range (similar to a few cm) communication with low-intensity ultrasounds "whispered" by males during courtship is not uncommon, contrary to the general notion of moths predominantly being silent. Sexual sound communication in moths may apply to many eared moths, perhaps even a majority. The low intensities and high frequencies explain that this was overlooked, revealing a bias towards what humans can sense, when studying (acoustic) communication in animals.	[Nakano, Ryo] NARO Inst Fruit Tree Sci, Breeding & Pest Management Div, Tsukuba, Ibaraki 3058605, Japan; [Nakano, Ryo] Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON M1C 1A4, Canada; [Takanashi, Takuma] Forestry & Forest Prod Res Inst, Dept Forest Entomol, Tsukuba, Ibaraki 3058687, Japan; [Surlykke, Annemarie] Univ Southern Denmark, Dept Biol, DK-5230 Odense M, Denmark	Surlykke, A (reprint author), Univ Southern Denmark, Dept Biol, Campusvej 55, DK-5230 Odense M, Denmark.	ams@biology.sdu.dk					ACHARYA L, 1992, CAN J ZOOL, V70, P1292, DOI 10.1139/z92-180; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; Conner WE, 2012, ANNU REV ENTOMOL, V57, P21, DOI 10.1146/annurev-ento-121510-133537; Schnitzler HU, 2003, TRENDS ECOL EVOL, V18, P386, DOI 10.1016/S0169-5347(03)00185-X; Rodriguez RL, 2004, PHYSIOL ENTOMOL, V29, P159, DOI 10.1111/j.1365-3032.2004.00380.x; Ryan MJ, 1998, SCIENCE, V281, P1999, DOI 10.1126/science.281.5385.1999; Fullard JH, 2001, P ROY SOC B-BIOL SCI, V268, P1375, DOI 10.1098/rspb.2001.1664; ter Hofstede HM, 2011, NATURWISSENSCHAFTEN, V98, P1057, DOI 10.1007/s00114-011-0851-7; Zuk M, 2006, BIOL LETT-UK, V2, P521, DOI 10.1098/rsbl.2006.0539; Endler JA, 1998, TRENDS ECOL EVOL, V13, P415, DOI 10.1016/S0169-5347(98)01471-2; Nakano R, 2008, P NATL ACAD SCI USA, V105, P11812, DOI 10.1073/pnas.0804056105; Conner WE, 1999, J EXP BIOL, V202, P1711; SURLYKKE A, 1985, J COMP PHYSIOL A, V156, P831, DOI 10.1007/BF00610835; Alem S, 2011, BEHAV ECOL SOCIOBIOL, V65, P2105, DOI 10.1007/s00265-011-1219-x; Zuk M, 1998, Q REV BIOL, V73, P415, DOI 10.1086/420412; ter Hofstede HM, 2013, J EXP BIOL, V216, P3954, DOI 10.1242/jeb.093294; Fullard JH, 2007, BIOL LETT-UK, V3, P26, DOI 10.1098/rsbl.2006.0550; Surlykke A, 1999, NATURWISSENSCHAFTEN, V86, P238, DOI 10.1007/s001140050607; van Staaden MJ, 1998, NATURE, V394, P773, DOI 10.1038/29517; Fullard JH, 2007, J EXP BIOL, V210, P2481, DOI 10.1242/jeb.001909; Ratcliffe JM, 2009, BIOL LETTERS, V5, P368, DOI 10.1098/rsbl.2009.0079; Miller LA, 2001, BIOSCIENCE, V51, P570, DOI 10.1641/0006-3568(2001)051[0570:HSIDAA]2.0.CO;2; SPANGLER HG, 1984, PHYSIOL ENTOMOL, V9, P87, DOI 10.1111/j.1365-3032.1984.tb00684.x; BELWOOD JJ, 1987, SCIENCE, V238, P64, DOI 10.1126/science.238.4823.64; BAILEY WJ, 1978, NATURE, V272, P444, DOI 10.1038/272444a0; BLEST AD, 1963, PROC R SOC SER B-BIO, V158, P196, DOI 10.1098/rspb.1963.0042; Conner WE, 2014, INSECT HEARING ACOUS, V1, P65, DOI DOI 10.1007/978-3-642-40462-7_5; Corcoran AJ, 2009, SCIENCE, V325, P325, DOI 10.1126/science.1174096; Corcoran AJ, 2010, CURR ZOOL, V56, P358; Corcoran AJ, 2012, J EXP BIOL, V215, P4278, DOI 10.1242/jeb.076943; Corcoran AJ, 2014, J COMP PHYSIOL A, V200, P811, DOI 10.1007/s00359-014-0924-0; Fullard JH, 1998, SPR HDB AUD, V10, P279; FULLARD JH, 1979, CAN J ZOOL, V57, P647, DOI 10.1139/z79-076; FULLARD JH, 1993, TRENDS ECOL EVOL, V8, P248, DOI 10.1016/0169-5347(93)90200-9; Fullard JH, 1997, J COMP PHYSIOL A, V181, P477, DOI 10.1007/s003590050131; Gerhardt H, 2002, ACOUSTIC COMMUNICATI; Gopfert MC, 2002, P ROY SOC B-BIOL SCI, V269, P89, DOI 10.1098/rspb.2001.1646; Greenfield M. D., 2014, INSECT HEARING ACOUS, V1, P81; Greenfield MD, 2000, ETHOL ECOL EVOL, V12, P259; Greenfield MD, 2009, ETHOLOGY, V115, P1137, DOI 10.1111/j.1439-0310.2009.01700.x; GWYNNE DT, 1986, ZOOL J LINN SOC-LOND, V88, P363, DOI 10.1111/j.1096-3642.1986.tb02253.x; Hedwig B, 2014, INSECT HEARING ACOUS, V1, P45; Kindl J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026476; Minet J, 2003, HDB ZOOLOGY HDB ZOOL, V2, P289; Nakano R, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0840; Nakano R, 2013, SCI REP-UK, V3, DOI 10.1038/srep02003; Nakano R, 2010, BIOL LETTERS, V6, P582, DOI 10.1098/rsbl.2010.0058; Nakano R, 2009, J EXP BIOL, V212, P4072, DOI 10.1242/jeb.032466; Nakano Ryo, 2009, Communicative & Integrative Biology, V2, P123; Nakano R, 2006, NATURWISSENSCHAFTEN, V93, P292, DOI 10.1007/s00114-006-0100-7; Nakano R, 2012, APPL ENTOMOL ZOOL, V47, P129, DOI 10.1007/s13355-012-0099-5; Nakano R, 2012, APPL ENTOMOL ZOOL, V47, P87, DOI 10.1007/s13355-012-0092-z; OBARA Y, 1979, APPL ENTOMOL ZOOL, V14, P130; Roeder KD, 1974, P CAN SOC ZOOL ANN M, P71; Ryan MJ, 2001, TRENDS COGN SCI, V5, P143, DOI 10.1016/S1364-6613(00)01616-8; Rydell J, 1997, P ROY SOC B-BIOL SCI, V264, P83; Sanderford MV, 1998, NATURWISSENSCHAFTEN, V85, P82, DOI 10.1007/s001140050458; Siemers BM, 2012, CURR BIOL, V22, pR563, DOI 10.1016/j.cub.2012.06.030; Skals N, 1999, J EXP BIOL, V202, P2937; SPANGLER HG, 1985, ANN ENTOMOL SOC AM, V78, P54; SPANGLER HG, 1988, ANNU REV ENTOMOL, V33, P59; Stoneman MG, 1988, ANIMAL SONAR PROCESS, P635; SURLYKKE A, 1989, NATURWISSENSCHAFTEN, V76, P132, DOI 10.1007/BF00366610; SURLYKKE A, 1986, J COMP PHYSIOL A, V159, P267, DOI 10.1007/BF00612309; Surlykke A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002036; SURLYKKE A, 1986, PHYSIOL ENTOMOL, V11, P221, DOI 10.1111/j.1365-3032.1986.tb00409.x; Surlykke A, 2003, J EXP BIOL, V206, P2653, DOI 10.1242/jeb.00469; Takanashi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013144; ter Hofstede HM, 2008, BIOL LETTERS, V4, P262, DOI 10.1098/rsbl.2007.0617	69	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-7594	1432-1351		J COMP PHYSIOL A	J. Comp. Physiol. A -Neuroethol. Sens. Neural Behav. Physiol.	JAN	2015	201	1			SI		111	121		10.1007/s00359-014-0945-8		11	Behavioral Sciences; Neurosciences; Physiology; Zoology	Behavioral Sciences; Neurosciences & Neurology; Physiology; Zoology	AY0ME	WOS:000347289700010		
J	Amagai, M				Amagai, Masayuki			Preface to Journal of Dermatology special issue: Pemphigus updates from around the world	JOURNAL OF DERMATOLOGY			English	Editorial Material									Keio Univ, Sch Med, Dept Dermatol, Tokyo, Japan	Amagai, M (reprint author), Keio Univ, Sch Med, Dept Dermatol, Tokyo, Japan.		Amagai, Masayuki/K-5325-2013					0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	JAN	2015	42	1			SI		2	2		10.1111/1346-8138.12774		1	Dermatology	Dermatology	AY1XE	WOS:000347381900002		
J	Ishii, K				Ishii, Ken			Importance of serological tests in diagnosis of autoimmune blistering diseases	JOURNAL OF DERMATOLOGY			English	Review						autoantibodies; autoimmunity; bullous pemphigoid; immunoassays; pemphigus	LINKED-IMMUNOSORBENT-ASSAY; EPIDERMOLYSIS-BULLOSA-ACQUISITA; TERMINAL ADHESIVE REGION; PARANEOPLASTIC PEMPHIGUS; VII COLLAGEN; DESMOGLEIN 3; PHAGE DISPLAY; RECOMBINANT DESMOGLEINS; IGA PEMPHIGUS; NEONATAL MICE	Autoimmune blistering diseases are organ-specific autoimmune diseases characterized by autoantibodies against structural proteins that maintain cell-cell (pemphigus diseases) and cell-matrix adhesions (pemphigoid diseases) in the skin and mucous membranes. Over the last few decades, identification of autoantigens and extensive characterization of autoantibodies have improved understanding of the pathogenesis of these diseases. In addition, the development of new sensitive and specific immunoassays enabled accurate diagnosis and proper evaluation of disease activity in autoimmune blistering diseases. In this review, we describe practical updates for molecular diagnostic tests for autoimmune blistering diseases and the basis for interpreting the results of the assays.	[Ishii, Ken] Toho Univ, Omori Med Ctr, Dept Dermatol, Tokyo 1438541, Japan	Ishii, K (reprint author), Toho Univ, Omori Med Ctr, Dept Dermatol, Ota Ku, 6-11-1 Omori Nishi, Tokyo 1438541, Japan.	ken.ishii@med.toho-u.ac.jp					Amagai M, 2003, J AM ACAD DERMATOL, V48, P244, DOI 10.1067/mjd.2003.7; Dainichi T, 2009, P NATL ACAD SCI USA, V106, P2800, DOI 10.1073/pnas.0809230106; Ohata C, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/562168; Sekiguchi M, 2001, J IMMUNOL, V167, P5439; Kozlowska A, 2003, J AM ACAD DERMATOL, V48, P117, DOI 10.1067/mjd.2003.23; GAMMON WR, 1993, J INVEST DERMATOL, V100, P618, DOI 10.1111/1523-1747.ep12472291; Sharma PM, 2009, J INVEST DERMATOL, V129, P2309, DOI 10.1038/jid.2009.41; Groth S, 2011, BRIT J DERMATOL, V164, P76, DOI 10.1111/j.1365-2133.2010.10056.x; Stanley JR, 2006, NEW ENGL J MED, V355, P1800, DOI 10.1056/NEJMra061111; ANHALT GJ, 1982, NEW ENGL J MED, V306, P1189, DOI 10.1056/NEJM198205203062001; Sardy M, 2002, J EXP MED, V195, P747, DOI 10.1084/jem.20011299; Ishii K, 1997, J IMMUNOL, V159, P2010; Amagai M, 1998, J CLIN INVEST, V102, P775, DOI 10.1172/JCI3647; Komorowski L, 2013, J AM ACAD DERMATOL, V68, pE89, DOI 10.1016/j.jaad.2011.12.032; Ishii K, 1999, ARCH DERMATOL, V135, P943, DOI 10.1001/archderm.135.8.943; Cheng SW, 2002, BRIT J DERMATOL, V147, P261, DOI 10.1046/j.1365-2133.2002.04838.x; Rose C, 2009, J AM ACAD DERMATOL, V61, P39, DOI 10.1016/j.jaad.2008.12.037; Lazarova Z, 2008, J AM ACAD DERMATOL, V58, P951, DOI 10.1016/j.jaad.2008.02.035; Chen M, 1997, J INVEST DERMATOL, V108, P68, DOI 10.1111/1523-1747.ep12285634; Yokouchi M, 2009, J INVEST DERMATOL, V129, P2156, DOI 10.1038/jid.2009.61; Bonciani D, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/239691; Horiguchi Y, 2008, J DERMATOL, V35, P737, DOI 10.1111/j.1346-8138.2008.00561.x; Hashimoto T, 2001, ARCH DERMATOL, V137, P735; Saleh MA, 2011, J DERMATOL SCI, V62, P169, DOI 10.1016/j.jdermsci.2011.03.003; Ishii K, 2005, J INVEST DERMATOL, V124, P939, DOI 10.1111/j.0022-202X.2005.23714.x; Payne AS, 2005, J CLIN INVEST, V115, P888, DOI 10.1172/JCI200524185; Vodegel RM, 2002, J AM ACAD DERMATOL, V47, P919, DOI 10.1067/mjd.2002.125079; Amagai M, 1999, BRIT J DERMATOL, V140, P351; Tsunoda K, 2003, J IMMUNOL, V170, P2170; Nagata Y, 2001, J INVEST DERMATOL, V116, P556, DOI 10.1046/j.1523-1747.2001.01263.x; Bhol KC, 2000, J IMMUNOL, V165, P2824; Hashimoto T, 1997, J INVEST DERMATOL, V109, P127, DOI 10.1111/1523-1747.ep12319025; Hirako Y, 1998, J BIOL CHEM, V273, P9711, DOI 10.1074/jbc.273.16.9711; Ishii Ken, 2013, Methods Mol Biol, V961, P219, DOI 10.1007/978-1-62703-227-8_13; Ishii K, 2008, J INVEST DERMATOL, V128, P939, DOI 10.1038/sj.jid.5701132; Kasperkiewicz M, 2014, J AM ACAD DERMATOL, V70, P780, DOI 10.1016/j.jaad.2013.11.043; Kobayashi M, 2002, J DERMATOL SCI, V30, P224, DOI 10.1016/S0923-1811(02)00109-3; LAPIERE JC, 1993, J CLIN INVEST, V92, P1831, DOI 10.1172/JCI116774; Li N, 2003, J EXP MED, V197, P1501, DOI 10.1084/jem.20022031; Matsumura K, 1996, ARCH DERMATOL RES, V288, P507, DOI 10.1007/BF02505245; Probst C, 2009, CLIN CHIM ACTA, V410, P13, DOI 10.1016/j.cca.2009.08.022; Saleh MA, 2012, J INVEST DERMATOL, V132, P1141, DOI 10.1038/jid.2011.449; Schepens I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012250; Yoshida M, 2006, J DERMATOL SCI, V41, P21, DOI 10.1016/j.jdermsci.2005.11.002; Zone JJ, 1998, J INVEST DERMATOL, V110, P207, DOI 10.1046/j.1523-1747.1998.00129.x	45	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	JAN	2015	42	1			SI		3	10		10.1111/1346-8138.12703		8	Dermatology	Dermatology	AY1XE	WOS:000347381900003		
J	Koga, M; Koga, K; Imafuku, S				Koga, Monji; Koga, Kaori; Imafuku, Shinichi			Spontaneous regression of an epidermolysis bullosa nevus on the sole	JOURNAL OF DERMATOLOGY			English	Article						dermoscopy; epidermolysis bullosa nevus; plantar; regression; sole	KINDLER SYNDROME; MELANOMA; SIMPLEX	Epidermolysis bullosa (EB) is a group of inherited rare diseases characterized by fragility and blistering of the skin and mucous membranes. An EB nevus (EBN) is a very rare acquired nevus that occurs only in patients with EB. An EBN usually arises in an area of previous blistering, and frequently has an atypical appearance that mimics malignant melanoma. We describe an older man with an EBN on the sole. Physical examination revealed irregularly pigmented band-like black macules on his right sole, suggestive of malignant melanoma. Dermoscopic examination showed a parallel furrow pattern with a monotonous area. The histopathological findings were consistent with a benign acquired nevus. Interestingly, the lesion regressed spontaneously within a year. To the best of our knowledge, this is the first reported case of EBN on the sole. Dermoscopy may be a useful addition to histopathological examination to ensure correct diagnosis of EBN.	[Koga, Monji; Imafuku, Shinichi] Fukuoka Univ, Dept Dermatol, Sch Med, Fukuoka 8140180, Japan; [Koga, Kaori] Fukuoka Univ Hosp, Dept Pathol, Fukuoka, Japan	Koga, M (reprint author), Fukuoka Univ, Dept Dermatol, Sch Med, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.	mob3mob3@yahoo.co.jp					Bauer JW, 2001, J AM ACAD DERMATOL, V44, P577, DOI 10.1067/mjd.2001.112217; Lai-Cheong JE, 2010, DERMATOL CLIN, V28, P119, DOI 10.1016/j.det.2009.10.013; Cash SH, 2007, ARCH DERMATOL, V143, P1164, DOI 10.1001/archderm.143.9.1164; de Queiroz Fuscaldi LA, 2011, CASE REP DERMATOL, V3, P235; Hocker TL, 2013, JAMA DERMATOL, V149, P1195, DOI 10.1001/jamadermatol.2013.4833; Lanschuetzer CM, 2005, BRIT J DERMATOL, V153, P97, DOI 10.1111/j.1365-2133.2005.06579.x; Natsuga K, 2005, CLIN EXP DERMATOL, V30, P636, DOI 10.1111/j.1365-2230.2005.01822.x; Shimizu S, 2014, ACTA DERM-VENEREOL, V94, P351, DOI 10.2340/00015555-1696; Sugiyama-Fukamatsu H, 2009, J DERMATOL, V36, P447, DOI 10.1111/j.1346-8138.2009.00674.x	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	JAN	2015	42	1			SI		37	39		10.1111/1346-8138.12655		3	Dermatology	Dermatology	AY1XE	WOS:000347381900008		
J	Kinjyo, C; Kaneko, T; Korekawa, A; Rokunohe, A; Aizu, T; Matsuzaki, Y; Nakano, H; Sawamura, D				Kinjyo, Chihiro; Kaneko, Takahide; Korekawa, Ayumi; Rokunohe, Akiko; Aizu, Takayuki; Matsuzaki, Yasushi; Nakano, Hajime; Sawamura, Daisuke			Oral lichen planus with antibodies to desmogleins 1 and 3	JOURNAL OF DERMATOLOGY			English	Article						autoimmunity; blister; enzyme-linked immunoassay; mucous membrane		Lichen planus (LP) is a chronic inflammatory disorder involving the skin or mucous membranes. Previous studies have demonstrated that some LP patients showed positive enzyme-linked immunosorbent assay (ELISA) for desmoglein (DSG) antibodies. We report a case with intractable painful oral lesions. ELISA indices for DSG1 and 3 antibodies were increased by 49 and 36, respectively. Histopathological analysis revealed irregular acanthosis and band-like infiltration of lymphocytes at the dermal-epidermal interface. Direct immunofluorescence revealed negative deposits of immunoglobulin G and C3 in intracellular spaces of the epidermis. Indirect immunofluorescence of normal skin also did not detect any antibodies. Consequently, we made a final diagnosis of oral LP. The previous two LP cases with positive ELISA for DSG antibodies and our case manifested the erosive form, the most advanced oral LP. Therefore, it is a possibility that severe damage of keratinocytes may induce generation of DSG antibodies. However, negative results of immunofluorescence and no relation between disease severity and titers of antibodies make the possibility unlikely. We should measure titers of DSG antibodies in LP patients and accumulate data to establish a valid conclusion.	[Kinjyo, Chihiro; Kaneko, Takahide; Korekawa, Ayumi; Rokunohe, Akiko; Aizu, Takayuki; Matsuzaki, Yasushi; Nakano, Hajime; Sawamura, Daisuke] Hirosaki Univ, Grad Sch Med, Dept Dermatol, Hirosaki, Aomori 0368562, Japan	Sawamura, D (reprint author), Hirosaki Univ, Grad Sch Med, Dept Dermatol, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.	derma@cc.hirosaki-u.ac.jp					Edwards Paul C, 2002, J Can Dent Assoc, V68, P494; Kato T, 2009, SKIN RES, V8, P173; Kishimoto K, 2005, RINSHO DERMA, V47, P741; Lukac J, 2006, CROAT MED J, V47, P53	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	JAN	2015	42	1			SI		40	41		10.1111/1346-8138.12661		2	Dermatology	Dermatology	AY1XE	WOS:000347381900009		
J	Abe, R				Abe, Riichiro			Immunological response in Stevens-Johnson syndrome and toxic epidermal necrolysis	JOURNAL OF DERMATOLOGY			English	Review						drug; hapten; p-i concept; Stevens-Johnson syndrome; toxic epidermal necrolysis	SOLUBLE FAS LIGAND; REGULATORY T-CELLS; INDUCED HYPERSENSITIVITY SYNDROME; CUTANEOUS ADVERSE-REACTIONS; DRUG HYPERSENSITIVITY; SERUM GRANULYSIN; T(H)17 CELLS; GRANZYME-B; HLA; ANTIGEN	Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening cutaneous adverse drug reactions that induce widespread epidermal necrosis. Recent advances in pharmacogenomic studies have provided evidence of genetic predispositions to SJS/TEN. Several concepts have been proposed to explain the pathogenesis of severe cutaneous adverse drug reactions. In the hapten concept, small molecules called haptens elicit an immune response only when attached to proteins. The p-i concept postulates that the causative drugs can stimulate cells by binding directly and reversibly to immune receptors. In addition, there is the idea that drugs alter the antigen by binding to the human leukocyte antigen pocket. With regard to keratinocyte death, several cell death mediators, such as FasL, granulysin and annexin A1, have been proposed as playing a role in SJS/TEN pathogenesis. A subset of T lymphocytes, including regulatory T cells, also may play a role in SJS/TEN.	[Abe, Riichiro] Hokkaido Univ, Dept Dermatol, Grad Sch Med, Sapporo, Hokkaido 0608638, Japan	Abe, R (reprint author), Hokkaido Univ, Dept Dermatol, Grad Sch Med, Kita Ku, N15 W7, Sapporo, Hokkaido 0608638, Japan.	aberi@med.hokudai.ac.jp					Kaspar AA, 2001, J IMMUNOL, V167, P350; Wei CY, 2012, HUM MOL GENET, V21, pR58, DOI 10.1093/hmg/dds341; Schnyder B, 1997, J CLIN INVEST, V100, P136, DOI 10.1172/JCI119505; Hari Y, 2001, CLIN EXP ALLERGY, V31, P1398, DOI 10.1046/j.1365-2222.2001.01164.x; Chung WH, 2008, NAT MED, V14, P1343, DOI 10.1038/nm.1884; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; ROUJEAU JC, 1995, NEW ENGL J MED, V333, P1600, DOI 10.1056/NEJM199512143332404; Chung WH, 2004, NATURE, V428, P486, DOI 10.1038/428486a; Zanni MP, 1998, J CLIN INVEST, V102, P1591, DOI 10.1172/JCI3544; Mittmann N, 2012, AM J CLIN DERMATOL, V13, P49, DOI 10.2165/11593240-000000000-00000; MADDEN DR, 1991, NATURE, V353, P321, DOI 10.1038/353321a0; Murata J, 2008, J ALLERGY CLIN IMMUN, V122, P992, DOI 10.1016/j.jaci.2008.06.013; Tapia B, 2004, J ALLERGY CLIN IMMUN, V114, P335, DOI 10.1016/j.jaci.2004.04.034; Pichler WJ, 2003, ANN INTERN MED, V139, P683; Medema JP, 1997, EUR J IMMUNOL, V27, P3492, DOI 10.1002/eji.1830271250; Kaniwa N, 2010, EPILEPSIA, V51, P2461, DOI 10.1111/j.1528-1167.2010.02766.x; Hung SL, 2005, P NATL ACAD SCI USA, V102, P4134, DOI 10.1073/pnas.0409500102; Kim SH, 2011, EPILEPSY RES, V97, P190, DOI 10.1016/j.eplepsyres.2011.08.010; Fujita Y, 2011, J AM ACAD DERMATOL, V65, P65, DOI 10.1016/j.jaad.2010.04.042; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; Krensky AM, 2009, TISSUE ANTIGENS, V73, P193, DOI 10.1111/j.1399-0039.2008.01218.x; Abe R, 2009, ANN INTERN MED, V151, P514; Louten J, 2009, J ALLERGY CLIN IMMUN, V123, P1004, DOI 10.1016/j.jaci.2009.04.003; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Takahashi R, 2009, J IMMUNOL, V182, P8071, DOI 10.4049/jimmunol.0804002; Abe R, 2003, AM J PATHOL, V162, P1515, DOI 10.1016/S0002-9440(10)64284-8; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; Chen P, 2011, NEW ENGL J MED, V364, P1126, DOI 10.1056/NEJMoa1009717; BASTUJIGARIN S, 1993, ARCH DERMATOL, V129, P92, DOI 10.1001/archderm.129.1.92; Chung WH, 2012, J DERMATOL SCI, V66, P190, DOI 10.1016/j.jdermsci.2012.04.002; Chang CC, 2011, INT J DERMATOL, V50, P221, DOI 10.1111/j.1365-4632.2010.04745.x; Ko TM, 2011, J ALLERGY CLIN IMMUN, V128, P1266, DOI 10.1016/j.jaci.2011.08.013; PODACK ER, 1984, J EXP MED, V160, P695, DOI 10.1084/jem.160.3.695; Viard I, 1998, SCIENCE, V282, P490, DOI 10.1126/science.282.5388.490; Nassif A, 2002, J INVEST DERMATOL, V118, P728, DOI 10.1046/j.1523-1747.2002.01622.x; Azukizawa H, 2003, EUR J IMMUNOL, V33, P1879, DOI 10.1002/eji.200323630; Illing PT, 2012, NATURE, V486, P554, DOI 10.1038/nature11147; Chung WH, 2010, EXPERT OPIN DRUG SAF, V9, P15, DOI 10.1517/14740330903427969; Yun J, 2012, ALLERGY, V67, P1338, DOI 10.1111/all.12008; Viard-Leveugle I, 2003, J BIOL CHEM, V278, P16183, DOI 10.1074/jbc.M212188200; Tassaneeyakul W, 2010, EPILEPSIA, V51, P926, DOI [10.1111/j.1528-1167.2010.02533.x, 10.1111/j.1528-1167.2009.02533.x]; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; Posadas SJ, 2002, J ALLERGY CLIN IMMUN, V109, P155, DOI 10.1067/mai.2002.120563; Azukizawa H, 2005, EUR J IMMUNOL, V35, P1722, DOI 10.1002/eji.200525773; Becquemont L, 2010, PHARMACOGENOMICS, V11, P277, DOI [10.2217/pgs.10.38, 10.2217/PGS.10.38]; Chessman D, 2008, IMMUNITY, V28, P822, DOI 10.1016/j.immuni.2008.04.020; DisPascuale MA, 2005, OPHTHALMOLOGY, V112, P904; Fujiyama T, 2013, J DERMATOL SCI, V73, P85; Gutierrez-Steil C, 1998, J CLIN INVEST, V101, P33, DOI 10.1172/JCI1165; Hanafusa T, 2012, J DERMATOL SCI, V65, P213, DOI 10.1016/j.jdermsci.2011.12.002; Horton H, 1998, ALLERGY, V53, P83, DOI 10.1111/j.1398-9995.1998.tb03778.x; Kim SD, 2009, J IMMUNOL, V183, P5511, DOI 10.4049/jimmunol.0802986; Lan CCE, 2006, ACTA DERM-VENEREOL, V86, P215, DOI 10.2340/00015555-0074; Lowin B, 1995, Curr Top Microbiol Immunol, V198, P1; Morel E, 2010, J ALLERGY CLIN IMMUN, V125, P703, DOI 10.1016/j.jaci.2009.10.030; Morel E, 2011, ALLERGY, V66, P360, DOI 10.1111/j.1398-9995.2010.02484.x; Moretta L, 2003, TRENDS IMMUNOL, V24, P136, DOI 10.1016/S1471-4906(03)00031-0; Pan XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034662; Pichler Werner J, 2002, Curr Opin Allergy Clin Immunol, V2, P301, DOI 10.1097/00130832-200208000-00003; Pichler WJ, 2005, TOXICOLOGY, V209, P95, DOI 10.1016/j.tox.2004.12.014; Reinherz EL, 2012, NATURE, V486, P479, DOI 10.1038/486479a; Saito N, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008227; Saito N, 2012, BRIT J DERMATOL, V167, P452, DOI 10.1111/j.1365-2133.2012.10921.x; Satou Y, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-46; SAYAMA K, 1994, J INVEST DERMATOL, V103, P330, DOI 10.1111/1523-1747.ep12394858; Schwartz RA, 2013, J AM ACAD DERMATOL, V69; Schwartz RA, 2013, J AM ACAD DERMATOL, V69, P85; Stur K, 2007, J INVEST DERMATOL, V127, P802, DOI 10.1038/sj.jid.5700648; Teraki Y, 2013, J ALLERGY CLIN IMMUN, V131, P907, DOI 10.1016/j.jaci.2012.08.042; Tohyama M, 2008, BRIT J DERMATOL, V159, P981, DOI 10.1111/j.1365-2133.2008.08750.x; Yeh CN, 2014, J INVEST DERMATOL, V134, P2768, DOI 10.1038/jid.2014.218; Yip VL, 2014, CLIN REV ALLERG IMMU, DOI [10.1007/s12016-014-8418-y, DOI 10.1007/S12016-014-8418-Y]; Yoshioka N, 2013, CLIN IMMUNOL, V148, P89, DOI 10.1016/j.clim.2013.04.002; Zhang MJ, 2012, J INFECT DIS, V205, P1111, DOI 10.1093/infdis/jis011	74	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	JAN	2015	42	1			SI		42	48		10.1111/1346-8138.12674		7	Dermatology	Dermatology	AY1XE	WOS:000347381900010		
J	Yonenaga, T; Saeki, H; Nakagawa, H; Fukuchi, O; Umezawa, Y; Hayashi, M; Ito, T; Yanaba, K; Tojyo, S; Fukuda, K				Yonenaga, Takenori; Saeki, Hidehisa; Nakagawa, Hidemi; Fukuchi, Osamu; Umezawa, Yoshinori; Hayashi, Mitsuha; Ito, Toshihiro; Yanaba, Koichi; Tojyo, Shinjiro; Fukuda, Kunihiko			Four cases of Japanese patients with psoriatic arthritis in whom effective treatments by anti-tumor necrosis factor-alpha drugs were evaluated by magnetic resonance imaging together with improvement of skin lesions	JOURNAL OF DERMATOLOGY			English	Article						anti-tumor necrosis factor- drugs; Japanese; magnetic resonance imaging; psoriatic arthritis; skin lesions	RHEUMATOID-ARTHRITIS; DISEASE-ACTIVITY; SCORING SYSTEM; INFLIXIMAB; PSAMRIS	Because psoriatic skin lesions of psoriatic arthritis (PsA) usually precede the onset of joint symptom, dermatologists are in an ideal position to screen and find individuals with PsA early in the disease course. There have been no reports from the dermatology field evaluating the effect of anti-tumor necrosis factor (TNF)- drugs on joint disorders using magnetic resonance imaging (MRI) in PsA patients. The purpose of this study was to elucidate the effectiveness of MRI in the evaluation of anti-TNF- drugs on joint disease of Japanese PsA patients. Data were collected from four adult Japanese male PsA patients. MRI of the affected hand was performed at baseline and 1-7months after infliximab or adalimumab treatment. T-1-weighted gadolinium-enhanced images with fat suppression were acquired in the coronal, sagittal and/or axial planes. We determined the apparent improvement of synovitis, periarticular inflammation, tenosynovitis and/or bone marrow edema by MRI after anti-TNF- treatments in all the patients together with the improvement of skin lesions. We also determined in one patient that these symptoms detected by MRI before treatment were alleviated within 1month and had disappeared 6months after treatment, suggesting the potentially early detection of the effect of anti-TNF- drugs on joint disease. We present four cases of Japanese patients with PsA in whom effective treatments by anti-TNF- drugs were evaluated by contrast-enhanced MRI. This imaging enables dermatologists and radiologists to assess and monitor early inflammatory changes, and to grant PsA patients earlier access to modern treatment such as biologics.	[Yonenaga, Takenori; Tojyo, Shinjiro; Fukuda, Kunihiko] Jikei Univ, Dept Radiol, Sch Med, Tokyo, Japan; [Nakagawa, Hidemi; Fukuchi, Osamu; Umezawa, Yoshinori; Hayashi, Mitsuha; Ito, Toshihiro; Yanaba, Koichi; Tojyo, Shinjiro] Jikei Univ, Dept Dermatol, Sch Med, Tokyo, Japan; [Saeki, Hidehisa] Nippon Med Sch, Dept Dermatol, Tokyo 1138603, Japan	Saeki, H (reprint author), Nippon Med Sch, Dept Dermatol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.	h-saeki@nms.ac.jp					Gelfand JM, 2005, J AM ACAD DERMATOL, V53, P573, DOI 10.1016/j.jaad.2005.03.046; McQueen F, 2007, J RHEUMATOL, V34, P859; FREDRIKSSON T, 1978, DERMATOLOGICA, V157, P238; Marzo-Ortega H, 2007, ANN RHEUM DIS, V66, P778, DOI 10.1136/ard.2006.063818; Narvaez J, 2012, SEMIN ARTHRITIS RHEU, V42, P234, DOI 10.1016/j.semarthrit.2012.03.016; Ostergaard M, 2009, J RHEUMATOL, V36, P1816, DOI 10.3899/jrheum.090352; Anandarajah AP, 2010, ANN RHEUM DIS, V69, P206, DOI 10.1136/ard.2008.100149; Inoue E, 2007, ANN RHEUM DIS, V66, P407, DOI 10.1136/ard.2006.054205; Haavardsholm EA, 2005, ARTHRITIS RHEUM, V52, P3860, DOI 10.1002/art.21493; Haavardsholm EA, 2009, ANN RHEUM DIS, V68, P1572, DOI 10.1136/ard.2008.091801; Boyesen P, 2011, J RHEUMATOL, V38, P2034, DOI 10.3899/jrheum.110420; Antoni C, 2002, ARTHRIT RHEUM-ARTHR, V47, P506, DOI 10.1002/art.10671; Cantini F, 2012, J RHEUMATOL, V39, P71, DOI 10.3899/jrheum.120249; Qureshi AA, 2008, J RHEUMATOL, V35, P1423; Sankowski Artur Jacek, 2013, Pol J Radiol, V78, P7, DOI 10.12659/PJR.883763; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2666	16	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	JAN	2015	42	1			SI		49	55		10.1111/1346-8138.12708		7	Dermatology	Dermatology	AY1XE	WOS:000347381900011		
J	Arai, S; Yoshino, T; Fujimura, T; Maruyama, S; Nakano, T; Mukuno, A; Sato, N; Katsuoka, K				Arai, Satoru; Yoshino, Takashi; Fujimura, Takao; Maruyama, Sachie; Nakano, Toshiaki; Mukuno, Akira; Sato, Naoya; Katsuoka, Kensei			Mycostatic effect of recombinant dermcidin against Trichophyton rubrum and reduced dermcidin expression in the sweat of tinea pedis patients	JOURNAL OF DERMATOLOGY			English	Article						recombinant dermcidin; sweat; tinea pedis; Trichophyton rubrum	HUMAN ANTIMICROBIAL PEPTIDE; SKIN; DERMATOPHYTOSIS; INNATE; INFECTIONS; IMMUNITY; GLANDS; CELLS; GAMMA	Trichophytosis, a common dermatophytosis, affects nearly 20-25% of the world's population. However, little is known about mechanisms for preventing colonization of Trichophyton on the skin. Dermcidin, an antimicrobial peptide that provides innate immunity to the skin and is constitutively secreted even in the absence of inflammatory stimulation, was studied to elucidate its antimycotic activity against Trichophyton. Recombinant dermcidin was determined to have antimycotic activity against Trichophyton rubrum, as evaluated by colony-forming unit (CFU) assays. The killing rate of dermcidin was 40.5% and 93.4% at 50g/mL (the average dermcidin concentration in healthy subjects) and 270g/mL, respectively. An effect of dermcidin treatment was found to be a reduction of the metabolic activity of Trichophyton as determined by nicotinamide adenine dinucleotide assay. Further, dermcidin concentrations in sweat of tinea pedis patients were found to be lower than those of healthy subjects. These findings suggest a mycostatic role for dermcidin, at normal sweat concentrations. Accordingly, we suspect that dermcidin, at normal sweat concentrations, inhibits growth of Trichophyton, where Trichophyton is subsequently eliminated in conjunction with epidermis turnover. Dermcidin, therefore, appears to play a role in the skin protection mechanism that prevents colonization of tinea pedis.	[Arai, Satoru; Fujimura, Takao; Nakano, Toshiaki; Mukuno, Akira; Sato, Naoya; Katsuoka, Kensei] Kitasato Univ, Sch Med, Dept Dermatol, Sagamihara, Kanagawa 2520374, Japan; [Yoshino, Takashi; Fujimura, Takao; Maruyama, Sachie] Kitasato Univ, Grad Sch Med Sci, Dept Environm Dermatol, Sagamihara, Kanagawa 2520374, Japan	Fujimura, T (reprint author), Kitasato Univ, Sch Med, Dept Dermatol, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	fujimura@med.kitasato-u.ac.jp					ALY R, 1994, J AM ACAD DERMATOL, V31, pS21, DOI 10.1016/S0190-9622(08)81262-5; Kohno T, 1998, J BIOMOL NMR, V12, P109, DOI 10.1023/A:1008254603368; Lopez-Garcia B, 2006, J ANTIMICROB CHEMOTH, V57, P877, DOI 10.1093/jac/dkl078; Monod M, 2008, MYCOPATHOLOGIA, V166, P285, DOI 10.1007/s11046-008-9105-4; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Rieg S, 2004, BRIT J DERMATOL, V151, P534, DOI 10.1111/j.1365-2133.2004.06081.x; Rieg S, 2006, J INVEST DERMATOL, V126, P354, DOI 10.1038/sj.jid.5700041; Lai YP, 2005, BIOCHEM BIOPH RES CO, V328, P243, DOI 10.1016/j.bbrc.2004.12.143; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; Schittek B, 2001, NAT IMMUNOL, V2, P1133, DOI 10.1038/ni732; Eckhard M, 2007, MYCOSES, V50, P14, DOI 10.1111/j.1439-0507.2007.01425.x; Saikawa Y, 2004, NATURE, V429, P363, DOI 10.1038/429363a; Cipakova I, 2006, PROTEIN EXPRES PURIF, V45, P269, DOI 10.1016/j.pep.2005.07.002; Havlickova B, 2008, MYCOSES, V51, P2, DOI 10.1111/j.1439-0507.2008.01606.x; Asahina M, 2008, J DIABETES COMPLICAT, V22, P278, DOI 10.1016/j.jdiacomp.2007.03.009; De Yang, 2000, J Exp Med, V192, P1069, DOI 10.1084/jem.192.7.1069; Jinquan Tan, 1996, Journal of Investigative Dermatology, V107, P5, DOI 10.1111/1523-1747.ep12294284; KOGA T, 1995, ACTA DERM-VENEREOL, V75, P81; Majczak G, 2007, GENET MOL RES, V6, P1000; Miyata T, 1996, J DERMATOL SCI, V13, P167, DOI 10.1016/S0923-1811(96)00546-4; Rieg S, 2005, J IMMUNOL, V174, P8003; Sawada Y, 2012, CLIN CANCER RES, V18, P3772, DOI 10.1158/1078-0432.CCR-12-0292; Schittek B, 2012, J INNATE IMMUN, V4, P349, DOI 10.1159/000336844	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	JAN	2015	42	1			SI		70	76		10.1111/1346-8138.12664		7	Dermatology	Dermatology	AY1XE	WOS:000347381900014		
J	Teraki, Y; Nakamura, K				Teraki, Yuichi; Nakamura, Kaori			Rubbing skin with nylon towels as a major cause of pseudomonas folliculitis in a Japanese population	JOURNAL OF DERMATOLOGY			English	Article						bathing; nylon towel; Pseudomonas aeruginosa; pseudomonas folliculitis	AERUGINOSA FOLLICULITIS; WHIRLPOOL; SPONGES	Pseudomonas folliculitis (PF) is a community-acquired skin infection, which develops after exposure to contaminated water such as whirlpools, swimming pools, water slides and hot tubs. In Japan, this condition has been sporadically reported, often in association with bathing; however, the exact cause of PF in the Japanese population remains unclear. In this study, we retrospectively reviewed 10 patients with PF diagnosed at our dermatology clinic (two males and eight females). Four patients had recurrences over 1-3years. Notably, eight of the 10 patients were rubbing their bodies with nylon towels or sponges placed in the bathrooms during bathing. Pseudomonas aeruginosa was isolated from the nylon towels used in two of the two patients examined. Discontinued use of nylon towels resulted in prompt resolution of PF and no recurrence in all cases. Our observation suggests that rubbing the skin with nylon towels contaminated with P.aeruginosa was a major cause of PF in a Japanese population.	[Teraki, Yuichi; Nakamura, Kaori] Saitama Med Univ, Saitama Med Ctr, Dept Dermatol, Kawagoe, Saitama 3508550, Japan	Teraki, Y (reprint author), Saitama Med Univ, Saitama Med Ctr, Dept Dermatol, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan.	teraki@saitama-med.ac.jp					BERGER RS, 1990, CUTIS, V45, P97; BOTTONE EJ, 1994, J CLIN MICROBIOL, V32, P469; BOTTONE EJ, 1993, J CLIN MICROBIOL, V31, P480; Kitamura M, 1998, BRIT J DERMATOL, V139, P359; MANIATIS AN, 1995, CLIN INFECT DIS, V21, P437; McCausland W.J., 1975, J ENV HLTH, V37, P455; SAUSKER WF, 1978, JAMA-J AM MED ASSOC, V239, P2362, DOI 10.1001/jama.239.22.2362	7	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	JAN	2015	42	1			SI		81	83		10.1111/1346-8138.12712		3	Dermatology	Dermatology	AY1XE	WOS:000347381900016		
J	Kano, S; Kurimoto, S; Ito, A; Yoshida, Y; Yamamoto, O				Kano, Shinya; Kurimoto, Shingo; Ito, Ayako; Yoshida, Yuichi; Yamamoto, Osamu			Granulomatous cheilitis with intralymphatic histiocytosis possibly associated with calcium deposition caused by chronic inflammation owing to dental metals and periodontitis	JOURNAL OF DERMATOLOGY			English	Article						cheilitis; granuloma; histiocyte; histopathology; X-ray spectroscopy	OROFACIAL GRANULOMATOSIS; DELAYED-HYPERSENSITIVITY	Granulomatous cheilitis (GC) is an uncommon disease and the pathogenesis of GC has not been clear. Here, we present two cases of GC associated with calcium deposition caused by chronic inflammation owing to dental metal allergy and periodontitis. Histopathologically, intralymphatic histiocytosis (IH) in addition to non-caseating granulomas was seen in both cases. The results of a patch test were positive for some dental metals. Qualitative analyses by energy-dispersive X-ray spectroscopy detected calcium from biopsy specimens. We considered that partial destruction of teeth by chronic inflammation induced reactive proliferation of histiocytes, resulting in IH. Our study suggests that GC and IH is a consequence of chronic inflammatory diseases caused by dental metals and periodontitis. Dental care is necessary for treatment of GC.	[Kano, Shinya; Kurimoto, Shingo; Ito, Ayako; Yoshida, Yuichi; Yamamoto, Osamu] Tottori Univ, Fac Med, Dept Med Sensory & Motor Organs, Div Dermatol, Yonago, Tottori 6838503, Japan	Yoshida, Y (reprint author), Tottori Univ, Fac Med, Dept Med Sensory & Motor Organs, Div Dermatol, 86 Nishi Cho, Yonago, Tottori 6838503, Japan.	yxyhifu1@med.tottori-u.ac.jp					Requena L, 2009, AM J DERMATOPATH, V31, P140, DOI 10.1097/DAD.0b013e3181986cc2; Lazarov A, 2003, J AM ACAD DERMATOL, V49, P1117, DOI 10.1016/S0190-9622(03)02185-6; Grave B, 2009, ORAL DIS, V15, P46, DOI 10.1111/j.1601-0825.2008.01500.x; OGRADY JT, 1994, HISTOPATHOLOGY, V24, P265, DOI 10.1111/j.1365-2559.1994.tb00519.x; Watanabe T, 2008, BRIT J DERMATOL, V158, P402, DOI 10.1111/j.1365-2133.2007.08295.x; Critchlow William Austin, 2014, Head Neck Pathol, V8, P209, DOI 10.1007/s12105-013-0488-2; Gonzalez-Garcia C, 2011, AM J DERMATOPATH, V33, P594, DOI 10.1097/DAD.0b013e3181f04912; Guttman-Yassky E, 2003, J EUR ACAD DERMATOL, V17, P344, DOI 10.1046/j.1468-3083.2003.00793.x; PRYCE DW, 1990, CLIN EXP DERMATOL, V15, P384, DOI 10.1111/j.1365-2230.1990.tb02123.x	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	JAN	2015	42	1			SI		84	86		10.1111/1346-8138.12713		3	Dermatology	Dermatology	AY1XE	WOS:000347381900017		
J	Miyajima, A; Komoda, M; Akagi, K; Yuzawa, K; Yoshimasu, T; Yamamoto, Y; Hirota, T				Miyajima, Atsushi; Komoda, Masayo; Akagi, Keita; Yuzawa, Kaoru; Yoshimasu, Takashi; Yamamoto, Yosuke; Hirota, Takashi			Experimental study of pharmacokinetics of external, whole-body bathing application of ivermectin	JOURNAL OF DERMATOLOGY			English	Article						bathing; ivermectin; rats; scabies; skin	SCABIES	As a novel method improving the safety of conventional oral ivermectin (IVM) for scabies treatment, we conceived an idea called the whole-body bathing method. In this method, the patients would bathe themselves in a bathing fluid containing IVM at an effective concentration. To evaluate the feasibility of the method, we investigated the IVM concentration in the skin and plasma after bathing rats in a fluid containing 100ng/mL of IVM. After the bathing, the concentration of IVM in the skin was more than 400ng/g wet weight and was maintained until 8h after the bathing. The concentration was clearly higher than that in patients taking IVM p.o. as previously reported; IVM was not detected in plasma in the present study. Thus, the method would be a preferable drug delivery system for the skin application of IVM compared with p.o. administration.	[Miyajima, Atsushi; Yamamoto, Yosuke; Hirota, Takashi] Tokyo Univ Sci, Dept Biopharmaceut, Fac Pharmaceut Sci, Noda, Chiba 2788510, Japan; [Komoda, Masayo; Akagi, Keita; Yuzawa, Kaoru; Yoshimasu, Takashi] Tokyo Univ Sci, Dept Safety Med, Fac Pharmaceut Sci, Noda, Chiba 2788510, Japan	Komoda, M (reprint author), Tokyo Univ Sci, Dept Safety Med, Fac Pharmaceut Sci, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	komo1207@rs.noda.tus.ac.jp					Mounsey KE, 2013, CURR OPIN INFECT DIS, V26, P133, DOI 10.1097/QCO.0b013e32835e1d57; Ariza L, 2013, EUR J CLIN MICROBIOL, V32, P373, DOI 10.1007/s10096-012-1752-1; Khan A, 2012, AM J INFECT CONTROL, V40, P451, DOI 10.1016/j.ajic.2011.05.014; Currie BJ, 2010, NEW ENGL J MED, V362, P717, DOI 10.1056/NEJMct0910329; Haas N, 2002, ARCH DERMATOL, V138, P1618, DOI 10.1001/archderm.138.12.1618; Hoek JA, 2008, EURO SURVEILL, P13; Makigami K, 2009, J DERMATOL, V36, P491, DOI 10.1111/j.1346-8138.2009.00691.x; Strong M, 2010, COCHRANE DB SYST REV, V2, P1	8	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	JAN	2015	42	1			SI		87	89		10.1111/1346-8138.12728		3	Dermatology	Dermatology	AY1XE	WOS:000347381900018		
J	Kawakami, H; Maeda, T; Abe, N; Matsumoto, Y; Mitsuhashi, Y; Tsuboi, R; Okubo, Y				Kawakami, Hiroshi; Maeda, Tatsurou; Abe, Namiko; Matsumoto, Yuka; Mitsuhashi, Yoshihiko; Tsuboi, Ryoji; Okubo, Yukari			Efficacy of adalimumab and methotrexate combination therapy on generalized pustular psoriasis patients unresponsive to infliximab monotherapy due to anti-infliximab antibody development	JOURNAL OF DERMATOLOGY			English	Letter									[Kawakami, Hiroshi; Maeda, Tatsurou; Abe, Namiko; Matsumoto, Yuka; Mitsuhashi, Yoshihiko; Tsuboi, Ryoji; Okubo, Yukari] Tokyo Med Univ, Dept Dermatol, Tokyo 1600023, Japan	Kawakami, H (reprint author), Tokyo Med Univ, Dept Dermatol, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	hero.4@hotmail.co.jp					Adisen E, 2010, J DERMATOL, V37, P703; Krieckaert CL, 2012, ANN RHEUM DIS, V71, P1914, DOI 10.1136/annrheumdis-2012-201544; Chaudhari U, 2001, LANCET, V357, P1842, DOI 10.1016/S0140-6736(00)04954-0; Zangrilli A, 2008, J DERMATOL TREAT, V19, P185, DOI 10.1080/09546630701759587	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	JAN	2015	42	1			SI		94	95		10.1111/1346-8138.12704		2	Dermatology	Dermatology	AY1XE	WOS:000347381900020		
J	Kanemaru, M; Tashima, S; Yamazaki, A; Masuda, K; Nagoshi, H; Kobayashi, T; Kuroda, J; Hiruma, M; Taniwaki, M; Katoh, N				Kanemaru, Mai; Tashima, Saki; Yamazaki, Akiko; Masuda, Koji; Nagoshi, Hisao; Kobayashi, Tsutomu; Kuroda, Junya; Hiruma, Masataro; Taniwaki, Masafumi; Katoh, Norito			Disseminated mucormycosis due to Rhizopus oryzae diagnosed by skin biopsy	JOURNAL OF DERMATOLOGY			English	Letter									[Kanemaru, Mai; Tashima, Saki; Yamazaki, Akiko; Masuda, Koji; Katoh, Norito] Kyoto Prefectural Univ Med, Dept Dermatol, Kyoto 6028566, Japan; [Nagoshi, Hisao; Kobayashi, Tsutomu; Kuroda, Junya; Taniwaki, Masafumi] Kyoto Prefectural Univ Med, Dept Med, Div Hematol & Oncol, Kyoto 6028566, Japan; [Hiruma, Masataro] Ochanomizu Inst Med Mycol & Allergol, Tokyo, Japan	Kanemaru, M (reprint author), Kyoto Prefectural Univ Med, Dept Dermatol, 465 Kajii Cho, Kyoto 6028566, Japan.	maiogu@koto.kpu-m.ac.jp					Roden MM, 2005, CLIN INFECT DIS, V41, P634, DOI 10.1086/432579; Ibrahim AS, 2012, CLIN INFECT DIS   S1, V54, P16; Spellberg Brad, 2010, Curr Infect Dis Rep, V12, P423, DOI 10.1007/s11908-010-0129-9	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	JAN	2015	42	1			SI		100	101		10.1111/1346-8138.12715		2	Dermatology	Dermatology	AY1XE	WOS:000347381900024		
J	Horie, K; Izumi, K; Nishie, W; Nomura, T; Nomura, Y; Arita, K; Shimizu, H				Horie, Keita; Izumi, Kentaro; Nishie, Wataru; Nomura, Toshifumi; Nomura, Yukiko; Arita, Ken; Shimizu, Hiroshi			Deep venous thrombosis in patients with Behcet's disease	JOURNAL OF DERMATOLOGY			English	Letter									[Horie, Keita; Izumi, Kentaro; Nishie, Wataru; Nomura, Toshifumi; Nomura, Yukiko; Arita, Ken; Shimizu, Hiroshi] Hokkaido Univ, Dept Dermatol, Grad Sch Med, Sapporo, Hokkaido 0608638, Japan	Izumi, K (reprint author), Hokkaido Univ, Dept Dermatol, Grad Sch Med, Kita Ku, N15 W7, Sapporo, Hokkaido 0608638, Japan.	izumi55kentaro@yahoo.co.jp					Sarica-Kucukoglu R, 2006, INT J DERMATOL, V45, P919, DOI 10.1111/j.1365-4632.2006.02832.x; Mackman N, 2008, NATURE, V451, P914, DOI 10.1038/nature06797; Houman MH, 2001, CLIN EXP RHEUMATOL, V19, pS48; International Team for the Revision of the International Criteria for Behcet's Disease, 2006, CLIN EXP RHEUMAT S42, V24, pS13; Lopez JA, 2004, HEMATOLOGY, V1, P439	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	JAN	2015	42	1			SI		101	102		10.1111/1346-8138.12741		2	Dermatology	Dermatology	AY1XE	WOS:000347381900025		
J	Kubota, N; Fujisawa, Y; Nakamura, Y; Tanaka, R; Saito, A; Maruyama, H; Ishii, Y; Furutra, J; Kawachi, Y; Fujimoto, M				Kubota, Noriko; Fujisawa, Yasuhiro; Nakamura, Yasuhiro; Tanaka, Ryota; Saito, Akimasa; Maruyama, Hiroshi; Ishii, Yoshiyuki; Furutra, Jyunichi; Kawachi, Yasuhiro; Fujimoto, Manabu			Angiosarcoma of the scalp in a patient with systemic sclerosis	JOURNAL OF DERMATOLOGY			English	Letter									[Kubota, Noriko; Fujisawa, Yasuhiro; Nakamura, Yasuhiro; Tanaka, Ryota; Saito, Akimasa; Maruyama, Hiroshi; Ishii, Yoshiyuki; Furutra, Jyunichi; Kawachi, Yasuhiro; Fujimoto, Manabu] Univ Tsukuba, Dept Dermatol, Tsukuba, Ibaraki 3058575, Japan	Fujisawa, Y (reprint author), Univ Tsukuba, Dept Dermatol, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	fujisan@md.tsukuba.ac.jp					Amo Y, 2002, ACTA DERM-VENEREOL, V82, P373, DOI 10.1080/000155502320624122; Manetti M, 2010, J CELL MOL MED, V14, P1241, DOI 10.1111/j.1582-4934.2010.01027.x; Arbiser JL, 2000, AM J PATHOL, V156, P1469, DOI 10.1016/S0002-9440(10)65015-8; Fonder MA, 2008, CUTIS, V81, P468; Puizina-Ivić Neira, 2005, Acta Dermatovenerol Alp Pannonica Adriat, V14, P20	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	JAN	2015	42	1			SI		102	104		10.1111/1346-8138.12705		3	Dermatology	Dermatology	AY1XE	WOS:000347381900026		
J	Uchiyama, M; Sakai, N; Maeda, T; Tsuboi, R; Mitsuhashi, Y				Uchiyama, Masaki; Sakai, Noriyasu; Maeda, Tatsuro; Tsuboi, Ryoji; Mitsuhashi, Yoshihiko			Late-onset neurofibromatosis revealing NF1 mutation	JOURNAL OF DERMATOLOGY			English	Letter							TYPE-1; MOSAICISM		[Uchiyama, Masaki; Sakai, Noriyasu; Maeda, Tatsuro; Tsuboi, Ryoji; Mitsuhashi, Yoshihiko] Tokyo Med Univ, Dept Dermatol, Tokyo 1600023, Japan	Uchiyama, M (reprint author), Tokyo Med Univ, Dept Dermatol, Shinjuku Ku, 6-7-1 Nishi Shinjuku, Tokyo 1600023, Japan.	sky777xyz@yahoo.co.jp					Upadhyaya M, 2007, AM J HUM GENET, V80, P140, DOI 10.1086/510781; Maertens O, 2007, AM J HUM GENET, V81, P243, DOI 10.1086/519562; Fernandez-Rodriguez J, 2011, HUM MUTAT, V32, P705, DOI 10.1002/humu.21500; Kehrer-Sawatzki H, 2008, J MED GENET, V45, P622, DOI 10.1136/jmg.2008.059329; Miller MB, 2000, INT J DERMATOL, V39, P376, DOI 10.1046/j.1365-4362.2000.00841-5.x	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	JAN	2015	42	1			SI		104	105		10.1111/1346-8138.12729		2	Dermatology	Dermatology	AY1XE	WOS:000347381900027		
J	Matsuzawa, M; Harada, K; Hosomura, N; Amemiya, H; Ando, N; Inozume, T; Kawamura, T; Shibagaki, N; Shimada, S				Matsuzawa, Miyuki; Harada, Kazutoshi; Hosomura, Naohiro; Amemiya, Hidetake; Ando, Noriko; Inozume, Takashi; Kawamura, Tatsuyoshi; Shibagaki, Naotaka; Shimada, Shinji			Non-occlusive mesenteric ischemia after chemotherapy for metastatic melanoma	JOURNAL OF DERMATOLOGY			English	Letter									[Matsuzawa, Miyuki; Harada, Kazutoshi; Ando, Noriko; Inozume, Takashi; Kawamura, Tatsuyoshi; Shibagaki, Naotaka; Shimada, Shinji] Univ Yamanashi, Fac Med, Dept Dermatol, Yamanashi 4093898, Japan; [Hosomura, Naohiro; Amemiya, Hidetake] Univ Yamanashi, Fac Med, Dept Surg 1, Yamanashi 4093898, Japan	Harada, K (reprint author), Univ Yamanashi, Fac Med, Dept Dermatol, Chuo Ku, 1110 Shimogato, Yamanashi 4093898, Japan.	harada8874@gmail.com					Oldenburg WA, 2004, ARCH INTERN MED, V164, P1054, DOI 10.1001/archinte.164.10.1054; Kazui T, 2012, ANN THORAC CARDIOVAS, V18, P56, DOI 10.5761/atcs.cr.10.01654; Nagao S, 2012, INT J GYNECOL CANCER, V22, P70, DOI 10.1097/IGC.0b013e318234f927; Olgun DC, 2014, JPN J RADIOL, V32, P113, DOI 10.1007/s11604-013-0273-x; Reginelli A, 2013, BMC SURG, V13, DOI 10.1186/1471-2482-13-S2-S51	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	JAN	2015	42	1			SI		105	106		10.1111/1346-8138.12734		2	Dermatology	Dermatology	AY1XE	WOS:000347381900028		
J	Numata, T; Okubo, Y; Uchiyama, M; Takeuchi, Y; Muro, M; Tsuboi, R; Gotoh, A; Nomura, M; Mitsuhashi, Y				Numata, Takafumi; Okubo, Yukari; Uchiyama, Masaki; Takeuchi, Yumi; Muro, Mayuko; Tsuboi, Ryoji; Gotoh, Akihiko; Nomura, Mizuho; Mitsuhashi, Yoshihiko			Adult case of Langerhans cell histiocytosis	JOURNAL OF DERMATOLOGY			English	Letter									[Numata, Takafumi; Okubo, Yukari; Uchiyama, Masaki; Takeuchi, Yumi; Muro, Mayuko; Tsuboi, Ryoji; Mitsuhashi, Yoshihiko] Tokyo Med Univ, Dept Dermatol, Tokyo 1600023, Japan; [Gotoh, Akihiko] Juntendo Univ, Sch Med, Dept Hematol, Tokyo 113, Japan; [Nomura, Mizuho] Mayumi Clin, Tokyo, Japan	Numata, T (reprint author), Tokyo Med Univ, Dept Dermatol, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	numata921@gmail.com					LICHTENSTEIN L, 1953, AMA ARCH PATHOL, V56, P84; Morimoto A, 2013, INT J HEMATOL, V97, P103, DOI 10.1007/s12185-012-1245-0; Arico M, 2003, EUR J CANCER, V39, P2341, DOI 10.1016/S0959-8049(03)00672-5; FAVARA BE, 1987, LANCET, V1, P208; Stockschlaeder M, 2006, EUR J HAEMATOL, V76, P363, DOI 10.1111/j.1600-0609.2006.00648.x	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	JAN	2015	42	1			SI		107	108		10.1111/1346-8138.12732		2	Dermatology	Dermatology	AY1XE	WOS:000347381900029		
J	Matsuzawa, T; Inozume, T; Takaki, M; Harada, K; Kawamura, T; Shibagaki, N; Shimada, S				Matsuzawa, Takamitsu; Inozume, Takashi; Takaki, Machiko; Harada, Kazutoshi; Kawamura, Tatsuyoshi; Shibagaki, Naotaka; Shimada, Shinji			Case of folliculotropic mycosis fungoides with prominent loss of T-cell antigens CD7 and CD26 in blood T cells	JOURNAL OF DERMATOLOGY			English	Letter									[Matsuzawa, Takamitsu; Inozume, Takashi; Takaki, Machiko; Kawamura, Tatsuyoshi; Shibagaki, Naotaka; Shimada, Shinji] Univ Yamanashi, Dept Dermatol, Fac Med, Yamanashi 4093898, Japan; [Harada, Kazutoshi] Tokyo Med Univ, Dept Dermatol, Tokyo 1608402, Japan	Matsuzawa, T (reprint author), Univ Yamanashi, Dept Dermatol, Fac Med, Chuo Ku, 1110 Shimokato, Yamanashi 4093898, Japan.	tmatsuzawa@yamanashi.ac.jp					[Anonymous], LETTERS	1	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	JAN	2015	42	1			SI		108	109		10.1111/1346-8138.12738		2	Dermatology	Dermatology	AY1XE	WOS:000347381900030		
J	Masuda, K; Murakami, M; Ohnishi, S; Kukida, M; Hanakawa, Y; Tohyama, M; Sayama, K				Masuda, Kana; Murakami, Masamoto; Ohnishi, Sachiko; Kukida, Masayoshi; Hanakawa, Yasushi; Tohyama, Mikiko; Sayama, Koji			Case of palmoplantar pustulosis that developed with acute glomerulonephritis	JOURNAL OF DERMATOLOGY			English	Letter									[Masuda, Kana; Murakami, Masamoto; Hanakawa, Yasushi; Tohyama, Mikiko; Sayama, Koji] Ehime Univ, Grad Sch Med, Dept Dermatol, Toon, Ehime 7910295, Japan; [Ohnishi, Sachiko] Ehime Univ, Grad Sch Med, Dept Hematol, Toon, Ehime 7910295, Japan; [Kukida, Masayoshi] Ehime Univ, Grad Sch Med, Dept Clin Immunol & Infect Dis, Toon, Ehime 7910295, Japan	Masuda, K (reprint author), Ehime Univ, Grad Sch Med, Dept Dermatol, Toon, Ehime 7910295, Japan.	masuda.kana.me@ehime-u.ac.jp					Gudjonsson JE, 2012, FITZPATRICKS DERMATO, P197; ROUJEAU JC, 1991, ARCH DERMATOL, V127, P1333, DOI 10.1001/archderm.127.9.1333; TAN RSH, 1974, BRIT J DERMATOL, V91, P209, DOI 10.1111/j.1365-2133.1974.tb15867.x; Yamamoto T, 2013, J DERMATOL, V40, P857, DOI 10.1111/1346-8138.12272; Yoshida Y, 2003, J DERMATOL, V30, P141	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	JAN	2015	42	1			SI		111	112		10.1111/1346-8138.12710		2	Dermatology	Dermatology	AY1XE	WOS:000347381900032		
J	Yokozawa, N; Nakamura, O; Saito, E; Tsutsui, S				Yokozawa, N.; Nakamura, O.; Saito, E.; Tsutsui, S.			Ovarian cavity fluid of the viviparous surfperch Neoditrema ransonnetii suppresses the spontaneous cytotoxic activity of head-kidney leucocytes against xenogeneic targets	JOURNAL OF FISH BIOLOGY			English	Article						cytotoxicity; immunosuppression; okitango; RTG-2; viviparity	XIPHOPHORUS-HELLERII HAECKEL; CARASSIUS-AURATUS-LANGSDORFII; GINBUNA CRUCIAN CARP; IMMUNE RELATIONS; ICTALURUS-PUNCTATUS; CYPRINUS-CARPIO; TUMOR TARGETS; T-CELLS; FISH; TELEOST	In this study, the effect of ovarian cavity fluid (OCF) from a surfperch Neoditrema ransonnetii on the cytotoxic activity of leucocytes was investigated. In an assay targeting RTG-2, a cell line derived from rainbow trout Oncorhynchus mykiss gonads, leucocytes from both the spleen and head kidney showed spontaneous killing activity. Pre-incubation with OCF significantly suppressed the cytotoxic activity of head-kidney leucocytes towards RTG-2. This suppressive activity was due to the presence of low molecular-mass materials. These results suggest that OCF plays significant roles in pregnancy by its ability to modulate cytotoxicity with maternal leucocytes.	[Yokozawa, N.; Nakamura, O.; Saito, E.; Tsutsui, S.] Kitasato Univ, Sch Marine Biosci, Sagamihara, Kanagawa 2520373, Japan	Nakamura, O (reprint author), Kitasato Univ, Sch Marine Biosci, Sagamihara, Kanagawa 2520373, Japan.	naosamu@kitasato-u.ac.jp					Yoder JA, 2004, COMP BIOCHEM PHYS C, V138, P271, DOI 10.1016/j.cca.2004.03.008; Poole JA, 2004, CLIN REV ALLERG IMMU, V26, P161, DOI 10.1385/CRIAI:26:3:161; Watanabe Y, 2009, DEV COMP IMMUNOL, V33, P187, DOI 10.1016/j.dci.2008.08.008; Saito S, 2010, AM J REPROD IMMUNOL, V63, P601, DOI 10.1111/j.1600-0897.2010.00852.x; HOGARTH PJ, 1973, J FISH BIOL, V5, P109, DOI 10.1111/j.1095-8649.1973.tb04436.x; Toda H, 2011, DEV COMP IMMUNOL, V35, P88, DOI 10.1016/j.dci.2010.08.010; BIELEK E, 1988, DEV COMP IMMUNOL, V12, P809, DOI 10.1016/0145-305X(88)90055-9; Bishop G. R., 2000, CELL IMMUNOL, V198, P125; Evans D. L., 1984, DEV COMP IMMUNOL, V8, P5; Fischer U, 2013, FISH SHELLFISH IMMUN, V35, P197, DOI 10.1016/j.fsi.2013.04.018; GRAVES SS, 1984, DEV COMP IMMUNOL, V8, P293, DOI 10.1016/0145-305X(84)90036-3; GREENLEE AR, 1991, DEV COMP IMMUNOL, V15, P153, DOI 10.1016/0145-305X(91)90006-K; HAYDEN BJ, 1985, DEV COMP IMMUNOL, V9, P627, DOI 10.1016/0145-305X(85)90028-X; HOGARTH PJ, 1972, J FISH BIOL, V4, P271, DOI 10.1111/j.1095-8649.1972.tb05675.x; HOGARTH PJ, 1972, J FISH BIOL, V4, P265, DOI 10.1111/j.1095-8649.1972.tb05674.x; Jaso-Friedmann L, 1997, MOL IMMUNOL, V34, P955, DOI 10.1016/S0161-5890(97)00086-2; Jaso-Friedmann L, 2001, DEV COMP IMMUNOL, V25, P701, DOI 10.1016/S0145-305X(01)00031-3; KURATA O, 1995, DEV COMP IMMUNOL, V19, P315, DOI 10.1016/0145-305X(95)00015-L; LALA PK, 1988, CELL IMMUNOL, V116, P411, DOI 10.1016/0008-8749(88)90241-9; MCKINNEY EC, 1994, DEV COMP IMMUNOL, V18, P305, DOI 10.1016/S0145-305X(94)90356-5; Nakamura O, 2004, J EXP ZOOL PART A, V301A, P38, DOI 10.1002/jez.a.20005; Saito E, 2009, FISH SHELLFISH IMMUN, V27, P549, DOI 10.1016/j.fsi.2009.07.006; SCODRAS JM, 1990, CELL IMMUNOL, V127, P352, DOI 10.1016/0008-8749(90)90138-H; Shen LL, 2004, DEV COMP IMMUNOL, V28, P139, DOI 10.1016/S0145-305X(03)00119-8; Somamoto T, 2014, DEV COMP IMMUNOL, V43, P197, DOI 10.1016/j.dci.2013.07.014; Somamoto T, 2013, DEV COMP IMMUNOL, V39, P370, DOI 10.1016/j.dci.2012.11.001; Tazumi Y, 2004, ZOOL SCI, V21, P739, DOI 10.2108/zsj.21.739; WOURMS JP, 1994, ISRAEL J ZOOL, V40, P551; WOURMS JP, 1981, AM ZOOL, V21, P473; Yaker I., 2003, ANN SURG ONCOL, V10, P469; YOSHIDA SH, 1995, DEV COMP IMMUNOL, V19, P71, DOI 10.1016/0145-305X(94)00053-I	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1112	1095-8649		J FISH BIOL	J. Fish Biol.	JAN	2015	86	1					139	147		10.1111/jfb.12549		9	Fisheries; Marine & Freshwater Biology	Fisheries; Marine & Freshwater Biology	AY1NH	WOS:000347359200010		
J	Kikko, T; Ishizaki, D; Ninomiya, K; Kai, Y; Fujioka, Y				Kikko, T.; Ishizaki, D.; Ninomiya, K.; Kai, Y.; Fujioka, Y.			Diel patterns of larval drift of honmoroko Gnathopogon caerulescens in an inlet of Ibanaiko Lagoon, Lake Biwa, Japan	JOURNAL OF FISH BIOLOGY			English	Article						Cyprinidae; endangered species; fisheries management; larvae; nursery	DANUBE SIDEARM-SYSTEM; CYPRINID FISHES; DOWNSTREAM MIGRATION; STREAM; RIVER; SURVIVAL; AGE	Diel drift patterns of larvae of the endangered cyprinid Gnathopogon caerelescens in an inlet of the Ibanaiko Lagoon, connected to Lake Biwa in Japan, were assessed in April 2012. Peak occurrence of yolk-sac larvae was within a few hours after dark. Drift of newly hatched larvae is considered to be an important biological mechanism that ensures larval dispersal and recruitment from the inlets (spawning grounds) to the lagoon which functions as a nursery ground.	[Kikko, T.; Ishizaki, D.; Ninomiya, K.] Shiga Prefectural Fisheries Expt Stn, Hikone, Shiga 5220057, Japan; [Kai, Y.] Kyoto Univ, Field Sci Educ & Res Ctr, Maizuru Fisheries Res Stn, Maizuru, Kyoto 6250086, Japan; [Fujioka, Y.] Lake Biwa Museum, Kusatsu, Shiga 5250001, Japan	Kikko, T (reprint author), Shiga Prefectural Fisheries Expt Stn, 2138-3 Hassaka, Hikone, Shiga 5220057, Japan.	kikkou-takeshi@pref.shiga.lg.jp					ALLAN JD, 1985, CAN J FISH AQUAT SCI, V42, P210, DOI 10.1139/f85-028; Zitek A, 2004, J FISH BIOL, V65, P1319, DOI 10.1111/j.1095-8649.2004.00533.x; Iguchi K, 1999, J FISH BIOL, V54, P705, DOI 10.1006/jfbi.1998.0909; Kikko Takeshi, 2014, Japanese Journal of Ichthyology, V61, P1; Reichard M, 2002, J FISH BIOL, V61, P1063, DOI 10.1006/jfbi.2002.2116; HARVEY BC, 1987, T AM FISH SOC, V116, P851, DOI 10.1577/1548-8659(1987)116<851:SOYFTD>2.0.CO;2; Janac M, 2013, ECOL FRESHW FISH, V22, P430, DOI 10.1111/eff.12037; Sonny D, 2006, FOLIA ZOOL, V55, P75; Fujioka Y, 2013, JPN J ICHTHYOL, V60, P57; Zitek A, 2004, J FISH BIOL, V65, P1339, DOI 10.1111/j.1095-8649.2004.00534.x; IGUCHI K, 1990, J FISH BIOL, V37, P255, DOI 10.1111/j.1095-8649.1990.tb05857.x; CORBETT BW, 1986, T AM FISH SOC, V115, P41, DOI 10.1577/1548-8659(1986)115<41:SALDOS>2.0.CO;2; Fujioka Y, 2010, RED DATA BOOK SHIGA, P475; HARVEY BC, 1991, CAN J FISH AQUAT SCI, V48, P1476, DOI 10.1139/f91-175; Hosoya K., 2005, MESSAGES NAIKO CONSE, P118; Kikko T, 2015, ENVIRON BIOL FISH, V98, P1151, DOI 10.1007/s10641-014-0348-2; NAESJE TF, 1986, T AM FISH SOC, V115, P89; Nakamura M., 1969, CYPRINID FISHES JAPA; Nakamura M, 1949, NIPPON SUISAN GAKK, V15, P88; PAVLOV DS, 1994, FOLIA ZOOL, V43, P193; Persat H, 1995, FOLIA ZOOL, V44, P43; Reichard M, 2007, ECOL FRESHW FISH, V16, P482, DOI 10.1111/j.1600-0633.2007.00229.x; Sagawa Shiro, 2005, Ecology and Civil Engineering, V7, P129; Shibata J, 2011, POPUL ECOL, V53, P143, DOI 10.1007/s10144-010-0213-x; Tago Y, 1999, AQUACULTURE SCI, V47, P201; Tago Y, 1999, AQUACULTURE SCI, V47, P215; TSUKAMOTO K, 1991, NIPPON SUISAN GAKK, V57, P2013	27	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1112	1095-8649		J FISH BIOL	J. Fish Biol.	JAN	2015	86	1					409	415		10.1111/jfb.12570		7	Fisheries; Marine & Freshwater Biology	Fisheries; Marine & Freshwater Biology	AY1NH	WOS:000347359200031		
J	Kishishita, S; Fujii, T; Ishikawa, K				Kishishita, Seiichiro; Fujii, Tatsuya; Ishikawa, Kazuhiko			Heterologous expression of hyperthermophilic cellulases of archaea Pyrococcus sp by fungus Talaromyces cellulolyticus	JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY			English	Article						Biomass; Cellulase; Fungus; Archaea; Production	ACREMONIUM-CELLULOLYTICUS; ENDOGLUCANASE; ENDOCELLULASE; HORIKOSHII; CELLULOSE; ENZYMES; SYSTEM; GENE	Talaromyces cellulolyticus (formerly known as Acremonium cellulolyticus) is one of the high cellulolytic enzyme-producing fungi. T. cellulolyticus exhibits the potential ability for high amount production of enzyme proteins. Using the homologous expression system under the control of a glucoamylase promoter, some kinds of cellulases of T. cellulolyticus can be expressed by T. cellulolyticus. On the other hand, hyperthermophilic cellulase has been expected to be useful in the industrial applications to biomass. The hyperthermophilic archaea Pyrococcus horikoshii and P. furiosus have GH family 5 and 12 hyperthermophilic endocellulase, respectively. The two kinds of hyperthermophilic endocellulases were successfully produced by T. cellulolyticus using the above expression system under the control of a glucoamylase promoter of T. cellulolyticus. These recombinant cellulases exhibited the same characteristics as those of the recombinant cellulases prepared in E. coli. The productions of the recombinant enzymes were estimated to be over 100 mg/L. In this study, we first report the overexpression of the hyperthermophilic enzymes of archaea using the fungal expression system.	[Kishishita, Seiichiro; Fujii, Tatsuya; Ishikawa, Kazuhiko] Natl Inst Adv Ind Sci & Technol, Biomass Refinery Res Ctr, Hiroshima 7390046, Japan	Ishikawa, K (reprint author), Natl Inst Adv Ind Sci & Technol, Biomass Refinery Res Ctr, 3-11-32 Kagamiyama, Hiroshima 7390046, Japan.	kazu-ishikawa@aist.go.jp			Japan-U.S. Cooperation Project for Research and Standardization of Clean Energy Technologies	This work was supported by the Japan-U.S. Cooperation Project for Research and Standardization of Clean Energy Technologies. This work was greatly assisted by contributions of Ms. Miho Yoshimi and Ms. Miyu Sumii, members of Biomass Refinery Research Center, National Institute of Advanced Industrial Science.	Ando S, 2002, APPL ENVIRON MICROB, V68, P430, DOI 10.1128/AEM.68.1.430-433.2002; Su XY, 2012, ADV APPL MICROBIOL, V81, P1, DOI 10.1016/B978-0-12-394382-8.00001-0; Kim HW, 2012, FEBS LETT, V586, P1009, DOI 10.1016/j.febslet.2012.02.029; Fang X, 2008, J BIOSCI BIOENG, V106, P115, DOI 10.1263/jbb.106.115; Fujii T, 2012, BIOSCI BIOTECH BIOCH, V76, P245, DOI 10.1271/bbb.110498; Bauer MW, 1999, J BACTERIOL, V181, P284; Fujii T, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-24; Fujii T, 2014, FEMS MICROBIOL LETT, V351, P32, DOI 10.1111/1574-6968.12352; Inoue H, 2013, J IND MICROBIOL BIOT, V40, P823, DOI 10.1007/s10295-013-1286-2; Kim HW, 2010, PROTEINS, V78, P496, DOI 10.1002/prot.22602; YAMANOBE T, 1987, AGR BIOL CHEM TOKYO, V51, P65	11	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1367-5435	1476-5535		J IND MICROBIOL BIOT	J. Ind. Microbiol. Biotechnol.	JAN	2015	42	1					137	141		10.1007/s10295-014-1532-2		5	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	AY0JC	WOS:000347282000013		
J	Poudel, P; Tashiro, Y; Miyamoto, H; Miyamoto, H; Okugawa, Y; Sakai, K				Poudel, Pramod; Tashiro, Yukihiro; Miyamoto, Hirokuni; Miyamoto, Hisashi; Okugawa, Yuki; Sakai, Kenji			Direct starch fermentation to L-lactic acid by a newly isolated thermophilic strain, Bacillus sp. MC-07	JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY			English	Article						Thermophilic fermentation; Bacillus sp MC-07; Starch; Direct lactic acid fermentation	L-(+)-LACTIC ACID; BACTERIUM; COAGULANS; PLANTARUM; CASSAVA	A newly isolated Bacillus sp. MC-07 showed 99.2 % 16S rRNA gene sequence similarity with the Bacillus thermoamylovorans LMG 18084(T). It demonstrated optimum and maximum growth temperatures of 50 and 62 A degrees C, respectively. The ability of MC-07 to produce optically pure l-lactic acid via direct fermentation of starch without enzymatic hydrolysis was investigated at different pH values (6.0-8.0) by intermittent adjustments every 12 h. During batch fermentation in mineral salt medium containing 0.001 % yeast extract at pH 7.0, 20 g/L of soluble starch was utilized to produce 16.6 g/L l-lactic acid at 50 A degrees C within 24 h of fermentation, with 100 % optical purity, 92.1 % lactic acid selectivity, and an l-lactic acid yield of 0.977 g/g. Direct starch fermentation at pHs 6.0, 6.5, 7.5, and 8.0 resulted in considerably lower concentrations of lactic acid than did at pH 7.0. Compared with B. thermoamylovorans LMG 18084(T), the ability of strain MC-07 to produce l-lactic acid was superior.	[Poudel, Pramod; Tashiro, Yukihiro; Okugawa, Yuki; Sakai, Kenji] Kyushu Univ, Grad Sch Bioresources & Bioenvironm Sci, Dept Biosci & Biotechnol, Lab Soil Microbiol,Div Syst Bioengn,Fac Agr,Higas, Fukuoka 8128581, Japan; [Tashiro, Yukihiro] Kyushu Univ, Inst Adv Study, Higashi Ku, Fukuoka 8128581, Japan; [Miyamoto, Hirokuni] Japan Ecosci Nikkan Kagaku Co Ltd, Chuo Ku, Chiba 2600034, Japan; [Miyamoto, Hirokuni] Chiba Univ, Grad Sch Adv Integrat Sci, Chiba 2638522, Japan; [Miyamoto, Hirokuni] Keio Sch Med, Dept Biochem & Integrat Med Biol, Shinjuku Ku, Tokyo 1608582, Japan; [Miyamoto, Hirokuni; Miyamoto, Hisashi] Sermas Co Ltd, Chiba 2720033, Japan; [Miyamoto, Hisashi] Miroku Co Ltd, Oita 8730006, Japan	Sakai, K (reprint author), Kyushu Univ, Grad Sch Bioresources & Bioenvironm Sci, Dept Biosci & Biotechnol, Lab Soil Microbiol,Div Syst Bioengn,Fac Agr,Higas, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	kensak@agr.kyushu-u.ac.jp			JSPS KAKENHI [26740050]; Kyushu University	This work was supported partly by JSPS KAKENHI Grant number 26740050 and by Kyushu University interdisciplinary programs in education and projects in research development.	Sanni AI, 2002, INT J FOOD MICROBIOL, V72, P53, DOI 10.1016/S0168-1605(01)00607-9; Zhao B, 2010, BIORESOURCE TECHNOL, V101, P6494, DOI 10.1016/j.biortech.2010.03.051; COMBETBLANC Y, 1995, INT J SYST BACTERIOL, V45, P9; Xiaodong W, 1997, BIOTECHNOL LETT, V19, P841, DOI 10.1023/A:1018321200591; John RP, 2009, BIOTECHNOL ADV, V27, P145, DOI 10.1016/j.biotechadv.2008.10.004; Zhang ZY, 2007, BIOCHEM ENG J, V35, P251, DOI 10.1016/j.bej.2007.01.028; Tashiro Y, 2013, BIORESOURCE TECHNOL, V146, P672, DOI 10.1016/j.biortech.2013.07.102; Zhou XD, 2013, APPL MICROBIOL BIOT, V97, P4309, DOI 10.1007/s00253-013-4710-7; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; YUMOTO I, 1995, BIOTECHNOL LETT, V17, P543, DOI 10.1007/BF00132025; Ou MS, 2011, J IND MICROBIOL BIOT, V38, P599, DOI 10.1007/s10295-010-0796-4; Guyot JP, 2000, J APPL MICROBIOL, V88, P176, DOI 10.1046/j.1365-2672.2000.00953.x; Petrov K, 2008, FOOD MICROBIOL, V25, P550, DOI 10.1016/j.fm.2008.02.005; Sakai K, 2006, J BIOSCI BIOENG, V101, P457, DOI 10.1263/jbb.101.457; Bomrungnok W, 2012, APCBEE PROC, V2, P97, DOI 10.1016/j.apcbee.2012.06.018; Görke Boris, 2008, Nat Rev Microbiol, V6, P613, DOI 10.1038/nrmicro1932; Narita J, 2004, J BIOSCI BIOENG, V97, P423, DOI 10.1016/S1389-1723(04)70230-3; Niisawa C, 2008, J GEN APPL MICROBIOL, V54, P149, DOI 10.2323/jgam.54.149; Petrova P, 2012, STARCH-STARKE, V64, P10, DOI 10.1002/star.201100074; Sakai K., 2000, FOOD SCI TECHNOL RES, V6, P140, DOI 10.3136/fstr.6.140; Saowanit T, 2014, J BIOSCI BIOENG, V117, P318; Shibata K, 2007, ENZYME MICROB TECH, V41, P149, DOI 10.1016/j.enzmictec.2006.12.020; Vishnu VC, 2002, WORLD J MICROB BIOT, V18, P429; Walton SL, 2010, J IND MICROBIOL BIOT, V37, P823, DOI 10.1007/s10295-010-0727-4	24	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1367-5435	1476-5535		J IND MICROBIOL BIOT	J. Ind. Microbiol. Biotechnol.	JAN	2015	42	1					143	149		10.1007/s10295-014-1534-0		7	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	AY0JC	WOS:000347282000014		
J	Inoda, T; Kamimura, S				Inoda, Toshio; Kamimura, Shinji			Choice of Prey Body Parts for Effective Feeding by Predaceous Diving Beetle Larvae, Dytiscus sharpi sharpi (Wehncke) (Coleoptera: Dytiscidae)	JOURNAL OF INSECT BEHAVIOR			English	Article						Feeding behavior; optimal foraging theory; partial consumption; diving beetle larvae	BUFO-AMERICANUS TADPOLES; PREDATION; VULNERABILITY; REPRODUCTION; DIETARY; SIZE	Diving beetle larvae use their mandibles in two ways: capturing prey and sucking their body fluid. Catching and consuming the prey's most nutritious body part leads to the highest feeding efficiency. To test this, Dytiscus sharpi sharpi larvae were given tadpoles (Rana ornativentris) as food and their feeding behaviors were observed. Dytiscus larvae preferred to catch tadpoles by the abdomens rather than by other parts. Tadpoles soon became immobilized and in most cases the beetle larvae started eating abdomens first. Beetle larvae tried to change biting site to tadpole's abdomen when the tadpole was initially caught by the head or tail. More food was absorbed from the abdomen than the head or tail suggesting that the feeding behavior of beetle larva is optimized to obtain nutrition efficiently from the tadpole abdomen.	[Inoda, Toshio] Conservat Lab Rare Water Insects, Katsushika, Tokyo 1250052, Japan; [Kamimura, Shinji] Chuo Univ, Dept Biol Sci, Fac Sci & Engn, Bunkyo Ku, Tokyo 1128551, Japan	Inoda, T (reprint author), Conservat Lab Rare Water Insects, Shibamata 5-17-10, Katsushika, Tokyo 1250052, Japan.	inoda@kxb.biglobe.ne.jp					YOUNG AM, 1967, PAN-PAC ENTOMOL, V43, P113; Ohba S, 2006, LIMNOLOGY, V7, P41, DOI 10.1007/s10201-006-0161-5; Inoda T, 2003, AM NAT, V162, P811, DOI 10.1086/378903; JOHANSSON A, 1992, HYDROBIOLOGIA, V248, P201, DOI 10.1007/BF00006148; KLAMKIN MS, 1976, AM MATH MON, V83, P478, DOI 10.2307/2318347; KLAMKIN MS, 1971, AM MATH MON, V78, P280, DOI 10.2307/2317530; Inoda T, 2012, ZOOL SCI, V29, P547, DOI 10.2108/zsj.29.547; Balduf WV, 1935, BIONOMICS ENTOMPHAGO, P200; Blunck H., 1923, Z WISS ZOOL, V121, P117; BROCKELM.WY, 1969, ECOLOGY, V50, P632, DOI 10.2307/1936252; BRODIE ED, 1978, HERPETOLOGICA, V34, P302; BRODIE ED, 1983, HERPETOLOGICA, V39, P67; FORMANOWICZ DR, 1981, J NEW YORK ENTOMOL S, V89, P152; FORMANOWICZ DR, 1982, COPEIA, P91, DOI 10.2307/1444272; FORMANOWICZ DR, 1987, J KANSAS ENTOMOL SOC, V60, P92; Inoda T, 2007, ZOOL SCI, V24, P1115, DOI 10.2108/zsj.24.1115; Inoda T, 2009, COLEOPTS BULL, V63, P340, DOI 10.1649/1152.1; Inoda T, 2013, APPL ENTOMOL ZOOL, V48, P397, DOI 10.1007/s13355-013-0176-4; Inoda T, 2004, COLEOPTS BULL, V58, P37, DOI 10.1649/591; Inoda T, 2003, ZOOL SCI, V20, P377, DOI 10.2108/zsj.20.377; JEFFRIES M, 1988, FRESHWATER BIOL, V19, P49, DOI 10.1111/j.1365-2427.1988.tb00326.x; KRUSE KC, 1983, OECOLOGIA, V58, P383, DOI 10.1007/BF00385240; Ministry Environment Government Japan, 2012, RED LIST OF JAP; Ministry of the Environment Government of Japan, 2011, NAT END SPEC WILD FA; Mori M, 2002, BUN ICHI SOGO SHUPPA; Mori M, 2001, NEJIREBANE, V96, P1; R Core Team, 2013, R LANG ENV STAT COMP; Wesenberg-Lund C, 1943, BIOL SUSSWASSERINSEK, P682; ZAR J. H., 1999, BIOSTATISTICAL ANAL	29	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0892-7553	1572-8889		J INSECT BEHAV	J. Insect Behav.	JAN	2015	28	1					26	36		10.1007/s10905-014-9475-z		11	Entomology	Entomology	AY6PP	WOS:000347688400003		
J	Kataoka, H				Kataoka, Hironao			Gustav Senn (1875-1945): The pioneer of chloroplast movement research	JOURNAL OF INTEGRATIVE PLANT BIOLOGY			English	Article						Chloroplast; Gustav Senn; Mougeotia; photomovement; Vaucheria	VAUCHERIA; MOUGEOTIA	Gustav Senn analyzed for the first time light-induced movement and arrangement of chloroplasts. Using many plant species he performed physiological analyses of chloroplast migration in response to external stimuli, with emphasis on light. He determined light paths within a cell by measuring refractive indices and optical thickness of cellular compartments and confirmed that chloroplasts migrate towards the region where the light intensity is optimum. After 6 to 7 years' concentrated study, Senn published the famous monograph Die Gestalts- und Lageveranderung der Pflanzen- Chromatophoren (The Changes in Shape and Position of Plant Chloroplasts) in 1908. This book has stimulated many plant physiologists and photobiologists, because Senn not only thoroughly classified and defined various types of light-induced chloroplast migration but also already described possible interaction of different photoreceptor systems in Mougeotia more than 50 years before the discovery of phytochrome. This book also contains still useful experimental hints and overlooked findings on the interaction between light and other factors, such as temperature, water content, and nourishment. After publishing this book, Senn retreated from the study of chloroplasts and became a researcher of the Greek philosopher, Theophrastus. In this review, I introduce his biographical background and then summarize some of his key research accomplishment.	Tohoku Univ, Bot Gardens, Aoba Ku, Sendai, Miyagi 9800862, Japan	Kataoka, H (reprint author), Tohoku Univ, Bot Gardens, Aoba Ku, 12-2 Kawauchi, Sendai, Miyagi 9800862, Japan.	hironao.kataoka@gmail.com					Suetsugu N, 2005, P NATL ACAD SCI USA, V102, P13705, DOI 10.1073/pnas.0504734102; Oikawa K, 2003, PLANT CELL, V15, P2805, DOI 10.1105/tpc.016428; Higa T, 2014, P NATL ACAD SCI USA, V111, P4327, DOI 10.1073/pnas.1317902111; Takahashi F, 2007, P NATL ACAD SCI USA, V104, P19625, DOI 10.1073/pnas.0707692104; Britz S. J., 1979, ENCY PLANT PHYSL, VVII, P170; Bunning E, 1975, GROSSE NATURFORSCHER, V37; Dietrich MR, 2015, J INTEGR PLANT BIOL, V57, P14, DOI 10.1111/jipb.12317; Engler A, 1900, DIE NATURLICHEN PFLA; FISCHERARNOLD G, 1963, PROTOPLASMA, V56, P495, DOI 10.1007/BF01252099; Haupt W, 1977, BEWEGUNGSPHYSIOLOGIE; HAUPT W, 1959, PLANTA, V53, P484, DOI 10.1007/BF01900644; Haupt W, 1984, MEMBRANES SENSORY TR, P331; Haupt W, 1970, PHOTOBIOLOGY MICROOR, P283; Higa T, 2015, J INTEGR PLANT BIOL, V57, P120, DOI 10.1111/jipb.12310; Kataoka H, 1980, LIGHT AND LIFE IN NA, P206; Kataoka H, 2015, YOHRYOKUTAI NO HIKAR; KATAOKA H, 1975, PLANT CELL PHYSIOL, V16, P439; KRISTIANSEN J, 1995, CHRYSOPHYTE ALGAE, P1; MINEYUKI Y, 1995, PROTOPLASMA, V185, P222, DOI 10.1007/BF01272863; Oltmanns F, 1892, FLORA, V75, P184; Pfeffer W, 1904, PFLANZENPHYSIOLOGIE, VII; Pfeffer W, 1893, VERHANDLUNG DER GESE, P1; Pfeffer W, 1881, PFLANZENPHYSIOLOGIE; SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3; Sakai Y, 2015, J INTEGR PLANT BIOL, V57, P93, DOI 10.1111/jipb.12284; Seitz K, 1982, STUDIES AQUATIC VASC, P89; Seitz K, 1979, ENCY PLANT PHYSL, V7, P150; Senn G, 1908, DIE GESTALTS UND LAG; Senn G, 1906, SAMMLUNG NATURWISSEN; Takahashi F, 2001, PLANT CELL PHYSIOL, V42, P274, DOI 10.1093/pcp/pce033; Thompson DW, 1945, NATURE, V3958, P289	31	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1672-9072	1744-7909		J INTEGR PLANT BIOL	J. Integr. Plant Biol.	JAN	2015	57	1					4	13		10.1111/jipb.12311		10	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	AY2IW	WOS:000347413600002		
J	Sakai, Y; Inoue, SI; Harada, A; Shimazaki, KI; Takagi, S				Sakai, Yuuki; Inoue, Shin-Ichiro; Harada, Akiko; Shimazaki, Ken-Ichiro; Takagi, Shingo			Blue-light-induced rapid chloroplast de-anchoring in Vallisneria epidermal cells	JOURNAL OF INTEGRATIVE PLANT BIOLOGY			English	Article						Avoidance response of chloroplasts; blue-light response; chloroplast de-anchoring; cytoplasmic calcium; phototropin	MEMBRANE H+-ATPASE; ZEA-MAYS L; MESOPHYLL-CELLS; CYTOSOLIC CA2+; PROTEIN-KINASE; PHOTORECEPTOR PHOTOTROPIN; INDUCED PHOSPHORYLATION; PHOTOSYNTHETIC CONTROL; FLAVIN MONONUCLEOTIDE; ACTIN CYTOSKELETON	In the outer periclinal cytoplasm of leaf epidermal cells of an aquatic angiosperm Vallisneria, blue light induces chloroplast de-anchoring, a rapid decline in the resistance of chloroplasts against centrifugal force. Chloroplast de-anchoring is known induced within 1min of irradiation with high-fluence-rate blue light specifically, preceding the commencement of chloroplasts migration toward the anticlinal cytoplasm. However, its regulatory mechanism has remained elusive, although pharmacological analysis suggested that a calcium release from intracellular calcium stores is necessary for the response. In search of the responsible photoreceptors, immunoblotting analysis using antibodies against phototropins demonstrated that cross-reactive polypeptides of 120-kDa exist in the plasma-membrane fraction prepared from the leaves. In vitro phosphorylation analysis revealed that 120-kDa polypeptides were phosphorylated by exposure to blue light in a fluence-dependent manner. The blue-light-induced phosphorylation activity was sensitive to a Ser/Thr kinase inhibitor, staurosporine, and unusually was retained at a high level for a long time in darkness. Furthermore, phototropin gene homologs (Vallisneria PHOTOTROPIN1 and PHOTOTROPIN2) expressed in leaves were isolated. We propose that calcium-regulated chloroplast de-anchoring, possibly mediated by phototropins, is an initial process of the blue-light-induced avoidance response of chloroplasts in Vallisneria.	[Sakai, Yuuki; Takagi, Shingo] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Osaka 5600043, Japan; [Inoue, Shin-Ichiro] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648602, Japan; [Harada, Akiko] Osaka Med Coll, Dept Biol, Osaka 5698686, Japan; [Shimazaki, Ken-Ichiro] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8128581, Japan	Sakai, Y (reprint author), Osaka Univ, Grad Sch Sci, Dept Biol Sci, Osaka 5600043, Japan.	yuukis0110@gmail.com			Japanese Ministry of Education, Culture, Sports, Science and Technology [19039020, 20570037]	We are grateful to Dr. Fumio Takahashi for his excellent help in gene isolation, and to Dr. Louis J. Irving for his critical reading of the manuscript. This work was supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology (grant Nos. 19039020 and 20570037 to S.T.).	Aggarwal C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055393; Anielska-Mazur A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-64; Yamashita H, 2011, PLANTA, V233, P357, DOI 10.1007/s00425-010-1299-2; Logan DC, 2010, SEMIN CELL DEV BIOL, V21, P550, DOI 10.1016/j.semcdb.2009.12.010; Takagi S, 2011, INT REV CEL MOL BIO, V286, P181, DOI 10.1016/B978-0-12-385859-7.00004-5; Suetsugu N, 2005, P NATL ACAD SCI USA, V102, P13705, DOI 10.1073/pnas.0504734102; Huala E, 1997, SCIENCE, V278, P2120, DOI 10.1126/science.278.5346.2120; Poutrain P, 2009, J EXP BOT, V60, P1387, DOI 10.1093/jxb/erp017; Kong SG, 2014, BBA-BIOENERGETICS, V1837, P522, DOI 10.1016/j.bbabio.2013.12.004; Wada M, 2004, CURR OPIN PLANT BIOL, V7, P626, DOI 10.1016/j.ppi.2004.09.005; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; Harada A, 2007, PHOTOCHEM PHOTOBIOL, V83, P102, DOI 10.1562/2006-03-08-IR-837; Folta KM, 2001, PLANT J, V26, P471, DOI 10.1046/j.1365-313x.2001.01038.x; Harada A, 2003, P NATL ACAD SCI USA, V100, P8583, DOI 10.1073/pnas.1336802100; Baum G, 1999, P NATL ACAD SCI USA, V96, P13554, DOI 10.1073/pnas.96.23.13554; Briggs WR, 2002, TRENDS PLANT SCI, V7, P204, DOI 10.1016/S1360-1385(02)02245-8; Wada M, 2003, ANNU REV PLANT BIOL, V54, P455, DOI 10.1146/annurev.arplant.54.031902.135023; Kagawa T, 2004, PLANT CELL PHYSIOL, V45, P416, DOI 10.1093/pcp/pch045; Inoue S, 2008, P NATL ACAD SCI USA, V105, P5626, DOI 10.1073/pnas.0709189105; Les DH, 2008, SYST BOT, V33, P49, DOI 10.1600/036364408783887483; Kinoshita T, 2003, PLANT PHYSIOL, V133, P1453, DOI 10.1104/pp.103.029629; Christie JM, 2007, ANNU REV PLANT BIOL, V58, P21, DOI 10.1146/annurev.arplant.58.032806.103951; Kagawa T, 2001, SCIENCE, V291, P2138, DOI 10.1126/science.291.5511.2138; Swartz TE, 2001, J BIOL CHEM, V276, P36493, DOI 10.1074/jbc.M103114200; Sakai T, 2001, P NATL ACAD SCI USA, V98, P6969, DOI 10.1073/pnas.101137598; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Stoelzle S, 2003, P NATL ACAD SCI USA, V100, P1456, DOI 10.1073/pnas.0333408100; Zhao X, 2013, PLANT PHYSIOL, V162, P1539, DOI 10.1104/pp.113.216556; Kadota A, 2009, P NATL ACAD SCI USA, V106, P13106, DOI 10.1073/pnas.0906250106; Banas AK, 2012, J EXP BOT, V63, P1559, DOI 10.1093/jxb/err429; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Takemiya A, 2005, PLANT CELL, V17, P1120, DOI 10.1105/tpc.104.030049; Tsuboi H, 2012, J PLANT RES, V125, P417, DOI 10.1007/s10265-011-0444-8; Kasahara M, 2002, PLANT PHYSIOL, V129, P762, DOI 10.1104/pp.002410; Bremer B, 2009, BOT J LINN SOC, V161, P105; Chen X, 2008, PLANT CELL, V20, P353, DOI 10.1105/tpc.107.052670; DONG XJ, 1995, PLANTA, V197, P257; Dong XJ, 1996, PROTOPLASMA, V195, P18, DOI 10.1007/BF01279183; Dong XJ, 1998, PLANT CELL PHYSIOL, V39, P1299; Harada A, 2009, PLANT CELL PHYSIOL, V50, P360, DOI 10.1093/pcp/pcn203; Harada A, 2002, PLANTA, V214, P870, DOI 10.1007/s00425-001-0690-4; Harada A, 2002, PLANTA, V214, P863, DOI 10.1007/s00425-001-0689-x; Higa T, 2015, J INTEGR PLANT BIOL, V57, P120, DOI 10.1111/jipb.12310; Inoue S, 2010, CURR OPIN PLANT BIOL, V13, P587, DOI 10.1016/j.pbi.2010.09.002; IZUTANI Y, 1990, PHOTOCHEM PHOTOBIOL, V51, P105, DOI 10.1111/j.1751-1097.1990.tb01690.x; Jarillo JA, 1998, PLANT PHYSIOL, V117, P719; Kanegae H, 2000, PLANT CELL PHYSIOL, V41, P415; Nozue K, 2000, PLANT PHYSIOL, V122, P1457; ODONNELL VB, 1993, BIOCHEM J, V290, P41; Okajima K, 2012, J BIOL CHEM, V287, P40972, DOI 10.1074/jbc.M112.406512; PALMER JM, 1993, PLANT PHYSIOL, V102, P1211; PALMER JM, 1993, PLANT PHYSIOL, V102, P1219; REYMOND P, 1992, PLANT PHYSIOL, V100, P655, DOI 10.1104/pp.100.2.655; Sakai Y, 2005, PLANTA, V221, P823, DOI 10.1007/s00425-005-1493-9; Sakurai N, 2005, PLANTA, V221, P66, DOI 10.1007/s00425-004-1416-1; Salomon M, 1997, PLANT PHYSIOL, V115, P485; Salomon M, 1996, PLANTA, V199, P336; Sato Y, 2001, PLANT PHYSIOL, V127, P497, DOI 10.1104/pp.127.2.497; SEITZ K, 1964, PROTOPLASMA, V58, P621, DOI 10.1007/BF01248181; SEITZ K, 1967, Z PFLANZENPHYSIOL, V56, P246; Senn G, 1908, DIE GESTALTS UND LAG; TAKAGI S, 1986, PLANT CELL PHYSIOL, V27, P953; Takagi S, 2009, J EXP BOT, V60, P3301, DOI 10.1093/jxb/erp193; TAKAGI S, 1991, J PLANT PHYSIOL, V138, P257; TAKAGI S, 1988, PLANT PHYSIOL, V88, P228, DOI 10.1104/pp.88.1.228; Takagi S, 2003, PLANT CELL, V15, P331, DOI 10.1105/tpc.007237; TAKAGI S, 1985, PLANT CELL PHYSIOL, V26, P941; Takamatsu H, 2011, PLANT CELL PHYSIOL, V52, P1973, DOI 10.1093/pcp/pcr130; TAKATA M, 1966, J GEN PHYSIOL, V50, P461, DOI 10.1085/jgp.50.2.461; Tlalka M, 1999, PLANT J, V20, P461, DOI 10.1046/j.1365-313x.1999.00621.x; ZACHERL M, 1998, PLANT PHYSIOL, V116, P869	71	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1672-9072	1744-7909		J INTEGR PLANT BIOL	J. Integr. Plant Biol.	JAN	2015	57	1					93	105		10.1111/jipb.12284		13	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	AY2IW	WOS:000347413600010		
J	Higa, T; Wada, M				Higa, Takeshi; Wada, Masamitsu			Clues to the signals for chloroplast photo-relocation from the lifetimes of accumulation and avoidance responses	JOURNAL OF INTEGRATIVE PLANT BIOLOGY			English	Article						Blue light; chloroplast movement; fern gametophyte; intracellular signaling; phototropin	ADAPTED PROTHALLIAL CELLS; ADIANTUM-CAPILLUS-VENERIS; BLUE-LIGHT RECEPTOR; LEMNA-TRISULCA L; FERN ADIANTUM; ACTIN-FILAMENTS; PHOTORELOCATION MOVEMENT; PLASMA-MEMBRANE; CYTOSOLIC CA2+; PHOTOTROPIN 1	Chloroplast photo-relocation movement is crucial for plant survival; however, the mechanism of this phenomenon is still poorly understood. Especially, the signal that goes from photoreceptor to chloroplast is unknown, although the photoreceptors (phototropin 1 and 2) have been identified and an actin structure (chloroplast actin filaments) has been characterized that is specific for chloroplast movement. Here, in gametophytes of the fern Adiantum capillus-veneris, gametophores of the moss Physcomiterella patens, and leaves of the seed plant Arabidopsis thaliana, we sought to characterize the signaling system by measuring the lifetime of the induced response. Chloroplast movements were induced by microbeam irradiation with high-intensity blue light and recorded. The lifetime of the avoidance state was measured as a lag time between switching off the beam and the loss of avoidance behavior, and that of the accumulation state was measured as the duration of accumulation behavior following the extinction of the beam. The lifetime for the avoidance response state is approximately 3-4min and that for the accumulation response is 19-28min. These data suggest that the two responses are based on distinct signals.	[Higa, Takeshi; Wada, Masamitsu] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8128581, Japan	Wada, M (reprint author), Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8128581, Japan.	wadascb@kyushu-u.org		Higa, Takeshi/0000-0002-3196-2160	Ministry of Education, Culture, Sports, Science, and Technology of Japan [23120523]; Japan Society for the Promotion of Science [20227001, 25120721, 25251033]	We thank Dr. Tomomichi Fujita for his kind gift of Physcomitrella patens gametophores. This work was supported in part by Grants-in-Aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (23120523 to M.W.) and the Japan Society for the Promotion of Science (20227001, 25120721, and 25251033 to M.W.).	Aggarwal C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055393; Leybaert L, 2012, PHYSIOL REV, V92, P1359, DOI 10.1152/physrev.00029.2011; Yamashita H, 2011, PLANTA, V233, P357, DOI 10.1007/s00425-010-1299-2; Tsuboi H, 2013, J PLANT RES, V126, P557, DOI 10.1007/s10265-012-0542-2; Sakamoto K, 2002, PLANT CELL, V14, P1723, DOI 10.1105/tpc.003293; Jarillo JA, 2001, NATURE, V410, P952, DOI 10.1038/35073622; Oikawa K, 2008, PLANT PHYSIOL, V148, P829, DOI 10.1104/pp.108.123075; Augustynowicz J, 1999, PLANT CELL ENVIRON, V22, P1239, DOI 10.1046/j.1365-3040.1999.00487.x; Oikawa K, 2003, PLANT CELL, V15, P2805, DOI 10.1105/tpc.016428; Kong SG, 2014, BBA-BIOENERGETICS, V1837, P522, DOI 10.1016/j.bbabio.2013.12.004; Wada M, 2013, PLANT SCI, V210, P177, DOI 10.1016/j.plantsci.2013.05.016; KADOTA A, 1992, BOT MAG TOKYO, V105, P265, DOI 10.1007/BF02489420; Kong SG, 2013, PLANT CELL PHYSIOL, V54, P80, DOI 10.1093/pcp/pcs151; Babourina O, 2002, P NATL ACAD SCI USA, V99, P2433, DOI 10.1073/pnas.042294599; Kagawa T, 1996, PLANTA, V198, P488, DOI 10.1007/BF00620067; Kong SG, 2013, PLANT CELL, V25, P572, DOI 10.1105/tpc.113.109694; Sato Y, 2001, J CELL SCI, V114, P269; Harada A, 2003, P NATL ACAD SCI USA, V100, P8583, DOI 10.1073/pnas.1336802100; INOUE Y, 1974, PLANT CELL PHYSIOL, V15, P717; Baum G, 1999, P NATL ACAD SCI USA, V96, P13554, DOI 10.1073/pnas.96.23.13554; Kagawa T, 2004, PLANT CELL PHYSIOL, V45, P416, DOI 10.1093/pcp/pch045; Kagawa T, 2004, PHOTOCH PHOTOBIO SCI, V3, P592, DOI 10.1039/b316285k; Kawai H, 2003, NATURE, V421, P287, DOI 10.1038/nature01310; Tsuboi H, 2011, J PLANT RES, V124, P201, DOI 10.1007/s10265-010-0364-z; Tsuboi H, 2010, J PLANT RES, V123, P381, DOI 10.1007/s10265-009-0284-y; Kagawa T, 2001, SCIENCE, V291, P2138, DOI 10.1126/science.291.5511.2138; Kong SG, 2011, MOL PLANT, V4, P771, DOI 10.1093/mp/ssr061; Sakai T, 2001, P NATL ACAD SCI USA, V98, P6969, DOI 10.1073/pnas.101137598; Stoelzle S, 2003, P NATL ACAD SCI USA, V100, P1456, DOI 10.1073/pnas.0333408100; Kadota A, 2009, P NATL ACAD SCI USA, V106, P13106, DOI 10.1073/pnas.0906250106; Banas AK, 2012, J EXP BOT, V63, P1559, DOI 10.1093/jxb/err429; Kasahara M, 2002, NATURE, V420, P829, DOI 10.1038/nature01213; Kong SG, 2006, PLANT J, V45, P994, DOI 10.1111/j.1365-313X.2006.02667.x; Nishiyama T, 2000, DNA RES, V7, P9, DOI 10.1093/dnares/7.1.9; Tsuboi H, 2012, J PLANT RES, V125, P417, DOI 10.1007/s10265-011-0444-8; Jaffe LF, 2010, CELL CALCIUM, V48, P102, DOI 10.1016/j.ceca.2010.08.007; KAGAWA T, 1994, J PLANT RES, V107, P389, DOI 10.1007/BF02344062; Kataoka H, 2015, J INTEGR PLANT BIOL, V57, P4, DOI 10.1111/jipb.12311; MALEC P, 1994, J THEOR BIOL, V169, P189, DOI 10.1006/jtbi.1994.1140; Nozue K, 1998, P NATL ACAD SCI USA, V95, P15826, DOI 10.1073/pnas.95.26.15826; Okajima K, 2012, J BIOL CHEM, V287, P40972, DOI 10.1074/jbc.M112.406512; Senn G, 1908, GESTALTS LAGEVERANDE; Suetsugu N, 2007, BIOL CHEM, V388, P927, DOI 10.1515/BC.2007.118; Tlalka M, 1999, PLANT J, V20, P461, DOI 10.1046/j.1365-313x.1999.00621.x; WADA M, 1982, PROTOPLASMA, V113, P132, DOI 10.1007/BF01282002; Wada M, 2005, LIGHT SENSING IN PLANTS, P193, DOI 10.1007/4-431-27092-2_22; WADA M, 1983, PLANT CELL PHYSIOL, V24, P1441; YATSUHASHI H, 1990, PLANT SCI, V68, P87, DOI 10.1016/0168-9452(90)90156-I	48	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1672-9072	1744-7909		J INTEGR PLANT BIOL	J. Integr. Plant Biol.	JAN	2015	57	1					120	126		10.1111/jipb.12310		7	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	AY2IW	WOS:000347413600012		
J	Hirakawa, Y; Nomura, T; Hasezawa, S; Higaki, T				Hirakawa, Yumi; Nomura, Toshihisa; Hasezawa, Seiichiro; Higaki, Takumi			Simplification of vacuole structure during plant cell death triggered by culture filtrates of Erwinia carotovora	JOURNAL OF INTEGRATIVE PLANT BIOLOGY			English	Article						Actin filaments; defense-related cell death; Erwinia carotovora; tobacco BY-2 cells; vacuoles	TOBACCO BY-2 CELLS; MEMBRANE DYNAMICS; DEFENSE RESPONSE; SUBSP CAROTOVORA; SALICYLIC-ACID; ARABIDOPSIS; ACTIN; PROTEIN; INDUCTION; DISTINCT	Vacuoles are suggested to play crucial roles in plant defense-related cell death. During programmed cell death, previous live cell imaging studies have observed vacuoles to become simpler in structure and have implicated this simplification as a prelude to the vacuole's rupture and consequent lysis of the plasma membrane. Here, we examined dynamics of the vacuole in cell cycle-synchronized tobacco BY-2 (Nicotiana tabacum L. cv. Bright Yellow 2) cells during cell death induced by application of culture filtrates of Erwinia carotovora. The filtrate induced death in about 90% of the cells by 24h. Prior to cell death, vacuole shape simplified and endoplasmic actin filaments disassembled; however, the vacuoles did not rupture until after plasma membrane integrity was lost. Instead of facilitating rupture, the simplification of vacuole structure might play a role in the retrieval of membrane components needed for defense-related cell death.	[Hirakawa, Yumi; Hasezawa, Seiichiro; Higaki, Takumi] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan; [Nomura, Toshihisa] RIKEN, Ctr Sustainable Resource Sci, Yokohama, Kanagawa 2300045, Japan	Higaki, T (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan.	higaki@k.u-tokyo.ac.jp			JSPS KAKENHI [25711017, 25291056, 24114007]	The authors are grateful to Dr. Toshio Sano of Hosei University for technical assistance. We thank Drs. Natsumaro Kutsuna and Kei H. Kojo of The University of Tokyo for helpful suggestions. We also thank Dr. Emiko Okubo-Kurihara of RIKEN for preliminary experiments. This work was supported by JSPS KAKENHI Grant Numbers 25711017 (T.H.), 25291056 (S.H.) and 24114007 (S.H.).	Abramoff MD, 2004, J BIOPHOTONICS INT, V11, P36; Nebenfuhr A, 1999, PLANT PHYSIOL, V121, P1127, DOI 10.1104/pp.121.4.1127; Van Gestel K, 2002, J EXP BOT, V53, P659, DOI 10.1093/jexbot/53.369.659; Higaki T, 2006, PLANT CELL PHYSIOL, V47, P839, DOI 10.1093/pcp/pcj056; Hofius D, 2009, CELL, V137, P773, DOI 10.1016/j.cell.2009.02.036; Higaki T, 2011, J PLANT RES, V124, P315, DOI 10.1007/s10265-011-0408-z; Matsuoka K, 1997, PLANT CELL, V9, P533; Hatsugai N, 2009, GENE DEV, V23, P2496, DOI 10.1101/gad.1825209; TURNER JG, 1974, PHYTOPATHOLOGY, V64, P885; Kariola T, 2003, MOL PLANT MICROBE IN, V16, P179, DOI 10.1094/MPMI.2003.16.3.179; Saito C, 2002, PLANT J, V29, P245, DOI 10.1046/j.0960-7412.2001.01189.x; Morita MT, 2002, PLANT CELL, V14, P47, DOI 10.1105/tpc.010216; Higaki T, 2007, PLANT CELL PHYSIOL, V48, P1414, DOI 10.1093/pcp/pcm109; Hara-Nishimura I, 2011, CELL DEATH DIFFER, V18, P1298, DOI 10.1038/cdd.2011.70; Hicks GR, 2004, PLANT PHYSIOL, V134, P1227, DOI 10.1104/pp.103.037382; Burke S., 2001, LC GC EUROPE ONLIN S, P19; Gattolin S, 2009, BMC PLANT BIOL, V18, P133; Hasegawa J, 2014, CYTOLOGIA IN PRESS; Hashiguchi Y, 2014, PLANT CELL PHYSIOL, V55, P811, DOI 10.1093/pcp/pcu020; Higaki T, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-81; Kadota Y, 2004, PLANT J, V40, P131, DOI 10.1111/j.1365-313X.2004.02197.x; Kumagai-Sano F, 2006, NAT PROTOC, V1, P2617; Kutsuna N, 2002, PLANT CELL PHYSIOL, V43, P965, DOI 10.1093/pcp/pcf138; PALVA TK, 1993, MOL PLANT MICROBE IN, V6, P190, DOI 10.1094/MPMI-6-190; Ponce de Leon I, 2007, BMC PLANT BIOL, V8, P52; PONTIER D, 1994, PLANT J, V5, P507; Ruthardt N, 2005, PROTOPLASMA, V225, P205, DOI 10.1007/s00709-005-0093-7; Sano T, 2005, PLANT J, V44, P595, DOI 10.1111/j.1365-313X.2005.02558.x; Sheahan MB, 2007, PROTOPLASMA, V230, P141, DOI 10.1007/s00709-006-0236-5; Uemura T, 2002, GENES CELLS, V7, P743, DOI 10.1046/j.1365-2443.2002.00550.x; Vidal S, 1998, MOL PLANT MICROBE IN, V11, P23, DOI 10.1094/MPMI.1998.11.1.23; Vidal S, 1997, PLANT J, V11, P115, DOI 10.1046/j.1365-313X.1997.11010115.x	32	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1672-9072	1744-7909		J INTEGR PLANT BIOL	J. Integr. Plant Biol.	JAN	2015	57	1					127	135		10.1111/jipb.12304		9	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	AY2IW	WOS:000347413600013		
J	Nomiyama, H; Yoshie, O				Nomiyama, Hisayuki; Yoshie, Osamu			Functional roles of evolutionary conserved motifs and residues in vertebrate chemokine receptors	JOURNAL OF LEUKOCYTE BIOLOGY			English	Review						micro-switch; DRY motif; CWxP motif; TxP motif; NPxxY motif; receptor activation mechanism	PROTEIN-COUPLED RECEPTORS; BETA(2) ADRENERGIC-RECEPTOR; AMINO-TERMINAL DOMAIN; LIGAND-BINDING; STRUCTURAL INSTABILITY; CONSTITUTIVE ACTIVITY; TRANSMEMBRANE HELIX; SMALL-MOLECULE; HUMAN CXCR4; ACTIVATION	Chemokine receptors regulate cell migration and homing. They belong to the rhodopsin-like family of GPCRs. Their ancestor genes emerged in the early stages of vertebrate evolution. Since then, the family has been greatly expanded through whole and segmental genome duplication events. During evolution, many amino acid changes have been introduced in individual chemokine receptors, but certain motifs and residues are highly conserved. Previously, we proposed a nomenclature system of the vertebrate chemokine receptors based on their evolutionary history and phylogenetic analyses. With the use of this classification system, we are now able to confidently assign the species orthologs of vertebrate chemokine receptors. Here, we systematically analyze conserved motifs and residues of each group of orthologous chemokine receptors that may play important roles in their signaling and biologic functions. Our present analysis may provide useful information on how individual chemokine receptors are activated upon ligand binding.	[Nomiyama, Hisayuki] Kumamoto Univ, Grad Sch Med Sci, Dept Mol Enzymol, Kumamoto 8608556, Japan; [Yoshie, Osamu] Kinki Univ, Fac Med, Dept Microbiol, Osaka, Japan	Nomiyama, H (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Mol Enzymol, Honjo 1-1-1, Kumamoto 8608556, Japan.	nomiyama@gpo.kumamoto-u.ac.jp					Jensen PC, 2007, MOL PHARMACOL, V72, P327, DOI 10.1124/mol.106.035543; Zhu L, 2013, CURR OPIN STRUC BIOL, V23, P539, DOI 10.1016/j.sbi.2013.05.003; White GE, 2013, PHARMACOL REV, V65, P47, DOI 10.1124/pr.111.005074; Rosenkilde MM, 2010, TRENDS PHARMACOL SCI, V31, P567, DOI 10.1016/j.tips.2010.08.006; Nibbs RJB, 2013, NAT REV IMMUNOL, V13, P815, DOI 10.1038/nri3544; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Rosenkilde MM, 2006, CURR TOP MED CHEM, V6, P1319; Ludeman JP, 2014, BRIT J PHARMACOL, V171, P1167, DOI 10.1111/bph.12455; Zlotnik A, 2011, NAT REV IMMUNOL, V11, P597, DOI 10.1038/nri3049; Fritze O, 2003, P NATL ACAD SCI USA, V100, P2290, DOI 10.1073/pnas.0435715100; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Rajagopalan L, 2006, BIOSCIENCE REP, V26, P325, DOI 10.1007/s10540-006-9025-9; Nomiyama H, 2011, DEV COMP IMMUNOL, V35, P705, DOI 10.1016/j.dci.2011.01.019; Peeters MC, 2011, TRENDS PHARMACOL SCI, V32, P35, DOI 10.1016/j.tips.2010.10.001; Monteclaro FS, 1996, J BIOL CHEM, V271, P19084; Scheer A, 1996, EMBO J, V15, P3566; Nomiyama H, 2010, CYTOKINE GROWTH F R, V21, P253, DOI 10.1016/j.cytogfr.2010.03.004; Graham GJ, 2009, EUR J IMMUNOL, V39, P342, DOI 10.1002/eji.200838858; Zlotnik A, 2012, IMMUNITY, V36, P705, DOI 10.1016/j.immuni.2012.05.008; Szpakowska M, 2012, BIOCHEM PHARMACOL, V84, P1366, DOI 10.1016/j.bcp.2012.08.008; Rasmussen SGF, 1999, MOL PHARMACOL, V56, P175; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Wu LJ, 1996, J BIOL CHEM, V271, P31202; Sallusto F, 2008, NAT IMMUNOL, V9, P949, DOI 10.1038/ni.f.214; Starr AE, 2012, J BIOL CHEM, V287, P5848, DOI 10.1074/jbc.M111.314609; Garcia-Perez J, 2011, J BIOL CHEM, V286, P33409, DOI 10.1074/jbc.M111.279596; BALDWIN JM, 1993, EMBO J, V12, P1693; Zhou NM, 2001, J BIOL CHEM, V276, P42826, DOI 10.1074/jbc.M106582200; Blanpain C, 2003, J BIOL CHEM, V278, P5179, DOI 10.1074/jbc.M205684200; Mirzadegan T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/bi027224+; Valentin-Hansen L, 2012, J BIOL CHEM, V287, P43516, DOI 10.1074/jbc.M112.395137; Seibert C, 2006, VIROLOGY, V349, P41, DOI 10.1016/j.virol.2006.01.018; Mantovani A, 1999, IMMUNOL TODAY, V20, P254, DOI 10.1016/S0167-5699(99)01469-3; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X; Graham GJ, 2012, IMMUNOL LETT, V145, P30, DOI 10.1016/j.imlet.2012.04.004; Mantovani A, 2006, NAT REV IMMUNOL, V6, P907, DOI 10.1038/nri1964; Hoffmann F, 2012, J BIOL CHEM, V287, P28362, DOI 10.1074/jbc.M111.335679; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Park SH, 2012, NATURE, V491, P779, DOI 10.1038/nature11580; Govaerts C, 2001, J BIOL CHEM, V276, P13217, DOI 10.1074/jbc.M011670200; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Alewijnse AE, 2000, MOL PHARMACOL, V57, P890; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Steen A, 2013, J BIOL CHEM, V288, P12511, DOI 10.1074/jbc.M112.449587; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Mortier A, 2011, EXP CELL RES, V317, P642, DOI 10.1016/j.yexcr.2010.11.016; Nomiyama H, 2013, GENES CELLS, V18, P1, DOI 10.1111/gtc.12013; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Schwartz Thue W., 1994, Current Opinion in Biotechnology, V5, P434, DOI 10.1016/0958-1669(94)90054-X; Bachelerie F., 2013, PHARMACOL REV, V66, P1, DOI DOI 10.1124/PR.113.007724; Bajoghli B, 2013, EUR J IMMUNOL, V43, P1686, DOI 10.1002/eji.201343557; Ballesteros J. A., 1995, METH NEUROSCI, P366, DOI DOI 10.1016/S1043-9471(05)80049-7; Blanpain C, 1999, J BIOL CHEM, V274, P34719, DOI 10.1074/jbc.274.49.34719; Hewit KD, 2014, J BIOL CHEM, V289, P12330, DOI 10.1074/jbc.M113.534545; Jensen AS, 2012, ADV VIROL, V2012, DOI DOI 10.1155/2012/231813; Jensen PC, 2009, METHOD ENZYMOL, V461, P171, DOI 10.1016/S0076-6879(09)05408-1; Kajumo F, 2000, VIROLOGY, V271, P240, DOI 10.1006/viro.2000.0308; Morin D, 1998, FEBS LETT, V441, P470, DOI 10.1016/S0014-5793(98)01585-3; Olivella M, 2013, BMC STRUCT BIOL, V13, DOI 10.1186/1472-6807-13-3; Pele J, 2014, PROTEINS, V82, P2141, DOI 10.1002/prot.24570; Rummel PC, 2013, MOL PHARMACOL, V84, P335, DOI 10.1124/mol.113.086702; Scholten DJ, 2012, BRIT J PHARMACOL, V165, P1617, DOI 10.1111/j.1476-5381.2011.01551.x; Steen A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00277; Zhou HP, 2000, ARCH BIOCHEM BIOPHYS, V373, P211, DOI 10.1006/abbi.1999.1555	65	1	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0741-5400	1938-3673		J LEUKOCYTE BIOL	J. Leukoc. Biol.	JAN	2015	97	1					39	47		10.1189/jlb.2RU0614-290R		9	Cell Biology; Hematology; Immunology	Cell Biology; Hematology; Immunology	AY3CZ	WOS:000347463400007		
J	Notomi, T; Mori, Y; Tomita, N; Kanda, H				Notomi, Tsugunori; Mori, Yasuyoshi; Tomita, Norihiro; Kanda, Hidetoshi			Loop-mediated isothermal amplification (LAMP): principle, features, and future prospects	JOURNAL OF MICROBIOLOGY			English	Review						loop-mediated isothermal amplification (LAMP); nucleic acid amplification test (NAT); point of care testing (POCT)	DIAGNOSIS; TUBERCULOSIS; GENE; DNA	Loop-mediated isothermal amplification (LAMP), a newly developed gene amplification method, combines rapidity, simplicity, and high specificity. Several tests have been developed based on this method, and simplicity is maintained throughout all steps, from extraction of nucleic acids to detection of amplification. In the LAMP reaction, samples are amplified at a fixed temperature through a repetition of two types of elongation reactions occurring at the loop regions: self-elongation of templates from the stem loop structure formed at the 3'-terminal and the binding and elongation of new primers to the loop region. The LAMP reaction has a wide range of possible applications, including point-of-care testing, genetic testing in resource-poor settings (such as in developing countries), and rapid testing of food products and environmental samples.	[Notomi, Tsugunori; Mori, Yasuyoshi; Tomita, Norihiro; Kanda, Hidetoshi] Eiken Chem Co Ltd, Div Res & Dev, Biochem Res Lab, Ohtawara, Tochigi 3240036, Japan	Notomi, T (reprint author), Eiken Chem Co Ltd, Div Res & Dev, Biochem Res Lab, 1381-3 Shimoishigami, Ohtawara, Tochigi 3240036, Japan.	Tsugunori_Notomi@eiken.co.jp					Mori Y, 2009, J INFECT CHEMOTHER, V15, P62, DOI 10.1007/s10156-009-0669-9; Hataoka Y, 2004, ANAL CHEM, V76, P3689, DOI 10.1021/ac035032u; Boehme CC, 2007, J CLIN MICROBIOL, V45, P1936, DOI 10.1128/JCM.02352-06; Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415; Mori Y, 2001, BIOCHEM BIOPH RES CO, V289, P150, DOI 10.1006/bbrc.2001.5921; Mori Y, 2013, J INFECT CHEMOTHER, V19, P404, DOI 10.1007/s10156-013-0590-0; Nakauchi M, 2011, J MED VIROL, V83, P10, DOI 10.1002/jmv.21934; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Mori Y, 2004, J BIOCHEM BIOPH METH, V59, P145, DOI 10.1016/j.jbbm.2003.12.005; Kopp MU, 1998, SCIENCE, V280, P1046, DOI 10.1126/science.280.5366.1046; Mitarai S, 2011, INT J TUBERC LUNG D, V15, P1211, DOI 10.5588/ijtld.10.0629; Tomita N, 2008, NAT PROTOC, V3, P877, DOI 10.1038/nprot.2008.57; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Notomi T., 2004, LOOP MEDIATED ISOTHE, P199	14	6	6	MICROBIOLOGICAL  SOCIETY KOREA	SEOUL	KOREA SCIENCE & TECHNOLOGY CENTER 803, 635-4 YEOGSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	1225-8873	1976-3794		J MICROBIOL	J. Microbiol.	JAN	2015	53	1					1	5		10.1007/s12275-015-4656-9		5	Microbiology	Microbiology	AY0GE	WOS:000347274700001		
J	Asami, Y; Goren, A; Okumura, Y				Asami, Yuko; Goren, Amir; Okumura, Yasuyuki			Work Productivity Loss With Depression, Diagnosed and Undiagnosed, Among Workers in an Internet-Based Survey Conducted in Japan	JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE			English	Article							MENTAL-HEALTH-SERVICES; EPIDEMIOLOGY; DISORDERS; PERFORMANCE; VALIDATION; SEVERITY; SYMPTOMS; VALIDITY; VERSION; IMPACT	Objective: The aim of this study was to investigate whether depression severity was associated with work impairments, regardless of the diagnosis. Methods: We conducted a cross-sectional study among 17,820 Japanese workers using an Internet-based survey. Work impairments were assessed using the Work Productivity and Activity Impairment questionnaire. Participants were grouped according to whether they had a past-year diagnosis of depression by physicians and current depression severity assessed with the Patient Health Questionnaire-9. Results: Among the undiagnosed, high severity respondents had greater overall work impairment than low severity respondents (33.3% vs 14.8%). Significant interactions between diagnosis and severity indicated greater impairments among undiagnosed than among diagnosed respondents (except on absenteeism). Conclusions: Depression severity was associated with work productivity loss, even among the undiagnosed, suggesting a need for early detection, referral, and treatment of depression in the workplace.	[Asami, Yuko] Pfizer Japan Inc, Global Established Pharma Med Affairs, Tokyo 1518589, Japan; [Goren, Amir] Kantar Hlth, Hlth Outcomes Practice, New York, NY USA; [Okumura, Yasuyuki] Inst Hlth Econ & Policy, Tokyo, Japan	Asami, Y (reprint author), Pfizer Japan Inc, Global Established Pharma Med Affairs, Shibuya Ku, Shinjuku Bunka Quint Bldg,3-22-7 Yoyogi, Tokyo 1518589, Japan.	yuko.asami@pfizer.com			Pfizer, Inc.	The authors thank Errol J. Philip, PhD, who provided support with literature review and manuscript editing as a paid consultant to Kantar Health, with funding from Pfizer, Inc.	Andrade L, 2003, INT J METH PSYCH RES, V12, P3, DOI 10.1002/mpr.138; Naganuma Y, 2006, PSYCHIAT CLIN NEUROS, V60, P240, DOI 10.1111/j.1440-1819.2006.01492.x; REILLY MC, 1993, PHARMACOECONOMICS, V4, P353, DOI 10.2165/00019053-199304050-00006; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kroenke K, 2002, PSYCHIAT ANN, V32, P509; Donohue JM, 2007, PHARMACOECONOMICS, V25, P7, DOI 10.2165/00019053-200725010-00003; Ryder AG, 2008, J ABNORM PSYCHOL, V117, P300, DOI 10.1037/0021-843X.117.2.300; Kessler RC, 2013, ANNU REV PUBL HEALTH, V34, P119, DOI 10.1146/annurev-publhealth-031912-114409; Kawakami N, 2005, PSYCHIAT CLIN NEUROS, V59, P441, DOI 10.1111/j.1440-1819.2005.01397.x; IsHak WW, 2011, HARVARD REV PSYCHIAT, V19, P229, DOI 10.3109/10673229.2011.614099; Wang PS, 2007, LANCET, V370, P841, DOI 10.1016/S0140-6736(07)61414-7; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Muramatsu K, 2007, PSYCHOL REP, V101, P952, DOI 10.2466/PRO.101.3.952-960; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Kido Y, 2013, PSYCHIAT CLIN NEUROS, V67, P101, DOI 10.1111/pcn.12008; Ministry of Health Labour and Welfare of Japan, 2012, PAT SURV 2011 KANJ C; Muramatsu K, 2008, JPN J PSYCHIAT TREAT, V23, P1299; Okumura Y, 2011, PRIM CARE COMPANION, V13; Tsuchiya M, 2012, PSYCHIAT RES, V198, P140, DOI 10.1016/j.psychres.2011.10.014; Wada K, 2013, IND HEALTH, V51, P482; World Health Organisation, 2000, WHO TECH REP SER, V894, P1; World Health Organization (WHO), 2012, DEPR	22	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1076-2752	1536-5948		J OCCUP ENVIRON MED	J. Occup. Environ. Med.	JAN	2015	57	1					105	110		10.1097/JOM.0000000000000310		6	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	AY3IP	WOS:000347477900019		
J	Shibata, O; Nakahara, H; Moroi, Y				Shibata, Osamu; Nakahara, Hiromichi; Moroi, Yoshikiyo			New Adsorption Model-Theory, Phenomena and New Concept-	JOURNAL OF OLEO SCIENCE			English	Review						Gibbs adsorption; Langmuir monolayer; surface tension; surface potential; PM-IRRAS	SURFACE-POTENTIAL MEASUREMENT; SODIUM DODECYL-SULFATE; AIR/SOLUTION INTERFACE; ETHYLENE-GLYCOL; CHLORIDE; EVAPORATION; MONOLAYER; MIXTURE	According to the conventional Gibbs adsorption model, which is a common assumption about the molecular concentration at surfaces, the adsorbed film of soluble amphiphiles is located at the air/solution interface just like Langmuir monolayer which is illustrated in many physical chemistry text books on "Colloid and Interface Science". According to many proofs of the experimental results here, the newer idea for the surface adsorption is confirmed and explained, which is quite different from the conventional Gibbs surface excess model at the air/solution interface.	[Shibata, Osamu; Nakahara, Hiromichi; Moroi, Yoshikiyo] Nagasaki Int Univ, Fac Pharmaceut Sci, Dept Biophys Chem, Nagasaki 8593298, Japan	Shibata, O (reprint author), Nagasaki Int Univ, Fac Pharmaceut Sci, Dept Biophys Chem, 2825-7 Huis Ten Bosch, Nagasaki 8593298, Japan.	wosamu@niu.ac.jp			Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science & Technology (MEXT), Japan; Science Research Grant of NIKKOL group	The research work presented in this short review was performed with the support of the Japan Society for the Promotion of Science (JSPS), the Ministry of Education, Culture, Sports, Science & Technology (MEXT), Japan, and Science Research Grant of NIKKOL group.	Adamson A. W., 1997, PHYSICAL CHEMISTRY O; An SW, 1996, LANGMUIR, V12, P2446, DOI 10.1021/la950851y; Nakahara H, 2011, J PHYS CHEM B, V115, P9077, DOI 10.1021/jp202940p; Tsierkezos NG, 1998, J CHEM ENG DATA, V43, P989, DOI 10.1021/je9800914; Shibata O, 2000, LANGMUIR, V16, P10281, DOI 10.1021/la000929x; IKEDA N, 1992, J COLLOID INTERF SCI, V149, P208, DOI 10.1016/0021-9797(92)90405-B; Warszynski P, 1998, J PHYS CHEM B, V102, P10948, DOI 10.1021/jp983901r; Defay R., 1966, SURFACE TENSION ADSO; Hiemenz P. C, 1986, PRINCIPLES OF COLLOI; Humphry-Baker R, 2006, LANGMUIR, V22, P11205, DOI 10.1021/la062014; MATSUKI H, 1994, J COLLOID INTERF SCI, V162, P203, DOI 10.1006/jcis.1994.1026; Moroi Y, 2007, CROAT CHEM ACTA, V80, P381; Moroi Y, 2004, J PHYS CHEM B, V108, P6351, DOI 10.1021/jp0306287; Moroi Y., 1992, MICELLES THEORETICAL; MOTOMURA K, 1981, J COLLOID INTERF SCI, V80, P32, DOI 10.1016/0021-9797(81)90156-9; MOTOMURA K, 1987, LANGMUIR, V3, P304, DOI 10.1021/la00074a029; Nakahara H, 2005, COLLOID SURFACE B, V41, P285, DOI 10.1016/j.colsurfb.2004.06.013; Nakahara H, 2008, J PHYS CHEM C, V112, P6398, DOI 10.1021/jp7108169; Nakahara H, 2005, LANGMUIR, V21, P9020, DOI 10.1021/la0520482; Rusdi M, 2005, LANGMUIR, V21, P7308, DOI 10.1021/la040134g; Rusdi M, 2005, B CHEM SOC JPN, V78, P604, DOI 10.1246/bcsj.78.604	21	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	JAN	2015	64	1					1	8		10.5650/jos.ess14213		8	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	AY3SX	WOS:000347503800001		
J	Ikeda, I				Ikeda, Ikuo			Factors Affecting Intestinal Absorption of Cholesterol and Plant Sterols and Stanols	JOURNAL OF OLEO SCIENCE			English	Review						ABCG5/ABCG8; cholesterol; cholesterol esterase; intestinal absorption; plant sterols	ACYL-COENZYME-A; MICELLAR CHOLESTEROL; DIETARY-CHOLESTEROL; STROKE-PRONE; BILIARY CHOLESTEROL; HYPERTENSIVE-RATS; MISSENSE MUTATION; ESTER HYDROLYSIS; BETA-SITOSTEROL; CACO-2 CELLS	Various factors affect intestinal absorption of cholesterol and plant sterols and stanols. Plant sterols and stanols are generally less absorptive than cholesterol. Differential absorption rates among various plant sterols and stanols have been also reported. Although it was suggested that differential absorption among cholesterol and various plant sterols was determined by difference in excretion rates of sterols and stanols through ATP-binding cassette transporter (ABC) G5/ABCG8 of intestinal cells, our study suggests that affinity for and solubility in bile salt micelles can be important determinants for differential absorption of plant sterols and stanols. It was also suggested that plant sterols were transiently incorporated into intestinal cells and then excreted to intestinal lumen through ABCG5/ABCG8. However, in a rat study, transient incorporation of sitosterol into intestinal cells was not observed, suggesting that sitosterol is differentiated from cholesterol at the incorporation site of intestinal cells. It is well established that plant sterols inhibit intestinal absorption of cholesterol and exert a hypocholesterolemic activity. Plant sterols are solubilized in bile salt micelles as cholesterol. Our study clearly showed that because the sterol-solubilizing capacity of bile salt micelles was limited, plant sterols solubilized in micelles reduced the solubility of cholesterol. This can be the major cause of inhibition of cholesterol absorption by plant sterols. Pancreatic cholesterol esterase accelerates intestinal absorption of unesterified cholesterol. Although it was suggested that cholesterol esterase accelerated esterification of cholesterol incorporated into intestinal cells and acted as a transporter at the surface of intestinal cells, our research revealed that the accelerated cholesterol absorption was caused by hydrolysis of phosphatidylcholine in bile salt micelles. It is thought that hydrolysis of phosphatidylcholine reduces the affinity of cholesterol for the micelles and accelerates the incorporation of cholesterol released from the micelles into intestinal cells.	Tohoku Univ, Grad Sch Agr Sci, Lab Food & Biomol Sci, Aoba Ku, Sendai, Miyagi 9818555, Japan	Ikeda, I (reprint author), Tohoku Univ, Grad Sch Agr Sci, Lab Food & Biomol Sci, Aoba Ku, Sendai, Miyagi 9818555, Japan.	iikeda@biochem.tohoku.ac.jp					CHANG CCY, 1995, J BIOL CHEM, V270, P29532; Brown AW, 2010, LIPIDS, V45, P855, DOI 10.1007/s11745-010-3456-6; Homan R, 1998, J LIPID RES, V39, P1197; Lee MH, 2001, NAT GENET, V27, P79; De Smet E, 2012, MOL NUTR FOOD RES, V56, P1058, DOI 10.1002/mnfr.201100722; IKEDA I, 1983, BIOCHIM BIOPHYS ACTA, V732, P651, DOI 10.1016/0005-2736(83)90243-2; Ikeda I, 2001, METABOLISM, V50, P1361, DOI 10.1053/meta.2001.26739; IKEDA I, 1988, J LIPID RES, V29, P1583; Howles PN, 1996, J BIOL CHEM, V271, P7196; Lu KM, 2001, TRENDS ENDOCRIN MET, V12, P314, DOI 10.1016/S1043-2760(01)00433-7; Ratnayake WMN, 2000, J NUTR, V130, P1166; Ikeda I, 2002, BBA-GEN SUBJECTS, V1571, P34, DOI 10.1016/S0304-4165(02)00204-0; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; BHAT SG, 1982, BIOCHEM BIOPH RES CO, V109, P486, DOI 10.1016/0006-291X(82)91747-8; BORJA CR, 1964, AM J PHYSIOL, V206, P223; FIELD FJ, 1984, J LIPID RES, V25, P389; GALLO LL, 1980, J LIPID RES, V21, P537; GALLO LL, 1984, J LIPID RES, V25, P604; GALLO LL, 1977, P SOC EXP BIOL MED, V156, P277; Hamada T, 2009, BIOSCI BIOTECH BIOCH, V73, P361, DOI 10.1271/bbb.80594; Hamada T, 2006, LIPIDS, V41, P551, DOI 10.1007/s11745-006-5004-y; Hamada T, 2005, BIOSCI BIOTECH BIOCH, V69, P1726, DOI 10.1271/bbb.69.1726; HUANG Y, 1990, J LIPID RES, V31, P2029; Hui DY, 1996, BBA-LIPID LIPID MET, V1303, P1, DOI 10.1016/0005-2760(96)00085-9; Igel M, 2003, J LIPID RES, V44, P533, DOI 10.1194/jlr.M200393-JLR200; IKEDA I, 1988, J LIPID RES, V29, P1573; Ikeda I, 2003, BIOSCI BIOTECH BIOCH, V67, P2381, DOI 10.1271/bbb.67.2381; Kato M, 2012, BIOSCI BIOTECH BIOCH, V76, P660, DOI 10.1271/bbb.110667; Liitjohann D., 1995, J LIPID RES, V36, P1763; LOPEZCANDALES A, 1993, BIOCHEMISTRY-US, V32, P12085, DOI 10.1021/bi00096a019; OKAMOTO KOZO, 1963, JAPAN CIRCULATION JOUR, V27, P282; Richimond B. L., 2001, GASTROENT, V120, P1193; SHAMIR R, 1995, BIOCHEMISTRY-US, V34, P6351, DOI 10.1021/bi00019a013; SLOTA T, 1983, GUT, V24, P653, DOI 10.1136/gut.24.7.653; von Bergmann K, 2005, AM J CARDIOL, V96, p10D, DOI 10.1016/j.amjcard.2005.03.014; WILSON MD, 1994, J LIPID RES, V35, P943; YAMORI Y, 1974, JPN CIRC J, V38, P1095; Yu HW, 2003, BMC CARDIOVASC DISOR, V3, DOI 10.1186/1471-2261-3-4; Yu LQ, 2002, P NATL ACAD SCI USA, V99, P16237, DOI 10.1073/pnas.252582399; Zhang JH, 2011, J BIOL CHEM, V286, P25088, DOI 10.1074/jbc.M111.244475	40	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	JAN	2015	64	1					9	18		10.5650/jos.ess14221		10	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	AY3SX	WOS:000347503800002		
J	Jia, ZC; Li, SY; Cong, PX; Wang, YM; Sugawara, T; Xue, CH; Xu, J				Jia, Zicai; Li, Shiyan; Cong, Peixu; Wang, Yuming; Sugawara, Tatsuya; Xue, Changhu; Xu, Jie			High Throughput Analysis of Cerebrosides from the Sea Cucumber Pearsonothria graeffei by Liquid Chromatography-Quadrupole-Time-of-Flight Mass Spectrometry	JOURNAL OF OLEO SCIENCE			English	Article						cerebrosides; liquid chromatography-quadrupole-time-of-flight mass spectrometry (LC-Q-TOF-MS); sea cucumber; Pearsonothria graeffei (P. graeffei); molecular species; high throughput analysis	TUMOR-SPECIFIC CYTOTOXICITY; SPHINGOID BASES; SHOTGUN LIPIDOMICS; CACO-2 CELLS; IN-VIVO; SPHINGOLIPIDS; ANTITUMOR; GLUCOSYLCERAMIDE; MS/MS; ACID	Liquid chromatography-mass spectrometry was one of the most powerful methods for identification and detection of chemical structures of lipids. In this study, the cerebrosides molecular species from the sea cucumber Pearsonothria graeffei (P graeffei) were high throughput identified by liquid chromatography-quadrupole-time-of-flight mass spectrometry (LC-Q-TOF-MS). Cerebrosides were separated and purified by solid-phase extraction with chloroform-methanol solution. Precursor ion scan spectra and product ion scan spectra were obtained through auto MS/MS analysis in the positive scan. Cerebroside molecules were selected according to the neutral loss fragments of 180 Da, and then the structures were identified according to pairs of specific products of sphingoid bases and their precursor ions. Eighty-nine cerebrosides molecular species were identified, large amounts of d17:1-C22:0h, t17:0-C24:1h, d17:1-C24:1h, d17:1-C23:0h, d17:1-C22:0 and d17:1-C23:0 were present which have hardly found in mammal. There were 13 classes of long-chain base (LCB), and the ratio of phytosphingosines and sphingosines was roughly 1:9, in which two of the most common LCBs were d17:1 and d18:1. The carbon numbers of fatty acids (FAs) were mainly 18 similar to 24, while 24 carbon fatty acids were predominant. The ratio of saturated fatty acid (SFA) and monounsaturated fatty acid (MUFA) was about 2:3, and the percentage of hydroxy fatty acid (HFA) was over 60%. The ratio of non-hydroxylated fatty acid (NFA)/HFA was also approximately 2:3. LC-Q-TOF-MS analysis should be useful for the structure determination of diverse cerebrosides molecular species. Meanwhile, this method provided a basis for structure-activity relationship studies and functional food development of the sea cucumber P graeffei as well.	[Jia, Zicai; Cong, Peixu; Wang, Yuming; Xue, Changhu; Xu, Jie] Ocean Univ China, Coll Food Sci & Engn, Qingdao 266003, Shandong, Peoples R China; [Li, Shiyan] Aquat Prod Qual Testing Ctr Zhejiang Prov, Hangzhou 310023, Zhejiang, Peoples R China; [Sugawara, Tatsuya] Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Sakyo Ku, Kyoto 6068502, Japan	Xu, J (reprint author), Ocean Univ China, Coll Food Sci & Engn, 5 Yu Shan Rd, Qingdao 266003, Shandong, Peoples R China.	xujie9@ouc.edu.cn			National Natural Science Foundation of China [31201329]; National Marine Public Welfare Scientific Research Project of China [201105029]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1188]	This work was supported by grants from National Natural Science Foundation of China (No. 31201329), National Marine Public Welfare Scientific Research Project of China (No. 201105029) and the Program for Changjiang Scholars and Innovative Research Team in University (IRT1188).	Matsuda F, 2009, PLANT J, V57, P555, DOI 10.1111/j.1365-313X.2008.03705.x; Oku H, 2009, CANCER CHEMOTH PHARM, V64, P485, DOI 10.1007/s00280-008-0896-2; Chen L, 2009, CHINESE CHEM LETT, V20, P1091, DOI 10.1016/j.cclet.2009.04.021; Sugawara T, 2006, BIOSCI BIOTECH BIOCH, V70, P2906, DOI 10.1271/bbb.60318; Tang J, 2010, MOLECULES, V15, P9288, DOI 10.3390/molecules15129288; Cha SW, 2007, ANAL CHEM, V79, P2373, DOI 10.1021/ac062251h; Han XL, 2005, J LIPID RES, V46, P163, DOI 10.1194/jlr.D400022-JLR200; NATORI T, 1994, TETRAHEDRON, V50, P2771, DOI 10.1016/S0040-4020(01)86991-X; Bartke N, 2006, MOL NUTR FOOD RES, V50, P1201, DOI 10.1002/mnfr.200600140; Duan RD, 2009, PROG LIPID RES, V48, P62, DOI 10.1016/j.plipres.2008.04.003; Pruett ST, 2008, J LIPID RES, V49, P1621, DOI 10.1194/jlr.R800012-JLR200; Chaurio RA, 2009, MOLECULES, V14, P4892, DOI 10.3390/molecules14124892; Oku H, 2007, CANCER CHEMOTH PHARM, V60, P767, DOI 10.1007/s00280-007-0422-y; Sugawara T, 2003, J NUTR, V133, P2777; Chrast R, 2011, J LIPID RES, V52, P419, DOI 10.1194/jlr.R009761; Xie C, 2012, BIOANALYSIS, V4, P937, DOI [10.4155/bio.12.43, 10.4155/BIO.12.43]; Sperling P, 2003, BBA-MOL CELL BIOL L, V1632, P1, DOI 10.1016/S1388-1981(03)00033-7; Matsuda F, 2010, PLANT PHYSIOL, V152, P566, DOI 10.1104/pp.109.148031; Hu XQ, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-25; Kwak SM, 2012, ARCH INTERN MED, V172, P686, DOI 10.1001/archinternmed.2012.262; Zhao Q, 2012, J SCI FOOD AGR, V92, P965, DOI 10.1002/jsfa.4678; Andrews GL, 2011, ANAL CHEM, V83, P5442, DOI 10.1021/ac200812d; Han XL, 2012, MASS SPECTROM REV, V31, P134, DOI 10.1002/mas.20342; Sugawara T, 2004, BIOSCI BIOTECH BIOCH, V68, P2541, DOI 10.1271/bbb.68.2541; Guo S, 2012, ADV MATER RES-SWITZ, V524-527, P2334, DOI 10.4028/www.scientific.net/AMR.524-527.2334; Harwood J., 1989, CRC CRIT R PLANT SCI, V1, P1; KARLSSON KA, 1970, LIPIDS, V5, P878, DOI 10.1007/BF02531119; KOYNOVA R, 1995, BBA-LIPID LIPID MET, V1255, P213, DOI 10.1016/0005-2760(94)00202-A; Leila H., 2011, BIOCHEM J, V438, P165; Margalit M, 2006, J PHARMACOL EXP THER, V319, P105, DOI 10.1024/jpet.106.104950; Merrill J. A. H., 2005, METHODS, V36, P207; Montagner A., 2011, ESSENT FATTY ACIDS, V85, P235; Ohashi Y, 2000, J LIPID RES, V41, P1118; Xu J, 2011, J AGR FOOD CHEM, V59, P12246, DOI 10.1021/jf203556s	34	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	JAN	2015	64	1					51	60		10.5650/jos.ess14136		10	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	AY3SX	WOS:000347503800006		
J	Tobe, S; Majima, T; Tadenuma, H; Suekuni, T; Sakai, K; Sakai, H; Abe, M				Tobe, Seiichi; Majima, Toshiaki; Tadenuma, Hirohiko; Suekuni, Tomonari; Sakai, Kenichi; Sakai, Hideki; Abe, Masahiko			Nonionic Surfactants Enhancing Bactericidal Activity at Their Critical Micelle Concentrations	JOURNAL OF OLEO SCIENCE			English	Article						ADBAC; bactericide; enhancement; MEE; nonionic surfactant	ACID METHYL-ESTERS; VIABILITY; ETHER	Bactericidal activities of benzalkonium chloride [also known as alkyldimethylbenzylammonium chloride (ADBAC)] containing nonionic surfactants such as methyl ester ethoxylates (MEE) with the alkyl group C8-C14 and oxyethylene (EO) group of average adduct number 3-15 were measured against Escherichia coli and Staphylococcus aureus. Sample solutions containing MEE in the vicinity of the critical micelle concentration exhibited a dramatic decrease in viable bacterial counts. MEE with an alkyl group of C12 and an oxyethylene group of lower adduct number exhibited little viable bacterial counts than those having higher EO adduct numbers. MEE with reduced EO adduct numbers increased fluorescence intensity in E. coli using the viability stain SYTO 9. Our results show that MEE molecules with low EO adduct numbers exhibited bactericidal activity by increasing the permeability of the E. coli cell membrane. Sample solution containing ADBAC and MEE molecules with lower EO adduct numbers also displayed higher zeta potentials. Moreover, ADBAC molecules incorporated into micelles of MEE with lower EO adduct numbers were adsorbed onto the surface of E. coli, which augmented bactericidal activity.	[Tobe, Seiichi; Tadenuma, Hirohiko] Lion Corp, Res & Dev Headquarters, Fabr Care Res Labs, Edogawa Ku, Tokyo 1320035, Japan; [Majima, Toshiaki; Suekuni, Tomonari] Lion Corp, Res & Dev Headquarters, Funct Mat Sci Res Labs, Edogawa Ku, Tokyo 1320035, Japan; [Sakai, Kenichi; Sakai, Hideki; Abe, Masahiko] Tokyo Univ Sci, Fac Sci & Technol, Dept Pure & Appl Chem, Noda, Chiba 2788510, Japan; [Sakai, Kenichi; Sakai, Hideki; Abe, Masahiko] Tokyo Univ Sci, Res Inst Sci & Technol, Noda, Chiba 2788510, Japan	Tobe, S (reprint author), Lion Corp, Res & Dev Headquarters, Fabr Care Res Labs, Edogawa Ku, 7-2-1 Hirai, Tokyo 1320035, Japan.	seto@lion.co.jp			Otsuka Electronics Corporation	We are grateful to Otsuka Electronics Corporation for support with the use of the zeta potential and particle size analyzer ELSZ-1000, and Nippon Nyukazai Corporation for providing the alkyl glycol ethers.	Stocks SM, 2004, CYTOM PART A, V61A, P189, DOI 10.1002/cyto.a.20069; [Anonymous], 2011, JAP PHARM; Yuan XZ, 2007, APPL MICROBIOL BIOT, V76, P1189, DOI 10.1007/s00253-007-1080-z; Rauwel G, 2012, J COLLOID INTERF SCI, V374, P176, DOI 10.1016/j.jcis.2012.02.006; Gomi M, 2012, BIOCONTROL SCI, V17, P175; TAYLOR IW, 1980, J HISTOCHEM CYTOCHEM, V28, P1224; Ray GB, 2006, J COLLOID INTERF SCI, V294, P248, DOI 10.1016/j.jcis.2005.07.006; Nakata K, 2011, J APPL MICROBIOL, V110, P568, DOI 10.1111/j.1365-2672.2010.04912.x; Aoki M., 1957, YAKUGAKU ZASSHI, V77, P1071; Attwood D., 1971, J PHARM PHARMACOL, P242; Bajpai Divya, 2007, J Oleo Sci, V56, P327; Bialowas E, 2004, IND ENG CHEM RES, V43, P6267, DOI 10.1021/ie049898h; Ding WX, 2009, BIOL PHARM BULL, V32, P311; EN1040, 2006, 1040 EN; FUJIWARA M, 1994, COLLOID POLYM SCI, V272, P797, DOI 10.1007/BF00652420; GERSHENFELD LOUIS, 1949, AMER JOUR PHARM, V121, P249; GOTO A, 1980, J PHYS CHEM-US, V84, P2268, DOI 10.1021/j100455a011; Gray L. M., 2003, J. WO Pat, Patent No. 053906; Hiramatsu K., 2012, MICROBIOLOGY, P66; Lehtinen J, 2004, CYTOM PART A, V60A, P165, DOI 10.1002/cyto.a.20026; Os N. M., 1993, PHYSICOCHEMICAL PROP, P212; Porter R. S., MERCK MANUAL HLTH CA; Russell A. D., 1992, PRINCIPLES PRACTICE, P7; SCHMOLKA IR, 1973, J SOC COSMET CHEM, V24, P577; Takenaka S, 2001, J Infect Chemother, V7, P87, DOI 10.1007/s101560100014; Tobe S., 2007, BOKIN BOBAI, V35, P269; Tobe S., 2014, Jpn. Pat, Patent No. [28942, 201428942]; Zimoch J, 2002, TENSIDE SURFACT DET, V39, P8	28	0	0	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	JAN	2015	64	1					61	68		10.5650/jos.ess14159		8	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	AY3SX	WOS:000347503800007		
J	Shimotori, Y; Hoshi, M; Seki, S; Osanai, T; Okabe, H; Ikeda, Y; Miyakoshi, T				Shimotori, Yasutaka; Hoshi, Masayuki; Seki, Syota; Osanai, Takeshi; Okabe, Hayato; Ikeda, Yoshitaka; Miyakoshi, Tetsuo			Preparation of Optically Pure delta-Lactones Using Diastereomeric Resolution with Amino Acid as Resolving Agent	JOURNAL OF OLEO SCIENCE			English	Article						delta-lactone; diastereomeric resolution; resolving agent; amino acid	BAEYER-VILLIGER OXIDATIONS; MITSUNOBU REACTION; VESPA-ORIENTALIS; BAKERS-YEAST; ENANTIOMERS; PHEROMONE; COMPOUND; HORNET; QUEEN	Synthesis of optically pure delta-lactones by diastereomeric resolution was investigated Amino acid derivatives, which can be obtained at a relatively low cost, were used as resolving agents. Six optically pure delta-lactones were efficiently synthesized using Cbz-L-alanine without other expensive resolving agents. Both enantiomers of delta-lactone obtained had over 98% enantiomeric excesses. This diastereomeric resolution is very efficient for the preparation of optically pure delta-lactones.	[Shimotori, Yasutaka; Hoshi, Masayuki] Kitami Inst Technol, Dept Biotechnol & Environm Chem, Kitami, Hokkaido 0908507, Japan; [Seki, Syota; Osanai, Takeshi; Okabe, Hayato; Ikeda, Yoshitaka; Miyakoshi, Tetsuo] Meiji Univ, Sch Sci & Technol, Dept Appl Chem, Kawasaki, Kanagawa, Japan	Shimotori, Y (reprint author), Kitami Inst Technol, Dept Biotechnol & Environm Chem, 165 Koen Cho, Kitami, Hokkaido 0908507, Japan.	yasu@mail.kitami-it.ac.jp					Shimotori Y, 2012, SYNTHETIC COMMUN, V42, P694, DOI 10.1080/00397911.2010.529230; Tamogami S, 2001, FLAVOUR FRAG J, V16, P161, DOI 10.1002/ffj.969; Reddy MVR, 2001, J ORGANOMET CHEM, V624, P239; Ogawa R, 2008, TETRAHEDRON-ASYMMETR, V19, P2458, DOI 10.1016/j.tetasy.2008.10.018; Iranpoor N, 2010, ORG BIOMOL CHEM, V8, P4436, DOI 10.1039/c004357e; Kayser MM, 1998, J ORG CHEM, V63, P7103, DOI 10.1021/jo980737v; Gruttadauria M, 2004, TETRAHEDRON LETT, V45, P83, DOI 10.1016/j.tetlet.2003.10.115; Schlutt B, 2007, J AGR FOOD CHEM, V55, P9634, DOI 10.1021/jf0721545; IKAN R, 1969, J INSECT PHYSIOL, V15, P1709, DOI 10.1016/0022-1910(69)90003-1; Chidley HG, 2013, FOOD CHEM, V136, P585, DOI 10.1016/j.foodchem.2012.08.029; Lipshutz BH, 2006, ORG LETT, V8, P5069, DOI 10.1021/ol0618757; Visai C, 1997, SCI HORTIC-AMSTERDAM, V70, P15, DOI 10.1016/S0304-4238(97)00032-0; MOSANDL A, 1988, Z LEBENSM UNTERS FOR, V187, P40, DOI 10.1007/BF01454321; Yamamoto T, 2002, TETRAHEDRON LETT, V43, P9081, DOI 10.1016/S0040-4039(02)02312-2; Wang XG, 2012, J FLUORINE CHEM, V133, P178, DOI 10.1016/j.jfluchem.2011.09.014; Oba M, 2013, TETRAHEDRON-ASYMMETR, V24, P464, DOI 10.1016/j.tetasy.2013.03.010; UTAKA M, 1987, J ORG CHEM, V52, P4363, DOI 10.1021/jo00228a039; Bernreuther A, 1991, PHYTOCHEM ANALYSIS, V2, P43, DOI 10.1002/pca.2800020109; Boggian DB, 2008, QSAR COMB SCI, V27, P823, DOI 10.1002/qsar.200820168; Boishebert V., 2006, CHEMOMETRICS INTELLI, V80, P13; Caras-Quintero D, 2002, CHEM COMMUN, P2690, DOI 10.1039/b207640c; Doig SD, 2003, ENZYME MICROB TECH, V32, P347, DOI 10.1016/S0141-0229(02)00317-4; Hsu JL, 2001, J ORG CHEM, V66, P8573, DOI 10.1021/jo016058t; Ichikawa A, 2008, BIOSCI BIOTECH BIOCH, V72, P2418, DOI 10.1271/bbb.80100; Ichikawa A, 2005, TETRAHEDRON-ASYMMETR, V16, P2559, DOI 10.1016/j.tetasy.2005.05.036; Jacques J., 1981, ENANTIOMERS RACEMATE; Kamal A, 2003, TETRAHEDRON-ASYMMETR, V14, P1575, DOI 10.1016/S0957-4166(03)00281-7; Kosaka N, 2004, EUR J ORG CHEM, P2325, DOI 10.1002/ejoc.200400027; Kozma D., 2002, OPTICAL RESOLUTIONS; Modranka J, 2012, BIOORGAN MED CHEM, V20, P5017, DOI 10.1016/j.bmc.2012.06.022; MORI K, 1985, TETRAHEDRON, V41, P547, DOI 10.1016/S0040-4020(01)96498-1; Nohira H., 2005, ENANTIOMER SEPARATIO, P165; Nohira H, 2000, HETEROCYCLES, V52, P1359; Onakunle OA, 1997, ENZYME MICROB TECH, V21, P245, DOI 10.1016/S0141-0229(96)00267-0; Pham XH, 2009, J MOL CATAL B-ENZYM, V60, P87, DOI 10.1016/j.molcatb.2008.12.023; Rouhi AM, 2003, CHEM ENG NEWS, V81, P45, DOI 10.1021/cen-v081n018.p045; Seio K, 2004, TETRAHEDRON LETT, V45, P6783, DOI 10.1016/j.tetlet.2004.07.060; Shimotori Y, 2007, FLAVOUR FRAG J, V22, P531, DOI 10.1002/ffj.1836; Stritzke K, 2002, EUR J ORG CHEM, P3884, DOI 10.1002/1099-0690(200211)2002:22<3884::AID-EJOC3884>3.0.CO;2-4; Yumoto K, 2010, HETEROCYCLES, V81, P421, DOI 10.3987/COM-09-11863	40	1	1	JAPAN OIL CHEMISTS SOC	TOKYO	YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO, 103-0027, JAPAN	1345-8957	1347-3352		J OLEO SCI	J. Oleo Sci.	JAN	2015	64	1					75	90		10.5650/jos.ess14124		16	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	AY3SX	WOS:000347503800009		
J	Kobori, Y; Miura, T				Kobori, Yasuhiro; Miura, Taku			Overcoming Coulombic Traps: Geometry and Electronic Characterizations of Light-Induced Separated Spins at the Bulk Heterojunction Interface	JOURNAL OF PHYSICAL CHEMISTRY LETTERS			English	Article							PHOTOSYNTHETIC REACTION CENTERS; CORRELATED RADICAL PAIRS; CHARGE-TRANSFER STATE; POLYMER SOLAR-CELLS; HOT EXCITON DISSOCIATION; SYNTHETIC DNA HAIRPINS; PARAMAGNETIC-RESONANCE; PHOTOVOLTAIC CELLS; ION-PAIRS; RHODOBACTER-SPHAEROIDES	Recent progress is overviewed on experimental elucidations of fundamental molecular functions of the light energy conversions by the photoactive layers of the organic photovoltalic (OPV) cells by means of the time-resolved electron paramagnetic resonance spectroscopy. Positions and orientations of the unpaired electrons and electronic coupling matrix elements are clarified in photoinduced, primary charge-separated (CS) states. Connections between the molecular geometries and the electronic couplings have been characterized for the initial CS states to elucidate how the structure, orbital delocalization, and molecular libration play roles on exothermic carrier dissociation via a vibrationally relaxed charge-transfer complex with prevention of the energy-wasting charge recombination. Superior functions to biological molecules are presented for the efficient photocurrent generations induced by orbital delocalization and by shallow trap depths at polymer-stacking domains. The above structural and electronic characteristics of the primary electron hole pairs are essential to evaluations, designs, and developments of the efficient solar cells using organic molecules.	[Kobori, Yasuhiro; Miura, Taku] Kobe Univ, Grad Sch Sci, Dept Chem, Nada Ku, Kobe, Hyogo 6578501, Japan; [Kobori, Yasuhiro] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Kobori, Y (reprint author), Kobe Univ, Grad Sch Sci, Dept Chem, Nada Ku, 1-1 Rokkoudai Cho, Kobe, Hyogo 6578501, Japan.	ykobori@kitty.kobe-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [25288004, 26620065]	The authors thank Prof. Hisao Murai (Shizuoka University), Prof. Hideo Ohkita (Kyoto University), Prof. Kazuhiro Marumoto (Tsukuba University), and Prof. Kiminior Maeda (Saitama University) for their useful support and discussions. This work was supported in part by a Grant-in-Aid for Scientific Research (No. 25288004 and 26620065) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Kobori Y, 2005, P NATL ACAD SCI USA, V102, P10017, DOI 10.1073/pnas.0504598102; Lilliu S, 2011, MACROMOLECULES, V44, P2725, DOI 10.1021/ma102817z; Imahori H, 2001, J PHYS CHEM A, V105, P1750, DOI 10.1021/jp003207n; Grzegorczyk WJ, 2010, J PHYS CHEM C, V114, P5182, DOI 10.1021/jp9119364; YU G, 1995, SCIENCE, V270, P1789, DOI 10.1126/science.270.5243.1789; Goldsmith RH, 2005, P NATL ACAD SCI USA, V102, P3540, DOI 10.1073/pnas.0408940102; Watanabe S, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3421538; Lan YK, 2008, J PHYS CHEM B, V112, P14857, DOI 10.1021/jp806967x; Kanai Y, 2007, NANO LETT, V7, P1967, DOI 10.1021/nl0707095; Niklas J, 2013, PHYS CHEM CHEM PHYS, V15, P9562, DOI 10.1039/c3cp51477c; Lee J, 2010, J AM CHEM SOC, V132, P11878, DOI 10.1021/ja1045742; Deibel C, 2010, ADV MATER, V22, P4097, DOI 10.1002/adma.201000376; D'Avino G, 2013, J PHYS CHEM C, V117, P12981, DOI 10.1021/jp402957g; Kim Y, 2006, NAT MATER, V5, P197, DOI 10.1038/nmat1574; Kandrashkin YE, 1998, APPL MAGN RESON, V15, P417; Kayunkid N, 2010, MACROMOLECULES, V43, P4961, DOI 10.1021/ma100551m; Jiang XM, 2002, ADV FUNCT MATER, V12, P587, DOI 10.1002/1616-3028(20020916)12:9<587::AID-ADFM587>3.0.CO;2-T; Grancini G, 2011, J PHYS CHEM LETT, V2, P1099, DOI 10.1021/jz200389b; Behrends J, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.125206; Tada A, 2011, NAT MATER, V10, P450, DOI [10.1038/nmat3026, 10.1038/NMAT3026]; Ko SW, 2012, J AM CHEM SOC, V134, P5222, DOI 10.1021/ja210954r; Li G, 2005, NAT MATER, V4, P864, DOI 10.1038/nmat1500; Guo JM, 2010, J AM CHEM SOC, V132, P9631, DOI 10.1021/ja9108787; GOULD IR, 1994, J AM CHEM SOC, V116, P8188, DOI 10.1021/ja00097a028; Osaka I, 2014, ADV MATER, V26, P331, DOI 10.1002/adma.201303059; Barker AJ, 2014, J AM CHEM SOC, V136, P12018, DOI 10.1021/ja505380j; Bakulin AA, 2012, SCIENCE, V335, P1340, DOI 10.1126/science.1217745; Wenger OS, 2005, SCIENCE, V307, P99, DOI 10.1126/science.1103818; Grancini G, 2013, NAT MATER, V12, P29, DOI [10.1038/nmat3502, 10.1038/NMAT3502]; Schumann S, 2011, J MATER CHEM, V21, P2381, DOI 10.1039/c0jm03048a; Choi JH, 2010, J MATER CHEM, V20, P475, DOI 10.1039/b916597e; Liu T, 2011, J PHYS CHEM C, V115, P2406, DOI 10.1021/jp109130y; ANDERSON PW, 1959, PHYS REV, V115, P2, DOI 10.1103/PhysRev.115.2; Lewis FD, 2000, J AM CHEM SOC, V122, P12346, DOI 10.1021/ja0028267; Lewis FD, 2001, ACCOUNTS CHEM RES, V34, P159, DOI 10.1021/ar0000197; Vandewal K, 2014, NAT MATER, V13, P63, DOI [10.1038/nmat3807, 10.1038/NMAT3807]; Tvingstedt K, 2009, J AM CHEM SOC, V131, P11819, DOI 10.1021/ja903100p; Baranovskii SD, 2012, J PHYS CHEM LETT, V3, P1214, DOI 10.1021/jz300123k; Kobori Y, 2013, J PHYS CHEM C, V117, P1589, DOI 10.1021/jp309421s; Krinichnyi VI, 2010, J PHYS CHEM C, V114, P16756, DOI 10.1021/jp105873r; Guo JM, 2010, J AM CHEM SOC, V132, P6154, DOI 10.1021/ja100302p; MILLER JR, 1981, J CHEM PHYS, V74, P6746, DOI 10.1063/1.441078; Saeki A, 2012, J AM CHEM SOC, V134, P19035, DOI 10.1021/ja309524f; Pensack RD, 2012, J PHYS CHEM C, V116, P4824, DOI 10.1021/jp2083133; Murthy DHK, 2012, J PHYS CHEM C, V116, P9214, DOI 10.1021/jp3007014; Clarke TM, 2010, CHEM REV, V110, P6736, DOI 10.1021/cr900271s; Poluektov OG, 2010, J PHYS CHEM B, V114, P14426, DOI 10.1021/jp1012347; BIXON M, 1989, BIOCHIM BIOPHYS ACTA, V977, P273, DOI 10.1016/S0005-2728(89)80081-7; Calvo R, 2000, J AM CHEM SOC, V122, P7327, DOI 10.1021/ja000399r; Carbonera D, 1998, J AM CHEM SOC, V120, P4398, DOI 10.1021/ja9712074; Carrington A., 1967, INTRO MAGNETIC RESON; CLOSS GL, 1987, J PHYS CHEM-US, V91, P3592, DOI 10.1021/j100297a026; Franco L, 2005, J PHYS CHEM B, V109, P13431, DOI 10.1021/jp0514877; Fukuju T, 1997, J PHYS CHEM A, V101, P7783, DOI 10.1021/jp971620y; HORE PJ, 1987, CHEM PHYS LETT, V137, P495, DOI 10.1016/0009-2614(87)80617-6; Kobori Y, 2010, J PHYS CHEM B, V114, P14621, DOI 10.1021/jp102330a; Kobori Y, 1999, J PHYS CHEM A, V103, P5416, DOI 10.1021/jp990359d; Kobori Y, 2011, J AM CHEM SOC, V133, P16770, DOI 10.1021/ja206898j; Kobori Y, 2004, J PHYS CHEM B, V108, P10226, DOI 10.1021/jp036925t; KOTHE G, 1991, CHEM PHYS LETT, V186, P474, DOI 10.1016/0009-2614(91)90454-H; KOTHE G, 1994, J PHYS CHEM-US, V98, P2706, DOI 10.1021/j100061a031; Krinichnyi VI, 2011, SOL ENERG MAT SOL C, V95, P2302, DOI 10.1016/j.solmat.2011.03.045; MICHELBEYERLE ME, 1988, CHEM PHYS LETT, V151, P188, DOI 10.1016/0009-2614(88)85271-0; Miura T, 2014, J PHYS CHEM LETT, V5, P30, DOI 10.1021/jz402300m; MURAI H, 1982, CHEM PHYS LETT, V87, P295, DOI 10.1016/0009-2614(82)83146-1; Nagamori T, 2013, ADV MATER, V25, P2362, DOI 10.1002/adma.201204015; NORRIS JR, 1990, J CHEM PHYS, V92, P4239, DOI 10.1063/1.457782; PRISNER TF, 1995, CHEM PHYS, V194, P361, DOI 10.1016/0301-0104(95)00016-H; Till U, 1997, J PHYS CHEM B, V101, P10939, DOI 10.1021/jp970686q; vanderEst A, 1997, J PHYS CHEM B, V101, P1437, DOI 10.1021/jp9622086; Voityuk AA, 2000, J PHYS CHEM B, V104, P9740, DOI 10.1021/jp001109w; Vukmirovic N, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3474618; Yuan Y, 2011, MACROMOLECULES, V44, P9341, DOI 10.1021/ma2017106	73	3	3	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-7185			J PHYS CHEM LETT	J. Phys. Chem. Lett.	JAN 1	2015	6	1					113	123		10.1021/jz5023202		11	Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Atomic, Molecular & Chemical	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	AY3XW	WOS:000347513700017		
J	Chen, HW; Sakai, N; Ikegami, M; Miyasaka, T				Chen, Hsin-Wei; Sakai, Nobuya; Ikegami, Masashi; Miyasaka, Tsutomu			Emergence of Hysteresis and Transient Ferroelectric Response in Organo-Lead Halide Perovskite Solar Cells	JOURNAL OF PHYSICAL CHEMISTRY LETTERS			English	Article							HIGH-PERFORMANCE; DEPOSITION	Although there has been rapid progress in the efficiency of perovskite-based solar cells, hysteresis in the current-voltage performance is not yet completely understood. Owing to its complex structure, it is not easy to attribute the hysteretic behavior to any one of different components, such as the bulk of the perovskite or different heterojunction interfaces. Among organo-lead halide perovskites, methylammonium lead iodide perovskite (CH3NH3PbI3) is known to have a ferroelectric property. The present investigation reveals a strong correlation between transient ferroelectric polarization of CH3NH3PbI3 induced by an external bias in the dark and hysteresis enhancement in photovoltaic characteristics. Our results demonstrate that the reverse bias poling (-0.3 to -1.1 V) of CH3NH3PbI3 photovoltaic layers prior to the photocurrent-voltage measurement generates stronger hysteresis whose extent changes significantly by the cell architecture. The phenomenon is interpreted as the effect of remanent polarization in the perovskite film on the photocurrent, which is most enhanced in planar perovskite structures without mesoporous scaffolds.	[Chen, Hsin-Wei; Ikegami, Masashi; Miyasaka, Tsutomu] Toin Univ Yokohama, Grad Sch Engn, Aoba Ku, Yokohama, Kanagawa 2258503, Japan; [Sakai, Nobuya] Univ Oxford, Clarendon Lab, Oxford OX1 3PU, England	Miyasaka, T (reprint author), Toin Univ Yokohama, Grad Sch Engn, Aoba Ku, 1614 Kuroganecho, Yokohama, Kanagawa 2258503, Japan.	miyasaka@toin.ac.jp			Japan Science and Technology Agency (JST) Advanced Low Carbon Technology R&D program (ALCA)	This research is supported in part by the Japan Science and Technology Agency (JST) Advanced Low Carbon Technology R&D program (ALCA). The authors thank Dr. Ajay K. Jena for his important discussion on the origin of hysteresis. H.W.C. thanks E. Sakanoshita for her device fabrication and measurements.	Frost JM, 2014, NANO LETT, V14, P2584, DOI 10.1021/nl500390f; Mei AY, 2014, SCIENCE, V345, P295, DOI 10.1126/science.1254763; Xiao ZG, 2014, ENERG ENVIRON SCI, V7, P2619, DOI 10.1039/c4ee01138d; Kojima A, 2009, J AM CHEM SOC, V131, P6050, DOI 10.1021/ja809598r; Burschka J, 2013, NATURE, V499, P316, DOI 10.1038/nature12340; Unger EL, 2014, ENERG ENVIRON SCI, V7, P3690, DOI 10.1039/c4ee02465f; Wei J, 2014, J PHYS CHEM LETT, V5, P3937, DOI 10.1021/jz502111u; Zhou HP, 2014, SCIENCE, V345, P542, DOI 10.1126/science.1254050; Jeon NJ, 2014, NAT MATER, V13, P897, DOI [10.1038/nmat4014, 10.1038/NMAT4014]; Stoumpos CC, 2013, INORG CHEM, V52, P9019, DOI 10.1021/ic401215x; Juarez-Perez EJ, 2014, J PHYS CHEM LETT, V5, P2390, DOI 10.1021/jz5011169; Gottesman R, 2014, J PHYS CHEM LETT, V5, P2662, DOI 10.1021/jz501373f; Sanchez RS, 2014, J PHYS CHEM LETT, V5, P2357, DOI 10.1021/jz5011187; Snaith HJ, 2014, J PHYS CHEM LETT, V5, P1511, DOI 10.1021/jz500113x; Lee MM, 2012, SCIENCE, V338, P643, DOI 10.1126/science.1228604; Roiati V, 2014, NANO LETT, V14, P2168, DOI 10.1021/nl500544c; Liu MZ, 2013, NATURE, V501, P395, DOI 10.1038/nature12509; Kutes Y, 2014, J PHYS CHEM LETT, V5, P3335, DOI 10.1021/jz501697b; Frost JM, 2014, APL MATER, V2, DOI 10.1063/1.4890246; Guichuan X., 2014, NAT MATER, V13, P476; Hui-Seon Kim, 2013, Nature Communications, V4, DOI 10.1038/ncomms3242; Kim HS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00591	22	48	50	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-7185			J PHYS CHEM LETT	J. Phys. Chem. Lett.	JAN 1	2015	6	1					164	169		10.1021/jz502429u		6	Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Atomic, Molecular & Chemical	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	AY3XW	WOS:000347513700024		
J	Ito, M; Masuda, Y; Nagai, K				Ito, Mikiya; Masuda, Yoshihiro; Nagai, Kazukiyo			Evaluation of long-term stability and degradation of polycarbonate based plastic glass	JOURNAL OF POLYMER ENGINEERING			English	Article						color measurement; degradation; long-term stability; plastic glass; polycarbonate (PC)	BISPHENOL-A POLYCARBONATE; POLY(METHYL METHACRYLATE); PHOTODEGRADATION; NANOCOMPOSITES; POLYMERS; BLENDS	Polycarbonate (PC) is mainly used as plastic glass in the industrial field. PC has many advantages such as light weight and high impact strength as compared to inorganic glass. However, the long-term stability of PC through the service life has not been fully examined. The authors analyzed the degradation behavior of PC glass through long-term artificial weathering conditions. The PC glass became yellowish through artificial weathering; however, the mechanical strength, for example, the flexural strength and the impact strength, were sufficient for its use as actual window glass of the public transportation. Moreover, improved PC is expected to have a longer service life as compared to ordinary PC. In addition, the evaluation of the degradation of PC-based plastic glass was studied with use of color measurement.	[Ito, Mikiya; Masuda, Yoshihiro] Railway Tech Res Inst, Mat Technol Div, Kokubunji, Tokyo 1858540, Japan; [Nagai, Kazukiyo] Meiji Univ, Dept Appl Chem, Tama Ku, Kawasaki, Kanagawa 2148571, Japan	Ito, M (reprint author), Railway Tech Res Inst, Mat Technol Div, 2-8-38 Hikari Cho, Kokubunji, Tokyo 1858540, Japan.	ito.mikiya.93@rtri.or.jp					[Anonymous], JRS671021J15AROA; Diepens M, 2007, POLYM DEGRAD STABIL, V92, P397, DOI 10.1016/j.polymdegradstab.2006.12.003; [Anonymous], 2011, SUGA TECHNICAL NEWS; Ito M, 2008, POLYM DEGRAD STABIL, V93, P1723, DOI 10.1016/j.polymdegradstab.2008.07.011; OLEFJORD I, 1980, MATER SCI ENG, V42, P161, DOI 10.1016/0025-5416(80)90025-7; Lorriot T, 1998, INT J FRACTURE, V91, P299, DOI 10.1023/A:1007583731072; Diepens M, 2010, POLYM DEGRAD STABIL, V95, P811, DOI 10.1016/j.polymdegradstab.2010.02.005; FACTOR A, 1987, MACROMOLECULES, V20, P2461, DOI 10.1021/ma00176a023; Factor A., 1996, POLYM DURABILITY; FUKUDA Y, 1991, POLYM DEGRAD STABIL, V34, P75, DOI 10.1016/0141-3910(91)90112-5; Ito M, 2011, FIRE MATER, V35, P171, DOI 10.1002/fam.1046; Ito M, 2008, J APPL POLYM SCI, V108, P3487, DOI 10.1002/app.27954; Kim S, 2008, POLYM ADVAN TECHNOL, V19, P496, DOI 10.1002/pat.1089; LEE LH, 1964, J POLYM SCI PART A, V2, P2859, DOI 10.1002/pol.1964.100020635; Matsukane M, 1969, POLYCARBONATE, P150; Nagai N, 2005, POLYM DEGRAD STABIL, V88, P224, DOI 10.1016/j.polymdegradstab.2004.11.001; Naraba K.J., 1960, JSME, V63, P910; OSAWA Z, 1991, POLYM DEGRAD STABIL, V32, P285, DOI 10.1016/0141-3910(91)90002-9; RAM A, 1985, POLYM ENG SCI, V25, P535, DOI 10.1002/pen.760250905; The Chemical Society of Japan, 2003, KAG BINR, P804; Thompson T, 1996, POLYM DURABILITY; Yaguchi N, 1997, RTRI REPORT, V11, P35; Yamazaki T., 1970, KOUZOURIKIGAKU, P60	23	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0334-6447	2191-0340		J POLYM ENG	J. Polym. Eng.	JAN	2015	35	1					31	40		10.1515/polyeng-2014-0085		10	Polymer Science	Polymer Science	AY3GT	WOS:000347473200004		
J	Kubota, T; Shibahara, Y; Fukutani, S; Fujii, T; Ohta, T; Kowatari, M; Mizuno, S; Takamiya, K; Yamana, H				Kubota, Takumi; Shibahara, Yuji; Fukutani, Satoshi; Fujii, Toshiyuki; Ohta, Tomoko; Kowatari, Munehiko; Mizuno, Satoshi; Takamiya, Koichi; Yamana, Hajimu			Cherenkov counting of Sr-90 and Y-90 in bark and leaf samples collected around Fukushima Daiichi Nuclear Power Plant	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Sr-90; Cs-137; Cherenkov counting; Fukushima nuclear accident; Vegetation samples	URINE SAMPLES; RAPID-DETERMINATION; RADIOACTIVE CESIUM; SEPARATION METHOD; SOIL; MIGRATION; ACCIDENT; RADIOSTRONTIUM; COMBINATION; STRONTIUM	The radioactivity of Sr-90 and Cs-137 in environmental samples, bark and leaf, collected around the Fukushima Daiichi Nuclear Power Plant in May 2013 was determined with the aim of investigating the migration of both nuclides using their radioactivity ratio. The radioactivity of Sr-90 was determined by using Cherenkov counting of Y-90 after purification using Sr resin and that of Cs-137 was determined by gamma-spectrometry. Quench correction in Cherenkov counting was investigated by measurements of samples spiked with purified Y-90 revealed that the radioactivity could be evaluated without quench correction. The radioactivity ratio of Sr-90 to Cs-137 in bark samples of 4.2 x 10(-3) and 1.2 x 10(-2) was compared with the results from soil samples collected in July 2011 to show that the migration of Sr-90 was slower than Cs-137 in bark and tree.	[Kubota, Takumi; Shibahara, Yuji; Fukutani, Satoshi; Fujii, Toshiyuki; Takamiya, Koichi; Yamana, Hajimu] Kyoto Univ, Inst Res Reactor, Osaka 5900494, Japan; [Ohta, Tomoko] Hokkaido Univ, Sapporo, Hokkaido 0608628, Japan; [Kowatari, Munehiko] Japan Atom Energy Agcy, Tokai, Ibaragi 3191195, Japan; [Mizuno, Satoshi] Fukushima Prefectural Govt, Nucl Power Safety Div, Fukushima 9608043, Japan	Kubota, T (reprint author), Kyoto Univ, Inst Res Reactor, Osaka 5900494, Japan.	t_kubota@rri.kyoto-u.ac.jp			KUR Research Program for Scientific Basis of Nuclear Safety	We wish to thank Mr. Mitsuyuki Konno and Mr. Satoru Matsuzaki for their help in collecting environmental samples. This work was supported by the KUR Research Program for Scientific Basis of Nuclear Safety.	Lopes I, 2010, J RADIOANAL NUCL CH, V286, P335, DOI 10.1007/s10967-010-0714-2; Kuroda K, 2013, J ENVIRON RADIOACTIV, V122, P37, DOI 10.1016/j.jenvrad.2013.02.019; Povinec PP, 2013, J RADIOANAL NUCL CH, V295, P1171, DOI 10.1007/s10967-012-1943-3; CURRIE LA, 1968, ANAL CHEM, V40, P586, DOI 10.1021/ac60259a007; Dai XX, 2013, J RADIOANAL NUCL CH, V296, P363, DOI 10.1007/s10967-012-1971-z; Dai XX, 2011, J RADIOANAL NUCL CH, V289, P461, DOI 10.1007/s10967-011-1096-9; Fernandez JM, 2006, J ENVIRON RADIOACTIV, V87, P209, DOI 10.1016/j.jenvrad.2005.11.010; Firestone R. B., 1996, 8 EDITION TABLE ISOT; Furuta E, 2013, J RADIOANAL NUCL CH, V297, P337, DOI 10.1007/s10967-012-2343-4; Grahek Z, 2012, J RADIOANAL NUCL CH, V292, P555, DOI 10.1007/s10967-011-1441-z; Herranz M, 2011, J ENVIRON RADIOACTIV, V102, P987, DOI 10.1016/j.jenvrad.2011.07.004; Itthipoonthanakorn T, 2013, J RADIOANAL NUCL CH, V297, P419, DOI 10.1007/s10967-012-2399-1; Karacan F, 2011, J RADIOANAL NUCL CH, V288, P685, DOI 10.1007/s10967-011-1037-7; Kubota T, 2013, J RADIOANAL NUCL CH, V296, P981, DOI 10.1007/s10967-012-2068-4; Lee MH, 2013, J RADIOANAL NUCL CH, V295, P1419, DOI 10.1007/s10967-012-1926-4; Lee SH, 2013, J RADIOANAL NUCL CH, V296, P727, DOI 10.1007/s10967-012-2030-5; MAHARA Y, 1993, J ENVIRON QUAL, V22, P722; Mahmood ZUW, 2012, J RADIOANAL NUCL CH, V291, P901, DOI 10.1007/s10967-011-1380-8; Maxwell SL, 2009, J RADIOANAL NUCL CH, V279, P901, DOI 10.1007/s10967-008-7387-0; Maxwell SL, 2013, J RADIOANAL NUCL CH, V295, P965, DOI 10.1007/s10967-012-1863-2; Maxwell SL, 2010, J RADIOANAL NUCL CH, V286, P273, DOI 10.1007/s10967-010-0653-y; Maxwell SL, 2009, J RADIOANAL NUCL CH, V279, P105, DOI 10.1007/s10967-007-7209-9; Nakanishi TM, 2013, J RADIOANAL NUCL CH, V296, P985, DOI 10.1007/s10967-012-2154-7; Popov L, 2010, J RADIOANAL NUCL CH, V285, P223, DOI 10.1007/s10967-010-0550-4; SATO J, 1977, GEOCHEM J, V11, P261; SATO J, 1980, INT J APPL RADIAT IS, V31, P130, DOI 10.1016/0020-708X(80)90058-7; Shibahara Y, 2014, P 48 KURRI SCI M, P174; Solecki J, 2011, J RADIOANAL NUCL CH, V289, P185, DOI 10.1007/s10967-011-1060-8; Solecki J, 2010, J RADIOANAL NUCL CH, V286, P27, DOI 10.1007/s10967-010-0657-7; Tumey SJ, 2013, J RADIOANAL NUCL CH, V296, P957, DOI 10.1007/s10967-012-2217-9	30	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	JAN	2015	303	1					39	46		10.1007/s10967-014-3348-y		8	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AY0OB	WOS:000347294600005		
J	Yoshida, Y; Nakazawa, T; Yoshikawa, H				Yoshida, Yasushi; Nakazawa, Toshiyuki; Yoshikawa, Hideki			Partition coefficient of Ra in witherite	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Ra; Witherite; Coprecipitation	CALCITE; RADIUM; BARIUM	The heterogeneous partition coefficient (lambda) for Ra in BaCO3 (witherite) was determined by coprecipitation using the free drift method. Initially, CO2 (100 %) was bubbled through a solution equilibrated with witherite. After a small amount of Ra was added into the solution, coprecipitation was induced by a slow increase in pH, caused by degassing CO2(g) from the solution. Kinetically controlled precipitation was restricted to be slow because of the slow degassing of CO2(g). The observed low precipitation rate allowed for the equilibrium partitioning of elements during coprecipitation of witherite. The value of lambda derived for Ra was (1.3 +/- A 0.7) x 10(-1), a value similar to that obtained from the coprecipitation of Ra in CaCO3 (calcite). The obtained results indicated that partitioning of Ra in carbonate-based minerals was not dependent on the similarity of its ionic radius with that of the metal in the host carbonate.	[Yoshida, Yasushi] NESI Inc, Hitachinaka, Ibaraki 3120005, Japan; [Nakazawa, Toshiyuki] Mitsubishi Mat Corp, Naka, Ibaraki 3110102, Japan; [Yoshikawa, Hideki] Japan Atom Energy Agcy, Tokai, Ibaraki 3191194, Japan	Yoshida, Y (reprint author), NESI Inc, 35 Shinko Cho, Hitachinaka, Ibaraki 3120005, Japan.	yoshida.yasushi76@jaea.go.jp					Doerner HA, 1925, J AM CHEM SOC, V47, P662, DOI 10.1021/ja01680a010; Tesoriero AJ, 1996, GEOCHIM COSMOCHIM AC, V60, P1053, DOI 10.1016/0016-7037(95)00449-1; LANGMUIR D, 1985, GEOCHIM COSMOCHIM AC, V49, P1593, DOI 10.1016/0016-7037(85)90264-9; Curti E, 1997, 9710 PSI; Jones MJ, 2011, APPL GEOCHEM, V26, P1231, DOI 10.1016/j.apgeochem.2011.04.012; Kitamura A, 2010, JAEA DATA CODE 2009; Klein C, 1993, MANUAL MINERALOGY; LORENS RB, 1981, GEOCHIM COSMOCHIM AC, V45, P553, DOI 10.1016/0016-7037(81)90188-5; Parkhurst DL, 1995, 954227 US GEOL SURV; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Stumm W., 1996, AQUATIC CHEM CHEM EQ; Yoshida Y, 2008, GEOCHEM J, V42, P295	12	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	JAN	2015	303	1					147	152		10.1007/s10967-014-3357-x		6	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AY0OB	WOS:000347294600018		
J	Kritsananuwat, R; Sahoo, SK; Fukushi, M; Pangza, K; Chanyotha, S				Kritsananuwat, R.; Sahoo, S. K.; Fukushi, M.; Pangza, K.; Chanyotha, S.			Radiological risk assessment of U-238, Th-232 and K-40 in Thailand coastal sediments at selected areas proposed for nuclear power plant sites	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Environmental radioactivity; Marine sediment; Gulf of Thailand; ICP-MS; gamma-spectroscopy	MARINE-SEDIMENTS; NATURAL RADIOACTIVITY; RADIONUCLIDES; SEA; BAY; URANIUM; CS-137; INDIA	This paper reports on the distribution of three natural radionuclides U-238, Th-232 and K-40 in marine sediments along the Gulf of Thailand to establish baseline data for future environmental monitoring. Sediments were collected from five potential sites selected for nuclear and thermal power plants commission as well as heavy industry development. Concentration of uranium and thorium were determined using inductively coupled plasma mass spectrometry (ICP-MS) as well as activity of U-238 series (Ra-226), Th-232 series (Ac-228) and K-40 by gamma-spectroscopy. The radiation hazard parameters were calculated based on United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR). Variation in concentration of natural radionuclides at different sampling areas could be attributed to organic matter content and sediment particle size. The radiological health hazards to the people living nearby sampling areas and the people who handle the marine sediments are within limits recommended by UNSCEAR.	[Kritsananuwat, R.; Fukushi, M.] Tokyo Metropolitan Univ, Dept Radiol Sci, Tokyo 158, Japan; [Kritsananuwat, R.; Sahoo, S. K.] Natl Inst Radiol Sci, Project Environm Dynam & Radiat Effects, Inage Ku, Chiba 260, Japan; [Pangza, K.; Chanyotha, S.] Chulalongkorn Univ, Dept Nucl Engn, Bangkok, Thailand	Sahoo, SK (reprint author), Natl Inst Radiol Sci, Project Environm Dynam & Radiat Effects, Inage Ku, 4-9-1 Anagawa, Chiba 260, Japan.	sahoo@nirs.go.jp			"Asian Human Resources Fund'', Tokyo Metropolitan Government, Tokyo, Japan at Tokyo Metropolitan University	RK is thankful to "Asian Human Resources Fund'', Tokyo Metropolitan Government, Tokyo, Japan for the award of Doctoral fellowship at Tokyo Metropolitan University. RK would like to thank the Chulalongkorn University team members for their kind support to collect the samples during field study.	Alfonso JA, 2014, J RADIOANAL NUCL CH, V300, P219, DOI 10.1007/s10967-014-2999-z; Malain D, 2012, APPL RADIAT ISOTOPES, V70, P1467, DOI 10.1016/j.apradiso.2012.04.017; Papaefthymiou H, 2013, J ENVIRON RADIOACTIV, V122, P43, DOI 10.1016/j.jenvrad.2013.02.020; [Anonymous], 2014, STAT COAST GEOENV TH; Ramasamy V, 2014, J ENVIRON RADIOACTIV, V127, P64, DOI 10.1016/j.jenvrad.2013.09.010; Lidman F, 2012, BIOGEOSCIENCES, V9, P4773, DOI 10.5194/bg-9-4773-2012; [Anonymous], 2014, GEOL THAIL; Dar MAR, 2013, RADIAT PROT DOSIM, V153, P361, DOI 10.1093/rpd/ncs104; El-Taher A, 2011, APPL RADIAT ISOTOPES, V69, P550, DOI 10.1016/j.apradiso.2010.11.010; Ergul HA, 2013, J ENVIRON RADIOACTIV, V126, P125, DOI 10.1016/j.jenvrad.2013.07.015; Gonzalez-Fernandez D, 2012, ENVIRON EARTH SCI, V66, P1175, DOI 10.1007/s12665-011-1325-0; Ibranhim MZ, 2005, J NUCL RELATED TECH, V2, P63; Kennedy VC, 1965, 433D US AT EN COMM G; Kilic O, 2011, J RADIOANAL NUCL CH, V289, P627, DOI 10.1007/s10967-011-1140-9; Kumar A, 2013, J RADIOANAL NUCL CH, V295, P835, DOI 10.1007/s10967-012-2166-3; Sam AK, 1998, J RADIOANAL NUCL CH, V237, P103, DOI 10.1007/BF02386670; Tripathi RM, 2013, J RADIOANAL NUCL CH, V295, P1829, DOI 10.1007/s10967-012-2106-2; UNSCEAR, 2000, SOURC EFF ION RAD; Yii MW, 2009, APPL RADIAT ISOTOPES, V67, P630, DOI 10.1016/j.apradiso.2008.11.019; Yii MW, 2011, J RADIOANAL NUCL CH, V289, P653, DOI 10.1007/s10967-010-0928-3; Zare MR, 2012, MAR POLLUT BULL, V64, P1956, DOI 10.1016/j.marpolbul.2012.05.005	21	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	JAN	2015	303	1					325	334		10.1007/s10967-014-3376-7		10	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AY0OB	WOS:000347294600039		
J	Watanabe, S; Hashimoto, K; Watanabe, S; Iida, Y; Hanaoka, H; Endo, K; Ishioka, NS				Watanabe, Satoshi; Hashimoto, Kazuyuki; Watanabe, Shigeki; Iida, Yasuhiko; Hanaoka, Hirofumi; Endo, Keigo; Ishioka, Noriko S.			Production of highly purified no-carrier-added Lu-177 for radioimmunotherapy	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						No-carrier-added Lu-177; Separation; Purification; Lu-177-labeled antibody	RADIOLABELED SOMATOSTATIN ANALOG; NEUROENDOCRINE TUMORS; BREAST-CANCER; SEPARATION; THERAPY; YTTERBIUM; TARGET; YB	No-carrier-added Lu-177 produced via the Yb-176(n, gamma)Yb-177 -> Lu-177 process was separated from the macroscopic amounts of the Yb target using reversed-phase ion-pair liquid chromatography. To produce a highly purified Lu-177 solution capable of labeling antibodies, the metallic impurities were removed using cation, chelating ion, and anion exchange columns. After the elimination of metallic impurities, the concentrations of Ca, Fe, and Zn were reduced from 87, 340, and 77 ppb to 13, 18, and 9 ppb, respectively. Consequently, the labeling yield of the Lu-177-labeled antibody increased from < 5 to 88 %.	[Watanabe, Satoshi; Watanabe, Shigeki; Ishioka, Noriko S.] Japan Atom Energy Agcy, Quantum Beam Sci Ctr, Takasaki, Gunma 3701292, Japan; [Hashimoto, Kazuyuki] Japan Atom Energy Agcy, Quantum Beam Sci Ctr, Tokai, Ibaraki 3191195, Japan; [Iida, Yasuhiko; Hanaoka, Hirofumi] Gunma Univ, Grad Sch Med, Dept Bioimaging Informat Anal, Maebashi, Gunma 3718511, Japan; [Endo, Keigo] Gunma Univ, Grad Sch Med, Dept Diagnost Radiol & Nucl Med, Maebashi, Gunma 3718511, Japan	Watanabe, S (reprint author), Japan Atom Energy Agcy, Quantum Beam Sci Ctr, Takasaki, Gunma 3701292, Japan.	watanabe.satoshi@jaea.go.jp					Koppe MJ, 2004, J NUCL MED, V45, P1224; Kwekkeboom DJ, 2005, J CLIN ONCOL, V23, P2754, DOI 10.1200/JCO.2005.08.066; Lebedev NA, 2000, APPL RADIAT ISOTOPES, V53, P421, DOI 10.1016/S0969-8043(99)00284-5; Dadachova E, 1997, APPL RADIAT ISOTOPES, V48, P477, DOI 10.1016/S0969-8043(96)00269-2; Paudyal P, 2009, ONCOL REP, V22, P115, DOI 10.3892/or_00000413; Kwekkeboom DJ, 2001, EUR J NUCL MED, V28, P1319, DOI 10.1007/s002590100574; Vera DRB, 2012, NUCL MED BIOL, V39, P3, DOI 10.1016/j.nucmedbio.2011.07.001; Forrer F, 2005, J NUCL MED, V46, P1310; Knogler K, 2006, NUCL MED BIOL, V33, P883, DOI 10.1016/j.nucmedbio.2006.08.001; Kam BLR, 2012, EUR J NUCL MED MOL I, V39, P103, DOI 10.1007/s00259-011-2039-y; Brouwers AH, 2004, J NUCL MED, V45, P327; [Anonymous], 2004, [No title captured], Patent No. 6716353; Horwitz EP, 2005, APPL RADIAT ISOTOPES, V63, P23, DOI 10.1016/j.apradiso.2005.05.005; BALASUBRAMANIAN PS, 1994, J RADIOAN NUCL CH AR, V185, P305, DOI 10.1007/BF02041303; Bilewicz A, 2009, J RADIOANAL NUCL CH, V280, P167, DOI 10.1007/s10967-008-7437-7; Chakravarty R, 2010, NUCL MED BIOL, V37, P811, DOI 10.1016/j.nucmedbio.2010.04.082; de Keizer B, 2008, EUR J NUCL MED MOL I, V35, P749, DOI 10.1007/s00259-007-0691-z; Grunberg J, 2005, CLIN CANCER RES, V115, P112; Hashimoto K, 2003, J RADIOANAL NUCL CH, V255, P575, DOI 10.1023/A:1022557121351; Knapp FF, 2005, J RADIOANAL NUCL CH, V263, P503, DOI 10.1007/s10967-005-0083-4; Lahiri S, 1998, APPL RADIAT ISOTOPES, V49, P911, DOI 10.1016/S0969-8043(97)10101-4; Mukai T, 2002, J PHARM PHARMACOL, V54, P1073, DOI 10.1211/002235702320266226; Persson M, 2007, CANCER RES, V67, P326, DOI 10.1158/0008-5472.CAN-06-2363; Rasaneh S, 2010, NUCL MED BIOL, V37, P949, DOI 10.1016/j.nucmedbio.2010.07.001; SAITO N, 1984, PURE APPL CHEM, V56, P523, DOI 10.1351/pac198456040523; Salouti M, 2011, NUCL MED BIOL, V38, P849, DOI 10.1016/j.nucmedbio.2011.02.009; Smith CJ, 2003, NUCL MED BIOL, V30, P101, DOI 10.1016/S0969-8051(02)00391-8; So LV, 2008, J RADIOANAL NUCL CHE, V277, P675, DOI 10.1007/s10967-007-7130-2; So LV, 2008, J RADIOANAL NUCL CHE, V277, P663, DOI 10.1007/s10967-007-7129-8; So LV, 2008, J RADIOANAL NUCL CHE, V277, P651, DOI 10.1007/s10967-007-7131-1	30	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	JAN	2015	303	1					935	940		10.1007/s10967-014-3534-y		6	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AY0OB	WOS:000347294600107		
J	Fujii, T; Uehara, A; Kitatsuji, Y; Yamana, H				Fujii, Toshiyuki; Uehara, Akihiro; Kitatsuji, Yoshihiro; Yamana, Hajimu			Theoretical and experimental study of the vibrational frequencies of UO2 (2+) and NpO2 (2+) in highly concentrated chloride solutions	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Raman spectrometry; Uranyl; Neptunyl; Chloride; Density functional theory	AQUEOUS-SOLUTION; DIOXOURANIUM(VI) ION; RAMAN-SPECTROSCOPY; COMPLEX-FORMATION; REDOX SPECIATION; AQUO COMPLEXES; URANYL; PERCHLORATE; URANIUM(VI); HYDROLYSIS	The nu(1) symmetric vibrational frequency of UO2 (2+) in chloride solutions was studied by Raman spectrometry and ab initio calculations. The nu(1) frequency experimentally obtained decreased with the increase of concentration of Cl in solvent chlorides. This is attributable to that hydration water molecules in the equatorial plane of UO2 (2+) are substituted by Cl- ions, which was consistent with the calculation results. The theoretical part was expanded to aqua- and chloro- Np(VI) complexes. The nu(1) frequencies of neptunyl species computed were acceptable compared with the reported Raman shifts.	[Fujii, Toshiyuki; Uehara, Akihiro; Yamana, Hajimu] Kyoto Univ, Inst Res Reactor, Kumatori, Sennan 5900494, Japan; [Kitatsuji, Yoshihiro] Japan Atom Energy Agcy, Sect Nucl Sci Res, Tokai, Ibaraki 3191195, Japan	Fujii, T (reprint author), Kyoto Univ, Inst Res Reactor, 2-1010 Asashiro Nishi, Kumatori, Sennan 5900494, Japan.	tosiyuki@rri.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [26420869]	This research was partly supported by Grants-in-Aid for Scientific Research (No. 26420869) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	ABERG M, 1983, INORG CHEM, V22, P3986; Dargent M, 2013, EUR J MINERAL, V25, P765, DOI 10.1127/0935-1221/2013/0025-2319; Fujii T, 2010, IOP CONF SER-MAT SCI, V9, DOI 10.1088/1757-899X/9/1/012061; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Antonio MR, 2001, RADIOCHIM ACTA, V89, P17; Vallet V, 2001, INORG CHEM, V40, P3516, DOI 10.1021/ic001405n; Hay PJ, 2000, J PHYS CHEM A, V104, P6259, DOI 10.1021/jp000519h; Ikeda-Ohno A, 2008, INORG CHEM, V47, P8294, DOI 10.1021/ic8009095; Fujii T, 2001, J ALLOY COMPD, V323, P859, DOI 10.1016/S0925-8388(01)01161-6; Uehara A, 2012, J APPL ELECTROCHEM, V42, P455, DOI 10.1007/s10800-012-0420-6; KUCHLE W, 1994, J CHEM PHYS, V100, P7535; Shamov GA, 2005, J PHYS CHEM A, V109, P10961, DOI 10.1021/jp053522f; Perdew JP, 1997, PHYS REV LETT, V78, P1396, DOI 10.1103/PhysRevLett.78.1396; NGUYENTRUNG C, 1992, INORG CHEM, V31, P5280, DOI 10.1021/ic00051a021; BASILE LJ, 1974, APPL SPECTROSC, V28, P142, DOI 10.1366/000370274774332812; Allen PG, 1997, INORG CHEM, V36, P4676, DOI 10.1021/ic970502m; Bridgeman AJ, 2003, FARADAY DISCUSS, V124, P239, DOI 10.1039/b210795n; BROOKER MH, 1980, J INORG NUCL CHEM, V42, P1431, DOI 10.1016/0022-1902(80)80109-6; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Fujii T, 2002, J NUCL SCI TECHNOL S, V3, P336; Fujii T, 2014, J RADIOANAL NUCL CH, V301, P293, DOI 10.1007/s10967-014-3130-1; Gaona X, 2012, RADIOCHIM ACTA, V100, P759, DOI 10.1524/ract.2012.1948; Hennig H, 2005, INORG CHEM, V44, P6655; MADIC C, 1984, INORG CHEM, V23, P1914, DOI 10.1021/ic00181a025; Moll H, 2003, RADIOCHIM ACTA, V91, P11, DOI 10.1524/ract.91.1.11.19008; NEWBERY JE, 1969, SPECTROCHIM ACTA A-M, VA 25, P1699, DOI 10.1016/0584-8539(69)80158-3; OECD Nuclear Energy Agency, 2003, UPDATE CHEM THERMODY; Rao LF, 2002, RADIOCHIM ACTA, V90, P581, DOI 10.1524/ract.2002.90.9-11_2002.581; Reich T, 2000, RADIOCHIM ACTA, V88, P633, DOI 10.1524/ract.2000.88.9-11.633; Semon L, 2001, CHEMPHYSCHEM, V2, P591, DOI 10.1002/1439-7641(20011015)2:10<591::AID-CPHC591>3.0.CO;2-B; Takao K, 2009, INORG CHEM, V48, P8803, DOI 10.1021/ic900981q; Tsushima S, 2002, CHEM PHYS LETT, V357, P73, DOI 10.1016/S0009-2614(02)00443-8; Uehara A, 2009, 15 NEANSCDOC, V15, P197; Wahlgren U, 1999, J PHYS CHEM A, V103, P8257, DOI 10.1021/jp990042d	34	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	JAN	2015	303	1					1015	1020		10.1007/s10967-014-3340-6		6	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AY0OB	WOS:000347294600118		
J	Ozaki, H; Nakada, M; Uzawa, K; Miyano, Y				Ozaki, Hiroaki; Nakada, Masayuki; Uzawa, Kiyoshi; Miyano, Yasushi			Effect of stamping condition on age deformation of textile carbon fiber reinforced polycarbonate laminates	JOURNAL OF REINFORCED PLASTICS AND COMPOSITES			English	Article						Textile carbon fiber; polycarbonate; stamping; age deformation; viscoelasticity	COMPOSITES	This study examines the effect of stamping condition on age deformation after stamping of textile carbon fiber reinforced polycarbonate laminates. The laminates were stamped to a hat shape at various stamping temperatures between the glass transition temperature T-g and the melting temperature T-m of polycarbonate. Then the age deformation, which is the hat angle variation, was measured. Results show that the age deformation occurs at the stamping temperature in the vicinity of T-g. The age deformation is suppressed when the stamping temperature is sufficiently higher than T-g. Furthermore, the long-term age deformation as the dimensional stability was predicted from the measured deformation at elevated temperature based on the time-temperature superposition principle for the viscoelasticity of the polycarbonate matrix.	[Ozaki, Hiroaki] Tsudakoma Corp, Composite Machinery Dept, Haku San, Ishikawa 9240016, Japan; [Ozaki, Hiroaki] Kanazawa Inst Technol, Grad Sch, Kanazawa, Ishikawa, Japan; [Nakada, Masayuki; Miyano, Yasushi] Kanazawa Inst Technol, Mat Syst Res Lab, Kanazawa, Ishikawa, Japan; [Uzawa, Kiyoshi] Kanazawa Inst Technol, Innovat Composite Mat Res & Dev Ctr, Kanazawa, Ishikawa, Japan	Ozaki, H (reprint author), Tsudakoma Corp, Composite Machinery Dept, 500 Miyanagaichi Machi, Haku San, Ishikawa 9240016, Japan.	h-ozaki@tsudakoma.co.jp					Vieille B, 2013, COMPOS PART B-ENG, V45, P821, DOI 10.1016/j.compositesb.2012.07.047; de Luca P, 1998, COMPOS PART A-APPL S, V29, P101, DOI 10.1016/S1359-835X(97)00060-2; Hou M, 1994, APPL COMPOSITE MAT, V1, P135, DOI 10.1007/BF00567575; Hwang SF, 2002, COMPOS PART A-APPL S, V33, P669, DOI 10.1016/S1359-835X(02)00004-0; Meyer BC, 2009, COMPOS STRUCT, V90, P225, DOI 10.1016/j.compstruct.2009.03.013; Padovec Z., 2012, APPL COMPUT MECH, V6, P25; TA instruments, 2011, RSA G2 SOL AN BROCH; Vieille B, 2014, COMPOS PART B-ENG, V63, P101, DOI 10.1016/j.compositesb.2014.03.025	8	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0731-6844	1530-7964		J REINF PLAST COMP	J. Reinf. Plast. Compos.	JAN	2015	34	1					19	27		10.1177/0731684414561901		9	Materials Science, Composites; Polymer Science	Materials Science; Polymer Science	AY2IP	WOS:000347413000002		
J	Yamashita, N; Ito, R; Nakano, M; Matsumoto, T				Yamashita, Naoyuki; Ito, Ryo; Nakano, Masataka; Matsumoto, Takaaki			TWO PERCENT HYPOHYDRATION DOES NOT IMPAIR SELF-SELECTED HIGH-INTENSITY INTERMITTENT EXERCISE PERFORMANCE	JOURNAL OF STRENGTH AND CONDITIONING RESEARCH			English	Article						anaerobic exercise performance; hydration status; negative fluid balance; self-selected exercise	SKELETAL-MUSCLE; INDUCED DEHYDRATION; SPRINT PERFORMANCE; BODY-MASS; HYDRATION; HUMANS; HEAT; METABOLISM; VOLUME; WATER	The level of hypohydration at which power output during intermittent exercise performance starts to decrease is not fully understood. The purpose of this study was to investigate the effects of 2% hypohydration without hyperthermia on intermittent exercise performance. Eight collegiate amateur boxers completed 2 exercise tests. On day 1, subjects hypohydrated by 2% of body mass by exercising in a hot environment, and on day 2, subjects performed intermittent exercise (4 3 2 minute per round [R] separated by 1-minute recovery) under a randomly assigned condition of with (HYP) or without (EUH) hypohydration. Each bout consisted of 8 3 5 seconds of maximal cycling exercise (0.05 kp 3 body mass) separated by 10 seconds of passive recovery. Mean power output per kilogram (MPO), total power output per kilogram (TPO), energy system relative contribution, and core rectal temperature (Tre) were measured. Changes in body mass before the exercise tests were 22.25 +/- 0.18% (HYP) and 20.17 +/- 0.19% (EUH) (p < 0.001). Mean power output, TPO, and each energy contribution ratio were not significantly different between the trials, and pre- and postexercise test Tre did not differ significantly between trials. Results demonstrated that approximately 2% hypohydration lies below the point at which power output during intermittent exercise starts to decline.	[Yamashita, Naoyuki; Ito, Ryo; Nakano, Masataka; Matsumoto, Takaaki] Chukyo Univ, Grad Sch Hlth & Sport Sci, Lab Exercise Physiol & Biomech, Toyota, Japan; [Ito, Ryo] Nihon Fukushi Univ, Univ Educ Ctr, Mihama, Japan; [Nakano, Masataka] Aichi Toho Univ, Fac Human Studies, Dept Human Hlth, Nagoya, Aichi, Japan	Yamashita, N (reprint author), Chukyo Univ, Grad Sch Hlth & Sport Sci, Lab Exercise Physiol & Biomech, Toyota, Japan.	naoyukiymst@gmail.com					Kraft JA, 2012, RES Q EXERCISE SPORT, V83, P282; Shirreffs SM, 1996, MED SCI SPORT EXER, V28, P1260, DOI 10.1097/00005768-199610000-00009; Judelson DA, 2007, SPORTS MED, V37, P907; CARTON RL, 1985, SPORTS MED, V2, P198; SJOGAARD G, 1985, AM J PHYSIOL, V248, pR190; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BRM.41.4.1149; Cheuvront SN, 2004, INT J SPORT NUTR EXE, V14, P532; Sawka MN, 2007, MED SCI SPORT EXER, V39, P1209, DOI 10.1249/mss.0b013e318124a664; Goulet EDB, 2011, BRIT J SPORT MED, V45, P1149, DOI 10.1136/bjsm.2010.077966; Gonzalez-Alonso J, 1999, J PHYSIOL-LONDON, V520, P577, DOI 10.1111/j.1469-7793.1999.00577.x; Kraft JA, 2011, J STRENGTH COND RES, V25, P778, DOI 10.1519/JSC.0b013e3181c1f79d; Bangsbo J, 2001, AM J PHYSIOL-ENDOC M, V280, pE956; Campos FAD, 2012, EUR J APPL PHYSIOL, V112, P1221, DOI 10.1007/s00421-011-2071-4; Gastin PB, 2001, SPORTS MED, V31, P725, DOI 10.2165/00007256-200131100-00003; NOSE H, 1983, JPN J PHYSIOL, V33, P1019, DOI 10.2170/jjphysiol.33.1019; Haseler LJ, 1999, J APPL PHYSIOL, V86, P2013; GAITANOS GC, 1993, J APPL PHYSIOL, V75, P712; BROZEK J, 1963, ANN NY ACAD SCI, V110, P113, DOI 10.1111/j.1749-6632.1963.tb17079.x; CRAIG FN, 1966, J APPL PHYSIOL, V21, P670; WILMORE JH, 1980, MED SCI SPORT EXER, V12, P216; Yoshida T, 2002, EUR J APPL PHYSIOL, V87, P529, DOI 10.1007/s00421-002-0651-z; Gonzalez-Alonso J, 2000, AM J PHYSIOL-HEART C, V278, pH321; Drust B, 2005, ACTA PHYSIOL SCAND, V183, P181, DOI 10.1111/j.1365-201X.2004.01390.x; Smith MS, 2000, EUR J APPL PHYSIOL, V83, P34, DOI 10.1007/s004210000251; Hall CJ, 2001, BRIT J SPORT MED, V35, P390, DOI 10.1136/bjsm.35.6.390; Thomas MM, 2006, J APPL PHYSIOL, V100, P1361, DOI 10.1152/jappalphysiol.00945.2005; ARMSTRONG LE, 1994, INT J SPORT NUTR, V4, P265; Watson G, 2005, MED SCI SPORT EXER, V37, P1168, DOI 10.1249/01.mss.0000170100.93279.be; Cheuvront Samuel N, 2003, Curr Sports Med Rep, V2, P202, DOI 10.1007/s11932-003-0006-5; Cheuvront SN, 2006, MED SCI SPORT EXER, V38, P1093, DOI 10.1249/01.mss.0000222838.74015.15; Gonzalez-Alonso J, 2008, J PHYSIOL-LONDON, V586, P45, DOI 10.1113/jphysiol.2007.142158; Judelson DA, 2008, J APPL PHYSIOL, V105, P816, DOI 10.1152/japplphysiol.01010.2007; Maxwell NS, 1999, MED SCI SPORT EXER, V31, P675, DOI 10.1097/00005768-199905000-00009; Maxwell NS, 2009, INTJ SPORT PHYSIOL, V4, P54; VOLLESTAD NK, 1994, J PHYSIOL-LONDON, V475, P359	35	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1064-8011	1533-4287		J STRENGTH COND RES	J. Strength Cond. Res.	JAN	2015	29	1					116	125				10	Sport Sciences	Sport Sciences	AY1YX	WOS:000347386800015		
J	Hirano, M; Kojima, H; Minami, H				Hirano, Masanori; Kojima, Hideo; Minami, Hideaki			Effect of Ga2O3 on Sintering and Phase Stability of Sc2O3-Doped Tetragonal Zirconia Prepared via Aqueous Solution Route	JOURNAL OF THE AMERICAN CERAMIC SOCIETY			English	Article							ELECTRICAL-CONDUCTIVITY; MECHANICAL-PROPERTIES; ALUMINA COMPOSITES; THERMAL-STABILITY; ION CONDUCTIVITY; Y-TZP; CERAMICS; TRANSFORMATION; DEGRADATION; WATER	The effects of the presence of Ga2O3 on low-temperature sintering and the phase stability of 4, 5, and 6mol% Sc2O3-doped tetragonal zirconia ceramics (4ScSZ, 5ScSZ, and 6ScSZ, respectively) were investigated. A series of zirconia sintered bodies with compositions (ZrO2)(0.99-x)(Sc2O3)(x)(Ga2O3)(0.01), x=0.04, 0.05, and 0.06 was fabricated by sintering at 1000 degrees C to 1500 degrees C for 1h using fine powders that were prepared via the combination of homogeneous precipitation method and hydrolysis technique using monoclinic zirconia sols synthesized through the forced hydrolysis of an aqueous solution of zirconium oxychloride at 100 degrees C for 168h. The presence of 1mol% Ga2O3 was effective in reducing sintering temperature necessary to fabricate dense bodies and enabled to obtain dense sintered bodies via sintering at 1100 degrees C for 1h. The phase stability, that is, low-temperature degradation behavior of the resultant zirconia ceramics was determined under hydrothermal condition. The zirconia ceramics codoped with 1mol% Ga2O3 and 6mol% Sc2O3 (1Ga6ScZ) fabricated via sintering at 1300 degrees C for 1h showed high phase stability without the appearance of monoclinic zirconia phase, that is the tetragonal-to-monoclinic phase transformation was not observed in the 1Ga6ScZ after treatment under hydrothermal condition at 150 degrees C for 30h.	[Hirano, Masanori; Kojima, Hideo; Minami, Hideaki] Aichi Inst Technol, Fac Engn, Dept Appl Chem, Toyota 4700392, Japan	Hirano, M (reprint author), Aichi Inst Technol, Fac Engn, Dept Appl Chem, Toyota 4700392, Japan.	hirano@aitech.ac.jp					GUPTA TK, 1978, J MATER SCI, V13, P1464, DOI 10.1007/BF00553200; MIZUTANI Y, 1994, SOLID STATE IONICS, V72, P271, DOI 10.1016/0167-2738(94)90158-9; LANGE FF, 1986, J AM CERAM SOC, V69, P237, DOI 10.1111/j.1151-2916.1986.tb07415.x; Byrappa K, 2007, PROG CRYST GROWTH CH, V53, P117, DOI 10.1016/j.pcrysgrow.2007.04.001; Hirano M, 2000, SOLID STATE IONICS, V133, P1, DOI 10.1016/S0167-2738(00)00706-2; Chevalier J, 1999, J AM CERAM SOC, V82, P2150; GARVIE RC, 1975, NATURE, V258, P703, DOI 10.1038/258703a0; Chevalier J, 2009, J AM CERAM SOC, V92, P1901, DOI 10.1111/j.1551-2916.2009.03278.x; YOSHIMURA M, 1987, J MATER SCI LETT, V6, P465, DOI 10.1007/BF01756800; Ota Y, 2010, J ELECTROCHEM SOC, V157, pB1707, DOI 10.1149/1.3489377; SATO T, 1985, J AM CERAM SOC, V68, P356, DOI 10.1111/j.1151-2916.1985.tb15239.x; BADWAL SPS, 1992, SOLID STATE IONICS, V53, P769, DOI 10.1016/0167-2738(92)90253-L; Guo X, 2004, CHEM MATER, V16, P3988, DOI 10.1021/cm040167h; KOBAYASHI K, 1981, SOLID STATE IONICS, V3-4, P489, DOI 10.1016/0167-2738(81)90138-7; BADWAL SPS, 1987, J MATER SCI, V22, P3231, DOI 10.1007/BF01161187; Baes Jr C.F., 1976, HYDROLYSIS CATIONS; Burgess J., 1978, METAL IONS SOLUTION, P264; STRICKLE.DW, 1965, J AM CERAM SOC, V48, P286, DOI 10.1111/j.1151-2916.1965.tb14742.x; DUH JG, 1988, J MATER SCI, V23, P2786, DOI 10.1007/BF00547451; HIRANO M, 1991, CERAM INT, V17, P359, DOI 10.1016/0272-8842(91)90034-W; Hirano M, 1999, J AM CERAM SOC, V82, P2861; Hirano M, 1997, J CERAM SOC JPN, V105, P37, DOI 10.2109/jcersj.105.37; Hirano M, 1999, J MATER SCI, V34, P1399, DOI 10.1023/A:1004583023044; Hirano M, 1998, SOLID STATE IONICS, V111, P161, DOI 10.1016/S0167-2738(98)00185-4; Hirano M, 2003, SOLID STATE IONICS, V158, P215, DOI 10.1016/S0167-2738(02)00912-8; HIRANO M, 1992, BRIT CERAM TRANS J, V91, P139; HIRANO M, 1991, J MATER SCI, V26, P5047, DOI 10.1007/BF00549890; HIRANO M, 1991, J AM CERAM SOC, V74, P606, DOI 10.1111/j.1151-2916.1991.tb04067.x; HUGHES AE, 1995, J EUR CERAM SOC, V15, P1125, DOI 10.1016/0955-2219(95)00083-7; ISHII T, 1992, SOLID STATE IONICS, V57, P153, DOI 10.1016/0167-2738(92)90078-4; KAGAWA M, 1987, J AM CERAM SOC, V70, pC212; MURASE Y, 1984, NIPPON SERAM KYO GAK, V92, P64; RUH R, 1977, J AM CERAM SOC, V60, P399, DOI 10.1111/j.1151-2916.1977.tb15521.x; SATO T, 1985, AM CERAM SOC BULL, V64, P1382; TSUKAMA K, 1985, J MATER SCI LETT, V4, P857, DOI 10.1007/BF00720523; WHALEN PJ, 1989, J AM CERAM SOC, V72, P319, DOI 10.1111/j.1151-2916.1989.tb06124.x	36	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-7820	1551-2916		J AM CERAM SOC	J. Am. Ceram. Soc.	JAN	2015	98	1					44	49		10.1111/jace.13291		6	Materials Science, Ceramics	Materials Science	AY0QQ	WOS:000347302000007		
J	Ohyanagi, M; Imai, T; Toyofuku, N; Nakagawa, D; Munir, ZA				Ohyanagi, Manshi; Imai, Takahito; Toyofuku, Naoki; Nakagawa, Daisuke; Munir, Zuhair A.			Microscopic and Spectroscopic Characterization of Stacking-Sequence Disordered SiC	JOURNAL OF THE AMERICAN CERAMIC SOCIETY			English	Article							BETA-SILICON-CARBIDE; X-RAY-DIFFRACTION; TRANSMISSION ELECTRON-MICROSCOPY; SOLID-STATE NMR; ORDER TRANSFORMATION; THIN-FILMS; CONSOLIDATION; PRESSURE; POLYTYPES; POWDER	Nanometric silicon carbide (SiC) powder (similar to 5nm) with a stacking-sequence disordered structure (SD-SiC), synthesized from elemental powders of Si and C, was investigated by microscopic and several spectroscopic methods. The structure of SD-SiC was characterized by transmission electron microscopy (TEM), C-13, and Si-29-NMR, and by infrared (IR), Raman, and X-ray photoelectron spectroscopy (XPS) methods. TEM characterizations showed relatively large deviations of the lattice parameters in the as-synthesized SiC, indicative of the presence of stacking-sequence disorder. IR analysis showed a weaker Si-C bond in the SD-SiC than in the 3C-SiC. XPS determinations showed that C and Si in SD-SiC are similar to those in 3C-SiC. Broader peaks of Si-29 and C-13 MAS-NMR also indicate that the structure of SD-SiC is different from that of 3C-SiC. Raman spectroscopy exhibited activities for the crystalline polytypes and the amorphous of SiC but lack of them for the SD-SiC. The inactivity of Raman spectroscopy for the SD-SiC along with large deviation of the lattice constant and the extremely broad X-ray diffraction peaks would indicate that SD-SiC is a possible intermediate state between conventional polytype SiC and amorphous SiC, that is, a possible new type of SiC.	[Ohyanagi, Manshi; Imai, Takahito; Toyofuku, Naoki; Nakagawa, Daisuke] Ryukoku Univ, Fac Sci & Technol, Dept Chem Mat, Otsu, Shiga 5202194, Japan; [Munir, Zuhair A.] Univ Calif Davis, Dept Chem Engn & Mat Sci, Davis, CA 95616 USA	Ohyanagi, M (reprint author), Ryukoku Univ, Fac Sci & Technol, Dept Chem Mat, Otsu, Shiga 5202194, Japan.	ohyanagi@rins.ryukoku.ac.jp			Japan Ministry of Education, Culture, Sport, Science and Technology	The authors acknowledge the partial support of this work by grant based on High-tech Research Center Program for private Universities from the Japan Ministry of Education, Culture, Sport, Science and Technology, and Professor Takahiko Nakaoki for technical supports (MO).	Yu ZR, 2001, SOL ENERG MAT SOL C, V66, P155, DOI 10.1016/S0927-0248(00)00168-9; Pimenta MA, 2007, PHYS CHEM CHEM PHYS, V9, P1276, DOI 10.1039/b613962k; CARDUNER KR, 1990, J AM CERAM SOC, V73, P2281, DOI 10.1111/j.1151-2916.1990.tb07589.x; UCHINO K, 1989, J AM CERAM SOC, V72, P1555, DOI 10.1111/j.1151-2916.1989.tb07706.x; Munir ZA, 2006, J MATER SCI, V41, P763, DOI 10.1007/s10853-006-6555-2; Powell AR, 2002, P IEEE, V90, P942, DOI 10.1109/JPROC.2002.1021560; DAVIS RF, 1991, P IEEE, V79, P677, DOI 10.1109/5.90132; Munir ZA, 2011, J AM CERAM SOC, V94, P1, DOI 10.1111/j.1551-2916.2010.04210.x; Nakashima S, 2003, J AM CERAM SOC, V86, P823; Ohyanagi M, 2004, SCRIPTA MATER, V50, P111, DOI 10.1016/j.scriptamat.2003.09.027; Tateyama H, 1997, CHEM MATER, V9, P766, DOI 10.1021/cm960471d; Wang PF, 2012, J APPL PHYS, V111, DOI 10.1063/1.3697681; YAMADA O, 1985, AM CERAM SOC BULL, V64, P319; Nakashima S, 1997, PHYS STATUS SOLIDI A, V162, P39, DOI 10.1002/1521-396X(199707)162:1<39::AID-PSSA39>3.0.CO;2-L; Anselmi-Tamburini U, 2005, J AM CERAM SOC, V88, P1382, DOI 10.1111/j.1551-2916.2005.00245.x; Chatterjee A, 2000, APPL PHYS LETT, V77, P1132, DOI 10.1063/1.1289661; DUBEY M, 1977, ACTA CRYSTALLOGR A, V33, P276, DOI 10.1107/S0567739477000692; Feng ZC, 2006, MICROELECTRON ENG, V83, P165, DOI 10.1016/j.mee.2005.10.044; FINLAY GR, 1985, J CHEM SOC CHEM COMM, P159, DOI 10.1039/c39850000159; Gaidar G. P., 2010, J THERMOELECT, V4, P11; Gubernat A, 2003, CERAM INT, V29, P961, DOI 10.1016/S0272-8842(03)00053-1; HARTMAN JS, 1987, J AM CHEM SOC, V109, P6059, DOI 10.1021/ja00254a026; Havel M., 2004, J MATER SCI, V39, P1683; Katharria YS, 2007, J NON-CRYST SOLIDS, V353, P4660, DOI 10.1016/j.jnoncrysol.2007.07.008; Kodera Y, 2006, J MATER SCI, V41, P727, DOI 10.1007/s10853-006-6501-3; MERLEMEJEAN T, 1995, J MOL STRUCT, V349, P105, DOI 10.1016/0022-2860(95)08720-G; Nagappa S, 2008, SCRIPTA MATER, V59, P995, DOI 10.1016/j.scriptamat.2008.07.010; Oh YS, 1999, J AM CERAM SOC, V82, P1076; Palosz B, 1998, MATER SCI FORUM, V278-2, P612; SHINOZAKI S, 1978, ACTA METALL MATER, V26, P769, DOI 10.1016/0001-6160(78)90027-5; SUZUKI H, 1980, J AM CERAM SOC, V63, P349, DOI 10.1111/j.1151-2916.1980.tb10741.x; WAGNER GW, 1989, J PHYS CHEM-US, V93, P5061, DOI 10.1021/j100350a012; Wang JP, 2010, APPL SURF SCI, V256, P1955, DOI 10.1016/j.apsusc.2009.10.044; Yamamoto T, 2004, J AM CERAM SOC, V87, P1436; Yamamoto T., 2004, J CERAM SOC JPN S112, V115, pS940; YOSHIDA M, 1993, PHYS REV B, V48, P10587, DOI 10.1103/PhysRevB.48.10587; Young DJ, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/11/115027	37	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-7820	1551-2916		J AM CERAM SOC	J. Am. Ceram. Soc.	JAN	2015	98	1					50	56		10.1111/jace.13280		7	Materials Science, Ceramics	Materials Science	AY0QQ	WOS:000347302000008		
J	Kobayashi, K; Kitajima, S; Igarashi, Y; Higuchi, T; Sakka, Y				Kobayashi, Kiyoshi; Kitajima, Shouta; Igarashi, Yukihito; Higuchi, Tohru; Sakka, Yoshio			Research and Development of the Coprecipitation Process for Lanthanum Germanate Oxyapatite	JOURNAL OF THE AMERICAN CERAMIC SOCIETY			English	Article							OXIDE; CONDUCTIVITIES; DIFFRACTION; GEL; SI	Although lanthanum germanate oxyapatite (La-Ge-O) has shown good potential for use as a solid electrolyte in energy storage applications, its synthesis has been challenging by either solid- or solution-state methods. In this study, a new synthesis of La-Ge-O was developed through a coprecipitation technique, in which a highly concentrated homogeneous aqueous solution of La and Ge was prepared from aqueous ammonium germanate and lanthanum nitrate solutions with the addition of dilute nitric acid. Several precipitates were formed by pH manipulation, including an amorphous material obtained at pH>3. Compared to the individual precipitation behaviors of the parent compounds, the amorphous precipitate was formed only from the aqueous two-component mixture, and appeared to contain both metals. This material was transformed into crystalline mixtures upon heating at 1273K. The crystalline phases were La2Ge3O9 and hexagonal-type GeO2 when the precipitate was formed below pH 8, and the La-Ge-O and La2Ge2O7 phases when the precipitate was formed around pH 8. Product formation from the coprecipitate was discussed based on X-ray diffraction and thermal analyses. The improved availability of La-Ge-O will allow more extensive investigations of its useful properties.	[Kobayashi, Kiyoshi; Sakka, Yoshio] Natl Inst Mat Sci, Mat Proc Unit, Tsukuba, Ibaraki 3050047, Japan; [Kobayashi, Kiyoshi; Kitajima, Shouta; Igarashi, Yukihito; Higuchi, Tohru] Tokyo Univ Sci, Dept Appl Phys, Fac Sci, Katsushika Ku, Tokyo 1258585, Japan	Kobayashi, K (reprint author), Natl Inst Mat Sci, Mat Proc Unit, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.	KOBAYASHI.kiyoshi@nims.go.jp	Higuchi, Tohru/C-6544-2012				Djerdj I, 2007, J SOLID STATE CHEM, V180, P2154, DOI 10.1016/j.jssc.2007.05.019; Leon-Reina L, 2003, CHEM MATER, V15, P2099, DOI 10.1021/cm031017u; Izumi F, 2007, SOL ST PHEN, V130, P15; Berastegui P, 2002, J SOLID STATE CHEM, V168, P294, DOI 10.1006/jssc.2002.9724; Bondar I. A., 1979, INORGANIC MAT, V15, P793; Bondar I. A., 1982, Ceramics International, V8, DOI 10.1016/0272-8842(82)90022-0; de Jesus FAA, 2010, J THERM ANAL CALORIM, V100, P537, DOI 10.1007/s10973-009-0178-1; de Jesus FAA, 2010, OPT MATER, V32, P1286, DOI 10.1016/j.optmat.2010.05.004; Frolova E, 2003, MAT SCI ENG C-BIO S, V23, P1093, DOI 10.1016/j.msec.2003.09.097; Frolova EV, 2004, SOLID STATE IONICS, V173, P125, DOI 10.1016/j.ssi.2004.09.011; Gorshkov MY, 2006, RUSS J ELECTROCHEM+, V42, P737, DOI 10.1134/S102319350607007X; Gutkina N. G., 1971, INORG MATER, V7, P1228; Haines J, 2002, J SOLID STATE CHEM, V166, P434, DOI 10.1006/jssc.2002.9625; Jarchow O, 1996, Z KRISTALLOGR, V211, P4, DOI 10.1524/zkri.1996.211.1.4; Kinnunen J, 1957, CHEM ANALYST, V46, P92; Kitajima K., 2014, CERAMIC T, V243, P103; Kobayashi K., 2014, J SOC INORG MAT JPN, V21, P296; Kobayashi K., JAP UNEXAM PAT APPL, Patent No. 2013-060333; Kobayashi K., 2008, SOLID STATE IONICS, V179, P2209; Lambert PM, 1998, INORG CHEM, V37, P1352, DOI 10.1021/ic970523g; Leon-Reina L, 2008, J SOLID STATE CHEM, V181, P2501, DOI 10.1016/j.jssc.2008.06.029; Marrero-Lopez D, 2011, FUEL CELLS, V11, P65, DOI 10.1002/fuce.201000024; McHale A. E., 1998, PHASE DIAGRAMS CERAM, P63; Orera A, 2011, FUEL CELLS, V11, P10, DOI 10.1002/fuce.201000020; Orera A, 2012, P NATL A SCI INDIA A, V82, P43, DOI 10.1007/s40010-012-0004-1; Petrova M. A., 1972, RUSS J INORG CHEM, V17, P436; Sansom JEH, 2003, SOL ST PHEN, V90-91, P189; Serezhkina SDV, 2005, J NON-CRYST SOLIDS, V351, P35, DOI [10.1016/j.jnoncrysol.2004.10.003, 10.1016/j,jnoncrysol.2004.10.003]; Tsuchel D. D., 1997, CHEM MATER, V9, P2852; Wang SF, 2013, SOLID STATE IONICS, V247, P48, DOI 10.1016/j.ssi.2013.05.018	30	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-7820	1551-2916		J AM CERAM SOC	J. Am. Ceram. Soc.	JAN	2015	98	1					66	70		10.1111/jace.13302		5	Materials Science, Ceramics	Materials Science	AY0QQ	WOS:000347302000010		
J	Cai, ZL; Wang, ZM; Wang, HH; Cheng, ZX; Li, BW; Guo, XL; Kimura, H; Kasahara, A				Cai, Zhong-Lan; Wang, Zeng-Mei; Wang, Huan-Huan; Cheng, Zhen-Xiang; Li, Bao-Wen; Guo, Xin-Li; Kimura, Hideo; Kasahara, Akira			An Investigation of the Nanomechanical Properties of 0.5Ba(Ti0.8Zr0.2)O-3-0.5(Ba0.7Ca0.3)TiO3 Thin Films	JOURNAL OF THE AMERICAN CERAMIC SOCIETY			English	Article							GRAIN-SIZE; MEMS; CERAMICS; COATINGS; ADHESION; FORCE	For practical application, the functional piezoelectric film in microelectromechanical systems should meet the requirement of physical properties, as well as the mechanical properties. In this article, 0.5Ba(Ti0.8Zr0.2)O-3-0.5(Ba0.7Ca0.3)TiO3 (0.5BZT-0.5BCT) thin films with varied properties were prepared on (100) Si substrates via a sol-gel technique at different annealing temperatures. The effects of the annealing temperature on the morphology, piezoelectricity, hardness, and elastic modulus were studied. Particular attention was paid to the surface frictional behavior of films, and the changes in the friction force can be radically explained in terms of differences in the hardness/elastic modulus ratio and the residual stress of films. And, it reveals that the higher ratio of hardness to elastic modulus and tensile residual stress can contribute to a lower friction force for 0.5BZT-0.5BCT film during sling friction.	[Cai, Zhong-Lan; Wang, Zeng-Mei; Wang, Huan-Huan; Guo, Xin-Li] Southeast Univ, Key Lab Construct Mat, Sch Mat Sci & Engn, Nanjing 211189, Jiangsu, Peoples R China; [Cheng, Zhen-Xiang] Univ Wollongong, Inst Superconducting & Elect Mat, North Wollongong, NSW 2500, Australia; [Li, Bao-Wen; Kimura, Hideo; Kasahara, Akira] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan	Wang, ZM (reprint author), Southeast Univ, Key Lab Construct Mat, Sch Mat Sci & Engn, Nanjing 211189, Jiangsu, Peoples R China.	zmwangster@gmail.com; cheng@uow.edu.au	Cheng, Zhenxiang/F-4638-2012		National Basic Research Program of China [2012CB619401]; Natural Science Foundation of China [51002029, 11134004]; GRENE (Green Network of Excellence) by Ministry of Education, Culture, Sports, Science and Technology-Japan; Australia Research Council	This work is financially sponsored in part by National Basic Research Program of China (grant no. 2012CB619401), Natural Science Foundation of China (grants no. 51002029 and 11134004). Part of this work was supported by the GRENE (Green Network of Excellence) project by Ministry of Education, Culture, Sports, Science and Technology-Japan. Z. X. Cheng thanks Australia Research Council for support through a Future Fellowship.	Liu WF, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.257602; Wang MR, 2006, MATER CHEM PHYS, V97, P219, DOI 10.1016/j.matcheinphys.2005.07.072; Spearing SM, 2000, ACTA MATER, V48, P179, DOI 10.1016/S1359-6454(99)00294-3; Agarwal R, 2007, J MICROELECTROMECH S, V16, P122, DOI 10.1109/JMEMS.2006.886010; Gao FM, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.015502; OKAZAKI K, 1973, J AM CERAM SOC, V56, P82, DOI 10.1111/j.1151-2916.1973.tb12363.x; Leyland A, 2000, WEAR, V246, P1, DOI 10.1016/S0043-1648(00)00488-9; Buscaglia V, 2006, J EUR CERAM SOC, V26, P2889, DOI 10.1016/j.jeurceramsoc.2006.02.005; BOGY DB, 1971, J APPL MECH, V38, P377; Wang ZM, 2013, J MATER CHEM C, V1, P522, DOI 10.1039/c2tc00020b; Piorra A, 2011, J APPL PHYS, V109, DOI 10.1063/1.3572056; Ledermann N, 2003, SENSOR ACTUAT A-PHYS, V105, P162, DOI 10.1016/S0924-4247(03)00090-6; Belova IV, 2003, J PHYS CHEM SOLIDS, V64, P873, DOI 10.1016/S0022-3697(02)00421-3; Domingos RF, 2009, ENVIRON SCI TECHNOL, V43, P7277, DOI 10.1021/es900249m; Pappacena KE, 2012, WEAR, V278, P62, DOI 10.1016/j.wear.2012.01.007; Patton ST, 2001, TRIBOL INT, V34, P481, DOI 10.1016/S0301-679X(01)00047-0; Bao HX, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/46/465401; Chung KH, 2007, SURF COAT TECH, V201, P7983, DOI 10.1016/j.surfcoat.2007.03.044; Jalalian A, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4867013; Jung Y. C., 2009, J VAC SCI TECHNOL A, V26, P777; Kolar D., 1980, MATER SCI RES, V13, P335; Kuczynski GC, 1949, J MET, V185, P169; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Ryan JV, 2010, INT J APPL CERAM TEC, V7, P675, DOI 10.1111/j.1744-7402.2009.02374.x; Sato K, 2003, SURF COAT TECH, V163, P135, DOI 10.1016/S0257-8972(02)00610-2; Wang WY, 2002, SENSOR ACTUAT A-PHYS, V97-8, P486, DOI 10.1016/S0924-4247(01)00821-4; Wang ZM, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4818121; Yu SH, 2006, CHEM MATER, V18, P5343, DOI 10.1021/cm052536v; Zheng XJ, 2003, ACTA MATER, V51, P3985, DOI 10.1016/S1359-6454(03)00208-8	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-7820	1551-2916		J AM CERAM SOC	J. Am. Ceram. Soc.	JAN	2015	98	1					114	118		10.1111/jace.13228		5	Materials Science, Ceramics	Materials Science	AY0QQ	WOS:000347302000017		
J	Wananuruksawong, R; Shinoda, Y; Akatsu, T; Wakai, F				Wananuruksawong, Raayaa; Shinoda, Yutaka; Akatsu, Takashi; Wakai, Fumihiro			Evolution of Microstructure and Intergranular Glass Chemistry in Plastically Deformed Nanocrystalline Si3N4 Ceramics	JOURNAL OF THE AMERICAN CERAMIC SOCIETY			English	Article							SILICON-NITRIDE CERAMICS; YTTRIUM OXYNITRIDE GLASSES; GRAIN-BOUNDARY FILMS; SUPERPLASTIC DEFORMATION; COMPRESSIVE DEFORMATION; MECHANICAL-PROPERTIES; SIALON CERAMICS; LIQUID-PHASE; BEHAVIOR; COMPOSITES	Nanograined Si3N4 ceramics with Y2O3-Al2O3-MgO as sintering additive exhibited superplastic elongation of >300% at 1923K with an initial strain rate of 5x10(-4)s(-1). Flow stress was less than 4MPa up to elongation of 130%. In the later stage of deformation, the flow stress increased with strain due to the grain growth and the alignment of elongated grains. The volume fraction of glassy phase significantly reduced due to vaporization of glassy phase. The chemical analysis by TEM/EDS revealed that the chemical composition of the near Si3N4 grain surface was different from that of the interior of the glass pocket at multigrain junctions due to absorption of additive cations on the Si3N4 grain. The chemistry of intergranular glassy phase changed significantly in the later stage of deformation accompanying the microstructural evolution. It is suggested that the flow stress, which depends on the viscosity of intergranular glassy phase, varies with the change in glass chemistry during deformation.	[Wananuruksawong, Raayaa; Shinoda, Yutaka; Akatsu, Takashi; Wakai, Fumihiro] Tokyo Inst Technol, Mat & Struct Lab, Secure Mat Ctr, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Wananuruksawong, R (reprint author), Tokyo Inst Technol, Mat & Struct Lab, Secure Mat Ctr, Midori Ku, R3-23 4259 Nagatsuta, Yokohama, Kanagawa 2268503, Japan.	wananuruksawong.r.aa@m.titech.ac.jp	WAKAI, Fumihiro/C-9658-2009; Shinoda, Yutaka/F-7502-2014	WAKAI, Fumihiro/0000-0002-8391-139X; 			Hampshire S, 2008, J EUR CERAM SOC, V28, P1475, DOI 10.1016/j.jeurceramsoc.2007.12.021; WU X, 1992, J AM CERAM SOC, V75, P2733, DOI 10.1111/j.1151-2916.1992.tb05497.x; WAKAI F, 1990, NATURE, V344, P421, DOI 10.1038/344421a0; Lemercier H, 1996, J NON-CRYST SOLIDS, V201, P128, DOI 10.1016/0022-3093(96)00147-0; Gu H, 1998, J AM CERAM SOC, V81, P3125, DOI 10.1111/j.1151-2916.1998.tb02747.x; CHEN IW, 1992, J AM CERAM SOC, V75, P1073, DOI 10.1111/j.1151-2916.1992.tb05540.x; Chihara K, 2008, MATER SCI ENG B-ADV, V148, P203, DOI 10.1016/j.mseb.2007.09.008; Gu H, 2006, MAT SCI ENG A-STRUCT, V422, P51, DOI 10.1016/j.msea.2006.01.012; HAMPSHIRE S, 1994, J EUR CERAM SOC, V14, P261, DOI 10.1016/0955-2219(94)90095-7; HWANG SL, 1994, J AM CERAM SOC, V77, P2575, DOI 10.1111/j.1151-2916.1994.tb04645.x; KLEEBE HJ, 1993, J AM CERAM SOC, V76, P1969, DOI 10.1111/j.1151-2916.1993.tb08319.x; KOHLI JT, 1992, PHYS CHEM GLASSES, V33, P73; Kondo N, 1999, MAT SCI ENG A-STRUCT, V268, P141, DOI 10.1016/S0921-5093(99)00117-3; Kondo N, 1996, MAT SCI ENG A-STRUCT, V206, P45, DOI 10.1016/0921-5093(95)09984-0; Kondo N, 1998, J AM CERAM SOC, V81, P3221, DOI 10.1111/j.1151-2916.1998.tb02759.x; Kondo N, 1998, J AM CERAM SOC, V81, P713; Nagano T, 2002, J EUR CERAM SOC, V22, P263, DOI 10.1016/S0955-2219(01)00258-8; Narimatsu E, 2006, J EUR CERAM SOC, V26, P1069, DOI 10.1016/j.jeurceramsoc.2004.11.016; Pomeroy MJ, 2003, J AM CERAM SOC, V86, P458; Rosenflanz A, 1997, J AM CERAM SOC, V80, P1341; ROUXEL T, 1992, J AM CERAM SOC, V75, P2363, DOI 10.1111/j.1151-2916.1992.tb05586.x; Rouxel T, 1997, J MATER RES, V12, P480, DOI 10.1557/JMR.1997.0070; Saito N, 2003, J AM CERAM SOC, V86, P711; SAKKA S, 1983, J NON-CRYST SOLIDS, V56, P147, DOI 10.1016/0022-3093(83)90460-X; Sun EY, 1996, J NON-CRYST SOLIDS, V208, P162, DOI 10.1016/S0022-3093(96)00510-8; TANAKA I, 1994, J AM CERAM SOC, V77, P911, DOI 10.1111/j.1151-2916.1994.tb07246.x; Testu S, 2001, ACTA MATER, V49, P3589, DOI 10.1016/S1359-6454(01)00250-6; Wananuruksawong R, 2013, INT J APPL CERAM TEC, V10, P756, DOI 10.1111/ijac.12026; Wang CM, 1996, J AM CERAM SOC, V79, P788; WANG JG, 1984, J AM CERAM SOC, V67, P399; Wasanapiarnpong T, 2006, J EUR CERAM SOC, V26, P3467, DOI 10.1016/j.jeurceramsoc.2005.10.011; Wasanapiarnpong T, 2006, J CERAM SOC JPN, V114, P733, DOI 10.2109/jcersj.114.733; Xu X, 2006, ACTA MATER, V54, P255, DOI 10.1016/j.actamat.2005.09.005; YOON CK, 1990, J AM CERAM SOC, V73, P1555, DOI 10.1111/j.1151-2916.1990.tb09796.x; Zhan GD, 2000, J AM CERAM SOC, V83, P3179	35	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-7820	1551-2916		J AM CERAM SOC	J. Am. Ceram. Soc.	JAN	2015	98	1					178	185		10.1111/jace.13259		8	Materials Science, Ceramics	Materials Science	AY0QQ	WOS:000347302000027		
J	Tu, R; Sun, QY; Zhang, S; Han, MX; Li, QZ; Hirayama, H; Zhang, LM; Goto, T				Tu, Rong; Sun, Qingyun; Zhang, Song; Han, Mingxu; Li, Qizhong; Hirayama, Hidenori; Zhang, Lianmeng; Goto, Takashi			Oxidation Behavior of ZrB2-SiC Composites at Low Pressures	JOURNAL OF THE AMERICAN CERAMIC SOCIETY			English	Article							DIBORIDE-SILICON-CARBIDE; HIGH-TEMPERATURE OXIDATION; OXYGEN PARTIAL-PRESSURE; ZIRCONIUM DIBORIDE; CERAMIC COMPOSITES; ACTIVE OXIDATION; PASSIVE TRANSITION; ATOMIC OXYGEN; DEGREES-C; IN-SITU	ZrB2-60mol%SiC composite with a eutectic microstructure was oxidized at 1573 to 1873K with reduced total pressures (P-tot) and low oxygen partial pressures (PO2). The mass change was continuously measured by a thermobalance, and then fit with a multiple paralinear model. Oxidation scale of SiO2/ZrO2+SiO2/ZrO2/ZrB2 was formed at PO2>0.13kPa, whereas only porous ZrO2 remained at PO2<0.13kPa, P-tot<1.33kPa and higher than 1773K. With increasing PO2, the parabolic oxidation constant decreased, whereas the linear oxidation constant increased.	[Tu, Rong; Sun, Qingyun; Zhang, Song; Zhang, Lianmeng] Wuhan Univ Technol, State Key Lab Adv Technol Mat Synth & Proc, Wuhan 430070, Peoples R China; [Tu, Rong; Zhang, Song; Han, Mingxu; Hirayama, Hidenori; Goto, Takashi] Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Li, Qizhong] Wuhan Univ Technol, Hubei Key Lab Adv Technol Automobile Parts, Wuhan 430070, Peoples R China	Zhang, S (reprint author), Wuhan Univ Technol, State Key Lab Adv Technol Mat Synth & Proc, 122 Luoshi Rd, Wuhan 430070, Peoples R China.	superkobe0104@gmail.com			National Natural Science Foundation of China [51102101, 51272196]; 111 Project [B13035]; Global COE program of Materials Integration, Tohoku University; WUT [2013-IV-097, 2013-VII-029, 2013-IV-115, 2013-IV-103, 303-47120002]	This work was supported by the National Natural Science Foundation of China, nos. 51102101, 51272196, and the 111 Project (B13035), and by the Global COE program of Materials Integration, Tohoku University. This research was also supported by self-determined and innovative research funds of WUT (2013-IV-097, 2013-VII-029, 2013-IV-115, 2013-IV-103, and 303-47120002).	Gao D, 2011, CORROS SCI, V53, P840, DOI 10.1016/j.corsci.2010.10.017; Ban'kovskaya IB, 2005, GLASS PHYS CHEM+, V31, P482, DOI 10.1007/s10720-005-0087-8; Wang YG, 2009, MAT SCI ENG A-STRUCT, V524, P129, DOI 10.1016/j.msea.2009.07.005; Harder B, 2013, J AM CERAM SOC, V96, P606, DOI 10.1111/jace.12104; Karlsdottir SN, 2008, J AM CERAM SOC, V91, P3652, DOI 10.1111/j.1551-2916.2008.02639.x; Han JC, 2007, SCRIPTA MATER, V57, P825, DOI 10.1016/j.scriptamat.2007.07.009; Monteverde F, 2003, J ELECTROCHEM SOC, V150, pB552, DOI 10.1149/1.1618226; Yan YJ, 2006, J AM CERAM SOC, V89, P3589, DOI 10.1111/j.1551-2916.2006.01270.x; Tian CY, 2011, CORROS SCI, V53, P3742, DOI 10.1016/j.corsci.2011.07.020; Narushima T, 1997, MATER T JIM, V38, P821; Hald H, 2003, AEROSP SCI TECHNOL, V7, P551, DOI 10.1016/S1270-9638(03)00054-3; Rezaie A, 2007, J EUR CERAM SOC, V27, P2495, DOI 10.1016/j.jeurceramsoc.2006.10.012; VAUGHN WL, 1990, J AM CERAM SOC, V73, P1540, DOI 10.1111/j.1151-2916.1990.tb09793.x; Gangireddy S, 2010, J EUR CERAM SOC, V30, P2365, DOI 10.1016/j.jeurceramsoc.2010.01.034; Li N, 2013, CORROS SCI, V73, P44, DOI 10.1016/j.corsci.2013.03.023; Wang CR, 2002, MATER CHEM PHYS, V74, P272, DOI 10.1016/S0254-0584(01)00486-2; Zhang GJ, 2000, J AM CERAM SOC, V83, P2330; Sarin P, 2010, J EUR CERAM SOC, V30, P2375, DOI 10.1016/j.jeurceramsoc.2010.03.009; Chamberlain AL, 2004, J AM CERAM SOC, V87, P1170; TRIPP WC, 1971, J ELECTROCHEM SOC, V118, P1195, DOI 10.1149/1.2408279; Opila E, 2004, J MATER SCI, V39, P5969, DOI 10.1023/B:JMSC.0000041693.32531.d1; Carney CM, 2009, J AM CERAM SOC, V92, P2046, DOI 10.1111/j.1551-2916.2009.03134.x; Han WB, 2008, J AM CERAM SOC, V91, P3328, DOI 10.1111/j.1551-2916.2008.02660.x; BALAT M, 1992, J MATER SCI, V27, P697, DOI 10.1007/BF02403882; Chamberlain AL, 2006, J AM CERAM SOC, V89, P450, DOI 10.1111/j.1551-2916.2005.00739.x; BARET G, 1991, J ELECTROCHEM SOC, V138, P2830, DOI 10.1149/1.2086066; BUTTERMA.WC, 1967, AM MINERAL, V52, P880; Chase M.W., 1986, JANAF THERMOCHEMICAL; Fahrenholtz WG, 2007, J AM CERAM SOC, V90, P143, DOI 10.1111/j.1551-2916.2006.01329.x; Gao D, 2010, CORROS SCI, V52, P3297, DOI 10.1016/j.corsci.2010.06.004; GULBRANS.EA, 1966, J ELECTROCHEM SOC, V113, P1311, DOI 10.1149/1.2423812; HINZE JW, 1976, J ELECTROCHEM SOC, V123, P1066, DOI 10.1149/1.2132997; Hu P, 2009, CORROS SCI, V51, P2724; Jacobson N, 2013, J AM CERAM SOC, V96, P838, DOI 10.1111/jace.12108; JACOBSON NS, 1990, J AM CERAM SOC, V73, P2330, DOI 10.1111/j.1151-2916.1990.tb07596.x; KOBAYASHI K, 1992, NIPPON SERAM KYO GAK, V100, P398; Marschall J, 2004, J MATER SCI, V39, P5959, DOI 10.1023/B:JMSC.0000041692.72915.e8; MROZ C, 1994, AM CERAM SOC BULL, V73, P141; NARUSHIMA T, 1993, J AM CERAM SOC, V76, P2521, DOI 10.1111/j.1151-2916.1993.tb03975.x; NARUSHIMA T, 1991, J AM CERAM SOC, V74, P2583, DOI 10.1111/j.1151-2916.1991.tb06803.x; NICKEL KG, 1994, NATO ADV SCI INST SE, V267, P59; Ordan'yan S. S., 1989, IAN SSSR NEORG MATER, V25, P1487; Ordan'yan S. S., 1989, IAN SSSR NEORG MATER, V25, P1752; Rezaie A, 2006, J AM CERAM SOC, V89, P3240, DOI 10.1111/j.1551-2916.2006.01229.x; ROGL P, 1988, CALPHAD, V12, P191, DOI 10.1016/0364-5916(88)90021-1; ROSNER DE, 1970, J PHYS CHEM-US, V74, P1829, DOI 10.1021/j100704a002; SINGH M, 1991, J AM CERAM SOC, V74, P724, DOI 10.1111/j.1151-2916.1991.tb06915.x; Tu R, 2009, KEY ENG MAT, V403, P217; Wang YG, 2012, J AM CERAM SOC, V95, P374, DOI 10.1111/j.1551-2916.2011.04945.x	49	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-7820	1551-2916		J AM CERAM SOC	J. Am. Ceram. Soc.	JAN	2015	98	1					214	222		10.1111/jace.13281		9	Materials Science, Ceramics	Materials Science	AY0QQ	WOS:000347302000032		
J	Zhang, S; Xu, QF; Tu, R; Goto, T; Zhang, LM				Zhang, Song; Xu, Qingfang; Tu, Rong; Goto, Takashi; Zhang, Lianmeng			Growth Mechanism and Defects of < 111 >-Oriented beta-SiC Films Deposited by Laser Chemical Vapor Deposition	JOURNAL OF THE AMERICAN CERAMIC SOCIETY			English	Article							PENDEO-EPITAXIAL GROWTH; HETEROEPITAXIAL GROWTH; DIAMOND FILMS; TEXTURE; MICROSTRUCTURE; SIMULATIONS; DIMENSIONS; SI(100); FACE	Two kinds of <111>-oriented -SiC films with pyramidlike and needlelike morphologies were obtained by laser chemical vapor deposition. Their mean grain size (<d>) as a function of the distance from substrate (h) follows power laws of <d> h(0.62) and <d> h(0.71), respectively. The planar defects in pyramidlike films were perpendicular to the growth direction, whereas those in needlelike -SiC films inclined to growth direction, which can be annihilated with meeting of anti-couple defect. This self-vanish of defects would develop a new approach to fabricate high quality <111>-oriented -SiC.	[Zhang, Song; Xu, Qingfang; Tu, Rong; Zhang, Lianmeng] Wuhan Univ Technol, State Key Lab Adv Technol Mat Synth & Proc, Wuhan 430070, Peoples R China; [Zhang, Song; Tu, Rong; Goto, Takashi] Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan	Tu, R (reprint author), Wuhan Univ Technol, State Key Lab Adv Technol Mat Synth & Proc, 122 Luoshi Rd, Wuhan 430070, Peoples R China.	turong@whut.edu.cn			National Natural Science Foundation of China [51102101, 51272196]; 111 Project [B13035]; Global COE program of Materials Integration, Tohoku University; Ministry of Education, Culture, Sports, Science and Technology, Japan [22246082]; Fundamental Research Funds for the Central Universities, China [WUT: 2013-IV-097, 2013-VII-029, 2013-IV-115, 2013-IV-103, 303-47120002]	This work was supported National Natural Science Foundation of China, nos. 51102101, 51272196 and the 111 Project (B13035), and in part by the Global COE program of Materials Integration, Tohoku University. This research was also supported by the Ministry of Education, Culture, Sports, Science and Technology, Japan Grant-in-Aid for Scientific Research (A), No. 22246082, and the Fundamental Research Funds for the Central Universities, China (WUT: 2013-IV-097, 2013-VII-029, 2013-IV-115, 2013-IV-103, and 303-47120002).	Abe K, 2008, THIN SOLID FILMS, V516, P637, DOI 10.1016/j.tsf.2007.06.199; CHENG C, 1988, J PHYS C SOLID STATE, V21, P1049, DOI 10.1088/0022-3719/21/6/012; WILD C, 1990, J APPL PHYS, V68, P973, DOI 10.1063/1.346663; Zhang S, 2014, J AM CERAM SOC, V97, P952, DOI 10.1111/jace.12706; YOSHINOBU T, 1992, J APPL PHYS, V72, P2006, DOI 10.1063/1.351628; Noh S, 2007, SENSOR ACTUAT A-PHYS, V136, P613, DOI 10.1016/j.sna.2006.12.024; SHIBAHARA K, 1987, APPL PHYS LETT, V50, P1888, DOI 10.1063/1.97676; Nagasawa H, 2006, CHEM VAPOR DEPOS, V12, P502, DOI 10.1002/cvde.200506466; Nagasawa H, 2002, J CRYST GROWTH, V237, P1244, DOI 10.1016/S0022-0248(01)02233-3; Fujie K, 2010, J ALLOY COMPD, V502, P238, DOI 10.1016/j.jallcom.2010.04.154; Spiecker E, 2007, ACTA MATER, V55, P3521, DOI 10.1016/j.actamat.2007.01.051; Jernigan GG, 2009, NANO LETT, V9, P2605, DOI 10.1021/nl900803z; WILD C, 1993, DIAM RELAT MATER, V2, P158, DOI 10.1016/0925-9635(93)90047-6; Hatta N, 2012, MATER SCI FORUM, V717-720, P173, DOI 10.4028/www.scientific.net/MSF.717-720.173; Chang WT, 2009, MICROSYST TECHNOL, V15, P875, DOI 10.1007/s00542-009-0836-z; Cho MS, 2007, PHYS STATUS SOLIDI C, V4, P2441, DOI 10.1002/pssc.200674845; Davis RF, 2001, J CRYST GROWTH, V225, P134, DOI 10.1016/S0022-0248(01)00836-3; KeskiKuha RAM, 1997, OPT ENG, V36, P157, DOI 10.1117/1.601128; Kikuchi H, 2005, J APPL PHYS, V98, DOI 10.1063/1.2135896; Kim BC, 2009, MATER SCI FORUM, V600-603, P219; Kim M, 2008, PHYS STATUS SOLIDI-R, V2, P13, DOI 10.1002/pssr.200701246; KITABATAKE M, 1993, J APPL PHYS, V74, P4438, DOI 10.1063/1.354385; Kumar RS, 2011, OPT ENG, V50, DOI 10.1117/1.3610987; Labrecht W. R. L., 1990, PHYS REV B, V41, P2948; Li LB, 2008, SURF INTERFACE ANAL, V40, P935, DOI 10.1002/sia.2806; Lien WC, 2010, ELECTROCHEM SOLID ST, V13, pD53, DOI 10.1149/1.3418619; Nishino K., 1983, APPL PHYS LETT, V42, P460; Paritosh D.J., 1999, ACTA MAT, V47, P2269, DOI 10.1016/S1359-6454(99)00086-5; Radmilovic V, 2007, DIAM RELAT MATER, V16, P74, DOI 10.1016/j.diamond.2006.03.017; Smereka P, 2005, ACTA MATER, V53, P1191, DOI 10.1016/j.actamat.2004.11.013; Tersoff J., 1989, MRS P, V141, P343; THIJSSEN JM, 1995, PHYS REV B, V51, P1985, DOI 10.1103/PhysRevB.51.1985; Van der Drift A., 1967, PHILIPS RES REP, V22, P267; Via F. L., 2012, J MATER RES, V28, P94; Virojanadara C, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.245403; Zhang S, 2012, J AM CERAM SOC, V95, P2782, DOI 10.1111/j.1551-2916.2012.05354.x; ZORMAN CA, 1995, J APPL PHYS, V78, P5136, DOI 10.1063/1.359745	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-7820	1551-2916		J AM CERAM SOC	J. Am. Ceram. Soc.	JAN	2015	98	1					236	241		10.1111/jace.13248		6	Materials Science, Ceramics	Materials Science	AY0QQ	WOS:000347302000035		
J	Tavakoli, AH; Armentrout, MM; Narisawa, M; Sen, S; Navrotsky, A				Tavakoli, Amir H.; Armentrout, Matthew M.; Narisawa, Masaki; Sen, Sabyasachi; Navrotsky, Alexandra			White Si-O-C Ceramic: Structure and Thermodynamic Stability	JOURNAL OF THE AMERICAN CERAMIC SOCIETY			English	Article							POLYMER-DERIVED CERAMICS; HIGH-TEMPERATURE CALORIMETRY; SILICON OXYCARBIDE GLASSES; AMORPHOUS CERAMICS; ENERGETICS; BEHAVIOR; THERMOCHEMISTRY; DIRECTIONS; PRECURSORS; NITRIDES	While pyrolysis of a polysiloxane precursor in argon typically produces a black amorphous Si-O-C ceramic containing free carbon (sp(2) carbon), pyrolyzing the same precursor in hydrogen leads to a white amorphous ceramic with a negligible amount of sp(2) carbon and a considerable hydrogen content. Si-29 magic-angle-spinning nuclear magnetic resonance (MAS NMR) spectroscopy confirms the existence of very similar bonding environments of Si atoms in the Si-O-C network for both samples. In addition, H-1 NMR spectroscopic measurements on both samples reveal that the hydrogen atoms are bonded mainly to carbon. For the thermodynamic analysis, the enthalpies of formation with respect to the most stable components (SiO2, SiC, C) of the black-and-white Si-O-C samples obtained after the pyrolysis at 1100 degrees C are determined using high-temperature oxidative drop-solution calorimetry in a molten oxide solvent. The white ceramic is 6kJ/g-atom more stable in enthalpy than the black one. Although the role of hydrogen in the thermodynamic stability of the white sample remains ambiguous, the thermodynamic findings and structural analysis suggest that the existence of sp(2)-bonded carbon in the amorphous network of polymer derived Si-O-C ceramics does not provide additional thermodynamic stability to the ceramic.	[Tavakoli, Amir H.; Armentrout, Matthew M.; Navrotsky, Alexandra] Univ Calif Davis, Peter A Rock Thermochem Lab, Davis, CA 95616 USA; [Tavakoli, Amir H.; Armentrout, Matthew M.; Navrotsky, Alexandra] Univ Calif Davis, NEAT ORU, Davis, CA 95616 USA; [Narisawa, Masaki] Osaka Prefecture Univ, Grad Sch Engn, Naka Ku, Sakai, Osaka 5998531, Japan; [Sen, Sabyasachi; Navrotsky, Alexandra] Univ Calif Davis, Dept Chem Engn & Mat Sci, Davis, CA 95616 USA	Navrotsky, A (reprint author), Univ Calif Davis, Peter A Rock Thermochem Lab, Davis, CA 95616 USA.	navea@ucdavis.edu			National Science Foundation [DMR-124077]	The authors acknowledge financial supports by the National Science Foundation, grant DMR-124077.	RENLUND GM, 1991, J MATER RES, V6, P2723, DOI 10.1557/JMR.1991.2723; Widgeon SJ, 2010, CHEM MATER, V22, P6221, DOI 10.1021/cm1021432; Colombo P, 2010, J AM CERAM SOC, V93, P1805, DOI 10.1111/j.1551-2916.2010.03876.x; SORARU GD, 1995, J AM CERAM SOC, V78, P379, DOI 10.1111/j.1151-2916.1995.tb08811.x; Tavakoli AH, 2012, ACTA MATER, V60, P4514, DOI 10.1016/j.actamat.2012.05.010; Narisawa M, 2012, B CHEM SOC JPN, V85, P724, DOI 10.1246/bcsj.20110357; Saha A, 2006, J AM CERAM SOC, V89, P2188, DOI 10.1111/j.1551-2916.2006.00920.x; Navrotsky A, 1997, PHYS CHEM MINER, V24, P222, DOI 10.1007/s002690050035; Bale C, 2002, CALPHAD, V26, P189, DOI 10.1016/S0364-5916(02)00035-4; Scarmi A, 2005, J NON-CRYST SOLIDS, V351, P2238, DOI 10.1016/j.jnoncrysol.2005.06.008; Narisawa M, 2013, SCRIPTA MATER, V69, P602, DOI 10.1016/j.scriptamat.2013.07.009; Mera G, 2013, J MATER CHEM A, V1, P3826, DOI 10.1039/c2ta00727d; Tavakoli AH, 2014, J AM CERAM SOC, V97, P303, DOI 10.1111/jace.12658; Brewer CM, 1999, J SOL-GEL SCI TECHN, V14, P49, DOI 10.1023/A:1008723813991; Varga T, 2007, J AM CERAM SOC, V90, P3213, DOI 10.1111/j.1551-2916.2007.01874.x; Colombo P, 2001, J AM CERAM SOC, V84, P2265; Cordelair J, 2000, J EUR CERAM SOC, V20, P1947, DOI 10.1016/S0955-2219(00)00068-6; Gallis S, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3482938; Liang JJ, 1999, J MATER RES, V14, P4630, DOI 10.1557/JMR.1999.0626; Liang JJ, 1999, J MATER RES, V14, P1959, DOI 10.1557/JMR.1999.0264; McHale JM, 1996, CHEM-EUR J, V2, P1514, DOI 10.1002/chem.19960021207; Monthioux M, 1996, J EUR CERAM SOC, V16, P721, DOI 10.1016/0955-2219(95)00186-7; Morcos RM, 2008, J AM CERAM SOC, V91, P2969, DOI 10.1111/j.1551-2916.2008.02543.x; Morcos RM, 2008, J AM CERAM SOC, V91, P2391, DOI 10.1111/j.1551-2916.2008.02427.x; Morcos RM, 2008, J AM CERAM SOC, V91, P3349, DOI 10.1111/j.1551-2916.2008.02626.x; NAVROTSKY A, 1977, PHYS CHEM MINER, V2, P89, DOI 10.1007/BF00307526; Navrotsky A, 2001, J ALLOY COMPD, V321, P300, DOI 10.1016/S0925-8388(01)00965-3; Robie R. A., 1995, US GEOLOGICAL SURVEY, V2131; Rouxel T, 2001, J AM CERAM SOC, V84, P1052; Zhang YH, 2006, J MATER RES, V21, P41, DOI 10.1557/JMR.2006.0033	30	5	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-7820	1551-2916		J AM CERAM SOC	J. Am. Ceram. Soc.	JAN	2015	98	1					242	246		10.1111/jace.13233		5	Materials Science, Ceramics	Materials Science	AY0QQ	WOS:000347302000036		
J	Venkatesan, R				Venkatesan, Radhika			Biosynthesis and Regulation of Herbivore-Induced Plant Volatile Emission	JOURNAL OF THE INDIAN INSTITUTE OF SCIENCE			English	Article						herbivory; jasmonates; phytohormones; plant volatile emission; terpenoids	GREEN LEAF VOLATILES; JASMONIC ACID; SIGNALING PATHWAYS; DEFENSE RESPONSES; METHYL SALICYLATE; ARABIDOPSIS-THALIANA; ISOCHORISMATE SYNTHASE; ETHYLENE BIOSYNTHESIS; TERPENE SYNTHASES; INSECT HERBIVORES	Volatile phytochemicals function as air-borne communication signals between plants and insects. Plants emit a bouquet of volatile organic compounds not only from flowers and fruits but also from vegetative tissues. Herbivore-induced plant volatiles (HIPVs) are released de novo in response to tissue damage by insects. They act as an indirect defense by attracting natural enemies of the herbivore, which sense them as sources of food and/or reproduction. Additionally, HIPVs can inhibit pathogen growth and mediate inter- and intra plant communication. HIPV emission varies with ontogeny, type of herbivore as well as environmental conditions. Plant hormones, particularly jasmonates, salicylic acid and ethylene, are implicated to play pivotal roles in the regulation of HIPV emission. Crosstalk among phytohormone signaling pathways enables fine-tuning of plant responses. This review presents biosynthesis of HIPVs and regulation by phytohormones.	RIKEN, Ctr Sustainable Resource Sci, Plant Prod Syst Res Grp, Yokohama, Kanagawa 2300045, Japan	Venkatesan, R (reprint author), RIKEN, Ctr Sustainable Resource Sci, Plant Prod Syst Res Grp, 1-7-22 Suehiro Tsurumi, Yokohama, Kanagawa 2300045, Japan.	radhika.venkatesan@riken.jp					Barrett LG, 2012, TRENDS PLANT SCI, V17, P282, DOI 10.1016/j.tplants.2012.02.009; Bruinsma M, 2009, J EXP BOT, V60, P2575, DOI 10.1093/jxb/erp101; Oyedemi SO, 2009, AFR J BIOTECHNOL, V8, P1280; Morawo T, 2014, CHEMOECOLOGY, V24, P127, DOI 10.1007/s00049-014-0154-5; Shiojiri K, 2006, P NATL ACAD SCI USA, V103, P16672, DOI 10.1073/pnas.0607780103; Argueso CT, 2007, J PLANT GROWTH REGUL, V26, P92, DOI 10.1007/s00344-007-0013-5; Kollner TG, 2008, PLANT CELL, V20, P482, DOI 10.1105/tpc.107.051672; Qu LJ, 2010, CHINESE SCI BULL, V55, P2211, DOI 10.1007/s11434-010-3245-x; van Loon LC, 2006, TRENDS PLANT SCI, V11, P184, DOI 10.1016/j.tplants.2006.02.005; Dudareva N, 2004, PLANT PHYSIOL, V135, P1893, DOI 10.1104/pp.104.049981; Ellis C, 2001, PLANT CELL, V13, P1025, DOI 10.1105/tpc.13.5.1025; El Hadi MAM, 2013, MOLECULES, V18, P8200, DOI 10.3390/molecules18078200; Bodenhausen N, 2007, MOL PLANT MICROBE IN, V20, P1406, DOI 10.1094/MPMI-20-11-1406; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; Stintzi A, 2000, P NATL ACAD SCI USA, V97, P10625, DOI 10.1073/pnas.190264497; Zhu JW, 2005, J CHEM ECOL, V31, P1733, DOI 10.1007/s10886-005-5923-8; Erb M, 2012, TRENDS PLANT SCI, V17, P250, DOI 10.1016/j.tplants.2012.01.003; Hu P, 2013, MOL CELL, V50, P504, DOI 10.1016/j.molcel.2013.04.027; Gols R, 2014, PLANT CELL ENVIRON, V37, P1741, DOI 10.1111/pce.12318; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Hemmerlin A, 2003, J BIOL CHEM, V278, P26666, DOI 10.1074/jbc.M302526200; Kessler A, 2004, SCIENCE, V305, P665, DOI 10.1126/science.1096931; Ruther J, 2005, J CHEM ECOL, V31, P2217, DOI 10.1007/s10886-005-6413-8; Ali JG, 2012, TRENDS PLANT SCI, V17, P293, DOI 10.1016/j.tplants.2012.02.006; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; Fernandez M, 2006, CRIT REV MICROBIOL, V32, P155, DOI 10.1080/10408410600880643; Santner A, 2009, NAT CHEM BIOL, V5, P301, DOI 10.1038/nchembio.165; Gomez SK, 2005, ARCH INSECT BIOCHEM, V58, P114, DOI 10.1002/arch.20037; Turner JG, 2002, PLANT CELL, V14, pS153, DOI 10.1105/tpc.000679; Allmann S, 2010, SCIENCE, V329, P1075, DOI 10.1126/science.1191634; Van Den Boom CEM, 2004, J CHEM ECOL, V30, P69, DOI 10.1023/B:JOEC.0000013183.72915.99; Engelberth J, 2004, P NATL ACAD SCI USA, V101, P1781, DOI 10.1073/pnas.0308037100; Scala A, 2013, INT J MOL SCI, V14, P17781, DOI 10.3390/ijms140917781; Dudareva N, 2006, CRIT REV PLANT SCI, V25, P417, DOI 10.1080/07352680600899973; Sasaki Y, 2001, DNA RES, V8, P153, DOI 10.1093/dnares/8.4.153; Matsui K, 2006, CURR OPIN PLANT BIOL, V9, P274, DOI 10.1016/j.pbi.2006.03.002; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; Laule O, 2003, P NATL ACAD SCI USA, V100, P6866, DOI 10.1073/pnas.1031755100; Wei JN, 2014, J EXP BOT, V65, P3289, DOI 10.1093/jxb/eru181; Pierre PS, 2011, J CHEM ECOL, V37, P368, DOI 10.1007/s10886-011-9934-3; Dicke M, 2003, BASIC APPL ECOL, V4, P27, DOI 10.1078/1439-1791-00131; van Poecke RMP, 2002, J EXP BOT, V53, P1793, DOI 10.1093/jxb/erf022; James DG, 2003, J CHEM ECOL, V29, P1601, DOI 10.1023/A:1024270713493; Irmisch S, 2013, PLANT CELL, V25, P4737, DOI 10.1105/tpc.113.118265; Boudet AM, 2007, PHYTOCHEMISTRY, V68, P2722, DOI 10.1016/j.phytochem.2007.06.012; HATANAKA A, 1993, PHYTOCHEMISTRY, V34, P1201, DOI 10.1016/0031-9422(91)80003-J; Bruce TJA, 2011, PHYTOCHEMISTRY, V72, P1605, DOI 10.1016/j.phytochem.2011.04.011; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; Heil M, 2008, NEW PHYTOL, V178, P41, DOI 10.1111/j.1469-8137.2007.02330.x; Heil M, 2007, P NATL ACAD SCI USA, V104, P5467, DOI 10.1073/pnas.0610266104; Pichersky E, 2006, SCIENCE, V311, P808, DOI 10.1126/science.1118510; Ulland S, 2008, CHEM SENSES, V33, P35, DOI 10.1093/chemse/bjm061; ODonnell PJ, 1996, SCIENCE, V274, P1914, DOI 10.1126/science.274.5294.1914; Sharkey TD, 2008, ANN BOT-LONDON, V101, P5, DOI 10.1093/aob/mcm240; Gao Y, 2012, NAT PROD REP, V29, P1153, DOI 10.1039/c2np20059g; Arimura G, 2005, BBA-MOL CELL BIOL L, V1734, P91, DOI 10.1016/j.bbalip.2005.03.001; Worrall D, 2012, NEW PHYTOL, V193, P770, DOI 10.1111/j.1469-8137.2011.03987.x; Schafer M, 2011, PLANT PHYSIOL, V156, P1520, DOI 10.1104/pp.111.173567; Abe H, 2013, PLANT PHYSIOL, V163, P1242, DOI 10.1104/pp.113.222802; Strawn MA, 2007, J BIOL CHEM, V282, P5919, DOI 10.1074/jbc.M605193200; Frost CJ, 2007, ECOL LETT, V10, P490, DOI 10.1111/j.1461-0248.2007.01043.x; Kessler A, 2006, OECOLOGIA, V148, P280, DOI 10.1007/s00442-006-0365-8; Dicke M, 2009, NAT CHEM BIOL, V5, P317, DOI 10.1038/nchembio.169; Halitschke R, 2008, ECOL LETT, V11, P24, DOI 10.1111/j.1461-0248.2007.01123.x; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; Dicke M, 2010, TRENDS PLANT SCI, V15, P167, DOI 10.1016/j.tplants.2009.12.002; Boatright J, 2004, PLANT PHYSIOL, V135, P1993, DOI 10.1104/pp.104.045468; Schmelz EA, 2003, PLANTA, V216, P665, DOI 10.1007/s00425-002-0898-y; Yang DL, 2012, P NATL ACAD SCI USA, V109, pE1192, DOI 10.1073/pnas.1201616109; Thaler JS, 2012, TRENDS PLANT SCI, V17, P260, DOI 10.1016/j.tplants.2012.02.010; Degenhardt J, 2009, P NATL ACAD SCI USA, V106, P13213, DOI 10.1073/pnas.0906365106; Baldwin IT, 2010, CURR BIOL, V20, pR392, DOI 10.1016/j.cub.2010.02.052; Bruinsma M, 2008, ENTOMOL EXP APPL, V128, P109, DOI 10.1111/j.1570-7458.2008.00695.x; Dave A., 2012, FRONT PLANT SCI, V3, P1; de Boer JG, 2004, ENTOMOL EXP APPL, V110, P181, DOI 10.1111/j.0013-8703.2004.00133.x; Dexter R, 2007, PLANT J, V49, P265, DOI 10.1111/j.1365-313X.2006.02954.x; Dicke M, 1999, J CHEM ECOL, V25, P1907, DOI 10.1023/A:1020942102181; Frost CJ, 2008, NEW PHYTOL, V180, P722, DOI 10.1111/j.1469-8137.2008.02599.x; Hettenhausen C., 2014, INSECT SCI, DOI [10.1111/1744-7917.12128, DOI 10.1111/1744-7917.12128]; Holopainen JK, 2012, ADV EXP MED BIOL, V739, P17, DOI 10.1007/978-1-4614-1704-0_2; Horiuchi J.I., 2001, FEBS LETT, V509, P332; Koeduka T., 2006, P NATL ACAD SCI USA, V103, P384; Kost C, 2006, J ECOL, V94, P619, DOI 10.1111/j.1365-2745.2006.01120.x; LEON J, 1995, P NATL ACAD SCI USA, V92, P10413, DOI 10.1073/pnas.92.22.10413; McCormick C.A., 2012, TRENDS PLANT SCI, V17, P303, DOI DOI 10.1016/J.TPLANTS.2012.03.012; Ozawa R, 2000, PLANT CELL PHYSIOL, V41, P391; Penaflor MFGV, 2013, NEOTROP ENTOMOL, V42, P331, DOI 10.1007/s13744-013-0147-z; Vasyukova NI, 2009, RUSS J PLANT PHYSL+, V56, P581, DOI 10.1134/S102144370905001X; War Abdul Rashid, 2011, Plant Signal Behav, V6, P1973, DOI 10.4161/psb.6.12.18053; Zhang PJ, 2013, NEW PHYTOL, V197, P1291, DOI 10.1111/nph.12106	92	1	1	INDIAN INST SCIENCE	BANGALORE	INDIAN INST SCIENCE, BANGALORE 560012, INDIA	0970-4140			J INDIAN I SCI	J. Indian Inst. Sci.	JAN-MAR	2015	95	1					25	34				10	Multidisciplinary Sciences	Science & Technology - Other Topics	AY6JJ	WOS:000347672400003		
J	Watanabe, Y; Yoshida, C; Atsumi, K; Yamada, M; Fukumoto, M				Watanabe, Yuta; Yoshida, Chisato; Atsumi, Keisuke; Yamada, Motohiro; Fukumoto, Masahiro			Influence of Substrate Temperature on Adhesion Strength of Cold-Sprayed Coatings	JOURNAL OF THERMAL SPRAY TECHNOLOGY			English	Article						adhesive strength; coefficient of thermal expansion; cold spray; preheating of substrate; thermal stress	DEPOSITION; MECHANISM; COPPER	Cold spraying is a promising process for fabricating functional coatings. Because of solid state particle deposition, the electrical and chemical properties of cold-sprayed coatings are almost similar to the bulk materials. The most important factor in depositing a particle through cold spraying is known as the critical velocity. When the particle velocity is beyond the critical velocity, the plastic deformation of both the sprayed metallic particle and the metallic substrate causes the removal of surface oxide layers and newly-formed surfaces are exposed. The newly-formed surface yields the metallic bond, and then cold spray deposition can occur. Therefore, the substrate conditions must also be considered in order to understand the cold spray process. In this study, the influence of substrate temperature on the adhesion strength of coatings was investigated by substrate pre-heating. The adhesion strength was examined by a shear adhesion test. This showed that substrate pre-heating enhances the adhesion strength with a specific combination of coating and substrate materials. Thermal stress and substrate surface oxidation have been suggested ss the causes of these.	[Watanabe, Yuta; Yoshida, Chisato; Atsumi, Keisuke; Yamada, Motohiro; Fukumoto, Masahiro] Toyohashi Univ Technol, Toyohashi, Aichi 4418580, Japan	Watanabe, Y (reprint author), Toyohashi Univ Technol, 1-1 Tempaku Cho, Toyohashi, Aichi 4418580, Japan.	yuta@isf.me.tut.ac.jp					Schmidt T, 2009, J THERM SPRAY TECHN, V18, P794, DOI 10.1007/s11666-009-9357-7; Gartner F, 2006, J THERM SPRAY TECHN, V15, P223, DOI 10.1361/105996306X108110; Fukumoto M, 2007, J THERM SPRAY TECHN, V16, P643, DOI 10.1007/s11666-007-9121-9; Spencer K, 2012, SURF COAT TECH, V206, P4249, DOI 10.1016/j.surfcoat.2012.04.034; Assadi H, 2003, ACTA MATER, V51, P4379, DOI [10.1016/S1359-6454(03)00274-X, 10.1016/S1359-6465(03)00274-X]; Van Steenkiste TH, 1999, SURF COAT TECH, V111, P62, DOI 10.1016/S0257-8972(98)00709-9; Luzin V, 2011, ACTA MATER, V59, P1259, DOI 10.1016/j.actamat.2010.10.058; Schmidt T, 2006, ACTA MATER, V54, P729, DOI 10.1016/j.actamat.2005.10.005; Ghelichi R., 2009, J FRATTURA INTEGRITA, V8, P30; Legoux JG, 2007, J THERM SPRAY TECHN, V16, P619, DOI 10.1007/s11666-007-9091-y; Nakano H, 2011, J THERM SPRAY TECHN, V20, P407, DOI 10.1007/s11666-010-9522-z; Papyrin A., 2007, DISCOVERY COLD SPRAY, P1	12	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1059-9630	1544-1016		J THERM SPRAY TECHN	J. Therm. Spray Technol.	JAN	2015	24	1-2					86	91		10.1007/s11666-014-0165-3		6	Materials Science, Coatings & Films	Materials Science	AY2JS	WOS:000347416800011		
J	List, A; Gartner, F; Mori, T; Schulze, M; Assadi, H; Kuroda, S; Klassen, T				List, A.; Gaertner, F.; Mori, T.; Schulze, M.; Assadi, H.; Kuroda, S.; Klassen, T.			Cold Spraying of Amorphous Cu50Zr50 Alloys	JOURNAL OF THERMAL SPRAY TECHNOLOGY			English	Article						amorphous structures; bulk metallic glass (BMG) alloy; cold gas dynamic spraying; mechanical properties; new materials; spray parameters; window of deposition	BULK METALLIC-GLASS; CU-ZR; SHEAR BANDS; BEHAVIOR; CRYSTALLIZATION; DEPOSITION; GAS	A new range of applications in cold spraying is expected for bulk metallic glass (BMG) coatings. For retaining amorphous structures in cast multi-component BMG parts, typically high purity raw material must be used. The present investigation explores an alternative approach, where cold spraying is used to deposit a technical-grade binary amorphous alloy. This approach is shown to be potentially cost-effective and suitable for rapid manufacturing. For this purpose, amorphous Cu50Zr50 was chosen as a model alloy system, and cold spraying was performed using nitrogen as process gas. By a systematic variation of the spray parameter sets, the critical velocities for coating formation were determined experimentally. Based on the current models of bonding of amorphous Cu50Zr50 powder in cold spraying, a new, more comprehensive concept of bonding and rebound is presented, which also considers the presence of liquefied interfaces and quenching rates for resolidification. Results concerning impact morphologies and coating formation demonstrate that under suitable choice of spray conditions, well-adhering coatings with amorphous structure of the Cu50Zr50 powders can be obtained by cold spraying.	[List, A.; Gaertner, F.; Schulze, M.; Assadi, H.; Klassen, T.] Univ Fed Armed Forces, Helmut Schmidt Univ, Hamburg, Germany; [Mori, T.; Kuroda, S.] Natl Inst Mat Sci, Tsukuba, Ibaraki, Japan	List, A (reprint author), Univ Fed Armed Forces, Helmut Schmidt Univ, Hamburg, Germany.	list@hsu-hh.de	Gaertner, Frank/K-2905-2014; Klassen, Thomas/H-3393-2012; Kuroda, Seiji/E-8587-2010; 	Gaertner, Frank/0000-0002-6757-5605; Klassen, Thomas/0000-0002-9521-3273; Assadi, Hamid/0000-0001-5327-1793			Concustell A, 2005, INTERMETALLICS, V13, P1214, DOI 10.1016/j.intermet.2005.04.003; Greer AL, 2013, MAT SCI ENG R, V74, P71, DOI 10.1016/j.mser.2013.04.001; Lewandowski JJ, 2006, NAT MATER, V5, P15, DOI 10.1038/nmat1536; Schroers J, 2009, JOM-US, V61, P21, DOI 10.1007/s11837-009-0128-1; Schmidt T, 2009, J THERM SPRAY TECHN, V18, P794, DOI 10.1007/s11666-009-9357-7; Inoue A, 2000, ACTA MATER, V48, P279, DOI 10.1016/S1359-6454(99)00300-6; ALTOUNIAN Z, 1982, J APPL PHYS, V53, P4755, DOI 10.1063/1.331304; Schroers J, 2001, ACTA MATER, V49, P2773, DOI 10.1016/S1359-6454(01)00159-8; Yoon S, 2006, SURF COAT TECH, V200, P6022, DOI 10.1016/j.surfcoat.2005.09.022; List A, 2012, J THERM SPRAY TECHN, V21, P531, DOI 10.1007/s11666-012-9750-5; Yoon S, 2007, MAT SCI ENG A-STRUCT, V449, P911, DOI 10.1016/j.msea.2006.02.433; Assadi H, 2011, J THERM SPRAY TECHN, V20, P1161, DOI 10.1007/s11666-011-9662-9; Schmidt T, 2006, J THERM SPRAY TECHN, V15, P488, DOI 10.1361/105996306X147144; Assadi H, 2003, ACTA MATER, V51, P4379, DOI [10.1016/S1359-6454(03)00274-X, 10.1016/S1359-6465(03)00274-X]; Schmidt T, 2006, ACTA MATER, V54, P729, DOI 10.1016/j.actamat.2005.10.005; Wang WH, 2004, MAT SCI ENG R, V44, P45, DOI 10.1016/j.mser.2004.03.001; KLEMENT W, 1960, NATURE, V187, P869, DOI 10.1038/187869b0; Schuh CA, 2007, ACTA MATER, V55, P4067, DOI 10.1016/j.actamat.2007.01.052; Miracle DB, 2011, ACTA MATER, V59, P2831, DOI 10.1016/j.actamat.2011.01.022; Lee SW, 2006, ACTA MATER, V54, P349, DOI 10.1016/j.actamat.2005.09.007; Pauly S, 2009, ACTA MATER, V57, P5445, DOI 10.1016/j.actamat.2009.07.042; Aschby M.F., 2006, SCRIPTA MATER, V54, P321; FRITSCH G, 1988, NATURWISSENSCHAFTEN, V75, P551, DOI 10.1007/BF00377718; Gallino I., 2010, J APPL PHYS, V108; Heinrich J, 2012, INTERMETALLICS, V25, P1, DOI 10.1016/j.intermet.2012.02.011; Inoue A, 1996, MATER T JIM, V37, P181; Kwon OJ, 2007, MAT SCI ENG A-STRUCT, V449, P169, DOI 10.1016/j.msea.2006.02.298; Schroers J, 2005, JOM-US, V57, P35, DOI 10.1007/s11837-005-0093-2; Schroers J, 2006, ADV MATER PROCESS, V164, P61; Stier O, 2014, J THERM SPRAY TECHN, V23, P131, DOI 10.1007/s11666-013-9972-1; Yoon S, 2011, J ALLOY COMPD, V509, P347, DOI 10.1016/j.jallcom.2010.09.024	31	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1059-9630	1544-1016		J THERM SPRAY TECHN	J. Therm. Spray Technol.	JAN	2015	24	1-2					108	118		10.1007/s11666-014-0187-x		11	Materials Science, Coatings & Films	Materials Science	AY2JS	WOS:000347416800014		
J	Hamahashi, K; Sato, M; Yamato, M; Kokubo, M; Mitani, G; Ito, S; Nagai, T; Ebihara, G; Kutsuna, T; Okano, T; Mochida, J				Hamahashi, K.; Sato, M.; Yamato, M.; Kokubo, M.; Mitani, G.; Ito, S.; Nagai, T.; Ebihara, G.; Kutsuna, T.; Okano, T.; Mochida, J.			Studies of the humoral factors produced by layered chondrocyte sheets	JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE			English	Article						articular cartilage; chondrocyte sheet; co-culture; enzyme-linked immunosorbent assay; humoral factor; scanning electron microscopy; temperature-responsive culture dish	RESPONSIVE CULTURE DISHES; HUMAN ARTICULAR CHONDROCYTES; CELL-CULTURE; CARTILAGE DEFECTS; SYNOVIAL-FLUID; TGF-BETA; TEMPERATURE; GRAFTS; EXPRESSION; TRANSPLANTATION	The authors aimed to repair and regenerate articular cartilage with layered chondrocyte sheets, produced using temperature-responsive culture dishes. The purpose of this study was to investigate the humoral factors produced by layered chondrocyte sheets. Articular chondrocytes and synovial cells were harvested during total knee arthroplasty. After co-culture, the samples were divided into three groups: a monolayer, 7day culture sheet group (group M); a triple-layered, 7day culture sheet group (group L); and a monolayer culture group with a cell count identical to that of group L (group C). The secretion of collagen type 1 (COL1), collagen type 2 (COL2), matrix metalloproteinase-13 (MMP13), transforming growth factor- (TGF), melanoma inhibitory activity (MIA) and prostaglandin E2 (PGE2) were measured by enzyme-linked immunosorbent assay (ELISA). Layered chondrocyte sheets produced the most humoral factors. PGE2 expression declined over time in group C but was significantly higher in groups M and L. TGF expression was low in group C but was significantly higher in groups M and L (p<0.05). Our results suggest that the humoral factors produced by layered chondrocyte sheets may contribute to cartilaginous tissue repair and regeneration. Copyright (c) 2012 John Wiley & Sons, Ltd.	[Hamahashi, K.; Sato, M.; Kokubo, M.; Mitani, G.; Ito, S.; Nagai, T.; Ebihara, G.; Kutsuna, T.; Mochida, J.] Tokai Univ, Sch Med, Dept Orthopaed Surg, Isehara, Kanagawa 2591193, Japan; [Yamato, M.; Okano, T.] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan	Sato, M (reprint author), Tokai Univ, Sch Med, Dept Orthopaed Surg, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	sato-m@is.icc.u-tokai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labour and Welfare of Japan	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, and Health and Labour Sciences Research Grants 'Research on Regenerative Medicine for Clinical Application' from the Ministry of Health, Labour and Welfare of Japan.	Kushida A, 2000, J BIOMED MATER RES, V51, P216, DOI 10.1002/(SICI)1097-4636(200008)51:2<216::AID-JBM10>3.0.CO;2-K; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Peterson L, 2003, J BONE JOINT SURG AM, V85A, P17; Ebihara G, 2012, BIOMATERIALS, V33, P3846, DOI 10.1016/j.biomaterials.2012.01.056; Nagai T, 2008, TISSUE ENG PT A, V14, P1183, DOI 10.1089/tea.2007.0114; Kaneshiro N, 2006, BIOCHEM BIOPH RES CO, V349, P723, DOI 10.1016/j.bbrc.2006.08.096; Nishida K, 2004, TRANSPLANTATION, V77, P379, DOI 10.1097/01.TP.0000110320.45678.30; OKANO T, 1993, J BIOMED MATER RES, V27, P1243, DOI 10.1002/jbm.820271005; Schnabel M, 2002, OSTEOARTHR CARTILAGE, V10, P62, DOI 10.1053/joca.2001.0482; Yamato M, 2001, TISSUE ENG, V7, P473, DOI 10.1089/10763270152436517; Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722; Roman-Blas JA, 2007, OSTEOARTHR CARTILAGE, V15, P1367, DOI 10.1016/j.joca.2007.04.011; Aoyama T, 2005, J BONE MINER RES, V20, P377, DOI 10.1359/JBMR.041122; Sekiya S, 2006, BIOCHEM BIOPH RES CO, V341, P573, DOI 10.1016/j.bbrc.2005.12.217; Nagai T, 2008, TISSUE ENG PT A, V14, P1225, DOI 10.1089/ten.tea.2007.0225; Pujol JP, 2008, CONNECT TISSUE RES, V49, P293, DOI 10.1080/03008200802148355; Harimoto M, 2002, J BIOMED MATER RES, V62, P464, DOI 10.1002/jbm.10228; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; OKANO T, 1995, BIOMATERIALS, V16, P297, DOI 10.1016/0142-9612(95)93257-E; Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Shimizu T, 2006, FASEB J, V20, P708, DOI 10.1096/fj.05-4715fje; Davidson ENB, 2006, ANN RHEUM DIS, V65, P1414, DOI 10.1136/ard.2005.045971; Ckarks JM, 1990, J ANAT, V171; Hangody L, 1997, ORTHOP INT, V5, P175; Hangody L, 2001, CLIN ORTHOP S, V391, P328; Itos S, 2012, BIOMATERIALS, V33, P5278; Kaneshiro N, 2007, EUR CELLS MATER, V13, P87; Kims KS, 2010, RHEUMATOL INT, V28, P543; Lehmann LJ, 2010, Z ORTHOP UNFALLCHIR, V148, P90, DOI 10.1055/s-0029-1186112; MACCONAILL MA, 1951, J BONE JOINT SURG BR, V33, P251; Mitani G, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-17; Mithoefer Kai, 2006, J Bone Joint Surg Am, V88 Suppl 1 Pt 2, P294, DOI 10.2106/JBJS.F.00292; Nishitani K, 2010, J CELL BIOCHEM, V109, P425, DOI 10.1002/jcb.22421; PAGET J, 1969, CLIN ORTHOP RELAT R, P7; Redman S N, 2005, Eur Cell Mater, V9, P23; Saito S, 2002, J BONE JOINT SURG BR, V84B, P1066, DOI 10.1302/0301-620X.84B7.12177; Schubert T, 2010, EXP MOL MED, V42, P166, DOI 10.3858/emm.2010.42.3.017; Steadman J. R., 2001, CLIN ORTHOP RELAT R, V391, P362, DOI DOI 10.1097/00003086-200110001-00033; Steadman J Richard, 2002, J Knee Surg, V15, P170; Szerb Imre, 2005, Bull Hosp Jt Dis, V63, P54	40	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-6254	1932-7005		J TISSUE ENG REGEN M	J. Tissue Eng. Regen. Med.	JAN	2015	9	1					24	30		10.1002/term.1610		7	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Engineering, Biomedical	Cell Biology; Biotechnology & Applied Microbiology; Engineering	AY3AW	WOS:000347457900003		
J	Parajuli, RP; Fujiwara, T; Umezaki, M; Watanabe, C				Parajuli, Rajendra Prasad; Fujiwara, Takeo; Umezaki, Masahiro; Watanabe, Chiho			Home environment and cord blood levels of lead, arsenic, and zinc on neurodevelopment of 24 months children living in Chitwan Valley, Nepal	JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY			English	Article						Neurodevelopment; Bayley scale; Nepal; Toxic and essential elements; HOME scale	EARLY COGNITIVE-DEVELOPMENT; NEUROBEHAVIORAL DEVELOPMENT; MOTOR DEVELOPMENT; EARLY-CHILDHOOD; BIRTH COHORT; NEUROPSYCHOLOGICAL DEVELOPMENT; INFANT NEURODEVELOPMENT; PSYCHOMOTOR DEVELOPMENT; INTELLECTUAL FUNCTION; MENTAL-DEVELOPMENT	In a birth cohort living in Chitwan Valley, lowland Nepal, we have previously reported inverse associations between in utero levels of lead (Pb), arsenic (As) and neurodevelopment at birth measured by the Brazelton Neonatal Behavioral Assessment Scale, third edition (NBAS III). In the present paper, a follow-up of the same cohort was made on 24-month-old infants regarding the neurodevelopmental effects of these metals, taking the postnatal environment into account. In total, the same100 mother-infant pairs as the previous study, whose Pb, As, and Zn concentrations in cord blood were known, were recruited. Postnatal raising environment was evaluated using the Home Observation for Measurement of Environment (HOME) scale. Neurodevelopment of children at 24 months of age (n = 74) was assessed using the Bayley Scale of Infant Development, Second Edition (BSID II). Multivariable regression adjusting for covariates was performed to determine the associations of in utero levels of toxic and essential elements and the home environment with neurodevelopment scores. Unlike the NBAS III conducted for newborns, none of the BSID II cluster scores in 24-month-old infants were associated with cord blood levels of Pb, As, and Zn. The total HOME score was positively associated with the mental development scale (MDI) score (coefficient= 0.67, at 95% CI= 0.03 to 1.31). In this cohort, a detrimental effect of in utero Pb and As on neurodevelopmental indicators observed at birth disappeared at 24 months, while an association between neurodevelopment and home environment continued. (C) 2014 Elsevier GmbH. All rights reserved.	[Parajuli, Rajendra Prasad; Umezaki, Masahiro; Watanabe, Chiho] Univ Tokyo, Dept Human Ecol, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; [Parajuli, Rajendra Prasad] Int Inst Child Rights & Dev, Victoria, BC V8W 3S2, Canada; [Fujiwara, Takeo] Natl Res Inst Child Hlth & Dev, Dept Social Med, Setagaya Ku, Tokyo 1578535, Japan	Parajuli, RP (reprint author), Univ Tokyo, Dept Human Ecol, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	parajulirp@humeco.m.u-tolcyo.ac.jp		Parajuli, Rajendra/0000-0002-4899-7212	Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Society for the Promotion of Science (JSPS) (KAKENHI) [20310146]	This study did not have any relationships or support which might be perceived as constituting a conflict of interest. This study was funded by the Grant-in-Aid for Scientific Research by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and the Japan Society for the Promotion of Science (JSPS) (KAKENHI project number: 20310146).	Al-Saleh I, 2009, J ENVIRON PATHOL TOX, V28, P283; DIETRICH KN, 1990, ENVIRON HEALTH PERSP, V89, P13, DOI 10.2307/3430891; Tamura T, 2003, AM J CLIN NUTR, V77, P1512; Bulas D, 2005, SEMIN PERINATOL, V29, P58, DOI 10.1053/j.semperi.2005.02.009; Tofail F, 2009, ENVIRON HEALTH PERSP, V117, P288, DOI 10.1289/ehp.11670; LOZOFF B, 1995, INT J BEHAV DEV, V18, P277; Black MM, 2004, AM J CLIN NUTR, V80, P903; Hamadani JD, 2011, INT J EPIDEMIOL, V40, P1593, DOI 10.1093/ije/dyr176; Torres-Sanchez L, 2007, ENVIRON HEALTH PERSP, V115, P435, DOI 10.1289/ehp.9566; Ribas-Fito N, 2003, PEDIATRICS, V111, pE580, DOI 10.1542/peds.111.5.e580; Surkan PJ, 2008, NEUROTOXICOLOGY, V29, P278, DOI 10.1016/j.neuro.2007.11.006; Calderon J, 2001, ENVIRON RES, V85, P69, DOI 10.1006/enrs.2000.4106; Hu H, 2006, ENVIRON HEALTH PERSP, V114, P1730, DOI 10.1289/ehp.9067; Henn BC, 2012, ENVIRON HEALTH PERSP, V120, P126, DOI 10.1289/ehp.1003300; WIGG NR, 1988, J EPIDEMIOL COMMUN H, V42, P213, DOI 10.1136/jech.42.3.213; von Ehrenstein OS, 2007, EPIDEMIOLOGY, V18, P44, DOI 10.1097/01.ede.0000248900.65613.a9; Hamadani JD, 2010, INT J EPIDEMIOL, V39, P1206, DOI 10.1093/ije/dyp369; Eskenazi B, 2006, PEDIATRICS, V118, P233, DOI 10.1542/peds.2005-3117; BELLINGER D, 1987, NEW ENGL J MED, V316, P1037, DOI 10.1056/NEJM198704233161701; Walkowiak J, 2001, LANCET, V358, P1602, DOI 10.1016/S0140-6736(01)06654-5; Badr LK, 2009, EARLY HUM DEV, V85, P279, DOI 10.1016/j.earlhumdev.2008.11.005; Wright RO, 2006, NEUROTOXICOLOGY, V27, P210, DOI 10.1016/j.neuro.2005.10.001; Jedrychowski W, 2009, EARLY HUM DEV, V85, P503, DOI 10.1016/j.earlhumdev.2009.04.006; Tian LL, 2009, BIOL TRACE ELEM RES, V132, P51, DOI 10.1007/s12011-009-8391-0; Tellez-Rojo MM, 2006, PEDIATRICS, V118, pE323, DOI 10.1542/peds.2005-3123; Jedrychowski W, 2009, NEUROEPIDEMIOLOGY, V32, P270, DOI 10.1159/000203075; Parajuli RP, 2013, ENVIRON RES, V121, P45, DOI 10.1016/j.envres.2012.10.010; Torres-Sanchez L, 2009, NEUROTOXICOLOGY, V30, P1162, DOI 10.1016/j.neuro.2009.08.010; Factor-Litvak P, 1999, ENVIRON HEALTH PERSP, V107, P9, DOI 10.2307/3434284; Concha G, 1998, INT ARCH OCC ENV HEA, V71, P42, DOI 10.1007/s004200050248; Parajuli RP, 2012, BIOL TRACE ELEM RES, V147, P75, DOI 10.1007/s12011-011-9309-1; Austin AMB, 2006, J RES CHILD ED, V20, P255; Badr Zahr LK, 2001, APPL NURS RES, V14, P125; Baker-Henningham H, 2009, J NUTR, V139, P1765, DOI 10.3945/jn.109.106294; Bayley N., 1993, BAYLEY SCALES INFANT; Black MM, 2004, PEDIATRICS, V113, P1297, DOI 10.1542/peds.113.5.1297; Black MM, 2000, J APPL DEV PSYCHOL, V21, P655, DOI 10.1016/S0193-3973(00)00059-9; Caldwell B. M., 1984, HOME OBSERVATION MEA; CDC, 2012, IMP MIL YOUR CHILD 2; Claus Henn B., 2011, ENV HLTH PERSPECT, V120, P126; Dakeishi Miwako, 2006, Environ Health, V5, P31, DOI 10.1186/1476-069X-5-31; DREHER MC, 1994, PEDIATRICS, V93, P254; Hamadani JD, 2010, FOOD NUTR BULL, V31, pS198; Hutton JL, 1997, ARCH DIS CHILD, V76, pF75; Janssen AJWM, 2008, DEV MED CHILD NEUROL, V50, P926, DOI 10.1111/j.1469-8749.2008.03108.x; Jedrychowski W, 2010, PEDIAT ALLERG IMM-UK, V21, P550, DOI 10.1111/j.1399-3038.2009.00905.x; Jedrychowski W, 2007, ENVIRON INT, V33, P1057, DOI 10.1016/j.envint.2007.06.001; Parajuli RP, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-56; Rocha-Amador D, 2007, CAD SAUDE PUBLICA S4, V23, pS579; Sandstead HH, 1998, AM J CLIN NUTR, V68, p470S; Shen XM, 1998, ENVIRON RES, V79, P1, DOI 10.1006/enrs.1998.3851; Simic N, 2009, THYROID, V19, P395, DOI 10.1089/thy.2008.0282; Taneja S, 2005, J PEDIATR-US, V146, P506, DOI 10.1016/j.jpeds.2004.10.061; WANG JD, 1989, AM J IND MED, V15, P111, DOI 10.1002/ajim.4700150112; Wasserman GA, 2004, ENVIRON HEALTH PERSP, V112, P1329, DOI 10.1289/ehp.6964; Wu YT, 2008, J PEDIATR PSYCHOL, V33, P102, DOI 10.1093/jpepsy/jsm067	56	1	1	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0946-672X			J TRACE ELEM MED BIO	J. Trace Elem. Med. Biol.		2015	29						315	320		10.1016/j.jtemb.2014.08.006		6	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	AY3QO	WOS:000347498000042		
J	Kobayashi, K; Hikone, M; Sakamoto, N; Iwabuchi, S; Kashiura, M; Takasaki, T; Fujita, H; Ohnishi, K				Kobayashi, Ken-ichiro; Hikone, Mayu; Sakamoto, Naoya; Iwabuchi, Sentaro; Kashiura, Masahiro; Takasaki, Tomohiko; Fujita, Hiroshi; Ohnishi, Kenji			Dengue-Associated Hemophagocytic Syndrome in a Japanese Traveler: A Case Report	JOURNAL OF TRAVEL MEDICINE			English	Article							HEMORRHAGIC-FEVER	Hemophagocytic syndrome (HPS) can develop as a complication of dengue in rare cases, but its relationship with dengue is not well known. We report a case of dengue-associated HPS with liver involvement and coagulopathy. The patient, a Japanese female traveler who had recently returned from Thailand, had severe complications of dengue infection, but she recovered fully with symptomatic treatment.	[Kobayashi, Ken-ichiro; Hikone, Mayu; Sakamoto, Naoya; Iwabuchi, Sentaro; Ohnishi, Kenji] Tokyo Metropolitan Bokutoh Gen Hosp, Dept Infect Dis, Sumida City, Tokyo 130022, Japan; [Kashiura, Masahiro] Tokyo Metropolitan Bokutoh Gen Hosp, Dept Emergency, Sumida City, Tokyo 130022, Japan; [Kashiura, Masahiro] Tokyo Metropolitan Bokutoh Gen Hosp, Crit Care Ctr, Sumida City, Tokyo 130022, Japan; [Takasaki, Tomohiko] Natl Inst Infect Dis, Dept Virol 1, Tokyo, Japan; [Fujita, Hiroshi] Tokyo Metropolitan Bokutoh Gen Hosp, Dept Transfus Med, Sumida City, Tokyo 130022, Japan	Kobayashi, K (reprint author), Tokyo Metropolitan Bokutoh Gen Hosp, Dept Infect Dis, 4-23-15 Koutohbashi, Sumida City, Tokyo 130022, Japan.	simr355@yahoo.co.jp					Carlos CC, 2005, AM J TROP MED HYG, V73, P435; Tan LH, 2012, J CLIN VIROL, V55, P79, DOI 10.1016/j.jcv.2012.06.005; Henter JI, 2007, PEDIATR BLOOD CANCER, V48, P124, DOI 10.1002/pbc.21039; Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327; desSouza LJ, 2007, BRAZ J INFECT DIS, V11, P407; Nakamura Itaru, 2009, Kansenshogaku Zasshi, V83, P60; Sam SS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002194; Souza Luiz José de, 2004, Braz J Infect Dis, V8, P156; Vijayalakshmi AM, 2009, INDIAN PEDIATR, V46, P545; Wills Bridget, 2009, Am J Trop Med Hyg, V81, P638, DOI 10.4269/ajtmh.2009.08-0008	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1195-1982	1708-8305		J TRAVEL MED	J. Travel Med.	JAN-FEB	2015	22	1					64	66		10.1111/jtm.12158		3	Medicine, General & Internal	General & Internal Medicine	AY1DX	WOS:000347334800010		
J	Inoue, M; Kihara, K; Yoshida, S; Ito, M; Takeshita, H; Ishioka, J; Matsuoka, Y; Numao, N; Saito, K; Fujii, Y				Inoue, Masaharu; Kihara, Kazunori; Yoshida, Soichiro; Ito, Masaya; Takeshita, Hideki; Ishioka, Junichiro; Matsuoka, Yoh; Numao, Noboru; Saito, Kazutaka; Fujii, Yasuhisa			A Novel Approach to Patient Self-Monitoring of Sonographic Examinations Using a Head-Mounted Display	JOURNAL OF ULTRASOUND IN MEDICINE			English	Article						clinical utility; head-mounted display; patient-centered care; sonography	SHARED DECISION-MAKING; CENTERED CARE; ULTRASONOGRAPHY; PERFORMANCE; CANCER; ULTRASOUND; SURGERY	Objectives Patients' use of a head-mounted display during their sonographic examinations could provide them with information about their diseases in real time and might help improve "patient-centered care." We conducted this prospective study to evaluate the feasibility of a modern head-mounted display for patient self-monitoring of sonographic examinations. Methods In November and December 2013, 58 patients were enrolled. Patients wore ahead-mounted display (HMZ-T2; Sony Corporation) Tokyo, Japan) during their sonographic examinations and watched their own images in real time. After the sonographic examinations, the patients completed a questionnaire, in which they evaluated the utility of the head-mounted display, their understanding of their diseases, their satisfaction with using the head-mounted display, and any adverse events. Until November 26, 2013, patients' names were requested on the questionnaire; after that date, the questionnaire was changed to be anonymous. Results Of the 58 patients, 56 (97%) elected to participate in this study. The head-mounted display was reported to have good image quality by 42 patients (75%) and good wearability by 39(70%). Thirty-six patients (64%) reported they had deepened their understanding of their diseases. There were no major complications, and only 2 patients (4%) had mild eye fatigue. There was no significant association between questionnaire results and patient characteristics. None of the questionnaire results changed significantly after the questionnaire was made anonymous. Conclusions The use of a modern head-mounted display by patients during sonographic examinations provided good image qualitywith acceptable wearability. It could deepen their understanding of their diseases and help develop patient-centered care.	[Inoue, Masaharu; Kihara, Kazunori; Yoshida, Soichiro; Ito, Masaya; Takeshita, Hideki; Ishioka, Junichiro; Matsuoka, Yoh; Numao, Noboru; Saito, Kazutaka; Fujii, Yasuhisa] Tokyo Med & Dent Univ, Dept Urol, Grad Sch, Bunkyo Ku, Tokyo 1138519, Japan; [Kihara, Kazunori; Ishioka, Junichiro] Tokyo Med & Dent Univ, Univ Hosp Med, Ctr Minimally Invas Surg, Tokyo 1138519, Japan	Kihara, K (reprint author), Tokyo Med & Dent Univ, Dept Urol, Grad Sch, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	k-kihara.uro@tmd.ac.jp			Sony Corporation (Tokyo, Japan)	Dr Kihara has received research funding from Sony Corporation (Tokyo, Japan); however, the sponsor had no control over the interpretation, writing or publication of this work.	Montori VM, 2006, HEALTH EXPECT, V9, P25, DOI 10.1111/j.1369-7625.2006.00359.x; Snyder CF, 2011, CANCER J, V17, P211, DOI 10.1097/PPO.0b013e318225ff89; King JS, 2006, AM J LAW MED, V32, P429; Mitsunori Y, 2013, J HEPATO-BIL-PAN SCI, V20, P234, DOI 10.1007/s00534-012-0507-9; Drake RE, 2009, PSYCHIAT SERV, V60, P1007, DOI 10.1176/appi.ps.60.8.1007; Kvale K, 2008, SCAND J CARING SCI, V22, P582, DOI 10.1111/j.1471-6712.2007.00579.x; Young HN, 2008, ARCH INTERN MED, V168, P1404, DOI 10.1001/archinte.168.13.1404; FUJII Y, 1995, EUR UROL, V27, P124; Liu D, 2009, ANESTH ANALG, V109, P1135, DOI 10.1213/ANE.0b013e3181b5a200; Machida Y, 2013, EJSO-EUR J SURG ONC, V39, P26, DOI 10.1016/j.ejso.2012.10.012; Prendergast CJ, 2009, J LAPAROENDOSC ADV S, V19, pS237, DOI 10.1089/lap.2008.0142; Bhayani Sam B, 2005, Rev Urol, V7, P211; Kawakami S, 2003, BJU INT, V91, P577, DOI 10.1046/j.1464-410X.2003.04029.x; Kawakami S, 2004, INT J UROL, V11, P613, DOI 10.1111/j.1442-2042.2004.00863.x; Kihara K, 2012, INT J UROL, V19, P886, DOI 10.1111/j.1442-2042.2012.03044.x; Legare F, 2010, COCHRANE DB SYST REV, V5, DOI DOI 10.1002/14651858.CD006732.PUB2; Liu D, 2010, ANESTH ANALG, V110, P1032, DOI 10.1213/ANE.0b013e3181d3e647; Matthias MS, 2013, PATIENT EDUC COUNS, V91, P176, DOI 10.1016/j.pec.2013.01.006; Morton B, 2008, RADIOGRAPHY, V14, P195, DOI 10.1016/j.radi.2007.02.004; Nakamura H, 2008, EUR J VASC ENDOVASC, V35, P96, DOI 10.1016/j.ejvs.2007.07.009; Straub C, 2008, PATIENT EDUC COUNS, V73, P544, DOI 10.1016/j.pec.2008.07.019; Takeshita H, 2014, J ULTRAS MED, V33, P1499, DOI 10.7863/ultra.33.8.1499; Topolsky J., I USED GOOGLE GLASS; Wilkes L, 2000, Aust J Rural Health, V8, P41, DOI 10.1046/j.1440-1584.2000.81258.x; Yasumoto M, 2004, J CLIN ULTRASOUND, V32, P82, DOI 10.1002/jcu.10234; Yoshida S, 2014, VIDEOSURGERY MINIINV, DOI [10.5114/wutm.2014.43040, DOI 10.5114/WUTM.2014.43040]; Yoshida S, 2015, UROL INT, V94, P117, DOI 10.1159/000356987	27	1	1	AMER INST ULTRASOUND MEDICINE	LAUREL	SUBSCRIPTION DEPT, 14750 SWEITZER LANE, STE 100, LAUREL, MD 20707-5906 USA	0278-4297	1550-9613		J ULTRAS MED	J. Ultrasound Med.	JAN	2015	34	1					29	35		10.7863/ultra.34.1.29		7	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	AY1PN	WOS:000347364800003		
J	Kato, A; Arii, J; Koyanagi, Y; Kawaguchi, Y				Kato, Akihisa; Arii, Jun; Koyanagi, Yoshio; Kawaguchi, Yasushi			Phosphorylation of Herpes Simplex Virus 1 dUTPase Regulates Viral Virulence and Genome Integrity by Compensating for Low Cellular dUTPase Activity in the Central Nervous System	JOURNAL OF VIROLOGY			English	Article							PROTEIN-KINASE US3; DEOXYURIDINE TRIPHOSPHATE NUCLEOTIDOHYDROLASE; THYMIDINE KINASE; ESCHERICHIA-COLI; INFECTED-CELLS; HORIZONTAL TRANSFER; TRIGEMINAL GANGLIA; MUTATION FREQUENCY; CATALYTIC-ACTIVITY; DEFICIENT MUTANTS	A mutation in herpes simplex virus 1 dUTPase (vdUTPase), which precluded its phosphorylation at Ser-187, decreased viral neurovirulence and increased mutation frequency in progeny virus genomes in the brains of mice where endogenous cellular dUTPase activity was relatively low, and overexpression of cellular dUTPase restored viral neurovirulence and mutation frequency altered by the mutation. Thus, phosphorylation of vdUTPase appeared to regulate viral virulence and genome integrity by compensating for low cellular dUTPase activity in vivo. IMPORTANCE Many DNA viruses encode a homolog of host cell dUTPases, which are known to function in accurate replication of cellular DNA genomes. The viral dUTPase activity has long been assumed to play a role in viral replication by preventing mutations in progeny virus genomes if cellular dUTPase activity was not sufficient. Here, we showed that a mutation in herpes simplex virus 1 dUTPase, which precluded its phosphorylation at Ser-187 and reduced its activity, decreased viral neurovirulence and increased mutation frequency in progeny virus genomes in the brains of mice where endogenous cellular dUTPase activity was relatively low. In contrast, overexpression of cellular dUTPase restored viral neurovirulence and mutation frequency altered by the mutation in the brains of mice. This is the first report, to our knowledge, directly showing that viral dUTPase activity regulates viral genome integrity and pathogenicity by compensating for insufficient cellular dUTPase activity in vivo.	[Kato, Akihisa; Arii, Jun; Kawaguchi, Yasushi] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Mol Virol, Tokyo, Japan; [Kato, Akihisa; Arii, Jun; Kawaguchi, Yasushi] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Infect Dis Control, Tokyo, Japan; [Koyanagi, Yoshio] Kyoto Univ, Inst Virus Res, Lab Viral Pathogenesis, Kyoto 606, Japan	Kawaguchi, Y (reprint author), Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Mol Virol, Tokyo, Japan.	ykawagu@ims.u-tokyo.ac.jp			Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Science, Sports and Technology (MEXT) of Japan; Takeda Science Foundation; Ichiro Kanehara Foundation	This study was supported by the Funding Program for Next Generation World-Leading Researchers and Grants for Scientific Research from the Japan Society for the Promotion of Science (JSPS); a contract research fund for the Program of Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) and a grant for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Science, Sports and Technology (MEXT) of Japan; and grants from the Takeda Science Foundation and the Ichiro Kanehara Foundation.	Turelli P, 1996, J VIROL, V70, P1213; Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; Kato A, 2014, J VIROL, V88, P655, DOI 10.1128/JVI.02710-13; Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev; Tanaka M, 2012, J VIROL, V86, P5264, DOI 10.1128/JVI.06913-11; KUNZ BA, 1991, ANNU REV GENET, V25, P339, DOI 10.1146/annurev.ge.25.120191.002011; Imai T, 2011, J VIROL, V85, P5003, DOI 10.1128/JVI.02314-10; Kato A, 2008, J VIROL, V82, P6172, DOI 10.1128/JVI.00044-08; PYLES RB, 1994, J VIROL, V68, P4514; Baldo AM, 1999, J VIROL, V73, P7710; EJERCITO PM, 1968, J GEN VIROL, V2, P357, DOI 10.1099/0022-1317-2-3-357; COEN DM, 1989, P NATL ACAD SCI USA, V86, P4736, DOI 10.1073/pnas.86.12.4736; Jakobsson J, 2006, MOL THER, V13, P484, DOI 10.1016/j.ymthe.2005.11.012; Nie CY, 2009, VIROLOGY, V394, P64, DOI 10.1016/j.virol.2009.08.011; Tanaka M, 2003, J VIROL, V77, P1382, DOI 10.1128/JVI.77.2.1382-1391.2003; Kato A, 2009, J VIROL, V83, P250, DOI 10.1128/JVI.01451-08; Morimoto T, 2009, MICROBIOL IMMUNOL, V53, P155, DOI 10.1111/j.1348-0421.2008.00104.x; Imai T, 2010, J VIROL, V84, P153, DOI 10.1128/JVI.01447-09; Fujii H, 2014, J VIROL, V88, P2359, DOI 10.1128/JVI.03621-13; Vertessy BG, 2009, ACCOUNTS CHEM RES, V42, P97, DOI 10.1021/ar800114w; Galperin MY, 2006, MOL MICROBIOL, V59, P5, DOI 10.1111/j.1365-2958.2005.04950.x; BESSMAN MJ, 1958, P NATL ACAD SCI USA, V44, P633, DOI 10.1073/pnas.44.7.633; Chen SH, 1998, J VIROL, V72, P6710; ELDER JH, 1992, J VIROL, V66, P1791; GORDON YJ, 1983, INVEST OPHTH VIS SCI, V24, P599; Hwang CB, 2011, DNA REPLICATION RELA; Hwang YT, 2003, VIROLOGY, V305, P388, DOI 10.1006/viro.2002.1776; JACOBSON JG, 1993, J VIROL, V67, P6903; Kato A, 2014, J VIROL, V88, P2775, DOI 10.1128/JVI.03300-13; Kato A, 2014, J VIROL, V88, P7776, DOI 10.1128/JVI.00603-14; Kouzminova EA, 2004, MOL MICROBIOL, V51, P1279, DOI 10.1046/j.1365-2958.2003.03924.x; Ladner RD, 1996, J BIOL CHEM, V271, P7745; LERNER DL, 1995, P NATL ACAD SCI USA, V92, P7480, DOI 10.1073/pnas.92.16.7480; McClure MA, 2001, CURR PROTEIN PEPT SC, V2, P313, DOI 10.2174/1389203013381062; McGeehan JE, 2001, CURR PROTEIN PEPT SC, V2, P325, DOI 10.2174/1389203013380964; Payne SL, 2001, CURR PROTEIN PEPT SC, V2, P381, DOI 10.2174/1389203013381008; PRESTON VG, 1984, VIROLOGY, V138, P58, DOI 10.1016/0042-6822(84)90147-8; PYLES RB, 1992, J VIROL, V66, P6706; Roizman B., 2013, FIELDS VIROLOGY, P1823; SEDWICK WD, 1986, MUTAT RES, V162, P7, DOI 10.1016/0027-5107(86)90066-7; SHLOMAI J, 1978, J BIOL CHEM, V253, P3305; TENSER RB, 1979, SCIENCE, V205, P915, DOI 10.1126/science.224454; THREADGILL DS, 1993, J VIROL, V67, P2592; WILLIAMS MV, 1979, J BIOL CHEM, V254, P2897	44	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	JAN	2015	89	1					241	248		10.1128/JVI.02497-14		8	Virology	Virology	AX8RL	WOS:000347176100021		
J	Ishikawa, K; Miura, C; Maejima, K; Komatsu, K; Hashimoto, M; Tomomitsu, T; Fukuoka, M; Yusa, A; Yamaji, Y; Namba, S				Ishikawa, Kazuya; Miura, Chihiro; Maejima, Kensaku; Komatsu, Ken; Hashimoto, Masayoshi; Tomomitsu, Tatsuya; Fukuoka, Misato; Yusa, Akira; Yamaji, Yasuyuki; Namba, Shigetou			Nucleocapsid Protein from Fig Mosaic Virus Forms Cytoplasmic Agglomerates That Are Hauled by Endoplasmic Reticulum Streaming	JOURNAL OF VIROLOGY			English	Article							DEPENDENT RNA-POLYMERASE; MYOSIN XI-K; PLANT-CELLS; INTRACELLULAR-TRANSPORT; PLASMODESMATAL LOCALIZATION; INTERCELLULAR MOVEMENT; TRANSVACUOLAR STRANDS; ACTIN MICROFILAMENTS; SECRETORY PATHWAY; EXPORT SITES	Although many studies have demonstrated intracellular movement of viral proteins or viral replication complexes, little is known about the mechanisms of their motility. In this study, we analyzed the localization and motility of the nucleocapsid protein (NP) of Fig mosaic virus (FMV), a negative-strand RNA virus belonging to the recently established genus Emaravirus. Electron microscopy of FMV-infected cells using immunogold labeling showed that NPs formed cytoplasmic agglomerates that were predominantly enveloped by the endoplasmic reticulum (ER) membrane, while nonenveloped NP agglomerates also localized along the ER. Likewise, transiently expressed NPs formed agglomerates, designated NP bodies (NBs), in close proximity to the ER, as was the case in FMV-infected cells. Subcellular fractionation and electron microscopic analyses of NP-expressing cells revealed that NBs localized in the cytoplasm. Furthermore, we found that NBs moved rapidly with the streaming of the ER in an actomyosin-dependent manner. Brefeldin A treatment at a high concentration to disturb the ER network configuration induced aberrant accumulation of NBs in the perinuclear region, indicating that the ER network configuration is related to NB localization. Dominant negative inhibition of the class XI myosins, XI-1, XI-2, and XI-K, affected both ER streaming and NB movement in a similar pattern. Taken together, these results showed that NBs localize in the cytoplasm but in close proximity to the ER membrane to form enveloped particles and that this causes passive movements of cytoplasmic NBs by ER streaming. IMPORTANCE Intracellular trafficking is a primary and essential step for the cell-to-cell movement of viruses. To date, many studies have demonstrated the rapid intracellular movement of viral factors but have failed to provide evidence for the mechanism or biological significance of this motility. Here, we observed that agglomerates of nucleocapsid protein (NP) moved rapidly throughout the cell, and we performed live imaging and ultrastructural analysis to identify the mechanism of motility. We provide evidence that cytoplasmic protein agglomerates were passively dragged by actomyosin-mediated streaming of the endoplasmic reticulum (ER) in plant cells. In virus-infected cells, NP agglomerates were surrounded by the ER membranes, indicating that NP agglomerates form the basis of enveloped virus particles in close proximity to the ER. Our work provides a sophisticated model of macromolecular trafficking in plant cells and improves our understanding of the formation of enveloped particles of negative-strand RNA viruses.	[Ishikawa, Kazuya; Miura, Chihiro; Maejima, Kensaku; Hashimoto, Masayoshi; Tomomitsu, Tatsuya; Fukuoka, Misato; Yusa, Akira; Yamaji, Yasuyuki; Namba, Shigetou] Univ Tokyo, Bunkyo Ku, Plant Pathol Lab, Grad Sch Agr & Life Sci, Tokyo 113, Japan; [Komatsu, Ken] Tokyo Univ Agr & Technol, Plant Pathol Lab, Fuchu, Tokyo, Japan	Namba, S (reprint author), Univ Tokyo, Bunkyo Ku, Plant Pathol Lab, Grad Sch Agr & Life Sci, Tokyo 113, Japan.	anamba@mail.ecc.u-tokyo.ac.jp	Komatsu, Ken/B-3244-2015	Komatsu, Ken/0000-0003-3323-7314	Japan Society for the Promotion of Science	This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science.	Agbeci M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003683; Amari K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002327; Yamaji Y, 2006, VIROLOGY, V347, P100, DOI 10.1016/j.virol.2005.11.031; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Cui XY, 2010, VIROLOGY, V397, P56, DOI 10.1016/j.virol.2009.11.015; Kakizawa S, 2004, MICROBIOL-SGM, V150, P135, DOI 10.1099/mic.0.26521-0; Nebenfuhr A, 1999, PLANT PHYSIOL, V121, P1127, DOI 10.1104/pp.121.4.1127; Ruigrok RWH, 2011, CURR OPIN MICROBIOL, V14, P504, DOI 10.1016/j.mib.2011.07.011; Schoelz JE, 2011, MOL PLANT, V4, P813, DOI 10.1093/mp/ssr070; Avisar D, 2009, PLANT PHYSIOL, V150, P700, DOI 10.1104/pp.109.136853; Holweg CL, 2007, CELL MOTIL CYTOSKEL, V64, P69, DOI 10.1002/cm.20164; Wei TY, 2008, J VIROL, V82, P12252, DOI 10.1128/JVI.01329-08; STAIGER CJ, 1994, CURR BIOL, V4, P215, DOI 10.1016/S0960-9822(00)00050-6; Cros JF, 2003, VIRUS RES, V95, P3, DOI 10.1016/S0168-1702(03)00159-X; Avisar D, 2012, J EXP BOT, V63, P241, DOI 10.1093/jxb/err265; Genoves A, 2010, MOL PLANT MICROBE IN, V23, P263, DOI 10.1094/MPMI-23-3-0263; Walter CT, 2011, J GEN VIROL, V92, P2467, DOI 10.1099/vir.0.035105-0; Avisar D, 2008, PLANT PHYSIOL, V146, P1098, DOI 10.1104/pp.107.113647; Shimizu T, 2009, ARCH VIROL, V154, P959, DOI 10.1007/s00705-009-0397-6; Wei TY, 2010, J VIROL, V84, P799, DOI 10.1128/JVI.01824-09; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Nayak DP, 2009, VIRUS RES, V143, P147, DOI 10.1016/j.virusres.2009.05.010; Sparkes I, 2011, MOL PLANT, V4, P805, DOI 10.1093/mp/ssr063; Kikkert M, 1999, J VIROL, V73, P2288; Elbeaino T, 2009, ARCH VIROL, V154, P1719, DOI 10.1007/s00705-009-0509-3; DaSilva LLP, 2004, PLANT CELL, V16, P1753, DOI 10.1105/tpc.022673; Cotton S, 2009, J VIROL, V83, P10460, DOI 10.1128/JVI.00819-09; Harries PA, 2010, MOL PLANT MICROBE IN, V23, P1381, DOI 10.1094/MPMI-05-10-0121; Ishikawa K, 2013, J GEN VIROL, V94, P682, DOI 10.1099/vir.0.047860-0; Fontana J, 2008, CELL MICROBIOL, V10, P2012, DOI 10.1111/j.1462-5822.2008.01184.x; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Laliberte JF, 2010, ANNU REV PHYTOPATHOL, V48, P69, DOI 10.1146/annurev-phyto-073009-114239; Sparkes IA, 2008, J EXP BOT, V59, P2499, DOI 10.1093/jxb/ern114; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Boevink P, 1998, PLANT J, V15, P441, DOI 10.1046/j.1365-313X.1998.00208.x; Kormelink R, 2011, VIRUS RES, V162, P184, DOI 10.1016/j.virusres.2011.09.028; Rajendran KS, 2003, J VIROL, V77, P9244, DOI 10.1128/JVI.77.17.9244.9258.2003; Ueda H, 2010, P NATL ACAD SCI USA, V107, P6894, DOI 10.1073/pnas.0911482107; Sparkes I, 2009, PLANT CELL, V21, P3937, DOI 10.1105/tpc.109.072249; Harries PA, 2009, P NATL ACAD SCI USA, V106, P17594, DOI 10.1073/pnas.0909239106; Peremyslov VV, 2013, PLANT CELL, V25, P3022, DOI 10.1105/tpc.113.113704; Hofmann C, 2009, PLANT PHYSIOL, V149, P1810, DOI 10.1104/pp.108.133827; Ishikawa K, 2012, J GEN VIROL, V93, P1612, DOI 10.1099/vir.0.042663-0; Appiano A, 1995, ACTA HORTIC, P585; Avisar D, 2008, J VIROL, V82, P2836, DOI 10.1128/JVI.02246-07; Elbeaino T, 2009, J GEN VIROL, V90, P1281, DOI 10.1099/vir.0.008649-0; Fagarasanu A, 2009, J CELL BIOL, V186, P541, DOI 10.1083/jcb.200904050; Feng ZK, 2013, NEW PHYTOL, V200, P1212, DOI 10.1111/nph.12447; Griffing LR, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00218; Harries PA, 2009, PLANT PHYSIOL, V149, P1005, DOI 10.1104/pp.108.131755; Hashimoto M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-103; Hoffmann A, 2004, PROTOPLASMA, V224, P201, DOI 10.1007/s00709-004-0068-0; Hussey PJ, 1998, PLANT J, V14, P353, DOI 10.1046/j.1365-313X.1998.00122.x; Kaukinen P, 2005, ARCH VIROL, V150, P1693, DOI 10.1007/s00705-005-0555-4; Liu JZ, 2005, PLANT PHYSIOL, V138, P1853, DOI 10.1104/pp.105.065722; Martelli G. P., 1993, Phytopathologia Mediterranea, V32, P33; Martinez-Turino S, 2010, J GEN VIROL, V91, P3075, DOI 10.1099/vir.0.023093-0; Niehl A, 2011, PROTOPLASMA, V248, P75, DOI 10.1007/s00709-010-0246-1; Ribeiro D, 2009, TRAFFIC, V10, P664, DOI 10.1111/j.1600-0854.2009.00900.x; Ribeiro D, 2013, PLANT CELL, V25, P3602, DOI 10.1105/tpc.113.114298; SHIMMEN T, 1995, PROTOPLASMA, V185, P188, DOI 10.1007/BF01272859; Takeuchi M, 1998, PLANT CELL PHYSIOL, V39, P590; VOIGT B, 2004, PLANT PHYSIOL, V84, P595; Watanabe T, 1999, J VIROL, V73, P2633; Yuan ZJ, 2011, VIRUS RES, V159, P62, DOI 10.1016/j.virusres.2011.04.023	66	2	2	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	JAN	2015	89	1					480	491		10.1128/JVI.02527-14		12	Virology	Virology	AX8RL	WOS:000347176100040		
J	Maeda, Y; Terasawa, H; Tanaka, Y; Mitsuura, C; Nakashima, K; Yusa, K; Harada, S				Maeda, Yosuke; Terasawa, Hiromi; Tanaka, Yuetsu; Mitsuura, Chisho; Nakashima, Kaori; Yusa, Keisuke; Harada, Shinji			Separate Cellular Localizations of Human T-Lymphotropic Virus 1 (HTLV-1) Env and Glucose Transporter Type 1 (GLUT1) Are Required for HTLV-1 Env-Mediated Fusion and Infection	JOURNAL OF VIROLOGY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LEUKEMIA-VIRUS; SURFACE CD4; CYTOPLASMIC DOMAIN; PROTEIN EXPRESSION; HIV-1 INFECTIVITY; PERIPHERAL-BLOOD; HIGH-FREQUENCY; CELLS; ENVELOPE	Interaction of the envelope glycoprotein (Env) of human T-lymphotropic virus 1 (HTLV-1) with the glucose transporter type 1 (GLUT1) expressed in target cells is essential for viral entry. This study found that the expression level of GLUT1 in virus-producing 293T cells was inversely correlated with HTLV-1 Env-mediated fusion activity and infectivity. Chimeric studies between GLUT1 and GLUT3 indicated that the extracellular loop 6 (ECL6) of GLUT1 is important for the inhibition of cell-cell fusion mediated by Env. When GLUT1 was translocated into the plasma membrane from intracellular storage sites by bafilomycin A1 (BFLA1) treatment in 293T cells, HTLV-1 Env-mediated cell fusion and infection also were inhibited without the overexpression of GLUT1, indicating that the localization of GLUT1 in intracellular compartments rather than in the plasma membrane is crucial for the fusion activity of HTLV-1 Env. Immunoprecipitation and laser scanning confocal microscopic analyses indicated that under normal conditions, HTLV-1 Env and GLUT1 do not colocalize or interact. BFLA1 treatment induced this colocalization and interaction, indicating that GLUT1 normally accumulates in intracellular compartments separate from that of Env. Western blot analyses of FLAG-tagged HTLV-1 Env in virus-producing cells and the incorporation of HTLV-1 Env in virus-like particles (VLPs) indicate that the processing of Env is inhibited by either overexpression of GLUT1 or BFLA1 treatment in virus-producing 293T cells. This inhibition probably is due to the interaction of the Env with GLUT1 in intracellular compartments. Taken together, separate intracellular localizations of GLUT1 and HTLV-1 Env are required for the fusion activity and infectivity of HTLV-I Env. IMPORTANCE The deltaretrovirus HTLV-1 is a causative agent of adult T-cell leukemia (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Although HTLV-1 is a complex retrovirus that has accessory genes, no HTLV-1 gene product has yet been shown to regulate its receptor GLUT1 in virus-producing cells. In this study, we found that a large amount of GLUT I or translocation of GLUT1 to the plasma membrane from intracellular compartments in virus-producing cells enhances the colocalization and interaction of GLUT I with HTLV-1 Env, leading to the inhibition of cell fusion activity and infectivity The results of our study suggest that GLUT1 normally accumulates in separate intracellular compartments from Env, which is indeed required for the proper processing of Env.	[Maeda, Yosuke; Terasawa, Hiromi; Mitsuura, Chisho; Nakashima, Kaori; Harada, Shinji] Kumamoto Univ, Fac Life Sci, Dept Med Virol, Kumamoto, Japan; [Tanaka, Yuetsu] Univ Ryukyus, Grad Sch Med, Dept Immunol, Okinawa, Japan; [Yusa, Keisuke] Natl Inst Hlth Sci, Div Biol Chem & Biol, Tokyo, Japan	Maeda, Y (reprint author), Kumamoto Univ, Fac Life Sci, Dept Med Virol, Kumamoto, Japan.	ymaeda@kumamoto-u.ac.jp			Ministry of Health of Japan	This work was supported by a grant in aid for scientific research from the Ministry of Health of Japan.	Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Hanon E, 2000, BLOOD, V95, P1386; RHEE SS, 1994, J VIROL, V68, P5156; Karube K, 2004, BRIT J HAEMATOL, V126, P81, DOI 10.1111/j.1365-2141.2004.04999.x; Jones KS, 2006, J VIROL, V80, P8291, DOI 10.1128/JVI.00389-06; Uchiyama T, 1997, ANNU REV IMMUNOL, V15, P15, DOI 10.1146/annurev.immunol.15.1.15; Nethe M, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-52; MCCUNE JM, 1988, CELL, V53, P55, DOI 10.1016/0092-8674(88)90487-4; Michalek RD, 2011, P NATL ACAD SCI USA, V108, P18348, DOI 10.1073/pnas.1108856108; Igakura T, 2003, SCIENCE, V299, P1713, DOI 10.1126/science.1080115; HINUMA Y, 1981, P NATL ACAD SCI-BIOL, V78, P6476, DOI 10.1073/pnas.78.10.6476; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031; Wu LJ, 1997, J EXP MED, V185, P1681, DOI 10.1084/jem.185.9.1681; Manel N, 2003, CELL, V115, P449, DOI 10.1016/S0092-8674(03)00881-X; AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; Cortes MJ, 2002, J BIOL CHEM, V277, P1770, DOI 10.1074/jbc.M109807200; Pais-Correia AM, 2010, NAT MED, V16, P83, DOI 10.1038/nm.2065; Mazurov D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000788; GESSAIN A, 1985, LANCET, V2, P407; Toulza F, 2008, BLOOD, V111, P5047, DOI 10.1182/blood-2007-10-118539; PALESE P, 1974, VIROLOGY, V61, P397, DOI 10.1016/0042-6822(74)90276-1; GARCIA JV, 1991, NATURE, V350, P508, DOI 10.1038/350508a0; Michel N, 2005, CURR BIOL, V15, P714, DOI 10.1016/j.cub.2005.02.058; Lama J, 1999, CURR BIOL, V9, P622, DOI 10.1016/S0960-9822(99)80284-X; Goon PKC, 2004, J IMMUNOL, V172, P1735; RICHARDSON JH, 1990, J VIROL, V64, P5682; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; BOUR S, 1995, J VIROL, V69, P1510; Nagai M, 2001, BLOOD, V98, P1858, DOI 10.1182/blood.V98.6.1858; LIU CG, 1995, J VIROL, V69, P1099; OSAME M, 1990, ANN NEUROL, V28, P50, DOI 10.1002/ana.410280110; Takatsuki K, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-16; Schubert U, 1998, J VIROL, V72, P2280; Grant C, 2002, J CELL PHYSIOL, V190, P133, DOI 10.1002/JCP.10053; MacIver NJ, 2008, J LEUKOCYTE BIOL, V84, P949, DOI 10.1189/jlb.0108024; Jones KS, 2008, NAT MED, V14, P429, DOI 10.1038/nm1745; Chinni SR, 1999, BIOCHEM J, V339, P599, DOI 10.1042/0264-6021:3390599; CLARKE MF, 1983, NATURE, V305, P60, DOI 10.1038/305060a0; Eiraku N, 1998, J IMMUNOL, V161, P6674; Foda M, 2001, MICROBIOL IMMUNOL, V45, P521; Hanon E, 2000, AIDS RES HUM RETROV, V16, P1711, DOI 10.1089/08892220050193191; Jacobs SR, 2008, J IMMUNOL, V180, P4476; Jinno A, 1998, BIOCHEM BIOPH RES CO, V243, P497, DOI 10.1006/bbrc.1998.8130; Jones KS, 2005, J VIROL, V79, P12692, DOI 10.1128/JVI.79.20.12692-12702.2005; Maeda Y, 2000, J VIROL, V74, P1787, DOI 10.1128/JVI.74.4.1787-1793.2000; Maeda Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089515; Manel N, 2005, J BIOL CHEM, V280, P29025, DOI 10.1074/jbc.M504549200; MARSHALL WL, 1992, J VIROL, V66, P5492; Monde K, 2007, J BIOL CHEM, V282, P36923, DOI 10.1074/jbc.M705298200; Moore JP, 1997, SCIENCE, V276, P51, DOI 10.1126/science.276.5309.51; Mwimanzi P, 2010, BIOCHEM BIOPH RES CO, V403, P422, DOI 10.1016/j.bbrc.2010.11.047; PEREZ LG, 1987, J VIROL, V61, P1609; PIQUE C, 1992, J VIROL, V66, P906; POPOVIC M, 1983, SCIENCE, V219, P856, DOI 10.1126/science.6600519; Satou Y, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-46; Simon JHM, 1997, J VIROL, V71, P5259; Takenouchi N, 2007, J VIROL, V81, P1506, DOI 10.1128/JVI.01522-06; TANAKA Y, 1991, J IMMUNOL, V147, P354; Trejo SR, 2000, VIROLOGY, V268, P41, DOI 10.1006/viro.2000.0143; WALTER MJ, 1994, ANN NY ACAD SCI, V724, P404, DOI 10.1111/j.1749-6632.1994.tb38939.x; YAMAMOTO N, 1982, SCIENCE, V217, P737, DOI 10.1126/science.6980467	62	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	JAN	2015	89	1					502	511		10.1128/JVI.02686-14		10	Virology	Virology	AX8RL	WOS:000347176100042		
J	Matsuno, K; Weisend, C; Kajihara, M; Matysiak, C; Williamson, BN; Simuunza, M; Mweene, AS; Takada, A; Tesh, RB; Ebihara, H				Matsuno, Keita; Weisend, Carla; Kajihara, Masahiro; Matysiak, Colette; Williamson, Brandi N.; Simuunza, Martin; Mweene, Aaron S.; Takada, Ayato; Tesh, Robert B.; Ebihara, Hideki			Comprehensive Molecular Detection of Tick-Borne Phleboviruses Leads to the Retrospective Identification of Taxonomically Unassigned Bunyaviruses and the Discovery of a Novel Member of the Genus Phlebovirus	JOURNAL OF VIROLOGY			English	Article							THROMBOCYTOPENIA SYNDROME VIRUS; TO-PERSON TRANSMISSION; SEVERE FEVER; BHANJA VIRUS; GENETIC-CHARACTERIZATION; SEROLOGICAL SURVEY; HEARTLAND VIRUS; CHINA; ANTIBODIES; INFECTION	Until the recent emergence of two human-pathogenic tick-borne phleboviruses (TBPVs) (severe fever with thrombocytopenia syndrome virus [SFTSV] and Heartland virus), TBPVs have been neglected as causative agents of human disease. In particular, no studies have addressed the global distribution of TBPVs, and consequently, our understanding of the mechanism(s) underlying their evolution and emergence remains poor. In order to provide a useful tool for the ecological and epidemiological study of TBPVs, we have established a simple system that can detect all known TBPVs, based on conventional reverse transcription-PCR (RT-PCR) with degenerate primer sets targeting conserved regions of the viral L genome segment. Using this system, we have determined that several viruses that had been isolated from ticks decades ago but had not been taxonomically identified are novel TBPVs. Full-genome sequencing of these viruses revealed a novel fourth TBPV cluster distinct from the three known TBPV clusters (i.e., the SETS, Bhanja, and Uukuniemi groups) and from the mosquito/sandfly-borne phleboviruses. Furthermore, by using tick samples collected in Zambia, we confirmed that our system had enough sensitivity to detect a new TBPV in a single tick homogenate. This virus, tentatively designated Shibuyunji virus after the region of tick collection, grouped into a novel fourth TBPV cluster. These results indicate that our system can be used as a first-line screening approach for TBPVs and that this kind of work will undoubtedly lead to the discovery of additional novel tick viruses and will expand our knowledge of the evolution and epidemiology of TBPVs. IMPORTANCE Tick-borne phleboviruses (TBPVs) have been largely neglected until the recent emergence of two virulent viruses, severe fever with thrombocytopenia syndrome virus and Heartland virus. Little is known about the global distribution of TBPVs or how these viruses evolved and emerged. A major hurdle to study the distribution of TBPVs is the lack of tools to detect these genetically divergent phleboviruses. In order to address this issue, we have developed a simple, rapid, and cheap RT-PCR system that can detect all known TBPVs and which led to the identification of several novel phleboviruses from previously uncharacterized tick-associated virus isolates. Our system can detect virus in a single tick sample and novel TBPVs that are genetically distinct from any of the known TBPVs. These results indicate that our system will be a useful tool for the surveillance of TBPVs and will facilitate understanding of the ecology of TBPVs.	[Matsuno, Keita; Weisend, Carla; Matysiak, Colette; Williamson, Brandi N.; Ebihara, Hideki] NIAID, Mol Virol & Host Pathogen Interact Unit, Virol Lab, Div Intramural Res,NIH,Rocky Mt Labs, Hamilton, MT USA; [Kajihara, Masahiro; Takada, Ayato] Hokkaido Univ, Div Global Epidemiol, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Simuunza, Martin; Mweene, Aaron S.; Takada, Ayato] Univ Zambia, Sch Vet Med, Dept Dis Control, Lusaka, Zambia; [Tesh, Robert B.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Tesh, Robert B.] Univ Texas Med Branch, Ctr Biodefense & Emerging Infect Dis, Galveston, TX 77555 USA	Ebihara, H (reprint author), NIAID, Mol Virol & Host Pathogen Interact Unit, Virol Lab, Div Intramural Res,NIH,Rocky Mt Labs, Hamilton, MT USA.	ebiharah@niaid.nih.gov			National Institute for Allergy and Infectious Diseases; U.S.-China Biomedical Collaborative Research Program; NIH [HHSN272201000040I/HHSN200004/D04]	The present work was funded by the Intramural Research Program of the National Institute for Allergy and Infectious Diseases and partially through the U.S.-China Biomedical Collaborative Research Program. R.B.T. was supported by NIH contract HHSN272201000040I/HHSN200004/D04.	Alkhovsky S. V., 2013, Voprosy Virusologii, V58, P18; Alkhovsky S. V., 2013, Voprosy Virusologii, V58, P15; Takahashi T, 2014, J INFECT DIS, V209, P816, DOI 10.1093/infdis/jit603; Hubalek Z, 2012, PARASITOL RES, V111, P9, DOI 10.1007/s00436-012-2910-1; MULLER R, 1994, J GEN VIROL, V75, P1345, DOI 10.1099/0022-1317-75-6-1345; Niu GY, 2013, EMERG INFECT DIS, V19, P756, DOI 10.3201/eid1905.120245; Wang J, 2014, EMERG INFECT DIS, V20, P1040, DOI 10.3201/eid2006.140003; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; Tokarz R, 2014, J VIROL, V88, P11480, DOI 10.1128/JVI.01858-14; Mourya DT, 2014, J VIROL, V88, P3605, DOI 10.1128/JVI.02617-13; Sun YL, 2012, J INFECT DIS, V206, P1085, DOI 10.1093/infdis/jis452; Zhang LJ, 2008, JAMA-J AM MED ASSOC, V300, P2263, DOI 10.1001/jama.2008.626; Gai ZT, 2012, J INFECT DIS, V206, P1095, DOI 10.1093/infdis/jis472; Palacios G, 2013, J VIROL, V87, P3187, DOI 10.1128/JVI.02719-12; Matsuno K, 2013, J VIROL, V87, P3719, DOI 10.1128/JVI.02845-12; McMullan LK, 2012, NEW ENGL J MED, V367, P834, DOI 10.1056/NEJMoa1203378; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Li ZF, 2014, J CLIN VIROL, V60, P185, DOI 10.1016/j.jcv.2014.03.020; Liu Y, 2012, VECTOR-BORNE ZOONOT, V12, P156, DOI 10.1089/vbz.2011.0758; Gai ZT, 2012, CLIN INFECT DIS, V54, P249, DOI 10.1093/cid/cir776; Savage HM, 2013, AM J TROP MED HYG, V89, P445, DOI 10.4269/ajtmh.13-0209; Bao CJ, 2011, CLIN INFECT DIS, V53, P1208, DOI 10.1093/cid/cir732; BARDOS V, 1977, Folia Parasitologica (Ceske Budejovice), V24, P381; BHATT PN, 1966, AM J TROP MED HYG, V15, P958; BUTENKO AM, 1979, VOP VIRUSOL+, P661; CALISHER CH, 1975, AM J TROP MED HYG, V24, P1040; Dilcher M, 2012, VIRUS GENES, V45, P311, DOI 10.1007/s11262-012-0785-y; HOFF GL, 1971, AM J TROP MED HYG, V20, P320; HUBALEK Z, 1984, ZBL BAKT-INT J MED M, V258, P540; HUBALEK Z, 1985, FOLIA PARASIT, V32, P279; Mahy BWJ, 2009, THE DICT OF VIROLOGY; Plyusnin A, 2012, VIRUS TAXONOMY, P725; SAIKKU P, 1973, AM J TROP MED HYG, V22, P400; Sonenshine D. E., 2013, BIOL TICKS; Sun JM, 2014, EPIDEMIOL INFECT; Swei A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062083; TAN DSK, 1967, NATURE, V214, P1154, DOI 10.1038/2141154a0; Vesenjak-Hirjan J, 1980, ARBOVIRUSES MEDITERR, P297	38	3	3	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	JAN	2015	89	1					594	604		10.1128/JVI.02704-14		11	Virology	Virology	AX8RL	WOS:000347176100050		
J	Panigrahi, R; Chandra, PK; Ferraris, P; Kurt, R; Song, K; Garry, RF; Reiss, K; Coe, IR; Furihata, T; Balart, LA; Wu, T; Dash, S				Panigrahi, Rajesh; Chandra, Partha K.; Ferraris, Pauline; Kurt, Ramazan; Song, Kyoungsub; Garry, Robert F.; Reiss, Krzysztof; Coe, Imogen R.; Furihata, Tomomi; Balart, Luis A.; Wu, Tong; Dash, Srikanta			Persistent Hepatitis C Virus Infection Impairs Ribavirin Antiviral Activity through Clathrin-Mediated Trafficking of Equilibrative Nucleoside Transporter 1	JOURNAL OF VIROLOGY			English	Article							AUTOPHAGY; THERAPY; REPLICATION; RESISTANCE; INTERFERON; MECHANISMS; EFFICACY	Ribavirin (RBV) continues to be an important component of interferon-free hepatitis C treatment regimens, as RBV alone does not inhibit hepatitis C virus (HCV) replication effectively; the reason for this ineffectiveness has not been established. In this study, we investigated the RBV resistance mechanism using a persistently HCV-infected cell culture system. The antiviral activity of RBV against HCV was progressively impaired in the persistently infected culture, whereas interferon lambda 1 (IFN-lambda 1), a type III IFN, showed a strong antiviral response and induced viral clearance. We found that HCV replication in persistently infected cultures induces an autophagy response that impairs RBV uptake by preventing the expression of equilibrative nucleoside transporter 1 (ENT1). The Huh-7.5 cell line treated with an autophagy inducer, Torin 1, downregulated membrane expression of ENT1 and terminated RBV uptake. In contrast, the autophagy inhibitors hydroxychloroquine (HCQ), 3-methyladenine (3-MA), and bafilomycin A1 (BafA1) prevented ENT1 degradation and enhanced RBV antiviral activity. The HCV-induced autophagy response, as well as treatment with Torin 1, degrades clathrin heavy chain expression in a hepatoma cell line. Reduced expression of the clathrin heavy chain by HCV prevents ENT1 recycling to the plasma membrane and forces ENT1 to the lysosome for degradation. This study provides a potential mechanism for the impairment of RBV antiviral activity in persistently HCV-infected cell cultures and suggests that inhibition of the HCV-induced autophagy response could be used as a strategy for improving RBV antiviral activity against HCV infection. IMPORTANCE The results from this work will allow a review of the competing theories of antiviral therapy development in the field of HCV virology. Ribavirin (RBV) remains an important component of interferon-free hepatitis C treatment regimens. The reason why RBV alone does not inhibit HCV replication effectively has not been established. This study provides a potential mechanism for why RBV antiviral activity is impaired in persistently HCV-infected cell cultures and suggests that inhibition of the HCV-induced autophagy response could be used as a strategy to increase RBV antiviral activity against HCV infection. Therefore, it is anticipated that this work would generate a great deal of interest, not only among virologists but also among the general public.	[Panigrahi, Rajesh; Chandra, Partha K.; Ferraris, Pauline; Kurt, Ramazan; Song, Kyoungsub; Wu, Tong; Dash, Srikanta] Tulane Univ, Sch Med, Dept Pathol & Lab Med, New Orleans, LA 70112 USA; [Kurt, Ramazan; Balart, Luis A.; Dash, Srikanta] Tulane Univ, Sch Med, Dept Med Gastroenterol & Hepatol, New Orleans, LA 70112 USA; [Garry, Robert F.] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA; [Reiss, Krzysztof] Stanley S Scott Canc Ctr, New Orleans, LA USA; [Coe, Imogen R.] Ryerson Univ, Dept Biol & Chem, Toronto, ON, Canada; [Furihata, Tomomi] Chiba Univ, Lab Pharmacol & Toxicol, Grad Sch Pharmaceut Sci, Chiba, Japan	Dash, S (reprint author), Tulane Univ, Sch Med, Dept Pathol & Lab Med, 1430 Tulane Ave, New Orleans, LA 70112 USA.	sdash@tulane.edu			NIH [CA127481, CA089121, AI103106]; Tulane University Health Sciences Center	This work was supported by NIH grants CA127481, CA089121, and AI103106 and by bridge funding received from the Tulane University Health Sciences Center.	Ravikumar B, 2010, NAT CELL BIOL, V12, P747, DOI 10.1038/ncb2078; Dreux M, 2011, VIRUSES-BASEL, V3, P1342, DOI 10.3390/v3081342; Shiffman ML, 2014, CURR OPIN GASTROEN, V30, P217, DOI 10.1097/MOG.0000000000000062; Chandra PK, 2014, AM J PATHOL, V184, P214, DOI 10.1016/j.ajpath.2013.10.005; Klionsky DJ, 2010, AUTOPHAGY, V6, P438, DOI 10.4161/auto.6.4.12244; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Hmwe SS, 2010, ANTIVIR RES, V85, P520, DOI 10.1016/j.antiviral.2009.12.008; Ibarra KD, 2009, J VIROL, V83, P4538, DOI 10.1128/JVI.02280-08; MCCORMICK JB, 1986, NEW ENGL J MED, V314, P20, DOI 10.1056/NEJM198601023140104; Casey J, 2013, BONE MARROW TRANSPL, V48, P1558, DOI 10.1038/bmt.2013.112; Pfeiffer JK, 2005, J VIROL, V79, P2346, DOI 10.1128/JVI.79.4.2346-2355.2005; Rautou PE, 2011, AM J PATHOL, V178, P2708, DOI 10.1016/j.ajpath.2011.02.021; Skrypek N, 2013, ONCOGENE, V32, P1714, DOI 10.1038/onc.2012.179; Lamb CA, 2013, NAT REV MOL CELL BIO, V14, P759, DOI 10.1038/nrm3696; Casey LC, 2013, CURR OPIN GASTROEN, V29, P243, DOI 10.1097/MOG.0b013e32835ff972; Paeshuyse J, 2011, CURR OPIN VIROL, V1, P590, DOI 10.1016/j.coviro.2011.10.030; Kong W, 2004, CURR DRUG METAB, V5, P63, DOI 10.2174/1389200043489162; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Rong YG, 2012, NAT CELL BIOL, V14, P924, DOI 10.1038/ncb2557; Yang YP, 2013, ACTA PHARMACOL SIN, V34, P625, DOI 10.1038/aps.2013.5; Mori K, 2013, HEPATOLOGY, V58, P1236, DOI 10.1002/hep.26421; Bao LL, 2014, EXP MOL PATHOL, V96, P149, DOI 10.1016/j.yexmp.2013.12.002; Clark V, 2012, LIVER INT, V32, P103, DOI 10.1111/j.1478-3231.2011.02711.x; Datta S, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-351; Dixit NM, 2006, CELL MOL LIFE SCI, V63, P832, DOI 10.1007/s00018-005-5455-y; Hoofnagle JH, 1996, J VIRAL HEPATITIS, V3, P247, DOI 10.1111/j.1365-2893.1996.tb00050.x; Ibarra KD, 2011, J VIROL, V85, P7273, DOI 10.1128/JVI.00629-11; Iikura M, 2012, ANTIMICROB AGENTS CH, V56, P1407, DOI 10.1128/AAC.05762-11; Lanford RE, 2001, J VIROL, V75, P8074, DOI 10.1128/JVI.75.17.8074-8081.2001; Liu SH, 2011, ANTIVIR RES, V89, P54, DOI 10.1016/j.antiviral.2010.11.004; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Nivillac NMI, 2011, EXP CELL RES, V317, P1567, DOI 10.1016/j.yexcr.2011.03.008; Panigrahi R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072791; Reddy KR, 2010, GASTROENTEROLOGY, V139, P1972, DOI 10.1053/j.gastro.2010.08.051; Shah NR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011265	35	4	4	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	JAN	2015	89	1					626	642		10.1128/JVI.02492-14		17	Virology	Virology	AX8RL	WOS:000347176100053		
J	Hau, PM; Deng, W; Jia, L; Yang, J; Tsurumi, T; Chiang, AKS; Huen, MSY; Tsao, SW				Hau, Pok Man; Deng, Wen; Jia, Lin; Yang, Jie; Tsurumi, Tatsuya; Chiang, Alan Kwok Shing; Huen, Michael Shing-Yan; Tsao, Sai Wah			Role of ATM in the Formation of the Replication Compartment during Lytic Replication of Epstein-Barr Virus in Nasopharyngeal Epithelial Cells	JOURNAL OF VIROLOGY			English	Article							DNA-DAMAGE RESPONSE; TELANGIECTASIA-MUTATED KINASE; DEPENDENT PROTEIN-KINASE; TRANSCRIPTION FACTOR SP1; DOUBLE-STRAND BREAKS; BZLF1 GENE PROMOTER; VIRAL REPLICATION; DOWNSTREAM COMPONENT; BRLF1 PROMOTER; REPAIR FACTORS	Epstein-Barr virus (EBV), a type of oncogenic herpesvirus, is associated with human malignancies. Previous studies have shown that lytic reactivation of EBV in latently infected cells induces an ATM-dependent DNA damage response (DDR). The involvement of ATM activation has been implicated in inducing viral lytic gene transcription to promote lytic reactivation. Its contribution to the formation of a replication compartment during lytic reactivation of EBV remains poorly defined. In this study, the role of ATM in viral DNA replication was investigated in EBV-infected nasopharyngeal epithelial cells. We observed that induction of lytic infection of EBV triggers ATM activation and localization of DDR proteins at the viral replication compartments. Suppression of ATM activity using a small interfering RNA (siRNA) approach or a specific chemical inhibitor profoundly suppressed replication of EBV DNA and production of infectious virions in EBV-infected cells induced to undergo lytic reactivation. We further showed that phosphorylation of Sp1 at the serine-101 residue is essential in promoting the accretion of EBV replication proteins at the replication compartment, which is crucial for replication of viral DNA. Knockdown of Sp1 expression by siRNA effectively suppressed the replication of viral DNA and localization of EBV replication proteins to the replication compartments. Our study supports an important role of ATM activation in lytic reactivation of EBV in epithelial cells, and phosphorylation of Sp1 is an essential process downstream of ATM activation involved in the formation of viral replication compartments. Our study revealed an essential role of the ATM-dependent DDR pathway in lytic reactivation of EBV, suggesting a potential antiviral replication strategy using specific DDR inhibitors. IMPORTANCE Epstein-Barr virus (EBV) is closely associated with human malignancies, including undifferentiated nasopharyngeal carcinoma (NPC), which has a high prevalence in southern China. EBV can establish either latent or lytic infection depending on the cellular context of infected host cells. Recent studies have highlighted the importance of the DNA damage response (DDR), a surveillance mechanism that evolves to maintain genome integrity, in regulating lytic EBV replication. However, the underlying molecular events are largely undefined. ATM is consistently activated in EBV-infected epithelial cells when they are induced to undergo lytic reactivation. Suppression of ATM inhibits replication of viral DNA. Furthermore, we observed that phosphorylation of Sp1 at the serine-101 residue, a downstream event of ATM activation, plays an essential role in the formation of viral replication compartments for replication of virus DNA. Our study provides new insights into the mechanism through which EBV utilizes the host cell machinery to promote replication of viral DNA upon lytic reactivation.	[Hau, Pok Man; Deng, Wen; Jia, Lin; Yang, Jie; Tsao, Sai Wah] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Hau, Pok Man; Deng, Wen; Jia, Lin; Yang, Jie; Tsao, Sai Wah] Univ Hong Kong, Li Ka Shing Fac Med, Ctr Canc Res, Hong Kong, Hong Kong, Peoples R China; [Deng, Wen] Univ Hong Kong, Li Ka Shing Fac Med, Sch Nursing, Hong Kong, Hong Kong, Peoples R China; [Tsurumi, Tatsuya] Aichi Canc Ctr, Res Inst, Div Virol, Nagoya, Aichi 464, Japan; [Chiang, Alan Kwok Shing] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; [Huen, Michael Shing-Yan] Univ Hong Kong, Genome Stabil Res Lab, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Huen, Michael Shing-Yan] Univ Hong Kong, Ctr Canc Res, Hong Kong, Hong Kong, Peoples R China	Tsao, SW (reprint author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China.	gswtsao@hku.hk			Research Grants Council, General Research Fund [HKU 779312, HKU 779713]; Research Grants Council, Area of Excellence Scheme [AoE/M 06/08]; Research Grants Council, Theme Based Research Scheme [T12-401/13-R]; Hong Kong University CRCG grant	This work as supported by the following grants: Research Grants Council, General Research Fund, grants HKU 779312 and HKU 779713; Research Grants Council, Area of Excellence Scheme, grant number AoE/M 06/08; Research Grants Council, Theme Based Research Scheme, grant number T12-401/13-R; and a Hong Kong University CRCG grant.	Iwahori S, 2008, CELL SIGNAL, V20, P1795, DOI 10.1016/j.cellsig.2008.06.007; Hagemeier SR, 2012, J VIROL, V86, P13360, DOI 10.1128/JVI.01850-12; Tsai PF, 2011, J VIROL, V85, P2373, DOI 10.1128/JVI.01602-10; Liu PF, 2003, VIROLOGY, V310, P199, DOI 10.1016/S0042-6822(03)00145-4; Li RF, 2011, CELL HOST MICROBE, V10, P390, DOI 10.1016/j.chom.2011.08.013; Chang LK, 2005, NUCLEIC ACIDS RES, V33, P6528, DOI 10.1093/nar/gki956; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Baumann M, 1999, EMBO J, V18, P6095, DOI 10.1093/emboj/18.21.6095; Kulinski JM, 2012, J VIROL, V86, P12826, DOI 10.1128/JVI.00917-12; Kudoh A, 2005, J BIOL CHEM, V280, P8156, DOI 10.1074/jbc.M411405200; Schwartz RA, 2009, J VIROL, V83, P6269, DOI 10.1128/JVI.00318-09; Ragoczy T, 2001, J VIROL, V75, P5240, DOI 10.1128/JVI.75.11.5240-5251.2001; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Ariumi Y, 2005, J VIROL, V79, P2973, DOI 10.1128/JVI.79.5.2973-2978.2005; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446; Schepers A, 2001, EMBO J, V20, P4588, DOI 10.1093/emboj/20.16.4588; Huang SY, 2012, J GEN VIROL, V93, P139, DOI 10.1099/vir.0.034405-0; Chun RF, 1998, J VIROL, V72, P2615; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; GRUFFAT H, 1995, J VIROL, V69, P1878; Tsang SH, 2014, J VIROL, V88, P3285, DOI 10.1128/JVI.03656-13; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Kanda T, 2004, J VIROL, V78, P7004, DOI 10.1128/JVI.78.12.7004-7015.2004; Daikoku T, 2005, J VIROL, V79, P3409, DOI 10.1128/JVI.79.6.3409-3418.2005; Simoes M, 2013, VET MICROBIOL, V165, P140, DOI 10.1016/j.vetmic.2013.01.007; Hui KF, 2013, MOL CANCER THER, V12, P747, DOI 10.1158/1535-7163.MCT-12-0811; Sinclair Alison, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010544; Olofsson BA, 2007, MOL CANCER RES, V5, P1319, DOI 10.1158/1541-7786.MCR-07-0374; FIXMAN ED, 1992, J VIROL, V66, P5030; Bai L, 2007, BIOCHEM BIOPH RES CO, V359, P817, DOI 10.1016/j.bbrc.2007.05.197; Bailey SG, 2009, J VIROL, V83, P11116, DOI 10.1128/JVI.00512-09; Baumann M, 1998, J VIROL, V72, P8105; Beishline K, 2012, MOL CELL BIOL, V32, P3790, DOI 10.1128/MCB.00049-12; Chaudhuri B, 2001, P NATL ACAD SCI USA, V98, P10085, DOI 10.1073/pnas.181347998; Chua HH, 2007, J VIROL, V81, P2459, DOI 10.1128/JVI.02289-06; Chua HH, 2012, J MED VIROL, V84, P1279, DOI 10.1002/jmv.23316; Countryman JK, 2008, J VIROL, V82, P4706, DOI 10.1128/JVI.00116-08; Daikoku T, 2006, J BIOL CHEM, V281, P11422, DOI 10.1074/jbc.M510314200; Damania B, 2004, NAT REV MICROBIOL, V2, P656, DOI 10.1038/nrmicro958; DIRENZO L, 1993, IMMUNOL LETT, V38, P207, DOI 10.1016/0165-2478(93)90008-P; HAMMERSCHMIDT W, 1988, CELL, V55, P427, DOI 10.1016/0092-8674(88)90028-1; Hawkins JB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003685; Iwahori S, 2007, J VIROL, V81, P9653, DOI 10.1128/JVI.00568-07; JACKSON SP, 1990, CELL, V63, P155, DOI 10.1016/0092-8674(90)90296-Q; Kudoh A, 2009, J VIROL, V83, P6641, DOI 10.1128/JVI.00049-09; LeRoux F, 1996, J GEN VIROL, V77, P501, DOI 10.1099/0022-1317-77-3-501; Li X, 2007, J BIOL CHEM, V282, P36177, DOI 10.1074/jbc.M706912200; Li X, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000781; Liao GL, 2005, J VIROL, V79, P245, DOI 10.1128/JVI.79.1.245-256.2005; LIEBERMAN PM, 1990, J VIROL, V64, P1143; Liu PF, 1998, J VIROL, V72, P8230; Liu SF, 1997, VIROLOGY, V228, P11, DOI 10.1006/viro.1996.8371; Luo MH, 2007, J VIROL, V81, P1934, DOI 10.1128/JVI.01670-06; Ma BBY, 2013, INVEST NEW DRUG, V31, P30, DOI 10.1007/s10637-012-9828-4; Moody CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000605; SATO H, 1990, J VIROL, V64, P5295; SCHEPERS A, 1993, EMBO J, V12, P3921; SMITH PR, 1993, J VIROL, V67, P3217; Sugimoto A, 2011, J VIROL, V85, P6127, DOI 10.1128/JVI.00258-11; Tarakanova VL, 2007, CELL HOST MICROBE, V1, P275, DOI 10.1016/j.chom.2007.05.008; Tempera I, 2010, BBA-GENE REGUL MECH, V1799, P236, DOI 10.1016/j.bbagrm.2009.10.004; TSAO SW, 2014, J PATHOL; Wilkinson DE, 2006, J CELL SCI, V119, P2695, DOI 10.1242/jcs.02981; Yokoyama N, 1999, J GEN VIROL, V80, P2879; Zhang Q, 1997, VIROLOGY, V230, P22, DOI 10.1006/viro.1997.8470	66	5	5	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	JAN	2015	89	1					652	668		10.1128/JVI.01437-14		17	Virology	Virology	AX8RL	WOS:000347176100055		
J	Ishikawa, K; Minamimoto, T; Mizuki, T; Furukawa, H				Ishikawa, Kosuke; Minamimoto, Toshiyuki; Mizuki, Takeo; Furukawa, Hiroshi			Surgical Management of Extensive Peristomal Pyoderma Gangrenosum Associated With Colon Cancer	JOURNAL OF WOUND OSTOMY AND CONTINENCE NURSING			English	Article						colonic neoplasms; negative-pressure wound; ostomy; pyoderma gangrenosum skin transplantation; surgical stomas; therapy	VACUUM-ASSISTED CLOSURE; CLINICAL-FEATURES; THERAPY	BACKGROUND: Extensive peristomal skin ulcer due to pyoderma gangrenosum is difficult to manage and causes significant morbidity. CASE: A 69-year-old man presented with a 10x7-cm painful peristomal skin necrosis during cancer chemotherapy for metastatic colon adenocarcinoma. The diagnosis of peristomal pyoderma gangrenosum was made on the basis of the presence of the skin necrosis with a well-defined, undermined, violaceous border. One month after the presentation along with daily cleansing and minimal debridement without immunosuppressive treatments, wound bed preparation was deemed sufficient for a split-thickness skin graft using negative pressure wound therapy for graft fixation. One month after the operation, the ulcer was completely healed and the patient could manage ostomy pouching independently. He died of cancer 5 months later; no recurrence of the ulcer was observed during this period. CONCLUSION: Peristomal pyoderma gangrenosum was successfully treated with skin grafting after local wound management. Negative pressure wound therapy was useful for skin graft fixation in the peristomal region.	[Ishikawa, Kosuke; Minamimoto, Toshiyuki] Hakodate Municipal Hosp, Dept Plast & Reconstruct Surg, Hakodate, Hokkaido 0418680, Japan; [Mizuki, Takeo] Hakodate Municipal Hosp, Dept Nursing Care, Hakodate, Hokkaido 0418680, Japan; [Furukawa, Hiroshi] Hokkaido Univ Grad Sch Med, Dept Plast & Reconstruct Surg, Hakodate, Hokkaido, Japan	Ishikawa, K (reprint author), Hakodate Municipal Hosp, Dept Plast & Reconstruct Surg, Minato Chou 1-10-1, Hakodate, Hokkaido 0418680, Japan.	kishikawa-hok@umin.org					Kiran RP, 2005, DIS COLON RECTUM, V48, P1397, DOI 10.1007/s10350-004-0944-x; Birke-Sorensen H, 2011, J PLAST RECONSTR AES, V64, pS1, DOI 10.1016/j.bjps.2011.06.001; Chow RKP, 1996, J AM ACAD DERMATOL, V34, P1047, DOI 10.1016/S0190-9622(96)90285-6; Cliff S, 1999, DERMATOL SURG, V25, P299, DOI 10.1046/j.1524-4725.1999.08193.x; Folkedahl Beverly, 2002, J Wound Ostomy Continence Nurs, V29, P109, DOI 10.1067/mjw.2002.122211; Havlik RJ, 1998, PLAST RECONSTR SURG, V101, P1909, DOI 10.1097/00006534-199806000-00020; Hughes AP, 2000, JAMA-J AM MED ASSOC, V284, P1546, DOI 10.1001/jama.284.12.1546; Lyon CC, 2001, J DERMATOL TREAT, V12, P13, DOI 10.1080/095466301750163518; Lyon CC, 2000, J AM ACAD DERMATOL, V42, P992, DOI 10.1016/S0190-9622(00)90292-5; Niezgoda JA, 2006, PLAST RECONSTR SURG, V117, p24E, DOI 10.1097/01.prs.0000200776.13868.02; Payne P J, 1994, J Wound Ostomy Continence Nurs, V21, P206; Poritz LS, 2008, J AM COLL SURGEONS, V206, P311, DOI 10.1016/j.jamcollsurg.2007.07.023; Rozen SM, 2001, ANN PLAS SURG, V47, P310, DOI 10.1097/00000637-200109000-00015; Sakai H, 2006, J DERMATOL, V33, P68, DOI 10.1111/j.1346-8138.2006.00014.x; Von den Driesch P, 1997, BRIT J DERMATOL, V137, P1000, DOI 10.1046/j.1365-2133.1997.20022083.x; Yoong S, 2008, DIS COLON RECTUM, V51, P1577, DOI 10.1007/s10350-008-9240-5	16	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1071-5754	1528-3976		J WOUND OSTOMY CONT	J. Wound Ostomy Cont. Nurs.	JAN-FEB	2015	42	1					102	105		10.1097/WON.0000000000000098		4	Nursing	Nursing	AY3BZ	WOS:000347460800016		
J	Ryu, K; Iriuchishima, T; Oshida, M; Saito, A; Kato, Y; Tokuhashi, Y; Aizawa, S				Ryu, Keinosuke; Iriuchishima, Takanori; Oshida, Midori; Saito, Akiyoshi; Kato, Yuki; Tokuhashi, Yasuaki; Aizawa, Shin			Evaluation of the morphological variations of the meniscus: a cadaver study	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Anatomy; Meniscus; Morphology; Subtypes; Discoid	DISCOID LATERAL MENISCUS; MEDIAL MENISCUS; KNEE-JOINT; OSTEOARTHRITIS	The purpose of this study was to reveal the prevalence of the subtypes of the meniscus using human cadaver knees. Four hundred and thirty-seven cadaveric knees in 219 subjects (formalin fixed, Japanese population) with a median age of 83 years (54-97) were included in this study. All soft tissues surrounding the knee, excluding the meniscus, were resected, and macroscopic assessment of the meniscus was performed. Meniscus subtypes were classified as: (1) normal meniscus, (2) complete discoid, (3) incomplete discoid, (4) ring-shaped, and (5) double-layered. All subtypes of the meniscus were observed in the lateral meniscus. Complete discoid lateral meniscus was observed in 27 knees (6.2 %), incomplete discoid lateral meniscus was observed in 139 knees (31.8 %), ring-shaped lateral meniscus was observed in 4 knees (0.9 %), and double-layered meniscus was observed in 2 knees (0.5 %). This study reports the accurate prevalence of ring-shaped and double-layered meniscus. None of the subtypes were detected in the medial meniscus in this study. For clinical relevance, the results of this study can be useful in assisting the diagnosis of meniscus tear in clinical situations.	[Ryu, Keinosuke; Saito, Akiyoshi] Surugadai Nihon Univ Hosp, Dept Orthoped Surg, Tokyo, Japan; [Iriuchishima, Takanori] Kamimoku Hotsprings Hosp, Dept Orthoped Surg, Minakami, Japan; [Oshida, Midori] Tokyo Teishin Hosp, Dept Orthoped Surg, Tokyo, Japan; [Kato, Yuki; Tokuhashi, Yasuaki] Nihon Univ, Sch Med, Dept Orthoped Surg, Tokyo, Japan; [Aizawa, Shin] Nihon Univ, Sch Med, Dept Funct Morphol, Tokyo, Japan	Ryu, K (reprint author), Surugadai Nihon Univ Hosp, Dept Orthoped Surg, Chiyodaku Kanda Surugadai 1-8-13, Tokyo, Japan.	keinosukeryu@yahoo.co.jp					Akgun I, 1998, ARTHROSCOPY, V14, P512, DOI 10.1016/S0749-8063(98)70082-9; Pandey V, 2010, KNEE SURG SPORT TR A, V18, P543, DOI 10.1007/s00167-009-0924-8; Pauli C, 2011, OSTEOARTHR CARTILAGE, V19, P1132, DOI 10.1016/j.joca.2011.05.008; Makris EA, 2011, BIOMATERIALS, V32, P7411, DOI 10.1016/j.biomaterials.2011.06.037; Arnold MP, 2000, ARTHROSCOPY, V16, P852, DOI 10.1053/jars.2000.8244; Atay OA, 2002, KNEE SURG SPORT TR A, V10, P280, DOI 10.1007/s00167-002-0292-0; Gines-Cespedosa A, 2007, CLIN ANAT, V20, P994, DOI 10.1002/ca.20516; KAPLAN EB, 1957, J BONE JOINT SURG AM, V39, P77; Bae JH, 2012, ARTHROSCOPY, V28, P936, DOI 10.1016/j.arthro.2011.12.003; CASSCELLS SW, 1978, CLIN ORTHOP RELAT R, P225; Chen LX, 2013, KNEE SURG SPORT TR A, V21, P398, DOI 10.1007/s00167-012-1979-5; Flouzat-Lachaniette C H, 2011, Orthop Traumatol Surg Res, V97, P826, DOI 10.1016/j.otsr.2011.07.011; Hwang SH, 2012, OSTEOARTHR CARTILAGE, V20, P110, DOI 10.1016/j.joca.2011.11.005; Karataglis D, 2006, KNEE, V13, P415, DOI 10.1016/j.knee.2006.04.009; Kato Yuki, 2004, Mod Rheumatol, V14, P154; Koukoulias NE, 2011, BMJ CASE REP, DOI [10.1136/bcr.10.2011.4914, DOI 10.1136/BCR.10.2011.4914]; SUZUKI S, 1991, Arthroscopy, V7, P267, DOI 10.1016/0749-8063(91)90124-G; Tachibana Yomei, 2003, Arthroscopy, V19, pE12; Takayama K, 2009, KNEE SURG SPORT TR A, V17, P1336, DOI 10.1007/s00167-009-0815-z; Wang Q, 2011, KNEE SURG SPORT TR A, V19, P2050, DOI 10.1007/s00167-011-1536-7; Watanabe M., 1969, ATLAS OF ARTHROSCOPY, V2nd; Watson-Jones R, 1930, P ROY SOC MED, V23, P1588; Yaniv Moshe, 2007, J Child Orthop, V1, P89, DOI 10.1007/s11832-007-0029-1	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	JAN	2015	23	1					15	19		10.1007/s00167-013-2612-y		5	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	AY2FX	WOS:000347405200005		
J	Kamimura, M; Umehara, J; Takahashi, A; Aizawa, T; Itoi, E				Kamimura, Masayuki; Umehara, Jutaro; Takahashi, Atsushi; Aizawa, Toshimi; Itoi, Eiji			Medial meniscus tear morphology and related clinical symptoms in patients with medial knee osteoarthritis	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Medial meniscal tears; Medial knee osteoarthritis; Clinical symptoms; Meniscus tear morphology	POSTERIOR HORN; FOLLOW-UP; RADIOGRAPHIC OSTEOARTHRITIS; MATCHED CONTROLS; ELDERLY PERSONS; RADIAL TEARS; MENISCECTOMY; ASSOCIATION; ROOT; MRI	The objective of this study was to examine the association between clinical symptoms and arthroscopic meniscal findings in patients with early to moderate medial knee osteoarthritis. One hundred and four patients (110 knees) were selected from a group of 132 patients (140 knees) aged a parts per thousand yen50 years who underwent arthroscopic surgery for medial meniscal tears. Inclusion criteria were as follows: (a) medial knee osteoarthritis and (b) simple medial meniscal tears extending to a parts per thousand yen1/4 of the meniscal margin. Subjective symptoms, location and nature of the pain, as well as the physical findings observed during initial assessment were evaluated using a standardized assessment chart. The relationship between arthroscopic meniscal findings and clinical symptoms was then analysed. Isolated meniscal tears were classified into four types: radial tear of the middle segment; posterior root tear; horizontal tear of the posterior segment; and flap tear. The following symptoms were reported at significantly higher frequencies: pain on standing and a catching sensation in patients with flap tears; pain on walking and nocturnal pain on rolling over in bed in patients with radial tears of the middle segment; and popliteal pain in patients with posterior root tears. This study demonstrates a relationship between the type of medial meniscal tear and characteristic clinical symptoms reported by patients with medial knee osteoarthritis. These results suggest that clinical symptoms in patients with osteoarthritis of the knee may be caused by meniscal tears. This evidence may help to better inform patients and surgeons regarding choice of treatment. Case control study, Level III.	[Kamimura, Masayuki; Takahashi, Atsushi; Aizawa, Toshimi; Itoi, Eiji] Tohoku Univ, Dept Orthopaed Surg, Sch Med, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Umehara, Jutaro] Senboku Kumiai Gen Hosp, Dept Orthopaed Surg, Daisen, Akita 0140027, Japan	Takahashi, A (reprint author), Tohoku Univ, Dept Orthopaed Surg, Sch Med, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	a-takahashi@med.tohoku.ac.jp					Yao L, 2004, SKELETAL RADIOL, V33, P260, DOI 10.1007/s00256-004-0751-4; Englund M, 2007, ARTHRITIS RHEUM, V56, P4048, DOI 10.1002/art.23071; Zanetti M, 2003, AM J ROENTGENOL, V181, P635; Christoforakis J, 2005, ARTHROSCOPY, V21, P1366, DOI 10.1016/j.arthro.2005.08.031; Ozkoc G, 2008, KNEE SURG SPORT TR A, V16, P849, DOI 10.1007/s00167-008-0569-z; Herrlin S, 2007, KNEE SURG SPORT TR A, V15, P393, DOI 10.1007/s00167-006-0243-2; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Robertson DD, 2009, J BONE JOINT SURG BR, V91B, P190, DOI 10.1302/0301-620X.91B2.21097; Hunter DJ, 2006, ARTHRITIS RHEUM, V54, P795, DOI 10.1002/art.21724; Pujol N, 2013, KNEE SURG SPORT TR A, V21, P1530, DOI 10.1007/s00167-012-2099-y; Herrlin SV, 2013, KNEE SURG SPORT TR A, V21, P358, DOI 10.1007/s00167-012-1960-3; Englund M, 2009, ARTHRITIS RHEUM, V60, P831, DOI 10.1002/art.24383; Bhattacharyya T, 2003, J BONE JOINT SURG AM, V85A, P4; Dervin GF, 2003, J BONE JOINT SURG AM, V85A, P10; Allaire R, 2008, J BONE JOINT SURG AM, V90A, P1922, DOI 10.2106/JBJS.G.00748; Pena E, 2005, CLIN BIOMECH, V20, P498, DOI 10.1016/j.clinbiomech.2005.01.009; Englund M, 2003, ARTHRITIS RHEUM, V48, P2178, DOI 10.1002/art.11088; Englund M, 2008, NEW ENGL J MED, V359, P1108, DOI 10.1056/NEJMoa0800777; Felson DT, 2001, ANN INTERN MED, V134, P541; Bin SI, 2004, ARTHROSCOPY, V20, P373, DOI 10.1016/j.arthro.2004.01.004; Roos EM, 2001, OSTEOARTHR CARTILAGE, V9, P316, DOI 10.1053/joca.2000.0391; Bin SI, 2008, ARTHROSCOPY, V24, P264, DOI 10.1016/j.arthro.2007.08.028; Choi Chul-Jun, 2011, Clin Orthop Surg, V3, P128, DOI 10.4055/cios.2011.3.2.128; Crevoisier X, 2001, ARTHROSCOPY, V17, P732, DOI 10.1053/jars.2001.20099; DANDY DJ, 1990, J BONE JOINT SURG BR, V72, P628; Day B, 1985, Arthroscopy, V1, P58, DOI 10.1016/S0749-8063(85)80080-3; Dervin GF, 2001, CAN J SURG, V44, P267; Habata T, 2004, ARCH ORTHOP TRAUM SU, V124, P642, DOI 10.1007/s00402-004-0659-4; Jones A O, 2006, Australas Radiol, V50, P306, DOI 10.1111/j.1440-1673.2006.01586.x; Matsusue Y, 1996, ARTHROSCOPY, V12, P39, DOI 10.1016/S0749-8063(96)90217-0; Metcalf MH, 2004, AM J SPORT MED, V32, P675, DOI 10.1177/0095399703258743; NOBLE J, 1975, J BONE JOINT SURG BR, V57, P180	32	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	JAN	2015	23	1					158	163		10.1007/s00167-014-2939-z		6	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	AY2FX	WOS:000347405200026		
J	Takahashi, H; Hara, H; Goto, T; Kamakari, K; Wataru, N; Mohri, S; Takahashi, N; Suzuki, H; Shibata, D; Kawada, T				Takahashi, Haruya; Hara, Hideyuki; Goto, Tsuyoshi; Kamakari, Kosuke; Wataru, Nomura; Mohri, Shinsuke; Takahashi, Nobuyuki; Suzuki, Hideyuki; Shibata, Daisuke; Kawada, Teruo			13-Oxo-9(Z),11(E),15(Z)-octadecatrienoic Acid Activates Peroxisome Proliferator-Activated Receptor gamma in Adipocytes	LIPIDS			English	Article						PPAR gamma; Oxylipin; Adipocyte; LC-MS; Adiponectin; Glucose uptake	REGULATE GENE-EXPRESSION; NECROSIS-FACTOR-ALPHA; PPAR-GAMMA; 3T3-L1 ADIPOCYTES; LIPID-METABOLISM; GLUCOSE-UPTAKE; INSULIN-RESISTANCE; HEPG2 HEPATOCYTES; FATTY-ACIDS; CELLS	Peroxisome proliferator-activated receptor (PPAR)gamma is expressed in adipose tissue and plays a key role in the regulation of adipogenesis. PPAR gamma activators are known to have potent antihyperglycemic activity and are used to treat insulin resistance associated with diabetes. Therefore, many natural and synthetic agonists of PPAR gamma are used in the treatment of glucose disorders. In the present study, we found that 13-oxo-9(Z),11(E),15(Z)-octadecatrienoic acid (13-oxo-OTA), a linolenic acid derivative, is present in the extract of tomato (Solanum lycopersicum), Mandarin orange (Citrus reticulata), and bitter gourd (Momordica charantia). We also found that 13-oxo-OTA activated PPAR gamma and induced the mRNA expression of PPAR gamma target genes in adipocytes, thereby promoting differentiation. Furthermore, 13-oxo-OTA induced secretion of adiponectin and stimulated glucose uptake in adipocytes. To our knowledge, this is the first study to report that 13-oxo-OTA induces adipogenesis through PPAR gamma activation and to present 13-oxo-OTA as a valuable food-derived compound that may be applied in the management of glucose metabolism disorders.	[Takahashi, Haruya; Hara, Hideyuki; Goto, Tsuyoshi; Kamakari, Kosuke; Wataru, Nomura; Mohri, Shinsuke; Takahashi, Nobuyuki; Kawada, Teruo] Kyoto Univ, Lab Mol Funct Food, Div Food Sci & Biotechnol, Grad Sch Agr, Kyoto 6110011, Japan; [Goto, Tsuyoshi; Takahashi, Nobuyuki; Kawada, Teruo] Kyoto Univ, Res Unit Physiol Chem, Kyoto 6068501, Japan; [Suzuki, Hideyuki; Shibata, Daisuke] Kazusa DNA Res Inst, Kisarazu, Chiba 2920818, Japan	Kawada, T (reprint author), Kyoto Univ, Res Unit Physiol Chem, Kyoto 6068501, Japan.	fat@kais.kyoto-u.ac.jp			Research and Development Projects for Application in Promoting New Policies Agriculture, Forestry, and Fisheries of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan [22228001, 24688015]; Japan Society for the Promotion of Science [24521]	The authors thank S. Shinoto and M. Sakai for secretarial and technical support, respectively. This work was supported in part by Research and Development Projects for Application in Promoting New Policies Agriculture, Forestry, and Fisheries of Japan, by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (22228001 and 24688015), and by Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists (24521).	Kim YI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031317; Duval C, 2002, TRENDS MOL MED, V8, P422, DOI 10.1016/S1471-4914(02)02385-7; Goto T, 2005, BIOCHEM BIOPH RES CO, V337, P440, DOI 10.1016/j.bbrc.2005.09.077; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; Shin DW, 2009, BIOCHEM PHARMACOL, V77, P125, DOI 10.1016/j.bcp.2008.09.033; Zapata-Bustos R, 2014, J ETHNOPHARMACOL, V152, P546, DOI 10.1016/j.jep.2014.01.041; Pajvani UB, 2004, J BIOL CHEM, V279, P12152, DOI 10.1074/jbc.M311113200; Chinetti G, 2000, INFLAMM RES, V49, P497, DOI 10.1007/s000110050622; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI200421625]; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Grechkin A, 1998, PROG LIPID RES, V37, P317, DOI 10.1016/S0163-7827(98)00014-9; Takahashi N, 2002, FEBS LETT, V514, P315, DOI 10.1016/S0014-5793(02)02390-6; Tonelli J, 2004, DIABETES, V53, P1621, DOI 10.2337/diabetes.53.6.1621; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Kim YI, 2011, MOL NUTR FOOD RES, V55, P585, DOI 10.1002/mnfr.201000264; Sheu SH, 2005, BIOCHEMISTRY-US, V44, P1193, DOI 10.1021/bi048032c; STEPHENS JM, 1991, J BIOL CHEM, V266, P21839; Kozak KR, 2002, J BIOL CHEM, V277, P23278, DOI 10.1074/jbc.M201084200; Goto T, 2011, BIOCHEM J, V438, P111, DOI 10.1042/BJ20101939; Kobayashi T, 2012, AM J PHYSIOL-ENDOC M, V302, pE1461, DOI 10.1152/ajpendo.00623.2011; Farmer EE, 2003, CURR OPIN PLANT BIOL, V6, P372, DOI 10.1016/S1369-5266(03)00045-1; Escher P, 2000, MUTAT RES-FUND MOL M, V448, P121, DOI 10.1016/S0027-5107(99)00231-6; Kintscher U, 2005, AM J PHYSIOL-ENDOC M, V288, pE287, DOI 10.1152/ajpendo.00440.2004; Iwata M, 2001, DIABETES, V50, P1083, DOI 10.2337/diabetes.50.5.1083; Takahashi N, 2003, FEBS LETT, V550, P190, DOI 10.1016/S0014-5793(03)00859-7; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Chambrier C, 2002, OBES RES, V10, P518, DOI 10.1038/oby.2002.70; Brun RP, 1997, J ENDOCRINOL, V155, P217, DOI 10.1677/joe.0.1550217; Choi SS, 2009, LIFE SCI, V84, P908, DOI 10.1016/j.lfs.2009.04.001; Delerive P, 2000, FEBS LETT, V471, P34, DOI 10.1016/S0014-5793(00)01364-8; Gardner AN, 1999, RUSS J PLANT PHYSL, V46, P114; Grygiel-Gorniak B, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-17; Han KL, 2006, BIOL PHARM BULL, V29, P110, DOI 10.1248/bpb.29.110; Medina-Gomez G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030064; NOLAN JJ, 1994, NEW ENGL J MED, V331, P1188, DOI 10.1056/NEJM199411033311803; Reinhold A, 2007, BIOCHEM PHARMACOL, V74, P612; Reyes C.D.L., 2014, PHYTOCHEMISTRY, V102, P152; Shang WB, 2007, LIFE SCI, V80, P618, DOI 10.1016/j.lfs.2006.10.021; Smilowitz JT, 2013, MOL NUTR FOOD RES, V57, P1319, DOI 10.1002/mnfr.201200808; Takahaski N, 2011, BIOFACTORS, V37, P309, DOI 10.1002/biof.165; Yang Y, 2007, BIOCHEM BIOPH RES CO, V353, P225, DOI 10.1016/j.bbrc.2006.11.134	44	3	3	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0024-4201	1558-9307		LIPIDS	Lipids	JAN	2015	50	1					3	12		10.1007/s11745-014-3972-x		10	Biochemistry & Molecular Biology; Nutrition & Dietetics	Biochemistry & Molecular Biology; Nutrition & Dietetics	AY0KH	WOS:000347285000002		
J	Shibamoto, S; Gooley, A; Yamamoto, K				Shibamoto, Shigeaki; Gooley, Andrew; Yamamoto, Kouhei			Separation Behavior of Octadecadienoic Acid Isomers and Identification of cis- and trans-Isomers Using Gas Chromatography	LIPIDS			English	Article						trans Fatty acid; Fatty acid analysis; GLC (GC) (gas-liquid chromatography); Mass spectrometry; HPLC (high performance liquid chromatography)	TRANS-FATTY-ACIDS; DIMETHYL DISULFIDE ADDUCTS; DOUBLE-BOND POSITION; MASS-SPECTROMETRY; METHYL-ESTERS; STATIONARY PHASES; LIQUID-CHROMATOGRAPHY; COLUMNS; OILS; DERIVATIVES	Using a strongly polar cyanopropyl capillary column we have investigated the gas chromatography (GC) separation behaviors of 24 octadecadienoic acid methyl ester (18:2ME) isomers compared against saturated methyl stearate (18:0ME) and arachidic acid methyl ester (20:0ME), and the dependency on the GC column temperature. The 24 isomers were obtained by performing cis-to trans-isomerization of six regioisomers: five of the 18:2ME isomers were prepared by the partial reduction of methyl alpha-linolenate and methyl gamma-linolenate C18 trienoic acids with different double bond positions, whereas the sixth isomer, 18:2ME (c5, c9), was obtained from a raw constituent fatty acid methyl ester (FAME) sample extracted from Japanese yew seeds. There are no reference standards commercially available for 18:2ME isomers, and in elucidating the elution order of these isomers this study should help the future identification of cis- and trans-type of 18:2ME. We also report the identification method of cis- and trans-type of FAME using equivalent chain lengths and attempt the identification of cis- and trans-type of 18:2ME isomers from partially hydrogenated canola oil.	[Shibamoto, Shigeaki] Shimadzu Co Ltd, Seika, Kyoto 6190237, Japan; [Gooley, Andrew] SGE Analyt Sci, Ringwood, Vic 3134, Australia; [Yamamoto, Kouhei] Osaka Prefecture Univ, Grad Sch Comprehens Rehabil, Osaka 5838555, Japan	Shibamoto, S (reprint author), Shimadzu Co Ltd, 3-9-4 Hikaridai, Seika, Kyoto 6190237, Japan.	sibamoto@shimadzu.co.jp					Ackman R. G., 1986, ANAL OILS FATS, P137; ACKMAN RG, 1974, J AM OIL CHEM SOC, V51, P42, DOI 10.1007/BF00000011; ANDO Y, 1989, J AM OIL CHEM SOC, V66, P1323; RATNAYAKE WMN, 1990, J AM OIL CHEM SOC, V67, P940, DOI 10.1007/BF02541853; Delmonte P, 2012, J CHROMATOGR A, V1233, P137, DOI 10.1016/j.chroma.2012.02.012; Mozaffarian D, 2009, EUR J CLIN NUTR, V63, pS22, DOI 10.1038/sj.ejcn.1602976; Mjos SA, 2003, J CHROMATOGR A, V1015, P151, DOI 10.1016/S0021-9673(03)01240-8; [Anonymous], 2005, CE1H05 AOCS; L'Abbe MR, 2009, EUR J CLIN NUTR, V63, pS50, DOI 10.1038/ejcn.2009.14; Precht D, 2000, NAHRUNG, V44, P222, DOI 10.1002/1521-3803(20000701)44:4<222::AID-FOOD222>3.0.CO;2-9; SHANTHA NC, 1992, J CHROMATOGR, V624, P37, DOI 10.1016/0021-9673(92)85673-H; EDER K, 1995, J CHROMATOGR B, V671, P113, DOI 10.1016/0378-4347(95)00142-6; Delmonte P, 2011, J CHROMATOGR A, V1218, P545, DOI 10.1016/j.chroma.2010.11.072; Martin CA, 2008, J CHROMATOGR A, V1194, P111, DOI 10.1016/j.chroma.2008.04.033; Goto H, 2012, J OLEO SCI, V61, P49, DOI 10.5650/jos.61.49; Aldai N, 2013, EUR J LIPID SCI TECH, V115, P1378, DOI 10.1002/ejlt.201300072; CHRISTIE WW, 1989, J LIPID RES, V30, P1471; BUSER HR, 1983, ANAL CHEM, V55, P818, DOI 10.1021/ac00257a003; VINCENTI M, 1987, ANAL CHEM, V59, P694, DOI 10.1021/ac00132a003; DUNKELBLUM E, 1985, J CHEM ECOL, V11, P265, DOI 10.1007/BF01411414; Mozaffarian D, 2009, EUR J CLIN NUTR, V63, pS5, DOI 10.1038/sj.ejcn.1602973; Uauy R, 2009, EUR J CLIN NUTR, V63, pS68, DOI 10.1038/ejcn.2009.15; Baylin A, 2003, J NUTR, V133, P1186; Christie WW, 2010, LIPID ANAL ISOLATION, P446; Christie WW, 1982, LIPID ANAL, P63; Christie WW, 1992, ADV LIPID METHODOLOG, P1; Christie WW, 2013, AOCS LIPID LIB MAS 7; CHRISTIE WW, 1988, J CHROMATOGR, V447, P305; Eulitz K, 1999, LIPIDS, V34, P873, DOI 10.1007/s11745-999-0435-z; FOLCH J, 1957, J BIOL CHEM, V226, P497; Harynuk J, 2006, CHROMATOGRAPHIA, V63, pS61, DOI 10.1365/s10337-006-0714-0; Kiridena W, 2007, J SEP SCI, V30, P740, DOI 10.1002/jssc.200600453; Kuksis A, 1978, HDB LIPID RES, V1, P1; MENSINK RP, 1990, NEW ENGL J MED, V323, P439, DOI 10.1056/NEJM199008163230703; Mjos SA, 2005, J CHROMATOGR A, V1100, P185, DOI 10.1016/j.chroma.2005.09.079; PRIVETT OS, 1966, LIPIDS, V1, P98, DOI 10.1007/BF02532998; Ragonese C, 2009, ANAL CHEM, V81, P5561, DOI 10.1021/ac9007094; Ratnayake WMN, 2004, J AOAC INT, V87, P523; Kiran CR, 2013, GRASAS ACEITES, V64, P95, DOI 10.3989/gya.073312; Shibahara A, 1985, J JPN OIL CHEM SOC, V34, P618; Shibahara A, 2008, J AM OIL CHEM SOC, V85, P93, DOI 10.1007/s11746-007-1169-7; SHIBAHARA A, 1993, BIOCHIM BIOPHYS ACTA, V1170, P245, DOI 10.1016/0005-2760(93)90006-U; SHIBAHARA A, 1986, LIPIDS, V21, P388, DOI 10.1007/BF02534933; SNYDER JM, 1982, J AM OIL CHEM SOC, V59, P469, DOI 10.1007/BF02636144; United States Department of Agriculture, 2013, FED REG; WOLFF RL, 1994, J AM OIL CHEM SOC, V71, P907, DOI 10.1007/BF02540472; YAMAMOTO K, 1991, CHEM PHYS LIPIDS, V60, P39, DOI 10.1016/0009-3084(91)90013-2; Yamamoto K, 1991, J JPN OIL CHEM SOC, V40, P497; YAMAMOTO K, 1991, LIPIDS, V26, P948, DOI 10.1007/BF02535982; Zeng AX, 2013, ANAL CHIM ACTA, V803, P166, DOI 10.1016/j.aca.2013.07.002	50	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0024-4201	1558-9307		LIPIDS	Lipids	JAN	2015	50	1					85	100		10.1007/s11745-014-3966-8		16	Biochemistry & Molecular Biology; Nutrition & Dietetics	Biochemistry & Molecular Biology; Nutrition & Dietetics	AY0KH	WOS:000347285000009		
J	Suzuki, A; Niibori, Y; Fomin, SA; Chugunov, VA; Hashida, T				Suzuki, Anna; Niibori, Yuichi; Fomin, Sergei A.; Chugunov, Vladimir A.; Hashida, Toshiyuki			Analysis of Water Injection in Fractured Reservoirs Using a Fractional-Derivative-Based Mass and Heat Transfer Model	MATHEMATICAL GEOSCIENCES			English	Article						Geothermal reservoir; Tracer test; Thermal breakthrough; Fractional advection-dispersion equation; Fault zone	ADVECTION-DISPERSION EQUATION; THERMAL BREAKTHROUGH; TRANSPORT; ROCKS; MEDIA	This research proposes a numerical scheme for evaluating the effect of cold-water injection into a geothermal reservoir. A fractional heat transfer equation (fHTE) is derived based on the fractional advection-dispersion equation (fADE) that describes non-Fickian dispersion in a fractured reservoir. Numerical simulations are conducted to examine the applicability of the fADE and the fHTE in interpreting tracer and thermal responses in a fault-related subsidiary structure associated with fractal geometry. A double-peak is exhibited when the surrounding rocks have a constant permeability. On the other hand, the peak in the tracer response gradually decreases when the permeability varies with distance from the fault zone according to a power law, which can be described by the fADE. The temperature decline is more gradual when the permeability of surrounding rocks varies spatially than when they have a constant permeability. The fHTE demonstrates good agreement with the temperature profiles for the different permeabilities of surrounding rocks. The retardation parameters in the fADE and the fHTE increase with the permeability of the surrounding rocks. The orders of the temporal fractional derivatives in the fADE and the fHTE vary with the permeability patterns.	[Suzuki, Anna] Tohoku Univ, Grad Sch Environm Studies, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Niibori, Yuichi; Hashida, Toshiyuki] Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 9808579, Japan; [Fomin, Sergei A.] Calif State Univ Chico, Dept Math & Stat, Chico, CA 95929 USA; [Chugunov, Vladimir A.] Kazan Fed Univ, Dept Appl Math, Kazan 420008, Russia	Suzuki, A (reprint author), Tohoku Univ, Grad Sch Environm Studies, Aoba Ku, 6-6-11-707 Aramaki Aza Aoba, Sendai, Miyagi 9808579, Japan.	anna.suzuki@rift.mech.tohoku.ac.jp			 [23-3250]	This work was supported by a Grant-in-Aid for the Japan Society for the Promotion of Science (Grant Number 23-3250).	Aksoy N, 2008, GEOTHERMICS, V37, P444, DOI 10.1016/j.geothermics.2007.12.003; Huang QZ, 2008, ADV WATER RESOUR, V31, P1578, DOI 10.1016/j.advwatres.2008.07.002; Benson DA, 2000, WATER RESOUR RES, V36, P1403, DOI 10.1029/2000WR900031; Shook GM, 2001, GEOTHERMICS, V30, P573, DOI 10.1016/S0375-6505(01)00015-3; GRINGARTEN AC, 1975, J GEOPHYS RES, V80, P4956, DOI 10.1029/JB080i035p04956; COATS KH, 1964, SOC PETROL ENG J, V4, P73; Savage HM, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007665; Evans JP, 1997, J STRUCT GEOL, V19, P1393, DOI 10.1016/S0191-8141(97)00057-6; Axelsson G, 2001, GEOTHERMICS, V30, P697, DOI 10.1016/S0375-6505(01)00026-8; Bodvarsson G., 1972, GEOTHERMICS, V1, P63, DOI DOI 10.1016/0375-6505(72)90013-2; BODVARSSON GS, 1982, J GEOPHYS RES, V87, P1031, DOI 10.1029/JB087iB02p01031; Fomin S, 2005, P ROY SOC A-MATH PHY, V461, P2923, DOI 10.1098/rspa.2005.1487; Horne RN, 1981, GRC T, V5, P291; Jaeger J. C., 1959, CONDUCTION HEAT SOLI; Kocabas I, 2004, GEOTHERMICS, V34, P27; Lauwerier H.A., 1955, APPL SCI RES       A, V5, P145, DOI DOI 10.1007/8F03184614; Le Garzic E, 2011, J STRUCT GEOL, V33, P519, DOI 10.1016/j.jsg.2011.01.012; Massart B, 2010, P WORLD GEOTHERM C, V1, P1; Pruess K., 1999, LBNL43134; Samko S., 1993, FRACTIONAL INTEGRALS; Suzuki A, 2012, GRC T, V36, P1391; Welty J., 2007, FUNDAMENTALS MOMENTU; WOODS AW, 1993, J FLUID MECH, V251, P563, DOI 10.1017/S0022112093003520; Xiao BQ, 2009, PHYS LETT A, V373, P4178, DOI 10.1016/j.physleta.2009.09.020; Zhang XX, 2007, ADV WATER RESOUR, V30, P1205, DOI 10.1016/j.advwatres.2006.11.002	25	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1874-8961	1874-8953		MATH GEOSCI	Math Geosci.	JAN	2015	47	1			SI		31	49		10.1007/s11004-014-9522-5		19	Geosciences, Multidisciplinary; Mathematics, Interdisciplinary Applications	Geology; Mathematics	AY6SD	WOS:000347694900003		
J	Kenzaka, T; Onishi, T				Kenzaka, Tsuneaki; Onishi, Tsubasa			Top of the Basilar Syndrome With Disturbed Consciousness	MAYO CLINIC PROCEEDINGS			English	Editorial Material									[Kenzaka, Tsuneaki; Onishi, Tsubasa] Jichi Med Univ Hosp, Div Gen Internal Med, Shimotsuke, Tochigi 3290498, Japan	Kenzaka, T (reprint author), Jichi Med Univ Hosp, Div Gen Internal Med, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	smile.kenzaka@jichi.ac.jp					Hattingen E, 2010, CLIN NEURORADIOL, V20, P81, DOI 10.1007/s00062-010-0009-6; PESSIN MS, 1987, NEUROLOGY, V37, P1742	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0025-6196	1942-5546		MAYO CLIN PROC	Mayo Clin. Proc.	JAN	2015	90	1					162	162		10.1016/j.mayocp.2014.06.025		1	Medicine, General & Internal	General & Internal Medicine	AY2ZW	WOS:000347455400026		
J	Chu, D; Nemoto, A; Ito, H				Chu, Donghui; Nemoto, Akihiko; Ito, Hiroshi			Biomimetic superhydrophobic polymer surfaces by replication of hierarchical structures fabricated using precision tooling machine and anodized aluminum oxidation	MICROSYSTEM TECHNOLOGIES-MICRO-AND NANOSYSTEMS-INFORMATION STORAGE AND PROCESSING SYSTEMS			English	Article							LOTUS LEAF; WETTABILITY; ARRAYS; HYDROPHOBICITY; FORCE; MICRO; NANO	This report describes a simple and controllable fabrication method of producing superhydrophobic polymer surfaces replicated from aluminum mold inserts in a thermal nanoimprint prepared using precision tooling and an anodized aluminum oxidation process. This producible fabrication method is applicable in the polymer manufacturing field. Patterned hierarchical polymer structures achieved a contact angle greater than 150A degrees without additional coatings. The contact angles were controlled by changing the nanorod length and area fraction of micro-sized convex. Additionally, patterned polymer structures exhibited droplet evaporation behaviors, which show the hysteresis of the solid surface. The hierarchical polymer structures show lower hysteresis than that of microstructures or nanostructures because of the short continuous contact line of nanoscale three-phase contact line and the large area of the micrometer air pocket.	[Chu, Donghui; Nemoto, Akihiko; Ito, Hiroshi] Yamagata Univ, Grad Sch Sci & Engn, Yonezawa, Yamagata 9928510, Japan; [Chu, Donghui] Samsung Cheil Ind Inc, Div Chem, Uiwang Si 437711, Gyeonggi Do, South Korea	Chu, D (reprint author), Yamagata Univ, Grad Sch Sci & Engn, 4-3-16 Jonan, Yonezawa, Yamagata 9928510, Japan.	tea40056@st.yamagata-u.ac.jp			Cheil Industries Inc., Korea	This research was financially supported by Cheil Industries Inc., Korea.	Cui YH, 2012, COLLOID SURFACE A, V394, P8, DOI 10.1016/j.colsurfa.2011.11.014; Sun MH, 2005, LANGMUIR, V21, P8978, DOI 10.1021/la050316q; Masuda H, 1997, APPL PHYS LETT, V71, P2770, DOI 10.1063/1.120128; Zhu K, 2007, NANO LETT, V7, P3739, DOI 10.1021/nl072145a; Zhang C, 2011, CHEM PHYS LETT, V508, P134, DOI 10.1016/j.cplett.2011.04.041; Bhushan B, 2009, PHILOS T R SOC A, V367, P1445, DOI 10.1098/rsta.2009.0011; Deng X, 2012, SCIENCE, V335, P67, DOI 10.1126/science.1207115; Li AP, 1998, J APPL PHYS, V84, P6023, DOI 10.1063/1.368911; Huovinen E, 2012, LANGMUIR, V28, P14747, DOI 10.1021/la303358h; Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546; Kwon Y, 2009, LANGMUIR, V25, P6129, DOI 10.1021/la803249t; Kako T, 2004, J MATER SCI, V39, P547, DOI 10.1023/B:JMSC.0000011510.92644.3f; Saarikoski I, 2009, APPL SURF SCI, V255, P9000, DOI 10.1016/j.apsusc.2009.06.073; Feng L, 2008, LANGMUIR, V24, P4114, DOI 10.1021/la703821h; Chu D, 2014, MICROSYST TECHNOL, V20, P193, DOI 10.1007/s00542-013-1758-3; Cortese B, 2008, LANGMUIR, V24, P2712, DOI 10.1021/la702764x; Han W, 2006, LANGMUIR, V22, P7956, DOI 10.1021/la061414u; Lee SM, 2007, J MICROMECH MICROENG, V17, P687, DOI 10.1088/0960-1317/17/4/003; Lee W, 2004, LANGMUIR, V20, P7665, DOI 10.1021/la049411+; Saarikoski I, 2012, SURF SCI, V606, P91, DOI 10.1016/j.susc.2011.09.005; Soolaman DM, 2005, J PHYS CHEM B, V109, P17967, DOI 10.1021/jp051182s; Xue CH, 2010, SCI TECHNOL ADV MAT, V11, P1	22	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0946-7076	1432-1858		MICROSYST TECHNOL	Microsyst. Technol.	JAN	2015	21	1					123	130		10.1007/s00542-014-2152-5		8	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Science & Technology - Other Topics; Materials Science; Physics	AY4MU	WOS:000347553500015		
J	Lee, JI; Shikida, M; Sato, K				Lee, Jeong Il; Shikida, Mitsuhiro; Sato, Kazuo			Polymer micromachining technologies for a table-shaped tactile sensor using thick sacrificial layer	MICROSYSTEM TECHNOLOGIES-MICRO-AND NANOSYSTEMS-INFORMATION STORAGE AND PROCESSING SYSTEMS			English	Article							OXYGEN PLASMA; POLYIMIDE; ADHESION; FILMS; ARRAY	This paper describes fabrication of a slim and flexible tactile sensor which has a three-dimensional table-shaped sensing part to equip intelligent robot's finger tips. To fabricate a three-dimensional structure of full polymer-based sensor, we propose a new fabrication method in polymer micromachining technologies such as thermo-compatible layer-by-layer process and thick sacrificial layer without wet or dry etching process. Three-dimensional structure patterning of up to 60-mu m thickness was achieved by using a photo-definable lithography process with a photoresist material as a thick sacrificial layer. All processes were designed considering process-compatibility and a low process temperature of below 110 A degrees C. These strategies were possible to make low-cost sensor with robust structure through the simplification of conventional micromachining process steps for economical fabrication.	[Lee, Jeong Il; Shikida, Mitsuhiro] Nagoya Univ, Dept Micronano Syst Engn, Nagoya, Aichi 4648603, Japan; [Sato, Kazuo] Aichi Inst Technol, Dept Mech Engn, Toyota, Aichi 4700392, Japan	Lee, JI (reprint author), Nagoya Univ, Dept Micronano Syst Engn, Nagoya, Aichi 4648603, Japan.	junke@kaz.mech.nagoya-u.ac.jp			18th Research Promotion Program for Foreign Researchers in the HORI Information Science Promotion Foundation, Japan; Global Center of Excellence (GCOE) program (Micro- and Nano-Mechatronics for Information-Based Society) of the Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was partially supported by the 18th Research Promotion Program for Foreign Researchers in the HORI Information Science Promotion Foundation, Japan and Global Center of Excellence (GCOE) program (Micro- and Nano-Mechatronics for Information-Based Society) of the Ministry of Education, Culture, Sports, Science and Technology, Japan. We would like to thank Dr. Jong Ho Kim and Dr. Hyun Joon Kwon of the Korea Research Institute of Standards and Science (KRISS) for their technical assistance of calibration.	Metz S, 2004, LAB CHIP, V4, P114, DOI 10.1039/b310866j; Lee MH, 2000, INT J ROBOT RES, V19, P636; Engel J, 2003, J MICROMECH MICROENG, V13, P359, DOI 10.1088/0960-1317/13/3/302; Kane BJ, 2000, J MICROELECTROMECH S, V9, P425, DOI 10.1109/84.896763; Kim SH, 2005, SURF COAT TECH, V200, P2072, DOI 10.1016/j.surfcoat.2005.05.021; Foulds IG, 2006, J MICROMECH MICROENG, V16, P2109, DOI 10.1088/0960-1317/16/10/026; Bao XQ, 2010, J MICROMECH MICROENG, V20; Foulds IG, 2008, J MICROMECH MICROENG, V18; Gardner JW, 2001, MICROSENSORS MEMS SM, P173; Kim JH, 2005, P IEEE INT C ROB AUT, P2589; Kwon HJ, 2011, MICROSYST TECHNOL, V17, P1721, DOI 10.1007/s00542-011-1368-x; Kwon HJ, 2010, MICROSYST TECHNOL, V16, P2029, DOI 10.1007/s00542-010-1125-6; Lee JI, 2005, P AS PAC S MASS FORC, P269; Mark J. E., 1999, POLYM DATA HDB; Maruo S, 2002, SENSOR ACTUAT A-PHYS, V100, P70, DOI 10.1016/S0924-4247(02)00043-2; Nakamura Y, 1996, THIN SOLID FILMS, V290, P367, DOI 10.1016/S0040-6090(96)09017-7; Nicholls HR, 1992, ADV TACTILE SENSING, P273; Song IH, 2003, J MICROMECH MICROENG, V13, P816, DOI 10.1088/0960-1317/13/6/304	18	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0946-7076	1432-1858		MICROSYST TECHNOL	Microsyst. Technol.	JAN	2015	21	1					239	246		10.1007/s00542-013-1961-2		8	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Science & Technology - Other Topics; Materials Science; Physics	AY4MU	WOS:000347553500031		
J	Koganezawa, S				Koganezawa, Shinji			Analysis of spring-back deformation of head-mounting-block after ball-swaging in hard disk drives	MICROSYSTEM TECHNOLOGIES-MICRO-AND NANOSYSTEMS-INFORMATION STORAGE AND PROCESSING SYSTEMS			English	Article								The spring-back deformation of a head-mounting-block (HMB) after ball-swaging was analytically solved from equations of elasticity. The analytical solution helps to elucidate the mechanism of HMB deformation after swaging and provides insight for designing an adequate HMB with reduced spring-back. This study estimates the displacement of the HMB tip caused by spring-back after swaging, taking the plastic deformation of the HMB into consideration. A suitable boss radius is also discussed.	Kansai Univ, Dept Mech Engn, Suita, Osaka, Japan	Koganezawa, S (reprint author), Kansai Univ, Dept Mech Engn, 3-3-35 Yamate Cho, Suita, Osaka, Japan.	skoga@kansai-u.ac.jp					Aoki K, 2007, MICROSYST TECHNOL, V13, P943, DOI 10.1007/s00542-006-0299-4; Ee KC, 2010, J ADV MECH DES SYST, V4, P88, DOI 10.1299/jamdsm.4.88; Khenukhieo P, 2010, KKU RES J, V15, P581	3	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0946-7076	1432-1858		MICROSYST TECHNOL	Microsyst. Technol.	JAN	2015	21	1					277	287		10.1007/s00542-013-2047-x		11	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Science & Technology - Other Topics; Materials Science; Physics	AY4MU	WOS:000347553500035		
J	Tani, H; Konishi, K; Norimatsu, W; Kusunoki, M; Tagawa, N				Tani, Hiroshi; Konishi, Keisuke; Norimatsu, Wataru; Kusunoki, Michiko; Tagawa, Norio			Application of vertically aligned carbon nanotubes on burnishing slider in cleaning process of magnetic disk surfaces	MICROSYSTEM TECHNOLOGIES-MICRO-AND NANOSYSTEMS-INFORMATION STORAGE AND PROCESSING SYSTEMS			English	Article							FRICTION; DECOMPOSITION; FILMS	The feasibility of using vertically aligned carbon nanotubes (CNTs) on a burnishing slider in the cleaning process of a magnetic disk surface was studied. Vertically aligned CNTs on SiC flat sliders were grown by the SiC surface decomposition method. Burnishing sliders with different CNT lengths were prepared for friction measurement on magnetic disks and for the burnishing test. Non-lubricated vertically aligned CNTs sliding on non-lubricated magnetic disks resulted in large friction; however, coating the CNTs and the disks with a perfluoropolyether lubricant film dramatically decreased the friction force. In addition, it was found that a specific amount of lubricant was needed on the CNTs to decrease the friction force and that the friction force depended on the CNT length. The particle burnishing test indicated that the 34-nm-long CNT burnishing slider with a rinsed lubricant film showed good burnishing performance.	[Tani, Hiroshi; Tagawa, Norio] Kansai Univ, Dept Mech Engn, Suita, Osaka 5648680, Japan; [Konishi, Keisuke] Kansai Univ, Grad Sch, Suita, Osaka 5648680, Japan; [Norimatsu, Wataru; Kusunoki, Michiko] Nagoya Univ, Nagoya, Aichi 4648601, Japan	Tani, H (reprint author), Kansai Univ, Dept Mech Engn, 3-3-35 Yamate Cho, Suita, Osaka 5648680, Japan.	hrstani@kansai-u.ac.jp	Norimatsu, Wataru/H-9318-2013		Japan Ministry of Education, Culture, Sports, Science and Technology (MEXT); MEXT KAK-ENHI [24360062]	This work was supported by a "Strategic Project to Support the Formation of Research Bases at Private Universities," Matching Fund Subsidy from the Japan Ministry of Education, Culture, Sports, Science and Technology (MEXT), and MEXT KAK-ENHI Grant No. 24360062.	Cambaz ZG, 2008, CARBON, V46, P841, DOI 10.1016/j.carbon.2008.02.013; Kusunoki M, 1999, PHIL MAG LETT, V79, P153, DOI 10.1080/095008399177381; Dickrell PL, 2005, TRIBOL LETT, V18, P59, DOI 10.1007/s11249-004-1752-0; Dickrell PL, 2006, TRIBOL LETT, V24, P85, DOI 10.1007/s11249-006-9162-0; Hirata A, 2004, TRIBOL INT, V37, P893, DOI 10.1016/j.triboint.2004.07.005; Kinoshita H, 2004, APPL PHYS LETT, V85, P2780, DOI 10.1063/1.1804254; Kusunoki M, 2002, CHEM PHYS LETT, V366, P458, DOI 10.1016/S0009-2614(02)01463-X; Miyake K, 2007, NANO LETT, V7, P3285, DOI 10.1021/nl0714482	8	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0946-7076	1432-1858		MICROSYST TECHNOL	Microsyst. Technol.	JAN	2015	21	1					295	300		10.1007/s00542-014-2135-6		6	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Science & Technology - Other Topics; Materials Science; Physics	AY4MU	WOS:000347553500037		
J	Yamashita, Y; Nagasaka, T; Naiki-Ito, A; Sato, S; Suzuki, S; Toyokuni, S; Ito, M; Takahashi, S				Yamashita, Yoriko; Nagasaka, Tetsuro; Naiki-Ito, Aya; Sato, Shinya; Suzuki, Shugo; Toyokuni, Shinya; Ito, Masafumi; Takahashi, Satoru			Napsin A is a specific marker for ovarian clear cell adenocarcinoma	MODERN PATHOLOGY			English	Article							PRIMARY LUNG ADENOCARCINOMA; SURFACTANT PROTEIN-B; GLYPICAN-3 EXPRESSION; ASPARTIC PROTEINASE; DIAGNOSTIC-UTILITY; ALPHA-FETOPROTEIN; CARCINOMA; KIDNEY; TISSUE; CHEMORESISTANCE	Ovarian clear cell adenocarcinoma has a relatively poor prognosis among the ovarian cancer subtypes because of its high chemoresistance. Differential diagnosis of clear cell adenocarcinoma from other ovarian surface epithelial tumors is important for its treatment. Napsin A is a known diagnostic marker for lung adenocarcinoma, and expression of napsin A is reported in a certain portion of thyroid and renal carcinomas. However, napsin A expression in ovarian surface epithelial tumors has not previously been examined. In this study, immunohistochemical analysis revealed that in 71 of 86 ovarian clear cell adenocarcinoma patients (83%) and all of the 13 patients with ovarian clear cell adenofibroma, positive napsin A staining was evident. No expression was observed in 30 serous adenocarcinomas, 11 serous adenomas or borderline tumors, 19 endometrioid adenocarcinomas, 22 mucinous adenomas or borderline tumors, 10 mucinous adenocarcinomas, or 3 yolk sac tumors of the ovary. Furthermore, expression of napsin A was not observed in the normal surface epithelium of the ovary, epithelia of the fallopian tubes, squamous epithelium, endocervical epithelium, or the endometrium of the uterus. Therefore, we propose that napsin A is another sensitive and specific marker for distinguishing ovarian clear cell tumors (especially adenocarcinomas) from other ovarian tumors.	[Yamashita, Yoriko; Naiki-Ito, Aya; Sato, Shinya; Suzuki, Shugo; Takahashi, Satoru] Nagoya City Univ, Grad Sch Med Sci, Dept Expt Pathol & Tumor Biol, Nagoya, Aichi 4678601, Japan; [Yamashita, Yoriko; Toyokuni, Shinya] Nagoya Univ, Grad Sch Med, Dept Pathol & Biol Responses, Nagoya, Aichi 4648601, Japan; [Nagasaka, Tetsuro] Nagoya Univ, Grad Sch Med, Dept Pathophysiol Lab Sci, Nagoya, Aichi 4648601, Japan; [Ito, Masafumi] Japanese Red Cross First Hosp, Dept Pathol, Nagoya, Aichi, Japan	Yamashita, Y (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Expt Pathol & Tumor Biol, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	k46581a@nucc.cc.nagoya-u.ac.jp	Toyokuni, Shinya/C-1358-2010; Yamashita, Yoriko/B-9810-2011	Toyokuni, Shinya/0000-0002-5757-1109; 	Japan Society for the Promotion of Science, Tokyo, Japan [23590394]	We thank Ms J Takekawa, Mr K Kato, and Mr N Misawa and the members of the Department of Pathology, Nagoya City University Hospital, for their excellent technical assistance, and Dr K Shinjo, Dr S Takeshita, and Dr K Kobayashi from the Department of Obstetrics and Gynecology of Nagoya University Hospital or Nagoya City University Hospital for providing patient samples and clinical information. This study was partly supported by a Grant-in-Aid from the Japan Society for the Promotion of Science, Tokyo, Japan, for Scientific Research (no. 23590394 to YY).	Lee JG, 2012, LUNG CANCER, V77, P156, DOI 10.1016/j.lungcan.2012.02.013; Chuman Y, 1999, FEBS LETT, V462, P129, DOI 10.1016/S0014-5793(99)01493-3; Choi CH, 2013, HUM PATHOL, V44, P1017, DOI 10.1016/j.humpath.2012.08.024; Ueno T, 2004, J BIOL CHEM, V279, P16178, DOI 10.1074/jbc.M312029200; Zhang P, 2010, ONCOL LETT, V1, P899, DOI 10.3892/ol_00000160; Sugiyama T, 2000, CANCER, V88, P2584, DOI 10.1002/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5; Hirano T, 2003, LUNG CANCER-J IASLC, V41, P155, DOI 10.1016/S0169-5002(03)00194-6; Rossi G, 2012, HISTOPATHOLOGY, V60, P361, DOI 10.1111/j.1365-2559.2011.03983.x; Bishop JA, 2010, HUM PATHOL, V41, P20, DOI 10.1016/j.humpath.2009.06.014; Fadare O, 2014, AM J SURG PATHOL, V38, P189, DOI 10.1097/PAS.0000000000000085; Tatnell PJ, 1998, FEBS LETT, V441, P43, DOI 10.1016/S0014-5793(98)01522-1; Ye JQ, 2011, APPL IMMUNOHISTO M M, V19, P313, DOI 10.1097/PAI.0b013e318205b059; Ohishi Y, 2009, HUM PATHOL, V40, P1168, DOI 10.1016/j.humpath.2009.01.002; DeLair D, 2011, AM J SURG PATHOL, V35, P36, DOI 10.1097/PAS.0b013e3181ff400e; Itamochi H, 2002, OBSTET GYNECOL, V100, P281, DOI 10.1016/S0029-7844(02)02040-9; Umezu T, 2010, J CLIN PATHOL, V63, P962, DOI 10.1136/jcp.2010.080234; Kato N, 2006, MODERN PATHOL, V19, P83, DOI 10.1038/modpathol.3800492; Ueno T, 2003, BRIT J CANCER, V88, P1229, DOI 10.1038/sj.bjc.6600879; Pearce CL, 2012, LANCET ONCOL, V13, P385, DOI 10.1016/S1470-2045(11)70404-1; Whithaus K, 2012, ARCH PATHOL LAB MED, V136, P155, DOI 10.5858/arpa.2011-0232-OA; Yamaguchi K, 2008, CLIN CANCER RES, V14, P32, DOI 10.1158/1078-0432.CCR-07-1614; Warth A, 2012, HISTOPATHOLOGY, V61, P1017, DOI 10.1111/j.1365-2559.2012.04308.x; Brasch F, 2003, J BIOL CHEM, V278, P49006, DOI 10.1074/jbc.M306844200; Mori K, 2002, ARCH HISTOL CYTOL, V65, P359, DOI 10.1679/aohc.65.359; Tsuchiya A, 2003, AM J PATHOL, V163, P2503, DOI 10.1016/S0002-9440(10)63605-X; Fadare O, 2012, APPL IMMUNOHISTO M M, V20, P580, DOI 10.1097/PAI.0b013e31824973d1; Miao Y, 2009, INT J GYNECOL CANCER, V19, P1545, DOI 10.1111/IGC.0b013e3181a844c8; Ballard M, 2013, ARCH PATHOL LAB MED, V137, P883, DOI 10.5858/arpa.2012-0583-LE; Toyama A, 2012, CANCER SCI, V103, P747, DOI 10.1111/j.1349-7006.2012.02224.x; Terry J, 2010, AM J SURG PATHOL, V34, P1805, DOI 10.1097/PAS.0b013e3181f7dae3; Silva EG, 2007, AM J SURG PATHOL, V31, P1203, DOI 10.1097/PAS.0b013e3180339ed7; Ballotta M. R., 1995, Pathologica (Genoa), V87, P87; Cetin A, 2007, EUR J GYNAECOL ONCOL, V28, P241; Chernock RD, 2013, AM J SURG PATHOL, V37, P1215, DOI 10.1097/PAS.0b013e318283b7b2; Hirano T, 2000, JPN J CANCER RES, V91, P1015; Kadivar M, 2013, APPL IMMUNOHISTO M M, V21, P191, DOI 10.1097/PAI.0b013e3182612643; Kandalaft PL, 2012, MODERN PATHOL, V25, p279A; KENNEDY AW, 1989, GYNECOL ONCOL, V32, P342, DOI 10.1016/0090-8258(89)90637-9; Li B, 2009, INT J GYNECOL CANCER, V19, P1347, DOI 10.1111/IGC.0b013e3181a83f1d; Lin F, 2008, AM J CLIN PATHOL, V129, P592, DOI [10.1309/Q0FLUXFJ4FTTW1XR, 10.1309/Q0FLUXFJ4FTTVV1XR]; Maeda D, 2009, MODERN PATHOL, V22, P824, DOI 10.1038/modpathol.2009.40; Mori K, 2001, ARCH HISTOL CYTOL, V64, P319, DOI 10.1679/aohc.64.319; Nolan LP, 2001, INT J GYNECOL PATHOL, V20, P155, DOI 10.1097/00004347-200104000-00007; Penson RT, 2013, CURR OPIN ONCOL, V25, P553, DOI 10.1097/CCO.0b013e328363e0c7; Sangoi AR, 2008, AM J SURG PATHOL, V32, P269, DOI 10.1097/PAS.0b013e31814fa9b0; Schauer-Vukasinovic V, 1999, FEBS LETT, V462, P135, DOI 10.1016/S0014-5793(99)01458-1; Schmidt LA, 2012, ARCH PATHOL LAB MED, V136, P1580, DOI 10.5858/arpa.2011-0486-OA; Takahashi Y, 2011, J OBSTET GYNAECOL RE, V37, P1842, DOI 10.1111/j.1447-0756.2011.01622.x; Yamashita Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057724	49	5	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	JAN	2015	28	1					111	117		10.1038/modpathol.2014.61		7	Pathology	Pathology	AY1XY	WOS:000347384200012		
J	Murakami, T; Mitomi, H; Saito, T; Takahashi, M; Sakamoto, N; Fukui, N; Yao, T; Watanabe, S				Murakami, Takashi; Mitomi, Hiroyuki; Saito, Tsuyoshi; Takahashi, Michiko; Sakamoto, Naoto; Fukui, Naoshi; Yao, Takashi; Watanabe, Sumio			Distinct WNT/beta-catenin signaling activation in the serrated neoplasia pathway and the adenoma- carcinoma sequence of the colorectum	MODERN PATHOLOGY			English	Article						serrated neoplasia pathway; sessile serrated adenoma/polyp; WNT/beta-catenin signaling	BRAF MUTATION STATUS; BETA-CATENIN; MICROSATELLITE INSTABILITY; PROMOTER METHYLATION; HYPERPLASTIC POLYPS; CANCER; GENE; APC; HYPERMETHYLATION; PROGRESSION	Sessile serrated adenoma/polyp (SSA/P) is considered as an early precursor in the serrated neoplasia pathway leading to colorectal cancer development. The conventional adenoma-carcinoma sequence is associated with activation of the WNTsignaling pathway, although its role in serrated lesions is still controversial. To clarify differences in WNT signaling activation in association with MLH1 methylation or BRAF/KRAS mutations between serrated and conventional routes, we performed beta-catenin immunostaining, methylation-specific PCR for MLH1 and WNT signaling associated genes such as AXIN2, APC, and MCC and secreted frizzled-related proteins (SFRPs), and direct sequencing of BRAF/KRAS in 27 SSA/Ps, 14 SSA/Ps with high-grade dysplasia and 9 SSA/Ps with submucosal carcinoma, as well as 19 conventional adenomas, 26 adenomas with high-grade dysplasia and 25 adenomas with submucosal carcinoma. Nuclear beta-catenin labelings were significantly lower in the serrated series than in their adenoma counterparts, and a significant increment in those labelings was found from SSA/Ps to those with high-grade dysplasia or submucosal carcinoma. The frequency of MLH1 and SFRP4 methylation was significantly higher in SSA/P series, as compared with corresponding adenoma series. AXIN2 and MCC were more frequently methylated in SSA/Ps with high-grade dysplasia and those with submucosal carcinoma than in adenoma counterparts. Stepwise increment of AXIN2 and MCC methylation was identified from SSA/Ps through those with high-grade dysplasia to those with submucosal carcinoma. A significant correlation was seen between nuclear beta-catenin expression and methylation of AXIN2 or MCC in the SSA/P series. BRAF mutation was more frequent, whereas KRAS mutation was less frequent in the SSA/P series as compared with the adenoma series. There was an inverse association of BRAF mutation with AXIN2 methylation in SSA/P series. In conclusion, WNT/beta-catenin signal activation mediated by the methylation of SFRP4, MCC, and AXIN2 may make different contributions to colorectal neoplasia between the serrated and conventional routes.	[Murakami, Takashi; Saito, Tsuyoshi; Takahashi, Michiko; Yao, Takashi] Juntendo Univ, Sch Med, Dept Human Pathol, Tokyo 113, Japan; [Murakami, Takashi; Sakamoto, Naoto; Watanabe, Sumio] Juntendo Univ, Sch Med, Dept Gastroenterol, Tokyo 113, Japan; [Mitomi, Hiroyuki] Dokkyo Med Univ, Sch Med, Dept Surg & Mol Pathol, Shimotsuga, Tochigi 3210293, Japan; [Fukui, Naoshi] Sagamihara Hosp, Natl Hosp Org, Clin Res Ctr, Kanagawa, Japan	Mitomi, H (reprint author), Dokkyo Med Univ, Sch Med, Dept Surg & Mol Pathol, 880 Kitakobayashi, Shimotsuga, Tochigi 3210293, Japan.	hmitomi@dokkyomed.ac.jp			Japan Society for the Promotion of Science [24590429, 23590434]	We thank Dr Seiji Igarashi (Division of Pathology, Tochigi Cancer Center), Dr Shin-ichi Ban (Department of Pathology, Saiseikai Kawaguchi General Hospital), Dr Minako Hirahashi (Department of Anatomic Pathology, Pathological Sciences, Graduate School of Medical Sciences, Kyushu University), and Dr Yumi Oshiro (Department of Pathology, Matsuyama Red Cross Hospital) for kindly providing samples and clinical information. We thank Mrs. Keiko Mitani for her histological assistance. The work was supported in part by a Grant-in-Aid from the Japan Society for the Promotion of Science (#24590429 to H Mitomi and #23590434 to T Saito).	Willert K, 1998, CURR OPIN GENET DEV, V8, P95, DOI 10.1016/S0959-437X(98)80068-3; Kim YH, 2008, INT J CANCER, V123, P2587, DOI 10.1002/ijc.23840; Miyoshi Yasuo, 1992, Human Molecular Genetics, V1, P229; Qi J, 2006, WORLD J GASTROENTERO, V12, P7113; Lazarus R, 2005, AM J CLIN PATHOL, V123, P349, DOI 10.1309/VBAGV3BR96N2EQTR; Jass JR, 2006, HISTOPATHOLOGY, V49, P121, DOI 10.1111/j.1365-2559.2006.02466.x; Koinuma K, 2006, ONCOGENE, V25, P139, DOI 10.1038/sj.onc.1209009; Yachida S, 2009, AM J SURG PATHOL, V33, P1823, DOI 10.1097/PAS.0b013e3181b6da19; Carr NJ, 2009, J CLIN PATHOL, V62, P516, DOI 10.1136/jcp.2008.061960; Joo M, 2009, HUM PATHOL, V40, P872, DOI 10.1016/j.humpath.2008.12.003; Fujita K, 2011, AM J SURG PATHOL, V35, P295, DOI 10.1097/PAS.0b013e318205df36; Kambara T, 2004, GUT, V53, P1137, DOI 10.1136/gut.2003.037671; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Manie E, 2009, CANCER RES, V69, P663, DOI 10.1158/0008-5472.CAN-08-1560; O'Brien MJ, 2006, AM J SURG PATHOL, V30, P1491, DOI 10.1097/01.pas.0000213313.36306.85; Dhir M, 2011, INT J CANCER, V129, P1889, DOI 10.1002/ijc.25847; Kim KM, 2011, AM J SURG PATHOL, V35, P1274, DOI 10.1097/PAS.0b013e318224cd2e; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Torlakovic E, 2003, AM J SURG PATHOL, V27, P65, DOI 10.1097/00000478-200301000-00008; Spring KJ, 2006, GASTROENTEROLOGY, V131, P1400, DOI 10.1053/j.gastro.2006.08.038; Patil DT, 2012, MODERN PATHOL, V25, P1423, DOI 10.1038/modpathol.2012.98; Kohonen-Corish MRJ, 2007, ONCOGENE, V26, P4435, DOI 10.1038/sj.onc.1210210; Li L, 2013, HUM PATHOL, V44, P1079, DOI 10.1016/j.humpath.2012.09.013; Fukuyama R, 2008, ONCOGENE, V27, P6044, DOI 10.1038/onc.2008.204; Imamhasan A, 2012, PATHOL INT, V62, P137, DOI 10.1111/j.1440-1827.2011.02758.x; Koinuma K, 2004, INT J CANCER, V108, P237, DOI 10.1002/ijc.11523; Sandmeier D, 2009, HISTOPATHOLOGY, V55, P206, DOI 10.1111/j.1365-2559.2009.03356.x; Snover DC, 2010, WHO CLASSIFICATION T, P160; Wu JM, 2008, AM J CLIN PATHOL, V129, P416, DOI 10.1309/603UQKM7C2KELGJU; Zhang W, 2007, DIS COLON RECTUM, V50, P1618, DOI 10.1007/s10350-007-0286-6	30	2	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	JAN	2015	28	1					146	158		10.1038/modpathol.2014.41		13	Pathology	Pathology	AY1XY	WOS:000347384200016		
J	Novo, L; Takeda, KM; Petteta, T; Dakwar, GR; van den Dikkenberg, JB; Remaut, K; Braeckmans, K; van Nostrum, CF; Mastrobattista, E; Hennink, WE				Novo, Luis; Takeda, Kaori M.; Petteta, Tamara; Dakwar, George R.; van den Dikkenberg, Joep B.; Remaut, Katrien; Braeckmans, Kevin; van Nostrum, Cornelus F.; Mastrobattista, Enrico; Hennink, Wim E.			Targeted Decationized Polyplexes for siRNA Delivery	MOLECULAR PHARMACEUTICS			English	Article						siRNA delivery; polymer; targeting; nanoparticle; biocompatibility	IN-VITRO CYTOTOXICITY; GENE DELIVERY; DRUG-DELIVERY; POLYMERIC MICELLES; RNA INTERFERENCE; CATIONIC LIPIDS; PLASMID DNA; NANOPARTICLES; THERAPEUTICS; CIRCULATION	The applicability of small interfering RNA (siRNA) in future therapies depends on the availability of safe and efficient carrier systems. Ideally, siRNA delivery requires a system that is stable in the circulation but upon specific uptake into target cells can rapidly release its cargo into the cytoplasm. Previously, we evaluated a novel generation of carrier systems (decationized polyplexes) for DNA delivery, and it was shown that folate targeted decationized polyplexes had an excellent safety profile and showed intracellular triggered release upon cell specific uptake. Targeted decationized polyplexes consist of a core of disulfide cross-linked poly(hydroxypropyl methacrylamide) (pHPMA) stably entrapping nucleic acids and a shell of poly(ethylene glycol) (PEG) decorated with folate molecules. In the present study, the applicability of folate targeted decationized polyplexes for siRNA delivery was investigated. This required optimization of the carrier system particularly regarding the cross-linking density of the core of the polyplexes. Stable and nanosized siRNA decationized polyplexes were successfully prepared by optimizing the cross-link density of their core. Upon incubation in human plasma, a significant portion of siRNA remained entrapped in the decationized polyplexes as determined by fluorescence correlation spectroscopy (FCS). When tested in a folate receptor overexpressing cell line stably expressing luciferase, Skov3-luc, sequence specific gene silencing was observed. As expected, neither interference on the intrinsic luciferase expression nor on the cell metabolic activity (determined by XTT) was induced by the free-polymer or the siRNA polyplexes. In conclusion, targeted decationized polyplexes are safe and stable carriers that interact with the targeted cells and rapidly disassemble upon cell entry making them promising siRNA delivery systems.	[Novo, Luis; Petteta, Tamara; van den Dikkenberg, Joep B.; van Nostrum, Cornelus F.; Mastrobattista, Enrico; Hennink, Wim E.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Pharmaceut, NL-3584 CG Utrecht, Netherlands; [Takeda, Kaori M.] Univ Tokyo, Grad Sch Engn, Dept Mat Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Dakwar, George R.; Remaut, Katrien; Braeckmans, Kevin] Univ Ghent, Fac Pharm, Lab Gen Biochem & Phys Pharm, Ghent Res Grp Nanomed, B-9000 Ghent, Belgium; [Braeckmans, Kevin] Univ Ghent, Ctr Nano & Biophoton, B-9000 Ghent, Belgium	Hennink, WE (reprint author), Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Pharmaceut, NL-3584 CG Utrecht, Netherlands.	w.e.hennink@uu.nl			Fundacao para a Ciencia e a Tecnologia (FCT); Portuguese Foundation for Science and Technology [SFRH/BD/47085/2008]	L. Novo is financially supported by Fundacao para a Ciencia e a Tecnologia (FCT), the Portuguese Foundation for Science and Technology, Grant SFRH/BD/47085/2008.	Aa M. A. E. M., 2007, PHARM RES, V24, P1590, DOI 10.1007/s11095-007-9287-3; Nelson CE, 2013, ACS NANO, V7, P8870, DOI 10.1021/nn403325f; Mintzer MA, 2009, CHEM REV, V109, P259, DOI 10.1021/cr800409e; Masago K, 2007, BIOMATERIALS, V28, P5169, DOI 10.1016/j.biomaterials.2007.07.019; Mok H, 2010, NAT MATER, V9, P272, DOI [10.1038/nmat2626, 10.1038/NMAT2626]; Kwok A, 2011, NANOMED-NANOTECHNOL, V7, P210, DOI 10.1016/j.nano.2010.07.005; Benoit DSW, 2011, BIOMACROMOLECULES, V12, P2708, DOI 10.1021/bm200485b; Lv HT, 2006, J CONTROL RELEASE, V114, P100, DOI 10.1016/j.jconrel.2006.04.014; Lee MH, 2013, CHEM REV, V113, P5071, DOI 10.1021/cr300358b; Buyens K, 2008, J CONTROL RELEASE, V126, P67, DOI 10.1016/j.jconrel.2007.10.024; Dohmen C, 2012, ACS NANO, V6, P5198, DOI 10.1021/nn300960m; Hilgenbrink AR, 2005, J PHARM SCI-US, V94, P2135, DOI 10.1002/jps.20457; Filipe V, 2010, PHARM RES-DORDR, V27, P796, DOI 10.1007/s11095-010-0073-2; Moghimi SM, 2005, MOL THER, V11, P990, DOI 10.1016/j.mythe.2005.02.010; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Videira M, 2014, NANOMED-NANOTECHNOL, V10, P689, DOI 10.1016/j.nano.2013.11.018; Harada-Shiba M, 2002, GENE THER, V9, P407, DOI 10.1038/sj.gt/3301665; Davis ME, 2009, MOL PHARMACEUT, V6, P659, DOI 10.1021/mp900015y; Novo L, 2013, J CONTROL RELEASE, V169, P246, DOI 10.1016/j.jconrel.2013.03.035; Zhao XB, 2008, EXPERT OPIN DRUG DEL, V5, P309, DOI 10.1517/17425247.5.3.309 ; Mao SR, 2006, BIOCONJUGATE CHEM, V17, P1209, DOI 10.1021/bc060129j; Yu SS, 2013, MOL PHARMACEUT, V10, P975, DOI 10.1021/mp300434e; Novo L, 2014, BIOCONJUGATE CHEM, V25, P802, DOI 10.1021/bc500074a; Vercauteren D, 2012, J CONTROL RELEASE, V161, P566, DOI 10.1016/j.jconrel.2012.05.020; Breunig M, 2008, J CONTROL RELEASE, V130, P57, DOI 10.1016/j.jconrel.2008.05.016; Luten J, 2008, J CONTROL RELEASE, V126, P97, DOI 10.1016/j.jconrel.2007.10.028; Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3; Manickam DS, 2010, J CONTROL RELEASE, V141, P77, DOI 10.1016/j.jconrel.2009.08.022; Jones CF, 2012, ACS NANO, V6, P9900, DOI 10.1021/nn303472r; van der Aa LJ, 2011, J CONTROL RELEASE, V150, P177, DOI 10.1016/j.jconrel.2010.11.030; Lu YJ, 2012, ADV DRUG DELIVER REV, V64, P342, DOI 10.1016/j.addr.2012.09.020; Yang Z, 2008, BIOCONJUGATE CHEM, V19, P1987, DOI 10.1021/bc800144a; Godbey WT, 2001, BIOMATERIALS, V22, P471, DOI 10.1016/S0142-9612(00)00203-9; Christie RJ, 2011, BIOMACROMOLECULES, V12, P3174, DOI 10.1021/bm2006714; Naeye B, 2013, BIOMATERIALS, V34, P2350, DOI 10.1016/j.biomaterials.2012.11.058; STORM G, 1995, ADV DRUG DELIVER REV, V17, P31, DOI 10.1016/0169-409X(95)00039-A; Ogris M, 1999, GENE THER, V6, P595, DOI 10.1038/sj.gt.3300900; Funhoff AM, 2004, PHARM RES, V21, P170, DOI 10.1023/B:PHAM.0000012165.68765.e6; Zuckerman JE, 2012, P NATL ACAD SCI USA, V109, P3137, DOI 10.1073/pnas.1200718109; Meng FH, 2009, BIOMATERIALS, V30, P2180, DOI 10.1016/j.biomaterials.2009.01.026; Sato A, 2007, J CONTROL RELEASE, V122, P209, DOI 10.1016/j.jconrel.2007.04.018; Troiber C, 2013, EUR J PHARM BIOPHARM, V84, P255, DOI 10.1016/j.ejpb.2012.08.014; Dakwar GR, 2014, ACTA BIOMATER, V10, P2965, DOI 10.1016/j.actbio.2014.03.012; Christie RJ, 2012, ACS NANO, V6, P5174, DOI 10.1021/nn300942b; Ryu JH, 2010, J AM CHEM SOC, V132, P17227, DOI 10.1021/ja1069932; Walkey CD, 2012, CHEM SOC REV, V41, P2780, DOI 10.1039/c1cs15233e; Meyer M, 2009, MOL PHARMACEUT, V6, P752, DOI 10.1021/mp9000124; Oh YK, 2009, ADV DRUG DELIVER REV, V61, P850, DOI 10.1016/j.addr.2009.04.018; Verbaan FJ, 2004, J GENE MED, V6, P64, DOI 10.1002/jbm.475; Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088; Meyer M, 2008, J AM CHEM SOC, V130, P3272, DOI 10.1021/ja710344v; Scholz C, 2012, J CONTROL RELEASE, V161, P554, DOI 10.1016/j.jconrel.2011.11.014; de Wolf HK, 2007, INT J PHARM, V331, P167, DOI 10.1016/j.ijpharm.2006.10.029; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Lonez C, 2012, ADV DRUG DELIVER REV, V64, P1749, DOI 10.1016/j.addr.2012.05.009; Daka A, 2012, ADV DRUG DELIVER REV, V64, P1508, DOI 10.1016/j.addr.2012.08.014; CHOKSAKULNIMITR S, 1995, J CONTROL RELEASE, V34, P233, DOI 10.1016/0168-3659(95)00007-U; Dohmen C, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2011.10; GRASSETT.DR, 1967, ARCH BIOCHEM BIOPHYS, V119, P41, DOI 10.1016/0003-9861(67)90426-2; Lee SJJ, 2010, ARTECH HSE INTEGR MI, P141; Matsumoto S, 2008, BIOMACROMOLECULES, V10, P119; Merkel O. M., 2008, BIOCONJUGATE CHEM, V20, P174; Merkel OM, 2011, BIOMATERIALS, V32, P2388, DOI 10.1016/j.biomaterials.2010.11.081; Novo L, 2014, J CONTROL RELEASE, V195, P162, DOI 10.1016/j.jconrel.2014.08.028; Regnstrom K, 2003, GENE THER, V10, P1575, DOI 10.1038/sj.gt.3302054; Takemoto H, 2010, BIOMATERIALS, V31, P8097, DOI 10.1016/j.biomaterials.2010.07.015; Wagner E., 2011, ACCOUNTS CHEM RES, V45, P1005	67	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1543-8384			MOL PHARMACEUT	Mol. Pharm.	JAN	2015	12	1					150	161		10.1021/mp500499x		12	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	AY3TX	WOS:000347506300015		
J	Ozawa, M; Tsume, Y; Zur, M; Dahan, A; Amidon, GL				Ozawa, Makoto; Tsume, Yasuhiro; Zur, Moran; Dahan, Arik; Amidon, Gordon L.			Intestinal Permeability Study of Minoxidil: Assessment of Minoxidil as a High Permeability Reference Drug for Biopharmaceutics Classification	MOLECULAR PHARMACEUTICS			English	Article						minoxidil; metoprolol; intestinal permeabilit; Biopharmaceutics Classification System (BCS)	BCS CLASSIFICATION; P-GLYCOPROTEIN; GASTROINTESTINAL-TRACT; HYPOTENSIVE AGENT; ABSORPTION; CACO-2; METOPROLOL; PHARMACOKINETICS; PERFUSION; JEJUNUM	The purpose of this study was to evaluate minoxidil as a high permeability reference drug for Biopharmaceutics Classification System (BCS). The permeability of minoxidil was determined in in situ intestinal perfusion studies in rodents and permeability studies across Caco-2 cell monolayers. The permeability of minoxidil was compared with that of metoprolol, an FDA reference drug for BCS classification. In rat perfusion studies, the permeability of minoxidil was somewhat higher than that of metoprolol in the jejunum, while minoxidil showed lower permeability than metoprolol in the ileum. The permeability of minoxidil was independent of intestinal segment, while the permeability of metoprolol was region-dependent. Similarly, in mouse perfusion study, the jejunal permeability of minoxidil was 2.5-fold higher than that of metoprolol. Minoxidil and metoprolol showed similar permeability in Caco-2 study at apical pH of 6.5 and basolateral pH of 7.4. The permeability of minoxidil was independent of pH, while metoprolol showed pH-dependent transport in Caco-2 study. Minoxidil exhibited similar permeability in the absorptive direction (AP-BL) in comparison with secretory direction (BL-AP), while metoprolol had higher efflux ratio (ER > 2) at apical pH of 6.5 and basolateral pH of 7.4. No concentration-dependent transport was observed for either minoxidil or metoprolol transport in Caco-2 study. Verapamil did not alter the transport of either compounds across Caco-2 cell monolayers. The permeability of minoxidil was independent of both pH and intestinal segment in intestinal perfusion studies and Caco-2 studies. Caco-2 studies also showed no involvement of carrier mediated transport in the absorption process of minoxidil. These results suggest that minoxidil may be an acceptable reference drug for BCS high permeability classification. However, minoxidil exhibited higher jejunal permeability than metoprolol and thus to use minoxidil as a reference drug would raise the permeability criteria for BCS high permeability classification.	[Ozawa, Makoto; Tsume, Yasuhiro; Amidon, Gordon L.] Univ Michigan, Coll Pharm, Ann Arbor, MI 48109 USA; [Ozawa, Makoto] Mochida Pharmaceut Co Ltd, Pharmaceut Res Ctr, Discovery Res, Pharmacokinet & Safety Lab, Gotemba, Shizuoka 4128524, Japan; [Zur, Moran; Dahan, Arik] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Pharmacol, Sch Pharm, IL-84105 Beer Sheva, Israel	Amidon, GL (reprint author), Univ Michigan, Coll Pharm, 428 Church St, Ann Arbor, MI 48109 USA.	glamidon@umich.edu					Lennernas H, 2005, J PHARM PHARMACOL, V57, P273, DOI 10.1211/022357055263; REGARDH CG, 1974, J PHARMACOKINET BIOP, V2, P347, DOI 10.1007/BF01061407; [Anonymous], 2007, CLIN RES REGUL AFF, DOI DOI 10.1080/10601330701273669; Gres MC, 1998, PHARMACEUT RES, V15, P726, DOI 10.1023/A:1011919003030; Cao XH, 2006, PHARM RES, V23, P1675, DOI 10.1007/s11095-006-9041-2; Shalaeva M, 2008, J PHARM SCI-US, V97, P2581, DOI 10.1002/jps.21287; Cook J, 2008, AAPS J, V10, P306, DOI 10.1208/s12248-008-9036-5; Fairstein M, 2013, AAPS J, V15, P589, DOI 10.1208/s12248-013-9462-x; Meyers RS, 2011, CLIN THER, V33, P1331, DOI 10.1016/j.clinthera.2011.09.003; Moss AM, 2012, MOL PHARMACEUT, V9, P2442, DOI 10.1021/mp200647a; Incecayir T, 2013, MOL PHARMACEUT, V10, P958, DOI 10.1021/mp300410n; Ku MS, 2008, AAPS J, V10, P208, DOI 10.1208/s12248-008-9020-0; Volpe DA, 2011, FUTURE MED CHEM, V3, P2063, DOI [10.4155/fmc.11.149, 10.4155/FMC.11.149]; AMIDON GL, 1995, PHARMACEUT RES, V12, P413, DOI 10.1023/A:1016212804288; ANTONACCIO MJ, 1990, AM J CARDIOL, V65, pA12; Dahan A, 2012, MOL PHARMACEUT, V9, P1847, DOI 10.1021/mp300140h; Dahan A, 2009, EUR J PHARM SCI, V36, P320, DOI 10.1016/j.ejps.2008.10.013; Dahan A, 2010, MOL PHARMACEUT, V7, P1827, DOI 10.1021/mp100175a; Dahan A, 2009, MOL PHARMACEUT, V6, P19, DOI 10.1021/mp800088f; Escribano E, 2012, INT J PHARMACEUT, V436, P472, DOI 10.1016/j.ijpharm.2012.07.010; European Medicines Agency (EMEA) Committee for Medicinal Products for Human Use, 2010, CPMPEWPQWP140198REV1; FLEISHAKER JC, 1989, J CLIN PHARMACOL, V29, P162; GOTTLIEB TB, 1972, CLIN PHARMACOL THER, V13, P436; Guerra F., COMP NONCLINICAL INT; Henchoz Y, 2009, ANAL BIOANAL CHEM, V394, P1919, DOI 10.1007/s00216-009-2862-1; Holmstock N, 2010, DRUG METAB DISPOS, V38, P1407, DOI 10.1124/dmd.110.032771; Holmstock N, 2012, DRUG METAB DISPOS, V40, P1473, DOI 10.1124/dmd.112.044677; JOBIN G, 1985, BRIT J CLIN PHARMACO, V19, pS97; KIM JS, 2006, MOL PHARMACEUT, V3, P686; LOWENTHAL DT, 1980, J CARDIOVASC PHARM, V2, pS93, DOI 10.1097/00005344-198000022-00002; Peternel L, 2012, J PHARM SCI-US, V101, P1436, DOI 10.1002/jps.23027; Pfizer Canada Inc, PROD MON LONITEN; THOMAS RC, 1975, J PHARM SCI, V64, P1366, DOI 10.1002/jps.2600640822; THOMAS RC, 1975, J PHARM SCI, V64, P1360, DOI 10.1002/jps.2600640821; U.S. Food and Drug Administration Center for Drug Evaluation and Research (CDER), 2003, HFD240 CDER US FDA; VIDON N, 1985, BRIT J CLIN PHARMACO, V19, pS107; Yang YS, 2007, MOL PHARM, V4, P608, DOI 10.1021/mp070028I	37	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1543-8384			MOL PHARMACEUT	Mol. Pharm.	JAN	2015	12	1					204	211		10.1021/mp500553b		8	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	AY3TX	WOS:000347506300020		
J	Mazzacurati, L; Marzulli, M; Reinhart, B; Miyagawa, Y; Uchida, H; Goins, WF; Li, AF; Kaur, B; Caligiuri, M; Cripe, T; Chiocca, N; Amankulor, N; Cohen, JB; Glorioso, JC; Grandi, P				Mazzacurati, Lucia; Marzulli, Marco; Reinhart, Bonnie; Miyagawa, Yoshitaka; Uchida, Hiroaki; Goins, William F.; Li, Aofei; Kaur, Balveen; Caligiuri, Michael; Cripe, Timothy; Chiocca, Nino; Amankulor, Nduka; Cohen, Justus B.; Glorioso, Joseph C.; Grandi, Paola			Use of miRNA Response Sequences to Block Off-target Replication and Increase the Safety of an Unattenuated, Glioblastoma-targeted Oncolytic HSV	MOLECULAR THERAPY			English	Article							HERPES-SIMPLEX-VIRUS; TYPE-1 INFECTION; BRAIN-TUMOR; MALIGNANT GLIOMA; STEM-CELLS; MICRORNA; MIR-124; CANCER; EXPRESSION; CONSTRUCTION	Glioblastoma multiforme (GBM) is an aggressive brain cancer for which there is no effective treatment. Oncolytic HSV vectors (oHSVs) are attenuated lytic viruses that have shown promise in the treatment of human GBM models in animals, but their efficacy in early phase patient trials has been limited. Instead of attenuating the virus with mutations in virulence genes, we engineered four copies of the recognition sequence for miR-124 into the 3'UTR of the essential ICP4 gene to protect healthy tissue against lytic virus replication; miR-124 is expressed in neurons but not in glioblastoma cells. Following intracranial inoculation into nude mice, the miR-124-sensitive vector failed to replicate or show overt signs of pathogenesis. To address the concern that this safety feature may reduce oncolytic activity, we inserted the miR-124 response elements into an unattenuated, human receptor (EGFR/ EGFRvIII)-specific HSV vector. We found that miR-124 sensitivity did not cause a loss of treatment efficiency in an orthotopic model of primary human GBM in nude mice. These results demonstrate that engineered miR-124 responsiveness can eliminate off-target replication by unattenuated oHSV without compromising oncolytic activity, thereby providing increased safety.	[Mazzacurati, Lucia; Marzulli, Marco; Reinhart, Bonnie; Miyagawa, Yoshitaka; Goins, William F.; Li, Aofei; Cohen, Justus B.; Glorioso, Joseph C.; Grandi, Paola] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA; [Mazzacurati, Lucia] Univ Pittsburgh, Sch Publ Hlth, Grad Program Human Genet, Pittsburgh, PA 15260 USA; [Uchida, Hiroaki] Tokyo Univ Pharm & Life Sci, Lab Oncol, Tokyo, Japan; [Li, Aofei] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Kaur, Balveen] Ohio State Univ, Coll Med, Dept Neurol Surg, Columbus, OH 43210 USA; [Caligiuri, Michael] Ohio State Univ, Coll Med, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA; [Caligiuri, Michael] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Cripe, Timothy] Ohio State Univ, Nationwide Childrens Hosp, Ctr Childhood Canc & Blood Dis, Columbus, OH 43210 USA; [Cripe, Timothy] Ohio State Univ, Nationwide Childrens Hosp, Div Hematol Oncol Blood & Marrow Transplantat, Columbus, OH 43210 USA; [Chiocca, Nino] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Neurosurg, Boston, MA 02115 USA; [Amankulor, Nduka; Grandi, Paola] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15261 USA; [Grandi, Paola] SVeB Univ Ferrara, Ferrara, Italy	Grandi, P (reprint author), Dept Neurol Surg, 450 Technol Dr,Room 419,Bridgeside Point 2, Pittsburgh, PA 15219 USA.	pag24@pitt.edu	kaur, Balveen/E-3355-2011		National Institutes of Health [CA119298, NS40923, NS064988-02, CA163205-01A1]; NIH	This work was supported by grants from the National Institutes of Health (CA119298, NS40923, NS064988-02 and CA163205-01A1) to J.C.G. B.R. was supported in part by an NIH T32 postdoctoral training grant in Molecular Microbial Persistence and Pathogenesis. We thank Nikolaus Osterrieder for the generous gift of pEPkan-S and pBAD-I-sceI plasmids; Chiocca for the GBM30 and Gli68 cell lines; Leib for KOS-HSV BAC. We also thank Mingdi Zhang for excellent technical assistance in all in vivo studies and Shaohua Huang for preparation of oHSV virus stocks.	Riddick G, 2011, NAT REV NEUROL, V7, P439, DOI 10.1038/nrneurol.2011.100; Xia HP, 2012, J BIOL CHEM, V287, P9962, DOI 10.1074/jbc.M111.332627; Kambara H, 2005, CANCER RES, V65, P2832, DOI 10.1158/0008-5472.CAN-04-3227; Hong CS, 2010, GENE THER, V17, P1200, DOI 10.1038/gt.2010.66; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Krisky DM, 1997, GENE THER, V4, P1120, DOI 10.1038/sj.gt.3300497; Grandi P, 2009, EXPERT REV NEUROTHER, V9, P505, DOI [10.1586/ern.09.9, 10.1586/ERN.09.9]; Macdonald SJ, 2012, J VIROL, V86, P6371, DOI 10.1128/JVI.00646-12; Markert JM, 2000, GENE THER, V7, P867, DOI 10.1038/sj.gt.3301205; Szymczak AL, 2005, EXPERT OPIN BIOL TH, V5, P627, DOI 10.1517/14712598.5.5.627; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Zhang Y, 2009, J MOL MED-JMM, V87, P43, DOI 10.1007/s00109-008-0403-6; Wei J, 2013, CANCER RES, V73, P3913, DOI 10.1158/0008-5472.CAN-12-4318; Cao XW, 2007, GENE DEV, V21, P531, DOI 10.1101/gad.1519207; Parker JN, 2009, NEUROTHERAPEUTICS, V6, P558, DOI 10.1016/j.nurt.2009.04.011; Karpowicz P, 2009, J NEUROSCI, V29, P3885, DOI 10.1523/JNEUROSCI.0037-09.2009; Gierasch WW, 2006, J VIROL METHODS, V135, P197, DOI 10.1016/j.jviromet.2006.03.014; Nduom EKE, 2012, CANCER J, V18, P100, DOI 10.1097/PPO.0b013e3182452e0d; Tischer BK, 2006, BIOTECHNIQUES, V40, P191, DOI 10.2144/000112096; Uchida H, 2010, J VIROL, V84, P12200, DOI 10.1128/JVI.01633-10; Maiorano NA, 2010, RNA BIOL, V7, P528; Doronina VA, 2008, MOL CELL BIOL, V28, P4227, DOI 10.1128/MCB.00421-08; Lavon I, 2010, NEURO-ONCOLOGY, V12, P422, DOI 10.1093/neuonc/nop061; Shi L, 2008, BRAIN RES, V1236, P185, DOI 10.1016/j.brainres.2008.07.085; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Barnes D, 2008, CELL HOST MICROBE, V4, P239, DOI 10.1016/j.chom.2008.08.003; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Katoh Y, 2008, INT J MOL MED, V22, P271, DOI 10.3892/ijmm_00000019; Uchida H, 2013, MOL THER, V21, P561, DOI 10.1038/mt.2012.211; Bennett JJ, 2002, CANCER GENE THER, V9, P935, DOI 10.1038/sj.cgt.7700510; Cawood R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000440; Currier MA, 2008, MOL THER, V16, P879, DOI 10.1038/mt.2008.49; Fujioka N, 1999, J VIROL, V73, P2401; He J, 2012, CURR MED CHEM, V19, P6050; Karsy Michael, 2012, Genes Cancer, V3, P3, DOI 10.1177/1947601912448068; Kelly EJ, 2010, J VIROL, V84, P1550, DOI 10.1128/JVI.01788-09; Lee CYF, 2009, CLIN CANCER RES, V15, P5126, DOI 10.1158/1078-0432.CCR-09-0051; MANICKAN E, 1995, J IMMUNOL, V155, P259; Ocana OH, 2008, EMBO REP, V9, P521, DOI 10.1038/embor.2008.84; SETHI KK, 1983, J GEN VIROL, V64, P443, DOI 10.1099/0022-1317-64-2-443; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Todo T, 2008, FRONT BIOSCI-LANDMRK, V13, P2060, DOI 10.2741/2823; Uchida H, 2013, J VIROL, V87, P1430, DOI 10.1128/JVI.02804-12; Ylosmaki E, 2008, J VIROL, V82, P11009, DOI 10.1128/JVI.01608-08	44	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1525-0016	1525-0024		MOL THER	Mol. Ther.	JAN	2015	23	1					99	107		10.1038/mt.2014.177		9	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	AY2ZG	WOS:000347453900013		
J	Chen, KF; Yin, S; Xue, DF				Chen, Kunfeng; Yin, Shu; Xue, Dongfeng			A binary A(x)B(1-x) ionic alkaline pseudocapacitor system involving manganese, iron, cobalt, and nickel: formation of electroactive colloids via in situ electric field assisted coprecipitation	NANOSCALE			English	Article							MULTIWALLED CARBON NANOTUBES; ELECTROCHEMICAL ENERGY-STORAGE; SOLID-PHASE EXTRACTION; HEAVY-METAL IONS; SUPERCAPACITOR ELECTRODES; ENVIRONMENTAL-SAMPLES; PERFORMANCE; GRAPHENE; CO3O4; CRYSTALLIZATION	A new "combinatorial transition-metal cation pseudocapacitor" was demonstrated by designing combinatorial transition-metal cation pseudocapacitors with binary A(x)B(1-x) salt electrodes involving manganese, iron, cobalt, and nickel cations in an alkaline aqueous electrolyte. Binary multi-valence cations were crystallized in the colloidal state through an in situ coprecipitation under an electric field. These electroactive colloids absorbed by carbon black and the PVDF matrix are highly redox-reactive with high specific capacitance values, where the specific electrode configuration can create short ion diffusion paths to enable fast and reversible Faradaic reactions. This work shows huge promise for developing high-performance electrical energy storage systems via designing the colloidal state of electroactive cations. Multiple redox cations in the colloidal state can show high redox activities, making them more suitable for potential application in pseudocapacitor systems.	[Chen, Kunfeng; Xue, Dongfeng] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Rare Earth Resource Utilizat, Changchun 130022, Peoples R China; [Yin, Shu] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan	Yin, S (reprint author), Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	shuyin@tagen.tohoku.ac.jp; dongfeng@ciac.ac.cn	Xue, Dongfeng/E-5881-2011; Chen, Kunfeng/L-7730-2013	Xue, Dongfeng/0000-0002-0748-0962; Chen, Kunfeng/0000-0001-9253-1885	National Natural Science Foundation of China [51125009, 91434118]; National Natural Science Foundation for Creative Research Group [21221061]; Chinese Academy of Science;  [25289245]	Financial support from the National Natural Science Foundation of China (grant nos. 51125009 and 91434118), the National Natural Science Foundation for Creative Research Group (grant no. 21221061), the Hundred Talents Program of Chinese Academy of Science, and the Grant-in-Aid for Science Research (No. 25289245) is acknowledged.	Chen KF, 2013, CRYSTENGCOMM, V15, P10367, DOI 10.1039/c3ce41802b; Reddy ALM, 2012, ADV MATER, V24, P5045, DOI 10.1002/adma.201104502; Zhao X, 2011, NANOSCALE, V3, P839, DOI 10.1039/c0nr00594k; Simon P, 2008, NAT MATER, V7, P845, DOI 10.1038/nmat2297; Rakhi RB, 2014, ACS APPL MATER INTER, V6, P4196, DOI 10.1021/am405849n; Zaghib K, 2013, MATERIALS, V6, P1028, DOI 10.3390/ma6031028; Shakir I, 2014, NANOSCALE, V6, P4125, DOI 10.1039/c3nr06820j; Augustyn V, 2013, NAT MATER, V12, P518, DOI [10.1038/nmat3601, 10.1038/NMAT3601]; Tuzen M, 2008, J HAZARD MATER, V152, P632, DOI 10.1016/j.jbazmat.2007.07.026; Lang XY, 2011, NAT NANOTECHNOL, V6, P232, DOI 10.1038/nnano.2011.13; Augustyn V, 2014, ENERG ENVIRON SCI, V7, P1597, DOI 10.1039/c3ee44164d; Rauda IE, 2013, ACCOUNTS CHEM RES, V46, P1113, DOI 10.1021/ar300167h; Tuzen M, 2007, J HAZARD MATER, V147, P219, DOI 10.1016/j.jhazmat.2006.12.069; Zhu MY, 2012, J PHYS CHEM C, V116, P16276, DOI 10.1021/jp304041m; Liu J, 2009, J AM CHEM SOC, V131, P12086, DOI 10.1021/ja9053256; Zhang HG, 2011, NAT NANOTECHNOL, V6, P277, DOI [10.1038/nnano.2011.38, 10.1038/NNANO.2011.38]; Xue T, 2014, J POWER SOURCES, V245, P194, DOI 10.1016/j.jpowsour.2013.06.135; Lu P, 2012, ELECTROCHIM ACTA, V78, P1, DOI 10.1016/j.electacta.2012.03.183; Tuzen M, 2008, BIORESOURCE TECHNOL, V99, P1563, DOI 10.1016/j.biortech.2007.04.013; Duran A, 2009, J HAZARD MATER, V169, P466, DOI 10.1016/j.jhazmat.2009.03.119; Yu ZN, 2013, ADV MATER, V25, P3302, DOI 10.1002/adma.201300572; Chen KF, 2014, RSC ADV, V4, P23338, DOI 10.1039/c4ra03037k; Liu F, 2012, ADV MATER, V24, P1089, DOI 10.1002/adma.201104691; Liu F, 2013, CHEM-EUR J, V19, P10716, DOI 10.1002/chem.201300679; Wang HL, 2010, J POWER SOURCES, V195, P3017, DOI 10.1016/j.jpowsour.2009.11.059; Chen KF, 2015, NANOSCALE, V7, P432, DOI 10.1039/c4nr05919k; Wang W, 2013, SMALL, V9, P3714, DOI 10.1002/smll.201300326; Lee GH, 2014, J PHYS CHEM C, V118, P2281, DOI 10.1021/jp4094904; Chen KF, 2014, ACS SUSTAIN CHEM ENG, V2, P440, DOI 10.1021/sc400338c; Sarkar D, 2013, J PHYS CHEM C, V117, P15523, DOI 10.1021/jp4039573; Chen KF, 2013, J PHYS CHEM C, V117, P10770, DOI 10.1021/jp4018025; Song MK, 2012, NANO LETT, V12, P3483, DOI 10.1021/nl300984y; Liu JP, 2011, ADV MATER, V23, P2076, DOI 10.1002/adma.201100058; Chen KF, 2014, J COLLOID INTERF SCI, V424, P84, DOI 10.1016/j.jcis.2014.03.022; Yang WL, 2013, ELECTROCHIM ACTA, V112, P378, DOI 10.1016/j.electacta.2013.08.056; Chen K., 2014, COLLOIDS INTERFACE S, V1, P39; Conway B. E., 1999, ELECTROCHEMICAL SUPE; Wang RT, 2014, SCI REP-UK, V4, DOI 10.1038/srep03712; Xue D., 2014, J COLLOID INTERF SCI, V416, P265; Yang GW, 2008, CHEM COMMUN, P6537, DOI 10.1039/b815647f	40	8	8	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2040-3364	2040-3372		NANOSCALE	Nanoscale		2015	7	3					1161	1166		10.1039/c4nr05880a		6	Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	AY1SZ	WOS:000347373500040		
J	Li, SS; Sakurai, S; Futaba, DN; Hata, K				Li, Shisheng; Sakurai, Shunsuke; Futaba, Don N.; Hata, Kenji			Breakdown of metallic single-wall carbon nanotube paths by NiO nanoparticle point etching for high performance thin film transistors	NANOSCALE			English	Article							FIELD-EFFECT TRANSISTORS; PREFERENTIAL DESTRUCTION; RAMAN-SPECTROSCOPY; IN-SITU; ARRAYS; OXIDATION	A selective and highly local etching of the metallic single-wall carbon nanotube (SWCNT) was demonstrated by using a NiO nanoparticle (NP) point etching technique. Following the NiO NP point etching at temperatures ranging from 250 to 350 degrees C, the current on/off ratios of the SWCNT field effect transistors (FETs) increased over 50-fold from similar to 10 s to similar to 10(4). Furthermore, the unavoidable drop in on-state current due to the reduction in current paths could be minimized to within one order of magnitude. Atomic force microscopy and Raman spectroscopy studies supported the view that the improvement in FET performance was attributed to the efficient and localized etching of metallic SWCNT paths solely around the NiO NPs, resulting in minimal damage to the semiconducting SWCNT networks.	[Li, Shisheng; Sakurai, Shunsuke; Futaba, Don N.; Hata, Kenji] Natl Inst Adv Ind Sci & Technol, Cent 5, Nanotube Res Ctr, Tsukuba, Ibaraki 3058565, Japan	Sakurai, S (reprint author), Natl Inst Adv Ind Sci & Technol, Cent 5, Nanotube Res Ctr, 1-1-1 Higashi, Tsukuba, Ibaraki 3058565, Japan.	shunsuke-sakurai@aist.go.jp	Futaba, Don /C-8294-2009		Japan Society for the Promotion of Science (JSPS) through its "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)	This work was supported by the Japan Society for the Promotion of Science (JSPS) through its "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program).	Dresselhaus MS, 2005, PHYS REP, V409, P47, DOI 10.1016/j.physrep.2004.10.006; Yu B, 2010, CARBON, V48, P2941, DOI 10.1016/j.carbon.2010.04.032; Ding L, 2009, NANO LETT, V9, P800, DOI 10.1021/nl803496s; Martel R, 2008, ACS NANO, V2, P2195, DOI 10.1021/nn800723u; Kaskela A, 2010, NANO LETT, V10, P4349, DOI 10.1021/nl101680s; Zhang GY, 2006, SCIENCE, V314, P974, DOI 10.1126/science.1133781; Li-Pook-Than A, 2013, ACS NANO, V7, P6507, DOI 10.1021/nn402412t; Zhang YY, 2008, J PHYS CHEM C, V112, P3849, DOI 10.1021/jp710691j; Li SS, 2012, ACS NANO, V6, P9657, DOI 10.1021/nn303070p; Li P, 2011, J MATER CHEM, V21, P11815, DOI 10.1039/c1jm10399g; Yu B, 2011, J AM CHEM SOC, V133, P5232, DOI 10.1021/ja2008278; Li JH, 2014, ACS NANO, V8, P8564, DOI 10.1021/nn503265g; Javey A, 2002, NAT MATER, V1, P241, DOI 10.1038/nmat769; Zhang GY, 2006, J AM CHEM SOC, V128, P6026, DOI 10.1021/ja061324b; Sun DM, 2013, SMALL, V9, P1188, DOI 10.1002/smll.201203154; Jin SH, 2013, NAT NANOTECHNOL, V8, P347, DOI [10.1038/nnano.2013.56, 10.1038/NNANO.2013.56]; Zhang RF, 2011, ADV MATER, V23, P3387, DOI 10.1002/adma.201100344; Zheng G, 2007, NANO LETT, V7, P1622, DOI 10.1021/nl070585w; Arnold MS, 2006, NAT NANOTECHNOL, V1, P60, DOI 10.1038/nnano.2006.52; Li YM, 2004, NANO LETT, V4, P317, DOI 10.1021/nl035097c; Liu BL, 2013, SMALL, V9, P1379, DOI 10.1002/smll.201202761; Hong G, 2009, J AM CHEM SOC, V131, P14642, DOI 10.1021/ja9068529; Sun DM, 2011, NAT NANOTECHNOL, V6, P156, DOI [10.1038/nnano.2011.1, 10.1038/NNANO.2011.1]; Durkop T, 2004, NANO LETT, V4, P35, DOI 10.1021/nl034841q; Gomez LM, 2009, NANO LETT, V9, P3592, DOI 10.1021/nl901802m; Yi JH, 2007, J NANOSCI NANOTECHNO, V7, P3394, DOI 10.1166/jnn.2007.843	26	2	2	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2040-3364	2040-3372		NANOSCALE	Nanoscale		2015	7	4					1280	1284		10.1039/c4nr06057a		5	Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	AY1TJ	WOS:000347374600003		
J	Kharlamova, MV; Sauer, M; Saito, T; Sato, Y; Suenaga, K; Pichler, T; Shiozawa, H				Kharlamova, Marianna V.; Sauer, Markus; Saito, Takeshi; Sato, Yuta; Suenaga, Kazu; Pichler, Thomas; Shiozawa, Hidetsugu			Doping of single-walled carbon nanotubes controlled via chemical transformation of encapsulated nickelocene	NANOSCALE			English	Article							TOMONAGA-LUTTINGER-LIQUID; CHARGE-TRANSFER; ELECTRONIC-PROPERTIES; OPTICAL-PROPERTIES; DIAMETER; GROWTH; SPECTRA; METALLOCENES; HALOGENIDES; TRANSITION	Controlled doping of carbon nanotubes is elemental for their electronic applications. Here we report an approach to tune the polarity and degree of doping of single-walled carbon nanotubes via filling with nickelocene followed by encapsulated reactions. Using Raman, photoemission spectroscopy and transmission electron microscopy, we show that nickelocene molecules transform into nickel carbides, nickel and inner carbon nanotubes with reaction temperatures as low as 250 degrees C. The doping efficiency is determined for each chemical component. Synchronous charge transfer among the molecular components allows bipolar doping of the carbon nanotubes to be achieved in a broad range of +/- 0.0012 e(-) per carbon.	[Kharlamova, Marianna V.; Sauer, Markus; Pichler, Thomas; Shiozawa, Hidetsugu] Univ Vienna, Fac Phys, A-1090 Vienna, Austria; [Saito, Takeshi; Sato, Yuta; Suenaga, Kazu] AIST, Nanotube Res Ctr, Tsukuba, Ibaraki 3058565, Japan	Kharlamova, MV (reprint author), Univ Vienna, Fac Phys, Strudlhofgasse 4, A-1090 Vienna, Austria.	mv.kharlamova@gmail.com; hidetsugu.shiozawa@univie.ac.at	Suenaga, Kazu/E-2339-2014; Pichler, Thomas/E-4351-2013	Suenaga, Kazu/0000-0002-6107-1123; Pichler, Thomas/0000-0001-5377-9896	Austrian Science Funds [P21333-N20]; Austrian Academy of Sciences; JSPS KAKENHI [25410246]	This work was supported by the Austrian Science Funds (P21333-N20). M.V.K. thanks the Austrian Academy of Sciences for a DOC-fFORTE fellowship. Y.S. acknowledges financial support by JSPS KAKENHI grant number 25410246. We thank S. Loyer and A. Stangl for technical assistance.	Saito T, 2008, J NANOSCI NANOTECHNO, V8, P6153, DOI 10.1166/jnn.2008.SW23; KIM KS, 1974, SURF SCI, V43, P625, DOI 10.1016/0039-6028(74)90281-7; Shiozawa H, 2010, ADV MATER, V22, P3685, DOI 10.1002/adma.201001211; Takenobu T, 2003, NAT MATER, V2, P683, DOI 10.1038/nmat976; Kharlamova MV, 2012, PHYS STATUS SOLIDI B, V249, P2328, DOI 10.1002/pssb.201200060; Ayala P, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.205427; Endo M, 2008, TOP APPL PHYS, V111, P13; Rauf H, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.096805; O'Connell MJ, 2005, NAT MATER, V4, P412, DOI 10.1038/nmat1367; Sloan J, 2003, CR PHYS, V4, P1063, DOI 10.1016/S1631-0705(03)00102-6; Kharlamova MV, 2012, J EXP THEOR PHYS+, V115, P485, DOI 10.1134/S1063776112080092; Lu J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.116804; Liu XJ, 2011, PHYS STATUS SOLIDI B, V248, P2492, DOI 10.1002/pssb.201100116; Sceats EL, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2349478; Ajayan PM, 2001, TOP APPL PHYS, V80, P391; Botka B, 2014, SMALL, V10, P1369, DOI 10.1002/smll.201302613; BETHUNE DS, 1993, NATURE, V363, P605, DOI 10.1038/363605a0; Takenobu T, 2005, ADV MATER, V17, P2430, DOI 10.1002/adma.200500759; Ishii H, 2003, NATURE, V426, P540, DOI 10.1038/nature02074; SINHAROY S, 1978, THIN SOLID FILMS, V53, P31, DOI 10.1016/0040-6090(78)90367-X; Kataura H, 2002, APPL PHYS A-MATER, V74, P349, DOI 10.1007/s003390201276; Kim KK, 2008, J AM CHEM SOC, V130, P12757, DOI 10.1021/ja8038689; Kharlamova MV, 2012, APPL PHYS A-MATER, V109, P25, DOI 10.1007/s00339-012-7091-3; Sasaki T, 2010, J ELECTRON MICROSC, V59, pS7, DOI 10.1093/jmicro/dfq027; Tasis D, 2006, CHEM REV, V106, P1105, DOI 10.1021/cr050569o; Sloan J, 2002, INORG CHIM ACTA, V330, P1, DOI 10.1016/S0020-1693(01)00774-5; Sauer M, 2013, PHYS STATUS SOLIDI B, V250, P2599, DOI 10.1002/pssb.201300124; Shiozawa H, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.046804; Araujo PT, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.241403; Tanaka Y, 2009, ANGEW CHEM INT EDIT, V48, P7655, DOI 10.1002/anie.200902468; Guan LH, 2005, CARBON, V43, P2780, DOI 10.1016/j.carbon.2005.05.025; Eliseev AA, 2012, CARBON, V50, P4021, DOI 10.1016/j.carbon.2012.04.046; Ilie A, 2011, ACS NANO, V5, P2559, DOI 10.1021/nn102189w; Li JB, 2013, CHEM MATER, V25, P4464, DOI 10.1021/cm401040d; Kataura H, 1999, SYNTHETIC MET, V103, P2555, DOI 10.1016/S0379-6779(98)00278-1; CAULETTI C, 1980, J ELECTRON SPECTROSC, V19, P327, DOI 10.1016/0368-2048(80)80058-2; Corio P, 2004, CHEM PHYS LETT, V383, P475, DOI 10.1016/j.cplett.2003.11.061; Liu XJ, 2012, ADV FUNCT MATER, V22, P3202, DOI 10.1002/adfm.201200224; Li LJ, 2005, NAT MATER, V4, P481, DOI 10.1038/nmat1396; Shiozawa H, 2008, ADV MATER, V20, P1443, DOI 10.1002/adma.200701466; LOCHEL BP, 1984, J ELECTROCHEM SOC, V131, P713; Sauer M, 2013, CARBON, V59, P237, DOI 10.1016/j.carbon.2013.03.014; Shiozawa H, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.153402; Kharlamova MV, 2013, APPL PHYS A-MATER, V112, P297, DOI 10.1007/s00339-013-7808-y; Fallah A, 2013, NANOSCALE, V5, P11755, DOI 10.1039/c3nr03233g; Garcia-Suarez VM, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.106804; Greenwood N.N., 1997, CHEM ELEMENTS; Iizumi Y, 2014, NANOSCALE, V6, P13910, DOI 10.1039/c4nr04398g; Kharlamova MV, 2013, APPL PHYS A-MATER, V111, P725, DOI 10.1007/s00339-013-7639-x; Kharlamova MV, 2013, PHYS-USP+, V56, P1047, DOI [10.3367/UFNe.0183.201311a.1145, 10.3367/UFNr.0183.201311a.1145]; Kharlamova MV, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2011-20457-6; Kim KK, 2010, NEW J CHEM, V34, P2183, DOI 10.1039/c0nj00138d; Kovacs GJ, 2008, THIN SOLID FILMS, V516, P7942, DOI 10.1016/j.tsf.2008.06.005; Larciprete R, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.115435; Leng YG, 2006, J NANOSCI NANOTECHNO, V6, P221; IIJIMA S, 1993, NATURE, V363, P603, DOI 10.1038/363603a0; Monthioux M, 2006, J MATER RES, V21, P2774, DOI 10.1557/JMR.2006.0366; Okazaki K, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.035434; Pfeiffer R, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.161404; Plank W, 2009, PHYS STATUS SOLIDI B, V246, P2724, DOI 10.1002/pssb.200982311; Pollack A, 2014, SMALL, V10, P5077, DOI 10.1002/smll.201401034; Pugmire DL, 1998, SURF SCI, V411, pL844, DOI 10.1016/S0039-6028(98)00408-7; RABALAIS JW, 1972, J CHEM PHYS, V57, P1185, DOI 10.1063/1.1678375; Saito T., 1998, PHYS PROPERTIES CARB; Sceats EL, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.245441; Schulte K, 2007, ADV MATER, V19, P3312, DOI 10.1002/adma.200700188; Shiozawa H, 2009, PHYS STATUS SOLIDI B, V246, P2626, DOI 10.1002/pssb.200982344	67	5	5	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2040-3364	2040-3372		NANOSCALE	Nanoscale		2015	7	4					1383	1391		10.1039/c4nr05586a		9	Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	AY1TJ	WOS:000347374600016		
J	Ciccarelli, C; Hals, KMD; Irvine, A; Novak, V; Tserkovnyak, Y; Kurebayashi, H; Brataas, A; Ferguson, A				Ciccarelli, Chiara; Hals, Kjetil M. D.; Irvine, Andrew; Novak, Vit; Tserkovnyak, Yaroslav; Kurebayashi, Hidekazu; Brataas, Arne; Ferguson, Andrew			Magnonic charge pumping via spin-orbit coupling	NATURE NANOTECHNOLOGY			English	Letter							FERROMAGNETIC-RESONANCE; MAGNETIZATION DYNAMICS; EFFECTIVE-FIELD; LAYER; HETEROSTRUCTURES; SEMICONDUCTORS; TORQUES; TA	The interplay between spin, charge and orbital degrees of freedom has led to the development of spintronic devices such as spin-torque oscillators and spin-transfer torque magnetic random-access memories. In this development, spin pumping represents a convenient way to electrically detect magnetization dynamics(1-6). The effect originates from direct conversion of low-energy quantized spin waves in the magnet, known as magnons, into a flow of spins from the precessing magnet to adjacent leads. In this case, a secondary spin-charge conversion element, such as heavy metals with large spin Hall angle(4-6) or multilayer layouts(7), is required to convert the spin current into a charge signal. Here, we report the experimental observation of charge pumping in which a precessing ferromagnet pumps a charge current, demonstrating direct conversion of magnons into high-frequency currents via the relativistic spin-orbit interaction. The generated electric current, unlike spin currents generated by spin-pumping, can be directly detected without the need of any additional spincharge conversion mechanism. The charge-pumping phenomenon is generic and gives a deeper understanding of its reciprocal effect, the spin orbit torque, which is currently attracting interest for their potential in manipulating magnetic information.	[Ciccarelli, Chiara; Irvine, Andrew; Kurebayashi, Hidekazu; Ferguson, Andrew] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; [Hals, Kjetil M. D.; Brataas, Arne] Norwegian Univ Sci & Technol, Dept Phys, NO-7491 Trondheim, Norway; [Hals, Kjetil M. D.] Univ Copenhagen, Niels Bohr Inst, Niels Bohr Int Acad, DK-2100 Copenhagen, Denmark; [Hals, Kjetil M. D.] Univ Copenhagen, Niels Bohr Inst, Ctr Quantum Devices, DK-2100 Copenhagen, Denmark; [Novak, Vit] ASCR, Inst Phys, Vvi, Prague 16253 6, Czech Republic; [Tserkovnyak, Yaroslav] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Kurebayashi, Hidekazu] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Ciccarelli, C (reprint author), Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England.	arne.brataas@ntnu.no	Brataas, Arne/C-6178-2014	Brataas, Arne/0000-0003-0867-6323			Kurebayashi H, 2014, NAT NANOTECHNOL, V9, P211, DOI [10.1038/nnano.2014.15, 10.1038/NNANO.2014.15]; Onsager L, 1931, PHYS REV, V37, P405, DOI 10.1103/PhysRev.37.405; Sandweg CW, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.216601; Garello K, 2013, NAT NANOTECHNOL, V8, P587, DOI [10.1038/nnano.2013.145, 10.1038/NNANO.2013.145]; Heinrich B, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.187601; Garate I, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.134403; Liu XY, 2006, J PHYS-CONDENS MAT, V18, pR245, DOI 10.1088/0953-8984/18/13/R02; Fang D, 2011, NAT NANOTECHNOL, V6, P413, DOI [10.1038/nnano.2011.68, 10.1038/NNANO.2011.68]; Kajiwara Y, 2010, NATURE, V464, P262, DOI 10.1038/nature08876; Tserkovnyak Y, 2005, REV MOD PHYS, V77, P1375, DOI 10.1103/RevModPhys.77.1375; Manchon A, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.212405; Pesin DA, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.014416; Kim J, 2013, NAT MATER, V12, P240, DOI [10.1038/nmat3522, 10.1038/NMAT3522]; Hals KMD, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.085423; Bernevig BA, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.033203; Mizukami S, 2001, JPN J APPL PHYS 1, V40, P580, DOI 10.1143/JJAP.40.580; Endo M, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3520514; Liu LQ, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.036601; Miron IM, 2011, NAT MATER, V10, P419, DOI [10.1038/nmat3020, 10.1038/NMAT3020]; Mosendz O, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.046601; Ralph DC, 2008, J MAGN MAGN MATER, V320, P1190, DOI 10.1016/j.jmmm.2007.12.019; Chernyshov A, 2009, NAT PHYS, V5, P656, DOI 10.1038/NPHYS1362; Wang XH, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.117201; Miron IM, 2010, NAT MATER, V9, P230, DOI [10.1038/nmat2613, 10.1038/NMAT2613]; Miron IM, 2011, NATURE, V476, P189, DOI 10.1038/nature10309; Manchon A, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.094422; Costache MV, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.216603; Fan X, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2709; Hals KMD, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/47002; Rojas Sanchez JC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3944; Jungwirth T, 2006, REV MOD PHYS, V78, P809, DOI 10.1103/RevModPhys.78.809; Tatara G, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.054403	32	8	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1748-3387	1748-3395		NAT NANOTECHNOL	Nat. Nanotechnol.	JAN	2015	10	1					50	54		10.1038/NNANO.2014.252		5	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science & Technology - Other Topics; Materials Science	AY2GC	WOS:000347405800019		
J	Reinartz, MT; Kalble, S; Littmann, T; Ozawa, T; Dove, S; Kaever, V; Wainer, IW; Seifert, R				Reinartz, Michael T.; Kaelble, Solveig; Littmann, Timo; Ozawa, Takeaki; Dove, Stefan; Kaever, Volkhard; Wainer, Irving W.; Seifert, Roland			Structure-bias relationships for fenoterol stereoisomers in six molecular and cellular assays at the beta(2)-adrenoceptor	NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY			English	Article						Functional selectivity; beta(2)-Adrenergic receptor; Biased ligand; Bias quantification; Structure-bias relationships; Fenoterol	BETA(2) ADRENERGIC-RECEPTOR; PROTEIN-COUPLED RECEPTORS; FUNCTIONAL SELECTIVITY; FUSION PROTEINS; FIELD ANALYSIS; AGONISTS; QUANTIFICATION; DERIVATIVES; MECHANISM; DYNAMICS	Functional selectivity is well established as an underlying concept of ligand-specific signaling via G protein-coupled receptors (GPCRs). Functionally, selective drugs could show greater therapeutic efficacy and fewer adverse effects. Dual coupling of the beta(2)-adrenoceptor (beta(2)AR) triggers a signal transduction via G(s)alpha and G(i)alpha proteins. Here, we examined 12 fenoterol stereoisomers in six molecular and cellular assays. Using beta(2)AR-G(s)alpha and beta(2)AR-G(i)alpha fusion proteins, (R,S')- and (S,S')-isomers of 4'-methoxy-1-naphthyl-fenoterol were identified as biased ligands with preference for G(s). G protein-independent signaling via beta-arrestin-2 was disfavored by these ligands. Isolated human neutrophils constituted an ex vivo model of beta(2)AR signaling and demonstrated functional selectivity through the dissociation of cAMP accumulation and the inhibition of formyl peptide-stimulated production of reactive oxygen species. Ligand bias was calculated using an operational model of agonism and revealed that the fenoterol scaffold constitutes a promising lead structure for the development of G(s)-biased beta(2)AR agonists.	[Reinartz, Michael T.; Kaelble, Solveig; Littmann, Timo; Kaever, Volkhard; Seifert, Roland] Hannover Med Sch, Inst Pharmacol, D-30625 Hannover, Germany; [Ozawa, Takeaki] Univ Tokyo, Dept Chem, Sch Sci, Tokyo 113, Japan; [Dove, Stefan] Univ Regensburg, Dept Pharmaceut & Med Chem 2, D-93053 Regensburg, Germany; [Kaever, Volkhard] Hannover Med Sch, Core Unit Metabol, D-30625 Hannover, Germany; [Wainer, Irving W.] NIA, Clin Invest Lab, Biomed Res Ctr, NIH, Baltimore, MD 21224 USA	Seifert, R (reprint author), Hannover Med Sch, Inst Pharmacol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	seifert.roland@mh-hannover.de	Kaever, Volkhard/G-3280-2013; 	Reinartz, Michael/0000-0002-4211-4562			Cazzola M, 2013, AM J RESP CRIT CARE, V187, P690, DOI 10.1164/rccm.201209-1739PP; Seifert R, 1999, MOL PHARMACOL, V56, P348; Casella I, 2011, BIOCHEM J, V438, P191, DOI 10.1042/BJ20110374; Evans BA, 2011, MOL PHARMACOL, V79, P298, DOI 10.1124/mol.110.067454; Deshpande DA, 2008, FASEB J, V22, P2134, DOI 10.1096/fj.07-102459; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Xiao RP, 2003, CIRCULATION, V108, P1633, DOI 10.1161/01.CIR.0000087595.17277.73; Galandrin S, 2007, TRENDS PHARMACOL SCI, V28, P423, DOI 10.1016/i.tips.2007.06.005; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Moore RH, 2007, AM J RESP CELL MOL, V36, P254, DOI 10.1165/rcmb.2006-0158OC; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Jozwiak K, 2010, BIOORGAN MED CHEM, V18, P728, DOI 10.1016/j.bmc.2009.11.062; Reiner S, 2010, J BIOL CHEM, V285, P36188, DOI 10.1074/jbc.M110.175604; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; White KL, 2014, MOL PHARMACOL, V85, P83, DOI 10.1124/mol.113.089649; Weitl N, 2008, J PHARMACOL EXP THER, V327, P760, DOI 10.1124/jpet.108.143412; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; GETHER U, 1995, J BIOL CHEM, V270, P28268; Zhu WZ, 2005, CIRC RES, V97, P507, DOI 10.1061/01.RES.0000184615.56822.bd; Deupi X, 2010, PHYSIOLOGY, V25, P293, DOI 10.1152/physiol.00002.2010; Woo AYH, 2012, ACTA PHARMACOL SIN, V33, P335, DOI 10.1038/aps.2011.201; Barnes PJ, 1999, J ALLERGY CLIN IMMUN, V104, pS10, DOI 10.1016/S0091-6749(99)70269-1; Woo AYH, 2009, MOL PHARMACOL, V75, P158, DOI 10.1124/mol.108.051078; Seifert R, 2013, BIOCHEM PHARMACOL, V86, P853, DOI 10.1016/j.bcp.2013.07.029; Misawa N, 2010, ANAL CHEM, V82, P2552, DOI 10.1021/ac100104q; Evans BA, 2010, BRIT J PHARMACOL, V159, P1022, DOI 10.1111/j.1476-5381.2009.00602.x; Chen X, 2012, J MED CHEM, V55, P7141, DOI 10.1021/jm300603y; Galandrin S, 2006, MOL PHARMACOL, V70, P1575, DOI 10.1124/mol.106.026716; Wenzel-Seifert K, 2000, MOL PHARMACOL, V58, P954; Jozwiak K, 2007, J MED CHEM, V50, P2903, DOI 10.1021/jm70030d; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Kenakin T, 2012, ACS CHEM NEUROSCI, V3, P193, DOI 10.1021/cn200111m; Uzkeser H, 2012, MEDIAT INFLAMM, DOI 10.1155/2012/438912; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Bock A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2028; Brunskole-Hummel I, 2013, PLOS ONE, V8; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Johnson Malcolm, 2002, Journal of Allergy and Clinical Immunology, V110, pS282, DOI 10.1067/mai.2002.129430; Kenakin T, 2012, BRIT J PHARMACOL, V168, P554; R Core Team, 2013, R LANG ENV STAT COMP; Schneider EH, 2010, METHOD ENZYMOL, V485, P459, DOI [10.1016/B978-0-12-381296-4.00025-7, 10.1016/S0076-6879(10)85025-6]; SEIFERT R, 1991, REV PHYSIOL BIOCH P, V117, P1; Seifert R, 1999, TRENDS PHARMACOL SCI, V20, P383, DOI 10.1016/S0165-6147(99)01368-1; Stallaert W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029420; Takakura M, 2012, ACS CHEM BIOL, V7, P901; Thompson GL, 2015, BRIT J PHARMACOL, V172, P287, DOI 10.1111/bph.12600; Tikhonova IG, 2013, BIOCHEMISTRY-US, V52, P5593, DOI 10.1021/bi400499n; van der Westhuizen ET, 2014, MOL PHARMACOL, V85, P492, DOI 10.1124/mol.113.088880	49	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0028-1298	1432-1912		N-S ARCH PHARMACOL	Naunyn-Schmiedebergs Arch. Pharmacol.	JAN	2015	388	1					51	65		10.1007/s00210-014-1054-5		15	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AY2GE	WOS:000347406000007		
J	Harada, E; Schacht, A; Koyama, T; Marangell, LB; Tsuji, T; Escobar, R				Harada, Eiji; Schacht, Alexander; Koyama, Tsukasa; Marangell, Lauren B.; Tsuji, Toshinaga; Escobar, Rodrigo			Efficacy comparison of duloxetine and SSRIs at doses approved in Japan	NEUROPSYCHIATRIC DISEASE AND TREATMENT			English	Article						duloxetine; selective serotonin reuptake inhibitors; Japan; approved dosage; meta-analysis; major depressive disorder	MAJOR DEPRESSIVE DISORDER; SEROTONIN-REUPTAKE INHIBITORS; 2ND-GENERATION ANTIDEPRESSANTS; COMPARATIVE BENEFITS; NON-INFERIORITY; DOUBLE-BLIND; METAANALYSIS; ESCITALOPRAM; PLACEBO; STATES	Background: Approved doses of antidepressants in Japan are usually lower than those in the USA and European Union, but to date meta-analyses comparing antidepressants have all used the higher doses approved in the USA and European Union and often have used indirect comparisons. The purpose of this study was to conduct an integrated database analysis of patient level data to compare the effects of duloxetine with those of selective serotonin reuptake inhibitors (SSRIs) at the doses approved in Japan. Methods: Pooled data were analyzed from four randomized, double-blind, placebo-controlled studies that compared duloxetine at the dose range approved in Japan (40-60 mg/day) with other SSRIs (paroxetine 20 mg/day or escitalopram 10 mg/day) and placebo in patients with major depressive disorder. In total, 1,694 patients were included in the analysis (duloxetine, n=688; selective serotonin reuptake inhibitors, n=690; placebo, n=316). The primary outcome measure was the mean change from baseline at week 8 in 17-item Hamilton Rating Scale for Depression (HAMD17) total and subscale scores. Results: Duloxetine and both selective serotonin reuptake inhibitors were superior to placebo in HAMD17 total score at week 8 in both the all-randomized group and the more severe subgroup (HAMD17 total scores >= 19). Duloxetine was superior to SSRIs in improving the HAMD17 Retardation subscale score (least squares mean difference [95% confidence interval]): all-randomized group, -0.33 [-0.60, -0.07], P=0.015; severe subgroup, -0.45 [-0.83, -0.07], P=0.020). Conclusion: Within the dose range approved in Japan for patients with major depressive disorder, duloxetine and selective serotonin reuptake inhibitors demonstrated comparable overall efficacy, with a possible advantage for duloxetine in improving loss of energy and interest. To the best of our knowledge, this analysis is unique not only in evaluating dosages specific to Japan, but also in using individual patient data and the same endpoint across studies to allow for strictly direct head-to-head data comparisons as opposed to pooling direct and indirect comparisons.	[Harada, Eiji] Eli Lilly Japan KK, Med Sci, Kobe, Hyogo 651, Japan; [Schacht, Alexander] Eli Lilly & Co, Global Stat Sci, Bad Homburg, Germany; [Koyama, Tsukasa] Ohyachi Hosp, Clin Res Ctr, Sapporo, Hokkaido, Japan; [Marangell, Lauren B.] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Marangell, Lauren B.] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Tsuji, Toshinaga] Shionogi & Co Ltd, Med Affairs, Osaka, Japan	Harada, E (reprint author), Eli Lilly Japan KK, Chuo Ku, Med Sci, 7-1-5 Isogamidori, Kobe, Hyogo 651, Japan.	harada_eiji@lilly.com			Eli Lilly and Company; Shionogi Co Ltd.; Astellas; Dainippon Sumitomo; GlaxoSmithKline; Pfizer	This study was funded by Eli Lilly and Company and Shionogi & Co Ltd. EH, AS, LM, and RE are employees and stockholders in Eli Lilly and Company. TK has received honoraria from Astellas, Eli Lilly Japan, Meiji Seika, Mitsubishi Tanabe, MSD, Otsuka, and Pfizer, and has received research grants from Astellas, Dainippon Sumitomo, GlaxoSmithKline, and Pfizer. TK is also an advisory board member for GlaxoSmithKline, and has served as a consultant for Asahi-kasei. TT is a full-time employee and stockholder in Shionogi & Co Ltd. A part of this paper was presented at The International College of Neuropsychopharmacology Special Congress on Addiction and Mental Health 2013 ( Kuala Lumpur City, Malaysia, October 1-4, 2013). Editorial assistance was provided by Angela Lorio and writing assistance was provided by Jody Arsenault, InVentiv Health Clinical, with financial support from Eli Lilly and Company. The authors report no other conflicts of interest in this work.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Mallinckrodt CH, 2007, NEUROPSYCHOBIOLOGY, V56, P73, DOI 10.1159/000111537; Gartlehner G, 2011, ANN INTERN MED, V155, P772, DOI 10.7326/0003-4819-155-11-201112060-00009; Thase ME, 2007, J CLIN PSYCHOPHARM, V27, P672, DOI 10.1097/jcp.0b013e31815a4412; Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; Lee P, 2007, PSYCHIAT CLIN NEUROS, V61, P295, DOI 10.1111/j.1440-1819.2007.01666.x; Gartlehner G, 2008, ANN INTERN MED, V149, P734; Papakostas GI, 2007, BIOL PSYCHIAT, V62, P1217, DOI 10.1016/j.biopsych.2007.03.027; Pigott TA, 2007, CURR MED RES OPIN, V23, P1303, DOI 10.1185/030079907X188107; Katz MM, 2004, NEUROPSYCHOPHARMACOL, V29, P566, DOI 10.1038/sj.npp.1300341; Hansen RA, 2005, ANN INTERN MED, V143, P415; Morilak DA, 2004, INT J NEUROPSYCHOPH, V7, P193, DOI 10.1017/S1461145704004080; BECH P, 1975, ACTA PSYCHIAT SCAND, V51, P161, DOI 10.1111/j.1600-0447.1975.tb00002.x; Nierenberg AA, 2007, CURR MED RES OPIN, V23, P401, DOI 10.1185/030079906X167453; Smith D, 2002, BRIT J PSYCHIAT, V180, P396, DOI 10.1192/bjp.180.5.396; Cleary P, 1977, DRUGS EXP CLIN RES, V1, P115; Gartlehner G, 2009, DRUG SAFETY, V32, P1159, DOI 10.2165/11318930-000000000-00000; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50; Japanese Society of Mood Disorders, 2012, TREATM GUID 2 MAJ DE; MAIER W, 1985, PHARMACOPSYCHIATRY, V18, P114, DOI 10.1055/s-2007-1017335; Martinez JM, 2012, INT CLIN PSYCHOPHARM, V27, P17, DOI 10.1097/YIC.0b013e32834ce11b; National Institute for Clinical Excellence, 2004, CLIN PRACT GUID 23 D; Thase M E, 2001, Manag Care, V10, P6; THASE ME, 1991, AM J PSYCHIAT, V148, P784; Treuer T, 2013, ASIA-PAC PSYCHIAT, V5, P219, DOI 10.1111/appy.12090	26	0	0	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-2021			NEUROPSYCH DIS TREAT	Neuropsychiatr. Dis. Treat.		2015	11						115	123		10.2147/NDT.S72642		9	Clinical Neurology; Psychiatry	Neurosciences & Neurology; Psychiatry	AY6RM	WOS:000347693300001		
J	Nakatsukasa, Y; Noferini, V; Townsend, A				Nakatsukasa, Yuji; Noferini, Vanni; Townsend, Alex			Computing the common zeros of two bivariate functions via Bezout resultants	NUMERISCHE MATHEMATIK			English	Article							POLYNOMIAL EIGENVALUE PROBLEMS; CHEBYSHEV SERIES FORM; MULTIPLE-EIGENVALUES; REAL ROOTS; MATRICES; SUBDIVISION; CURVES	The common zeros of two bivariate functions can be computed by finding the common zeros of their polynomial interpolants expressed in a tensor Chebyshev basis. From here we develop a bivariate rootfinding algorithm based on the hidden variable resultant method and B,zout matrices with polynomial entries. Using techniques including domain subdivision, B,zoutian regularization, and local refinement we are able to reliably and accurately compute the simple common zeros of two smooth functions with polynomial interpolants of very high degree (). We analyze the resultant method and its conditioning by noting that the B,zout matrices are matrix polynomials. Two implementations are available: one on the Matlab Central File Exchange and another in the roots command in Chebfun2 that is adapted to suit Chebfun's methodology.	[Nakatsukasa, Yuji] Univ Tokyo, Grad Sch Informat Sci & Technol, Dept Math Informat, Tokyo 1138656, Japan; [Noferini, Vanni] Univ Manchester, Sch Math, Manchester M13 9PL, Lancs, England; [Townsend, Alex] Univ Oxford, Math Inst, Oxford OX2 6GG, England	Noferini, V (reprint author), Univ Manchester, Sch Math, Manchester M13 9PL, Lancs, England.	nakatsukasa@mist.i.u-tokyo.ac.jp; vanni.noferini@manchester.ac.uk; townsend@maths.ox.ac.uk			EPSRC grant [EP/I005293/1]; ERC Advanced Grant MATFUN [267526]; EPSRC [EP/P505666/1]; ERC	Yuji Nakatsukasa was partially supported by EPSRC grant EP/I005293/1.; Vanni Noferini was supported by ERC Advanced Grant MATFUN (267526).; Alex Townsend was supported by EPSRC grant EP/P505666/1 and the ERC grant FP7/2007-2013 to L. N. Trefethen.	Tisseur F, 2000, LINEAR ALGEBRA APPL, V309, P339, DOI 10.1016/S0024-3795(99)00063-4; Emiris IZ, 1999, J SYMB COMPUT, V28, P3, DOI 10.1006/jsco.1998.0266; Bini DA, 2004, THEOR COMPUT SCI, V315, P319, DOI 10.1016/j.tcs.2004.01.016; MANOCHA D, 1994, ACM T GRAPHIC, V13, P73, DOI 10.1145/174462.174617; Boyd JP, 2007, J COMPUT APPL MATH, V205, P281, DOI 10.1016/j.cam.2006.05.006; Xie HQ, 2003, LINEAR ALGEBRA APPL, V374, P143, DOI 10.1016/S0024-3795(03)00581-0; Diaz-Toca GM, 2013, COMPUT AIDED GEOM D, V30, P116, DOI 10.1016/j.cagd.2012.06.006; Bini DA, 2006, NUMER ALGORITHMS, V43, P151, DOI 10.1007/s11075-006-9048-0; Mackey DS, 2006, SIAM J MATRIX ANAL A, V28, P971, DOI 10.1137/050628350; Beyn WJ, 2012, LINEAR ALGEBRA APPL, V436, P3839, DOI 10.1016/j.laa.2011.03.030; Boyd JP, 2002, SIAM J NUMER ANAL, V40, P1666, DOI 10.1137/S0036142901398325; Aruliah Dhavide A., 2007, P 2007 INT WORKSH SY, P55; Asakura J., 2009, JSIAM LETT, V1, P52; ATKINSON F. V., 1972, MULTIPARAMETER EIGEN; Bai Z., 2000, TEMPLATES SOLUTION A; Barnett S., 1980, LINEAR MULTILINEAR A, V8, P271, DOI 10.1080/03081088008817332; Bates D.J., 2013, NUMERICALLY SOLVING; Bezout E., 1779, THESIS PIERRES PARIS; Bini DA, 2013, LINEAR ALGEBRA APPL, V439, P1130, DOI 10.1016/j.laa.2013.02.024; Bornemann F., 2004, SIAM 100 DIGIT CHALL; Boyd JP, 2006, APPL NUMER MATH, V56, P1077, DOI 10.1016/j.apnum.2005.09.007; Boyd JP, 2006, APPL MATH COMPUT, V174, P1642, DOI 10.1016/j.amc.2005.07.009; Buchberger B., 1998, GROBNER BASIS APPL, V251, P3; Cox D., 2007, IDEALS VARIETIES ALG; Dreesen P., 2012, P 16 IFAC S SYST ID, P1203; Gohberg I, 2009, CLASS APPL MATH, V58, P1, DOI 10.1137/1.9780898719024; Harnack C.G.A., 1876, MATH ANN, V10, P189; Higham N. J., 2002, ACCURACY STABILITY N; Hilton A., 1996, INT C IM PROC, V1; Hochstenbach ME, 2004, SIAM J MATRIX ANAL A, V26, P477, DOI 10.1137/S0895479802418318; Jonsson G., 2005, MATH COMPUT, V74, P221; Kapur D., 1995, Proceedings of the 1995 International Symposium on Symbolic and Algebraic Computation, ISSAC '95, DOI 10.1145/220346.220370; Kirwan F., 1992, COMPLEX ALGEBRAIC CU; Kravitsky N., 1980, INTEGR EQUAT OPER TH, V3, P97, DOI 10.1007/BF01682873; Li RC, 2012, LINEAR ALGEBRA APPL, V437, P202, DOI 10.1016/j.laa.2012.01.035; Marks II R.J., 1991, INTRO SHANNON SAMPLI; MEHRMANN V., 2005, MITT GES ANGEW MATH, V27, P121; Muhic A, 2010, LINEAR ALGEBRA APPL, V432, P2529, DOI 10.1016/j.laa.2009.12.022; Nakatsukasa Y., 2014, PREPRINT; Nakatsukasa Y., 2013, COMPUTING COMMON ZER; Parlett B. N., 1998, SYMMETRIC EIGENVALUE; Plaumann D., 2012, MATH METHODS SYST OP, V222, P259; Sagraloff M., GALLERY ALGEBRAIC CU; Salmon G., 1885, LESSONS INTRO MODERN; Sorber L., 2013, PREPRINT; SUN JG, 1992, NUMER MATH, V61, P265, DOI 10.1007/BF01385508; Townsend A, 2013, SIAM J SCI COMPUT, V35, pC495, DOI 10.1137/130908002; Trefethen L.N., 2002, SIAM NEWS, V35; Trefethen LN, 2013, APPROXIMATION THEORY AND APPROXIMATION PRACTICE, P1; Trefethen L.N., 2013, CHEBFUN VERSION 4 2; Van Loan C. F., 1996, MATRIX COMPUTATIONS; Sommese AJ, 2005, NUMERICAL SOLUTION OF SYSTEMS OF POLYNOMIALS: ARISING IN ENGINEERING AND SCIENCE, P1, DOI 10.1142/9789812567727; Wilkinson James H., 1984, STUDIES NUMERICAL AN	53	3	3	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0029-599X	0945-3245		NUMER MATH	Numer. Math.	JAN	2015	129	1					181	209		10.1007/s00211-014-0635-z		29	Mathematics, Applied	Mathematics	AY2GH	WOS:000347406300007		
J	Okuma, Y; Hosomi, Y; Imamura, A				Okuma, Yusuke; Hosomi, Yukio; Imamura, Akifumi			Lung cancer patients harboring epidermal growth factor receptor mutation among those infected by human immunodeficiency virus	ONCOTARGETS AND THERAPY			English	Article						non-small cell lung cancer; human immunodeficiency virus; antiretroviral therapy; epidermal growth factor receptor mutation; non-AIDS-defining cancers	ACTIVE ANTIRETROVIRAL THERAPY; INTENSIVE CHEMOTHERAPY; SMOKING-CESSATION; UNITED-STATES; AIDS; HIV; GEFITINIB; INDINAVIR; LYMPHOMA; SURVIVAL	With the advent of antiretroviral therapy, lung cancer has become a crucial health problem among individuals living with human immunodeficiency virus (HIV). In East Asian populations, the frequency of lung cancer patients harboring epidermal growth factor receptor (EGFR) mutations is greater than in other populations. Herein, we present two cases of advanced non- small cell lung cancer with EGFR mutations in patients treated with EGFR- tyrosine kinase inhibitors. Both patients were male, 67 and 59 years of age, with known HIV infection and immunologically stable disease with antiretroviral therapy. Case 1 was treated with erlotinib for recurrent adenocarcinoma metastasizing to the liver and brain harboring EGFR mutation in exon 21 L858R. The duration of treatment efficacy was 9.7 months. Case 2 had an EGFR mutation exon 19 in- frame deletion with bone metastasis and was treated with gefitinib for 22.1 months in combination with antiretroviral therapy. These advanced lung cancer patients living with HIV with EGFR mutations demonstrate the promising effectiveness and safety of EGFR- tyrosine kinase inhibitors concomitant with antiretroviral therapy for an extended period.	[Okuma, Yusuke; Hosomi, Yukio] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Thorac Oncol & Resp Med, Tokyo 1138677, Japan; [Imamura, Akifumi] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Infect Dis, Tokyo 1138677, Japan	Okuma, Y (reprint author), Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Thorac Oncol & Resp Med, 3-18-22 Honkomagome, Tokyo 1138677, Japan.	y-okuma@cick.jp					Makinson A, 2010, J THORAC ONCOL, V5, P562, DOI 10.1097/JTO.0b013e3181d3ccf2; Shah NT, 2005, J CLIN ONCOL, V23, P165, DOI 10.1200/JCO.2005.04.057; Sepkowitz KA, 2001, NEW ENGL J MED, V344, P1764, DOI 10.1056/NEJM200106073442306; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Niaura R, 2000, CLIN INFECT DIS, V31, P808, DOI 10.1086/314048; Shiels MS, 2011, J NATL CANCER I, V103, P753, DOI 10.1093/jnci/djr076; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Lavole A, 2009, LUNG CANCER, V65, P345, DOI 10.1016/j.lungcan.2008.11.018; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Herida M, 2003, J CLIN ONCOL, V21, P3447, DOI 10.1200/JCO.2003.01.096; Engels EA, 2006, AIDS, V20, P1645, DOI 10.1097/01.aids.0000238411.75324.59; Galicier L, 2007, BLOOD, V110, P2846, DOI 10.1182/blood-2006-10-051771; Burns DN, 1996, J ACQ IMMUN DEF SYND, V13, P374; Erickson TM, 2008, J THORAC ONCOL, V3, P1353, DOI 10.1097/JTO.0b013e31818b1ae1; Hakimian R, 2007, J THORAC ONCOL, V2, P268; Hooker CM, 2012, ANN THORAC SURG, V93, P405, DOI 10.1016/j.athoracsur.2011.11.012; HUGHES JR, 1993, J SUBST ABUSE TREAT, V10, P181, DOI 10.1016/0740-5472(93)90043-2; Okuma Y, 2014, ANN ONCOLOGY S4, V25, piv545; Oriol A, 2003, HAEMATOLOGICA, V88, P445; Pakkala Suchita, 2010, J Thorac Oncol, V5, P1864, DOI 10.1097/JTO.0b013e3181f387fd; Rudek MA, 2014, CANCER-AM CANCER SOC, V120, P1194, DOI 10.1002/cncr.28554; Sanchez X, 1997, J BIOL CHEM, V272, P27529, DOI 10.1074/jbc.272.44.27529; Wang ES, 2003, CANCER, V98, P1196, DOI 10.1002/cncr.11628	26	0	0	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-6930			ONCOTARGETS THER	OncoTargets Ther.		2015	8									10.2147/OTT.S76712		4	Biotechnology & Applied Microbiology; Oncology	Biotechnology & Applied Microbiology; Oncology	AY0MZ	WOS:000347291700001		
J	Siar, CH; Tsujigiwa, H; Ishak, I; Hussin, NM; Nagatsuka, H; Ng, KH				Siar, Chong Huat; Tsujigiwa, Hidetsugu; Ishak, Ismadi; Hussin, Nurmawarnis Mat; Nagatsuka, Hitoshi; Ng, Kok Han			RANK, RANKL, and OPG in recurrent solid/multicystic ameloblastoma: their distribution patterns and biologic significance	ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY			English	Article							KERATOCYSTIC ODONTOGENIC-TUMORS; KAPPA-B LIGAND; BREAST-CANCER; OSTEOCLAST DIFFERENTIATION; RECEPTOR ACTIVATOR; DENTIGEROUS CYSTS; EXPRESSION; BONE; OSTEOPROTEGERIN; NECROSIS	Objectives. To determine the distribution patterns of bone resorption regulators, receptor activator of nuclear factor kappa-B (RANK), RANK ligand (RANKL), and osteoprotegerin (OPG) in recurrent ameloblastoma (RAs) and to clarify their impact on the biologic behavior of these neoplasms. Materials and Methods. Fifteen paraffin-embedded RA cases were subjected to immunohistochemistry for expression of RANK, RANKL, and OPG. Results. The RANK-RANKL-OPG triad was heterogeneously detected in RA samples. RANK, essential for osteoclast differentiation, was strongly expressed in tumoral epithelium. Conversely, RANKL, an osteoclast activator, was markedly underexpressed, and protein localization was predominantly stromal. OPG, an osteoclastogenesis inhibitory factor, was detected in neoplastic epithelium more than in stroma, suggesting functional inactivation of RANKL. Most RA (n = 12/15; 80%) exhibited a bimolecular spatial expression pattern, the most common being RANK-positive/OPG-positive (n = 8/15; 53.3%). All three proteins showed no significant correlation with the clinical/histopathologic parameters in RA patients (P > .05). Conclusions. The RANK(+)/RANKL(low/-)/OPG(+) phenotype observed in RA suggests an altered local bonemetabolism characterized by low bone resorptive activity in these recurrent tumors.	[Siar, Chong Huat; Ishak, Ismadi; Hussin, Nurmawarnis Mat] Univ Malaya, Fac Dent, Dept Oromaxillofacial Surg & Med Sci, Kuala Lumpur 50603, Malaysia; [Tsujigiwa, Hidetsugu] Okayama Univ Sci, Fac Sci, Dept Life Sci, Lab Histopathol, Okayama, Japan; [Nagatsuka, Hitoshi] Okayama Univ Sci, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral Pathol & Med, Okayama, Japan; [Ng, Kok Han] Inst Med Res, Unit Stomatol, Kuala Lumpur, Malaysia; [Ng, Kok Han] Inst Med Res, Unit Stomatol, Kuala Lumpur 50588, Malaysia	Siar, CH (reprint author), Univ Malaya, Fac Dent, Dept Oromaxillofacial Surg & Med Sci, Kuala Lumpur 50603, Malaysia.	Siarch@um.edu.my	Siar, Chong Huat/A-9467-2010; Management Center, Dental Research/C-2478-2013		Ministry of Higher Education Malaysia Fundamental Research Grant Scheme [FP038-2013 A]; Japan Society for Promotion of Science (JSPS) KAKENHI [C26462783, 25893141]	This study was jointly supported by the Ministry of Higher Education Malaysia Fundamental Research Grant Scheme (FP038-2013 A), Japan Society for Promotion of Science (JSPS) KAKENHI Grant-in-Aid for Scientific Research (C26462783) and Grant-in-Aid for Research Activity Start-up (25893141).	Abu-Amer Yousef, 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P347, DOI 10.2174/1568008054863808; Andrade FR, 2008, ORAL SURG ORAL MED O, V106, P548, DOI 10.1016/j.tripleo.2008.05.042; Shipman CM, 2003, CANCER RES, V63, P912; Menezes R, 2008, J ENDODONT, V34, P932, DOI 10.1016/j.joen.2008.05.002; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Ito R, 2003, VIRCHOWS ARCH, V443, P146, DOI 10.1007/s00428-003-0845-8; de Moraes M, 2011, ARCH ORAL BIOL, V56, P1256, DOI 10.1016/j.archoralbio.2011.05.009; Gong YL, 2009, ORAL ONCOL, V45, P515, DOI 10.1016/j.oraloncology.2008.07.004; Ibrahim T, 2011, CLIN BREAST CANCER, V11, P369, DOI 10.1016/j.clbc.2011.05.001; Proff P, 2009, CLIN ORAL INVEST, V13, P355, DOI 10.1007/s00784-009-0268-2; Khosla S, 2001, ENDOCRINOLOGY, V142, P5050, DOI 10.1210/en.142.12.5050; Shang M, 2013, CLIN BIOCHEM, V46, P1493, DOI 10.1016/j.clinbiochem.2013.03.011; Samara S, 2014, EXP MOL PATHOL, V96, P9, DOI 10.1016/j.yexmp.2013.10.014; Roodman GD, 2006, ANN NY ACAD SCI, V1068, P100, DOI 10.1196/annals.1346.013; Cao HL, 2013, INT J CARDIOL, V166, P702, DOI 10.1016/j.ijcard.2011.11.099; Barnes L, 2005, WHO CLASSIFICATION T; Bello IO, 2007, J ORAL PATHOL MED, V36, P48; Chen YC, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2781; da Silva TA, 2008, ORAL SURG ORAL MED O, V105, P333, DOI 10.1016/j.tripleo.2007.06.009; de Matos FR, 2013, J ORAL MAXIL SURG, V71, P1886, DOI 10.1016/j.joms.2013.05.023; Kumamoto H, 2004, J ORAL PATHOL MED, V33, P46, DOI 10.1111/j.1600-0714.2004.00204.x; Mello LA, 2013, J ORAL PATHOL MED, V42, P454, DOI 10.1111/jop.12033; Ohazama A, 2004, J DENT RES, V83, P241; Qian Y, 2010, J ORAL PATHOL MED, V39, P592, DOI 10.1111/j.1600-0714.2009.00882.x; Rani C. S. Sheela, 2000, Molecular Cell Biology Research Communications, V3, P145, DOI 10.1006/mcbr.2000.0205; Sandra F, 2006, ORAL ONCOL, V42, P415, DOI 10.1016/j.oraloncology.2005.09.009; Sandra F, 2005, ORAL ONCOL, V41, P637, DOI 10.1016/j.oraloncology.2005.02.008; Siar CH, 2014, J ORAL PATHOL MED, V43, P45, DOI 10.1111/jop.12065; Tay JYY, 2004, J DENT RES, V83, P349; Tekkesin Merva Soluk, 2011, Head Neck Pathol, V5, P248, DOI 10.1007/s12105-011-0271-1; Trinkaus M, 2009, ONCOL REP, V21, P1153, DOI 10.3892/or_00000335; Zakopoulos A, 2007, ORAL SURG ORAL MED O, V103, pe24, DOI 10.1016/j.tripleo.2006.12.056	32	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	2212-4403	1528-395X		OR SURG OR MED OR PA	Oral Surg. Oral Med. Oral Pathol. Oral Radiol.	JAN	2015	119	1					83	91		10.1016/j.oooo.2014.09.017		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AY1FB	WOS:000347338000020		
J	Suzuki, M; Yoshino, N; Shimada, M; Tetsumura, A; Matsumura, T; Fukayama, H; Kurabayashi, T				Suzuki, Madoka; Yoshino, Norio; Shimada, Masahiko; Tetsumura, Akemi; Matsumura, Tomoka; Fukayama, Haruhisa; Kurabayashi, Tohru			Trigeminal neuralgia: differences in magnetic resonance imaging characteristics of neurovascular compression between symptomatic and asymptomatic nerves	ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY			English	Article							MICROVASCULAR DECOMPRESSION; VASCULAR COMPRESSION; HEMIFACIAL SPASM; PATHOGENESIS; ANGIOGRAPHY; ZONE	Objectives. Neurovascular compression (NVC) of the trigeminal nerve is the primary cause of trigeminal neuralgia (TN) but is known to occur in both symptomatic and asymptomatic nerves. The purposes of this study were to evaluate the relationship between the magnetic resonance imaging (MRI) findings regarding the site of NVC and the manifestation of TN symptoms. Methods. In 147 patients with unilateral TN, the presence or absence of NVC was evaluated on MRI in both symptomatic and asymptomatic nerves. In cases with NVC, the shortest distance from the trigeminal nerve root to the responsible vessel was measured. Results. The mean distance from the trigeminal nerve root to the site of NVC in asymptomatic nerves (3.85 +/- 2.69 mm) was significantly greater than that in symptomatic nerves (0.94 +/- 1.27 mm). When the distance was 3 mm or less, the rate of the manifestation of TN symptoms was 83.1% (103/124). On the other hand, it was only 19.6% (9/46) in cases with a distance of greater than 3 mm. Conclusions. Whether or not NVC of the trigeminal nerve was symptomatic was closely related to the distance from the trigeminal nerve root to the responsible blood vessel.	[Suzuki, Madoka; Yoshino, Norio; Shimada, Masahiko; Tetsumura, Akemi; Kurabayashi, Tohru] Tokyo Med & Dent Univ, Grad Sch, Dept Oral & Maxillofacial Radiol, Tokyo 1138549, Japan; [Matsumura, Tomoka; Fukayama, Haruhisa] Tokyo Med & Dent Univ, Grad Sch, Dept Anesthesiol & Clin Physiol, Tokyo 1138549, Japan	Yoshino, N (reprint author), Tokyo Med & Dent Univ, Grad Sch, Dept Oral & Maxillofacial Radiol, Tokyo 1138549, Japan.	norio.orad@tmd.ac.jp					MASUR H, 1995, J NEUROL, V242, P93, DOI 10.1007/BF00887823; Barker FG, 1996, NEW ENGL J MED, V334, P1077, DOI 10.1056/NEJM199604253341701; Anderson VC, 2006, NEUROSURGERY, V58, P666, DOI 10.1227/01.NEU.0000197117.34888.DE; Peker S, 2009, ACTA NEUROCHIR, V151, P1081, DOI 10.1007/s00701-009-0329-y; Yoshino N, 2003, RADIOLOGY, V228, P539, DOI 10.1148/radiol.2282020439; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Love S, 2001, BRAIN, V124, P2347, DOI 10.1093/brain/124.12.2347; GARDNER WJ, 1962, J NEUROSURG, V19, P947, DOI 10.3171/jns.1962.19.11.0947; Nurmikko TJ, 2001, BRIT J ANAESTH, V87, P117, DOI 10.1093/bja/87.1.117; Kitt CA, 2000, PAIN, V85, P3, DOI 10.1016/S0304-3959(99)00310-3; Miller JP, 2009, J NEUROSURG, V110, P627, DOI 10.3171/2008.6.17620; Baechli H, 2007, EUR SURG RES, V39, P51, DOI 10.1159/000098436; Davis LE, 2001, CURR TREAT OPTIONS N, V3, P401, DOI 10.1007/s11940-001-0028-3; De Ridder D, 2002, NEUROSURGERY, V51, P427, DOI 10.1227/01.NEU.0000020080.8116.9D; Erbay SH, 2006, NEURORADIOLOGY, V48, P26, DOI 10.1007/s00234-005-0008-5; Fukuda H, 2003, SURG NEUROL, V59, P93, DOI 10.1016/S0090-3019(02)00993-X; Guclu B, 2011, ACTA NEUROCHIR, V153, P2365, DOI 10.1007/s00701-011-1168-1; Headache Classification Committee of The International Headache Society, 2004, CEPHALALGIA, V24, P9; Janetta PJ, 2007, J NEUROSURG, V107, P216; Leclercq D, 2013, Diagn Interv Imaging, V94, P993, DOI 10.1016/j.diii.2013.08.002; Lorenzoni J, 2012, EUR J RADIOL, V81, P1851, DOI 10.1016/j.ejrad.2009.09.017; Raslan AM, 2009, J NEUROSURG, V111, P733, DOI 10.3171/2009.3.JNS08393; TASH RR, 1989, RADIOLOGY, V172, P767; Zhou Q, 2012, MAGN RESON IMAGING, V30, P666, DOI 10.1016/j.mri.2011.12.022	24	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	2212-4403	1528-395X		OR SURG OR MED OR PA	Oral Surg. Oral Med. Oral Pathol. Oral Radiol.	JAN	2015	119	1					113	118		10.1016/j.oooo.2014.09.013		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AY1FB	WOS:000347338000024		
J	Hashimoto, K; Nagao, T; Saito, T; Kinoshita, H				Hashimoto, Kengo; Nagao, Toru; Saito, Terumi; Kinoshita, Hiroyuki			Methotrexate-associated lymphoproliferative disorders of the tongue developing in patients with rheumatoid arthritis: a report of 2 cases and a review	ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY			English	Review							EPSTEIN-BARR-VIRUS; LYMPHOMA; DISEASE; REGRESSION; THERAPY	Incidences of lymphoproliferative disorders (LPDs) in patients with compromised immune systems associated with immunosuppressants such as methotrexate (MTX) administered for the treatment of rheumatoid arthritis (RA) are reportedly increasing. Although extranodal lesions develop in half of the patients with MTX-associated LPDs, only a few studies have reported on intraoral lesions. We evaluated 2 elderly women with MTX-associated LPDs who had received MTX for the treatment of RA and presented with atypical ulceration of the tongue. Biopsy specimens demonstrated polymorphous B-cell LPD, probably associated with MTX. Epstein-Barr virus (EBV) was identified by immunohistochemistry for latent membrane protein 1 and by EBV-encoded RNA in situ hybridization. After MTX withdrawal, in both cases, ulcers showed complete regression at 8 weeks, and no subsequent treatment was required. Close monitoring of LPDs is mandatory, because recurrence within 10 months has been reported in half of the patients in whom LPDs had initially regressed.	[Hashimoto, Kengo; Nagao, Toru; Saito, Terumi] Okazaki City Hosp, Dept Oral & Maxillofacial Surg & Stomatol, Okazaki, Aichi, Japan; [Kinoshita, Hiroyuki] Social Insurance Chukyo Hosp, Dept Oral & Maxillofacial Surg, Nagoya, Aichi, Japan	Nagao, T (reprint author), Okazaki City Hosp, Dept Oral & Maxillofacial Surg, Aza Goshoai 3-1 Kouryuji Cho, Okazaki, Aichi 4448553, Japan.	tnagao@dpc.agu.ac.jp					Hoshida Y, 2007, J RHEUMATOL, V34, P322; Salloum E, 1996, J CLIN ONCOL, V14, P1943; Dojcinov SD, 2010, AM J SURG PATHOL, V34, P405, DOI 10.1097/PAS.0b013e3181cf8622; Feng WH, 2004, J NATL CANCER I, V96, P1691, DOI 10.1093/jnci/djh313; Baecklund E, 2006, ARTHRITIS RHEUM, V54, P692, DOI 10.1002/art.21675; Colmegna I, 2012, CLIN PHARMACOL THER, V91, P607, DOI 10.1038/clpt.2011.325; Mariette X, 2002, BLOOD, V99, P3909, DOI 10.1182/blood.V99.11.3909; Baecklund E, 2003, ARTHRITIS RHEUM, V48, P1543, DOI 10.1002/art.11144; Ichikawa A, 2013, EUR J HAEMATOL, V91, P20, DOI 10.1111/ejh.12116; ELLMAN MH, 1991, J RHEUMATOL, V18, P1741; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Fujibayashi Takashi, 2004, Mod Rheumatol, V14, P425, DOI 10.3109/s10165-004-0338-x; Hoshida Y, 2004, INT J CANCER, V108, P443, DOI 10.1002/ijc.11582; Kikuchi Kentaro, 2010, Head Neck Pathol, V4, P305, DOI 10.1007/s12105-010-0202-6; KREMER JM, 1986, ARTHRITIS RHEUM, V29, P822, DOI 10.1002/art.1780290702; Noraini AR, 2009, SINGAP MED J, V50, P1189; Pastor-Nieto María Antonia, 2009, Actas Dermosifiliogr, V100, P142; Saag KG, 2008, ARTHRIT RHEUM-ARTHR, V59, P762, DOI 10.1002/art.23721; Swerdlow SH, 2008, WHO CLASSIFICATION T, P350; Tanaka A, 2008, J ORAL MAXIL SURG, V66, P1492, DOI 10.1016/j.joms.2007.05.006	20	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	2212-4403	1528-395X		OR SURG OR MED OR PA	Oral Surg. Oral Med. Oral Pathol. Oral Radiol.	JAN	2015	119	1					E1	E5		10.1016/j.oooo.2014.04.002		5	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AY1FB	WOS:000347338000001		
J	Sugawara, C; Takahashi, A; Kawano, F; Kudoh, T; Yamada, A; Ishimaru, N; Hara, K; Miyamoto, Y				Sugawara, Chieko; Takahashi, Akira; Kawano, Fumiaki; Kudoh, Takaharu; Yamada, Akiko; Ishimaru, Naozumi; Hara, Kanae; Miyamoto, Youji			Neuroendocrine tumor in the mandible: a case report with imaging and histopathologic findings	ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CARCINOID-TUMORS; CHROMOGRANIN-A; PROGNOSTIC-FACTORS; ENDOCRINE TUMORS; CELL-CARCINOMA; DIAGNOSIS; CLASSIFICATION; SYNAPTOPHYSIN; GUIDELINES	Neuroendocrine tumors (NETs) arise from neuroendocrine cells and are mostly observed in the gastrointestinal tract, pancreas, and lungs. NETs in the oral and maxillofacial region are extremely rare. We report a case of a 59-year-old woman with an NET in the mandible. The patient did not show any symptoms except for remarkable swelling and bleeding. The lesion appeared as a radiolucent honeycomb abnormality with bone destruction on panoramic radiography. The histopathologic diagnosis following a biopsy was NET. Contrast-enhanced computed tomography (CT), F-18-fluorodeoxyglucose positron emission computed tomography (F-18-FDG PET/CT), and adrenal scintigraphy-labeled meta-iodobenylguanidine were the modalities added to identify the primary site. Multiple lesions were confirmed in the gastrointestinal tract. Endoscopy was performed to identify the lesions, and several lesions were observed protruding from the mucous membranes. However, the endoscopy specimens did not yield an accurate diagnosis because adequate samples were not acquired. Blood and urine tests revealed no functional activity caused by the tumors. Although the origin was not histopathologically confirmed with endoscopy, this patient was situationally diagnosed with nonfunctional NET originating from the duodenum, as demonstrated by the metastases in the mandible.	[Sugawara, Chieko; Kawano, Fumiaki] Univ Tokushima, Grad Sch, Dept Comprehens Dent, Inst Hlth Biosci, Tokushima 7708504, Japan; [Takahashi, Akira; Kudoh, Takaharu; Hara, Kanae; Miyamoto, Youji] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral Surg, Tokushima 7708504, Japan; [Yamada, Akiko; Ishimaru, Naozumi] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral Mol Pathol, Tokushima 7708504, Japan	Sugawara, C (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral Hlth Sci Comprehens Dent, 3-18-15 Kuramoto Cho, Tokushima 7708504, Japan.	Sugawara@tokushima-u.ac.jp		Kudoh, Takaharu/0000-0003-1897-8296			Chang S, 2007, RADIOGRAPHICS, V27, P1667, DOI 10.1148/rg.276075001; Pape UF, 2008, CANCER-AM CANCER SOC, V113, P256, DOI 10.1002/cncr.23549; Panzuto F, 2005, ENDOCR-RELAT CANCER, V12, P1083, DOI 10.1677/ERC1.01017; Modlin IM, 2003, CANCER, V97, P934, DOI 10.1002/cncr.11105; Brennan SM, 2010, CANCER-AM CANCER SOC, V116, P888, DOI 10.1002/cncr.24858; Adams S, 1998, EUR J NUCL MED, V25, P79; Ferlito A, 2005, ORAL ONCOL, V41, P878, DOI 10.1016/j.oraloncology.2004.12.005; Campana D, 2007, J CLIN ONCOL, V25, P1967, DOI 10.1200/JCO.2006.10.1535; WIEDENMANN B, 1991, ACTA ONCOL, V30, P435; Ito T, 2010, J GASTROENTEROL, V45, P234, DOI 10.1007/s00535-009-0194-8; Virgolini I, 2010, EUR J NUCL MED MOL I, V37, P2004, DOI 10.1007/s00259-010-1512-3; Sahani DV, 2013, RADIOLOGY, V266, P38, DOI 10.1148/radiol.12112512; Rindi G, 2007, VIRCHOWS ARCH, V451, P757, DOI 10.1007/s00428-007-0452-1; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Salama AR, 2009, ORAL SURG ORAL MED O, V108, P242, DOI 10.1016/j.tripleo.2009.03.030; Plockinger U, 2004, NEUROENDOCRINOLOGY, V80, P394, DOI 10.1159/000085237; Meeker A, 2014, MOL CELL ENDOCRINOL, V386, P101, DOI 10.1016/j.mce.2013.07.015; Klimstra DS, 2010, PANCREAS, V39, P707, DOI 10.1097/MPA.0b013e3181ec124e; Fujiyoshi Y, 2008, HISTOPATHOLOGY, V52, P305, DOI 10.1111/j.1365-2559.2007.02950.x; Rinke A, 2009, J CLIN ONCOL, V27, P4656, DOI 10.1200/JCO.2009.22.8510; Rockall AG, 2007, BEST PRACT RES CL EN, V21, P43, DOI 10.1016/j.beem.2007.01.003; Modlin IM, 2005, GASTROENTEROLOGY, V128, P1717, DOI 10.1053/j.gastro.2005.03.038; Lloyd RV, 2003, ENDOCR PATHOL, V14, P293, DOI 10.1385/EP:14:4:293; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377; Modlin IM, 2010, ALIMENT PHARM THER, V31, P169, DOI 10.1111/j.1365-2036.2009.04174.x; Oberg KE, 2010, GASTROENTEROLOGY, V139, P742, DOI 10.1053/j.gastro.2010.07.002; Ochsenreither S, 2009, ANTICANCER RES, V29, P3411; Klimstra DS, 2013, SEMIN ONCOL, V40, P23, DOI 10.1053/j.seminoncol.2012.11.001; Oberg K, 2011, CANCER METAST REV, V30, P3, DOI 10.1007/s10555-011-9292-1; Turaga KK, 2011, CA-CANCER J CLIN, V61, P113, DOI 10.3322/caac.20097; Castano JP, 2014, CANCER METAST REV, V33, P353, DOI 10.1007/s10555-013-9465-1; Coleman H, 1996, ORAL SURG ORAL MED O, V81, P74, DOI 10.1016/S1079-2104(96)80152-1; Dahan L, 2009, ENDOCR-RELAT CANCER, V16, P1351, DOI 10.1677/ERC-09-0104; Kasprzak Aldona, 2007, Polish Journal of Pathology, V58, P23; Kauhanen S, 2009, ENDOCR-RELAT CANCER, V16, P255, DOI 10.1677/ERC-08-0229; Miki K, 2012, AURIS NASUS LARYNX, V39, P98, DOI 10.1016/j.anl.2011.02.007; Mills SE, 2002, MODERN PATHOL, V15, P264, DOI 10.1038/modpathol.3880522; Oberg K, 2005, Rocz Akad Med Bialymst, V50, P62; PETERS E, 1991, HEAD NECK-J SCI SPEC, V13, P234, DOI 10.1002/hed.2880130313; RINDI G, 1986, HISTOCHEMISTRY, V85, P19, DOI 10.1007/BF00508649; Yang S, 2011, INT J ORAL MAX SURG, V40, P991, DOI 10.1016/j.ijom.2011.03.008	41	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	2212-4403	1528-395X		OR SURG OR MED OR PA	Oral Surg. Oral Med. Oral Pathol. Oral Radiol.	JAN	2015	119	1					E41	E48		10.1016/j.oooo.2014.09.024		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AY1FB	WOS:000347338000007		
J	Tomihara, K; Hamashima, T; Nagao, T; Nakamori, K; Sasahara, M; Noguchi, M				Tomihara, Kei; Hamashima, Takeru; Nagao, Toshitaka; Nakamori, Kenji; Sasahara, Masakiyo; Noguchi, Makoto			Sarcomatoid salivary duct carcinoma of the palate: a rare case report	ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY			English	Article							OF-THE-LITERATURE; GLAND; VARIANT; EXPRESSION; RECEPTOR	Salivary duct carcinoma (SDC) is an uncommon neoplasm that most commonly occurs in major salivary glands, mainly the parotid gland. SDC is rarely found in the minor salivary glands of the oral cavity. This report presents an extremely rare case of sarcomatoid SDC originating in a minor salivary gland of the palate. The tumor was histologically characterized by the presence of both carcinomatous and sarcomatoid components. The patient presented with a painless mass in the right palate, which slowly increased in size over 20 years. The clinical course of the present case suggests that the tumor most probably developed as a result of malignant transformation of a preexisting benign tumor of the palatal salivary gland. This report describes the clinical and histologic features of this extremely rare case of sarcomatoid SDC with reference to the relevant literature.	[Tomihara, Kei; Nakamori, Kenji; Noguchi, Makoto] Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Dept Oral & Maxillofacial Surg, Toyama 9300194, Japan; [Hamashima, Takeru; Sasahara, Masakiyo] Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Dept Pathol, Toyama 9300194, Japan; [Nagao, Toshitaka] Tokyo Med Univ, Dept Anat Pathol, Tokyo 1608402, Japan	Tomihara, K (reprint author), Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Dept Oral & Maxillofacial Surg, 2630 Sugitani, Toyama 9300194, Japan.	Tomihara@med.u-toyama.ac.jp					Guarneri V, 2008, ONCOLOGIST, V13, P838, DOI 10.1634/theoncologist.2008-0048; Lewis JE, 1996, CANCER, V77, P223, DOI 10.1002/(SICI)1097-0142(19960115)77:2<223::AID-CNCR1>3.0.CO;2-N; Jaehne M, 2005, CANCER, V103, P2526, DOI 10.1002/cncr.21116; Simpson RHW, 2003, AM J SURG PATHOL, V27, P1070, DOI 10.1097/00000478-200308000-00004; BRANDWEIN MS, 1990, CANCER, V65, P2307, DOI 10.1002/1097-0142(19900515)65:10<2307::AID-CNCR2820651024>3.0.CO;2-1; Henley JD, 2000, HUM PATHOL, V31, P208, DOI 10.1016/S0046-8177(00)80221-X; Huh KH, 2003, ORAL SURG ORAL MED O, V95, P752, DOI 10.1067/moe.2003.246; Ide F, 2003, VIRCHOWS ARCH, V443, P686, DOI 10.1007/s00428-003-0876-1; Jeong HS, 2006, J LARYNGOL OTOL, V120, P154, DOI 10.1017/S0022215105003518; Kapadia SB, 1998, MODERN PATHOL, V11, P1033; Kleinsasser O, 1968, Arch Klin Exp Ohren Nasen Kehlkopfheilkd, V192, P100, DOI 10.1007/BF00301495; Mori M, 2010, ACTA CYTOL, V54, P695; Nagao T, 2004, AM J CLIN PATHOL, V122, P222, DOI 10.1309/5J4008QRY1HWW5W4; Nagao T, 2004, AM J SURG PATHOL, V28, P319, DOI 10.1097/00000478-200403000-00004; Padberg Barbara-Christina, 2005, Ann Diagn Pathol, V9, P86, DOI 10.1016/j.anndiagpath.2004.12.005; Seifert G, 1991, HISTOLOGICAL TYPING; Skalova A, 2001, PATHOL RES PRACT, V197, P621, DOI 10.1078/0344-0338-00136; STEPHEN J, 1986, ORAL SURG ORAL MED O, V61, P597, DOI 10.1016/0030-4220(86)90102-7; Thamilselvi R, 2010, INDIAN J PATHOL MICR, V53, P808, DOI 10.4103/0377-4929.72102	19	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	2212-4403	1528-395X		OR SURG OR MED OR PA	Oral Surg. Oral Med. Oral Pathol. Oral Radiol.	JAN	2015	119	1					E27	E32		10.1016/j.oooo.2014.08.007		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AY1FB	WOS:000347338000005		
J	Sam, S; Shinogi, Y				Sam, Sreymom; Shinogi, Yoshiyuki			Performance assessment of Farmer Water User Community: a case study in Stung Chinit irrigation system, Cambodia	PADDY AND WATER ENVIRONMENT			English	Article						Farmer Water User Community; Participatory irrigation management; Logit model; Performance assessment; Irrigation management	MANAGEMENT; TURKEY	This paper aims at assessing performance of Farmer Water User Community (FWUC) using financial indicators and level of farmers' satisfaction to diagnose the problem and potential in improving the FWUC's performance. Both descriptive statistics and logistic regression models were used to analyze the collected data. An irrigation service fee (ISF) collection indicator shows a very good rate as nearly 97 % of farmers have paid in 2011, but a self-sufficient indicator reveals that the best percentage up to the same year is just 55 % that FWUC can pay for the expense, while the other share comes from government' subsidy. Descriptively, only 36 % of respondents are totally satisfied with the overall performance, while the rest is either satisfied or dissatisfied. The logit model used to assess the performance of FWUC through farmers' perceptions claims that all operative indicators including timeliness, adequacy, appropriate maintenance and proper ISF are statistically significant and affect their satisfaction. Among all, only equity indicator is not yet satisfied specifically for tailenders. Lesson learned from this case study allows a consideration on three aspects to improve the performance of the FWUC: farmer initiation, checking for consistency between the transferred scheme and local's capacity as well as the scheme's quality before the transfer.	[Sam, Sreymom; Shinogi, Yoshiyuki] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Fukuoka 812, Japan	Sam, S (reprint author), Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Fukuoka 812, Japan.	sreymomsam@yahoo.com; yshinogi@bpes.kyushu-u.ac.jp					Baum C, 2006, INTRO MODERN ECONOME; Bhatta K, 2006, NEPAL SPRINGER NETHE, DOI [10.1007/s10795-005-9001-8, DOI 10.1007/S10795-005-9001-8]; Bos MG, 2005, IRRIGATION AND DRAINAGE PERFORMANCE ASSESSMENT: PRACTICAL GUIDELINES, P1; Brok S, 2011, REPORT RESULTS WORK; Gorton M, 2009, INT ASS AGR EC C BEI; Hoanh C. T., 2009, CONTESTED WATERSCAPE, P143; Kadirbeyodlu Z, 2011, USERS PERCEPTIONS WA; Kuscu H, 2009, AFR J AGR RES, V4, P124; LAHMAYER INTERNATIONAL & SMEC Cambodia Consulting, 2006, IRR IFR IRR SYST MAN; MOWRAM, 2006, RAINF TEMP; Ostrom E, 2002, IMPROVING IRRIGATION; Ostrom E., 1999, WORKSH POL THEOR POL; Rousseau P, 2009, STUNG CHINIT IRRIGAT; Shivakoti GP, 2005, ASIAN IRRIGATION TRA; Uysal OK, 2010, AGR WATER MANAGE, V97, P1017, DOI 10.1016/j.agwat.2010.02.007; Vermillion LD, 1997, IMPACTS IRRIGATION M; WRMRCD, 2010, CDRI WORK PAP SER	17	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1611-2490	1611-2504		PADDY WATER ENVIRON	Paddy Water Environ.	JAN	2015	13	1					19	27		10.1007/s10333-013-0402-2		9	Agricultural Engineering; Agronomy	Agriculture	AY0MN	WOS:000347290600003		
J	Singla, A; Inubushi, K				Singla, Ankit; Inubushi, Kazuyuki			Effect of slag-type fertilizers on N2O flux from komatsuna vegetated soil and CH4 flux from paddy vegetated soil	PADDY AND WATER ENVIRONMENT			English	Article						Slag-type fertilizers; Chemical fertilizer; Komatsuna; Paddy; N2O; CH4	METHANE EMISSION; PHOSPHATE DESORPTION; SILICATE FERTILIZER; WATER MANAGEMENT; WETLAND RICE; NITROGEN; FIELDS; SUPPRESSION; ANDISOL; CARBON	Slag-type fertilizer, which is a byproduct of the steel industry, contains high amount of active iron oxide and silica. This byproduct acts as an oxidizing agent in the agricultural soils and may have positive impact on the soil properties and plant growth. It can suppress CH4 emission, while may also affect N2O emission. A pot experiment with komatsuna and a microcosm experiment with rice were conducted to determine the effect of slag-type fertilizers (Agripower and Minekaru) on N2O and CH4 flux, respectively. The application rate of silica was kept similar for both fertilizers which caused four times higher iron application in Minekaru treatment compared to Agripower treatment. The observation results revealed that the Agripower and Minekaru treatment emitted more N2O only in the initial stage of the experiment compared to the control soil. The cumulative N2O emission over 59 days of the experiment was not significantly different between the various treatments. Minekaru-treated soil significantly decreased seasonal and cumulative CH4 flux over 112 days of the experiment compared to Agripower and control soil, while Agripower did not affect compared to the control. It was possibly due to higher iron application in Minekaru treatment than Agripower treatment. The application of Agripower and Minekaru increased shoot weight, panicle numbers, and weight of panicles in paddy. This study suggests that the application of slag-type fertilizers neither affect cumulative N2O emission nor plant biomass in komatsuna. The application of Minekaru significantly decreased CH4 evolution; while Agripower and Minekaru increased plant biomass in paddy vegetated soil.	[Singla, Ankit; Inubushi, Kazuyuki] Chiba Univ, Grad Sch Hort, Matsudo, Chiba 2718510, Japan	Inubushi, K (reprint author), Chiba Univ, Grad Sch Hort, Matsudo, Chiba 2718510, Japan.	ankitsingla2607@yahoo.co.in; inubushi@faculty.chiba-u.jp			Nippon Steel and Sumitomo Metal Corporation, Japan	Slag-type fertilizers were provided by Nippon Steel and Sumitomo Metal Corporation, Japan. This research study was also financially supported by Nippon Steel and Sumitomo Metal Corporation, Japan. The first author is also thankful to the Indian Council of Agricultural Research, New Delhi, India.	Amkha S, 2009, SOIL SCI PLANT NUTR, V55, P772, DOI 10.1111/j.1747-0765.2009.00418.x; Anderson JM, 1989, HDB METHODS ISSS ED, P42; Shariatmadari H, 1999, SOIL SCI SOC AM J, V63, P1167; Cai ZC, 1997, PLANT SOIL, V196, P7, DOI 10.1023/A:1004263405020; Huang B, 2009, CHEMOSPHERE, V74, P481, DOI 10.1016/j.chemosphere.2008.10.015; Singla A, 2014, PADDY WATER ENVIRON, V12, P239, DOI 10.1007/s10333-013-0357-3; YAGI K, 1990, SOIL SCI PLANT NUTR, V36, P599; Henckel T, 2000, ENVIRON MICROBIOL, V2, P666, DOI 10.1046/j.1462-2920.2000.00149.x; Ali MA, 2008, BIOL FERT SOILS, V44, P597, DOI 10.1007/s00374-007-0243-5; Inubushi K, 1999, BIOL FERT SOILS, V29, P401, DOI 10.1007/s003740050571; Peters GP, 2013, NAT CLIM CHANGE, V3, P4; MOSIER A, 1991, NATURE, V350, P330, DOI 10.1038/350330a0; Hayakawa A, 2009, SOIL BIOL BIOCHEM, V41, P521, DOI 10.1016/j.soilbio.2008.12.011; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; Conrad R, 1996, MICROBIOL REV, V60, P609; Jackel U, 2000, SOIL BIOL BIOCHEM, V32, P1811, DOI 10.1016/S0038-0717(00)00094-8; MA JF, 1989, SOIL SCI PLANT NUTR, V35, P347; Ebid A, 2008, PLANT SOIL, V304, P241, DOI 10.1007/s11104-008-9543-2; Conrad R, 2002, NUTR CYCL AGROECOSYS, V64, P59, DOI 10.1023/A:1021178713988; Furukawa Y, 2002, NUTR CYCL AGROECOSYS, V64, P193, DOI 10.1023/A:1021150831735; Bodegom VP, 2001, APPL ENVIRON MICROB, V67, P3586; Cannavo P, 2004, SOIL BIOL BIOCHEM, V36, P463, DOI 10.1016/j.soilbio.2003.10.023; Carole RS, 1971, MICROCHEM J, V16, P657; FAO, 2002, LAND WAT DIG MED SER; Hanson RS, 1980, ADV APPL MICROBIOL, V26, P13; HUSIN YA, 1995, CHEMOSPHERE, V31, P3153, DOI 10.1016/0045-6535(95)00173-6; Intergovernmental Panel on Climate Change, 2007, CLIMATE CHANGE 2007; Inubushi K., 1989, JPN J SOIL SCI PLANT, V60, P318; Inubushi K, 1996, BIOL FERT SOILS, V23, P292; Jackel U, 2005, SOIL BIOL BIOCHEM, V37, P2150, DOI 10.1016/j.soilbio.2005.03.003; Jin X, 2003, GEOPHYS RES LETT, V30, P31; Lee CH, 2012, BIOL FERT SOILS, V48, P435, DOI 10.1007/s00374-011-0637-2; Lee YB, 2004, SOIL SCI PLANT NUTR, V50, P493; Mer J.L., 2001, EUR J SOIL BIOL, V37, P25; MINAMI K, 1994, FERT RES, V37, P167, DOI 10.1007/BF00748935; Muller C, 2004, SOIL BIOL BIOCHEM, V36, P453, DOI 10.1016/j.soilbio.2003.08.027; Neue HU, 1993, ATMOSPHERIC METHANE, P254; Singh J. S., 1995, Tropical Ecology, V36, P145; Singla A, 2013, BIOL FERT SOILS, V49, P971, DOI 10.1007/s00374-013-0796-4; Singla A, 2013, INT J AGR ENV BIOTEC, V6, P233; Takahashi E., 1990, Comments on Agricultural and Food Chemistry, V2, P99; Watanabe A., 1999, J GEOPHYS RES, V104, P623	42	4	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1611-2490	1611-2504		PADDY WATER ENVIRON	Paddy Water Environ.	JAN	2015	13	1					43	50		10.1007/s10333-013-0405-z		8	Agricultural Engineering; Agronomy	Agriculture	AY0MN	WOS:000347290600005		
J	Win, KT; Nonaka, R; Win, AT; Sasada, Y; Toyota, K; Motobayashi, T				Win, Khin Thawda; Nonaka, Ryoko; Win, Aye Thida; Sasada, Yu; Toyota, Koki; Motobayashi, Takashi			Effects of water saving irrigation and rice variety on greenhouse gas emissions and water use efficiency in a paddy field fertilized with anaerobically digested pig slurry	PADDY AND WATER ENVIRONMENT			English	Article						Forage rice; Carbon efficiency ratio (CER); Greenhouse gases intensity (GHGI); Global warming potential (GWP); Water use efficiency (WUE); Water saving irrigation	METHANE EMISSION; NITROUS-OXIDE; SOIL REDOX; AMMONIA VOLATILIZATION; CROPPING SYSTEMS; CATTLE SLURRY; N2O EMISSIONS; MANAGEMENT; GROWTH; CHINA	Proper floodwater management during the cultivation period of paddy rice is essential for regulating the trade-off between methane and nitrous oxide emissions, as well as for saving irrigation water resource and maintaining crop productivity. To elucidate the effects of water saving irrigation (WS) and rice variety on different agro-environmental parameters such as CH4 and N2O emissions, global warming potential (GWP), greenhouse gases intensity (GHGI), carbon efficiency ratio, water use efficiency (WUE), rice growth and yield, a field experiment was conducted with two factors of split-plot design consisting of (1) main factor; WS (WS in which irrigation was withdrawn at soil Eh < -150 mV and kept 0-1 cm floodwater afterward) and continuous flooding (CF), and (2) sub-factor; a forage rice variety Leaf Star (LS) and a normal rice variety Kinuhikari (KN). Results showed that WS irrigation significantly (P < 0.05) mitigated CH4 emission by 65 % and by 60 %, and enhanced WUE significantly (P < 0.01) by 180 % from that of CF. Carbon use efficiency of the grain and aboveground biomass carbon increased by 2.4 and 2.5 times, respectively, and GHGI was reduced by 3.1 times in WS. No significant differences were observed in the plant height, tiller number, rice biomass, N uptake and C accumulation between water treatments but the rice varieties: LS showed significantly (P < 0.05) higher values in these parameters than KN. This study highlighted that the WS is an effective measure for mitigating GWP, saving water while sustaining crop productivity.	[Win, Khin Thawda; Nonaka, Ryoko; Win, Aye Thida; Sasada, Yu; Toyota, Koki] Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn, Koganei, Tokyo 1848588, Japan; [Motobayashi, Takashi] Tokyo Univ Agr & Technol, Fac Agr, Fuchu, Tokyo 1838509, Japan	Toyota, K (reprint author), Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn, 2-24-16 Naka, Koganei, Tokyo 1848588, Japan.	kokit@cc.tuat.ac.jp			Japan Science and Technology (JST); National Natural Science Foundation of China (NSFC) [40821140540]; Green Biomass Research for Improvement of Local Energy self-sufficiency from the Ministry of Education, Science, Sports and Culture of Japan;  [19201018]	This study was supported by Japan Science and Technology (JST), National Natural Science Foundation of China (NSFC, No: 40821140540), a Grant-in-Aid for Scientific Research (No. 19201018), and the Green Biomass Research for Improvement of Local Energy self-sufficiency from the Ministry of Education, Science, Sports and Culture of Japan. The authors thank Dr. Masanori Okazaki, Dean, Bio-Applications and Systems Engineering, Tokyo University of Agriculture and Technology (TUAT) for C and N analyses and for his suggestions. We also gratefully thank Mr. Akira Watanabe, Ebara Co., for providing the anaerobically digested slurries.	Akiyama H, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002378; Ookawa T, 2010, PLANT PROD SCI, V13, P58, DOI 10.1626/pps.13.58; Minamikawa K, 2005, AGR ECOSYST ENVIRON, V107, P397, DOI 10.1016/j.agee.2004.08.006; Johnson-Beebout SE, 2009, GEODERMA, V149, P45, DOI 10.1016/j.geoderma.2008.11.012; Yagi K, 1996, GLOBAL BIOGEOCHEM CY, V10, P255, DOI 10.1029/96GB00517; Tyagi L, 2010, SCI TOTAL ENVIRON, V408, P1085, DOI 10.1016/j.scitotenv.2009.09.010; Kato Y, 2009, FIELD CROP RES, V113, P328, DOI 10.1016/j.fcr.2009.06.010; Cai ZC, 1999, SOIL SCI PLANT NUTR, V45, P1; Bouman BAM, 2007, ADV AGRON, V92, P187, DOI 10.1016/S0065-2113(04)92004-4; Shang QY, 2011, GLOBAL CHANGE BIOL, V17, P2196, DOI 10.1111/j.1365-2486.2010.02374.x; ButterbachBahl K, 1997, PLANT CELL ENVIRON, V20, P1175, DOI 10.1046/j.1365-3040.1997.d01-142.x; Xiong ZQ, 2008, NUTR CYCL AGROECOSYS, V80, P189, DOI 10.1007/s10705-007-9132-4; Jiao ZH, 2006, COMMUN SOIL SCI PLAN, V37, P1889, DOI 10.1080/00103620600767124; Itoh M, 2011, AGR ECOSYST ENVIRON, V141, P359, DOI 10.1016/j.agee.2011.03.019; Mosier AR, 2006, J ENVIRON QUAL, V35, P1584, DOI 10.2134/jeq2005.0232; Win KT, 2009, SOIL SCI PLANT NUTR, V55, P190, DOI 10.1111/j.1747-0765.2008.00337.x; Kreye C, 2007, NUTR CYCL AGROECOSYS, V77, P293, DOI 10.1007/s10705-006-9068-0; Li CS, 2006, J ENVIRON QUAL, V35, P1554, DOI 10.2134/jeq2005.0208; Bhatia A, 2005, ATMOS ENVIRON, V39, P6976, DOI 10.1016/j.atmosenv.2005.07.052; Hadi A, 2010, PADDY WATER ENVIRON, V8, P319, DOI 10.1007/s10333-010-0210-x; Qin YM, 2010, BIOL FERT SOILS, V46, P825, DOI 10.1007/s00374-010-0493-5; Aulakh MS, 2000, NUTR CYCL AGROECOSYS, V58, P357, DOI 10.1023/A:1009831712602; Eller G, 2001, APPL ENVIRON MICROB, V67, P2395, DOI 10.1128/AEM.67.6.2395-2403.2001; Hou H, 2007, WATER AIR SOIL POLL, V183, P37, DOI 10.1007/s11270-007-9353-9; IPCC (Intergovernmental Panel on Climate Change), 2007, CLIM CHANG 2007 PHYS; Kanno T, 1997, NUTR CYCL AGROECOSYS, V49, P147, DOI 10.1023/A:1009778517545; Katayanagi K, 2012, SOIL SCI PLANT NUTR, V58, P360, DOI DOI 10.1080/00380768.2012.682955; Kato H, 2008, JARQ-JPN AGR RES Q, V42, P231; Liu WK, 2011, ACTA AGR SCAND B-S P, V61, P391, DOI 10.1080/09064710.2010.482539; Matsunaka T, 2006, INT C SER, V1293, P242, DOI DOI 10.1016/J.ICS.2006.03.016; Ministry of Agriculture Forestry and Fisheries (MAFF), 2012, MONTHL STAT AGR FOR; Miyata H., 2005, Japanese Journal of Soil Science and Plant Nutrition, V76, P619; Sasada Y, 2011, BIOL FERT SOILS, V47, P948; Sass RL, 1999, J GEOPHYS RES-ATMOS, V104, P26943, DOI 10.1029/1999JD900081; Towprayoon S, 2005, CHEMOSPHERE, V59, P1549; United States Environmental Protection Agency (USEPA), 2006, GLOB ANTHR NONCO2 GA; Win KT, 2012, PADDY WATER ENVIRON, V10, P281, DOI 10.1007/s10333-011-0279-x; Win KT, 2010, BIOL FERT SOILS, V46, P589, DOI 10.1007/s00374-010-0465-9; Yan X, 2009, GLOBAL BIOGEOCHEM CY, V23, P2002; Yu KW, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002251; Yu KW, 2003, SOIL SCI SOC AM J, V67, P1952; Yu KW, 2001, BIOL FERT SOILS, V34, P25, DOI 10.1007/s003740100350; Zhao LM, 2011, PADDY WATER ENVIRON, V9, P25, DOI 10.1007/s10333-011-0257-3; Zhou S, 2009, WATER AIR SOIL POLL, V191, P171; Zou JW, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002401	45	2	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1611-2490	1611-2504		PADDY WATER ENVIRON	Paddy Water Environ.	JAN	2015	13	1					51	60		10.1007/s10333-013-0406-y		10	Agricultural Engineering; Agronomy	Agriculture	AY0MN	WOS:000347290600006		
J	Do, NT; Yoshimura, Y; Harada, M; Hiramatsu, K				Nguyen Thuy Do; Yoshimura, Yuichiro; Harada, Masayoshi; Hiramatsu, Kazuaki			Generation of hydrogen sulfide in the deepest part of a reservoir under anoxic water conditions	PADDY AND WATER ENVIRONMENT			English	Article						Continuous oxygen-free state; Hypolimnion; One-dimensional hydraulic ecosystem model; Redox potential	LAKES	The generation of hydrogen sulfide in a reservoir can be characterized by a massive influx of organic matter, manifest thermal stratification, and an extreme anoxic state specifically at the hypolimnion layer in summer. It has been reported that in this deep layer of a thermally stratified water body, where dissolved oxygen is depleted and redox potential falls sharply below the value of zero, the prolonged oxygen-free period and negative redox potential may potentiate the production of toxic hydrogen sulfide. The main aim of this study was to simulate the varying concentration of hydrogen sulfide at the deepest part of the reservoir based on intensive monitoring of water quality parameters. A one-dimensional hydraulic ecosystem model was applied to simulate vertical distribution of dissolved oxygen (DO) continuously in time. Based on the simulated DO, the length of continuous oxygen-free state in the deepest layer was specified and then utilized to estimate the temporal changes of oxidation-reduction potential (ORP) using a polynomial regression model. Finally, a linear regression model for hydrogen sulfide was fitted from the observed ORP, based on which, the temporal changes of hydrogen sulfide concentration were modeled using the simulated ORP. The introduction of several calculations gave good simulated results of hydrogen sulfide concentration, and this approach can be considered useful for predictive and explanatory purposes in further research investigating toxic hydrogen sulfide at the hypolimnion of the reservoir.	[Nguyen Thuy Do] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Dept Agroenvironm Sci, Higashi Ku, Fukuoka 8128581, Japan; [Yoshimura, Yuichiro] Minist Agr Forestry & Fisheries, Gen Affairs Sect, Rural Dev Bur, Chiyoda Ku, Tokyo 1008950, Japan; [Harada, Masayoshi; Hiramatsu, Kazuaki] Kyushu Univ, Dept Agroenvironm Environm Sci, Fac Agr, Higashi Ku, Fukuoka 8128581, Japan	Do, NT (reprint author), Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Dept Agroenvironm Sci, Higashi Ku, Hakozaki 6-10-1, Fukuoka 8128581, Japan.	dothuynguyen@gmail.com			JSPS [19380138]; Kyushu University New Campus Planning Office	This research was partly supported by a JSPS Grant-in-Aid for Scientific Research (B) (Project number: 19380138) and the Kyushu University New Campus Planning Office.	Zerkle AL, 2010, GEOCHIM COSMOCHIM AC, V74, P4953, DOI 10.1016/j.gca.2010.06.015; DUNNETTE DA, 1985, WATER RES, V19, P875, DOI 10.1016/0043-1354(85)90146-0; HERLIHY AT, 1985, APPL ENVIRON MICROB, V49, P179; Mortimer CH, 1941, J ECOL, V29, P280, DOI 10.2307/2256395; Carla MK, 2012, WATER AIR SOIL POLL, V223, P1415; DAKE JMK, 1969, WATER RESOUR RES, V5, P484, DOI 10.1029/WR005i002p00484; Harada M, 2009, J RAINWATER CATCHMEN, V14, P87; HENDERSONSELLERS B, 1982, J GEOPHYS RES-OC ATM, V87, P5860, DOI 10.1029/JC087iC08p05860; Kent WT, 1990, ANONYMOUS RESERVOIR; KONDO J, 1979, J PHYS OCEANOGR, V9, P360, DOI 10.1175/1520-0485(1979)009<0360:OWDCAT>2.0.CO;2; Luther GW, 2003, AQUAT GEOCHEM, V9, P87; Smith LL, 1976, EFFECT HYDROGEN SULF; Stumm W, 1973, AQUATIC CHEM INTRO E, P117	13	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1611-2490	1611-2504		PADDY WATER ENVIRON	Paddy Water Environ.	JAN	2015	13	1					101	113		10.1007/s10333-013-0412-0		13	Agricultural Engineering; Agronomy	Agriculture	AY0MN	WOS:000347290600011		
J	El-Shafaey, E; Aoki, T; Ishii, M; Sasaki, M; Yamada, K				El-Shafaey, E.; Aoki, T.; Ishii, M.; Sasaki, M.; Yamada, K.			A Descriptive Study of the Bovine Stomach Using Computed Tomography	PAKISTAN VETERINARY JOURNAL			English	Article						Anatomical landmarks; Atlas; Bovine; Computed tomography; Forestomach	CT; DIAGNOSIS; CALF; CATTLE; TRACT; DOGS	The aim of this study was to create a descriptive atlas of the detailed anatomical features of the bovine forestomach compartments using computed tomography (CT). CT images were respectively selected from the imaging database of twenty healthy Holstein Friesian calves aged from 5 to 7 months. This database was obtained from the Veterinary Medical Centre of Obihiro University of Agriculture and Veterinary Medicine. For each cow, transverse, sagittal and dorsal plane images were obtained. All CT images of the bovine forestomach were labelled and serially interpret using correlated cross-sectional anatomical references. The structures that were identified in the abdominal cavity include the stomach with its four compartments (rumen, reticulum, omasum and abomasum), small and large intestines, liver, spleen, kidneys and aorta abdominalis. There was good differentiation of the anatomical landmarks between various forestomach compartments on CT images. The location and size of the forestomach parts was depicted using soft tissue window. In conclusion, multi-slice CT provided well defined baseline reference images for the bovine stomach compartments for educational, research and radiological purposes. (C) 2014 PVJ. All rights reserved	[El-Shafaey, E.] Mansoura Univ, Fac Vet Med, Dept Surg Anaesthesiol & Radiol, Mansoura 35516, Dakahlia, Egypt; [Aoki, T.; Ishii, M.; Yamada, K.] Obihiro Univ Agr & Vet Med, Dept Vet Clin Sci, Obihiro, Hokkaido 0808555, Japan; [Sasaki, M.] Obihiro Univ Agr & Vet Med, Dept Basic Vet Med, Obihiro, Hokkaido 0808555, Japan	Yamada, K (reprint author), Obihiro Univ Agr & Vet Med, Dept Vet Clin Sci, Obihiro, Hokkaido 0808555, Japan.	kyamada@obihiro.ac.jp					Alsafy M, 2012, ANAT HISTOL EMBRYOL, V10, P1; Schraufnagel DE, 2008, AM J ROENTGENOL, V191, P748, DOI 10.2214/AJR.07.3455; Schmidt MJ, 2012, VET J, V191, P85, DOI 10.1016/j.tvjl.2010.12.026; Lee KJ, 2011, J VET MED SCI, V73, P113, DOI 10.1292/jvms.10-0233; Zotti A, 2009, RES VET SCI, V87, P171, DOI 10.1016/j.rvsc.2009.02.003; Zhou X, 2006, COMPUT MED IMAG GRAP, V30, P299, DOI 10.1016/j.compmedimag.2006.06.002; Finnen A, 2011, J VET INTERN MED, V25, P143, DOI 10.1111/j.1939-1676.2010.0659.x; Kassem MM, 2011, RES VET SCI, V90, P9, DOI 10.1016/j.rvsc.2010.05.005; Nuss K, 2011, TIERAERZTL PRAX G N, V39, P317; Braun U, 2012, RES VET SCI, V93, P1407, DOI 10.1016/j.rvsc.2012.03.012; Braun U, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-2; Henning BC, 2012, ANAT HISTOL EMBRYOL, V41, P106, DOI 10.1111/j.1439-0264.2011.01108.x; Hollo G, 2007, J ANIM SCI, V20, P1901; Klaus-Dieter B, 2011, BOVINE ANATOMY, P66; Marcio T, 2007, VET J, V174, P133; Mohamed T, 2011, VET MED-CZECH, V56, P255; Nade Toshihiro, 2005, Animal Science Journal, V76, P513, DOI 10.1111/j.1740-0929.2005.00298.x; Natalia H, 2012, AM J VET RES, V73, P646; Ober CP, 2010, ANAT HISTOL EMBRYOL, V39, P233, DOI 10.1111/j.1439-0264.2010.01001.x; Schultz RM, 2009, VET RADIOL ULTRASOUN, V50, P625, DOI 10.1111/j.1740-8261.2009.01593.x; Shimizu J, 2009, VET REC, V165, P200, DOI 10.1136/vr.165.7.200; Van Hoogmoed L, 1998, VET RADIOL ULTRASOUN, V39, P117	22	0	0	UNIV AGRICULTURE, FAC VETERINARY SCIENCE	FAISALABAD	UNIV AGRICULTURE, FAC VETERINARY SCIENCE, FAISALABAD, 00000, PAKISTAN	0253-8318	2074-7764		PAK VET J	Pak. Vet. J.		2015	35	1					18	22				5	Veterinary Sciences	Veterinary Sciences	AY2DN	WOS:000347398800004		
J	Otomaru, K; Kubota, S; Tokimori, M				Otomaru, Konosuke; Kubota, Sei; Tokimori, Makiko			Maternally and Naturally Acquired Antibodies to Pasteurella multocida in Japanese Black Calves	PAKISTAN VETERINARY JOURNAL			English	Article						Antibody titer; Immunity; Japanese black calves; Pasteurella multocida	BEEF-CALVES; VACCINATION; HAEMOLYTICA; IMMUNITY; DAMS	We investigated the dynamics and duration of antibody titer against Pasteurella multocida in Japanese Black calves. Twenty unvaccinated calves from two Japanese Black breeding farms in Japan, were studied. Blood samples were obtained from all calves at 1, 4, 8, 12, 16 and 20 weeks after birth, and also obtained from their dams once at 1 week after calving. Antibody titer against P. multocida in calves at 1 week of age after birth was well correlated with that in their damsat 1 week after calving. Maternally derived antibody titer against P. multocida reached the lowest at 4 weeks of age. Calves began producing antibody against P. multocida by themselves between 4 and 8 weeks of age. These results might help designing a vaccination program against P. multocida for Japanese Black calves. (C)2014 PVJ. All rights reserved	[Otomaru, Konosuke] Kagoshima Prefectural Federat Agr Mutual Aid Asso, Kagoshima 8910132, Japan; [Kubota, Sei] Kyoto Biken Labs, Dept Vet Med, Kyoto 6110041, Japan; [Tokimori, Makiko] Hokusatsu Agr Mutual Aid Assoc, Kagoshima 8951813, Japan	Otomaru, K (reprint author), Kagoshima Prefectural Federat Agr Mutual Aid Asso, Kagoshima 8910132, Japan.	otomaru@vet.kagoshima-u.ac.jp					Prado ME, 2006, VET IMMUNOL IMMUNOP, V111, P301, DOI 10.1016/j.vetimm.2005.10.013; Abubakar MS, 2013, PAK VET J, V33, P101; Michael GB, 2012, J ANTIMICROB CHEMOTH, V67, P84, DOI 10.1093/jac/dkr406; ALLEN JW, 1991, CAN J VET RES, V55, P341; HODGINS DC, 1994, CAN J VET RES, V58, P31; Pardon B, 2011, VET REC, V169, P278, DOI 10.1136/vr.d4406; Barrington GM, 2001, VET CLIN N AM-FOOD A, V17, P463; El-Eragi AMS, 2001, TROP ANIM HEALTH PRO, V33, P275, DOI 10.1023/A:1010575617393; Horimoto M, 1990, J JPN ASS INF DIS, V64, P1205; Kurcubic VS, 2014, PAK VET J, V34, P11; Nonnecke BJ, 2012, J DAIRY SCI, V95, P221, DOI 10.3168/jds.2011-4712; Otomaru K., 2012, Journal of the Japan Veterinary Medical Association, V65, P767; Woolums AR, 2013, AM J VET RES, V74, P343, DOI 10.2460/ajvr.74.2.343	13	0	0	UNIV AGRICULTURE, FAC VETERINARY SCIENCE	FAISALABAD	UNIV AGRICULTURE, FAC VETERINARY SCIENCE, FAISALABAD, 00000, PAKISTAN	0253-8318	2074-7764		PAK VET J	Pak. Vet. J.		2015	35	1					108	110				3	Veterinary Sciences	Veterinary Sciences	AY2DN	WOS:000347398800026		
J	Yamamoto, H; Oda, Y				Yamamoto, Hidetaka; Oda, Yoshinao			Gastrointestinal stromal tumor: Recent advances in pathology and genetics	PATHOLOGY INTERNATIONAL			English	Review						gastrointestinal stromal tumor; KIT; leiomyosarcoma; PDGFRA; succinate dehydrogenase	SUCCINATE-DEHYDROGENASE; PDGFRA MUTATIONS; C-KIT; IMATINIB MESYLATE; DOWN-REGULATION; CARNEY TRIAD; SOFT-TISSUE; GISTS; DIAGNOSIS; RISK	The discovery of KIT gene mutation in gastrointestinal stromal tumor (GIST) has provided a paradigm shift in the classification, diagnosis and molecular-targeted therapy of gastrointestinal mesenchymal tumors. There is growing evidence of phenotype-genotype (KIT, platelet-derived growth factor receptor-alpha, succinate dehydrogenase or other driver gene mutation) and genotype-therapeutic (sensitivity to imatinib) correlations in GIST. Risk stratification based on mitotic counts, tumor size and rupture is useful for the prognostication and management of patients with GIST. Blood vessel invasion is a strong indicator of liver metastasis in GIST. In addition, novel biomarkers such as cell-cycle regulators, microRNAs and their targets have been discovered by using high throughput molecular analyses. In contrast, leiomyosarcoma of the gastrointestinal tract has become a very rare entity in the KIT' era, and its molecular pathogenetic mechanism is unclear. Recent studies have revealed a wide spectrum of cytological atypia, mitotic counts and biological behavior of gastrointestinal smooth muscle tumors, suggesting the necessity of establishing the criteria for malignancy. Collectively, both classical histopathological procedures and modern molecular investigations are indispensable for the evolution of diagnosis and treatment of GIST and mimics.	Kyushu Univ, Dept Anat Pathol, Grad Sch Med Sci, Fukuoka 8128582, Japan; Kyushu Univ Hosp, Div Pathol, Fukuoka 812, Japan	Yamamoto, H (reprint author), Kyushu Univ, Dept Anat Pathol, Grad Sch Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	hidetaka@surgpath.med.kyushu-u.ac.jp					Agaimy A, 2009, HISTOPATHOLOGY, V54, P295, DOI 10.1111/j.1365-2559.2008.03214.x; Patil DT, 2011, ARCH PATHOL LAB MED, V135, P1298, DOI 10.5858/arpa.2011-0022-RA; Yamamoto H, 2004, AM J SURG PATHOL, V28, P479, DOI 10.1097/00000478-200404000-00007; Stratakis CA, 2009, J INTERN MED, V266, P43, DOI 10.1111/j.1365-2796.2009.02110.x; Joensuu H, 2008, HUM PATHOL, V39, P1411, DOI 10.1016/j.humpath.2008.06.025; Lasota J, 2006, SEMIN DIAGN PATHOL, V23, P91, DOI 10.1053/j.semdp.2006.08.006; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Antonescu CR, 2013, AM J SURG PATHOL, V37, P385, DOI 10.1097/PAS.0b013e31826c1761; Dwight T, 2013, AM J SURG PATHOL, V37, P226, DOI 10.1097/PAS.0b013e3182671155; Fletcher CDM, 2002, HUM PATHOL, V33, P459, DOI 10.1053/hupa.2002.123545; Joensuu H, 2012, LANCET ONCOL, V13, P265, DOI 10.1016/S1470-2045(11)70299-6; Liegl B, 2009, AM J SURG PATHOL, V33, P437, DOI 10.1097/PAS.0b013e318186b158; Yamamoto H, 2010, HUM PATHOL, V41, P605, DOI 10.1016/j.humpath.2009.09.016; Corless CL, 2005, J CLIN ONCOL, V23, P5357, DOI 10.1200/JCO.2005.14.068; Rege TA, 2011, AM J SURG PATHOL, V35, P495, DOI 10.1097/PAS.0b013e31820e5f7d; Yamamoto H, 2013, MODERN PATHOL, V26, P563, DOI 10.1038/modpathol.2012.198; Miettinen M, 2006, AM J SURG PATHOL, V30, P90, DOI 10.1097/01.pas.0000176433.81079.bd; Doyle LA, 2014, HISTOPATHOLOGY, V64, P53, DOI 10.1111/his.12302; Antonescu CR, 2005, CLIN CANCER RES, V11, P4182, DOI 10.1158/1078-0432.CCR-04-2245; Debiec-Rychter M, 2006, EUR J CANCER, V42, P1093, DOI 10.1016/j.ejca.2006.01.030; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Janeway KA, 2011, P NATL ACAD SCI USA, V108, P314, DOI 10.1073/pnas.1009199108; Miettinen M, 2005, AM J SURG PATHOL, V29, P1373, DOI 10.1097/01.pas.0000172190.79552.8b; Gill AJ, 2012, PATHOLOGY, V44, P285, DOI 10.1097/PAT.0b013e3283539932; Joensuu H, 2001, NEW ENGL J MED, V344, P1052, DOI 10.1056/NEJM200104053441404; Miettinen M, 2011, AM J SURG PATHOL, V35, P1712, DOI 10.1097/PAS.0b013e3182260752; Corless CL, 2014, MODERN PATHOL, V27, pS1, DOI 10.1038/modpathol.2013.173; Miettinen M, 2009, AM J SURG PATHOL, V33, P1267, DOI 10.1097/PAS.0b013e3181a13e99; Pantaleo MA, 2014, EUR J HUM GENET, V22, P32, DOI 10.1038/ejhg.2013.80; Choi H, 2007, J CLIN ONCOL, V25, P1753, DOI 10.1200/JCO.2006.07.3049; Miettinen M, 2006, SEMIN DIAGN PATHOL, V23, P70, DOI 10.1053/j.semdp.2006.09.001; Andersson J, 2006, GASTROENTEROLOGY, V130, P1573, DOI 10.1053/j.gastro.2006.01.043; Yamamoto H, 2011, PATHOBIOLOGY, V78, P132, DOI 10.1159/000323564; Antonescu CR, 2011, J PATHOL, V223, P251, DOI 10.1002/path.2798; Antonescu CR, 2006, SEMIN DIAGN PATHOL, V23, P63, DOI 10.1053/j.semdp.2006.08.003; Carney JA, 2002, AM J MED GENET, V108, P132, DOI 10.1002/ajmg.10235; CARNEY JA, 1977, NEW ENGL J MED, V296, P1517, DOI 10.1056/NEJM197706302962609; Fukasawa T, 2000, JPN J CANCER RES, V91, P1241; Haller F, 2008, J PATHOL, V215, P253, DOI 10.1002/path.2352; Hornick Jason L, 2003, Ann Diagn Pathol, V7, P60, DOI 10.1053/adpa.2003.50010; Imbalzano AN, 2005, CANCER CELL, V7, P294, DOI 10.1016/j.ccr.2005.04.001; Long KB, 2010, AM J SURG PATHOL, V34, P907, DOI 10.1097/PAS.0b013e3181d9f18f; Nakamura N, 2005, HUM PATHOL, V36, P828, DOI 10.1016/j.humpath.2005.03.012; Sakurai S, 2001, PATHOL INT, V51, P524, DOI 10.1046/j.1440-1827.2001.01224.x; Suehara Y, 2008, CLIN CANCER RES, V14, P1707, DOI 10.1158/1078-0432.CCR-07-1478; Yamamoto H, 2013, HISTOPATHOLOGY, V63, P194, DOI 10.1111/his.12159; Yamamoto H, 2011, AM J SURG PATHOL, V35, P1287, DOI 10.1097/PAS.0b013e3182206f15; Yamamoto H, 2010, HUM PATHOL, V41, P1422, DOI 10.1016/j.humpath.2010.02.013; Yamamoto H, 2009, J CANCER RES CLIN, V135, P791, DOI 10.1007/s00432-008-0514-z	50	2	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	JAN	2015	65	1					9	18		10.1111/pin.12230		10	Pathology	Pathology	AY0XH	WOS:000347317200003		
J	Fuchinoue, F; Hirotani, Y; Nakanishi, Y; Yamaguchi, H; Nishimaki, H; Noda, H; Tang, XY; Iizuka, M; Amano, S; Sugitani, M; Nemoto, N; Masuda, S				Fuchinoue, Fumi; Hirotani, Yukari; Nakanishi, Yoko; Yamaguchi, Hiromi; Nishimaki, Haruna; Noda, Hiroko; Tang, Xiao Yan; Iizuka, Misato; Amano, Sadao; Sugitani, Masahiko; Nemoto, Norimichi; Masuda, Shinobu			Overexpression of PGC1 alpha and accumulation of p62 in apocrine carcinoma of the breast	PATHOLOGY INTERNATIONAL			English	Article						apocrine carcinoma; mitochondria; p62; PGC1 alpha	CANCER; CELLS; ACTIVATION; NRF2	Apocrine carcinoma is categorized as a special type of breast carcinoma because of its specific morphological features. To clarify the characteristics of apocrine carcinoma from the point of view of the mitochondrial profile, we conducted a comparative study between apocrine and non-apocrine carcinomas. The expressions of mitochondrial related factors (PGC1, Nrf1, Nrf2, mtTFA and COX4) were examined in a testing set of breast cancer tissue. Apocrine carcinomas showed a clear tendency towards higher mRNA expression levels of PGC1 than non-apocrine carcinomas. The expression of the selected factor, PGC1, as well as that of p62 was further examined. The results revealed that apocrine carcinomas showed a higher immunohistochemical positivity rate for PGC1 (21.3% vs. 3.2%; P = 0.008), and that the mRNA expression level of PGC1 was significantly higher in apocrine carcinoma than in non-apocrine carcinoma (P = 0.007). The immunohistochemical positivity rate for p62 protein was also higher in apocrine carcinomas (44.7% vs. 21.0%; P = 0.015), although no significant difference in the p62 mRNA expression level was detected between the two types of carcinoma (P = 0.633). In conclusion, this study revealed that apocrine carcinoma overexpressed PGC1 contributing to mitochondrial biogenesis, and also p62 protein accumulation.	[Fuchinoue, Fumi; Hirotani, Yukari; Nakanishi, Yoko; Yamaguchi, Hiromi; Nishimaki, Haruna; Noda, Hiroko; Tang, Xiao Yan; Sugitani, Masahiko; Nemoto, Norimichi; Masuda, Shinobu] Nihon Univ, Dept Pathol, Sch Med, Tokyo 1738610, Japan; [Yamaguchi, Hiromi] Nihon Univ, Dept Funct Morphol, Sch Med, Tokyo 1738610, Japan; [Iizuka, Misato; Amano, Sadao] Nihon Univ, Dept Breast & Endocrine Surg, Sch Med, Tokyo 1738610, Japan	Masuda, S (reprint author), Nihon Univ, Dept Pathol, Sch Med, Itabashi Ku, 30-1 Ohyaguchi Kamicho, Tokyo 1738610, Japan.	masuda.shinobu@nihon-u.ac.jp			MEXT KAKENHI [25860282]; Strategic Research Base Development Program for Private Universities; MEXT	Authors thank to Ai Itoh and Fumiko Oikawa for technical supports. This study was supported by MEXT KAKENHI (Grant-in-Aid for Young Scientists (B): 25860282) and by Strategic Research Base Development Program for Private Universities subsidized by MEXT (2010).	Moritani S, 2011, AM J SURG PATHOL, V35, P861, DOI 10.1097/PAS.0b013e31821a7f3e; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Masuda S, 2012, PATHOL INT, V62, P295, DOI 10.1111/j.1440-1827.2012.02790.x; Farmer P, 2005, ONCOGENE, V24, P4660, DOI 10.1038/sj.onc.1208561; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Ertel A, 2012, CELL CYCLE, V11, P253, DOI 10.4161/cc.11.2.19006; Li LJ, 2013, CANCER CELL, V24, P738, DOI 10.1016/j.ccr.2013.10.025; Allred DC, 1998, MODERN PATHOL, V11, P155; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Inoue D, 2012, CANCER SCI, V103, P760, DOI 10.1111/j.1349-7006.2012.02216.x; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Inami Y, 2011, J CELL BIOL, V193, P275, DOI 10.1083/jcb.201102031; Kim S, 2013, TUMOR BIOL, V34, P1699, DOI 10.1007/s13277-013-0707-1; Kim S, 2012, TUMOR BIOL, V33, P1681, DOI 10.1007/s13277-012-0424-1; Nakamura K, 2010, J BIOL CHEM, V285, P2077, DOI 10.1074/jbc.M109.065102; EUSEBI V, 1986, AM J PATHOL, V123, P532; Girnun GD, 2012, SEMIN CELL DEV BIOL, V23, P381, DOI 10.1016/j.semcdb.2012.01.007; Luo Rong-Zhen, 2013, Onco Targets Ther, V6, P883, DOI 10.2147/OTT.S46222; Nakanishi Y, 2013, ACTA HISTOCHEM CYTOC, V46, P85, DOI 10.1267/ahc.12024; Page DL, 2002, AM JOINT COMMITTEE C; RODDY HJ, 1980, ULTRASTRUCT PATHOL, V1, P385; The Japanese Breast Cancer Society, 2012, GEN RUL CLIN PATH RE	23	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	JAN	2015	65	1					19	26		10.1111/pin.12235		8	Pathology	Pathology	AY0XH	WOS:000347317200004		
J	Makino, M; Kawaguchi, K; Shimojo, H; Nakamura, H; Nagasawa, M; Kodama, R				Makino, Mutsuki; Kawaguchi, Kenji; Shimojo, Hisashi; Nakamura, Hironori; Nagasawa, Masaki; Kodama, Ryo			Extensive lanthanum deposition in the gastric mucosa: The first histopathological report	PATHOLOGY INTERNATIONAL			English	Article						chronic kidney disease; gastrointestinal absorption; lanthanum carbonate	CHRONIC-RENAL-FAILURE; GASTROINTESTINAL ABSORPTION; CARBONATE; PATIENT	Lanthanum carbonate is one of the new phosphate binders used for the treatment of hyperphosphatemia in patients with chronic kidney disease. It is poorly absorbed from the gastrointestinal tract, forms insoluble complexes within the lumen, and prevents the absorption of dietary phosphate. A 63-year-old female with a 7-year history of peritoneal dialysis, who was treated with lanthanum carbonate for four years, underwent endoscopic submucosal dissection for intramucosal gastric cancer. Resected specimens showed massive accumulation of macrophages containing fine, granular, brown material in the lamina propria. This was confirmed as lanthanum deposition by scanning electron microscopy with energy dispersive x-ray spectroscopy. Although lanthanum may be poorly absorbed, increased tissue accumulation of lanthanum, particularly in the liver and bone, has been reported in animals with chronic kidney disease. This report indicates enhanced gastrointestinal absorption of lanthanum in some patients or conditions, although its clinical significance awaits further studies.	[Makino, Mutsuki; Kawaguchi, Kenji] Shinonoi Gen Hosp, Dept Diagnost Pathol, Nagano 3888004, Japan; [Nakamura, Hironori; Nagasawa, Masaki] Shinonoi Gen Hosp, Dept Nephrol, Nagano 3888004, Japan; [Kodama, Ryo] Shinonoi Gen Hosp, Dept Gastroenterol, Nagano 3888004, Japan; [Shimojo, Hisashi] Shinshu Univ, Dept Pathol, Sch Med, Nagano, Japan	Makino, M (reprint author), Shinonoi Gen Hosp, Dept Diagnost Pathol, 666-1 Shinonoi Ai, Nagano 3888004, Japan.	mumujanuary12@yahoo.co.jp					Davis RL, 2009, NEPHROL DIAL TRANSPL, V24, P3247, DOI 10.1093/ndt/gfp364; Slatopolsky E, 2005, KIDNEY INT, V68, P2809, DOI 10.1111/j.1523-1755.2005.00753.x; Damment SJP, 2008, CLIN PHARMACOKINET, V47, P553, DOI 10.2165/00003088-200847090-00001; MAGNUSSON M, 1991, GUT, V32, P754, DOI 10.1136/gut.32.7.754; Lacour B, 2005, KIDNEY INT, V67, P1062, DOI 10.1111/j.1523-1755.2005.00171.x; Thakral C, 2007, CONTRAST MEDIA MOL I, V2, P199, DOI 10.1002/cmmi.146; Rombola G, 2012, J NEPHROL, V25, P490, DOI 10.5301/jn.5000118; Spasovski GB, 2006, NEPHROL DIAL TRANSPL, V21, P2217, DOI 10.1093/ndt/gfl146; Bervoets ARJ, 2009, KIDNEY INT, V75, P389, DOI 10.1038/ki.2008.571; ITTEL TH, 1988, NEPHROL DIAL TRANSPL, V3, P617; Vaziri ND, 2013, AM J NEPHROL, V38, P99, DOI 10.1159/000353764; VAZIRI ND, 1985, AM J GASTROENTEROL, V80, P608	12	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	JAN	2015	65	1					33	37		10.1111/pin.12227		5	Pathology	Pathology	AY0XH	WOS:000347317200006		
J	Watanabe, H; Osawa, Y; Goto, S; Habuka, M; Imai, N; Ito, Y; Hirose, T; Chou, T; Ohashi, R; Shimizu, A; Ehara, T; Shimotori, T; Narita, I				Watanabe, Hirofumi; Osawa, Yutaka; Goto, Shin; Habuka, Masato; Imai, Naofumi; Ito, Yumi; Hirose, Takayuki; Chou, Takaaki; Ohashi, Ryuji; Shimizu, Akira; Ehara, Takashi; Shimotori, Takashi; Narita, Ichiei			A case of endocapillary proliferative glomerulonephritis with macrophages phagocytosing monoclonal immunoglobulin lambda light chain	PATHOLOGY INTERNATIONAL			English	Article						crystal-storing histiocytosis; endocapillary hypercellularity; membranoproliferative glomerulonephritis; monoclonal gammopathy-associated proliferative glomerulonephritis; multiple myeloma	CRYSTAL-STORING HISTIOCYTOSIS; IMMUNE-COMPLEX GLOMERULONEPHRITIS; MULTIPLE-MYELOMA; DEPOSITION DISEASE; RENAL-FAILURE; IGG DEPOSITS; GAMMOPATHY; DISORDER; KIDNEY	Multiple myeloma (MM) is a plasma-cell neoplasm that can cause renal disorders. Renal lesions in MM can present with a very rare pathological manifestation involving a specific monoclonal immunoglobulin (Ig). We report the case of a 33-year-old woman who had edema, fatigue, elevated serum creatinine levels, hypoalbuminemia, and hypercholesterolemia. She had persistent hematuria and proteinuria lasting 3 years. Serum protein electrophoresis showed an M-spike, and serum immunofixation demonstrated the presence of monoclonal IgG . She had proteinuria in the nephrotic range, and a monoclonal fragment was present on urine immunofixation. Renal biopsy showed proliferative glomerulonephritis with light chain and C3c deposition and inflammatory cell infiltration with CD68. Macrophage lysosomes contained light chains, suggesting their partial phagocytosis. She was diagnosed with symptomatic MM and was treated with bortezomib and dexamethasone and an autologous peripheral stem cell transplant conditioned with intravenous melphalan. She achieved a partial response with decreased serum monoclonal protein and improved renal function. This case may be categorized as a monoclonal gammopathy-associated proliferative glomerulonephritis. The biopsy finding of partially phagocytosed Ig light chains by macrophages is very rare; this pathological condition is similar to crystal-storing histiocytosis.	[Watanabe, Hirofumi; Goto, Shin; Habuka, Masato; Imai, Naofumi; Ito, Yumi; Narita, Ichiei] Niigata Univ, Div Clin Nephrol & Rheumatol, Grad Sch Med & Dent Sci, Niigata 9518510, Japan; [Osawa, Yutaka; Shimotori, Takashi] Niigata Rinko Hosp, Dept Internal Med, Niigata, Japan; [Hirose, Takayuki; Chou, Takaaki] Niigata Canc Ctr Hosp, Dept Internal Med, Niigata, Japan; [Ohashi, Ryuji] Nippon Med Sch, Dept Pathol, Tokyo 113, Japan; [Shimizu, Akira] Nippon Med Sch, Dept Pathol Analyt Human Pathol, Tokyo 113, Japan; [Ehara, Takashi] Matsumoto Univ, Grad Sch Hlth Sci, Dept Hlth & Sport Sci, Matsumoto, Nagano, Japan	Goto, S (reprint author), Niigata Univ, Div Clin Nephrol & Rheumatol, Grad Sch Med & Dent Sci, Chuo Ku, 1-757 Asahimachi Dori, Niigata 9518510, Japan.	gotos@med.niigata-u.ac.jp					Korbet SM, 2006, J AM SOC NEPHROL, V17, P2533, DOI 10.1681/ASN.2006020139; Nasr SH, 2004, KIDNEY INT, V65, P85, DOI 10.1111/j.1523-1755.2004.00365.x; PREUDHOMME JL, 1994, KIDNEY INT, V46, P965, DOI 10.1038/ki.1994.355; Nasr SH, 2009, J AM SOC NEPHROL, V20, P2055, DOI 10.1681/ASN.2009010110; Guo SH, 2011, KIDNEY INT, V80, P946, DOI 10.1038/ki.2011.249; Montseny JJ, 1998, NEPHROL DIAL TRANSPL, V13, P1438, DOI 10.1093/ndt/13.6.1438; El Hamel C, 2010, NEPHROL DIAL TRANSPL, V25, P2982, DOI 10.1093/ndt/gfq129; Blade J, 1998, ARCH INTERN MED, V158, P1889, DOI 10.1001/archinte.158.17.1889; Sethi S, 2013, MAYO CLIN PROC, V88, P1284, DOI 10.1016/j.mayocp.2013.08.002; Ronco PM, 2001, J AM SOC NEPHROL, V12, P1558; Dimopoulos MA, 2008, LEUKEMIA, V22, P1485, DOI 10.1038/leu.2008.131; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Lebeau A, 2002, BLOOD, V100, P1817; Sethi S, 2002, AM J KIDNEY DIS, V39, P183, DOI 10.1053/ajkd.2002.29914; Keeling J, 2004, LAB INVEST, V84, P1322, DOI 10.1038/labinvest.3700161; Komatsuda A, 2012, INTERNAL MED, V51, P3273, DOI 10.2169/internalmedicine.51.8513; Kowalewska J, 2011, FOLIA HISTOCHEM CYTO, V49, P537, DOI 10.5603/FHC.2011.0077; Kyle RA, 2004, NEW ENGL J MED, V351, P1860, DOI 10.1056/NEJMra041875; Nikolic-Paterson DJ, 2001, NEPHROL DIAL TRANSPL, V16, P3; Taneda S, 2008, AM J KIDNEY DIS, V52, P621, DOI 10.1053/j.ajkd.2008.02.370	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	JAN	2015	65	1					38	42		10.1111/pin.12229		5	Pathology	Pathology	AY0XH	WOS:000347317200007		
J	Matsushita, Y; Fujita, S; Kawasaki, G; Hirota, Y; Rokutanda, S; Yamashita, K; Yanamoto, S; Ikeda, T; Umeda, M				Matsushita, Yuki; Fujita, Shuichi; Kawasaki, Goro; Hirota, Yoshinosuke; Rokutanda, Satoshi; Yamashita, Kentaro; Yanamoto, Souichi; Ikeda, Tohru; Umeda, Masahiro			Granular cell ameloblastoma: Case report of a particular ameloblastoma histologically resembling oncocytoma	PATHOLOGY INTERNATIONAL			English	Article						CD68; CK19; granular cell ameloblastoma; oncocytoma	GLAND	Granular cell ameloblastoma is classified as a histological subtype of solid/multicystic ameloblastoma. Usual granular cell ameloblastoma is histologically characterized by granular changes of stellate-like cells located in the inner portion of the epithelial follicles. Here we report a case of another type of granular cell ameloblastoma, showing predominant anastomosing double-stranded trabeculae of granular cells. This type of granular cell ameloblastoma is extremely rare, and the World Health Organization classification does not contain the entity. We tentatively termed it anastomosing granular cell ameloblastoma' in this report. The present case suggests the importance of differential diagnosis because the histology of anastomosing granular cell ameloblastoma' resembles that of salivary gland oncocytoma rather than that of usual granular cell ameloblastoma. The trabeculae observed in our case continued to the peripheral cells of a small amount of epithelial sheets of plexiform ameloblastoma, and the tumor cells were positive for CK19, which is regarded as an immunohistochemical marker of odontogenic epithelium. Similar to usual granular cell ameloblastoma, the tumor cells had CD68-positive granules. For precise diagnosis of this condition, immunohistochemistry using CK19 and CD68, as well as detailed histological observation, are recommended.	[Matsushita, Yuki; Kawasaki, Goro; Hirota, Yoshinosuke; Rokutanda, Satoshi; Yamashita, Kentaro; Yanamoto, Souichi; Umeda, Masahiro] Nagasaki Univ, Dept Clin Oral Oncol, Unit Translat Med, Grad Sch Biomed Sci, Nagasaki 8528588, Japan; [Fujita, Shuichi; Ikeda, Tohru] Nagasaki Univ, Dept Oral Pathol & Bone Metab, Unit Basic Med Sci, Course Med & Dent Sci,Grad Sch Biomed Sci, Nagasaki 8528588, Japan	Matsushita, Y (reprint author), Nagasaki Univ, Dept Clin Oral Oncol, Unit Translat Med, Grad Sch Biomed Sci, 1-7-1 Sakamoto, Nagasaki 8528588, Japan.	matsushita@nagasaki-u.ac.jp	Matsushita, Yuki/H-3188-2015	Matsushita, Yuki/0000-0001-9577-3249			Gardner DG, 2005, PATHOLOGY GENETICS H, V9, P296; Gupta S, 2012, ANN SAUDI MED, V32, P537, DOI 10.5144/0256-4947.2012.30.5.1342; HARTMAN KS, 1974, ORAL SURG ORAL MED O, V38, P241, DOI 10.1016/0030-4220(74)90063-2; Hunasgi S, 2013, CASE REP DENT, V2013, DOI DOI 10.1155/2013/372781; Huvos AG, 2005, WHO CLASSIFICATION T, P266; Kato Hisashi, 2012, Tokai J Exp Clin Med, V37, P30; Kumamoto H, 2001, J ORAL PATHOL MED, V30, P245, DOI 10.1034/j.1600-0714.2001.300409.x; Kumamoto H, 2001, ORAL DIS, V7, P171, DOI 10.1034/j.1601-0825.2001.0070306.x; Neville BW, 2008, ORAL MAXILLOFACIAL P, P678; Oza Nirima, 2012, J Oral Maxillofac Pathol, V16, P446, DOI 10.4103/0973-029X.102516; Ozolek JA, 2005, LARYNGOSCOPE, V115, P1097, DOI 10.1097/01.MLG.0000163497.61332.77; Robinson RA, 2012, TUMOURS CYSTS JAWS, P49; Shintaku M, 1997, HISTOPATHOLOGY, V31, P408, DOI 10.1046/j.1365-2559.1997.2870891.x; Taneeru Sravya, 2013, J Clin Exp Dent, V5, pe154, DOI 10.4317/jced.51015; Thompson LD, 1996, CANCER, V78, P2281, DOI 10.1002/(SICI)1097-0142(19961201)78:11<2281::AID-CNCR3>3.0.CO;2-Q; YAMAMOTO G, 1989, INT J ORAL MAX SURG, V18, P140, DOI 10.1016/S0901-5027(89)80110-9	16	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	JAN	2015	65	1					43	47		10.1111/pin.12231		5	Pathology	Pathology	AY0XH	WOS:000347317200008		
J	Suzuki, H; Takeda, H; Yamashiro, K; Soma, T; Osanai, T; Hiraga, H; Isu, K; Tamakawa, M; Nojima, T				Suzuki, Hiroaki; Takeda, Hiroko; Yamashiro, Katsushige; Soma, Tamotsu; Osanai, Toshihisa; Hiraga, Hiroaki; Isu, Kazuo; Tamakawa, Mitsuharu; Nojima, Takayuki			A case of pure sclerosing epithelioid fibrosarcoma with a cytogenetic and fluorescence in situ hybridization study	PATHOLOGY INTERNATIONAL			English	Letter							VARIANT		[Suzuki, Hiroaki; Takeda, Hiroko; Yamashiro, Katsushige] Natl Hosp Org Hokkaido Canc Ctr, Div Diagnost Pathol, Sapporo, Hokkaido, Japan; [Soma, Tamotsu; Osanai, Toshihisa; Hiraga, Hiroaki; Isu, Kazuo] Natl Hosp Org Hokkaido Canc Ctr, Div Orthoped, Sapporo, Hokkaido, Japan; [Tamakawa, Mitsuharu] Sapporo Med Univ, Dept Diagnost Radiol, Sapporo, Hokkaido, Japan; [Nojima, Takayuki] Kanazawa Med Univ, Dept Pathol, Uchinada, Ishikawa 92002, Japan	Suzuki, H (reprint author), Natl Hosp Org Hokkaido Canc Ctr, Div Diagnost Pathol, Sapporo, Hokkaido, Japan.						Lau PPL, 2013, AM J SURG PATHOL, V37, P734, DOI 10.1097/PAS.0b013e31827560f8; MEISKINDBLOM JM, 1995, AM J SURG PATHOL, V19, P979, DOI 10.1097/00000478-199509000-00001; Arbajian E, 2014, AM J SURG PATHOL, V38, P801, DOI 10.1097/PAS.0000000000000158; Doyle LA, 2012, AM J SURG PATHOL, V36, P1444, DOI 10.1097/PAS.0b013e3182562bf8; Wang WL, 2012, MODERN PATHOL, V25, P846, DOI 10.1038/modpathol.2011.214; Donner LR, 2000, CANCER GENET CYTOGEN, V119, P127, DOI 10.1016/S0165-4608(99)00225-3; Folpe AL, 2013, WHO CLASSIFICATION T, P95; Gisselsson D, 1998, CANCER GENET CYTOGEN, V107, P102, DOI 10.1016/S0165-4608(98)00098-3; Kindblom LG, 2013, WHO CLASSIFICATION T, P97; Ogose A, 2004, CANCER GENET CYTOGEN, V152, P136, DOI 10.1016/j.cancergenyto.2003.11.007	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	JAN	2015	65	1					48	50		10.1111/pin.12223		3	Pathology	Pathology	AY0XH	WOS:000347317200009		
J	Tsukamoto, Y; Hao, H; Kajimoto, N; Katayama, A; Suzuki, C; Terada, T; Nakano, T; Hanaoka, K; Hirota, S				Tsukamoto, Yoshitane; Hao, Hiroyuki; Kajimoto, Noriko; Katayama, Atsushi; Suzuki, Chihiro; Terada, Takayuki; Nakano, Takashi; Hanaoka, Kenji; Hirota, Seiichi			Sarcomatoid pleural mesothelioma with osteosarcomatous, chondrosarcomatous and rhabdomyoblastic elements: An extremely rare autopsy case	PATHOLOGY INTERNATIONAL			English	Letter							MALIGNANT MESOTHELIOMA; DIFFERENTIATION; DIAGNOSIS		[Tsukamoto, Yoshitane; Hao, Hiroyuki; Kajimoto, Noriko; Katayama, Atsushi; Suzuki, Chihiro; Hirota, Seiichi] Hyogo Coll Med, Dept Surg Pathol, Nishinomiya, Hyogo 6638501, Japan; [Terada, Takayuki; Nakano, Takashi] Hyogo Coll Med, Div Resp Med, Dept Internal Med, Nishinomiya, Hyogo 6638501, Japan; [Hanaoka, Kenji] Natl Hosp Org Himeji Med Ctr, Div Resp Med, Dept Internal Med, Himeji, Hyogo, Japan	Tsukamoto, Y (reprint author), Hyogo Coll Med, Dept Surg Pathol, Nishinomiya, Hyogo 6638501, Japan.						Klebe S, 2008, MODERN PATHOL, V21, P1084, DOI 10.1038/modpathol.2008.125; Klebe S, 2010, MODERN PATHOL, V23, P470, DOI 10.1038/modpathol.2009.180; Husain AN, 2013, ARCH PATHOL LAB MED, V137, P647, DOI 10.5858/arpa.2012-0214-OA; Donna A, 1996, PATHOL RES PRACT, V192, P1252; Klabatsa A, 2012, HISTOPATHOLOGY, V60, P1164, DOI 10.1111/j.1365-2559.2012.04220.x; KRISHNA J, 1993, THORAX, V48, P409, DOI 10.1136/thx.48.4.409; Kushitani K, 2008, PATHOL INT, V58, P75, DOI 10.1111/j.1440-1827.2007.02193.x; Okamoto T, 1998, Nihon Kokyuki Gakkai Zasshi, V36, P696; Shiota H, 2013, ANN THORAC CARDIOVAS, V19, P297, DOI 10.5761/atcs.cr.12.01964; YOUSEM SA, 1987, ARCH PATHOL LAB MED, V111, P62	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	JAN	2015	65	1					51	53		10.1111/pin.12226		3	Pathology	Pathology	AY0XH	WOS:000347317200010		
J	Nishibe, S; Imanishi, H; Mieda, T; Tsujita, M				Nishibe, Shinichi; Imanishi, Hirokazu; Mieda, Tsutomu; Tsujita, Miki			The Effects of Dexmedetomidine Administration on the Pulmonary Artery Pressure and the Transpulmonary Pressure Gradient After the Bidirectional Superior Cavopulmonary Shunt	PEDIATRIC CARDIOLOGY			English	Article						Dexmedetomidine; Pulmonary artery pressure; Transpulmonary pressure gradient; Bidirectional superior cavopulmonary shunt; Single ventricle; Cardiac surgery	CARDIAC-SURGERY; CHILDREN; VOLUNTEERS; SEDATION; PATIENT	The hemodynamic effects of dexmedetomidine (DEX) on pulmonary artery pressure (PAP) are not fully understood in patients with a single-ventricle physiology. The objective of this retrospective study was to characterize the effect of perioperative DEX infusion on PAP and the transpulmonary pressure gradient after a bidirectional superior cavopulmonary shunt (BCPS) operation. We retrieved physiologic data including the heart rate, incidence of cardiac pacing, systolic and diastolic arterial blood pressure (ABP), and superior vena cava (SVC) and inferior vena cava (IVC) pressures from the medical records of all patients < 12 months of age who underwent a BCPS operation. Patients with an additional Norwood or Damus-Kaye-Stansel procedure, those with additional pulmonary blood flow, and those without both a SVC and an IVC catheter were excluded from the present study. Following the BCPS operation, the SVC pressure is equivalent to the PAP. Similarly, the IVC pressure is equivalent to the common atrial pressure (CAP). Accordingly, we can directly assess the transpulmonary pressure gradient, defined as the difference between the PAP and the CAP, using simultaneous SVC and IVC pressure measurements. Twenty-nine patients were included in the present study. We did not find any increase in the PAP, CAP, PAP/systolic ABP ratio, or the transpulmonary pressure gradient as of 6 h after admission to the intensive care unit when the patients were treated with DEX infusion at a median (interquartile ranges) dose of 0.6 mcg/kg/h (0.4, 0.64 mcg/kg/h). We concluded that the administration of DEX to children with a single-ventricle physiology is acceptable.	[Nishibe, Shinichi; Imanishi, Hirokazu; Mieda, Tsutomu; Tsujita, Miki] Saitama Med Univ, Dept Anesthesiol, Saitama Int Med Ctr, Saitama 3501298, Japan	Nishibe, S (reprint author), Saitama Med Univ, Dept Anesthesiol, Saitama Int Med Ctr, 1397-1 Yamane, Saitama 3501298, Japan.	nishibe@saitama-med.ac.jp					Mason KP, 2011, ANESTH ANALG, V113, P1129, DOI 10.1213/ANE.0b013e31822b8629; Ickeringill M, 2004, ANAESTH INTENS CARE, V32, P741; Chrysostomou C, 2006, PEDIATR CRIT CARE ME, V7, P126, DOI 10.1097/01.PCC.0000200967.76996.07; Tokuhira N, 2009, PEDIATR CRIT CARE ME, V10, P207, DOI 10.1097/PCC.0b013e31819a3a3e; Hsu YW, 2004, ANESTHESIOLOGY, V101, P1066, DOI 10.1097/00000542-200411000-00005; Friesen RH, 2013, ANESTH ANALG, V117, P953, DOI 10.1213/ANE.0b013e3182a15aa6; Ebert TJ, 2000, ANESTHESIOLOGY, V93, P382, DOI 10.1097/00000542-200008000-00016; Gaies MG, 2010, PEDIATR CRIT CARE ME, V11, P234, DOI 10.1097/PCC.0b013e3181b806fc; Tobias JD, 2013, PEDIATR CARDIOL, V34, P779, DOI 10.1007/s00246-013-0659-7; Hosokawa K, 2010, PEDIATR CRIT CARE ME, V11, P39, DOI 10.1097/PCC.0b013e3181b062d7; Lam F, 2012, PEDIATR CARDIOL, V33, P1069, DOI 10.1007/s00246-012-0227-6; Lazol JP, 2010, PEDIATR CRIT CARE ME, V11, P589, DOI 10.1097/PCC.0b013e3181ceae7d; Potts AL, 2009, PEDIATR ANESTH, V19, P1119, DOI 10.1111/j.1460-9592.2009.03133.x; Reichlina A, 2014, EUR J CARDIO-THORAC, V45, P620, DOI 10.1093/ejcts/ezt420; Seyrek M, 2011, J CARDIOTHOR VASC AN, V25, P856, DOI 10.1053/j.jvca.2011.06.006; Snapir A, 2009, BRIT J ANAESTH, V102, P38, DOI 10.1093/bja/aen316; Tobias JD, 2011, PEDIATR CARDIOL, V32, P1075, DOI 10.1007/s00246-011-0092-8	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0172-0643	1432-1971		PEDIATR CARDIOL	Pediatr. Cardiol.	JAN	2015	36	1					151	157		10.1007/s00246-014-0979-2		7	Cardiac & Cardiovascular Systems; Pediatrics	Cardiovascular System & Cardiology; Pediatrics	AY2GK	WOS:000347406700023		
J	Kimura, M; Kikuchi, A; Ichinoi, N; Kure, S				Kimura, Masato; Kikuchi, Atsuo; Ichinoi, Natsuko; Kure, Shigeo			Novel TBX5 Duplication in a Japanese Family with Holt-Oram Syndrome	PEDIATRIC CARDIOLOGY			English	Article						Array-based comparative genomic hybridization; Duplication; Holt-Oram syndrome; Multiplex ligation-dependent probe amplification; T-box; TBX5	MUTATIONS; HEART; CARDIOGENESIS; GENES	Holt-Oram syndrome is an autosomal dominant disorder characterized by upper limb malformations in the preaxial radial ray and cardiac septation and/or a conduction abnormality. It has been demonstrated that Holt-Oram syndrome is caused by mutations in the T-box transcription factor gene TBX5. Numerous germline mutations (more than 90) of this gene have been reported; however, TBX5 mutations are only identified in up to 74 % of typical Holt-Oram syndrome patients. We report a Japanese family with 2 affected individuals with the typical Holt-Oram syndrome phenotype, namely bilateral asymmetrical radial ray deformities and an atrial septal defect. An array-based comparative genomic hybridization study revealed an 11-kb duplication at 12q24.1. Moreover, a multiplex ligation-dependent probe amplification study confirmed the duplication of exons 1-6 of TBX5. Although a small duplication in TBX5 (6 bases) has been reported, a large duplication of this gene has not been described previously in typical Holt-Oram syndrome patients. All typical Holt-Oram syndrome cases in which a mutation is not identified should be screened for TBX5 exon duplications.	[Kimura, Masato; Kikuchi, Atsuo; Ichinoi, Natsuko; Kure, Shigeo] Tohoku Univ, Grad Sch Med, Dept Pediat, Aoba Ku, Sendai, Miyagi 9808574, Japan	Kimura, M (reprint author), Tohoku Univ, Grad Sch Med, Dept Pediat, Aoba Ku, 1-1 Seiryocho, Sendai, Miyagi 9808574, Japan.	mkimura774@med.tohoku.ac.jp					Akrami S M, 2001, J Med Genet, V38, pE44, DOI 10.1136/jmg.38.12.e44; BASSON CT, 1994, NEW ENGL J MED, V330, P885, DOI 10.1056/NEJM199403313301302; Packham EA, 2003, HUM MOL GENET, V12, pR37, DOI 10.1093/hmg/ddg077; HOLT M, 1960, BRIT HEART J, V22, P236; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Li QY, 1997, NAT GENET, V15, P21; Basson CT, 1999, P NATL ACAD SCI USA, V96, P2919, DOI 10.1073/pnas.96.6.2919; McDermott DA, 2005, PEDIATR RES, V58, P981, DOI 10.1203/01.PDR.0000182593.95441.64; Takeuchi JK, 1999, NATURE, V398, P810; Borozdin Wiktor, 2006, Hum Mutat, V27, P975, DOI 10.1002/humu.9449; Bouman A, 2013, EUR J MED GENET, V56, P463, DOI 10.1016/j.ejmg.2013.06.012; Debeer P, 2007, CLIN ORTHOP RELAT R, P20, DOI 10.1097/BLO.0b013e3181123ffe; Fan C, 2003, J BIOL CHEM, V278, P8780, DOI 10.1074/jbc.M208120200; Hatcher CJ, 2001, DEV BIOL, V230, P177, DOI 10.1006/dbio.2000.0134; Marques Bonet T, 2009, TRENDS GENET, V10, P443; Patel C, 2012, EUR J HUM GENET, V20, P863, DOI 10.1038/ejhg.2012.16	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0172-0643	1432-1971		PEDIATR CARDIOL	Pediatr. Cardiol.	JAN	2015	36	1					244	247		10.1007/s00246-014-1028-x		4	Cardiac & Cardiovascular Systems; Pediatrics	Cardiovascular System & Cardiology; Pediatrics	AY2GK	WOS:000347406700036		
J	Nakamura, H; Koga, H; Okazaki, T; Urao, M; Miyano, G; Okawada, M; Doi, T; Watayo, H; Ogasawara, Y; Lane, GJ; Yamataka, A				Nakamura, Hiroki; Koga, Hiroyuki; Okazaki, Tadaharu; Urao, Masahiko; Miyano, Go; Okawada, Manabu; Doi, Takashi; Watayo, Hiroko; Ogasawara, Yuki; Lane, Geoffrey J.; Yamataka, Atsuyuki			Does pneumoperitoneum adversely affect growth, development and liver function in biliary atresia patients after laparoscopic portoenterostomy?	PEDIATRIC SURGERY INTERNATIONAL			English	Article						Biliary atresia; Development; Growth; Liver function; Pneumoperitoneum; Laparoscopic portoenterostomy	CARBON-DIOXIDE PNEUMOPERITONEUM; KASAI PORTOENTEROSTOMY; CHOLEDOCHAL CYST; HEPATIC-FUNCTION; BLOOD-FLOW; RAT MODEL; CHOLECYSTECTOMY; SURGERY; EXPERIENCE; APOPTOSIS	We assessed the effect of high partial pressure of arterial carbon dioxide (PaCO2) due to pneumoperitoneum (PP) on growth (height/weight) and development (gross/fine motor function, receptive/expressive communication, and social interaction), by comparing outcome after portoenterostomy (PE) for biliary atresia (BA) using laparoscopic PE (LPE: n = 13) and open PE (OPE: n = 13) cases performed between 2005 and 2014. Our PE is based on Kasai's original PE. All data were collated prospectively. Differences in duration of follow-up (LPE: 38.8 months; OPE: 38.1 months), jaundice clearance (LPE: 12/13 = 92.3 %; OPE: 9/13 = 69.2 %), survival with the native liver (LPE: 10/13 = 76.9 %; OPE: 9/13 = 69.2 %), incidence of cholangitis, hypersplenism, and incidence of esophageal varices were not significant. Mean intraoperative PaCO2 was significantly higher in LPE (LPE: 50.1 mmHg; OPE: 40.7 mmHg, p < 0.05). Liver function impairment was not statistically different, although LPE results were slightly worse. There was no overall delay in growth observed, although height/weight gain was more consistent in LPE. The pattern of developmental delay observed was similar for LPE and OPE suggesting that developmental delay is not PE-related; in other words, PP is not implicated in developmental delay. PP during LPE would appear to have no adverse effects on overall growth/development and liver function in BA patients.	[Nakamura, Hiroki; Koga, Hiroyuki; Miyano, Go; Okawada, Manabu; Doi, Takashi; Lane, Geoffrey J.; Yamataka, Atsuyuki] Juntendo Univ, Dept Pediat Gen & Urogenital Surg, Sch Med, Bunkyo Ku, Tokyo 1138421, Japan; [Okazaki, Tadaharu; Ogasawara, Yuki] Juntendo Univ, Dept Pediat Surg, Urayasu Hosp, Chiba, Japan; [Urao, Masahiko; Watayo, Hiroko] Juntendo Univ, Dept Pediat Surg, Nerima Hosp, Tokyo, Japan	Yamataka, A (reprint author), Juntendo Univ, Dept Pediat Gen & Urogenital Surg, Sch Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	yama@juntendo.ac.jp					Esteves E, 2002, PEDIATR SURG INT, V18, P737, DOI 10.1007/s00383-002-0791-6; Guven HE, 2007, J GASTROINTEST LIVER, V16, P391; Jaeschke H, 2003, GASTROENTEROLOGY, V125, P1246, DOI 10.1053/S0016-5085(03)01209-5; Koivusalo AM, 1997, ANESTH ANALG, V85, P886, DOI 10.1097/00000539-199710000-00032; Saber AA, 2000, AM SURGEON, V66, P699; Tan M, 2003, WORLD J GASTROENTERO, V9, P364; Koga H, 2011, J LAPAROENDOSC ADV S, V21, P291, DOI 10.1089/lap.2010.0162; Galizia G, 2001, SURG ENDOSC-ULTRAS, V15, P477, DOI 10.1007/s004640000343; Chan KWE, 2014, PEDIATR SURG INT, V30, P605, DOI 10.1007/s00383-014-3499-5; Laje P, 2010, J PEDIATR SURG, V45, P1791, DOI 10.1016/j.jpedsurg.2010.02.117; Richter S, 2001, ANESTH ANALG, V93, P872, DOI 10.1097/00000539-200110000-00014; Davenport M, 2012, SEMIN PEDIATR SURG, V21, P175, DOI 10.1053/j.sempedsurg.2012.05.010; Lee HM, 2004, J PEDIATR SURG, V39, P804, DOI 10.1016/j.jpedsurg.2004.02.018; Aspelund G, 2007, J PEDIATR SURG, V42, P869, DOI 10.1016/j.jpedsurg.2006.12.052; Bickel A, 2007, ANN SURG, V246, P31, DOI 10.1097/01.sla.0000262784.44278.b5; Chan KWE, 2011, PEDIATR SURG INT, V27, P671, DOI 10.1007/s00383-011-2859-7; Jesch NK, 2005, SURG ENDOSC, V19, P804, DOI 10.1007/s00464-004-2189-0; Kasai M, 1974, Prog Pediatr Surg, V6, P5; KIRSCH AJ, 1994, UROLOGY, V43, P453, DOI 10.1016/0090-4295(94)90230-5; Kuebler JF, 2007, J PEDIATR SURG, V42, P244, DOI 10.1016/j.jpedsurg.2006.09.023; Martinez-Ferro Marcelo, 2005, Semin Pediatr Surg, V14, P206, DOI 10.1053/j.sempedsurg.2005.06.003; Mogilner JG, 2008, EUR J PEDIATR SURG, V18, P380, DOI 10.1055/s-2008-1038920; Morino M, 1998, SURG ENDOSC-ULTRAS, V12, P968, DOI 10.1007/s004649900758; Nakamura H, 2012, PEDIATR SURG INT, V28, P205, DOI 10.1007/s00383-011-3019-9; Nakamura Y., 2010, JMAJ, V53, P259; Nguyen NT, 2003, AM J SURG, V186, P40, DOI 10.1016/S0002-9610(03)00106-5; Sahin DA, 2007, J LAP SURG TECH, V17, P726; Sefr R, 2003, SURG ENDOSC, V17, P947, DOI 10.1007/s00464-002-9046-9; Shimotakahara A, 2008, SURG ENDOSC, V22, P1813, DOI 10.1007/s00464-007-9703-0; Ure BM, 2011, ANN SURG, V253, P826, DOI 10.1097/SLA.0b013e318211d7d8; Ure Benno M, 2007, Semin Pediatr Surg, V16, P217, DOI 10.1053/j.sempedsurg.2007.06.002; Wada M, 2014, PEDIATR SURG INT, V30, P863, DOI 10.1007/s00383-014-3551-5; Yamataka A, 2012, SEMIN PEDIATR SURG, V21, P201, DOI 10.1053/j.sempedsurg.2012.05.011	33	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-0358	1437-9813		PEDIATR SURG INT	Pediatr. Surg. Int.	JAN	2015	31	1					45	51		10.1007/s00383-014-3625-4		7	Pediatrics; Surgery	Pediatrics; Surgery	AY0MW	WOS:000347291400006		
J	Murakami, H; Yazaki, Y; Seo, S; Ochi, T; Okawada, M; Doi, T; Miyano, G; Koga, H; Lane, GJ; Ochiai, T; Yamataka, A				Murakami, Hiroshi; Yazaki, Yuta; Seo, Shogo; Ochi, Takanori; Okawada, Manabu; Doi, Takashi; Miyano, Go; Koga, Hiroyuki; Lane, Geoffrey J.; Ochiai, Takumi; Yamataka, Atsuyuki			A single surgeon's experience of 65 cases of penoplasty for congenital megaprepuce, with special reference to mid- to long-term follow-up	PEDIATRIC SURGERY INTERNATIONAL			English	Article						Congenital megaprepuce; Buried penis; Penoplasty; Penile cosmesis; Mid- to long-term follow-up	BURIED PENIS	There are few reports about postoperative outcome of penoplasty (PP). We present the results of mid- to long-term follow-up of PP performed for congenital megaprepuce (CMP). Data from 65 CMP cases treated by PP performed by a single surgeon from 2000 to 2014 were collected prospectively. All cases were treated using the technique reported by Cuckow (Pediatric surgery. Springer, Berlin, pp 543-554, 2006). Mean age at PP was 5.9 years (range 0.4-13.9). All cases presented as infants and some 12 cases (18.5 %) had PP when 10 or more years old. There were no intra- and postoperative complications. Mean duration of follow-up was 3.6 years (range 0.1-17.5). Duration of follow-up was 4 years or less in 48 (73.8 %), 5-9 years in 13 (20.0 %), and 10 or more years in 4 (6.2 %). While postoperative penile cosmesis was good in 63/65 (96.9 %) cases without scrotal deformity, 2/65 (3.1 %) had redundant penile skin excised upon the recommendation of the treating surgeon even though the patients and parents were unconcerned. Mid- to long-term follow-up of our PP cases shows that outcome is cosmetically acceptable and stable.	[Murakami, Hiroshi; Seo, Shogo; Ochi, Takanori; Okawada, Manabu; Doi, Takashi; Miyano, Go; Koga, Hiroyuki; Lane, Geoffrey J.; Yamataka, Atsuyuki] Juntendo Univ, Dept Pediat Gen & Urogenital Surg, Sch Med, Bunkyo Ku, Tokyo 1138421, Japan; [Yazaki, Yuta; Seo, Shogo; Ochi, Takanori; Ochiai, Takumi] Tokyo Metropolitan Hlth & Med Treatment Corp, Tobu Chiiki Hosp, Dept Surg, Tokyo, Japan	Yamataka, A (reprint author), Juntendo Univ, Dept Pediat Gen & Urogenital Surg, Sch Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	yama@juntendo.ac.jp					Chuang JH, 2001, J PEDIATR SURG, V36, P426, DOI 10.1053/jpsu.2001.21606; Cromie WJ, 1998, J UROLOGY, V160, P1482, DOI 10.1016/S0022-5347(01)62597-7; Alexander A, 2010, J PEDIATR SURG, V45, P1741, DOI 10.1016/j.jpedsurg.2010.03.033; Cuckow P, 2006, PEDIAT SURG, P543, DOI 10.1007/3-540-30258-1_52; Elder JS, 2007, CAMPBELLWALSH UROLOG, P3745; Keyes EL, 1919, PHIMOSIS PARAPHIMOSI, P649; King ICC, 2013, ISRN UROL, P1; Rod J, 2013, J PEDIATR UROL, V9, P784, DOI 10.1016/j.jpurol.2012.10.010; Sadler TW, 1990, LANGMANS MED EMBRYOL, P283; Smeulders N, 2000, BJU INT, V86, P523, DOI 10.1046/j.1464-410X.2000.00752.x	10	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-0358	1437-9813		PEDIATR SURG INT	Pediatr. Surg. Int.	JAN	2015	31	1					89	92		10.1007/s00383-014-3627-2		4	Pediatrics; Surgery	Pediatrics; Surgery	AY0MW	WOS:000347291400012		
J	Manabe, H; Fukumoto, M; Yagi, T				Manabe, Hiroyuki; Fukumoto, Masaaki; Yagi, Tohru			Conductive rubber electrodes for earphone-based eye gesture input interface	PERSONAL AND UBIQUITOUS COMPUTING			English	Article						EOG; Electrode; Conductive rubber; Earphone; Eye gesture; Motion artifact	DRY	An eartip made of conductive rubber that also realizes biopotential electrodes is proposed for a daily-use earphone-based eye gesture input interface. Several prototypes, each with three electrodes to capture electrooculogram (EOG), are implemented on earphones and examined. Experiments with one subject over a 10-day period reveal that all prototypes capture EOG similarly but they differ as regards stability of the baseline and the presence of motion artifacts. Another experiment conducted on a simple eye-controlled application with six subjects shows that the proposed prototype minimizes motion artifacts and offers good performance. Artifacts induced by daily motion while wearing the proposed electrode and eye gesture performance are also measured, and we discuss how to deal with them. We conclude that conductive rubber with mixed Ag filler is the most suitable setup in our experiment.	[Manabe, Hiroyuki; Fukumoto, Masaaki] NTT DOCOMO, Res Labs, Yokosuka, Kanagawa, Japan; [Manabe, Hiroyuki; Yagi, Tohru] Tokyo Inst Technol, Tokyo 152, Japan	Manabe, H (reprint author), NTT DOCOMO, Res Labs, 3-6 Hikarino Oka, Yokosuka, Kanagawa, Japan.	manabehiroyuki@acm.org; fukumoto@acm.org; tyagi@mei.titech.ac.jp	Yagi, Tohru/I-1545-2015				Searle A, 2000, PHYSIOL MEAS, V21, P271, DOI 10.1088/0967-3334/21/2/307; Poh MZ, 2009, IEEE INT SYM WRBL CO, P153, DOI 10.1109/ISWC.2009.35; Amft O, 2005, LECT NOTES COMPUT SC, V3660, P56; Ryu CY, 2005, P ANN INT IEEE EMBS, P3479; Drewes H, 2007, LECT NOTES COMPUT SC, V4663, P475; Peltokangas M, 2012, IEEE T INF TECHNOL B, V16, P935, DOI 10.1109/TITB.2012.2208982; Brewster S., 2003, P SIGCHI C HUM FACT, P473; Buil V, 2005, P 7 INT C HUM COMP I, P377, DOI 10.1145/1085777.1085877; Bulling A, 2009, CHI 09, P3259; Gargiulo G, 2008, 2008 IEEE BIOMEDICAL CIRCUITS AND SYSTEMS CONFERENCE - INTELLIGENT BIOMEDICAL SYSTEMS (BIOCAS), P273, DOI 10.1109/BIOCAS.2008.4696927; Ishiguro Y, 2010, P AUGM HUM 10; JENKNER FL, 1967, ELECTROEN CLIN NEURO, V23, P570, DOI 10.1016/0013-4694(67)90026-0; Manabe H, 2011, P UIST11, P309; Manabe H., 2006, CHI 06 HUM FACT COMP, P1073, DOI 10.1145/1125451.1125655; Manabe H, 2011, IPSJ, V52, P1515; Manabe H., 2013, P ISWC 13, P33; Mardanbegi D, 2012, P ETRA 12, P139; Matsumura K, 2012, P IUI 12, P305; McAdams E, 2011, INTEGR CIRCUIT SYST, P31, DOI 10.1007/978-1-4419-6597-4_3; Muhlsteff J, 2004, P ANN INT IEEE EMBS, V26, P2212; Ottenbacher J, 2004, P ISWC 04, V1, P186; Pun K. H., 2004, Proceedings. Sixth IEEE International Conference on Automatic Face and Gesture Recognition; Rouck A, 1981, INT OPHTHALMOL, V3, P179, DOI 10.1007/BF00130702; Sano A, 2010, CORRES HUM INTERFACE, V12, P1; Sparks K, 2006, MED SCI SPORTS EXERC, V38, pS5; Taniguchi K, 2010, P INT 10 2010; Triki M., 2007, P IEEE PIMRC SEP, P1; Vehkaoja AT, 2005, P ANN INT IEEE EMBS, P5865, DOI 10.1109/IEMBS.2005.1615824	28	0	0	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	1617-4909	1617-4917		PERS UBIQUIT COMPUT	Pers. Ubiquitous Comput.	JAN	2015	19	1			SI		143	154		10.1007/s00779-014-0818-8		12	Computer Science, Information Systems; Telecommunications	Computer Science; Telecommunications	AY0NH	WOS:000347292500014		
J	Kim, S; Takahashi, S; Tanaka, J				Kim, Seokhwan; Takahashi, Shin; Tanaka, Jiro			A location-sensitive visual interface on the palm: interacting with common objects in an augmented space	PERSONAL AND UBIQUITOUS COMPUTING			English	Article						Location awareness; Interface on body; Augmented reality; Ubiquitous; System; Interaction		We have created a visual interface using the human palm that is location sensitive and always available. To accomplish this, we constructed an augmented space in an actual workspace by installing several depth cameras. To manage and connect the multiple depth cameras, we constructed a distributed system based on scalable client--server architecture. By merging depth images from different cameras, the distributed system can track the locations of users within their area of coverage. The system also has a convenient feature that allows users to collect the locations of objects while visualizing the objects via images from the depth cameras. Consequently, the locations of both users and objects are available to the system, thus providing a location-based context for determining which user is close to which object. As a result, the visual interface on the palm becomes location sensitive, which could lead to various applications in daily life. In this paper, we describe the implementation of the aforementioned system and demonstrate its potential applicability.	[Kim, Seokhwan; Takahashi, Shin; Tanaka, Jiro] Univ Tsukuba, Dept Comp Sci, Tsukuba, Ibaraki 3050006, Japan	Kim, S (reprint author), Univ Tsukuba, Dept Comp Sci, Tsukuba, Ibaraki 3050006, Japan.	skim@iplab.cs.tsukuba.ac.jp; shin@cs.tsukuba.ac.jp; jiro@cs.tsukuba.ac.jp					Harrison C, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P453; Liu H, 2007, IEEE T SYST MAN CY C, V37, P1067, DOI 10.1109/TSMCC.2007.905750; Helal S, 2005, COMPUTER, V38, P50, DOI 10.1109/MC.2005.107; [Anonymous], 2007, P 20 ANN ACM S US IN, DOI 10.1145/1294211.1294238; Sinha SN, 2011, MACH VISION APPL, V22, P207, DOI 10.1007/s00138-007-0105-z; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Brumitt B, 2000, LECT NOTES COMPUT SC, V1927, P12; Du H., 2011, P 13 INT C UB COMP A, P75; Erdem CE, 2010, P 3 INT WORKSH AFF I, P9, DOI 10.1145/1877826.1877831; Fukushima N, 2010, INTERFERENCE IR LIGH; Gustafson S., 2010, P 23 ANN ACM S US IN, P3, DOI 10.1145/1866029.1866033; Harrison C., 2011, P 24 ANN ACM S US IN, P441, DOI DOI 10.1145/2047196.2047255; Kim S, 2012, T HUM INTERFACE SOC, V14, P445; Kim S, 2010, P 2010 IEEE ACIS 9 I, P819; Le JC, 2008, P 21 ANN ACM S US IN, P287; Lee C, 2003, IEEE PERVAS COMPUT, V2, P89; Lee J, 2006, LECT NOTES ARTIF INT, V4088, P502; Marquardt N., 2011, P 24 ANN ACM S US IN, P315; Patel SN, 2006, LECT NOTES COMPUT SC, V3968, P272; Pinhanez C., 2001, LNCS, V2201, P315; Rekimoto J., 1997, Proceedings of the ACM Symposium on User Interface Software and Technology. 10th Annual Symposium. UIST '97, DOI 10.1145/263407.263505; SHIN C, 2009, UB VIRT REAL 2009 IS, P21; Wilson A.D., 2010, P 23 ANN ACM S US IN, P273, DOI DOI 10.1145/1866029.1866073	23	0	0	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	1617-4909	1617-4917		PERS UBIQUIT COMPUT	Pers. Ubiquitous Comput.	JAN	2015	19	1			SI		175	187		10.1007/s00779-014-0769-0		13	Computer Science, Information Systems; Telecommunications	Computer Science; Telecommunications	AY0NH	WOS:000347292500016		
J	Shakushiro, K; Kawano, H; Nakata, M; Kita, A; Maeda, A; Watanabe, S; Sako, K; Oku, N				Shakushiro, Kohsuke; Kawano, Hiroki; Nakata, Mari; Kita, Aya; Maeda, Atsushi; Watanabe, Shunsuke; Sako, Kazuhiro; Oku, Naoto			Formulation Design and Evaluation of Liposomal Sepantronium Bromide (YM155), a Small-Molecule Survivin Suppressant, Based on Pharmacokinetic Modeling and Simulation	PHARMACEUTICAL RESEARCH			English	Article						Drug release; Liposome; Modeling; Simulation; Sepantroniumbromide (YM155)	LONG-CIRCULATING LIPOSOMES; LARGE UNILAMELLAR VESICLES; DRUG-RELEASE; THERAPEUTIC ACTIVITY; SOLID TUMORS; CANCER; BIODISTRIBUTION; DOXORUBICIN; RATES; CHEMOTHERAPY	Sepantronium bromide (YM155) is administered by 168-hour continuous infusions in clinical studies due to its time-dependent pharmacological efficacy and rapid elimination from plasma. To enable more convenient administration, i.e., bolus injections with low frequency, we prepared liposomal formulations of YM155 and evaluated their antitumor activities. A kinetic simulation model of liposomal YM155 to predict the free drug concentration in both tumor and plasma was developed. A liposomal formulation with the target drug release rate was prepared based on the simulation. Antitumor activities of the formulation were examined in various tumor xenograft mouse models. In addition, antitumor activities of liposomal formulations with different drug release rates were compared in order to confirm the validity of the simulation-based prediction. Liposomal YM155 with the release half-life of 48 h was prepared as a promising formulation. This formulation showed significantly potent antitumor activities in tumor xenograft models by weekly bolus injections. Further studies demonstrated that this release rate was optimal for YM155 in terms of both efficacy and safety. We successfully developed a liposomal formulation of YM155 that could substitute for long-term continuous infusion of the drug solution in clinical settings by being given as weekly bolus injections.	[Shakushiro, Kohsuke; Kawano, Hiroki; Maeda, Atsushi; Watanabe, Shunsuke; Sako, Kazuhiro] Technol Astellas Pharma Inc, Pharmaceut Res & Technol Labs, Yaizu, Shizuoka 4250072, Japan; [Nakata, Mari; Kita, Aya] Astellas Pharma Inc, Drug Discovery Res, Tsukuba, Ibaraki 3058585, Japan; [Oku, Naoto] Univ Shizuoka, Sch Pharmaceut Sci, Dept Med Biochem, Shizuoka 4228526, Japan	Shakushiro, K (reprint author), Technol Astellas Pharma Inc, Pharmaceut Res & Technol Labs, 180 Ozumi, Yaizu, Shizuoka 4250072, Japan.	kohsuke.shakushiro@astellas.com					Allen Theresa M., 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P513, DOI 10.2174/187152006778699121; Gabizon AA, 2001, CANCER INVEST, V19, P424, DOI 10.1081/CNV-100103136; Harrington KJ, 2001, CLIN CANCER RES, V7, P243; Johnston MJW, 2006, BBA-BIOMEMBRANES, V1758, P55, DOI 10.1016/j.bbamem.2006.01.009; GABIZON AA, 1995, ADV DRUG DELIVER REV, V16, P285, DOI 10.1016/0169-409X(95)00030-B; Tolcher AW, 2012, ANN ONCOL, V23, P968, DOI 10.1093/annonc/mdr353; Qian S, 2012, CURR DRUG METAB, V13, P372; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; WEBB MS, 1995, BRIT J CANCER, V72, P896, DOI 10.1038/bjc.1995.430; Charrois GJR, 2004, BBA-BIOMEMBRANES, V1663, P167, DOI 10.1016/j.bbamem.2004.03.006; Nishikawa M, 1996, ADV DRUG DELIVER REV, V21, P135, DOI 10.1016/S0169-409X(96)00403-6; Takeuchi H, 2000, J CONTROL RELEASE, V68, P195, DOI 10.1016/S0168-3659(00)00260-1; HARAN G, 1993, BIOCHIM BIOPHYS ACTA, V1151, P201, DOI 10.1016/0005-2736(93)90105-9; Nakahara T, 2007, CANCER RES, V67, P8014, DOI 10.1158/0008-5472.CAN-07-1343; Tolcher AW, 2008, J CLIN ONCOL, V26, P5198, DOI 10.1200/JCO.2008.17.2064; Vail DM, 2004, SEMIN ONCOL, V31, P16, DOI 10.1053/j.seminoncol.2004.08.002; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; Gabizon A, 1997, ADV DRUG DELIVER REV, V24, P337, DOI 10.1016/S0169-409X(96)00476-0; Drummond DC, 2008, J PHARM SCI-US, V97, P4696, DOI 10.1002/jps.21358; BANGHAM AD, 1965, J MOL BIOL, V13, P238; Nakahara T, 2011, CANCER SCI, V102, P614, DOI 10.1111/j.1349-7006.2010.01834.x; Emerson DL, 2000, CLIN CANCER RES, V6, P2903; SESSA G, 1968, J LIPID RES, V9, P310; Cullis PR, 1997, BBA-REV BIOMEMBRANES, V1331, P187, DOI 10.1016/S0304-4157(97)00006-3; DALEKE DL, 1990, BIOCHIM BIOPHYS ACTA, V1024, P352, DOI 10.1016/0005-2736(90)90365-U; Lee CC, 2005, NAT BIOTECHNOL, V23, P1517, DOI 10.1038/nbt1171; Lim HJ, 2000, J PHARMACOL EXP THER, V292, P337; Minematsu T, 2012, BIOPHARM DRUG DISPOS, V33, P160, DOI 10.1002/bdd.1781; Minematsu T, 2008, BIOMED CHROMATOGR, V22, P763, DOI 10.1002/bmc.996; Mukthavaram R, 2013, INT J NANOMED, V8, P3991, DOI 10.2147/IJN.S51949; Murakami Y, 2013, NUCL MED BIOL, V40, P221, DOI 10.1016/j.nucmedbio.2012.10.002; Nakahara T, 2011, ANTI-CANCER DRUG, V22, P454, DOI 10.1097/CAD.0b013e328344ac68; QI XR, 1995, PHARMACEUT RES, V12, P49, DOI 10.1023/A:1016230518884; Takada A, 2009, INT J PHARMACEUT, V377, P52, DOI 10.1016/j.ijpharm.2009.04.039; Yang YH, 2012, EUR J PHARM BIOPHARM, V80, P332, DOI 10.1016/j.ejpb.2011.10.013	35	1	1	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0724-8741	1573-904X		PHARM RES-DORDR	Pharm. Res.	JAN	2015	32	1					238	247		10.1007/s11095-014-1458-4		10	Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Chemistry; Pharmacology & Pharmacy	AY2HF	WOS:000347408800017		
J	Nakamura, K; Denda, T; Kokubugata, G; Huang, CJ; Peng, CI; Yokota, M				Nakamura, Koh; Denda, Tetsuo; Kokubugata, Goro; Huang, Chiun-Jr; Peng, Ching-I; Yokota, Masatsugu			Phylogeny and biogeography of the Viola iwagawae-tashiroi species complex (Violaceae, section Plagiostigma) endemic to the Ryukyu Archipelago, Japan	PLANT SYSTEMATICS AND EVOLUTION			English	Article						Biogeography; Continental islands; cpDNA; ITS; Landbridge; Vicariance-dispersal	EAST-ASIAN ISLANDS; CHLOROPLAST DNA; MOLECULAR PHYLOGENY; GENETIC-VARIATION; SEQUENCES; INFERENCE; REPTILIA; SQUAMATA; ORIGIN; DIFFERENTIATION	In continental island biogeography, geologically age-old straits have been considered to be the most likely barriers in determining geographical patterns of speciation/genetic differentiation among islands. Straits with similar ages may have had different influences if geographical width across the straits had fluctuated differently in the past. However, this issue has seldom been discussed. We explored it by studying the Viola iwagawaetashiroi species complex in the Ryukyu Archipelago, Japan. The archipelago is divided into three island groups, the northern, central, and southern Ryukyus, by two old straits called the Tokara and Kerama gaps, which are roughly of the same age. Bayesian and maximum parsimony phylogenetic analyses of section Plagiostigma and Bayesian molecular dating using multiple calibration points were conducted based on nuclear ribosomal DNA internal transcribed spacer (ITS) sequences. To reveal the detailed genealogy of the species complex, statistical parsimony networks were estimated separately for the ITS and chloroplast DNA (cpDNA) sequences and a calibrated multispecies coalescent tree based on both ITS and cpDNA sequences was constructed. Results suggest that the V. iwagawae-tashiroi species complex originated in the Ryukyu Archipelago when this region formed part of the East Asian continental margin or was formed by a few larger islands and that the complex was already distributed across the archipelago by the late Pliocene-early Pleistocene. Divergence time estimations suggest that the Kerama Gap has been a long-term effective barrier to dispersal preventing gene flow across it, whereas recent dispersal over the Tokara Gap was inferred. These contrasting results are likely explained by the fact that the minimum geographical width across the straits is geohistorically and currently greater over the Kerama Gap than at the Tokara Gap.	[Nakamura, Koh; Huang, Chiun-Jr; Peng, Ching-I] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Denda, Tetsuo; Yokota, Masatsugu] Univ Ryukyus, Fac Sci, Lab Ecol & Systemat, Nishihara, Okinawa 9030213, Japan; [Kokubugata, Goro] Natl Museum Nat & Sci, Dept Bot, Tsukuba, Ibaraki 3050005, Japan	Nakamura, K (reprint author), Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan.	kohnakamur@gmail.com; bopeng@sinica.edu.tw			Academia Sinica	We thank Mihoko Murakami for providing DNA samples. The associate editor Isabel Sanmartin and three reviewers provided constructive criticism of the manuscript. This study was supported in part by a postdoctoral fellowship from Academia Sinica to K. N. and a research grant from Academia Sinica to C.-I P.	Akiyama S, 1999, FLORA JAPAN IIC, P161; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; MUSE SV, 1992, GENETICS, V132, P269; Maekawa K, 1999, MOL PHYLOGENET EVOL, V13, P360, DOI 10.1006/mpev.1999.0647; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Zhai SN, 2012, J BIOGEOGR, V39, P1347, DOI 10.1111/j.1365-2699.2012.02685.x; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; Heled J, 2012, SYST BIOL, V61, P138, DOI 10.1093/sysbio/syr087; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Simmons MP, 2000, SYST BIOL, V49, P369; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; CORRIVEAU JL, 1988, AM J BOT, V75, P1443, DOI 10.2307/2444695; Watanabe K, 2006, AM J BOT, V93, P442, DOI 10.3732/ajb.93.3.442; Bittkau C, 2005, MOL ECOL, V14, P4065, DOI 10.1111/j.1365-294X.2005.02725.x; Nakamura K, 2009, J BIOGEOGR, V36, P919, DOI 10.1111/j.1365-2699.2008.02057.x; [Anonymous], 2013, KOREAN PLANT NAMES I; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Hiramatsu M, 2001, AM J BOT, V88, P1230, DOI 10.2307/3558334; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103; Marcussen T, 2012, SYST BIOL, V61, P107, DOI 10.1093/sysbio/syr096; Poulakakis N, 2003, MOL PHYLOGENET EVOL, V28, P38, DOI 10.1016/S1055-7903(03)00037-X; Ota H, 1998, RES POPUL ECOL, V40, P189, DOI 10.1007/BF02763404; Atkins H, 2001, BIOL J LINN SOC, V72, P143, DOI 10.1111/j.1095-8312.2001.tb01306.x; Ballard HE, 1999, SYST BOT, V23, P439; Ballard HE, 2000, EVOLUTION, V54, P1521, DOI 10.1111/j.0014-3820.2000.tb00698.x; Chen Y.S., 2007, FLORA CHINA, V13, P74; Doyle J. L. ., 1987, PHYTOCHEMISTRY B, V19, P11; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Fujiki T, 2008, QUATERN INT, V184, P75, DOI 10.1016/j.quaint.2007.09.009; Hall T. A., 1999, NUCL ACIDS S SER, V4, P95, DOI DOI 10.1111/J.1469-8137.2009.02874.X; Hama E, 1975, GENSHOKU NIHON NO SU; Hisheh S, 1998, BIOL J LINN SOC, V65, P329; Igari M, 2005, WILD VIOLETS JAPAN; KATO J, 1994, BIOCHEM SYST ECOL, V22, P491, DOI 10.1016/0305-1978(94)90043-4; Kato Y, 2004, SYST ENTOMOL, V29, P1, DOI 10.1111/j.1365-3113.2004.00238.x; Kawana T, 2002, FORMATION RYUKYU ARC, P59; Kimura M, 2002, FORMATION RYUKYU ARC, P19; Kimura M, 2002, FORMATION RYUKYU ARC; Koba Motoharu, 1992, Quaternary Research (Tokyo), V31, P359; Kuroda T, 2002, FORMATION RYUKYU ARC, P85; Liang Guan-Xin, 2010, Acta Botanica Yunnanica, V32, P477, DOI 10.3724/SP.J.1143.2010.10122; Maekawa F, 1974, FLORA VEGETATION JAP, P33; Marcussen T, 2011, AM J BOT, V98, P1978, DOI 10.3732/ajb.1100208; Marcussen T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-45; Merrill E.D., 1923, ENUMERATION PHILIPPI, V3; Mitsui Y, 2012, PLANT SYST EVOL, V298, P985, DOI 10.1007/s00606-012-0608-6; Motokawa J, 2003, ZOOL SCI, V20, P97, DOI 10.2108/zsj.20.97; Nakamura K, 2010, J BIOGEOGR, V37, P1907, DOI 10.1111/j.1365-2699.2010.02342.x; Ohdachi S, 2001, MOL ECOL, V10, P2199, DOI 10.1046/j.1365-294X.2001.01359.x; Osozawa S, 2011, INT GEOL REV, V54, P1369; Otsuka H, 2000, TROPICS, V10; Qin G, 2010, J TROP SUBTROP BOT, V6, P633; Seo Akihiro, 2001, Acta Phytotaxonomica et Geobotanica, V52, P135; Seo Akihiro, 2004, APG Acta Phytotaxonomica et Geobotanica, V55, P29; Swofford D. L., 2002, PAUP PHYLOGENETIC AN; Toda M, 1997, ZOOL SCI, V14, P859; Walker EH, 1976, FLORA OKINAWA SO RYU; Wang C. R., 1991, FLORA REIPUBLICAE PO, V51; WANG J-C, 1990, Taiwania, V35, P12; Wang JC, 1993, FLORA TAIWAN, V3, P807; White TJ, 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Yokota M, 2006, THREATENED WILDLIFE, P119; Yoo KO, 2010, J SYST EVOL, V48, P474, DOI 10.1111/j.1759-6831.2010.00102.x; Yoo Kioug, 2005, [Korean Journal of plant Taxonomy, 식물분류학회지], V35, P7; Yoshioka H, 1981, SHINKAKI, V112, P64	69	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0378-2697	1615-6110		PLANT SYST EVOL	Plant Syst. Evol.	JAN	2015	301	1					337	351		10.1007/s00606-014-1076-y		15	Plant Sciences; Evolutionary Biology	Plant Sciences; Evolutionary Biology	AY0NS	WOS:000347293700026		
J	Takata, N; Taniguchi, T				Takata, Naoki; Taniguchi, Toru			Expression divergence of cellulose synthase (CesA) genes after a recent whole genome duplication event in Populus	PLANTA			English	Article						Cellulose synthase; Functional divergence; Gene duplication; Secondary cell wall; Whole genome duplication	VASCULAR-RELATED NAC-DOMAIN6; SECONDARY WALL BIOSYNTHESIS; TRANSCRIPTION FACTORS; XYLEM DIFFERENTIATION; ARABIDOPSIS-THALIANA; REGULATORY ELEMENTS; WOOD FORMATION; POPLAR; TRICHOCARPA; EVOLUTION	Secondary cell wall-associated CesA genes in Populus have undergone a functional differentiation in expression pattern that may be attributable to evolutionary alteration of regulatory modules. Gene duplication is an important mechanism for functional divergence of genes. Secondary cell wall-associated cellulose synthase genes (CesA4, CesA7 and CesA8) are duplicated in Populus plants due to a recent whole genome duplication event. Here, we demonstrate that duplicate CesA genes show tissue-dependent expression divergence in Populus plants. Real-time PCR analysis of Populus CesA genes suggested that Pt x tCesA8-B was more highly expressed than Pt x tCesA8-A in phloem and secondary xylem tissue of mature stem. Histochemical and histological analyses of transformants expressing a GFP-GUS fusion gene driven by Populus CesA promoters revealed that the duplicate CesA genes showed different expression patterns in phloem fibers, secondary xylem, root cap and leaf trichomes. We predicted putative cis-regulatory motifs that regulate expression of secondary cell wall-associated CesA genes, and identified 19 motifs that are highly conserved in the CesA gene family of eudicotyledonous plants. Furthermore, a transient transactivation assay identified candidate transcription factors that affect levels and patterns of expression of Populus CesA genes. The present study reveals that secondary cell wall-associated CesA genes in Populus have undergone a functional differentiation in expression pattern that may be attributable to evolutionary alteration of regulatory modules.	[Takata, Naoki; Taniguchi, Toru] Forestry & Forest Prod Res Inst, Forest Biores Ctr, Hitachi, Ibaraki 3191301, Japan; [Taniguchi, Toru] Forestry & Forest Prod Res Inst, Forest Tree Breeding Ctr, Hitachi, Ibaraki 3191301, Japan	Takata, N (reprint author), Forestry & Forest Prod Res Inst, Forest Biores Ctr, Hitachi, Ibaraki 3191301, Japan.	naokitakata@affrc.go.jp			Japan Society for the Promotion of Science [23880029]	We thank Prof. Masaaki Sakuta for a gift of pUC18-CaMV35S::LUC and pUC18-CaMV35S::RLUC constructs. We thank Dr. Misato Ohtani (Nara Institute of Science and Technology) for helpful advice on luciferase transient expression assays. We are grateful to Ms. Maki Konnai and Tomoko Okuyama in our laboratory for their technical assistance. This work was supported in part by a Grant-in-Aid for Young Scientists (Start-up) from the Japan Society for the Promotion of Science (23880029 to NT).	Suzuki S, 2006, PLANT PHYSIOL, V142, P1233, DOI 10.1104/pp.106.086678; Tzfira T, 2005, PLANT MOL BIOL, V57, P503, DOI 10.1007/s11103-005-0340-5; Kalluri UC, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-59; Tanaka K, 2003, PLANT PHYSIOL, V133, P73, DOI 10.1104/pp.103.022442; Bocock PN, 2008, PLANTA, V227, P565, DOI 10.1007/s00425-007-0639-3; Holland N, 2000, PLANT PHYSIOL, V123, P1313, DOI 10.1104/pp.123.4.1313; Taylor NG, 2003, P NATL ACAD SCI USA, V100, P1450, DOI 10.1073/pnas.0337628100; Hsu CY, 2011, P NATL ACAD SCI USA, V108, P10756, DOI 10.1073/pnas.1104713108; Zhong RQ, 2011, PLANT PHYSIOL, V157, P1452, DOI 10.1104/pp.111.181354; Zhong RQ, 2008, PLANT CELL, V20, P2763, DOI 10.1105/tpc.108.061325; Yamaguchi M, 2011, PLANT J, V66, P579, DOI [10.1111/j.1365-313X.2011.04514.x, 10.1111/j.1365-313x.2011.04514.x]; Eriksson ME, 2000, NAT BIOTECHNOL, V18, P784; Freeling M, 2006, GENOME RES, V16, P805, DOI 10.1101/gr.3681406; Mitsuda N, 2005, PLANT CELL, V17, P2993, DOI 10.1105/tpc.105.036004; Burton RA, 2004, PLANT PHYSIOL, V134, P224, DOI 10.1104/pp.103.032904; Yin YB, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-99; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Oakley RV, 2007, PLANT PHYSIOL, V145, P961, DOI 10.1104/pp.107.107086; Song DL, 2010, NEW PHYTOL, V187, P777, DOI 10.1111/j.1469-8137.2010.03315.x; Yamaguchi M, 2010, PLANT PHYSIOL, V153, P906, DOI 10.1104/pp.110.154013; Ohashi-Ito K, 2010, PLANT CELL, V22, P3461, DOI 10.1105/tpc.110.075036; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Wilkins O, 2009, PLANT PHYSIOL, V149, P981, DOI 10.1104/pp.108.132795; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Kim WC, 2012, PLANT MOL BIOL, V78, P489, DOI 10.1007/s11103-012-9880-7; Kumar M, 2009, TRENDS PLANT SCI, V14, P248, DOI 10.1016/j.tplants.2009.02.004; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275; Rodgers-Melnick E, 2012, GENOME RES, V22, P95, DOI 10.1101/gr.125146.111; Betancur L, 2010, J INTEGR PLANT BIOL, V52, P205, DOI 10.1111/j.1744-7909.2010.00934.x; Romero I, 1998, PLANT J, V14, P273; Gardiner JC, 2003, PLANT CELL, V15, P1740, DOI 10.1105/tpc.012815; JEFFERSON RA, 1987, EMBO J, V6, P3901; Force A, 1999, GENETICS, V151, P1531; Ohtani M, 2011, PLANT J, V67, P499, DOI 10.1111/j.1365-313X.2011.04614.x; Creux NM, 2008, NEW PHYTOL, V179, P722, DOI 10.1111/j.1469-8137.2008.02517.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Hao J, 2012, J EXP BOT, V63, P6267, DOI 10.1093/jxb/ers278; Creux NM, 2013, PLANTA, V237, P799, DOI 10.1007/s00425-012-1792-x; Dharmawardhana P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-150; Hanada K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000781; Handakumbura PP, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-131; Hussey SG, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00325; Jimenez-Delgado Senda, 2009, Briefings in Functional Genomics & Proteomics, V8, P266, DOI 10.1093/bfgp/elp029; Kim HJ, 2011, PLANT SCI, V180, P323, DOI 10.1016/j.plantsci.2010.10.003; Kim WC, 2012, PLANT J, V73, P26; Lee TH, 2012, NUCLEIC ACIDS RES, V41, pD1152, DOI DOI 10.1093/NAR/GKS1104; Nanjo T, 2004, PLANT CELL PHYSIOL, V45, P1738, DOI 10.1093/pcp/pci009; Ohta T, 2003, GENETICA, V118, P209, DOI 10.1023/A:1024130431575; Shimada S, 2007, J EXP BOT, V58, P957, DOI 10.1093/jxb/erl256; Takata N, 2009, NEW PHYTOL, V181, P808, DOI 10.1111/j.1469-8137.2008.02714.x; Wang S, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-138; Wu AM, 2009, PLANT CELL REP, V28, P1539, DOI 10.1007/s00299-009-0753-8; Xiao YL, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-18; Zhong RQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069219; Zou C, 2011, P NATL ACAD SCI USA, V108, P14992, DOI 10.1073/pnas.1103202108	56	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0032-0935	1432-2048		PLANTA	Planta	JAN	2015	241	1					29	42		10.1007/s00425-014-2217-9		14	Plant Sciences	Plant Sciences	AY0OM	WOS:000347295900002		
J	Seki, Y; Kikuchi, Y; Yoshimoto, R; Aburai, K; Kanai, Y; Ruike, T; Iwabata, K; Goitsuka, R; Sugawara, F; Abe, M; Sakaguchi, K				Seki, Yasutaka; Kikuchi, Yukiko; Yoshimoto, Ryo; Aburai, Kenichi; Kanai, Yoshihiro; Ruike, Tatsushi; Iwabata, Kazuki; Goitsuka, Ryo; Sugawara, Fumio; Abe, Masahiko; Sakaguchi, Kengo			Promotion of crystalline cellulose degradation by expansins from Oryza sativa	PLANTA			English	Article						Cellulase; HPLC; X-Ray diffraction; Pre-reacted experiment; Addition order experiment; Synergistic activity	WALL EXTENSION; FUEL ETHANOL; BIOMASS; PROTEIN; SACCHARIFICATION; DISRUPTION; PLANTS	Enzymatic activities of Oryza sativa expansins, which were heterologously overexpressed in Escherichia coli , were analyzed. Results suggested that expansins promote degradation of cellulose by cellulase in a synergistic manner. Sustainable production of future biofuels is dependent on efficient saccharification of lignocelluloses. Expansins have received a lot of attention as proteins promoting biological degradation of cellulose using cellulase. The expansins are a class of plant cell wall proteins that induce cell wall loosening without hydrolysis. In this study, the expansins from Oryza sativa were classified using phylogenetic analysis and five proteins were selected for functional evaluation. At low cellulose loading, the cellulase in expansin mixtures was up to 2.4 times more active than in mixtures containing only cellulase, but at high cellulose loading the activity of cellulase in expansin mixtures and cellulase only mixtures did not differ. Furthermore, expansin activity was greater in cellulase mixtures compared with cellulase-deficient mixtures. Therefore, the expansins showed significant synergistic activity with cellulase. Expansin may play an important role in efficient saccharification of cellulose.	[Seki, Yasutaka; Kanai, Yoshihiro; Ruike, Tatsushi; Iwabata, Kazuki; Sugawara, Fumio; Sakaguchi, Kengo] Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, Noda, Chiba 2788510, Japan; [Seki, Yasutaka; Goitsuka, Ryo] Tokyo Univ Sci, Inst Biomed Sci, Dept Res, Noda, Chiba 2788510, Japan; [Kikuchi, Yukiko; Yoshimoto, Ryo; Aburai, Kenichi; Abe, Masahiko] Tokyo Univ Sci, Dept Ind Chem, Noda, Chiba 2788510, Japan	Sakaguchi, K (reprint author), Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	j0312705@ed.tus.ac.jp; kengo@rs.noda.tus.ac.jp					Gilbert HJ, 2008, CURR OPIN PLANT BIOL, V11, P338, DOI 10.1016/j.pbi.2008.03.004; MIWA I, 1972, CLIN CHIM ACTA, V37, P538, DOI 10.1016/0009-8981(72)90483-4; Kim ES, 2009, BIOTECHNOL BIOENG, V102, P1342, DOI 10.1002/bit.22193; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Yan LF, 2008, CELLULOSE, V15, P789, DOI 10.1007/s10570-008-9233-5; Saloheimo M, 2002, EUR J BIOCHEM, V269, P4202, DOI 10.1046/j.1432-1033.2002.03095.x; MCQUEENMASON S, 1994, P NATL ACAD SCI USA, V91, P6574, DOI 10.1073/pnas.91.14.6574; Wang YG, 2011, APPL MICROBIOL BIOT, V91, P1353, DOI 10.1007/s00253-011-3421-1; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; MCQUEENMASON S, 1992, PLANT CELL, V4, P1425; Dashtban M, 2009, INT J BIOL SCI, V5, P578; Hattori K, 2004, POLYM J, V36, P123, DOI 10.1295/polymj.36.123; Cosgrove DJ, 1997, P NATL ACAD SCI USA, V94, P6559, DOI 10.1073/pnas.94.12.6559; Arantes V, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-4; Baker JO, 2000, APPL BIOCHEM BIOTECH, V84-6, P217, DOI 10.1385/ABAB:84-86:1-9:217; Chen XA, 2010, APPL ENVIRON MICROB, V76, P2556, DOI 10.1128/AEM.02499-09; Jager G, 2011, BIOTECHNOL BIOFUELS, V4, P33, DOI [10.1186/1754-6834-4-33, DOI 10.1186/1754-6834-4-33]; Lee HJ, 2010, MOL CELLS, V29, P379, DOI 10.1007/s10059-010-0033-z; Lin H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075022; LYND LR, 1991, SCIENCE, V251, P1318, DOI 10.1126/science.251.4999.1318; Pimentel D., 2005, NAT RESOUR RES, V14, P65, DOI DOI 10.1007/S11053-005-4679-8; Sampedro J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-242; Sanchez OJ, 2008, BIORESOURCE TECHNOL, V99, P5270, DOI 10.1016/j.biortech.2007.11.013; Terinte N., 2011, LENZINGER BERICHTE, V89, P118; Wang MH, 2010, APPL BIOCHEM BIOTECH, V162, P2027, DOI 10.1007/s12010-010-8978-0; Zhou QX, 2011, WORLD J MICROB BIOT, V27, P1905, DOI 10.1007/s11274-011-0650-5	26	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0032-0935	1432-2048		PLANTA	Planta	JAN	2015	241	1					83	93		10.1007/s00425-014-2163-6		11	Plant Sciences	Plant Sciences	AY0OM	WOS:000347295900006		
J	Kiyoto, S; Yoshinaga, A; Takabe, K				Kiyoto, Shingo; Yoshinaga, Arata; Takabe, Keiji			Relative deposition of xylan and 8-5 '-linked lignin structure in Chamaecyparis obtusa, as revealed by double immunolabeling by using monoclonal antibodies	PLANTA			English	Article						Chamaecyparis; Lignification; 8-5 ' Linkage; Monoclonal antibody; Wood cell wall; Xylan deposition	TRANSMISSION ELECTRON-MICROSCOPY; SECONDARY CELL-WALLS; DOWN-REGULATION; ARABIDOPSIS-THALIANA; NORWAY SPRUCE; TENSION WOOD; IN-SITU; LIGNIFICATION; IMMUNOLOCALIZATION; ARABINOXYLANS	Immunolabeling by using monoclonal antibodies showed that xylan deposition precedes the formation of 8-5'-linked structure of lignin in normal and compression woods of Chamaecyparis obtusa. Xylan deposition and formation of 8-5'-linked lignin structure in differentiating xylems from normal and compression woods in Chamaecyparis obtusa were examined by immunoelectron microscopy using monoclonal antibodies (LM10 or LM11) to detect xylan localization. The 8-5'-linked lignin structure was immunolocalized using KM1 antibody. Xylan and 8-5'-linked lignin double immunolabeling was performed using secondary antibodies labeled with colloidal gold particles of different diameters. In normal wood, KM1 labeling occurred in the compound middle lamella (CML) and S-1 layer during S-1 layer formation and increased as S-2 and S-3 layers formed, with labeling occurring at the outer part of the previous layer. In compression wood, mild KM1 labeling occurred in the CML and outer part of the S-1 layer at the later S-1 layer formation stage, with increased labeling as the S-2 layer formed. Minor labeling occurred in the outer part of the S-2 layer during helical cavity formation. Comparison between KM1 labeling and KMnO4 staining suggested that lignin other than 8-5'-linked structure was formed during early lignification, and the proportion of 8-5'-linked lignin structure increased at later stages of lignification in both normal and compression woods. LM10 and LM11 labeling occurred slightly earlier than KM1 labeling, suggesting that xylan deposition preceded the formation of 8-5'-linked lignin in normal and compression woods. Less labeling by KM1, LM10, and LM11 occurred in the outer part of the S-2 layer in compression wood, which has abundant lignin. Thus, lignin in these parts is composed of lignin substructures other than the 8-5' linkage.	[Kiyoto, Shingo; Yoshinaga, Arata; Takabe, Keiji] Kyoto Univ, Grad Sch Agr, Div Forest & Biomat Sci, Lab Tree Cell Biol,Sakyo Ku, Kyoto 6068502, Japan	Kiyoto, S (reprint author), Kyoto Univ, Grad Sch Agr, Div Forest & Biomat Sci, Lab Tree Cell Biol,Sakyo Ku, Kyoto 6068502, Japan.	kiyoto@kais.kyoto-u.ac.jp					Day A, 2005, PLANTA, V222, P234, DOI 10.1007/s00425-005-1537-1; Joseleau JP, 1997, PLANT PHYSIOL, V114, P1123, DOI 10.1104/pp.114.3.1123; Kukkola EM, 2003, PLANTA, V217, P229, DOI 10.1007/s00425-003-0983-x; Kukkola EM, 2004, PLANTA, V218, P497, DOI 10.1007/s00425-003-1107-3; Kim JS, 2010, PLANTA, V232, P817, DOI 10.1007/s00425-010-1225-7; Salmen L, 1998, J PULP PAP SCI, V24, P99; TERASHIMA N, 1988, WOOD SCI TECHNOL, V22, P259; Reis D, 2004, CR BIOL, V327, P785, DOI 10.1016/j.crvi.2004.04.008; Pilate G, 2004, CR BIOL, V327, P889, DOI 10.1016/j.crvi.2004.07.006; Joseleau JP, 2004, PLANTA, V219, P338, DOI 10.1007/s00425-004-1226-5; Joseleau JP, 2007, CELL CHEM TECHNOL, V41, P487; LAPIERRE C, 1991, HOLZFORSCHUNG, V45, P61, DOI 10.1515/hfsg.1991.45.1.61; Kim JS, 2011, PLANTA, V233, P721, DOI 10.1007/s00425-010-1333-4; Leple JC, 2007, PLANT CELL, V19, P3669, DOI 10.1105/tpc.107.054148; BLAND DE, 1971, HOLZFORSCHUNG, V25, P137, DOI 10.1515/hfsg.1971.25.5.137; HEPLER PK, 1970, AM J BOT, V57, P85, DOI 10.2307/2440382; Ruel K, 2009, NEW PHYTOL, V184, P99, DOI 10.1111/j.1469-8137.2009.02951.x; Kim JS, 2010, PLANTA, V232, P109, DOI 10.1007/s00425-010-1152-7; Donaldson LA, 2012, PLANT PHYSIOL, V158, P642, DOI 10.1104/pp.111.184036; Ligrone R, 2008, PLANT SYST EVOL, V270, P257, DOI 10.1007/s00606-007-0617-z; Fornale S, 2012, MOL PLANT, V5, P817, DOI 10.1093/mp/ssr097; MAURER A, 1990, HOLZFORSCHUNG, V44, P453, DOI 10.1515/hfsg.1990.44.6.453; Ruel K, 1999, IAWA J, V20, P203; Altaner CM, 2010, TREE PHYSIOL, V30, P782, DOI 10.1093/treephys/tpq021; Koutaniemi S, 2012, PLANTA, V236, P739, DOI 10.1007/s00425-012-1653-7; Musel G, 1997, PLANTA, V201, P146, DOI 10.1007/BF01007699; Zeier J, 1999, PLANTA, V209, P1, DOI 10.1007/s004250050601; Guillon F, 2004, J CEREAL SCI, V40, P167, DOI 10.1016/j.jcs.2004.06.004; Goujon T, 2003, PLANTA, V217, P218, DOI 10.1007/s00425-003-0987-6; Grunwald C, 2001, TREES-STRUCT FUNCT, V15, P503, DOI 10.1007/s00468-001-0126-6; Chabannes M, 2001, PLANT J, V28, P271, DOI 10.1046/j.1365-313X.2001.01159.x; HOFFMANN P, 1976, HOLZFORSCHUNG, V30, P62, DOI 10.1515/hfsg.1976.30.2.62; Joseleau JP, 2004, CR BIOL, V327, P809, DOI 10.1016/j.crvi.2004.06.003; Kavousi B, 2010, PHYTOCHEMISTRY, V71, P531, DOI 10.1016/j.phytochem.2010.01.008; Kim YS, 1997, HOLZFORSCHUNG, V51, P411; Kim YoonSoo, 1996, Mogjae Gonghak = Journal of the Korean Wood Science and Technology, V24, P68; Kiyoto S, 2013, PLANTA, V237, P705, DOI 10.1007/s00425-012-1784-x; Kutscha P, 1975, HOLZFORSCHUNG, V29, P79; Martone PT, 2009, CURR BIOL, V19, P169, DOI 10.1016/j.cub.2008.12.031; McCartney L, 2005, J HISTOCHEM CYTOCHEM, V53, P543, DOI 10.1369/jhc.4B6578.2005; MICHALOWICZ G, 1990, HOLZFORSCHUNG, V44, P39, DOI 10.1515/hfsg.1990.44.1.39; Ordaz-Ortiz JJ, 2004, CARBOHYD POLYM, V57, P425, DOI 10.1016/j.carbpol.2004.05.016; Pettersson B, 1988, NORD PULP PAP RES J, V3, P152; RUEL K, 1994, J TRACE MICROPROBE T, V12, P247; Ruel K, 2002, PLANT BIOLOGY, V4, P2, DOI 10.1055/s-2002-20429; Ruel K, 2001, PHYTOCHEMISTRY, V57, P875, DOI 10.1016/S0031-9422(01)00118-2; Ruel K., 2006, Maderas: Ciencia y Technologia, V8, P107, DOI 10.4067/S0718-221X2006000200004; SAKA S, 1979, WOOD FIBER SCI, V11, P99; TAKABE K, 1986, Research Bulletin of the Hokkaido University Forests, V43, P783	49	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0032-0935	1432-2048		PLANTA	Planta	JAN	2015	241	1					243	256		10.1007/s00425-014-2181-4		14	Plant Sciences	Plant Sciences	AY0OM	WOS:000347295900017		
J	Bulanov, SV; Esirkepov, TZ; Kando, M; Koga, J; Kondo, K; Korn, G				Bulanov, S. V.; Esirkepov, T. Zh; Kando, M.; Koga, J.; Kondo, K.; Korn, G.			On the problems of relativistic laboratory astrophysics and fundamental physics with super powerful lasers	PLASMA PHYSICS REPORTS			English	Article							HIGH-ENERGY ELECTRONS; NONLINEAR THOMSON SCATTERING; FIELD LINE RECONNECTION; GAMMA-RAY FLARES; MAGNETIC-FIELD; COSMIC-RAYS; PARTICLE-ACCELERATION; CURRENT SHEETS; CRAB-NEBULA; ELECTROMAGNETIC-RADIATION	The ways toward modeling of astrophysical processes and extreme field regimes with super-power lasers are discussed. The main attention is paid to the problem of limited similarity in using the dimensionless parameters characterizing the processes in the laser and astrophysical plasmas. As the most typical examples, we address the magnetic reconnection and collisionless shock waves relevant to the problem of ultrarelativistic particle acceleration. In the extreme field limits we consider the regimes of dominant radiation reaction, changing the electromagnetic wave-matter interaction. In these regimes it, in particular, results in a new powerful source of ultra high-brightness gamma-rays and will make possible electron-positron pair creation in vacuum in a multiphoton processes. This will allow modeling under terrestrial laboratory conditions the processes in astrophysical objects and paves the way to experimental verifications using ultra intense lasers as they are currently developed within the ELI project.	[Bulanov, S. V.; Esirkepov, T. Zh; Kando, M.; Koga, J.; Kondo, K.] JAEA, Kansai Photon Sci Inst, Kizugawa, Kyoto, Japan; [Bulanov, S. V.] Russian Acad Sci, Prokhorov Inst Gen Phys, Moscow 119991, Russia; [Korn, G.] Acad Sci Czech Republic, Inst Phys, ELI Beamlines, Prague, Czech Republic	Bulanov, SV (reprint author), JAEA, Kansai Photon Sci Inst, 8-1-7 Umemidai, Kizugawa, Kyoto, Japan.		Bulanov, Sergei/A-1721-2013				Ablowitz MJ, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.036305; Aharonian FA, 2002, PHYS REV D, V66, DOI 10.1103/PhysRevD.66.023005; Akhiezer A. I., 1956, SOV PHYS JETP, V30, P915; Alfven H., 1963, COSMIC ELECTRODYNAMI; Amatuni A. Ts., 1998, PHYS REV SPEC TOP-AC, V1, DOI 10.1103/PhysRevSTAB.1.034001; Duclous R, 2011, PLASMA PHYS CONTR F, V53, DOI 10.1088/0741-3335/53/1/015009; Borghesi M, 2006, FUSION SCI TECHNOL, V49, P412; SCHWINGER J, 1951, PHYS REV, V82, P664, DOI 10.1103/PhysRev.82.664; Fedotov AM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.080402; Breit G, 1934, PHYS REV, V46, P1087, DOI 10.1103/PhysRev.46.1087; Zenitani S, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.095001; Silva LO, 2003, ASTROPHYS J, V596, pL121, DOI 10.1086/379156; Uchiyama Y, 2007, NATURE, V449, P576, DOI 10.1038/nature06210; Teubner U, 2009, REV MOD PHYS, V81, P445, DOI 10.1103/RevModPhys.81.445; Sauter F, 1931, Z PHYS, V69, P742, DOI 10.1007/BF01339461; Nakamura T, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.195001; COPPI B, 1966, PHYS REV LETT, V16, P1207, DOI 10.1103/PhysRevLett.16.1207; Kar S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.185006; Midorikawa K, 2011, NAT PHOTONICS, V5, P640, DOI 10.1038/nphoton.2011.265; Gahn C, 2002, PHYS PLASMAS, V9, P987, DOI 10.1063/1.1446879; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; Schutzhold R, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.130404; Beskin VS, 2010, PHYS-USP+, V53, P1199, DOI 10.3367/UFNe.0180.201012a.1241; WILKS SC, 1992, PHYS REV LETT, V69, P1383, DOI 10.1103/PhysRevLett.69.1383; Bulanov SS, 2006, J EXP THEOR PHYS+, V102, P9, DOI 10.1134/S106377610601002X; Esirkepov T, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.175003; ZATSEPIN GT, 1966, JETP LETT-USSR, V4, P78; Bulanov SS, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.026412; Dromey B, 2006, NAT PHYS, V2, P456, DOI 10.1038/nphys338; Macchi A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.085003; BULANOV SV, 1994, PHYS PLASMAS, V1, P745, DOI 10.1063/1.870766; Zelenyi LM, 2011, PLASMA PHYS REP+, V37, P118, DOI 10.1134/S1063780X1102005X; Abdo AA, 2011, SCIENCE, V331, P739, DOI 10.1126/science.1199705; Chen H, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.015003; ZELENYI LM, 1990, J GEOPHYS RES, V95, P3883, DOI 10.1029/JA095iA04p03883; Borghesi M, 2002, PHYS PLASMAS, V9, P2214, DOI 10.1063/1.1459457; Panchenko AV, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.056402; Cowan TE, 2000, PHYS REV LETT, V84, P903, DOI 10.1103/PhysRevLett.84.903; Bahk SW, 2004, OPT LETT, V29, P2837, DOI 10.1364/OL.29.002837; Fuchs M, 2009, NAT PHYS, V5, P826, DOI 10.1038/NPHYS1404; Bulanov SV, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.085001; GREISEN K, 1966, PHYS REV LETT, V16, P748, DOI 10.1103/PhysRevLett.16.748; Esarey E, 2009, REV MOD PHYS, V81, P1229, DOI 10.1103/RevModPhys.81.1229; Medvedev MV, 1999, ASTROPHYS J, V526, P697, DOI 10.1086/308038; Kim IJ, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.165003; Nakashima K, 2002, PHYS PLASMAS, V9, P1505, DOI 10.1063/1.1464145; Ping YL, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.031101; Ridgers CP, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.165006; Pukhov A, 2002, APPL PHYS B-LASERS O, V74, P355, DOI 10.1007/s003400200795; Sokolov IV, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.036412; Zelenyi L, 2013, SPACE SCI REV, V178, P441, DOI 10.1007/s11214-013-9959-8; TAJIMA T, 1979, PHYS REV LETT, V43, P267, DOI 10.1103/PhysRevLett.43.267; Gordienko S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.103903; Ji LL, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.145003; Zhong JY, 2010, NAT PHYS, V6, P984, DOI 10.1038/NPHYS1790; WEIBEL ES, 1959, PHYS REV LETT, V2, P83, DOI 10.1103/PhysRevLett.2.83; KATSOULEAS T, 1983, PHYS REV LETT, V51, P392, DOI 10.1103/PhysRevLett.51.392; Ruffini R, 2010, PHYS REP, V487, P1, DOI 10.1016/j.physrep.2009.10.004; Pegoraro F, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.065002; Woolsey NC, 2001, PHYS PLASMAS, V8, P2439, DOI 10.1063/1.1351831; Yamada M, 2010, REV MOD PHYS, V82, P603, DOI 10.1103/RevModPhys.82.603; Tavani M, 2011, SCIENCE, V331, P736, DOI 10.1126/science.1200083; Marklund M, 2006, REV MOD PHYS, V78, P591, DOI 10.1103/RevModPhys.78.591; Bell AR, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.200403; Zhidkov A, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.185002; Mourou GA, 2006, REV MOD PHYS, V78, P309, DOI 10.1103/RevModPhys.78.309; Honda M, 2000, PHYS PLASMAS, V7, P1302, DOI 10.1063/1.873941; Malkov MA, 2001, REP PROG PHYS, V64, P429, DOI 10.1088/0034-4885/64/4/201; Naumova N, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.025002; Krasnoselskikh VV, 2002, PHYS PLASMAS, V9, P1192, DOI 10.1063/1.1457465; Bamber C, 1999, PHYS REV D, V60, DOI 10.1103/PhysRevD.60.092004; Bulanov SS, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.220404; Heisenberg W, 1936, Z PHYS, V98, P714, DOI 10.1007/BF01343663; Pirozhkov AS, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2816443; Remington BA, 2006, REV MOD PHYS, V78, P755, DOI 10.1103/RevModPhys.78.755; ASKARYAN GA, 1994, JETP LETT+, V60, P251; Di Piazza A, 2012, REV MOD PHYS, V84, P1177, DOI 10.1103/RevModPhys.84.1177; Treumann RA, 2009, ASTRON ASTROPHYS REV, V17, P409, DOI 10.1007/s00159-009-0024-2; Cerutti B, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4872024; Daido H, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/5/056401; Robinson APL, 2009, PLASMA PHYS CONTR F, V51, DOI 10.1088/0741-3335/51/2/024004; Brady CS, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.245006; Sandhu AS, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.225002; Leemans WP, 2006, NAT PHYS, V2, P696, DOI 10.1038/nphys418; Popov VS, 2004, PHYS-USP+, V47, P855, DOI 10.1070/PU2004v047n09ABEH001812; Bulanov SS, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.220407; Roth M, 2001, PHYS REV LETT, V86, P436, DOI 10.1103/PhysRevLett.86.436; Bulanov SV, 1997, PHYS REV LETT, V78, P4205, DOI 10.1103/PhysRevLett.78.4205; Krausz F, 2009, REV MOD PHYS, V81, P163, DOI 10.1103/RevModPhys.81.163; Bulanov SV, 2009, EUR PHYS J D, V55, P483, DOI 10.1140/epjd/e2009-00138-1; KADOMTSEV BB, 1987, REP PROG PHYS, V50, P115, DOI 10.1088/0034-4885/50/2/001; Tamburini M, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/12/123005; DUNGEY JW, 1953, PHILOS MAG, V44, P725; ARONS J, 1992, ASTROPHYS J, V388, P561, DOI 10.1086/171174; Artemyev A, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.043106; Askar'yan G. A., 1996, Comments on Plasma Physics and Controlled Fusion, V17; ASKARYAN GA, 1995, PLASMA PHYS REP, V21, P835; Balogh A, 2012, SPACE SCI REV, V173, P1, DOI 10.1007/s11214-012-9937-6; Begelman MC, 2001, ASTROPHYS J, V551, P897, DOI 10.1086/320240; BELL AR, 1978, MON NOT R ASTRON SOC, V182, P147; Beresteskii V.B., 1982, QUANTUM ELECTRODYNAM; Berezinskii V.S., 1990, ASTROPHYSICS COSMIC; BERRY MV, 1982, J PHYS A-MATH GEN, V15, P3693, DOI 10.1088/0305-4470/15/12/021; Beskin V. S., 1993, PHYS PULSAR MAGNETOS; Birkeland K., 1908, NORWEGIAN AURORA POL; Blandford RD, 1978, ASTROPHYS J, V221, P29, DOI [DOI 10.1086/182658, 10.1086/182658]; BLUMENTH.GR, 1970, REV MOD PHYS, V42, P237, DOI 10.1103/RevModPhys.42.237; BRATMAN VL, 1995, PHYS LETT A, V206, P377, DOI 10.1016/0375-9601(95)00648-M; Browning PK, 2001, J GEOPHYS RES-SPACE, V106, P18677, DOI 10.1029/2001JA900014; BUCHNER J, 1989, J GEOPHYS RES, V94, P11821, DOI 10.1029/JA094iA09p11821; Bulanov SS, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.4752214; Bulanov S. V., 1975, RADIOPHYS QUANT EL, V18, P1511; Bulanov S. V., 1998, J SUPPL SER, V117, P599; Bulanov S. V., 1974, T FIAN, V74, P88; Bulanov S. V., 1976, Soviet Astronomy, V19; Bulanov SV, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4848758; Bulanov S. V., 1988, Soviet Astronomy, V32; Bulanov S. V., 2002, PLASMA PHYS REP, V28, P493; Bulanov SV, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.4764056; Bulanov SV, 2011, NUCL INSTRUM METH A, V660, P31, DOI 10.1016/j.nima.2011.09.029; Bulanov S. V., 1984, Soviet Astronomy, V28; Bulanov S. V., 2006, Plasma Physics and Controlled Fusion, V48, DOI 10.1088/0741-3335/48/12B/S03; Bulanov S. V., PHYS USP IN PRESS; Bulanov SV, 2013, PROC SPIE, V8780, DOI 10.1117/12.2020847; Bulanov SV, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.4757981; Bulanov S. V., 1979, SOV J PLASMA PHYS, V5, P157; Bulanov S. V, 1979, SOV ASTRON LETT, V5, P521; Bulanov S. V., 1985, Soviet Journal of Plasma Physics, V11; Bulanov SV, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.135003; Bulanov SS, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3683001; Bulanov SS, 2010, PHYS LETT A, V374, P476, DOI 10.1016/j.physleta.2009.11.009; Bulanov SS, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.062110; Bulanov SS, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.036408; BULANOV SV, 1985, SOV ASTRON LETT+, V11, P159; Bulanov SV, 2000, PLASMA PHYS REP+, V26, P1005, DOI 10.1134/1.1331136; BULANOV SV, 1990, PHYS REP, V186, P1, DOI 10.1016/0370-1573(90)90002-J; Bulanov S.V., 2004, PLASMA PHYS REP, V30, P21; Bulanov SV, 1996, PLASMA PHYS REP, V22, P783; BULANOV SV, 1995, PHYS LETT A, V203, P219, DOI 10.1016/0375-9601(95)00340-9; Bulanov SV, 2009, CR PHYS, V10, P216, DOI 10.1016/j.crhy.2009.03.001; Bulanov SV, 2013, PHYS-USP+, V56, P429, DOI [10.3367/UFNe.0183.201305a.0449, 10.3367/UFNr.0183.201305a.0449]; Bulanov SV, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.056605; Bychekov VY, 2001, PLASMA PHYS REP+, V27, P1017, DOI 10.1134/1.1426135; Califano F, 1997, PHYS REV E, V56, P963, DOI 10.1103/PhysRevE.56.963; Chandrasekhar S., 1934, Monthly Notices of the Royal Astronomical Society, V94; Chang FY, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.111101; Chen P, 2014, EUR PHYS J-SPEC TOP, V223, P1121, DOI 10.1140/epjst/e2014-02163-5; Chen PS, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.161101; CHIAN ACL, 1981, PHYS REV A, V24, P2773, DOI 10.1103/PhysRevA.24.2773; Dieckmann ME, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/1/013029; Dieckmann ME, 2006, PLASMA PHYS CONTR F, V48, P1515, DOI 10.1088/0741-3335/48/10/005; Dittrich W., 2000, PROBING QUANTUM VACU; Dollar F, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.175005; Dumlu CK, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.250402; Ebisuzaki T, 2014, ASTROPART PHYS, V56, P9, DOI 10.1016/j.astropartphys.2014.02.004; Echkina EY, 2010, PLASMA PHYS REP+, V36, P15, DOI 10.1134/S1063780X10010022; Eddington A.S., 1925, Monthly Notices of the Royal Astronomical Society, V85; Einstein A, 1905, ANN PHYS-BERLIN, V17, P891; Erokhin AN, 2012, PLASMA PHYS REP+, V38, P396, DOI 10.1134/S1063780X12040022; Erokhin N. S., 1987, Soviet Physics - Doklady, V32; Esirkepov TZ, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.265001; Esirkepov TZ, 2013, EAS PUBLICATIONS, V58, P7, DOI 10.1051/eas/1258001; FALTHAMM.CG, 1974, SPACE SCI REV, V15, P803; Fermi E., 1949, Physical Review, V75, DOI 10.1103/PhysRev.75.1169; FERMI E, 1954, ASTROPHYS J, V119, P1, DOI 10.1086/145789; Forbes T, 2000, MAGNETIC RECONNECTIO; Fortov V. E., 2007, PHYS USPEKHI, V50, P347; Frank AG, 2010, PHYS-USP+, V53, P941, DOI 10.3367/UFNe.0180.201009h.0982; Ginzburg V L, 1970, PROPAGATION ELECTROM; GOLDREICH P, 1978, PHYS SCRIPTA, V17, P225, DOI 10.1088/0031-8949/17/3/015; Gonoskov A, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.014801; Gordeev AV, 2010, PLASMA PHYS REP+, V36, P30, DOI 10.1134/S1063780X10010034; Gryaznykh DA, 1998, JETP LETT+, V67, P257, DOI 10.1134/1.567660; GUNN JE, 1969, PHYS REV LETT, V22, P728, DOI 10.1103/PhysRevLett.22.728; Gurevich A. V., 1974, SOV PHYS JETP, V38, P291; Gus'kov SY, 2001, QUANTUM ELECTRON+, V31, P885, DOI 10.1070/QE2001v031n10ABEH002070; Gus'kov SY, 2013, PLASMA PHYS REP+, V39, P1, DOI 10.1134/S1063780X13010017; Hester JJ, 2008, ANNU REV ASTRON ASTR, V46, P127, DOI 10.1146/annurev.astro.45.051806.110608; Higashimori K., 2012, PHYS REV LETT, V110; Kadomtsev B. B., 1970, Soviet Physics - Doklady, V15; Kando M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.235003; Kando M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.135001; Kar S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.225004; Kato TN, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3372138; Kazimura Y, 1998, ASTROPHYS J, V498, pL183, DOI 10.1086/311316; KELDYSH LV, 1965, SOV PHYS JETP-USSR, V20, P1307; Kichigin GN, 2001, J EXP THEOR PHYS+, V92, P895, DOI 10.1134/1.1385629; Koga J, 2006, J PLASMA PHYS, V72, P1315, DOI 10.1017/S0022377806005708; Koga J, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.2013067; Koga JK, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.053823; KOOPMAN DW, 1967, PHYS REV LETT, V18, P533, DOI 10.1103/PhysRevLett.18.533; Kostomarov DP, 2003, DOKL PHYS, V48, P216, DOI 10.1134/1.1581314; Krymskii G. F., 1977, Soviet Physics - Doklady, V22; Kugland N. L., 2012, NATURE PHYS, V11, P809; Kulagin VV, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2799164; Kuramitsu Y, 2008, ASTROPHYS J LETT, V682, pL113, DOI 10.1086/591247; Landau L. D., 1980, CLASSICAL THEORY FIE; Lebedew P, 1901, ANN PHYS-BERLIN, V6, P433; Levy MC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5149; Lichtenberg A., 1984, REGULAR CHAOTIC DYNA; Matsumoto Y, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.215003; Medvedev MV, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.045401; Milne E.A., 1926, Monthly Notices of the Royal Astronomical Society, V86; Mourou G., 2011, ELI EXTREME LIGHT IN; Narozhny N. B., 2004, PHYS LETT A, V338, P1; Naumova NM, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.063902; NIKISHOV AI, 1970, SOV PHYS USPEKHI, V13, P303, DOI 10.1070/PU1970v013n02ABEH004234; Parker E. N., 1979, COSMICAL MAGNETIC FI; Pegoraro F, 2005, PHYS LETT A, V347, P133, DOI 10.1016/j.physleta.2005.09.004; PIRAN T, 1982, ASTROPHYS J, V257, pL23, DOI 10.1086/183801; Pirozhkov AS, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2158145; Pirozhkov AS, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.135004; Poston T., 1978, CATASTROPHE THEORY I; Reed SA, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3139860; Ritus V. I., 1987, Issues in intense-field quantum electrodynamics; Romagnani L, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.025004; Rosanov N, 2008, JETP LETT+, V88, P501, DOI 10.1134/S0021364008200071; Rosanov NN, 2011, JETP LETT+, V93, P308, DOI 10.1134/S0021364011060105; Rozanov N. N., 1993, Journal of Experimental and Theoretical Physics, V76; Sakai J, 2002, PHYS PLASMAS, V9, P2959, DOI 10.1063/1.1484156; Savin D. W., 2010, WORKSH HIGH EN DENS; SCHWINGER J, 1954, P NATL ACAD SCI USA, V40, P132, DOI 10.1073/pnas.40.2.132; Sedov L. I., 1959, SIMILARITY DIMENSION; Shaviv NJ, 2000, ASTROPHYS J, V532, pL137, DOI 10.1086/312585; Shintake T., 2003, NUCL INSTRUM METH A, V507, P11; Sircombe NJ, 2006, ASTRON ASTROPHYS, V452, P371, DOI 10.1051/0004-6361:20054074; Sironi L, 2013, ASTROPHYS J, V771, DOI 10.1088/0004-637X/771/1/54; Sokolov A.A., 1954, SOV PHYS JETP, V24, P249; SPEISER TW, 1965, J GEOPHYS RES, V70, P4219, DOI 10.1029/JZ070i017p04219; Stegun I. A., 1965, HDB MATH FUNCTIONS F; Sweet P. A., 1958, ELECTROMAGNETIC PHEN, P122; SYROVATSKII SI, 1981, ANNU REV ASTRON ASTR, V19, P163, DOI 10.1146/annurev.aa.19.090181.001115; Takabe H, 2008, PLASMA PHYS CONTR F, V50, DOI 10.1088/0741-3335/50/12/124057; Ternov I. M., 1995, Physics-Uspekhi, V38, DOI 10.1070/PU1995v038n04ABEH000082; Abraham J, 2007, SCIENCE, V318, P938, DOI 10.1126/science.1151124; Thomas AGR, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.041004; Tidman D. A., 1971, SHOCK WAVES COLLISIO; Treumann R.A., 2013, FRONT PHYS, V1, P31, DOI DOI 10.3389/FPHY.2013.00031; Vainshtein D. L., 1995, PLASMA PHYS REP, V21, P484; Veksler V. I., 1957, ATOM ENERGY, V2, P427; Vshivkov VA, 1998, PHYS PLASMAS, V5, P2727, DOI 10.1063/1.872961; Wang XM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2988; Willingale L, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3377787; Zander F. A., 1924, TECHNIKA ZHIZN, P15; ZELDOVIC.YB, 1972, SOV PHYS JETP-USSR, V34, P467; Zelenyi L. M., 1979, Soviet Astronomy, V23; Zelenyi LM, 2013, PHYS-USP+, V56, P347, DOI [10.3367/UFNe.0183.201304b.0365, 10.3367/UFNr.0183.201304b.0365]; Zhidkov A, 2014, PHYS REV SPEC TOP-AC, V17, DOI 10.1103/PhysRevSTAB.17.054001	248	8	8	MAIK NAUKA/INTERPERIODICA/SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013-1578 USA	1063-780X	1562-6938		PLASMA PHYS REP+	Plasma Phys. Rep.	JAN	2015	41	1					1	51		10.1134/S1063780X15010018		51	Physics, Fluids & Plasmas	Physics	AY4ER	WOS:000347531500001		
J	Tsurugi, H; Yamamoto, K; Rochat, R; Mashima, K				Tsurugi, Hayato; Yamamoto, Keishi; Rochat, Raphael; Mashima, Kazushi			Non-bridged half-metallocene complexes of group 4-6 metals with chelating ligands as well-defined catalysts for alpha-olefin polymerization	POLYMER JOURNAL			English	Review							LIVING COORDINATION POLYMERIZATION; ZIEGLER-NATTA POLYMERIZATION; CHAIN-TRANSFER POLYMERIZATION; SANDWICH CHROMIUM(III) CATALYSTS; TITANOCENE CHLORIDES SYNTHESIS; ETHYLENE POLYMERIZATION; ZIRCONIUM COMPLEXES; SYNDIOSPECIFIC POLYMERIZATION; STEREOBLOCK POLYOLEFINS; ALKENE POLYMERIZATION	Tremendous effort has been directed toward the design of an organic ligand framework around the catalytically active metal center of homogeneous catalyst precursors. This work is aimed at controlling not only the reactivity of the metal catalysts for alpha-olefin polymerization but also the molecular weight, molecular weight distribution, polymer microstructure and monomer content of the copolymers. Among the catalyst precursor categories, non-bridged half-metallocene complexes supported by a variety of chelating ligands are attractive catalyst motifs for ethylene homopolymerization, ethylene/alpha-olefin copolymerization and stereoselective polymerization of alpha-olefins. These motifs are attractive in terms of their rather simple synthetic protocols and the wide range of potential architectural designs of the attached ligands. This review article summarizes recent developments regarding non-bridged half-metallocene complexes of group 4-6 metals with anionic chelating ligands. In contrast to the conventional metallocene initiators Cp2MX2 (Cp = eta(5)-C5H5), half-metallocene complexes of the type CpM(L boolean AND L)X-2 (L boolean AND L = chelating ligands) offer the advantage of catalyst modification. Steric and/or electronic modification of the coordination environment can be achieved by changing one cyclopentadienyl ligand of a metallocene complex to another ligand, such as three-, four-, five-, six-or seven-membered chelates having bidentate or tridentate coordinations and being monoanionic, dianionic or trianionic. Half-metallocene complexes with a four-membered chelating ring are focused on due to their unique dynamic behaviors of metal-centered racemization and chain transfer. The structural uniqueness of the metal complexes, the effects of the chelate ring sizes on their productivity and the activation processes of the metal complexes with cocatalysts are highlighted.	[Tsurugi, Hayato; Yamamoto, Keishi; Rochat, Raphael; Mashima, Kazushi] Osaka Univ, JST, Grad Sch Engn Sci, Dept Chem, Toyonaka, Osaka 5608531, Japan	Mashima, K (reprint author), Osaka Univ, JST, Grad Sch Engn Sci, Dept Chem, Toyonaka, Osaka 5608531, Japan.	mashima@chem.es.osaka-u.ac.jp			JSPS	HT acknowledges financial support by a Grant-in-Aid for Young Scientists (A). KY expresses his special thanks for the financial support provided by the JSPS Research Fellowship for Young Scientists.	Alesso G, 2011, J ORGANOMET CHEM, V696, P2330, DOI 10.1016/j.jorganchem.2011.02.011; Mashima K, 2005, J ORGANOMET CHEM, V690, P4414, DOI 10.1016/j.jorganchem.2004.12.035; McKnight AL, 1998, CHEM REV, V98, P2587, DOI 10.1021/cr940442r; Zuo WW, 2009, J POLYM SCI POL CHEM, V47, P357, DOI 10.1002/pola.23139; Heintz RA, 1998, ORGANOMETALLICS, V17, P5477, DOI 10.1021/om980796z; Huang YB, 2009, DALTON T, P767, DOI 10.1039/b820798b; Harney MB, 2006, ANGEW CHEM INT EDIT, V45, P2400, DOI 10.1002/anie.200600027; Liang YF, 1996, ORGANOMETALLICS, V15, P5284, DOI 10.1021/om960774h; Richter J, 1998, J MOL CATAL A-CHEM, V130, P149, DOI 10.1016/S1381-1169(97)00209-4; Crawford KE, 2013, J AM CHEM SOC, V135, P8778, DOI 10.1021/ja402262x; Champouret Y, 2010, ORGANOMETALLICS, V29, P3125, DOI 10.1021/om1002649; Sita LR, 1998, ORGANOMETALLICS, V17, P5228, DOI 10.1021/om980706q; [Anonymous], 1980, ADV ORGANOMET CHEM, DOI 10.1016/S0065-3055(08)60307-X; Tsurugi H, 2006, J MOL CATAL A-CHEM, V254, P131, DOI 10.1016/j.molcata.2006.01.070; Nomura K, 2007, J MOL CATAL A-CHEM, V267, P1, DOI 10.1016/j.molcata.2006.11.006; Firth AV, 1999, J ORGANOMET CHEM, V591, P185, DOI 10.1016/S0022-328X(99)00422-2; Bott RKJ, 2003, J ORGANOMET CHEM, V665, P135, DOI 10.1016/S0022-328X(02)02106-X; BHANDARI G, 1995, ORGANOMETALLICS, V14, P738, DOI 10.1021/om00002a023; KAROL FJ, 1972, J POLYM SCI A1, V10, P2621, DOI 10.1002/pol.1972.150100910; Jayaratne KC, 2000, J AM CHEM SOC, V122, P958, DOI 10.1021/ja993808w; Domski GJ, 2007, PROG POLYM SCI, V32, P30, DOI 10.1016/j.progpolymsci.2006.11.001; Champouret Y, 2008, ANGEW CHEM INT EDIT, V47, P6069, DOI 10.1002/anie.200801498; Yasumoto T, 2005, ORGANOMETALLICS, V24, P3375, DOI 10.1021/om050108t; Sun MT, 2011, DALTON T, V40, P10184, DOI 10.1039/c1dt10659g; Xu TQ, 2007, J AM CHEM SOC, V129, P2236, DOI 10.1021/ja0671363; BUIJINK JK, 1991, Z NATURFORSCH B, V46, P1328; THOMAS BJ, 1991, J AM CHEM SOC, V113, P893, DOI 10.1021/ja00003a024; Coates GW, 2002, ANGEW CHEM INT EDIT, V41, P2236, DOI 10.1002/1521-3773(20020703)41:13<2236::AID-ANIE2236>3.0.CO;2-3; Wei J, 2010, ANGEW CHEM INT EDIT, V49, P9140, DOI 10.1002/anie.201004709; Koterwas LA, 1999, ORGANOMETALLICS, V18, P4183, DOI 10.1021/om990481z; THOMAS BJ, 1988, J AM CHEM SOC, V110, P5902, DOI 10.1021/ja00225a053; KAMINSKY W, 1983, MAKROMOL CHEM-RAPID, V4, P417; Heinemann O, 1998, J ORGANOMET CHEM, V553, P477, DOI 10.1016/S0022-328X(97)00122-8; Champouret Y, 2010, ORGANOMETALLICS, V29, P167, DOI 10.1021/om900869p; Sun MT, 2010, NEW J CHEM, V34, P2979, DOI 10.1039/c0nj00439a; Huang YB, 2009, ORGANOMETALLICS, V28, P4170, DOI 10.1021/om900279p; Boffa LS, 2000, CHEM REV, V100, P1479, DOI 10.1021/cr990251u; Tabernero V, 2002, J ORGANOMET CHEM, V663, P173, DOI 10.1016/S0022-328X(02)01733-3; Chen EYX, 2009, CHEM REV, V109, P5157, DOI 10.1021/cr9000258; MacAdams LA, 2005, J AM CHEM SOC, V127, P1082, DOI 10.1021/ja043877x; Dohring A, 2000, ORGANOMETALLICS, V19, P388, DOI 10.1021/om990643r; BRINTZINGER HH, 1995, ANGEW CHEM INT EDIT, V34, P1143, DOI 10.1002/anie.199511431; Bergamo AL, 2013, CATAL COMMUN, V42, P113, DOI 10.1016/j.catcom.2013.08.016; BHANDARI G, 1995, CHEM-EUR J, V1, P199, DOI 10.1002/chem.19950010309; Chen J, 2005, J POLYM SCI POL CHEM, V43, P1562, DOI 10.1002/pola.20621; CHERNEGA AN, 1993, J CHEM SOC CHEM COMM, P1415, DOI 10.1039/c39930001415; Clark A., 1970, CATAL REV, V3, P145, DOI 10.1080/01614947008076858; Doherty S, 1998, ORGANOMETALLICS, V17, P3408, DOI 10.1021/om980222u; DOI Y, 1985, MAKROMOL CHEM-RAPID, V6, P639; DOI Y, 1988, TRANSITION MET CATAL, V2, P182; DOI Y, 1979, MACROMOLECULES, V12, P814, DOI 10.1021/ma60071a004; DOI Y, 1986, MACROMOLECULES, V19, P2896, DOI 10.1021/ma00166a002; Dove AP, 2005, CHEM COMMUN, P2152, DOI 10.1039/b418778d; Gibson VC, 2003, CHEM REV, V103, P283, DOI 10.1021/cr980461r; Gibson VC, 2000, J CHEM SOC DALTON, P1969, DOI 10.1039/b002631j; GLADYSZ JA, 2000, CHEM REV, V100, P4; GOMEZ R, 1994, J CHEM SOC CHEM COMM, P2607, DOI 10.1039/c39940002607; GOMEZ R, 1995, J ORGANOMET CHEM, V491, P153, DOI 10.1016/0022-328X(94)05237-6; GROGNEC EL, 2001, CHEM-EUR J, V7, P4572; GROGNEC EL, 1999, INORG CHEM COMMUN, V2, P95; GROGNEC EL, 2000, ORGANOMETALLICS, V19, P3842; Harney MB, 2006, ANGEW CHEM INT EDIT, V45, P6140, DOI 10.1002/anie.200601616; Huang JL, 2002, MACROMOLECULES, V35, P4871, DOI 10.1021/ma012064f; Jayaratne KC, 2000, J AM CHEM SOC, V122, P10490, DOI 10.1021/ja002558c; Jayaratne KC, 2001, J AM CHEM SOC, V123, P10754, DOI 10.1021/ja016184e; KAROL FJ, 1973, J POLYM SCI POL CHEM, V11, P413, DOI 10.1002/pol.1973.170110208; Keaton RJ, 2002, J AM CHEM SOC, V124, P5932, DOI 10.1021/ja017294o; Keaton RJ, 2001, J AM CHEM SOC, V123, P6197, DOI 10.1021/ja0057326; Keaton RJ, 2000, J AM CHEM SOC, V122, P12909, DOI 10.1021/ja0056771; Kim Y, 2000, MACROMOL RAPID COMM, V21, P1148, DOI 10.1002/1521-3927(20001101)21:16<1148::AID-MARC1148>3.0.CO;2-E; Kim Y, 2001, MACROMOL RAPID COMM, V22, P573; Kim Y, 2001, J ORGANOMET CHEM, V634, P19, DOI 10.1016/S0022-328X(01)01105-6; Kim Y, 1999, ORGANOMETALLICS, V18, P36, DOI 10.1021/om980784d; Kim YJ, 2002, ORGANOMETALLICS, V21, P1127, DOI 10.1021/om0109197; Lee KS, 2006, J ORGANOMET CHEM, V691, P1121, DOI 10.1016/j.jorganchem.2005.10.019; Liu JY, 2011, ORGANOMETALLICS, V30, P4052, DOI 10.1021/om200317x; Liu SF, 2009, J POLYM SCI POL CHEM, V47, P3154, DOI 10.1002/pola.23413; Liu SR, 2010, POLYMER, V51, P1921, DOI 10.1016/j.polymer.2010.03.012; MacAdams LA, 2002, ORGANOMETALLICS, V21, P952, DOI 10.1021/om010857k; Mani G, 2004, ANGEW CHEM INT EDIT, V43, P2263, DOI 10.1002/anie.200353040; MASHIMA K, 1995, J ORGANOMET CHEM, V502, P19, DOI 10.1016/0022-328X(95)05638-6; Mashima K, 2002, J ORGANOMET CHEM, V663, P5, DOI 10.1016/S0022-328X(02)01728-X; MASHIMA K, 1993, J AM CHEM SOC, V115, P10990, DOI 10.1021/ja00076a067; MASHIMA K, 1995, ORGANOMETALLICS, V14, P2633, DOI 10.1021/om00006a008; Nakamura A, 2001, J ORGANOMET CHEM, V621, P224, DOI 10.1016/S0022-328X(00)00857-3; Matsuo Y, 2001, ANGEW CHEM INT EDIT, V40, P960, DOI 10.1002/1521-3773(20010302)40:5<960::AID-ANIE960>3.0.CO;2-W; Matsuo Y, 2000, CHEM LETT, P1114, DOI 10.1246/cl.2000.1114; MAUPOEY MG, 2003, ORGANOMETALLICS, V22, P2694; NATTA G, 1962, J AM CHEM SOC, V84, P1488, DOI 10.1021/ja00867a029; OKAMOTO T, 1988, ORGANOMETALLICS, V7, P2266, DOI 10.1021/om00101a003; OKAMOTO T, 1988, J AM CHEM SOC, V110, P5008, DOI 10.1021/ja00223a018; Qi CH, 2005, J ORGANOMET CHEM, V690, P2941, DOI 10.1016/j.jorganchem.2005.03.016; Rieger B., 2003, LATE TRANSITION META; Saeed I, 2009, INORG CHEM, V48, P5011, DOI 10.1021/ic9004246; Sanz M, 2004, ORGANOMETALLICS, V23, P5324, DOI 10.1021/om049596f; Scheirs J, 2000, METALLOCENE BASED PO; Sita LR, 2009, ANGEW CHEM INT EDIT, V48, P2464, DOI 10.1002/anie.200802661; Sun WH, 2010, ORGANOMETALLICS, V29, P732, DOI 10.1021/om9010033; Tang XY, 2014, DALTON T, V43, P222, DOI 10.1039/c3dt51659h; Tang XY, 2013, DALTON T, V42, P499, DOI 10.1039/c2dt31445b; Theopold KH, 1998, EUR J INORG CHEM, P15; Tsurugi H, 2003, CHEM LETT, V32, P756, DOI 10.1246/cl.2003.756; Tsurugi H, 2006, ORGANOMETALLICS, V25, P5210, DOI 10.1021/om0606921; Vollmerhaus R, 1999, ORGANOMETALLICS, V18, P2731, DOI 10.1021/om990341p; Wang LS, 1997, J AM CHEM SOC, V119, P4453, DOI 10.1021/ja964078k; Wei J, 2013, J AM CHEM SOC, V135, P2132, DOI 10.1021/ja312463f; Wei J, 2010, ANGEW CHEM INT EDIT, V49, P1768, DOI 10.1002/anie.200906658; YASUDA H, 1985, J AM CHEM SOC, V107, P2410, DOI 10.1021/ja00294a036; Yasumoto T, 2007, CHEM LETT, V36, P1030, DOI 10.1246/cl.2007.1030; Yasumoto T, 2013, DALTON T, V42, P9120, DOI 10.1039/c2dt32481d; Zhang W, 2008, MACROMOLECULES, V41, P7829, DOI 10.1021/ma801962v; Zhang W, 2008, J AM CHEM SOC, V130, P442, DOI 10.1021/ja078120v; Zhang W, 2008, ADV SYNTH CATAL, V350, P439, DOI 10.1002/adsc.200700506; Zhang YH, 2004, ORGANOMETALLICS, V23, P3512, DOI 10.1021/om049835z; Zhang YH, 2003, J AM CHEM SOC, V125, P9062, DOI 10.1021/ja029780x; Zhang YH, 2003, J AM CHEM SOC, V125, P8746, DOI 10.1021/ja0349453; Zuo WW, 2008, J POLYM SCI POL CHEM, V46, P3396, DOI 10.1002/pola.22693	117	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	JAN	2015	47	1					2	17		10.1038/pj.2014.82		16	Polymer Science	Polymer Science	AY1DG	WOS:000347333100002		
J	Osaka, I				Osaka, Itaru			Semiconducting polymers based on electron-deficient pi-building units	POLYMER JOURNAL			English	Review							FIELD-EFFECT TRANSISTORS; THIOPHENE-THIAZOLOTHIAZOLE COPOLYMERS; SOLAR-CELL APPLICATIONS; CHARGE-TRANSPORT; MOLECULAR DESIGN; ORGANIC METALS; HIGH-MOBILITY; ACCEPTOR; PERFORMANCE; STABILITY	The development of new semiconducting polymers is one of the most important issues to address in improving the performance of organic electronic devices. Donor-acceptor semiconducting polymers, in which the backbone consists of alternating electronrich (donor) and electron-deficient (acceptor) heterocyclic pi-building units, are emerging materials that promote intermolecular interactions and offer desirable electronic structures, in turn leading to high charge carrier transport. This review focuses on the development of donor-acceptor semiconducting polymers using electron-deficient pi-building units, such as thiazolo[5,4-d] thiazole, benzo[1,2-d: 4,5-d'] bisthiazole, naphtho[1,2-c: 5,6-c'] bis[1,2,5] thiadiazole and thieno[3,2-b] thiophene-2,5-dione. All of the polymers form crystalline structures in thin films and possess deep highest occupied molecular orbital energy levels; consequently, the polymers demonstrate high charge carrier mobilities with high air stability. Based on these studies, several key parameters were identified that must be taken into account when designing high-performance polymers: the symmetry of the building units, backbone shape and delocalization of the pi-electrons along the backbone. Notably, many of the polymers synthesized in the studies exhibit high photovoltaic performance, indicating that such crystalline polymers are also useful for solar cell applications. Thus, this review affords an important guideline for the development of high-performance semiconducting polymers.	[Osaka, Itaru] RIKEN, Ctr Emergent Matter Sci, Wako, Saitama, Japan	Osaka, I (reprint author), Japan Sci & Technol Agcy, Chiyoda Ku, Tokyo 1020075, Japan.	itaru.osaka@riken.jp	Osaka, Itaru/B-3153-2010		Ministry of Education, Culture, Sports, Science and Technology [2035008800, 24685030]; Precursory Research for Embryonic Science and Technology (Japan Science and Technology Agency); Sumitomo Foundation; Strategic Promotion of Innovative Research and Development (Japan Science and Technology Agency)	The author thanks Prof Richard D. McCullough (Harvard University) and Prof Kazuo Takimiya (RIKEN) for all of their support as research supervisors. The author also thanks all of his co-workers and collaborators for their great contributions to the studies covered in this review. The author is grateful for the financial support from Grant-in-Aid for Scientific Research (Nos. 2035008800 and 24685030; Ministry of Education, Culture, Sports, Science and Technology), Precursory Research for Embryonic Science and Technology (Japan Science and Technology Agency) and the Sumitomo Foundation. Portions of the work were also supported by Strategic Promotion of Innovative Research and Development (Japan Science and Technology Agency) and the Sumitomo Foundation.	Ando S, 2004, CHEM LETT, V33, P1170, DOI 10.1246/cl.2004.1170; Osaka I, 2010, ADV MATER, V22, P4993, DOI 10.1002/adma.201002117; Anthopoulos TD, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2715028; Osaka I, 2009, J AM CHEM SOC, V131, P2521, DOI 10.1021/ja801475h; MATAKA S, 1991, B CHEM SOC JPN, V64, P68, DOI 10.1246/bcsj.64.68; Pappenfus TM, 2002, J AM CHEM SOC, V124, P4184, DOI 10.1021/ja025553j; Osaka I, 2012, J AM CHEM SOC, V134, P3498, DOI 10.1021/ja210687r; Ahmed E, 2009, MACROMOLECULES, V42, P8615, DOI 10.1021/ma9015278; Osaka I, 2014, J MATER CHEM C, V2, P2307, DOI 10.1039/c3tc32386b; Osaka I, 2014, ADV MATER, V26, P331, DOI 10.1002/adma.201303059; Osaka I, 2008, ACCOUNTS CHEM RES, V41, P1202, DOI 10.1021/ar800130s; McCullough RD, 1998, ADV MATER, V10, P93, DOI 10.1002/(SICI)1521-4095(199801)10:2<93::AID-ADMA93>3.0.CO;2-F; Osaka I, 2007, ADV MATER, V19, P4160, DOI 10.1002/adma.200701058; Sirringhaus H, 1999, NATURE, V401, P685, DOI 10.1038/44359; WOLFE JF, 1981, MACROMOLECULES, V14, P915, DOI 10.1021/ma50005a005; Ando S, 2005, J AM CHEM SOC, V127, P5336, DOI 10.1021/ja042219+; OSAHENI JA, 1992, CHEM MATER, V4, P1282, DOI 10.1021/cm00024a031; FERRARIS J, 1973, J AM CHEM SOC, V95, P948, DOI 10.1021/ja00784a066; deLeeuw DM, 1997, SYNTHETIC MET, V87, P53, DOI 10.1016/S0379-6779(97)80097-5; Facchetti A, 2011, CHEM MATER, V23, P733, DOI 10.1021/cm102419z; Ando S, 2004, J MATER CHEM, V14, P1787, DOI 10.1039/b403699a; Wang M, 2011, J AM CHEM SOC, V133, P9638, DOI 10.1021/ja201131h; Beaujuge PM, 2011, J AM CHEM SOC, V133, P20009, DOI 10.1021/ja2073643; Osaka I, 2012, ACS MACRO LETT, V1, P437, DOI 10.1021/mz300065t; Bao Z, 1996, APPL PHYS LETT, V69, P4108, DOI 10.1063/1.117834; Jones BA, 2007, J AM CHEM SOC, V129, P15259, DOI 10.1021/ja075242e; Osaka I, 2010, CHEM MATER, V22, P4191, DOI 10.1021/cm101052b; Sirringhaus H, 2010, ADV MATER, V22, P3893, DOI 10.1002/adma.200902857; Osaka I, 2013, J AM CHEM SOC, V135, P8834, DOI 10.1021/ja404064m; Osaka I, 2012, ADV MATER, V24, P425, DOI 10.1002/adma.201103065; Bao Z., 2007, ORGANIC FIELD EFFECT; Brabec C., 2008, ORGANIC PHOTOVOLTAIC; Chen SY, 2011, CHEM LETT, V40, P998, DOI 10.1246/cl.2011.998; Chesterfield RJ, 2003, ADV MATER, V15, P1278, DOI 10.1002/adma.200305200; Kawashima K, 2013, POLYM CHEM-UK, V4, P5224, DOI 10.1039/c3py00161j; Kunugi Y, 2004, J MATER CHEM, V14, P1367, DOI 10.1039/b401209g; Leclerc M., 2010, DESIGN SYNTHESIS CON; Lei T, 2013, CHEM MATER, V26, P594; Malliaras G. G., 2007, SEMICONDUCTING POLYM; Martin N, 1997, J MATER CHEM, V7, P1661, DOI 10.1039/a702314f; McCulloch I, 2009, ADV MATER, V21, P1091, DOI 10.1002/adma.200801650; Mei J., 2013, CHEM MATER, V26, P604; Mike J. F., 2009, J ORG CHEM, V75, P495; Noriega R., 2011, ORGANIC ELECT; OSAHENI JA, 1995, J AM CHEM SOC, V117, P7389, DOI 10.1021/ja00133a012; Skotheim T. A., 1997, HDB CONDUCTING POLYM; Takimiya K., 2013, CHEM MATER, V26, P587; TESTAFERRI L, 1978, J ORG CHEM, V43, P2197, DOI 10.1021/jo00405a024; YUI K, 1987, J CHEM SOC CHEM COMM, P1816, DOI 10.1039/c39870001816	49	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	JAN	2015	47	1					18	25		10.1038/pj.2014.90		8	Polymer Science	Polymer Science	AY1DG	WOS:000347333100003		
J	Aoyama, Y; Yamanari, T; Murakami, TN; Nagamori, T; Marumoto, K; Tachikawa, H; Mizukado, J; Suda, H; Yoshida, Y				Aoyama, Yoshinori; Yamanari, Toshihiro; Murakami, Takurou N.; Nagamori, Tatsuya; Marumoto, Kazuhiro; Tachikawa, Hiroto; Mizukado, Junji; Suda, Hiroyuki; Yoshida, Yuji			Initial photooxidation mechanism leading to reactive radical formation of polythiophene derivatives	POLYMER JOURNAL			English	Article							POLYMER SOLAR-CELLS; SUPEROXIDE ION; THIN-FILMS; DEGRADATION; POLY(3-ALKYLTHIOPHENES); OXYGEN; P3HT; POLY(3-HEXYLTHIOPHENE); INVOLVEMENT; STABILITY	We investigated the initial photooxidation mechanism leading to reactive radical formation of polythiophene derivatives by focusing on the differences in the photochemical behaviors of photounstable poly(3-hexylthiophene) (P3HT) and photostable poly (3-octyloxythiophene) (P3OOT). Electron spin resonance measurements revealed that the [P3HT](+center dot) (formed by oxygen doping) decayed, whereas no change was observed in the photostable [P3OOT](+center dot) after light irradiation. Furthermore, the absorption decrease of the [P3HT](+center dot) (P3HT) was suppressed by superoxide dismutase. Therefore, the oxygen dopant is superoxide, which might also initiate the oxidation of P3HT. The photochemical difference between P3HT and P3OOT can be explained by the reaction of an a-proton with superoxide in the case of P3HT.	[Aoyama, Yoshinori; Yoshida, Yuji] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Yokohama, Kanagawa 2268503, Japan; [Aoyama, Yoshinori; Yamanari, Toshihiro; Murakami, Takurou N.; Yoshida, Yuji] Natl Inst Adv Ind Sci & Technol, Res Ctr Photovolta Technol, Ibaraki, Japan; [Nagamori, Tatsuya; Marumoto, Kazuhiro] Univ Tsukuba, Inst Mat Sci, Ibaraki, Japan; [Tachikawa, Hiroto] Hokkaido Univ, Fac Engn, Div Mat Chem, Sapporo, Hokkaido 060, Japan; [Mizukado, Junji; Suda, Hiroyuki] Natl Inst Adv Ind Sci & Technol, Res Inst Innovat Sustainable Chem, Ibaraki, Japan	Yoshida, Y (reprint author), Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Midori Ku, 4259 Nagatsutatyo, Yokohama, Kanagawa 2268503, Japan.	yuji.yoshida@aist.go.jp					Manceau M, 2009, POLYM DEGRAD STABIL, V94, P898, DOI 10.1016/j.polymdegradstab.2009.03.005; Grossiord N, 2012, ORG ELECTRON, V13, P432, DOI 10.1016/j.orgel.2011.11.027; TAINER JA, 1983, NATURE, V306, P284, DOI 10.1038/306284a0; Jorgensen M, 2012, ADV MATER, V24, P580, DOI 10.1002/adma.201104187; Koizumi H, 2005, J PHYS CHEM B, V109, P15288, DOI 10.1021/jp051989k; MCCULLOUGH RD, 1993, J ORG CHEM, V58, P904, DOI 10.1021/jo00056a024; Aoyama Y, 2013, POLYM DEGRAD STABIL, V98, P899, DOI 10.1016/j.polymdegradstab.2013.01.006; Wang MQ, 2008, SOL ENERG MAT SOL C, V92, P766, DOI 10.1016/j.solmat.2008.01.015; Manceau M, 2011, SOL ENERG MAT SOL C, V95, P1315, DOI 10.1016/j.solmat.2010.09.021; Iwan A, 2012, ORG ELECTRON, V13, P2525, DOI 10.1016/j.orgel.2012.07.029; Aguirre A, 2011, ORG ELECTRON, V12, P1657, DOI 10.1016/j.orgel.2011.06.020; Voroshazi E, 2011, SOL ENERG MAT SOL C, V95, P1303, DOI 10.1016/j.solmat.2010.09.007; Jin H, 2010, SOL ENERG MAT SOL C, V94, P465, DOI 10.1016/j.solmat.2009.11.007; Rivaton A, 2010, POLYM DEGRAD STABIL, V95, P278, DOI 10.1016/j.polymdegradstab.2009.11.021; Guerrero A, 2012, SOL ENERG MAT SOL C, V100, P185, DOI 10.1016/j.solmat.2012.01.012; Manceau M, 2008, MACROMOL RAPID COMM, V29, P1823, DOI 10.1002/marc.200800421; Chen L, 2014, CHEM PHYS LETT, V605, P98, DOI 10.1016/j.cplett.2014.05.030; Hoke ET, 2012, ADV ENERGY MATER, V2, P1351, DOI 10.1002/aenm.201200169; Seemann A, 2011, SOL ENERGY, V85, P1238, DOI 10.1016/j.solener.2010.09.007; Sperlich A, 2011, J PHYS CHEM B, V115, P13513, DOI 10.1021/jp2077215; Shen YM, 2012, SOL ENERG MAT SOL C, V99, P263, DOI 10.1016/j.solmat.2011.12.008; Abdou MSA, 1997, J AM CHEM SOC, V119, P4518, DOI 10.1021/ja964229j; Hintz H, 2010, POLYM DEGRAD STABIL, V95, P818, DOI 10.1016/j.polymdegradstab.2010.02.004; ABDOU MSA, 1993, MACROMOLECULES, V26, P2954, DOI 10.1021/ma00063a047; Jorgensen M, 2008, SOL ENERG MAT SOL C, V92, P686, DOI 10.1016/j.solmat.2008.01.005; Chemical Society of Japan, 1990, KIK KAG SOS, V7, P3; CRANK G, 1984, AUST J CHEM, V37, P845; Das N. C., 2010, RENEW ENERG, V35, P2683; Eberhardt M. K., 2001, REACTIVE OXYGEN META, P51; Hatakeyama K, 2009, B CHEM SOC JPN, V82, P202, DOI 10.1246/bcsj.82.202; Marumoto K, 2012, ADV ENERGY MATER, V2, P591, DOI 10.1002/aenm.201100774; MOROOKA Y, 1976, CHEM LETT, P1293, DOI 10.1246/cl.1976.1293; Takeo O, 1999, ACTIVE OXYGEN SPECIE, V27	33	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	JAN	2015	47	1					26	30		10.1038/pj.2014.81		5	Polymer Science	Polymer Science	AY1DG	WOS:000347333100004		
J	Iwata, S; Abe, M; Shoda, S; Kobayashi, S				Iwata, Satoru; Abe, Mitsunori; Shoda, Shin-ichiro; Kobayashi, Shiro			Oxidation-reduction alternating copolymerization of germylene and N-phenyl-p-quinoneimine	POLYMER JOURNAL			English	Article							GERMANIUM-CONTAINING POLYMERS; GROUP-4B METAL ALKYLS; BENZOQUINONE DERIVATIVES; POLY(GERMANIUM ENOLATE); CARBENE ANALOGS; MAIN-CHAIN; POLYMERIZATION; RADICALS; AMIDES; STANNYLENES	The germylenes bis[bis(trimethylsilyl) amido] germanium (1a) and bis[t-butyl-trimethylsilyl] amido] germanium (1b) were reacted with N-phenyl-p-quinoneimine (2) to give copolymers (3a and 3b) with alternating tetravalent germanium and p-aminophenol units. The copolymerization took place smoothly at 0 degrees C without added catalyst or initiator. 1 acted as a reductant monomer, and 2 acted as an oxidant monomer (oxidation-reduction alternating copolymerization). Product copolymers were obtained in very high yields and had high molecular weights. The copolymers were soluble in toluene, benzene, n-hexane and chloroform, whereas they were insoluble in acetonitrile and acetone. Additionally, they were stable toward hydrolytic degradation. Electron spin resonance (ESR) spectroscopic studies of the reaction suggested a structure of a stable germyl radical and a plausible mechanism of biradical copolymerization.	[Iwata, Satoru; Abe, Mitsunori; Shoda, Shin-ichiro; Kobayashi, Shiro] Tohoku Univ, Grad Sch Engn, Dept Chem Mat, Sendai, Miyagi 980, Japan; [Kobayashi, Shiro] Kyoto Inst Technol, Ctr Fiber & Text Sci, Kyoto 6068585, Japan	Kobayashi, S (reprint author), Kyoto Inst Technol, Ctr Fiber & Text Sci, Sakyo Ku, Kyoto 6068585, Japan.	kobayash@kit.ac.jp					NEUMANN WP, 1991, CHEM REV, V91, P311, DOI 10.1021/cr00003a002; Mizuhata Y, 2009, CHEM REV, V109, P3479, DOI 10.1021/cr900093s; Asay M, 2011, CHEM REV, V111, P354, DOI 10.1021/cr100216y; Armitage D. A., 1982, COMPREHENSIVE ORGANO, V2, P1; Bona M. A. D., 1998, J CHEM SOC DA, V1998, P1187, DOI 10.1039/a709141i; CAO S, 1994, J MACROMOL SCI PURE, VA31, P627; FESSENDE.RW, 1965, J CHEM PHYS, V43, P2704, DOI 10.1063/1.1697199; Fetizon M., 1971, J ORG CHEM, V36, P1339, DOI 10.1021/jo00809a004; FJELDBERG T, 1986, J CHEM SOC DALTON, P1551, DOI 10.1039/dt9860001551; GYNANE MJS, 1977, J CHEM SOC DALTON, P2004, DOI 10.1039/dt9770002004; HUDSON A, 1976, J CHEM SOC DALTON, P2369, DOI 10.1039/dt9760002369; IWATA S, 1995, ORGANOMETALLICS, V14, P5533, DOI 10.1021/om00012a020; Kobayashi S, 1996, MACROMOLECULES, V29, P486, DOI 10.1021/ma951208l; KOBAYASHI S, 1991, MACROMOLECULES, V24, P2129, DOI 10.1021/ma00008a072; KOBAYASHI S, 1992, MAKROMOL CHEM-M SYMP, V54-5, P225, DOI 10.1002/masy.19920540119; KOBAYASHI S, 1993, ADV MATER, V5, P57, DOI 10.1002/adma.19930050114; KOBAYASHI S, 1995, J AM CHEM SOC, V117, P2187, DOI 10.1021/ja00113a008; Kobayashi S, 1995, ACTA POLYM, V46, P471, DOI 10.1002/actp.1995.010460611; KOBAYASHI S, 1981, POLYM BULL, V5, P331; Kobayashi S., 1997, DESK REFERENCE FUNCT, P169; KOBAYASHI S, 1992, J AM CHEM SOC, V114, P4929, DOI 10.1021/ja00038a083; KOBAYASHI S, 1994, J AM CHEM SOC, V116, P6047, DOI 10.1021/ja00092a097; KOBAYASHI S, 1990, J AM CHEM SOC, V112, P1625, DOI 10.1021/ja00160a050; Kobayashi S., 1993, RING OPENING POLYM; KOBAYASHI S, 1993, CHEM LETT, P1385, DOI 10.1246/cl.1993.1385; KOBAYASHI S, 1993, CHEM LETT, P25, DOI 10.1246/cl.1993.25; Kobayashi S., 1989, CHEM EXPRESS, V4, P41; Li Y, 2014, CHEM COMMUN, V50, P3356, DOI 10.1039/c4cc00251b; MARUYAMA K, 1964, B CHEM SOC JPN, V37, P897, DOI 10.1246/bcsj.37.897; Riviere P., 1982, COMPREHENSIVE ORGANO, V2, P399; RONCIN J, 1969, J CHEM PHYS, V51, P577, DOI 10.1063/1.1672037; SAEGUSA T, 1981, MACROMOLECULES, V14, P463, DOI 10.1021/ma50003a049; Shoda S, 1997, TETRAHEDRON, V53, P15281, DOI 10.1016/S0040-4020(97)00963-0; Shoda S., 1997, CATALYSIS PRECISION; Shoda SI, 1996, MACROMOL CHEM PHYSIC, V197, P2437, DOI 10.1002/macp.1996.021970807; Sweeder RD, 2003, ORGANOMETALLICS, V22, P3222, DOI 10.1021/om0302589	36	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	JAN	2015	47	1					31	36		10.1038/pj.2014.84		6	Polymer Science	Polymer Science	AY1DG	WOS:000347333100005		
J	Tien, ND; Nishikawa, Y; Hashimoto, M; Tosaka, M; Sasaki, S; Sakurai, S				Nguyen-Dung Tien; Nishikawa, Yukihiro; Hashimoto, Masato; Tosaka, Masatoshi; Sasaki, Sono; Sakurai, Shinichi			Three-dimensional analyses of spherulite morphology in poly(oxyethylene) and its blends with amorphous poly(d, l-lactic acid) using X-ray computerized tomography	POLYMER JOURNAL			English	Article							ISOTACTIC POLYPROPYLENE; LAMELLAR MORPHOLOGY; GROWTH; CRYSTALLIZATION; DENDRITES; POLYMERS; CRACKING; MELT	Here, we report on the three-dimensional structural analyses of huge spherulites of poly(oxyethylene) (PEG) using X-ray computerized tomography (CT) in blends of PEG and amorphous poly(d, l-lactic acid). Large spherulite formation is characteristic of PEG, and its direct observation using X-ray CT is reported here for the first time. Slit-shaped cracks that were straight or curved were clearly observed using X-ray CT. Furthermore, scanning electron microscopic observation revealed that the cracks were parallel to bundles of lamellar crystallites. From these observations, we conclude that a set of radial cracks observed by X-ray CT is a signature of a huge spherulite. Several aspects that are representative of an axialite structure are presented, and they are in good agreement with the intuitively proposed structural model for axialite long ago, although the size scale is much larger in our study.	[Nguyen-Dung Tien; Sasaki, Sono; Sakurai, Shinichi] Kyoto Inst Technol, Dept Biobased Mat Sci, Kyoto 606, Japan; [Nguyen-Dung Tien] Kyoto Inst Technol, Venture Lab, Kyoto 606, Japan; [Nishikawa, Yukihiro; Hashimoto, Masato] Kyoto Inst Technol, Dept Macromol Sci & Engn, Kyoto 606, Japan; [Nishikawa, Yukihiro; Sasaki, Sono; Sakurai, Shinichi] Kyoto Inst Technol, Polymer Mat Sci Res Grp, Kyoto 606, Japan; [Tosaka, Masatoshi] Kyoto Univ, Inst Chem Res, Kyoto 606, Japan; [Sasaki, Sono; Sakurai, Shinichi] Kyoto Inst Technol, Polymer Mat Sci Res Grp, Kyoto 606, Japan	Sakurai, S (reprint author), Kyoto Inst Technol, Dept Biobased Mat Sci, Kyoto 606, Japan.	kiro@kit.ac.jp; shin@kit.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [25102524]	This study was partially supported by the Grant-in-Aid for Scientific Research on Innovative Areas, 'New Polymeric Materials Based on Element-Blocks' (No. 25102524), from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Nishikawa Y, 2013, INT J POLYM MATER PO, V62, P295, DOI 10.1080/00914037.2012.664215; Granasy L, 2003, NAT MATER, V2, P92, DOI 10.1038/nmat815; Wang ZB, 2008, MACROMOLECULES, V41, P7584, DOI 10.1021/ma8005697; BASSETT DC, 1985, POLYMER, V26, P717, DOI 10.1016/0032-3861(85)90109-0; KELLER A, 1955, J POLYM SCI, V17, P447, DOI 10.1002/pol.1955.120178601; BASSETT DC, 1984, POLYMER, V25, P935, DOI 10.1016/0032-3861(84)90076-4; Brandrup J., 1989, POLYM HDB; COISH RA, 1979, EARTH PLANET SC LETT, V42, P389, DOI 10.1016/0012-821X(79)90048-7; Davis BK, 1996, J VOLCANOL GEOTH RES, V71, P1, DOI 10.1016/0377-0273(95)00063-1; Fowler AD, 2002, PRECAMBRIAN RES, V115, P311, DOI 10.1016/S0301-9268(02)00014-1; Fraschini C, 2005, J POLYM SCI POL PHYS, V43, P3308, DOI 10.1002/polb.20616; Herman GT, 2009, ADV PATTERN RECOGNIT, P1, DOI 10.1007/978-1-84628-723-7; INOUE M, 1961, J POLYM SCI, V55, P443, DOI 10.1002/pol.1961.1205516203; Khoury F., 1976, TREATISE SOLID STATE, P335; KHOURY F, 1966, J RES NBS A PHYS CH, VA 70, P29, DOI 10.6028/jres.070A.006; Nishikawa Y, 2012, POLYMER, V53, P4287, DOI 10.1016/j.polymer.2012.07.040; PRASAD PBV, 1984, CRYST RES TECHNOL, V19, P1549, DOI 10.1002/crat.2170191204; PRICE FP, 1973, J PHYS CHEM-US, V77, P396, DOI 10.1021/j100622a018; Sand K. K., 2011, CRYST GROWTH DES, V12, P842; Schultz J. M., 2001, POLYM CRYSTALLIZATIO; Sperling LH, 1986, INTRO PHYS POLYM SCI; TANAKA H, 1985, PHYS REV LETT, V55, P1102, DOI 10.1103/PhysRevLett.55.1102; Tien ND, 2014, POLYMER, V55, P2562, DOI 10.1016/j.polymer.2014.03.048; Tien ND, 2013, POLYMER, V54, P4653, DOI 10.1016/j.polymer.2013.06.028; Woodward A. E., 1989, ATLAS POLYM MORPHOLO	25	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	JAN	2015	47	1					37	44		10.1038/pj.2014.83		8	Polymer Science	Polymer Science	AY1DG	WOS:000347333100006		
J	Naga, N; Sakurai, T; Furukawa, H				Naga, Naofumi; Sakurai, Takaaki; Furukawa, Hidemitsu			Structure and formation processes of syndiotactic-polystyrene or styrene-based copolymer-organic solvent gels studied using scanning microscopic light scattering	POLYMER JOURNAL			English	Article							PHYSICAL GELATION; THERMOREVERSIBLE GELATION; INFRARED-SPECTROSCOPY; CHLOROFORM; PHASES; VOLUME; SIZE	The network structure of syndiotactic-polystyrene (sPS)- or syndiotactic-poly(styrene-co-4-R-styrene)-organic solvent gels has been quantitatively studied by means of scanning microscopic light scattering (SMILS). SMILS analysis indicated that sPS gels prepared in chloroform, benzene, toluene, and o-dichlorobenzene (ODCB) formed network structures with small mesh sizes, similar to 0.6-1.8 nm, and large cluster structures, similar to 1000-6000 nm. The cluster size in the gels increased with increasing sPS concentration. The mesh and cluster sizes of sPS gels prepared in ODCB was the smallest among the used solvents owing to its high viscosity. Gelation of the St/CH(3)St (MeSt)-toluene system at high temperatures induced slow gel formation and made it possible to trace the time evolution of the network structure by SMILS. tert-C(4)H(9)St (BuSt) units in St/BuSt drastically decreased the gel formation rate, and the formation process of the St/BuSt-toluene system could be traced by SMILS and FT-IR spectroscopy at room temperature. The results indicated growth of the cluster structure during gelation. St/4-hydroxystyrene formed gels in dioxane. A gel of an St copolymer containing an anthracene (An) group was prepared in toluene, and photodimerization of the An groups was induced by UV irradiation accompanied by formation of the large cluster structure.	[Naga, Naofumi; Sakurai, Takaaki] Shibaura Inst Technol, Grad Sch Engn & Sci, Tokyo 1358548, Japan; [Furukawa, Hidemitsu] Yamagata Univ, Life Printing Innovat Ctr 3D, Yamagata 990, Japan	Naga, N (reprint author), Shibaura Inst Technol, Grad Sch Engn & Sci, Coll Engn, Koto Ku, 3-7-5 Toyosu, Tokyo 1358548, Japan.	nnaga@sic.shibaura-it.ac.jp					Daniel C, 1997, POLYMER, V38, P4193, DOI 10.1016/S0032-3861(96)01005-1; Furukawa H, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.031406; Daniel C, 2003, MACROMOLECULES, V36, P5742, DOI 10.1021/ma034430w; Daniel C, 2003, MACROMOLECULES, V36, P1713, DOI 10.1021/ma0215641; Daniel C, 1996, POLYMER, V37, P1273, DOI 10.1016/0032-3861(96)80854-8; Daniel C, 2007, MACROMOL SYMP, V251, P1, DOI 10.1002/masy.200750501; Furukawa H, 2006, HIGH PERFORM POLYM, V18, P837, DOI 10.1177/0954008306068270; Gowd EB, 2009, PROG POLYM SCI, V34, P280, DOI 10.1016/j.progpolymsci.2008.11.002; Itagaki H, 2005, MACROMOLECULES, V38, P9625, DOI 10.1021/ma051743d; KOBAYASHI M, 1993, APPL SPECTROSC, V47, P1417, DOI 10.1366/0003702934067450; KOBAYASHI M, 1995, MACROMOLECULES, V28, P7376, DOI 10.1021/ma00126a015; KOBAYASHI M, 1990, MACROMOLECULES, V23, P78, DOI 10.1021/ma00203a015; Malik S, 2005, MACROMOLECULES, V38, P4888, DOI 10.1021/ma047355d; MUNCH JP, 1977, J PHYS-PARIS, V38, P971, DOI 10.1051/jphys:01977003808097100; Naga N, 2009, MACROMOLECULES, V42, P3454, DOI 10.1021/ma802745x; Nakatani H, 1997, POLYMER, V38, P4751, DOI 10.1016/S0032-3861(96)01067-1; Rudder J. D., 2002, MACROMOLECULES, V35, P9529; Shimizu H, 2005, POLYM J, V37, P294, DOI 10.1295/polymj.37.294	18	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	JAN	2015	47	1					45	52		10.1038/pj.2014.85		8	Polymer Science	Polymer Science	AY1DG	WOS:000347333100007		
J	Osa, M; Itoda, Y; Suzuki, Y; Yumoto, T; Yoshida, A				Osa, Masashi; Itoda, Yu; Suzuki, Yuki; Yumoto, Takaya; Yoshida, Ayaka			A fluorescence probe study on the effects of surfactants on cloud points in aqueous poly(N-isopropylacrylamide) solutions	POLYMER JOURNAL			English	Article							COIL-GLOBULE TRANSITION; SODIUM DODECYL-SULFATE; N-ISOPROPYLACRYLAMIDE; PHASE-TRANSITION; WATER; PH	Fluorescence probe methods were used to investigate micelle formation of poly(N-isopropylacrylamide) (PNIPA) with two types of surfactants, anionic sodium n-dodecyl sulfate (SDS) and cationic n-dodecyltrimethylammonium chloride (DTAC), in aqueous solutions using pyrene or 1-pyrenecarboxaldehyde as a fluorescence probe. Two PNIPA samples, one having a hydrophobic chain-end group and the other having a negatively charged hydrophilic chain-end group, were used to investigate the effects of the chain-end group on the formation of the micelles. The critical aggregation concentration, at which surfactant molecules begin to bind to PNIPA chains to form micelles, was observed to be much lower for PNIPA solutions containing SDS than for solutions containing DTAC. This is consistent with previous results showing that the cloud point in PNIPA solutions containing SDS begins to increase from its value in surfactant-free solutions at a much lower concentration of added surfactant than that in solutions containing DTAC. It was also observed that there is a discrepancy in the emission spectra of solutions containing SDS between the two PNIPA samples but not for solutions containing DTAC, indicating that the chain-end groups of PNIPA may affect the microenvironmental polarity in the micelles composed of PNIPA and the surfactants.	[Osa, Masashi; Itoda, Yu; Suzuki, Yuki; Yumoto, Takaya; Yoshida, Ayaka] Aichi Univ Educ, Dept Chem, Kariya, Aichi 4488542, Japan	Osa, M (reprint author), Aichi Univ Educ, Dept Chem, 1 Hirosawa,Igaya Cho, Kariya, Aichi 4488542, Japan.	mosa@auecc.aichi-edu.ac.jp					Abuin E, 1999, COLLOID SURFACE A, V147, P55, DOI 10.1016/S0927-7757(98)00753-5; Al-Manasir N, 2012, COLLOID POLYM SCI, V290, P931, DOI 10.1007/s00396-012-2607-0; KOKUFUTA E, 1993, MACROMOLECULES, V26, P1053, DOI 10.1021/ma00057a027; SCHILD HG, 1991, LANGMUIR, V7, P665, DOI 10.1021/la00052a013; WOOTEN WC, 1957, J POLYM SCI, V25, P403, DOI 10.1002/pol.1957.1202511102; SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R; Wu C, 1996, J POLYM SCI POL PHYS, V34, P1597; Walter R, 1996, MACROMOLECULES, V29, P4019, DOI 10.1021/ma951529x; MEEWES M, 1991, MACROMOLECULES, V24, P5811, DOI 10.1021/ma00021a014; SCHILD HG, 1990, LANGMUIR, V6, P1676, DOI 10.1021/la00101a009; RINGSDORF H, 1991, MACROMOLECULES, V24, P1678, DOI 10.1021/ma00007a034; Kawaguchi T, 2008, POLYM J, V40, P455, DOI 10.1295/polymj.PJ2007227; GODDARD ED, 1986, COLLOID SURFACE, V19, P255, DOI 10.1016/0166-6622(86)80340-7; Holmberg K., 2003, SURFACTANTS POLYM AQ; Ise T, 2011, POLYM J, V43, P164, DOI 10.1038/pj.2010.121; KALYANASUNDARAM K, 1977, J PHYS CHEM-US, V81, P2176, DOI 10.1021/j100538a008; Kawaguchi T, 2009, J PHYS CHEM B, V113, P5440, DOI 10.1021/jp9005795; Kawaguchi T, 2008, POLYM J, V40, P528, DOI 10.1295/polymj.PJ2008024; Kobayashi K, 2009, POLYM J, V41, P416, DOI 10.1295/polymj.PJ2008315; Osa M, 2013, POLYM J, V45, P681, DOI 10.1038/pj.2012.183; Uehara N, 2014, LANGMUIR, V30, P6367, DOI 10.1021/la500900n; Wu W, 2014, J POLYM RES, V21, DOI 10.1007/s10965-014-0494-4	22	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	JAN	2015	47	1					59	65				7	Polymer Science	Polymer Science	AY1DG	WOS:000347333100009		
J	Tokuda, K; Ogino, T; Kotera, M; Nishino, T				Tokuda, Kaya; Ogino, Tomoya; Kotera, Masaru; Nishino, Takashi			Simple method for lowering poly(methyl methacrylate) surface energy with fluorination	POLYMER JOURNAL			English	Article							PERFLUOROALKYL SIDE-CHAINS; POLY(ACRYLIC ACID); COPOLYMERS; MONOLAYERS; ADHESION; DIBLOCK	A poly(methyl methacrylate) (PMMA) surface was fluorinated by immersion in 3-(perfluoro-7-methyloctyl)-1,2-epoxypropene and subsequent heat treatment at 120 degrees C. The water contact angle on PMMA increased from 67 degrees to 111 degrees after the fluorination treatment with no loss of optical transparency. This high contact angle corresponds to a surface free energy of 10 mJ m(-2), which is much lower than that of poly(tetrafluoroethylene) (22 mJ m(-2)). X-ray photoelectron spectroscopy analysis revealed that the surface was almost completely covered by fluoroalkyl groups, which imparted high hydrophobicity. This simple fluorination method effectively lowers the surface free energy of PMMA. The fluorinated PMMA also demonstrated low albumin adsorption, low blood clotting and antifouling properties against fingerprints. These characteristics reveal that fluorinated PMMA generated by a simple immersion treatment could serve as an antithrombogenic or antifingerprint fouling material.	[Tokuda, Kaya; Ogino, Tomoya; Kotera, Masaru; Nishino, Takashi] Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Kobe, Hyogo 6578501, Japan	Nishino, T (reprint author), Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Nada Ku, Kobe, Hyogo 6578501, Japan.	tnishino@kobe-u.ac.jp					SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815; Nystrom D, 2009, ACS APPL MATER INTER, V1, P816, DOI 10.1021/am800235e; TAMADA Y, 1993, J COLLOID INTERF SCI, V155, P334, DOI 10.1006/jcis.1993.1044; Durand N, 2011, MACROMOLECULES, V44, P6249, DOI 10.1021/ma200921b; Urushihara Y, 2005, LANGMUIR, V21, P2614, DOI 10.1021/la047317n; Guo YL, 2010, ACS NANO, V4, P5749, DOI 10.1021/nn101463j; Nishino T, 2004, J COLLOID INTERF SCI, V279, P364, DOI 10.1016/j.jcis.2004.06.082; Park D, 2010, LANGMUIR, V26, P9772, DOI 10.1021/la100032n; Nishino T, 1999, LANGMUIR, V15, P4321, DOI 10.1021/la981727s; HARE EF, 1954, J PHYS CHEM-US, V58, P236, DOI 10.1021/j150513a011; Tsougeni K, 2010, LANGMUIR, V26, P13883, DOI 10.1021/la101957w; WASSERMAN SR, 1989, LANGMUIR, V5, P1074, DOI 10.1021/la00088a035; Booth B. D., 2011, LANGMUIR, V27, P5090; Fowkes S. M., 1963, J PHYS CHEM-US, V67, P2538; Kessman AJ, 2011, LANGMUIR, V27, P5968, DOI 10.1021/la2000238; Klein RJ, 2011, LANGMUIR, V27, P12423, DOI 10.1021/la202294f; McCarley RL, 2005, J AM CHEM SOC, V127, P842, DOI 10.1021/ja0454135; Nishino T, 1999, INT J ADHES ADHES, V19, P399, DOI 10.1016/S0143-7496(98)00063-3; Sogiv J, 1980, J AM CHEM SOC, V102, P92; Sumiya K., 1982, J ADHES SOC JPN, V18, P345; Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4; TERLINGEN JGA, 1994, J APPL POLYM SCI, V52, P39, DOI 10.1002/app.1994.070520105; TERLINGEN JGA, 1993, J APPL POLYM SCI, V50, P1529, DOI 10.1002/app.1993.070500906; TILLMAN N, 1989, LANGMUIR, V5, P101, DOI 10.1021/la00085a019; Vroman L, 1969, J Biomed Mater Res, V3, P43, DOI 10.1002/jbm.820030106; Zisman W. A., 1964, ADV CHEM SER, p[43, 1]	27	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	JAN	2015	47	1					66	70		10.1038/pj.2014.91		5	Polymer Science	Polymer Science	AY1DG	WOS:000347333100010		
J	Ohno, S; Hasegawa, S; Liu, HH; Ishihara, K; Yusa, SI				Ohno, Sayaka; Hasegawa, Shoto; Liu, Huihua; Ishihara, Kazuhiko; Yusa, Shin-ichi			Aggregation behavior in water of amphiphilic diblock copolymers bearing biocompatible phosphorylcholine and cholesteryl groups	POLYMER JOURNAL			English	Article							BLOCK-COPOLYMERS; LIGHT-SCATTERING; DISPERSION POLYMERIZATION; MULTIPLE MORPHOLOGIES; FLUORESCENT-PROBES; MOLECULAR-WEIGHT; AQUEOUS-SOLUTION; BINARY-MIXTURES; POLYMERS; MICELLES	Poly(2-(methacryloyloxy) ethyl phosphorylcholine)-block-poly(cholesteryl 6-methacryloyloxyhexanoate) (PMPC82-b-PChM(n)) copolymers with different PChM block lengths were prepared via reversible addition-fragmentation chain transfer controlled/living radical polymerization using a PMPC-based macro-chain transfer agent. The subscript number and n (= 3 and 6) refer to the degree of polymerization of the PMPC and PChM blocks, respectively. PMPC82-b-PChM(n) cannot dissolve in water directly due to the strong hydrophobic nature of the PChM block. To prepare the aqueous solution, the diblock copolymer was dissolved in an organic solvent and then dialyzed against pure water. These diblock copolymers formed spherical and rod-like micelles in water, depending on the composition of cholesteryl (Chol) group in the polymer. The prepared aggregates were characterized using static light scattering, dynamic light scattering, transmission electron microscopy and fluorescence probe techniques. The characterization results suggest that the morphology of the polymer aggregates can be controlled from spherical to rod-like micelles by increasing the number of Chol groups in the polymer.	[Ohno, Sayaka; Hasegawa, Shoto; Yusa, Shin-ichi] Univ Hyogo, Grad Sch Engn, Dept Mat Sci & Chem, Himeji, Hyogo 6712280, Japan; [Liu, Huihua] Federat Univ Australia, Sch Hlth Sci, Mt Helen, Vic, Australia; [Ishihara, Kazuhiko] Univ Tokyo, Dept Mat Engn, Tokyo, Japan	Yusa, SI (reprint author), Univ Hyogo, Grad Sch Engn, Dept Mat Sci & Chem, 2167 Shosha, Himeji, Hyogo 6712280, Japan.	yusa@eng.u-hyogo.ac.jp			Japan Society for the Promotion of Science (JSPS) [25288101]; Network Joint Research Center for Materials and Devices [2013B25]	This work was financially supported by a Grant-in-Aid for Scientific Research (25288101) from the Japan Society for the Promotion of Science (JSPS) and the Network Joint Research Center for Materials and Devices (2013B25).	ABE K, 1977, MACROMOLECULES, V10, P1259, DOI 10.1021/ma60060a020; Pinol R, 2007, MACROMOLECULES, V40, P5625, DOI 10.1021/ma071064y; Zhang LF, 1996, J AM CHEM SOC, V118, P3168, DOI 10.1021/ja953709s; QUINTANA JR, 1995, MACROMOLECULES, V28, P4139, DOI 10.1021/ma00116a013; Venkataraman S, 2013, MACROMOLECULES, V46, P4839, DOI 10.1021/ma400423b; Jia L, 2009, SOFT MATTER, V5, P3446, DOI 10.1039/b907485f; Blanazs A, 2012, MACROMOLECULES, V45, P5099, DOI 10.1021/ma301059r; Hayward RC, 2010, MACROMOLECULES, V43, P3577, DOI 10.1021/ma9026806; Mitsukami Y, 2001, MACROMOLECULES, V34, P2248, DOI 10.1021/ma0018087; Xu JP, 2005, J CONTROL RELEASE, V107, P502, DOI 10.1016/j.jconrel.2005.06.013; MCCLURE WO, 1966, BIOCHEMISTRY-US, V5, P1908, DOI 10.1021/bi00870a018; Boisse S, 2009, MACROMOLECULES, V42, P8688, DOI 10.1021/ma9018137; XU RL, 1991, MACROMOLECULES, V24, P87, DOI 10.1021/ma00001a014; VILLACAMPA M, 1995, MACROMOLECULES, V28, P4144, DOI 10.1021/ma00116a014; KONISHI T, 1991, MACROMOLECULES, V24, P5614, DOI 10.1021/ma00020a021; SHANNON PJ, 1983, MACROMOLECULES, V16, P1677, DOI 10.1021/ma00244a023; ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355; ZIMM BH, 1948, J CHEM PHYS, V16, P1093, DOI 10.1063/1.1746738; HUBER K, 1985, MACROMOLECULES, V18, P1461, DOI 10.1021/ma00149a017; AKCASU AZ, 1979, MACROMOLECULES, V12, P276, DOI 10.1021/ma60068a022; Zhou YX, 2011, MACROMOLECULES, V44, P3924, DOI 10.1021/ma102922u; Jakes J, 1995, COLLECT CZECH CHEM C, V60, P1781, DOI 10.1135/cccc19951781; YAMAGUCHI T, 1989, MACROMOLECULES, V22, P1141, DOI 10.1021/ma00193a024; Nakai K, 2013, LANGMUIR, V29, P9651, DOI 10.1021/la401063b; He WD, 2011, MACROMOLECULES, V44, P3358, DOI 10.1021/ma2000674; Iwasaki Y, 2006, BIOMACROMOLECULES, V7, P1433, DOI 10.1021/bm050917w; Lima MMD, 2003, LANGMUIR, V19, P24; Lobb EJ, 2001, J AM CHEM SOC, V123, P7913, DOI 10.1021/ja003906d; Ma I., 2003, MACROMOLECULES, V35, P9306; OVERATH P, 1973, BIOCHEMISTRY-US, V12, P2625, DOI 10.1021/bi00738a012; Yang H, 2010, MACROMOLECULES, V43, P10442, DOI 10.1021/ma100921s	31	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	JAN	2015	47	1					71	76		10.1038/pj.2014.92		6	Polymer Science	Polymer Science	AY1DG	WOS:000347333100011		
J	Kato, T; Kanba, S				Kato, Tadafumi; Kanba, Shigenobu			Conquering depression	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Editorial Material									[Kato, Tadafumi] RIKEN Brain Sci Inst, Lab Mol Dynam Mental Disorders, Wako, Saitama, Japan; [Kanba, Shigenobu] Kyushu Univ, Dept Neuropsychiat, Fukuoka 812, Japan	Kato, T (reprint author), RIKEN Brain Sci Inst, Lab Mol Dynam Mental Disorders, Wako, Saitama, Japan.						Onishi Y, 2013, CLIN DRUG INVEST, V33, P597, DOI 10.1007/s40261-013-0104-y; Kanba S, 2012, PSYCHIAT CLIN NEUROS, V67, P285; Ono Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074902; SHINFUKU N, 1969, FORTSCHR NEUROL P I, V37, P545	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	JAN	2015	69	1			SI		1	2		10.1111/pcn.12257		2	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	AY1BP	WOS:000347328800001		
J	Teraishi, T; Hori, H; Sasayama, D; Matsuo, J; Ogawa, S; Ishida, I; Nagashima, A; Kinoshita, Y; Ota, M; Hattori, K; Higuchi, T; Kunugi, H				Teraishi, Toshiya; Hori, Hiroaki; Sasayama, Daimei; Matsuo, Junko; Ogawa, Shintaro; Ishida, Ikki; Nagashima, Anna; Kinoshita, Yukiko; Ota, Miho; Hattori, Kotaro; Higuchi, Teruhiko; Kunugi, Hiroshi			Personality in remitted major depressive disorder with single and recurrent episodes assessed with the Temperament and Character Inventory	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article						harm avoidance; major depression; recurrence; remission; Temperament and Character Inventory	AGE-OF-ONSET; BIPOLAR DISORDER; HARM AVOIDANCE; YOUNG-ADULTS; EPIDEMIOLOGY; NEUROTICISM; POPULATION; VARIABLES; SPECTRUM; TRAITS	AimPrevious studies consistently reported increased harm avoidance (HA) assessed with the Temperament and Character Inventory (TCI) in patients with major depressive disorder (MDD). However, such findings may have been related with depression severity and number of depressive episodes. The aims of the present study were twofold: to examine TCI personality profile in remitted MDD (DSM-IV) patients and to compare TCI personality between MDD patients with single episode (SGL-MDD) and those with recurrent episodes (REC-MDD) in order to elucidate personality profile associated with recurrence. MethodsTCI was administered to 86 outpatients with remitted SGL-MDD (12 male and 17 female patients; mean age 43.212.1 years) and REC-MDD (26 male and 31 female patients; 40.311.6 years), and 529 healthy controls (225 men and 304 women; 43.4 +/- 15.5 years), matched for age, sex and education years. Logistic regression analyses were performed in which single/recurrent episodes of depression were the dependent variable and age, sex, age of onset, family history of psychiatric disease and TCI scores were entered as possible predictors. ResultsThe remitted MDD patients had significantly higher scores on HA (P<0.001) and lower scores on self-directedness (P<0.001), compared with the controls. HA (P=0.03), its subscore, fatigability (P=0.03), and family history of psychiatric disease were found to be positive predictors for recurrence. ConclusionThere are differences in personality profile between remitted MDD patients and controls, and between remitted REC-MDD and SGL-MDD patients, suggesting that they are trait markers. HA and fatigability might be useful to assess risk for recurrence of depression.	[Teraishi, Toshiya; Hori, Hiroaki; Sasayama, Daimei; Matsuo, Junko; Ogawa, Shintaro; Ishida, Ikki; Nagashima, Anna; Kinoshita, Yukiko; Ota, Miho; Hattori, Kotaro; Kunugi, Hiroshi] Natl Inst Neurosci, Dept Mental Disorder Res, Tokyo, Japan; [Higuchi, Teruhiko] Natl Ctr Neurol & Psychiat, Kodaira, Tokyo 1878502, Japan	Kunugi, H (reprint author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Disorder Res, 4-1-1 Ogawahigashi, Kodaira, Tokyo 1878502, Japan.	hkunugi@ncnp.go.jp			Intramural Research Grant for Neurological and Psychiatric Disorders of the NCNP; Health and Labour Sciences Research Grants; Ministry of Education, Culture, Sports, Science and Technology of Japan	This study was supported by an Intramural Research Grant for Neurological and Psychiatric Disorders of the NCNP, Health and Labour Sciences Research Grants, and 'Understanding of molecular and environmental bases for brain health' carried out under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan. We thank Yuki Mitsuyama, Junko Iida, Manami Sakairi, Kentaro Yoda and Miku Fujita for assistance in the neuropsychological tests and recruitment of participants and all the volunteers for their participation. All authors declare that they have no conflicts of interest.	Akkaya C, 2013, NOROPSIKIYATRI ARS, V50, P122, DOI 10.4274/npa.y6279; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Andrade L, 2003, INT J METH PSYCH RES, V12, P3, DOI 10.1002/mpr.138; Jylha P, 2009, DEPRESS ANXIETY, V26, P325, DOI 10.1002/da.20385; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P853; Smith DJ, 2005, J AFFECT DISORDERS, V87, P83, DOI 10.1016/j.jad.2005.03.014; Otsubo T, 2005, PSYCHIAT CLIN NEUROS, V59, P517, DOI 10.1111/j.1440-1819.2005.01408.x; Klein DN, 1999, J AFFECT DISORDERS, V55, P149, DOI 10.1016/S0165-0327(99)00020-8; Fanous AH, 2007, PSYCHOL MED, V37, P1163, DOI 10.1017/S0033291707000244; Brody AL, 2000, J CLIN PSYCHIAT, V61, P349; Solomon DA, 2000, AM J PSYCHIAT, V157, P229, DOI 10.1176/appi.ajp.157.2.229; Angst J, 2003, J AFFECT DISORDERS, V73, P133, DOI 10.1016/S0165-0327(02)00322-1; Abrams KY, 2004, PSYCHIAT CLIN NEUROS, V58, P240, DOI 10.1111/j.1440-1819.2004.01226.x; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975; BOYCE P, 1993, J AFFECT DISORDERS, V27, P101, DOI 10.1016/0165-0327(93)90082-U; Evans L, 2005, J AFFECT DISORDERS, V85, P153, DOI 10.1016/j.jad.2003.10.015; Engstrom C, 2004, J AFFECT DISORDERS, V82, P131, DOI 10.1016/j.jad.2003.09.004; Ormel J, 2001, AM J PSYCHIAT, V158, P885, DOI 10.1176/appi.ajp.158.6.885; Farmer A, 2003, ARCH GEN PSYCHIAT, V60, P490, DOI 10.1001/archpsyc.60.5.490; Celikel FC, 2009, COMPR PSYCHIAT, V50, P556, DOI 10.1016/j.comppsych.2008.11.012; Hori H, 2008, PSYCHIAT RES, V160, P175, DOI 10.1016/j.psychres.2007.05.015; Burcusa SL, 2007, CLIN PSYCHOL REV, V27, P959, DOI 10.1016/j.cpr.2007.02.005; Nery FG, 2009, DEPRESS ANXIETY, V26, P382, DOI 10.1002/da.20478; BLAND RC, 1986, ARCH GEN PSYCHIAT, V43, P1085; CLONINGER CR, 1987, ARCH GEN PSYCHIAT, V44, P573; AKISKAL HS, 1983, ARCH GEN PSYCHIAT, V40, P801; Fava M, 1996, AM J PSYCHIAT, V153, P1308; Gaecka E, 2013, MOL BIOL REP, V40, P1693; Gelfin Y, 1998, AM J PSYCHIAT, V155, P290; HAMILTON M, 1967, BRIT J SOC CLIN PSYC, V6, P278; Jylha P, 2006, EUR PSYCHIAT, V21, P389, DOI 10.1016/j.eurpsy.2005.09.003; Kijimas N, 1996, ARCH PSYCHIAT DIAGN, V7, P379; Koorevaar AML, 2013, J AFFECT DISORDERS, V151, P178, DOI 10.1016/j.jad.2013.05.075; Kraepelin E, 1903, PSYCHIAT LEHRBUCH ST; MULDER RT, 1994, PSYCHOL REP, V75, P1315; Panel Development, 1985, AM J PSYCHIAT, V142, P469; Richter J, 2000, EUR ARCH PSY CLIN N, V250, P40, DOI 10.1007/PL00007538; Sasayama D, 2011, J AFFECT DISORDERS, V132, P319, DOI 10.1016/j.jad.2011.03.009; Smith DJ, 2005, J AFFECT DISORDERS, V84, P167, DOI 10.1016/j.jad.2004.02.005; Takahashi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063756	40	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	JAN	2015	69	1			SI		3	11		10.1111/pcn.12218		9	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	AY1BP	WOS:000347328800002		
J	Ozaki, N; Otsubo, T; Kato, M; Higuchi, T; Ono, H; Kamijima, K				Ozaki, Norio; Otsubo, Tempei; Kato, Masaki; Higuchi, Teruhiko; Ono, Hiroaki; Kamijima, Kunitoshi		ADMIRE Study Grp	Efficacy of aripiprazole augmentation in Japanese patients with major depressive disorder: A subgroup analysis and Montgomery-Asberg Depression Rating Scale and Hamilton Rating Scale for Depression item analyses of the Aripiprazole Depression Multicenter Efficacy study	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article						aripiprazole; augmentation therapy; Japanese; major depressive disorder; subgroup analysis	TREATMENT-RESISTANT DEPRESSION; DOUBLE-BLIND; ADJUNCTIVE THERAPY; INADEQUATE-RESPONSE; ANTIDEPRESSANTS; METAANALYSIS; GUIDELINES; RECEPTORS; SAFETY	AimResults from this randomized, placebo-controlled study of aripiprazole augmentation to antidepressant therapy (ADT) in Japanese patients with major depressive disorder (MDD) (the Aripiprazole Depression Multicenter Efficacy [ADMIRE] study) revealed that aripiprazole augmentation was superior to ADT alone and was well tolerated. In subgroup analyses, we investigated the influence of demographic- and disease-related factors on the observed responses. We also examined how individual symptom improvement was related to overall improvement in MDD. MethodsData from the ADMIRE study were analyzed. Subgroup analyses were performed on the primary outcome measures: the mean change in the Montgomery-angstrom sberg Depression Rating Scale (MADRS) total score from the end of selective serotonin reuptake inhibitor (SSRI)/serotonin norepinephrine reuptake inhibitor (SNRI) treatment to the end of the randomized treatment. ResultsChanges in the MADRS total scores were consistently greater with aripiprazole than placebo in each of the subgroups. Efficacy was not related to sex, age, number of adequate ADT trials in the current episode, MDD diagnosis, number of depressive episodes, duration of the current episode, age at first depressive episode, time since the first depressive episode, type of SSRI/SNRI, or severity at the end of SSRI/SNRI treatment phase. Compared to placebo, aripiprazole resulted in significant and rapid improvement on seven of the 10 MADRS items, including sadness. ConclusionThese post-hoc analyses indicated that aripiprazole was effective for a variety of Japanese patients with MDD who had exhibited inadequate responses to ADT. Additionally, we suggest that aripiprazole significantly and rapidly improved the core depressive symptoms.	[Ozaki, Norio] Nagoya Univ, Dept Psychiat, Grad Sch Med, Nagoya, Aichi 4668550, Japan; [Otsubo, Tempei] Tokyo Shinjuku Med Ctr, Dept Psychiat & Psychosomat Med, Tokyo, Japan; [Higuchi, Teruhiko] Natl Ctr Neurol & Psychiat, Tokyo, Japan; [Ono, Hiroaki] Otsuka Pharmaceut Co Ltd, Tokyo, Japan; [Kato, Masaki] Kansai Med Univ, Dept Neuropsychiat, Osaka, Japan; [Kamijima, Kunitoshi] Int Univ Hlth & Welf, Otawara, Japan	Ozaki, N (reprint author), Nagoya Univ, Dept Psychiat, Grad Sch Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	ozaki-n@med.nagoya-u.ac.jp	Ozaki, Norio/M-8908-2014	Ozaki, Norio/0000-0002-7360-4898	Otsuka Pharmaceutical Co., Ltd.; Abbvie; Asahi Kasei Pharma; Astellas; Dainippon Sumitomo; Eisai; Eli Lilly; GlaxoSmithKline; Janssen; Meiji Seika Pharma; Mochida; MSD; Novartis Pharma; Ono; Otsuka; Pfizer; Shionogi; Takeda; Tanabe Mitsubishi; Sanofi; Yoshitomi; Abbot; Bristol-Myers Squibb; Chugai; Kyowa-Hakko Kirin; Taisho Toyama	The authors thank the participants of this study and the members of the ADMIRE study group. We acknowledge Sakiko Yamada (Otsuka Pharmaceutical Co., Ltd) for editorial assistance with the manuscript. This study was supported by Otsuka Pharmaceutical Co., Ltd. Dr Ozaki has received research support or speakers' honoraria from, or has served as a consultant to, Abbvie, Asahi Kasei Pharma, Astellas, Dainippon Sumitomo, Eisai, Eli Lilly, GlaxoSmithKline, Janssen, Meiji Seika Pharma, Mochida, MSD, Novartis Pharma, Ono, Otsuka, Pfizer, Shionogi, Takeda, Tanabe Mitsubishi, Sanofi, and Yoshitomi. Dr Otsubo has received speakers' honoraria from Eli Lilly, GlaxoSmithKline, Mochida, MSD, Otsuka, Pfizer, and Tanabe Mitsubishi. Dr Kato has received speakers' honoraria from GlaxoSmithKline and Otsuka. Dr Higuchi has received research support or speakers' honoraria from, or has served as a consultant to, Abbot, Asahi Kasei Pharma, Bristol-Myers Squibb, Chugai, Dainippon Sumitomo, Eli Lilly, GlaxoSmithkline, Janssen, Kyowa-Hakko Kirin, Meiji Seika Pharma, Mochida, MSD, Otsuka, Pfizer, Shionogi, Taisho Toyama and Tanabe Mitsubishi. Mr Ono is an employee of Otsuka Pharmaceutical Co., Ltd. Dr Kamijima has served as a consultant to Asahi Kasei Pharma and has received speakers' honoraria from Pfizer, GlaxoSmithKline, Otsuka, Astellas, Eli Lilly, Shionogi, Dainihon Sumitomo, MSD, Yoshitomi, and Mochida.	Papakostas GI, 2007, J CLIN PSYCHIAT, V68, P826; Berman RM, 2007, J CLIN PSYCHIAT, V68, P843; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Bauer M, 2013, WORLD J BIOL PSYCHIA, V14, P334, DOI 10.3109/15622975.2013.804195; Burris KD, 2002, J PHARMACOL EXP THER, V302, P381, DOI 10.1124/jpet.102.033175; Lam RW, 2009, J AFFECT DISORDERS, V117, pS26, DOI 10.1016/j.jad.2009.06.041; El-Khalili N, 2010, INT J NEUROPSYCHOPH, V13, P917, DOI 10.1017/S1461145710000015; Fava M, 2003, BIOL PSYCHIAT, V53, P649, DOI 10.1016/S0006-3223(03)00231-2; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; Stark AD, 2007, PSYCHOPHARMACOLOGY, V190, P373, DOI 10.1007/s00213-006-0621-y; Marcus RN, 2008, J CLIN PSYCHOPHARM, V28, P156, DOI [10.1097/JCP.0b013e31816774f9, 10.1097/JCP.0b13e318677489]; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Nelson JC, 2009, AM J PSYCHIAT, V166, P980, DOI 10.1176/appi.ajp.2009.09030312; Tohen M, 2010, J CLIN PSYCHIAT, V71, P451, DOI 10.4088/JCP.08m04984gre; Kamijima K, 2013, J AFFECT DISORDERS, V151, P899, DOI 10.1016/j.jad.2013.07.035; Berman RM, 2009, CNS SPECTRUMS, V14, P197; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Nelson JC, 2010, J AFFECT DISORDERS, V120, P133, DOI 10.1016/j.jad.2009.06.026; Pharmaceuticals and Medical Devices Agency in Japan, 2011, RAND DOUBL BLIND NON; Reimherr FW, 2010, J CLIN PSYCHOPHARM, V30, P300, DOI 10.1097/JCP.0b013e3181db320f; Romera I, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-51; Shelton RC, 2007, INT CLIN PSYCHOPHARM, V22, P348; Thase Michael E, 2008, Prim Care Companion J Clin Psychiatry, V10, P440	23	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	JAN	2015	69	1			SI		34	42		10.1111/pcn.12214		9	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	AY1BP	WOS:000347328800005		
J	Yasuda, K; Kobayashi, K; Yamaguchi, M; Tanaka, K; Fujii, T; Kitahara, Y; Tamaoki, T; Matsushita, Y; Nunomura, A; Motohashi, N				Yasuda, Kazuyuki; Kobayashi, Kaoru; Yamaguchi, Masayasu; Tanaka, Koichi; Fujii, Tomokazu; Kitahara, Yuichi; Tamaoki, Toshio; Matsushita, Yutaka; Nunomura, Akihiko; Motohashi, Nobutaka			Seizure threshold and the half-age method in bilateral electroconvulsive therapy in Japanese patients	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article						dosing strategy; electroconvulsive therapy; Japanese; race; seizure threshold	ELECTRODE PLACEMENT; UNILATERAL ECT; BENZODIAZEPINES; DURATION; NUMBER	AimSeizure threshold (ST) in electroconvulsive therapy (ECT) has not been reported previously in Japanese patients. We investigated ST in bilateral ECT in Japanese patients using the dose-titration method. The associations between demographic and clinical characteristics and ST were analyzed to identify the predictors of ST. Finally, the validity of the half-age method for the stimulus dose was evaluated. MethodsFifty-four Japanese patients with mood disorder, schizophrenia, and other psychotic disorders received an acute course of bilateral ECT using a brief-pulse device. ST was determined at the first session using a fixed titration schedule. ST was correlated with age, sex, body mass index, history of previous ECT, and psychotropic drugs on multiple regression analysis. Furthermore, the rate of accomplished seizures was calculated using the half-age method. ResultsMean ST was 136mC. ST was influenced by age, sex, history of previous ECT, and medication with benzodiazepines. The accomplished seizure rate using the half-age method was 72%, which was significantly lower in men and subjects on benzodiazepines. ConclusionST in Japanese patients was equal to or slightly higher than that previously reported in other ethnic groups, which might be attributable, at least in part, to high prevalence of and large-dose benzodiazepine prescription. Higher age, male gender, no history of ECT, and benzodiazepines were related to higher ST. The half-age method was especially useful in female patients and subjects without benzodiazepine medication.	[Yasuda, Kazuyuki; Kobayashi, Kaoru; Yamaguchi, Masayasu; Tanaka, Koichi; Fujii, Tomokazu; Kitahara, Yuichi; Tamaoki, Toshio; Matsushita, Yutaka; Nunomura, Akihiko; Motohashi, Nobutaka] Univ Yamanashi, Dept Neuropsychiat, Interdisciplinary Grad Sch Med & Engn, Chuo Ku, Yamanashi 4093898, Japan	Yasuda, K (reprint author), Univ Yamanashi, Dept Neuropsychiat, Interdisciplinary Grad Sch Med & Engn, Chuo Ku, 1110 Shimokato, Yamanashi 4093898, Japan.	kyasuda@yamanashi.ac.jp			Japan Society for the Promotion of Science [23791319]	This work was supported by a Grant-in-Aid for Young Scientists (B) (Grant no. 23791319) from the Japan Society for the Promotion of Science. All authors have no commercial associations that may pose as a conflict of interest in connection with the manuscript.	Abrams R., 2002, ELECTROCONVULSIVE TH; American Psychiatric Association Task Force on D. S. M. I. V. American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Petrides G, 2009, J ECT, V25, P232; SACKEIM H, 1987, ARCH GEN PSYCHIAT, V44, P355; Kellner CH, 2010, BRIT J PSYCHIAT, V196, P226, DOI 10.1192/bjp.bp.109.066183; Beyer J, 1998, ELECTROCONVULSIVE TH; Boylan LS, 2000, J ECT, V16, P3, DOI 10.1097/00124509-200003000-00002; Chanpattana W, 2000, PSYCHIAT RES, V96, P31, DOI 10.1016/S0165-1781(00)00186-4; Chung KF, 2001, J ECT, V17, P254, DOI 10.1097/00124509-200112000-00004; COFFEY CE, 1995, BIOL PSYCHIAT, V37, P713, DOI 10.1016/0006-3223(95)00262-F; Colenda CC, 1996, CONVULSIVE THER, V12, P3; Dawkins K, 2000, PROG NEURO-PSYCHOPH, V24, P1289, DOI 10.1016/S0278-5846(00)00144-5; Gangadhar BN, 1998, J ECT, V14, P259; Guy W., 1976, ECDEU ASSESSMENT MAN; Inagaki A., 2006, JPN J CLIN PSYCHOPHA, V9, P1443; Kellner CH, 1997, HDB OF ECT; KRUEGER RB, 1993, BIOL PSYCHIAT, V33, P272, DOI 10.1016/0006-3223(93)90294-N; Kubota F, 2003, CLIN ELECTROENCEPHAL, V34, P23; Loo CK, 2006, AUST NZ J PSYCHIAT, V40, P632, DOI 10.1111/j.1440-1614.2006.01862.x; Motohashi N, 2004, J ECT, V20, P21, DOI 10.1097/00124509-200403000-00005; PETTINATI HM, 1990, AM J PSYCHIAT, V147, P1029; Scott AIF, 2005, ECT HDB 2 REPORT ROY; Scott AIF, 1999, J ECT, V15, P118; STANDISHBARRY HMAS, 1985, ACTA PSYCHIAT SCAND, V71, P269, DOI 10.1111/j.1600-0447.1985.tb01283.x; STROMGREN LS, 1980, ACTA PSYCHIAT SCAND, V62, P158; vansWaarde JA, 2009, EUR ARCH PSY CLIN N, V259, P467; Weiner RD, 2000, PRACTICE ELECTROCONV; Williams MD, 2008, J ECT, V24, P117, DOI 10.1097/YCT.0b013e31815c6641	28	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	JAN	2015	69	1			SI		49	54		10.1111/pcn.12225		6	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	AY1BP	WOS:000347328800007		
J	Nakanishi, M; Yamauchi, T; Takeshima, T				Nakanishi, Miharu; Yamauchi, Takashi; Takeshima, Tadashi			National strategy for suicide prevention in Japan: Impact of a national fund on progress of developing systems for suicide prevention and implementing initiatives among local authorities	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article						health policy; Japan; local government; suicide	INTERVENTION; RATES	AimIn Japan, the Cabinet Office released the General Principles of Suicide Prevention Policy' in 2007 and suggested nine initiatives. In 2009, a national fund was launched to help prefectures (the administrative divisions of Japan) and local authorities implement five categories of suicide-prevention programs. This paper examines the impact of the national fund on the establishment of the systems for suicide prevention and the implementation of these initiatives among local authorities. MethodsThe present study included 1385 local authorities (79.5%) from all 47 prefectures that responded to the cross-sectional questionnaire survey. ResultsImproved suicide-prevention systems and the implementation of nine initiatives in April 2013 were observed among 265 local authorities (19.1%) that implemented Training of community service providers' and Public awareness campaigns'; 178 local authorities (12.9%) that implemented Face-to-face counseling', Training of community service providers' and Public awareness campaigns'; and 324 local authorities (23.4%) that implemented Trauma-informed policies and practices'. There was no significant difference in suicide-prevention systems and the implementation of nine initiatives between 203 local authorities (14.7%) that implemented only Public awareness campaigns' and 231 local authorities (16.7%) that did not implement any suicide-prevention programs. ConclusionThe results of our study suggest that the national fund promoted the establishment of community systems for suicide prevention and helped implement initiatives among local authorities. The national suicide-prevention strategy in Japan should explore a standard package of programs to guide community suicide-prevention efforts with a sustained workforce among local authorities.	[Nakanishi, Miharu] Tokyo Metropolitan Inst Med Sci, Mental Hlth & Nursing Res Team, Tokyo 1568506, Japan; [Yamauchi, Takashi; Takeshima, Tadashi] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Ctr Suicide Prevent, Tokyo, Japan	Nakanishi, M (reprint author), Tokyo Metropolitan Inst Med Sci, Mental Hlth & Nursing Res Team, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	mnakanishi-tky@umin.ac.jp		Nakanishi, Miharu/0000-0001-6200-9279	Cabinet Office; Ministry of Health, Labor, and Welfare; Center for Suicide Prevention, NIMH, NCNP in Japan	This work was funded by a joint program by the Cabinet Office; the Ministry of Health, Labor, and Welfare; and the Center for Suicide Prevention, NIMH, NCNP in Japan. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of data; or preparation, review, and approval of the manuscript. The paper represents the personal views of the authors and is not the official view of the Cabinet Office; the Ministry of Health, Labor, and Welfare; or the Center for Suicide Prevention, NIMH, NCNP in Japan. We declare that we have no conflicts of interest in relation to this study.	Fountoulakis KN, 2011, J AFFECT DISORDERS, V130, P10, DOI 10.1016/j.jad.2010.06.009; Cabinet Office, 2012, 2012 WHIT PAP SUIC P; Canadian Association for Suicide Prevention, 2004, CASP NAT SUIC PREV S; Department of Health, 2002, NAT SUIC PREV STRAT; Department of Health and Ageing, 2008, LIV IS EV LIF FRAM P; Hakanen J, 1996, Crisis, V17, P167, DOI 10.1027/0227-5910.17.4.167; Kaga Makiko, 2009, Leg Med (Tokyo), V11 Suppl 1, pS18, DOI 10.1016/j.legalmed.2009.01.015; LONNQVIST JK, 1995, PSYCHIAT CLIN NEUROS, V49, pS111, DOI 10.1111/j.1440-1819.1995.tb01912.x; Motohashi Y, 2007, SUICIDE LIFE-THREAT, V37, P593, DOI 10.1521/suli.2007.37.5.593; Norwegian Board of Health, 1994, NAT PLAN SUIC PREV 1; Ono Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074902; Organization for Economic Cooperation and Development, 2013, OECD HLTH DAT 2013; Oyama H, 2005, PSYCHIAT CLIN NEUROS, V59, P337, DOI 10.1111/j.1440-1819.2005.01379.x; Rossow I, 2009, SUICIDE LIFE-THREAT, V39, P614, DOI 10.1521/suli.2009.39.6.614; Scottish Executive, 2002, CHOOS LIF NAT STRAT; Socialstyrelsen, 2006, FORSL TILL NAT PROGR; U. S. Department of Health and Human Services (HHS), 2012, 2012 NAT STRAT SUIC; Wada K, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1191; WHO, 2012, PUBL HLTH ACT PREV S	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	JAN	2015	69	1			SI		55	64		10.1111/pcn.12222		10	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	AY1BP	WOS:000347328800008		
J	Reese, JB; Blackford, A; Sussman, J; Okuyama, T; Akechi, T; Bainbridge, D; Howell, D; Snyder, CF				Reese, Jennifer Barsky; Blackford, Amanda; Sussman, Jonathan; Okuyama, Toru; Akechi, Tatsuo; Bainbridge, Daryl; Howell, Doris; Snyder, Claire F.			Cancer patients' function, symptoms and supportive care needs: a latent class analysis across cultures	QUALITY OF LIFE RESEARCH			English	Article						Patient-reported outcomes; Quality of life; Cancer; Supportive care needs; Latent class analysis	ONCOLOGY CLINICAL-PRACTICE; QUESTIONNAIRE; INSTRUMENT	Patient-reported outcomes (PROs) are an umbrella term covering a range of outcomes, including symptoms, functioning, health-related quality of life, and supportive care needs. Research regarding the appropriate PRO questionnaires to use is informative. A previously published latent class analysis (LCA) examined patterns of function, symptoms, and supportive care needs in a sample of US cancer patients. The current analysis investigated whether the findings from the original study were replicated in new samples from different countries and whether a larger sample combining all the data would affect the classes identified. This secondary analysis of data from 408 Japanese and 189 Canadian cancer patients replicated the methods used in the original LCA using data from 117 US cancer patients. In all samples, subjects completed the EORTC-QLQ-C30 and Supportive Care Needs Survey Short Form-34 (SCNS-SF34). We first dichotomized individual function, symptom, and need domain scores. We then performed LCA to investigate the patterns of domains for each of the outcomes, both in the individual country samples and then combining the data from all three samples. Across all analyses, class assignment was made by level of function, symptoms, or needs. In individual samples, only two-class models ("high" vs. "low") were generally identifiable while in the combined sample, three-class models ("high" vs. "moderate" vs. "low") best fit the data for all outcomes. In this analysis, the level of burden experienced by patients was the key factor in defining classes.	[Reese, Jennifer Barsky] Johns Hopkins Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21224 USA; [Blackford, Amanda; Snyder, Claire F.] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Sussman, Jonathan; Bainbridge, Daryl] McMaster Univ, Dept Oncol, Hamilton, ON, Canada; [Okuyama, Toru] Nagoya City Univ Hosp, Div Palliat Care & Psychooncol, Nagoya, Aichi, Japan; [Okuyama, Toru; Akechi, Tatsuo] Nagoya City Univ, Grad Sch Med Sci, Dept Psychiat & Cognit Behav Med, Nagoya, Aichi, Japan; [Howell, Doris] Princess Margaret Hosp, Univ Hlth Network, Toronto, ON M4X 1K9, Canada; [Howell, Doris] Univ Toronto, Lawrence Bloomberg Fac Nursing, Toronto, ON, Canada; [Snyder, Claire F.] Johns Hopkins Sch Med, Dept Med, Div Gen Internal Med, Baltimore, MD 21224 USA; [Snyder, Claire F.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA	Reese, JB (reprint author), Johns Hopkins Sch Med, Dept Psychiat & Behav Sci, 5510 Nathan Shock Dr,Suite 100, Baltimore, MD 21224 USA.	jreese13@jhmi.edu			American Cancer Society [MRSG-08-011-01-CPPB]; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins [P30CA006973]; Ministry of Health, Labour and Welfare, Japan; Canadian Institutes of Health Research; Ontario Ministry of Health Long-term Care	The authors wish to thank Elizabeth Garrett-Mayer, PhD, for her valuable review of a preliminary draft and for assistance with revising the manuscript. Dr. Snyder is supported by the American Cancer Society (MRSG-08-011-01-CPPB) and is a member of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (P30CA006973). The original Japanese data collection was supported in part by Grants-in-Aid for Cancer Research and the Third Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health, Labour and Welfare, Japan. The original Canadian data collection was supported by Canadian Institutes of Health Research and Ontario Ministry of Health & Long-term Care.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Acquadro C, 2003, VALUE HEALTH, V6, P522, DOI 10.1046/j.1524-4733.2003.65309.x; Okuyama T, 2009, PSYCHO-ONCOL, V18, P1003, DOI 10.1002/pon.1482; Snyder CF, 2007, SUPPORT CARE CANCER, V15, P1075, DOI 10.1007/s00520-007-0223-1; Sanson-Fisher R, 2000, CANCER, V88, P226, DOI 10.1002/(SICI)1097-0142(20000101)88:1<226::AID-CNCR30>3.0.CO;2-P; Snyder CF, 2008, QUAL LIFE RES, V17, P665, DOI 10.1007/s11136-008-9331-8; Snyder CF, 2010, QUAL LIFE RES, V19, P1045, DOI 10.1007/s11136-010-9655-z; Bonevski B, 2000, CANCER, V88, P217, DOI 10.1002/(SICI)1097-0142(20000101)88:1<217::AID-CNCR29>3.0.CO;2-Y; Dodd M J, 2001, Oncol Nurs Forum, V28, P465; Fan G, 2007, Curr Oncol, V14, P173, DOI 10.3747/co.2007.145; Fayers P. M., 1998, EORTC REFERENCE VALU; Gift AG, 2003, NURS RES, V52, P393, DOI 10.1097/00006199-200311000-00007; Lanza S.T., 2013, HDB PSYCHOL RES METH, V2, P691; Miaskowski C, 2004, J NATL CANC I MONOGR, V2004, P17, DOI DOI 10.1093/JNCIMONOGRAPHS/LGH023; Snyder CF, 2009, QUAL LIFE RES, V18, P991, DOI 10.1007/s11136-009-9519-6; U.S. Food and Drug Administration, 2009, GUID IND PAT REP OUT	16	3	3	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-9343	1573-2649		QUAL LIFE RES	Qual. Life Res.	JAN	2015	24	1					135	146		10.1007/s11136-014-0629-4		12	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Health Care Sciences & Services; Public, Environmental & Occupational Health	AY0OO	WOS:000347296200013		
J	Mitsiadis, TA; Harada, H				Mitsiadis, Thimios A.; Harada, Hidemitsu			Regenerated teeth: the future of tooth replacement. An update	REGENERATIVE MEDICINE			English	Editorial Material						ameloblasts; dentin; enamel; nanotechnology; regeneration; stem cells; tooth	PLURIPOTENT STEM-CELLS; DENTAL-PULP; TISSUE REGENERATION; THERAPY; DIFFERENTIATION; REPAIR		[Mitsiadis, Thimios A.] Univ Zurich, ZZM, Fac Med, Orofacial Dev & Regenerat Unit, CH-8032 Zurich, Switzerland; [Harada, Hidemitsu] Iwate Med Univ, Dept Anat, Div Dev Biol & Regenerat Med, Yahaba, Iwate 0283694, Japan	Mitsiadis, TA (reprint author), Univ Zurich, ZZM, Fac Med, Orofacial Dev & Regenerat Unit, Plattenstr 11, CH-8032 Zurich, Switzerland.	thimios.mitsiadis@zzm.uzh.ch					Otsu K, 2012, STEM CELLS DEV, V21, P1156, DOI 10.1089/scd.2011.0210; Bluteau G, 2008, EUR CELLS MATER, V16, P1; Dickinson LE, 2011, MACROMOL BIOSCI, V11, P36, DOI 10.1002/mabi.201000245; Mitsiadis TA, 2007, EXP CELL RES, V313, P3377, DOI 10.1016/j.yexcr.2007.07.027; Mitsiadis TA, 2011, REGEN MED, V6, P135, DOI [10.2217/rme.10.101, 10.2217/RME.10.101]; Shinmura Y, 2008, J CELL PHYSIOL, V217, P728, DOI 10.1002/jcp.21546; Oshima M, 2014, ODONTOLOGY, V102, P123, DOI 10.1007/s10266-014-0168-z; Volponi AA, 2010, TRENDS CELL BIOL, V20, P715, DOI 10.1016/j.tcb.2010.09.012; Yang B, 2012, BIOMATERIALS, V33, P2449, DOI 10.1016/j.biomaterials.2011.11.074; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; d'Aquino R, 2009, EUR CELLS MATER, V18, P75; Arakaki M, 2012, J BIOL CHEM, V287, P10590, DOI 10.1074/jbc.M111.285874; Kraehenbuehl TP, 2011, NAT METHODS, V8, P731, DOI 10.1038/nmeth.1671; Ferreira L, 2008, CELL STEM CELL, V3, P136, DOI 10.1016/j.stem.2008.07.020; Wang L, 2011, TISSUE ENG PT A, V17, P1015, DOI 10.1089/ten.tea.2010.0140; Huang GTJ, 2010, TISSUE ENG PT A, V16, P605, DOI 10.1089/ten.TEA.2009.0518; Mitsiadis TA, 2009, BIRTH DEFECTS RES C, V87, P199, DOI 10.1002/bdrc.20160; Mitsiadis TA, 2012, NANOMEDICINE-UK, V7, P1743, DOI [10.2217/nnm.12.146, 10.2217/NNM.12.146]; Caton J, 2011, J CELL MOL MED, V15, P1054, DOI 10.1111/j.1582-4934.2010.01251.x; Mooney DJ, 2008, CELL STEM CELL, V2, P205, DOI 10.1016/j.stem.2008.02.005; Sun HH, 2011, J TISSUE ENG REGEN M, V5, pE1, DOI 10.1002/term.369; Ikeda E, 2009, P NATL ACAD SCI USA, V106, P13475, DOI 10.1073/pnas.0902944106; Arakaki M, 2013, J ORAL BIOSCI, V55, P191; d'Aquino R, 2008, STEM CELL REV, V4, P21, DOI 10.1007/s12015-008-9013-5; Jimenez-Rojo L, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00107; Oshima M, 2014, SCI REP-UK, V4, DOI 10.1038/srep06044; Oshima M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021531; Oshima Masamitsu, 2012, Methods Mol Biol, V887, P149, DOI 10.1007/978-1-61779-860-3_14; Otsu K, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00036	29	1	2	FUTURE MEDICINE LTD	LONDON	UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3 1QB, ENGLAND	1746-0751	1746-076X		REGEN MED	Regen. Med.		2015	10	1					5	8		10.2217/RME.14.78		4	Cell & Tissue Engineering; Engineering, Biomedical	Cell Biology; Engineering	AY3CI	WOS:000347461700002		
J	Uzawa, Y; Otsuji, M; Nakazawa, K; Fan, W; Yamada, Y				Uzawa, Yoshihiro; Otsuji, Mikiya; Nakazawa, Koichi; Fan, Wei; Yamada, Yoshitsugu			Derivation of recruitment function from the pressure-volume curve in an acute lung injury model	RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY			English	Article						Alveolar recruitment; Pressure-volume curve; ARDS	RESPIRATORY-DISTRESS-SYNDROME; END-EXPIRATORY PRESSURE; MECHANICAL VENTILATION; REGIONAL-DISTRIBUTION; INFLECTION POINTS; FAILURE; RECRUITMENT/DERECRUITMENT; DERECRUITMENT	Lung volume changes involve the recruitment of collapsed alveoli and the expansion of already opened alveoli. This study aimed to determine the alveolar recruitment function by using a mathematical model from a pressure-volume curve (P-V curve). We assumed a lung model as V-L = R(P)V(0)f(P), where R recruitment function is the fraction of recruited alveoli, V-0 is the resting lung volume at FRC of a fully recruited lung, and f(P) corresponds to the normalized compliance function of the lungs open to ventilation. Seven white rabbits were subjected to saline-lavage lung injury, and P-V curves were calculated using the slow inflation technique. We obtained the P-R curve from the P-V curve, and two curves were differently shaped after lung injury. We concluded that the recruitment function was obtained from the P-V curve and that the P-R curve estimated the recruitment and derecruitment status. (C) 2014 Elsevier B.V. All rights reserved.	[Uzawa, Yoshihiro] Kameda Med Ctr, Dept Rehabil, Kamogawa, Chiba 2968602, Japan; [Otsuji, Mikiya] Univ Tokyo, Fac Med, Dept Anesthesiol, Bunkyo Ku, Tokyo 1138655, Japan; [Nakazawa, Koichi; Fan, Wei] Tokyo Med & Dent Univ, Dept Anesthesiol & Crit Care Med, Bunkyo Ku, Tokyo 1138519, Japan; [Yamada, Yoshitsugu] Univ Tokyo, Grad Sch Med, Dept Anesthesiol, Bunkyo Ku, Tokyo 1138655, Japan	Uzawa, Y (reprint author), Kameda Med Ctr, Dept Rehabil, 929 Higashi, Kamogawa, Chiba 2968602, Japan.	yoshiuzawa@yahoo.co.jp; mohtsuji-tIcy@umin.ac.jp; nakazawa.mane@tmd.ac.jp; cnmgfw@hotmail.co.jp; YAMADAY-ANE@h.u-tokyo.ac.jp					Crotti S, 2001, AM J RESP CRIT CARE, V164, P131; Gattinoni L, 2005, INTENS CARE MED, V31, P776, DOI 10.1007/s00134-005-2627-z; GATTINONI L, 1987, AM REV RESPIR DIS, V136, P730; GATTINONI L, 1995, AM J RESP CRIT CARE, V151, P1807; Caironi P, 2010, AM J RESP CRIT CARE, V181, P578, DOI 10.1164/rccm.200905-0787OC; Albaiceta GM, 2004, AM J RESP CRIT CARE, V170, P1066, DOI 10.1164/rccm.200312-1644OC; LACHMANN B, 1980, ACTA ANAESTH SCAND, V24, P231; Venegas JG, 1998, J APPL PHYSIOL, V84, P389; Nieszkowska A, 2004, CRIT CARE MED, V32, P1496, DOI 10.1097/01.CCM.0000130170.88512.07; Barbas CSV, 2005, CURR OPIN CRIT CARE, V11, P18, DOI 10.1097/00075198-200502000-00004; Halter JM, 2003, AM J RESP CRIT CARE, V167, P1620, DOI 10.1164/rccm.200205-435OC; Fan E, 2005, JAMA-J AM MED ASSOC, V294, P2889, DOI 10.1001/jama.294.22.2889; Chiumello D, 2008, AM J RESP CRIT CARE, V178, P346, DOI 10.1164/rccm.200710-1589OC; Caramez MP, 2009, INTENS CARE MED, V35, P740, DOI 10.1007/s00134-009-1412-9; Karmrodt J, 2006, BRIT J ANAESTH, V97, P883, DOI 10.1093/bja/ael275; Gattinoni L, 2006, NEW ENGL J MED, V354, P1775, DOI 10.1056/NEJMoa052052; Benditt Joshua O, 2005, Respir Care, V50, P68; Carney DE, 1999, AM J RESP CRIT CARE, V160, P1697; DiRocco JD, 2007, INTENS CARE MED, V33, P1204, DOI 10.1007/s00134-007-0629-8; Downie JM, 2004, AM J RESP CRIT CARE, V169, P957, DOI 10.1164/rccm.200305-614OC; Escolar JD, 2002, HISTOL HISTOPATHOL, V17, P383; Lu Q, 2006, CRIT CARE, V10, DOI 10.1186/cc4956; Marco F.D., 2007, INTENS CARE MED, V33, P2109; Suh GY, 2002, CRIT CARE MED, V30, P1848, DOI 10.1097/01.CCM.0000021177.83239.1A; Takeuchi M, 2002, ANESTHESIOLOGY, V97, P682, DOI 10.1097/00000542-200209000-00023; Vieira SRR, 1999, AM J RESP CRIT CARE, V159, P1612	26	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1569-9048	1878-1519		RESP PHYSIOL NEUROBI	Respir. Physiol. Neuro.	JAN 1	2015	205						16	20		10.1016/j.resp.2014.09.008		5	Physiology; Respiratory System	Physiology; Respiratory System	AY6CI	WOS:000347654800003		
J	Umezawa, N; Arisaka, H; Sakuraba, S; Sugita, T; Matsumoto, A; Kaku, Y; Yoshida, K; Kuwana, S				Umezawa, Nobuo; Arisaka, Hirofumi; Sakuraba, Shigeki; Sugita, Takeo; Matsumoto, Akiko; Kaku, Yuki; Yoshida, Kazu-ichi; Kuwana, Shun-ichi			Orexin-B antagonized respiratory depression induced by sevoflurane, propofol, and remifentanil in isolated brainstem-spinal cords of neonatal rats	RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY			English	Article						Orexin; Respiration; Anesthetics; Isolated brainstem; Neontal rat	GABA(A) RECEPTORS; NEWBORN RATS; NEURONS; RHYTHM; SLEEP; PHARMACOKINETICS; CHEMORECEPTION; HYPOTHALAMUS; WAKEFULNESS; HYPOCRETIN	Orexins (hypocretins) play a crucial role in arousal, feeding, and endocrine function. We previously reported that orexin-B activated respiratory neurons in the isolated brainstem-spinal cords of neonatal rats. We herein determined whether orexin-B antagonized respiratory depression induced by sevoflurane, propofol, or remifentanil. We recorded C4 nerve bursts as an index of inspiratory activity in a brainstem-spinal cord preparation. The preparation was superfused with a solution equilibrated with 3% sevoflurane alone for 10 min and the superfusate was then switched to a solution containing sevoflurane plus orexin-B. Sevoflurane decreased the C4 burst rate and the integrated C4 amplitude. The C4 burst rate and amplitude were reversed by 0.5 mu M orexin-B, but not by 0.1 mu M orexin-B. The decrease induced in the C4 burst rate by 10 mu M propofol or 0.01 mu M remifentanil was significantly antagonized by 0.1 mu M orexin-B. Respiratory depression induced by a higher concentration (0.1 mu M) of remifentanil was not restored by 0.1 mu M orexin-B. These results demonstrated that orexin-B antagonized respiratory depression induced by sevoflurane, propofol, or remifentanil. (C) 2014 Elsevier B.V. All rights reserved.	[Umezawa, Nobuo; Arisaka, Hirofumi; Sakuraba, Shigeki; Sugita, Takeo; Matsumoto, Akiko; Yoshida, Kazu-ichi] Kanagawa Dent Univ, Dept Anesthesiol, Yokosuka, Kanagawa 2388580, Japan; [Kaku, Yuki; Kuwana, Shun-ichi] Uekusa Gakuen Univ, Fac Hlth Sci, Dept Physiol, Chiba 2640007, Japan; [Kaku, Yuki] Ibaraki Prefectural Univ Hlth Sci, Ctr Med Sci, Ibaraki 3000394, Japan	Kuwana, S (reprint author), Uekusa Gakuen Univ, Fac Hlth Sci, Dept Physiol, Chiba 2640007, Japan.	s-kuwana@uekusa.ac.jp			Science Research Fund of the Uekusa Gakuen University	This work was supported by the Science Research Fund of the Uekusa Gakuen University.	Yip GMS, 2013, NAT CHEM BIOL, V9, P715, DOI [10.1038/nchembio.1340, 10.1038/NCHEMBIO.1340]; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; WESTMORELAND CL, 1993, ANESTHESIOLOGY, V79, P893, DOI 10.1097/00000542-199311000-00005; Shirasaka T, 2011, J ANESTH, V25, P65, DOI 10.1007/s00540-010-1071-6; Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190; Peyron C, 1998, J NEUROSCI, V18, P9996; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Matute E, 2004, BRIT J ANAESTH, V93, P422, DOI 10.1093/bja/aeh217; Nambu T, 1999, BRAIN RES, V827, P243, DOI 10.1016/S0006-8993(99)01336-0; Garcia PS, 2010, CURR NEUROPHARMACOL, V8, P2, DOI 10.2174/157015910790909502; Maleszka A, 2013, J PHYSIOL PHARMACOL, V64, P55; ELDRIDGE FL, 1971, AM J PHYSIOL, V221, P535; EGAN TD, 1993, ANESTHESIOLOGY, V79, P881, DOI 10.1097/00000542-199311000-00004; Date Y, 1999, P NATL ACAD SCI USA, V96, P748, DOI 10.1073/pnas.96.2.748; Nakamura A, 2007, J APPL PHYSIOL, V102, P241, DOI 10.1152/japplphysiol.00679.2006; Yang B, 2002, J NEUROSCI, V22, P6303; Fujii M, 2004, NEUROSCI RES, V50, P355, DOI 10.1016/j.neures.2004.07.009; Guyenet PG, 2013, BRAIN RES, V1511, P126, DOI 10.1016/j.brainres.2012.10.028; Ito Y, 2009, LIFE SCI, V85, P322, DOI 10.1016/j.lfs.2009.06.010; Kashiwagi M, 2004, ANESTH ANALG, V99, P49, DOI 10.1213/01.ANE.0000117226.45704.65; Kuribayashi J, 2008, ANESTHESIOLOGY, V109, P233, DOI 10.1097/ALN.0b013e31817f5baf; Kuroki C, 2013, ANESTH ANALG, V116, P1001, DOI 10.1213/ANE.0b013e31828842f0; Kuwaki T, 2010, RESP PHYSIOL NEUROBI, V173, P223, DOI 10.1016/j.resp.2010.02.006; Kuwana S, 1998, BRAIN RES, V786, P194, DOI 10.1016/S0006-8993(97)01476-5; MURAKOSHI T, 1985, BRIT J PHARMACOL, V86, P95; Nattie E, 2000, RESP PHYSIOL, V122, P223, DOI 10.1016/S0034-5687(00)00161-4; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Sthiuchi T., 2009, CELL METAB, V10, P466; Stucke AG, 2005, ANESTHESIOLOGY, V103, P57, DOI 10.1097/00000542-200507000-00012; Sugita T, 2014, RESP PHYSIOL NEUROBI, V200, P105, DOI 10.1016/j.resp.2014.06.006; Zhang LN, 2012, ANESTH ANALG, V115, P789, DOI 10.1213/ANE.0b013e3182645ea3	31	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1569-9048	1878-1519		RESP PHYSIOL NEUROBI	Respir. Physiol. Neuro.	JAN 1	2015	205						61	65		10.1016/j.resp.2014.10.013		5	Physiology; Respiratory System	Physiology; Respiratory System	AY6CI	WOS:000347654800010		
J	Miyabe, Y; Miyabe, C; Nanki, T				Miyabe, Yoshishige; Miyabe, Chie; Nanki, Toshihiro			Could retinoids be a potential treatment for rheumatic diseases?	RHEUMATOLOGY INTERNATIONAL			English	Review						Retinoid; T cells; B cells; Rheumatoid arthritis; Rheumatic diseases	TUMOR-NECROSIS-FACTOR; VITAMIN-A; T-CELLS; DENDRITIC CELLS; SYNTHETIC RETINOIDS; ANTIBODY-PRODUCTION; COLLAGEN ARTHRITIS; SYSTEMIC-SCLEROSIS; ACID RECEPTORS; IN-VITRO	Retinoid, a derivative of vitamin A, is a general term used to describe compounds that bind to and activate retinoic acid receptors [RARs (RAR alpha, RAR beta, and RAR gamma)] and/or retinoid X receptors [RXRs (RXR alpha, RXR beta, and RXR gamma)]. They have been shown to surpress the differentiation of Th1/Th17 cells and induce the development of Th1/regulatory T cells. They also affect the proliferation of B cells as both an inducer and suppressor. Furthermore, retinoids may induce the maturation of dendritic cells and production of interleukin-10 from monocytes/macrophages. We recently demonstrated that retinoids suppressed the production of reactive oxygen species, the release of elastase from neutrophils by inhibiting mitogen-activated protein kinase signals, and both the migration speed and chemotaxis directionality of neutrophils. Retinoids, such as all-trans retinoic acid and tamibarotene, were previously shown to have positive effects on animal models of several rheumatic diseases, including arthritis, myositis, and vasculitis in vivo. Moreover, retinoids have been used in a pilot study to effectively treat patients with lupus nephritis and systemic sclerosis. We herein reviewed the effects of retinoids on immune cells, animal models of rheumatic diseases, and rheumatic patients.	[Miyabe, Yoshishige; Miyabe, Chie] Harvard Univ, Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Ctr Immunol & Inflammatory Dis,Med Sch, Charlestown, MA 02129 USA; [Nanki, Toshihiro] Teikyo Univ, Dept Clin Res Med, Itabashi Ku, Tokyo 1738605, Japan	Nanki, T (reprint author), Teikyo Univ, Dept Clin Res Med, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	nanki@med.teikyo-u.ac.jp			Chugai Pharmaceutical Co., LTD.; Eisai Co., LTD.; Ono Pharmaceutical Co., LTD.; Mitsubishi Tanabe Pharma Corporation; Takeda Pharmaceutical Co., LTD; AbbVie Inc.; UCB Japan Co. Ltd.; Astellas Pharma Inc.; Pfizer Japan Inc.; Bristol-Myers Squibb; Santen Pharmaceutical Co., Ltd.; Taisho Toyama Pharmaceutical Co., Ltd.; Asahi Kasei Pharma Corporation	Dr. Nanki reports grants and personal fees from Chugai Pharmaceutical Co., LTD., grants and personal fees from Eisai Co., LTD., grants from Ono Pharmaceutical Co., LTD., grants and personal fees from Mitsubishi Tanabe Pharma Corporation., grants and personal fees from Takeda Pharmaceutical Co., LTD, grants and personal fees from AbbVie Inc., personal fees from UCB Japan Co. Ltd., personal fees from Astellas Pharma Inc., grants from Pfizer Japan Inc., personal fees from Bristol-Myers Squibb, personal fees from Santen Pharmaceutical Co., Ltd., personal fees from Taisho Toyama Pharmaceutical Co., Ltd., and grants from Asahi Kasei Pharma Corporation outside the submitted work.	KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Wang XC, 2007, J CLIN IMMUNOL, V27, P193, DOI 10.1007/s10875-006-9068-5; Yipp BG, 2013, BLOOD, V122, P2784, DOI 10.1182/blood-2013-04-457671; Miwako I, 2007, DRUGS TODAY, V43, P563, DOI 10.1358/dot.2007.43.8.1072615; Ertesvag A, 2002, J IMMUNOL, V169, P5555; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Tombetti E, 2013, J RHEUMATOL, V40, P2047, DOI 10.3899/jrheum.130536; MEHTA K, 1994, J LEUKOCYTE BIOL, V55, P336; Saurer L, 2007, J IMMUNOL, V179, P3504; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Iwata M, 2003, INT IMMUNOL, V15, P1017, DOI 10.1093/intimm/dxg101; Smith EV, 2011, CLIN EXP DERMATOL, V36, P119, DOI 10.1111/j.1365-2230.2010.03921.x; Yamada H, 2007, J NUTR, V137, P2696; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Takeuchi T, 2009, MOD RHEUMATOL, V19, P478, DOI 10.1007/s10165-009-0195-8; Kagechika H, 2002, CURR MED CHEM, V9, P591, DOI 10.2174/0929867024606975; CANTORNA MT, 1995, EUR J IMMUNOL, V25, P1673, DOI 10.1002/eji.1830250629; Tanaka Y, 2012, CURR OPIN RHEUMATOL, V24, P319, DOI 10.1097/BOR.0b013e3283524e4c; Ohnishi K, 2007, INT J CLIN ONCOL, V12, P313, DOI 10.1007/s10147-007-0694-6; Na SY, 1999, J BIOL CHEM, V274, P7674, DOI 10.1074/jbc.274.12.7674; Xu ZM, 2007, CRIT REV IMMUNOL, V27, P367; Barrington RA, 2009, P NATL ACAD SCI USA, V106, P14490, DOI 10.1073/pnas.0903477106; Rouster-Stevens KA, 2014, ARTHRIT CARE RES, V66, P783, DOI 10.1002/acr.22192; Nagy L, 2012, PHYSIOL REV, V92, P739, DOI 10.1152/physrev.00004.2011; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Nozaki Y, 2005, CLIN EXP IMMUNOL, V139, P74, DOI 10.1111/j.1365-2249.2005.02654.x; Chambon P, 1996, FASEB J, V10, P940; Hoshino K, 1999, J IMMUNOL, V162, P3749; Xiao S, 2008, J IMMUNOL, V181, P2277; Kinoshita K, 2010, AM J KIDNEY DIS, V55, P344, DOI 10.1053/j.ajkd.2009.06.012; Komano Y, 2011, J RHEUMATOL, V38, P1258, DOI 10.3899/jrheum.101009; Hoag KA, 2002, J NUTR, V132, P3736; BRINCKERHOFF CE, 1983, SCIENCE, V221, P756, DOI 10.1126/science.6308759; BIRD HA, 1988, RHEUMATOL INT, V8, P55, DOI 10.1007/BF00271835; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Bohne M, 1997, INFLAMM RES, V46, P423, DOI 10.1007/s000110050216; CAMISA C, 1982, J AM ACAD DERMATOL, V6, P620, DOI 10.1016/S0190-9622(82)70051-9; Chen Q, 2007, CELL IMMUNOL, V249, P37, DOI 10.1016/j.cellimm.2007.11.001; Chen QY, 2005, P NATL ACAD SCI USA, V102, P14142, DOI 10.1073/pnas.0505018102; COBLE BI, 1987, ACTA DERM-VENEREOL, V67, P481; Darmanin S, 2007, J IMMUNOL, V179, P4616; Dzhagalov I, 2007, J IMMUNOL, V178, P2113; Engedal N, 2004, INT IMMUNOL, V16, P443, DOI 10.1093/intimm/dxh048; Ertesvag A, 2007, BLOOD, V109, P3865, DOI 10.1182/blood-2006-09-046748; Gravallese EM, 1996, ARTHRITIS RHEUM, V39, P1021, DOI 10.1002/art.1780390620; Gu BB, 2009, INT IMMUNOPHARMACOL, V9, P223, DOI 10.1016/j.intimp.2008.11.014; Harigai M, 2007, NEW ENGL J MED, V357, P1874, DOI 10.1056/NEJMc070728; Ikeda T, 2004, J DERMATOL SCI, V34, P62, DOI 10.1016/j.jdermsci.2003.11.007; Kagechika H, 2005, J MED CHEM, V48, P5875, DOI 10.1021/jm0581821; Kuwabara K, 1996, FEBS LETT, V378, P153, DOI 10.1016/0014-5793(95)01440-3; Miyabe C, 2013, ARTHRITIS RHEUM-US, V65, P503, DOI 10.1002/art.37784; Montemurro P, 1999, BRIT J HAEMATOL, V107, P294, DOI 10.1046/j.1365-2141.1999.01698.x; Ohyanagi N, 2009, ARTHRITIS RHEUM, V60, P3118, DOI 10.1002/art.24930; Sato A, 2010, MOD RHEUMATOL, V20, P244, DOI 10.1007/s10165-009-0265-y; TRENTHAM DE, 1982, J IMMUNOL, V129, P2668; van de Kerkhof PCM, 2006, DERMATOL THER, V19, P252, DOI 10.1111/j.1529-8019.2006.00082.x; Watanabe K, 2010, J IMMUNOL, V184, P2785, DOI 10.4049/jimmunol.0901823; Zhu LY, 1999, ARTERIOSCL THROM VAS, V19, P2105	58	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0172-8172	1437-160X		RHEUMATOL INT	Rheumatol. Int.	JAN	2015	35	1					35	41		10.1007/s00296-014-3067-2		7	Rheumatology	Rheumatology	AX9WX	WOS:000347251000004		
J	Takahara, T; Shimizu, M; Nakagishi, Y; Kinjo, N; Yachie, A				Takahara, Tadamori; Shimizu, Masaki; Nakagishi, Yasuo; Kinjo, Noriko; Yachie, Akihiro			Serum IL-18 as a potential specific marker for differentiating systemic juvenile idiopathic arthritis from incomplete Kawasaki disease	RHEUMATOLOGY INTERNATIONAL			English	Article						Interleukin 18; Systemic juvenile idiopathic arthritis; Incomplete Kawasaki disease	MACROPHAGE ACTIVATION SYNDROME; INTERLEUKIN-18; CYTOKINE	Clinical features and laboratory parameters in patients with incomplete Kawasaki disease (KD) and systemic juvenile idiopathic arthritis (s-JIA) tend to overlap. Furthermore, there have been no definite biomarkers for these diseases. This situation makes the clinical diagnosis of these patients difficult. In this study, we aimed to measure serum interleukin (IL)-18 and IL-6 levels in patients with s-JIA who were initially diagnosed with incomplete KD and compare these data with those in patients with complete KD and arthritis. Serum IL-18 levels in patients with s-JIA were significantly elevated compared with those in patients with KD and arthritis. Pediatricians should be aware that the presentation of s-JIA can mimic incomplete KD. Because the clinical features overlap, a high index of suspicion is warranted. The measurement of serum IL-18 may be useful for differentiating s-JIA from KD.	[Takahara, Tadamori] Hyogo Prefectural Tsukaguchi Hosp, Dept Pediat, Amagasaki, Hyogo, Japan; [Shimizu, Masaki; Yachie, Akihiro] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Sch Med, Dept Pediat, Kanazawa, Ishikawa 9208641, Japan; [Nakagishi, Yasuo] Hyogo Prefectural Kobe Childrens Hosp, Dept Pediat Rheumatol, Kobe, Hyogo, Japan; [Kinjo, Noriko] Univ Ryukyus, Sch Med, Dept Pediat, Nishihara, Okinawa 90301, Japan	Shimizu, M (reprint author), Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Sch Med, Dept Pediat, 13-1 Takaramachi, Kanazawa, Ishikawa 9208641, Japan.	shimizum@staff.kanazawa-u.ac.jp	Yachie, Akihiro/C-4660-2015				Abuhammour W., 2008, Journal of Pediatric Infectious Diseases, V3, P91; Novick D, 2013, SEMIN IMMUNOL, V25, P439, DOI 10.1016/j.smim.2013.10.014; Shimizu M, 2010, RHEUMATOLOGY, V49, P1645, DOI 10.1093/rheumatology/keq133; Petty RE, 2004, J RHEUMATOL, V31, P390; Ravelli A, 2005, J PEDIATR-US, V146, P598, DOI 10.1016/j.jpeds.2004.12.016; Kumar S, 2013, RHEUMATOL INT, V33, P1065, DOI 10.1007/s00296-010-1650-8; Binstadt BA, 2005, PEDIATRICS, V116, pE89, DOI 10.1542/peds.2004-2190; Dogra S, 2013, INDIAN J PEDIATR, V80, P783, DOI 10.1007/s12098-012-0893-7; Gong GWK, 2006, J PEDIATR-US, V148, P800, DOI 10.1016/j.jpeds.2006.01.039; Komatsu H, 2007, J PAEDIATR CHILD H, V43, P707, DOI 10.1111/j.1440-1754.2007.01189.x; Lang BA, 2006, J RHEUMATOL, V33, P803; Rigante D, 2010, RHEUMATOL INT, V30, P535, DOI 10.1007/s00296-009-0960-1; Stabile A, 2006, Eur Rev Med Pharmacol Sci, V10, P229; SVANTESSON H, 1983, ACTA PAEDIATR SCAND, V72, P345, DOI 10.1111/j.1651-2227.1983.tb09726.x	14	3	3	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0172-8172	1437-160X		RHEUMATOL INT	Rheumatol. Int.	JAN	2015	35	1					81	84		10.1007/s00296-014-3059-2		4	Rheumatology	Rheumatology	AX9WX	WOS:000347251000010		
J	Obara, K; Maejima, H; Mii, S; Katayama, C; Takasu, H; Amoh, Y				Obara, Koya; Maejima, Hideki; Mii, Sumiyuki; Katayama, Chieko; Takasu, Hiroshi; Amoh, Yasuyuki			A case of cutaneous sarcoid vasculitis with livedo and review of the literature	RHEUMATOLOGY INTERNATIONAL			English	Letter							INVOLVEMENT; LESIONS		[Obara, Koya; Maejima, Hideki; Mii, Sumiyuki; Katayama, Chieko; Takasu, Hiroshi; Amoh, Yasuyuki] Kitasato Univ, Sch Med, Dept Dermatol, Sagamihara, Kanagawa 2520374, Japan	Obara, K (reprint author), Kitasato Univ, Sch Med, Dept Dermatol, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	obarakoya@yahoo.co.jp					Wei CH, 2010, AUSTRALAS J DERMATOL, V51, P198, DOI 10.1111/j.1440-0960.2010.00630.x; Takenoshita H, 2010, EUR J DERMATOL, V20, P640, DOI 10.1684/ejd.2010.1034; Mana J, 1997, ARCH DERMATOL, V133, P882, DOI 10.1001/archderm.133.7.882; Fernandes SRM, 2000, SEMIN ARTHRITIS RHEU, V30, P33, DOI 10.1053/sarh.2000.8364; Carlson J, 2007, AM J DERMATOPATH, V29, P32, DOI 10.1097/01.dad.0000245198.80847.ff; Hayashi S, 2009, INT J DERMATOL, V48, P1217, DOI 10.1111/j.1365-4632.2009.04123.x; TAKEMURA T, 1992, HUM PATHOL, V23, P1216, DOI 10.1016/0046-8177(92)90288-E; Asahina A, 2013, J DERMATOL, V40, P501, DOI 10.1111/1346-8138.12120; Janette JC, 2013, ARTHRITIS RHEUM, V65, P1; Poonawalla T, 2007, CLIN EXP DERMATOL, V33, P282	10	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0172-8172	1437-160X		RHEUMATOL INT	Rheumatol. Int.	JAN	2015	35	1					195	196		10.1007/s00296-014-3063-6		2	Rheumatology	Rheumatology	AX9WX	WOS:000347251000028		
J	Yamaguchi, H; Nishijima, A; Kawakami, A				Yamaguchi, Hiroaki; Nishijima, Ai; Kawakami, Atsushi			Control of two manipulation points of a cooperative transportation system with two car-like vehicles following parametric curve paths	ROBOTICS AND AUTONOMOUS SYSTEMS			English	Article						Nonholonomic system; Differential geometry; Chained form; Cooperative transportation; Path-following; Lyapunov's second method	NONHOLONOMIC MOBILE ROBOTS; N-TRAILER SYSTEM; CHAINED FORM; ARTICULATED VEHICLES; TRACKING CONTROL; STABILIZATION	The present paper proposes a new feedback control law for a cooperative transportation system comprising two car-like vehicles. The proposed feedback control law controls the two manipulation points, which are revolute joints coupling the two vehicles to a carrier, to follow their parametric curve paths, such as Bezier curves at variable velocities. Thus, the proposed feedback control law makes it possible to specify the motion of the carrier quantitatively using design parameters such as the path shapes and the variable velocity profiles. The convergence of the position of the first manipulation point to its desired position on the first path is guaranteed by linear control theory, and the convergence of the position of the second manipulation point to its desired position on the second path is guaranteed by Lyapunov's second method. In particular, the design of the Lyapunov functions is facilitated by a new form of differential equations that are equivalent to time differential equations in a chained form into which the kinematic equations of the system are converted. The validity of the proposed feedback control law is verified experimentally. (C) 2014 Elsevier B.V. All rights reserved.	[Yamaguchi, Hiroaki; Nishijima, Ai; Kawakami, Atsushi] Aoyama Gakuin Univ, Dept Integrated Informat Technol, Coll Sci & Engn, Chuo Ku, Sagamihara, Kanagawa 2525258, Japan	Yamaguchi, H (reprint author), Aoyama Gakuin Univ, Dept Integrated Informat Technol, Coll Sci & Engn, Chuo Ku, 5-10-1 Fuchinobe, Sagamihara, Kanagawa 2525258, Japan.	yamaguchi@it.aoyama.ac.jp					Abou-Samah M, 2006, AUTON ROBOT, V21, P227, DOI 10.1007/s10514-005-9717-9; Yufka A, 2010, IEEE SYS MAN CYBERN, P3300; TILBURY D, 1995, IEEE T ROBOTIC AUTOM, V11, P807, DOI 10.1109/70.478428; TILBURY D, 1995, IEEE T AUTOMAT CONTR, V40, P802, DOI 10.1109/9.384215; ROUCHON P, 1993, PROCEEDINGS OF THE 32ND IEEE CONFERENCE ON DECISION AND CONTROL, VOLS 1-4, P2700, DOI 10.1109/CDC.1993.325686; LAUMOND JP, 1993, IEEE T ROBOTIC AUTOM, V9, P755, DOI 10.1109/70.265919; Jiang ZP, 1999, IEEE T AUTOMAT CONTR, V44, P265, DOI 10.1109/9.746253; Lamiraux F, 1999, IEEE T ROBOTIC AUTOM, V15, P640, DOI 10.1109/70.781968; Altafini C, 2003, IEEE T CONTR SYST T, V11, P598, DOI 10.1109/TCST.2003.813374; SAMPEI M, 1995, IEEE T CONTR SYST T, V3, P125, DOI 10.1109/87.370718; Bolzern P, 1998, IEEE T CONTR SYST T, V6, P515, DOI 10.1109/87.701346; Lamiraux F, 2004, IEEE T ROBOTIC AUTOM, V20, P967, DOI 10.1109/TRO.2004.829459; Brockett R. W., 1983, DIFFERENTIAL GEOMETR, P181; BUSHNELL LG, 1995, INT J ROBOT RES, V14, P366, DOI 10.1177/027836499501400405; Bushnell LG, 1995, PROCEEDINGS OF THE 34TH IEEE CONFERENCE ON DECISION AND CONTROL, VOLS 1-4, P3837, DOI 10.1109/CDC.1995.479196; DeSantis RM, 2002, PROCEEDINGS OF THE 2002 IEEE INTERNATIONAL SYMPOSIUM ON INTELLIGENT CONTROL, P206, DOI 10.1109/ISIC.2002.1157763; HASHIMOTO M, 1993, IROS 93 : PROCEEDINGS OF THE 1993 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOL 1-3, P1944, DOI 10.1109/IROS.1993.583900; Isidori A., 1989, NONLINEAR CONTROL SY; Kosuge K., 1999, P IEEE INT C INT ROB, V3, P1681, DOI 10.1109/IROS.1999.811720; Kosuge K, 1998, IEEE INT CONF ROBOT, P2989; Lamiraux F, 2005, IEEE ROBOT AUTOM MAG, V12, P14, DOI 10.1109/MRA.2005.1411414; Lizarraga DA, 2001, INT J CONTROL, V74, P1612, DOI 10.1080/00207170110086935; Loh C. C., 2012, PROCEDIA ENG, V41, P860; Morin P, 2012, IEEE DECIS CONTR P, P1003, DOI 10.1109/CDC.2012.6427071; SAMSON C, 1995, IEEE T AUTOMAT CONTR, V40, P64, DOI 10.1109/9.362899; Sekhavat S, 1998, IEEE T ROBOTIC AUTOM, V14, P671, DOI 10.1109/70.720344; Sklyarenko Y., 2013, P 2013 IEEE INT C ME, P774; SORDALEN OJ, 1993, PROCEEDINGS : IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOLS 1-3, P382, DOI 10.1109/ROBOT.1993.292011; Sordalen O.J., 1993, P 32 IEEE C DEC CONT, V2, P978; Suzuki R., 2012, T JAPAN SOC MECH ENG, V78, P3650; TILBURY D, 1995, INT J ROBUST NONLIN, V5, P343, DOI 10.1002/rnc.4590050410; Vendittelli M., 2000, P 2000 IEEE INT C RO, V2, P1817, DOI 10.1109/ROBOT.2000.844859; Vendittelli M, 1999, ICRA '99: IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOLS 1-4, PROCEEDINGS, P823, DOI 10.1109/ROBOT.1999.770076; Yamaguchi H., 2003, Transactions of the Society of Instrument and Control Engineers, V39; Yamaguchi H., 2010, P 7 IFAC S INT AUT V, P163; Yamaguchi H., 2009, J ROBOTICS MECHATRON, V21, P57; Yang X., 2014, INT J CONTROL, V77, P949; Yang X., 2003, ARTIF LIFE ROBOT, P48	38	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-8890	1872-793X		ROBOT AUTON SYST	Robot. Auton. Syst.	JAN	2015	63		1				165	178		10.1016/j.robot.2014.07.007		14	Automation & Control Systems; Computer Science, Artificial Intelligence; Robotics	Automation & Control Systems; Computer Science; Robotics	AY3UG	WOS:000347507200015		
J	Ho, VA; Hirai, S				Ho, Van Anh; Hirai, Shinichi			A novel model for assessing sliding mechanics and tactile sensation of human-like fingertips during slip action	ROBOTICS AND AUTONOMOUS SYSTEMS			English	Article						Human fingertip modeling; Beam bundle model; Haptics; Localized slippage; Slip detection	SENSE	This paper presents a model for displaying friction and localized stick/slip of sliding inhomogeneous human-like fingertips, to understand how slippage occurs and its role in assessing tactile sensing mechanics. In the absence of friction, the fingertip slides, as on an ice surface, in the virtual world of haptic interfaces. Slippage of fingertip at very low velocity can reflect micro stick/slip on a contact area, which is challenging to represent in any friction model. To overcome these drawbacks, we propose that a Beam Bundle Model (BBM) can be used to model a human fingertip during pushing and sliding actions, especially during stick-to-slip transition. To construct its three-dimensional, non-homogeneous structure, we obtained a sequential series of magnetic resonance images, showing consecutive cross-sectional layers of a fingertip with distribution of skin, tissue, bone, and nail. Simulation results showed that this model could generate not only normal force distribution caused by pushing, but also response of friction during stick-to-slip transition. Secondly, and more interestingly, the model dynamically produced localized displacement phenomena on the contact area during stick-to-slip phase, indicating how slippage enlarges the contact area prior to total slippage of the fingertip. These findings may better assess the sliding processes of human fingertips, and how and when slippage occurs on the contact surface. This model may be a useful platform for studying tactile perception of fingertips. (C) 2014 Elsevier B.V. All rights reserved.	[Ho, Van Anh; Hirai, Shinichi] Ritsumeikan Univ, Soft Robot Lab, Kusatsu, Shiga 5258577, Japan	Ho, VA (reprint author), Ritsumeikan Univ, Soft Robot Lab, 1-1-1 Noji Higashi, Kusatsu, Shiga 5258577, Japan.	hoanhvan@gmail.com; hirai@se.ritsumei.ac.jp					Lee MH, 2000, INT J ROBOT RES, V19, P636; Dandekar K, 2003, J BIOMECH ENG-T ASME, V125, P682, DOI 10.1115/1.1613673; Astrom K.J., 2008, IEEE CONTROL SYSTEMS, P101; Hertenstein MJ, 2011, HANDBOOK OF TOUCH: NEUROSCIENCE, BEHAVIORAL, AND HEALTH PERSPECTIVES, P299; Ho V.A., 2011, ROBOTICS SCI SYSTEMS, VVII; Ho VA, 2011, IEEE T ROBOT, V27, P411, DOI 10.1109/TRO.2010.2103470; Johnson J.L., 1985, CONTACT MECH; KAO I, 1992, INT J ROBOT RES, V11, P20, DOI 10.1177/027836499201100102; Konyo M., 2012, J RSJ, V30, P23; Maeno T., 2000, IEEE C ROB AUT, P3895; Mindlin RD, 1949, T ASME, V16, P259; Nahvi A., P ASME C; Shimawaki S., 2007, J ENV ENG, V2, P56, DOI 10.1299/jee.2.56; Srinivasan MA, 1996, J BIOMECH ENG-T ASME, V118, P48, DOI 10.1115/1.2795945; Tada M., 2012, J RSJ, V30, P17; Tada M., 2001, Transactions of the Institute of Electronics, Information and Communication Engineers D-II, VJ84D-II; Tada M, 2004, P ANN INT IEEE EMBS, V26, P2045; Wang ZK, 2012, IEEE T INSTRUM MEAS, V61, P3147, DOI 10.1109/TIM.2012.2205102; Xydas N., 2000, IEEE INT C ROB AUT A, V3, P2179	19	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-8890	1872-793X		ROBOT AUTON SYST	Robot. Auton. Syst.	JAN	2015	63		3		SI		253	267		10.1016/j.robot.2014.09.009		15	Automation & Control Systems; Computer Science, Artificial Intelligence; Robotics	Automation & Control Systems; Computer Science; Robotics	AY3UI	WOS:000347507400004		
J	Funatsu, T; Shimizu, N; Kuruppu, M; Matsui, K				Funatsu, Takahiro; Shimizu, Norikazu; Kuruppu, Mahinda; Matsui, Kikuo			Evaluation of Mode I Fracture Toughness Assisted by the Numerical Determination of K-Resistance	ROCK MECHANICS AND ROCK ENGINEERING			English	Article						Fracture toughness; SCB specimen; Fracture process zone; DEM; K-resistance curve	SUGGESTED METHOD; PARTICLE MODEL; ELEMENT METHOD; BRITTLE ROCKS; SPECIMENS; GEOMETRY; LIMESTONE	The fracture toughness of a rock often varies depending on the specimen shape and the loading type used to measure it. To investigate the mode I fracture toughness using semi-circular bend (SCB) specimens, we experimentally studied the fracture toughness using SCB and chevron bend (CB) specimens, the latter being one of the specimens used extensively as an International Society for Rock Mechanics (ISRM) suggested method, for comparison. The mode I fracture toughness measured using SCB specimens is lower than both the level I and level II fracture toughness values measured using CB specimens. A numerical study based on discontinuum mechanics was conducted using a two-dimensional distinct element method (DEM) for evaluating crack propagation in the SCB specimen during loading. The numerical results indicate subcritical crack growth as well as sudden crack propagation when the load reaches the maximum. A K-resistance curve is drawn using the crack extension and the load at the point of evaluation. The fracture toughness evaluated by the K-resistance curve is in agreement with the level II fracture toughness measured using CB specimens. Therefore, the SCB specimen yields an improved value for fracture toughness when the increase of K-resistance with stable crack propagation is considered.	[Funatsu, Takahiro] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058567, Japan; [Shimizu, Norikazu] Yamaguchi Univ, Ube, Yamaguchi 7558611, Japan; [Kuruppu, Mahinda] Curtin Univ, Kalgoorlie, WA 6433, Australia; [Matsui, Kikuo] Kyushu Univ, Nishi Ku, Fukuoka 8190395, Japan	Funatsu, T (reprint author), Natl Inst Adv Ind Sci & Technol, 1-1-1 Higashi, Tsukuba, Ibaraki 3058567, Japan.	funatsu-t@aist.go.jp					Chang SH, 2002, ENG GEOL, V66, P79, DOI 10.1016/S0013-7952(02)00033-9; BARKER LM, 1977, ENG FRACT MECH, V9, P361, DOI 10.1016/0013-7944(77)90028-5; CHONG KP, 1988, ENG FRACT MECH, V30, P701, DOI 10.1016/0013-7944(88)90160-9; Potyondy DO, 2004, INT J ROCK MECH MIN, V41, P1329, DOI 10.1016/j.ijrmms.2004.09.011; Iqbal MJ, 2007, ROCK MECH ROCK ENG, V40, P453, DOI 10.1007/s00603-006-0107-6; D'Addetta GA, 2002, GRANUL MATTER, V4, P77, DOI 10.1007/s10035-002-0103-9; Wang QZ, 1999, ENG FRACT MECH, V64, P193, DOI 10.1016/S0013-7944(99)00065-X; CUNDALL PA, 1979, GEOTECHNIQUE, V29, P47; Funatsu T, 2004, INT J ROCK MECH MIN, V41, P927, DOI 10.1016/j.ijrmms.2004.02.008; Kuruppu MD, 2014, ROCK MECH ROCK ENG, V47, P267, DOI 10.1007/s00603-013-0422-7; Aliha MRM, 2012, INT J ROCK MECH MIN, V51, P128, DOI 10.1016/j.ijrmms.2012.01.017; FOWELL RJ, 1995, INT J ROCK MECH MIN, V32, P57, DOI 10.1016/0148-9062(94)00015-U; Tutluoglu L, 2011, INT J ROCK MECH MIN, V48, P1248, DOI 10.1016/j.ijrmms.2011.09.019; CHONG KP, 1987, ENG FRACT MECH, V28, P43, DOI 10.1016/0013-7944(87)90118-4; FOWELL RJ, 1994, INT J ROCK MECH MIN, V31, P571, DOI 10.1016/0148-9062(94)90001-9; Cho N, 2007, INT J ROCK MECH MIN, V44, P997, DOI 10.1016/j.ijrmms.2007.02.002; Azevedo NM, 2006, COMPUT METHOD APPL M, V195, P4579, DOI 10.1016/j.cma.2005.10.005; Dai F, 2007, P SEM ANN C EXP EXP, P1383; Funatsu T, 2008, J MMIJ, V124, P611, DOI 10.2473/journalofmmij.124.611; GUO H, 1993, ENG GEOL, V33, P177, DOI 10.1016/0013-7952(93)90056-I; Itasca Consulting Group Inc, 2004, PART FLOW COD 2 DIM; Khan K, 2000, ROCK MECH ROCK ENG, V33, P179, DOI 10.1007/s006030070006; LIM IL, 1994, INT J ROCK MECH MIN, V31, P185, DOI 10.1016/0148-9062(94)90463-4; MATSUKI K, 1991, INT J ROCK MECH MIN, V28, P365, DOI 10.1016/0148-9062(91)90075-W; Nasseri MHB, 2006, PURE APPL GEOPHYS, V163, P917, DOI 10.1007/s00024-006-0064-8; Ouchterlony F, 1981, ASTM STP, P237; Ouchterlony F., 1988, INT J ROCK MECH MIN, V25, P71; Schmidt RA, 1980, P 21 US S ROCK MECH, P581; Tan YQ, 2009, J EUR CERAM SOC, V29, P1029, DOI 10.1016/j.jeurceramsoc.2008.07.060	29	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0723-2632	1434-453X		ROCK MECH ROCK ENG	Rock Mech. Rock Eng.	JAN	2015	48	1					143	157		10.1007/s00603-014-0550-8		15	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	AY0OQ	WOS:000347296400010		
J	Yaakob, Y; Yusop, MZM; Takahashi, C; Rosmi, MS; Kalita, G; Tanemura, M				Yaakob, Yazid; Yusop, Mohd Zamri Mohd; Takahashi, Chisato; Rosmi, Mohamad Saufi; Kalita, Golap; Tanemura, Masaki			In situ transmission electron microscopy of Ag-incorporated carbon nanofibers: the effect of Ag nanoparticle size on graphene formation	RSC ADVANCES			English	Article							FIELD-EMISSION PROCESS; SILVER; COPPER; NANOTUBE; POINT; FILMS	We have studied graphene formation from a single Ag-incorporated carbon nanofiber (CNF) during electron emission using in situ transmission electron microscopy. The formation of graphene from the Ag-incorporated CNF structure was observed under a high current of between 900 nA to 2.03 mu A during field and thermal electron emission. Joule heating during the process generated an increased temperature, estimated at approximately 440 K to 1030 K, leading to the transformation of a significant amount of the amorphous carbon surrounding Ag particles to a graphene structure, and to the nearly simultaneous evaporation of Ag particles. This evaporation interrupted the thermal electron emission process, thus leading to a decrease of the emission current to similar to 300 nA. Also, graphene stopped forming after the Ag particles had evaporated. In this paper, the effect of Ag particle size on its ability to catalyze the fabrication of high-quality graphene are discussed.	[Yaakob, Yazid; Yusop, Mohd Zamri Mohd; Rosmi, Mohamad Saufi; Kalita, Golap; Tanemura, Masaki] Nagoya Inst Technol, Dept Frontier Mat, Showa Ku, Nagoya, Aichi 4668555, Japan; [Yaakob, Yazid] Univ Putra Malaysia, Fac Sci, Dept Phys, Upm Serdang 43400, Selangor, Malaysia; [Yusop, Mohd Zamri Mohd] Univ Teknol Malaysia, Dept Mat, Fac Mech Engn, Skudai 81310, Johor, Malaysia; [Takahashi, Chisato] Aichi Gakuin Univ, Sch Pharm, Chikusa Ku, Nagoya, Aichi 4648650, Japan; [Rosmi, Mohamad Saufi] Univ Pendidikan Sultan Idris, Fac Sci & Math, Dept Chem, Tanjong Malim 35900, Perak, Malaysia	Tanemura, M (reprint author), Nagoya Inst Technol, Dept Frontier Mat, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.	tanemura.masaki@nitech.ac.jp	Mohd Yusop, Mohd Zamri/K-6600-2012	Mohd Yusop, Mohd Zamri/0000-0003-0897-2712	Japan Society for the Promotion of Science (JSPS) [23360020]	This work was partially supported by a grant from the Japan Society for the Promotion of Science (JSPS; Grant-in-Aid for Scientific Research B, Grant no. 23360020).	Xu Z, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2103420; Edgcombe CJ, 2001, J MICROSC-OXFORD, V203, P188, DOI 10.1046/j.1365-2818.2001.00890.x; Liu M, 2011, NATURE, V474, P64, DOI 10.1038/nature10067; Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245; Kim K, 2011, NATURE, V479, P338, DOI 10.1038/nature10680; Xiao SF, 2005, J PHYS CHEM B, V109, P20339, DOI 10.1021/jp054551t; GEIGER F, 1987, INT J THERMOPHYS, V8, P425, DOI 10.1007/BF00567103; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Liu N, 2011, NANO LETT, V11, P297, DOI 10.1021/nl103962a; Jiang Q, 2003, MATER CHEM PHYS, V82, P225, DOI 10.1016/S0254-0584(03)00201-3; Chen SS, 2011, ACS NANO, V5, P1321, DOI 10.1021/nn103028d; Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996; Takagi D, 2006, NANO LETT, V6, P2642, DOI 10.1021/nl061797g; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235; Wintterlin J, 2009, SURF SCI, V603, P1841, DOI 10.1016/j.susc.2008.08.037; Gao L, 2010, NANO LETT, V10, P3512, DOI 10.1021/nl1016706; Ayhan ME, 2014, RSC ADV, V4, P26866, DOI 10.1039/c4ra02867h; Pasricha R, 2009, SMALL, V5, P2253, DOI 10.1002/smll.200900726; Asaka K, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3630132; Ayhan ME, 2013, PHYS STATUS SOLIDI-R, V7, P1076, DOI 10.1002/pssr.201308159; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Ghosh P, 2011, CHEM COMMUN, V47, P4820, DOI 10.1039/c1cc10655d; Jones HA, 1927, PHYS REV, V30, P201, DOI 10.1103/PhysRev.30.201; Meyer J. C., 2007, NATURE, V446; Oznuluer T, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3584006; Reina A., 2009, NANO LETT, V9, P130; Takahashi C, 2014, CARBON, V75, P277, DOI 10.1016/j.carbon.2014.04.002; Takeuchi D, 2008, J PHYS CONF SER, V100, DOI 10.1088/1742-6596/100/1/012029; Vincent P, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.075406; Wang ZP, 2011, J NANOSCI NANOTECHNO, V11, P10677, DOI 10.1166/jnn.2011.4021; WHITTAKER AG, 1978, NATURE, V276, P695, DOI 10.1038/276695a0; Yaakob Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.11NL01; Yusop MZM, 2012, ACS NANO, V6, P9567, DOI 10.1021/nn302889e; Zamri M, 2011, J VAC SCI TECHNOL B, V29, DOI 10.1116/1.3591420	34	0	0	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2046-2069			RSC ADV	RSC Adv.		2015	5	8					5647	5651		10.1039/c4ra11059e		5	Chemistry, Multidisciplinary	Chemistry	AY0RQ	WOS:000347304900023		
J	Masuda, T; Terasaki, A; Akimoto, AM; Nagase, K; Okano, T; Yoshida, R				Masuda, Tsukuru; Terasaki, Ayako; Akimoto, Aya Mizutani; Nagase, Kenichi; Okano, Teruo; Yoshida, Ryo			Control of swelling-deswelling behavior of a self-oscillating gel by designing the chemical structure	RSC ADVANCES			English	Article							BELOUSOV-ZHABOTINSKY REACTION; IONIC LIQUID; DRIVEN; ACTUATORS; CHEMISTRY; SYSTEMS; MOTION	We have developed a novel "self-oscillating" gel that exhibits an autonomous mechanical oscillation without any external stimuli. Here the ternary self-oscillating polymer composed of N-isopropylacrylamide and N-(3-aminopropyl)methacrylamide and Ru(bpy)(3) was newly synthesized by atom transfer radical polymerization (ATRP) and the gel was prepared. For the self-oscillating polymers and gels with various compositions, their phase transition and self-oscillating behaviors were investigated considering the potential for biomedical application. It was demonstrated that the swelling-deswelling behavior of the self-oscillating gels can be controlled by changing the composition ratio of the free amino group present in the polymer and the conjugated Ru(bpy)(3) moieties. Therefore the hydrophilic/hydrophobic balance is controllable and adjustable by this composition ratio.	[Masuda, Tsukuru; Terasaki, Ayako; Akimoto, Aya Mizutani; Yoshida, Ryo] Univ Tokyo, Sch Engn, Dept Mat Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Nagase, Kenichi; Okano, Teruo] Tokyo Womens Med Univ TWIns, Inst Adv Biomed Engn & Sci, Shinjuku Ku, Tokyo 1628666, Japan	Yoshida, R (reprint author), Univ Tokyo, Sch Engn, Dept Mat Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	ryo@cross.t.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [22245037]; Japan Society for the Promotion of Science for Young Scientists [269992]	This work was supported in part by a Grant-in-Aid for Scientific Research to R.Y. from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Grant no. 22245037) and Research Fellowships to T.M. from the Japan Society for the Promotion of Science for Young Scientists (no. 269992). We acknowledge Dr Zulma A. Jimenez for helpful suggestions.	Techawanitchai P, 2012, SOFT MATTER, V8, P2844, DOI 10.1039/c2sm07277g; Shiraki Y, 2012, ANGEW CHEM INT EDIT, V51, P6112, DOI 10.1002/anie.201202028; Ueki T, 2013, CHEM COMMUN, V49, P6947, DOI 10.1039/c3cc38432b; Maeda S, 2007, ADV MATER, V19, P3480, DOI 10.1002/adma.200700625; Suzuki D, 2012, SOFT MATTER, V8, P11447, DOI 10.1039/c2sm26477c; PEEK BM, 1991, INT J PEPT PROT RES, V38, P114; Yashin VV, 2010, PROG POLYM SCI, V35, P155, DOI 10.1016/j.progpolymsci.2009.10.003; Tamate R, 2014, ANGEW CHEM INT EDIT, V53, P11248, DOI 10.1002/anie.201406953; Yoshida R, 2010, ADV MATER, V22, P3463, DOI 10.1002/adma.200904075; Howse JR, 2006, NANO LETT, V6, P73, DOI 10.1021/nl0520617; Mitsunaga R, 2013, CHEM COMMUN, V49, P4935, DOI 10.1039/c3cc42054j; Dong L, 2007, SOFT MATTER, V3, P1223, DOI 10.1039/b706563a; Yoshida R, 2002, J AM CHEM SOC, V124, P8095, DOI 10.1021/ja012584q; Zhou HW, 2013, SOFT MATTER, V9, P4956, DOI 10.1039/c3sm00021d; Ueki T, 2014, PHYS CHEM CHEM PHYS, V16, P10388, DOI 10.1039/c4cp00980k; Ueki T, 2014, SOFT MATTER, V10, P1349, DOI 10.1039/c3sm51537k; Masuda T, 2013, ANGEW CHEM INT EDIT, V52, P7468, DOI 10.1002/anie.201301988; Matsumoto A, 2010, CHEM COMMUN, V46, P2203, DOI 10.1039/b920319b; Liu F, 2010, PROG POLYM SCI, V35, P3, DOI 10.1016/j.progpolymsci.2009.10.002; Murase Y, 2009, LANGMUIR, V25, P483, DOI 10.1021/la8029006; Hidaka M, 2011, J CONTROL RELEASE, V150, P171, DOI [10.1016/j.jconrel.2010.11.026, 10.1016/j.jcoarel.2010.11.026]; Kobayashi J, 2013, REACT FUNCT POLYM, V73, P939, DOI 10.1016/j.reactfunctpolym.2013.01.017; Matsumoto A, 2009, ADV MATER, V21, P4372, DOI 10.1002/adma.200900693; Miyata T., 2002, SUPRAMOLECULAR DESIG, P191; Ueki T, 2013, LANGMUIR, V29, P13661, DOI 10.1021/la402688e; Yashin VV, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/6/066601; Yoshida R, 2014, NPG ASIA MATER, V6, DOI 10.1038/am.2014.32; Yoshida R., 1996, J AM CHEM SOC, V118, P5135	28	3	3	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2046-2069			RSC ADV	RSC Adv.		2015	5	8					5781	5787		10.1039/c4ra10675j		7	Chemistry, Multidisciplinary	Chemistry	AY0RQ	WOS:000347304900043		
J	Kondo, S; Taguchi, Y; Bie, Y				Kondo, Shin-ichi; Taguchi, Yuka; Bie, Yi			Solvent dependent intramolecular excimer emission of di(1-pyrenyl)silane and di(1-pyrenyl)methane derivatives	RSC ADVANCES			English	Article							TIME-RESOLVED FLUORESCENCE; ANTHRACENE; PHOTOPHYSICS; PATHWAYS; DYNAMICS	Di(1-pyrenyl)silane and di(1-pyrenyl)methane derivatives showed unprecedented intramolecular excimer emission in polar organic solvents such as DMSO and the ratio of excimer/monomer emissions strongly depends on the dielectric constants of the solvents.	[Kondo, Shin-ichi; Taguchi, Yuka; Bie, Yi] Yamagata Univ, Fac Sci, Dept Mat & Biol Chem, Yamagata 9908560, Japan; [Kondo, Shin-ichi] Yamagata Univ, Inst Reg Innovat, Kaminoyama, Yamagata 9993101, Japan	Kondo, S (reprint author), Yamagata Univ, Fac Sci, Dept Mat & Biol Chem, Yamagata 9908560, Japan.	kondo@sci.kj.yamagata-u.ac.jp	Kondo, Shin-ichi/E-4954-2010		JSPS; Yamagata University	The authors would like to thank Professors Tatsuya Nabeshima and Masaki Yamamura for measurements of HRMS (ESI) of the compounds. This work was partially supported by a Grant-in-Aid for Scientific Research (C), JSPS and YU-COE (E), Yamagata University.	DONG DC, 1984, CAN J CHEM, V62, P2560, DOI 10.1139/v84-437; ZACHARIASSE KA, 1984, J AM CHEM SOC, V106, P1045, DOI 10.1021/ja00316a038; Kaanumalle LS, 2005, J AM CHEM SOC, V127, P3674, DOI 10.1021/ja0425381; Kondo S, 2013, ORG LETT, V15, P520, DOI 10.1021/ol303332k; FIELDING PE, 1967, J CHEM PHYS, V47, P247, DOI 10.1063/1.1711853; Kondo S, 2006, ORG LETT, V8, P4621, DOI 10.1021/ol061855p; WINNIK FM, 1993, CHEM REV, V93, P587, DOI 10.1021/cr00018a001; Birks J. B., 1970, PHOTOPHYSICS AROMATI; Boo BH, 2005, J PHYS CHEM A, V109, P4280, DOI 10.1021/jp0406621; CHUNG YB, 1991, CHEM PHYS LETT, V176, P453; Delercq D., 1993, J AM CHEM SOC, V115, P5702; HARA K, 1988, J AM CHEM SOC, V110, P1911, DOI 10.1021/ja00214a040; Karatsu T, 2003, J PHYS CHEM B, V107, P12184, DOI 10.1021/jp0355760; Laali KK, 1997, J ORG CHEM, V62, P5804, DOI 10.1021/jo9707343; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE; Lekha PK, 2010, CHEM-EUR J, V16, P3699, DOI 10.1002/chem.200902391; Reichardt C., 1988, SOLVENTS SOLVENT EFF; Reimlinger H., 1964, CHEM BER, P349; Yang DDH, 2003, J AM CHEM SOC, V125, P5107, DOI 10.1021/ja020403u; Zhang GQ, 2007, CHEM-EUR J, V13, P3630, DOI 10.1002/chem.200600514	20	0	0	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2046-2069			RSC ADV	RSC Adv.		2015	5	8					5846	5849		10.1039/c4ra12153h		4	Chemistry, Multidisciplinary	Chemistry	AY0RQ	WOS:000347304900050		
J	Hlaing, NN; Sreekantan, S; Othman, R; Pung, SY; Hinode, H; Kurniawan, W; Thant, AA; Mohamed, AR; Salime, C				Hlaing, Nwe Ni; Sreekantan, Srimala; Othman, Radzali; Pung, Swee-Yong; Hinode, Hirofumi; Kurniawan, Winarto; Thant, Aye Aye; Mohamed, Abdul Rahman; Salime, Chris			Sol-gel hydrothermal synthesis of microstructured CaO-based adsorbents for CO2 capture	RSC ADVANCES			English	Article							INORGANIC HOLLOW SPHERES; NANO-SIZED CACO3; CALCIUM-CARBONATE; LOOPING CYCLES; FAST PRECIPITATION; WATER-TREATMENT; MIXED-SOLUTIONS; SORBENTS; MICROSPHERES; OXIDE	In this study, microstructured CaO-based adsorbents were synthesized by a sol-gel hydrothermal method using calcium nitrate tetrahydrate, citric acid and sodium hydroxide as precursors. Experiments with different NaOH concentrations (2, 6 and 10 M) were carried out to investigate the effects on the morphologies and CO2 adsorption activities of the synthesized adsorbents. X-ray diffraction (XRD) and field-emission scanning electron microscopy (FESEM) results showed that different NaOH concentrations resulted in different crystal phases and morphologies. A novel three-dimensional (3D) hierarchical calcite (CaCO3) hollow microspherical adsorbent composed of one-dimensional (1D) spike-shaped nanorods was obtained with 2 M NaOH. XRD analyses confirmed that the hierarchical CaCO3 hollow microspheres were characteristic of the calcite phase. The FESEM image revealed that the microspheres were composed of 1D spike-shaped nanorods with an average length of 500 nm. The cross-sectional FESEM image showed that the microspheres had hollow structures with an average inner cavity of 2 mu m and a shell thickness of approximately 0.5 mu m. The CO2 adsorption performance of the synthesized adsorbents was investigated using thermogravimetry-differential thermal analysis (TG-DTA) apparatus. The results indicated that the novel hierarchical calcite (CaCO3) hollow microspherical adsorbent composed of one-dimensional (1D) spike-shaped nanorods possessed higher carbonation conversion of 45% after 15 cycles, which was about 22% higher than that of other adsorbents synthesized with 6 and 10 M NaOH concentration and limestone. This property could be attributed to the 3D hierarchical hollow microsphere structure, 1D spike-shaped nanorod structure, trimodal pore size distribution and large BET surface area (44.85 m(2) g(-1)) of the novel adsorbent.	[Hlaing, Nwe Ni; Sreekantan, Srimala; Othman, Radzali; Pung, Swee-Yong] Univ Sains Malaysia, Sch Mat & Mineral Resources Engn, Nibong Tebal 14300, Penang, Malaysia; [Hlaing, Nwe Ni; Hinode, Hirofumi; Kurniawan, Winarto] Tokyo Inst Technol, Dept Int Dev Engn, Meguro Ku, Tokyo 152, Japan; [Hlaing, Nwe Ni; Thant, Aye Aye] Univ Yangon, Dept Phys, Kamayut 11041, Yangon, Myanmar; [Mohamed, Abdul Rahman] Univ Sains Malaysia, Sch Chem Engn, Low Carbon Econ LCE Res Grp, Nibong Tebal 14300, Penang, Malaysia; [Salime, Chris] Surya Univ, Tangerang 15810, Banten, Indonesia	Sreekantan, S (reprint author), Univ Sains Malaysia, Sch Mat & Mineral Resources Engn, Engn Campus, Nibong Tebal 14300, Penang, Malaysia.	nwenihlaing76@gmail.com; srimala@usm.my; hinode@ide.titech.ac.jp	Pung, Swee/C-6249-2011; Sreekantan, Srimala/C-6211-2012	Sreekantan, Srimala/0000-0001-5125-8683	AUN/SEED Net Project [304/6050219]; RU [814154]; Japan International Cooperation Agency (JICA); Ministry of Higher Education (MOHE) Malaysia [203/PKT/6723001]	The authors thank the AUN/SEED Net Project under grant no. 304/6050219, RU grant no. 814154, Japan International Cooperation Agency (JICA) and Long Term Research Grant (LRGS) (203/PKT/6723001) from the Ministry of Higher Education (MOHE) Malaysia for their financial support. The authors thank Mr Jon Koki, Technical Department, Center for Advanced Materials Analysis, Tokyo Institute of Technology, for FESEM analysis. The authors also greatly acknowledge the Universiti Sains Malaysia and Tokyo Institute of Technology for the use of their facilities.	Gunasekaran S, 2006, J RAMAN SPECTROSC, V37, P892, DOI 10.1002/jrs.1518; Cao AM, 2005, ANGEW CHEM INT EDIT, V44, P4391, DOI 10.1002/anie.200500946; Wan MX, 2008, ADV MATER, V20, P2926, DOI 10.1002/adma.200800466; Chen M, 2013, ADV MATER, V25, P5343, DOI 10.1002/adma.201301911; Jiang SD, 2012, J PHYS CHEM C, V116, P4484, DOI 10.1021/jp211648x; Xia LY, 2011, J MATER CHEM, V21, P9020, DOI 10.1039/c1jm10126a; Wei W, 2008, J AM CHEM SOC, V130, P15808, DOI 10.1021/ja8039585; Wang YS, 2010, J COLLOID INTERF SCI, V352, P393, DOI 10.1016/j.jcis.2010.08.060; Afkhamipour M, 2014, INT J GREENH GAS CON, V25, P9, DOI 10.1016/j.ijggc.2014.03.005; Enomae T, 2004, APPITA J, V57, P493; Qi LM, 2002, ADV MATER, V14, P300; Frost RL, 2004, THERMOCHIM ACTA, V409, P79, DOI 10.1016/S0040-6031(03)00332-0; Luo C, 2010, IND ENG CHEM RES, V49, P11778, DOI 10.1021/ie1012745; Wang SP, 2014, ACS APPL MATER INTER, V6, P18072, DOI 10.1021/am5049527; Ouyang JM, 2006, J CRYST GROWTH, V293, P118, DOI 10.1016/j.jcrysgro.2006.05.008; Abanades JC, 2003, ENERG FUEL, V17, P308, DOI 10.1021/ef020152a; Fei JB, 2008, ADV MATER, V20, P452, DOI 10.1002/adma.200701231; Grasa GS, 2006, IND ENG CHEM RES, V45, P8846, DOI 10.1021/ie0606946; Lu H, 2006, IND ENG CHEM RES, V45, P3944, DOI 10.1021/ie051325x; Hu J, 2011, CHEM SOC REV, V40, P5472, DOI 10.1039/c1cs15103g; Lou XW, 2008, ADV MATER, V20, P3987, DOI 10.1002/adma.200800854; Sing KSW, 1995, J POROUS MAT, V2, P5, DOI 10.1007/BF00486564; Akgsornpeak A, 2014, CHEM ENG J, V237, P189, DOI 10.1016/j.cej.2013.10.023; Bian ZF, 2012, J AM CHEM SOC, V134, P2325, DOI 10.1021/ja210270m; Manovic V, 2008, ENVIRON SCI TECHNOL, V42, P4170, DOI 10.1021/es800152s; Zhao DH, 2013, MATER LETT, V104, P28, DOI 10.1016/j.matlet.2013.04.018; Li ZS, 2006, IND ENG CHEM RES, V45, P1911, DOI 10.1021/ie0512111; Yang ZH, 2009, IND ENG CHEM RES, V48, P10765, DOI 10.1021/ie901137s; Witoon T, 2011, CERAM INT, V37, P3291, DOI 10.1016/j.ceramint.2011.05.125; Gupta H, 2002, IND ENG CHEM RES, V41, P4035, DOI 10.1021/ie010867l; Manovic V, 2008, ENERG FUEL, V22, P1851, DOI 10.1021/ef800011z; Choi S, 2009, CHEMSUSCHEM, V2, P796, DOI 10.1002/cssc.200900036; Wang B, 2011, J AM CHEM SOC, V133, P17146, DOI 10.1021/ja208346s; BARKER R, 1974, J APPL CHEM BIOTECHN, V24, P221, DOI 10.1002/jctb.5020240405; Alvarez D, 2005, IND ENG CHEM RES, V44, P5608, DOI 10.1021/ie050305s; Virtudazo RVR, 2011, IOP CONF SER-MAT SCI, V18, DOI 10.1088/1757-899X/18/6/062014; Cheng Y, 2005, J PHYS CHEM B, V109, P11548, DOI 10.1021/jp050641m; Zhu YQ, 2011, CHEM ENG J, V175, P512, DOI 10.1016/j.cej.2011.09.084; Sun P, 2008, AICHE J, V54, P1668, DOI 10.1002/aic.11491; Santos ET, 2012, FUEL, V94, P624, DOI 10.1016/j.fuel.2011.10.011; Li YJ, 2008, CHEM ENG TECHNOL, V31, P237, DOI 10.1002/ceat.200700371; Lu H, 2008, IND ENG CHEM RES, V47, P6216, DOI 10.1021/ie8002182; Yu CH, 2012, AEROSOL AIR QUAL RES, V12, P745, DOI 10.4209/aaqr.2012.05.0132; Sun P, 2007, AICHE J, V53, P2432, DOI 10.1002/aic.11251; Lysikov AI, 2007, IND ENG CHEM RES, V46, P4633, DOI 10.1021/ie0702328; Ding SJ, 2011, NANOSCALE, V3, P3586, DOI 10.1039/c1nr10581g; Abanades JC, 2004, AICHE J, V50, P1614, DOI 10.1002/aic.10132; Ghiasi M, 2012, CRYST RES TECHNOL, V47, P471, DOI 10.1002/crat.201100240; Sun ZQ, 2013, NANO RES, V6, P726, DOI 10.1007/s12274-013-0350-6; Feng B, 2007, ENERG FUEL, V21, P426, DOI 10.1021/ef0604036; Florin NH, 2009, CHEM ENG SCI, V64, P187, DOI 10.1016/j.ces.2008.10.021; SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603; Guan YY, 2014, LANGMUIR, V30, P3681, DOI 10.1021/la404914g; Butler M.F., 2008, CRYST GROWTH DES, V9, P534, DOI DOI 10.1021/CG8008333; Chedella SCV, 2010, INT ENDOD J, V43, P509, DOI 10.1111/j.1365-2591.2010.01708.x; Donat F., 2011, ENVIRON SCI TECHNOL, V46, P1262; Dong HX, 2013, SENSOR ACTUAT B-CHEM, V178, P302, DOI 10.1016/j.snb.2012.12.103; Dong W., 2010, LANGMUIR, V27, P366; Gopi SP, 2012, POWDER TECHNOL, V225, P58, DOI 10.1016/j.powtec.2012.03.032; Guan XF, 2011, J ALLOY COMPD, V509, P3367, DOI 10.1016/j.jallcom.2010.12.067; Lee I, 2010, J CRYST GROWTH, V312, P1741, DOI 10.1016/j.jcrysgro.2010.02.026; Liu T, 2010, MATER LETT, V64, P2575, DOI 10.1016/j.matlet.2010.08.050; Liu W, 2009, ENVIRON SCI TECHNOL, V44, P841; Luo C, 2012, CHEM ENG TECHNOL, V35, P547, DOI 10.1002/ceat.201000299; Palmer SJ, 2011, J IND ENG CHEM, V17, P56, DOI 10.1016/j.jiec.2010.10.009; PETROV I, 1975, SPECTROCHIM ACTA A, VA 31, P309, DOI 10.1016/0584-8539(75)80025-0; Yang XD, 2014, POWDER TECHNOL, V256, P272, DOI 10.1016/j.powtec2014.02.020; Zhao CJ, 2014, IND ENG CHEM RES, V53, P14065, DOI 10.1021/ie502559t; Zhao LN, 2012, COLLOID SURFACE A, V393, P139, DOI 10.1016/j.colsurfa.2011.11.012; Zhu LP, 2009, NANOSCALE RES LETT, V4, P550, DOI 10.1007/s11671-009-9279-9	70	2	2	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2046-2069			RSC ADV	RSC Adv.		2015	5	8					6051	6060		10.1039/c4ra14355h		10	Chemistry, Multidisciplinary	Chemistry	AY0RQ	WOS:000347304900078		
J	Chin, KZ				Chin, Kazuo			New insights in the management of patients with obstructive sleep apnea	SLEEP AND BIOLOGICAL RHYTHMS			English	Review						breathing; sleep apnea; sleep disorders	POSITIVE AIRWAY PRESSURE; PROSTAGLANDIN-D-SYNTHASE; CORONARY-HEART-DISEASE; METABOLIC SYNDROME; DAYTIME SLEEPINESS; BLOOD-PRESSURE; RISK-FACTOR; WORKING POPULATION; GLUCOSE-METABOLISM; INSULIN-RESISTANCE	The prevalence of patients with obstructive sleep apnea (OSA) is high and increasing. Controlling OSA is an important issue for a medical domain. OSA adversely affects multiple organs and systems in individuals, with particular relevance to cardiovascular diseases. Patients with OSA have several signs and symptoms such as snoring, hypersomnolence, general fatigue, and cognitive impairment. Since OSA is a significant issue for a medical domain, many investigations on the pathophysiology of OSA have been conducted. Another important factor in the development of cardiovascular diseases and sleepiness is sleep duration. Therefore, an association between OSA and sleep duration has an impact on the development of cardiovascular diseases and other common diseases.	[Chin, Kazuo] Kyoto Univ, Grad Sch Med, Dept Resp Care & Sleep Control Med, Kyoto 6068507, Japan	Chin, KZ (reprint author), Kyoto Univ, Grad Sch Med, Dept Resp Care & Sleep Control Med, Sakyo Ku, Shogoin 54,Kawahara Cho, Kyoto 6068507, Japan.	chink@kuhp.kyoto-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology; Respiratory Failure Research Group and Health Science Research Grants from the Japanese Ministry of Health, Labor and Welfare; Japan Vascular Disease Research Foundation; Philips-Respironics; Teijin Pharma; Fukuda Denshi; Fukuda Lifetec Keigji	This work was supported in part by grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology, Respiratory Failure Research Group and Health Science Research Grants from the Japanese Ministry of Health, Labor and Welfare, and the Japan Vascular Disease Research Foundation. The Department of Respiratory Care and Sleep Control Medicine is funded by endowments from Philips-Respironics, Teijin Pharma, Fukuda Denshi, and Fukuda Lifetec Keigji to Kyoto University.	Ram A, 1997, BRAIN RES, V751, P81, DOI 10.1016/S0006-8993(96)01401-1; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Robinson GV, 2006, EUR RESPIR J, V27, P1229, DOI 10.1183/09031936.06.00062805; Foster GD, 2009, DIABETES CARE, V32, P1017, DOI 10.2337/dc08-1776; Drager LF, 2010, ATHEROSCLEROSIS, V208, P490, DOI 10.1016/j.atherosclerosis.2009.08.016; Drager LF, 2011, CHEST, V140, P534, DOI 10.1378/chest.10-2223; Barcelo A, 2008, THORAX, V63, P946, DOI 10.1136/thx.2007.093740; Aronsohn RS, 2010, AM J RESP CRIT CARE, V181, P507, DOI 10.1164/rccm.200909-1423OC; Chin K, 2006, J HYPERTENS, V24, P2091, DOI 10.1097/01.hjh.0000244960.69985.4c; Grassi G, 2005, HYPERTENSION, V46, P321, DOI 10.1161/01.HYP.0000174243.39897.6c; Campos-Rodriguez F, 2014, AM J RESP CRIT CARE, V189, P1544, DOI 10.1164/rccm.201311-2012OC; [Anonymous], 2009, AM J RESP CRIT CARE, V179, P228; Luyster FS, 2012, SLEEP, V35, P727, DOI 10.5665/sleep.1846; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Spiegel K, 2009, NAT REV ENDOCRINOL, V5, P253, DOI 10.1038/nrendo.2009.23; Barbe F, 2001, ANN INTERN MED, V134, P1015; Choi KM, 2008, INT J OBESITY, V32, P1091, DOI 10.1038/ijo.2008.62; Hall MH, 2008, SLEEP, V31, P635; UENO R, 1983, P NATL ACAD SCI-BIOL, V80, P1735, DOI 10.1073/pnas.80.6.1735; Drager LF, 2013, J AM COLL CARDIOL, V62, P569, DOI 10.1016/j.jacc.2013.05.045; Redline S, 2010, AM J RESP CRIT CARE, V182, P269, DOI 10.1164/rccm.200911-1746OC; ENGLEMAN HM, 1994, LANCET, V343, P572, DOI 10.1016/S0140-6736(94)91522-9; Harada Y, 2012, J SLEEP RES, V21, P410, DOI 10.1111/j.1365-2869.2012.00997.x; Resnick HE, 2003, DIABETES CARE, V26, P702, DOI 10.2337/diacare.26.3.702; Arnardottir ES, 2009, SLEEP, V32, P447; Marin JM, 2010, AM J RESP CRIT CARE, V182, P325, DOI 10.1164/rccm.200912-1869OC; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Campos-Rodriguez F, 2012, ANN INTERN MED, V156, P115, DOI 10.7326/0003-4819-156-2-201201170-00006; [Anonymous], 1999, SLEEP, V22, P667; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104; Jelic S, 2010, CIRCULATION, V121, P1014, DOI 10.1161/CIRCULATIONAHA.109.900357; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Chihara Y, 2013, SLEEP, V36, P229, DOI 10.5665/sleep.2378; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Somers VK, 2008, CIRCULATION, V118, P1080, DOI 10.1161/CIRCULATIONAHA.107.189375; Lam DCL, 2010, CHEST, V138, P1101, DOI 10.1378/chest.10-0596; Al Lawati NM, 2009, PROG CARDIOVASC DIS, V51, P285, DOI 10.1016/j.pcad.2008.08.001; Marshall NS, 2008, SLEEP, V31, P1079; Gottlieb DJ, 2010, CIRCULATION, V122, P352, DOI 10.1161/CIRCULATIONAHA.109.901801; Nakayama-Ashida Y, 2008, SLEEP, V31, P419; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Dinges DF, 1997, SLEEP, V20, P267; Ramachandran A, 2010, LANCET, V375, P408, DOI 10.1016/S0140-6736(09)60937-5; Young T, 2008, SLEEP, V31, P1071; Barbe F, 2012, JAMA-J AM MED ASSOC, V307, P2161, DOI 10.1001/jama.2012.4366; Ayas NT, 2004, SLEEP, V27, P249; Pepin JL, 2010, AM J RESP CRIT CARE, V182, P954, DOI 10.1164/rccm.200912-1803OC; Knutson KL, 2011, DIABETES CARE, V34, P1171, DOI 10.2337/dc10-1962; BaHammam A, 2004, RESPIRATION, V71, P385, DOI 10.1159/000079644; Centers for Disease Control and Prevention (CDC), 2005, MMWR MORB MORTAL WKL, V54; Chihara Y, 2013, EUR RESPIR J, V42, P1563, DOI 10.1183/09031936.00133512; Chin K, 2010, SLEEP, V33, P89; Colten HR, 2006, SLEEP DISORDERS SLEE; Einhorn Daniel, 2007, Endocr Pract, V13, P355; Harada Y, 2011, J SLEEP RES, V20, P538, DOI 10.1111/j.1365-2869.2011.00912.x; Harada Yuka, 2014, Ann Am Thorac Soc, V11, P383, DOI 10.1513/AnnalsATS.201306-182OC; Hirawa N, 2002, HYPERTENSION, V39, P449, DOI 10.1161/hy0202.102835; Inoue T, 2008, ATHEROSCLEROSIS, V201, P385, DOI 10.1016/j.atherosclerosis.2008.03.010; JOHNS MW, 1991, SLEEP, V14, P540; Ministry of Health Labor and Welfare, 2006, REP NAT HLTH NUTR SU; Nolan GM, 2007, SLEEP, V30, P189; Polotsky VY, 2009, AM J RESP CRIT CARE, V180, P910; Punjabi NM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000132; Toyama Y, 2013, CHEST, V143, P720, DOI 10.1378/chest.12-0338	65	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1446-9235	1479-8425		SLEEP BIOL RHYTHMS	Sleep Biol. Rhythms	JAN	2015	13	1					18	25		10.1111/sbr.12085		8	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AY3BT	WOS:000347460300003		
J	Koyama, T; Sato, S; Kanbayashi, T; Kondo, H; Watanabe, H; Nishino, S; Shimizu, T; Ito, H; Ono, K				Koyama, Takashi; Sato, Shinichi; Kanbayashi, Takashi; Kondo, Hideaki; Watanabe, Hiroyuki; Nishino, Seiji; Shimizu, Tetsuo; Ito, Hiroshi; Ono, Kyoichi			Apnea during Cheyne-Stokes-like breathing detected by a piezoelectric sensor for screening of sleep disordered breathing	SLEEP AND BIOLOGICAL RHYTHMS			English	Article						apnea; cardiorespiratory monitoring; heart diseases; piezoelectric sensor; sleep; sleep-disordered breathing	CONGESTIVE-HEART-FAILURE; APNOEA/HYPOPNOEA SYNDROME; RISK-FACTORS; OXIMETRY; POLYSOMNOGRAPHY; RESPIRATION; DIAGNOSIS; AUTOSET(TM); TRANSDUCER; SYSTEM	A simplified diagnostic/monitoring instrument for use in primary screening for sleep-disordered breathing (SDB) has been desired. This study was designed to assess the validity of a newly developed piezoelectric sensor as a simple and noninvasive tool for primary screening for sleep-disordered breathing. Forty-three consecutive patients suspected of having sleep-disordered breathing and 10 healthy volunteers were enrolled. Breathing movement was detected with the piezoelectric sensor (180 x 30 x 1mm), which was placed under a bed sheet under patients, and simultaneous polysomnographic recordings were obtained. We counted the number of apneas of >10s, irrespective of central or obstructive, that appeared during Cheyne-Stokes-like breathing with a waxing and waning pattern with an amplitude ratio of >10 in the piezoelectric sensor signal. The correlation coefficient between the number of apneas and apnea-hypopnea index (AHI) was 0.74 (P < 0.0001). The sensitivity/specificity of the number of apneas for distinguishing non-SDB patients from mild SDB patients (AHI 5) were 92.1/60.0% and those for separating moderate to severe (AHI 15) and severe (AHI 30) SDB patients from the other patients were 96.9/100% and 93.8/86.5%, respectively. There were no complaints from patients about the use of the piezoelectric sensor. The results indicate that the number of apneas detected by this piezoelectric sensor during Cheyne-Stokes-like breathing is a potential new index for primary screening for SDB at least for cardiac patients. Thus, the piezoelectric-sensor system might be useful for simple, noninvasive and comfortable SDB screening at home, hospitals and health care facilities.	[Koyama, Takashi; Watanabe, Hiroyuki; Ito, Hiroshi] Akita Univ, Dept Cardiovasc & Resp Med, Grad Sch Med, Akita 0108543, Japan; [Sato, Shinichi; Ono, Kyoichi] Akita Univ, Dept Cell Physiol, Grad Sch Med, Akita 0108543, Japan; [Sato, Shinichi; Kanbayashi, Takashi; Shimizu, Tetsuo] Akita Univ, Dept Neuropsychiat, Grad Sch Med, Akita 0108543, Japan; [Kondo, Hideaki] Saiseikai Nagasaki Hosp, Nagasaki, Japan; [Sato, Shinichi; Nishino, Seiji] Stanford Univ, Sch Med, Sleep & Circadian Neurobiol Lab, Palo Alto, CA 94304 USA	Ono, K (reprint author), Akita Univ, Dept Cell Physiol, Grad Sch Med, 1-1-1 Hondo, Akita 0108543, Japan.	onok@med.akita-u.ac.jp			Japan Science and Technology Agency (JST); Vehicle Racing Commemorative Foundation; Suzuken Memorial Foundation; Nakatani Foundation of Electronic Measuring Technology Advancement	The authors thank the following students of Akita University School of Medicine for their technical contributions to the data analysis: Mayu Uwano, Yui Hirakawa, Hiroko Hamaguchi, Tatsuya Ema, and Ken Miyabe. This study was supported in part by the Japan Science and Technology Agency (JST), Vehicle Racing Commemorative Foundation, Suzuken Memorial Foundation, and Nakatani Foundation of Electronic Measuring Technology Advancement. There are no conflicts of interest.	Abraham William T, 2006, Congest Heart Fail, V12, P241, DOI 10.1111/j.1527-5299.2006.05693.x; ALIHANKA J, 1979, ELECTROEN CLIN NEURO, V46, P731, DOI 10.1016/0013-4694(79)90113-5; Amir O, 2010, SLEEP BREATH, V15, P855; Niijima K, 2007, J OCCUP HEALTH, V49, P1, DOI 10.1539/joh.49.1; Vazquez JC, 2000, THORAX, V55, P302, DOI 10.1136/thorax.55.4.302; Bitter T, 2011, EUR HEART J, V32, P61, DOI 10.1093/eurheartj/ehq327; Raymond B, 2003, J SLEEP RES, V12, P53, DOI 10.1046/j.1365-2869.2003.00330.x; Wattanakit K, 2008, ATHEROSCLEROSIS, V197, P125, DOI 10.1016/j.atherosclerosis.2007.02.029; Koyama T, 2011, CIRC J, V75, P710, DOI 10.1253/circj.CJ-10-0956; Mayer P, 1998, EUR RESPIR J, V12, P770, DOI 10.1183/09031936.98.12040770; Whitelaw WA, 2005, AM J RESP CRIT CARE, V171, P188, DOI 10.1164/rccm.200310-1360OC; Javaheri S, 1998, CIRCULATION, V97, P2154; STOOHS R, 1992, CHEST, V101, P1221, DOI 10.1378/chest.101.5.1221; Bradley TD, 2003, CIRCULATION, V107, P1822, DOI 10.1161/01.CIR.0000061758.05044.64; Sin DD, 1999, AM J RESP CRIT CARE, V160, P1101; Kushida CA, 2001, SLEEP MED, V2, P389, DOI 10.1016/S1389-9457(00)00098-8; Heneghan C, 2008, SLEEP, V31, P1432; Oldenburg O, 2007, EUR J HEART FAIL, V9, P251, DOI 10.1016/j.ejheart.2006.08.003; Sin DD, 2000, CIRCULATION, V102, P61; Ting H, 2009, SLEEP MED, V10, P720, DOI 10.1016/j.sleep.2008.07.010; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Kiely JL, 1996, EUR RESPIR J, V9, P2360, DOI 10.1183/09031936.96.09112360; Amir O, 2012, J SLEEP RES, V21, P94, DOI 10.1111/j.1365-2869.2011.00927.x; Berry RB, 2013, AASM MANUAL SCORING; DARK DS, 1987, CHEST, V91, P833, DOI 10.1378/chest.91.6.833; Erman Milton K, 2007, J Clin Sleep Med, V3, P387; HANLY PJ, 1989, CHEST, V96, P480, DOI 10.1378/chest.96.3.480; Iber C, 2007, AASM MANUAL SCORING; Levy P, 1996, CHEST, V109, P395, DOI 10.1378/chest.109.2.395; MacDonald Mary, 2008, J Clin Sleep Med, V4, P38; PRYOR WW, 1951, CIRCULATION, V4, P233; Rechtschaffen A., 1968, MANUAL STANDARDIZED; Sato S, 2008, AM J PHYSIOL-HEART C, V294, pH1708, DOI 10.1152/ajpheart.01122.2007; Sato S, 2010, NEONATOLOGY, V98, P179, DOI 10.1159/000283994; Sato S, 2006, MED BIOL ENG COMPUT, V44, P353, DOI 10.1007/s11517-006-0047-z; Sato S, 2011, BIODEVICES 2011, P280; Terada S, 2011, INT J CARDIOL, V146, P423, DOI 10.1016/j.ijcard.2010.10.095	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1446-9235	1479-8425		SLEEP BIOL RHYTHMS	Sleep Biol. Rhythms	JAN	2015	13	1					57	67		10.1111/sbr.12097		11	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AY3BT	WOS:000347460300007		
J	Kubota, Y; Iso, H; Ikehara, S; Tamakoshi, A				Kubota, Yasuhiko; Iso, Hiroyasu; Ikehara, Satoyo; Tamakoshi, Akiko			Relationship between sleep duration and cause-specific mortality in diabetic men and women based on self-reports	SLEEP AND BIOLOGICAL RHYTHMS			English	Article						diabetes mellitus; mortality; sleep duration	ALL-CAUSE MORTALITY; GLYCEMIC CONTROL; MULTIETHNIC COHORT; RISK-FACTOR; MELLITUS; DEATH; INTERVENTIONS; ASSOCIATION; GLUCOSE; HEALTH	Sleep duration could affect glucose tolerance and mortality. However, the impact that sleep duration has on prognosis of people with diabetes is unclear. A cohort of Japanese self-reported diabetic people (1674 men and 1240 women) aged 40 to 79 years without a history of cardiovascular disease, cancer, renal diseases or pulmonary tuberculosis at baseline (1988 to 1990) were followed until 2009. The average sleep duration was grouped into the following five categories: 5 (5.4), 6 (5.5-6.4), 7 (6.5-7.4, reference), 8 (7.5-8.4), and 9 (8.5) hours. Multivariable hazard ratios were calculated for total and cause-specific mortality in each category by using Cox proportional hazard model. During 45329 person-years of follow-up, 1315 deaths from all-cause (785 men and 530 women), 389 from cardiovascular disease (210 men and 179 women), 359 from cancer (244 men and 115 women), and 138 from infectious disease (87 men and 51 women) were documented. Multivariable hazard ratios (95% CI) were as follows; for men, 1.49 (1.02-2.17) for all-cause in 5h sleepers; 1.53 (1.22-1.91) for all-cause in 9h sleepers; 1.56 (1.01-2.41) for cardiovascular disease in 9h sleepers; 3.08 (1.17-8.12) for infectious disease in 5h sleepers; 2.23 (1.13-4.39) for infectious disease in 9h sleepers; for women, 1.44 (1.09-1.90) for all-cause in 9h sleepers; 2.03 (1.05-3.94) for cancer in 5h sleepers. In conclusion, diabetic people with 5h or 9h of sleep had significantly higher risks of mortality than 7-hour diabetic sleepers.	[Kubota, Yasuhiko; Iso, Hiroyasu; Ikehara, Satoyo] Osaka Univ, Dept Social & Environm Med, Grad Sch Med, Suita, Osaka 5650871, Japan; [Tamakoshi, Akiko] Hokkaido Univ, Dept Publ Hlth, Grad Sch Med, Sapporo, Hokkaido 060, Japan	Iso, H (reprint author), Osaka Univ, Dept Social & Environm Med, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	iso@pbhel.med.osaka-u.ac.jp			Ministry of Education, Science, Sports and Culture of Japan (Monbusho); Japanese Ministry of Education, Culture, Sports, Science, and Technology (Monbukagaku-sho) [61010076, 62010074, 63010074, 1010068, 2151065, 3151064, 4151063, 5151069, 6279102, 11181101, 17015022, 18014011, 20014026, 20390156]	This study was supported by the Ministry of Education, Science, Sports and Culture of Japan (Monbusho) and the Japanese Ministry of Education, Culture, Sports, Science, and Technology (Monbukagaku-sho): grant numbers 61010076, 62010074, 63010074, 1010068, 2151065, 3151064, 4151063, 5151069, 6279102, 11181101, 17015022, 18014011, 20014026, and 20390156. We thank all staff members involved in this study for their valuable help in conducting the baseline survey and follow-up.	Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Tamakoshi A, 2013, J EPIDEMIOL, V23, P227, DOI 10.2188/jea.JE20120161; Knutson KL, 2006, ARCH INTERN MED, V166, P1768, DOI 10.1001/archinte.166.16.1768; Gottlieb DJ, 1999, AM J RESP CRIT CARE, V159, P502; BUSH TL, 1989, AM J PUBLIC HEALTH, V79, P1554, DOI 10.2105/AJPH.79.11.1554; Trento M, 2008, ACTA DIABETOL, V45, P225, DOI 10.1007/s00592-008-0047-6; Ohkuma T, 2013, DIABETES CARE, V36, P611, DOI 10.2337/dc12-0904; Bertoni AG, 2001, DIABETES CARE, V24, P1044, DOI 10.2337/diacare.24.6.1044; Iso H, 2006, ANN INTERN MED, V144, P554; Ikehara S, 2009, SLEEP, V32, P295; Patel SR, 2006, SLEEP, V29, P881; Kim BK, 2013, J KOREAN MED SCI, V28, P1334, DOI 10.3346/jkms.2013.28.9.1334; Tamakoshi A, 2004, SLEEP, V27, P51; Avery L, 2012, DIABETES CARE, V35, P2681, DOI 10.2337/dc11-2452; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104; Punjabi NM, 2002, AM J RESP CRIT CARE, V165, P677, DOI 10.1164/rccm.2104087; Beihl DA, 2009, ANN EPIDEMIOL, V19, P351, DOI 10.1016/j.annepidem.2008.12.001; Dietrich E, 2013, DRUG DES DEV THER, V7, P1399, DOI 10.2147/DDDT.S48937; Kurina LM, 2013, ANN EPIDEMIOL, V23, P361, DOI 10.1016/j.annepidem.2013.03.015; Hays NP, 2008, PHARMACOL THERAPEUT, V118, P181, DOI 10.1016/j.pharmthera.2008.02.003; Joshu CE, 2012, INT J CANCER, V131, P1667, DOI 10.1002/ijc.27394; KEHOE R, 1994, AM J EPIDEMIOL, V139, P813; Kim Y, 2013, PREV MED, V57, P377, DOI 10.1016/j.ypmed.2013.06.017; Kong APS, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-76; Lin YT, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-56; Okumura T, 2014, METABOLISM, V63, P484; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829; Morimoto A., 2010, JMAJ - Japan Medical Association Journal, V53, P36; Wan Mahmood WA, 2013, INT J ENDOCRINOL, V2013, DOI DOI 10.1155/2013/341506	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1446-9235	1479-8425		SLEEP BIOL RHYTHMS	Sleep Biol. Rhythms	JAN	2015	13	1					85	93		10.1111/sbr.12091		9	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AY3BT	WOS:000347460300010		
J	Ayuse, T; Yanamoto, S; Shinohara, K; Uchimura, N; Esaki, K; Takafumi, K				Ayuse, Takao; Yanamoto, Souichi; Shinohara, Kazuyuki; Uchimura, Naohisa; Esaki, Kazuhisa; Takafumi, Kato			Problem-based learning is suitable for the curriculum of "Sleep disorders and disease" for students in dentistry	SLEEP AND BIOLOGICAL RHYTHMS			English	Letter							EDUCATION		[Ayuse, Takao] Nagasaki Univ, Dept Clin Physiol, Course Med & Dent Sci, Unit Translat Med,Grad Sch Biomed Sci, Nagasaki 852, Japan; [Yanamoto, Souichi] Nagasaki Univ, Dept Clin Oral Oncol, Course Med & Dent Sci, Unit Translat Med,Grad Sch Biomed Sci, Nagasaki 852, Japan; [Shinohara, Kazuyuki] Nagasaki Univ, Dept Neurobiol & Behav, Course Med & Dent Sci, Unit Translat Med,Grad Sch Biomed Sci, Nagasaki 852, Japan; [Uchimura, Naohisa; Esaki, Kazuhisa] Kurume Univ, Sch Med, Dept Neuropsychiat, Kurume, Fukuoka 830, Japan; [Takafumi, Kato] Osaka Univ, Grad Sch Dent, Dept Oral Anat & Neurobiol, Suita, Osaka, Japan	Ayuse, T (reprint author), Nagasaki Univ, Dept Clin Physiol, Course Med & Dent Sci, Unit Translat Med,Grad Sch Biomed Sci, Nagasaki 852, Japan.						Ayuse T, 2004, J DENT RES, V83, P718; Simmons MS, 2012, SLEEP BREATH, V16, P383, DOI 10.1007/s11325-011-0507-z; Tsuda H, 2014, SLEEP BIOL RHYTHMS, V12, P232, DOI 10.1111/sbr.12068; Tsuiki S, 2007, SLEEP BIOL RHYTHMS, V5, P294, DOI 10.1111/j.1479-8425.2007.00325.x	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1446-9235	1479-8425		SLEEP BIOL RHYTHMS	Sleep Biol. Rhythms	JAN	2015	13	1					109	110		10.1111/sbr.12088		2	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AY3BT	WOS:000347460300014		
J	Matsubara, R; Koide, M; Shin, YS; Shimada, T; Hayashi, M				Matsubara, Ryosuke; Koide, Miki; Shin, Yong-Soon; Shimada, Toshiyuki; Hayashi, Masahiko			A Concise Synthesis of Asymmetrically 4,5-Disubstituted 9,9-Dimethyl-9H-xanthenes	SYNTHESIS-STUTTGART			English	Article						xanthenes; metalation; cross-coupling; palladium; zinc	ARYL; PALLADIUM; HALIDES; LIGANDS; REGIOSELECTIVITY; CHLORIDES; CATALYST; BROMIDES; OLEFIN	A concise synthesis of asymmetrically 4,5-disubstituted 9,9-dimethyl-9H-xanthenes was developed. The monolithiation of 4,5-dibromo-9H-xanthene, subsequent zincation, and the Negishi coupling with diverse electrophiles afforded the corresponding 4-aryl- or 4-vinyl-9H-xanthenes in good yields and with high selectivity. The second substitution reactions were performed under mild reaction conditions, thus providing a convenient synthetic route to functionalized molecules based on the 9H-xanthene skeleton.	[Matsubara, Ryosuke; Koide, Miki; Shin, Yong-Soon; Shimada, Toshiyuki; Hayashi, Masahiko] Kobe Univ, Grad Sch Sci, Dept Chem, Nada Ku, Kobe, Hyogo 6578501, Japan	Matsubara, R (reprint author), Kobe Univ, Grad Sch Sci, Dept Chem, Nada Ku, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan.	matsubara.ryosuke@people.kobe-u.ac.jp			MEXT, Japan; UBE Foundation; Japan Prize Foundation; Chugai Pharmaceutical Co., Ltd. Award in Synthetic Organic Chemistry, Japan	Financial support from a Grant-in-Aid for Scientific Research on Innovative Areas 'Advanced Molecular Transformations by Organocatalysts' from MEXT, Japan, The UBE Foundation, The Japan Prize Foundation, and Chugai Pharmaceutical Co., Ltd. Award in Synthetic Organic Chemistry, Japan is appreciated.	MILSTEIN D, 1978, J AM CHEM SOC, V100, P3636, DOI 10.1021/ja00479a077; KRANENBURG M, 1995, ORGANOMETALLICS, V14, P3081, DOI 10.1021/om00006a057; Liu SY, 2005, J AM CHEM SOC, V127, P5278, DOI 10.1021/ja042849b; Malaise G, 2001, TETRAHEDRON LETT, V42, P7417, DOI 10.1016/S0040-4039(01)01588-X; MIZOROKI T, 1971, B CHEM SOC JPN, V44, P581, DOI 10.1246/bcsj.44.581; NOWICK JS, 1990, J AM CHEM SOC, V112, P8902, DOI 10.1021/ja00180a038; ISHIYAMA T, 1995, J ORG CHEM, V60, P7508, DOI 10.1021/jo00128a024; Larsen MA, 2014, J AM CHEM SOC, V136, P4287, DOI 10.1021/ja412563e; Littke AF, 2002, J AM CHEM SOC, V124, P6343, DOI 10.1021/ja020012f; Morimoto H, 2011, ANGEW CHEM INT EDIT, V50, P3793, DOI 10.1002/anie.201100633; Sakai M, 1997, ORGANOMETALLICS, V16, P4229, DOI 10.1021/om9705113; HECK RF, 1972, J ORG CHEM, V37, P2320, DOI 10.1021/jo00979a024; Grugel H, 2012, ORG LETT, V14, P3780, DOI 10.1021/ol3015896; KING AO, 1977, J CHEM SOC CHEM COMM, P683, DOI 10.1039/c39770000683; KOSUGI M, 1977, CHEM LETT, P301, DOI 10.1246/cl.1977.301; MIYAURA N, 1979, J CHEM SOC CHEM COMM, P866, DOI 10.1039/c39790000866; Oishi M, 2009, CHEM COMMUN, P1909, DOI 10.1039/b823249k; Reinert S, 2008, CHEM COMMUN, P2272, DOI 10.1039/b717796h; Schwalbe M, 2012, CHEM-EUR J, V18, P15449, DOI 10.1002/chem.201201728; Takita R, 2008, ORG LETT, V10, P5003, DOI 10.1021/ol8020995	20	1	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0039-7881	1437-210X		SYNTHESIS-STUTTGART	Synthesis	JAN	2015	47	2					187	192		10.1055/s-0034-1379368		6	Chemistry, Organic	Chemistry	AY1WX	WOS:000347381100005		
J	Kanou, T; Okami, J; Tokunaga, T; Ishida, D; Kuno, H; Higashiyama, M				Kanou, Takashi; Okami, Jiro; Tokunaga, Toshiteru; Ishida, Daisuke; Kuno, Hidenori; Higashiyama, Masahiko			Prognostic factors in patients with postoperative brain recurrence from completely resected non-small cell lung cancer	THORACIC CANCER			English	Article						Brain metastasis; lung cancer; postoperative recurrence; prognostic factors	TYROSINE KINASE INHIBITORS; STEREOTACTIC RADIOSURGERY; SURGICAL-TREATMENT; RADIATION-THERAPY; METASTASES; CARCINOMA; RISK; SURVIVAL; MUTATION; SURGERY	BackgroundTreatment strategies for brain metastasis from lung cancer have been making progress. The aim of this retrospective analysis was to investigate the post-recurrent prognostic factors in patients with brain metastasis after complete resection of non-small cell lung cancer (NSCLC). MethodsWe retrospectively reviewed the medical records of 40 patients found to have postoperative brain metastasis from NSCLC in our institution from 2002 to 2008. All patients had undergone radical pulmonary resection for the lung cancer. The impact of numerous variables on survival were assessed, including gender, age, carcinoembryonic antigen (CEA), tumor size, N status, histological type, number of brain metastases, tumor size of brain metastasis, presence of symptoms from the brain tumor(s), and use of perioperative chemotherapy. ResultsThe median follow-up was 20.6 months (range, 3.4-66 months). The five-year survival rate from the diagnosis of brain recurrence was 22.5%. In univariate analysis, the favorable prognostic factors after brain recurrence included a normal range of CEA, no extracranial metastasis, no symptoms from the brain metastasis, brain metastasis (less than 2cm), and radical treatment (craniotomy or stereotactic radiosurgery [SRS]). The multivariate Cox model identified that a small brain metastasis and radical treatment were independent favorable prognostic factors. ConclusionsThis study found that the implementation of radical therapy for metastatic brain tumor(s) when the tumor is still small contributed to an increase in patients' life expectancy.	[Kanou, Takashi; Okami, Jiro; Tokunaga, Toshiteru; Ishida, Daisuke; Kuno, Hidenori; Higashiyama, Masahiko] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Gen Thorac Surg, Osaka 5378511, Japan	Kanou, T (reprint author), Osaka Med Ctr Canc & Cardiovasc Dis, Dept Gen Thorac Surg, Osaka 5378511, Japan.	kanoutakashi0999@yahoo.co.jp					Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Andrews DW, 2004, LANCET, V363, P1665, DOI 10.1016/S0140-6736(04)16250-8; Rodrigus P, 2001, LUNG CANCER-J IASLC, V32, P129, DOI 10.1016/S0169-5002(00)00227-0; Porta R, 2011, EUR RESPIR J, V37, P624, DOI 10.1183/09031936.00195609; Schoggl A, 2000, ACTA NEUROCHIR, V142, P621, DOI 10.1007/s007010070104; Park SJ, 2012, LUNG CANCER, V77, P556, DOI 10.1016/j.lungcan.2012.05.092; Bindal AK, 1996, J NEUROSURG, V84, P748, DOI 10.3171/jns.1996.84.5.0748; Lagerwaard FJ, 1999, INT J RADIAT ONCOL, V43, P795, DOI 10.1016/S0360-3016(98)00442-8; SORENSEN JB, 1988, J CLIN ONCOL, V6, P1474; Aoyama H, 2006, JAMA-J AM MED ASSOC, V295, P2483, DOI 10.1001/jama.295.21.2483; Abrahams JM, 2001, J NEUROSURG, V95, P595, DOI 10.3171/jns.2001.95.4.0595; Bartolotti M, 2012, EXPERT REV ANTICANC, V12, P1429, DOI [10.1586/era.12.121, 10.1586/ERA.12.121]; Mamon HJ, 2005, J CLIN ONCOL, V23, P1530, DOI 10.1200/JCO.2005.04.123; Saitoh Y, 1999, LUNG CANCER-J IASLC, V24, P99, DOI 10.1016/S0169-5002(99)00034-3; FIGLIN RA, 1988, NEW ENGL J MED, V318, P1300, DOI 10.1056/NEJM198805193182004; Granone P, 2001, EUR J CARDIO-THORAC, V20, P361, DOI 10.1016/S1010-7940(01)00744-8; Sakamoto J, 2014, INT J CLIN ONCOL, V19, P50, DOI 10.1007/s10147-012-0503-8; YANO T, 1994, J THORAC CARDIOV SUR, V108, P680; YANO T, 1994, J THORAC CARDIOV SUR, V107, P1398	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1759-7706	1759-7714		THORAC CANCER	Thorac. Cancer	JAN	2015	6	1					38	42		10.1111/1759-7714.12137		5	Oncology; Respiratory System	Oncology; Respiratory System	AY4IQ	WOS:000347541900007		
J	Mizuuchi, H; Suda, K; Kitahara, H; Shimamatsu, S; Kohno, M; Okamoto, T; Maehara, Y				Mizuuchi, Hiroshi; Suda, Kenichi; Kitahara, Hirokazu; Shimamatsu, Shinichiro; Kohno, Mikihiro; Okamoto, Tatsuro; Maehara, Yoshihiko			Solitary pulmonary metastasis from malignant melanoma of the bulbar conjunctiva presenting as a pulmonary ground glass nodule: Report of a case	THORACIC CANCER			English	Article						Bronchioloalveolar; differential diagnosis; melanoma; neoplasm metastasis; solitary pulmonary nodule	CT; OPACITY	We herein report a case of solitary pulmonary metastasis from malignant melanoma that presented as a pulmonary ground glass nodule. A 57-year-old man who had undergone resection of a malignant melanoma of the right bulbar conjunctiva at the age of 51 was referred to our hospital for management of ground glass opacity in his left lung. Because radiological examination suggested the nodule was an adenocarcinoma in situ, computed tomography (CT) follow-up was planned. CT examination performed nine months later showed that the nodule had grown from 6mm to 8mm. Moreover, CT performed one and a half years after first detection revealed that the nodule had grown up to 10mm. The patient, therefore, underwent partial resection of the lung for diagnosis and treatment. Pathological examination of the resected specimen revealed atypical cells with melanin granules proliferating in a lepidic-like fashion. The cells were positive on S-100 staining, indicating a pulmonary metastasis from malignant melanoma. Thus, metastatic tumors from malignant melanoma can present as ground glass opacities.	[Mizuuchi, Hiroshi; Suda, Kenichi] Kinki Univ, Fac Med, Dept Surg, Div Thorac Surg, Osaka 5898511, Japan; [Mizuuchi, Hiroshi; Suda, Kenichi; Kitahara, Hirokazu; Shimamatsu, Shinichiro; Kohno, Mikihiro; Okamoto, Tatsuro; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan	Suda, K (reprint author), Kinki Univ, Fac Med, Dept Surg, Div Thorac Surg, 377-2 Ohno Higashi, Osaka 5898511, Japan.	ascaris@surg2.med.kyushu-u.ac.jp			JPJS KAKENHI [25830119]	The authors thank Dr. Shinji Okano for his expert contribution. This work was partially supported by JPJS KAKENHI Grant Number 25830119 (K. Suda).	Kang MJ, 2010, CLIN IMAG, V34, P396, DOI 10.1016/j.clinimag.2009.10.036; Eskelin S, 2000, OPHTHALMOLOGY, V107, P1443, DOI 10.1016/S0161-6420(00)00182-2; Chua TC, 2012, ANN SURG ONCOL, V19, P1774, DOI 10.1245/s10434-011-2197-y; Collins J, 1997, AM J ROENTGENOL, V169, P355; Folio LR, 2013, ACAD RADIOL, V20, P604, DOI 10.1016/j.acra.2012.12.013; Oda S, 2011, ACAD RADIOL, V18, P63, DOI 10.1016/j.acra.2010.08.022; Okita Riki, 2005, Ann Thorac Surg, V79, pe1, DOI 10.1016/j.athoracsur.2004.03.096	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1759-7706	1759-7714		THORAC CANCER	Thorac. Cancer	JAN	2015	6	1					97	100		10.1111/1759-7714.12124		4	Oncology; Respiratory System	Oncology; Respiratory System	AY4IQ	WOS:000347541900016		
J	Fujiwara, A; Higashiyama, M; Kanou, T; Okami, J; Tokunaga, T; Tomita, Y; Kodama, K				Fujiwara, Ayako; Higashiyama, Masahiko; Kanou, Takashi; Okami, Jiro; Tokunaga, Toshiteru; Tomita, Yasuhiko; Kodama, Ken			Granulocyte-colony stimulating factor (G-CSF) producing malignant pleural mesothelioma: Report of a case	THORACIC CANCER			English	Article						Granulocyte-colony stimulating factor (G-CSF); leukocytosis; malignant pleural mesothelioma; resection	AUTOCRINE GROWTH; INTERLEUKIN-6; CARCINOMA; CANCER; CELLS	This report presents a case of malignant pleural mesothelioma (MPM) producing granulocyte colony-stimulating factor (G-CSF) that was treated by tumor resection. A 76-year-old male presented with a huge right-side chest wall tumor, along with a slight fever and chest wall pain. Laboratory findings showed an increased white blood cell count (64600 cells/L) and C-reactive protein level (20.57mg/dL). The patient underwent surgical removal of the tumor along with tissue from the chest wall and histopathological analysis led to a diagnosis of sarcomatous type of MPM. Immunohistochemical findings for both anti-human G-CSF and interleukin-6 monoclonal antibodies were positive. Although the general condition of the patient quickly improved after surgery, local recurrence occurred two months later and he died of respiratory failure seven months after the operation, though surgery provided symptom relief. G-CSF-producing MPMs usually show a poor prognosis, though less-invasive surgery may be considered for relief of symptoms.	[Fujiwara, Ayako; Higashiyama, Masahiko; Kanou, Takashi; Okami, Jiro; Tokunaga, Toshiteru] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Gen Thorac Surg, Osaka 5378511, Japan; [Tomita, Yasuhiko] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Pathol, Osaka 5378511, Japan; [Kodama, Ken] Yao Municipal Hosp, Dept Gen Thorac Surg, Yao, Japan	Fujiwara, A (reprint author), Osaka Med Ctr Canc & Cardiovasc Dis, Dept Thorac Surg, 1-3-3 Nakamichi Higashinari, Osaka 5378511, Japan.	fujiwara-ay@mc.pref.osaka.jp					Kawaguchi M, 2010, INT J CLIN ONCOL, V15, P191, DOI 10.1007/s10147-010-0023-3; Adachi Y, 2006, INT J CANCER, V119, P1303, DOI 10.1002/ijc.22006; Kasuga I, 2001, CHEST, V119, P981, DOI 10.1378/chest.119.3.981; Paule B, 2007, WORLD J UROL, V25, P477, DOI 10.1007/s00345-007-0175-6; Coward J, 2011, CLIN CANCER RES, V17, P6083, DOI 10.1158/1078-0432.CCR-11-0945; Maeda S, 2009, HEPATOLOGY, V50, P1851, DOI 10.1002/hep.23199; Furihata M, 1999, PATHOL INT, V49, P1010, DOI 10.1046/j.1440-1827.1999.00970.x; Hirata T, 2003, LEUKEMIA RES, V27, P343, DOI 10.1016/S0145-2126(02)00179-0; Kojima K, 2002, HISTOL HISTOPATHOL, V17, P1005; Nishimura M, 2006, ANN THORAC SURG, V82, P1904, DOI 10.1016/j.athoracsur.2006.02.009; Obermueller E, 2004, CANCER RES, V64, P7801, DOI 10.1158/0008-5472.CAN-03-3301; Ohbayashi H, 1999, INTERNAL MED, V38, P668, DOI 10.2169/internalmedicine.38.668; Ohsugi Y, 2009, CLIN MED THER, V1, P1677; RIKIMARU T, 1995, EUR RESPIR J, V8, P183, DOI 10.1183/09031936.95.08010183; ROBINSON WA, 1974, ANN NY ACAD SCI, V230, P212, DOI 10.1111/j.1749-6632.1974.tb14451.x; Saeki T, 1990, Gan No Rinsho, V36, P2469; Shannon M F, 1992, Growth Factors, V7, P181, DOI 10.3109/08977199209046923; TACHIBANA M, 1995, CANCER RES, V55, P3438; Usami N, 2007, J THORAC ONCOL, V2, P257, DOI 10.1097/JTO.0b013e318031b61e; Yoshimoto Akihiro, 2005, Int J Clin Oncol, V10, P58, DOI 10.1007/s10147-004-0432-2	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1759-7706	1759-7714		THORAC CANCER	Thorac. Cancer	JAN	2015	6	1					105	109		10.1111/1759-7714.12140		5	Oncology; Respiratory System	Oncology; Respiratory System	AY4IQ	WOS:000347541900018		
J	Sato, S; Noh, JY; Sato, S; Suzuki, M; Yasuda, S; Matsumoto, M; Kunii, Y; Mukasa, K; Sugino, K; Ito, K; Nagataki, S; Taniyama, M				Sato, Shotaro; Noh, Jaeduk Yoshimura; Sato, Shiori; Suzuki, Miho; Yasuda, Shigemitsu; Matsumoto, Masako; Kunii, Yo; Mukasa, Koji; Sugino, Kiminori; Ito, Koichi; Nagataki, Shigenobu; Taniyama, Matsuo			Comparison of Efficacy and Adverse Effects Between Methimazole 15 mg+Inorganic Iodine 38 mg/Day and Methimazole 30 mg/Day as Initial Therapy for Graves' Disease Patients with Moderate to Severe Hyperthyroidism	THYROID			English	Article							THYROTOXICOSIS; SCHOOLCHILDREN; REMISSION; VALUES; VOLUME; MG	Background: Methimazole (MMI) is usually used at an initial dose of 30 mg/day for severe Graves' disease (GD) hyperthyroidism, but adverse effects are more frequent at this dose than at MMI 15 mg/day. Objectives: We designed a regimen to address the lack of a primary therapeutic effect of the MMI 15 mg/day by combining it with inorganic iodine at 38.2 mg/day. Our aim was to compare the two regimens (MMI 15 mg+inorganic iodine at 38.2 mg/day (M15+I) vs. MMI 30 mg/day (M30)) in terms of therapeutic effect, adverse effects, and remission rate. Design and Patients: In a prospective study, 310 patients with untreated GD (serum free thyroxine (fT4) >= 5 ng/dL) were assigned to one of the two regimens. Potassium iodide was discontinued in the M15+I group as soon as the serum fT4 level was within the reference range (0.8-1.6 ng/dL). Results: Percentages of patients achieving an fT4 level within reference range in <= 30, <= 60, or 90 days on the study treatment regimens were 45.3%, 73.9%, and 82.0% respectively for the M15+I group, and 24.8%, 63.1%, and 75.2% respectively for the M30 group. Hence, the proportions of patients achieving this goal in <= 30 or <= 60 days were significantly larger in the M15+I group. Adverse effects that required discontinuation of MMI were more frequent in the M30-treated than in the M15+I-treated group (14.8% vs. 7.5%; p=0.0387). The remission rates in the M15+I and M30 groups were 19.9% and 14.8%-higher in the former, but the difference did not reach statistical significance. Conclusion: The results of this study raise the possibility that M15+I is superior to M30 as a primary treatment for moderate to severe hyperthyroidism caused by GD.	[Sato, Shotaro; Noh, Jaeduk Yoshimura; Sato, Shiori; Suzuki, Miho; Yasuda, Shigemitsu; Matsumoto, Masako; Kunii, Yo; Mukasa, Koji; Sugino, Kiminori; Ito, Koichi; Nagataki, Shigenobu] Ito Hosp, Dept Internal Med, Tokyo 1508308, Japan; [Sato, Shotaro; Taniyama, Matsuo] Showa Univ, Fujigaoka Hosp, Dept Internal Med, Div Endocrinol & Metab, Yokohama, Kanagawa 227, Japan	Noh, JY (reprint author), Ito Hosp, Shibuya Ku, 4-3-6 Jingumae, Tokyo 1508308, Japan.	h-yoshimura@ito-hospital.jp					Nakamura H, 2007, J CLIN ENDOCR METAB, V92, P2157, DOI 10.1210/jc.2006-2135; ROTI E, 1988, CLIN ENDOCRINOL, V28, P305, DOI 10.1111/j.1365-2265.1988.tb01217.x; Zimmermann MB, 2004, AM J CLIN NUTR, V79, P231; Fuse Y, 2007, THYROID, V17, P145, DOI 10.1089/thy.2006.0209; Takata K, 2009, THYROID, V19, P559, DOI 10.1089/thy.2008.0364; Otsuka F, 2012, CLIN ENDOCRINOL, V77, P310, DOI 10.1111/j.1365-2265.2012.04365.x; Basaria S, 2005, AM J MED, V118, P706, DOI 10.1016/j.amjmed.2004.11.028; Kashiwai T, 2003, ENDOCR J, V50, P45, DOI 10.1507/endocrj.50.45; Bahn Chair RS, 2011, THYROID, V21, P593, DOI DOI 10.1089/THY.2010.0417; DANOWSKI TS, 1946, J CLIN INVEST, V25, P597, DOI 10.1172/JCI101742; HARDEN RM, 1964, CLIN SCI, V27, P399; Mashio Y, 1997, ENDOCR J, V44, P553, DOI 10.1507/endocrj.44.553; Nagataki S, 1974, EFFECT EXCESS QUANTI; Nagataki S, 1996, AUTOREGULATION EFFEC; Nagataki S, 1974, HDB PHYSIOLOGY     7, VIII, P329; NAGATAKI S, 1970, J CLIN ENDOCR METAB, V30, P469; Page SR, 1996, CLIN ENDOCRINOL, V45, P511, DOI 10.1046/j.1365-2265.1996.00800.x; Plummer HS, 1923, JAMA-J AM MED ASSOC, V80, P1955; Takata K, 2010, CLIN ENDOCRINOL, V72, P845, DOI 10.1111/j.1365-2265.2009.03745.x; Thompson WO, 1930, ARCH INTERN MED, V45, P481; VOLPE R, 1962, ANN INTERN MED, V56, P577; WARTOFSK.L, 1970, J CLIN INVEST, V49, P78, DOI 10.1172/JCI106225; WARTOFSK.L, 1973, JAMA-J AM MED ASSOC, V226, P1083, DOI 10.1001/jama.226.9.1083; WINKLER AW, 1947, J CLIN INVEST, V26, P446, DOI 10.1172/JCI101828	24	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1050-7256	1557-9077		THYROID	Thyroid	JAN 1	2015	25	1					43	50		10.1089/thy.2014.0084		8	Endocrinology & Metabolism	Endocrinology & Metabolism	AY4GP	WOS:000347536600006		
J	Moritani, S				Moritani, Sueyoshi			Impact of Lymph Node Metastases with Recurrent Laryngeal Nerve Invasion on Patients with Papillary Thyroid Carcinoma	THYROID			English	Article							CENTRAL NECK DISSECTION; VOCAL CORD PARALYSIS; SURGICAL-MANAGEMENT; CANCER; PROGNOSIS; SURVIVAL; SURGERY	Background: Although rare, invasion by papillary thyroid carcinoma (PTC) of the upper aerodigestive tract significantly affects patients' prognosis and quality of life. Within the central compartment, the recurrent laryngeal nerve (RLN) is most frequently invaded by lymph node metastases (LNM). However, such an invasion has not been described in the literature, although reports on RLN invasion by primary tumors have been published. The present study aimed to characterize LNM with RLN invasion in patients with PTC. Methods: The participants of this retrospective investigation were selected from 629 PTC patients who received initial surgical treatment at our institution between January 1981 and December 2012. They included 38 (6%) patients with 40 cases of RLN invasion by LNM (LNM invasion group) and 112 (17.8%) patients with 117 cases of RLN invasion by the primary tumor (primary invasion group). Results: In the LNM invasion group, 70% of the RLN invasion cases occurred on the right side, whereas those in the primary invasion group were almost equally distributed. RLN invasion caused vocal cord paralysis, affecting 13 nerves (32.5%) in the LNM invasion group and 68 nerves (58%) in the primary invasion group. Significant differences in laterality and preoperative vocal cord paralysis were observed between the two groups. In the LNM invasion group, the longest diameter of metastatic lymph nodes (mean +/- standard deviation) of patients with RLN paralysis was 21 +/- 8 mm, whereas it was significantly different at 14 +/- 7 mm in those without RLN paralysis. Conclusions: Our results indicate that most patients with RLN invasion by LNM did not experience preoperative vocal cord paralysis. LNM invasion of the RLN (70%) more often occurred on the right side as expected given the complexity and three-dimensional anatomy of the RLN in the right paratracheal region compared to the left. RLN invasion by LNM should be considered if preoperative paratracheal nodal disease, especially when bulky, is noted in the right paratracheal region.	Kusatsu Gen Hosp, Ctr Head & Neck Surg, Kusatsu, Shiga 5258585, Japan	Moritani, S (reprint author), Kusatsu Gen Hosp, Ctr Head & Neck Surg, 1660 Yabase Cho, Kusatsu, Shiga 5258585, Japan.	suemoritani@gmail.com					Amini K, 2007, ANN OTO RHINOL LARYN, V116, P324; EJNELL H, 1984, LARYNGOSCOPE, V94, P954; Miyauchi A, 2009, SURGERY, V146, P1056, DOI 10.1016/j.surg.2009.09.018; Mulla M, 2012, CLIN ENDOCRINOL, V76, P131, DOI 10.1111/j.1365-2265.2011.04162.x; Choi YJ, 2010, WORLD J SURG, V34, P1494, DOI 10.1007/s00268-010-0541-1; Giordano D, 2012, THYROID, V22, P911, DOI 10.1089/thy.2012.0011; Machens A, 2001, SURGERY, V129, P23, DOI 10.1067/msy.2001.108699; Barczynski M, 2013, BRIT J SURG, V100, P410, DOI 10.1002/bjs.8985; MCCAFFREY TV, 1994, HEAD NECK-J SCI SPEC, V16, P165, DOI 10.1002/hed.2880160211; Sadowski BM, 2009, SURGERY, V146, P696, DOI 10.1016/j.surg.2009.06.046; Czaja JM, 1997, ARCH OTOLARYNGOL, V123, P484; Isshiki N, 2000, ACTA OTO-LARYNGOL, V120, P120, DOI 10.1080/000164800750000748; ISSHIKI N, 1978, ARCH OTOLARYNGOL, V104, P555; Hotomi M, 2012, WORLD J SURG, V36, P1231, DOI 10.1007/s00268-012-1518-z; Hwang HS, 2011, LARYNGOSCOPE, V121, P487, DOI 10.1002/lary.21227; McCaffrey JC, 2006, LARYNGOSCOPE, V116, P1, DOI 10.1097/01.MLG.0000200428.26975.86; Carling T, 2012, THYROID, V22, P237, DOI 10.1089/thy.2011.0317; Moreno MA, 2012, THYROID, V22, P347, DOI 10.1089/thy.2011.0121; Ark N, 2008, SURG ONCOL CLIN N AM, V17, P145, DOI 10.1016/j.soc.2007.10.009; Aynehchi BB, 2010, OTOLARYNG HEAD NECK, V143, P749, DOI 10.1016/j.otohns.2010.09.031; Hirata K, 1992, Kaibogaku Zasshi, V67, P634; Ito Y, 2012, ENDOCR J, V59, P539; Kamani D, 2013, OTOLARYNG HEAD NECK, V149, P682, DOI 10.1177/0194599813504735; Kihara M, 2014, SURGERY, V155, P184, DOI 10.1016/j.surg.2013.06.052; Lang BHH, 2013, ANN SURG ONCOL, V20, P2951, DOI 10.1245/s10434-013-2984-8; Lee DW, 2013, EJSO-EUR J SURG ONC, V39, P191, DOI 10.1016/j.ejso.2012.07.119; Makay O, 2008, LANGENBECK ARCH SURG, V393, P681, DOI 10.1007/s00423-008-0320-8; Martins AS, 2001, INT SURG, V86, P213; McCaffrey J C, 2000, Cancer Control, V7, P246; Nishida T, 1997, ANN SURG, V226, P85, DOI 10.1097/00000658-199707000-00012; Patel Kepal N, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P112, DOI 10.1097/01.moo.0000156161.82671.43; Roh JL, 2009, AM J SURG, V197, P459, DOI 10.1016/j.amjsurg.2008.04.017; Sanuki T, 2010, J ONCOL, V2010; Zaydfudim V, 2008, SURGERY, V144, P1070, DOI 10.1016/j.surg.2008.08.034	34	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1050-7256	1557-9077		THYROID	Thyroid	JAN 1	2015	25	1					107	111		10.1089/thy.2014.0152		5	Endocrinology & Metabolism	Endocrinology & Metabolism	AY4GP	WOS:000347536600013		
J	Arauchi, A; Yang, CH; Cho, S; Jarboe, EA; Peterson, CM; Bae, YH; Okano, T; Janat-Amsbury, MM				Arauchi, Ayumi; Yang, Chieh-Hsiang; Cho, Sungpil; Jarboe, Elke A.; Peterson, C. Matthew; Bae, You Han; Okano, Teruo; Janat-Amsbury, Margit M.			An Immunocompetent, Orthotopic Mouse Model of Epithelial Ovarian Cancer Utilizing Tissue Engineered Tumor Cell Sheets	TISSUE ENGINEERING PART C-METHODS			English	Article							ENDOTHELIAL GROWTH-FACTOR; CARDIOMYOCYTE SHEETS; CHEMICAL INDUCTION; MESOTHELIAL CELLS; CULTURE SURFACES; CANINE MODEL; CARCINOMA; TRANSPLANTATION; TEMPERATURE; INVASION	Despite the development of a myriad of anticancer drugs that appeared promising in preclinical ovarian cancer animal models, they failed to predict efficacy in clinical testing. To improve the accuracy of preclinical testing of efficacy and toxicity, including pharmacokinetic and pharmacodynamic evaluations, a novel animal model was developed and characterized. In this study, murine ID8 (epithelial ovarian cancer [EOC]) cells as injected cell suspensions (ICS) and as intact cultured monolayer cell sheets (CS) were injected or surgically grafted, respectively, into the left ovarian bursa of 6-8 week-old, female C57BL/6 black mice and evaluated at 8 and 12 weeks after engraftment. Tumor volumes at 8 weeks were as follows: 30.712 +/- 18.800 mm(3) versus 55.837 +/- 10.711 mm(3) for ICS and CS, respectively, p=0.0990 (n=5). At 12 weeks, tumor volumes were 128.129 +/- 44.018 mm(3) versus 283.953 +/- 71.676 mm(3) for ICS and CS, respectively, p=0.0112 (n=5). The ovarian weights at 8 and 12 weeks were 0.02138 +/- 0.01038 g versus 0.04954 +/- 0.00667 g for ICS and CS, respectively (8 weeks), p=0.00602 (n=5); and 0.10594 +/- 0.03043 g versus 0.39264 +/- 0.09271 g for ICS and CS, respectively (12 weeks), p=0.0008 (n=5). These results confirm a significant accelerated tumorigenesis in CS-derived tumors compared with ICS-derived tumors when measured by tumor volume/time and ovarian weight/time. Furthermore, the CS-derived tumors closely replicated the metastatic spread found in human EOC and histopathological identity with the primary tumor of origin.	[Arauchi, Ayumi; Okano, Teruo] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan; [Yang, Chieh-Hsiang; Cho, Sungpil; Janat-Amsbury, Margit M.] Univ Utah, Dept Obstet & Gynecol, Div Gynecol Oncol, Salt Lake City, UT 84112 USA; [Jarboe, Elke A.] Univ Utah, ARUP, Dept Pathol, Salt Lake City, UT 84112 USA; [Peterson, C. Matthew] Univ Utah, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Salt Lake City, UT 84112 USA; [Peterson, C. Matthew; Bae, You Han; Okano, Teruo; Janat-Amsbury, Margit M.] Nano Inst Utah, Ctr Nanomed, Salt Lake City, UT USA; [Bae, You Han; Janat-Amsbury, Margit M.] Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA	Janat-Amsbury, MM (reprint author), Univ Utah, Dept Obstet & Gynecol, Div Gynecol Oncol, Salt Lake City, UT 84112 USA.	margit.janat-amsbury@hsc.utah.edu			University of Utah's Department of Obstetrics and Gynecology; University of Utah Program in Personalized Health Care and Formation of Innovation Center for Fusion of Advanced Technologies in the Special Coordination Funds for Promoting Science and Technology "Cell Sheet Tissue Engineering Center (CSTEC)''; Global Center of Excellence (GCOE) Program, Multidisciplinary Education and Technology and Research Center for Regenerative Medicine (MERCREM), from the Ministry of Education, Culture, Sports Science, and Technology (MEXST), Japan	The authors thank Yongen Sun, MD, for his expertise and surgical skills in conducting animal experiments. This study was supported by grants from the University of Utah's Department of Obstetrics and Gynecology, the University of Utah Program in Personalized Health Care and Formation of Innovation Center for Fusion of Advanced Technologies in the Special Coordination Funds for Promoting Science and Technology "Cell Sheet Tissue Engineering Center (CSTEC),'' and the Global Center of Excellence (GCOE) Program, Multidisciplinary Education and Technology and Research Center for Regenerative Medicine (MERCREM), from the Ministry of Education, Culture, Sports Science, and Technology (MEXST), Japan.	Alexander K., 2005, NAT REV, V4, P161; Amadori D., 1997, Frontiers in Bioscience (online), V2, pG8; Ang J. E., 2007, ADV GENE MOL CELL TH, V1, P68; Yamato M, 2007, PROG POLYM SCI, V32, P1123, DOI 10.1016/j.progpolymsci.2007.06.002; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Shimizu T, 2006, TISSUE ENG, V12, P499, DOI 10.1089/ten.2006.12.499; Roy R, 2009, J CLIN ONCOL, V27, P5287, DOI 10.1200/JCO.2009.23.5556; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Kanzaki M, 2008, EUR J CARDIO-THORAC, V34, P864, DOI 10.1016/j.ejcts.2008.05.048; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; OKANO T, 1993, J BIOMED MATER RES, V27, P1243, DOI 10.1002/jbm.820271005; Paley PJ, 1997, CANCER, V80, P98, DOI 10.1002/(SICI)1097-0142(19970701)80:1<98::AID-CNCR13>3.0.CO;2-A; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; KRARUP T, 1969, INT J CANCER, V4, P61, DOI 10.1002/ijc.2910040109; Yamato M, 2001, TISSUE ENG, V7, P473, DOI 10.1089/10763270152436517; Landen CN, 2008, J CLIN ONCOL, V26, P995, DOI 10.1200/JCO.2006.07.9970; Miyagawa S, 2005, TRANSPLANTATION, V80, P1586, DOI 10.1097/01.tp.0000181163.69108.dd; Iwanicki MP, 2011, CANCER DISCOV, V1, P144, DOI 10.1158/2159-8274.CD-11-0010; Ohashi K, 2007, NAT MED, V13, P880, DOI 10.1038/nm1576; JACOBS AJ, 1984, GYNECOL ONCOL, V18, P177, DOI 10.1016/0090-8258(84)90025-8; Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722; Vang R, 2009, ADV ANAT PATHOL, V16, P267, DOI 10.1097/PAP.0b013e3181b4fffa; GODWIN AK, 1992, J NATL CANCER I, V84, P592, DOI 10.1093/jnci/84.8.592; Kraman M, 2010, SCIENCE, V330, P827, DOI 10.1126/science.1195300; Malpica A, 2004, AM J SURG PATHOL, V28, P496, DOI 10.1097/00000478-200404000-00009; Sekiya S, 2006, BIOCHEM BIOPH RES CO, V341, P573, DOI 10.1016/j.bbrc.2005.12.217; Kelland LR, 2004, EUR J CANCER, V40, P827, DOI 10.1016/j.ejca.2003.11.028; Memon IA, 2005, J THORAC CARDIOV SUR, V130, P1333, DOI 10.1016/j.jtcvs.2005.07.023; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kenny HA, 2007, INT J CANCER, V121, P1463, DOI 10.1002/ijc.22874; Sekine H, 2011, TISSUE ENG PT A, V17, P2973, DOI 10.1089/ten.tea.2010.0659; Iwata T, 2009, BIOMATERIALS, V30, P2716, DOI 10.1016/j.biomaterials.2009.01.032; YAMADA N, 1990, MAKROMOL CHEM-RAPID, V11, P571; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Ohki T, 2006, GUT, V55, P1704, DOI 10.1136/gut.2005.088518; Zhang L, 2002, AM J PATHOL, V161, P2295, DOI 10.1016/S0002-9440(10)64505-1; NIEDBALA MJ, 1985, EXP CELL RES, V160, P499, DOI 10.1016/0014-4827(85)90197-1; Spannuth WA, 2008, NAT CLIN PRACT ONCOL, V5, P194, DOI 10.1038/ncponc1051; Matsuda N, 2007, ADV MATER, V19, P3089, DOI 10.1002/adma.200701978; Kanzaki M, 2007, BIOMATERIALS, V28, P4294, DOI 10.1016/j.biomaterials.2007.06.009; Anton K, 2009, CURR PHARM BIOTECHNO, V10, P185; Arauchi A, 2009, TISSUE ENG PT A, V15, P3943, DOI 10.1089/ten.TEA.2009.0119; Cho S., 2013, ANTICANCER RES, V33, P3; Gordon P. S., 2013, ALTCHEKS DIAGNOSIS M, P357; Greenaway J, 2008, GYNECOL ONCOL, V108, P385, DOI 10.1016/j.ygyno.2007.10.035; James E. T., 2007, AJP, V170, P793; Lengyel Ernst, 2010, Am J Pathol, V177, P1053, DOI 10.2353/ajpath.2010.100105; Levanon K., 2006, J CLIN ONCOL, V26, P5284; Robert M. H., 1999, INVEST NEW DRUGS, V17, P343; Togo Shinsaku, 2013, Cancers (Basel), V5, P149, DOI 10.3390/cancers5010149; Torng PL, 2004, GYNECOL ONCOL, V92, P559, DOI 10.1016/j.ygyno.2003.11.011; TUNCA JC, 1985, GYNECOL ONCOL, V21, P54, DOI 10.1016/0090-8258(85)90232-X	53	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3384	1937-3392		TISSUE ENG PART C-ME	Tissue Eng. Part C-Methods	JAN 1	2015	21	1					23	34		10.1089/ten.tec.2014.0040		12	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	AY4HI	WOS:000347538400003		
J	Kitajima, K; Murakami, T; Koyama, I; Nakajima, I; Fuchinoue, S				Kitajima, K.; Murakami, T.; Koyama, I.; Nakajima, I.; Fuchinoue, S.			LONG-TERM OUTCOME OF RENAL ALLOGRAFT AFTER SEQUENTIAL LIVER-KIDNEY TRANSPLANTATION FROM A SINGLE LIVING DONOR	TRANSPLANT INTERNATIONAL			English	Meeting Abstract									[Kitajima, K.; Murakami, T.; Koyama, I.; Nakajima, I.; Fuchinoue, S.] Tokyo Womens Med Univ Hosp, Dept Surg, Kidney Ctr, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0934-0874	1432-2277		TRANSPL INT	Transpl. Int.	JAN	2015	28			1		11	3	3				1	Surgery; Transplantation	Surgery; Transplantation	AY1BZ	WOS:000347329700011		
J	Seino, S; Sasaki, S; Owashi, T; Oya, K; Iwamori, S				Seino, Shou; Sasaki, Shunsuke; Owashi, Tatsuki; Oya, Kei; Iwamori, Satoru			Effects of copper interfacial layer on surface characteristics, adhesion and wear durability of fluorocarbon thin film sputtered onto polyimide film substrate	VACUUM			English	Article						Polytetrafluoroethylene (PTFE); Polyimide (PI); r.f. sputtering; Hydrophobicity; Adhesion	CRYSTAL MICROBALANCE QCM; PLASMA; OXYGEN; PTFE; IRRADIATION; IMPROVEMENT	Sputtering is one of effective technologies to enhance functions of polymer film surfaces, and polymer film coating by the sputtering is one of the surface modification technologies. Polyimide (PI) has good thermal and chemical stabilities, and excellent mechanical property, and high performance PI films can be achieved by controlling of nanostructured surfaces, e.g., hydrophobic PI film can be applied for precision instruments such as printer transfer belt. Polytetrafluoroethylene (PTFE) has also excellent thermal and chemical stabilities, lubricant and insulating properties and hydrophobicity, however, it is difficult to form the PTFE thin film on a polymer film substrate without peeling. Although PTFE thin film was deposited onto a PI film substrate by r.f. sputtering to enhance the hydrophobicity of the PI film substrate, there still remains a serious drawback in the adhesion between the sputtered PTFE thin film and the PI film substrate. A copper (Cu) thin film was introduced between the PTFE thin film and PI film substrate (PTFE/Cu/PI). Although the surface roughness and hydrophobicity of the PTFE/PI laminate decreased due to the introduction of the Cu thin film layer, the adhesion between the sputtered PTFE thin film and PI film substrate was improved without deterioration of wear durability. (C) 2014 Elsevier Ltd. All rights reserved.	[Seino, Shou; Sasaki, Shunsuke; Owashi, Tatsuki; Oya, Kei; Iwamori, Satoru] Tokai Univ, Hiratsuka, Kanagawa 2591292, Japan	Iwamori, S (reprint author), Tokai Univ, 4-1-1 Kitakaname, Hiratsuka, Kanagawa 2591292, Japan.	iwamori@tokai-u.jp					Stelmashuk V, 2005, VACUUM, V77, P131, DOI 10.1016/j.vacuum.2004.08.011; Feng L, 2002, ADV MATER, V14, P1857, DOI 10.1002/adma.200290020; [Anonymous], 1983, THIN FILM HDB; Yoshino K, 2013, VACUUM, V93, P84, DOI 10.1016/j.vacuum.2013.01.009; BIEDERMAN H, 1977, THIN SOLID FILMS, V41, P329, DOI 10.1016/0040-6090(77)90319-4; Biederman H, 2000, VACUUM, V59, P594, DOI 10.1016/S0042-207X(00)00321-3; Biederman H, 2001, THIN SOLID FILMS, V392, P208, DOI 10.1016/S0040-6090(01)01029-X; COBURN JW, 1979, J VAC SCI TECHNOL, V16, P391, DOI 10.1116/1.569958; HARROP R, 1969, THIN SOLID FILMS, V3, P109, DOI 10.1016/0040-6090(69)90083-2; Hong JH, 2006, SURF COAT TECH, V201, P197, DOI 10.1016/j.surfcoat.2005.11.084; Iwamori S, 2012, SENSOR ACTUAT B-CHEM, V171, P769, DOI 10.1016/j.snb.2012.05.070; Iwamori S, 1997, J VAC SCI TECHNOL B, V15, P53, DOI 10.1116/1.589255; Iwamori S, 2012, IEEJ E, V132, P149; Iwamori S, 2012, MATER LETT, V66, P349, DOI 10.1016/j.matlet.2011.08.041; Iwamori S, 2008, SURF COAT TECH, V203, P59, DOI 10.1016/j.surfcoat.2008.07.035; Iwamori S, 2005, ADHESION ASPECTS THI, V2, P215; Iwamori S., 2010, VACUUM, V84, P592; Kim HM, 2013, SURF COAT TECH, V228, P5389; KOH SK, 1990, POLYM ENG SCI, V30, P137, DOI 10.1002/pen.760300302; Kusano E, 2011, THIN SOLID FILMS, V520, P404, DOI 10.1016/j.tsf.2011.07.034; Lee SW, 2004, NUCL INSTRUM METH B, V219, P963, DOI 10.1016/j.nimb.2004.01.197; Matsumoto H, 2010, CHEM LETT, V39, P102, DOI 10.1246/cl.2010.102; Seino S, 2013, JPN J APPL PHYS, V52; Wei TC, 2005, SURF COAT TECH, V200, P2214, DOI 10.1016/j.surfcoat.2005.04.028; YAMADA Y, 1993, JPN J APPL PHYS, V3, P5090	25	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-207X			VACUUM	Vacuum	JAN	2015	111						160	165		10.1016/j.vacuum.2014.10.001		6	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AY3WM	WOS:000347510300026		
J	Mochizuki, H; Goto-Koshino, Y; Takahashi, M; Fujino, Y; Ohno, K; Tsujimoto, H				Mochizuki, H.; Goto-Koshino, Y.; Takahashi, M.; Fujino, Y.; Ohno, K.; Tsujimoto, H.			Demonstration of the Cell Clonality in Canine Hematopoietic Tumors by X-chromosome Inactivation Pattern Analysis	VETERINARY PATHOLOGY			English	Article						dogs; clonality; X-linked clonality; leukemia; lymphoma	ANDROGEN-RECEPTOR GENE; MALIGNANT-LYMPHOMAS; METHYLATION; ASSAY; DOGS; CLASSIFICATION; EXPRESSION; DIAGNOSIS; LEUKEMIA; REFLECT	X-chromosome inactivation pattern (XCIP) analysis has been widely used to assess cell clonality in various types of human neoplasms. In this study, a polymerase chain reaction-based canine XCIP analysis of the androgen receptor (AR) gene was applied for the assessment of cell clonality in canine hematopoietic tumors. This XCIP analysis is based on the polymorphic CAG repeats in the AR gene and the difference of methylation status between active and inactive X chromosomes. We first examined the polymorphisms of 2 CAG tandem repeats in the AR gene in 52 male and 150 female dogs of various breeds. The 2 polymorphic CAG repeats contained 9 to 12 and 10 to 14 CAGs in the first and second CAG repeats, respectively. Of the 150 female dogs, 74 (49.3%) were heterozygous for the first and/or second polymorphic CAG tandem repeats, indicating the utility of XCIP analysis in these dogs. Canine XCIP analysis was then applied to clinical samples from female dogs with canine high-grade lymphoma, chronic myelogenous leukemia, acute myelogenous leukemia, and benign lymph node hyperplasia. Of 10 lymphoma cell samples, 9 (90%) showed skewed XCIPs, indicating their clonal origins, whereas all the nonneoplastic lymph node samples showed balanced XCIPs. Moreover, bone marrow specimen from a dog with acute myelogenous leukemia and peripheral leukocyte specimens from 2 dogs with chronic myelogenous leukemia showed skewed XCIPs. XCIP analysis was successfully employed to demonstrate the cell clonality of canine hematopoietic tumors in this study and will be applicable to evaluate the clonality in various proliferative disorders in dogs.	[Mochizuki, H.; Goto-Koshino, Y.; Takahashi, M.; Fujino, Y.; Ohno, K.; Tsujimoto, H.] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Internal Med, Tokyo 1138657, Japan	Tsujimoto, H (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Internal Med, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	atsuji@mail.ecc.u-tokyo.ac.jp	Mochizuki, Hiroyuki/L-9510-2015	Mochizuki, Hiroyuki/0000-0002-1520-0393	Japan Society for the Promotion of Science [KAKENHI 23381082]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by the Japan Society for the Promotion of Science (KAKENHI 23381082).	Busque L, 2009, BLOOD, V113, P3472, DOI 10.1182/blood-2008-12-195677; Zhang P, 2006, HUM PATHOL, V37, P1350, DOI 10.1016/j.humpath.2006.05.005; Burnett RC, 2003, VET PATHOL, V40, P32, DOI 10.1354/vp.40-1-32; Swierczek SI, 2012, BLOOD, V119, pE100, DOI 10.1182/blood-2011-11-390351; FournelFleury C, 1997, J COMP PATHOL, V117, P35, DOI 10.1016/S0021-9975(97)80065-5; ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Juopperi TA, 2011, VET PATHOL, V48, P182, DOI 10.1177/0300985810389317; FIALKOW PJ, 1967, P NATL ACAD SCI USA, V58, P1468, DOI 10.1073/pnas.58.4.1468; Valli VE, 2011, VET PATHOL, V48, P198, DOI 10.1177/0300985810379428; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Breen M, 2008, CHROMOSOME RES, V16, P145, DOI 10.1007/s10577-007-1212-4; Jones TD, 2005, CANCER, V104, P1195, DOI 10.1002/cncr.21288; Levine RL, 2006, BLOOD, V107, P4139, DOI 10.1182/blood-2005-09-3900; Bell RJ, 2008, CYTOGENET GENOME RES, V122, P37, DOI 10.1159/000151314; Blue Julia T., 2003, Toxicologic Pathology, V31, P44, DOI 10.1080/01926230390177659; Cermak J, 2005, LEUKEMIA RES, V29, P371, DOI 10.1016/j.leukres.2004.08.008; Chen George L, 2007, Blood, V110, P1411, DOI 10.1182/blood-2006-09-018655; Delcour NM, 2013, J COMP PATHOL, V149, P192, DOI 10.1016/j.jcpa.2013.01.004; FEY MF, 1988, BLOOD REV, V2, P78, DOI 10.1016/0268-960X(88)90028-8; Gale RE, 1996, LEUKEMIA, V10, P362; Helfand SC, 2010, SCHALMS VET HEMATOLO, P455; Jain N. C., 1991, Veterinary Clinical Pathology, V20, P63; Jarrard DF, 1998, CANCER RES, V58, P5310; McDonald HL, 2000, GENE CHROMOSOME CANC, V28, P246, DOI 10.1002/1098-2264(200007)28:3<246::AID-GCC2>3.0.CO;2-0; Mitterbauer G, 1999, AM J CLIN PATHOL, V112, P93; Mochizuki H, 2012, VET PATHOL, V49, P963, DOI 10.1177/0300985812439216; Mochizuki H, 2011, VET IMMUNOL IMMUNOP, V140, P307, DOI 10.1016/j.vetimm.2010.12.010; Moore PF, 2010, SCHALMS VET HEMATOLO, P540; Mossner M, 2013, J MED GENET, V50, P108, DOI 10.1136/jmedgenet-2012-101093; Peng HZ, 1997, J PATHOL, V181, P223; R DEVELOPMENT CORE TEAM, 2005, R LANG ENV STAT COMP; SHIBUYA H, 1993, ANIM GENET, V24, P345; Spangler WL, 1998, VET PATHOL, V35, P488; WAGNER LA, 1995, BLOOD, V86, P3265; Walsh PS, 1996, NUCLEIC ACIDS RES, V24, P2807, DOI 10.1093/nar/24.14.2807; WIGGANS RG, 1978, BLOOD, V52, P659	36	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0300-9858	1544-2217		VET PATHOL	Vet. Pathol.	JAN	2015	52	1					61	69		10.1177/0300985814528217		9	Pathology; Veterinary Sciences	Pathology; Veterinary Sciences	AY0QC	WOS:000347300600008		
J	Yoshimura, H; Michishita, M; Ohkusu-Tsukada, K; Matsuda, Y; Ishiwata, T; Naito, Z; Takahashi, K				Yoshimura, H.; Michishita, M.; Ohkusu-Tsukada, K.; Matsuda, Y.; Ishiwata, T.; Naito, Z.; Takahashi, K.			Cellular Sources of Tenascin-C in Canine Mammary Carcinomas	VETERINARY PATHOLOGY			English	Article						dogs; immunohistochemistry; in situ hybridization; mammary tumor; mammary carcinoma; myoepithelial cell; myofibroblast; tenascin-C	STROMAL MYOFIBROBLASTS; TUMORS; EXPRESSION; COMPONENT; CANCER; CELLS	Tenascin-C (Tn-C) is an extracellular matrix glycoprotein implicated in the progression of several human cancers. In canine mammary carcinomas, accumulation of Tn-C has been recognized in 3 different areas: regions of proliferating myoepithelial cells in complex carcinoma, basement membrane zone in low-grade simple carcinoma, and reactive stroma in high-grade simple carcinoma. To identify the Tn-C synthesizing cells in these areas, we utilized double-labeling immunohistochemistry, branched DNA in situ hybridization, and in situ hybridization-immunohistochemistry double-labeling techniques. In complex carcinomas, Tn-C was generated by proliferating myoepithelial cells. Tn-C in low-grade simple carcinomas was also derived from myoepithelial cells existing as a basal monolayer. However, stromal Tn-C in high-grade carcinomas was mainly synthesized by fibroblasts/myofibroblasts, similar to human breast cancer. Thus, the origin of Tn-C in canine mammary carcinomas differs between low- and high-grade malignancies. The role of myoepithelial cell-generated Tn-C is not yet understood.	[Yoshimura, H.; Michishita, M.; Ohkusu-Tsukada, K.; Takahashi, K.] Nippon Vet & Life Sci Univ, Dept Vet Pathol, Tokyo 1808602, Japan; [Yoshimura, H.; Matsuda, Y.; Ishiwata, T.; Naito, Z.] Nippon Med Sch, Dept Pathol, Tokyo 113, Japan; [Yoshimura, H.; Matsuda, Y.; Ishiwata, T.; Naito, Z.] Nippon Med Sch, Dept Integrat Oncol Pathol, Tokyo 113, Japan	Takahashi, K (reprint author), Nippon Vet & Life Sci Univ, Dept Vet Pathol, 1-7-1 Kyonan Cho, Tokyo 1808602, Japan.	kimimasa@nvlu.ac.jp			 [25-11084]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported in part by a grant-in-aid for fellows of the Japan Society for the Promotion of Science (No. 25-11084 to H.Y.).	Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Orend G, 2006, CANCER LETT, V244, P143, DOI 10.1016/j.canlet.2006.02.017; Pena L, 2013, VET PATHOL, V50, P94, DOI 10.1177/0300985812447830; Adams M, 2002, CANCER RES, V62, P3289; ARAI K, 1994, J VET MED SCI, V56, P809; Chiquet-Ehrismann R, 2003, J PATHOL, V200, P488, DOI 10.1002/path.1415; Faustino AMR, 2002, J COMP PATHOL, V126, P1, DOI 10.1053/jcpa.2001.0519; Mukaratirwa S, 2005, INT J EXP PATHOL, V86, P219, DOI 10.1111/j.0959-9673.2005.00425.x; Qian X, 2003, DIAGN MOL PATHOL, V12, P1, DOI 10.1097/00019606-200303000-00001; Sanchez-Cespedes R, 2011, J COMP PATHOL, V145, P25, DOI 10.1016/j.jcpa.2010.11.006; Yoshimura H, 2011, VET PATHOL, V48, P313, DOI 10.1177/0300985810369901; Yoshimura H, 2011, HISTOL HISTOPATHOL, V26, P297	12	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0300-9858	1544-2217		VET PATHOL	Vet. Pathol.	JAN	2015	52	1					92	96		10.1177/0300985814522817		5	Pathology; Veterinary Sciences	Pathology; Veterinary Sciences	AY0QC	WOS:000347300600012		
J	Ueda, J; Kurosawa, N				Ueda, Junko; Kurosawa, Norio			Characterization of an extracellular thermophilic chitinase from Paenibacillus thermoaerophilus strain TC22-2b isolated from compost	WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY			English	Article						Paenibacillus thermoaerophilus; Thermophile; Chitinase; Chitin	RALSTONIA SP A-471; CHITINOLYTIC ENZYMES; PURIFICATION; BACTERIUM; EXPRESSION; CLONING; NOV.; CHIA	Paenibacillus thermoaerophilus strain TC22-2b, a thermophilic bacterium with an optimum growth temperature of 50-55 A degrees C isolated from compost (55 A degrees C) in Japan, secreted a chitinase into culture medium in the presence of colloidal chitin. Adding glucose, lactose, mannose, or sucrose to culture medium decreased the amount of chitinase in culture supernatants. This chitinase was purified by ammonium sulfate precipitation, colloidal chitin adsorption, and ion exchange chromatography. The apparent molecular mass of this enzyme was approximately 48 kDa, and its N-terminal amino acid sequence was determined to be Ala-Val-Ser-Thr-Gly-Lys-Lys. The optimum temperature and pH for chitinase activity were 60 A degrees C and pH 4, respectively. The chitinase retained 68 % of its initial activity after incubation at 50 A degrees C for 2 h. Using p-nitrophenyl N,N'-diacetyl-beta-d-chitobioside [pNP-(GlcNAc)(2)] as a substrate, the K (m), V (max), and k (cat) values for this enzyme were 1.4 mM, 0.058 mM min(-1), and 9.6 s(-1), respectively. Analysis of hydrolysis products showed that the chitinase digested N-acetyl-chitooligosaccharides in an endo manner. N-acetylglucosamine dimers were not degraded by the enzyme. When colloidal chitin was used as the substrate, N-acetylglucosamine dimers, -trimers, and -tetramers were detected as hydrolysis products. Thus, the thermophilic chitinase may prove useful for industrial applications in chitooligosaccharide production from chitin biomass.	[Ueda, Junko; Kurosawa, Norio] Soka Univ, Dept Environm Engn Symbiosis, Fac Engn, Hachioji, Tokyo 1928577, Japan	Ueda, J (reprint author), Soka Univ, Dept Environm Engn Symbiosis, Fac Engn, 1-236 Tangi Machi, Hachioji, Tokyo 1928577, Japan.	weda-bom39you@soka.gr.jp					Cohen-Kupiec R, 1998, CURR OPIN BIOTECH, V9, P270, DOI 10.1016/S0958-1669(98)80058-X; Haki GD, 2003, BIORESOURCE TECHNOL, V89, P17, DOI 10.1016/S0960-8524(03)00033-6; ASH C, 1993, ANTON LEEUW INT J G, V64, P253; Kudan S, 2009, APPL BIOCHEM BIOTECH, V157, P23, DOI 10.1007/s12010-008-8328-7; Dahiya N, 2006, APPL MICROBIOL BIOT, V71, P773, DOI 10.1007/s00253-005-0183-7; Singh AK, 2011, APPL BIOCHEM BIOTECH, V164, P77, DOI 10.1007/s12010-010-9116-8; Bhattacharya D, 2007, CRIT REV BIOTECHNOL, V27, P21, DOI 10.1080/07388550601168223; FLACH J, 1992, EXPERIENTIA, V48, P701, DOI 10.1007/BF02124285; SHAIKH SA, 1993, WORLD J MICROB BIOT, V9, P468, DOI 10.1007/BF00328035; Kurosawa N, 1998, INT J SYST BACTERIOL, V48, P451; MIYASHITA K, 1991, J GEN MICROBIOL, V137, P2065; Waghmare SR, 2010, CARBOHYD RES, V345, P2630, DOI 10.1016/j.carres.2010.09.023; Taechowisan T, 2003, ANN MICROBIOL, V53, P447; Ueda J, 2013, INT J SYST EVOL MICR, V63, P3330, DOI 10.1099/ijs.0.048090-0; [Anonymous], 2007, BIOTECHNOL BIOPROC E, DOI DOI 10.1007/BF02931076; Shibasaki H, 2014, APPL MICROBIOL BIOT, V98, P7845, DOI 10.1007/s00253-014-5692-9; Stefanidi E, 2008, EXTREMOPHILES, V12, P541, DOI 10.1007/s00792-008-0155-9; Chang WT, 2003, CURR MICROBIOL, V47, P102, DOI 10.1007/s00284-002-3955-7; Patil RS, 2000, ENZYME MICROB TECH, V26, P473, DOI 10.1016/S0141-0229(00)00134-4; Nawani NN, 2002, J APPL MICROBIOL, V93, P965, DOI 10.1046/j.1365-2672.2002.01766.x; Gooday GW, 1997, CHITIN CHITOSAN RES, V3, P233; GOODAY GW, 1990, ADV MICROB ECOL, V11, P387; Guo RunFang, 2008, Agricultural Sciences in China, V7, P1458, DOI 10.1016/S1671-2927(08)60403-4; Han SJ, 2011, APPL MICROBIOL BIOT, V89, P613, DOI 10.1007/s00253-010-2890-y; HIRANO S, 1988, AGR BIOL CHEM TOKYO, V52, P2111; Hobel CFV, 2005, EXTREMOPHILES, V9, P53, DOI 10.1007/s00792-004-0422-3; IMOTO T, 1971, AGR BIOL CHEM TOKYO, V35, P1154; Jung Woo-Jin, 2005, Journal of Microbiology and Biotechnology, V15, P274; Loni PP, 2014, J BASIC MICROB, V53, P1; Nagpure A, 2013, J BASIC MICROB, V53, P429, DOI 10.1002/jobm.201100648; Park HJ, 2009, ENZYME MICROB TECH, V45, P391, DOI 10.1016/j.enzmictec.2009.07.002; Reguera G, 2003, ARCH MICROBIOL, V180, P434, DOI 10.1007/s00203-003-0611-y; ROBERTS RL, 1982, ANAL BIOCHEM, V127, P402, DOI 10.1016/0003-2697(82)90194-4; Sambrook J., 1989, MOL CLONING LAB MANU; Songsiriritthigul C, 2010, BIORESOURCE TECHNOL, V101, P4096, DOI 10.1016/j.biortech.2010.01.036; Sutrisno A, 2004, APPL MICROBIOL BIOT, V63, P398, DOI 10.1007/s00253-003-1351-2; Tanabe T, 2000, J BIOSCI BIOENG, V89, P27, DOI 10.1016/S1389-1723(00)88046-9; Tanaka T, 1999, APPL ENVIRON MICROB, V65, P5338; Ueda M, 2005, BIOSCI BIOTECH BIOCH, V69, P842, DOI 10.1271/bbb.69.842	39	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0959-3993	1573-0972		WORLD J MICROB BIOT	World J. Microbiol. Biotechnol.	JAN	2015	31	1					135	143		10.1007/s11274-014-1754-5		9	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	AY0PF	WOS:000347298100013		
J	Torres, A; Calafate, CT; Cano, JC; Manzoni, P; Ji, YS				Torres, Alvaro; Calafate, Carlos T.; Cano, Juan-Carlos; Manzoni, Pietro; Ji, Yusheng			Evaluation of flooding schemes for real-time video transmission in VANETs	AD HOC NETWORKS			English	Article						V2V; V2I; Real-time video; Flooding; H.265; Simulation	BROADCAST; PROTOCOL; DENSITY	Long-distance real-time video flooding over Vehicular Ad-hoc Networks (VANETs) is challenging due to the dynamic nature of vehicular networks. Real-time video transmission has high requirements in terms of bandwidth and delay, while VANETs are characterized by very limited radio resources and high mobility. Our objective is to compare ten different flooding schemes specially designed for this task and select the best in terms of packet arrival ratio and Peak Signal-to-Noise Ratio (PSNR). Additionally, we propose Automatic Copies Distance Based (ACDB), an improved flooding scheme, to cope with variable vehicle density situations. Furthermore, to ensure a good behavior under all types of circumstances, we also study the impact of Global Positioning System (GPS) drift on these schemes. Simulation results show that long-distance real-time video flooding transmission is feasible under certain vehicle density conditions and the quality achieved is enough to allow using such solutions in future applications. (C) 2014 Elsevier B.V. All rights reserved.	[Torres, Alvaro; Calafate, Carlos T.; Cano, Juan-Carlos; Manzoni, Pietro] Univ Politecn Valencia, Dept Comp Engn, Valencia 46022, Spain; [Ji, Yusheng] Res Org Informat & Syst, Natl Inst Informat, Chiyoda Ku, Tokyo 1018430, Japan	Calafate, CT (reprint author), Univ Politecn Valencia, Dept Comp Engn, Camino Vera S-N, Valencia 46022, Spain.	atcortes@batousay.com; calafate@disca.upv.es; jucano@disca.upv.es; pmanzoni@disca.upv.es; kei@nii.ac.jp	Calafate, Carlos/A-4215-2009; icmol, icmol/I-5784-2015	Calafate, Carlos/0000-0001-5729-3041; 	Ministerio de Economia y Competitividad, Spain [TIN2011-27543-C03-01]; Ministerio de Educacion, Spain, under the FPU program [AP2009-2415]; National Institute of Informatics International Internship Program	This work was partially supported by the Ministerio de Economia y Competitividad, Spain, under Grant TIN2011-27543-C03-01, by the Ministerio de Educacion, Spain, under the FPU program, AP2009-2415, and by the National Institute of Informatics International Internship Program.	Soldo F, 2011, IEEE T PARALL DISTR, V22, P1085, DOI 10.1109/TPDS.2010.173; Sanguesa JA, 2013, SENSORS-BASEL, V13, P2399, DOI 10.3390/s130202399; Cuomo F, 2014, AD HOC NETW, V21, P42, DOI 10.1016/j.adhoc.2014.04.008; Tseng YC, 2003, IEEE T COMPUT, V52, P545; [Anonymous], 2012, COMMUN SURV TUT IEEE, DOI DOI 10.1109/SURV.2011.082911.00067; Yan T, 2014, IEEE T WIREL COMMUN, V13, P861, DOI 10.1109/TWC.2013.122313.130547; Baguena Miguel, 2013, 2013 IEEE International Conference on Communications Workshops (ICC), DOI 10.1109/ICCW.2013.6649393; Baguena M., 2012, WIRELESS DAYS WD 201, P1; Behrisch M., 2011, SIMUL 2011 3 INT C A, P63; Fogue Manuel, 2013, IEEE T PP MOB COMPUT, P1; GUO M, 2005, 3 IEEE INT C PERV CO, V2005, P171; KOUMARAS H, 2012, FUT NETW MOB SUMM FU, V2012, P1; Martinez FJ, 2010, LECT NOTES COMPUT SC, V6091, P265, DOI 10.1007/978-3-642-12963-6_21; Martinez FJ, 2011, WIRELESS PERS COMMUN, V56, P559, DOI 10.1007/s11277-010-9989-4; Mershad K, 2012, IEEE T INTELL TRANSP, V13, P1099, DOI 10.1109/TITS.2012.2183124; Nakorn KN, 2013, IEICE T COMMUN, VE96B, P1112, DOI 10.1587/transcom.E96.B.1112; Ni S., 1999, P 5 ANN ACM IEEE INT, P151, DOI 10.1145/313451.313525; OSAFUNE T, 2006, P 6 INT C ITS TEL 20, V2006, P757; PINOL P, 2013, WIR DAYS WD 2013 IFI, P1; Pinol P., 2012, P 7 ACM WORKSH PERF, P7; Ros F., 2009, IEEE VTC2009 SPR BAR, P1; TORNELL SM, 2013, ASSESSING THE EFFECT; Wu C, 2012, IEICE T COMMUN, VE95B, P415, DOI 10.1587/transcom.E95.B.415	23	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1570-8705	1570-8713		AD HOC NETW	Ad Hoc Netw.	JAN	2015	24		B		SI		3	20		10.1016/j.adhoc.2014.07.030		18	Computer Science, Information Systems; Telecommunications	Computer Science; Telecommunications	AY4YQ	WOS:000347581300002		
J	Tatsuishi, W; Adachi, H; Murata, M; Tomono, J; Okonogi, S; Okada, S; Hasegawa, Y; Ezure, M; Kaneko, T; Ohshima, S				Tatsuishi, Wataru; Adachi, Hitoshi; Murata, Makoto; Tomono, Junichi; Okonogi, Shuichi; Okada, Syuichi; Hasegawa, Yutaka; Ezure, Masahiko; Kaneko, Tatsuo; Ohshima, Shigeru			Postoperative Hyperglycemia and Atrial Fibrillation After Coronary Artery Bypass Graft Surgery	CIRCULATION JOURNAL			English	Article						Atrial fibrillation; Coronary artery bypass grafting; Glucose; Risk factor	P-WAVE DISPERSION; CARDIAC-SURGERY; ATHEROSCLEROSIS RISK; DIABETES-MELLITUS; CRITICALLY-ILL; IMPACT; HYPOGLYCEMIA; METAANALYSIS; COMMUNITIES; PREVENTION	Background: Postoperative atrial fibrillation (AF) is a common complication following coronary artery bypass grafting (CABG). We investigated the risk factors for postoperative AF and analyzed the relationship between blood sugar concentration (BS) and AF after CABG. Methods and Results: A total of 199 consecutive patients who underwent isolated CABG were retrospectively examined and classified according to the presence (n=95) or absence (n=104) of postoperative AF. On univariate analysis mean postoperative BS (P<0.001), postoperative drainage volume (P<0.001), age (P=0.034), presence of diabetes mellitus (DM; P=0.004), and postoperative estimated glomerular filtration rate (P=0.032) were significant risk factors for postoperative AF. On multivariate analysis mean postoperative BS (OR, 1.041; 95% CI: 1.008-1.079; P<0.001), postoperative drainage volume (OR, 1.003; 95% CI: 1.001-1.006; P=0.001), and age (OR, 1.040; 95% CI: 1.002-1.083; P=0.041) were significant risk factors for postoperative AF. Postoperative AF often occurred in patients with high postoperative BS, irrespective of DM. The BS cut-off that predicted postoperative AF occurrence was 180 mg/dl. A strong positive correlation existed between the time of the maximum postoperative BS and AF onset time (rho=0.746). Conclusions: Mean postoperative BS and postoperative drainage volume are risk factors for AF after CABG. AF was strongly associated with maximum postoperative BS. Intensive glycemic control could reduce AF occurrence after CABG.	[Tatsuishi, Wataru] Tokyo Womens Med Univ, Med Ctr East, Dept Cardiovasc Surg, Tokyo 1168567, Japan; [Tatsuishi, Wataru; Okonogi, Shuichi; Okada, Syuichi; Hasegawa, Yutaka; Ezure, Masahiko; Kaneko, Tatsuo] Gunma Prefectural Cardiovasc Ctr, Dept Cardiovasc Surg, Maebashi, Gumma, Japan; [Adachi, Hitoshi; Murata, Makoto; Tomono, Junichi; Ohshima, Shigeru] Gunma Prefectural Cardiovasc Ctr, Dept Cardiol, Maebashi, Gumma, Japan	Tatsuishi, W (reprint author), Tokyo Womens Med Univ, Med Ctr East, Dept Cardiovasc Surg, Arakawa Ku, Nishioku 2-1-10, Tokyo 1168567, Japan.	wataru0812_drt@ybb.ne.jp					Zhang XL, 2012, ENDOCRINE, V41, P398, DOI 10.1007/s12020-012-9623-1; Sezai A, 2013, CIRC J, V77, P2244, DOI 10.1253/circj.CJ-13-0754; Wiener RS, 2008, JAMA-J AM MED ASSOC, V300, P933, DOI 10.1001/jama.300.8.933; Lazar HL, 2009, ANN THORAC SURG, V87, P663, DOI 10.1016/j.athoracsur.2008.11.011; Teraguchi I, 2012, CIRC J, V76, P2690, DOI 10.1253/circj.CJ-12-0303; Thoren E, 2012, INTERACT CARDIOV TH, V14, P588, DOI 10.1093/icvts/ivr162; Furnary AP, 2003, J THORAC CARDIOV SUR, V125, P1007, DOI 10.1067/mtc.2003.181; Zhang YQ, 2003, J BIOL CHEM, V278, P10417, DOI 10.1074/jbc.M211044200; Huxley RR, 2012, HEART, V98, P133, DOI 10.1136/heartjnl-2011-300503; Mathew JP, 2004, JAMA-J AM MED ASSOC, V291, P1720, DOI 10.1001/jama.291.14.1720; Guo YT, 2012, J AM COLL CARDIOL, V60, P2263, DOI 10.1016/j.jacc.2012.04.063; Watanabe H, 2008, CIRCULATION, V117, P1255, DOI 10.1161/CIRCULATIONAHA.107.744466; Chandy J, 2004, ANESTH ANALG, V98, P303, DOI 10.1213/01.ANE.0000096195.47734.2F; Neef S, 2010, CIRC RES, V106, P1134, DOI 10.1161/CIRCRESAHA.109.203836; Chua SK, 2013, CIRC J, V77, P2303, DOI 10.1253/circj.CJ-13-0273; Yazici M, 2007, CIRC J, V71, P880, DOI 10.1253/circj.71.880; Kaireviciute D, 2009, EUR HEART J, V30, P410, DOI 10.1093/eurheartj/ehn609; Ommen SR, 1997, NEW ENGL J MED, V336, P1429, DOI 10.1056/NEJM199705153362006; Aranki SF, 1996, CIRCULATION, V94, P390; Korantzopoulos P, 2007, INT J CARDIOL, V115, P135, DOI 10.1016/j.ijcard.2006.04.026; Shen J, 2011, J THORAC CARDIOV SUR, V141, P559, DOI 10.1016/j.jtcvs.2010.03.011; Huxley RR, 2011, AM J CARDIOL, V108, P56, DOI 10.1016/j.amjcard.2011.03.004; Amar D, 2004, J AM COLL CARDIOL, V44, P1248, DOI 10.1016/j.jacc.2004.05.078; Lazar HL, 2004, CIRCULATION, V109, P1497, DOI 10.1161/01.CIR.0000121747.71054.79; Eckert B, 1998, CLIN PHYSIOL, V18, P570, DOI 10.1046/j.1365-2281.1998.00138.x; Zacharias A, 2005, CIRCULATION, V112, P3247, DOI 10.1161/CIRCULATIONAHA.105.553743/DC1; Huxley RR, 2011, CIRCULATION, V123, P1501, DOI 10.1161/CIRCULATIONAHA.110.009035; Bradley D, 2005, CHEST, V128, p39S, DOI 10.1378/chest.128.2_suppl.39S; Burkett E, 2009, CRIT CARE RESUSC, V11, P8; Dobrev D, 2010, N-S ARCH PHARMACOL, V381, P195, DOI 10.1007/s00210-009-0457-1; Endoh Y, 2011, J ARRHYTHMIA, V27, P106; Heijman Jordi, 2012, Wien Med Wochenschr, V162, P287; Hreiche R, 2009, J MOL CELL CARDIOL, V47, P210, DOI 10.1016/j.yjmcc.2009.02.004; Karabag T, 2011, KARDIOL POL, V69, P566; Li Z, 2002, J ELECTROCARDIOL, V35, P227, DOI 10.1054/jelc.2002.33973; Solomon AJ, 2000, ANN THORAC SURG, V69, P126, DOI 10.1016/S0003-4975(99)01187-X; Tukek T, 2001, CLIN CARDIOL, V24, P676; Weber UK, 1998, EUR HEART J, V19, P794	38	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JAN	2015	79	1					112	118		10.1253/circj.CJ-14-0989		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX4KD	WOS:000346900700021		
J	Dobrovolskaya, O; Pont, C; Sibout, R; Martinek, P; Badaeva, E; Murat, F; Chosson, A; Watanabe, N; Prat, E; Gautier, N; Gautier, V; Poncet, C; Orlov, YL; Krasnikov, AA; Berges, H; Salina, E; Laikova, L; Salse, J				Dobrovolskaya, Oxana; Pont, Caroline; Sibout, Richard; Martinek, Petr; Badaeva, Ekaterina; Murat, Florent; Chosson, Audrey; Watanabe, Nobuyoshi; Prat, Elisa; Gautier, Nadine; Gautier, Veronique; Poncet, Charles; Orlov, Yuriy L.; Krasnikov, Alexander A.; Berges, Helene; Salina, Elena; Laikova, Lyudmila; Salse, Jerome			FRIZZY PANICLE Drives Supernumerary Spikelets in Bread Wheat	PLANT PHYSIOLOGY			English	Article							CHROMOSOMAL LOCATION; MERISTEM IDENTITY; TETRAPLOID WHEAT; BRANCHED SPIKE; GENES; INHERITANCE; INFLORESCENCE; ARCHITECTURE; TRITICEAE; RACHIS	Bread wheat (Triticum aestivum) inflorescences, or spikes, are characteristically unbranched and normally bear one spikelet per rachis node. Wheat mutants on which supernumerary spikelets (SSs) develop are particularly useful resources for work towards understanding the genetic mechanisms underlying wheat inflorescence architecture and, ultimately, yield components. Here, we report the characterization of genetically unrelated mutants leading to the identification of the wheat FRIZZY PANICLE (FZP) gene, encoding a member of the APETALA2/Ethylene Response Factor transcription factor family, which drives the SS trait in bread wheat. Structural and functional characterization of the three wheat FZP homoeologous genes (WFZP) revealed that coding mutations of WFZP-D cause the SS phenotype, with the most severe effect when WFZP-D lesions are combined with a frameshift mutation in WFZP-A. We provide WFZP-based resources that may be useful for genetic manipulations with the aim of improving bread wheat yield by increasing grain number.	[Dobrovolskaya, Oxana; Orlov, Yuriy L.; Salina, Elena; Laikova, Lyudmila] Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia; [Pont, Caroline; Murat, Florent; Chosson, Audrey; Gautier, Veronique; Poncet, Charles; Salse, Jerome] Univ Clermont Ferrand, INRA, Unite Mixte Rech 1095, F-63100 Clermont Ferrand 2, France; [Sibout, Richard] INRA, Unite Mixte Rech 1318, Inst Jean Pierre Bourgin, Saclay Plant Sci, F-78000 Versailles, France; [Sibout, Richard] AgroParisTech, Inst Jean Pierre Bourgin, RD10, F-78000 Versailles, France; [Martinek, Petr] Agrotest Fyto Ltd, Kromeriz 76701, Czech Republic; [Badaeva, Ekaterina] Russian Acad Sci, Vavilov Inst Gen Genet, Moscow 3119333, Russia; [Watanabe, Nobuyoshi] Ibaraki Univ, Coll Agr, Inashiki, Ibaraki 3000393, Japan; [Prat, Elisa; Gautier, Nadine; Berges, Helene] INRA, Ctr Natl Ressources Genom Vegetales, F-31326 Castanet Tolosan, France; [Orlov, Yuriy L.] Novosibirsk State Univ, Novosibirsk 630090, Russia; [Krasnikov, Alexander A.] Russian Acad Sci, Siberian Branch, Cent Siberian Bot Garden, Novosibirsk 630090, Russia	Dobrovolskaya, O (reprint author), Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia.	oxanad@bionet.nsc.ru; jsalse@clermont.inra.fr	Orlov, Yuriy/F-1520-2013	Orlov, Yuriy/0000-0003-0587-1609	Russian Foundation for Basic Research [10-04-01458-a, 12-04-00897-a]; Agence Nationale de la Recherche (programs ANRjc-PaleoCereal) [ANR-09-JCJC-0058-01]; Agence Nationale de la Recherche (programs ANR Blanc-PAGE) [ANR-2011-BSV6-00801]; Presidium of Russian Academy of Sciences Molecular and Cell Biology [6.14]; French Embassy in Russia, Department for Science, Technology, and Space; Ministry of Agriculture of the Czech Republic [RO0211]	This work was supported by grants from the Russian Foundation for Basic Research (project nos. 10-04-01458-a and 12-04-00897-a), the Agence Nationale de la Recherche (programs ANRjc-PaleoCereal [reference no. ANR-09-JCJC-0058-01] and ANR Blanc-PAGE [reference no. ANR-2011-BSV6-00801]), the program of the Presidium of Russian Academy of Sciences Molecular and Cell Biology (project no. 6.14), the French Embassy in Russia, Department for Science, Technology, and Space (Mobility grant in 2012 to O.D.), and the Ministry of Agriculture of the Czech Republic (project no. RO0211 to P.M.).	Acevedo E., 2002, BREAD WHEAT IMPROVEM; Amagai Y, 2014, GENET RESOUR CROP EV, V61, P465, DOI 10.1007/s10722-013-0050-9; Tanaka W, 2013, PLANT CELL PHYSIOL, V54, P313, DOI 10.1093/pcp/pct016; Chuck G, 2002, SCIENCE, V298, P1238, DOI 10.1126/science.1076920; Komatsu M, 2003, DEVELOPMENT, V130, P3841, DOI 10.1242/dev.00564; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Peng ZS, 1998, EUPHYTICA, V103, P109, DOI 10.1023/A:1018323310621; Sharman BC, 1944, NATURE, V153, P497, DOI 10.1038/153497a0; Feldman M, 2005, CYTOGENET GENOME RES, V109, P250, DOI 10.1159/000082407; Miralles DJ, 2007, J AGR SCI, V145, P139, DOI 10.1017/S0021859607006752; Pont C, 2013, PLANT J, V76, P1030, DOI 10.1111/tpj.12366; Rao NN, 2008, P NATL ACAD SCI USA, V105, P3646, DOI 10.1073/pnas.0709059105; Muramatsu M, 2009, BREEDING SCI, V59, P617, DOI 10.1270/jsbbs.59.617; Dobrovolskaya O, 2009, THEOR APPL GENET, V119, P867, DOI 10.1007/s00122-009-1095-1; Sakuma S, 2011, PLANT CELL PHYSIOL, V52, P738, DOI 10.1093/pcp/pcr025; PENNELL AL, 1983, EUPHYTICA, V32, P767, DOI 10.1007/BF00042157; Coffman FA, 1924, J HERED, V15, P187; Dalmais M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065503; Derbyshire P, 2013, PLANT PHYSIOL, V161, P1291, DOI 10.1104/pp.112.212340; DOBROVOLSKAYA O, 2008, C P BREEDING, V2008, P133; Feldman M., 2001, THE WHEAT BOOK, P1; Haque MA, 2012, GENET RESOUR CROP EV, V59, P831, DOI 10.1007/s10722-011-9722-5; KLINDWORTH DL, 1990, GENOME, V33, P509; Klindworth DL, 1997, J HERED, V88, P229; KLINDWORTH DL, 1990, GENOME, V33, P515; KORIC S, 1980, J SCI AGR RES ZAGREB, V142, P271; LAIKOVA LI, 2005, P 9 WORKSH GEN BREED, P388; Li J., 2011, TRITICEAE GENOM GENE, V2, P1; Malcomber S. T., 2006, ADV BOT RES, V44, P423; MARTINEK P, 2012, OBILNARSKE LISTY, V4, P90; NICOLIS JS, 1977, J THEOR BIOL, V68, P563, DOI 10.1016/0022-5193(77)90106-0; Quraishi UM, 2009, FUNCT INTEGR GENOMIC, V9, P473, DOI 10.1007/s10142-009-0129-8; SEARS ER, 1954, ANEUPLOIDS COMMON WH, P3; SWAMINAT.MS, 1966, CURR SCI INDIA, V35, P91; Tanno K, 2004, THEOR APPL GENET, V110, P145, DOI 10.1007/s00122-004-1816-4; Yang WY, 2005, GENET RESOUR CROP EV, V52, P847, DOI 10.1007/s10722-003-6089-2; Zhang RuiQi, 2013, Acta Agronomica Sinica, V39, P29	37	5	6	AMER SOC PLANT BIOLOGISTS	ROCKVILLE	15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA	0032-0889	1532-2548		PLANT PHYSIOL	Plant Physiol.	JAN	2015	167	1					189	199		10.1104/pp.114.250043		11	Plant Sciences	Plant Sciences	AX8PE	WOS:000347170300013		
J	Makino, Y; Imai, Y; Igura, T; Hori, M; Fukuda, K; Sawai, Y; Kogita, S; Fujita, N; Takehara, T; Murakami, T				Makino, Yuki; Imai, Yasuharu; Igura, Takumi; Hori, Masatoshi; Fukuda, Kazuto; Sawai, Yoshiyuki; Kogita, Sachiyo; Fujita, Norihiko; Takehara, Tetsuo; Murakami, Takamichi			Comparative evaluation of three-dimensional Gd-EOB-DTPA-enhanced MR fusion imaging with CT fusion imaging in the assessment of treatment effect of radiofrequency ablation of hepatocellular carcinoma	ABDOMINAL IMAGING			English	Article						Hepatocellular carcinoma; Radiofrequency ablation; Fusion imaging; Ablative margin; Gd-EOB-DTPA	LOCAL TUMOR PROGRESSION; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; PROSPECTIVE RANDOMIZED-TRIAL; COMPUTED-TOMOGRAPHY FUSION; IRREVERSIBLE ELECTROPORATION; MULTIDETECTOR CT; FOLLOW-UP; MARGIN; REGISTRATION; LIVER	To assess the feasibility of fusion of pre- and post-ablation gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging (Gd-EOB-DTPA-MRI) to evaluate the effects of radiofrequency ablation (RFA) of hepatocellular carcinoma (HCC), compared with similarly fused CT images This retrospective study included 67 patients with 92 HCCs treated with RFA. Fusion images of pre- and post-RFA dynamic CT, and pre- and post-RFA Gd-EOB-DTPA-MRI were created, using a rigid registration method. The minimal ablative margin measured on fusion imaging was categorized into three groups: (1) tumor protruding outside the ablation zone boundary, (2) ablative margin 0-< 5.0 mm beyond the tumor boundary, and (3) ablative margin a parts per thousand yen5.0 mm beyond the tumor boundary. The categorization of minimal ablative margins was compared between CT and MR fusion images. In 57 (62.0%) HCCs, treatment evaluation was possible both on CT and MR fusion images, and the overall agreement between them for the categorization of minimal ablative margin was good (kappa coefficient = 0.676, P < 0.01). MR fusion imaging enabled treatment evaluation in a significantly larger number of HCCs than CT fusion imaging (86/92 [93.5%] vs. 62/92 [67.4%], P < 0.05). Fusion of pre- and post-ablation Gd-EOB-DTPA-MRI is feasible for treatment evaluation after RFA. It may enable accurate treatment evaluation in cases where CT fusion imaging is not helpful.	[Makino, Yuki; Imai, Yasuharu; Igura, Takumi; Fukuda, Kazuto; Sawai, Yoshiyuki; Kogita, Sachiyo] Ikeda Municipal Hosp, Dept Gastroenterol, Ikeda, Osaka 5638510, Japan; [Hori, Masatoshi] Osaka Univ, Grad Sch Med, Dept Radiol, Suita, Osaka 5650871, Japan; [Fujita, Norihiko] Ikeda Municipal Hosp, Dept Radiol, Ikeda, Osaka 5638510, Japan; [Takehara, Tetsuo] Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Suita, Osaka 5650871, Japan; [Murakami, Takamichi] Kinki Univ, Fac Med, Dept Radiol, Osaka 5898511, Japan	Imai, Y (reprint author), Ikeda Municipal Hosp, Dept Gastroenterol, 3-1-18 Johnan, Ikeda, Osaka 5638510, Japan.	yasuimai@hosp.ikeda.osaka.jp					Abi-Jaoudeh Nadine, 2013, Tech Vasc Interv Radiol, V16, P168, DOI 10.1053/j.tvir.2013.02.012; Abi-Jaoudeh N, 2012, J VASC INTERV RADIOL, V23, P737, DOI 10.1016/j.jvir.2012.02.006; Koda M, 2012, EUR J RADIOL, V81, P1400, DOI 10.1016/j.ejrad.2011.03.004; Giesel F. L., 2009, Experimental Oncology, V31, P106; Sano K, 2011, RADIOLOGY, V261, P834, DOI 10.1148/radiol.11101840; Makino Y, 2013, HEPATOL RES, V43, P950, DOI 10.1111/hepr.12049; Peng ZW, 2013, J CLIN ONCOL, V31, P426, DOI 10.1200/JCO.2012.42.9936; Khankan AA, 2008, J MAGN RESON IMAGING, V27, P546, DOI 10.1002/jmri.21050; Yoon JH, 2010, J VASC INTERV RADIOL, V21, P348, DOI 10.1016/j.jvir.2009.11.014; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Onishi H, 2012, EUR RADIOL, V22, P845, DOI 10.1007/s00330-011-2316-y; Kim S, 2010, J MAGN RESON IMAGING, V31, P348, DOI 10.1002/jmri.22038; Nakazawa T, 2007, AM J ROENTGENOL, V188, P480, DOI 10.2214/AJR.05.2079; Murakami T, 2011, ONCOLOGY-BASEL, V81, P86, DOI 10.1159/000333267; Di Martino M, 2010, RADIOLOGY, V256, P806, DOI 10.1148/radiol.10091334; Crum WR, 2004, BRIT J RADIOL, V77, pS140, DOI 10.1259/bjr/25329214; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Passera K, 2013, BMC MED IMAGING, V13, DOI 10.1186/1471-2342-13-3; Kim YS, 2010, AM J ROENTGENOL, V195, P758, DOI 10.2214/AJR.09.2954; de Lope CR, 2012, J HEPATOL, V56, pS75, DOI 10.1016/S0168-8278(12)60009-9; Kogita S, 2010, EUR RADIOL, V20, P2405, DOI 10.1007/s00330-010-1812-9; Koda M, 2012, EUR J RADIOL, V81, P2730, DOI 10.1016/j.ejrad.2011.11.013; Okada M, 2010, J MAGN RESON IMAGING, V32, P903, DOI 10.1002/jmri.22333; Dromain C, 2002, RADIOLOGY, V223, P255, DOI 10.1148/radiol.2231010780; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Peng ZW, 2012, RADIOLOGY, V262, P689, DOI 10.1148/radiol.11110637; Bangard C, 2008, J MAGN RESON IMAGING, V28, P263, DOI 10.1002/jmri.21423; Carrillo A, 2000, IEEE T MED IMAGING, V19, P175, DOI 10.1109/42.845176; Fujioka C, 2006, ACAD RADIOL, V13, P986, DOI 10.1016/j.acra.2006.05.011; Kim KW, 2011, AM J ROENTGENOL, V196, pW565, DOI 10.2214/AJR.10.5122; Makino Y, 2013, ONCOLOGY-BASEL, V84, P44, DOI 10.1159/000345889; Mannelli L, 2013, LIVER INT, V33, P104, DOI 10.1111/liv.12000; Niculescu G, 2007, P ANN INT IEEE EMBS, P856, DOI 10.1109/IEMBS.2007.4352425; Tomonari A, 2013, HEPATOL RES, V43, P728, DOI 10.1111/hepr.12022; Wood BJ, 2010, J VASC INTERV RADIOL, V21, pS257, DOI 10.1016/j.jvir.2010.05.003; Zhang Y, 2014, RADIOLOGY, V271, P721, DOI 10.1148/radiol.14130989	36	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-8925	1432-0509		ABDOM IMAGING	Abdom. Imaging	JAN	2015	40	1					102	111		10.1007/s00261-014-0201-2		10	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	AX9UI	WOS:000347247100012		
J	Takeuchi, M; Kawai, T; Suzuki, T; Naiki, T; Kawai, N; Fujiyoshi, Y; Inagaki, H; Kohri, K; Hara, M; Shibamoto, Y				Takeuchi, Mitsuru; Kawai, Tatsuya; Suzuki, Tomohiro; Naiki, Taku; Kawai, Noriyasu; Fujiyoshi, Yukio; Inagaki, Hiroshi; Kohri, Kenjiro; Hara, Masaki; Shibamoto, Yuta			MRI for differentiation of renal cell carcinoma with sarcomatoid component from other renal tumor types	ABDOMINAL IMAGING			English	Article						Carcinoma; Renal Cell; Sarcomatoid renal cell carcinoma; Magnetic resonance imaging; T2-weighted imaging; Diagnosis; Differential	PATHOLOGICAL CORRELATION; IMAGING FINDINGS; KIDNEY; PAPILLARY; SUBTYPES; CT	To investigate the usefulness of MRI for detection of sarcomatoid renal cell carcinoma (SRCC) components within RCC and differentiation from other renal tumors. Two observers independently interpreted T2-weighted images of 10 patients with pathologically confirmed RCCs with SRCC and 131 with non-SRCC renal tumors, with special reference to conspicuously low signal intensity (SI) areas (T2LIA) compared to the renal cortex. SRCC probability was classified as (1) definitely non-SRCC, no T2LIA; (2) probably non-SRCC, < 1 cm T2LIA; (3) low probability of SRCC, homogeneous tumor with 1-3 cm T2LIA; (4) probably SRCC, heterogeneous tumor with 1-3 cm T2LIA; and (5) definitely SRCC, > 3 cm T2LIA, multiple > 1 cm T2LIAs, or showing disruption of the pseudocapsule. The observers used chemical shift imaging to exclude the area representing hemorrhage or hemosiderin deposition from T2LIA. Scores of 4/5 were regarded as positive for evaluating the accuracy and area under the receiver operating characteristic curve. The SI ratio of the lowest SI in the tumor to that of the renal cortex in the 1 and a parts per thousand yen2 score groups was compared using Mann-Whitney's U test. Sensitivity, specificity, accuracy, and positive and negative predictive values were 90%, 95%, 94%, 56%, and 99%, respectively, and area under the receiver operating characteristic curve was 0.93. The mean SI ratio of the lowest SI in the tumor to that of the renal cortex was significantly lower in the a parts per thousand yen2 score group (0.58) than in the 1 score group (1.36). MRI predicted RCC with SRCC with a moderate positive predictive value and a high negative predictive value.	[Takeuchi, Mitsuru; Kawai, Tatsuya; Suzuki, Tomohiro; Shibamoto, Yuta] Nagoya City Univ, Grad Sch Med Sci, Dept Radiol, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Takeuchi, Mitsuru; Kawai, Tatsuya; Suzuki, Tomohiro; Naiki, Taku; Kawai, Noriyasu; Fujiyoshi, Yukio; Inagaki, Hiroshi; Kohri, Kenjiro; Shibamoto, Yuta] Sch Med, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Naiki, Taku; Kawai, Noriyasu; Kohri, Kenjiro] Nagoya City Univ, Grad Sch Med Sci, Dept Nephrourol, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Fujiyoshi, Yukio; Inagaki, Hiroshi] Nagoya City Univ, Grad Sch Med Sci, Dept Clin Pathol, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Hara, Masaki] Nagoya City West Med Ctr, Dept Radiol, Kita Ku, Nagoya, Aichi 4628508, Japan	Takeuchi, M (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Radiol, Mizuho Ku, 1 Kawasumi Mizuho Cho, Nagoya, Aichi 4678601, Japan.	m2rbimn@gmail.com			JSPS KAKENHI [25861116]	This work was supported by JSPS KAKENHI Grant Number 25861116.	Crispen PL, 2011, EUR UROL, V59, P18, DOI 10.1016/j.eururo.2010.08.042; Sun MRM, 2009, RADIOLOGY, V250, P793, DOI 10.1148/radiol.2503080995; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Jinzaki M, 1997, RADIOLOGY, V205, P497; Mian BM, 2002, J UROLOGY, V167, P65, DOI 10.1016/S0022-5347(05)65384-0; HANLEY JA, 1982, RADIOLOGY, V143, P29; Oliva MR, 2009, AM J ROENTGENOL, V192, P1524, DOI 10.2214/AJR.08.1727; Shuch B, 2009, J UROLOGY, V182, P2164, DOI 10.1016/j.juro.2009.07.049; Shinmoto H, 1998, JMRI-J MAGN RESON IM, V8, P690, DOI 10.1002/jmri.1880080327; Pickhardt PJ, 2001, AM J ROENTGENOL, V176, P627; Prasad SR, 2006, RADIOGRAPHICS, V26, P1795, DOI 10.1148/rg.266065010; Bastide C, 2009, BJU INT, V103, P1544, DOI 10.1111/j.1464-410X.2009.08357.x; Brown PH, 2003, RADIOLOGY, V229, P930, DOI 10.1148/radiol.2293030609; de Peralta-Venturina M, 2001, AM J SURG PATHOL, V25, P275, DOI 10.1097/00000478-200103000-00001; Giannakis D, 2009, UROL INT, V82, P367, DOI 10.1159/000209375; Johnson TRC, 2005, J COMPUT ASSIST TOMO, V29, P481, DOI 10.1097/01.rct.0000166637.24037.41; MUCCI B, 1987, CLIN RADIOL, V38, P249, DOI 10.1016/S0009-9260(87)80058-2; Rosenkrantz AB, 2011, CLIN IMAG, V35, P459, DOI 10.1016/j.clinimag.2010.11.002; Sasiwimonphan K, 2012, RADIOLOGY, V33, P160; SHIRKHODA A, 1987, RADIOLOGY, V162, P353; Takeuchi M, 2013, CLIN IMAG, V37, P908, DOI 10.1016/j.clinimag.2013.04.010; Yoshimitsu K, 2006, J MAGN RESON IMAGING, V23, P339, DOI 10.1002/jmri.20509	22	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-8925	1432-0509		ABDOM IMAGING	Abdom. Imaging	JAN	2015	40	1					112	119		10.1007/s00261-014-0185-y		8	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	AX9UI	WOS:000347247100013		
J	Jono, Y; Yamasaki, M; Kawamura, Y				Jono, Yuri; Yamasaki, Michiaki; Kawamura, Yoshihito			Quantitative evaluation of creep strain distribution in an extruded Mg-Zn-Gd alloy of multimodal microstructure	ACTA MATERIALIA			English	Article						Magnesium alloy; Long-period stacking ordered phase; Creep; Strain; Grain boundary sliding	RESISTANT MAGNESIUM ALLOYS; STACKING ORDERED STRUCTURE; MECHANICAL-PROPERTIES; RARE-EARTH; DEFORMATION MECHANISMS; ELEVATED-TEMPERATURES; LPSO PHASE; Y-ALLOY; ELECTRON-MICROSCOPY; SUPERPLASTIC FLOW	The creep behavior of an extruded Mg-Zn-Gd alloy with a long-period stacking ordered (LPSO) phase is investigated at 473 K under applied stress ranging from 150 to 270 MPa. The microstructure of the extruded alloy is characterized by a multimodal microstructure consisting of three main regions: dynamically recrystallized (DRXed) alpha-Mg grains with random orientation; worked alpha-Mg grains with < 1 0 (1) over bar 0 > fiber texture; and fiber-shaped LPSO phase grains. Creep behavior of the extruded alloy shows a high stress exponent of n approximate to 11. Local creep strain distribution in the alloy creeping under 210 MPa is evaluated based on distortion/displacement observed with micro-grid markers. The share contributed to total creep deformation by intra-grain sliding (IGS) in the DRXed and textured grain regions and grain boundary sliding (GBS) is determined methodically in this study. Rates of contribution are similar to 79% and similar to 21% with IGS and GBS, respectively. To be exact, the shares contributed by IGS are similar to 21% and similar to 58% in the DRXed and the fiber-textured grain regions, respectively. The greater part of GBS with small strain occurs in the DRXed grain region, but the rest of GBS trailing large local strain is detected at the grain boundary between the DRXed grain and the worked grain showing a high Schmid factor. The magnitude of the slip-induced GBS that occurs at grain boundaries around the worked grain is dependent on two discrete parameters: angle of grain boundary; and Schmid factor of the worked grain. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Jono, Yuri; Yamasaki, Michiaki; Kawamura, Yoshihito] Kumamoto Univ, Dept Mat Sci, Magnesium Res Ctr, Chuo Ku, Kumamoto 8608555, Japan	Yamasaki, M (reprint author), Kumamoto Univ, Dept Mat Sci, Magnesium Res Ctr, Chuo Ku, 2-39-1 Kurokami, Kumamoto 8608555, Japan.	yamasaki@kumamoto-u.ac.jp			JSPS Core-to-Core Program; MEXT Japan	The authors wish to express their appreciation to Professor Tsuyoshi Mayama at Kumamoto University for his assistance in the calculation of equivalent strain. This work was supported by the JSPS Core-to-Core Program and grants-in-aid for Scientific Research (B) and Scientific Research on Priority Areas "Synchro-LPSO Structures" from MEXT Japan.	Suzuki M, 1998, MAT SCI ENG A-STRUCT, V252, P248, DOI 10.1016/S0921-5093(98)00662-5; Bettles CJ, 2009, MAT SCI ENG A-STRUCT, V505, P6, DOI 10.1016/j.msea.2008.11.004; Koike J, 2003, MATER TRANS, V44, P445, DOI 10.2320/matertrans.44.445; Onorbe E, 2013, METALL MATER TRANS A, V44A, P2869, DOI 10.1007/s11661-013-1628-8; Martin G, 2013, EXP MECH, V53, P205, DOI 10.1007/s11340-012-9628-y; Smola B, 2002, MAT SCI ENG A-STRUCT, V324, P113, DOI 10.1016/S0921-5093(01)01291-6; Nie JF, 2005, SCRIPTA MATER, V53, P1049, DOI 10.1016/j.scriptamat.2005.07.004; Watanabe H, 1999, ACTA MATER, V47, P3753, DOI 10.1016/S1359-6454(99)00253-0; Vostry P, 1999, PHYS STATUS SOLIDI A, V175, P491, DOI 10.1002/(SICI)1521-396X(199910)175:2<491::AID-PSSA491>3.0.CO;2-F; Suzuki M, 2003, SCRIPTA MATER, V48, P997, DOI 10.1016/S1359-6462(02)00590-0; Nie JF, 2012, METALL MATER TRANS A, V43A, P3891, DOI 10.1007/s11661-012-1217-2; Abe E, 2011, PHIL MAG LETT, V91, P690, DOI 10.1080/09500839.2011.609149; Luo ZP, 2000, J MATER SCI LETT, V19, P813, DOI 10.1023/A:1006793411506; Mordike BL, 2001, MAT SCI ENG A-STRUCT, V302, P37, DOI 10.1016/S0921-5093(00)01351-4; Anyanwu IA, 2001, MATER TRANS, V42, P1212, DOI 10.2320/matertrans.42.1212; Smola B, 2004, J ALLOY COMPD, V378, P196, DOI 10.1016/j.jallcom.2003.01.099; Yamasaki M, 2014, SCRIPTA MATER, V78-79, P13, DOI 10.1016/j.scriptamat.2014.01.013; Abe E, 2002, ACTA MATER, V50, P3845, DOI 10.1016/S1359-6454(02)00191-X; Yamasaki M, 2011, ACTA MATER, V59, P3646, DOI 10.1016/j.actamat.2011.02.038; Luo AA, 2002, JOM-J MIN MET MAT S, V54, P42, DOI 10.1007/BF02701073; Martin G, 2013, SCRIPTA MATER, V68, P695, DOI 10.1016/j.scriptamat.2013.01.017; Nishijima M, 2006, MATER TRANS, V47, P2109, DOI 10.2320/matertrans.47.2109; Moreno IP, 2003, SCRIPTA MATER, V48, P1029, DOI 10.1016/S1359-6462(02)00595-X; Maruyama K, 2002, METALL MATER TRANS A, V33, P875, DOI 10.1007/s11661-002-0157-7; Hagihara K, 2013, MATER TRANS, V54, P693, DOI [10.2320/matertrans.M1201208, 10.2320/matertrans.MI201208]; Kim WJ, 2001, ACTA MATER, V49, P3337, DOI 10.1016/S1359-6454(01)00008-8; del Valle JA, 2007, ACTA MATER, V55, P455, DOI 10.1016/j.actamat.2006.08.039; Antion C, 2003, ACTA MATER, V51, P5335, DOI 10.1016/S1359-6454(03)00391-4; Yamasaki M, 2007, ACTA MATER, V55, P6798, DOI 10.1016/j.actamat.2007.08.033; Hagihara K, 2010, ACTA MATER, V58, P6282, DOI 10.1016/j.actamat.2010.07.050; Egusa D, 2012, ACTA MATER, V60, P166, DOI 10.1016/j.actamat.2011.09.030; Nie JF, 2000, ACTA MATER, V48, P1691, DOI 10.1016/S1359-6454(00)00013-6; Yamasaki M, 2013, ACTA MATER, V61, P2065, DOI 10.1016/j.actamat.2012.12.026; VAGARALI SS, 1981, ACTA METALL MATER, V29, P1969, DOI 10.1016/0001-6160(81)90034-1; Pekguleryuz MO, 2003, ADV ENG MATER, V5, P866, DOI 10.1002/adem.200300403; Garces G, 2012, MAT SCI ENG A-STRUCT, V539, P48, DOI 10.1016/j.msea.2012.01.023; Kawamura Y, 2007, MATER TRANS, V48, P2986, DOI 10.2320/matertrans.MER2007142; Kawamura Y, 2001, MATER TRANS, V42, P1172, DOI 10.2320/matertrans.42.1172; Chakrabarty J., 1987, THEORY PLASTICITY; Felippa C.A., 2014, NONLINEAR FINITE ELE; Hagihara K, 2011, MATER TRANS, V52, P1096, DOI 10.2320/matertrans.MC201007; Gao X, 2006, MAT SCI ENG A-STRUCT, V431, P322, DOI 10.1016/j.msea.2006.06.018; Ishida Y., 1967, METAL SCI J, V1, P171; Jono Y, 2013, MATER TRANS, V54, P703, DOI [10.2320/matertrans.M1201218, 10.2320/matertrans.MI201218]; VALIEV RZ, 1983, ACTA METALL MATER, V31, P2121, DOI 10.1016/0001-6160(83)90031-7; Lubliner J., 2008, PLASTICITY THEORY; MCLEAN D, 1971, PHILOS MAG, V23, P467, DOI 10.1080/14786437108216396; Mordike BL, 2002, MAT SCI ENG A-STRUCT, V324, P103, DOI 10.1016/S0921-5093(01)01290-4; Morikawa T, 2010, MATER SCI FORUM, V638-642, P1574, DOI 10.4028/www.scientific.net/MSF.638-642.1574; Onorbe E., 2011, SCRIPTA MATER, V65, P716; Spigarelli S, 2001, MATER SCI TECH SER, V17, P627; Stanford N, 2011, ACTA MATER, V59, P4866, DOI 10.1016/j.actamat.2011.04.028; VAGARALI SS, 1982, ACTA METALL MATER, V30, P1157, DOI 10.1016/0001-6160(82)90009-8; WATANABE T, 1978, PHILOS MAG A, V37, P649; Wei LY, 1996, J MATER SCI, V31, P387, DOI 10.1007/BF01139156; Yamasaki M, 2005, SCRIPTA MATER, V53, P799, DOI 10.1016/j.scriptamat.2005.06.006; Yoshimoto S, 2006, MATER TRANS, V47, P959, DOI 10.2320/matertrans.47.959	57	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-6454	1873-2453		ACTA MATER	Acta Mater.	JAN 1	2015	82						198	211		10.1016/j.actamat.2014.08.050		14	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	AX6FE	WOS:000347017800019		
J	Deutges, M; Barth, HP; Chen, YZ; Borchers, C; Kirchheim, R				Deutges, Martin; Barth, Hans Peter; Chen, Yuzeng; Borchers, Christine; Kirchheim, Reiner			Hydrogen diffusivities as a measure of relative dislocation densities in palladium and increase of the density by plastic deformation in the presence of dissolved hydrogen	ACTA MATERIALIA			English	Article						Palladium; Hydrogen embrittlement; Plastic deformation; Dislocation density; Diffusion	VACANCY FORMATION ENERGIES; REDUCING GRAIN-BOUNDARY; ELECTROCHEMICAL METHODS; SOLUTE SEGREGATION; CELL-FORMATION; METALS; SOLUBILITY; DIFFUSION; FRACTURE; LINE	The effect of dissolved hydrogen on the dislocation density in cold-rolled palladium was investigated in order to provide evidence of a line energy reduction caused by hydrogen dislocation interaction as proposed by the defactant concept. For this issue, palladium samples were electrochemically charged with hydrogen and subsequently cold rolled. Using conventional methods (X-ray diffraction, transmission electron microscopy) and a newly developed diffusion method, it was shown that the dislocation density after deformation increases with increasing hydrogen concentration. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Deutges, Martin; Barth, Hans Peter; Borchers, Christine; Kirchheim, Reiner] Univ Gottingen, Inst Mat Phys, D-37077 Gottingen, Germany; [Chen, Yuzeng] Northwestern Polytech Univ, State Key Lab Solidificat Proc, Xian, Peoples R China; [Kirchheim, Reiner] Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2 CNER, Fukuoka 812, Japan	Deutges, M (reprint author), Univ Gottingen, Inst Mat Phys, Friedrich Hund Pl 1, D-37077 Gottingen, Germany.	mdeutges@ump.gwdg.de	Chen, Yuzeng/F-7002-2013; Borchers, Christine/K-4295-2015	Borchers, Christine/0000-0002-4805-7597	Deutsche Forschungsgemeinschaft [KI-230/34]	The authors are grateful for financial support by the Deutsche Forschungsgemeinschaft (KI-230/34).	BOES N, 1976, J LESS-COMMON MET, V49, P223, DOI 10.1016/0022-5088(76)90037-0; TABATA T, 1983, SCRIPTA METALL MATER, V17, P947, DOI 10.1016/0036-9748(83)90268-5; WEST AJ, 1979, METALL TRANS A, V10, P1675, DOI 10.1007/BF02811700; ALBRECHT J, 1982, METALL TRANS A, V13, P811, DOI 10.1007/BF02642394; GROMA I, 1988, J APPL CRYSTALLOGR, V21, P47, DOI 10.1107/S0021889887009178; Kirchheim R, 2009, INT J MATER RES, V100, P483, DOI 10.3139/146.110065; Kirchheim R, 2007, ACTA MATER, V55, P5129, DOI 10.1016/j.actamat.2007.05.047; Buckley CE, 2001, J APPL CRYSTALLOGR, V34, P119, DOI 10.1107/S0021889800018239; WILLIAMSON GK, 1953, ACTA METALL MATER, V1, P22, DOI 10.1016/0001-6160(53)90006-6; Chen YZ, 2013, ACTA MATER, V61, P3172, DOI 10.1016/j.actamat.2013.02.006; Birnbaum HK, 2003, MRS BULL, V28, P479, DOI 10.1557/mrs2003.143; WILLIAMSON GK, 1956, PHILOS MAG, V1, P34, DOI 10.1080/14786435608238074; Chen YZ, 2013, SCRIPTA MATER, V68, P743, DOI 10.1016/j.scriptamat.2013.01.005; Borchers C, 2008, ADV ENG MATER, V10, P11, DOI 10.1002/adem.200700252; Kirchheim R, 2007, ACTA MATER, V55, P5139, DOI 10.1016/j.actamat.2007.05.033; Ungar T, 1999, PHYS STATUS SOLIDI A, V171, P425, DOI 10.1002/(SICI)1521-396X(199902)171:2<425::AID-PSSA425>3.0.CO;2-W; Maxelon M, 2001, ACTA MATER, V49, P2625, DOI 10.1016/S1359-6454(01)00185-9; Ferreira PJ, 1998, ACTA MATER, V46, P1749, DOI 10.1016/S1359-6454(97)00349-2; HOLT DL, 1970, J APPL PHYS, V41, P3197, DOI 10.1063/1.1659399; Escobar DP, 2011, CORROS SCI, V53, P3166, DOI 10.1016/j.corsci.2011.05.060; ROZENAK P, 1990, ACTA METALL MATER, V38, P2031, DOI 10.1016/0956-7151(90)90070-W; SINGMAN CN, 1984, J CHEM EDUC, V61, P137; KIRCHHEIM R, 1988, PROG MATER SCI, V32, P261, DOI 10.1016/0079-6425(88)90010-2; Barnoush A, 2010, ACTA MATER, V58, P5274, DOI 10.1016/j.actamat.2010.05.057; Katz Y, 2001, ENG FRACT MECH, V68, P619, DOI 10.1016/S0013-7944(00)00119-3; Fukai Y, 2000, J ALLOY COMPD, V313, P121, DOI 10.1016/S0925-8388(00)01195-6; Barnoush A, 2012, SCRIPTA MATER, V66, P414, DOI 10.1016/j.scriptamat.2011.12.004; BIRNBAUM HK, 1994, MAT SCI ENG A-STRUCT, V176, P191, DOI 10.1016/0921-5093(94)90975-X; Cizek J, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.224106; Cizek J, 2007, PHYS STATUS SOLIDI C, V4, P3485, DOI 10.1002/pssc.200675739; Deutges M, 2013, SCRIPTA MATER, V68, P71, DOI 10.1016/j.scriptamat.2012.09.020; Gibbs J. W, 1876, T CONNECTICUT ACADEM, VIII, P108; Hahner P, 1996, ACTA MATER, V44, P2345, DOI 10.1016/1359-6454(95)00364-9; Hirth J., 1968, THEORY DISLOCATIONS; Holt D.L., 1970, SEC INT C STRENGTH M, P477; Kheradmand N, 2012, PHILOS MAG, V92, P3216, DOI 10.1080/14786435.2012.690939; KIRCHHEIM R, 1981, ACTA METALL MATER, V29, P835, DOI 10.1016/0001-6160(81)90126-7; Kirchheim R, 2001, PHYS SCRIPTA, VT94, P58, DOI 10.1238/Physica.Topical.094a00058; KIRCHHEIM R, 1985, J NON-CRYST SOLIDS, V70, P323, DOI 10.1016/0022-3093(85)90104-8; ROBERTSON IM, 1986, ACTA METALL MATER, V34, P353, DOI 10.1016/0001-6160(86)90071-4; Vokl J., 1981, HYPERFINE INTERACT, V8, P631, DOI 10.1007/BF01037538; Wilkens M., 1970, Physica Status Solidi A, V2, DOI 10.1002/pssa.19700020224; ZUCHNER H, 1984, J LESS-COMMON MET, V101, P363, DOI 10.1016/0022-5088(84)90112-7; ZUCHNER H, 1970, Z NATURFORSCH PT A, VA 25, P1490	44	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-6454	1873-2453		ACTA MATER	Acta Mater.	JAN 1	2015	82						266	274		10.1016/j.actamat.2014.09.013		9	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	AX6FE	WOS:000347017800025		
J	Liu, J; Sepehri-Amin, H; Ohkubo, T; Hioki, K; Hattori, A; Schrefl, T; Hono, K				Liu, J.; Sepehri-Amin, H.; Ohkubo, T.; Hioki, K.; Hattori, A.; Schrefl, T.; Hono, K.			Grain size dependence of coercivity of hot-deformed Nd-Fe-B anisotropic magnets	ACTA MATERIALIA			English	Article						Nd-Fe-B; Permanent magnet; Coercivity; Microstructure; Micromagnetic simulations	PERMANENT-MAGNETS; MAGNETIZATION REVERSAL; SINTERED MAGNETS; NDFEB MAGNETS; PARTICLE-SIZE; MICROSTRUCTURE; ENHANCEMENT; POWDERS; ORIGIN; PR	The dependence of the coercivity of hot-deformed anisotropic Nd-Fe-B magnets on grain size has been studied by processing the magnets at different temperatures. Higher coercivity was obtained in fine-grained magnets processed at lower temperature (700 degrees C), in which intergranular phases formed uniformly along the grain boundaries. On the other hand, large Nd-rich triple-junction phases were frequently observed in the larger grain-sized magnets processed at higher temperature (900 degrees C). Three-dimensional atom probe analyses showed that the Nd content in the intergranular phase decreased as the processing temperature increased. The origin of the coercivity difference in these hot-deformed magnets processed at different temperatures is discussed based on micromagnetic analysis of the observed microstructures complemented with finite-element micromagnetic simulations. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Liu, J.; Sepehri-Amin, H.; Ohkubo, T.; Hono, K.] Natl Inst Mat Sci, Elements Strategy Initiat Ctr Magnet Mat, Tsukuba, Ibaraki 3050047, Japan; [Liu, J.; Hono, K.] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058577, Japan; [Hioki, K.; Hattori, A.] Daido Steel Co Ltd, Nagoya, Aichi 4578545, Japan; [Schrefl, T.] Danube Univ Krems, Ctr Integrated Sensor Syst, Krems, Austria	Hono, K (reprint author), Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan.	kazuhiro.hono@nims.go.jp	Hono, Kazuhiro/B-9202-2008	Hono, Kazuhiro/0000-0001-7367-0193	Japan Science Technology Agency, CREST	This work was in part supported by Japan Science Technology Agency, CREST.	Akiya T, 2014, J APPL PHYS, V115, DOI 10.1063/1.4869062; CROAT JJ, 1984, APPL PHYS LETT, V44, P148, DOI 10.1063/1.94584; Uestuener K, 2006, IEEE T MAGN, V42, P2897, DOI 10.1109/TMAG.2006.879889; LEE RW, 1985, IEEE T MAGN, V21, P1958, DOI 10.1109/TMAG.1985.1064031; TSAI DS, 1987, IEEE T MAGN, V23, P3607, DOI 10.1109/TMAG.1987.1065517; LEE RW, 1985, APPL PHYS LETT, V46, P790, DOI 10.1063/1.95884; Akiya T, 2014, SCRIPTA MATER, V81, P48, DOI 10.1016/j.scriptamat.2014.03.002; MISHRA RK, 1987, J APPL PHYS, V62, P967, DOI 10.1063/1.339709; CROAT JJ, 1984, J APPL PHYS, V55, P2078, DOI 10.1063/1.333571; RAMESH R, 1988, J APPL PHYS, V64, P6416, DOI 10.1063/1.342055; KRONMULLER H, 1987, PHYS STATUS SOLIDI B, V144, P385, DOI 10.1002/pssb.2221440134; Sepehri-Amin H, 2013, ACTA MATER, V61, P6622, DOI 10.1016/j.actamat.2013.07.049; NOTHNAGEL P, 1991, J MAGN MAGN MATER, V101, P379, DOI 10.1016/0304-8853(91)90786-A; MISHRA RK, 1986, APPL PHYS LETT, V48, P733, DOI 10.1063/1.96704; Li WF, 2009, J MAGN MAGN MATER, V321, P1100, DOI 10.1016/j.jmmm.2008.10.032; Sepehri-Amin H, 2013, SCRIPTA MATER, V68, P167, DOI 10.1016/j.scriptamat.2012.10.005; Liu J, 2013, ACTA MATER, V61, P5387, DOI 10.1016/j.actamat.2013.05.027; Sepehri-Amin H, 2014, SCRIPTA MATER, V89, P29, DOI 10.1016/j.scriptamat.2014.06.020; Schrefl T, 1998, J APPL PHYS, V83, P6262, DOI 10.1063/1.367666; Cui WB, 2011, ACTA MATER, V59, P7768, DOI 10.1016/j.actamat.2011.09.006; Hioki K., 2013, J MAGN SOC JPN; Hock S., 1988, THESIS U STUTTGART, P118; Hock S, 1988, THESIS U STUTTGART; Hono K, 2012, SCRIPTA MATER, V67, P530, DOI 10.1016/j.scriptamat.2012.06.038; Kirchner A, 2004, J ALLOY COMPD, V365, P286, DOI 10.1016/S0925-8388(03)00661-3; KRENTZ JE, 1991, J APPL PHYS, V70, P6474, DOI 10.1063/1.349935; Sagawa M., 2012, 22 INT WORKSH RAR EA; Sepehri-Amin H, 2010, SCRIPTA MATER, V63, P1124, DOI 10.1016/j.scriptamat.2010.08.021; Thielsch J, 2012, J APPL PHYS, V111, DOI 10.1063/1.4712635; Une Y., 2010, 21 INT WORKSH RAR EA; Volkov VV, 1999, J APPL PHYS, V85, P3254, DOI 10.1063/1.369668	31	4	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-6454	1873-2453		ACTA MATER	Acta Mater.	JAN 1	2015	82						336	343		10.1016/j.actamat.2014.09.021		8	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	AX6FE	WOS:000347017800032		
J	Louzguine-Luzgin, DV; Bazlov, AI; Ketov, SV; Greer, AL; Inoue, A				Louzguine-Luzgin, D. V.; Bazlov, A. I.; Ketov, S. V.; Greer, A. L.; Inoue, A.			Crystal growth limitation as a critical factor for formation of Fe-based bulk metallic glasses	ACTA MATERIALIA			English	Article						Bulk metallic glasses; Crystallization; Growth-control; Strain; Diffraction	FORMING ABILITY; AMORPHOUS-ALLOYS; MAGNETIC-PROPERTIES; LATTICE STRAIN; CRYSTALLIZATION; STRENGTH; DIFFUSION; CORROSION; STEELS; SIZE	In the present work we study the formation mechanism and crystallization behavior of Fe-based bulk metallic glasses influenced by the addition of rare-earth elements. Samples are characterized by conventional X-ray diffractometry, optical microscopy, and high-resolution fielde-mission-gun scanning and transmission electron microscopy. In the rare-earth-containing alloys, bulk metallic glasses are formed with populations of quenched-in nuclei. Consequently, crystallization on isothermal annealing occurs without any incubation period. This behavior, not typical of bulk metallic glasses in general, implies that in the rare-earth-containing alloys glass formation is possible only because of restricted crystal growth: both on cooling from the molten and on heating from the glassy state, growth of the primary chi-Fe36Cr12Mo10 crystals is too slow to be significant on a reasonable timescale. The low growth rate is connected with large inhomogeneous strain in the growing nanoparticles, while nucleation of eutectic colonies is hampered by slow diffusion of a rare-earth alloying element. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Louzguine-Luzgin, D. V.; Bazlov, A. I.; Ketov, S. V.; Greer, A. L.] Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Bazlov, A. I.] Natl Univ Sci & Technol MISiS, Moscow 119049, Russia; [Greer, A. L.] Univ Cambridge, Dept Mat Sci & Met, Cambridge CB3 0FS, England; [Inoue, A.] Josai Int Univ, Int Inst Green Mat, Togane 2838555, Japan; [Inoue, A.] Tianjin Univ, Sch Mat Sci & Engn, Tianjin 300072, Peoples R China; [Inoue, A.] King Abdulaziz Univ, Dept Phys, Jeddah 22254, Saudi Arabia	Louzguine-Luzgin, DV (reprint author), Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan.	dml@wpi-aimr.tohoku.ac.jp	LOUZGUINE, Dmitri/D-2492-2010; Inoue, Akihisa/E-5271-2015; Ketov, Sergey/G-5558-2011	LOUZGUINE, Dmitri/0000-0001-5716-4987; 	World Premier International Research Center Initiative (WPI), MEXT, Japan; Ministry of Education and Science of the Russian Federation in the framework of Increase Competitiveness Program of NUST "MISiS" [K2-2014-013]	This work was supported by the World Premier International Research Center Initiative (WPI), MEXT, Japan, and in part by the Ministry of Education and Science of the Russian Federation in the framework of Increase Competitiveness Program of NUST "MISiS" (No. K2-2014-013).	Amiya K, 2008, REV ADV MATER SCI, V18, P27; Mittemeijer EJ, 2008, Z KRISTALLOGR, V223, P552, DOI 10.1524/zkri.2008.1213; GREER AL, 1995, SCIENCE, V267, P1947, DOI 10.1126/science.267.5206.1947; Johnson WL, 1999, MRS BULL, V24, P42; Inoue A, 2000, ACTA MATER, V48, P279, DOI 10.1016/S1359-6454(99)00300-6; Suryanarayana C, 2013, INT MATER REV, V58, P131, DOI 10.1179/1743280412Y.0000000007; Inoue A, 2004, ACTA MATER, V52, P4093, DOI 10.1016/j.actamat.2004.05.022; Johnson WL, 2011, SCIENCE, V332, P828, DOI 10.1126/science.1201362; Schroers J, 2001, ACTA MATER, V49, P2773, DOI 10.1016/S1359-6454(01)00159-8; Perepezko JH, 2004, PROG MATER SCI, V49, P263, DOI 10.1016/S0079-6425(03)00028-8; Faupel F, 2003, REV MOD PHYS, V75, P237, DOI 10.1103/RevModPhys.75.237; Pang SJ, 2001, MATER T JIM, V42, P376, DOI 10.2320/matertrans.42.376; Gu XJ, 2007, J MATER RES, V22, P344, DOI 10.1557/JMR.2007.0036; TURNBULL D, 1969, CONTEMP PHYS, V10, P473, DOI 10.1080/00107516908204405; CHEN HS, 1980, REP PROG PHYS, V43, P353, DOI 10.1088/0034-4885/43/4/001; Nitta H, 2006, ACTA MATER, V54, P2833, DOI 10.1016/j.actamat.2006.02.020; Duarte MJ, 2014, ACTA MATER, V71, P20, DOI 10.1016/j.actamat.2014.02.027; Sha G, 2003, ACTA MATER, V51, P1883, DOI 10.1016/S1359-6454(02)00595-5; Ponnambalam V, 2004, J MATER RES, V19, P1320, DOI [10.1557/JMR.2004.0176, 10.1557/jmr.2004.0176]; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Louzguine-Luzgin DV, 2013, INTERMETALLICS, V33, P67, DOI 10.1016/j.intermet.2012.09.019; Inoue A, 1995, MATER T JIM, V36, P1427; [Anonymous], INT CTR DIFFRACTION; Amiya K, 2006, MATER TRANS, V47, P1615, DOI 10.2320/matertrans.47.1615; Duarte MJ, 2013, SCIENCE, V341, P372, DOI 10.1126/science.1230081; Lu ZP, 2003, APPL PHYS LETT, V83, P2581, DOI 10.1063/1.1614833; Shen TD, 2001, ACTA MATER, V49, P837, DOI 10.1016/S1359-6454(00)00365-7; Zhang T, 2007, MATER TRANS, V48, P1157, DOI 10.2320/matertrans.48.1157; Baser T.A., 2006, J ALLOY COMPD, V190, P14569; Chen QJ, 2007, J ALLOY COMPD, V427, P190, DOI 10.1016/j.jallcom.2006.03.013; Gale W.F., 2004, SMITHELLS METALS REF, Veight, P4; GREER AL, 1982, ACTA METALL MATER, V30, P171, DOI 10.1016/0001-6160(82)90056-6; Gu XJ, 2008, ACTA MATER, V56, P88, DOI 10.1016/j.actamat.2007.09.011; Hin C, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.134118; Hirata A, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.144205; Inoue A, 1998, METALL MATER TRANS A, V29, P1779, DOI 10.1007/s11661-998-0001-9; KASPER JS, 1954, ACTA METALL MATER, V2, P456, DOI 10.1016/0001-6160(54)90066-8; Lad'yanov VI, 2010, J NON-CRYST SOLIDS, V356, P65, DOI 10.1016/j.jnoncrysol.2009.10.011; Lai J.K., 1979, WELD RES SUPPL WELD, V1, P1; Louzguine DV, 2002, J MATER RES, V17, P1014, DOI 10.1557/JMR.2002.0149; Louzguine-Luzgin DV, 2009, J MATER RES, V24, P1886, DOI 10.1557/JMR.2009.0219; Louzguine-Luzgin DV, 2009, INTERMETALLICS, V17, P477, DOI 10.1016/j.intermet.2008.12.008; Lyasotsky IV, 2014, J ALLOY COMPD, V586, pS20, DOI 10.1016/j.jallcom.2013.03.112; Nishiyama N, 1999, ACTA MATER, V47, P1487, DOI 10.1016/S1359-6454(99)00030-0; Purushotham E, 2013, B MATER SCI, V36, P973, DOI 10.1007/s12034-013-0553-1; Sourmail T, 2001, MATER SCI TECH SER, V17, P1; Spaepen F., 1976, P 2 INT C RAP QUENCH, P205; Takasawa K, 2002, MATER TRANS, V43, P178, DOI 10.2320/matertrans.43.178; Tian HH, 1999, PHILOS MAG A, V79, P1769; Zhang T, 2011, CHINESE SCI BULL, V56, P3972, DOI 10.1007/s11434-011-4765-8	50	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-6454	1873-2453		ACTA MATER	Acta Mater.	JAN 1	2015	82						396	402		10.1016/j.actamat.2014.09.025		7	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	AX6FE	WOS:000347017800037		
J	Aoki, N; Murray, ME; Ogaki, K; Fujioka, S; Rutherford, NJ; Rademakers, R; Ross, OA; Dickson, DW				Aoki, Naoya; Murray, Melissa E.; Ogaki, Kotaro; Fujioka, Shinsuke; Rutherford, Nicola J.; Rademakers, Rosa; Ross, Owen A.; Dickson, Dennis W.			Hippocampal sclerosis in Lewy body disease is a TDP-43 proteinopathy similar to FTLD-TDP Type A	ACTA NEUROPATHOLOGICA			English	Article						Hippocampal sclerosis; Lewy body disease; Neuropathology; TDP-43; TMEM106B	FRONTOTEMPORAL LOBAR DEGENERATION; ALZHEIMERS-DISEASE; PROGRANULIN GENE; RISK-FACTOR; DEMENTIA; PATHOLOGY; FEATURES; MUTATIONS; BODIES; NEUROPATHOLOGY	Hippocampal sclerosis (HpScl) is frequent in frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP), but it also occurs in dementia of the elderly with or without accompanying Alzheimer type pathology. HpScl has been hypothesized to be a neurodegenerative process given its association with TDP-43 pathology, but this is still controversial. TDP-43 pathology is found in Lewy body disease (LBD), but no study has focused on the pathologic and genetic characteristics of HpScl in LBD. We found HpScl in 5.2 % of 669 LBD cases (289 transitional and 380 diffuse). Older age, higher Braak neurofibrillary tangle (NFT) stage, and presence of TDP-43 pathology were associated with HpScl. There was no difference in the frequency of HpScl between transitional and diffuse LBD, suggesting that Lewy-related pathology appears to have no direct association with HpScl. All HpScl cases had TDP-43 pathology consistent with Type A pattern. HpScl cases harbored genetic variation in TMEM106B that has been previously associated with FTLD-TDP. Interestingly, the severity of TDP-43-positive fine neurites in CA1 sector, a possible pathologic precursor of HpScl, was associated with the TMEM106B variant. These results demonstrate HpScl in LBD is a TDP-43 proteinopathy and is similar to FTLD-TDP Type A. Furthermore, a subset of LBD cases without HpScl ("pre-HpScl") had similar pathologic and genetic characteristics to typical HpScl, suggesting that the spectrum of HpScl pathology may be wider than previously thought. Some cases with many extracellular NFTs also had a similar profile. We suggest that HpScl is "masked" in these cases.	[Aoki, Naoya; Murray, Melissa E.; Ogaki, Kotaro; Fujioka, Shinsuke; Rutherford, Nicola J.; Rademakers, Rosa; Ross, Owen A.; Dickson, Dennis W.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Fujioka, Shinsuke] Fukuoka Univ, Dept Neurol, Fukuoka 81401, Japan; [Rutherford, Nicola J.] Univ Florida, McKnight Brain Inst, Ctr Translat Res Neurodegenerat Dis, Dept Neurosci, Gainesville, FL 32610 USA	Dickson, DW (reprint author), Mayo Clin, Dept Neurosci, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	dickson.dennis@mayo.edu	Murray, Melissa/C-2763-2015; 	Murray, Melissa/0000-0001-7379-2545	Uehara Memorial Foundation; Mangurian Foundation; NIH [P50NS72187, P50AG16574, R01NS076471]	We are grateful to all patients, family members, and caregivers who agreed to brain donation; without their donation these studies would have been impossible. We also acknowledge expert technical assistance of Linda Rousseau and Virginia Phillips for histology and Monica Castanedes-Casey for immunohistochemistry. This research was supported in part by a research Grant from the Uehara Memorial Foundation, The Mangurian Foundation, and NIH Grant P50NS72187, P50AG16574, and R01NS076471.	Ala TA, 2000, NEUROLOGY, V54, P843; Higashi S, 2007, BRAIN RES, V1184, P284, DOI 10.1016/j.brainres.2007.09.048; Josephs KA, 2009, ACTA NEUROPATHOL, V118, P349, DOI 10.1007/s00401-009-0547-7; Pao WC, 2011, ALZ DIS ASSOC DIS, V25, P364, DOI 10.1097/WAD.0b013e31820f8f50; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239; DICKSON DW, 1994, ACTA NEUROPATHOL, V88, P212; Finch N, 2011, NEUROLOGY, V76, P467, DOI 10.1212/WNL.0b013e31820a0e3b; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106; Zarow C, 2008, CURR NEUROL NEUROSCI, V8, P363, DOI 10.1007/s11910-008-0057-3; Nelson PT, 2011, BRAIN, V134, P1506, DOI 10.1093/brain/awr053; Nelson PT, 2013, ACTA NEUROPATHOL, V126, P161, DOI 10.1007/s00401-013-1154-1; Mackenzie IRA, 2007, ACTA NEUROPATHOL, V114, P49, DOI 10.1007/s00401-007-0223-8; Mackenzie IRA, 2011, ACTA NEUROPATHOL, V122, P111, DOI 10.1007/s00401-011-0845-8; Nelson PT, 2014, ACTA NEUROPATHOL, V127, P825, DOI 10.1007/s00401-014-1282-2; Arai T, 2009, ACTA NEUROPATHOL, V117, P125, DOI 10.1007/s00401-008-0480-1; Josephs KA, 2007, J NEUROPATH EXP NEUR, V66, P142, DOI 10.1097/nen.0b013e31803020cf; Rutherford NJ, 2012, NEUROLOGY, V79, P717, DOI 10.1212/WNL.0b013e318264e3ac; Amador-Ortiz C, 2007, ANN NEUROL, V61, P435, DOI 10.1002/ana.21154; Dickson DW, 2010, NEURODEGENER DIS, V7, P170, DOI 10.1159/000289231; Murray ME, 2014, ACTA NEUROPATHOL, V128, P411, DOI 10.1007/s00401-014-1302-2; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Josephs KA, 2014, ACTA NEUROPATHOL, V127, P811, DOI 10.1007/s00401-014-1269-z; Yokota O, 2010, ACTA NEUROPATHOL, V120, P789, DOI 10.1007/s00401-010-0731-9; Nakashima-Yasuda H, 2007, ACTA NEUROPATHOL, V114, P221, DOI 10.1007/s00401-007-0261-2; Murray ME, 2013, ACTA NEUROPATHOL, V126, P545, DOI 10.1007/s00401-013-1161-2; Rademakers R, 2008, HUM MOL GENET, V17, P3631, DOI 10.1093/hmg/ddn257; Hatanpaa KJ, 2008, J NEUROPATH EXP NEUR, V67, P271, DOI 10.1097/NEN.0b013e31816a12a6; Kosaka K, 2014, PSYCHIAT CLIN NEUROS, V68, P391, DOI 10.1111/pcn.12179; Kosaka K, 2000, NEUROPATHOLOGY, V20, pS73; Lin WL, 2009, J NEUROPATH EXP NEUR, V68, P1167, DOI 10.1097/NEN.0b013e3181baacec; Mackenzie IRA, 2006, BRAIN, V129, P3081, DOI 10.1093/brain/awl271	32	6	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0001-6322	1432-0533		ACTA NEUROPATHOL	Acta Neuropathol.	JAN	2015	129	1					53	64		10.1007/s00401-014-1358-z		12	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	AX9UN	WOS:000347247600004		
J	Matsubara, S				Matsubara, Shigeki			Perimortem cesarean section: three possible procedures to overcome atonic bleeding after successful resuscitation	ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA			English	Letter							PLACENTA PREVIA; HEMORRHAGE		Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi, Japan	Matsubara, S (reprint author), Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi, Japan.	matsushi@jichi.ac.jp					Matsubara S, 2013, ACTA OBSTET GYN SCAN, V92, P378, DOI 10.1111/aogs.12077; Matsubara S, 2014, ARCH GYNECOL OBSTET, V290, P613, DOI 10.1007/s00404-014-3380-8; Drukker L, 2014, ACTA OBSTET GYN SCAN, V93, P965, DOI 10.1111/aogs.12464; Matsubara S, 2014, J CLIN CASE REP, V4, P356; Matsubara S, 2014, AUST NZ J OBSTET GYN, V54, P283, DOI 10.1111/ajo.12184; Matsubara S, 2013, ARCH GYNECOL OBSTET, V287, P389, DOI 10.1007/s00404-012-2513-1	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6349	1600-0412		ACTA OBSTET GYN SCAN	Acta Obstet. Gynecol. Scand.	JAN	2015	94	1					121	121		10.1111/aogs.12501		1	Obstetrics & Gynecology	Obstetrics & Gynecology	AX1JS	WOS:000346704100023		
J	Drack, M; Graz, I; Sekitani, T; Someya, T; Kaltenbrunner, M; Bauer, S				Drack, Michael; Graz, Ingrid; Sekitani, Tsuyoshi; Someya, Takao; Kaltenbrunner, Martin; Bauer, Siegfried			An Imperceptible Plastic Electronic Wrap	ADVANCED MATERIALS			English	Article							25TH ANNIVERSARY ARTICLE; STRETCHABLE ELECTRONICS; HIGH-PERFORMANCE; THIN-FILM; SKIN; TRANSPARENT; ULTRATHIN; DESIGN; SENSORS; TRANSISTORS		[Drack, Michael; Graz, Ingrid; Kaltenbrunner, Martin; Bauer, Siegfried] Johannes Kepler Univ Linz, Dept Soft Matter Phys, A-4040 Linz, Austria; [Sekitani, Tsuyoshi; Someya, Takao] Univ Tokyo, Bunkyo Ku, Tokyo 1138656, Japan; [Sekitani, Tsuyoshi; Someya, Takao] Japan Sci & Technol Agcy JST, Exploratory Res Adv Technol ERATO, Bunkyo Ku, Tokyo 1130032, Japan	Drack, M (reprint author), Johannes Kepler Univ Linz, Dept Soft Matter Phys, Altenbergerstr 69, A-4040 Linz, Austria.	Michael.Drack@jku.at	Bauer, Siegfried/A-2354-2009; Kaltenbrunner, Martin/G-8743-2012; Graz, Ingrid/A-7994-2011	Kaltenbrunner, Martin/0000-0002-7247-9183; Graz, Ingrid/0000-0001-7205-4161	Austrian Science Fund [FWFP22912-N20]; COST [MP1003]; ERC Advanced Research Grant "Soft Map"; JST Someya Bio-Harmonized ERATO grant	This work partially supported by the Austrian Science Fund (FWFP22912-N20), by COST in the framework of ESNAM (MP1003), and by the ERC Advanced Research Grant "Soft Map". The work in Tokyo was supported by the JST Someya Bio-Harmonized ERATO grant. The authors thank Klaus Haselgrubler and Gunther Hesser for their help with the SEM images, Wolfgang Hilber for Cu sample preparation, and Stefan Schausberger for help with experimental setups.	Khang DY, 2006, SCIENCE, V311, P208, DOI 10.1126/science.1121401; White MS, 2013, NAT PHOTONICS, V7, P811, DOI [10.1038/nphoton.2013.188, 10.1038/NPHOTON.2013.188]; Robinson AP, 2011, LANGMUIR, V27, P4279, DOI 10.1021/la103213n; Rosset S, 2013, APPL PHYS A-MATER, V110, P281, DOI 10.1007/s00339-012-7402-8; Cherenack K, 2012, J APPL PHYS, V112, DOI 10.1063/1.4742728; Bauer S, 2014, ADV MATER, V26, P149, DOI 10.1002/adma.201303349; Keplinger C, 2013, SCIENCE, V341, P984, DOI 10.1126/science.1240228; Lipomi DJ, 2012, CHEM MATER, V24, P373, DOI 10.1021/cm203216m; Ware T, 2013, POLYM REV, V53, P108, DOI 10.1080/15583724.2012.751924; Park M, 2014, NANO TODAY, V9, P244, DOI 10.1016/j.nantod.2014.04.00; Hammock ML, 2013, ADV MATER, V25, P5997, DOI 10.1002/adma.201302240; Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/nmat2745, 10.1038/NMAT2745]; Kaltenbrunner M, 2013, NATURE, V499, P458, DOI 10.1038/nature12314; Bettinger CJ, 2010, ADV MATER, V22, P651, DOI 10.1002/adma.200902322; Liang JJ, 2014, ACS NANO, V8, P1590, DOI 10.1021/nn405887k; Lacour SP, 2005, P IEEE, V93, P1459, DOI 10.1109/JPROC.2005.851502; Zang JF, 2012, J MECH PHYS SOLIDS, V60, P1265, DOI 10.1016/j.jmps.2012.03.009; Sekitani T, 2008, SCIENCE, V321, P1468, DOI 10.1126/science.1160309; Webb RC, 2013, NAT MATER, V12, P938, DOI [10.1038/nmat3755, 10.1038/NMAT3755]; Irimia-Vladu M, 2010, ADV FUNCT MATER, V20, P4069, DOI 10.1002/adfm.201001031; Hwang SW, 2013, ADV FUNCT MATER, V23, P4087, DOI 10.1002/adfm.201300127; Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157; Xu S, 2014, SCIENCE, V344, P70, DOI 10.1126/science.1250169; Wagner S, 2012, MRS BULL, V37, P207, DOI 10.1557/mrs.2012.37; Tao H, 2012, ADV MATER, V24, P1067, DOI 10.1002/adma.201103814; Lipomi DJ, 2011, NAT NANOTECHNOL, V6, P788, DOI [10.1038/nnano.2011.184, 10.1038/NNANO.2011.184]; Kim YJ, 2013, J MATER CHEM B, V1, P3781, DOI 10.1039/c3tb20183j; Zhang YH, 2013, SOFT MATTER, V9, P8062, DOI 10.1039/c3sm51360b; Viventi J, 2011, NAT NEUROSCI, V14, P1599, DOI 10.1038/nn.2973; Graz IM, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3076103; Brosteaux D, 2007, IEEE ELECTR DEVICE L, V28, P552, DOI 10.1109/LED.2007.897887; Robinson A, 2014, J APPL PHYS, V115, DOI 10.1063/1.4871279; Zang JF, 2013, NAT MATER, V12, P321, DOI [10.1038/nmat3542, 10.1038/NMAT3542]; Hwang SW, 2014, ADV MATER, V26, P3905, DOI 10.1002/adma.201306050; Lee MS, 2013, NANO LETT, V13, P2814, DOI 10.1021/nl401070p; Jablonski M, 2013, MICROELECTRON RELIAB, V53, P956, DOI 10.1016/j.microrel.2013.04.002; Axisa F., 2007, 29 ANN INT C IEEE EN, P5687, DOI [10.1109/IEMBS.2007.4353637, DOI 10.1109/IEMBS.2007.4353637]; Cheng HY, 2014, INT J SOLIDS STRUCT, V51, P3113, DOI 10.1016/j.ijsolstr.2014.05.012; Graz IM, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3570661; Ho J, 2010, IEEE ELECTR INSUL M, V26, P20, DOI 10.1109/MEI.2010.5383924; Kaltenbrunner M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1772; Qi L., 2014, J INT COUNCIL ELECT, V4, P1; Rogers J. A., 2014, MRS BULL, V39, P514; Xu LZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4329	44	8	8	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0935-9648	1521-4095		ADV MATER	Adv. Mater.	JAN	2015	27	1					34	40		10.1002/adma.201403093		7	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	AX9RL	WOS:000347239600004		
J	Ando, M; Kehoe, TB; Yoneya, M; Ishii, H; Kawasaki, M; Duffy, CM; Minakata, T; Phillips, RT; Sirringhaus, H				Ando, Masahiko; Kehoe, Tom B.; Yoneya, Makoto; Ishii, Hiroyuki; Kawasaki, Masahiro; Duffy, Claudia M.; Minakata, Takashi; Phillips, Richard T.; Sirringhaus, Henning			Evidence for Charge-Trapping Inducing Polymorphic Structural-Phase Transition in Pentacene	ADVANCED MATERIALS			English	Article							THIN-FILM TRANSISTORS; ORGANIC SEMICONDUCTORS; TRANSPORT		[Ando, Masahiko; Kawasaki, Masahiro] Hitachi Ltd, Cent Res Lab, Ibaraki 3191292, Japan; [Kehoe, Tom B.; Duffy, Claudia M.; Phillips, Richard T.; Sirringhaus, Henning] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; [Yoneya, Makoto] Natl Inst Adv Ind Sci & Technol, Nanosyst Res Inst, Tsukuba, Ibaraki 3058568, Japan; [Ishii, Hiroyuki] Univ Tsukuba, Inst Appl Phys, Tsukuba, Ibaraki 3058573, Japan; [Ishii, Hiroyuki] Univ Tsukuba, Tsukuba Res Ctr Interdisciplinary Mat Sci, Tsukuba, Ibaraki 3058573, Japan; [Minakata, Takashi] Asahi Kasei Corp, R&D Ctr, Fuji, Shizuoka, Japan	Ando, M (reprint author), Hitachi Ltd, Cent Res Lab, 7-1-1 Omika, Ibaraki 3191292, Japan.	masahiko.ando.ph@hitachi.com	Yoneya, Makoto/J-4182-2015	Yoneya, Makoto/0000-0002-4727-2498	EPSRC/Cambridge Integrated Knowledge Centre; Hitachi; EPSRC; PRESTO "Molecular technology and creation of new functions"	The authors thank Prof. Richard Friend of the Cavendish Laboratory and Dr. D. Williams of Hitachi Cambridge Laboratory for their continuous support. They also thank the EPSRC/Cambridge Integrated Knowledge Centre for financial support (ROOT project). T.B.K. and C.M.D. thank Hitachi for funding. R.T.P. acknowledges EPSRC support. H.I. thanks JST-PRESTO "Molecular technology and creation of new functions" for financial support. M. A., T. B. K., and M. Y. thank Prof. Alberto Girlando of Parma University for fruitful discussion.	Troisi A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.086601; Oxborrow M, 2012, NATURE, V488, P353, DOI 10.1038/nature11339; Minemawari H, 2011, NATURE, V475, P364, DOI 10.1038/nature10313; Yoneya M, 2010, J MATER CHEM, V20, P10397, DOI 10.1039/c0jm01577f; Duffy CM, 2008, CHEM MATER, V20, P7252, DOI 10.1021/cm801689f; ANDERSON PW, 1958, PHYS REV, V109, P1492, DOI 10.1103/PhysRev.109.1492; Chang JF, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.066601; Heim T, 2004, NANO LETT, V4, P2145, DOI 10.1021/nl0487673; Siegrist T, 2007, ADV MATER, V19, P2079, DOI 10.1002/adma.200602072; Sirringhaus H, 2009, ADV MATER, V21, P3859, DOI 10.1002/adma.200901136; POWELL MJ, 1989, APPL PHYS LETT, V54, P1323, DOI 10.1063/1.100704; Valeev EF, 2006, J AM CHEM SOC, V128, P9882, DOI 10.1021/ja061827h; Troisi A, 2006, J PHYS CHEM A, V110, P4065, DOI 10.1021/jp055432g; Brillante A, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.195308; Germs WC, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.016601; Brillante A, 2005, ADV MATER, V17, P2549, DOI 10.1002/adma.200501350; Ciuchi S, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.081202; Eheler B., 2012, NANO LETT, V12, P1053; Hallam T, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/2/025203; Hallam T, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.256803; Ishii H, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.245206; Lang DV, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.086802; Park CB, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3680248; Picon JD, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.235106; Sirringhaus H, 2012, PHYS STATUS SOLIDI B, V249, P1655, DOI 10.1002/pssb.201248143; Tello M, 2008, ADV FUNCT MATER, V18, P3907, DOI 10.1002/adfm.200800009; Troisi A, 2005, CHEM MATER, V17, P5024, DOI 10.1021/cm051150h; Unge M, 2003, SYNTHETIC MET, V139, P239, DOI 10.1016/S0379-6779(03)00125-5; Yuan YB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4005	29	3	3	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0935-9648	1521-4095		ADV MATER	Adv. Mater.	JAN	2015	27	1					122	129		10.1002/adma.201403556		8	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	AX9RL	WOS:000347239600017		
J	Yamamoto, K; Watanabe, K; Kikuchi, Y; Oka, S; Gatanaga, H				Yamamoto, Kei; Watanabe, Koji; Kikuchi, Yoshimi; Oka, Shinichi; Gatanaga, Hiroyuki			Long-Term Functional Prognosis of Patients with HIV-Associated Progressive Multifocal Leukoencephalopathy in the Era of Combination ART	AIDS PATIENT CARE AND STDS			English	Letter							ACTIVE ANTIRETROVIRAL THERAPY; CLINICAL-COURSE; HAART; IMPROVES		[Yamamoto, Kei; Watanabe, Koji; Kikuchi, Yoshimi; Oka, Shinichi; Gatanaga, Hiroyuki] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo 1628655, Japan; [Oka, Shinichi; Gatanaga, Hiroyuki] Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan	Gatanaga, H (reprint author), Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	higatana@acc.ncgm.go.jp					Albrecht H, 1998, AIDS, V12, P1149, DOI 10.1097/00002030-199810000-00006; Khanna N, 2009, CLIN INFECT DIS, V48, P1459, DOI 10.1086/598335; Engsig FN, 2009, J INFECT DIS, V199, P77, DOI 10.1086/595299; Clifford DB, 1999, NEUROLOGY, V52, P623; De Luca A, 2008, AIDS, V22, P1759, DOI 10.1097/QAD.0b013e32830a5043; Cinque P, 2009, LANCET INFECT DIS, V9, P625, DOI 10.1016/S1473-3099(09)70226-9; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Lima MA, 2010, J NEUROL NEUROSUR PS, V81, P1288, DOI 10.1136/jnnp.2009.179002; Berenguer J, 2003, CLIN INFECT DIS, V36, P1047, DOI 10.1086/374048; Falco V, 2008, JAIDS-J ACQ IMM DEF, V49, P26, DOI 10.1097/QAI.0b013e31817bec64; Harrison DM, 2011, J NEUROIMMUNOL, V238, P81, DOI 10.1016/j.jneuroim.2011.07.003; Wyen C, 2005, AIDS PATIENT CARE ST, V19, P486, DOI 10.1089/apc.2005.19.486	12	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1087-2914	1557-7449		AIDS PATIENT CARE ST	Aids Patient Care STDS	JAN 1	2015	29	1					1	3		10.1089/apc.2014.0189		3	Public, Environmental & Occupational Health; Infectious Diseases	Public, Environmental & Occupational Health; Infectious Diseases	AY0MI	WOS:000347290100001		
J	Sawada, N; Iwasaki, M; Yamaji, T; Shimazu, T; Sasazuki, S; Inoue, M; Tsugane, S				Sawada, None; Iwasaki, Motoki; Yamaji, Taiki; Shimazu, Taichi; Sasazuki, Shizuka; Inoue, Manami; Tsugane, Shoichiro		Japan Public Hlth Ctr Based Prospe	Fiber intake and risk of subsequent prostate cancer in Japanese men	AMERICAN JOURNAL OF CLINICAL NUTRITION			English	Article						JPHC Study; fiber intake; prospective study; prostate cancer; Japanese men	FOOD FREQUENCY QUESTIONNAIRE; DIETARY FIBER; INSULIN-RESISTANCE; COLORECTAL-CANCER; COHORT-I; HEALTH; PRODUCT; JPHC; INTERVENTION; CONSUMPTION	Background: Dietary fiber may reduce the risk of prostate cancer, possibly by increasing circulating concentrations of sex hormone binding globulin and improving insulin sensitivity. However, results from previous epidemiologic studies of fiber intake and prostate cancer are inconsistent, and to our knowledge, no study has comprehensively evaluated the effects of soluble and insoluble fiber on prostate cancer in Asia. Objective: The objective was to examine the association between fiber intake and prostate cancer in Japanese men. Design: We conducted a population-based prospective study in 43,435 Japanese men aged 45-74 y. Participants responded to a validated questionnaire, which included 138 food items. Follow-up was from 1995 through 2009. HRs and 95% CIs of incidence were calculated according to quartiles of fiber intake. Results: During the 11.6-y follow-up, of the 825 men newly diagnosed with prostate cancer, 213 had advanced-stage cancer, 582 had organ-localized disease, and 30 had an undetermined stage of disease. Among them, 217 cases were detected by subjective symptoms. Total fiber was not associated with total or advanced prostate cancer, with respective multivariable HRs for the highest and lowest quartiles of 1.00 (95% CI: 0.77, 1.29; P-trend = 0.97) and 0.67 (95% CI: 0.42, 1.07; P-trend = 0.30). Total fiber and insoluble fiber intake were associated with a decreased risk of advanced cancers detected by subjective symptoms, with multivariate HRs (95% CIs) across increasing quartiles of 1.00, 0.58, 0.62, and 0.44 (0.21, 0.92; P-trend = 0.05) for total fiber and 1.00, 0.60, 0.52, and 0.46 (0.22, 0.93; P-trend = 0.04) for insoluble fiber. Soluble fiber intake showed no association with prostate cancer. Conclusions: Dietary fiber is inversely associated with advanced prostate cancer detected by subjective symptoms even among populations with relatively low intake, such as Japanese. These results suggest that a very low intake of dietary fiber is associated with an increased risk of prostate cancer.	[Sawada, None; Iwasaki, Motoki; Yamaji, Taiki; Shimazu, Taichi; Sasazuki, Shizuka; Inoue, Manami; Tsugane, Shoichiro] Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Epidemiol & Prevent Grp, Tokyo 1040045, Japan; [Inoue, Manami] Univ Tokyo, Grad Sch Med, Dept Hlth & Human Secur, Tokyo, Japan	Sawada, N (reprint author), Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Epidemiol & Prevent Div, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	nsawada@ncc.go.jp			National Cancer Center Research and Development Fund [23-A-31(toku), 26-A-2]; Ministry of Health, Labour and Welfare of Japan	Supported by a National Cancer Center Research and Development Fund [23-A-31(toku) and 26-A-2; since 2011] and a Grant-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare of Japan (1989-2010).	Longcope C, 2000, J CLIN ENDOCR METAB, V85, P293, DOI 10.1210/jc.85.1.293; Bylund A, 2003, EUR J CANCER PREV, V12, P407, DOI 10.1097/01.cej.0000090180.08740.05; Kaaks R, 2003, EUR J CLIN NUTR, V57, P1079, DOI 10.1038/sj.ejcn.1601647; Roddam AW, 2008, J NATL CANCER I, V100, P170, DOI 10.1093/jnci/djm323; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Kurahashi N, 2008, AM J EPIDEMIOL, V167, P71, DOI 10.1093/aje/kwm249; Drake I, 2012, AM J CLIN NUTR, V96, P1409, DOI 10.3945/ajcn.112.039438; Hickey K, 2001, EPIDEMIOL REV, V23, P115; Guillon F, 2002, BRIT J NUTR, V88, pS293, DOI 10.1079/BJN2002720; Bradbury KE, 2014, AM J CLIN NUTR, V100, p394S, DOI 10.3945/ajcn.113.071357; Nilsson AC, 2010, J NUTR, V140, P1932, DOI 10.3945/jn.110.123604; Kurahashi N, 2008, CANCER EPIDEM BIOMAR, V17, P930, DOI 10.1158/1055-9965.EPI-07-2681; Mantzoros CS, 1997, BRIT J CANCER, V76, P1115, DOI 10.1038/bjc.1997.520; Lau C, 2005, DIABETES CARE, V28, P1397, DOI 10.2337/diacare.28.6.1397; Rowlands MA, 2009, INT J CANCER, V124, P2416, DOI 10.1002/ijc.24202; TSUGANE S, 1990, CANCER CAUSE CONTROL, V1, P189, DOI 10.1007/BF00053172; Weickert MO, 2008, J NUTR, V138, P439; Close DR, 1998, CANCER EPIDEM BIOMAR, V7, P627; Nimptsch K, 2011, CANCER CAUSE CONTROL, V22, P51, DOI 10.1007/s10552-010-9671-x; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; SHIMIZU H, 1991, BRIT J CANCER, V63, P963, DOI 10.1038/bjc.1991.210; Deschasaux M, 2014, J NUTR, V144, P504, DOI 10.3945/jn.113.189670; Foundation for Promotion of Cancer Research, 2013, CANC STAT JAP 2013; Hsing AW, 2003, J NATL CANCER I, V95, P67, DOI 10.1093/jnci/95.1.67; Ishihara J, 2003, J EPIDEMIOL, V13, pS134; Kimura T, 2012, CHIN J CANCER, V31, P421, DOI 10.5732/cjc.011.10324; Kokubo Y, 2011, EUR J CLIN NUTR, V65, P1233, DOI 10.1038/ejcn.2011.100; Kurahashi N, 2007, CANCER EPIDEM BIOMAR, V16, P538, DOI 10.1158/1055-9965.EPI-06-0517; Lewis JE, 2009, NUTR CANCER, V61, P216, DOI 10.1080/01635580802419756; Neveu Bertrand, 2014, Res Rep Urol, V6, P27, DOI 10.2147/RRU.S58643; Otani T, 2006, INT J CANCER, V119, P1475, DOI 10.1002/ijc.22007; Parkin DM, 2002, CANC INCIDENCE 5 CON, VVIII; Research Group on Health and Nutrition Information, 2013, NAT HLTH NUTR SURV J; Resource Council; Science and Technology Agency; the Government of Japan, 2005, STAND TABL FOOD COMP; Sasaki S, 2003, J EPIDEMIOL, V13, pS106; Sawada N, 2014, INT J CANCER, V134, P971, DOI 10.1002/ijc.28423; Shim Jee-Youn, 2007, Nutr Res Pract, V1, P266, DOI 10.4162/nrp.2007.1.4.266; Suzuki R, 2009, INT J CANCER, V124, P245, DOI 10.1002/ijc.23908; Tabung F, 2012, PROSTATE CANC, V2012; Tatsumi Y, 2013, J DIABETES INVEST, V4, P626, DOI 10.1111/jdi.12100; Tsugane S, 2014, JPN J CLIN ONCOL, V44, P777, DOI 10.1093/jjco/hyu096; Wakai K, 2007, CANCER EPIDEM BIOMAR, V16, P668, DOI 10.1158/1055-9965.EPI-06-0664; Wakai K, 2006, J EPIDEMIOL, V16, P125, DOI 10.2188/jea.16.125; WALKER ARP, 1992, BRIT J CANCER, V65, P438, DOI 10.1038/bjc.1992.89; Willett W., 1998, NUTR EPIDEMIOLOGY; World Cancer Research Fund/ American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P	46	2	2	AMER SOC NUTRITION-ASN	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0002-9165	1938-3207		AM J CLIN NUTR	Am. J. Clin. Nutr.	JAN	2015	101	1					118	125		10.3945/ajcn.114.089581		8	Nutrition & Dietetics	Nutrition & Dietetics	AX4ID	WOS:000346895700014		
J	Saraya, T; Takizawa, H				Saraya, Takeshi; Takizawa, Hajime			Evidence of Pulmonary Disseminated Cryptococcosis: Diffuse Multiple Micronodules on Thoracic Computed Tomography	AMERICAN JOURNAL OF MEDICINE			English	Letter									[Saraya, Takeshi; Takizawa, Hajime] Kyorin Univ, Sch Med, Dept Resp Med, Tokyo, Japan	Saraya, T (reprint author), Kyorin Univ, Sch Med, Dept Resp Med, Tokyo, Japan.						Shimoda M, 2014, INTERNAL MED, V53, P1641, DOI 10.2169/internalmedicine.53.2005; Sperry BW, 2014, AM J MED, V127, P707, DOI 10.1016/j.amjmed.2014.04.007	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9343	1555-7162		AM J MED	Am. J. Med.	JAN	2015	128	1					E15	E15		10.1016/j.amjmed.2014.09.019		1	Medicine, General & Internal	General & Internal Medicine	AX6KB	WOS:000347030100011		
J	Susa, C; Kagaya, H; Saitoh, E; Baba, M; Kanamori, D; Mikushi, S; Ozaki, K; Uematsu, H; Minakuchi, S				Susa, Chiaki; Kagaya, Hitoshi; Saitoh, Eiichi; Baba, Mikoto; Kanamori, Daisuke; Mikushi, Shinya; Ozaki, Kenichiro; Uematsu, Hiroshi; Minakuchi, Shunsuke			Classification of Sequential Swallowing Types Using Videoendoscopy with High Reproducibility and Reliability	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Dysphagia; Sequential Swallowing; Videoendoscopy; Videofluoroscopy	CONSISTENCY; TRANSPORT	Objective: This study aimed to classify sequential swallowing types using videoendoscopy (VE) avoiding radiation exposure and compare the results using videofluoroscopy (VF). Design: Twenty-one healthy adults simultaneously underwent VF and VE during sequential straw drinking. Each discrete swallow was classified into an L-segmental type (laryngeal vestibule opens after swallow) or L-continuous type (laryngeal vestibule closure continues after swallow) using VF and a V-segmental type (velopharynx opens after swallow) or V-continuous type (velopharynx closure continues after swallow) using VE. Test-retest reproducibility and interrater and intrarater reliability were evaluated in ten healthy adults. Results: Of 128 swallows, 94 were L-segmental and 34 were L-continuous types as per VF, whereas 95 were V-segmental and 33 were V-continuous types as per VE. The leading edge of the bolus at swallow onset was significantly deeper in L-continuous types (P = 0.001). Laryngeal vestibule closure on VF images corresponded to velopharyngeal closure on VE images for 127 of 128 swallows (kappa = 0.98, P < 0.001). All subjects showed the same types of swallows in the first and the second studies. Both interrater and intrarater reliability were high. Conclusion: VE showed high reproducibility and reliability in the classification of sequential swallowing types.	[Susa, Chiaki; Uematsu, Hiroshi; Minakuchi, Shunsuke] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Gerontol & Gerodontol, Bunkyo Ku, Tokyo 1138549, Japan; [Kagaya, Hitoshi; Saitoh, Eiichi] Fujita Hlth Univ, Sch Med, Dept Rehabil Med 1, Toyoake, Aichi 47011, Japan; [Baba, Mikoto; Ozaki, Kenichiro] Ashikaga Red Cross Hosp, Dept Rehabil, Ashikaga, Tochigi, Japan; [Kanamori, Daisuke] Fujita Hlth Univ, Sch Med, Dept Dent, Toyoake, Aichi 47011, Japan; [Mikushi, Shinya] Nagasaki Univ, Hosp Med & Dent, Dept Special Care Dent, Nagasaki 852, Japan	Susa, C (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Gerontol & Gerodontol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.						Wu CH, 1997, LARYNGOSCOPE, V107, P396; Perie S, 1998, LARYNGOSCOPE, V108, P1712; Hiiemae KM, 1999, DYSPHAGIA, V14, P31, DOI 10.1007/PL00009582; DODDS WJ, 1990, AM J ROENTGENOL, V154, P953; Dozier TS, 2006, LARYNGOSCOPE, V116, P1489, DOI 10.1097/01.mlg.0000227724.61801.b4; Saitoh E, 2007, DYSPHAGIA, V22, P100, DOI 10.1007/s00455-006-9060-5; Chi-Fishman G, 2000, J SPEECH LANG HEAR R, V43, P1481; JACOB P, 1989, GASTROENTEROLOGY, V97, P1469; Bastian Robert W., 1993, Dysphagia, V8, P359, DOI 10.1007/BF01321780; Daniels SK, 2004, J SPEECH LANG HEAR R, V47, P33, DOI 10.1044/1092-4388(2004/004); DODDS WJ, 1989, AM J ROENTGENOL, V153, P1197; Kidder Thomas M., 1994, Dysphagia, V9, P256, DOI 10.1007/BF00301919; Logemann JA, 1998, EVALUATION TREATMENT; Ozaki K, 2010, TOHOKU J EXP MED, V220, P41, DOI 10.1620/tjem.220.41; PALMER J B, 1992, Dysphagia, V7, P187, DOI 10.1007/BF02493469	15	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	JAN	2015	94	1					38	43		10.1097/PHM.0000000000000144		6	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	AX6ZR	WOS:000347067100009		
J	Urushima, H; Nishimura, J; Mizushima, T; Hayashi, N; Maeda, K; Ito, T				Urushima, Hayato; Nishimura, Junichi; Mizushima, Tsunekazu; Hayashi, Noriyuki; Maeda, Kazuhisa; Ito, Toshinori			Perilla frutescens extract ameliorates DSS-induced colitis by suppressing proinflammatory cytokines and inducing anti-inflammatory cytokines	AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY			English	Article						interleukin-17A; Perilla frutescens; T helper 17; tumor necrosis factor-alpha; regulatory T cells	INFLAMMATORY-BOWEL-DISEASE; NF-KAPPA-B; REGULATORY T-CELLS; INTESTINAL EPITHELIAL-CELLS; GENE-DEFICIENT MICE; GROWTH-FACTOR-BETA; CROHNS-DISEASE; LEAF EXTRACT; INTERLEUKIN-10; INFLIXIMAB	Anti-inflammatory effects have been reported in Perilla frutescens leaf extract (PE), which is a plant of the genus belonging to the Lamiaceae family. We examined the effect of PE on dextran sulfate sodium (DSS)-induced colitis. Preliminarily, PE was safely administered for 7 wk without any adverse effects. In the preventive protocol, mice were fed 1.5% DSS solution dissolved in distilled water (control group) or 0.54% PE solution (PE group) ad libitum for 7 days. In the therapeutic protocol, distilled water or 0.54% PE solution was given for 10 days just after administration of 1.5% DSS for 5 days. PE intake significantly improved body weight loss. The serum cytokine profile demonstrated that TNF-alpha, IL-17A, and IL-10 were significantly lower in the PE group than in the control group. In the therapeutic protocol, mice in the PE group showed significantly higher body weight and lower histological colitis scores compared with mice in the control group on day 15. The serum cytokine profile demonstrated that TGF-beta was significantly higher in the PE group than in the control group. In distal colon mRNA expression, TNF-alpha, and IL-17A were significantly downregulated. In vitro analyses of biologically active ingredients, such as luteolin, apigenin, and rosmarinic acid, in PE were performed. Luteolin suppressed production of proinflammatory cytokines, such as TNF-alpha, IL-1 beta, IL-6, and IL-17A. Apigenin also suppressed secretion of IL-17A and increased the anti-inflammatory cytokine IL-10. Rosmarinic acid increased the regulatory T cell population. We conclude that PE might be useful in treatment and prevention of DSS-induced colitis.	[Urushima, Hayato; Hayashi, Noriyuki; Maeda, Kazuhisa; Ito, Toshinori] Osaka Univ, Grad Sch Med, Dept Complementary & Alternat Med, Suita, Osaka 5650871, Japan; [Nishimura, Junichi; Mizushima, Tsunekazu; Ito, Toshinori] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Suita, Osaka 5650871, Japan	Urushima, H (reprint author), Osaka Univ, Grad Sch Med, Dept Complementary & Alternat Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	h-urushima@cam.med.osaka-u.ac.jp					Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Cheifetz A, 2003, AM J GASTROENTEROL, V98, P1315, DOI 10.1016/S0002-9270(03)00231-4; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra020831; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Yanai H, 2011, AM J GASTROENTEROL, V106, P685, DOI 10.1038/ajg.2011.103; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Rennick DM, 1997, J LEUKOCYTE BIOL, V61, P389; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Sands BE, 2004, NEW ENGL J MED, V350, P876, DOI 10.1056/NEJMoa030815; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; NAKAMURA M, 1992, GUT, V33, P933, DOI 10.1136/gut.33.7.933; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Shin TY, 2000, IMMUNOPHARM IMMUNOT, V22, P489, DOI 10.3109/08923970009026007; Ueda H, 2001, BIOSCI BIOTECH BIOCH, V65, P1673, DOI 10.1271/bbb.65.1673; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Nicholas C, 2007, J IMMUNOL, V179, P7121; Ruiz PA, 2006, J NUTR, V136, P664; Park CM, 2011, EUR J PHARMACOL, V660, P454, DOI 10.1016/j.ejphar.2011.04.007; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Hundorfean G, 2012, INFLAMM BOWEL DIS, V18, P180, DOI 10.1002/ibd.21677; Iba Y, 2003, INT IMMUNOPHARMACOL, V3, P485, DOI 10.1016/S1567-5769(02)00299-0; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Billioud V, 2011, AM J GASTROENTEROL, V106, P674, DOI 10.1038/ajg.2011.60; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Hur SJ, 2012, NUTR RES, V32, P801, DOI 10.1016/j.nutres.2012.09.013; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Jiang WL, 2009, SHOCK, V32, P608, DOI 10.1097/SHK.0b013e3181a48e86; Liang YC, 1999, CARCINOGENESIS, V20, P1945, DOI 10.1093/carcin/20.10.1945; Nishitani Y, 2013, BIOFACTORS, V39, P522, DOI 10.1002/biof.1091; Yu QT, 2007, INFLAMM BOWEL DIS, V13, P191, DOI 10.1002/ibd.20053; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Holtta V, 2008, INFLAMM BOWEL DIS, V14, P1175, DOI 10.1002/ibd.20475; Fale PL, 2013, FOOD FUNCT, V4, P426, DOI 10.1039/c2fo30318c; Ganjare AB, 2011, FITOTERAPIA, V82, P1052, DOI 10.1016/j.fitote.2011.06.008; HONDA G, 1986, CHEM PHARM BULL, V34, P1672; Igarashi M, 2013, EVID-BASED COMPL ALT, DOI 10.1155/2013/925342; Imaoka K, 1993, Arerugi, V42, P74; Ishihara T, 1999, Arerugi, V48, P443; Karrasch T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000596; KOEZUKA Y, 1985, PLANTA MED, V51, P480, DOI 10.1055/s-2007-969568; Makino T, 1999, NEPHRON, V83, P40, DOI 10.1159/000045471; Makino T, 2001, PLANTA MED, V67, P24, DOI 10.1055/s-2001-10878; Mizushima T, 2004, INFLAMM BOWEL DIS, V10, P182, DOI 10.1097/00054725-200405000-00002; Sanada Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023933; Song J, 2008, J PHARMACOL EXP THER, V324, P276, DOI 10.1124/jpet.106.119172; Ueda H, 1997, BIOSCI BIOTECH BIOCH, V61, P1292; Watanabe K, 2001, J HEALTH SCI, V47, P327, DOI 10.1248/jhs.47.327	50	2	2	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0193-1857	1522-1547		AM J PHYSIOL-GASTR L	Am. J. Physiol.-Gastroint. Liver Physiol.	JAN 1	2015	308	1					G32	G41		10.1152/ajpgi.00294.2014		10	Gastroenterology & Hepatology; Physiology	Gastroenterology & Hepatology; Physiology	AX9OI	WOS:000347231400004		
J	Horino, T; Sato, F; Hosaka, Y; Hoshina, T; Tamura, K; Nakaharai, K; Kato, T; Nakazawa, Y; Yoshida, M; Hori, S				Horino, Tetsuya; Sato, Fumiya; Hosaka, Yumiko; Hoshina, Tokio; Tamura, Kumi; Nakaharai, Kazuhiko; Kato, Tetsuro; Nakazawa, Yasushi; Yoshida, Masaki; Hori, Seiji			Predictive Factors for Metastatic Infection in Patients With Bacteremia Caused by Methicillin-Sensitive Staphylococcus aureus	AMERICAN JOURNAL OF THE MEDICAL SCIENCES			English	Article						Staphylococcus aureus; Bacteremia; Metastatic infection; Predictive factors	CLINICAL-PRACTICE GUIDELINES; C-REACTIVE PROTEIN; STREPTOCOCCUS SPECIES BACTEREMIA; DISEASES SOCIETY; MANAGEMENT; AMERICA; COMPLICATIONS; SURVEILLANCE; DIAGNOSIS; MORTALITY	Background: Metastatic infections such as infective endocarditis and psoas abscess are serious complications of Staphylococcus aureus bacteremia because failure to identify these infections may result in bacteremia relapse or poor prognosis. In the present study, we determined the predictive factors for metastatic infection due to methicillin-sensitive S. aureus bacteremia. Methods: A retrospective cohort study was conducted among patients with methicillin-sensitive S. aureus bacteremia at the Jikei University Hospital between January 2008 and December 2012. Factors analyzed included the underlying disease, initial antimicrobial treatment and primary site of infection. Results: During the 5-year study period, 73 patients met the inclusion criteria and were assessed. The most common primary site of bacteremia was catheter-related bloodstream infection (25/73 [34.2%]). Metastatic infection occurred in 14 of 73 patients (19.2%) (infective endocarditis [3], septic pulmonary abscess [3], spondylitis [4], psoas abscess [4], epidural abscess [3] and septic arthritis [1]). Six patients had multiple metastatic infections. Multivariate analysis revealed that the predictive factors associated with the development of metastatic infection were a delay in appropriate antimicrobial treatment of >48 hours, persistent fever for >72 hours after starting antibiotic treatment and lowest C-reactive protein levels of >3 mg/dL during 2 weeks after the onset of bacteremia. Conclusions: This study demonstrated that additional diagnostic tests should be conducted to identify metastatic infection, particularly in patients with delayed antimicrobial treatment, persistent fever and persistently high C-reactive protein levels.	[Horino, Tetsuya; Sato, Fumiya; Hosaka, Yumiko; Hoshina, Tokio; Tamura, Kumi; Nakaharai, Kazuhiko; Kato, Tetsuro; Nakazawa, Yasushi; Yoshida, Masaki; Hori, Seiji] Jikei Univ, Sch Med, Dept Infect Dis & Infect Control, Tokyo 1058461, Japan	Horino, T (reprint author), Jikei Univ, Sch Med, Dept Infect Dis & Infect Control, Minato Ku, 3-25-8 Nishi Shimbashi, Tokyo 1058461, Japan.	horino@jikei.ac.jp					Paul M, 2010, J ANTIMICROB CHEMOTH, V65, P2658, DOI 10.1093/jac/dkq373; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Fowler VG, 2003, ARCH INTERN MED, V163, P2066, DOI 10.1001/archinte.163.17.2066; Osmon DR, 2013, CLIN INFECT DIS, V56, P1, DOI 10.1093/cid/cis966; Liu C, 2011, CLIN INFECT DIS, V52, pE18, DOI 10.1093/cid/ciq146; Fowler VG, 2005, CLIN INFECT DIS, V40, P695; Jensen AG, 2002, ARCH INTERN MED, V162, P25, DOI 10.1001/archinte.162.1.25; Jenkins TC, 2008, CLIN INFECT DIS, V46, P1000, DOI 10.1086/529190; Fowler VG, 1998, CLIN INFECT DIS, V27, P478; Shorr AF, 2006, CRIT CARE MED, V34, P2588, DOI 10.1097/01.CCM.0000239121.09533.09; Lobo SMA, 2003, CHEST, V123, P2043, DOI 10.1378/chest.123.6.2043; Welsch T, 2008, SURGERY, V143, P20, DOI 10.1016/j.surg.2007.06.010; Vos FJ, 2012, MEDICINE, V91, P86, DOI 10.1097/MD.0b013e31824d7ed2; Bassetti M, 2012, CLIN MICROBIOL INFEC, V18, P862, DOI 10.1111/j.1469-0691.2011.03679.x; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Rieg S, 2009, J INFECTION, V59, P232, DOI 10.1016/j.jinf.2009.07.015; Choi SH, 2012, EUR J CLIN MICROBIOL, V31, P2963, DOI 10.1007/s10096-012-1648-0; Cuijpers MLH, 2007, EUR J CLIN MICROBIOL, V26, P105, DOI 10.1007/s10096-006-0238-4; Komiya K, 2012, J CRIT CARE, V27; Lee CC, 2008, SHOCK, V29, P322, DOI 10.1097/shk.0b01361815077ca; Lesens O, 2004, J INFECTION, V48, P245, DOI 10.1016/j.jinf.2003.10.010; Tschaikowsky K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023615	22	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0002-9629	1538-2990		AM J MED SCI	Am. J. Med. Sci.	JAN	2015	349	1					24	28				5	Medicine, General & Internal	General & Internal Medicine	AX7CS	WOS:000347075200007		
J	Tanaka-Hayashi, A; Hayashi, S; Inoue, R; Ito, T; Konno, K; Yoshida, T; Watanabe, M; Yoshimura, T; Mori, H				Tanaka-Hayashi, Ayumi; Hayashi, Shuuhei; Inoue, Ran; Ito, Tomokazu; Konno, Kohtarou; Yoshida, Tomoyuki; Watanabe, Masahiko; Yoshimura, Tohru; Mori, Hisashi			Is D-aspartate produced by glutamic-oxaloacetic transaminase-1 like 1 (Got1l1): a putative aspartate racemase?	AMINO ACIDS			English	Article						Glutamic-oxaloacetic transaminase-1 like 1; D-Aspartate; Knockout mice; Testis; Hippocampus; Recombinant protein expression	AMPA RECEPTOR EXPRESSION; RAT PINEALOCYTES; SERINE RACEMASE; MAMMALIAN BRAIN; ACID; GENE; AMINOTRANSFERASE; BIOSYNTHESIS; RELEASE; NEURONS	d-Aspartate is an endogenous free amino acid in the brain, endocrine tissues, and exocrine tissues in mammals, and it plays several physiological roles. In the testis, d-aspartate is detected in elongate spermatids, Leydig cells, and Sertoli cells, and implicated in the synthesis and release of testosterone. In the hippocampus, d-aspartate strongly enhances N-methyl-d-aspartate receptor-dependent long-term potentiation and is involved in learning and memory. The existence of aspartate racemase, a candidate enzyme for d-aspartate production, has been suggested. Recently, mouse glutamic-oxaloacetic transaminase 1-like 1 (Got1l1) has been reported to synthesize substantially d-aspartate from l-aspartate and to be involved in adult neurogenesis. In this study, we investigated the function of Got1l1 in vivo by generating and analyzing Got1l1 knockout (KO) mice. We also examined the enzymatic activity of recombinant Got1l1 in vitro. We found that Got1l1 mRNA is highly expressed in the testis, but it is not detected in the brain and submandibular gland, where d-aspartate is abundant. The d-aspartate contents of wild-type and Got1l1 KO mice were not significantly different in the testis and hippocampus. The recombinant Got1l1 expressed in mammalian cells showed l-aspartate aminotransferase activity, but lacked aspartate racemase activity. These findings suggest that Got1l1 is not the major aspartate racemase and there might be an as yet unknown d-aspartate-synthesizing enzyme.	[Tanaka-Hayashi, Ayumi; Inoue, Ran; Yoshida, Tomoyuki; Mori, Hisashi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Mol Neurosci, Toyama 9300194, Japan; [Hayashi, Shuuhei; Ito, Tomokazu; Yoshimura, Tohru] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Konno, Kohtarou; Watanabe, Masahiko] Hokkaido Univ, Grad Sch Med, Dept Anat, Sapporo, Hokkaido 0608638, Japan	Mori, H (reprint author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Mol Neurosci, Toyama 9300194, Japan.	yosimura@agr.nagoya-u.ac.jp; hmori@med.u-toyama.ac.jp	WATANABE, Masahiko/A-4055-2012		Ministry of Education, Science, Sports and Culture of Japan	We thank Dr. Tomoko Shiroshima for technical assistance. Fluorescence in situ hybridization was supported by a Grant-in-Aid for Scientific Research on Innovation Areas (Comprehensive Brain Science Network) from the Ministry of Education, Science, Sports and Culture of Japan.	Horio M, 2013, NEUROCHEM INT, V62, P843, DOI 10.1016/j.neuint.2013.02.015; Sakai K, 1998, ARCH BIOCHEM BIOPHYS, V351, P96, DOI 10.1006/abbi.1997.0539; Wolosker H, 2000, NEUROSCIENCE, V100, P183, DOI 10.1016/S0306-4522(00)00321-3; Miya K, 2008, J COMP NEUROL, V510, P641, DOI 10.1002/cne.21822; Topo E, 2010, AMINO ACIDS, V38, P1561, DOI 10.1007/s00726-009-0369-x; Mishina M, 2007, NEUROSCI RES, V58, P105, DOI 10.1016/j.neures.2007.01.004; D'Aniello A, 2000, FASEB J, V14, P699; Errico F, 2011, NEUROBIOL AGING, V32, P2229, DOI 10.1016/j.neurobiolaging.2010.01.002; Ito T, 2008, BIOCHEM J, V409, P399, DOI 10.1042/BJ20070642; Taniguchi M, 1998, NUCLEIC ACIDS RES, V26, P679, DOI 10.1093/nar/26.2.679; Furuchi T, 2005, BIOL PHARM BULL, V28, P1566, DOI 10.1248/bpb.28.1566; Errico F, 2012, AMINO ACIDS, V43, P1861, DOI 10.1007/s00726-012-1356-1; Fukaya M, 2006, EUR J NEUROSCI, V24, P2177, DOI 10.1111/j.1460-9568.2006.05081.x; Kudo T, 2012, J NEUROSCI, V32, P18035, DOI 10.1523/JNEUROSCI.4057-12.2012; DAniello A, 1996, LIFE SCI, V59, P97, DOI 10.1016/0024-3205(96)00266-4; Kim PM, 2010, P NATL ACAD SCI USA, V107, P3175, DOI 10.1073/pnas.0914706107; Wang LP, 2011, J BIOL CHEM, V286, P13765, DOI 10.1074/jbc.M110.178228; Ishio S, 1998, NEUROSCI LETT, V249, P143, DOI 10.1016/S0304-3940(98)00414-5; Takigawa Y, 1998, BIOCHEM BIOPH RES CO, V248, P641, DOI 10.1006/bbrc.1998.8971; DOUBLET P, 1992, J BACTERIOL, V174, P5772; Hashimoto A, 1997, PROG NEUROBIOL, V52, P325, DOI 10.1016/S0301-0082(97)00019-1; KOCHHAR S, 1992, EUR J BIOCHEM, V203, P563, DOI 10.1111/j.1432-1033.1992.tb16584.x; Liu LD, 1998, BIOSCI BIOTECH BIOCH, V62, P193, DOI 10.1271/bbb.62.193; Masuda W, 2003, ARCH BIOCHEM BIOPHYS, V420, P46, DOI 10.1016/j.abb.2003.09.032; Yamazaki M, 2010, EUR J NEUROSCI, V31, P2204, DOI 10.1111/j.1460-9568.2010.07254.x	25	1	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0939-4451	1438-2199		AMINO ACIDS	Amino Acids	JAN	2015	47	1					79	86		10.1007/s00726-014-1847-3		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AX9UX	WOS:000347248500007		
J	Kawashima, T; Salinger, J; Hida, K; Takai, K; Nakamaru-Ogiso, E				Kawashima, Takaaki; Salinger, Jeremy; Hida, Koichi; Takai, Katsuji; Nakamaru-Ogiso, Eiko			Unusual reactivity of beta-hydroxy-serotonin, a forgotten serotonin derivative	AMINO ACIDS			English	Article						Serotonin; Serotonin derivatives; beta-hydroxylation; Rapid racemization; Tryptophan; Enzymatic derivatization	SIDE-CHAIN OXIDASE; INVIVO RACEMIZATION; AMINO-ACIDS; HYDROXYTRYPTAMINES; RESIDUES	Serotonin (5-HT) is a well-known biogenic amine which regulates mood, sleep, and is involved in muscle contraction and blood coagulation. Based on an analogy to norepinephrine, a beta-hydroxylated derivative of dopamine which has diverse physiological functions, beta-hydroxy-serotonin (beta-OH-5-HT) originally encouraged interest as a potential pharmacological agent. Four decades ago, its organic synthesis was attempted. However, due to difficulties with the synthesis and the compound's instability, rigorous identification and characterization of beta-OH-5-HT proved evasive. Here, we successfully synthesized beta-OH-5-HT from 5-HT using a Pseudomonas enzyme, tryptophan side chain oxidase type I (TSOI), and we determined the structure by 2D-NMR and characterized beta-OH-5-HT in detail. The CD spectra showed no optical activity, suggesting a racemic mixture. To separate dl-beta-OH-5-HT, we synthesized l-Ala-5-HT and derivatized it into erythro- and threo-l-Ala-beta-OH-5-HT with TSOI. Interestingly, both isolated fractions returned to a diastereoisomeric mixture within two hours at pH 5.0. Later, we found that, under acidic conditions, beta-OH-5-HT readily reacted with nucleophiles like alcohols or thiols, yielding a variety of dl-beta-substituted-5-HT. The unusual properties of beta-OH-5-HT might be attributed to the unique nature of a beta-hydroxyl group adjacent to an indole ring and amino group. The mechanism for the rapid racemization of beta-OH-5-HT is discussed.	[Kawashima, Takaaki; Takai, Katsuji; Nakamaru-Ogiso, Eiko] Univ Tokyo, Grad Sch Med, Inst Int Hlth, Dept Biomed Chem, Tokyo 1130033, Japan; [Salinger, Jeremy; Nakamaru-Ogiso, Eiko] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Johnson Res Fdn, Philadelphia, PA 19104 USA; [Hida, Koichi; Nakamaru-Ogiso, Eiko] Fukuoka Prefectural Univ, Fac Nursing, Dept Expt Nursing, Fukuoka 8258585, Japan	Nakamaru-Ogiso, E (reprint author), Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Johnson Res Fdn, Rm 1009B Stellar Chance Bldg,422 Curie Blvd, Philadelphia, PA 19104 USA.	eikoo@mail.med.upenn.edu			Ministry of Education, Culture, Sports, Science and Technology in Japan [09270211, 15590267]; Naito Foundation; American Heart Association [11SDG5560001]	This work was supported in part by Grants from the Ministry of Education, Culture, Sports, Science and Technology in Japan (09270211 to KT and 15590267 to E. N-O.), the Naito Foundation (to E. N-O.), and American Heart Association Grant 11SDG5560001 (to E. N-O.). We thank Dr.s H. Tanno and T. Futamura for the bulk supply of Pseudomonas cells.	AMES DE, 1956, J CHEM SOC, P1984, DOI 10.1039/jr9560001984; YAMADA S, 1983, J ORG CHEM, V48, P843, DOI 10.1021/jo00154a019; Bergmann M, 1932, BER DTSCH CHEM GES, V65, P1192, DOI 10.1002/cber.19320650722; Richard JP, 2001, CURR OPIN CHEM BIOL, V5, P626, DOI 10.1016/S1367-5931(01)00258-7; Sharma V, 2010, J HETEROCYCLIC CHEM, V47, P491, DOI 10.1002/jhet.349; Hoyer D, 2002, PHARMACOL BIOCHEM BE, V71, P533, DOI 10.1016/S0091-3057(01)00746-8; MANNING JM, 1970, J AM CHEM SOC, V92, P7449, DOI 10.1021/ja00728a033; BADA JL, 1984, METHOD ENZYMOL, V106, P98; Dugas H., 1996, BIOORGANIC CHEM CHEM; Essman WB, 1977, SP BOOKS DIVISION SP; FERLEVIDOVIC A, 1983, PERIOD BIOL, V85, P361; FRIEDMAN HA, 1980, ORG PREP PROCED INT, V12, P297; HELLBERG H, 1955, J PHARM PHARMACOL, V7, P191; HIBERT MF, 1990, J MED CHEM, V33, P1594, DOI 10.1021/jm00168a011; ITO S, 1981, J BIOL CHEM, V256, P7834; Nakamaru E, 1990, AMINO ACIDS CHEM BIO, P1059; NiBeilliu ME, 2004, BIOCHEM J, V381, P847, DOI 10.1042/BJ20040388; PLAVSIC V, 1974, CROAT CHEM ACTA, V46, P217; PLAVSIC V, 1976, J PHARM PHARMACOL, V28, P424; POWERS JC, 1968, J ORG CHEM, V33, P2044, DOI 10.1021/jo01269a072; SHEEHAN JC, 1965, J AM CHEM SOC, V87, P2492, DOI 10.1021/ja01089a034; Silverstein R. M., 1967, SPECTROMETRIC IDENTI; Smithuis L O, 1969, Pharm Weekbl, V104, P1141; Stahl E., 1969, THIN LAYER CHROMATOG; STEINBERG SM, 1984, BIOORG CHEM, V12, P349, DOI 10.1016/0045-2068(84)90016-6; TAKAI K, 1987, METHOD ENZYMOL, V142, P195, DOI 10.1016/S0076-6879(87)42029-6; ZAVALA F, 1983, J BIOL CHEM, V258, P344	27	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0939-4451	1438-2199		AMINO ACIDS	Amino Acids	JAN	2015	47	1					189	198		10.1007/s00726-014-1854-4		10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AX9UX	WOS:000347248500017		
J	Bouchekioua, Y; Mimura, M; Watanabe, S				Bouchekioua, Youcef; Mimura, Masaru; Watanabe, Shigeru			Air flow cued spatial learning in mice	ANIMAL COGNITION			English	Article						Spatial learning; Air flow; Morris pool; Mice	GANGLION-CELLS; NAVIGATION; RATS; LOCALIZATION; STRATEGIES; ACUITY; MOUSE	Spatial learning experiments in rodents typically employ visual cues that are associated with a goal place, even though it is now well established that they have poor visual acuity. We assessed here the possibility of spatial learning in mice based on an air flow cue in a dry version of the Morris water maze task. A miniature fan was placed at each of the four cardinal points of the circular maze, but only one blew air towards the centre of the maze. The three other fans were blowing towards their own box. The mice were able to learn the task only if the spatial relationship between the air flow cue and the position of the goal place was kept constant across trials. A change of this spatial relationship resulted in an increase in the time to find the goal place. We report here the first evidence of spatial learning relying on an air flow cue.	[Bouchekioua, Youcef; Mimura, Masaru] Keio Univ, Dept Neuropsychiat, Sch Med, Shinjuku Ku, Tokyo 1088582, Japan; [Watanabe, Shigeru] Keio Univ, Dept Psychol, Minato Ku, Tokyo 1088582, Japan	Bouchekioua, Y (reprint author), Keio Univ, Dept Neuropsychiat, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1088582, Japan.	youcef.bouchekioua@z3.keio.jp			 [21300125]	We thank Paul Craddock and Virginie Suybeng for comments on an earlier version of the manuscript and help regarding language. Thanks are also due to Ei-Ichi Izawa, Yuko Ikkatai and Shinbo Akihiro for insightful discussions. This work was supported by Grant-in-Aids for Scientific Research (21300125).	Rossier J, 2000, BEHAV BRAIN RES, V117, P209, DOI 10.1016/S0166-4328(00)00293-X; Chamizo VD, 2006, LEARN BEHAV, V34, P348, DOI 10.3758/BF03193198; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; Mehta SB, 2007, PLOS BIOL, V5, P309, DOI 10.1371/journal.pbio.0050015; Jacobs WJ, 1997, LEARN MOTIV, V28, P521, DOI 10.1006/lmot.1997.0977; BALKEMA GW, 1982, J NEUROPHYSIOL, V48, P968; Collett TS, 1997, J COMP PHYSIOL A, V181, P47, DOI 10.1007/s003590050092; Cressant A, 2007, BEHAV BRAIN RES, V177, P22, DOI 10.1016/j.bbr.2006.11.010; Hamilton DA, 1999, PSYCHOBIOLOGY, V27, P453; Hermer-Vazquez L, 2005, BEHAV LAB RAT HDB TE, P60; HUTSON KA, 1986, J NEUROPHYSIOL, V56, P1196; Lashley KS, 1930, PEDAGOG SEMIN J GEN, V37, P481; POWERS MK, 1978, VISION RES, V18, P1533, DOI 10.1016/0042-6989(78)90008-1; Prados J, 1998, PSYCHOBIOLOGY, V26, P42; STONE C, 1993, VISUAL NEUROSCI, V10, P31; Watanabe S, 2007, PHYSIOL BEHAV, V92, P906, DOI 10.1016/j.physbeh.2007.06.019	18	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1435-9448	1435-9456		ANIM COGN	Anim. Cogn.	JAN	2015	18	1					399	404		10.1007/s10071-014-0809-1		6	Behavioral Sciences; Zoology	Behavioral Sciences; Zoology	AX9WD	WOS:000347249100038		
J	Yamasaki, S; Tanimoto, K; Kohno, K; Kadowaki, M; Takase, K; Kondo, S; Kubota, A; Takeshita, M; Okamura, S				Yamasaki, Satoshi; Tanimoto, Kazuki; Kohno, Kentarou; Kadowaki, Masanori; Takase, Ken; Kondo, Seiji; Kubota, Akira; Takeshita, Morishige; Okamura, Seiichi			UGT1A1*6 polymorphism predicts outcome in elderly patients with relapsed or refractory diffuse large B-cell lymphoma treated with carboplatin, dexamethasone, etoposide and irinotecan	ANNALS OF HEMATOLOGY			English	Article						Elderly patients; Diffuse large B-cell lymphoma; Relapsed; Irinotecan; UGT1A1	MALIGNANT-LYMPHOMA; PHARMACOKINETICS; COMBINATION; CANCER; CPT-11	The uridine diphosphate glucuronosyltransferase (UGT) gene 1A1*6 polymorphism, which affects irinotecan metabolism, has been associated with improved survival in lymphoma patients treated with of carboplatin, dexamethasone, etoposide and irinotecan (CDE-11). This study assessed the efficacy of CDE-11 relative to the UGT1A1*6 polymorphism in 27 elderly patients with relapsed or refractory diffuse large B-cell lymphoma who were ineligible for high-dose chemotherapy plus autologous stem cell transplantation. The 2-year survival rate after initial CDE-11 treatment was significantly higher in patients with than without UGT1A1*6 (57% vs. 5%). The most common grade 4 adverse event in patients with the UGT1A1*6 genotypes was neutropenia (88.9%), but there were no gastrointestinal adverse events or treatment-related deaths. Disease progression was the most frequent cause of death. CDE-11 was well tolerated and provided clinical benefit to elderly patients with relapsed or refractory diffuse large B-cell lymphoma. The response to CDE-11 likely correlated with UGT1A1*6 polymorphisms, but further prospective studies are warranted to optimize irinotecan-based chemotherapies relative to UGT1A1 polymorphism.	[Yamasaki, Satoshi; Tanimoto, Kazuki; Kohno, Kentarou; Kadowaki, Masanori; Takase, Ken; Kondo, Seiji; Kubota, Akira; Okamura, Seiichi] Natl Hosp Org Kyushu Med Ctr, Dept Hematol, Chuo Ku, Fukuoka 8108563, Japan; [Yamasaki, Satoshi; Tanimoto, Kazuki; Kohno, Kentarou; Kadowaki, Masanori; Takase, Ken; Kondo, Seiji; Kubota, Akira; Okamura, Seiichi] Natl Hosp Org Kyushu Med Ctr, Clin Res Inst, Chuo Ku, Fukuoka 8108563, Japan; [Tanimoto, Kazuki] Japanese Red Cross Fukuoka Hosp, Dept Hematol Oncol, Fukuoka, Japan; [Kondo, Seiji] Saga Prefectural Hosp Koseikan, Dept Hematol, Saga, Japan; [Takeshita, Morishige] Fukuoka Univ, Fac Med, Dept Pathol, Fukuoka 81401, Japan	Yamasaki, S (reprint author), Natl Hosp Org Kyushu Med Ctr, Dept Hematol, Chuo Ku, 1-8-1 Jigyohama, Fukuoka 8108563, Japan.	yamas009@kyumed.jp					Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Han JY, 2006, J CLIN ONCOL, V24, P2237, DOI 10.1200/JCO.2005.03.0239; Mathijssen RHJ, 2001, CLIN CANCER RES, V7, P2182; KANO Y, 1992, INT J CANCER, V50, P604, DOI 10.1002/ijc.2910500420; Haioun C, 2000, J CLIN ONCOL, V18, P3025; Araki K, 2006, CANCER SCI, V97, P1255, DOI 10.1111/j.1349-7006.2006.00321.x; Kobayashi Michiya, 2012, World J Gastrointest Oncol, V4, P170, DOI 10.4251/wjgo.v4.i7.170; Liu X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058489; Sarkozy C, 2013, CLIN CANCER RES, V19, P1660, DOI 10.1158/1078-0432.CCR-12-2837; Suzumiya J, 2004, INT J HEMATOL, V79, P266, DOI 10.1532/IJH97.03071	10	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0939-5555	1432-0584		ANN HEMATOL	Ann. Hematol.	JAN	2015	94	1					65	69		10.1007/s00277-014-2170-5		5	Hematology	Hematology	AX8GX	WOS:000347149100007		
J	Hirano, D; Kato, H; Kodaira, T; Yatabe, Y; Ueda, N; Murakami, S; Higuchi, Y; Taji, H; Nakamura, S; Yamamoto, K; Kinoshita, T				Hirano, Daiki; Kato, Harumi; Kodaira, Takeshi; Yatabe, Yasushi; Ueda, Norihiro; Murakami, Satsuki; Higuchi, Yusuke; Taji, Hirofumi; Nakamura, Shigeo; Yamamoto, Kazuhito; Kinoshita, Tomohiro			Salvage therapy with single agent L-asparaginase followed by local irradiation in an elderly patient with CD56-positve primary isolated extramedullary T-cell lymphoblastic lymphoma of the sinus	ANNALS OF HEMATOLOGY			English	Letter							LEUKEMIA; CLASSIFICATION; REGIMENS		[Hirano, Daiki; Kato, Harumi; Ueda, Norihiro; Murakami, Satsuki; Higuchi, Yusuke; Taji, Hirofumi; Yamamoto, Kazuhito; Kinoshita, Tomohiro] Aichi Canc Ctr Hosp, Dept Hematol & Cell Therapy, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Kodaira, Takeshi] Aichi Canc Ctr Hosp, Dept Radiat Oncol, Nagoya, Aichi 4648681, Japan; [Yatabe, Yasushi; Nakamura, Shigeo] Aichi Canc Ctr Hosp, Dept Pathol & Mol Diagnost, Nagoya, Aichi 4648681, Japan; [Nakamura, Shigeo] Nagoya Univ Hosp, Dept Pathol & Clin Labs, Nagoya, Aichi, Japan	Kato, H (reprint author), Aichi Canc Ctr Hosp, Dept Hematol & Cell Therapy, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	hkato@aichi-cc.jp	Nakamura, Shigeo/I-1571-2012				Hoelzer D, 2002, BLOOD, V99, P4379, DOI 10.1182/blood-2002-01-0110; Sakata K, 2006, RADIOTHER ONCOL, V79, P179, DOI 10.1016/j.radonc.2006.03.014; Hunault-Berger M, 2011, HAEMATOL-HEMATOL J, V96, P245, DOI 10.3324/haematol.2010.027862; [Anonymous], 1997, BLOOD, V89, P3909; Thomas DA, 2004, BLOOD, V104, P1624, DOI 10.1182/blood-2003-12-4428; Sive JI, 2012, BRIT J HAEMATOL, V157, P463, DOI 10.1111/j.1365-2141.2012.09095.x; Landsburg DJ, 2013, AM J HEMATOL, V88, P657, DOI 10.1002/ajh.23468	7	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0939-5555	1432-0584		ANN HEMATOL	Ann. Hematol.	JAN	2015	94	1					173	175		10.1007/s00277-014-2128-7		3	Hematology	Hematology	AX8GX	WOS:000347149100021		
J	Yamamoto, K; Yakushijin, K; Sanada, Y; Kawamoto, S; Nakamachi, Y; Kawano, S; Matsuoka, H; Minami, H				Yamamoto, Katsuya; Yakushijin, Kimikazu; Sanada, Yukinari; Kawamoto, Shinichiro; Nakamachi, Yuji; Kawano, Seiji; Matsuoka, Hiroshi; Minami, Hironobu			Conversion from nuclear bilobation to indentation in BCR/ABL1-positive acute myeloid leukemia lacking CD34 and HLA-DR expression	ANNALS OF HEMATOLOGY			English	Letter							INTERNAL TANDEM DUPLICATION; FEATURES		[Yamamoto, Katsuya; Yakushijin, Kimikazu; Sanada, Yukinari; Kawamoto, Shinichiro; Matsuoka, Hiroshi; Minami, Hironobu] Kobe Univ, Grad Sch Med, Dept Med, Div Med Oncol Hematol,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Nakamachi, Yuji; Kawano, Seiji] Kobe Univ Hosp, Div Clin Lab, Kobe, Hyogo, Japan	Yamamoto, K (reprint author), Kobe Univ, Grad Sch Med, Dept Med, Div Med Oncol Hematol,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	kyamamo@med.kobe-u.ac.jp					Andersen MT, 2008, LEUKEMIA, V22, P951, DOI 10.1038/leu.2008.17; Chen WN, 2009, CANCER, V115, P5481, DOI 10.1002/cncr.24610; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Arber DA, 2008, WHO CLASSIFICATION T, P112; Carluccio P, 2014, EUR J HAEMATOL, V92, P121, DOI 10.1111/ejh.12217; Konoplev S, 2013, LEUKEMIA LYMPHOMA, V54, P138, DOI 10.3109/10428194.2012.701739; Kussick SJ, 2004, LEUKEMIA, V18, P1591, DOI 10.1038/sj.leu.2403458; Nagendra S, 2002, AM J CLIN PATHOL, V117, P651; Sakai H, 2013, BRIT J HAEMATOL, V162, P145, DOI 10.1111/bjh.12411	9	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0939-5555	1432-0584		ANN HEMATOL	Ann. Hematol.	JAN	2015	94	1					177	179		10.1007/s00277-014-2133-x		3	Hematology	Hematology	AX8GX	WOS:000347149100022		
J	Imai, H; Mori, K; Wakuda, K; Ono, A; Akamatsu, H; Shukuya, T; Taira, T; Kenmotsu, H; Naito, T; Kaira, K; Murakami, H; Endo, M; Nakajima, T; Yamamoto, N; Takahashi, T				Imai, Hisao; Mori, Keita; Wakuda, Kazushige; Ono, Akira; Akamatsu, Hiroaki; Shukuya, Takehito; Taira, Tetsuhiko; Kenmotsu, Hirotsugu; Naito, Tateaki; Kaira, Kyoichi; Murakami, Haruyasu; Endo, Masahiro; Nakajima, Takashi; Yamamoto, Nobuyuki; Takahashi, Toshiaki			Progression-free survival, post-progression survival, and tumor response as surrogate markers for overall survival in patients with extensive small cell lung cancer	ANNALS OF THORACIC MEDICINE			English	Article						Extensive small cell lung cancer; overall survival; post-progression survival; progression-free survival; tumor response	PHASE-III TRIAL; COLORECTAL-CANCER; END-POINTS; TOPOTECAN; THERAPY; TIME	OBJECTIVES: The effects of first-line chemotherapy on overall survival (OS) might be confounded by subsequent therapies in patients with small cell lung cancer (SCLC). We examined whether progression-free survival (PFS), post-progression survival (PPS), and tumor response could be valid surrogate endpoints for OS after first-line chemotherapies for patients with extensive SCLC using individual-level data. METHODS: Between September 2002 and November 2012, we analyzed 49 cases of patients with extensive SCLC who were treated with cisplatin and irinotecan as first-line chemotherapy. The relationships of PFS, PPS, and tumor response with OS were analyzed at the individual level. RESULTS: Spearman rank correlation analysis and linear regression analysis showed that PPS was strongly correlated with OS (r = 0.97, p < 0.05, R-2 = 0.94), PFS was moderately correlated with OS (r = 0.58, p < 0.05, R-2 = 0.24), and tumor shrinkage was weakly correlated with OS (r = 0.37, p < 0.05, R-2 = 0.13). The best response to second-line treatment, and the number of regimens employed after progression beyond first-line chemotherapy were both significantly associated with PPS (p = 0.05). CONCLUSION: PPS is a potential surrogate for OS in patients with extensive SCLC. Our findings also suggest that subsequent treatment after disease progression following first-line chemotherapy may greatly influence OS.	[Imai, Hisao; Wakuda, Kazushige; Ono, Akira; Akamatsu, Hiroaki; Shukuya, Takehito; Taira, Tetsuhiko; Kenmotsu, Hirotsugu; Naito, Tateaki; Kaira, Kyoichi; Murakami, Haruyasu; Yamamoto, Nobuyuki; Takahashi, Toshiaki] Shizuoka Canc Ctr, Div Thorac Oncol, Nagaizumi, Shizuoka 4118777, Japan; [Mori, Keita] Shizuoka Canc Ctr, Clin Trial Coordinat Off, Nagaizumi, Shizuoka 4118777, Japan; [Endo, Masahiro] Shizuoka Canc Ctr, Div Diagnost Radiol, Nagaizumi, Shizuoka 4118777, Japan; [Nakajima, Takashi] Shizuoka Canc Ctr, Div Diagnost Pathol, Nagaizumi, Shizuoka 4118777, Japan; [Yamamoto, Nobuyuki] Wakayama Med Univ, Dept Internal Med 3, Wakayama, Japan	Imai, H (reprint author), Shizuoka Canc Ctr, Div Thorac Oncol, Nagaizumi, Shizuoka 4118777, Japan.	m06701014@gunma-u.ac					Sundar S, 2012, GYNECOL ONCOL, V125, P493, DOI 10.1016/j.ygyno.2011.12.420; Weir CJ, 2006, STAT MED, V25, P183, DOI 10.1002/sim.2319; Reck M, 2009, J CLIN ONCOL, V27, P1227, DOI 10.1200/JCO.2007.14.5466; Fleischer F, 2009, STAT MED, V28, P2669, DOI 10.1002/sim.3637; O'Brien MER, 2006, J CLIN ONCOL, V24, P5441, DOI 10.1200/JCO.2006.06.5821; Jotte R, 2011, J CLIN ONCOL, V29, P287, DOI 10.1200/JCO.2010.29.8851; Inoue A, 2008, J CLIN ONCOL, V26, P5401, DOI 10.1200/JCO.2008.18.1974; Kalemkerian GP, 2013, J NATL COMPR CANC NE, V11, P78; Johnson KR, 2006, LANCET ONCOL, V7, P741, DOI 10.1016/S1470-2045(06)70800-2; Saad ED, 2010, J CLIN ONCOL, V28, P1958, DOI 10.1200/JCO.2009.25.5414; Broglio KR, 2009, JNCI-J NATL CANCER I, V101, P1642, DOI 10.1093/jnci/djp369; Hayashi H, 2012, ANN ONCOL, V23, P1537, DOI 10.1093/annonc/mdr487; van Meerbeeck JP, 2011, LANCET, V378, P1741, DOI 10.1016/S0140-6736(11)60165-7; Eckardt JR, 2007, J CLIN ONCOL, V25, P2086, DOI 10.1200/JCO.2006.08.3998; Foster NR, 2011, CANCER-AM CANCER SOC, V117, P1262, DOI 10.1002/cncr.25526; Hotta K, 2009, J THORAC ONCOL, V4, P311, DOI 10.1097/JTO.0b013e3181989bd2; von Pawel J, 1999, J CLIN ONCOL, V17, P658; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Petrelli F, 2013, ANN ONCOL, V24, P186, DOI 10.1093/annonc/mds289; Hotta K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026646; Imai H, 2013, NEOPLASMA, V61, P233; Jotte R, 2011, J CLIN ONCOL S15, V29; Noda Kazumasa, 2002, New England Journal of Medicine, V346, P85, DOI 10.1056/NEJMoa003034	23	3	3	SAUDI THORACIC SOC	RIYADH	PO BOX 106911, RIYADH, 11676, SAUDI ARABIA	1817-1737	1998-3557		ANN THORAC MED	Ann. Thorac. Med.	JAN-MAR	2015	10	1					61	66		10.4103/1817-1737.146885		6	Cardiac & Cardiovascular Systems; Respiratory System	Cardiovascular System & Cardiology; Respiratory System	AX4NP	WOS:000346909400011		
J	Shimizu, A; Kasegawa, H; Tabata, M; Fukui, T; Takanashi, S				Shimizu, Atsushi; Kasegawa, Hitoshi; Tabata, Minoru; Fukui, Toshihiro; Takanashi, Shuichiro			Long-Term Outcomes of Mitral Valve Repair for Isolated Commissural Prolapse: Up to 17-Year Experience	ANNALS OF THORACIC SURGERY			English	Article							DEGENERATIVE DISEASE; ECHOCARDIOGRAPHY; REGURGITATION; ANNULOPLASTY; REPLACEMENT; ANTERIOR	Background. Mitral valve repair has been shown to be effective for degenerative mitral regurgitation (MR). However, outcomes of mitral valve repair for commissural prolapse has not been well defined. Commissural prolapse has been often categorized into the groups of posterior leaflet prolapse or bileaflet prolapse, and outcomes and prognosis of isolated commissural prolapse has been rarely reported. We aimed to determine clinical and echocardiographic outcomes of mitral valve repair for isolated commissural lesion. Methods. Between 1992 and 2010, 1,112 patients underwent mitral valve repair for degenerative MR at our institution. Among those, we reviewed 122 patients with isolated commissural prolapse. We analyzed operative outcomes, long-term survival rate, freedom from reoperation rate, and freedom from recurrent moderate or severe MR rate. Results. The mean age was 57.0 +/- 14.4 years old, 83 patients (68.0%) were men, 16 patients (13.1%) had infective endocarditis, 43 patients (35.2%) had atrial fibrillation, 27 patients (22.1%) had anterolateral commissural prolapse, 91 (74.6%) had posteromedial commissural prolapse, and 4 (3.3%) had bilateral commissural prolapse. We performed leaflet resection in 111 (91.0%) (concomitant sliding plasty in 43), chordal replacement in 94 (77.0%), and ring annuloplasty in 121 patients (99.2%). Residual mild MR was confirmed in 7 patients (5.7%) on predischarge echocardiography. No patients had moderate or severe MR at the time of discharge. Fifteen-year survival and freedom from mitral reoperation were 87.6% and 93.0%, respectively. Freedom from recurrent moderate or severe MR at 15 years was 87.4%. Conclusions. Mitral valve repair for isolated commissural prolapse demonstrated excellent early and late outcomes. (C) 2015 by The Society of Thoracic Surgeons	[Shimizu, Atsushi; Kasegawa, Hitoshi; Tabata, Minoru; Fukui, Toshihiro; Takanashi, Shuichiro] Sakakibara Heart Inst, Dept Cardiovasc Surg, Fuchu, Tokyo 1830003, Japan	Kasegawa, H (reprint author), Sakakibara Heart Inst, Dept Cardiovasc Surg, 3-16-1 Asahi Cho, Fuchu, Tokyo 1830003, Japan.	zbn25716@nifty.com					Alvarez JM, 1996, J THORAC CARDIOV SUR, V112, P238, DOI 10.1016/S0022-5223(96)70244-1; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3; CARPENTIER A, 1983, J THORAC CARDIOV SUR, V86, P323; David TE, 2005, J THORAC CARDIOV SUR, V130, P1242, DOI 10.1016/j.jtcvs.2005.06.046; Adams DH, 2006, ANN THORAC SURG, V82, P2096, DOI 10.1016/j.athoracsur.2006.06.043; Gillinov AM, 1998, J THORAC CARDIOV SUR, V116, P734, DOI 10.1016/S0022-5223(98)00450-4; David TE, 2013, J THORAC CARDIOV SUR, V145, P1563, DOI 10.1016/j.jtcvs.2012.05.030; Gillinov AM, 2008, J THORAC CARDIOV SUR, V135, P885, DOI 10.1016/j.jtcvs.2007.11.039; [Anonymous], 2006, CIRCULATION, V114, pe84; Braunberger E, 2001, CIRCULATION S1, V104, P18411; De Bonis M, 2014, J THORAC CARDIOV SUR, V147, P1900, DOI 10.1016/j.jtcvs.2013.07.009; Duran CMG, 1999, J CARDIAC SURG, V14, P471; KASEGAWA H, 1994, ANN THORAC SURG, V57, P237; Kasegawa H, 2008, J HEART VALVE DIS, V17, P162	14	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	JAN	2015	99	1					43	47		10.1016/j.athoracsur.2014.04.144		5	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	AX6KI	WOS:000347030800016		
J	Miyahara, S; Nakai, H; Izawa, N; Yamanaka, K; Sakamoto, T; Nomura, Y; Inoue, T; Matsumori, M; Okada, K; Okita, Y				Miyahara, Shunsuke; Nakai, Hidekazu; Izawa, Naoto; Yamanaka, Katsuhiro; Sakamoto, Toshihito; Nomura, Yoshikatsu; Inoue, Takeshi; Matsumori, Masamichi; Okada, Kenji; Okita, Yutaka			Influences of Chronic Obstructive Pulmonary Disease on Outcomes of Total Arch Replacement	ANNALS OF THORACIC SURGERY			English	Article							AORTIC-VALVE-REPLACEMENT; SURGERY; HYPOTHERMIA; PREDICTORS; PERFUSION; GRAFT	Background. Although an association between chronic obstructive pulmonary disease (COPD) and adverse surgical outcomes has been proposed, the impact of COPD severity on postoperative outcomes remains unclear. Our objective was to analyze the prognostic implication of COPD severity on outcomes after total aortic arch replacement. Methods. Between October 1999 and December 2012, 269 patients undergoing total arch replacement through median sternotomy, who were elective cases with pre-operative spirometry records, were retrospectively reviewed. Patients were divided into four groups: control group, with ratio of forced expiratory volume of air in 1 second (FEV1) to forced vital capacity (FVC) of 70% or greater; mild airflow obstruction, with FEV1/FVC ratio less than 70% and FEV1 80% or greater of predicted; moderate airflow obstruction, FEV1/FVC ratio less than 70% and FEV1 50% to 79% of predicted; severe airflow obstruction, FEV1/FVC ratio less than 70% and FEV1 less than 50% of predicted. Symptoms of functional dyspnea and disability were also assessed. Multivariate logistic and Cox regression methods were used to determine if there was an independent association between COPD and short-term and long-term outcomes, respectively. Results. The in-hospital mortality rate was 2.2% (6 of 269). A consistent trend of increasing frequency of postoperative respiratory complications with advanced airflow obstruction was noted. In multivariate analysis, in-hospital mortality (p = 0.022), incidence of respiratory complications (p = 0.021) and overall mortality (p = 0.025) was significantly associated with the symptoms of COPD, respectively. Conclusions. The severity of COPD as defined by spirometry and symptoms of functional dyspnea may be an important prognostic marker of patients undergoing total arch replacement. (C) 2015 by The Society of Thoracic Surgeons	Kobe Univ, Dept Surg, Div Cardiovasc Surg, Grad Sch Med, Kobe, Hyogo 6500017, Japan	Okita, Y (reprint author), Kobe Univ, Sch Med, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	yokita@med.kobe-u.ac.jp					Amano Jun, 2013, Gen Thorac Cardiovasc Surg, V61, P578, DOI 10.1007/s11748-013-0289-2; Milewski RK, 2010, J THORAC CARDIOV SUR, V140, P590, DOI 10.1016/j.jtcvs.2010.02.055; Bestall JC, 1999, THORAX, V54, P581; Kulik A, 2011, ANN THORAC SURG, V92, P889, DOI 10.1016/j.athoracsur.2011.04.067; Di Eusanio M, 2011, J THORAC CARDIOV SUR, V141, P940, DOI 10.1016/j.jtcvs.2010.05.044; Okada K, 2012, J THORAC CARDIOV SUR, V144, P139, DOI 10.1016/j.jtcvs.2011.08.039; Dunning J, 2011, J THORAC CARDIOV SUR, V142, P776, DOI 10.1016/j.jtcvs.2011.04.048; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Asimakopoulos G, 1999, ANN THORAC SURG, V68, P1107, DOI 10.1016/S0003-4975(99)00781-X; Grossi EA, 2008, ANN THORAC SURG, V85, P102, DOI 10.1016/j.athoracsur.2007.05.010; Asano Mitsuru, 2007, Interact Cardiovasc Thorac Surg, V6, P283, DOI 10.1510/icvts.2006.144428; Iba Y, 2013, J THORAC CARDIOVAS S, V145, P72; Matsuyama S, 2012, J THORAC CARDIOV SUR, V143, P1377, DOI 10.1016/j.jtcvs.2011.07.016; Morimoto N, 2008, EUR J CARDIO-THORAC, V34, P798, DOI 10.1016/j.ejcts.2008.07.010; Motomura N, 2008, CIRCULATION S, V118, P153; Nashef SAM, 2012, EUR J CARDIO-THORAC, V41, P734, DOI 10.1093/ejcts/ezs043; Ohta N, 2006, J VASC SURG, V43, P721, DOI 10.1016/j.jvs.2005.11.054; Okita Y, 2013, J THORAC CARDIOVAS S, V145, P63; Pacini D, 2012, EUR J CARDIO-THORAC, V42, P249, DOI 10.1093/ejcts/ezr304; Toda R, 2009, INTERNAL MED, V48, P513, DOI 10.2169/internalmedicine.48.1781	20	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	JAN	2015	99	1					72	78		10.1016/j.athoracsur.2014.08.031		7	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	AX6KI	WOS:000347030800022		
J	Arakawa, M; Miyata, H; Uchida, N; Motomura, N; Katayama, A; Tamura, K; Sueda, T; Takamoto, S				Arakawa, Miwa; Miyata, Hiroaki; Uchida, Naomichi; Motomura, Noboru; Katayama, Akira; Tamura, Kentaro; Sueda, Taijiro; Takamoto, Shinichi			Postoperative Atrial Fibrillation After Thoracic Aortic Surgery	ANNALS OF THORACIC SURGERY			English	Article							ARTERY-BYPASS GRAFT; CARDIAC-SURGERY; ARRHYTHMIAS; PREVENTION; INFLAMMATION; POPULATION; MORTALITY; HEART	Background. Postoperative atrial fibrillation (POAF) increases considerably the chances of morbidity and mortality after cardiac surgery. The objective of this study was to identify the major risk factors responsible for POAF after thoracic aortic surgery in order to define preventive measures. Methods. We analyzed 12,260 records (between January 1, 2004, and December 31, 2008) obtained from the Japan Adult Cardiovascular Surgery Database. Patients with history of AF were excluded. Data were collected for 12 preoperative and 10 operative risk factors that had been proven or believed to influence POAF. The relationship between the risk factors and outcome was assessed by the Fisher exact test, Student t test, and multiple logistic regression analysis. Results. The patients' mean age (+/- standard deviation) was 67.5 +/- 12.7 years, and 27% of the subjects were women. The incidence of POAF was 17.1%. The following risk factors were associated with increased POAF: age p < 0.0001), history of smoking (p < = 0.020), hypertension (p = 0.020), congestive heart failure (p < 0.0001), urgent operation (p = 0.023), and concomitant with nonelective coronary artery bypass (p = 0.022). Postoperative mortality and postoperative stroke were significantly increased in patients with POAF (p < 0.0001 in both cases). The odds ratios for the POAF risk factors were as follows: replacement of the ascending aorta, 1.67; aortic arch, 1.62; aortic root, 1.42; concomitant with valve operation, 1.35; age, 1.27; and urgent operation, 1.22. Conclusions. Several risk factors contribute to the incidence of POAF after thoracic aortic surgery. We found that POAF significantly increased 30-day operative mortality (p < 0.0001). Our findings can be used to develop a risk stratification system for the prediction of POAF. (C) 2015 by The Society of Thoracic Surgeons	Hiroshima City Asa Hosp, Dept Cardiovasc Surg, Hiroshima, Japan; Univ Tokyo, Grad Sch Med, Dept Healthcare Qual Assessment, Tokyo, Japan; Tsuchiya Gen Hosp, Dept Cardiovasc Surg, Hiroshima, Japan; Sakakibara Heart Inst Okayama, Dept Cardiovasc Surg, Okayama, Japan; Hiroshima Univ, Dept Surg, Grad Sch Biomed Sci, Hiroshima, Japan; Mitsui Mem Hosp, Dept Cardiovasc Surg, Tokyo 101, Japan	Arakawa, M (reprint author), 2-1-1 Kabeminami,Asakita Ku, Hiroshima 7310293, Japan.	sutohmiwa@gmail.com					Halonen J, 2010, ANN INTERN MED, V153, P703, DOI [10.7326/0003-4819-153-11-201012070-00003, 10.1059/0003-4819-153-11-201012070-00003]; ANDREWS TC, 1991, CIRCULATION, V84, P236; KONINGS KTS, 1994, CIRCULATION, V89, P1665; Motomura N, 2008, CIRCULATION, V118, pS153, DOI 10.1161/CIRCULATIONAHA.107.756684; Maisel WH, 2001, ANN INTERN MED, V135, P1061; Lamm G, 2006, J CARDIOTHOR VASC AN, V20, P51, DOI 10.1053/j.jvca.2005.03.026; Tselentakis EV, 2006, J SURG RES, V135, P68, DOI 10.1016/j.jss.2006.03.024; CRESWELL LL, 1993, ANN THORAC SURG, V56, P539; Echahidi N, 2008, J AM COLL CARDIOL, V51, P793, DOI 10.1016/j.jacc.2007.10.043; Ishii Y, 2005, CIRCULATION, V111, P2881, DOI 10.1161/CIRCULATIONAHA.104.475194; Abdelhadi RH, 2004, AM J CARDIOL, V93, P1176, DOI 10.1016/j.amjcard.2004.01.053; LEVY MN, 1971, CIRC RES, V29, P437; Hogue CW, 1998, CIRCULATION, V98, P429; El-Chami MF, 2010, J AM COLL CARDIOL, V55, P1370, DOI 10.1016/j.jacc.2009.10.058; Mariscalco G, 2009, ANN THORAC SURG, V88, P1871, DOI 10.1016/j.athoracsur.2009.07.074; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Cox J L, 1999, Semin Thorac Cardiovasc Surg, V11, P299; Fujita T, 2010, J THORAC CARDIOV SUR, V140, P1332, DOI 10.1016/j.jtcvs.2010.01.030; Fuster V, 2006, J AM COLL CARDIOL, V48, P854, DOI 10.1016/j.jacc.2006.07.009; Kowey PR, 1997, AM J CARDIOL, V79, P1114	20	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	JAN	2015	99	1					103	108		10.1016/j.athoracsur.2014.08.019		6	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	AX6KI	WOS:000347030800030		
J	Miyata, H; Tomotaki, A; Motomura, N; Takamoto, S				Miyata, Hiroaki; Tomotaki, Ai; Motomura, Noboru; Takamoto, Shinichi			Operative Mortality and Complication Risk Model for All Major Cardiovascular Operations in Japan	ANNALS OF THORACIC SURGERY			English	Article							BYPASS-GRAFTING SURGERY; VALVE SURGERY; AORTIC DISSECTION; 1ST REPORT; SOCIETY; DATABASE; 30-DAY	Background. The Japan Cardiovascular Surgery Database (JCVSD) is a nationwide benchmarking project to improve the quality of cardiovascular surgery in Japan. This study aimed to develop new JACVD risk models not only for operative mortality but also for each postoperative complication for coronary artery bypass grafting (CABG) operations, valve operations, and thoracic aortic operations. Methods. We analyzed 24,704 isolated CABG operations, 26,137 valve operations, and 18,228 thoracic aortic operations. Risk models were developed for each operation for operative death, permanent stroke, renal failure, prolonged ventilation (> 24 hours), deep sternal wound infection, and reoperation for bleeding. The population was divided into an 80% development sample and a 20% validation sample. The statistical model was constructed by multiple logistic regression analysis. Model discrimination was tested using the area under the receiver operating characteristic curve (C index). Results. The 30-day mortality rates for isolated CABG, valve, and thoracic aortic operations were 1.5%, 2.5%, and 6.0%, respectively, and operative mortality rates were 2.4%, 3.8%, and 8.4%, respectively. The C indices for the end points of isolated CABG, valve, and aortic thoracic operations were 0.6358 for (deep sternal infection) to 0.8655 (operative mortality), 0.6114 (reoperation for bleeding) to 0.8319 (operative death), and 0.6311 (gastrointestinal complication) to 0.7591 (operative death), respectively. Conclusions. These risk models increased the discriminatory power of former models. Thus, our models can be said to reflect the current state of Japan. With respect to major complications, useful feedback can now be provided through the Japan Cardiovascular Surgery Database Web-based system. (C) 2015 by The Society of Thoracic Surgeons	Univ Tokyo, Grad Sch Med, Dept Healthcare Qual Assessment, Tokyo, Japan; Japan Cardiovasc Surg Database Org, Tokyo, Japan	Miyata, H (reprint author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1138655, Japan.	hiroaki.miyata@gmail.com			JACVSD	We thank all of the data managers and hospitals that participated in the Japan Cardiovascular Surgery Database project for their great efforts in collecting data. S.T. received a research grant from the Management of JACVSD.	Shahian DM, 2009, ANN THORAC SURG, V88, pS43, DOI 10.1016/j.athoracsur.2009.05.055; Shahian DM, 2009, ANN THORAC SURG, V88, pS2, DOI 10.1016/j.athoracsur.2009.05.053; Motomura N, 2008, ANN THORAC SURG, V86, P1866, DOI 10.1016/j.athoracsur.2008.08.001; Motomura N, 2008, CIRCULATION, V118, pS153, DOI 10.1161/CIRCULATIONAHA.107.756684; Rankin JS, 2013, ANN THORAC SURG, V95, P1484, DOI 10.1016/j.athoracsur.2012.11.077; [Anonymous], 2011, GUID DIAGN TREATM AO; Raghupathy A, 2008, AM J CARDIOL, V102, P1562, DOI 10.1016/j.amjcard.2008.07.049; O'Brien SM, 2009, ANN THORAC SURG, V88, pS23, DOI 10.1016/j.athoracsur.2009.05.056; Motomura N, 2010, J HEART VALVE DIS, V19, P684; Nashef SAM, 2012, EUR J CARDIO-THORAC, V41, P734, DOI 10.1093/ejcts/ezs043; Steg PG, 2007, JAMA-J AM MED ASSOC, V297, P1197, DOI 10.1001/jama.297.11.1197; Williams ML, 2010, ANN THORAC SURG, V90, P1812, DOI 10.1016/j.athoracsur.2010.05.023; Williams ML, 2010, ANN THORAC SURG, V90, P1816	13	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	JAN	2015	99	1					130	139		10.1016/j.athoracsur.2014.07.038		10	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	AX6KI	WOS:000347030800037		
J	Asamura, H				Asamura, Hisao			INVITED COMMENTARY	ANNALS OF THORACIC SURGERY			English	Editorial Material							LUNG-CANCER; ADENOCARCINOMA		Natl Canc Ctr, Chuo Ku, Tokyo 1040045, Japan	Asamura, H (reprint author), Natl Canc Ctr, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	hasamura@ncc.go.jp					Suzuki K, 2002, ANN THORAC SURG, V74, P1635, DOI 10.1016/S0003-4975(02)03895-X; Asamura H, 2013, J THORAC CARDIOV SUR, V146, P24, DOI 10.1016/j.jtcvs.2012.12.047; NOGUCHI M, 1995, CANCER, V75, P2844, DOI 10.1002/1097-0142(19950615)75:12<2844::AID-CNCR2820751209>3.0.CO;2-#; Cho JH, 2015, ANN THORAC SURG, V99, P218, DOI 10.1016/j.athoracsur.2014.07.068; HOLMES CE, 1995, ANN THORAC SURG, V60, P615; Travis WD, 2011, J THORAC ONCOL, V6, P144	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	JAN	2015	99	1					222	223		10.1016/j.athoracsur.2014.08.014		3	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	AX6KI	WOS:000347030800056		
J	Anayama, T; Qiu, J; Chan, H; Nakajima, T; Weersink, R; Daly, M; McConnell, J; Waddell, T; Keshavjee, S; Jaffray, D; Irish, JC; Hirohashi, K; Wada, H; Orihashi, K; Yasufuku, K				Anayama, Takashi; Qiu, Jimmy; Chan, Harley; Nakajima, Takahiro; Weersink, Robert; Daly, Michael; McConnell, Judy; Waddell, Thomas; Keshavjee, Shaf; Jaffray, David; Irish, Jonathan C.; Hirohashi, Kentaro; Wada, Hironobu; Orihashi, Kazumasa; Yasufuku, Kazuhiro			Localization of Pulmonary Nodules Using Navigation Bronchoscope and a Near-Infrared Fluorescence Thoracoscope	ANNALS OF THORACIC SURGERY			English	Article							INDOCYANINE GREEN FLUORESCENCE; EARLY LUNG-CANCER; SPIRAL COMPUTED-TOMOGRAPHY; LYMPH-NODE BIOPSY; CONE-BEAM CT; ASYMPTOMATIC SMOKERS; SURGERY; RESECTION; MICROCOILS; ARM	Background. Video-assisted thoracoscopic wedge resection of multiple small, non-visible, and nonpalpable pulmonary nodules is a clinical challenge. We propose an ultra-minimally invasive technique for localization of pulmonary nodules using the electromagnetic navigation bronchoscope (ENB)-guided transbronchial indocyanine green (ICG) injection and intraoperative fluorescence detection with a near-infrared (NIR) fluorescence thoracoscope. Methods. Fluorescence properties of ICG topically injected into the lung parenchyma were determined using a resected porcine lung. The combination of ENB-guided ICG injection and NIR fluorescence detection was tested using a live porcine model. An electromagnetic sensor integrated flexible bronchoscope was geometrically registered to the three-dimensional chest computed tomographic image data by way of a real-time electromagnetic tracking system. The ICG mixed with iopamidol was injected into the pulmonary nodules by ENB guidance; ICG fluorescence was visualized by a near-infrared (NIR) thoracoscope. Results. The ICG existing under 24-mm depth of inflated lung was detectable by the NIR fluorescence thoracoscope. The size of the fluorescence spot made by 0.1 mL of ICG was 10.4 +/- 2.2 mm. An ICG or iopamidol spot remained at the injected point of the lung for more than 6 hours in vivo. The ICG fluorescence spot injected into the pulmonary nodule with ENB guidance was identified at the pulmonary nodule with the NIR thoracoscope. Conclusions. The ENB-guided transbronchial ICG injection and intraoperative NIR thoracoscopic detection is a feasible method to localize multiple pulmonary nodules. (C) 2015 by The Society of Thoracic Surgeons	Univ Hlth Network, Toronto Gen Hosp, Div Thorac Surg, Dept Surg, Toronto, ON M5G 2C4, Canada; Kochi Univ, Kochi Med Sch, Dept Surg 2, Kochi 780, Japan; Univ Hlth Network, Princess Margaret Hosp, Dept Radiat Med, Toronto, ON M5G 2C4, Canada; Princess Margaret Canc Ctr, Dept Otolaryngol Head & Neck Surgery Surg Oncol, Toronto, ON, Canada	Yasufuku, K (reprint author), Univ Hlth Network, Toronto Gen Hosp, Div Thorac Surg, 200 Elizabeth St, Toronto, ON M5G 2C4, Canada.	kazuhiro.yasufuku@uhn.ca					Powell TI, 2004, ANN SURG, V240, P481, DOI 10.1097/01.sla.0000137132.01881.57; Zaman M, 2012, INTERACT CARDIOV TH, V15, P266, DOI 10.1093/icvts/ivs068; Suzuki K, 1999, CHEST, V115, P563, DOI 10.1378/chest.115.2.563; Daly MJ, 2006, MED PHYS, V33, P3767, DOI 10.1118/1.2349687; Hirche C, 2010, BREAST CANCER RES TR, V121, P373, DOI 10.1007/s10549-010-0760-z; Swensen SJ, 2002, AM J RESP CRIT CARE, V165, P508, DOI 10.1164/rccm.2107006; Saito H, 2002, J THORAC CARDIOV SUR, V124, P1198, DOI 10.1067/mtc.2002.127331; Hutteman M, 2011, BREAST CANCER RES TR, V127, P163, DOI 10.1007/s10549-011-1419-0; Weersink RA, 2011, MED PHYS, V38, P6458, DOI 10.1118/1.3658569; Murawa D, 2009, BRIT J SURG, V96, P1289, DOI 10.1002/bjs.6721; Mayo JR, 2009, RADIOLOGY, V250, P576, DOI 10.1148/radiol.2502080442; Fujiwara M, 2009, J PLAST RECONSTR AES, V62, pE373, DOI 10.1016/j.bjps.2007.12.074; Fujisawa Y, 2012, J SURG ONCOL, V106, P41, DOI 10.1002/jso.23045; Bellomi M, 2010, ANN THORAC SURG, V90, P1759, DOI 10.1016/j.athoracsur.2010.08.016; Polom K, 2012, EJSO-EUR J SURG ONC, V38, P137, DOI 10.1016/j.ejso.2011.11.004; Jaffray DA, 2000, MED PHYS, V27, P1311, DOI 10.1118/1.599009; Namikawa K, 2011, EUR J DERMATOL, V21, P184, DOI 10.1684/ejd.2010.1237; Khereba M, 2012, J THORAC CARDIOV SUR, V144, P1160, DOI 10.1016/j.jtcvs.2012.08.034; Atuegwu NC, 2008, PHYS MED BIOL, V53, P4355, DOI 10.1088/0031-9155/53/16/009; Crane LM, 2010, J VIS EXP; Daly MJ, 2010, SPIE MED IMAGING, P7625; Diederich S, 2004, EUR RADIOL, V14, P691, DOI 10.1007/s00330-003-2200-5; Diederich S, 2002, RADIOLOGY, V222, P773, DOI 10.1148/radiol.2223010490; Hayashi T, 2012, HEAD NECK-J SCI SPEC, V34, P758, DOI 10.1002/hed.21651; Henschke CI, 2000, CANCER, V89, P2474; Ito N, 2004, SURG TODAY, V34, P581, DOI 10.1007/s00595-004-2780-y; Jaffray DA, 2002, P SOC PHOTO-OPT INS, V4682, P209, DOI 10.1117/12.465561; Jangra D, 2005, J INVEST SURG, V18, P265, DOI 10.1080/08941930500248946; Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Saito H, 2007, LUNG CANCER, V58, P348, DOI 10.1016/j.lungcan.2007.06.018; Sakamoto T, 2001, ANN THORAC SURG, V72, P296, DOI 10.1016/S0003-4975(01)02604-2; Siewerdsen JH, 2009, SPIE MED IMAGING, P7261; TEMPLETON PA, 1993, CHEST, V104, P953, DOI 10.1378/chest.104.3.953; Weiser TS, 2008, ANN THORAC SURG, V85, pS797, DOI 10.1016/j.athoracsur.2007.11.052; Wipper S, 2006, THESIS, P18	35	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	JAN	2015	99	1					224	230		10.1016/j.athoracsur.2014.07.050		7	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	AX6KI	WOS:000347030800057		
J	Numata, S; Samura, T; Tsutsumi, Y; Ohashi, H				Numata, Satoshi; Samura, Takaaki; Tsutsumi, Yasushi; Ohashi, Hirokazu			Paraplegia Due to Intramedullary Hemorrhage After Mitral Valve Repair	ANNALS OF THORACIC SURGERY			English	Article							SURGERY	We report the case of a patient who developed paraplegia after mitral valve repair and maze procedure. The first day after surgery, marked weakness of both lower extremities was noted. Neurologic examination showed almost complete loss of sensory and motor function below the level of the first thoracic vertebrae. Magnetic resonance imaging showed intramedullary hemorrhage ranging from the C7 to Th2 segments. Preoperative anticoagulation therapy and general heparinization during heart surgery may cause this rare complication. (C) 2015 by The Society of Thoracic Surgeons	[Numata, Satoshi; Samura, Takaaki; Tsutsumi, Yasushi; Ohashi, Hirokazu] Fukui Cardiovasc Ctr, Dept Cardiovasc Surg, Fukui 9100833, Japan	Numata, S (reprint author), Fukui Cardiovasc Ctr, Dept Cardiovasc Surg, 2-228 Shinpo, Fukui 9100833, Japan.	snumat@yahoo.co.jp					Kreppel D, 2003, NEUROSURG REV, V26, P1, DOI 10.1007/s10143-002-0224-y; Miranda M, 2014, ANN THORAC SURG, V97, P326, DOI 10.1016/j.athoracsur.2013.06.103; Pelletier MP, 2002, J CARDIAC SURG, V17, P410; Saxena P, 2012, J CARDIAC SURG, V27, P45, DOI 10.1111/j.1540-8191.2011.01330.x; Thomas NJ, 1999, J THORAC CARDIOVASC, V114, P834	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	JAN	2015	99	1					302	303		10.1016/j.athoracsur.2014.03.050		2	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	AX6KI	WOS:000347030800075		
J	Kanzaki, T; Yamagishi, M; Miyazaki, T; Maeda, Y; Yaku, H				Kanzaki, Tomohito; Yamagishi, Masaaki; Miyazaki, Takako; Maeda, Yoshinobu; Yaku, Hitoshi			Valve-Sparing Neoaortic Root Replacement Late After the Norwood and Fontan Procedures	ANNALS OF THORACIC SURGERY			English	Article							LEFT-HEART SYNDROME	Neoaortic root dilatation is a significant and inevitable late complication in patients after the Norwood operation. In this report, we describe a patient who had left pulmonary artery compression and severe neoaortic regurgitation from a severely dilated neoaortic root 11 years after the Norwood operation and subsequent Fontan procedure. We performed successful valve-sparing neoaortic root replacement in this patient. (C) 2015 by The Society of Thoracic Surgeons	Kyoto Prefectural Univ Med, Dept Pediat Cardiovasc Surg, Childrens Med Ctr, Kyoto 6028566, Japan; Kyoto Prefectural Univ Med, Dept Surg, Div Cardiovasc Surg, Kyoto 6028566, Japan	Kanzaki, T (reprint author), Kyoto Prefectural Univ Med, Dept Pediat Cardiovasc Surg, Childrens Med Ctr, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	tomo20kp@yahoo.co.jp					Elefteriades JA, 2002, ANN THORAC SURG, V74, pS1877, DOI 10.1016/S0003-4975(02)04147-4; Cohen MS, 2003, J AM COLL CARDIOL, V42, P533, DOI 10.1016/S0735-1097(03)00715-0; Lalezari S, 2003, J THORAC CARDIOV SUR, V126, P1053, DOI 10.1016/S0022-5223(03)00971-1; Coselli JS, 2002, ANN THORAC SURG, V74, pS1892, DOI 10.1016/S0003-4975(02)04262-5; Erez E, 2012, J HEART VALVE DIS, V21, P175; Luciani GB, 2003, CIRCULATION, V108, P61, DOI 10.1161/01.cir.0000089183.92233.75; Pizarro C, 2011, J THORAC CARDIOV SUR, V141, P1083, DOI 10.1016/j.jtcvs.2010.07.076; Shuhaiber JH, 2006, J THORAC CARDIOV SUR, V131, P478, DOI 10.1016/j.jtcvs.2005.09.047	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	JAN	2015	99	1					309	312		10.1016/j.athoracsur.2014.02.084		5	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	AX6KI	WOS:000347030800079		
J	Nakamura, Y; Aoki, M; Hagino, I; Koshiyama, H; Akiyama, S; Fujiwara, T				Nakamura, Yuki; Aoki, Mitsuru; Hagino, Ikuo; Koshiyama, Hiroshi; Akiyama, Shou; Fujiwara, Tadashi			Biventricular Repair of Double-Outlet Right Ventricle and Closing Ventricular Septal Defect	ANNALS OF THORACIC SURGERY			English	Article							CREATION	We report an infant with double-outlet right ventricle and progressive left ventricular failure caused by a closing apical muscular ventricular septal defect detected during follow-up, who achieved successful biventricular repair after surgical opening and enlargement of a closed perimembranous ventricular septal defect. (C) 2015 by The Society of Thoracic Surgeons	[Nakamura, Yuki; Aoki, Mitsuru; Hagino, Ikuo; Koshiyama, Hiroshi; Akiyama, Shou; Fujiwara, Tadashi] Chiba Childrens Hosp, Dept Cardiovasc Surg, Chiba 2660007, Japan	Aoki, M (reprint author), Chiba Childrens Hosp, Dept Cardiovasc Surg, Midori Ku, 579-1 Heta, Chiba 2660007, Japan.	a.aoki@outlook.com					Cavalini JF, 1998, PEDIATR CARDIOL, V19, P490, DOI 10.1007/s002469900367; Lin CH, 2013, PEDIATR CARDIOL, V34, P743, DOI 10.1007/s00246-012-0337-1; MARINO B, 1983, BRIT HEART J, V49, P608; Meadows J, 2007, J THORAC CARDIOV SUR, V133, P912, DOI 10.1016/j.jtcvs.2006.09.037; SERRAF A, 1993, CIRCULATION, V88, P177	5	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	JAN	2015	99	1					312	314		10.1016/j.athoracsur.2014.02.074		4	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	AX6KI	WOS:000347030800080		
J	Watanabe, Y; Sato, M; Nakamura, Y; Hoshikawa, Y; Harada, A; Nagata, T; Yotsumoto, G; Imoto, Y; Okada, Y; Kondo, T				Watanabe, Yui; Sato, Masami; Nakamura, Yoshihiro; Hoshikawa, Yasushi; Harada, Aya; Nagata, Toshiyuki; Yotsumoto, Goichi; Imoto, Yutaka; Okada, Yoshinori; Kondo, Takashi			Right Lower Lobe Autotransplantation for Locally Advanced Central Lung Cancer	ANNALS OF THORACIC SURGERY			English	Article							PNEUMONECTOMY	A 44-year-old man with locally advanced central lung cancer was treated by right lower lobe lung autotransplantation after pneumonectomy using an extracellular phosphate-buffered solution for cold lung preservation. The advantage of the ex vivo operation made it possible to perform safe and definitive cancer resection without massive bleeding. Cold lung preservation brought some advantages, such as reducing the risk of ischemia-reperfusion injury compared with warm ischemia and allowing enough time to achieve microscopically negative margins. The patient returned to normal life with minimum loss of pulmonary reserve and no recurrence of lung cancer for 6 months. (C) 2015 by The Society of Thoracic Surgeons	[Sato, Masami] Kagoshima Univ, Dept Gen Thorac Surg, Grad Sch Med & Dent Sci, Kagoshima 8908520, Japan; Tohoku Univ, Dept Thorac Surg, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; Kagoshima Univ, Dept Cardiovasc & Gastroenterol Surg, Grad Sch Med & Dent Sci, Kagoshima 8908520, Japan	Sato, M (reprint author), Kagoshima Univ, Dept Gen Thorac Surg, Grad Sch Med & Dent Sci, 8-35-1 Sakuragaoka, Kagoshima 8908520, Japan.	m-sato@m2.kufm.kagoshima-u.ac.jp					Berthet JP, 2013, ANN THORAC SURG, V96, P1988, DOI 10.1016/j.athoracsur.2013.07.011; Jiang F, 2008, J THORAC ONCOL, V3, P609, DOI 10.1097/JTO.0b013e31817589a8; Noda M, 2013, ANN THORAC SURG, V96, pE17, DOI 10.1016/j.athoracsur.2013.01.029; Okada Y, 2012, SURG TODAY, V42, P152, DOI 10.1007/s00595-011-0052-1; Oto T, 2012, EUR J CARDIO-THORAC, V42, P579, DOI 10.1093/ejcts/ezs224; Reardon MJ, 2004, TEX HEART I J, V31, P360	6	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	JAN	2015	99	1					323	326		10.1016/j.athoracsur.2014.02.065		5	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	AX6KI	WOS:000347030800085		
J	Watanabe, G; Ishikawa, N				Watanabe, Go; Ishikawa, Norihiko			Use of Barbed Suture in Robot-Assisted Mitral Valvuloplasty	ANNALS OF THORACIC SURGERY			English	Article							ANNULOPLASTY; CLIPS	Robot-assisted annuloplasty using a mitral band has a major issue: suturing is time consuming because knot tying is performed mechanically under endoscopic view. We suture the mitral band to the native valve by running sutures using the V-Loc barbed suture nonabsorbable wound closure device (Covidien, Mansfield, MA) with 3-0 monofilament. This technique allows rapid suturing of the band to the valve. Although conventional interrupted sutures leave multiple knots protruding on the band, using the V-Loc eliminates the need to tie surgical knots and leaves a clean surface, which may potentially reduce the risk of thrombogenesis. This method is highly useful for robotic mitral annuloplasty. (C) 2015 by The Society of Thoracic Surgeons	[Watanabe, Go; Ishikawa, Norihiko] Kanazawa Univ, Grad Sch Med Sci, Dept Gen & Cardiothorac Surg, Kanazawa, Ishikawa, Japan	Watanabe, G (reprint author), New Heart Watanabe Inst, Suginami Ku, 3-19-11 Hamadayama, Tokyo 1680065, Japan.	watago6633@gmail.com					von Oppell UO, 2000, ANN THORAC SURG, V70, P2166, DOI 10.1016/S0003-4975(00)02047-6; Cook RC, 2007, J THORAC CARDIOV SUR, V133, P1264, DOI 10.1016/j.jtcvs.2006.10.079; Reade CC, 2005, ANN THORAC SURG, V79, P1372, DOI 10.1016/j.athoracsur.2004.02.072	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	JAN	2015	99	1					343	345		10.1016/j.athoracsur.2014.07.054		3	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	AX6KI	WOS:000347030800095		
J	Fujiwara, A; Inoue, M; Kusumoto, H; Shintani, Y; Maeda, T; Okumura, M				Fujiwara, Ayako; Inoue, Masayoshi; Kusumoto, Hidenori; Shintani, Yasushi; Maeda, Tetsuo; Okumura, Meinoshin			Myasthenic Crisis Caused By Preoperative Chemotherapy With Steroid for Advanced Thymoma	ANNALS OF THORACIC SURGERY			English	Article							GRAVIS	We report the case of a 44-year-old woman with Masaoka stage IV, World Health Organization type B1 thymoma associated with pure red cell aplasia, thrombocytopenia, and myasthenia gravis, which occurred during preoperative chemotherapy with high-dose methylprednisolone. Noninvasive positive-pressure ventilation, intravenous immunoglobulin infusion, and methylprednisolone pulse therapy were performed for the myasthenic crisis. Disseminated thymoma was markedly reduced after these treatments, and macroscopic complete resection was performed after achieving control of pure red cell aplasia, myasthenia gravis, and thrombocytopenia using cyclosporine A. Chemotherapy, including high-dose methylprednisolone, may carry a risk of myasthenic crisis, although the regimen is effective against lymphocyte-rich thymoma. (C) 2015 by The Society of Thoracic Surgeons	Osaka Univ, Grad Sch Med, Dept Gen Thorac Surg, Osaka, Japan; Osaka Univ, Grad Sch Med, Dept Hematol, Osaka, Japan	Inoue, M (reprint author), Osaka Univ, Grad Sch Med, Dept Gen Thorac Surg, 2-2 L5, Suita, Osaka 5650871, Japan.	mi@thoracic.med.osaka-u.ac.jp					Kobayashi Y, 2006, CANCER, V106, P1901, DOI 10.1002/cncr.21875; Spaggiari L, 2012, CURR OPIN ONCOL, V24, P117, DOI 10.1097/CCO.0b013e32834ea6bb; Shelly S, 2011, CELL MOL IMMUNOL, V8, P199, DOI 10.1038/cmi.2010.74; Bae JS, 2006, J CLIN NEUROSCI, V13, P1006, DOI 10.1016/j.jocn.2005.12.041; CHRISTENSEN PB, 1995, ACTA NEUROL SCAND, V91, P192; Funakoshi Y, 2005, J CANCER RES CLIN, V131, P314, DOI 10.1007/s00432-004-0646-8; Venuta Federico, 2012, Gen Thorac Cardiovasc Surg, V60, P1, DOI 10.1007/s11748-011-0814-0	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	JAN	2015	99	1					E11	E13		10.1016/j.athoracsur.2014.10.022		3	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	AX6KI	WOS:000347030800004		
J	Hamaji, M; Neal, JW; Burt, BM				Hamaji, Masatsugu; Neal, Joel W.; Burt, Bryan M.			Unicentric, Multifocal Castleman Disease of the Mediastinum Associated With Cerebellitis	ANNALS OF THORACIC SURGERY			English	Article								A 30-year-old man presented with rapidly progressive cerebellar symptoms. Brain magnetic resonance imaging was consistent with cerebellitis. A subsequent chest computed tomography revealed a multilobulated anterior mediastinal mass, which was diagnosed on the surgical biopsy specimen as hyaline vascular Castleman disease. After resection of the mediastinal mass and multiple involved adjacent mediastinal lymph nodes, the cerebellitis resolved. To the best of our knowledge, this is the first report of Castleman disease associated with cerebellitis. This rare case of suspected paraneoplastic cerebellitis related to a multifocal unicentric Castleman disease confined to the mediastinum is discussed. (C) 2015 by The Society of Thoracic Surgeons	Kyoto Univ, Dept Thorac Surg, Kyoto, Japan; Stanford Univ, Sch Med, Dept Med, Div Oncol, Stanford, CA 94305 USA; Baylor Coll Med, Dept Surg, Div Thorac Surg, Houston, TX 77030 USA	Burt, BM (reprint author), Baylor Coll Med, One Baylor Plaza,BCM 390, Houston, TX 77030 USA.	bryan.burt@bcm.edu					Talat N, 2011, ONCOLOGIST, V16, P1316, DOI 10.1634/theoncologist.2011-0075; Dalmau J, 2008, LANCET NEUROL, V7, P327, DOI 10.1016/S1474-4422(08)70060-7; Muskardin TW, 2012, CURR OPIN RHEUMATOL, V24, P76, DOI 10.1097/BOR.0b013e32834db525; Talat N, 2012, ANN SURG, V255, P677, DOI 10.1097/SLA.0b013e318249dcdc; Jongsma TEF, 2007, EUR J INTERN MED, V18, P87, DOI 10.1016/j.ejim.2007.09.019; Schulte KM, 2011, BMJ CASE REP	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	JAN	2015	99	1					E7	E9		10.1016/j.athoracsur.2014.10.028		3	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	AX6KI	WOS:000347030800003		
J	Miyazaki, T; Yamasaki, N; Tsuchiya, T; Matsumoto, K; Takagi, K; Nagayasu, T				Miyazaki, Takuro; Yamasaki, Naoya; Tsuchiya, Tomoshi; Matsumoto, Keitaro; Takagi, Katsunori; Nagayasu, Takeshi			Airway Stent Insertion Simulated With a Three-Dimensional Printed Airway Model	ANNALS OF THORACIC SURGERY			English	Article							TRANSPLANTATION	A 30-year-old man underwent right single-lung transplantation for chronic obstructive pulmonary disease. The bronchial anastomosis developed ischemic change, resulting in stenosis of the intermediate bronchus. A modified Y-shaped airway stent with the fabricated orifice of the upper lobe was inserted by rigid bronchoscopy. Before the operation, a three-dimensional printed bronchial model of this patient was made for surgical simulation. This model enabled us to perform the operation easily, quickly, and successfully. The patient's condition improved after airway stent insertion. The three-dimensional printed airway model provided sufficient preoperative understanding of the patient's anatomy for planning the surgical procedure. (C) 2015 by The Society of Thoracic Surgeons	Dept Surg Oncol, Nakasaki, Japan; Nagasaki Grad Sch Biomed Sci, Hybrid Profess Dev Ctr, Dept Med Engn, Nakasaki, Japan	Yamasaki, N (reprint author), Nagasaki Grad Sch Biomed Sci, Dept Surg Oncol, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	ynaoya@nagasaki-u.ac.jp			Medical-Engineering Hybrid Professional Development Program in the Nagasaki University Graduate School of Biomedical Sciences	This study was funded by the Medical-Engineering Hybrid Professional Development Program in the Nagasaki University Graduate School of Biomedical Sciences. We thank Naokado Matsuo, Medical-Engineering Hybrid Professional Development Center, Nagasaki University Graduate School of Biomedical Sciences, for making the 3D printed model.	Akiba T, 2013, ANN THORAC CARDIOVAS; Chang JW, 2014, ARTIF ORGANS, V38, pE95, DOI 10.1111/aor.12310; Zein NN, 2013, LIVER TRANSPLANT, V19, P1304, DOI 10.1002/lt.23729; Higuchi T, 2011, SURG TODAY, V41, P1302, DOI 10.1007/s00595-010-4429-3; Dutau H, 2010, J HEART LUNG TRANSPL, V29, P658, DOI 10.1016/j.healun.2009.12.011; Rengier F, 2010, INT J COMPUT ASS RAD, V5, P335, DOI 10.1007/s11548-010-0476-x; Bustamante S, 2014, J CARDIOTHOR VASC AN, V28, P1122, DOI 10.1053/j.jvca.2013.08.015; Nakada T, 2014, INTERACT CARDIOV TH, V19, P696, DOI 10.1093/icvts/ivu174	8	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	JAN	2015	99	1					E21	E23		10.1016/j.athoracsur.2014.10.021		3	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	AX6KI	WOS:000347030800007		
J	Islam, MS; Ahmed, MK; Raknuzzaman, M; Habibullah-Al-Mamun, M; Masunaga, S				Islam, Md Saiful; Ahmed, Md Kawser; Raknuzzaman, Mohammad; Habibullah-Al-Mamun, Md; Masunaga, Shigeki			Metal Speciation in Sediment and Their Bioaccumulation in Fish Species of Three Urban Rivers in Bangladesh	ARCHIVES OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY			English	Article							SEQUENTIAL EXTRACTION PROCEDURE; ECOLOGICAL RISK-ASSESSMENT; HEAVY-METALS; SURFACE SEDIMENTS; TRACE-METALS; COASTAL SEDIMENTS; MEDITERRANEAN SEA; MARINE-SEDIMENTS; BED SEDIMENTS; WASTE-WATER	Six trace metals (chromium [Cr], nickel [Ni], copper [Cu], arsenic [As], cadmium [Cd] and lead [Pb]) were measured in sediments and soft tissues of three commonly consumed fish species (Channa punctatus, Heteropneustes fossilis, and Trichogaster fasciata) collected from three urban rivers around Dhaka City, Bangladesh. The abundance of total metals in sediments varied in the decreasing order of Cr > Ni > Pb > Cu > As > Cd. Sequential extraction tests showed that the studied metals were predominantly associated with the residual fraction followed by the organically bound phase. The range of metal concentration in fish species were as follows: Cr (0.75-4.8), Ni (0.14-3.1), Cu (1.1-7.2), As (0.091-0.53), Cd (0.008-0.13), and Pb (0.052-2.7 mg/kg wet weight [ww]). The rank of biota-sediment accumulation factor for fish species were in the descending order of Cu > As > Pb > Ni > Cr > Cd. Metal concentrations in fish exceeded the international permissible standards suggesting that these species are not safe for human consumption.	[Islam, Md Saiful; Raknuzzaman, Mohammad; Habibullah-Al-Mamun, Md; Masunaga, Shigeki] Yokohama Natl Univ, Fac & Grad Sch Environm & Informat Sci, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan; [Islam, Md Saiful] Patuakhali Sci & Technol Univ, Dept Soil Sci, Dumki 8602, Patuakhali, Bangladesh; [Ahmed, Md Kawser] Univ Dhaka, Dept Oceanog, Earth & Environm Sci Fac, Dhaka 1000, Bangladesh; [Raknuzzaman, Mohammad; Habibullah-Al-Mamun, Md] Univ Dhaka, Dept Fisheries, Dhaka 1000, Bangladesh	Islam, MS (reprint author), Yokohama Natl Univ, Fac & Grad Sch Environm & Informat Sci, Hodogaya Ku, 79-7 Tokiwadai, Yokohama, Kanagawa 2408501, Japan.	msaifulpstu@yahoo.com; kawser@univdhaka.edu; mohammad-raknuzzaman-jc@ynu.jp; almamunhabib@gmail.com; masunaga@ynu.ac.jp	Masunaga, Shigeki/F-1315-2011	Masunaga, Shigeki/0000-0003-0608-2337	Leadership Program in Sustainable Living with Environmental Risk (SLER) at Yokohama National University under the aid of Strategic Funds for the Promotion of Science and Technology from the Ministry of Education, Culture, Sports, Science and Technology; Graduate School of Environment and Information Sciences, Yokohama National University, Japan	The authors are grateful for financial support from the Leadership Program in Sustainable Living with Environmental Risk (SLER) at Yokohama National University under the aid of Strategic Funds for the Promotion of Science and Technology from the Ministry of Education, Culture, Sports, Science and Technology and also for Research Collaboration Promotion Fund provided by the Graduate School of Environment and Information Sciences, Yokohama National University, Japan. Furthermore, we are thankful for the kind help from the members of Dhaka University, Bangladesh, during field sampling.	Abdallah MAM, 2007, ENVIRON MONIT ASSESS, V132, P111, DOI 10.1007/s10661-006-9507-z; Ahmad S, 1996, ENVIRON POLLUT, V31, P31; Ahmed F, 2012, ENVIRON MONIT ASSESS, V184, P4383, DOI 10.1007/s10661-011-2271-8; Ahumada I, 1999, COMMUN SOIL SCI PLAN, V30, P1507, DOI 10.1080/00103629909370303; Al Sayegh PS, 2012, ENVIRON MONIT ASSESS, V184, P2647; Alam AMS, 2003, DHAKA U J SCI, V51, P201; Ali M. Y., 2008, Hydro Nepal: Journal of Water, Energy and Environment, V3, P25; Ikem A, 2011, CHEMOSPHERE, V82, P259, DOI 10.1016/j.chemosphere.2010.09.048; Terra BF, 2008, WATER AIR SOIL POLL, V187, P275, DOI 10.1007/s11270-007-9515-9; Sundaray SK, 2011, J HAZARD MATER, V186, P1837, DOI 10.1016/j.jhazmat.2010.12.081; Nouri J, 2011, ENVIRON EARTH SCI, V62, P639, DOI 10.1007/s12665-010-0553-z; Morrison HA, 1996, ENVIRON SCI TECHNOL, V30, P3377, DOI 10.1021/es960280b; Dural M, 2007, FOOD CHEM, V102, P415, DOI 10.1016/j.foodchem.2006.03.001; Hare L, 1996, NATURE, V380, P430, DOI 10.1038/380430a0; Rath P, 2009, J HAZARD MATER, V163, P632, DOI 10.1016/j.jhazmat.2008.07.048; Kim KW, 1998, J GEOCHEM EXPLOR, V64, P409, DOI 10.1016/S0375-6742(98)00045-4; Burger J, 2005, ENVIRON RES, V99, P403, DOI 10.1016/j.envres.2005.02.001; Fytianos K, 2004, ENVIRON INT, V30, P11, DOI 10.1016/S0160-4120(03)00143-0; Abdel-Ghani NT, 2007, INT J ENVIRON SCI TE, V4, P451, DOI 10.1007/BF03325980; Rauret G, 1999, J ENVIRON MONITOR, V1, P57, DOI 10.1039/a807854h; Bastami KD, 2012, MAR POLLUT BULL, V64, P2877, DOI 10.1016/j.marpolbul.2012.08.015; Zhang WF, 2012, MAR POLLUT BULL, V64, P712, DOI 10.1016/j.marpolbul.2012.01.042; Ahmad MK, 2010, INT J ENVIRON RES, V4, P321; Jones B, 1997, MAR POLLUT BULL, V34, P768, DOI 10.1016/S0025-326X(97)00047-7; Yi YJ, 2011, ENVIRON POLLUT, V159, P2575, DOI 10.1016/j.envpol.2011.06.011; Mohiuddin KM, 2011, INT J ENVIRON SCI TE, V8, P723, DOI 10.1007/BF03326257; Dhanakumar S, 2013, ARCH ENVIRON CON TOX, V65, P14, DOI 10.1007/s00244-013-9886-4; Yilmaz AB, 2005, TURK J VET ANIM SCI, V29, P257; El Nemr A, 2006, ENVIRON MONIT ASSESS, V118, P89, DOI 10.1007/s10661-006-0985-9; Abdallah MAM, 2008, ENVIRON MONIT ASSESS, V146, P139, DOI 10.1007/s10661-007-0066-8; Tang WZ, 2013, ECOTOX ENVIRON SAFE, V98, P317, DOI 10.1016/j.ecoenv.2013.09.038; Liang Y, 2003, CHEMOSPHERE, V52, P1647, DOI 10.1016/S0045-6535(03)00505-8; Morillo J, 2004, CHEMOSPHERE, V55, P431, DOI 10.1016/j.chemosphere.2003.10.047; Yang ZF, 2009, J HAZARD MATER, V166, P1186, DOI 10.1016/j.jhazmat.2008.12.034; Mazej Z, 2010, ARCH ENVIRON CON TOX, V58, P998, DOI 10.1007/s00244-009-9417-5; Dassenakis M, 1998, APPL GEOCHEM, V13, P197, DOI 10.1016/S0883-2927(97)00065-6; Xia XH, 2011, J HAZARD MATER, V186, P2043, DOI 10.1016/j.jhazmat.2010.12.104; van der Oost R, 2003, ENVIRON TOXICOL PHAR, V13, P57, DOI 10.1016/S1382-6689(02)00126-6; Svete P, 2001, J ENVIRON MONITOR, V3, P586, DOI 10.1039/b106311c; Howari FM, 2001, WATER AIR SOIL POLL, V132, P43, DOI 10.1023/A:1012062814873; TESSIER A, 1979, ANAL CHEM, V51, P844, DOI 10.1021/ac50043a017; Rahman MS, 2012, FOOD CHEM, V134, P1847, DOI 10.1016/j.foodchem.2012.03.099; Sutherland RA, 2003, ADV ENVIRON RES, V8, P37, DOI 10.1016/S1093-0191(02)00144-2; Akcay H, 2003, WATER RES, V37, P813, DOI 10.1016/S0043-1354(02)00392-5; Singh KP, 2005, J HYDROL, V312, P14, DOI 10.1016/j.jhydrol.2005.01.021; Fu J, 2014, J HAZARD MATER, V270, P102, DOI [10.1016/j.jhazmat.2014.01.044, 10.1010/j.jhazmat.2014.01.044]; Jain CK, 2008, ENVIRON MONIT ASSESS, V141, P35, DOI 10.1007/s10661-007-9876-y; Asuquo F. Emile, 2004, Environmentalist, V24, P29, DOI 10.1023/B:ENVR.0000046344.04734.39; Campbell LM, 2005, SCI TOTAL ENVIRON, V351, P247, DOI 10.1016/j.scitotenv.2005.02.043; Christl I, 2001, ENVIRON SCI TECHNOL, V35, P2512, DOI 10.1021/es0002520; Food and Agricultural Organization/World Health Organization, 2004, WHO FOOD ADDITIVES S, V52; Gupta A, 2009, ENVIRON MONIT ASSESS, V157, P449, DOI 10.1007/s10661-008-0547-4; HAMILTON RS, 1984, SCI TOTAL ENVIRON, V33, P59, DOI 10.1016/0048-9697(84)90381-4; Islam M. S., 2014, Journal of Water and Environment Technology, V12, P109, DOI 10.2965/jwet.2014.109; Islam MM, 2006, P 17 IASTED INT C MO; Karbassi A. R., 2005, International Journal of Environmental Science and Technology, V1, DOI 10.1007/BF03325847; Kenniburgh DG, 1996, ENVIRON SCI TECHNOL, V30, P1687; Li HB, 2012, SCI TOTAL ENVIRON, V432, P202, DOI 10.1016/j.scitotenv.2012.05.100; Luoma SN, 2008, METAL CONTAMINATION IN AQUATIC ENVIRONMENTS: SCIENCE AND LATERAL MANAGEMENT, P93; McLean J. E., 1992, EPA540S92018; Moniruzzaman Mohammad, 2009, Bangladesh Journal of Scientific and Industrial Research, V44; Niwa Y, 2011, QUATERN INT, V230, P78, DOI 10.1016/j.quaint.2009.11.042; Oyeyiola AO, 2011, ENVIRON MONIT ASSESS, V172, P319, DOI 10.1007/s10661-010-1336-4; Pempkowiak J, 1999, CHEMOSPHERE, V39, P313, DOI 10.1016/S0045-6535(99)00112-5; Pustišek N., 2001, Journal of Soils and Sediments, V1, P25; Rahman MS, 2014, ENVIRON EARTH SCI, V71, P2293, DOI 10.1007/s12665-013-2631-5; Saikia A.K., 2012, Bulletin of Environment Pharmacology and Life Sciences, V1, P10; Salmonas W., 1980, ENVIRON TECHNOL LETT, V1, P506; Sekhar K. C., 2003, ENVIRON INT, V29, P1001, DOI DOI 10.1016/S0160-4120(03)00094-1; SHARIF AKM, 1993, SCI TOTAL ENVIRON, V138, P117, DOI 10.1016/0048-9697(93)90409-Y; Sow AY, 2013, B ENVIRON CONTAM TOX, V91, P6, DOI 10.1007/s00128-013-1009-4; Stone M, 1996, WATER AIR SOIL POLL, V87, P149, DOI 10.1007/BF00696834; Tao Yu, 2012, Ecotoxicol Environ Saf, V81, P55, DOI 10.1016/j.ecoenv.2012.04.014; TESSIER A, 1987, HYDROBIOLOGIA, V149, P43, DOI 10.1007/BF00048645; US EPA, 2001, EPA823B01002 OFF WAT; Wang WX, 2008, COMP BIOCHEM PHYS C, V148, P315, DOI 10.1016/j.cbpc.2008.04.003; Waqar A, 2006, ARAB J SCI ENG, V31, P89; Yap CK, 2002, ENVIRON INT, V28, P17	78	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-4341	1432-0703		ARCH ENVIRON CON TOX	Arch. Environ. Contam. Toxicol.	JAN	2015	68	1					92	106		10.1007/s00244-014-0079-6		15	Environmental Sciences; Toxicology	Environmental Sciences & Ecology; Toxicology	AX9UQ	WOS:000347247900011		
J	Ueki, A; Shibuya, T; Kaku, N; Ueki, K				Ueki, Atsuko; Shibuya, Toru; Kaku, Nobuo; Ueki, Katsuji			Aminocella lysinolytica gen. nov., sp nov., a L-lysine-degrading, strictly anaerobic bacterium in the class Clostridia isolated from a methanogenic reactor of cattle farms	ARCHIVES OF MICROBIOLOGY			English	Article						Aminocella lysinolytica; Butyrate; Clostridia; L-Lysine; Methanogenesis; Vitamin B-12	EUBACTERIUM-MINUTUM; PERIODONTAL POCKETS; ACIDS; DEGRADATION; WASTE; PROPIONATE; ARGININE; RESIDUE; RUMEN; FIELD	A strictly anaerobic bacterial strain (WN037(T)) was isolated from a methanogenic reactor. Cells were Gram-positive rods. Strain WN037(T) was asaccharolytic. The strain fermented l-lysine in the presence of B-vitamin mixture or vitamin B-12 and produced acetate and butyrate. l-arginine and casamino acids poorly supported the growth. Strain WN037(T) used neither other amino acids nor organic acids examined. The strain had C-18:1 omega 7c, C-16:0 and C-18:1 omega 7c DMA as the predominant cellular fatty acids. The genomic DNA G + C content was 44.2 mol %. Phylogenetic analysis based on the 16S rRNA gene sequence placed strain WN037(T) in the family Eubacteriaceae in the class Clostridia. The closest relative was Eubacterium pyruvativorans (sequence similarity, 92.8 %). Based on the comprehensive analyses, the novel genus and species, Aminocella lysinolytica gen. nov., sp. nov. was proposed to accommodate the strain. The type strain is WN037(T) (= JCM 19863(T) = DSM 28287(T)).	[Ueki, Atsuko; Shibuya, Toru; Kaku, Nobuo; Ueki, Katsuji] Yamagata Univ, Fac Agr, Tsuruoka, Yamagata 9978555, Japan	Ueki, A (reprint author), Yamagata Univ, Fac Agr, Wakaba Machi 1-23, Tsuruoka, Yamagata 9978555, Japan.	uatsuko@tds1.tr.yamagata-u.ac.jp			Institute for Fermentation, Osaka	This work was partly supported by a grant-in-aid from the Institute for Fermentation, Osaka.	Abe K, 2012, J GEN APPL MICROBIOL, V58, P405; Akasaka H, 2003, INT J SYST EVOL MICR, V53, P1991, DOI 10.1099/ijs.0.02764-0; Uematsu H, 1996, MICROB ECOL HEALTH D, V9, P305; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Uematsu H, 2003, ARCH ORAL BIOL, V48, P423, DOI 10.1016/S0003-9969(03)00031-1; Ganesan A, 2008, INT J SYST EVOL MICR, V58, P2003, DOI 10.1099/ijs.0.65645-0; KOMAGATA K, 1987, METHOD MICROBIOL, V19, P161; MOORE LVH, 1994, INT J SYST BACTERIOL, V44, P338; Ramsay IR, 2001, BIODEGRADATION, V12, P247, DOI 10.1023/A:1013116728817; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Buckel W., 1999, BIOL PROCARYOTES, P278; Diaz C, 2007, INT J SYST EVOL MICR, V57, P1914, DOI 10.1099/ijs.0.63614-0; Felsenstein J., 2006, PHYLIP PHYLOGENY INF; Holdeman L.V., 1977, ANAEROBE LAB MANUAL; HOLDEMAN LV, 1980, INT J SYST BACTERIOL, V30, P163; Ludwig W, 2009, BERGEYS MANUAL SYSTE, V3, P865; MILLER LT, 1982, J CLIN MICROBIOL, V16, P584; Nishiyama T, 2009, INT J SYST EVOL MICR, V59, P981, DOI 10.1099/ijs.0.001719-0; PASTER BJ, 1993, INT J SYST BACTERIOL, V43, P107; Poco SE, 1996, INT J SYST BACTERIOL, V46, P31; Russell JB, 2005, ANAEROBE, V11, P177, DOI 10.1016/j.anaerobe.2005.01.001; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Satoh A, 2002, ANAEROBE, V8, P233, DOI 10.1006/anae.2003.0438; Smith EA, 1997, ANAEROBE, V3, P327, DOI 10.1006/anae.1997.0121; Ueki A, 2009, INT J SYST EVOL MICR, V59, P3161, DOI 10.1099/ijs.0.011858-0; Ueki A, 2008, INT J SYST EVOL MICR, V58, P346, DOI 10.1099/ijs.0.65486-0; Wade WG, 1999, INT J SYST BACTERIOL, V49, P1939; Wade WG, 2009, BERGEYS MANUAL SYSTE, V3, P865; Wallace RJ, 2003, INT J SYST EVOL MICR, V53, P965, DOI 10.1099/ijs.0.02110-0	29	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0302-8933	1432-072X		ARCH MICROBIOL	Arch. Microbiol.	JAN	2015	197	1					97	104		10.1007/s00203-014-1066-z		8	Microbiology	Microbiology	AX9US	WOS:000347248100011		
J	Lim, YP; Cheng, CH; Chen, WC; Chang, SY; Hung, DZ; Chen, JJ; Wan, L; Ma, WC; Lin, YH; Chen, CY; Yokoi, T; Nakajima, M; Chen, CJ				Lim, Yun-Ping; Cheng, Ching-Hao; Chen, Wei-Cheng; Chang, Shih-Yu; Hung, Dong-Zong; Chen, Jih-Jung; Wan, Lei; Ma, Wei-Chih; Lin, Yu-Hsien; Chen, Cing-Yu; Yokoi, Tsuyoshi; Nakajima, Miki; Chen, Chao-Jung			Allyl isothiocyanate (AITC) inhibits pregnane X receptor (PXR) and constitutive androstane receptor (CAR) activation and protects against acetaminophen- and amiodarone-induced cytotoxicity	ARCHIVES OF TOXICOLOGY			English	Article						Allyl isothiocyanate; Pregnane X receptor; Cytochrome P450 3A4; Constitutive androstane receptor; Cytochrome P450 2B6; Inducer-drug interaction; Drug-induced cytotoxicity	DRUG-METABOLIZING-ENZYMES; HUMAN CYP2B6 GENE; NUCLEAR RECEPTOR; INDUCED HEPATOTOXICITY; HUMAN HEPATOCYTES; CYP3A4 INDUCTION; TREATED PATIENTS; LOWER EXPRESSION; P-GLYCOPROTEIN; CELLS	Antagonizing the action of the pregnane X receptor (PXR) may have important clinical implications for preventing inducer-drug interactions and improving therapeutic efficacy. We identified a widely distributed isothiocyanate, allyl isothiocyanate (AITC), which acts as an effective antagonist of the nuclear receptor pregnane X receptor (PXR, NR1I2) and constitutive androstane receptor (CAR, NR1I3). HepG2 cells were used to assay reporter function, mRNA levels, and protein expression. Catalytic activities of the PXR and CAR target genes, CYP3A4 and CYP2B6, respectively, were also assessed in differentiated HepaRG cells. Protective effects of AITC on rifampin-induced cytotoxicity were observed, and transient transfection assays showed that AITC was able to effectively attenuate the agonist effects of rifampin and CITCO on human PXR and CAR activity, respectively. AITC-mediated reduction in the transcriptional activity of PXR and CAR correlated well with the suppression of CYP3A4 and CYP2B6 expression in HepG2 cells, which reflected the reduced catalytic activities of both of these genes following AITC treatment in differentiated HepaRG cells. Furthermore, AITC disrupts the co-regulations of PXR with several important co-regulators. Furthermore, the antagonist effect of AITC against PXR was found in HepaRG cells upon addition of acetaminophen (APAP) and amiodarone, indicating that AITC protects cells from drug-induced cytotoxicity. Taken together, our results show that AITC inhibits the transactivation effects of PXR and CAR and reduces the expression and function of CYP3A4 and CYP2B6. Additionally, AITC reversed the cytotoxic effects of APAP and amiodarone induced by PXR ligand. Results from this study suggest that AITC could be a powerful agent for reducing potentially dangerous interactions between transcriptional inducers of CYP enzymes and therapeutic drugs.	[Lim, Yun-Ping; Cheng, Ching-Hao; Chen, Wei-Cheng; Hung, Dong-Zong; Ma, Wei-Chih; Lin, Yu-Hsien; Chen, Cing-Yu] China Med Univ, Coll Pharm, Dept Pharm, Taichung 40402, Taiwan; [Lim, Yun-Ping; Hung, Dong-Zong] China Med Univ Hosp, Dept Emergency, Toxicol Ctr, Taichung, Taiwan; [Cheng, Ching-Hao] Changhua Show Chwan Mem Hosp, Dept Pharm, Changhua, Taiwan; [Chang, Shih-Yu] Chung Shan Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Chen, Jih-Jung] Tajen Univ, Grad Inst Pharmaceut Technol, Pingtung, Taiwan; [Wan, Lei] China Med Univ, Sch Chinese Med, Taichung 40402, Taiwan; [Yokoi, Tsuyoshi; Nakajima, Miki] Kanazawa Univ, Fac Pharmaceut Sci, Kanazawa, Ishikawa 920, Japan; [Chen, Chao-Jung] China Med Univ, Grad Inst Integrated Med, Taichung 40402, Taiwan; [Chen, Chao-Jung] China Med Univ Hosp, Dept Med Res, Prote Core Lab, Taichung, Taiwan	Lim, YP (reprint author), China Med Univ, Coll Pharm, Dept Pharm, 91 Hsueh Shih Rd, Taichung 40402, Taiwan.	limyp@mail2000.com.tw; cjchen@mail.cmu.edu.tw	Nakajima, Miki/C-3990-2015; Chen, Chao-Jung/E-5481-2011	Chen, Chao-Jung/0000-0003-3834-9243	National Science Council, Executive Yuan, Taiwan, R.O.C. [NSC-101-2320-B-039-007-MY3]; China Medical University Hospital, Taichung, Taiwan [DMR-103-049]; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW103-TDU-B-212-113002]; China Medical University under the Aim for the Top University Plan of the Ministry of Education, Taiwan	This study was supported by National Science Council, Executive Yuan, Taiwan, R.O.C. (NSC-101-2320-B-039-007-MY3), China Medical University Hospital, Taichung, Taiwan (DMR-103-049), in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW103-TDU-B-212-113002), and by China Medical University under the Aim for the Top University Plan of the Ministry of Education, Taiwan. We thank Dr. Hongbing Wang (Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland) for kindly providing human CAR3 and CYP2B6 reporter constructs.	Boelsterli UA, 2007, TOXICOL APPL PHARM, V220, P92, DOI 10.1016/j.taap.2006.12.013; DAHLIN DC, 1984, P NATL ACAD SCI-BIOL, V81, P1327, DOI 10.1073/pnas.81.5.1327; Guengerich FP, 2008, CHEM RES TOXICOL, V21, P70, DOI 10.1021/tx700079z; Wang HW, 2007, CLIN CANCER RES, V13, P2488, DOI 10.1158/1078-0432.CCR-06-1592; Guo GL, 2004, TOXICOL SCI, V82, P374, DOI 10.1093/toxsci/kfh286; POTTER WZ, 1974, PHARMACOLOGY, V12, P129, DOI 10.1159/000136531; Ahlin G, 2009, DRUG METAB DISPOS, V37, P2275, DOI 10.1124/dmd.109.028654; Zhang J, 2002, SCIENCE, V298, P422, DOI 10.1126/science.1073502; Conney AH, 2003, ANNU REV PHARMACOL, V43, P1, DOI 10.1146/annurev.pharmtox.43.100901.135754; Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698; James LP, 2003, DRUG METAB DISPOS, V31, P1499, DOI 10.1124/dmd.31.12.1499; Chen YK, 2010, J PHARMACOL EXP THER, V334, P999, DOI 10.1124/jpet.110.168294; Watkins RE, 2003, BIOCHEMISTRY-US, V42, P1430, DOI 10.1021/bi0268753; Pascussi JM, 2005, J CLIN INVEST, V115, P177, DOI 10.1172/JCI200521867; Moore LB, 2002, MOL ENDOCRINOL, V16, P977, DOI 10.1210/me.16.5.977; Chen YK, 2012, BIOCHEM PHARMACOL, V83, P1112, DOI 10.1016/j.bcp.2012.01.030; Xiao D, 2003, CARCINOGENESIS, V24, P891, DOI 10.1093/carcin/bgg023; Gao J, 2012, TRENDS PHARMACOL SCI, V33, P552, DOI 10.1016/j.tips.2012.07.003; Rodriguez-Antona C, 2002, XENOBIOTICA, V32, P505, DOI 10.1080/00498250210128675; Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043; Guengerich FP, 2007, CHEM RES TOXICOL, V20, P344, DOI 10.1021/tx600260a; Kliewer SA, 2002, ENDOCR REV, V23, P687, DOI 10.1210/er.2001.0038; Ha HR, 2005, EUR J PHARM SCI, V24, P271, DOI 10.1016/j.ejps.2004.10.015; Zhang YS, 2010, MOL NUTR FOOD RES, V54, P127, DOI 10.1002/mnfr.200900323; Wagner AE, 2012, J CELL MOL MED, V16, P836, DOI 10.1111/j.1582-4934.2011.01367.x; Chen TS, 2010, ADV DRUG DELIVER REV, V62, P1257, DOI 10.1016/j.addr.2010.07.008; Cheng J, 2012, TRENDS PHARMACOL SCI, V33, P323, DOI 10.1016/j.tips.2012.03.003; Chen T, 2010, J PHARMACOL EXP THER, V332, P106, DOI 10.1124/jpet.109.159210; Zhou CC, 2007, MOL PHARMACOL, V71, P220, DOI 10.1124/mol.106.029264; Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703; Synold TW, 2001, NAT MED, V7, P584, DOI 10.1038/87912; Wang HB, 2008, CURR DRUG METAB, V9, P598, DOI 10.2174/138920008785821710; Xie W, 2000, GENE DEV, V14, P3014, DOI 10.1101/gad.846800; Wang HW, 2008, MOL ENDOCRINOL, V22, P838, DOI 10.1210/me.2007-0218; Jacobs MN, 2005, TOXICOL APPL PHARM, V209, P123, DOI 10.1016/j.taap.2005.03.015; Wang HW, 2011, J CLIN INVEST, V121, P3220, DOI 10.1172/JCI41514; Moya M, 2010, CHEM-BIOL INTERACT, V184, P376, DOI 10.1016/j.cbi.2010.01.008; Rigalli JP, 2011, TOXICOLOGY, V285, P18, DOI 10.1016/j.tox.2011.03.015; Goodwin B, 1999, MOL PHARMACOL, V56, P1329; Kawamoto T, 1999, MOL CELL BIOL, V19, P6318; Itoh M, 2006, J PHARMACOL EXP THER, V319, P693, DOI 10.1124/jpet.106.107573; Zhang YS, 1998, CANCER RES, V58, P4632; Guillouzo A, 2007, CHEM-BIOL INTERACT, V168, P66, DOI 10.1016/j.cbi.2006.12.003; Wang HB, 2003, DRUG METAB DISPOS, V31, P620, DOI 10.1124/dmd.31.5.620; Krul C, 2002, CARCINOGENESIS, V23, P1009, DOI 10.1093/carcin/23.6.1009; Nielsen PV, 2000, INT J FOOD MICROBIOL, V60, P219, DOI 10.1016/S0168-1605(00)00343-3; Lim YP, 2012, EVID-BASED COMPL ALT, DOI 10.1155/2012/242810; Cheng J, 2009, DRUG METAB DISPOS, V37, P1611, DOI 10.1124/dmd.109.027565; Bauer B, 2006, MOL PHARMACOL, V70, P1212, DOI 10.1124/mol.106.023796; BECKETT GJ, 1985, GUT, V26, P26, DOI 10.1136/gut.26.1.26; Bollard M, 1997, FOOD CHEM TOXICOL, V35, P933, DOI 10.1016/S0278-6915(97)00103-8; EFSA, 2010, EFSA J, V8, P1943; FLANAGAN RJ, 1982, J PHARM PHARMACOL, V34, P638; Goodwin B, 2001, MOL PHARMACOL, V60, P427; Hancock J F, 1992, Methods Mol Biol, V8, P153, DOI 10.1385/0-89603-191-8:153; Healan-Greenberg C, 2008, DRUG METAB DISPOS, V36, P500, DOI 10.1124/dmd.107.019547; Hosomi H, 2010, TOXICOL IN VITRO, V24, P1032, DOI 10.1016/j.tiv.2009.11.020; Hu ZP, 2007, CURR DRUG METAB, V8, P157, DOI 10.2174/138920007779815995; Kostrubsky VE, 1997, ANN CLIN LAB SCI, V27, P57; Krausova L, 2011, BIOCHEM PHARMACOL, V82, P1180; Lake BG, 1998, TOXICOLOGY, V131, P9, DOI 10.1016/S0300-483X(98)00085-7; Liu CL, 2012, MAR DRUGS, V10, P242, DOI 10.3390/md10010242; Lo WS, 2012, ARCH TOXICOL, V86, P1927, DOI 10.1007/s00204-012-0902-7; Mahamuni SP, 2012, BIOMEDICINE, V2, P137; MASON JW, 1987, NEW ENGL J MED, V316, P455; Matsuda H, 2007, EUR J PHARMACOL, V561, P172, DOI 10.1016/j.ejphar.2006.12.040; McCarthy TC, 2004, J PHARMACOL EXP THER, V311, P864, DOI 10.1124/jpet.104.072785; Munday R, 2002, NUTR CANCER, V44, P52, DOI 10.1207/S15327914NC441_7; Nijssen L.M., 2009, VCF VOLATILE COMPOUN; REIMERS D, 1971, Praxis der Pneumologie, V25, P255; Schulman IG, 2010, ADV DRUG DELIVER REV, V62, P1307, DOI 10.1016/j.addr.2010.07.002; Shin IS, 2004, INT J FOOD MICROBIOL, V94, P255, DOI 10.1016/S0168-1650(03)00297-6; Sultana T, 2003, J AGR FOOD CHEM, V51, P3586, DOI 10.1021/jf021116c; Takezawa T, 2012, DRUG METAB PHARMACOK, V27, P430, DOI 10.2133/dmpk.DMPK-11-RG-126; Walko CM, 2012, CANCER CHEMOTH PHARM, V69, P1189, DOI 10.1007/s00280-011-1815-5; YUN CH, 1993, DRUG METAB DISPOS, V21, P403; Zambon Serenella, 2010, Drug Metab Lett, V4, P120	77	3	3	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5761	1432-0738		ARCH TOXICOL	Arch. Toxicol.	JAN	2015	89	1					57	72		10.1007/s00204-014-1230-x		16	Toxicology	Toxicology	AY0KZ	WOS:000347286700007		
J	Kanno, S; Hirano, S; Chiba, S; Takeshita, H; Nagai, T; Takada, M; Sakamoto, K; Mukai, T				Kanno, Sanae; Hirano, Seishiro; Chiba, Shoetsu; Takeshita, Hiroshi; Nagai, Tomonori; Takada, Meri; Sakamoto, Kana; Mukai, Toshiji			The role of Rho-kinases in IL-1 beta release through phagocytosis of fibrous particles in human monocytes	ARCHIVES OF TOXICOLOGY			English	Article						Rho-kinase (ROCK); Inflammasome; Carbon nanotube; Asbestos; THP-1 cell	WALLED CARBON NANOTUBES; NLRP3 INFLAMMASOME; NALP3 INFLAMMASOME; P2X(7) RECEPTOR; T-CELLS; ACTIVATION; ASBESTOS; MACROPHAGES; NANOPARTICLES; BINDING	Long fibers, such as asbestos and carbon nanotubes (CNTs), are more potent activators of inflammatory and genotoxicity than short or tangled fibers. Fibrous particles trigger interleukin (IL)-1 beta secretion and cause inflammatory diseases through NLRP3 inflammasomes in phagocytotic cells. However, the mechanism involved in fibrous particle-induced inflammation has not been well documented. In this study, we focused on GTPase effector Rho-kinases (ROCK1, and 2), which are known to be involved in a wide range of cellular functions such as adhesion, regulation of cytoskeleton, and phagocytosis. We examined whether ROCKs are associated with multi-walled CNT (MWCNT)- or asbestos-induced IL-1 beta secretion in human monocytic THP-1 cells using a selective inhibitor and small interfering RNA. THP-1 cells were differentiated to macrophages by PMA and were exposed to MWCNTs, crocidolite asbestos or lipopolysaccharide (LPS) in the presence or absence of Y27632 (ROCK inhibitor) or Z-YVAD (caspase-1 inhibitor). Exposure of the cells to MWCNTs or asbestos provoked IL-1 beta secretion, but this secretion was suppressed by both Y27632 and Z-YVAD, whereas LPS-induced IL-1 beta secretion was inhibited only by Z-YVAD and not by Y27632. siRNA designed for knockdown of both ROCK1 and ROCK2 suppressed MWCNT- and asbestos-induced IL-1 beta secretion, but did not change LPS-induced IL-1 beta secretion. Moreover, Y27632 suppressed pro-IL-1 beta protein levels and the release of activated-cathepsin B and activated-caspase-1 induced by MWCNTs or asbestos. In contrast, LPS-induced pro-IL-1 beta protein was not suppressed by Y27632. These results suggest that ROCKs are involved in fibrous particle-induced inflammasome responses in THP-1 cells.	[Kanno, Sanae; Chiba, Shoetsu; Takeshita, Hiroshi; Nagai, Tomonori; Takada, Meri; Sakamoto, Kana; Mukai, Toshiji] St Marianna Univ, Sch Med, Dept Legal Med, Miyamae Ku, Kawasaki, Kanagawa 2168511, Japan; [Hirano, Seishiro] Natl Inst Environm Studies, Res Ctr Environm Risk, Tsukuba, Ibaraki 3058506, Japan	Kanno, S (reprint author), St Marianna Univ, Sch Med, Dept Legal Med, Miyamae Ku, 2-16-1 Sugao, Kawasaki, Kanagawa 2168511, Japan.	sanae@marianna-u.ac.jp			JSPS KAKENHI [24590868]	We would like to thank Mr. T. Ikawa for the technical support. This work was supported by JSPS KAKENHI (Grant No. 24590868).	Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Niemi K, 2011, J IMMUNOL, V186, P6119, DOI 10.4049/jimmunol.1002843; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Meunier E, 2012, NANOMED-NANOTECHNOL, V8, P987, DOI 10.1016/j.nano.2011.11.004; Olazabal IM, 2002, CURR BIOL, V12, P1413, DOI 10.1016/S0960-9822(02)01069-2; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Ishizaki T, 1996, EMBO J, V15, P1885; Hirano S, 2008, TOXICOL APPL PHARM, V232, P244, DOI 10.1016/j.taap.2008.06.016; Qu Y, 2007, J IMMUNOL, V179, P1913; Kanno S, 2007, TOXICOL SCI, V97, P398, DOI 10.1093/toxsci/kfm050; Sakamaki I, 2008, CANCER SCI, V99, P2268, DOI 10.1111/j.1349-7006.2008.00939.x; Freche B, 2007, SEMIN IMMUNOPATHOL, V29, P249, DOI 10.1007/s00281-007-0085-0; Shi JJ, 2007, ARCH IMMUNOL THER EX, V55, P61, DOI 10.1007/s00005-007-0009-7; Inoue K, 2010, FREE RADICAL BIO MED, V48, P924, DOI 10.1016/j.freeradbiomed.2010.01.013; Hirano S, 2010, TOXICOL APPL PHARM, V249, P8, DOI 10.1016/j.taap.2010.08.019; Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Yazdi AS, 2010, P NATL ACAD SCI USA, V107, P19449, DOI 10.1073/pnas.1008155107; LEUNG T, 1995, J BIOL CHEM, V270, P29051; Schinwald A, 2012, TOXICOL SCI, V128, P461, DOI 10.1093/toxsci/kfs171; Mossman BT, 2011, J TOXICOL ENV HEAL B, V14, P76, DOI 10.1080/10937404.2011.556047; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Rock KL, 2013, NAT REV RHEUMATOL, V9, P13, DOI 10.1038/nrrheum.2012.143; Yoneda A, 2005, J CELL BIOL, V170, P443, DOI 10.1083/jcb.200412043; Delgermaa V, 2011, B WORLD HEALTH ORGAN, V89, P716, DOI 10.2471/BLT.11.086678; Osuka A, 2012, SHOCK, V37, P47, DOI 10.1097/SHK.0b013e318234f7ff; Kohyama N, 1996, AM J IND MED, V30, P515, DOI 10.1002/(SICI)1097-0274(199611)30:5<515::AID-AJIM1>3.0.CO;2-S; Palomaki J, 2011, ACS NANO, V5, P6861, DOI 10.1021/nn200595c; Hirano S, 2012, TOXICOL APPL PHARM, V259, P96, DOI 10.1016/j.taap.2011.12.012; Kanno S, 2013, ARCH TOXICOL, V87, P1245, DOI 10.1007/s00204-013-1027-3; KekaIS Mohiuddin, 2014, ARCH TOXICOL, V88, P145; Li MY, 2012, CYTOKINE, V60, P718, DOI 10.1016/j.cyto.2012.08.025; MCCARTY DJ, 1963, CURR THER RES CLIN E, V5, P284; Mitchell JA, 2007, J ENDOCRINOL, V193, P323, DOI 10.1677/JOE-07-0067; Nagai H, 2010, ARCH BIOCHEM BIOPHYS, V502, P1, DOI 10.1016/j.abb.2010.06.015; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Sandberg WJ, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-32; Schinwald A, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-34; Shukla A, 2009, AM J RESP CELL MOL, V41, P114, DOI 10.1165/rcmb.2008-0146OC; Shvedova AA, 2008, AM J PHYSIOL-LUNG C, V295, pL552, DOI 10.1152/ajplung.90287.2008; Soldatos AN, 2003, INSECT BIOCHEM MOLEC, V33, P1075, DOI 10.1016/S0965-1748(03)00119-X; Takesono A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008774; ZALMA R, 1987, CAN J CHEM, V65, P2338	44	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5761	1432-0738		ARCH TOXICOL	Arch. Toxicol.	JAN	2015	89	1					73	85		10.1007/s00204-014-1238-2		13	Toxicology	Toxicology	AY0KZ	WOS:000347286700008		
J	Iwata, S; Nakayamada, S; Fukuyo, S; Kubo, S; Yunoue, N; Wang, SP; Yoshikawa, M; Saito, K; Tanaka, Y				Iwata, Shigeru; Nakayamada, Shingo; Fukuyo, Shunsuke; Kubo, Satoshi; Yunoue, Naoki; Wang, Sheau-Pey; Yoshikawa, Maiko; Saito, Kazuyoshi; Tanaka, Yoshiya			Activation of Syk in Peripheral Blood B Cells in Patients With Rheumatoid Arthritis A Potential Target for Abatacept Therapy	ARTHRITIS & RHEUMATOLOGY			English	Article							CYCLIC CITRULLINATED PEPTIDE; SPLEEN TYROSINE KINASE; TRYPTOPHAN CATABOLISM; AMERICAN-COLLEGE; DOUBLE-BLIND; RITUXIMAB; VALIDATION; EXPRESSION; ANTIBODIES; RECEPTORS	Objective. B cells play a pivotal role in the pathogenesis of autoimmune diseases. Although Syk functions as a key molecule in B cell receptor signaling, the pathologic role of Syk in B cells in rheumatoid arthritis (RA) remains unclear. The purpose of this study was to assess the relevance of activation of Syk in B cells to the pathologic development of RA and to the responsiveness of RA patients to treatment with biologics. Methods. Healthy subjects (n = 36) and patients with moderate or severe RA disease activity (n = 70) were studied. The phosphorylation of Syk (pSyk) in peripheral blood B cells was measured by flow cytometry, and its correlation with clinical characteristics and changes after administration of biologic agents was evaluated. Results. Levels of pSyk in peripheral blood B cells were preferentially higher in patients with RA compared to healthy subjects. Patients with significantly higher pSyk levels were strongly positive for anti- citrullinated protein antibodies (ACPAs). High pSyk levels were not correlated with the severity of disease activity. Treatment with abatacept, but not tumor necrosis factor inhibitors, significantly reduced the levels of pSyk in RA peripheral blood B cells. Abatacept also significantly reduced the proportion of follicular helper T (Tfh) cells. Conclusion. Levels of pSyk in peripheral blood B cells were significantly elevated in patients with RA, and these patients also exhibited strong positivity for ACPAs. These data suggest that abatacept seems to inhibit the phosphorylation of Syk in B cells, as well as the development of Tfh cells, thus highlighting the relevance of B cell-T cell interactions as a potential target of abatacept therapy in RA.	[Iwata, Shigeru; Nakayamada, Shingo; Fukuyo, Shunsuke; Kubo, Satoshi; Yunoue, Naoki; Wang, Sheau-Pey; Yoshikawa, Maiko; Saito, Kazuyoshi; Tanaka, Yoshiya] Univ Occupat & Environm Hlth Japan, Kitakyushu, Fukuoka 8078555, Japan	Tanaka, Y (reprint author), Univ Occupat & Environm Hlth Japan, Sch Med, Dept Internal Med 1, 1-1 Iseigaoka,Yahata Nishi, Kitakyushu, Fukuoka 8078555, Japan.	tanaka@med.uoeh-u.ac.jp			Research Grant on Rare and Intractable diseases; Ministry of Health, Labor, and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan; University of Occupational and Environmental Health Japan; Astellas; Takeda; Santen; Mitsubishi-Tanabe; Pfizer; Janssen; Eisai; Eli Lilly Japan; Quintiles; MSD; Asahi-Kasei; AbbVie; Chugai; Bristol-Myers Squibb; Daiichi-Sankyo	Supported in part by a Research Grant on Rare and Intractable diseases and a Research Grant-In-Aid for Scientific Research from the Ministry of Health, Labor, and Welfare of Japan, the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and the University of Occupational and Environmental Health Japan and by a Grant for Advanced Research from the University of Occupational and Environmental Health Japan.; Dr. Tanaka has received consulting fees, speaking fees, and/or honoraria from Astellas, Takeda, Santen, Mitsubishi-Tanabe, Pfizer, Janssen, Eisai, Daiichi-Sankyo, UCB, GlaxoSmithKline, Bristol-Myers Squibb, Abbott Japan, Astra-Zeneca, Eli Lilly Japan, Quintiles, MSD, and Asahi-Kasei (less than $ 10,000 each) and from AbbVie and Chugai (more than $10,000 each) and has received research grants from Bristol-Myers Squibb, Mitsubishi-Tanabe, AbbVie, MSD, Chugai, Astellas, and Daiichi-Sankyo.	Aletaha D, 2005, ARTHRITIS RES THER, V7, pR796, DOI 10.1186/ar1740; Emery P, 2006, ARTHRITIS RHEUM, V54, P1390, DOI 10.1002/art.21778; Roll P, 2006, ARTHRITIS RHEUM, V54, P2377, DOI 10.1002/art.22019; Podolanczuk A, 2009, BLOOD, V113, P3154, DOI 10.1182/blood-2008-07-166439; Smolen JS, 2003, RHEUMATOLOGY, V42, P244, DOI 10.1093/rheumatology/keg072; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Wang J, 2013, CLIN EXP IMMUNOL, V174, P212, DOI 10.1111/cei.12162; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Gottenberg JE, 2012, ANN RHEUM DIS, V71, P1815, DOI 10.1136/annrheumdis-2011-201109; Roll P, 2008, ARTHRITIS RHEUM-US, V58, P1566, DOI 10.1002/art.23473; TANIGUCHI T, 1991, J BIOL CHEM, V266, P15790; Amara K, 2013, J EXP MED, V210, P445, DOI 10.1084/jem.20121486; Mellor AL, 1999, IMMUNOL TODAY, V20, P469, DOI 10.1016/S0167-5699(99)01520-0; Harre U, 2012, J CLIN INVEST, V122, P1791, DOI 10.1172/JCI60975; Karampetsou MP, 2011, CLIN IMMUNOL, V140, P8, DOI 10.1016/j.clim.2011.01.012; Cha HS, 2006, J PHARMACOL EXP THER, V317, P571, DOI 10.1124/jpet.105.097436; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; Cohen SB, 2006, ARTHRITIS RHEUM, V54, P2793, DOI 10.1002/art.22025; Meltzer EO, 2005, J ALLERGY CLIN IMMUN, V115, P791, DOI 10.1016/j.jaci.2005.01.040; Yamada H, 2008, ANN RHEUM DIS, V67, P1299, DOI 10.1136/ard.2007.080341; Anolik JH, 2009, IMMUNOL RES, V45, P144, DOI 10.1007/s12026-009-8096-7; Bajpai M, 2009, IDRUGS, V12, P174; Emery P, 2010, ANN RHEUM DIS, V69, P510, DOI 10.1136/ard.2009.119016; Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012; Mellor AL, 2003, J IMMUNOL, V171, P1652; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Stadanlick JE, 2008, NAT IMMUNOL, V9, P1379, DOI 10.1038/ni.1666; Anolik JH, 2004, ARTHRITIS RHEUM, V50, P3580, DOI 10.1002/art.20592; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Genovese MC, 2011, ARTHRITIS RHEUM-US, V63, P337, DOI 10.1002/art.30114; de la Torre I, 2010, ANN RHEUM DIS, V69, P2181, DOI 10.1136/ard.2010.131326; Schwartzberg PL, 2009, NAT REV IMMUNOL, V9, P39, DOI 10.1038/nri2456; Mellor AL, 2003, J IMMUNOL, V170, P5809; Vital EM, 2010, ARTHRITIS RHEUM-US, V62, P1273, DOI 10.1002/art.27359; Nakayamada S, 2012, CURR OPIN IMMUNOL, V24, P297, DOI 10.1016/j.coi.2012.01.014; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Beaven MA, 1996, CURR OPIN IMMUNOL, V8, P766, DOI 10.1016/S0952-7915(96)80002-1; Cabrian KM, 1996, TRANSPLANT P, V28, P3261; De Rycke L, 2005, ANN RHEUM DIS, V64, P299, DOI 10.1136/ard.2004.023523; Henneken M, 2005, ARTHRITIS RES THER, V7, P1001; Iwata S, 2012, J ALLERGY CLIN IMMUN, V129, P1594, DOI 10.1016/j.jaci.2012.03.014; LINSLEY PS, 1992, SCIENCE, V257, P792, DOI 10.1126/science.1496399; Platt AM, 2010, J IMMUNOL, V185, P1558, DOI 10.4049/jimmunol.1001311; Rudnicka W, 2009, EUR J IMMUNOL, V39, P1211, DOI 10.1002/eji.200838617; Sato Kojiro, 2008, Allergol Int, V57, P109, DOI 10.2332/allergolint.R-07-158; van der Linden MPM, 2009, ARTHRITIS RHEUM, V60, P2232, DOI 10.1002/art.24716; vanGestel AM, 1996, ARTHRITIS RHEUM, V39, P34, DOI 10.1002/art.1780390105; Wong WSF, 2004, BBA-PROTEINS PROTEOM, V1697, P53, DOI 10.1016/j.bbapap.2003.11.013; Wossning T, 2006, J EXP MED, V203, P2829, DOI 10.1084/jem.20060967	49	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	JAN	2015	67	1					63	73		10.1002/art.38895		11	Rheumatology	Rheumatology	AX4QY	WOS:000346917700008		
J	Ali, A; Zhu, XF; Kwiecinski, J; Gjertsson, I; Lindholm, C; Iwakura, Y; Wang, XY; Lycke, N; Josefsson, E; Pullerits, R; Jin, T				Ali, Abukar; Zhu, Xuefeng; Kwiecinski, Jakub; Gjertsson, Inger; Lindholm, Catharina; Iwakura, Yoichiro; Wang, Xiaoyang; Lycke, Nils; Josefsson, Elisabet; Pullerits, Rille; Jin, Tao			Antibiotic-Killed Staphylococcus aureus Induces Destructive Arthritis in Mice	ARTHRITIS & RHEUMATOLOGY			English	Article							TUMOR-NECROSIS-FACTOR; CELL WALL COMPONENTS; SEPTIC ARTHRITIS; BACTERIAL-DNA; DEXAMETHASONE THERAPY; SYNOVIAL-FLUID; IMMUNE-SYSTEM; DOUBLE-BLIND; TNF-ALPHA; RECEPTOR	Objective. Permanent reduction in joint function is a severe postinfectious complication in patients with Staphylococcus aureus septic arthritis. We undertook this study to determine whether this reduction in joint function might be caused by persistent joint inflammation after the adequate eradication of bacteria by antibiotics. Methods. After intraarticular injection of cloxacillin-killed S aureus into mouse knee joints, we investigated whether antibiotic-killed S aureus induced joint inflammation and elucidated the molecular and cellular mechanisms of this type of arthritis. Results. Intraarticular injection of antibiotic-killed S aureus induced mild-to-moderate synovitis and bone erosions that lasted for a minimum of 14 days. Compared with wild-type animals, mice deficient in tumor necrosis factor receptor type I (TNFRI), receptor for advanced glycation end products (RAGE), or Toll-like receptor 2 (TLR-2) had a significantly reduced frequency and severity of synovitis. Combined depletion of monocytes and neutrophils also resulted in a significantly lower frequency of synovitis. Among bacterial factors, insoluble cell debris played a more important role than bacterial DNA or soluble components in inducing joint inflammation. Importantly, anti-TNF therapy abrogated joint inflammation induced by antibiotic-killed S aureus. Conclusion. Antibiotic-killed S aureus induced and maintained joint inflammation mediated through TLR-2, TNFRI, and RAGE. The cross-talk between neutrophils and monocytes is responsible for this type of arthritis. Anti-TNF therapy might be used as a novel strategy, in combination with antibiotics, to treat staphylococcal septic arthritis.	[Ali, Abukar; Zhu, Xuefeng; Kwiecinski, Jakub; Gjertsson, Inger; Lindholm, Catharina; Wang, Xiaoyang; Lycke, Nils; Josefsson, Elisabet; Pullerits, Rille; Jin, Tao] Univ Gothenburg, Sahlgrenska Acad, S-41346 Gothenburg, Sweden; [Iwakura, Yoichiro] Tokyo Univ Sci, Chiba, Japan	Jin, T (reprint author), Univ Gothenburg, Sahlgrenska Acad, Dept Rheumatol & Inflammat Res, Guldhedsgatan 10A, S-41346 Gothenburg, Sweden.	tao.jin@rheuma.gu.se	Jin, Tao/K-3323-2015; 	Jin, Tao/0000-0001-9039-0628; Kwiecinski, Jakub/0000-0001-9472-2896	Swedish Medical Research Council; Swedish Agreement Concerning Research and Education of Doctors (ALF); Goteborg Medical Society; Swedish Medical Society; Stiftelsen Clas Groschinskys Minnesfond; Rune and Ulla Amlovs Foundation; Tore Nilsons Foundation; Nanna Svartz Foundation; Swedish Association against Rheumatism; Lundberg Foundation; Gothenburg Association against Rheumatism; University of Gothenburg; Toleranzia AB	Supported by the Swedish Medical Research Council, the Swedish Agreement Concerning Research and Education of Doctors (ALF), the Goteborg Medical Society, the Swedish Medical Society, the Stiftelsen Clas Groschinskys Minnesfond, the Rune and Ulla Amlovs Foundation, the Tore Nilsons Foundation, the Nanna Svartz Foundation, the Swedish Association against Rheumatism, the Lundberg Foundation, the Gothenburg Association against Rheumatism, and the University of Gothenburg.; Dr. Lycke has received consulting fees, speaking fees, and/or honoraria from Toleranzia AB (less than $10,000).	Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Constien R, 2001, GENESIS, V30, P36, DOI 10.1002/gene.1030; Goldenberg DL, 1998, LANCET, V351, P197, DOI 10.1016/S0140-6736(97)09522-6; Harel L, 2011, J PEDIATR ORTHOPED, V31, P211, DOI 10.1097/BPO.0b013e3182092869; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Verdrengh M, 2006, J INFECT DIS, V194, P1597, DOI 10.1086/508751; Yoshimura A, 1999, J IMMUNOL, V163, P1; Deng GM, 1999, NAT MED, V5, P702, DOI 10.1038/9554; Bigbee CL, 2007, ARTHRITIS RHEUM, V56, P2557, DOI 10.1002/art.22750; Shirtliff ME, 2002, CLIN MICROBIOL REV, V15, P527, DOI 10.1128/CMR.15.4.527-544.2002; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Fritz D, 2012, NEUROLOGY, V79, P2177, DOI 10.1212/WNL.0b013e31827595f7; Hemmi H, 2000, NATURE, V408, P740; Kaandorp CJE, 1997, ANN RHEUM DIS, V56, P470, DOI 10.1136/ard.56.8.470; Chavakis T, 2003, J EXP MED, V198, P1507, DOI 10.1084/jem.20030800; Sakiniene E, 1996, ARTHRITIS RHEUM, V39, P1596, DOI 10.1002/art.1780390921; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Fei Y, 2011, J INFECT DIS, V204, P348, DOI 10.1093/infdis/jir266; TIMMERMAN CP, 1993, INFECT IMMUN, V61, P4167; Odio CM, 2003, PEDIATR INFECT DIS J, V22, P883, DOI 10.1097/01.inf.0000091293.32187.7b; Sundquist M, 2005, J IMMUNOL, V175, P3287; Verdrengh M, 1997, INFECT IMMUN, V65, P2517; Andersson U, 2012, ANNU REV IMMUNOL, V30, P313, DOI 10.1146/annurev-immunol-020711-075015; Simelyte E, 2000, INFECT IMMUN, V68, P3535; Bockenstedt LK, 2012, J CLIN INVEST, V122, P2652, DOI 10.1172/JCI58813; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Du XN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019583; Fries Walter, 2008, Int J Med Sci, V5, P169; Henningsson L, 2010, INFECT IMMUN, V78, P3783, DOI 10.1128/IAI.00385-10; Jin T, 2003, ARTHRITIS RES THER, V5, pR9, DOI 10.1186/ar606; Liu ZQ, 2001, ARTHRITIS RES, V3, P375, DOI 10.1186/ar330; Osiri M, 1998, ASIAN PAC J ALLERGY, V16, P155; Pullerits R, 2003, ARTHRITIS RHEUM, V48, P1693, DOI 10.1002/art.11028; Stevens AM, 1996, THEORY PRACTICE HIST; Surguladze D, 2009, CANCER RES, V69, P5643, DOI 10.1158/0008-5472.CAN-09-0487; Tarkowski A, 1998, MOL MED TODAY, V4, P15, DOI 10.1016/S1357-4310(97)80540-0; van Zoelen MA, 2011, CRIT CARE, V15, DOI 10.1186/cc9990; van der Heijden IM, 1999, ARTHRITIS RHEUM, V42, P2198, DOI 10.1002/1529-0131(199910)42:10<2198::AID-ANR23>3.0.CO;2-N; van Langevelde P, 1999, ANTIMICROB AGENTS CH, V43, P2984; van Langevelde P, 1998, ANTIMICROB AGENTS CH, V42, P3073	40	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	JAN	2015	67	1					107	116		10.1002/art.38902		10	Rheumatology	Rheumatology	AX4QY	WOS:000346917700012		
J	Takahashi, T; Asano, Y; Ichimura, Y; Toyama, T; Taniguchi, T; Noda, S; Akamata, K; Tada, Y; Sugaya, M; Kadono, T; Sato, S				Takahashi, Takehiro; Asano, Yoshihide; Ichimura, Yohei; Toyama, Tetsuo; Taniguchi, Takashi; Noda, Shinji; Akamata, Kaname; Tada, Yayoi; Sugaya, Makoto; Kadono, Takafumi; Sato, Shinichi			Amelioration of Tissue Fibrosis by Toll-like Receptor 4 Knockout in Murine Models of Systemic Sclerosis	ARTHRITIS & RHEUMATOLOGY			English	Article							BLEOMYCIN-INDUCED SCLERODERMA; TIGHT-SKIN; CLINICAL-SIGNIFICANCE; AUTOIMMUNE-DISEASE; PULMONARY-FIBROSIS; IMMUNE-RESPONSES; INNATE IMMUNITY; REGULATES SKIN; LUNG FIBROSIS; SERUM-LEVELS	Objective. Bleomycin-induced fibrosis and the tight skin (TSK/+) mouse are well-established experimental murine models of human systemic sclerosis (SSc). Growing evidence has demonstrated the pivotal role of Toll-like receptors (TLRs) in several autoimmune inflammatory diseases, including SSc. This study was undertaken to determine the role of TLR-4 in the fibrotic processes in these murine models. Methods. We generated a murine model of bleomycin-induced SSc using TLR-4(-/-) mice and TLR-4(-/-); TSK/+ mice. The mechanisms by which TLR-4 contributes to pathologic tissue fibrosis were investigated in these 2 models by histologic examination, hydroxyproline assay, enzyme-linked immunosorbent assay, real-time polymerase chain reaction, and flow cytometry. Results. Dermal and lung fibrosis was attenuated in bleomycin-treated TLR-4(-/-) mice compared with their wild-type counterparts. Inflammatory cell infiltration, expression of various inflammatory cytokines, and pathologic angiogenesis induced by bleomycin treatment were suppressed with TLR-4 deletion. Furthermore, the increased expression of interleukin-6 (IL-6) in fibroblasts, endothelial cells, and immune cells in response to bleomycin in vivo and to lipopolysaccharide in vitro was notably abrogated in the absence of TLR-4. Moreover, TLR-4 deletion was associated with alleviated B cell activation and skew toward a Th2/Th17 response against bleomycin treatment. Importantly, in TSK/+ mice, another SSc murine model, TLR-4 abrogation attenuated hypodermal fibrosis. Conclusion. These results indicate the pivotal contribution of TLR-4 to the pathologic tissue fibrosis of SSc murine models. Our results indicate the critical role of TLR-4 signaling in the development of tissue fibrosis, suggesting that biomolecular TLR-4 targeting might be a potential therapeutic approach to SSc.	[Takahashi, Takehiro; Asano, Yoshihide; Ichimura, Yohei; Toyama, Tetsuo; Taniguchi, Takashi; Noda, Shinji; Akamata, Kaname; Tada, Yayoi; Sugaya, Makoto; Kadono, Takafumi; Sato, Shinichi] Univ Tokyo, Grad Sch Med, Tokyo 1138655, Japan	Asano, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Dermatol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yasano-tky@umin.ac.jp; satos-der@h.u-tokyo.ac.jp			Ministry of Health, Welfare, and Labor of Japan (Health Science Research grants); Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science [24-4204]	Supported by the Ministry of Health, Welfare, and Labor of Japan (Health Science Research grants), the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and the Japan Society for the Promotion of Science (Grant-in-Aid for JSPS Fellows no. 24-4204 to Dr. Takahashi).	Akbarshahi H, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-219; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Yoshizaki A, 2008, J RHEUMATOL, V35, P1825; Yoshizaki A, 2009, J CLIN IMMUNOL, V29, P180, DOI 10.1007/s10875-008-9252-x; Shima Y, 2010, RHEUMATOLOGY, V49, P2408, DOI 10.1093/rheumatology/keq275; Aliprantis AO, 2007, P NATL ACAD SCI USA, V104, P2827, DOI 10.1073/pnas.0700021104; Kaviratne M, 2004, J IMMUNOL, V173, P4020; Yamamoto T, 1999, J INVEST DERMATOL, V112, P456, DOI 10.1046/j.1523-1747.1999.00528.x; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Sato S, 2001, J DERMATOL SCI, V27, P140, DOI 10.1016/S0923-1811(01)00128-1; Hasegawa M, 1997, J RHEUMATOL, V24, P328; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Asano Y, 2010, J DERMATOL, V37, P54, DOI 10.1111/j.1346-8138.2009.00758.x; Akira S, 2003, J BIOL CHEM, V278, P38105, DOI 10.1074/jbc.R300028200; Komura K, 2008, J RHEUMATOL, V35, P120; Wilson MS, 2010, J EXP MED, V207, P535, DOI 10.1084/jem.20092121; Rincon M, 1997, J EXP MED, V185, P461, DOI 10.1084/jem.185.3.461; O'Reilly S, 2012, RHEUMATOLOGY, V51, P1540, DOI 10.1093/rheumatology/kes090; Ogura H, 2008, IMMUNITY, V29, P628, DOI 10.1016/j.immuni.2008.07.018; ISHIKAWA O, 1992, J RHEUMATOL, V19, P1202; Khan K, 2012, ANN RHEUM DIS, V71, P1235, DOI 10.1136/annrheumdis-2011-200955; Li YJ, 2011, J EXP MED, V208, P1459, DOI 10.1084/jem.20102510; Liu B, 2006, J IMMUNOL, V177, P6880; Okamoto Y, 2012, ARTHRITIS RHEUM-US, V64, P3726, DOI 10.1002/art.34643; Matsushita T, 2006, J RHEUMATOL, V33, P275; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Yoshizaki A, 2008, AM J PATHOL, V172, P1650, DOI 10.2353/ajpath.2008.071049; Yoshizaki A, 2010, J IMMUNOL, V185, P2502, DOI 10.4049/jimmunol.0901778; Bhattacharyya S, 2013, AM J PATHOL, V182, P192, DOI 10.1016/j.ajpath.2012.09.007; Saito E, 2002, J CLIN INVEST, V109, P1453, DOI 10.1172/JCI200215078; Varga J, 2007, J CLIN INVEST, V117, P557, DOI 10.1172/JCI31139; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Cassoni P, 2006, MOL CANCER RES, V4, P351, DOI 10.1158/1541-7786; AKIRA S, 1990, FASEB J, V4, P2860; Lafyatis R, 2009, CURR OPIN RHEUMATOL, V21, P617, DOI 10.1097/BOR.0b013e32832fd69e; Hasegawa M, 1999, CLIN EXP IMMUNOL, V117, P159; Sakkas LI, 2006, NAT CLIN PRACT RHEUM, V2, P679, DOI 10.1038/ncprheum0346; Gallucci RM, 2004, J INVEST DERMATOL, V122, P764, DOI 10.1111/j.0022-202X.2004.22323.x; GREEN MC, 1976, AM J PATHOL, V82, P493; JIMENEZ SA, 1986, J BIOL CHEM, V261, P657; Jordan S, 2014, ANN RHEUM DIS; Kitaba S, 2012, AM J PATHOL, V180, P165, DOI 10.1016/j.ajpath.2011.09.013; Kodera T, 2002, P NATL ACAD SCI USA, V99, P3800, DOI 10.1073/pnas.052709999; Kraaij Marina D, 2008, Biologics, V2, P389; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; McElwee K J, 2002, Clin Exp Dermatol, V27, P410, DOI 10.1046/j.1365-2230.2002.01075.x; Yamamoto T, 2011, INT J RHEUMATOL, V2011; Yamamoto T, 2003, J INVEST DERMATOL, V121, P510, DOI 10.1046/j.1523-1747.2003.12408.x; Zeini M, 2006, J IMMUNOL, V177, P3327; Zhu H, 2004, AUTOIMMUNITY, V37, P51, DOI 10.1080/08916930310001633782	50	7	8	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	JAN	2015	67	1					254	265		10.1002/art.38901		12	Rheumatology	Rheumatology	AX4QY	WOS:000346917700027		
J	Chiba, T; Matsuo, H; Kawamura, Y; Nagamori, S; Nishiyama, T; Wei, L; Nakayama, A; Nakamura, T; Sakiyama, M; Takada, T; Taketani, Y; Suma, S; Naito, M; Oda, T; Kumagai, H; Moriyama, Y; Ichida, K; Shimizu, T; Kanai, Y; Shinomiya, N				Chiba, Toshinori; Matsuo, Hirotaka; Kawamura, Yusuke; Nagamori, Shushi; Nishiyama, Takashi; Wei, Ling; Nakayama, Akiyoshi; Nakamura, Takahiro; Sakiyama, Masayuki; Takada, Tappei; Taketani, Yutaka; Suma, Shino; Naito, Mariko; Oda, Takashi; Kumagai, Hiroo; Moriyama, Yoshinori; Ichida, Kimiyoshi; Shimizu, Toru; Kanai, Yoshikatsu; Shinomiya, Nariyoshi			NPT1/SLC17A1 Is a Renal Urate Exporter in Humans and Its Common Gain-of-Function Variant Decreases the Risk of Renal Underexcretion Gout	ARTHRITIS & RHEUMATOLOGY			English	Article							AMINO-ACID TRANSPORTER; MULTIINSTITUTIONAL COLLABORATIVE COHORT; URIC-ACID; DYSFUNCTIONAL VARIANTS; IDENTIFICATION; ABCG2; SERUM; SUSCEPTIBILITY; HYPERURICEMIA; HYPOURICEMIA	Objective. Serum uric acid (SUA) levels in humans are mainly regulated by urate transporters. Recent genome-wide association studies suggested that common variants of the human sodium-dependent phosphate cotransporter type 1 gene (NPT1/SLC17A1) influence SUA. NPT1 has been reported to mediate urate transport, but its physiologic role in regulating SUA in humans remains unclear. Furthermore, the findings of replication studies of the relationship between NPT1 variants and gout have been inconsistent. The aims of this study were to investigate the effect of NPT1 on gout and to determine its physiologic role. Methods. Five hundred forty-five male Japanese patients with gout and 1,115 male Japanese control subjects were genotyped for rs1165196 (I269T), a common missense variant in NPT1. Analyses of the association between rs1165196 and gout were then conducted, focusing especially on renal underexcretion (RUE) gout. Immunohistochemical analysis and functional analysis using Xenopus oocytes were also performed. Results. Single-nucleotide polymorphism rs1165196 significantly decreased the risk of RUE gout (odds ratio 0.73, P = 0.031) but did not confer a risk for all gout (P = 0.123). The immunohistochemical analysis revealed that human NPT1 is localized to the apical membrane of the renal proximal tubule. The functional analysis using Xenopus oocyte expression systems showed that rs1165196 increases NPT1-mediated urate export. Conclusion. This study showed that NPT1 is a urate exporter located in the renal proximal tubule in humans, and that its common gain-of-function variant, rs1165196, causes RUE gout, a major subtype of gout. These findings enable us to deepen our understanding of the physiologic role of NPT1 as a renal urate exporter as well as its pathophysiologic role in gout.	[Chiba, Toshinori; Matsuo, Hirotaka; Kawamura, Yusuke; Nakayama, Akiyoshi; Nakamura, Takahiro; Sakiyama, Masayuki; Oda, Takashi; Kumagai, Hiroo; Shinomiya, Nariyoshi] Natl Def Med Coll, Tokorozawa, Saitama 3598513, Japan; [Nagamori, Shushi; Nishiyama, Takashi; Wei, Ling; Kanai, Yoshikatsu] Osaka Univ, Osaka, Japan; [Takada, Tappei] Tokyo Univ Hosp, Tokyo 113, Japan; [Takada, Tappei] Univ Tokyo, Tokyo, Japan; [Taketani, Yutaka] Univ Tokushima, Grad Sch, Tokushima 770, Japan; [Suma, Shino; Naito, Mariko] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Oda, Takashi] Hachioji Med Ctr, Hachioji, Tokyo, Japan; [Oda, Takashi] Tokyo Med Univ, Hachioji, Tokyo, Japan; [Moriyama, Yoshinori] Okayama Univ, Okayama, Japan; [Ichida, Kimiyoshi] Tokyo Univ Pharm & Life Sci, Tokyo, Japan; [Ichida, Kimiyoshi] Jikei Univ, Sch Med, Tokyo, Japan; [Shimizu, Toru] Midorigaoka Hosp, Osaka, Japan	Matsuo, H (reprint author), Natl Def Med Coll, Dept Integrat Physiol & Bionano Med, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	hmatsuo@ndmc.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labour, and Welfare of Japan; Ministry of Defense of Japan; Japan Society for the Promotion of Science; Kawano Masanori Memorial Foundation for the Promotion of Pediatrics, AstraZeneca (VRI Research Grant); Takeda Science Foundation; Gout Research Foundation of Japan	Supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Ministry of Health, Labour, and Welfare of Japan, the Ministry of Defense of Japan, the Japan Society for the Promotion of Science, the Kawano Masanori Memorial Foundation for the Promotion of Pediatrics, AstraZeneca (VRI Research Grant), the Takeda Science Foundation, and the Gout Research Foundation of Japan.	Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Woodward OM, 2009, P NATL ACAD SCI USA, V106, P10338, DOI 10.1073/pnas.0901249106; Enomoto A, 2002, NATURE, V417, P447; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Urano W, 2010, ANN RHEUM DIS, V69, P1232, DOI 10.1136/ard.2008.106856; Matsuo H, 2000, NEUROREPORT, V11, P3507, DOI 10.1097/00001756-200011090-00021; Kanai Y, 2000, J BIOL CHEM, V275, P20787, DOI 10.1074/jbc.M000634200; Dinour D, 2010, J AM SOC NEPHROL, V21, P64, DOI 10.1681/ASN.2009040406; Yang QO, 2010, CIRC-CARDIOVASC GENE, V3, P523, DOI [10.1161/CIRCGENETICS.109.934455, 10.1161/CIRCGENETICS.110.934455]; Matsuo H, 2008, AM J HUM GENET, V83, P744, DOI 10.1016/j.ajhg.2008.11.001; Hamajima N, 2007, ASIAN PAC J CANCER P, V8, P317; Uchino H, 2000, BIOCHEM BIOPH RES CO, V270, P254, DOI 10.1006/bbrc.2000.2407; Matsuo H, 2002, J BIOL CHEM, V277, P21017, DOI 10.1074/jbc.M200019200; WALLACE SL, 1977, ARTHRITIS RHEUM, V20, P895, DOI 10.1002/art.1780200320; Matsuo H, 1999, ARCH NEUROL-CHICAGO, V56, P721, DOI 10.1001/archneur.56.6.721; Asai Y, 2009, NAGOYA J MED SCI, V71, P137; Guideline Revising Committee of Japanese Society of Gout and Nucleic Acid Metabolism, 2010, GUID MAN HYP GOUT, P60; Hollis-Moffatt JE, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3816; Ichida K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1756; Iharada M, 2010, J BIOL CHEM, V285, P26107, DOI 10.1074/jbc.M110.122721; Indraratna PL, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3191; Kawamura Y, 2011, NUCLEOS NUCLEOT NUCL, V30, P1105, DOI 10.1080/15257770.2011.623685; Matsuo H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02014; Matsuo H, 2004, NEUROSCI LETT, V358, P123, DOI 10.1016/j.neulet.2004.01.014; Matsuo H, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000237; Nakayama A, 2013, HUM CELL, V26, P133, DOI 10.1007/s13577-013-0073-8; Nakayama A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05227; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; SIMKIN PA, 1979, ANN INTERN MED, V91, P44; Stark K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007729	30	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	JAN	2015	67	1					281	287		10.1002/art.38884		7	Rheumatology	Rheumatology	AX4QY	WOS:000346917700030		
J	Yokoyama, K; Ikeya, M; Umeda, K; Oda, H; Nodomi, S; Nasu, A; Matsumoto, Y; Izawa, K; Horigome, K; Kusaka, T; Tanaka, T; Saito, MK; Yasumi, T; Nishikomori, R; Ohara, O; Nakayama, N; Nakahata, T; Heike, T; Toguchida, J				Yokoyama, Koji; Ikeya, Makoto; Umeda, Katsutsugu; Oda, Hirotsugu; Nodomi, Seishiro; Nasu, Akira; Matsumoto, Yoshihisa; Izawa, Kazushi; Horigome, Kazuhiko; Kusaka, Toshimasa; Tanaka, Takayuki; Saito, Megumu K.; Yasumi, Takahiro; Nishikomori, Ryuta; Ohara, Osamu; Nakayama, Naoki; Nakahata, Tatsutoshi; Heike, Toshio; Toguchida, Junya			Enhanced Chondrogenesis of Induced Pluripotent Stem Cells From Patients With Neonatal-Onset Multisystem Inflammatory Disease Occurs via the Caspase 1-Independent cAMP/Protein Kinase A/CREB Pathway	ARTHRITIS & RHEUMATOLOGY			English	Article							COLD AUTOINFLAMMATORY SYNDROME; MUCKLE-WELLS-SYNDROME; LOW-LEVEL MOSAICISM; NLRP3 INFLAMMASOME; ARTICULAR SYNDROME; SOMATIC MOSAICISM; PERIODIC SYNDROME; CIAS1 MUTATIONS; CYCLIC-AMP; PROTEIN	Objective. Neonatal-onset multisystem inflammatory disease (NOMID) is a dominantly inherited auto-inflammatory disease caused by NLRP3 mutations. NOMID pathophysiology is explained by the NLRP3 inflammasome, which produces interleukin-1 beta (IL-1 beta). However, epiphyseal overgrowth in NOMID is resistant to anti-IL-1 therapy and may therefore occur independently of the NLRP3 inflammasome. This study was undertaken to investigate the effect of mutated NLRP3 on chondrocytes using induced pluripotent stem cells (iPSCs) from patients with NOMID. Methods. We established isogenic iPSCs with wild-type or mutant NLRP3 from 2 NOMID patients with NLRP3 somatic mosaicism. The iPSCs were differentiated into chondrocytes in vitro and in vivo. The phenotypes of chondrocytes with wild-type and mutant NLRP3 were compared, particularly the size of the chondrocyte tissue produced. Results. Mutant iPSCs produced larger chondrocyte masses than wild-type iPSCs owing to glycosaminoglycan overproduction, which correlated with increased expression of the chondrocyte master regulator SOX9. In addition, in vivo transplantation of mutant cartilaginous pellets into immunodeficient mice caused disorganized endochondral ossification. Enhanced chondrogenesis was independent of caspase 1 and IL-1, and thus the NLRP3 inflammasome. Investigation of the human SOX9 promoter in chondroprogenitor cells revealed that the CREB/ATF-binding site was critical for SOX9 overexpression caused by mutated NLRP3. This was supported by increased levels of cAMP and phosphorylated CREB in mutant chondroprogenitor cells. Conclusion. Our findings indicate that the intrinsic hyperplastic capacity of NOMID chondrocytes is dependent on the cAMP/PKA/CREB pathway, independent of the NLRP3 inflammasome.	[Yokoyama, Koji; Ikeya, Makoto; Umeda, Katsutsugu; Oda, Hirotsugu; Nodomi, Seishiro; Nasu, Akira; Matsumoto, Yoshihisa; Izawa, Kazushi; Horigome, Kazuhiko; Kusaka, Toshimasa; Tanaka, Takayuki; Saito, Megumu K.; Yasumi, Takahiro; Nishikomori, Ryuta; Nakahata, Tatsutoshi; Heike, Toshio; Toguchida, Junya] Kyoto Univ, Kyoto 6068507, Japan; [Oda, Hirotsugu] RIKEN, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Matsumoto, Yoshihisa] Nagoya City Univ, Nagoya, Aichi, Japan; [Horigome, Kazuhiko] Dainippon Sumitomo Pharma, Osaka, Japan; [Ohara, Osamu] RIKEN, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Ohara, Osamu] Kazusa DNA Res Inst, Kisarazu, Japan; [Nakayama, Naoki] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA	Nishikomori, R (reprint author), Kyoto Univ, Grad Sch Med, Dept Pediat, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	rnishiko@kuhp.kyoto-u.ac.jp; togjun@frontier.kyoto-u.ac.jp			Japanese Ministry of Health, Labor, and Welfare; Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT Leading Project for Realization of Regenerative Medicine); Japanese Science and Technology Agency (Program for Intractable Diseases Research Utilizing Disease-Specific Induced Pluripotent Stem Cells); Secom Science and Technology Foundation; Induced Pluripotent Stem Cell Research Fund	Supported by Grants-in-Aid for Scientific Research from the Japanese Ministry of Health, Labor, and Welfare, the Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT Leading Project for Realization of Regenerative Medicine), the Japanese Science and Technology Agency (Program for Intractable Diseases Research Utilizing Disease-Specific Induced Pluripotent Stem Cells), the Secom Science and Technology Foundation, and the Induced Pluripotent Stem Cell Research Fund.	Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357; Lachmann HJ, 2009, NEW ENGL J MED, V360, P2416, DOI 10.1056/NEJMoa0810787; Kawaguchi J, 2005, BONE, V36, P758, DOI 10.1016/j.bone.2004.07.019; Tanaka N, 2011, ARTHRITIS RHEUM-US, V63, P3625, DOI 10.1002/art.30512; Aksentijevich I, 2002, ARTHRITIS RHEUM, V46, P3340, DOI 10.1002/art.10688; Almeida MQ, 2011, HUM MOL GENET, V20, P165, DOI 10.1093/hmg/ddq455; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Akiyama H, 2011, J BONE MINER METAB, V29, P390, DOI 10.1007/s00774-011-0273-9; Tew SR, 2005, OSTEOARTHR CARTILAGE, V13, P80, DOI 10.1016/j.joca.2004.10.011; Kufer TA, 2011, NAT IMMUNOL, V12, P121, DOI 10.1038/ni.1985; Cucchiarini M, 2013, J MOL MED, V91, P625, DOI 10.1007/s00109-012-0978-9; Cucchiarini M, 2007, ARTHRITIS RHEUM, V56, P158, DOI 10.1002/art.22299; Tanaka T, 2012, BLOOD, V120, P1299, DOI 10.1182/blood-2012-03-417881; Gattorno M, 2013, ARTHRITIS RHEUM-US, V65, P1137, DOI 10.1002/art.37882; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Lee GS, 2012, NATURE, V492, P123, DOI 10.1038/nature11588; Hoffman HM, 2004, LANCET, V364, P1779, DOI 10.1016/S0140-6736(04)17401-1; Arostegui JI, 2010, ARTHRITIS RHEUM-US, V62, P1158, DOI 10.1002/art.27342; Tsuda M, 2003, J BIOL CHEM, V278, P27224, DOI 10.1074/jbc.M303471200; Saito M, 2008, BLOOD, V111, P2132, DOI 10.1182/blood-2007-06-094201; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; zur Nieden NI, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-1; Huang WD, 2000, MOL CELL BIOL, V20, P4149, DOI 10.1128/MCB.20.11.4149-4158.2000; Hill SC, 2007, PEDIATR RADIOL, V37, P145, DOI 10.1007/s00247-006-0358-0; Hawkins PN, 2003, NEW ENGL J MED, V348, P2583, DOI 10.1056/NEJM200306193482523; Mackie EJ, 2011, J ENDOCRINOL, V211, P109, DOI 10.1530/JOE-11-0048; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Aoyama T, 2004, J BIOL CHEM, V279, P28789, DOI 10.1074/jbc.M401273200; Barberi T, 2005, PLOS MED, V2, P554, DOI 10.1371/journal.pmed.0020161; Bonar SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035979; Carroll SH, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.2; Kajita Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049709; Kim Y, 2011, J BONE MINER METAB, V29, P123, DOI 10.1007/s00774-010-0206-z; Nasu A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053771; Rossol M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2339; Saito M, 2005, ARTHRITIS RHEUM, V52, P3579, DOI 10.1002/art.21404; Sakai H, 2012, INT IMMUNOL, V24, P5, DOI 10.1093/intimm/dxr088; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Umeda K, 2012, SCI REP-UK, V2, DOI 10.1038/srep00455; Ushita M, 2009, OSTEOARTHR CARTILAGE, V17, P1065, DOI 10.1016/j.joca.2009.02.003; Yoon YM, 2000, J BONE MINER RES, V15, P2197, DOI 10.1359/jbmr.2000.15.11.2197	42	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	JAN	2015	67	1					302	314		10.1002/art.38912		13	Rheumatology	Rheumatology	AX4QY	WOS:000346917700033		
J	Koga, H; Muneta, T; Yagishita, K; Watanabe, T; Mochizuki, T; Horie, M; Nakamura, T; Otabe, K; Sekiya, I				Koga, Hideyuki; Muneta, Takeshi; Yagishita, Kazuyoshi; Watanabe, Toshifumi; Mochizuki, Tomoyuki; Horie, Masafumi; Nakamura, Tomomasa; Otabe, Koji; Sekiya, Ichiro			Mid- to Long-term Results of Single-Bundle Versus Double-Bundle Anterior Cruciate Ligament Reconstruction: Randomized Controlled Trial	ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY			English	Article							GRAFT FIXATION ANGLES; ACL RECONSTRUCTION; FOLLOW-UP; CLINICAL-EVALUATION; PATELLAR TENDON; HAMSTRINGS	Purpose: To evaluate the mid-to long-term results of a randomized controlled trial of single-bundle (SB) versus double-bundle (DB) anterior cruciate ligament (ACL) reconstruction using a semitendinosus tendon. Methods: Seventy-eight patients who underwent primary ACL reconstruction with an autologous semitendinosus tendon were prospectively randomized into 2 groups: SB reconstruction (n = 39) and DB reconstruction (n = 39). In both groups, grafts were fixed at 30 degrees of flexion with a total tension of 80 N. The following evaluation methods were used: clinical examination, KT-1000 arthrometer (MEDmetric, San Diego, CA) measurement, muscle strength, Tegner activity score, Lysholm score, subjective rating scale regarding patient satisfaction and sports performance level, graft retear, contralateral ACL tear, and additional meniscus surgery. Results: Fifty-three patients (25 in SB group and 28 in DB group) who were followed up for a minimum of 3 years (mean, 69 months; range, 36 to 140 months) were evaluated. Preoperatively, there were no differences between the groups. Postoperatively, the Lachman and pivot-shift test results were better in the DB group (P = .024 and P < .0001, respectively). KT measurements were better in the DB group (mean, 1.4 mm v 2.7 mm; P = .0023). The Tegner score was also better in the DB group (P = .033). There were no significant differences in range of motion, muscle strength, Lysholm score, subjective rating scale, graft retear, and secondary meniscal tear. Conclusions: In ACL reconstruction using the transtibial approach, DB reconstruction was significantly better than SB reconstruction regarding anterior and rotational stability during the 3- to 12-year follow-up. The results of KT measurements and the Lachman and pivot-shift tests were significantly better in the DB group, whereas there was no difference in the anterior drawer test results. The Tegner score was also better in the DB group; however, there were no differences in the other subjective findings.	[Koga, Hideyuki; Muneta, Takeshi; Yagishita, Kazuyoshi; Watanabe, Toshifumi; Mochizuki, Tomoyuki; Horie, Masafumi; Nakamura, Tomomasa; Otabe, Koji; Sekiya, Ichiro] Tokyo Med & Dent Univ, Hosp Med, Dept Orthopaed Surg, Tokyo 1138519, Japan	Koga, H (reprint author), Tokyo Med & Dent Univ, Hosp Med, Dept Orthopaed Surg, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	koga.orj@tmd.ac.jp					Ferretti M, 2007, ARTHROSCOPY, V23, P1218, DOI 10.1016/j.arthro.2007.09.008; Park SJ, 2010, ARTHROSCOPY, V26, P630, DOI 10.1016/j.arthro.2009.09.006; Muneta T, 1998, SCAND J MED SCI SPOR, V8, P283, DOI 10.1111/j.1600-0838.1998.tb00484.x; Woo SLY, 2002, J BONE JOINT SURG AM, V84A, P907; Koga H, 2012, AM J SPORT MED, V40, P615, DOI 10.1177/0363546511426696; Aglietti P, 2010, AM J SPORT MED, V38, P25, DOI 10.1177/0363546509347096; Sastre S, 2010, KNEE SURG SPORT TR A, V18, P32, DOI 10.1007/s00167-009-0844-7; Wang JQ, 2009, CHINESE MED J-PEKING, V122, P706, DOI 10.3760/cma.j.issn.0366-6999.2009.06.022; Song EK, 2013, AM J SPORT MED, V41, P2340, DOI 10.1177/0363546513498998; Koga H, 2013, ARTHROSCOPY, V29, P529, DOI 10.1016/j.arthro.2012.10.018; Misonoo G, 2012, KNEE, V19, P87, DOI 10.1016/j.knee.2011.01.003; Muneta T, 2007, ARTHROSCOPY, V23, P618, DOI 10.1016/j.arthro.2007.04.010; Suomalainen P, 2012, AM J SPORT MED, V40, P1511, DOI 10.1177/0363546512448177; NAKAJIMA H, 1979, ARCH ORTHOP TRAUM SU, V95, P233, DOI 10.1007/BF00389691; Yagi M, 2002, AM J SPORT MED, V30, P660; Muneta T, 2013, KNEE SURG SPORT TR A, V21, P906, DOI 10.1007/s00167-012-2023-5; Streich NA, 2008, KNEE SURG SPORT TR A, V16, P232, DOI 10.1007/s00167-007-0480-z; Siebold R, 2008, ARTHROSCOPY, V24, P137, DOI 10.1016/j.arthro.2007.11.013; Hussein M, 2012, AM J SPORT MED, V40, P512, DOI 10.1177/0363546511426416; Gobbi A, 2012, CLIN ORTHOP RELAT R, V470, P824, DOI 10.1007/s11999-011-1940-9; Yagi M, 2007, CLIN ORTHOP RELAT R, P100, DOI 10.1097/BLO.0b013e31802ba45c; Zaffagnini S, 2008, SCAND J MED SCI SPOR, V18, P573, DOI 10.1111/j.1600-0838.2007.00697.x; Adachi N, 2004, J BONE JOINT SURG BR, V86B, P515, DOI 10.1302/0301-620X.86B4.14856; Suomalainen P, 2011, AM J SPORT MED, V39, P1615, DOI 10.1177/0363546511405024; Araki D, 2011, INT ORTHOP, V35, P439, DOI 10.1007/s00264-010-1110-9; Zaffagnini S, 2011, KNEE SURG SPORT TR A, V19, P390, DOI 10.1007/s00167-010-1225-y; Hefti F, 1993, Knee Surg Sports Traumatol Arthrosc, V1, P226; Ibrahim SAR, 2009, J BONE JOINT SURG BR, V91B, P1310, DOI 10.1302/0301-620X.91B10.21886; LYSHOLM J, 1982, AM J SPORT MED, V10, P150, DOI 10.1177/036354658201000306; Song EK, 2009, AM J SPORT MED, V37, P1705, DOI 10.1177/0363546509333478; TEGNER Y, 1985, CLIN ORTHOP RELAT R, P43; Tiamklang T, 2012, COCHRANE DB SYST REV, V11; Volpi P, 2010, INJURY, V41, P1168, DOI 10.1016/j.injury.2010.09.029; Yamazaki J, 2010, KNEE SURG SPORT TR A, V19, P418	34	2	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0749-8063	1526-3231		ARTHROSCOPY	Arthroscopy	JAN	2015	31	1					69	76		10.1016/j.arthro.2014.07.020		8	Orthopedics; Surgery	Orthopedics; Surgery	AX6KY	WOS:000347032400018		
J	Adachi, K; Buseck, PR				Adachi, Kouji; Buseck, Peter R.			Changes in shape and composition of sea-salt particles upon aging in an urban atmosphere	ATMOSPHERIC ENVIRONMENT			English	Article						Sea salt; CalNex; Los Angeles; Aging; Light scattering	MARINE BOUNDARY-LAYER; X-RAY-MICROANALYSIS; AEROSOL-PARTICLES; NITRATE FORMATION; NS-SOOT; CLIMATE; CONSTITUENTS; SCATTERING; CHEMISTRY; CARBON	Sea salt is one of the most abundant types of natural aerosol particles and significantly influences local and global climate. It is an important constituent of samples collected between June 10 and 15 in the Los Angeles area during the 2010 CalNex campaign. The sea-salt particles reacted with other species in the atmosphere and became Na-bearing aerosol (NaA) particles. Using transmission electron microscopy, we found that Na occurred in almost half of all analyzed particles (similar to 3500), although commonly only in minor amounts. Almost all the NaA particles contained S but not Cl, suggesting that Cl was depleted through particle formation to sulfate, nitrate, or both in the urban atmosphere. We observed both rounded and euhedral NaA particles. The rounded ones consisted mainly of aged sea salt (>12 h) that had reacted extensively with sulfate, whereas the euhedral ones occurred in samples from relatively fresh marine air. The shapes and compositions of NaA particles changed within 3 h in the urban atmosphere. Moreover, our calculations indicate that light scattering from NaA particles depends on their shapes (e.g., roughly spherical, flat, or elongated). These compositions and shapes affect hygroscopicities and light scattering, respectively, both of which influence their climate effects. (C) 2014 Elsevier Ltd. All rights reserved.	[Adachi, Kouji] Meteorol Res Inst, Tsukuba, Ibaraki 3050052, Japan; [Adachi, Kouji; Buseck, Peter R.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ USA; [Adachi, Kouji; Buseck, Peter R.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ USA	Adachi, K (reprint author), Meteorol Res Inst, 1-1 Nagamine, Tsukuba, Ibaraki 3050052, Japan.	adachik@mri-jma.go.jp; pbuseck@asu.edu			NSF [AGS-1032312]; JSPS KAKENHI [25740008]	We thank J. Surratt, J. Seinfeld, J. Jimenez, J. de Gouw, and J. Stutz for help with CalNex sample collections and B. Draine and P. Flatau for providing the DDSCAT 6.1 code. The authors acknowledge the NOM Air Resources Laboratory (ARL) for the provision of the HYSPLIT model and READY website (http://www.arl.noaa.gov/ready.php) and the use of TEM facilities within the LeRoy Eyring Center for Solid State Science at Arizona State University and the Meteorological Research Institute. This study was supported by NSF grant AGS-1032312 and JSPS KAKENHI Grant number 25740008.	Adachi K, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015102; Allan JD, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004208; Ryerson TB, 2013, J GEOPHYS RES-ATMOS, V118, P5830, DOI 10.1002/jgrd.50331; MCINNES LM, 1994, J GEOPHYS RES-ATMOS, V99, P8257, DOI 10.1029/93JD03453; Posfai M, 2010, ANNU REV EARTH PL SC, V38, P17, DOI 10.1146/annurev.earth.031208.100032; DeCarlo PF, 2004, AEROSOL SCI TECH, V38, P1185, DOI 10.1080/027868290903907; POSFAI M, 1994, ATMOS ENVIRON, V28, P1747, DOI 10.1016/1352-2310(94)90137-6; Gard EE, 1998, SCIENCE, V279, P1184, DOI 10.1126/science.279.5354.1184; LORIMER GW, 1987, MINERAL MAG, V51, P49, DOI 10.1180/minmag.1987.051.359.05; Adachi K, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047540; Virtanen A, 2010, NATURE, V467, P824, DOI 10.1038/nature09455; Hayes PL, 2013, J GEOPHYS RES-ATMOS, V118, P9233, DOI 10.1002/jgrd.50530; Buseck PR, 1999, P NATL ACAD SCI USA, V96, P3372, DOI 10.1073/pnas.96.7.3372; Adachi K, 2010, ENVIRON SCI TECHNOL, V44, P2299, DOI 10.1021/es902505b; Wagner NL, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017810; Adachi K, 2008, ATMOS CHEM PHYS, V8, P6469; DRAINE BT, 1994, J OPT SOC AM A, V11, P1491, DOI 10.1364/JOSAA.11.001491; Chamaillard K, 2003, J QUANT SPECTROSC RA, V79, P577, DOI 10.1016/S0022-4073(02)00309-6; Mahowald NM, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006459; Laskin A, 2002, ENVIRON SCI TECHNOL, V36, P4948, DOI 10.1021/es020551k; Adachi K, 2013, J GEOPHYS RES-ATMOS, V118, P3723, DOI 10.1002/jgrd.50321; Buseck PR, 2014, AEROSOL SCI TECH, V48, P777, DOI 10.1080/02786826.2014.919374; Buseck PR, 2008, ELEMENTS, V4, P389, DOI 10.2113/gselements.4.6.389; Laskin A, 2003, SCIENCE, V301, P340, DOI 10.1126/science.1085374; Laskin A, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017743; Freney EJ, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013558; Li J, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002310; Murphy DM, 1998, NATURE, V392, P62, DOI 10.1038/32138; Adachi K, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012868; Dall'Osto M, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004747; De Bock LA, 2000, J ATMOS CHEM, V37, P299, DOI 10.1023/A:1006416600722; Draine B.T., 2003, USER GUIDE DISCRETE, P46; Draxler R. R., 2011, HYSPLIT HYBRID SINGL; Ebert M, 2000, J AEROSOL SCI, V31, P613, DOI 10.1016/S0021-8502(99)00549-2; Finlayson-Pitts BJ, 2000, J PHYS CHEM A, V104, P11463, DOI 10.1021/jp002968n; Hara K, 2005, TELLUS B, V57, P230, DOI 10.1111/j.1600-0889.2005.00142.x; Lewis E.R., 2004, GEOPHYS MONOGR SER, V152, P413, DOI DOI 10.1029/GM152; MOURI H, 1993, TELLUS B, V45, P80, DOI 10.1034/j.1600-0889.1993.00007.x; Pakkanen TA, 1996, ATMOS ENVIRON, V30, P2475, DOI 10.1016/1352-2310(95)00492-0; POSFAI M, 1995, J GEOPHYS RES-ATMOS, V100, P23063, DOI 10.1029/95JD01636; Ro CU, 2001, ENVIRON SCI TECHNOL, V35, P4487, DOI 10.1021/es0155231; Seinfeld J. H., 2006, ATMOSPHERIC CHEM PHY	42	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1352-2310	1873-2844		ATMOS ENVIRON	Atmos. Environ.	JAN	2015	100						1	9		10.1016/j.atmosenv.2014.10.036		9	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	AY0CZ	WOS:000347266700001		
J	Takashima, H; Kanaya, Y; Irie, H				Takashima, Hisahiro; Kanaya, Yugo; Irie, Hitoshi			Spatiotemporal inhomogeneity in NO2 over Fukuoka observed by ground-based MAX-DOAS	ATMOSPHERIC ENVIRONMENT			English	Article						Nitrogen dioxide; MAX-DOAS; Boundary layer; Land-sea breeze; Japan	ABSORPTION CROSS-SECTION; RADIATIVE-TRANSFER; RESEARCH VESSEL; EAST-ASIA; RETRIEVAL; FORMALDEHYDE; VALIDATION; INSTRUMENT; SCIAMACHY; PACIFIC	Continuous NO2 profile observations have been made using ground-based Multi-Axis Differential Optical Absorption Spectroscopy (MAX-DOAS) at Fukuoka (33.55 degrees N, 130.36 degrees E), an urban area in Japan. Throughout the year, NO2 variations measured by MAX-DOAS (0-100 m) are in good agreement with in situ surface NO2 measurements on several-day, week-to-week, and seasonal timescales. We investigated the spatiotemporal inhomogeneity in NO2 over Fukuoka by observing at two azimuth angles: the Tenjin (towards the city center) and Itoshima (away from the city center) directions. In terms of diurnal variations, NO2 in both directions show clear morning maxima, on account of local emissions in the morning and the development of a boundary layer. The concentrations in the early morning are nearly the same in both directions, but they are higher in the Tenjin direction during most of the daytime on average. Variability in both directions, as well as spatial inhomogeneity, is large during most of the daytime except for in the morning. The diurnal maximum for 0-1 km between 10 and 13 LT is sometimes observed in the Tenjin direction; in some cases, 1 h after this maximum, a maximum is also observed in the Itoshima direction. The NO2 maxima for the upper level (1-2 km) in both directions are also delayed from the maximum in the Tenjin direction for 0-1 km. Analysis of the surface wind field indicates that the NO2 inhomogeneity is strongly related to vertical/horizontal transport of high concentrations of NO2 from the city center, and to horizontal transport of low concentrations from the ocean via a land sea breeze. Three-dimensional continuous observations by MAX-DOAS are potentially a powerful tool for increasing our understanding of pollutant transport and mixing in urban areas. (C) 2014 Elsevier Ltd. All rights reserved.	[Takashima, Hisahiro] Fukuoka Univ, Fac Sci, Fukuoka 81401, Japan; [Takashima, Hisahiro; Kanaya, Yugo] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Dept Environm Geochem Cycle Res, Yokohama, Kanagawa, Japan; [Irie, Hitoshi] Chiba Univ, Ctr Environm Remote Sensing CEReS, Chiba, Japan	Takashima, H (reprint author), Fukuoka Univ, Fac Sci, Fukuoka 81401, Japan.	hisahiro@fukuoka-u.ac.jp					Richter A, 2005, NATURE, V437, P129, DOI 10.1038/nature04092; Irie H, 2011, ATMOS MEAS TECH, V4, P1027, DOI 10.5194/amt-4-1027-2011; Ma JZ, 2013, ATMOS CHEM PHYS, V13, P1547, DOI 10.5194/acp-13-1547-2013; Clemer K, 2010, ATMOS MEAS TECH, V3, P863, DOI 10.5194/amt-3-863-2010; Wagner T, 2007, ATMOS CHEM PHYS, V7, P1809; Irie H, 2012, ATMOS MEAS TECH, V5, P2403, DOI 10.5194/amt-5-2403-2012; Honninger G, 2004, ATMOS CHEM PHYS, V4, P231; Kannari A, 2007, ATMOS ENVIRON, V41, P3428, DOI 10.1016/j.atmosenv.2006.12.015; Heckel A, 2005, ATMOS CHEM PHYS, V5, P909; Sinreich R, 2005, FARADAY DISCUSS, V130, P153, DOI [10.1039/b419274p, 10.1039/B419274P]; Sinreich R, 2010, ATMOS CHEM PHYS, V10, P11359, DOI 10.5194/acp-10-11359-2010; Vandaele AC, 1998, J QUANT SPECTROSC RA, V59, P171, DOI 10.1016/S0022-4073(97)00168-4; Pinardi G, 2013, ATMOS MEAS TECH, V6, P167, DOI 10.5194/amt-6-167-2013; Wittrock F, 2004, ATMOS CHEM PHYS, V4, P955; Irie H, 2008, ATMOS CHEM PHYS, V8, P341; Iwabuchi H, 2006, J ATMOS SCI, V63, P2324, DOI 10.1175/JAS3755.1; Boersma KF, 2011, ATMOS MEAS TECH, V4, P1905, DOI 10.5194/amt-4-1905-2011; Bogumil K, 2003, J PHOTOCH PHOTOBIO A, V157, P167, DOI 10.1016/S1010-6030(03)00062-5; Fayt C., 2011, QDOAS 1 00 SOFTWARE; Friess U, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006618; Hermans C, 2003, NATO SCI S SS IV EAR, V27, P193; Irie H, 2009, SOLA, V5, P117, DOI 10.2151/sola.2009-030; Kanaya Y., 2014, ATMOSPHERIC CHEM PHY, V14, P2883, DOI [DOI 10.5194/ACPD-14-2883-2014, 10.5194/acpd-14-2883-2014]; Platt U., 1994, AIR MONITORING SPECT, V127; RODGERS CD, 2000, SER ATMOS OCEANIC PL, V2, P12036; Takashima H, 2011, ATMOS ENVIRON, V45, P2593, DOI 10.1016/j.atmosenv.2010.10.055; Takashima H, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD011939; Takashima H, 2012, ATMOS MEAS TECH, V5, P2351, DOI 10.5194/amt-5-2351-2012; Volkamer Rainer, 2009, Proceedings of the SPIE - The International Society for Optical Engineering, V7462, DOI 10.1117/12.826792; Wagner T, 2007, ATMOS CHEM PHYS, V7, P3129; Wagner T, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004904	31	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1352-2310	1873-2844		ATMOS ENVIRON	Atmos. Environ.	JAN	2015	100						117	123		10.1016/j.atmosenv.2014.10.057		7	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	AY0CZ	WOS:000347266700015		
J	Pokhrel, A; Kawamura, K; Seki, O; Matoba, S; Shiraiwa, T				Pokhrel, Ambarish; Kawamura, Kimitaka; Seki, Osamu; Matoba, Sumio; Shiraiwa, Takayuki			Ice core profiles of saturated fatty acids (C-12:0-C-30:0) and oleic acid (C-18:1) from southern Alaska since 1734 AD: A link to climate change in the Northern Hemisphere	ATMOSPHERIC ENVIRONMENT			English	Article						Fatty acids; Alaskan ice core; Marine-derived organic matter; Atmospheric circulation; Atmospheric transport; Climate change	ARCTIC SEA-ICE; MARINE AEROSOLS; ORGANIC-MATTER; DICARBOXYLIC-ACIDS; ISOTOPIC COMPOSITION; SEASONAL-VARIATIONS; MOLECULAR MARKER; WESTERN PACIFIC; UNITED-STATES; OCEAN SURFACE	An ice core drilled at Aurora Peak in southeast Alaska was analyzed for homologous series of straight chain fatty acids (C-12:0-C-30:0) including unsaturated fatty acid (oleic acid) using gas chromatography (GC/FID) and GC/mass spectrometry (GC/MS). Molecular distributions of fatty acids are characterized by even carbon number predominance with a peak at palmitic acid (C-16:0, av. 20.3 +/- SD. 29.8 ng/g-ice) followed by oleic acid (C-18:1, 19.6 +/- 38.6 ng/g-ice) and myristic acid (C-14:0, 15.3 +/- 21.9 ng/g-ice). The historical trends of short-chain fatty acids, together with correlation analysis with inorganic ions and organic tracers suggest that short-chain fatty acids (except for C-12:0 and C-15:0) were mainly derived from sea surface micro layers through bubble bursting mechanism and transported over the glacier through the atmosphere. This atmospheric transport process is suggested to be linked with Kamchatka ice core SD record from Northeast Asia and Greenland Temperature Anomaly (GTA). In contrast, long-chain fatty acids (C-20.0-C-30:0) are originated from terrestrial higher plants, soil organic matter and dusts, which are also linked with GTA. Hence, this study suggests that Alaskan fatty acids are strongly influenced by Pacific Decadal Oscillation/North Pacific Gyre Oscillation and/or extra tropical North Pacific surface climate and Arctic oscillation. We also found that decadal scale variability of C-18:1/C-18:0 ratios in the Aurora Peak ice core correlate with the Kamchatka ice core SD, which reflects climate oscillations in the North Pacific. This study suggests that photochemical aging of organic aerosols could be controlled by climate periodicity. (C) 2014 Elsevier Ltd. All rights reserved.	[Pokhrel, Ambarish; Kawamura, Kimitaka; Seki, Osamu; Matoba, Sumio; Shiraiwa, Takayuki] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 060, Japan; [Pokhrel, Ambarish] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan	Kawamura, K (reprint author), Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 060, Japan.	kawamura@lowtem.hokudai.ac.jp	Kawamura, Kimitaka/B-3839-2011		Japan Society for the Promotion of Science [19340137, 24221001]; Institute of Low Temperature Science, Hokkaido University	This study was in part supported by the Japan Society for the Promotion of Science through Grant-in-Aid Nos. 19340137 and 24221001. We also acknowledge the support from the Institute of Low Temperature Science, Hokkaido University for the ice core program.	GARRETT WD, 1967, DEEP-SEA RES, V14, P221, DOI 10.1016/0011-7471(67)90007-1; Kinnard C, 2011, NATURE, V479, P509, DOI 10.1038/nature10581; ROGGE WF, 1993, ENVIRON SCI TECHNOL, V27, P2700, DOI 10.1021/es00049a008; Di Lorenzo E, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032838; Rogge WF, 2006, ATMOS ENVIRON, V40, P27, DOI 10.1016/j.atmosenv.2005.07.076; Lean J, 2000, GEOPHYS RES LETT, V27, P2425, DOI 10.1029/2000GL000043; SIMONEIT BRT, 1991, ATMOS ENVIRON A-GEN, V25, P2111, DOI 10.1016/0960-1686(91)90088-O; Seki O, 2010, EARTH PLANET SC LETT, V292, P201, DOI 10.1016/j.epsl.2010.01.037; LECHEVALIER MP, 1977, BIOCHEM SYST ECOL, V5, P249, DOI 10.1016/0305-1978(77)90021-7; DANSGAARD W, 1964, TELLUS, V16, P436; Simoneit BRT, 2002, APPL GEOCHEM, V17, P129, DOI 10.1016/S0883-2927(01)00061-0; Parkinson CL, 2002, ANN GLACIOL, V34, P441, DOI 10.3189/172756402781817725; Bendle J, 2007, GEOCHIM COSMOCHIM AC, V71, P5934, DOI 10.1016/j.gca.2007.09.029; Yasunari TJ, 2009, SOLA, V5, P77, DOI 10.2151/sola.2009-020; Fine PM, 2001, ENVIRON SCI TECHNOL, V35, P2665, DOI 10.1021/es001466k; Legrand M, 1997, REV GEOPHYS, V35, P219, DOI 10.1029/96RG03527; Kobashi T, 2013, CLIM PAST, V9, P583, DOI 10.5194/cp-9-583-2013; Oliveira C, 2007, ATMOS ENVIRON, V41, P5555, DOI 10.1016/j.atmosenv.2007.03.001; Kunwar B, 2014, ATMOS CHEM PHYS, V14, P1819, DOI 10.5194/acp-14-1819-2014; Kawamura K, 1996, GEOPHYS RES LETT, V23, P2665, DOI 10.1029/96GL02428; Numaguti A, 1999, J GEOPHYS RES-ATMOS, V104, P1957, DOI 10.1029/1998JD200026; Fu PQ, 2012, ATMOS ENVIRON, V55, P234, DOI 10.1016/j.atmosenv.2012.02.061; Ho KF, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013304; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Cavalieri DJ, 1997, SCIENCE, V278, P1104, DOI 10.1126/science.278.5340.1104; Napolitano GE, 1997, BIOCHEM SYST ECOL, V25, P739, DOI 10.1016/S0305-1978(97)00053-7; Kawamura K, 2004, GEO SOC S P, P243; KAWAMURA K, 1987, NATURE, V325, P330, DOI 10.1038/325330a0; Fang M, 1999, ATMOS ENVIRON, V33, P783, DOI 10.1016/S1352-2310(98)00210-6; Parkinson CL, 1999, J GEOPHYS RES-OCEANS, V104, P20837, DOI 10.1029/1999JC900082; Cahill CF, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003271; Conte MH, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001922; de Vernal A, 2008, GEOPHYS MONOGR SER, V180, P27, DOI 10.1029/180GM04; Fang JSE, 2002, ENVIRON SCI TECHNOL, V36, P2598, DOI 10.1021/es015863m; Fukuda T, 2011, ANN GLACIOL, V52, P138, DOI 10.3189/172756411797252130; Ho KF, 2011, ATMOS CHEM PHYS, V11, P2197, DOI 10.5194/acp-11-2197-2011; Kawamura K, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001810; Kawamura K., 1991, J GREENL B GLACIER R, V9, P59; Kawamura K, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014515; Kawamura K, 1995, BIOGEOCHEMICAL PROCE, P31; Kawamura K., 1995, J P NIPR S POLAR MET, V6, P99; Lean JL, 2010, WIRES CLIM CHANGE, V1, P111, DOI 10.1002/wcc.018; MARTY JC, 1979, J GEOPHYS RES-OC ATM, V84, P5707, DOI 10.1029/JC084iC09p05707; Matsumoto K, 2007, GEOCHEM J, V41, P483; Miyazaki Y, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042483; Mkoma SL, 2014, TELLUS B, V66, DOI 10.3402/tellusb.v66.20176; Mochida M, 2003, J GEOPHYS RES-ATMOS, V108, DOI [10.1029/2002JD002355, 10.1029/2002JD003249]; Mochida M, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007773; Naraoka H, 2000, CHEM GEOL, V165, P23, DOI 10.1016/S0009-2541(99)00159-X; Nishikiori M., 1997, P NIPR S POL MET GLA, V11, P76; Ohkouchi N, 1997, GEOCHIM COSMOCHIM AC, V61, P1911, DOI 10.1016/S0016-7037(97)00040-9; Oros DR, 1999, AEROSOL SCI TECH, V31, P433, DOI 10.1080/027868299303986; Sato T, 2014, CLIM PAST, V10, P393, DOI 10.5194/cp-10-393-2014; Savarino J, 1998, J GEOPHYS RES-ATMOS, V103, P8267, DOI 10.1029/97JD03748; SIMONEIT BRT, 1989, J ATMOS CHEM, V8, P251, DOI 10.1007/BF00051497; SIMONEIT BRT, 1982, ATMOS ENVIRON, V16, P2139, DOI 10.1016/0004-6981(82)90284-0; Tsushima A., 2014, CLIM PAST DISCUSS, V10, P1421	57	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1352-2310	1873-2844		ATMOS ENVIRON	Atmos. Environ.	JAN	2015	100						202	209		10.1016/j.atmosenv.2014.11.007		8	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	AY0CZ	WOS:000347266700025		
J	Hasegawa, M; Kutsukake, N				Hasegawa, Masaru; Kutsukake, Nobuyuki			Bayesian competitiveness estimation predicts dominance turnover among wild male chimpanzees	BEHAVIORAL ECOLOGY AND SOCIOBIOLOGY			English	Article						Bayesian approach; Coalition; Contest; Dominance; Pan troglodytes	CHAIN MONTE-CARLO; PAN-TROGLODYTES; COALITIONARY AGGRESSION; CAMARGUE STALLIONS; COOPERATION; RANK; PATERNITY; HIERARCHIES; STABILITY; COMMUNITY	It is predicted that asymmetries in competitiveness (or resource holding potential (RHP)) would determine the outcomes of animal contests, but it has been difficult to estimate RHP in practice. In long-living animals, individual RHP changes as they age, making it necessary to quantify the individual trajectories of RHP rather than estimate a single representative value. Based on a Bayesian approach and a literature review, we estimated the age-related RHP trajectories of wild male chimpanzees, Pan troglodytes, and studied whether estimated RHP predicted the turnover of alpha males. A model containing a quadratic relationship between age and RHP fitted to the longitudinal changes in male dominance rankings well. When alpha male turnover occurred, the estimated RHP of the new alpha male was higher than were those of previous alpha males, which was explained by age. An exception to this pattern involved cases in which males formed coalitions. In these cases, a temporary increase in the RHP of the new alpha male, which was not attributed to age, was necessary for turnover. Cross-validation analysis showed that the turnover of alpha males was predictable except when males achieved alpha status via coalition formation; this exception is explainable by the instability of coalition partners in this species. This study provides a predictive framework for the occurrence of dominance turnover using incomparable long-term data and sophisticated statistical operations.	[Hasegawa, Masaru; Kutsukake, Nobuyuki] Grad Univ Adv Studies, Dept Evolutionary Studies Biosyst, Kanagawa, Japan	Kutsukake, N (reprint author), Grad Univ Adv Studies, Dept Evolutionary Studies Biosyst, Kanagawa, Japan.	kutsu@soken.ac.jp			MEXT [25711025]	We are grateful to the members of the laboratory of the Graduate University for Advanced Studies. We thank also Drs. Ai Kawamori, Tomohiro Harano, and Fumiaki Nomano for their technical advice. This study was financially supported by MEXT (No. 25711025 to NK).	Mitani JC, 2009, EVOL ANTHROPOL, V18, P215, DOI 10.1002/evan.20229; BOYD R, 1983, ANIM BEHAV, V31, P45, DOI 10.1016/S0003-3472(83)80172-9; Kass RE, 1998, AM STAT, V52, P93, DOI 10.2307/2685466; RISS D, 1977, FOLIA PRIMATOL, V27, P134, DOI 10.1159/000155784; Newton-Fisher NE, 2010, AM J PHYS ANTHROPOL, V142, P417, DOI 10.1002/ajpa.21241; Feh C, 1999, ANIM BEHAV, V57, P705, DOI 10.1006/anbe.1998.1009; Boesch C, 2006, AM J PHYS ANTHROPOL, V130, P103, DOI 10.1002/ajpa.20341; Langergraber KE, 2007, P NATL ACAD SCI USA, V104, P7786, DOI 10.1073/pnas.0611449104; Arnott G, 2009, ANIM BEHAV, V77, P991, DOI 10.1016/j.anbehav.2009.02.010; Kokko H, 2013, ANIMAL CONTESTS, P5; Robbins MM, 2005, BEHAVIOUR, V142, P779, DOI 10.1163/1568539054729123; Sherratt TN, 2013, ANIMAL CONTESTS, P33; Wittig RM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3155; Albers PCH, 2001, ANIM BEHAV, V61, P489, DOI 10.1006/anbe.2000.1571; Wroblewski EE, 2009, ANIM BEHAV, V77, P873, DOI 10.1016/j.anbehav.2008.12.014; Romero T, 2010, J ETHOL, V28, P113, DOI 10.1007/s10164-009-0162-z; Jackson AL, 2009, ECOL LETT, V12, pE1, DOI 10.1111/j.1461-0248.2008.01233.x; Neumann C, 2011, ANIM BEHAV, V82, P911, DOI 10.1016/j.anbehav.2011.07.016; Briffa M, 2013, ANIMAL CONTESTS, P47; Pusey AE, 2005, INT J PRIMATOL, V26, P3, DOI 10.1007/s10764-005-0721-2; Duffy KG, 2007, CURR BIOL, V17, pR586, DOI 10.1016/j.cub.2007.06.001; De Vries H, 1998, ANIM BEHAV, V55, P827, DOI 10.1006/anbe.1997.0708; McDonald DB, 2013, BEHAV ECOL, V24, P511, DOI 10.1093/beheco/ars192; Adams ES, 2005, ANIM BEHAV, V69, P1191, DOI 10.1016/j.anbehav.2004.08.011; Kemp DJ, 2001, BEHAV ECOL SOCIOBIOL, V49, P429, DOI 10.1007/s002650100318; Mitani JC, 2009, ANIM BEHAV, V77, P633, DOI 10.1016/j.anbehav.2008.11.021; Gilby IC, 2013, BEHAV ECOL SOCIOBIOL, V67, P373, DOI 10.1007/s00265-012-1457-6; Fedurek P, 2013, ANIM BEHAV, V86, P189, DOI 10.1016/j.anbehav.2013.05.010; Lewis RJ, 2002, Q REV BIOL, V77, P149, DOI 10.1086/343899; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; Koski SE, 2012, INT J PRIMATOL, V33, P905, DOI 10.1007/s10764-012-9623-2; Shev A, 2012, ANIM BEHAV, V84, P1523, DOI 10.1016/j.anbehav.2012.09.026; Schulke O, 2010, CURR BIOL, V20, P2207, DOI 10.1016/j.cub.2010.10.058; Bissonnette A, 2009, ANIM BEHAV, V78, P329, DOI 10.1016/j.anbehav.2009.05.010; BRADLEY RA, 1952, BIOMETRIKA, V39, P324, DOI 10.1093/biomet/39.3-4.324; NOE R, 1990, ANIM BEHAV, V39, P78, DOI 10.1016/S0003-3472(05)80728-6; SMITH JM, 1976, ANIM BEHAV, V24, P159, DOI 10.1016/S0003-3472(76)80110-8; Mutshinda CM, 2011, J ANIM ECOL, V80, P101, DOI 10.1111/j.1365-2656.2010.01743.x; Gilby IC, 2008, BEHAV ECOL SOCIOBIOL, V62, P1831, DOI 10.1007/s00265-008-0612-6; Bissonnette A, 2009, ETHOLOGY, V115, P671, DOI 10.1111/j.1439-0310.2009.01652.x; Boesch C., 2000, CHIMPANZEES TAI FORE; Briefer E, 2010, BMC BIOL, V8, P14; Cheney DL, 2011, P NATL ACAD SCI USA, V108, P10902, DOI 10.1073/pnas.1100291108; Clutton-Brock TH, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0074; de Waal F., 1982, CHIMPANZEE POLITICS; Earley RL, 2013, ANIMAL CONTESTS, P199; FEH C, 1990, ANIM BEHAV, V40, P995, DOI 10.1016/S0003-3472(05)81007-3; Gelman A., 2007, DATA ANAL USING REGR; Gelman A., 2013, BAYESIAN DATA ANAL; Goodall J., 1986, CHIMPANZEES GOMBE PA; Harcourt AH, 1992, COALITIONS ALLIANCE; Kaburu SSK, 2013, AM J PRIMATOL, V75, P789, DOI 10.1002/ajp.22135; Kappeler Peter M., 2012, P3; Loretto M-C, 2012, INT J COMP PSYCHOL, V25, P180; Lunn D., 2012, BUGS BOOK PRACTICAL; Matsuzawa T, 2011, PRIMATOL MONOGR, P1, DOI 10.1007/978-4-431-53921-6; Mesterton-Gibbons M, 2011, J THEOR BIOL, V274, P187, DOI 10.1016/j.jtbi.2010.12.031; Mitani JC, 2003, BEHAVIOUR, V140, P869, DOI 10.1163/156853903770238355; Nakamura M, 1998, ANIM BEHAV, V55, P277, DOI 10.1006/anbe.1997.0599; Nishida Toshisada, 1996, P114, DOI 10.1017/CBO9780511752414.011; NISHIDA T, 1983, Primates, V24, P318, DOI 10.1007/BF02381978; Nishida T, 2011, CHIMPANZEES LAKESHOR; Nishida T, 2002, MAHALE CHIMPANZEES 3; Noe Ronald, 2001, EC NATURE SOCIAL DIL; Ntzoufras I., 2009, BAYESIAN MODELING US; Plummer M., 2006, R NEWS, V6, P7; R Development Core Team, 2013, R LANG ENV STAT COMP; Reynolds V, 2005, CHIMPANZEES BUDONGO; RUTBERG AT, 1986, BEHAVIOUR, V96, P62, DOI 10.1163/156853986X00225; Spiegelhalter D., 2003, WINBUGS USER MANUAL; van Lawick-Goodall J, 1971, THE SHADOW OF MAN; van Schaik CP, 2004, BEHAV ECOL SOCIOBIOL, V57, P101, DOI 10.1007/s00265-004-0818-1; Veravecke H, 1999, BEHAVIOUR, V136, P423; von Rohr CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032494; Watts David P., 2012, P313; Wrangham Richard W., 1996, P45, DOI 10.1017/CBO9780511752414.006	77	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-5443	1432-0762		BEHAV ECOL SOCIOBIOL	Behav. Ecol. Sociobiol.	JAN	2015	69	1					89	99		10.1007/s00265-014-1821-9		11	Behavioral Sciences; Ecology; Zoology	Behavioral Sciences; Environmental Sciences & Ecology; Zoology	AX8HS	WOS:000347151400009		
J	Sakaue, H; Takata, T; Fujii, N; Sasaki, H; Fujii, N				Sakaue, Hiroaki; Takata, Takumi; Fujii, Norihiko; Sasaki, Hiroshi; Fujii, Noriko			Alpha B- and beta A3-crystallins containing D-Aspartic acids exist in a monomeric state	BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS			English	Article						Racemization; Monomerization; D-Asp; alpha B-crystallin; beta A3-crystallin	AGE-RELATED-CHANGES; HUMAN LENS; SIMULTANEOUS STEREOINVERSION; MASS-SPECTROMETRY; CATARACT LENSES; A-CRYSTALLIN; ASP ISOMERS; DEAMIDATION; BETA; BETA-B2-CRYSTALLIN	Crystallin stability and subunit-subunit interaction are essential for eye lens transparency. There are three types of crystallins in lens, designated as alpha-, beta-, and gamma-crystallins. Alpha-crystallin is a hetero-polymer of about 800 kDa, consisting of 35-40 subunits of two different alpha A- and alpha B-subunits, each of 20 kDa.The beta/gamma-crystallin superfamily comprises oligomeric beta-crystallin (2-6 subunits) and monomeric gamma-clystallin. Since lens proteins have very long half-lives, they undergo numerous post-translational modifications including racemization, isomerization, deamidation, oxidation, glycation, and truncation, which may decrease crystallin solubility and ultimately cause cataract formation. Racemization and isomerization of aspartyl (Asp) residues have been detected only in polymeric a- and oligomeric beta-crystallin, while the situation in monomeric gamma-clystallin has not been studied. Here, we investigated the racemization and isomerization of Asp in the gamma-crystallin fraction of elderly donors. The results show that Asp residues of gamma S-, gamma 1D- and gamma C-crystallins were not racemized and isomerized. However, strikingly, we found that a portion of aB-crystallin and SA3-crystallin moved to the lower molecular weight fraction which is the same size of y-crystallin. In those fractions, Asp-96 of alpha B-crystallin and Asp-37 of beta A3-crystallin were highly inverted, which do not occur in the native lens higher molecular weight fraction. Our results indicate the possibility that the inversion of Asp residues may induce dissociation of (alpha B- and beta A3-crystallins from the polymeric and oligomeric states. This is the first report that stereoinversion of amino acids disturbs lens protein assembly in aged human lens. (C) 2014 Elsevier B.V. All rights reserved.	[Sakaue, Hiroaki; Fujii, Noriko] Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan; [Takata, Takumi; Fujii, Noriko] Kyoto Univ, Inst Res Reactor, Kumatori, Osaka 5900494, Japan; [Fujii, Norihiko] Teikyo Univ, Radioisotope Res Ctr, Kaga Itabashi Ku, Tokyo 1738605, Japan; [Sasaki, Hiroshi] Kanazawa Med Univ, Dept Ophthalmol, Uchinada, Ishikawa 9200293, Japan	Fujii, N (reprint author), Kyoto Univ, Inst Res Reactor, Kumatori, Osaka 5900494, Japan.	nfujii@rri.kyoto-u.ac.jp					Fujii N, 2002, BIOCHEM BIOPH RES CO, V294, P1047, DOI 10.1016/S0006-291X(02)00597-1; Amano M, 2011, ANAL CHEM, V83, P3857, DOI 10.1021/ac200321v; Lampi KJ, 2014, PROG BIOPHYS MOL BIO, V115, P21, DOI 10.1016/j.pbiomolbio.2014.02.004; Hanson SRA, 2000, EXP EYE RES, V71, P195, DOI 10.1006/exer.2000.0868; Hooi MYS, 2011, AGE, V33, P131, DOI 10.1007/s11357-010-9171-7; Takata T, 2010, EXP EYE RES, V91, P336, DOI 10.1016/j.exer.2010.05.019; Kaji Y, 2010, CHEM BIODIVERS, V7, P1364, DOI 10.1002/cbdv.200900329; ROHER AE, 1993, J BIOL CHEM, V268, P3072; Hanson SRA, 1998, EXP EYE RES, V67, P301, DOI 10.1006/exer.1998.0530; Sharma KK, 2009, BBA-GEN SUBJECTS, V1790, P1095, DOI 10.1016/j.bbagen.2009.05.008; Smith MA, 2007, PROTEIN SCI, V16, P615, DOI 10.1110/ps.062659107; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; Fujii N, 1999, BIOCHEM BIOPH RES CO, V263, P322, DOI 10.1006/bbrc.1999.1279; FUJII N, 1994, J BIOCHEM-TOKYO, V116, P663; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Rao G, 2008, MOL VIS, V14, P666; Ma ZX, 1998, EXP EYE RES, V67, P21, DOI 10.1006/exer.1998.0482; Fujii N, 2011, BIOCHEMISTRY-US, V50, P8628, DOI 10.1021/bi200983g; Takata T, 2008, PROTEIN SCI, V17, P1565, DOI 10.1110/ps.035410.108; Wilmarth PA, 2006, J PROTEOME RES, V5, P2554, DOI 10.1021/pr050473a; Fujii N, 2010, AMINO ACIDS, V39, P1393, DOI 10.1007/s00726-010-0597-0; Fujii N, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.399972; FUJII N, 1994, BBA-PROTEIN STRUCT M, V1204, P157, DOI 10.1016/0167-4838(94)90003-5; GEIGER T, 1987, J BIOL CHEM, V262, P785; Gossler-Schofberger R, 2012, ARCH BIOCHEM BIOPHYS, V522, P100, DOI 10.1016/j.abb.2012.04.006; Gupta R, 2010, MOL VIS, V16, P2242; Lampi KJ, 2006, BIOCHEMISTRY-US, V45, P3146, DOI 10.1021/bi052051k	27	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1570-9639	0006-3002		BBA-PROTEINS PROTEOM	BBA-Proteins Proteomics	JAN	2015	1854	1					1	9		10.1016/j.bbapap.2014.10.006		9	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	AX5CC	WOS:000346943700001		
J	Koike, A; Minamiguchi, I; Fujimori, K; Amano, F				Koike, Atsushi; Minamiguchi, Isato; Fujimori, Ko; Amano, Fumio			Nitric Oxide Is an Important Regulator of Ileme Oxygenase-1 Expression in the Lipopolysaccharide and Interferon-gamma-Treated Murine Macrophage-Like Cell Line J774.1/JA-4	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						macrophage; heme oxygenase-1; lipopolysaccharide; interferon-gamma; nitric oxide; superoxide anion	MANGANESE SUPEROXIDE-DISMUTASE; TUMOR-NECROSIS-FACTOR; HEME OXYGENASE; RESPIRATORY BURST; HO-1 EXPRESSION; CARBON-MONOXIDE; INNATE IMMUNITY; INDUCTION; STRESS; GENE	Heme oxygenase-1 (HO-1) catabolizes the degradation of heme into bilirubin, carbon monoxide, and iron ions. The HO-1 products provide antioxidant cytoprotection in addition to having potent antiinflammatory and immunomodulatory functions. HO-1 is induced by its substrate heme and environmental factors including oxidative and heat stresses. Although previous studies reported that lipopolysaccharide (LPS) induced the expression of both the HO-1 gene and its protein in macrophages, the major regulators of HO-1 expression remain unknown. To identify these regulators, we used two types of cell, the murine macrophage-like cell line J774.1/JA-4 and its LPS-resistant mutant, LPS1916. Based on a comparison of the results obtained with these cells, we found that nitric oxide (NO) was closely linked to the induction of HO-1. Real-time polymerase chain reaction (PCR) showed that the time course for inducible HO-1 mRNA by LPS or LPS+interferon (IFN)-gamma was similar to that for inducible NO synthase (iNOS) mRNA. Furthermore, the expression of iNOS mRNA and protein increased earlier than that of HO-1 mRNA and protein. N-Nitro-L-arginine methyl ester, an NO synthase inhibitor, reduced both HO-1 expression and NO production in LPS+IFN-gamma-treated JA-4 cells. Furthermore, NOC-12, an NO donor, significantly induced HO-1 expression not only in JA-4 but also in LPS1916 cells. Reactive oxygen species (ROS) scavengers, such as superoxide dismutase and catalase, did not affect HO-1 protein expression in LPS+IFN-gamma-treated JA-4 cells. These results suggest that, among ROS, NO plays an important role in HO-1 induction in activated macrophages treated with LPS+IFN-gamma.	[Koike, Atsushi; Minamiguchi, Isato; Fujimori, Ko; Amano, Fumio] Osaka Univ Pharmaceut Sci, Lab Biodef & Regulat, Takatsuki, Osaka 5691094, Japan	Amano, F (reprint author), Osaka Univ Pharmaceut Sci, Lab Biodef & Regulat, 4-20-1 Nasahara, Takatsuki, Osaka 5691094, Japan.	amano@gly.oups.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by a Grant-in-Aid for the Promotion of Science in Tokushima Knowledge Cluster Project, and a Grant-in-Aid for High Technology Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Amano F, 2012, ADV BIOSCI BIOTECHNO, V03, P770; AMANO F, 1985, FEBS LETT, V192, P263, DOI 10.1016/0014-5793(85)80121-6; Amano F, 1996, J ENDOTOXIN RES, V3, P415; MAINES MD, 1988, FASEB J, V2, P2557; Hayashi S, 2004, GENE, V336, P241, DOI 10.1016/j.gene.2004.04.002; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; NATHAN C, 1992, FASEB J, V6, P3051; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Sun JY, 2004, P NATL ACAD SCI USA, V101, P1461, DOI 10.1073/pnas.0308083100; Harada H, 2008, FREE RADICAL RES, V42, P297, DOI 10.1080/10715760801975735; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; KEYSE SM, 1989, P NATL ACAD SCI USA, V86, P99, DOI 10.1073/pnas.86.1.99; Song Y, 2003, WORLD J GASTROENTERO, V9, P1799; NATHAN C, 1994, J BIOL CHEM, V269, P13725; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; ASSREUY J, 1994, EUR J IMMUNOL, V24, P672, DOI 10.1002/eji.1830240328; Rushworth SA, 2005, J IMMUNOL, V175, P4408; VISNER GA, 1990, J BIOL CHEM, V265, P2856; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; Siow RCM, 1999, CARDIOVASC RES, V41, P385, DOI 10.1016/S0008-6363(98)00278-8; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Chung HT, 2001, BIOCHEM BIOPH RES CO, V282, P1075, DOI 10.1006/bbrc.2001.4670; CAMHI SL, 1995, AM J RESP CELL MOL, V13, P387; VISNER GA, 1992, BIOCHEM BIOPH RES CO, V188, P453; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Um HC, 2011, NITRIC OXIDE-BIOL CH, V25, P161, DOI 10.1016/j.niox.2011.06.001; Elbirt KK, 1999, P ASSOC AM PHYSICIAN, V111, P438; Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Wu LY, 2005, PHARMACOL REV, V57, P585, DOI 10.1124/pr.57.4.3; Gotoh T, 2006, ARTERIOSCL THROM VAS, V26, P1439, DOI 10.1161/01.ATV.0000223900.67024.15; AMANO F, 1991, INFECT IMMUN, V59, P2166; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Camhi S L, 1995, New Horiz, V3, P170; DeCoursey TE, 2010, PHYSIOLOGY, V25, P27, DOI 10.1152/physiol.00039.2009; Dennery PA, 2000, CURR TOP CELL REGUL, V36, P181; DOUGALL WC, 1991, ENDOCRINOLOGY, V129, P2376; Foresti R, 2003, BIOCHEM J, V372, P381, DOI 10.1042/BJ20021516; Forman HJ, 2002, AM J RESP CRIT CARE, V166, pS4, DOI 10.1164/rccm.2206007; HARRIS CA, 1991, J IMMUNOL, V147, P149; INOUE S, 1995, INFECT IMMUN, V63, P1876; JAISWAL AK, 1994, BIOCHEM PHARMACOL, V48, P439, DOI 10.1016/0006-2952(94)90272-0; Koizumi S, 2007, J BIOL CHEM, V282, P8715, DOI 10.1074/jbc.M609427200; LePage C, 1996, IMMUNOLOGY, V89, P274, DOI 10.1046/j.1365-2567.1996.d01-728.x; MASUDA A, 1988, FASEB J, V2, P3087; Motterlini R, 1996, AM J PHYSIOL-HEART C, V270, pH107; Naughton P, 2002, J BIOL CHEM, V277, P40666, DOI 10.1074/jbc.M203863200; Ray A, 2003, IMMUNOL LETT, V89, P143, DOI 10.1016/S0165-2478(03)00135-4; Srisook K, 2005, METHOD ENZYMOL, V396, P414, DOI 10.1016/S0076-6879(05)96035-7; Tracz MJ, 2007, AM J PATHOL, V170, P1820, DOI 10.2353/ajpath.2007.061093; WONG GHW, 1988, SCIENCE, V242, P941, DOI 10.1126/science.3263703	54	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	JAN	2015	38	1					7	16				10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX5FF	WOS:000346951500002		
J	Matsui, R; Uchida, S; Namiki, N				Matsui, Rakan; Uchida, Shinya; Namiki, Noriyuki			Combination Effect of Physical and Gustatory Taste Masking for Propiverine Hydrochloride Orally Disintegrating Tablets on Palatability	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						orally disintegrating tablet (ODT); propiverine; organoleptic masking; gustatory sensation study	OVERACTIVE BLADDER SYMPTOMS; QUALITY-OF-LIFE; MANNITOL; JAPAN; TIME	Orally disintegrating tablets (ODTs) containing propiverine hydrochloride (which is extremely bitter and leaves a feeling of numbness in the mouth) were prepared with a combined use of physical and organoleptic taste masking. Propiverine-loaded masking particles (PLMPs) were prepared with different amounts of gastric-soluble coatings as physical masking. ODTs without organoleptic masking were prepared by mixing each group of PLMPs with Ludifiash (R), crospovidone, and magnesium stearate. ODTs with organoleptic masking were also prepared by addition of L-menthol, aspartame, thaumatin, and cinnamon. Fifteen-minute dissolution of propiverine in solutions with pH 1.2 was >= 85% for all ODTs, whereas that in pH 6.8 solutions was <= 85% and increased with physical masking. A single blind randomized crossover trial was conducted. Ten healthy volunteers were asked to quantify the bitterness, numbness, and overall palatability using a 100-mm visual analog scale (VAS) at the period of disintegration as well as 1 and 5 min later. VAS scores of bitterness, numbness, and overall palatability improved along with increasing amounts of physical masking, and the effects persisted for 5 min. VAS scores for numbness increased over time regardless of the amount of physical masking. Bitterness, numbness, and overall palatability were significantly improved by organoleptic masking if the amount of physical masking was small. Combined use of physical and organoleptic masking is useful for improving palatability of ODTs containing propiverine.	[Matsui, Rakan; Uchida, Shinya; Namiki, Noriyuki] Univ Shizuoka, Sch Pharmaceut Sci, Dept Pharm Practice & Sci, Suruga Ku, Shizuoka 4228526, Japan	Namiki, N (reprint author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Pharm Practice & Sci, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	namiki@u-shizuoka-ken.ac.jp					Stoltenberg I, 2011, EUR J PHARM BIOPHARM, V78, P462, DOI 10.1016/j.ejpb.2011.02.005; Takao T, 2013, UROLOGY, V82, P189, DOI 10.1016/j.urology.2013.02.024; Shu T, 2002, CHEM PHARM BULL, V50, P193, DOI 10.1248/cpb.50.193; CARLSSON AM, 1983, PAIN, V16, P87, DOI 10.1016/0304-3959(83)90088-X; Yan YD, 2010, BIOL PHARM BULL, V33, P1364; Nakano Y, 2013, INT J PHARMACEUT, V446, P160, DOI 10.1016/j.ijpharm.2013.02.019; Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; Homma Y, 2005, BJU INT, V96, P1314, DOI 10.1111/j.1464-410X.2005.05835.x; Xu J, 2008, INT J PHARM, V359, P63, DOI 10.1016/j.ijpharm.2008.03.019; Koizumi K, 1997, INT J PHARM, V152, P127, DOI 10.1016/S0378-5173(97)04924-7; Sohi H, 2004, DRUG DEV IND PHARM, V30, P429, DOI 10.1081/DDC-120037477; Asimakopoulos AD, 2012, UROL INT, V89, P259, DOI 10.1159/000339600; Komatsu T, 2009, LUTS, V1, P20, DOI 10.1111/j.1757-5672.2009.00006.x; Ouslander JG, 2004, NEW ENGL J MED, V350, P786; Randale SA, 2010, CHEM PHARM BULL, V58, P443; Sugiura T, 2012, CHEM PHARM BULL, V60, P315, DOI 10.1248/cpb.60.315; Uchida S, 2013, INT J PHARMACEUT, V446, P1, DOI 10.1016/j.ijpharm.2013.02.008; Ushiroyama Takahisa, 2000, Journal of Medicine (Westbury), V31, P311; Yoshita T, 2013, BIOL PHARM BULL, V36, P1488	19	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	JAN	2015	38	1					17	22				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX5FF	WOS:000346951500003		
J	Kurosaki, T; Nakasone, C; Kodama, Y; Egashira, K; Harasawa, H; Muro, T; Nakagawa, H; Kitahara, T; Higuchi, N; Nakamura, T; Sasaki, H				Kurosaki, Tomoaki; Nakasone, Chihiro; Kodama, Yukinobu; Egashira, Kanoko; Harasawa, Hitomi; Muro, Takahiro; Nakagawa, Hiroo; Kitahara, Takashi; Higuchi, Norihide; Nakamura, Tadahiro; Sasaki, Hitoshi			Splenic Gene Delivery System Using Self-assembling Nano-complex with Phosphatidylserine Analog	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						gene delivery; spleen; 1,2-dioleoyl-sn-glycero-3-phospo-L-serin; plasmid DNA; ternary complex	CATIONIC POLYMERS; DNA VACCINE; ME SIGNALS; IN-VIVO; EAT-ME; CLEARANCE; CELLS; POLYETHYLENIMINE; NANOPARTICLES; PHAGOCYTOSIS	The recognition of phosphatidylserine on the erythrocyte membrane mediates erythrophagocytosis by resident spleen macrophages. The application of phosphatidylserine to a gene vector may be a novel approach for splenic drug delivery. Therefore, we chose 1,2-dioleoyl-sn-glycero-3-phospho-L-serin (DOPS) as an analogue of phosphatidylserine for splenic gene delivery of plasmid DNA (pDNA). In the present study, we successfully prepared a stable pDNA ternary complex using DOPS and polyethyleneimine (PEI) and evaluated its efficacy and safety. The pDNA/PEI complex had a positive charge and showed high transgene efficacy, although it caused cytotoxicity and agglutination. The addition of DOPS changed the zeta-potential of the pDNA/PEI complex to negative. It is known that anionic complexes are not taken up well by cells. Surprisingly, however, the pDNA/PEI/DOPS complex showed relatively high transgene efficacy in vitro. Fluorescence microscope observation revealed that the pDNA/PEI/DOPS complex internalized the cells while maintaining the complex formation. The injection of the pDNA/PEI complex killed most mice within 24h at high doses, although all mice in the pDNA/PEI/DOPS complex group survived. The ternary complex with DOPS showed markedly better safety compared with the pDNA/PEI complex. The pDNA/PEI/DOPS complex showed high gene expression selectively in the spleen after intravenous injection into mice. Thus the ternary complex with DOPS can be used to deliver pDNA to the spleen, in which immune cells are abundant. It appears to have an excellent safety level, although further study to determine the mechanism of action is necessary.	[Kurosaki, Tomoaki; Nakasone, Chihiro; Kodama, Yukinobu; Egashira, Kanoko; Harasawa, Hitomi; Muro, Takahiro; Nakagawa, Hiroo; Kitahara, Takashi; Higuchi, Norihide; Nakamura, Tadahiro; Sasaki, Hitoshi] Nagasaki Univ Hosp, Dept Hosp Pharm, Nagasaki 8528501, Japan	Sasaki, H (reprint author), Nagasaki Univ Hosp, Dept Hosp Pharm, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	sasaki@nagasaki-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	This study was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Almalik A, 2013, MACROMOL BIOSCI, V13, P1671, DOI 10.1002/mabi.201300302; ZACHOWSKI A, 1993, BIOCHEM J, V294, P1; Cherif MS, 2011, VACCINE, V29, P9038, DOI 10.1016/j.vaccine.2011.09.031; Lv HT, 2006, J CONTROL RELEASE, V114, P100, DOI 10.1016/j.jconrel.2006.04.014; Tang MX, 1997, GENE THER, V4, P823, DOI 10.1038/sj.gt.3300454; Kurosaki T, 2008, J PHARM PHARM SCI, V11, P56; Dash PR, 1999, GENE THER, V6, P643, DOI 10.1038/sj.gt.3300843; Poon IKH, 2010, CELL DEATH DIFFER, V17, P381, DOI 10.1038/cdd.2009.195; Kichler A, 2001, J GENE MED, V3, P135, DOI 10.1002/jgm.173; Kato-Kataoka A, 2010, J CLIN BIOCHEM NUTR, V47, P246, DOI 10.3164/jcbn.10-62; Pozo AL, 2009, BLOOD REV, V23, P105, DOI 10.1016/j.blre.2008.10.001; Zandvoort A, 2002, CLIN EXP IMMUNOL, V130, P4, DOI 10.1046/j.1365-2249.2002.01953.x; Kurosaki T, 2011, MOL PHARMACEUT, V8, P913, DOI 10.1021/mp2001268; Daleke DL, 2003, J LIPID RES, V44, P233, DOI 10.1194/jlr.R200019-JLR200; Cesta MF, 2006, TOXICOL PATHOL, V34, P455, DOI 10.1080/01926230600867743; Godbey WT, 1999, J CONTROL RELEASE, V60, P149, DOI 10.1016/S0168-3659(99)00090-5; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Hunter AC, 2010, BBA-BIOENERGETICS, V1797, P1203, DOI 10.1016/j.bbabio.2010.03.026; Bratosin D, 1998, BIOCHIMIE, V80, P173, DOI 10.1016/S0300-9084(98)80024-2; Hunter AC, 2006, ADV DRUG DELIVER REV, V58, P1523, DOI 10.1016/j.addr.2006.09.008; Filion MC, 1998, INT J PHARM, V162, P159, DOI 10.1016/S0378-5173(97)00423-7; Grimsley C, 2003, TRENDS CELL BIOL, V13, P648, DOI 10.1016/j.tcb.2003.10.004; Ravichandran KS, 2010, J EXP MED, V207, P1807, DOI 10.1084/jem.20101157; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Jager R, 2007, J INT SOC SPORT NUTR, V4, DOI 10.1186/1550-2783-4-23; Jorissen BL, 2002, NUTR NEUROSCI, V5, P337, DOI 10.1080/1028415021000033802; Kurosaki T, 2013, BIOL PHARM BULL, V36, P1800; Takahashi M, 2003, CELL IMMUNOL, V226, P105, DOI 10.1016/j.cellimm.2003.11.008	28	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	JAN	2015	38	1					23	29				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX5FF	WOS:000346951500004		
J	Hattori, Y; Hara, E; Shingu, Y; Minamiguchi, D; Nakamura, A; Arai, S; Ohno, H; Kawano, K; Fujii, N; Yonemochi, E				Hattori, Yoshiyuki; Hara, Eriko; Shingu, Yumiko; Minamiguchi, Daiki; Nakamura, Ayako; Arai, Shohei; Ohno, Hiroaki; Kawano, Kumi; Fujii, Nobutaka; Yonemochi, Etsuo			siRNA Delivery into Tumor Cells by Cationic Cholesterol Derivative-Based Nanoparticles and Liposomes	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						cationic nanoparticle; cationic liposome; small interfering RNA (siRNA) delivery; transfection; cholesteryl carbamate	SMALL INTERFERING RNA; GENE TRANSFECTION; EFFICIENCY; CARRIERS; THERAPY; CANCER; DNA; SIZE	Previously, we reported that cationic nanoparticles (NP) composed of diamine-type cholesteryl-3-carboxamide (OH-Chol, N-(2-(2-hydroxyethylamino)ethyl)cholesteryl-3-carboxamide) and Tween 80 could deliver small interfering RNA (siRNA) with high transfection efficiency into tumor cells. In this study, we synthesized new diamine-type cationic cholesteryl carbamate (OH-C-Chol, cholesteryl (2-(2-hydroxyethyl)amino)ethyl)carbamate) and triamine-type carbamate (OH-NC-Chol, cholesteryl (2-((2-(2-hydroxyethyl)amino)ethyl)amino)ethyl)carbamate), and prepared cationic nanoparticles composed of OH-C-Chol or OH-NC-Chol with Tween 80 (NP-C and NP-NC, respectively), as well as cationic liposomes composed of OH-C-Chol or OH-NC-Chol with 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) (LP-C and LP-NC, respectively) for evaluation of their possible use as siRNA delivery vectors. LP-C and LP-NC/siRNA complexes (lipoplexes) exhibited larger gene silencing effects than NP-C and NP-NC/siRNA complexes (nanoplexes), respectively, in human breast tumor MCF-7 cells, although the NP-C nanoplex showed high association with the cells. In particular, LP-NC lipoplex could induce strong gene suppression, even at a concentration of 5 nm siRNA. From these results, cationic liposomes composed of OH-NC-Chol and DOPE may have potential as gene vectors for siRNA transfection to tumor cells.	[Hattori, Yoshiyuki; Hara, Eriko; Shingu, Yumiko; Nakamura, Ayako; Arai, Shohei; Kawano, Kumi; Fujii, Nobutaka; Yonemochi, Etsuo] Hoshi Univ, Inst Med Chem, Shinagawa Ku, Tokyo 1428501, Japan; [Minamiguchi, Daiki; Ohno, Hiroaki] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan	Hattori, Y (reprint author), Hoshi Univ, Inst Med Chem, Shinagawa Ku, 2-4-41 Ebara, Tokyo 1428501, Japan.	yhattori@hoshi.ac.jp			Japan Society for the Promotion of Science (KAKENHI Grant) [26460046]; Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan	This project was supported in part by a Grant-in-Aid for Scientific Research (C), Japan Society for the Promotion of Science (KAKENHI Grant Number 26460046), and the Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan.	Pai SI, 2006, GENE THER, V13, P464, DOI 10.1038/sj.gt.3302694; Spagnou S, 2004, BIOCHEMISTRY-US, V43, P13348, DOI 10.1021/bi048950a; Ivanova EA, 2013, ORG BIOMOL CHEM, V11, P7164, DOI 10.1039/c3ob40442k; Dioury F, 2007, TETRAHEDRON, V63, P204, DOI 10.1016/j.tet.2006.10.024; Ross PC, 1999, GENE THER, V6, P651, DOI 10.1038/sj.gt.3300863; Gao Y, 2011, INT J NANOMED, V6, P1017, DOI 10.2147/IJN.S17040; Turek J, 2000, J GENE MED, V2, P32, DOI 10.1002/(SICI)1521-2254(200001/02)2:1<32::AID-JGM78>3.0.CO;2-U; Mochizuki S, 2013, BBA-BIOMEMBRANES, V1828, P412, DOI 10.1016/j.bbamem.2012.10.017; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Takeuchi K, 1996, FEBS LETT, V397, P207, DOI 10.1016/S0014-5793(96)01136-2; Ozpolat B, 2014, ADV DRUG DELIVER REV, V66, P110, DOI 10.1016/j.addr.2013.12.008; Mevel M, 2010, J CONTROL RELEASE, V143, P222, DOI 10.1016/j.jconrel.2009.12.001; Hasegawa S, 2002, BIOORG MED CHEM LETT, V12, P1299, DOI 10.1016/S0960-894X(02)00119-1; Hattori Y, 2013, INT J PHARMACEUT, V443, P221, DOI 10.1016/j.ijpharm.2012.12.017; Hattori Y, 2008, BIOORG MED CHEM LETT, V18, P5228, DOI 10.1016/j.bmcl.2008.08.070; Hattori Y, 2005, J BIOMED NANOTECHNOL, V1, P176, DOI 10.1166/jbn.2005.019; Hattori Y, 2008, BIOL PHARM BULL, V31, P2294, DOI 10.1248/bpb.31.2294; Igarashi S, 2006, J CONTROL RELEASE, V112, P362, DOI 10.1016/j.jconrel.2006.03.003; Inoh Y, 2011, BIOCHEM BIOPH RES CO, V414, P635, DOI 10.1016/j.bbrc.2011.09.147; Kawaura C, 1998, FEBS LETT, V421, P69, DOI 10.1016/S0014-5793(97)01532-9; Hattori Y, 2005, CANCER GENE THER, V12, P796, DOI 10.1038/sj.cgt.7700844; Maslov MA, 2010, CARBOHYD RES, V345, P2438, DOI 10.1016/j.carres.2010.09.012; Zintchenko A, 2008, BIOCONJUGATE CHEM, V19, P1448, DOI 10.1021/bc800065f	23	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	JAN	2015	38	1					30	38				9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX5FF	WOS:000346951500005		
J	Okina, Y; Takeuchi, F; Yokomichi, T; Takada, Y; Kataoka, T				Okina, Yuji; Takeuchi, Fumihiko; Yokomichi, Tomonobu; Takada, Yohei; Kataoka, Takao			Cardenolide Aglycones Inhibit Tumor Necrosis Factor alpha-Induced Expression of Intercellular Adhesion Molecule-1 at the Translation Step by Blocking Na+/K+-ATPase	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						cardenolide aglycone; tumor necrosis factor alpha; intercellular adhesion molecule-1; Na+/K+-ATPase; cardiac glycoside; ouabagenin	NF-KAPPA-B; OLEANDRIN SUPPRESSES ACTIVATION; TNF RECEPTOR 1; CARDIAC-GLYCOSIDES; CALCIUM OSCILLATIONS; CARDIOTONIC STEROIDS; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; NERIUM-OLEANDER; NA,K-ATPASE	Cardiac glycosides, which are inhibitors of Na+/K+-ATPase, are classified into cardenolides and bufadienolides. We have recently shown that two cardenolide glycosides, ouabain and odoroside A, inhibit Na+/K+-ATPase, thereby preventing nuclear factor kappa B-inducible protein expression by blocking Na+-dependent amino acid transport. In this study, we investigated the mechanism of action of cardenolide aglycones in tumor necrosis factor alpha (TNF-alpha)-induced gene expression. Ouabagenin, digitoxigenin, and digoxigenin were found to inhibit the TNF-alpha-induced cell-surface expression of intercellular adhesion molecule-1 (ICAM-1) in human lung carcinoma A549 cells. Those cardenolide aglycones did not inhibit the TNF-alpha-induced expression of ICAM-1 mRNA, but strongly inhibited the TNF-alpha-induced expression of ICAM-1 as translation product. The inhibition of the TNF-alpha-induced ICAM-1 expression by ouabagenin, digitoxigenin, and digoxigenin was significantly reversed by the ectopic expression of ouabain-resistant rat Na+/K+-ATPase alpha 1 isoform. Moreover, knockdown of Na+/K+-ATPase alpha 1 isoform augmented the inhibition of the TNF-alpha-induced ICAM-1 expression by ouabagenin or ouabain. These results clearly indicate that cardenolide aglycones inhibit the TNF-alpha-induced ICAM-1 expression at the translation step by blocking Na+/K+-ATPase.	[Okina, Yuji; Takeuchi, Fumihiko; Yokomichi, Tomonobu; Takada, Yohei; Kataoka, Takao] Kyoto Inst Technol, Dept Appl Biol, Sakyo Ku, Kyoto 6068585, Japan; [Kataoka, Takao] Tokyo Inst Technol, Ctr Biol Resources & Informat, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Kataoka, T (reprint author), Kyoto Inst Technol, Dept Appl Biol, Sakyo Ku, Kyoto 6068585, Japan.	takao.kataoka@kit.ac.jp			Japan Society for the Promotion of Science [22380060, 25292061]	We are very grateful to Drs. Yoshikazu Tahara and Yutaro Hayashi for the gift of Na<SUP>+</SUP>/K<SUP>+</SUP>-ATPase. This work was supported partly by Grants-in-Aid for Scientific Research (KAKENHI) Grant Numbers 22380060 and 25292061 (to T.K.) from the Japan Society for the Promotion of Science.	Hyde R, 2003, BIOCHEM J, V373, P1, DOI 10.1042/BJ20030405; Aizman O, 2001, P NATL ACAD SCI USA, V98, P13420, DOI 10.1073/pnas.221315298; Manna SK, 2000, CANCER RES, V60, P3838; Roebuck KA, 1999, J LEUKOCYTE BIOL, V66, P876; Cook-Mills JM, 2005, J LEUKOCYTE BIOL, V77, P487, DOI 10.1189/jlb.0904554; Miyakawa-Naito A, 2003, J BIOL CHEM, V278, P50355, DOI 10.1074/jb.M305378200; Zhao M, 2007, J NAT PROD, V70, P1098, DOI 10.1021/np068066g; Katz A, 2010, J BIOL CHEM, V285, P19582, DOI 10.1074/jbc.M110.119248; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Tabary O, 2006, CELL SIGNAL, V18, P652, DOI 10.1016/j.cellsig.2005.06.004; Mijatovic T, 2007, J PATHOL, V212, P170, DOI 10.1002/path.2172; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Schoner W, 2007, AM J PHYSIOL-CELL PH, V293, pC509, DOI 10.1152/ajpcell.00098.2007; Melero CP, 2000, MOLECULES, V5, P51, DOI 10.3390/50100051; DIAMOND MS, 1990, J CELL BIOL, V111, P3129, DOI 10.1083/jcb.111.6.3129; Cornelius F, 2013, J BIOL CHEM, V288, P6602, DOI 10.1074/jbc.M112.442137; Prassas I, 2008, NAT REV DRUG DISCOV, V7, P926, DOI 10.1038/nrd2682; Kado S, 2001, LIFE SCI, V68, P727, DOI 10.1016/S0024-3205(00)00968-1; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; Li JA, 2006, J AM SOC NEPHROL, V17, P1848, DOI 10.1681/ASN.2005080894; Takada Y, 2009, BIOCHEM PHARMACOL, V78, P1157, DOI 10.1016/j.bcp.2009.06.027; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Jagielska J, 2009, ATHEROSCLEROSIS, V206, P390, DOI 10.1016/j.atherosclerosis.2009.03.019; Bai LM, 2011, J WOOD SCI, V57, P47, DOI 10.1007/s10086-010-1138-x; Bai YH, 2011, J WOOD SCI, V57, P56, DOI 10.1007/s10086-010-1132-3; Dostanic-Larson I, 2006, AM J PHYSIOL-REG I, V290, pR524, DOI 10.1152/ajpregu.00838.2005; Fridman E, 2012, J BIOL CHEM, V287, P6518, DOI 10.1074/jbc.M111.273698; HAYASHI Y, 1989, BIOCHIM BIOPHYS ACTA, V983, P217, DOI 10.1016/0005-2736(89)90237-X; Hirano S, 2013, EUR J PHARMACOL, V701, P144, DOI 10.1016/j.ejphar.2013.01.019; Kataoka T, 2012, EUR J PHARMACOL, V676, P1, DOI 10.1016/j.ejphar.2011.11.044; Kataoka T, 2009, J ANTIBIOT, V62, P655, DOI 10.1038/ja.2009.98; KIMURA G, 1975, INT J CANCER, V15, P694, DOI 10.1002/ijc.2910150419; Kobayashi T, 2007, J BIOCHEM, V142, P157, DOI 10.1093/jb/mvm150; Manna SK, 2006, J CELL PHYSIOL, V207, P195, DOI 10.1002/jcp.20555; Mitsuda S, 2014, FEBS OPEN BIO, V4, P229, DOI 10.1016/j.fob.2014.02.009; Perne A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008292; Sreenivasan Y, 2003, BIOCHEM PHARMACOL, V66, P2223, DOI 10.1016/j.bcp.2003.07.010; Srivastava M, 2004, P NATL ACAD SCI USA, V101, P7693, DOI 10.1073/pnas.0402030101; Takada Y, 2008, MOL CELL BIOCHEM, V319, P99, DOI 10.1007/s11010-008-9882-6; Valente RC, 2010, CELL BIOL TOXICOL, V26, P201, DOI 10.1007/s10565-009-9136-8; Wong C. W., 2012, INT J CELL BIOL, V2012, DOI [10.1155/2012/340296, DOI 10.1155/2012/340296]; Yamada Y, 2011, J ANTIBIOT, V64, P361, DOI 10.1038/ja.2011.23; Yamada Y, 2011, EUR J PHARMACOL, V667, P113, DOI 10.1016/j.ejphar.2011.05.072; Yang QF, 2005, P NATL ACAD SCI USA, V102, P9631, DOI 10.1073/pnas.0504097102; Zhao M, 2011, CHEM PHARM BULL, V59, P371, DOI 10.1248/cpb.59.371	46	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	JAN	2015	38	1					39	47				9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX5FF	WOS:000346951500006		
J	Sato, I; Yagata, H; Ohashi, Y				Sato, Izumi; Yagata, Hiroshi; Ohashi, Yasuo			The Accuracy of Japanese Claims Data in Identifying Breast Cancer Cases	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						claims data; diagnosis; breast cancer; cancer registry	MEDICARE CLAIMS; REGISTRY DATA; AGREEMENT; ABILITY	In use of a claims database for a study, an inaccurate diagnosis of breast cancer based on claims data may lead to invalid study results. The aim of this study was to assess the accuracy of definitions for identifying breast cancer cases from the Japanese claims database. The study cohort consisted of women with no prior cancer-related history, from the claims data at a single institution between January 1 and December 31, 2011. We developed 14 definitions for identifying breast cancer based on claims data, using a combination of diagnosis codes and treatment procedure codes. We calculated the sensitivity, specificity, and positive predictive value (PPV) of each definition, compared to cases identified from the standardized hospital-based cancer registry as a standard reference. A total of 50056 women were included in the study cohort from the claims database. We identified 633 breast cancer cases from the cancer registry. Of 14 definitions, 12 exhibited higher sensitivity than 90%, while the others exhibited lower sensitivity than 40%. The specificities of all definitions were high (>= 99%), and the PPVs were between 65.8 and 90.7%. We selected the most optimal definition obtained from combinations of diagnosis and cancer treatment codes (surgery, chemotherapy, medication, radiation procedure), which had high values for sensitivity (90.4%), specificity (99.8%), and PPV (87.3%). Definitions obtained via combinations of the diagnosis codes and procedure codes could be used to accurately identify breast cancer cases from the claims database. Further studies in a multi-institutional setting are planned to confirm our results.	[Sato, Izumi; Ohashi, Yasuo] Univ Tokyo, Grad Sch Med, Tokyo 1130033, Japan; [Yagata, Hiroshi] St Lukes Int Hosp, Chuo Ku, Tokyo 1048560, Japan	Sato, I (reprint author), Natl Ctr Global Hlth & Med, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	izumisato-tky@umin.ac.jp			NPO Japan Clinical Research Support Unit (J-CRSU); St. Luke's International Hospital	The authors wish to thank Yutaka Matsuyama, Ayano Takeuchi, Satoshi Iimuro, Yukari Uemura, Kiyoshi Kubota, Nobuhiro Ooba for useful comments regarding this study. The authors also wish to thank NPO Japan Clinical Research Support Unit (J-CRSU) and the St. Luke's International Hospital for their support.	Schneeweiss S, 2005, J CLIN EPIDEMIOL, V58, P323, DOI 10.1016/j.jclinepi.2004.10.012; Cooper GS, 2000, MED CARE, V38, P411, DOI 10.1097/00005650-200004000-00008; Couris CM, 2009, J CLIN EPIDEMIOL, V62, P660, DOI 10.1016/j.jclinepi.2008.07.013; Warren JL, 1999, MED CARE, V37, P445, DOI 10.1097/00005650-199905000-00004; SOLIN LJ, 1994, J MED SYST, V18, P23, DOI 10.1007/BF00999321; Koroukian SM, 2003, HEALTH SERV RES, V38, P947, DOI 10.1111/1475-6773.00155; McClish DK, 1997, AM J EPIDEMIOL, V145, P227; Freeman JL, 2000, J CLIN EPIDEMIOL, V53, P605, DOI 10.1016/S0895-4356(99)00173-0; Setoguchi S, 2007, CANCER CAUSE CONTROL, V18, P561, DOI 10.1007/s10552-007-0131-1; Hall GC, 2012, PHARMACOEPIDEM DR S, V21, P1, DOI 10.1002/pds.2229; Centers for Disease Control and Prevention, INT CLASS DIS 9 REV; ELLIS RP, 1988, J HEALTH ECON, V7, P215, DOI 10.1016/0167-6296(88)90026-4; Health Insurance Claims Review & Reimbursement Services, 2013, COMP PROC SYST CLAIM; Joint Committee of Cancer Registries, CANC REG STAND REG S; Matsuda S., 2008, Eurohealth, V14, P25; Ministry of Health. Labour and Welfare, CANC CONTR MEAS; Ministry of Health Labour and Welfare, OV MED SERV REG JAP; Ministry of Health. Labour and Welfare, GUID DEV DES CANC CA; Ministry of Health. Labour and Welfare, GUID PROV CLAIMS DAT; Sobue T, 2008, INT J CLIN ONCOL, V13, P97, DOI 10.1007/s10147-008-0761-7; Strom BL, 2012, PHARMACOEPIDEM DR S, V2012, P219; Wang K, 2010, J MED SYST, V34, P95, DOI 10.1007/s10916-008-9220-2; Warren JL, 1996, HEALTH CARE FINANC R, V18, P237; WHITTLE J, 1991, MED CARE, V29, P1226, DOI 10.1097/00005650-199112000-00005; World Health Organization, INT CLASS DIS ICD	25	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	JAN	2015	38	1					53	57				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX5FF	WOS:000346951500008		
J	Takahiro, R; Nakamura, S; Kohno, H; Yoshimura, N; Nakamura, T; Ozawa, S; Hirono, K; Ichida, F; Taguchi, M				Takahiro, Rikako; Nakamura, Saki; Kohno, Hiroyuki; Yoshimura, Naoki; Nakamura, Tsuneyuki; Ozawa, Sayaka; Hirono, Keiichi; Ichida, Fukiko; Taguchi, Masato			Contribution of CYP3A Isoforms to Dealkylation of PDE5 Inhibitors: A Comparison between Sildenafil N-Demethylation and Tadalafil Demethylenation	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						CYP3A; sildenafil; tadalafil; negative cooperativity; two binding sites model	PULMONARY ARTERIAL-HYPERTENSION; SUBSTRATE-INHIBITION; HEPATIC IMPAIRMENT; MASS-SPECTROMETRY; HUMAN PLASMA; PHARMACOKINETICS; IDENTIFICATION; METABOLITE; EXPRESSION; KINETICS	The aim of this study was to characterize the kinetics of metabolite formation of the phosphodiesterase type-5 (PDE5) inhibitors sildenafil and tadalafil by CYP3A4, CYP3A5, and CYP3A7 isoforms. The formations of N-desmethyl sildenafil and desmethylene tadalafil were examined using CYP3A supersomes co-expressing human P450 oxidoreductase and cytochrome b(5). Both sildenafil N-demethylation and tadalafil demethylenation were catalyzed by CYP3A4, CYP3A5, and to a lesser extent by CYP3A7. The kinetics of desalkyl metabolite formation of the two drugs were well fitted to the Hill equation; however, the Hill coefficients (n) suggested CYP3A-mediated negative cooperativity. Next, we analyzed the kinetics with a two binding sites model assuming two reaction steps: reaction 1 with high-affinity and low-capacity metabolism and reaction 2 with low-affinity and high-capacity metabolism. The kinetics of desalkyl metabolite formation were also fitted to the two binding sites model. The intrinsic clearance (CLint) values of reactions 1 and 2 for sildenafil N-demethylation were 0.733 and 0.033 mu L/min/pmol P450 for CYP3A4, 0.788 and 0.019 mu L/min/pmol P450 for CYP3A5, and 0.079 and 0.004 mu L/min/pmol P450 for CYP3A7, respectively. The CLint values of reactions 1 and 2 for tadalafil demethylenation were 0.187 and 0.014 mu L/min/pmol P450 for CYP3A4, 0.050 and <0.001 mu L/min/pmol P450 far CYP3A5, and 0.004 and <0.001 mu L/min/pmol P450 for CYP3A7, respectively. These results may provide the basis not only for understanding the metabolic properties of the two PDE5 inhibitors, but also for one possible explanation of the mechanisms of CYP3A-mediated negative cooperativity.	[Takahiro, Rikako; Nakamura, Saki; Kohno, Hiroyuki; Taguchi, Masato] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Toyama 9300194, Japan; [Yoshimura, Naoki] Toyama Univ, Fac Med, Dept Surg 1, Toyama 9300194, Japan; [Nakamura, Tsuneyuki] Kanazawa Med Univ, Dept Pediat, Uchinada, Ishikawa 9200293, Japan; [Ozawa, Sayaka; Hirono, Keiichi; Ichida, Fukiko] Toyama Univ, Fac Med, Dept Pediat, Toyama 9300194, Japan	Taguchi, M (reprint author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, 2630 Sugitani, Toyama 9300194, Japan.	taguchi@pha.u-toyama.ac.jp			Japan Society for the Promotion of Sciences (JSPS KAKENHI Grant) [24590182]	This work was supported in part by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Sciences (JSPS KAKENHI Grant Number 24590182).	Al-Ghazawi M, 2007, J PHARMACEUT BIOMED, V43, P613, DOI 10.1016/j.jpba.2006.07.028; Ring BJ, 2005, CLIN PHARMACOL THER, V77, P63, DOI 10.1016/j.clpt.2004.09.006; Reed MC, 2010, BIOESSAYS, V32, P422, DOI 10.1002/bies.200900167; Lin Y, 2001, DRUG METAB DISPOS, V29, P368; Ghofrani HA, 2004, J AM COLL CARDIOL, V44, P1488, DOI 10.1016/j.jacc.2004.06.060; Takatsuki S, 2012, PEDIATR CARDIOL, V33, P683, DOI 10.1007/s00246-012-0180-4; Rybalkin SD, 2003, CIRC RES, V93, P280, DOI 10.1161/01.RES.0000087541.15600.2B; Stevens JC, 2003, J PHARMACOL EXP THER, V307, P573, DOI 10.1124/jpet.103.054841; Williams JA, 2002, DRUG METAB DISPOS, V30, P883, DOI 10.1124/dmd.30.8.883; Shlobin OA, 2012, LUNG, V190, P573, DOI 10.1007/s00408-012-9408-6; Karatza AA, 2005, INT J CARDIOL, V100, P267, DOI 10.1016/j.ijcard.2004.09.002; Lacroix D, 1997, EUR J BIOCHEM, V247, P625, DOI 10.1111/j.1432-1033.1997.00625.x; Hyland R, 2001, BRIT J CLIN PHARMACO, V51, P239, DOI 10.1046/j.1365-2125.2001.00318.x; Farthing CA, 2010, J CHROMATOGR B, V878, P2891, DOI 10.1016/j.jchromb.2010.07.022; Jackson G, 2006, J SEX MED, V3, P28, DOI 10.1111/j.1743-6109.2005.00196.x; Forgue ST, 2007, BRIT J CLIN PHARMACO, V63, P24, DOI 10.1111/j.1365-2125.2006.02726.x; Forgue ST, 2006, BRIT J CLIN PHARMACO, V61, P280, DOI 10.1111/j.1365-2125.2005.02553.x; Kim J, 2003, J PHARMACEUT BIOMED, V32, P317, DOI 10.1016/S0731-7085(03)00088-8; Kohno H, 2014, THER DRUG MONIT, V36, P576, DOI 10.1097/FTD.0000000000000055; Korzekwa KR, 1998, BIOCHEMISTRY-US, V37, P4137, DOI 10.1021/bi9715627; Ku HY, 2008, DRUG METAB DISPOS, V36, P986, DOI 10.1124/dmd.107.020099; Lewis Gregory D, 2004, Curr Heart Fail Rep, V1, P183, DOI 10.1007/s11897-004-0007-6; Loh PT, 2008, TRANSPL P, V40, P1690, DOI 10.1016/j.transproceed.2008.04.010; Miller GP, 2001, BIOCHEMISTRY-US, V40, P7262, DOI 10.1021/bi010402z; Muirhead GJ, 2002, BRIT J CLIN PHARMACO, V53, p21S, DOI 10.1046/j.0306-5251.2001.00029.x; Nichols DJ, 2002, BRIT J CLIN PHARMACO, V53, p5S, DOI 10.1046/j.0306-5251.2001.00027.x; Phillips DL, 2004, AAPS J, V6, pW5308; Ring BJ, 2004, DRUG METAB REV, V36, P70; Sim SC, 2005, GENOMICS, V15, P625; Vos RM, 2008, J CHROMATOGR B, V876, P283, DOI 10.1016/j.jchromb.2008.10.052	30	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	JAN	2015	38	1					58	65				8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX5FF	WOS:000346951500009		
J	Di, HL; Ye, L; Neogi, SB; Meng, HC; Yan, H; Yamasaki, S; Shi, L				Di, Huiling; Ye, Lei; Neogi, Sucharit Basu; Meng, Hecheng; Yan, He; Yamasaki, Shinji; Shi, Lei			Development and Evaluation of a Loop-Mediated Isothermal Amplification Assay Combined with Enrichment Culture for Rapid Detection of Very Low Numbers of Vibrio parahaemolyticus in Seafood Samples	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						Vibrio parahaemolyticus; loop-mediated isothermal amplification; rapid detection; enrichment culture; seafood	THERMOSTABLE DIRECT HEMOLYSIN; REAL-TIME PCR; OYSTERS; VULNIFICUS; GENE; PURIFICATION; SHRIMP; JAPAN; TDH; TRH	The aim of this study was to develop and evaluate a rapid and effective method to detect Vibrio parahaemolyticus, a leading pathogen causing seafood-borne gastroenteritis. A newly designed loop-mediated isothermal amplification (LAMP) assay including a short enrichment period was optimized. This assay correctly detected all the target strains (n=61) but none of the non-target strains (n=34). Very low numbers of V. parahaemolyticus (2 colony forming unit (CFU) per gram of seafood) could be detected within 3 h and the minimum time of the whole assay was only 5h. Comparative screening of various seafood samples (n=70) indicated that the LAMP assay is superior to polymerase chain reaction (PCR) and conventional culture methods because it is more rapid and less complex. This highly sensitive LAMP assay can be applicable as the method of choice in large-scale and rapid screening of seafood and environmental samples to detect V. parahaenwlyticus strains.	[Di, Huiling; Ye, Lei; Neogi, Sucharit Basu; Yan, He; Yamasaki, Shinji; Shi, Lei] S China Univ Technol, Coll Light Ind & Food Sci, Guangzhou 510640, Guangdong, Peoples R China; [Meng, Hecheng; Yamasaki, Shinji] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Osaka 5988531, Japan	Yamasaki, S (reprint author), S China Univ Technol, Coll Light Ind & Food Sci, Guangzhou 510640, Guangdong, Peoples R China.	shinji@vet.osakafu-u.ac.jp			Major State Basic Research Development Program of China (973 Program) [2010CB35704, 2012CB723705]; Guangzhou technological planning projects [11C12080718]; Xiamen Science and Technology Major Project [3502Z20110001]; Guangdong Province Nature Science Foundation, China [10451064101005159]; Food Safety Key Lab of Liaoning Province Open Project Funding [LNSAKF2011002]	This work was supported by the Major State Basic Research Development Program of China (973 Program) (No. 2010CB35704; No. 2012CB723705), Guangzhou technological planning projects (11C12080718), Xiamen Science and Technology Major Project (3502Z20110001), Guangdong Province Nature Science Foundation, China (10451064101005159), and the Food Safety Key Lab of Liaoning Province Open Project Funding (LNSAKF2011002).	Alam MJ, 2003, ENVIRON MICROBIOL, V5, P706, DOI 10.1046/j.1462-2920.2003.00458.x; NAIR GB, 1985, APPL ENVIRON MICROB, V50, P724; Nair GB, 2007, CLIN MICROBIOL REV, V20, P39, DOI 10.1128/CMR.00025-06; Vugia D., 2009, Morbidity and Mortality Weekly Report, V58, P333; Robert-Pillot A, 2010, INT J FOOD MICROBIOL, V143, P190, DOI 10.1016/j.ijfoodmicro.2010.08.016; Cook DW, 2002, J FOOD PROTECT, V65, P79; Zhang YQ, 2012, FOOD RES INT, V45, P1011, DOI 10.1016/j.foodres.2011.02.015; Neogi SB, 2010, LETT APPL MICROBIOL, V51, P293, DOI 10.1111/j.1472-765X.2010.02895.x; Bej AK, 1999, J MICROBIOL METH, V36, P215, DOI 10.1016/S0167-7012(99)00037-8; Nordstrom JL, 2007, APPL ENVIRON MICROB, V73, P5840, DOI 10.1128/AEM.00460-07; Yamazaki W, 2011, FOOD MICROBIOL, V28, P1238, DOI 10.1016/j.fm.2011.04.007; Luan XY, 2008, CURR MICROBIOL, V57, P218, DOI 10.1007/s00284-008-9177-x; HONDA T, 1988, INFECT IMMUN, V56, P961; DePaola A, 2003, APPL ENVIRON MICROB, V69, P1521, DOI [10.1128/AEM.69.3.1521-1526.2003, 10.1128/AEM.69.3.1521-1526]; Su YC, 2007, FOOD MICROBIOL, V24, P549, DOI 10.1016/j.fm.2007.01.005; Venkateswaran K, 1998, APPL ENVIRON MICROB, V64, P681; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; Han F, 2007, APPL ENVIRON MICROB, V73, P7096, DOI 10.1128/AEM.01116-07; Park KS, 2004, INFECT IMMUN, V72, P6659, DOI 10.1128/IAI.72.11.6659-6665.2004; Mahmud ZH, 2007, INT J FOOD MICROBIOL, V118, P92, DOI 10.1016/j.ijfoodmicro.2007.05.009; Chen SY, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-41; Food and Agriculture Organization of the United Nations, RISK ASS VIBR PAR SE; FUJINO T., 1953, MED JOUR OSAKA UNIV, V4, P299; Haldar S, 2010, LETT APPL MICROBIOL, V50, P146, DOI 10.1111/j.1472-765X.2009.02769.x; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; SHINODA S, 1991, J GEN MICROBIOL, V137, P2705; TADA J, 1992, MOL CELL PROBE, V6, P477, DOI 10.1016/0890-8508(92)90044-X; Yamazaki W, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-163	28	2	2	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	JAN	2015	38	1					82	87				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX5FF	WOS:000346951500012		
J	Takakuwa, M; Iwamoto, J				Takakuwa, Masayuki; Iwamoto, Jun			Five-Year Experience with Risedronate Therapy for Patients with Increased Fracture Risk: A Practice-Based Observational Study	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						risedronate; geometry; bone mineral density; advanced hip assessment; femur strength index	POSTMENOPAUSAL OSTEOPOROSIS; BONE-DENSITY; ESTABLISHED POSTMENOPAUSAL; NONVERTEBRAL FRACTURES; DIAGNOSTIC-CRITERIA; VERTEBRAL FRACTURES; HIP FRACTURE; WOMEN; EFFICACY; GEOMETRY	The purpose of this practice-based observational study was to examine the effects of long-term treatment with risedronate in patients with an increased fracture risk. Seventy patients (4 men and 66 postmenopausal women; mean age, 68.0 years) with osteoporosis or osteopenia and clinical risk factors for fractures were treated with risedronate at either 2.5 mg/d or 17.5 mg/week for 5 years. The bone mineral density (BMD) of the lumbar spine and proximal femur, and the structural geometric parameters of the proximal femur were evaluated by dual-energy X-ray absorptiometry with advanced hip assessment software at baseline and after each year of treatment. The lumbar spine BMD rapidly increased during the first year of the treatment and steadily increased throughout the 5-year treatment period. The BMD of the femoral neck and total hip also significantly increased during the first 3 and 2 years of treatment, respectively, then gradually declined and reached the baseline level after 5 years of treatment. The cross-sectional moment of inertia, cross-sectional area, and mean width of the femoral neck region of interest significantly increased during the first 2 years, and these increases were maintained throughout the 5-year treatment period. The femur strength index and section modulus also significantly increased following time courses similar to those of the above three parameters. These results suggest that risedronate produced both a sustained increase in the lumbar spine BMD and improvement in the femoral structural geometric parameters for 5 years of treatment.	[Takakuwa, Masayuki] Takakuwa Orthopaed Nagayama Clin, Asahikawa, Hokkaido 0798413, Japan; [Iwamoto, Jun] Keio Univ, Sch Med, Inst Integrated Sports Med, Shinjuku Ku, Tokyo 1608582, Japan	Iwamoto, J (reprint author), Keio Univ, Sch Med, Inst Integrated Sports Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	jiwamoto@a8.keio.jp					Anitha D, 2013, OSTEOPOROSIS INT, V24, P3043, DOI 10.1007/s00198-013-2424-4; Ringe JD, 2007, RHEUMATOL INT, V27, P425, DOI 10.1007/s00296-006-0288-z; Reginster JY, 2000, OSTEOPOROSIS INT, V11, P83, DOI 10.1007/s001980050010; Mellstrom DD, 2004, CALCIFIED TISSUE INT, V75, P462, DOI 10.1007/s00223-004-0286-7; Murad MH, 2012, J CLIN ENDOCR METAB, V97, P1871, DOI 10.1210/jc.2011-3060; Compston JE, 2012, J BONE MINER RES, V27, P240, DOI 10.1002/jbmr.1542; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; Shane E, 2014, J BONE MINER RES, V29, P1, DOI 10.1002/jbmr.1998; Faulkner KG, 2006, OSTEOPOROSIS INT, V17, P593, DOI 10.1007/s00198-005-0019-4; Orimo H, 1998, J BONE MINER METAB, V16, P139, DOI 10.1007/s007740050038; Ramamurthi K, 2012, OSTEOPOROSIS INT, V23, P543, DOI 10.1007/s00198-011-1578-1; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Ito M, 2014, OSTEOPOROSIS INT, V25, P1163, DOI 10.1007/s00198-013-2596-y; Harris ST, 1999, JAMA-J AM MED ASSOC, V282, P1344, DOI 10.1001/jama.282.14.1344; Kishimoto H, 2006, J BONE MINER METAB, V24, P405, DOI 10.1007/s00774-006-0706-z; Das S, 2013, DRUG DES DEV THER, V7, P435, DOI 10.2147/DDDT.S31504; Beck TJ, 2009, J BONE MINER RES, V24, P1369, DOI [10.1359/jbmr.090307, 10.1359/JBMR.090307]; Orimo H, 2001, J BONE MINER METAB, V19, P331, DOI 10.1007/s007740170001; Kawai M, 2011, NAT REV DRUG DISCOV, V10, P141, DOI 10.1038/nrd3299; Cummings SR, 2013, J BONE MINER RES, V28, P433, DOI 10.1002/jbmr.1854; Harrington JT, 2004, CALCIFIED TISSUE INT, V74, P129, DOI 10.1007/s00223-003-0042-4; Ishijima M, 2009, CALCIFIED TISSUE INT, V85, P398, DOI 10.1007/s00223-009-9295-x; Khosla S, 2007, J BONE MINER RES, V22, P1479, DOI 10.1359/JBMR.0707ONJ; Ohnaru K, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-331; Roux C, 2004, CURR MED RES OPIN, V20, P433, DOI 10.1185/030079903125003125; Takada J, 2011, J BONE MINER METAB, V29, P458, DOI 10.1007/s00774-010-0242-8; Takakuwa M, 2011, J BONE MINER METAB, V29, P88, DOI 10.1007/s00774-010-0196-x; Takakuwa M, 2012, CLIN DRUG INVEST, V32, P121, DOI 10.2165/11597990-000000000-00000; Wells GA, 2008, COCHRANE DB SYST REV, V23; YOSHIKAWA T, 1994, J BONE MINER RES, V9, P1053; Zhong ZM, 2009, CLIN DRUG INVEST, V29, P349, DOI 10.2165/00044011-200929050-00007	31	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	JAN	2015	38	1					88	95				8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX5FF	WOS:000346951500013		
J	Yamaguchi, Y; Matsueda, S; Matsunaga, K; Takashio, N; Toma-Fukai, S; Yamagata, Y; Shibata, N; Wachino, J; Shibayama, K; Arakawa, Y; Kurosaki, H				Yamaguchi, Yoshihiro; Matsueda, Satoshi; Matsunaga, Kazuyo; Takashio, Nobutoshi; Toma-Fukai, Sachiko; Yamagata, Yuriko; Shibata, Naohiro; Wachino, Jun-ichi; Shibayama, Keigo; Arakawa, Yoshichika; Kurosaki, Hiromasa			Crystal Structure of IMP-2 Metallo-beta-lactamase from Acinetobacter spp.: Comparison of Active-Site Loop Structures between IMP-1 and IMP-2	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						antibiotic resistance; beta-lactam antibiotic; metallo-beta-lactamase; X-ray crystallography	PSEUDOMONAS-AERUGINOSA; BACTEROIDES-FRAGILIS; MERCAPTOCARBOXYLATE INHIBITOR; IMIPENEM RESISTANCE; CLINICAL ISOLATE; BINDING; DETERMINANTS; RESOLUTION; RESIDUES; INTEGRON	IMP-2, a subclass B1 metallo-beta-lactamase (MBL), is a Zn(II)-containing hydrolase. This hydrolase, involved in antibiotic resistance, catalyzes the hydrolysis of the C-N bond of the beta-lactam ring in beta-lactam antibiotics such as benzylpenicillin and imipenem. The crystal structure of IMP-2 MBL from Acinetobacter spp. was determined at 2.3 angstrom resolution. This structure is analogous to that of subclass B1 MBLs such as IMP-1 and VIM-2. Comparison of the structures of IMP-1 and IMP-2, which have an 85% amino acid identity, suggests that the amino acid substitution at position 68 on a beta-strand (beta 3) (Pro in IMP-1 versus Ser in IMP-2) may be a staple factor affecting the flexibility of loop 1 (comprising residues at positions 60-66; EVNGWGV). In the IMP-1 structure, loop 1 adopts an open, disordered conformation. On the other hand, loop 1 of IMP-2 forms a closed conformation in which the side chain of Trp64, involved in substrate binding, is oriented so as to cover the active site, even though there is an acetate ion in the active site of both IMP-1 and IMP-2. Loop 1 of IMP-2 has a more flexible structure in comparison to IMP-1 due to having a Ser residue instead of the Pro residue at position 68, indicating that this difference in sequence may be a trigger to induce a more flexible conformation in loop 1.	[Yamaguchi, Yoshihiro] Kumamoto Univ, Environm Safety Ctr, Chuo Ku, Kumamoto 8608555, Japan; [Matsueda, Satoshi; Matsunaga, Kazuyo; Takashio, Nobutoshi; Yamagata, Yuriko; Kurosaki, Hiromasa] Kumamoto Univ, Grad Sch Pharmaceut Sci, Chuo Ku, Kumamoto 8620973, Japan; [Toma-Fukai, Sachiko] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Shibata, Naohiro; Shibayama, Keigo] Natl Inst Infect Dis, Dept Bacterial Pathogenesis & Infect Control, Tokyo 2080011, Japan; [Wachino, Jun-ichi; Arakawa, Yoshichika] Nagoya Univ, Grad Sch Med, Dept Bacteriol, Showa Ku, Nagoya, Aichi 4668550, Japan	Yamaguchi, Y (reprint author), Kumamoto Univ, Environm Safety Ctr, Chuo Ku, 2-39-1 Kurokami, Kumamoto 8608555, Japan.	yyamagu@gpo.kumamoto-u.ac.jp; ayasaya@gpo.kumamoto-u.ac.jp	Arakawa, Yoshichika/P-5997-2015		Ministry of Health, Labour and Welfare of Japan [H24-Shinkou-Ippan-010]; JSPS KAKENHI Grant [24659059, 10363524]	This work was supported by H24-Shinkou-Ippan-010 from the Ministry of Health, Labour and Welfare of Japan, and in part by JSPS KAKENHI Grant Numbers 24659059 and 10363524.	AMBLER RP, 1980, PHILOS T ROY SOC B, V289, P321, DOI 10.1098/rstb.1980.0049; BUSH K, 1995, ANTIMICROB AGENTS CH, V39, P1211; Concha NO, 1996, STRUCTURE, V4, P823, DOI 10.1016/S0969-2126(96)00089-5; Brown NG, 2011, ANTIMICROB AGENTS CH, V55, P5696, DOI 10.1128/AAC.00340-11; Moali C, 2003, CHEM BIOL, V10, P319, DOI 10.1016/S1074-5521(03)00070-X; Garcia-Saez I, 2008, J MOL BIOL, V375, P604, DOI 10.1016/j.jmb.2007.11.012; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Galleni M, 2001, ANTIMICROB AGENTS CH, V45, P660, DOI 10.1128/AAC.45.3.660-663.2001; Riccio ML, 2000, ANTIMICROB AGENTS CH, V44, P1229, DOI 10.1128/AAC.44.5.1229-1235.2000; OSANO E, 1994, ANTIMICROB AGENTS CH, V38, P71; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Shibata N, 2003, J CLIN MICROBIOL, V41, P5407, DOI 10.1128/JCM.41.12.5407-5413.2003; ARAKAWA Y, 1995, ANTIMICROB AGENTS CH, V39, P1612; Yamaguchi Y, 2007, J MED CHEM, V50, P6647, DOI 10.1021/jm701031n; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Materon IC, 2001, PROTEIN SCI, V10, P2556, DOI 10.1110/ps.ps.40884; Yamaguchi Y, 2010, J BIOCHEM, V147, P905, DOI 10.1093/jb/mvq029; Toney JH, 2001, J BIOL CHEM, V276, P31913, DOI 10.1074/jbc.M104742200; Kurosaki H, 2006, CHEMMEDCHEM, V1, P969, DOI 10.1002/cmdc.200600115; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Scrofani SDB, 1999, BIOCHEMISTRY-US, V38, P14507, DOI 10.1021/bi990986t; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; CARFI A, 1995, EMBO J, V14, P4914; Borra PS, 2011, J MOL BIOL, V411, P174, DOI 10.1016/j.jmb.2011.05.035; Concha NO, 2000, BIOCHEMISTRY-US, V39, P4288, DOI 10.1021/bi992569m; WATANABE M, 1991, ANTIMICROB AGENTS CH, V35, P147; DeLano W. L., 2002, PYMOL MOL GRAPHICS S; Fitzgerald PMD, 1998, BIOCHEMISTRY-US, V37, P6791, DOI 10.1021/bi9730339; Materon IC, 2004, J MOL BIOL, V344, P653, DOI 10.1016/j.jmb.2004.09.074	30	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	JAN	2015	38	1					96	101				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX5FF	WOS:000346951500014		
J	Muhammad, JS; Zaidi, SF; Shaharyar, S; Refaat, A; Usmanghani, K; Saiki, I; Sugiyama, T				Muhammad, Jibran Sualeh; Zaidi, Syed Faisal; Shaharyar, Saeeda; Refaat, Alaa; Usmanghani, Khan; Saiki, Ikuo; Sugiyama, Toshiro			Anti-inflammatory Effect of Cinnamaldehyde in Helicobacter pylori Induced Gastric Inflammation	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						cinnamaldehyde; Helicobacter pylori; nuclear factor kappa B; interleukin-8; Cinnamomum cassia; human gastric epithelial cell	NF-KAPPA-B; EPITHELIAL-CELLS; MEDICINAL-PLANTS; INFECTION; METRONIDAZOLE; MODULATION; ACTIVATION; EXPRESSION; RESISTANCE; RESPONSES	Cinnamomum cassia is widely employed for gastrointestinal complaints such as dyspepsia, flatulence, diarrhea, and vomiting. Studies report cinnamaldehyde (CM) as a major active constituent of cinnamon. The aim of this study was to evaluate the anti-inflammatory mechanism of CM on Helicobacter (H.) pylori-infected gastric epithelial cells in order to validate cinnamon traditional use in gastrointestinal (GI)-related disorders. AGS/MKN-45 cells and H. pylori (193C) were employed for co-culture experiments. Anti-H. pylori cytotoxic and anti-adhesion activity of CM were determined. Enzyme linked immunosorbent assay, real time polymerase chain reaction analysis and immunoblotting were used to measure the effect on interleukin-8 (IL-8) secretion/expression. The effect on activation of nuclear factor kappa B (NF-kappa B) was determined by immunoblot analysis. The non-cytotoxic CM (<= 125 mu m) was also non-bactericidal at the given time, suggesting the effect in H. pylori/cell co-culture system was not due to alteration in H. pylori viability or the toxicity to the cells. Also, CM did not show any anti-adhesion effect against H. pylori/cell co-culture. However, pre-incubation of the cells with CM significantly inhibited the IL-8 secretion/expression from H. pylori-infected cells (p<0.01). In addition, CM suppressed H. pylori-induced NF-kappa B activation and prevented degradation of inhibitor (1)-kappa B This study provides evidence that the anti-inflammatory effect of C. cassia on H. pylori-infected gastric cells is due to blockage of the NF-kappa B pathway by cinnamaldehyde. This agent can be considered as a potential candidate for in vivo and clinical studies against various H. pylori related gastric pathogenic processes.	[Muhammad, Jibran Sualeh; Zaidi, Syed Faisal; Sugiyama, Toshiro] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Gastroenterol & Hematol, Toyama 9300194, Japan; [Zaidi, Syed Faisal; Shaharyar, Saeeda] Aga Khan Univ, Dept Biol & Biomed Sci, Fac Hlth Sci, Karachi 74800, Pakistan; [Zaidi, Syed Faisal] King Saud Bin Abdulaziz Univ Hlth Sci, Dept Basic Med Sci, Coll Med, Jeddah 21423, Saudi Arabia; [Refaat, Alaa; Saiki, Ikuo] Toyama Univ, Inst Nat Med, Div Pathogen Biochem, Toyama 9300194, Japan; [Usmanghani, Khan] Hamdard Univ, Fac Eastern Med, Dept Basic Clin Sci, Karachi 74600, Pakistan	Zaidi, SF (reprint author), King Saud Bin Abdulaziz Univ Hlth Sci, Coll Med, Dept Basic Med Sci, Jeddah 21423, Saudi Arabia.	sfaisalhz@gmail.com; tsugi@med.u-toyama.ac.jp			FHS-Research Committee of the Aga Khan University, Karachi, Pakistan	We are thankful to Prof. Dr. Hiroaki Sakurai (Dept. of Cancer Cell Biology, University of Toyama) for gifting primary antibodies for immunoblot analysis, Mrs. Toyomi Kozawa (Dept. of Gastroenterology, University of Toyama) for technical assistance and Mohammad Aziz Rajani (Dept. of Biological and Biomedical Sciences, Aga Khan University) for providing assistance in few experiments. This work was partially funded by Grant from the FHS-Research Committee of the Aga Khan University, Karachi, Pakistan.	Ando T, 1996, AM J GASTROENTEROL, V91, P1150; Kim DH, 2007, BIOGERONTOLOGY, V8, P545, DOI 10.1007/s10522-007-9098-2; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74; Wondrak GT, 2010, MOLECULES, V15, P3338, DOI 10.3390/molecules15053338; Crabtree JE, 1996, ALIMENT PHARM THERAP, V10, P29; Zaidi SF, 2012, J ETHNOPHARMACOL, V141, P403, DOI 10.1016/j.jep.2012.03.001; Osato MS, 2001, ARCH INTERN MED, V161, P1217, DOI 10.1001/archinte.161.9.1217; Vitor JMB, 2011, FEMS IMMUNOL MED MIC, V63, P153, DOI 10.1111/j.1574-695X.2011.00865.x; CRABTREE JE, 1995, J CLIN PATHOL, V48, P41, DOI 10.1136/jcp.48.1.41; Meyer F, 2000, INFECT IMMUN, V68, P6265, DOI 10.1128/IAI.68.11.6265-6272.2000; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Muhammad JS, 2013, J PAK MED ASSOC, V63, P1528; Keates S, 1997, GASTROENTEROLOGY, V113, P1099, DOI 10.1053/gast.1997.v113.pm9322504; Zaidi SFH, 2009, BIOL PHARM BULL, V32, P1931, DOI 10.1248/bpb.32.1931; Kaefer CM, 2008, J NUTR BIOCHEM, V19, P347, DOI 10.1016/j.jnutbio.2007.11.003; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; O'Mahony R, 2005, WORLD J GASTROENTERO, V11, P7499; Muhammad JS, 2012, J PAK MED ASSOC, V62, P955; McColl KEL, 2010, NEW ENGL J MED, V362, P1597, DOI 10.1056/NEJMcp1001110; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; POUNDER RE, 1995, ALIMENT PHARM THERAP, V9, P33; SELLINS KS, 1987, J IMMUNOL, V139, P3199; Hatakeyama M, 2005, CANCER SCI, V96, P835, DOI 10.1111/j.1349-7006.2005.00130.x; O'Connor A, 2013, HELICOBACTER, V18, P58, DOI 10.1111/hel.12075; Zaidi SFH, 2009, HELICOBACTER, V14, P588, DOI 10.1111/j.1523-5378.2009.00724.x; Hayashi S, 1998, ANTIMICROB AGENTS CH, V42, P1895; Marchildon PA, 2003, J CLIN MICROBIOL, V41, P1480, DOI 10.1128/JCM.41.4.1480-1485.2003; BENBARUCH A, 1995, J BIOL CHEM, V270, P11703; Chu SH, 2003, DIGEST DIS SCI, V48, P257, DOI 10.1023/A:1021963007225; FUCHS CS, 1995, NEW ENGL J MED, V333, P32, DOI 10.1056/NEJM199507063330107; Hayashi S, 1997, J GASTROEN HEPATOL, V12, P373, DOI 10.1111/j.1440-1746.1997.tb00445.x; Hong JW, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-237; Lopez-Lazaro M, 2008, MOL NUTR FOOD RES, V52, pS103, DOI 10.1002/mnfr.200700238; Maeda S, 2000, GASTROENTEROLOGY, V119, P97, DOI 10.1053/gast.2000.8540; Nir Y, 2000, HELICOBACTER, V5, P94, DOI 10.1046/j.1523-5378.2000.00014.x; Ranasinghe P, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-275; Schistosomes liver flukes and Helicobacter pylori, 1994, IARC MONOGR EVAL CAR, V61, P1; Sherif M, 2004, J CLIN MICROBIOL, V42, P4832, DOI 10.1028/JCM.42.10.4832-4834.2004; Suzuki H, 2009, NEUROGASTROENT MOTIL, V21, P688, DOI 10.1111/j.1365-2982.2009.01290.x; Tabak M, 1999, J ETHNOPHARMACOL, V67, P269, DOI 10.1016/S0378-8741(99)00054-9; Usmanghani K, 2006, HERB MARKET ANAL KAR, P63; Zaidi SFH, 2009, J ETHNOPHARMACOL, V121, P86, DOI 10.1016/j.jep.2008.11.001	43	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	JAN	2015	38	1					109	115				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX5FF	WOS:000346951500016		
J	Miki, Y; Koyama, K; Kurusu, H; Hirano, K; Beppu, M; Fujiwara, Y				Miki, Yuichi; Koyama, Keisuke; Kurusu, Haruna; Hirano, Kazuya; Beppu, Masatoshi; Fujiwara, Yasuyuki			Nucleolin Is a Receptor for Maleylated-Bovine Serum Albumin on Macrophages	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						macrophage; maleylated-bovine serum albumin; nucleolin; scavenger receptor	SHUTTLING PROTEIN NUCLEOLIN; APOPTOTIC CELLS; SCAVENGER RECEPTORS; RECOGNITION; CLEARANCE; GLYCOPROTEIN; PHAGOCYTOSIS; HOMEOSTASIS; LEADS; MICE	Scavenger receptors have a broad range of functions that include pathogen clearance, and identification of the scavenger receptor family has been of great benefit to the field of physiology. The shuttling-protein nucleolin has recently been shown to possess scavenger receptor-like activity. We therefore investigated whether or not nucleolin is a receptor for maleylated-bovine serum albumin (maleylated-BSA), which is a common ligand for scavenger receptors. Binding and phagocytosis of native control-BSA by thioglycollate-elicited mouse peritoneal macrophages was weak, but that of maleylated-BSA was strong. Surface plasmon-resonance analysis revealed that nucleolin strongly associated with maleylated-BSA but not control-BSA or maleic anhydride. Further, co-treatment of macrophages with anti-nucleolin antibody, but not control-immunoglobulin G, inhibited binding of maleylated-BSA. In addition, antineoplastic guanine rich oligonucleotide (AGRO), a nucleolin-specific oligonucleotide aptamer, inhibited binding of maleylated-BSA. Further, binding of maleylated-BSA to nucleolin-transfected HEK293 cells was higher than that by control HEK cells. These results indicate that nucleolin is a receptor that enables macrophages to recognize maleylated-BSA.	[Miki, Yuichi; Koyama, Keisuke; Kurusu, Haruna; Hirano, Kazuya; Beppu, Masatoshi; Fujiwara, Yasuyuki] Tokyo Univ Pharm & Life Sci, Sch Pharm, Hachioji, Tokyo 1920392, Japan	Miki, Y (reprint author), Tokyo Univ Pharm & Life Sci, Sch Pharm, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	miki@ps.toyaku.ac.jp					Alford PB, 1998, BIOCHEM BIOPH RES CO, V245, P185, DOI 10.1006/bbrc.1998.8400; Nisole S, 2002, J BIOL CHEM, V277, P20877, DOI 10.1074/jbc.M110024200; DEVERDUGO UR, 1995, J VIROL, V69, P6751; Miksa M, 2009, J IMMUNOL METHODS, V342, P71, DOI 10.1016/j.jim.2008.11.019; Fadok VA, 2001, J CLIN INVEST, V108, P957, DOI 10.1172/JCI14122; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Sinclair JF, 2002, J BIOL CHEM, V277, P2876, DOI 10.1074/jbc.M110230200; Maderna P, 2003, BBA-MOL BASIS DIS, V1639, P141, DOI 10.1016/j.bbadis.2003.09.004; Mongelard F, 2010, CURR OPIN MOL THER, V12, P107; Canton J, 2013, NAT REV IMMUNOL, V13, P621, DOI 10.1038/nri3515; Tada R, 2014, INT IMMUNOPHARMACOL, V19, P5, DOI 10.1016/j.intimp.2013.12.027; Feng H, 2011, ARTERIOSCL THROM VAS, V31, P2543, DOI 10.1161/ATVBAHA.111.234716; VANREGENMORTEL MHV, 1994, DEV BIOL STAND, V83, P143; HABEEB AFS, 1966, ANAL BIOCHEM, V14, P328, DOI 10.1016/0003-2697(66)90275-2; Bose S, 2004, J VIROL, V78, P8146, DOI 10.1128/JVI.78.15.8146-8158.2004; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; Wang Y, 2011, CELL BIOL INT, V35, P677, DOI 10.1042/CBI20100625; Hirano K, 2005, J BIOL CHEM, V280, P39284, DOI 10.1074/jbc.M505275200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Butler P J, 1972, Methods Enzymol, V25, P191, DOI 10.1016/S0076-6879(72)25016-9; HAMPTON RY, 1991, NATURE, V352, P342, DOI 10.1038/352342a0; Jalkanen J, 2003, MOL THER, V8, P903, DOI 10.1016/j.ymthe.2003.009.012; Liu JH, 2012, J NEUROIMMUNOL, V250, P71, DOI 10.1016/j.jneuroim.2012.05.002; Miki Y, 2009, BIOL PHARM BULL, V32, P564; Miki Y, 2014, BIOL PHARM BULL, V37, P588; Miki Y, 2007, BIOCHEM BIOPH RES CO, V363, P57, DOI 10.1016/j.bbrc.2007.08.089; Oguri E, 2012, BIOL PHARM BULL, V35, P551; Ozawa D, 2013, BIOL PHARM BULL, V36, P1587; Watanabe T, 2010, J CANCER RES CLIN, V136, P911, DOI 10.1007/s00432-009-0733-y	29	1	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	JAN	2015	38	1					116	121				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX5FF	WOS:000346951500017		
J	Makanga, JO; Kobayashi, M; Ikeda, H; Christianto, A; Toyoda, H; Yamada, M; Kawasaki, T; Inazu, T				Makanga, Juliet O.; Kobayashi, Misa; Ikeda, Hiroki; Christianto, Antonius; Toyoda, Hidenao; Yamada, Mitsunori; Kawasaki, Toshisuke; Inazu, Tetsuya			Generation of Rat Induced Pluripotent Stem Cells Using a Plasmid Vector and Possible Application of a Keratan Sulfate Glycan Recognizing Antibody in Discriminating Teratoma Formation Phenotypes	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						induced pluripotent stem cell; teratoma; R-10G antibody; glycobiology		Induced pluripotent stem cells (iPSCs) offer an invaluable tool for biological research and regenerative medicine. We report establishment of rat iPSCs (riPSCs) using a plasmid vector encoding four transcription factors, Oct3/4, Sox2, c-Myc and Klf4. Although all riPSC clones were generated and cultured under the same conditions, expressed hallmark pluripotency markers and differentiated successfully in vitro, the expression of a keratan sulfate glycan epitope with unique properties defined by R-10G antibody varied in the riPSC clones. In contrast, tumor rejection antigen (TRA)-1-81 epitope expression was comparable. A clone highly reactive to R-10G antibody formed teratomas in vivo consisting of cells from all three germ layers. However, clones expressing a lower level of the epitope defined by R-10G resulted in tumors with rapid growth consisting of undifferentiated cells. Additionally, riPSCs could be successfully differentiated into a neuronal lineage including glutamate neurons that responded to agonist stimulation. These observations demonstrate a glycophenotypic difference that may potentially serve as a useful probe for riPSC evaluation and to study the role of glycans in pluripotency and carcinogenesis in these cells.	[Makanga, Juliet O.; Kobayashi, Misa; Ikeda, Hiroki; Christianto, Antonius; Inazu, Tetsuya] Ritsumeikan Univ, Coll Pharmaceut Sci, Lab Funct Genom, Kusatsu, Shiga 5258577, Japan; [Toyoda, Hidenao] Ritsumeikan Univ, Coll Pharmaceut Sci, Lab Bioanalyt Chem, Kusatsu, Shiga 5258577, Japan; [Yamada, Mitsunori] NHO, Saigata Med Ctr, Neuropathol Lab, Dept Clin Res, Niigata 9493193, Japan; [Kawasaki, Toshisuke] Ritsumeikan Univ, Res Ctr Glycobiotechnol, Kusatsu, Shiga 5258577, Japan	Inazu, T (reprint author), Ritsumeikan Univ, Coll Pharmaceut Sci, Lab Funct Genom, Kusatsu, Shiga 5258577, Japan.	tinazu@fc.ritsumei.ac.jp			Japan Society for the Promotion of Science [C-24570171, 24110517]; Japan Science and Technology Agency [AS242Z01520P, AS251Z01560P]; R-GIRO (Ritsumeikan Global Innovation Research Organization) Program	We thank Dr. K. Kaji for kindly providing the plasmid used in this work. We thank Mr. Koga, Igarashi, and Hirocho, Ms. Karima and Konishi for technical support. This work was supported by Grants-in-Aid for Scientific Research C-24570171 (to T.K.), for Scientific Research on Innovative Areas 24110517 (to T.K.) from the Japan Society for the Promotion of Science, Grants-in-Aid for Adaptable and Seamless Technology Transfer Program through target-driven R&D, AS242Z01520P (to T.K.) and AS251Z01560P (to H.T.), from the Japan Science and Technology Agency, and by the R-GIRO (Ritsumeikan Global Innovation Research Organization) Program (to H.T.).	Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Kawabe K, 2013, GLYCOBIOLOGY, V23, P322, DOI 10.1093/glycob/cws159; Fujitani N, 2013, P NATL ACAD SCI USA, V110, P2105, DOI 10.1073/pnas.1214233110; Jacob HJ, 2010, TRENDS GENET, V26, P510, DOI 10.1016/j.tig.2010.08.006; ANDREWS PW, 1984, HYBRIDOMA, V3, P347, DOI 10.1089/hyb.1984.3.347; Li WL, 2010, METHODS MOL BIOL, V636, P293, DOI 10.1007/978-1-60761-691-7_18; Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005; Tateno H, 2011, J BIOL CHEM, V286, P20345, DOI 10.1074/jbc.M111.231274; Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; KANNAGI R, 1983, EMBO J, V2, P2355; Chang MY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009838; Jiang MG, 2013, J BIOL CHEM, V288, P27150, DOI 10.1074/jbc.M113.492900; Merkl C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055170; Tomioka I, 2010, GENES CELLS, V15, P959, DOI 10.1111/j.1365-2443.2010.01437.x	14	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	JAN	2015	38	1					127	133				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX5FF	WOS:000346951500019		
J	Sakashita, Y; Abe, K; Katagiri, N; Kambe, T; Saitoh, T; Utsunomiya, I; Horiguchi, Y; Taguchi, K				Sakashita, Yuichi; Abe, Kenji; Katagiri, Nobuyuki; Kambe, Toshie; Saitoh, Toshiaki; Utsunomiya, Iku; Horiguchi, Yoshie; Taguchi, Kyoji			Effect of Psilocin on Extracellular Dopamine and Serotonin Levels in the Mesoaccumbens and Mesocortical Pathway in Awake Rats	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						psilocin; dopamine; serotonin; nucleus accumbens; ventral tegmental area; medial prefrontal cortex	HEALTHY-HUMAN VOLUNTEERS; VENTRAL TEGMENTAL AREA; PREPULSE INHIBITION; AGONIST PSILOCYBIN; PREFRONTAL CORTEX; RECEPTORS; RELEASE; HUMANS; SCHIZOPHRENIA; PSYCHOSIS	Psilocin (3[2-(dimethylamino)ethyl]-1H-indol-4-ol) is a hallucinogenic component of the Mexican mushroom Psilocybe mexicana and a skeletal serotonin (5-HT) analogue. Psilocin is the active metabolite of psilocybin (3[2-(dimethylamino)ethyl]-1H-indol-4-yl dihydrogen phosphate). In the present study, we examined the effects of systemically administered psilocin on extracellular dopamine and 5-HT concentrations in the ventral tegmental area (VTA), nucleus accumbens, and medial prefrontal cortex of the dopaminergic pathway in awake rats using in vivo micro dialysis. Intraperitoneal administration of psilocin (5, 10 mg/kg) significantly increased extracellular dopamine levels in the nucleus accumbens. Psilocin did not affect the extracellular 5-HT level in the nucleus accumbens. Conversely, systemic administration of psilocin (10 mg/kg) significantly increased extracellular 5-HT levels in the medial prefrontal cortex of rats, but dopamine was decreased in this region. However, neither extracellular dopamine nor 5-HT levels in the VTA were altered by administration of psilocin. Behaviorally, psilocin significantly increased the number of head twitches. Thus, psilocin affects the dopaminergic system in the nucleus accumbens. In the serotonergic system, psilocin contribute to a crucial effect in the medial prefrontal cortex. The present data suggest that psilocin increased both the extracellular dopamine and 5-HT concentrations in the mesoaccumbens and/or mesocortical pathway.	[Sakashita, Yuichi; Katagiri, Nobuyuki; Taguchi, Kyoji] Showa Pharmaceut Univ, Dept Med Pharmacol, Machida, Tokyo 1940042, Japan; [Abe, Kenji] Ohu Univ, Sch Pharmaceut Sci, Dept Pharmacol, Koriyama, Fukushima 9638611, Japan; [Kambe, Toshie] Showa Pharmaceut Univ, Dept Pharmacol, Machida, Tokyo 1940042, Japan; [Saitoh, Toshiaki] Nihon Pharmaceut Univ, Fac Pharmaceut Sci, Inamachi, Saitama 3620806, Japan; [Utsunomiya, Iku] Showa Pharmaceut Univ, Dept Dev Educ, Machida, Tokyo 1940042, Japan; [Horiguchi, Yoshie] Showa Pharmaceut Univ, Dept Med Chem, Machida, Tokyo 1940042, Japan	Taguchi, K (reprint author), Showa Pharmaceut Univ, Dept Med Pharmacol, 3-3165 Higashitamagawagakuen, Machida, Tokyo 1940042, Japan.	taguchi@ac.shoyaku.ac.jp					Blair JB, 2000, J MED CHEM, V43, P4701, DOI 10.1021/jm000339w; Vollenweider FX, 2007, NEUROPSYCHOPHARMACOL, V32, P1876, DOI 10.1038/sj.npp.1301324; Vollenweider FX, 1998, NEUROREPORT, V9, P3897, DOI 10.1097/00001756-199812010-00024; Griffiths RR, 2006, PSYCHOPHARMACOLOGY, V187, P268, DOI 10.1007/s00213-006-0457-5; Millan MJ, 2003, J PHARMACOL EXP THER, V306, P954, DOI 10.1124/jpet.103.051797; Moreno FA, 2006, J CLIN PSYCHIAT, V67, P1735; Carter OL, 2005, NEUROPSYCHOPHARMACOL, V30, P1154, DOI 10.1038/sj.npp.1300621; Quednow BB, 2012, NEUROPSYCHOPHARMACOL, V37, P630, DOI 10.1038/npp.2011.228; WOLBACH AB, 1962, PSYCHOPHARMACOLOGIA, V3, P219, DOI 10.1007/BF00412109; Santana N, 2004, CEREB CORTEX, V14, P1100, DOI 10.1093/cercor/bhh070; Pozzi L, 2002, J NEUROCHEM, V82, P93, DOI 10.1046/j.1471-4159.2002.00947.x; Nichols DE, 2004, PHARMACOL THERAPEUT, V101, P131, DOI 10.1016/j.pharmthera.2003.11.002; Vollenweider FX, 1997, NEUROPSYCHOPHARMACOL, V16, P357, DOI 10.1016/S0893-133X(96)00246-1; Hasler F, 2002, J PHARMACEUT BIOMED, V30, P331, DOI 10.1016/S0731-7085(02)00278-9; Sard H, 2005, BIOORG MED CHEM LETT, V15, P4555, DOI 10.1016/j.bmcl.2005.06.104; Carter OL, 2007, PSYCHOPHARMACOLOGY, V195, P415, DOI 10.1007/s00213-007-0930-9; Grob CS, 2011, ARCH GEN PSYCHIAT, V68, P71, DOI 10.1001/archgenpsychiatry.2010.116; Alex KD, 2007, PHARMACOL THERAPEUT, V113, P296, DOI 10.1016/j.pharmthera.2006.08.004; Kapur S, 1996, AM J PSYCHIAT, V153, P466; Halberstadt AL, 2011, J PSYCHOPHARMACOL, V25, P1548, DOI 10.1177/0269881110388326; Wittmann M, 2007, J PSYCHOPHARMACOL, V21, P50, DOI 10.1177/0269881106065859; BENLOUCIF S, 1991, EUR J PHARMACOL, V200, P1, DOI 10.1016/0014-2999(91)90658-D; Franberg O, 2012, SYNAPSE, V66, P650, DOI 10.1002/syn.21551; Gouzoulis-Mayfrank E, 1998, BEHAV PHARMACOL, V9, P561, DOI 10.1097/00008877-199811000-00011; GUAN XM, 1989, BRAIN RES BULL, V23, P541, DOI 10.1016/0361-9230(89)90198-6; Hasler F, 1997, Pharm Acta Helv, V72, P175, DOI 10.1016/S0031-6865(97)00014-9; JOYCE JN, 1993, PSYCHOPHARMACOLOGY, V112, pS16, DOI 10.1007/BF02245004; PARSONS LH, 1993, J NEUROCHEM, V61, P1611, DOI 10.1111/j.1471-4159.1993.tb09794.x; Paxinos G., 1986, RAT BRAIN STEREOTAXI; POMPEIANO M, 1994, MOL BRAIN RES, V23, P163, DOI 10.1016/0169-328X(94)90223-2; Rojas-Corrales MO, 2007, PSYCHOPHARMACOLOGY, V190, P221, DOI 10.1007/s00213-006-0619-5; Vollenweider FX, 1999, NEUROPSYCHOPHARMACOL, V20, P424, DOI 10.1016/S0893-133X(98)00108-0; Winter JC, 2007, PHARMACOL BIOCHEM BE, V87, P472, DOI 10.1016/j.pbb.2007.06.003; Yamaguchi M, 2004, J HEALTH SCI, V50, P600, DOI 10.1248/jhs.50.600	34	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	JAN	2015	38	1					134	138				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX5FF	WOS:000346951500020		
J	Sakamoto, K; Mori, A; Nakahara, T; Morita, M; Ishii, K				Sakamoto, Kenji; Mori, Asami; Nakahara, Tsutomu; Morita, Masahiko; Ishii, Kunio			Effect of Long-Term Treatment of L-Ornithine on Visual Function and Retinal Histology in the Rats	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						L-ornithine; gyrate atrophy of the choroid and retina; retinal ganglion cell	AMINO-ACID-METABOLISM; 13-WEEK ORAL TOXICITY; NEURONAL CELL-DEATH; GYRATE ATROPHY; HEALTHY-VOLUNTEERS; NITRIC-OXIDE; MOUSE MODEL; HYPERORNITHINEMIA; DEGENERATION; ASPARTATE	L-Ornithine is a non-proteinogenic amino acid, abundant in freshwater clams and commercially available as an oral nutritional supplement. L-Ornithine is metabolized by ornithine-delta-aminotransferase. Deficiency of this enzyme causes gyrate atrophy of the choroid and retina, an autosomal recessive hereditary disease characterized by the triad of progressive chorioretinal degeneration, early cataract formation, and type II muscle fiber atrophy, with hyperornithinemia. However, it is unknown whether long-term L-ornithine supplementation affects visual function and retinal histology. The aim of the present study is to determine the effect of long-term supplementation of excess amounts of L-ornithine on visual function and retinal histology in rats. Male Brown Norway rats at six weeks of age were allowed free access to chow containing 4% (w/w) L-ornithine (the high ornithine diet) or that containing 4% (w/w) casein (the control diet) for 49 weeks. The dose of L-ornithine calculated from the food intake was approximately 0.8 g/d/animal, which was 100 times higher than the recommended dose for healthy humans. The amplitude of the a-wave of the scotopic rod-cone electroretinogram and the number of cells in the ganglion cell layer in the L-ornithine-treated group were larger than those in the control group 49 weeks after initiating the test diet. No functional or histological damage to the retina was seen up to 49 weeks after the start of the high-ornithine diet. The present study demonstrated that long-term supplementation of very high doses of L-ornithine for at least 49 weeks did not induce retinal damage.	[Sakamoto, Kenji; Mori, Asami; Nakahara, Tsutomu; Ishii, Kunio] Kitasato Univ, Sch Pharmaceut Sci, Dept Mol Pharmacol, Minato Ku, Tokyo 1088641, Japan; [Morita, Masahiko] Kyowa Hakko Bio Co Ltd, Healthcare Prod Dev Ctr, Tsukuba, Ibaraki 3050841, Japan	Sakamoto, K (reprint author), Kitasato Univ, Sch Pharmaceut Sci, Dept Mol Pharmacol, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.	sakamotok@pharm.kitasato-u.ac.jp			Kyowa Hakko Bio Co., Ltd.	Kunio Ishii received a research Grant from Kyowa Hakko Bio Co., Ltd. Masahiko Morita is an employee of Kyowa Hakko Bio Co., Ltd.	Sakamoto K, 2010, EUR J PHARMACOL, V635, P56, DOI 10.1016/j.ejphar.2010.03.001; Ando A, 2000, EXP EYE RES, V70, P89, DOI 10.1006/exer.1999.0750; Sakamoto K, 2009, EXP EYE RES, V88, P974, DOI 10.1016/j.exer.2008.12.011; Durante W, 2007, CLIN EXP PHARMACOL P, V34, P906, DOI 10.1111/j.1440-1681.2007.04638.x; Shi HP, 2002, J SURG RES, V106, P299, DOI 10.1006/jsre.2002.6471; Sakamoto K, 2009, HUM MOL GENET, V18, P178, DOI 10.1093/hmg/ddn327; SHIH VE, 1969, AM J DIS CHILD, V117, P83; Li H, 2001, AM J PHYSIOL-ENDOC M, V280, pE75; BUCCI L, 1990, NUTR RES, V10, P239, DOI 10.1016/S0271-5317(05)80265-9; Sakamoto K, 2011, J OCUL PHARMACOL TH, V27, P419, DOI 10.1089/jop.2010.0141; Sugino T, 2008, NUTR RES, V28, P738, DOI 10.1016/j.nutres.2008.08.008; Palmieri F, 2008, BBA-BIOENERGETICS, V1777, P564, DOI 10.1016/j.bbabio.2008.03.008; Moinard C, 2008, BRIT J NUTR, V99, P855, DOI 10.1017/S0007114507841110; Aoki M, 2010, JPN PHARMACOL THER, V38, P807; Berkowitz BA, 1998, INVEST OPHTH VIS SCI, V39, P391; DAUNEANGLARD G, 1993, PHARMACOL TOXICOL, V73, P29; Deutman A F, 1978, Int Ophthalmol, V1, P49, DOI 10.1007/BF00133277; El-Sayyad HIH, 2014, CLIN EXP OPHTHALMOL, V42, P169, DOI [10.1111/ceo.12123, 0.1111/ceo.12123]; EVAINBRION D, 1982, CLIN ENDOCRINOL, V17, P119, DOI 10.1111/j.1365-2265.1982.tb01571.x; Ha HC, 1998, P NATL ACAD SCI USA, V95, P11140, DOI 10.1073/pnas.95.19.11140; Hayasaka S, 2011, BRIT J NUTR, V106, P801, DOI 10.1017/S0007114511003291; Javadzadeh Alireza, 2007, J Med Case Rep, V1, P27, DOI 10.1186/1752-1947-1-27; KAISER-KUPFER M I, 1980, Science (Washington D C), V210, P1128, DOI 10.1126/science.7444439; KIYOSAWA I, 1995, EXP ANIM TOKYO, V43, P651; Kowalski P, 2006, J PHARMACEUT BIOMED, V41, P1061, DOI 10.1016/j.jpba.2006.01.049; KUWABARA T, 1981, OPHTHALMOLOGY, V88, P331; Masuko T, 1999, J PHARMACOL EXP THER, V290, P1026; MIZUNO K, 1981, Nippon Ganka Gakkai Zasshi, V85, P1864; Ohkubo Y, 2005, TOHOKU J EXP MED, V205, P335, DOI 10.1620/tjem.205.335; Sakamoto K, 2014, EXP EYE RES, V120, P90, DOI 10.1016/j.exer.2014.01.008; Sakamoto K, 2010, J PHARMACOL SCI, V112, P327, DOI 10.1254/jphs.09302FP; Torisu H, 2009, SHONIKA SHINRYO, V72, P352; Tsubuku S, 2004, INT J TOXICOL, V23, P101, DOI 10.1080/10915810490435622; Tsubuku S, 2004, INT J TOXICOL, V23, P107, DOI 10.1080/10915810490435677; VALLE D, 1980, J CLIN INVEST, V65, P371, DOI 10.1172/JCI109680; Wang T, 2000, P NATL ACAD SCI USA, V97, P1224, DOI 10.1073/pnas.97.3.1224; Wang T, 1996, J CLIN INVEST, V97, P2753, DOI 10.1172/JCI118730; Wren AF, 2002, J AGR FOOD CHEM, V50, P2180, DOI 10.1021/jf011066w	38	1	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	JAN	2015	38	1					139	143				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX5FF	WOS:000346951500021		
J	Nielsen, EJB; Kamei, N; Takeda-Morishita, M				Nielsen, Ebbe Juel Bech; Kamei, Noriyasu; Takeda-Morishita, Mariko			Safety of the Cell-Penetrating Peptide Penetratin as an Oral Absorption Enhancer	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						oral delivery; cell-penetrating peptide; absorption enhancer; penetratin; lipopolysaccharide; toxicity	DELIVERY; BIOAVAILABILITY; ENDOTOXINS	Novel delivery technology using cell-penetrating peptides (CPPs) have recently shown their potential and are emerging as promising candidates for an oral protein and peptide delivery systems. As with for the development of any absorption enhancer that is meant to function across an epithelial layer covering a surface highly exposed to pathogens such as the intestines, concern arises about the safety of such enhancers. The purpose of this study was to investigate the effect of 7d of consecutive oral administrations of CPPs and a typical enterotoxin, lipopolysaccharide (LPS) to mice to determine the degree, if any, of damage caused to the hepatic tissue. Following the 7-d dosing regimen, we could not detect significantly increased levels of the liver enzymes alanine aminotransferase and aspartate aminotransferase in plasma of mice treated with CPP and LPS compared to the controls, whereas heightened levels were observed in animals receiving the bile salt. In conclusion, the repeated use of CPPs as an oral absorption enhancer for macromolecules was found to be a safe strategy.	[Nielsen, Ebbe Juel Bech; Kamei, Noriyasu; Takeda-Morishita, Mariko] Kobe Gakuin Univ, Fac Pharmaceut Sci, Lab Drug Delivery Syst, Chuo Ku, Kobe, Hyogo 6508586, Japan; [Nielsen, Ebbe Juel Bech] Novo Nordisk AS, DK-2760 Malov, Denmark	Takeda-Morishita, M (reprint author), Kobe Gakuin Univ, Fac Pharmaceut Sci, Lab Drug Delivery Syst, Chuo Ku, 1-1-3 Minatojima, Kobe, Hyogo 6508586, Japan.	mmtakeda@pharm.kobegakuin.ac.jp			JSPS KAKENHI Grant [23590056]	This study was supported in part by JSPS KAKENHI Grant Number-23590056.	Akase T, 2011, EVID-BASED COMPL ALT, V2011; Khafagy ES, 2009, INT J PHARMACEUT, V381, P49, DOI 10.1016/j.ijpharm.2009.07.022; LEIST M, 1995, AM J PATHOL, V146, P1220; Nakajima T, 2009, MOL PHARMACOL, V75, P782, DOI 10.1124/mol.108.052928; Sonaje K, 2011, BIOMATERIALS, V32, P8712, DOI 10.1016/j.biomaterials.2011.07.086; Morishita M, 2012, ADV DRUG DELIVER REV, V64, P479, DOI 10.1016/j.addr.2012.02.008; Nielsen EJB, 2014, J CONTROL RELEASE, V189, P19, DOI 10.1016/j.jconrel.2014.06.022; Kamei N, 2013, J PHARM SCI-US, V102, P3998, DOI 10.1002/jps.23708; Maher S, 2009, ADV DRUG DELIVER REV, V61, P1427, DOI 10.1016/j.addr.2009.09.006; Renukuntla J, 2013, INT J PHARMACEUT, V447, P75, DOI 10.1016/j.ijpharm.2013.02.030; Rekha MR, 2013, INT J PHARMACEUT, V440, P48, DOI 10.1016/j.ijpharm.2012.03.056; Fujimoto M, 2012, EVID-BASED COMPL ALT, DOI 10.1155/2012/892697; Khafagy ES, 2013, EUR J PHARM BIOPHARM, V85, P736, DOI 10.1016/j.ejpb.2013.09.014; Morishita M, 2009, ORAL DELIVERY SYSTEM; NOLAN JP, 1989, HEPATOLOGY, V10, P887, DOI 10.1002/hep.1840100523	15	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	JAN	2015	38	1					144	146				3	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX5FF	WOS:000346951500022		
J	Namekata, I; Hamaguchi, S; Tanaka, H				Namekata, Iyuki; Hamaguchi, Shogo; Tanaka, Hikaru			Pharmacological Discrimination of Plasmalemmal and Mitochondrial Sodium-Calcium Exchanger in Cardiomyocyte-Derived H9c2 Cells	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						mitochondria; Na+-Ca+ exchanger; SEA0400; Ca2+ imaging	GUINEA-PIG MYOCARDIUM; NA+/CA2+ EXCHANGER; VENTRICULAR MYOCARDIUM; SELECTIVE INHIBITOR; HEART-MITOCHONDRIA; NA+-CA2+ EXCHANGER; NA/CA EXCHANGE; SEA0400; CA2+; REPERFUSION	We examined the effects of SEA0400 and CGP-37157 on the plasmalemmal Na+-Ca2+ exchanger (NCX) and mitochondrial NCX using H9c2 cardiomyocytes loaded with Ca2+-sensitive fluorescent probes. The plasmalemmal NCX activity, which was measured as the increase in cytoplasmic Ca2+ concentration after application of low Na+ extracellular solution, was inhibited by SEA0400 but not by CGP-37157. The mitochondrial NCX activity, which was measured in permeabilized H9c2 cells as the decrease in mitochondrial Ca2+ concentration after application of Ca2+-free extramitochondrial solution, was inhibited by CGP-37157 but not by SEA0400. These results indicate that SEA0400 and CGP-37157 act as selective inhibitors towards plasmalemmal and mitochondrial NCX, respectively, and provide pharmacological evidence that the plasmalemmal and mitochondrial NCX are distinct molecular entities.	[Namekata, Iyuki; Hamaguchi, Shogo; Tanaka, Hikaru] Toho Univ, Fac Pharmaceut Sci, Dept Pharmacol, Chiba 2748510, Japan	Namekata, I (reprint author), Toho Univ, Fac Pharmaceut Sci, Dept Pharmacol, Chiba 2748510, Japan.	iyuki@phar.toho-u.ac.jp					Gunter TE, 2000, CELL CALCIUM, V28, P285, DOI 10.1054/ceca.2000.0168; Omelchenko A, 2003, J PHARMACOL EXP THER, V306, P1050, DOI 10.1124/jpet.103.053389; Iwamoto T, 2004, J PHARMACOL SCI, V96, P27, DOI 10.1254/jphs.FMJ04002X6; Bers DM, 2010, METHOD CELL BIOL, V99, P1, DOI [10.1016/B978-0-12-374841-6.00001-3, 10.1016/S0091-679X(10)99001-8]; COX DA, 1993, J CARDIOVASC PHARM, V21, P595; Cai XJ, 2004, J BIOL CHEM, V279, P5867, DOI 10.1074/jbc.M310908200; Namekata I, 2006, EUR J PHARMACOL, V543, P108, DOI 10.1016/j.ejphar.2006.06.012; Saotome M, 2005, AM J PHYSIOL-HEART C, V288, pH1820, DOI 10.1152/ajpheart.00589.2004; Bernardi P, 1999, PHYSIOL REV, V79, P1127; Matsuda T, 2001, J PHARMACOL EXP THER, V298, P249; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Namekata I, 2009, J PHARMACOL SCI, V110, P111, DOI 10.1254/jphs.08159SC; Venetucci LA, 2007, ANN NY ACAD SCI, V1099, P315, DOI 10.1196/annals.1387.033; Castaldo P, 2009, PROG NEUROBIOL, V87, P58, DOI 10.1016/j.pneurobio.2008.09.017; Tanaka H, 2002, BRIT J PHARMACOL, V135, P1096, DOI 10.1038/sj.bjp.0704574; Bers DM, 2002, ANN NY ACAD SCI, V976, P500; CROMPTON M, 1978, EUR J BIOCHEM, V82, P25, DOI 10.1111/j.1432-1033.1978.tb11993.x; Kar P, 2009, ARCH BIOCHEM BIOPHYS, V482, P66, DOI 10.1016/j.abb.2008.11.024; Kim BJ, 2006, WORLD J GASTROENTERO, V12, P796; LI WH, 1992, J BIOL CHEM, V267, P17983; Namekata I, 2006, J PHARMACOL SCI, V101, P356, DOI 10.1254/jphs.SCJ06002X; Namekata I, 2005, LIFE SCI, V77, P312, DOI 10.1016/j.lfs.2004.10.065; Namekata I, 2008, N-S ARCH PHARMACOL, V376, P385, DOI 10.1007/s00210-007-0228-9; Smets I, 2004, AM J PHYSIOL-RENAL, V286, pF784, DOI 10.1152/ajprenal.00284.2003; Takahashi K, 2003, EUR J PHARMACOL, V458, P155, DOI 10.1016/S0014-2999(02)02732-2; Tanaka H, 2007, J PHARMACOL SCI, V103, P241, DOI 10.1254/jphs.FP0060911; Tanaka H, 2004, J PHARMACOL SCI, V96, P499, DOI 10.1254/jphs.RCJ04001X	27	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	JAN	2015	38	1					147	150				4	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX5FF	WOS:000346951500023		
J	Andoh, T; Kitamura, R; Kuraishi, Y				Andoh, Tsugunobu; Kitamura, Ryo; Kuraishi, Yasushi			Milnacipran Inhibits Oxaliplatin-Induced Mechanical Allodynia through Spinal Action in Mice	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						milnacipran; oxaliplatin; allodynia; intrathecal injection; spinal cord	LOCUS-COERULEUS NEURONS; NEUROPATHIC PAIN; IN-VIVO; NEUROTOXICITY; RATS; HYPERSENSITIVITY; ANTIDEPRESSANTS; AMITRIPTYLINE; VENLAFAXINE; PREVENTION	We investigated whether milnacipran, a serotonin noradrenaline reuptake inhibitor, would have therapeutic effect on oxaliplatin-induced mechanical allodynia in mice. A single intraperitoneal injection of oxaliplatin (3 mg/kg) induced mechanical allodynia, which peaked on day 10 after injection and almost completely subsided by day 20. Ten days post-oxaliplatin injection, the intraperitoneal administration of milnacipran (3-30 mg/kg) significantly and dose-dependently inhibited the established mechanical allodynia. Intrathecal injections of milnacipran (2.1-21 mu g/site) also significantly and dose-dependently inhibited mechanical allodynia, but intracisternal and intracereboventricular injections at the same doses did not. The present results suggest that milnacipran is effective against oxaliplatin-induced mechanical allodynia and that the antiallodynic effect is mainly mediated by actions on the spinal cord.	[Andoh, Tsugunobu; Kitamura, Ryo; Kuraishi, Yasushi] Grad Sch Med & Pharmaceut Sci, Dept Appl Pharmacol, Toyama 9300194, Japan	Kuraishi, Y (reprint author), Grad Sch Med & Pharmaceut Sci, Dept Appl Pharmacol, 2630 Sugitani, Toyama 9300194, Japan.	kuraisiy@pha.u-toyama.ac.jp			Joint Usage/Research Center (Joint Usage/Research Center for Science-Based Natural Medicine), Institute of Natural Medicine, University of Toyama; Takeda Science Foundation	This research was supported by a Grant-in-Aid for the Cooperative Research Project from Joint Usage/Research Center (Joint Usage/Research Center for Science-Based Natural Medicine), Institute of Natural Medicine, University of Toyama in 2011 and Takeda Science Foundation 2009.	King T, 2006, J PAIN, V7, P513, DOI 10.1016/j.jpain.2006.02.001; Durand JP, 2012, ANN ONCOL, V23, P200, DOI 10.1093/annonc/mdr045; Yang YH, 2012, SUPPORT CARE CANCER, V20, P1491, DOI 10.1007/s00520-011-1237-2; Yoshimura M, 2006, J PHARMACOL SCI, V101, P107, DOI 10.1254/jphys.CRJ06008X; Katsuyama S, 2013, BIOMED RES-TOKYO, V34, P105; Kautio AL, 2009, ANTICANCER RES, V29, P2601; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; Park SB, 2013, CA-CANCER J CLIN, V63, P419, DOI 10.3322/caac.21204; Pasetto LM, 2006, CRIT REV ONCOL HEMAT, V59, P159, DOI 10.1016/j.critrevonc.2006.01.001; Vaishnavi SN, 2004, BIOL PSYCHIAT, V55, P320, DOI 10.1016/j.biopysch.2003.09.006; Zhao M, 2014, J PHARMACOL SCI, V124, P514, DOI 10.1254/jphs.13249SC; Alba-Delgado C, 2012, PAIN, V153, P1438, DOI 10.1016/j.pain.2012.03.034; Gauchan P, 2009, J PHARMACOL SCI, V109, P469, DOI 10.1254/jphs.08325SC; Bruzos-Cidon C, 2014, EUR NEUROPSYCHOPHARM, V24, P1112, DOI 10.1016/j.euroneuro.2014.02.007; Sakurai M, 2009, PAIN, V147, P165, DOI 10.1016/j.pain.2009.09.003; Quasthoff S, 2002, J NEUROL, V249, P9, DOI 10.1007/PL00007853; Berrocoso E, 2007, J PHARMACOL EXP THER, V322, P101, DOI 10.1124/jpet.107.120915; Kitamura R., 2013, Journal of Traditional Medicines, V30, P183; Mateo Y, 2000, NEUROPHARMACOLOGY, V39, P2036, DOI 10.1016/S0028-3908(00)00041-1; MORET C, 1985, NEUROPHARMACOLOGY, V24, P1211, DOI 10.1016/0028-3908(85)90157-1; Obata H, 2010, J PHARMACOL EXP THER, V334, P1059, DOI 10.1124/jpet.110.168336; Sada H, 2012, J PHARMACOL SCI, V118, P547, DOI 10.1254/jphs.12006SC; Saif M Wasif, 2005, Ther Clin Risk Manag, V1, P249; Suzuki T, 2008, ANESTH ANALG, V106, P1309, DOI 10.1213/ane.0b013e318167889a; Takasaki I, 2001, J PHARMACOL EXP THER, V296, P270; TIBIRICA E, 1991, J PHARMACOL EXP THER, V256, P606	26	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	JAN	2015	38	1					151	154				4	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX5FF	WOS:000346951500024		
J	Higo, M; Isobe, K; Kondo, T; Yamaguchi, M; Takeyama, S; Drijber, RA; Torigoe, Y				Higo, Masao; Isobe, Katsunori; Kondo, Takuya; Yamaguchi, Moe; Takeyama, Saki; Drijber, Rhae A.; Torigoe, Yoichi			Temporal variation of the molecular diversity of arbuscular mycorrhizal communities in three different winter cover crop rotational systems	BIOLOGY AND FERTILITY OF SOILS			English	Article						Arbuscular mycorrhizal fungi; Community structure; Crop rotation; Cover crop; Temporal variation	FUNGI COLONIZING ROOTS; AGRICULTURAL MANAGEMENT; SOIL AGGREGATION; VITIS-VINIFERA; NONHOST PLANTS; BIODIVERSITY; MAIZE; COLONIZATION; TILLAGE; GROWTH	A clear understanding of the significance of arbuscular mycorrhizal fungi (AMF) to phosphorus (P) nutrition in intensively managed cover crop rotational systems with soybean [Glycine max (L.) Merr.] will impact how we currently manage these systems, particularly crop rotation decisions. We investigated the impact of wheat (Triticum aestivum L.), rapeseed (Brassica napus L.), or fallow on composition of AMF communities in soil over 2 years of a consecutive soybean rotational system. The composition of AMF communities was characterized on the basis of the large subunit (LSU) ribosomal DNA (rDNA). AMF spore abundance in soil after cultivation of wheat was higher than that after rapeseed or fallow for the all sampling years. Phylogenetic analysis identified 19 AMF phylotypes, including five Glomus; three Gigaspora; two of Acaulospora, Funneliformis, and Rhizophagus; one of Racocetra, Claroideoglomus, Diversispora, and Sclerocystis; and an unknown glomeromycete in soil. Dominant phylotypes of Glomerales occurred widely across the winter cover crop rotations. However, the phylotype richness and diversity of AMF communities were unchanged among crop rotations and years. Redundancy analysis (RDA) demonstrated that AMF communities within a crop rotation were not significantly different. However, when analyzed over a 2-year period, the composition of AMF communities was clearly influenced by year where the distribution of specific AMF phylotypes responded to the winter cover crop management. Thus, diversity of AMF communities in soil was clearly shifted by rotation year, which indicated that other abiotic environmental factors may impact composition AMF communities more than winter cover crop rotational systems.	[Higo, Masao; Isobe, Katsunori; Kondo, Takuya; Yamaguchi, Moe; Takeyama, Saki; Torigoe, Yoichi] Nihon Univ, Coll Bioresource Sci, Fujisawa, Kanagawa 2520880, Japan; [Drijber, Rhae A.] Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68583 USA	Higo, M (reprint author), Nihon Univ, Coll Bioresource Sci, 1866 Kameino, Fujisawa, Kanagawa 2520880, Japan.	higo.masao@nihon-u.ac.jp					Alguacil MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034887; Schweiger PF, 1999, AGRON J, V91, P998; Duhamel M, 2013, TRENDS PLANT SCI, V18, P597, DOI 10.1016/j.tplants.2013.08.010; Douds DD, 1999, AGR ECOSYST ENVIRON, V74, P77, DOI 10.1016/S0167-8809(99)00031-6; Lekberg Y, 2005, NEW PHYTOL, V168, P189, DOI 10.1111/j.1469-8137.2005.01490.x; Ryan MH, 2012, AGR ECOSYST ENVIRON, V163, P37, DOI 10.1016/j.agee.2012.03.011; Singh PK, 2013, PROTOPLASMA, V250, P663, DOI 10.1007/s00709-012-0453-z; Rasmussen PE, 1998, SOIL TILL RES, V47, P197, DOI 10.1016/S0167-1987(98)00106-8; Kabir Z, 2000, AGR ECOSYST ENVIRON, V78, P167, DOI 10.1016/S0167-8809(99)00121-8; Sarwar M, 1998, PLANT SOIL, V201, P103, DOI 10.1023/A:1004381129991; Trouvelot S, 1999, MYCORRHIZA, V8, P203, DOI 10.1007/s005720050235; Daniell TJ, 2001, FEMS MICROBIOL ECOL, V36, P203, DOI 10.1016/S0168-6496(01)00134-9; CAMPBELL CA, 1991, SOIL BIOL BIOCHEM, V23, P443, DOI 10.1016/0038-0717(91)90007-7; Opik M, 2013, MYCORRHIZA, V23, P411, DOI 10.1007/s00572-013-0482-2; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Higo M, 2014, BIOL FERT SOILS, V50, P913, DOI 10.1007/s00374-014-0912-0; ANGUS JF, 1994, PLANT SOIL, V162, P107, DOI 10.1007/BF01416095; Torrecillas E, 2012, APPL ENVIRON MICROB, V78, P6180, DOI 10.1128/AEM.01287-12; Wang MY, 2009, PEDOSPHERE, V19, P663; Holland TC, 2014, BIOL FERT SOILS, V50, P667, DOI 10.1007/s00374-013-0887-2; Renker C, 2006, MYCORRHIZA, V16, P525, DOI 10.1007/s00572-006-0067-4; Sikes BA, 2009, J ECOL, V97, P1274, DOI 10.1111/j.1365-2745.2009.01557.x; Rosendahl S, 2008, NEW PHYTOL, V178, P253, DOI 10.1111/j.1469-8137.2008.02378.x; Schreiner RP, 2009, MYCOLOGIA, V101, P599, DOI 10.3852/08-169; Alguacil MM, 2011, SOIL BIOL BIOCHEM, V43, P167, DOI 10.1016/j.soilbio.2010.09.029; BIERMANN B, 1983, NEW PHYTOL, V95, P97, DOI 10.1111/j.1469-8137.1983.tb03472.x; Karasawa T, 2012, PLANT SOIL, V353, P355, DOI 10.1007/s11104-011-1036-z; Altieri MA, 1999, AGR ECOSYST ENVIRON, V74, P19, DOI 10.1016/S0167-8809(99)00028-6; Lumini E, 2010, ENVIRON MICROBIOL, V12, P2165, DOI 10.1111/j.1462-2920.2009.02099.x; Alguacil MD, 2010, SOIL BIOL BIOCHEM, V42, P1114, DOI 10.1016/j.soilbio.2010.03.012; Brown PD, 1997, ADV AGRON, V61, P167, DOI 10.1016/S0065-2113(08)60664-1; Njeru EM, 2014, AGRON SUSTAIN DEV, V34, P841, DOI 10.1007/s13593-013-0197-y; Jansa J, 2008, NEW PHYTOL, V177, P779, DOI 10.1111/j.1469-8137.2007.02294.x; Broeckling CD, 2008, APPL ENVIRON MICROB, V74, P738, DOI 10.1128/AEM.02188-07; Chaparro JM, 2012, BIOL FERT SOILS, V48, P489, DOI 10.1007/s00374-012-0691-4; Van Tuinen D, 1998, MOL ECOL, V7, P879, DOI 10.1046/j.1365-294x.1998.00410.x; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Lekberg Y, 2012, J ECOL, V100, P151, DOI 10.1111/j.1365-2745.2011.01894.x; Ryan MH, 2002, PLANT SOIL, V244, P263, DOI 10.1023/A:1020207631893; Vetrovsky T, 2013, BIOL FERT SOILS, V49, P1027, DOI 10.1007/s00374-013-0801-y; Jansa J, 2003, ECOL APPL, V13, P1164, DOI 10.1890/1051-0761(2003)13[1164:STATCS]2.0.CO;2; Balestrini R, 2010, ENV MICROBIOL REP, V2, P594, DOI 10.1111/j.1758-2229.2010.00160.x; Lekberg Y, 2008, BIOL FERT SOILS, V44, P917, DOI 10.1007/s00374-008-0274-6; Buyer JS, 2010, SOIL BIOL BIOCHEM, V42, P831, DOI 10.1016/j.soilbio.2010.01.020; Liu Y, 2009, FEMS MICROBIOL ECOL, V67, P81, DOI 10.1111/j.1574-6941.2008.00597.x; Oehl F, 2003, APPL ENVIRON MICROB, V69, P2816, DOI 10.1128/AEM.69.5.2816-2824.2003; Toljander JF, 2008, FEMS MICROBIOL ECOL, V65, P323, DOI 10.1111/j.1574-6941.2008.00512.x; Jansa J, 2002, MYCORRHIZA, V12, P225, DOI [10.1007/s005572-002-0163-z, 10.1007/s00572-002-0163-z]; Gollotte A, 2004, MYCORRHIZA, V14, P111, DOI 10.1007/s00572-003-0244-7; Hijri I, 2006, MOL ECOL, V15, P2277, DOI 10.1111/j.1365-294X.2006.02921.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Borriello R, 2012, BIOL FERT SOILS, V48, P911, DOI 10.1007/s00374-012-0683-4; Brundrett M, 1996, ACIAR MONOGR, V32; Clark A., 2007, SUSTAINABLE AGR NETW, V9; DOUDS DD, 1995, AGR ECOSYST ENVIRON, V52, P111, DOI 10.1016/0167-8809(94)00550-X; Douds DD, 2004, SOIL BIOL FERTILITY, P129, DOI 10.1007/978-1-4020-6619-1_7; Gosling P, 2006, AGR ECOSYST ENVIRON, V113, P117; Hartmann A, 2008, PLANT SOIL, V321, P235, DOI DOI 10.1007/S11104-008-9814-Y; Higo M, 2011, ANN MICROBIOL, V61, P383, DOI 10.1007/s13213-010-0142-0; Higo M, 2013, BIOL FERT SOILS, V49, P1085, DOI 10.1007/s00374-013-0807-5; Higo M, 2010, PLANT PROD SCI, V13, P74, DOI 10.1626/pps.13.74; Isobe K, 2014, PLANT PROD SCI, V17, P260, DOI 10.1626/pps.17.260; Isobe K, 1999, JPN J CROP SCI, V68, P118; Karasawa T, 2002, SOIL BIOL BIOCHEM, V34, P851, DOI 10.1016/S0038-0717(02)00017-2; Karpouzas DG, 2014, ECOL INDIC, V39, P44, DOI 10.1016/j.ecolind.2013.12.004; Lehman RM, 2012, APPL SOIL ECOL, V61, P300, DOI 10.1016/j.apsoil.2011.11.008; Mader P, 2002, SCIENCE, V296, P1694, DOI 10.1126/science.1071148; Mathimaran N, 2007, AGR ECOSYST ENVIRON, V119, P22, DOI 10.1016/j.agee.2006.06.004; Michalson EL, 1999, CONSERVATION FARMING, P1; MILLER RM, 1992, MYCORRHIZAS IN ECOSYSTEMS, P171; Ministry of Agriculture Forestry and Fisheries, 2012, STAT REP AGR FOR FIS; Oehl Fritz, 2011, IMA Fungus, V2, P191, DOI 10.5598/imafungus.2011.02.02.10; Oka N, 2010, SOIL SCI PLANT NUTR, V56, P824, DOI 10.1111/j.1747-0765.2010.00518.x; Piotrowski JS, 2004, NEW PHYTOL, V164, P365, DOI 10.1111/j.1469-8137.2004.01181.x; Rosa E. A. S., 1997, Horticultural Reviews, V19, P99; Ryan Megan H., 2008, P189, DOI 10.1007/978-1-4020-9316-6_10; Ryder MH, 2008, J AM WATER RESOUR AS, V44, P640, DOI 10.1111/j.1752-1688.2008.00189.x; Sasvari Z, 2011, BIOL FERT SOILS, V47, P167, DOI 10.1007/s00374-010-0519-z; SCHREINER RP, 1993, NEW PHYTOL, V123, P107; Smilauer P., 2002, CANOCO REFERENCE MAN; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P1; Uchida Toinoko, 2011, Japanese Journal of Crop Science, V80, DOI 10.1626/jcs.80.277; Vandenkoornhuyse P, 2003, MOL ECOL, V12, P3085, DOI 10.1046/j.1365-294X.2003.01967.x; Vandenkoornhuyse P, 2002, MOL ECOL, V11, P1555, DOI 10.1046/j.1365-294X.2002.01538.x; VIERHEILIG H, 1995, SOIL BIOL BIOCHEM, V27, P1113, DOI 10.1016/0038-0717(95)00021-6; VIERHEILIG H, 1990, SYMBIOSIS, V9, P199; Yasumoto S, 2012, PLANT PROD SCI, V14, P339	87	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0178-2762	1432-0789		BIOL FERT SOILS	Biol. Fertil. Soils	JAN	2015	51	1					21	32		10.1007/s00374-014-0945-4		12	Soil Science	Agriculture	AX8GU	WOS:000347148900003		
J	Tanaka, N; Ota, H; Fukumori, K; Miyake, J; Yamato, M; Okano, T				Tanaka, Nobuyuki; Ota, Hiroki; Fukumori, Kazuhiro; Miyake, Jun; Yamato, Masayuki; Okano, Teruo			Micro-patterned cell-sheets fabricated with stamping-force-controlled micro-contact printing (vol 35, pg 9802, 2014)	BIOMATERIALS			English	Correction									[Tanaka, Nobuyuki; Ota, Hiroki; Fukumori, Kazuhiro; Yamato, Masayuki; Okano, Teruo] Tokyo Womens Med Univ, TWIns, Inst Adv Biomed Engn & Sci, Shinjuku Ku, Tokyo 1628666, Japan; [Tanaka, Nobuyuki; Miyake, Jun] Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan	Okano, T (reprint author), Tokyo Womens Med Univ, TWIns, Inst Adv Biomed Engn & Sci, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	tokano@twmu.ac.jp					Tanaka N, 2014, BIOMATERIALS, V35, P9802, DOI 10.1016/j.biomaterials.2014.08.043	1	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	JAN	2015	38						109	109		10.1016/j.biomaterials.2014.10.071		1	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	AY0GU	WOS:000347276300012		
J	Kudou, M; Okazaki, F; Asai-Nakashima, N; Ogino, C; Kondo, A				Kudou, Motonori; Okazaki, Fumiyoshi; Asai-Nakashima, Nanami; Ogino, Chiaki; Kondo, Akihiko			Expression of cold-adapted beta-1,3-xylanase as a fusion protein with a ProS2 tag and purification using immobilized metal affinity chromatography with a high concentration of ArgHCl	BIOTECHNOLOGY LETTERS			English	Article						Arginine hydrochloride; Immobilized metal affinity chromatography; Protein S from Myxococcus xanthus; Psychroflexus torquis; Psychrophile; Solubility-enhancing fusion tag; beta-1; 3-Xylanase	ESCHERICHIA-COLI; MYXOCOCCUS-XANTHUS; ARGININE; ELUTION	Cold-adapted beta-1,3-xylanase (P.t.Xyn26A) from the psychrotrophic bacterium, Psychroflexus torquis, was expressed as a fusion protein with tandem repeats of the N-terminal domain of Protein S from Myxocuccus xanthus (ProS2) in Escherichia coli. After cell lysis in phosphate buffer, most of the ProS2-P.t.Xyn26A was located in the insoluble fraction and aggregated during purification. Arginine hydrochloride (ArgHCl) efficiently solubilized the ProS2-P.t.Xyn26A. The solubilized ProS2-P.t.Xyn26A was purified using immobilized metal affinity chromatography (IMAC) with 500 mM ArgHCl. After cleavage of ProS2-P.t.Xyn26A by human rhinovirus 3C protease, we confirmed that recombinant P.t.Xyn26A maintained its native fold. This is the first report of the expression of a cold-adapted enzyme fused with a ProS2 tag under IMAC purification using a high concentration of ArgHCl. These insights into the expression and purification should be useful during the handling of cold-adapted enzymes.	[Kudou, Motonori; Okazaki, Fumiyoshi; Asai-Nakashima, Nanami] Kobe Univ, Org Adv Sci & Technol, Nada Ku, Kobe, Hyogo 6578501, Japan; [Ogino, Chiaki; Kondo, Akihiko] Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Nada Ku, Kobe, Hyogo 6578501, Japan	Kondo, A (reprint author), Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Nada Ku, 1-1 Rokkodaicho, Kobe, Hyogo 6578501, Japan.	akondo@kobe-u.ac.jp			MEXT, Japan	This work was supported by Special Coordination Funds for Promoting Science and Technology, Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovative Bioproduction Kobe), MEXT, Japan.	Arakawa T, 2004, PROTEIN EXPRES PURIF, V36, P244, DOI 10.1016/j.pep.2004.04.009; Bowman JP, 1998, MICROBIOL-UK, V144, P1601; Russell NJ, 2000, EXTREMOPHILES, V4, P83, DOI 10.1007/s007920050141; Qing GL, 2004, NAT BIOTECHNOL, V22, P877, DOI 10.1038/nbt984; Abe R, 2009, BIOCHEM BIOPH RES CO, V381, P306, DOI 10.1016/j.bbrc.2009.01.054; Tsumoto K, 2007, J CHROMATOGR A, V1154, P81, DOI 10.1016/j.chroma.2007.02.061; DAVAIL S, 1994, J BIOL CHEM, V269, P17448; Block H, 2009, METHOD ENZYMOL, V463, P439, DOI 10.1016/S0076-6879(09)63027-5; Cheung RCF, 2012, APPL MICROBIOL BIOT, V96, P1411, DOI 10.1007/s00253-012-4507-0; Kobayashi H, 2009, APPL ENVIRON MICROB, V75, P5356, DOI 10.1128/AEM.00691-09; BOWDEN GA, 1991, BIO-TECHNOL, V9, P725, DOI 10.1038/nbt0891-725; Ejima D, 2005, J CHROMATOGR A, V1094, P49, DOI 10.1016/j.chroma.2005.07.086; Esposito D, 2006, CURR OPIN BIOTECH, V17, P353, DOI 10.1016/j.copbio.2006.06.003; INOUYE M, 1979, P NATL ACAD SCI USA, V76, P209, DOI 10.1073/pnas.76.1.209; Jonsdottir G, 2004, PROTEIN EXPRES PURIF, V33, P110, DOI 10.1016/j.pep.2003.09.012	15	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0141-5492	1573-6776		BIOTECHNOL LETT	Biotechnol. Lett.	JAN	2015	37	1					89	94		10.1007/s10529-014-1666-3		6	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	AX6JK	WOS:000347028400010		
J	Funabashi, H; Yanagi, S; Suzuki, S; Mie, M; Kobatake, E				Funabashi, Hisakage; Yanagi, Satoshi; Suzuki, Shigeya; Mie, Masayasu; Kobatake, Eiry			Assembly of zinc finger motif-fused enzymes on a dsDNA scaffold for catalyzing consecutive reactions with a proximity effect	BIOTECHNOLOGY LETTERS			English	Article						DNA scaffolds; Enzyme assembly; Firefly luciferase; Proximity effect; Pyruvate phosphate dikinase; Zinc finger motifs	DNA SCAFFOLDS; NANOSTRUCTURES; LUCIFERASE; COMPLEXES; CASCADES; PROTEIN	The feasibility of assembling enzymes, catalyzing consecutive reactions, on to a double-stranded DNA (dsDNA) scaffold utilizing zinc finger motifs is described. The catalytic activities of two zinc finger motif-fused enzymes catalyzing a bioluminescence reaction with energy recycling, namely pyruvate phosphate dikinase and firefly luciferase, have been evaluated. Bioluminescence measurements with dsDNA scaffolds coding a different distance between the binding sites for each zinc finger motif-fused enzyme confirmed the effect of the distance, proving the proximity effect of ATP recycling presumed to be the result of efficient intermediate diffusion. Thus, fusion to zinc finger motifs offers a promising option for the assembly of bi-enzymes, catalyzing a consecutive reaction, onto a dsDNA scaffold with a proximity effect.	[Funabashi, Hisakage; Yanagi, Satoshi; Mie, Masayasu; Kobatake, Eiry] Tokyo Inst Technol, Dept Biol Informat, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Suzuki, Shigeya] Kikkoman Food Prod Co, Dept Biochem, Noda, Chiba 2780037, Japan	Kobatake, E (reprint author), Tokyo Inst Technol, Dept Environm Chem & Engn, Grad Sch Interdisciplinary Sci & Engn, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.	hisafuna@hiroshima-u.ac.jp; syanagi@bio.titech.ac.jp; shsuzuki@mail.kikkoman.co.jp; mie.m.aa@m.titech.ac.jp; kobatake.e.aa@m.titech.ac.jp	Mie, Masayasu/C-5995-2015	Mie, Masayasu/0000-0003-2255-3346			Fu JL, 2012, ACCOUNTS CHEM RES, V45, P1215, DOI 10.1021/ar200295q; Wilner OI, 2009, NANO LETT, V9, P2040, DOI 10.1021/nl900302z; Negi S, 2008, CHEM-EUR J, V14, P3236, DOI 10.1002/chem.200701320; Niemeyer CM, 2010, ANGEW CHEM INT EDIT, V49, P1200, DOI 10.1002/anie.200904930; Muller J, 2008, BIOCHEM BIOPH RES CO, V377, P62, DOI 10.1016/j.bbrc.2008.09.078; Ooi AT, 2006, BIOCHEMISTRY-US, V45, P3620, DOI 10.1021/bi0517032; Wilner OI, 2009, NAT NANOTECHNOL, V4, P249, DOI [10.1038/nnano.2009.50, 10.1038/NNANO.2009.50]; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Fu JL, 2012, J AM CHEM SOC, V134, P5516, DOI 10.1021/ja300897h; Blancafort P, 2004, MOL PHARMACOL, V66, P1361, DOI 10.1124/mol.104.002758.; Beerli RR, 2002, NAT BIOTECHNOL, V20, P135, DOI 10.1038/nbt0202-135; Niemeyer CM, 2002, CHEMBIOCHEM, V3, P242, DOI 10.1002/1439-7633(20020301)3:2/3<242::AID-CBIC242>3.0.CO;2-F; Ebihara T, 2002, BIOTECHNOL LETT, V24, P147, DOI 10.1023/A:1013858814175; Eisaki N, 1999, BBA-PROTEIN STRUCT M, V1431, P363, DOI 10.1016/S0167-4838(99)00057-6	14	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0141-5492	1573-6776		BIOTECHNOL LETT	Biotechnol. Lett.	JAN	2015	37	1					109	114		10.1007/s10529-014-1644-9		6	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	AX6JK	WOS:000347028400013		
J	Sumigama, S				Sumigama, S.			Surgical techniques at caesarean might modify placenta accreta risk Reply	BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY			English	Editorial Material							ANASTOMOSIS; SUTURES		Nagoya Univ, Grad Sch Med, Dept Obstet & Gynecol, Nagoya, Aichi 4648601, Japan	Sumigama, S (reprint author), Nagoya Univ, Grad Sch Med, Dept Obstet & Gynecol, Nagoya, Aichi 4648601, Japan.						Baguneid MS, 2001, J VASC SURG, V33, P812, DOI 10.1067/mva.2001.112806; Coelho GR, 2008, TRANSPL P, V40, P3545, DOI 10.1016/j.transproceed.2008.06.066; Gupta H, 2008, ASIAN J SURG, V31, P104, DOI 10.1016/S1015-9584(08)60069-X; Sumigama S, 2014, BJOG-INT J OBSTET GY, V121, P866, DOI 10.1111/1471-0528.12717	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1470-0328	1471-0528		BJOG-INT J OBSTET GY	BJOG	JAN	2015	122	1					144	144		10.1111/1471-0528.13203		1	Obstetrics & Gynecology	Obstetrics & Gynecology	AX4QB	WOS:000346915500029		
J	Gondo, T; Poon, BY; Matsumoto, K; Bernstein, M; Sjoberg, DD; Eastham, JA				Gondo, Tatsuo; Poon, Bing Ying; Matsumoto, Kazuhiro; Bernstein, Melanie; Sjoberg, Daniel D.; Eastham, James A.			Clinical role of pathological downgrading after radical prostatectomy in patients with biopsy confirmed Gleason score 3+4 prostate cancer	BJU INTERNATIONAL			English	Article						prostate; prostatic neoplasms; prostatectomy; downgrading; active surveillance; decision curve analysis	ACTIVE SURVEILLANCE; LOW-RISK; GRADING SYSTEM; INTERMEDIATE; EXPERIENCE; SPECIMENS; OUTCOMES; MEN	Objective To identify preoperative factors predicting Gleason score downgrading after radical prostatectomy (RP) in patients with biopsy Gleason score 3+4 prostate cancer and to determine if prediction of downgrading can identify potential candidates for active surveillance (AS). Patients and Methods We identified 1317 patients with biopsy Gleason score 3+4 prostate cancers who underwent RP at the Memorial Sloan-Kettering Cancer Center between 2005 and 2013. Several preoperative and biopsy characteristics were evaluated by forward selection regression, and selected predictors of downgrading were analysed by multivariable logistic regression. Decision curve analysis was used to evaluate the clinical utility of the multivariate model. Results Gleason score was downgraded after RP in 115 patients (9%). We developed a multivariable model using age, prostate-specific antigen density, percentage of positive cores with Gleason pattern 4 cancer out of all cores taken, and maximum percentage of cancer involvement within a positive core with Gleason pattern 4 cancer. The area under the curve for this model was 0.75 after 10-fold cross validation. However, decision curve analysis revealed that the model was not clinically helpful in identifying patients who will downgrade at RP for the purpose of reassigning them to AS. Conclusion While patients with pathological Gleason score 3 + 3 with tertiary Gleason pattern <= 4 at RP in patients with biopsy Gleason score 3 + 4 prostate cancer may be potential candidates for AS, decision curve analysis showed limited utility of our model to identify such men. Future study is needed to identify new predictors to help identify potential candidates for AS among patients with biopsy confirmed Gleason score 3 + 4 prostate cancer.	[Gondo, Tatsuo; Matsumoto, Kazuhiro; Bernstein, Melanie; Eastham, James A.] Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, New York, NY 10065 USA; [Poon, Bing Ying; Sjoberg, Daniel D.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Gondo, Tatsuo] Tokyo Med Univ, Dept Urol, Tokyo 1608402, Japan	Eastham, JA (reprint author), Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, 1275 York Ave, New York, NY 10065 USA.	easthamj@mskcc.org			Sidney Kimmel Center for Prostate and Urologic Cancers; National Institutes of Health (NIH)/National Cancer Institute (NCI) Cancer Center Support Grant [P30 CA008748]	Supported by the Sidney Kimmel Center for Prostate and Urologic Cancers, and supported in part by a National Institutes of Health (NIH)/National Cancer Institute (NCI) Cancer Center Support Grant to the Memorial Sloan-Kettering Cancer Center (award number P30 CA008748).	Adam M, 2014, J UROLOGY, V192, P97, DOI 10.1016/j.juro.2014.01.029; Bjurlin MA, 2013, J UROLOGY, V189, P2039, DOI 10.1016/j.juro.2013.02.072; Klotz L, 2013, CURR OPIN ENDOCRINOL, V20, P204, DOI 10.1097/MED.0b013e328360332a; Ross AE, 2011, PROSTATE, V71, P1568, DOI 10.1002/pros.21373; Vargas HA, 2012, RADIOLOGY, V265, P478, DOI 10.1148/radiol.12120041; Helpap B, 2006, VIRCHOWS ARCH, V449, P622, DOI 10.1007/s00428-006-0310-6; Tosoian JJ, 2011, J CLIN ONCOL, V29, P2185, DOI 10.1200/JCO.2010.32.8112; Freedland SJ, 2007, UROLOGY, V69, P495, DOI 10.1016/j.urology.2006.10.036; Cooperberg MR, 2011, J CLIN ONCOL, V29, P228, DOI 10.1200/JCO.2010.31.4252; Welch HG, 2009, J NATL CANCER I, V101, P1325, DOI 10.1093/jnci/djp278; Tosoian JJ, 2013, J UROLOGY, V190, P1218, DOI 10.1016/j.juro.2013.04.071; Ross HM, 2012, AM J SURG PATHOL, V36, P1346, DOI 10.1097/PAS.0b013e3182556dcd; Epstein JI, 2012, EUR UROL, V61, P1019, DOI 10.1016/j.eururo.2012.01.050; Bul M, 2012, BJU INT, V110, P1672, DOI 10.1111/j.1464-410X.2012.11434.x; Zlotta AR, 2013, JNCI-J NATL CANCER I, V105, P1050, DOI 10.1093/jnci/djt151; Ploussard G, 2011, EUR UROL, V60, P291, DOI 10.1016/j.eururo.2011.05.006; Moussa AS, 2009, BJU INT, V103, P43, DOI 10.1111/j.1464-410X.2008.08059.x; Van der Kwast TH, 2013, NAT REV UROL, V10, P473, DOI 10.1038/nrurol.2013.112; Mullins JK, 2012, J UROLOGY, V188, P2219, DOI 10.1016/j.juro.2012.08.028; Cohen MS, 2008, EUR UROL, V54, P371, DOI 10.1016/j.eururo.2008.03.049; Klotz L, 2013, CURR OPIN UROL, V23, P239, DOI 10.1097/MOU.0b013e32835f8f6b; Donohue JF, 2006, J UROLOGY, V176, P991, DOI 10.1016/j.juro.2006.04.048; Eggener SE, 2013, J UROLOGY, V189, pS19, DOI 10.1016/j.juro.2012.11.023; Ellis CL, 2013, BJU INT, V111, pE306, DOI 10.1111/j.1464-410X.2012.11680.x; Whitson JM, 2013, UROL ONCOL-SEMIN ORI, V31, P442, DOI 10.1016/j.urolonc.2011.02.010	25	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1464-4096	1464-410X		BJU INT	BJU Int.	JAN	2015	115	1					81	86		10.1111/bju.12769		6	Urology & Nephrology	Urology & Nephrology	AX0OK	WOS:000346651400017		
J	Lin, LS; Horigome, H; Kato, Y; Kikuchi, T; Nakahara, S; Sumazaki, R				Lin, Lisheng; Horigome, Hitoshi; Kato, Yoshiaki; Kikuchi, Toshihiro; Nakahara, Satoko; Sumazaki, Ryo			Significant associations between hemostatic/fibrinolytic systems and accumulation of cardiovascular risk factors in Japanese elementary schoolchildren	BLOOD COAGULATION & FIBRINOLYSIS			English	Article						cardiovascular risk factor; fibrinolysis; hemostasis; metabolic syndrome; obesity; pediatric	PLASMINOGEN-ACTIVATOR INHIBITOR-1; C-REACTIVE PROTEIN; METABOLIC SYNDROME; OBESE CHILDREN; PREDICTION; FIBRINOGEN; DISEASE; STATE; INTERVENTION; METAANALYSIS	The aim of this study was to establish the reference values of hemostatic/fibrinolytic markers and investigate their relationship with physical constitution and cardiovascular risk factors in a normal schoolchildren population. This study comprised 148 healthy Japanese children aged 9-10 years (males 73; females 75). We performed laboratory tests including blood levels of leptin, high-sensitive C-reactive protein (hs-CRP), hemostatic and fibrinolytic markers [plasminogen activator inhibitor 1 (PAI-1), coagulation factor VII (FVII), coagulation factor X (FX), fibrinogen (Fbg), protein C, protein S], as well as common biochemical markers in the morning after an overnight fast. We investigated the mean, 10th, 50th and 90th percentile values of these markers. All parameters were compared between two groups, that is those with body mass index (BMI) 90th percentile or higher and BMI less than 90th percentile, and between subgroups based on the number of cardiovascular risk factors. Multiple-linear regression was used to assess associations between these hematological parameters and the components related to metabolic syndrome (MetS). Alanine aminotransferase (ALT), uric acid, leptin, hs-CRP, and all hemostatic/fibrinolytic markers (PAI-1, FVII, FX, Fbg, protein C, protein S) tested were significantly higher in the group with BMI 90th percentile or higher, and increased with accumulation of cardiovascular risk factors. Multiple-linear regression analysis showed that these values were associated with one or more components related to MetS. Reference values of hemostatic/fibrinolytic markers in Japanese schoolchildren were obtained. Many hemostatic/fibrinolytic markers showed significant association with BMI and accumulation of cardiovascular risk factors in normal Japanese schoolchildren. (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.	[Lin, Lisheng; Horigome, Hitoshi; Kato, Yoshiaki; Sumazaki, Ryo] Univ Tsukuba, Dept Child Hlth, Grad Sch Comprehens Human Sci, Ibaraki, Japan; [Kikuchi, Toshihiro] Kensei Gen Hosp, Dept Phys Therapy, Ibaraki, Japan; [Nakahara, Satoko] Kensei Gen Hosp, Dept Pediat, Ibaraki, Japan	Lin, LS (reprint author), Univ Tsukuba, Dept Child Hlth, Grad Sch Comprehens Human Sci, 1-1-1 Tenodai, Tsukuba, Ibaraki 3058575, Japan.	lishenglin5433@gmail.com			Japanese Ministry of Health, Labor and Welfare	The authors would like to thank Dr Enbo Ma for statistical advice, and Brian K. Purdue for native-speaker revision. The first draft of the manuscript was written by Lisheng Lin. This study was conducted at the University of Tsukuba. Grants or financial support for this work: this study was supported in part by a grant-in-aid from the Japanese Ministry of Health, Labor and Welfare.	Balagopal P, 2011, CIRCULATION, V123, P2749, DOI 10.1161/CIR.0b013e31821c7c64; Yoshinaga M, 2008, CIRC J, V72, P1874, DOI 10.1253/circj.CJ-08-0180; Danesh J, 2005, JAMA-J AM MED ASSOC, V294, P1799, DOI 10.1001/jama.294.14.1799; Fritsch P, 2010, ATHEROSCLEROSIS, V212, P650, DOI 10.1016/j.atherosclerosis.2010.06.028; De Pergola G, 2002, J ENDOCRINOL INVEST, V25, P899; Vendrell J, 2004, OBES RES, V12, P962, DOI 10.1038/oby.2004.118; Balagopal P, 2005, J PEDIATR-US, V146, P342, DOI 10.1016/j.jpeds.2004.11.033; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Wang JY, 2012, J PEDIATR-US, V161, P753, DOI 10.1016/j.jpeds.2012.03.036; Meyer AA, 2006, PEDIATRICS, V117, P1560, DOI 10.1542/peds.2005-2140; Wallace AM, 2001, CIRCULATION, V104, P3052, DOI 10.1161/hc5001.101061; Ford ES, 2005, DIABETES CARE, V28, P878, DOI 10.2337/diacare.28.4.878; Sola E, 2009, THROMB RES, V123, P697, DOI 10.1016/j.thromres.2008.07.017; Rutter MK, 2004, CIRCULATION, V110, P380, DOI 10.1161/01.CIR.0000136581.59584.0E; Koskinen J, 2009, CIRCULATION, V120, P229, DOI 10.1161/CIRCULATIONAHA.108.845065; Wannamethee SG, 2005, ARCH INTERN MED, V165, P2644, DOI 10.1001/archinte.165.22.2644; Monagle P, 2006, THROMB HAEMOSTASIS, V95, P362, DOI 10.1160/TH05-01-0047; Singh A, 2012, BRIT J HAEMATOL, V158, P523, DOI 10.1111/j.1365-2141.2012.09160.x; Balagopal P, 2008, J THROMB HAEMOST, V6, P1296, DOI 10.1111/j.1538-7836.2008.03037.x; CUCUIANU M, 1993, NOUV REV FR HEMATOL, V35, P481; Deguchi H, 2001, BLOOD, V97, P1907, DOI 10.1182/blood.V97.7.1907; Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents National Heart Lung and Blood Institute, 2011, PEDIATRICS S5, V128, pS213, DOI DOI 10.1542/PEDS.2009-2107C; Feiq DI, 2008, NEW ENGL J MED, V359, P1811; Ferguson MA, 1999, AM J CLIN NUTR, V69, P1130; Horigome H, 2012, CLIN APPL THROMB-HEM, V18, P189, DOI 10.1177/1076029611418962; Kohyama-Koganeya A, 2011, J LIPID RES, V52, P1392, DOI 10.1194/jlr.M014266; Mertens I, 2002, Obes Rev, V3, P85, DOI 10.1046/j.1467-789X.2002.00056.x; Ministry of Education Culture Sports Science and Technology, 2008, ANN REP SCH HLTH SUR; Ohzeki Takehiko, 2011, Nihon Rinsho, V69 Suppl 1, P745; Scheer FAJL, 2014, BLOOD, V123, P590, DOI 10.1182/blood-2013-07-517060; Semeraro F, 2012, THROMB HAEMOSTASIS, V108, P311, DOI 10.1160/TH11-12-0864; Siklar Z, 2001, CLIN APPL THROMB-HEM, V17, P585; Sosothikul D, 2007, J PEDIAT HEMATOL ONC, V29, P19, DOI 10.1097/MPH.0b013e3180308749	33	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0957-5235	1473-5733		BLOOD COAGUL FIBRIN	Blood Coagul. Fibrinolysis	JAN	2015	26	1					75	80		10.1097/MBC.0000000000000187		6	Hematology	Hematology	AX6JB	WOS:000347027500012		
J	Tsumaki, N; Okada, M; Yamashita, A				Tsumaki, Noriyuki; Okada, Minoru; Yamashita, Akihiro			iPS cell technologies and cartilage regeneration	BONE			English	Article						iPS cells; Cartilage regeneration; Direct reprogramming; Disease modeling	PLURIPOTENT STEM-CELLS; MESENCHYMAL PROGENITOR CELLS; HUMAN ARTICULAR CHONDROCYTES; IN-VITRO CHONDROGENESIS; II COLLAGEN EXPRESSION; DEFINED FACTORS; SOMATIC-CELLS; DIRECTED DIFFERENTIATION; TISSUE REGENERATION; MONOLAYER-CULTURE	Articular cartilage covers the ends of bone and provides shock absorption and lubrication to the diarthrodial joints. Cartilage has a limited capacity for repair when injured, and there is a need for cell sources for chondrocytes that can be transplanted as part of a regenerative medicine approach. Induced pluripotent stem cells (iPSCs) have pluripotency and the potential for self-renewal similar to embryonic stem cells (ESCs), but are not associated with the ethical issues that have plagued ESCs. Recent progress has made it possible to generate integration-free iPSCs and to differentiate iPSCs toward chondrocytes. An iPSC library prepared from donors homozygous for common HLA types is being developed, and will be able to provide allogeneic iPSC-derived chondrocytes at low cost that can cover the majority of the population. As an. alternative approach, chondrocytic cells can be induced directly from dermal fibroblasts without going through the iPSC stage. Another important application of the iPSC technology is modeling cartilage diseases, such as skeletal dysplasia. Chondrogenically differentiated iPSCs generated from patients would recapitulate the pathology, and may serve as a useful platform both for exploring the disease mechanisms and for drug screening. This article is part of a Special Issue entitled "Stem Cells and Bone". (C) 2014 Elsevier Inc. All rights reserved.	[Tsumaki, Noriyuki; Okada, Minoru; Yamashita, Akihiro] Kyoto Univ, Ctr IPS Cell Res & Applicat, Dept Cell Growth & Differentiat, Cell Induct & Regulat Field, Kyoto 6068507, Japan; [Tsumaki, Noriyuki] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	Tsumaki, N (reprint author), Kyoto Univ, Ctr IPS Cell Res & Applicat, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan.	ntsumaki@cira.kyoto-u.ac.jp					Adkisson HD, 2010, STEM CELL RES, V4, P57, DOI 10.1016/j.scr.2009.09.004; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Gourraud PA, 2012, STEM CELLS, V30, P180, DOI 10.1002/stem.772; Oldershaw RA, 2012, INT J EXP PATHOL, V93, P389, DOI 10.1111/j.1365-2613.2012.00837.x; Ikeda T, 2004, ARTHRITIS RHEUM, V50, P3561, DOI 10.1002/art.20611; Bigdeli N, 2009, STEM CELLS, V27, P1812, DOI 10.1002/stem.114; Craft AM, 2013, DEVELOPMENT, V140, P2597, DOI 10.1242/dev.087890; Koyama N, 2013, STEM CELLS DEV, V22, P102, DOI 10.1089/scd.2012.0127; Huh YH, 2007, J BIOL CHEM, V282, P17123, DOI 10.1074/jbc.M700599200; Hiramatsu K, 2011, J CLIN INVEST, V121, P640, DOI 10.1172/JCI44605; Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Okita K, 2013, STEM CELLS, V31, P458, DOI 10.1002/stem.1293; Toh WS, 2010, BIOMATERIALS, V31, P6968, DOI 10.1016/j.biomaterials.2010.05.064; Quarto N, 2012, STEM CELLS, V30, P2709, DOI 10.1002/stem.1250; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Ko JY, 2014, BIOMATERIALS, V35, P3571, DOI 10.1016/j.biomaterials.2014.01.009; Roberts S, 2009, KNEE, V16, P398, DOI 10.1016/j.knee.2009.02.004; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Kobayashi T, 2010, CELL, V142, P787, DOI 10.1016/j.cell.2010.07.039; Aigner T, 2010, OSTEOARTHR CARTILAGE, V18, pS2, DOI 10.1016/j.joca.2010.07.013; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Koay EJ, 2007, STEM CELLS, V25, P2183, DOI 10.1634/stemcells.2007-0105; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/nmeth.1591, 10.1038/NMETH.1591]; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Mithoefer K, 2009, AM J SPORT MED, V37, P2053, DOI 10.1177/0363546508328414; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1172482; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Jia FJ, 2010, NAT METHODS, V7, P197, DOI [10.1038/nmeth.1426, 10.1038/NMETH.1426]; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Nakagawa T, 2009, ARTHRITIS RHEUM-US, V60, P3686, DOI 10.1002/art.27229; Zhou WB, 2009, STEM CELLS, V27, P2667, DOI 10.1002/stem.201; Sudo K, 2007, STEM CELLS, V25, P1610, DOI 10.1634/stemcells.2006-0504; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0; Marlovits S, 2004, J BONE JOINT SURG BR, V86B, P286, DOI 10.1302/0301-620X.86B2.14918; Warman ML, 2011, AM J MED GENET A, V155A, P943, DOI 10.1002/ajmg.a.33909; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Hwang NS, 2008, P NATL ACAD SCI USA, V105, P20641, DOI 10.1073/pnas.0809680106; Medvedev SP, 2011, STEM CELLS DEV, V20, P1099, DOI 10.1089/scd.2010.0249; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Turner M, 2013, CELL STEM CELL, V13, P382, DOI 10.1016/j.stem.2013.08.003; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Ladewig J, 2013, NAT REV MOL CELL BIO, V14, P225, DOI 10.1038/nrm3543; BENYA PD, 1978, CELL, V15, P1313, DOI 10.1016/0092-8674(78)90056-9; Bai HY, 2010, J BIOMED MATER RES A, V94A, P539, DOI 10.1002/jbm.a.32732; Barberi T, 2005, PLOS MED, V2, P554, DOI 10.1371/journal.pmed.0020161; CHESTERMAN P J, 1968, Journal of Bone and Joint Surgery British Volume, V50B, P184; Egawa N., 2012, SCI TRANSL MED, V4; Fortier LA, 2012, J KNEE SURG, V25, P3, DOI 10.1055/s-0032-1310389; Haenebalcke L, 2013, CELL REP, V3, P335, DOI 10.1016/j.celrep.2013.01.016; Hwang NS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002498; Ishii R, 2012, MOL BIOL CELL, V23, P3511, DOI 10.1091/mbc.E11-10-0869; LAYMAN DL, 1972, EXP CELL RES, V73, P107, DOI 10.1016/0014-4827(72)90107-3; Lee J, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4470; Matsumoto E, 2012, BIOCHEM BIOPH RES CO, V420, P124, DOI 10.1016/j.bbrc.2012.02.127; Matsumoto Y, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-190; Minegishi Y, 2013, OSTEOARTHR CARTILAGE, V21, P1968, DOI 10.1016/j.joca.2013.09.004; Oldershaw RA, 2010, NAT BIOTECHNOL, V28, P1221, DOI 10.1038/nbt.1683; Outani H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077365; Outani H, 2011, BIOCHEM BIOPH RES CO, V411, P607, DOI 10.1016/j.bbrc.2011.06.194; Park S, 2013, TISSUE ENG PART B RE; Poumasr B, 2011, STEM CELLS, V29, P1933; Quarto N, 2012, P NATL ACAD SCI USA, V109, P215, DOI 10.1073/pnas.1113442109; Sun N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003552; Tay FC, 2013, J GENE MED, V15, P384, DOI 10.1002/jgm.2745; Umeda K, 2012, SCI REP-UK, V2, DOI 10.1038/srep00455; Vats A, 2006, TISSUE ENG, V12, P1687, DOI 10.1089/ten.2006.12.1687; Zhang Y, 2012, BIOMATERIALS, V33, P7394, DOI 10.1016/j.biomaterials.2012.06.070	79	4	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	8756-3282	1873-2763		BONE	Bone	JAN	2015	70				SI		48	54		10.1016/j.bone.2014.07.011		7	Endocrinology & Metabolism	Endocrinology & Metabolism	AX4HX	WOS:000346895100007		
J	Takahashi, S; Okada, N; Nobuchi, T				Takahashi, Sayaka; Okada, Naoki; Nobuchi, Tadashi			Relationship between vessel porosity and leaf emergence pattern in ring- and diffuse-porous deciduous trees in a temperate hardwood forest	BOTANY			English	Article						vessel diameter; leaf phenology; vessel arrangement; seasonal change; functional ecology	EARLYWOOD VESSELS; CAMBIAL ACTIVITY; WOODY-PLANTS; REACTIVATION; AMERICANA; PHENOLOGY; SEEDLINGS; MOVEMENT; STEMS; TIMES	To elucidate the functional relationship between intra-annual variations in vessel diameter and leaf emergence pattern of ring-porous and diffuse-porous deciduous trees in temperate forests, we determined the temporal relationships between leaf phenology and vessel formation. Cylindrical stem cores were periodically collected from each of five ring-and diffuse-porous species, and the leaf and vessel formation were observed simultaneously. In the ring-porous species, vessel formation began within 2 weeks of leaf appearance, and most wide vessels were formed within 2 weeks of full leaf expansion. More of the trees with intermediate-type formed medium-sized vessels or sparse wide vessels than trees with the flush-type leaf emergence, especially between full leaf expansion and the end of shoot elongation. Narrow vessel formation began 2-8 weeks after full leaf expansion in all specimens. The transition between the pore-and non-pore zones was abrupt in the flush-type species, and gradual in the intermediate-type species. In contrast, diffuse-porous species formed vessels 0-8 weeks after full leaf expansion. Our findings suggest that ring-porous species form leaves and vessels synchronously to accommodate water-transport requirements, whereas diffuse-porous species form these tissues asynchronously; thus, unlike the latter type, the former species change vessel diameters according to leaf formation.	[Takahashi, Sayaka; Okada, Naoki; Nobuchi, Tadashi] Kyoto Univ, Grad Sch Agr, Div Forest & Biomat Sci, Sakyo Ku, Kyoto 6068502, Japan	Takahashi, S (reprint author), Kyoto Univ, Grad Sch Agr, Div Forest & Biomat Sci, Sakyo Ku, Oiwake Cho Kitashirakawa, Kyoto 6068502, Japan.	sayakane@kais.kyoto-u.ac.jp					Fonti P, 2007, NEW PHYTOL, V173, P562, DOI 10.1111/j.1469-8137.2006.01945.x; Begum S, 2013, PHYSIOL PLANTARUM, V147, P46, DOI 10.1111/j.1399-3054.2012.01663.x; Utsumi Y, 1998, PLANT PHYSIOL, V117, P1463, DOI 10.1104/pp.117.4.1463; Suzuki M, 1996, IAWA J, V17, P431; Utsumi Y, 1999, PLANT PHYSIOL, V121, P897, DOI 10.1104/pp.121.3.897; KIKUZAWA K, 1983, CAN J BOT, V61, P2133; ZASADA JC, 1969, CAN J BOTANY, V47, P1965; Sass-Klaassen U, 2011, DENDROCHRONOLOGIA, V29, P171, DOI 10.1016/j.dendro.2011.01.002; CHANEY WR, 1977, ANN BOT-LONDON, V41, P1093; ATKINSON CJ, 1988, ANN BOT-LONDON, V61, P679; Panchen ZA, 2014, NEW PHYTOL, V203, P1208, DOI 10.1111/nph.12892; Umebayashi T, 2008, IAWA J, V29, P247; Takahashi S, 2013, ECOL RES, V28, P615, DOI 10.1007/s11284-013-1053-x; Carlquist S., 2001, COMP WOOD ANATOMY SY; Denne M. P., 1976, Wood structure in biological and technological research (Leiden Botanical Series No. 3)., P204; DIGBY J, 1966, ANN BOT-LONDON, V30, P607; ELLMORE GS, 1986, AM J BOT, V73, P1771, DOI 10.2307/2444244; EWERS FW, 1989, AM J BOT, V76, P1452, DOI 10.2307/2444432; Forest Research Station of Graduate School of Agriculture Kyoto University, 2002, MET OBS KYOT U NO 13; Fukushima K., 2003, SECONDARY XYLEM FORM, P33; GREENIDGE KNH, 1955, AM J BOT, V42, P582, DOI 10.2307/2485315; Hayashi S., 1991, WOOD RES I KYOTO U, V23, P1; Hayashi Y., 1987, ILLUSTRATED TREES CO; Imagawa H., 1972, Research Bulletins of the College Experiment Forests, Hokkaido University, V29, P55; Inoue S., 2002, FORESTS TREES KYUSHU; Itoh T., 1995, ANATOMICAL DESCRIP 1, VI, P81; Itoh T., 1997, ANATOMICAL DESCRIP 3, VIII, P83; Kudo K, 2014, ANN BOT-LONDON, V113, P1021, DOI 10.1093/aob/mcu026; Ladefoged K., 1952, DET KON DANSKE VIDEN, V7, P1; LECHOWICZ MJ, 1984, AM NAT, V124, P821, DOI 10.1086/284319; Lodewick J.E., 1928, B NY STATE COLL FORE, V23, P1; Meyer F.G., 1984, FLORA JAPAN; Miyazawa Y, 2004, TREE PHYSIOL, V24, P631; Sass J.E., 1951, BOT MICROTECHNIQUE, P69; Suzuki M., 2000, PHENOLOGICAL ANAL WO, V2000, P132; Takahashi S., 2008, FOR RES KYOTO, V77, P123; Tyree MT, 2002, XYLEM STRUCTURE ASCE; Wakuta R., 1973, B KYOTO U FOR, V45, P204; Wheeler E. A., 1989, IAWA B, V10, P219, DOI DOI 10.1163/22941932-90000496; WOODCOCK D W, 1989, Aliso, V12, P287; Yagi T, 2004, CAN J BOT, V82, P228, DOI [10.1139/B03-124, 10.1139/b03-124]	41	1	1	CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	1916-2790	1916-2804		BOTANY	Botany	JAN	2015	93	1					31	39		10.1139/cjb-2014-0129		9	Plant Sciences	Plant Sciences	AY0PP	WOS:000347299200004		
J	Mukai, H; Noguchi, S; Akiyama, F; Inaji, H; Iwase, H; Horiguchi, J; Kurebayashi, J; Hirata, K; Toi, M; Kurosumi, M; Kohno, N; Nishimura, R; Nakamura, S; Imoto, S; Iwase, T; Endo, T; Saeki, T; Ogawa, Y; Ito, Y; Tokuda, Y; Ikeda, T				Mukai, Hirofumi; Noguchi, Shinzaburo; Akiyama, Futoshi; Inaji, Hideo; Iwase, Hirotaka; Horiguchi, Jun; Kurebayashi, Junichi; Hirata, Koichi; Toi, Masakazu; Kurosumi, Masafumi; Kohno, Norio; Nishimura, Reiki; Nakamura, Seigo; Imoto, Shigeru; Iwase, Takuji; Endo, Tokiko; Saeki, Toshiaki; Ogawa, Yasuhiro; Ito, Yoshinori; Tokuda, Yutaka; Ikeda, Tadashi			2013 clinical practice guidelines (The Japanese Breast Cancer Society): history, policy and mission	BREAST CANCER			English	Editorial Material									[Mukai, Hirofumi] Natl Canc Ctr Hosp East, Div Breast & Med Oncol, Kashiwa, Chiba, Japan; [Noguchi, Shinzaburo] Osaka Univ, Grad Sch Med, Dept Breast & Endocrine Surg, Osaka, Japan; [Akiyama, Futoshi] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Pathol, Tokyo, Japan; [Inaji, Hideo] Kaizuka City Hosp, Dept Breast Surg, Osaka, Japan; [Iwase, Hirotaka] Kumamoto Univ, Grad Sch Med Sci, Dept Breast & Endocrine Surg, Kumamoto, Japan; [Horiguchi, Jun] Gunma Univ, Grad Sch Med, Dept Thorac & Visceral Organ Surg, Maebashi, Gumma 371, Japan; [Kurebayashi, Junichi] Kawasaki Med Univ, Dept Breast & Thyroid Surg, Okayama, Japan; [Hirata, Koichi] Sapporo Med Univ, Sch Med, Dept Surg Surg Oncol & Sci, Sapporo, Hokkaido, Japan; [Toi, Masakazu] Kyoto Univ, Grad Sch Med, Dept Surg Breast Surg, Kyoto, Japan; [Kurosumi, Masafumi] Saitama Canc Ctr, Dept Pathol, Saitama, Japan; [Kohno, Norio] Tokyo Med Univ Hosp, Dept Breast Oncol, Tokyo, Japan; [Nishimura, Reiki] Kumamoto City Hosp, Dept Breast & Endocrine Surg, Kumamoto, Japan; [Nakamura, Seigo] Showa Univ, Sch Med, Dept Surg, Div Breast Surg Oncol, Tokyo 142, Japan; [Imoto, Shigeru] Kyorin Univ, Sch Med, Dept Breast Surg, Tokyo, Japan; [Iwase, Takuji] Japanese Fdn Canc Res, Canc Inst Hosp, Breast Oncol Ctr, Dept Breast Surg Oncol, Tokyo, Japan; [Endo, Tokiko] Nagoya Med Ctr, Dept Radiol, Nagoya, Aichi, Japan; [Saeki, Toshiaki] Saitama Med Sch, Int Med Ctr, Dept Breast Oncol, Saitama, Japan; [Ogawa, Yasuhiro] Kochi Med Sch, Dept Radiol, Kochi, Japan; [Ito, Yoshinori] Japanese Fdn Canc Res, Canc Inst Hosp, Breast Oncol Ctr, Tokyo, Japan; [Tokuda, Yutaka] Tokai Univ, Sch Med, Dept Breast & Endocrine Surg, Hiratsuka, Kanagawa 25912, Japan; [Ikeda, Tadashi] Teikyo Univ, Sch Med, Dept Surg, Tokyo 173, Japan	Mukai, H (reprint author), Natl Canc Ctr Hosp East, Div Breast & Med Oncol, 6-5-1 Kashiwanoha, Kashiwa, Chiba, Japan.	hrmukai@east.ncc.go.jp						0	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	JAN	2015	22	1					1	4		10.1007/s12282-014-0550-2		4	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AX8GA	WOS:000347146900001		
J	Mukai, H; Aihara, T; Yamamoto, Y; Takahashi, M; Toyama, T; Sagara, Y; Yamaguchi, H; Akabane, H; Tsurutani, J; Hara, F; Fujisawa, T; Yamamoto, N; Ohsumi, S				Mukai, Hirofumi; Aihara, Tomohiko; Yamamoto, Yutaka; Takahashi, Masato; Toyama, Tatsuya; Sagara, Yasuaki; Yamaguchi, Hiroshi; Akabane, Hiromitsu; Tsurutani, Junji; Hara, Fumikata; Fujisawa, Tomomi; Yamamoto, Naohito; Ohsumi, Shozo			The Japanese Breast Cancer Society Clinical Practice Guideline for systemic treatment of breast cancer	BREAST CANCER			English	Editorial Material							POSTOPERATIVE ADJUVANT THERAPY; RANDOMIZED CONTROLLED-TRIAL; NATIONAL SURGICAL ADJUVANT; CYP2D6 GENOTYPE; TAMOXIFEN; WOMEN; CHEMOTHERAPY; TEGAFUR; URACIL; CYCLOPHOSPHAMIDE		[Mukai, Hirofumi] Natl Canc Ctr Hosp East, Div Breast & Med Oncol, Kashiwa, Chiba, Japan; [Aihara, Tomohiko] Aihara Hosp, Breast Ctr, Osaka, Japan; [Yamamoto, Yutaka] Kumamoto Univ Hosp, Innovat Ctr Translat Res, Dept Mol Targeting Therapy Breast Canc, Kumamoto, Japan; [Takahashi, Masato] Hokkaido Canc Ctr, Dept Breast Surg, Sapporo, Hokkaido, Japan; [Toyama, Tatsuya] Nagoya City Univ Hosp, Dept Breast & Endocrine Surg, Nagoya, Aichi, Japan; [Sagara, Yasuaki] Sagara Hosp, Dept Breast Ctr, Kagoshima, Japan; [Yamaguchi, Hiroshi] Saiseikai Fukuoka Gen Hosp, Dept Breast Surg, Fukuoka, Japan; [Akabane, Hiromitsu] Asahikawa Kosei Gen Hosp, Dept Breast Surg, Asahikawa, Hokkaido, Japan; [Tsurutani, Junji] Kinki Univ, Fac Med, Dept Med Oncol, Osaka, Japan; [Hara, Fumikata; Ohsumi, Shozo] Natl Hosp Org, Shikoku Canc Ctr, Dept Breast Oncol, Shikoku, Ehime, Japan; [Fujisawa, Tomomi] Gunma Prefectural Canc Ctr, Dept Breast Oncol, Ota, Gunma, Japan; [Yamamoto, Naohito] Chiba Canc Ctr, Div Breast Surg, Chiba 2608717, Japan	Mukai, H (reprint author), Natl Canc Ctr Hosp East, Div Breast & Med Oncol, 6-5-1 Kashiwanoha, Kashiwa, Chiba, Japan.	hrmukai@east.ncc.go.jp					Cardoso F, 2012, BREAST, V21, P242, DOI 10.1016/j.breast.2012.03.003; Rae JM, 2012, JNCI-J NATL CANCER I, V104, P452, DOI 10.1093/jnci/djs126; Fisher B, 1999, LANCET, V353, P1993, DOI 10.1016/S0140-6736(99)05036-9; Dezentje VO, 2013, BREAST CANCER RES TR, V140, P363, DOI 10.1007/s10549-013-2619-6; Kiyotani K, 2010, J CLIN ONCOL, V28, P1287, DOI 10.1200/JCO.2009.25.7246; Fossati R, 1998, J CLIN ONCOL, V16, P3439; Sledge GW, 2003, J CLIN ONCOL, V21, P588, DOI 10.1200/JCO.2003.08.013; Regan MM, 2012, J NATL CANCER I, V104, P441, DOI 10.1093/jnci/djs125; Jin Y, 2005, J NATL CANCER I, V97, P30, DOI 10.1093/jnci/dji005; Muss HB, 2009, NEW ENGL J MED, V360, P2055, DOI 10.1056/NEJMoa0810266; Watanabe T, 2009, J CLIN ONCOL, V27, P1368, DOI 10.1200/JCO.2008.18.3939; Lim HS, 2007, J CLIN ONCOL, V25, P3837, DOI 10.1200/JCO.2007.11.4850; Goetz MP, 2005, J CLIN ONCOL, V23, P9312, DOI 10.1200/JCO.2005.03.3266; O'Shaughnessy JA, 2012, ONCOLOGIST, V17, P476, DOI 10.1634/theoncologist.2011-0281; Ghersi D, 2005, BRIT J CANCER, V93, P293, DOI 10.1038/sj.bjc.6602680; George WD, 2003, LANCET, V362, P95; Noguchi S, 2005, J CLIN ONCOL, V23, P2172, DOI 10.1200/JCO.2005.02.158; Ohashi Y, 2009, BREAST CANC RES TREA, V119, P633; Park Y, 2009, BRIT J CANCER, V101, P598, DOI 10.1038/sj.bjc.6605218; Staley H, 2012, COCHRANE DB SYST REV, V10	20	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	JAN	2015	22	1					5	15		10.1007/s12282-014-0563-x		11	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AX8GA	WOS:000347146900002		
J	Taira, N; Arai, M; Ikeda, M; Iwasaki, M; Okamura, H; Takamatsu, K; Yamamoto, S; Ohsumi, S; Mukai, H				Taira, Naruto; Arai, Masami; Ikeda, Masahiko; Iwasaki, Motoki; Okamura, Hitoshi; Takamatsu, Kiyoshi; Yamamoto, Seiichiro; Ohsumi, Shozo; Mukai, Hirofumi			The Japanese Breast Cancer Society clinical practice guideline for epidemiology and prevention of breast cancer	BREAST CANCER			English	Editorial Material							BRCA2 MUTATION CARRIERS; BODY-MASS INDEX; HORMONE REPLACEMENT THERAPY; ATOMIC-BOMB SURVIVORS; POSTMENOPAUSAL WOMEN; REPRODUCTIVE FACTORS; COLLABORATIVE REANALYSIS; OVARIAN CYSTS; MEDICAL CONDITIONS; PHYSICAL-ACTIVITY		[Taira, Naruto] Okayama Univ Hosp, Dept Breast & Endocrine Surg, Okayama 7008558, Japan; [Arai, Masami] Japanese Fdn Canc Res, Canc Inst Hosp, Clin Lab Genet Diag, Tokyo, Japan; [Ikeda, Masahiko] Fukuyama City Hosp, Dept Breast & Thyroid Surg, Hiroshima, Japan; [Iwasaki, Motoki] Natl Canc Ctr, Res Inst, Res Ctr Canc Prevent & Screening, Epidemiol & Prevent Div, Tokyo 104, Japan; [Okamura, Hitoshi] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Psychosocial Rehabil, Hiroshima, Japan; [Takamatsu, Kiyoshi] Ichikawa Gen Hosp, Tokyo Dent Coll, Dept Obstet & Gynecol, Ichikawa, Chiba, Japan; [Yamamoto, Seiichiro] Natl Canc Ctr, Res Inst, Res Ctr Canc Prevent & Screening, Publ Hlth Policy Res Div, Tokyo 104, Japan; [Ohsumi, Shozo] Natl Hosp Org, Shikoku Canc Ctr, Dept Breast Oncol, Matsuyama, Ehime, Japan; [Mukai, Hirofumi] Natl Canc Ctr Hosp East, Div Breast & Med Oncol, Kashiwa, Chiba, Japan	Ohsumi, S (reprint author), Natl Hosp Org, Shikoku Canc Ctr, Dept Breast Oncol, Matsuyama, Ehime, Japan.	ntaira@md.okayama-u.ac.jp; sosumi@shikoku-cc.go.jp					Holmes MD, 2007, INT J CANCER, V120, P2672, DOI 10.1002/ijc.22575; Pfeiler G, 2011, J CLIN ONCOL, V29, P2653, DOI 10.1200/JCO.2010.33.2585; Pronk A, 2010, AM J EPIDEMIOL, V171, P953, DOI 10.1093/aje/kwq029; Dong JY, 2011, BREAST CANCER RES TR, V125, P315, DOI 10.1007/s10549-010-1270-8; Domchek SM, 2010, JAMA-J AM MED ASSOC, V304, P967, DOI 10.1001/jama.2010.1237; KELSEY JL, 1993, EPIDEMIOL REV, V15, P36; Protani M, 2010, BREAST CANCER RES TR, V123, P627, DOI 10.1007/s10549-010-0990-0; Xue F, 2007, LANCET ONCOL, V8, P1088, DOI 10.1016/S1470-2045(07)70377-7; Nelson HD, 2012, ANN INTERN MED, V156, P635, DOI [10.7326/0003-4819-156-9-201205010-00006, 10.1059/0003-4819-156-9-201205010-00006]; Barrett-Connor E, 2006, NEW ENGL J MED, V355, P125, DOI 10.1056/NEJMoa062462; Hermsen BBJ, 2007, BRIT J CANCER, V96, P1335, DOI 10.1038/sj.bjc.6603725; Suzuki S, 2008, CANCER EPIDEM BIOMAR, V17, P3396, DOI 10.1158/1055-9965.EPI-08-0497; White KK, 2012, INT J CANCER, V131, pE705, DOI 10.1002/ijc.27373; Sestak I, 2010, J CLIN ONCOL, V28, P3411, DOI 10.1200/JCO.2009.27.2021; Saeki T, 2008, INT J CLIN ONCOL, V13, P8, DOI 10.1007/s10147-007-0728-0; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Ballard-Barbash R, 2012, J NATL CANCER I, V104, P815, DOI 10.1093/jnci/djs207; Costantino JP, 1999, J NATL CANCER I, V91, P1541, DOI 10.1093/jnci/91.18.1541; Schwartzbaum J, 2007, SCAND J WORK ENV HEA, V33, P336; Henderson TO, 2010, ANN INTERN MED, V152, P444, DOI 10.7326/0003-4819-152-7-201004060-00009; Nechuta SJ, 2012, AM J CLIN NUTR, V96, P123, DOI 10.3945/ajcn.112.035972; Yamamoto S, 2003, J NATL CANCER I, V95, P906, DOI 10.1093/jnci/95.12.906; Larsson SC, 2007, INT J CANCER, V121, P856, DOI 10.1002/ijc.22717; Fournier A, 2008, BREAST CANCER RES TR, V107, P103, DOI 10.1007/s10549-007-9523-x; Ibrahim EM, 2011, MED ONCOL, V28, P753, DOI 10.1007/s12032-010-9536-x; Iwasaki M, 2007, EUR J CANCER PREV, V16, P116, DOI 10.1097/01.cej.0000228410.14095.2d; Boyle P, 2012, BRIT J CANCER, V107, P1608, DOI 10.1038/bjc.2012.414; NAGATA C, 1995, JPN J CANCER RES, V86, P910; Doody MM, 2000, SPINE, V25, P2052; Saslow D, 2007, CA-CANCER J CLIN, V57, P75; Hartmann LC, 2005, NEW ENGL J MED, V353, P229, DOI 10.1056/NEJMoa044383; Rebbeck TR, 2004, J CLIN ONCOL, V22, P1055, DOI 10.1200/JCO.2004.04.188; Goss PE, 2011, NEW ENGL J MED, V364, P2381, DOI 10.1056/NEJMoa1103507; Kabat GC, 2010, CANCER CAUSE CONTROL, V21, P821, DOI 10.1007/s10552-010-9508-7; Rebbeck TR, 2009, J NATL CANCER I, V101, P80, DOI 10.1093/jnci/djn442; Suzuki R, 2011, INT J CANCER, V129, P1214, DOI 10.1002/ijc.25744; DUPONT WD, 1985, NEW ENGL J MED, V312, P146, DOI 10.1056/NEJM198501173120303; King MC, 2001, JAMA-J AM MED ASSOC, V286, P2251, DOI 10.1001/jama.286.18.2251; Kroenke CH, 2005, J CLIN ONCOL, V23, P1370, DOI 10.1200/JCO.2005.01.079; Iwasaki M, 2008, J CLIN ONCOL, V26, P1677, DOI 10.1200/JCO.2007.13.9964; Miller MD, 2007, PREV MED, V44, P93, DOI 10.1016/j.ypmed.2006.08.015; Kuhl C, 2010, J CLIN ONCOL, V28, P1450, DOI 10.1200/JCO.2009.23.0839; CAMORIANO JK, 1990, J CLIN ONCOL, V8, P1327; Suzuki R, 2010, INT J CANCER, V127, P685, DOI 10.1002/ijc.25079; Dong JY, 2011, BREAST CANCER RES TR, V127, P23, DOI 10.1007/s10549-011-1467-5; Trock BJ, 2006, J NATL CANCER I, V98, P459, DOI 10.1093/jnci/djj102; Collins JA, 2005, HUM REPROD UPDATE, V11, P545, DOI 10.1093/humupd/dmi028; Pharoah PDP, 1997, INT J CANCER, V71, P800, DOI 10.1002/(SICI)1097-0215(19970529)71:5<800::AID-IJC18>3.0.CO;2-B; TOKUNAGA M, 1994, RADIAT RES, V138, P209, DOI 10.2307/3578591; Cuzick J, 2003, LANCET, V361, P296, DOI 10.1016/S0140-6736(03)12342-2; Weiss HA, 1999, INT J EPIDEMIOL, V28, P816, DOI 10.1093/ije/28.5.816; Green J, 2011, LANCET ONCOL, V12, P785, DOI 10.1016/S1470-2045(11)70154-1; Megdal SP, 2005, EUR J CANCER, V41, P2023, DOI 10.1016/j.ejca.2005.05.010; Preston DL, 2002, RADIAT RES, V158, P220, DOI 10.1667/0033-7587(2002)158[0220:REOBCR]2.0.CO;2; Kawai M, 2011, BREAST CANCER RES TR, V128, P817, DOI 10.1007/s10549-011-1381-x; Kahlenborn C, 2006, MAYO CLIN PROC, V81, P1290; Talamini R, 1997, BRIT J CANCER, V75, P1699, DOI 10.1038/bjc.1997.289; Greiser CM, 2005, HUM REPROD UPDATE, V11, P561, DOI 10.1093/humupd/dmi031; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Suzuki R, 2011, PREV MED, V52, P227, DOI 10.1016/j.ypmed.2011.01.016; Chlebowski RT, 2010, JAMA-J AM MED ASSOC, V304, P1684, DOI 10.1001/jama.2010.1500; Page DL, 2003, LANCET, V361, P125, DOI 10.1016/S0140-6736(03)12230-1; Anderson GL, 2012, LANCET ONCOL, V13, P476, DOI 10.1016/S1470-2045(12)70075-X; Kawai M, 2010, CANCER CAUSE CONTROL, V21, P135, DOI 10.1007/s10552-009-9443-7; Bosetti C, 2006, INT J CANCER, V119, P1679, DOI 10.1002/ijc.22016; Calle EE, 1996, LANCET, V347, P1713; Beral V, 2002, LANCET, V360, P187; Beral V, 1997, LANCET, V350, P1047; Beral V, 2012, LANCET ONCOL, V13, P1141, DOI 10.1016/S1470-2045(12)70425-4; DUPONT WD, 1994, NEW ENGL J MED, V331, P10, DOI 10.1056/NEJM199407073310103; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Katanoda K, 2007, JPN J CLIN ONCOL, V37, P638, DOI 10.1093/jjco/hym122; Kawamura T, 2005, JPN J CLIN ONCOL, V35, P758; Knight JA, 2006, INT J CANCER, V118, P197, DOI 10.1002/ijc.21298; Knight JA, 2008, BREAST CANCER RES TR, V109, P157, DOI 10.1007/s10549-007-9634-4; MA L, 1992, CANCER CAUSE CONTROL, V3, P517, DOI 10.1007/BF00052748; Meijers-Heijboer H, 2001, NEW ENGL J MED, V345, P159, DOI 10.1056/NEJM200107193450301; Nagata C, 2007, JPN J CLIN ONCOL, V37, P568, DOI 10.1093/jjco/hym062; Nagata C, 2006, JPN J CLIN ONCOL, V36, P387, DOI 10.1093/jjco/hyl031; National Comprehensive Cancer Network (NCCN), 2013, NCCN CLIN PRACT GUID; Nishio K, 2007, CANCER CAUSE CONTROL, V18, P801, DOI 10.1007/s10552-007-9023-7; Page DL, 1996, CANCER EPIDEM BIOMAR, V5, P29; Pijep A, 2012, BMJ-BRIT MED J, V345, pe5660; Pirie K, 2008, INT J EPIDEMIOL, V37, P1069, DOI 10.1093/ije/dyn110; Sung J, 2009, AM J EPIDEMIOL, V170, P53, DOI 10.1093/aje/kwp088; Tamakoshi K, 2005, CANCER SCI, V96, P57, DOI 10.1111/j.1349-7006.2004.00010.x; TOKUNAGA M, 1987, RADIAT RES, V112, P243, DOI 10.2307/3577254; World Cancer Research Fund/ American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P	88	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	JAN	2015	22	1					16	27		10.1007/s12282-014-0555-x		12	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AX8GA	WOS:000347146900003		
J	Tozaki, M; Isomoto, I; Kojima, Y; Kubota, K; Kuroki, Y; Ohnuki, K; Ohsumi, S; Mukai, H				Tozaki, Mitsuhiro; Isomoto, Ichiro; Kojima, Yasuyuki; Kubota, Kazunori; Kuroki, Yoshifumi; Ohnuki, Koji; Ohsumi, Shozo; Mukai, Hirofumi			The Japanese Breast Cancer Society Clinical Practice Guideline for screening and imaging diagnosis of breast cancer	BREAST CANCER			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; DATA SYSTEM LEXICON; FDG-PET; DIFFERENTIAL-DIAGNOSIS; CONSERVING SURGERY; DISTANT METASTASES; ELASTOGRAPHY; ULTRASOUND; WOMEN; US		[Tozaki, Mitsuhiro; Ohsumi, Shozo] Kameda Kyobashi Clin, Diagnost Imaging Ctr, Chuo Ku, Tokyo, Japan; [Isomoto, Ichiro] St Francis Hosp, Dept Radiol, Nagasaki, Japan; [Kojima, Yasuyuki] St Marianna Univ, Sch Med, Dept Surg, Div Breast & Endocrine Surg, Kawasaki, Kanagawa, Japan; [Kubota, Kazunori] Tokyo Med & Dent Univ Hosp, Dept Med Informat, Tokyo, Japan; [Kuroki, Yoshifumi] Tochigi Canc Ctr, Diagnost Imaging Div, Utsunomiya, Tochigi, Japan; [Ohnuki, Koji] Iwate Cent Prefectural Hosp, Div Breast & Endocrine Surg, Morioka, Iwate, Japan; [Ohsumi, Shozo] Natl Hosp Org, Shikoku Canc Ctr, Dept Breast Oncol, Matsuyama, Ehime, Japan; [Mukai, Hirofumi] Natl Canc Ctr Hosp East, Div Breast & Med Oncol, Kashiwa, Chiba, Japan	Ohsumi, S (reprint author), Kameda Kyobashi Clin, Diagnost Imaging Ctr, Chuo Ku, 3-1-1 Kyobashi,Tokyo Sq Garden 4F, Tokyo, Japan.	sosumi@shikoku-cc.go.jp					Akashi-Tanaka S, 2012, ANN SURG, V256, P157, DOI 10.1097/SLA.0b013e31825b6cb1; American College of Radiology, 2003, BREAST IM REP DAT SY; American College of Radiology, 2008, ACR PRACT GUID PERF; Koolen BB, 2012, BREAST CANCER RES TR, V131, P117, DOI 10.1007/s10549-011-1767-9; Simmons C, 2009, ANN ONCOL, V20, P1499, DOI 10.1093/annonc/mdp028; Yoon JH, 2011, AM J ROENTGENOL, V196, P730, DOI 10.2214/AJR.10.4654; Alvarez S, 2006, AM J ROENTGENOL, V186, P1342, DOI 10.1021/2214/AJR.05.0936; Hong AS, 2005, AM J ROENTGENOL, V184, P1260; Houssami N, 2011, BREAST CANCER RES TR, V129, P659, DOI 10.1007/s10549-011-1632-x; Ohuchi N, 2011, JPN J CLIN ONCOL, V41, P275, DOI 10.1093/jjco/hyq214; Leong LCH, 2010, CLIN RADIOL, V65, P887, DOI 10.1016/j.crad.2010.06.008; Raza S, 2008, RADIOLOGY, V248, P773, DOI 10.1148/radiol.2483071786; Cho N, 2010, J ULTRAS MED, V29, P1; Brennan ME, 2012, BREAST, V21, P112, DOI 10.1016/j.breast.2011.10.005; Mann RM, 2008, EUR RADIOL, V18, P1307, DOI 10.1007/s00330-008-0863-7; Elmore JG, 2005, JAMA-J AM MED ASSOC, V293, P1245, DOI 10.1001/jama.293.10.1245; Berg WA, 2008, JAMA-J AM MED ASSOC, V299, P2151, DOI 10.1001/jama.299.18.2151; Turnbull L, 2010, LANCET, V375, P563, DOI 10.1016/S0140-6736(09)62070-5; Meng W, 2011, ULTRASOUND MED BIOL, V37, P1436, DOI 10.1016/j.ultrasmedbio.2011.05.022; Tozaki M, 2012, JPN J RADIOL, V30, P659, DOI 10.1007/s11604-012-0106-3; Obdeijn IM, 2013, AM J ROENTGENOL, V200, P304, DOI 10.2214/AJR.12.9185; [Anonymous], 2009, ANN INTERN MED, V151, P716; Berg WA, 2012, RADIOLOGY, V262, P435, DOI 10.1148/radiol.11110640; Eubank WB, 2004, AM J ROENTGENOL, V183, P479; Pisano ED, 2005, RADIOLOGY, V234, P353, DOI 10.1148/radiol.2342030897; Costantini M, 2006, J ULTRAS MED, V25, P649; Teh W, 1998, EUR J CANCER, V34, P449, DOI 10.1016/S0959-8049(97)10066-1; Esen G, 2005, EUR RADIOL, V15, P1215, DOI 10.1007/s00330-004-2605-9; Raza S, 2010, J ULTRAS MED, V29, P551; Amir E, 2012, J CLIN ONCOL, V30, P587, DOI 10.1200/JCO.2010.33.5232; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Riegger C, 2012, EUR J NUCL MED MOL I, V39, P852, DOI 10.1007/s00259-012-2077-0; von Minckwitz G, 2008, J NATL CANCER I, V100, P552, DOI 10.1093/jnci/djn089; Abdullah N, 2009, RADIOLOGY, V252, P665, DOI 10.1148/radiol.2523080670; Quon A, 2005, J CLIN ONCOL, V23, P1664, DOI 10.1200/JCO.2005.11.024; Itoh A, 2006, RADIOLOGY, V239, P341, DOI 10.1148/radiol.2391041676; BASSETT LW, 1991, RADIOLOGY, V180, P831; Cooper KL, 2011, EJSO-EUR J SURG ONC, V37, P187, DOI 10.1016/j.ejso.2011.01.003; Davis PL, 1996, BREAST CANCER RES TR, V37, P1, DOI 10.1007/BF01806626; Force USPST, 2009, ANN INTERN MED, V151, pW; Jeevan R, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4505; Kanemura S, 1999, JPN J CANCER RES, V90, P607; Knutson D, 2007, AM FAM PHYSICIAN, V75, P1660; Kojima S, 2007, EUR J CANCER, V43, P1842, DOI 10.1016/j.ejca.2007.05.010; Osako Tomo, 2007, Breast Cancer, V14, P255, DOI 10.2325/jbcs.14.255; Schroeder RJ, 2003, EUR RADIOL, V13, P68, DOI 10.1007/s00330-002-1413-3; Shimauchi A, 2006, AM J ROENTGENOL, V187, P322, DOI 10.2214/AJR.05.0876; Siggelkow W, 2004, EUR J NUCL MED MOL I, V31, pS118; Thompson AM, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2771; Tozaki M, 2010, JPN J RADIOL, V28, P527, DOI 10.1007/s11604-010-0464-7; Tozaki M, 2009, AM J ROENTGENOL, V193, P840, DOI 10.2214/AJR.08.2128; Uematsu T, 2008, BREAST CANCER RES TR, V112, P461, DOI 10.1007/s10549-008-9890-y; Wang SY, 2013, BREAST CANCER RES TR, V138, P137, DOI 10.1007/s10549-013-2420-6; Yap CS, 2001, J NUCL MED, V42, P1334	54	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	JAN	2015	22	1					28	36		10.1007/s12282-014-0557-8		9	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AX8GA	WOS:000347146900004		
J	Komoike, Y; Inokuchi, M; Itoh, T; Kitamura, K; Kutomi, G; Sakai, T; Jinno, H; Wada, N; Ohsumi, S; Mukai, H				Komoike, Yoshifumi; Inokuchi, Masafumi; Itoh, Toshikazu; Kitamura, Kaoru; Kutomi, Goro; Sakai, Takehiko; Jinno, Hiromitsu; Wada, Noriaki; Ohsumi, Shozo; Mukai, Hirofumi			Japan Breast Cancer Society clinical practice guideline for surgical treatment of breast cancer	BREAST CANCER			English	Editorial Material							LYMPH-NODE BIOPSY; CARCINOMA IN-SITU; SKIN-SPARING MASTECTOMY; 20-YEAR FOLLOW-UP; AXILLARY DISSECTION; LOCAL RECURRENCE; NEOADJUVANT CHEMOTHERAPY; CONSERVING SURGERY; RADICAL-MASTECTOMY; PHYLLODES TUMORS		[Komoike, Yoshifumi] Kinki Univ, Fac Med, Dept Surg, Sect Breast & Endocrine Surg, Osaka 5898511, Japan; [Inokuchi, Masafumi] Kanazawa Univ Hosp, Dept Breast Oncol, Kanazawa, Ishikawa, Japan; [Itoh, Toshikazu] Rinku Gen Med Ctr, Dept Surg, Izumisano, Osaka, Japan; [Kitamura, Kaoru] Nagumo Clin Fukuoka, Dept Breast Surg, Fukuoka, Japan; [Kutomi, Goro] Sapporo Med Univ Hosp, Dept Surg Surg Oncol & Sci, Sapporo, Hokkaido, Japan; [Sakai, Takehiko] Japanese Fdn Canc Res, Canc Inst Hosp, Breast Oncol Ctr, Tokyo, Japan; [Jinno, Hiromitsu] Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan; [Wada, Noriaki] Natl Canc Ctr Hosp East, Dept Breast Surg, Kashiwa, Chiba, Japan; [Ohsumi, Shozo] Natl Hosp Org, Shikoku Canc Ctr, Dept Breast Oncol, Matsuyama, Ehime, Japan; [Mukai, Hirofumi] Natl Canc Ctr Hosp East, Div Breast & Med Oncol, Kashiwa, Chiba, Japan	Ohsumi, S (reprint author), Natl Hosp Org, Shikoku Canc Ctr, Dept Breast Oncol, Matsuyama, Ehime, Japan.	komoike@surg.med.kindai.ac.jp; sosumi@shikoku-cc.go.jp					Akashi-Tanaka S, 2004, ANN SURG, V239, P238, DOI 10.1097/01.sla.0000109157.15687.d9; Silverstein MJ, 1996, CANCER, V77, P2267, DOI 10.1002/(SICI)1097-0142(19960601)77:11<2267::AID-CNCR13>3.0.CO;2-V; Singletary SE, 2002, AM J SURG, V184, P383, DOI 10.1016/S0002-9610(02)01012-7; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Hoffmann K, 2010, ANN SURG ONCOL, V17, P1546, DOI 10.1245/s10434-010-0931-5; Gralow JR, 2008, J CLIN ONCOL, V26, P814, DOI 10.1200/JCO.2007.15.3510; Shien T, 2009, ONCOL REP, V21, P827, DOI 10.3892/or_00000291; Mauri D, 2005, J NATL CANCER I, V97, P188; Giacalone PL, 2010, BREAST CANCER RES TR, V122, P439, DOI 10.1007/s10549-010-0951-7; Galimberti V, 2013, LANCET ONCOL, V14, P297, DOI 10.1016/S1470-2045(13)70035-4; Houssami N, 2010, EUR J CANCER, V46, P3219, DOI 10.1016/j.ejca.2010.07.043; Jenkinson MD, 2011, EUR J CANCER, V47, P649, DOI 10.1016/j.ejca.2010.11.033; Veronesi U, 2002, NEW ENGL J MED, V347, P1227, DOI 10.1056/NEJMoa020989; Krag DN, 2010, LANCET ONCOL, V11, P927, DOI 10.1016/S1470-2045(10)70207-2; Zavagno G, 2008, ANN SURG, V247, P207, DOI 10.1097/SLA.0b013e31812e6a73; Durr HR, 2002, CLIN ORTHOP RELAT R, P191; Altundag K, 2007, CANCER, V110, P2640, DOI 10.1002/cncr.23088; Noguchi M, 2000, BREAST CANCER RES TR, V63, P31, DOI 10.1023/A:1006428105579; Fisher B, 2002, NEW ENGL J MED, V347, P567, DOI 10.1056/NEJMoa020128; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Ishitobi M, 2011, ONCOLOGY-BASEL, V81, P381, DOI 10.1159/000335265; Yen TWF, 2005, J AM COLL SURGEONS, V200, P516, DOI 10.1016/j.jamcollsurg.2004.11.012; Lanitis S, 2010, ANN SURG, V251, P632, DOI 10.1097/SLA.0b013e3181d35bf8; FOWBLE B, 1989, INT J RADIAT ONCOL, V17, P703; Soran A, 2009, BREAST J, V15, P399, DOI 10.1111/j.1524-4741.2009.00744.x; Grover VK, 2009, J POSTGRAD MED, V55, P257, DOI 10.4103/0022-3859.58928; Orr RK, 1999, ANN SURG ONCOL, V6, P109, DOI 10.1007/s10434-999-0109-1; Mahmoud-Ahmed AS, 2002, INT J RADIAT ONCOL, V54, P810, DOI 10.1016/S0360-3016(02)02967-X; Virnig BA, 2010, J NATL CANCER I, V102, P170, DOI 10.1093/jnci/djp482; Xing Y, 2006, BRIT J SURG, V93, P539, DOI 10.1002/bjs.5209; Dworkin RH, 2007, PAIN, V132, P237, DOI 10.1016/j.pain.2007.08.033; Veronesi U, 2006, LANCET ONCOL, V7, P983, DOI 10.1016/S1470-2045(06)70947-0; Fleissig A, 2006, BREAST CANCER RES TR, V95, P279, DOI 10.1007/s10549-005-9025-7; Khan SA, 2002, SURGERY, V132, P620, DOI 10.1067/msy.2002.127544; Boughey J, 2012, CANCER RES, V72, p94s; Abe O, 2005, LANCET, V366, P2087; DANFORTH DN, 1986, J CLIN ONCOL, V4, P655; de Bresser J, 2010, EJSO-EUR J SURG ONC, V36, P114, DOI 10.1016/j.ejso.2009.09.007; Gupta R, 2000, EUR J SURG ONCOL, V26, P363, DOI 10.1053/ejso.1999.0899; Hind D, 2006, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004272.PUB2; Ito T, 2012, J CLIN ONCOL S, V30; Jang JH, 2012, ANN SURG ONCOL, V19, P2612, DOI 10.1245/s10434-012-2307-5; Kapiris I, 2001, EUR J SURG ONCOL, V27, P723, DOI 10.1053/ejso.2001.1207; Kitamura K, 2011, J LYMPHOEDEMA, V6, P60; Kuehn T, 2012, CANCER RES, V72, p95s; McNeely ML, 2010, COCHRANE DATABASE SY; Nakajima H, 2009, ANN SURG ONCOL, V16, P1982, DOI 10.1245/s10434-009-0429-1; Nakamura Seigo, 2002, Breast Cancer, V9, P15, DOI 10.1007/BF02967541; Paepke S, 2009, ANN SURG, V250, P288, DOI 10.1097/SLA.0b013e3181b0c7d8; Pergolizzi S, 1997, ANTICANCER RES, V17, P2303; Prabhu R, 2012, INT J RADIAT ONCOL, V82, pE587, DOI 10.1016/j.ijrobp.2011.09.024; ROSEN PP, 1983, ANN SURG, V197, P276, DOI 10.1097/00000658-198303000-00006; Sharma R, 2011, PLAST RECONSTR SURG, V127, P1763, DOI 10.1097/PRS.0b013e31820cf24c; Shen SC, 2012, ANN SURG ONCOL, V19, P1122, DOI 10.1245/s10434-011-2082-8; Torresan Renato Zocchio, 2003, Breast J, V9, P389, DOI 10.1046/j.1524-4741.2003.09505.x; VANOOIJEN B, 1993, BRIT J SURG, V80, P1299, DOI 10.1002/bjs.1800801026; Varadarajan R, 2006, ONCOLOGY-BASEL, V71, P456, DOI 10.1159/000107111; Venus MR, 2010, J PLAST RECONSTR AES, V63, P101, DOI 10.1016/j.bjps.2008.08.064; VERONESI U, 1987, CANCER, V59, P682, DOI 10.1002/1097-0142(19870215)59:4<682::AID-CNCR2820590403>3.0.CO;2-Z; WAGMAN LD, 1990, SURG GYNECOL OBSTET, V170, P12; Welter S, 2008, EUR J CARDIO-THORAC, V34, P1228, DOI 10.1016/j.ejcts.2008.07.063	61	0	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	JAN	2015	22	1					37	48		10.1007/s12282-014-0558-7		12	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AX8GA	WOS:000347146900005		
J	Sekiguchi, K; Ogawa, Y; Sanuki, N; Arahira, S; Ogo, E; Yoshimura, M; Yamauchi, C; Oguchi, M; Ohsumi, S; Mukai, H				Sekiguchi, Kenji; Ogawa, Yasuhiro; Sanuki, Naoko; Arahira, Satoko; Ogo, Etsuyo; Yoshimura, Michio; Yamauchi, Chikako; Oguchi, Masahiko; Ohsumi, Shozo; Mukai, Hirofumi			The Japanese Breast Cancer Society clinical practice guideline for radiotherapy of breast cancer	BREAST CANCER			English	Editorial Material							CARCINOMA-IN-SITU; RANDOMIZED CONTROLLED-TRIAL; DIAGNOSED BRAIN METASTASES; REGIONAL NODAL FAILURE; RADIATION-THERAPY; CONSERVATIVE SURGERY; POSTOPERATIVE RADIOTHERAPY; NEOADJUVANT CHEMOTHERAPY; POSTMASTECTOMY RADIATION; AXILLARY DISSECTION		[Sekiguchi, Kenji] St Lukes Int Hosp, Dept Radiat Oncol, Chuo Ku, Tokyo 1048560, Japan; [Ogawa, Yasuhiro] Kochi Univ, Sch Med, Dept Diagnost Radiol & Radiat Oncol, Kochi 780, Japan; [Sanuki, Naoko] Ofuna Chuo Hosp, Radiat Oncol Ctr, Kamakura, Kanagawa, Japan; [Arahira, Satoko] Natl Canc Ctr Hosp East, Dept Radiat Oncol, Kashiwa, Chiba, Japan; [Ogo, Etsuyo] Kurume Univ, Sch Med, Dept Heavy Particle Therapy & Radiat Oncol, Kurume, Fukuoka 830, Japan; [Yoshimura, Michio] Kyoto Univ, Grad Sch Med, Dept Radiat Oncol & Image Appl Therapy, Kyoto, Japan; [Yamauchi, Chikako] Shiga Med Ctr Adults, Dept Radiat Oncol, Moriyama, Shiga, Japan; [Oguchi, Masahiko] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Radiat Oncol, Tokyo, Japan; [Ohsumi, Shozo] Natl Hosp Org, Shikoku Canc Ctr, Dept Breast Oncol, Matsuyama, Ehime, Japan; [Mukai, Hirofumi] Natl Canc Ctr Hosp East, Div Breast & Med Oncol, Kashiwa, Chiba, Japan	Ohsumi, S (reprint author), Natl Hosp Org, Shikoku Canc Ctr, Dept Breast Oncol, Matsuyama, Ehime, Japan.	kenjisek@luke.or.jp; sosumi@shikoku-cc.go.jp					Bentzen SM, 2008, LANCET, V371, P1098; Liljegren G, 1999, J CLIN ONCOL, V17, P2326; van der Hage JA, 2001, J CLIN ONCOL, V19, P4224; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Mamounas EP, 2012, J CLIN ONCOL, V30, P3960, DOI 10.1200/JCO.2011.40.8369; Lutz S, 2011, INT J RADIAT ONCOL, V79, P965, DOI 10.1016/j.ijrobp.2010.11.026; Renton SC, 1996, EUR J SURG ONCOL, V22, P17, DOI 10.1016/S0748-7983(96)91253-6; Nielsen HM, 2006, J CLIN ONCOL, V24, P2268, DOI 10.1200/JCO.2005.02.8738; Forrest AP, 1996, LANCET, V348, P708, DOI 10.1016/S0140-6736(96)02133-2; Peintinger F, 2006, CANCER, V107, P1248, DOI 10.1002/cncr.22111; Overgaard M, 1999, LANCET, V353, P1641, DOI 10.1016/S0140-6736(98)09201-0; Grills IS, 2003, INT J RADIAT ONCOL, V56, P658, DOI 10.1016/S0360-3016(03)00017-8; McGuire SE, 2007, INT J RADIAT ONCOL, V68, P1004, DOI 10.1016/j.ijrobp.2007.01.023; Gaspar L, 1997, INT J RADIAT ONCOL, V37, P745, DOI 10.1016/S0360-3016(96)00619-0; Bijker N, 2006, J CLIN ONCOL, V24, P3381, DOI 10.1200/JCO.2006.06.1366; Fowble BL, 2012, INT J RADIAT ONCOL, V83, P494, DOI 10.1016/j.ijrobp.2012.01.068; Veronesi U, 2001, ANN ONCOL, V12, P997, DOI 10.1023/A:1011136326943; Pepels MJ, 2011, BREAST CANCER RES TR, V125, P301, DOI 10.1007/s10549-010-1210-7; Whelan TJ, 2010, NEW ENGL J MED, V362, P513, DOI 10.1056/NEJMoa0906260; Vinh-Hung V, 2004, JNCI-J NATL CANCER I, V96, P115, DOI 10.1093/jnci/djh013; Romestaing P, 1997, J CLIN ONCOL, V15, P963; Gaspar LE, 2010, J NEURO-ONCOL, V96, P17, DOI 10.1007/s11060-009-0060-9; Bauman G, 2005, RADIOTHER ONCOL, V75, P258, DOI 10.1016/j.radonc.2005.03.003; Hughes LL, 2009, J CLIN ONCOL, V27, P5319, DOI 10.1200/JCO.2009.21.8560; Sperduto PW, 2012, J CLIN ONCOL, V30, P419, DOI 10.1200/JCO.2011.38.0527; Bentzen SM, 2008, LANCET ONCOL, V9, P331, DOI 10.1016/S1470-2045(08)60348-7; Lim M, 2006, INT J RADIAT ONCOL, V65, P1149, DOI 10.1016/j.ijrobp.2006.02.006; FISHER B, 1985, NEW ENGL J MED, V312, P674, DOI 10.1056/NEJM198503143121102; Clark RM, 1996, J NATL CANCER I, V88, P1659, DOI 10.1093/jnci/88.22.1659; Huang J, 2003, J CLIN ONCOL, V21, P555, DOI 10.1200/JCO.2003.04.171; Cuzick J, 2011, LANCET ONCOL, V12, P21, DOI 10.1016/S1470-2045(10)70266-7; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Kocher M, 2011, J CLIN ONCOL, V29, P134, DOI 10.1200/JCO.2010.30.1655; Overgaard M, 2007, RADIOTHER ONCOL, V82, P247, DOI 10.1016/j.radonc.2007.02.001; Overgaard M, 1997, NEW ENGL J MED, V337, P949, DOI 10.1056/NEJM199710023371401; Smith BD, 2011, INT J RADIAT ONCOL, V81, P59, DOI 10.1016/j.ijrobp.2010.04.042; Louis-Sylvestre C, 2004, J CLIN ONCOL, V22, P97, DOI 10.1200/JCO.2004.12.108; Aoyama H, 2006, JAMA-J AM MED ASSOC, V295, P2483, DOI 10.1001/jama.295.21.2483; Malmstrom P, 2003, EUR J CANCER, V39, P1690, DOI 10.1016/S0959-8049(03)00324-1; Wapnir IL, 2011, J NATL CANCER I, V103, P478, DOI 10.1093/jnci/djr027; Bartelink H, 2007, J CLIN ONCOL, V25, P3259, DOI 10.1200/JCO.2007.11.4991; van Tienhoven G, 1999, EUR J CANCER, V35, P32, DOI 10.1016/S0959-8049(98)00301-3; Linskey ME, 2010, J NEURO-ONCOL, V96, P45, DOI 10.1007/s11060-009-0073-4; Ragaz J, 2005, JNCI-J NATL CANCER I, V97, P116, DOI 10.1093/jnci/djh297; Sartor CL, 2005, J CLIN ONCOL, V23, P30, DOI 10.1200/JCO.2005.12.044; Holmberg L, 2008, J CLIN ONCOL, V26, P1247, DOI 10.1200/JCO.2007.12.7969; BUCHHOLZ TA, 1993, INT J RADIAT ONCOL, V26, P23, DOI 10.1016/0360-3016(93)90169-V; BUZDAR AU, 1993, CANCER, V71, P3680, DOI 10.1002/1097-0142(19930601)71:11<3680::AID-CNCR2820711134>3.0.CO;2-O; Abe O, 2005, LANCET, V366, P2087; Correa C, 2010, J NATL CANC I MONOGR, V2010, P162, DOI DOI 10.1093/JNCIMONOGRAPHS/LGQ039; Darby S, 2011, LANCET, V378, P1707, DOI DOI 10.1016/S0140-6736(11)61629-2; Gebski V, 2006, JNCI-J NATL CANCER I, V98, P26, DOI 10.1093/jnci/djj002; Goodwin A, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000563.pub6; James ML, 2010, COCHRANE DB SYST REV, V11; Yu Jeong Il, 2010, Int J Radiat Oncol Biol Phys, V78, P1135, DOI 10.1016/j.ijrobp.2009.09.037; Karlsson P, 2011, INT J RADIAT ONCOL, V80, P398, DOI 10.1016/j.ijrobp.2010.02.042; Livi L, 2010, INT J RADIAT ONCOL, V76, P978, DOI 10.1016/j.ijrobp.2009.03.001; Metz JM, 2000, CANCER J, V6, P324; Pejavar S, 2006, INT J RADIAT ONCOL, V66, P1320, DOI 10.1016/j.ijrobp.2006.07.1379; RECHT A, 1991, J CLIN ONCOL, V9, P988; Tsao MN, 2012, COCHRANE DB SYST REV, V4; Tsao May N, 2012, Pract Radiat Oncol, V2, P210, DOI 10.1016/j.prro.2011.12.004; Tsoutsou PG, 2009, CRIT REV ONCOL HEMAT, V71, P102, DOI 10.1016/j.critrevonc.2008.09.002; Whelan TJ, 2011, J CLIN ONCOL S, V29	64	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	JAN	2015	22	1					49	58		10.1007/s12282-014-0548-9		10	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AX8GA	WOS:000347146900006		
J	Horii, R; Honma, N; Ogiya, A; Kozuka, Y; Fukuda, T; Yoshida, M; Ohsumi, S; Mukai, H				Horii, Rie; Honma, Naoko; Ogiya, Akiko; Kozuka, Yuji; Fukuda, Takayo; Yoshida, Masayuki; Ohsumi, Shozo; Mukai, Hirofumi			The Japanese Breast Cancer Society Clinical Practice Guideline for pathological diagnosis of breast cancer	BREAST CANCER			English	Editorial Material							NEEDLE-ASPIRATION-CYTOLOGY; SURGICAL ADJUVANT BREAST; CARCINOMA IN-SITU; CORE-NEEDLE; ESTROGEN-RECEPTOR; AMERICAN-SOCIETY; NEOADJUVANT CHEMOTHERAPY; CONSERVATION SURGERY; WORKING GROUP; FOLLOW-UP		[Horii, Rie] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Pathol, Koto Ku, Tokyo 1358550, Japan; [Honma, Naoko] Tokyo Metropolitan Inst Gerontol, Res Team Geriatr Pathol, Tokyo, Japan; [Ogiya, Akiko] Japanese Fdn Canc Res, Canc Inst Hosp, Breast Oncol Ctr, Tokyo, Japan; [Kozuka, Yuji] Mie Univ Hosp, Dept Pathol, Tsu, Mie, Japan; [Fukuda, Takayo] St Marianna Univ, Grad Sch Med, Dept Translat Oncol, Kawasaki, Kanagawa, Japan; [Yoshida, Masayuki] Natl Canc Ctr, Dept Pathol, Tokyo, Japan; [Ohsumi, Shozo] Natl Hosp Org, Shikoku Canc Ctr, Dept Breast Oncol, Matsuyama, Ehime, Japan; [Mukai, Hirofumi] Natl Canc Ctr Hosp East, Div Breast & Med Oncol, Kashiwa, Chiba, Japan	Ohsumi, S (reprint author), Natl Hosp Org, Shikoku Canc Ctr, Dept Breast Oncol, Matsuyama, Ehime, Japan.	rhorii-pathology@jfcr.or.jp; sosumi@shikoku-cc.go.jp					van der Hage JA, 2001, J CLIN ONCOL, V19, P4224; Pijnappel RM, 2004, BRIT J CANCER, V90, P595, DOI 10.1038/sj.bjc.6601559; Fukamachi K, 2010, JPN J CLIN ONCOL, V40, P513, DOI 10.1093/jjco/hyq006; Silverstein MJ, 1996, CANCER, V77, P2267, DOI 10.1002/(SICI)1097-0142(19960601)77:11<2267::AID-CNCR13>3.0.CO;2-V; Singletary SE, 2002, AM J SURG, V184, P383, DOI 10.1016/S0002-9610(02)01012-7; Allred DC, 2012, J CLIN ONCOL, V30, P1268, DOI 10.1200/JCO.2010.34.0141; Lebeau A, 2010, J CLIN ONCOL, V28, P3264, DOI 10.1200/JCO.2009.25.9366; BLOOM HJG, 1957, BRIT J CANCER, V11, P359, DOI 10.1038/bjc.1957.43; Bear HD, 2006, J CLIN ONCOL, V24, P2019, DOI 10.1200/JCO.2005.04.1665; Tsujimoto M, 2007, CLIN CANCER RES, V13, P4807, DOI 10.1158/1078-0432.CCR-06-2512; Fabi A, 2011, CLIN CANCER RES, V17, P2055, DOI 10.1158/1078-0432.CCR-10-1920; Houssami N, 2010, EUR J CANCER, V46, P3219, DOI 10.1016/j.ejca.2010.07.043; Li SC, 2012, BREAST CANCER RES TR, V135, P325, DOI 10.1007/s10549-012-2063-z; Niikura N, 2012, J CLIN ONCOL, V30, P593, DOI 10.1200/JCO.2010.33.8889; Esbona K, 2012, ANN SURG ONCOL, V19, P3236, DOI 10.1245/s10434-012-2492-2; Veronesi U, 2002, NEW ENGL J MED, V347, P1227, DOI 10.1056/NEJMoa020989; Hatada T, 2000, J AM COLL SURGEONS, V190, P299, DOI 10.1016/S1072-7515(99)00300-2; Pisano ED, 2001, RADIOLOGY, V219, P785; Lyman GH, 2005, J CLIN ONCOL, V23, P7703, DOI 10.1200/JCO.2005.08.001; Tsuda H, 1998, JPN J CLIN ONCOL, V28, P486, DOI 10.1093/jjco/28.8.486; Fisher B, 2001, J CLIN ONCOL, V19, P931; Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, pE48, DOI 10.1043/1543-2165-134.7.e48; Dowsett M, 2011, J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; Leake R, 2000, J CLIN PATHOL, V53, P634, DOI 10.1136/jcp.53.8.634; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Arteaga CL, 2012, NAT REV CLIN ONCOL, V9, P16, DOI 10.1038/nrclinonc.2011.177; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Chen XS, 2012, BREAST CANCER RES TR, V134, P957, DOI 10.1007/s10549-012-1990-z; Westenend PJ, 2001, CANCER CYTOPATHOL, V93, P146, DOI 10.1002/cncr.9021; van de Ven S, 2011, CANCER TREAT REV, V37, P422, DOI 10.1016/j.ctrv.2010.11.006; Ballo MS, 1996, CANCER, V78, P773; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Endo Y, 2011, INT J CLIN ONCOL, V16, P512, DOI 10.1007/s10147-011-0215-5; Feoli F, 2008, ACTA CYTOL, V52, P145, DOI 10.1159/000325472; Giard RW, 1987, ACTA CYTOL, V31, P301; Giuliano AE, 2001, JAMA-J AM MED ASSOC, V306, P385; Guarneri V, 2010, CANCER TREAT REV, V36, pS62, DOI 10.1016/S0305-7372(10)70022-0; Gumus H, 2012, DIAGN INTERV RADIOL, V18, P354, DOI 10.4261/1305-3825.DIR.5024-11.1; Horii R, 2014, BREAST CANCER-TOKYO, V21, P598, DOI 10.1007/s12282-012-0436-0; Penault-Llorca F, 2009, AM J CLIN PATHOL, V132, P539, DOI 10.1309/AJCPV2I0HGPMGBSQ; Penco S, 2010, AM J ROENTGENOL, V195, P1255, DOI 10.2214/AJR.10.4208; Sahoo S, 2009, ARCH PATHOL LAB MED, V133, P633, DOI 10.1043/1543-2165-133.4.633; Umemura Shinobu, 2006, Breast Cancer, V13, P232, DOI 10.2325/jbcs.13.232; Wolmark N, 2001, J NATL CANC I MONOGR, V30, P96; Yamaguchi R, 2012, ONCOL REP, V28, P1606, DOI 10.3892/or.2012.2014; Yamashita Hiroko, 2006, Breast Cancer, V13, P74, DOI 10.2325/jbcs.13.74	46	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	JAN	2015	22	1					59	65		10.1007/s12282-014-0549-8		7	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AX8GA	WOS:000347146900007		
J	Uematsu, T				Uematsu, Takayoshi			Focal breast edema associated with malignancy on T2-weighted images of breast MRI: peritumoral edema, prepectoral edema, and subcutaneous edema	BREAST CANCER			English	Review						Breast; MRI; Edema; T2-weighted image; High signal intensity	LYMPHATIC DRAINAGE PATTERNS; DIAGNOSTIC-ACCURACY; CANCER; CARCINOMA; LESIONS; ENHANCEMENT; MAMMOGRAPHY; FEATURES	Edema, defined as high signal intensity on T2-weighted images, is a useful breast MRI finding, which compensates for the moderate specificity of breast MRI. Although diffuse breast edema can be caused by benign and malignant etiologies, focal edema is commonly associated with malignancy except for previous procedures including biopsy and surgery. For more accurate comprehension of the appropriate usage of breast edema, focal breast edema should be divided into three different types: peritumoral edema, prepectoral edema, and subcutaneous edema. It is useful to review and clarify these types of focal breast edema based on pathological findings as this may help predict the likelihood of malignancy in breast MRI lesions.	Shizuoka Canc Ctr Hosp, Breast Imaging & Breast Intervent Sect, Shizuoka 4118777, Japan	Uematsu, T (reprint author), Shizuoka Canc Ctr Hosp, Breast Imaging & Breast Intervent Sect, Shizuoka 4118777, Japan.	t.uematsu@scchr.jp					Uematsu T, 2009, RADIOLOGY, V250, P638, DOI 10.1148/radiol.2503081054; Estourgie SH, 2004, ANN SURG, V239, P232, DOI 10.1097/01.sla.0000109156.26378.90; Dietzel M, 2010, J COMPUT ASSIST TOMO, V34, P587, DOI 10.1097/RCT.0b013e3181db9f0e; Costantini M, 2012, CLIN BREAST CANCER, V12, P331, DOI 10.1016/j.clbc.2012.07.002; Morris EA, 2007, RADIOL CLIN N AM, V45, P863, DOI 10.1016/i.rcl.2007.07.002; Kuhl C, 2007, RADIOLOGY, V244, P356, DOI 10.1148/radiol.2442051620; Uematsu T, 2012, AM J ROENTGENOL, V198, P1223, DOI 10.2214/AJR.11.7350; Baltzer PAT, 2010, BREAST J, V16, P233, DOI 10.1111/j.1524-4741.2010.00915.x; Baltzer PAT, 2011, J COMPUT ASSIST TOMO, V35, P361, DOI 10.1097/RCT.0b013e31821065c3; Blumgart EI, 2011, BREAST CANCER RES TR, V130, P699, DOI 10.1007/s10549-011-1737-2; Chatterji M, 2007, MAGN RESON IMAGING C, V18, P207; Dietzel M, 2010, ACTA RADIOL, V51, P885, DOI 10.3109/02841851.2010.504232; Kawashima H, 2010, J MAGN RESON IMAGING, V32, P1117, DOI 10.1002/jmri.22279; Kuhl Christiane K, 2007, Magn Reson Imaging Clin N Am, V15, P315, DOI 10.1016/j.mric.2007.08.003; Kwak JY, 2005, YONSEI MED J, V46, P1; Malich A, 2005, AM J ROENTGENOL, V185, P964, DOI 10.2214/AJR.04.1073; Morakkabati N, 2003, RADIOLOGY, V229, P893, DOI 10.1148/radiol.2293020167; Ran Sophia, 2010, Pathophysiology, V17, P229, DOI 10.1016/j.pathophys.2009.11.003; Renz DM, 2008, EUR RADIOL, V18, P2370, DOI 10.1007/s00330-008-1029-3; Uematsu T, 2013, BREAST CANC; Uematsu T, 2012, BREAST CANCER-TOKYO, V19, P289, DOI 10.1007/s12282-012-0346-1; Uematsu T, 2014, BREAST CANCER-TOKYO, V21, P115, DOI 10.1007/s12282-012-0425-3; Yasumura K, 1997, BREAST CANC, V31, P161; Yuen S, 2007, J MAGN RESON IMAGING, V25, P502, DOI 10.1002/jmri.20845	24	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	JAN	2015	22	1					66	70		10.1007/s12282-014-0572-9		5	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AX8GA	WOS:000347146900008		
J	Honma, N; Horii, R; Iwase, T; Saji, S; Younes, M; Ito, Y; Akiyama, F				Honma, Naoko; Horii, Rie; Iwase, Takuji; Saji, Shigehira; Younes, Mamoun; Ito, Yoshinori; Akiyama, Futoshi			Ki-67 evaluation at the hottest spot predicts clinical outcome of patients with hormone receptor-positive/HER2-negative breast cancer treated with adjuvant tamoxifen monotherapy	BREAST CANCER			English	Article						Ki-67; Breast cancer; Tamoxifen; Estrogen receptor; Progesterone receptor; Estrogen receptor-beta	ESTROGEN-RECEPTOR-BETA; INTERNATIONAL EXPERT CONSENSUS; II-ALPHA EXPRESSION; CELL-PROLIFERATION; PROGNOSTIC-SIGNIFICANCE; NUCLEAR ANTIGEN; PRIMARY THERAPY; LABELING INDEX; CARCINOMA; TRIAL	The clinicopathological importance of Ki-67 in breast cancers has been intensely studied; however, there have been few systematic large studies of patients treated with predefined adjuvant therapy. Further, Ki-67 evaluation methodology differed among studies, which prevents Ki-67 from being used for clinical practice. We performed a large systematic study using routinely processed tissues and compared various scoring methods. Representative slides of archival tissue blocks of 442 consecutive invasive breast cancers from women treated with adjuvant tamoxifen monotherapy and having a long follow-up period were subjected to immunohistochemistry using anti-Ki-67 monoclonal antibody, Mib-1. Both the average score across the section and the score at the hottest spot were assessed. Ki-67 evaluated at the hottest spot, not the average score across the section, independently predicted poor clinical outcomes of patients with hormone receptor-positive/HER2-negative cancer. Ki-67 was not a predictor of clinical outcome in patients with triple-negative breast cancer. Overall, high Ki-67 level significantly correlated with classic unfavorable clinicopathological factors, correlating negatively with the status of estrogen receptor (ER)-alpha and progesterone receptor (PR), and positively with HER2 status and grade. ER-beta status positively correlated with the Ki-67 level. Ki-67 evaluation at the hottest spot was superior to that determined by average score across the section as a predictor of outcome in patients with hormone receptor-positive/HER2-negative breast cancers treated with endocrine monotherapy. The different result obtained in patients with triple-negative carcinomas needs to be further investigated.	[Honma, Naoko] Tokyo Metropolitan Inst Gerontol, Res Team Geriatr Pathol, Itabashi Ku, Tokyo 1730015, Japan; [Honma, Naoko; Horii, Rie; Akiyama, Futoshi] Inst Canc Res, Dept Pathol, Koto Ku, Tokyo 1358550, Japan; [Iwase, Takuji] Canc Inst Hosp, Breast Oncol Ctr, Koto Ku, Tokyo 1358550, Japan; [Saji, Shigehira] Kyoto Univ, Grad Sch Med, Dept Target Therapy Oncol, Sakyo Ku, Kyoto 6068507, Japan; [Younes, Mamoun] Univ Texas Med Sch Houston, Dept Pathol & Lab Med, Houston, TX 77030 USA; [Ito, Yoshinori] Canc Inst Hosp, Breast Oncol Ctr, Koto Ku, Tokyo 1358550, Japan	Honma, N (reprint author), Tokyo Metropolitan Inst Gerontol, Res Team Geriatr Pathol, Itabashi Ku, 35-2 Sakaecho, Tokyo 1730015, Japan.	nhonma@tmig.or.jp			JSPS KAKENHI [17590324]; Ministry of Health, Labor and Welfare of Japan [17-7]	We thank Drs. Goi Sakamoto and Kaiyo Takubo for their administrative support, and Ms. Tomoyo Kakita, Ms. Mayumi Ogawa, Mr. Genkichi Iwakoshi, Ms. Kazuko Yokokawa, and the technical staff of the Department of Pathology, Cancer Institute for their excellent technical support. This work was supported by JSPS KAKENHI (17590324) and a grant-in-aid for Cancer Research from the Ministry of Health, Labor and Welfare of Japan (No. 17-7).	Goldhirsch A, 2009, ANN ONCOL, V20, P1319, DOI 10.1093/annonc/mdp322; Seshadri R, 1996, INT J CANCER, V69, P135, DOI 10.1002/(SICI)1097-0215(19960422)69:2<135::AID-IJC12>3.0.CO;2-8; Cheang MCU, 2009, J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Jirstrom K, 2005, J CLIN PATHOL, V58, P1135, DOI 10.1136/jcp.2005.027185; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1; GERDES J, 1983, INT J CANCER, V31, P13, DOI 10.1002/ijc.2910310104; Rudolph P, 1999, BREAST CANCER RES TR, V55, P61, DOI 10.1023/A:1006159016703; Urruticoechea A, 2005, J CLIN ONCOL, V23, P7212, DOI 10.1200/JCO.2005.07.501; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Tsuda H, 1998, JPN J CLIN ONCOL, V28, P486, DOI 10.1093/jjco/28.8.486; Skliris GP, 2006, BRIT J CANCER, V95, P616, DOI 10.1038/sj.bjc.6603295; Tsuda H, 2000, JPN J CANCER RES, V91, P451; O'Neill PA, 2004, BRIT J CANCER, V91, P1694, DOI 10.1038/sj.bjc.6602183; Mengel M, 2002, J PATHOL, V198, P292, DOI 10.1002/path.1218; Viale G, 2008, J CLIN ONCOL, V26, P5569, DOI 10.1200/JCO.2008.17.0829; Trihia H, 2003, CANCER, V97, P1321, DOI 10.1002/cncr.11188; de Azambuja E, 2007, BRIT J CANCER, V96, P1504, DOI 10.1038/sj.bjc.6603756; Honma N, 2008, J CLIN ONCOL, V26, P3727, DOI 10.1200/JCO.2007.14.2968; GERDES J, 1991, AM J PATHOL, V138, P867; Jensen EV, 2001, P NATL ACAD SCI USA, V98, P15197, DOI 10.1073/pnas.211556298; Billgren AM, 2002, BREAST CANCER RES TR, V71, P161, DOI 10.1023/A:1013899614656; Bottini A, 2001, BRIT J CANCER, V85, P1106, DOI 10.1054/bjoc.2001.2048; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1; Liu SQ, 2001, CLIN CANCER RES, V7, P1716; Rudolph P, 1999, J PATHOL, V187, P207; Rudolph P, 2001, HUM PATHOL, V32, P311, DOI 10.1053/hupa.2001.22748; Tavassoli F.A., 2003, WHO CLASSIFICATION T; Thor AD, 1999, J CLIN ONCOL, V17, P470	29	4	4	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	JAN	2015	22	1					71	78		10.1007/s12282-013-0455-5		8	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AX8GA	WOS:000347146900009		
J	Okada, N; Narita, Y; Takada, M; Kato, H; Ambo, Y; Nakamura, F; Kishida, A; Kashimura, N				Okada, Naoya; Narita, Yoshiaki; Takada, Minoru; Kato, Hiroaki; Ambo, Yoshiyasu; Nakamura, Fumitaka; Kishida, Akihiro; Kashimura, Nobuichi			Early removal of drains and the incidence of seroma after breast surgery	BREAST CANCER			English	Article						Axillary lymph node dissection; Seroma; Breast cancer	PROSPECTIVE RANDOMIZED-TRIAL; AXILLARY LYMPHADENECTOMY; CANCER SURGERY; CLINICAL-TRIAL; MASTECTOMY; DISCHARGE; CLEARANCE	Women undergoing surgery for primary breast cancer routinely have suction drains inserted deep to the wounds. A lack of data exists in relating how long suction drains should stay in situ after major breast surgery. This study evaluates the appropriate timing of drain removal by comparing the 5-day-long postoperative drainage or drain removal when less than 50 mL/24 h to conventional drain removal. This controlled clinical trial was undertaken between February 1997 and May 2012 with a total of 214 consecutive patients who underwent elective total or partial mastectomy with level II axillary lymph node dissection. The main outcome measures included the length of hospital stay, and surgical morbidity, especially seroma formation. In the study group, the age and operation time were significantly increased compared to the conventional group whereas the median hospital stay was significantly shorter in the study group than the control group (7 days vs. 9 days; p < 0.05). The incidence of seroma was 42.8 % in the study group and 31.6 % in the control group (p = 0.14). The mean number of outpatient visits for seroma was 3.6 in the study group and 1.5 in the control group (p < 0.05). Drainage volume of more than 150 mL/24 h all resulted in seroma formation. The new criteria for early drain removal are safe and acceptable despite the slightly increased chance of seroma formation.	[Okada, Naoya; Narita, Yoshiaki; Takada, Minoru; Kato, Hiroaki; Ambo, Yoshiyasu; Nakamura, Fumitaka; Kishida, Akihiro; Kashimura, Nobuichi] Teine Keijinkai Hosp, Dept Surg, Teine Ku, Sapporo, Hokkaido 0068555, Japan	Okada, N (reprint author), Teine Keijinkai Hosp, Dept Surg, Teine Ku, 1-12 Maeda, Sapporo, Hokkaido 0068555, Japan.	o_naoya_o@me.com					Ackroyd R, 1997, BREAST, V6, P271, DOI 10.1016/S0960-9776(97)90003-5; Amit A, 2006, ANZ J SURG, V76, P1088; Gupta R, 2001, EUR J SURG ONCOL, V27, P26, DOI 10.1053/ejso.2000.1054; CHILSON TR, 1992, AM SURGEON, V58, P750; AITKEN DR, 1983, SURG CLIN N AM, V63, P1331; TADYCH K, 1987, SURG GYNECOL OBSTET, V165, P483; Purushotham AD, 2002, BRIT J SURG, V89, P286, DOI 10.1046/j.0007-1323.2001.02031.x; Barton A, 2006, AM J SURG, V191, P652, DOI 10.1016/j.amjsurg.2006.01.037; Bryant M, 1987, BRIT J SURG, V58, P239; Droeser RA, 2009, BREAST, V18, P109, DOI 10.1016/j.breast.2009.02.003; He XD, 2011, MED ONCOL, V28, pS22, DOI 10.1007/s12032-010-9673-2; JEFFREY SS, 1995, ARCH SURG-CHICAGO, V130, P909; Kopelman D, 1999, EUR J SURG, V165, P117; Talbot ML, 2002, ANZ J SURG, V72, P488, DOI 10.1046/j.1445-2197.2002.02456.x; YII M, 1995, ANN ROY COLL SURG, V77, P377	15	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	JAN	2015	22	1					79	83		10.1007/s12282-013-0457-3		5	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AX8GA	WOS:000347146900010		
J	Ishizuna, K; Ota, D; Fukuuchi, A; Teraoka, M; Fujii, A; Mori, M; Nishi, T				Ishizuna, Kazuo; Ota, Daisuke; Fukuuchi, Atsushi; Teraoka, Megumi; Fujii, Akiko; Mori, Masaya; Nishi, Tsunehiro			A case of femoral diaphyseal fracture after long-term treatment with zoledronic acid	BREAST CANCER			English	Article						Bisphosphonate; Zoledronic acid; Femoral fracture	SUBTROCHANTERIC STRESS-FRACTURES; SUPPRESSED BONE TURNOVER; PLACEBO-CONTROLLED TRIAL; BREAST-CANCER; SKELETAL COMPLICATIONS; ACCUMULATES MICRODAMAGE; ALENDRONATE THERAPY; PAMIDRONATE; METASTASES; WOMEN	We report here a case of femoral diaphyseal fracture thought to be caused by oversuppression of bone remodeling due to long-term bisphosphonate treatment. The patient was a 63-year-old postmenopausal woman. She had undergone left lumpectomy and sentinel node biopsy for left breast cancer at age 57. The case was diagnosed as pT2N0M0, stage IIA breast cancer. The biopsy sample was positive for hormone receptors and negative for HER2 protein. Postoperatively, exemestane was administered as adjuvant therapy. Right axillary lymph node metastasis was found at age 59, and right axillary lymph node dissection was performed. Postoperatively, epirubicin/cyclophosphamide and paclitaxel were administered. Subsequently, letrozole was administered. However, bone metastases to the first thoracic vertebra and right ilium were found at age 60, and zoledronic acid administration (4 mg/month) for bone metastasis was initiated. The patient developed a transverse fracture in the proximal left femoral diaphysis when she walked on a flat surface after zoledronic acid was administered for 2 years, 10 months. She was treated with an intramedullary nail for left femoral diaphyseal fracture. Cancellous bone of the medullary cavity was histopathologically examined, but there were no metastatic lesions from the breast cancer and no osteoblasts or osteoclasts were observed. Zoledronic acid was immediately discontinued in this patient. In recent years, cases of atypical femoral diaphyseal fractures caused by minor trauma in patients undergoing long-term bisphosphonate treatment have been reported. Thus, careful observation is required for patients who are anticipating bisphosphonate treatment.	[Ishizuna, Kazuo; Ota, Daisuke; Fukuuchi, Atsushi; Teraoka, Megumi; Nishi, Tsunehiro] Mitsui Mem Hosp, Dept Breast Endocrine Surg, Chiyoda Ku, Tokyo 1018643, Japan; [Fujii, Akiko; Mori, Masaya] Mitsui Mem Hosp, Dept Pathol, Chiyoda Ku, Tokyo 1018643, Japan	Ishizuna, K (reprint author), Mitsui Mem Hosp, Dept Breast Endocrine Surg, Chiyoda Ku, Kandaizumicho 1, Tokyo 1018643, Japan.	k.ishizuna@hotmail.co.jp					Ali T, 2009, AGE AGEING, V38, P625, DOI 10.1093/ageing/afp106; Hultborn R, 1999, ANTICANCER RES, V19, P3383; Hortobagyi GN, 1996, NEW ENGL J MED, V335, P1785, DOI 10.1056/NEJM199612123352401; Mavrokokki T, 2007, J ORAL MAXIL SURG, V65, P415, DOI 10.1016/j.joms.2006.10.061; Lenart BA, 2008, NEW ENGL J MED, V358, P1304, DOI 10.1056/NEJMc0707493; Theriault RL, 1999, J CLIN ONCOL, V17, P846; Odvina CV, 2005, J CLIN ENDOCR METAB, V90, P1294, DOI 10.1210/jc.2004-0952; Hortobagyi GN, 1998, J CLIN ONCOL, V16, P2038; Kohno N, 2005, J CLIN ONCOL, V23, P3314, DOI 10.1200/JCO.2005.05.116; Black DM, 2010, NEW ENGL J MED, V362, P1761, DOI 10.1056/NEJMoa1001086; Conte PF, 1996, J CLIN ONCOL, V14, P2552; Neviaser AS, 2008, J ORTHOP TRAUMA, V22, P346, DOI 10.1097/BOT.0b013e318172841c; Russell RGG, 1999, BONE, V25, P97, DOI 10.1016/S8756-3282(99)00116-7; Kwek EBK, 2008, INJURY, V39, P224, DOI 10.1016/j.injury.2007.08.036; Armamento-Villareal R, 2009, CALCIFIED TISSUE INT, V85, P37, DOI 10.1007/s00223-009-9263-5; BUTLER JE, 1982, AM J SPORT MED, V10, P228, DOI 10.1177/036354658201000407; Cheung RK, 2007, HONG KONG MED J, V13, P484; Dell R, 2009, ASBMR 2010 ANN M TOR; Edwards MH, 2010, OSTEOPOROSIS INT, V21, P701, DOI 10.1007/s00198-009-0986-y; Komatsubara S, 2004, J BONE MINER RES, V19, P999, DOI 10.1359/JBMR.040126; Komatsubara S, 2003, J BONE MINER RES, V18, P512, DOI 10.1359/jbmr.2003.18.3.512; Odvina CV, 2009, CLIN ENDOCRINOL OXF, V72, P161; Wernecke Greg, 2008, HSS J, V4, P123, DOI 10.1007/s11420-008-9077-4	23	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	JAN	2015	22	1					90	94		10.1007/s12282-011-0304-3		5	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AX8GA	WOS:000347146900012		
J	Mori, H; Uemura, N; Okazaki, M				Mori, Hiroki; Uemura, Noriko; Okazaki, Mutsumi			Nipple reconstruction with banked costal cartilage after vertical-type skin-sparing mastectomy and deep inferior epigastric artery perforator flap	BREAST CANCER			English	Article						Skin-sparing mastectomy; Deep inferior epigastric artery perforator flap; Banked cartilage; Nipple reconstruction		We recently used skin-sparing mastectomy (SSM), the deep inferior epigastric artery perforator (DIEP) flap, and delayed nipple reconstruction with banked costal cartilage. Eight patients who underwent these reconstructions between 2008 and 2010 were reviewed. SSM was performed by vertical-type incision. We transferred the DIEP flap using an internal thoracic vessel and banked costal cartilage into an abdominal wound. Three to 6 months later, we removed the cartilage and cut it into a cylindrical shape. We fixed the cartilage on the dermal base of a modified C-V flap. No flap necrosis or exposure of cartilage was seen and the scar was acceptable in all cases. At a mean follow-up of 12.6 months, 59% of the nipple projection was maintained in comparison to immediately postoperatively. Our new concept is the combination of SSM, DIEP, and banked cartilage, and furthermore putting the cartilage on a dermal base. With support from the dermis, a large, complicated cartilage form is unnecessary.	[Mori, Hiroki; Uemura, Noriko; Okazaki, Mutsumi] Tokyo Med & Dent Univ, Dept Plast & Reconstruct Surg, Bunkyo Ku, Tokyo 1138519, Japan	Mori, H (reprint author), Tokyo Med & Dent Univ, Dept Plast & Reconstruct Surg, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	moriplas@tmd.ac.jp		mori, hiroki/0000-0003-3190-6852			Heitland A, 2006, J PLAST RECONSTR AES, V59, P1063, DOI 10.1016/j.bjps.2005.02.021; Scholz T, 2008, PLAST RECONSTR SURG, V122, P1603, DOI 10.1097/PRS.0b013e31818a9a0a; BRENT B, 1992, PLAST RECONSTR SURG, V90, P355; Mori H, 2008, J PLAST RECONSTR AES, V61, P1109, DOI 10.1016/j.bjps.2008.04.010; Yamamoto Y, 2001, BRIT J PLAST SURG, V54, P723, DOI 10.1054/bjps.2001.3703; Yano Kenji, 2007, Breast Cancer, V14, P406, DOI 10.2325/jbcs.14.406	6	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1340-6868	1880-4233		BREAST CANCER-TOKYO	Beast Cancer	JAN	2015	22	1					95	97		10.1007/s12282-011-0329-7		3	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	AX8GA	WOS:000347146900013		
J	Inoue, K; Shishido, A; Vaccaro, N; Jiao, J; Stieltjes, H; Bernard, A; Yu, M; Chien, C				Inoue, Kouichi; Shishido, Akira; Vaccaro, Nicole; Jiao, James; Stieltjes, Hans; Bernard, Apexa; Yu, Margaret; Chien, Caly			Pharmacokinetics of abiraterone in healthy Japanese men: dose-proportionality and effect of food timing	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						Abiraterone acetate; Dose-proportionality; Food effect; Japanese; Pharmacokinetics	RESISTANT PROSTATE-CANCER; I CLINICAL-TRIAL; PHASE-I; OPEN-LABEL; ACETATE; POLYMORPHISMS; VOLUNTEERS; INHIBITOR; CYP17	Abiraterone acetate (AA) was recently approved for castration-resistant prostate cancer in Japan. Two phase 1 studies were conducted to assess the pharmacokinetics of abiraterone after single-dose administration in Japanese healthy men and to evaluate the effects of food timing on abiraterone pharmacokinetics after single-dose administration of AA in Japanese and Caucasian healthy men. In the dose-proportionality study, subjects (n = 30 Japanese) were randomly assigned to receive single doses of 250, 500, and 1,000 mg AA, and in the food-timing study, subjects (n = 22 Japanese and n = 23 Caucasian) randomly received single doses of 1,000 mg AA under fasted (overnight) and three different modified fasting conditions. Mean C (max) and AUC(a) for abiraterone increased dose-dependently in Japanese healthy men; however, 90 % confidential interval (CI) was outside the predefined dose-proportionality criteria. Based on geometric mean ratios and 90 % CIs (versus overnight fasting condition), abiraterone exposure (AUC) increased significantly with dosing 1 h premeal, 2 h postmeal, or in between two meals 4 h apart by 57 %, 595 %, and 649 %, respectively. No clinically meaningful difference was observed in the pharmacokinetics of abiraterone between Caucasian and Japanese subjects.	[Inoue, Kouichi; Shishido, Akira] Janssen Pharmaceut KK, Tokyo, Japan; [Vaccaro, Nicole; Jiao, James; Bernard, Apexa; Yu, Margaret; Chien, Caly] Janssen Res & Dev LLC, Titusville, NJ 08560 USA; [Stieltjes, Hans] Janssen Res & Dev, Beerse, Belgium	Chien, C (reprint author), Janssen Res & Dev LLC, Titusville, NJ 08560 USA.	CCHIEN@its.jnj.com			Janssen Research and Development, LLC; Janssen Research and Development Division, NV, Belgium; Janssen Pharmaceutical, KK, Japan; Janssen Research & Development, LLC, USA	We acknowledge PRA International, the Netherlands, for analyzing all plasma samples for abiraterone. The authors are most grateful to the study subjects for their contributions and the investigational staff for the medical care. The authors acknowledge Ashwini Patil, MS (SIRO Clinpharm Pvt. Ltd.) for writing assistance (funded by Janssen Research and Development, LLC), and Namit Ghildyal, PhD (Janssen Research & Development, LLC) for additional editorial support for the development of this manuscript. The authors received funding support from Janssen Research and Development Division, NV, Belgium, Janssen Pharmaceutical, KK, Japan, and Janssen Research & Development, LLC, USA.	Acharya M, 2011, ANN M AM ASS PHARM S; Singh BN, 1999, CLIN PHARMACOKINET, V37, P213, DOI 10.2165/00003088-199937030-00003; Attard G, 2008, J CLIN ONCOL, V26, P4563, DOI 10.1200/JCO.2007.15.9749; Lamba JK, 2002, ADV DRUG DELIVER REV, V54, P1271, DOI 10.1016/S0169-409X(02)00066-2; Tolcher AW, 2012, CANCER CHEMOTH PHARM, V70, P305, DOI 10.1007/s00280-012-1916-9; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Acharya M, 2012, CANCER CHEMOTH PHARM, V69, P1583, DOI 10.1007/s00280-012-1865-3; Kim K, 2004, J CLIN PHARMACOL, V44, P1083, DOI 10.1177/0091270004268128; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Ryan CJ, 2010, J CLIN ONCOL, V28, P1481, DOI 10.1200/JCO.2009.24.1281; Saruwatari J, 2010, EUR J CLIN PHARMACOL, V66, P899, DOI 10.1007/s00228-010-0834-1; Pithavala YK, 2012, CANCER CHEMOTH PHARM, V70, P103, DOI 10.1007/s00280-012-1888-9; Ryan CJ, 2013, NEW ENGL J MED, V368, P138, DOI 10.1056/NEJMoa1209096; Bernard A, 2015, CLIN PHARM DRUG DEV, V4, P63, DOI 10.1002/cpdd.132; Chi KN, 2013, EUROPEAN J CANC, V49; Cullen Jennifer, 2012, J Carcinog, V11, P7, DOI 10.4103/1477-3163.94025; Derks M, 2011, CLIN THER, V33, P754, DOI 10.1016/j.clinthera.2011.05.046; Hildebrandt MAT, 2007, PHARMACOGENOMICS J, V7, P133, DOI 10.1038/sj.tpj.6500404; Ingelman-Sundberg M, 2004, N-S ARCH PHARMACOL, V369, P89, DOI 10.1007/s00210-003-0819-z; Jada SR, 2006, ASCO ANN M P, V24, p18S; Kawahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048186; LE Marbury T, 2014, J CLIN PHARMACOL, V54, P732; Namiki M, 2010, JPN J CLIN ONCOL, V40, pi70, DOI 10.1093/jjco/hyq130; Nishimura K, 2013, INT J CLIN ONCOL, V18, P306, DOI 10.1007/s10147-012-0380-1; Suzuki K., 2009, JMAJ - Japan Medical Association Journal, V52, P478	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	JAN	2015	75	1					49	58		10.1007/s00280-014-2616-4		10	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	AX8IL	WOS:000347153200006		
J	Nojiri, T; Hosoda, H; Kimura, T; Miura, K; Ishikane, S; Tokudome, T; Shintani, Y; Inoue, M; Miyazato, M; Okumura, M; Kangawa, K				Nojiri, Takashi; Hosoda, Hiroshi; Kimura, Toru; Miura, Koichi; Ishikane, Shin; Tokudome, Takeshi; Shintani, Yasushi; Inoue, Masayoshi; Miyazato, Mikiya; Okumura, Meinoshin; Kangawa, Kenji			Atrial natriuretic peptide protects against cisplatin-induced acute kidney injury	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						Atrial natriuretic peptide; Acute kidney injury; Cisplatin	MESANGIAL CELLS; NEPHROTOXICITY; PROLIFERATION; KINASE	Cisplatin is an effective chemotherapeutic agent used in the treatment of a wide variety of malignancies. Acute kidney injury (AKI) is the major toxicity associated with cisplatin and sometimes necessitates a reduction in dose or discontinuation of treatment. Atrial natriuretic peptide (ANP) is secreted by the heart and exerts a wide range of renoprotective effects, including anti-inflammatory activity. The objective of this study was to investigate the protective effects of ANP on cisplatin-induced AKI in mice. Mice were randomly divided into three groups: control, cisplatin (20 mg/kg, intraperitoneal)/vehicle treatment, and cisplatin/ANP (1.5 mu g/kg/min via osmotic-pump, subcutaneous) treatment. At 72 h after cisplatin injection, serum blood urea nitrogen and creatinine, urine albumin/creatinine, and renal expression of mRNAs encoding tumor necrosis factor-alpha, interleukin (IL)-1 beta, IL-6, intercellular adhesion molecule-1, monocyte chemoattractant protein-1, and transforming growth factor (TGF)-beta were measured using real-time polymerase chain reaction. Histological changes were also evaluated. ANP treatment significantly attenuated cisplatin-induced increases in serum blood urea nitrogen and creatinine, urine albumin/creatinine, and renal expression of IL-1 beta, IL-6, intercellular adhesion molecule-1, and monocyte chemoattractant protein-1 mRNAs. Cisplatin-induced renal dysfunction and renal tubular necrosis were thus attenuated by ANP treatment. Our results indicate that ANP exhibits a protective effect against cisplatin-induced AKI in mice. ANP may thus be of value in prophylactic strategies aimed at mitigating the adverse effects associated with chemotherapy agents, including cisplatin.	[Nojiri, Takashi; Kimura, Toru; Ishikane, Shin; Tokudome, Takeshi; Miyazato, Mikiya; Kangawa, Kenji] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Biochem, Suita, Osaka 5658565, Japan; [Nojiri, Takashi; Kimura, Toru; Shintani, Yasushi; Inoue, Masayoshi; Okumura, Meinoshin] Osaka Univ, Grad Sch Med, Dept Gen Thorac Surg, Suita, Osaka, Japan; [Hosoda, Hiroshi; Miura, Koichi] Natl Cerebral & Cardiovasc Ctr, Dept Regenerat Med & Tissue Engn, Suita, Osaka 5658565, Japan	Nojiri, T (reprint author), Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Biochem, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	nojiri@ri.ncvc.go.jp			Takeda Science Foundation [26861136]; Japan Research Foundation for Clinical Pharmacology; Osaka Cancer Society; Kobayashi Foundation for Cancer Research, Japan	This work was supported in part by a Grant-in-Aid for Scientific Research (26861136) and a Grant from the Takeda Science Foundation, Japan Research Foundation for Clinical Pharmacology, Osaka Cancer Society, and Kobayashi Foundation for Cancer Research, Japan.	Nishikimi T, 2009, REGUL PEPTIDES, V154, P44, DOI 10.1016/j.regpep.2009.02.006; SAITO Y, 1987, CIRCULATION, V76, P115; Nishikimi T, 2006, CARDIOVASC RES, V69, P318, DOI 10.1016/j.cardiores.2005.10.001; Nojiri T, 2014, PULM PHARMACOL THER, V29, P24, DOI 10.1016/j.pupt.2014.01.003; Pandey KN, 2000, BIOCHEM BIOPH RES CO, V271, P374, DOI 10.1006/bbrc.2000.2627; Maimaitiyiming H, 2013, AM J PHYSIOL-RENAL, V305, pF881, DOI 10.1152/ajprenal.00192.2013; Yao X, 2007, AM J MED SCI, V334, P115, DOI 10.1097/MAJ.0b013e31812dfe1e; Morikawa S, 2009, J AM COLL CARDIOL, V53, P1040, DOI 10.1016/j.jacc.2008.10.061; TOTSUNE K, 1994, HYPERTENSION, V24, P758; Sezai A, 2011, J AM COLL CARDIOL, V58, P897, DOI 10.1016/j.jacc.2011.03.056; Kitakaze M, 2007, LANCET, V370, P1483, DOI 10.1016/S0140-6736(07)61634-1; Pabla N, 2008, KIDNEY INT, V73, P994, DOI 10.1038/sj.ki.5002786; Allgren RL, 1997, NEW ENGL J MED, V336, P828, DOI 10.1056/NEJM199703203361203; Mori Y, 2014, EUR J ANAESTH, V31, P381, DOI 10.1097/EJA.0000000000000035; Roson MI, 2006, AM J NEPHROL, V26, P590, DOI 10.1159/000098148; WOLF G, 1992, J AM SOC NEPHROL, V3, P1270	16	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	JAN	2015	75	1					123	129		10.1007/s00280-014-2624-4		7	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	AX8IL	WOS:000347153200013		
J	Uwagawa, T; Sakamoto, T; Abe, K; Okui, N; Hata, D; Shiba, H; Futagawa, Y; Aiba, K; Yanaga, K				Uwagawa, Tadashi; Sakamoto, Taro; Abe, Kyohei; Okui, Norimitsu; Hata, Daigo; Shiba, Hiroaki; Futagawa, Yasuro; Aiba, Keisuke; Yanaga, Katsuhiko			Phase I trial of S-1 every other day in combination with gemcitabine/cisplatin for inoperable biliary tract cancer	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						Biliary tract cancer; Gemcitabine; Cisplatin; S-1; Phase I	ADVANCED CHOLANGIOCARCINOMA; GASTRIC-CANCER; CISPLATIN; FEASIBILITY; ONCOLOGY	To date, gemcitabine-based or fluoropyrimidine-based regimens are recommended for unresectable advanced biliary tract cancer. Then, we conducted a phase I study of gemcitabine/cisplatin and S-1 that is an oral fluoropyrimidine. The aim of this study was to determine the dose-limiting toxicity (DLT), maximum-tolerated dose, and a recommended phase II dose of S-1. Response was assessed as a secondary endpoint. Patients who have been diagnosed with unresectable or postoperative recurrent biliary tract cancer received cisplatin (25 mg/m(2) i.v. for 120 min) followed by gemcitabine (1,000 mg/m(2) i.v. for 30 min) on days 1 and 8, and oral S-1 on alternate days; this regimen was repeated at 21-day intervals. A standard '3 + 3' phase I dose-escalation design was adopted. This study was registered with University hospital Medical Information Network (UMIN) Center in Japan, number UMIN000008415. Twelve patients were evaluable in this study. No patients developed DLTs. Recommended dose of S-1 was 80 (< 1.25 m(2)), 100 (1.25 a parts per thousand currency sign 1.5 m(2)), and 120 mg (1.5 m(2)a parts per thousand yen) per day. One patient could achieve conversion to curative surgery. This phase I study was performed safely and demonstrated encouraging response.	[Uwagawa, Tadashi; Sakamoto, Taro; Abe, Kyohei; Okui, Norimitsu; Hata, Daigo; Shiba, Hiroaki; Futagawa, Yasuro; Yanaga, Katsuhiko] Jikei Univ, Sch Med, Dept Surg, Minato Ku, Tokyo 1068471, Japan; [Uwagawa, Tadashi; Aiba, Keisuke] Jikei Univ, Sch Med, Dept Hematol & Med Oncol, Minato Ku, Tokyo 1068471, Japan	Uwagawa, T (reprint author), Jikei Univ, Sch Med, Dept Surg, Minato Ku, 3-19-18 Nishi Shinbashi, Tokyo 1068471, Japan.	uwatadashi@msn.com					Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI [10.1016/S1470-2045(08)70035-4, 10.1016/S1470-204S(08)70035-4]; Sasaki T, 2013, CANCER CHEMOTH PHARM, V71, P973, DOI 10.1007/s00280-013-2090-4; Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721; Sohal DPS, 2013, ANN ONCOL, V24, P3061, DOI 10.1093/annonc/mdt416; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Tatebe S, 2014, GASTRIC CANCER, V17, P508, DOI 10.1007/s10120-013-0289-z; Morizane C, 2013, CANCER SCI, V104, P1211, DOI 10.1111/cas.12218; Borbath I, 2013, ANN ONCOL, V24, P2824, DOI 10.1093/annonc/mdt337; de Groen PC, 1999, NEW ENGL J MED, V341, P1368, DOI 10.1056/NEJM199910283411807; Hezel AF, 2014, BR J CANC IN PRESS; Kanai M, 2012, CANCER CHEMOTH PHARM, V69, P1181, DOI 10.1007/s00280-011-1818-2; Kang MJ, 2012, ACTA ONCOL, V51, P860, DOI 10.3109/0284186X.2012.682628; Kogashiwa Y, 2012, ANTICANCER RES, V32, P4035; Santini D, 2012, ONCOLOGY-BASEL, V82, P75, DOI 10.1159/000329079; Sasaki T, 2012, INVEST NEW DRUG, V30, P708, DOI 10.1007/s10637-010-9553-9	15	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	JAN	2015	75	1					191	196		10.1007/s00280-014-2636-0		6	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	AX8IL	WOS:000347153200020		
J	Isobe, K; Hata, Y; Tochigi, N; Kaburaki, K; Kobayashi, H; Makino, T; Otsuka, H; Ishida, F; Hirota, N; Sano, G; Sugino, K; Sakamoto, S; Takai, Y; Shibuya, K; Iyoda, A; Homma, S				Isobe, Kazutoshi; Hata, Yoshinobu; Tochigi, Naobumi; Kaburaki, Kyohei; Kobayashi, Hiroshi; Makino, Takashi; Otsuka, Hajime; Ishida, Fumiaki; Hirota, Nao; Sano, Go; Sugino, Keishi; Sakamoto, Susumu; Takai, Yujiro; Shibuya, Kazutoshi; Iyoda, Akira; Homma, Sakae			Usefulness of Nanofluidic Digital PCR Arrays to Quantify T790M Mutation in EGFR-mutant Lung Adenocarcinoma	CANCER GENOMICS & PROTEOMICS			English	Article						Digital PCR; non-small-cell lung cancer; epidermal growth factor receptor tyrosine kinase inhibitor; T790M	GROWTH-FACTOR RECEPTOR; ACQUIRED-RESISTANCE; SENSITIVE DETECTION; CANCER; GEFITINIB; CHEMOTHERAPY; ERLOTINIB	Aim: The present pilot study assessed the usefulness of nanofluidic digital polymerase chain reaction (PCR) arrays in epidermal growth factor receptor (EGFR)mutant lung adenocarcinoma after tyrosine kinase inhibitor (TKI) resistance. Patients and Methods: We enrolled 12 patients with primary lung adenocarcinoma with sensitive EGFR mutation-confirmed T790M status by re-biopsy after TKI resistance. Nanofluidic digital PCR arrays were used to quantify T790M in genomic DNA from the pre-treatment primary site and in serum cell-free DNA (cfDNA). Results: On digital PCR, quantified T790M at the pre-treatment primary site was higher in re-biopsy-positive T790M patients (n=4) than in re-biopsy-negative patients (n=8) (0.78% +/- 0.36% vs. 0.07%+/- 0.09%, p< 0.01). T790M at the pre-treatment primary site correlated with progression-free survival (PFS) after gefitinib therapy (r=0.67, p=0.016). Conclusion: Use of digital PCR to quantify T790M at the primary site of EGFR-mutant lung adenocarcinoma predicted T790M emergence in re-biopsies after TKI resistance and PFS after gefitinib therapy.	[Isobe, Kazutoshi; Kaburaki, Kyohei; Kobayashi, Hiroshi; Ishida, Fumiaki; Hirota, Nao; Sano, Go; Sugino, Keishi; Sakamoto, Susumu; Takai, Yujiro; Homma, Sakae] Toho Univ, Sch Med, Div Resp Med, Tokyo 1438541, Japan; [Hata, Yoshinobu; Makino, Takashi; Otsuka, Hajime; Iyoda, Akira] Toho Univ, Sch Med, Div Chest Surg, Tokyo 1438541, Japan; [Tochigi, Naobumi; Shibuya, Kazutoshi] Toho Univ, Sch Med, Dept Surg Pathol, Tokyo 1438541, Japan	Isobe, K (reprint author), Toho Univ, Sch Med, Div Resp Med, Ota Ku, 6-11-1 Omori Nishi, Tokyo 1438541, Japan.	kazutoshiisobe@aol.com			Japanese Ministry of Education, Culture, Sports, Science and Technology [26462140]	The Authors would like to thank Atsushi Kakimoto, Hiroki Todoroki and Satoshi Natsume of SRL Inc. (Tokyo, Japan). We are also grateful to David Kipler for his editorial review of this article. This study was supported in part by a Grant-in-aid for Scientific Research (C) no. 26462140 from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; Su KY, 2012, J CLIN ONCOL, V30, P433, DOI 10.1200/JCO.2011.38.3224; Ogino A, 2007, CANCER RES, V67, P7807, DOI 10.1158/0008-5472.CAN-07-0681; Oxnard GR, 2011, CLIN CANCER RES, V17, P1616, DOI 10.1158/1078-0432.CCR-10-2692; Engelman JA, 2006, J CLIN INVEST, V116, P2695, DOI 10.1172/JCI28656; Ohashi K, 2013, J CLIN ONCOL, V31, P1070, DOI 10.1200/JCO.2012.43.3912; Wang J, 2010, CLIN CHEM, V56, P623, DOI 10.1373/clinchem.2009.134973; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Azzoli CG, 2011, J CLIN ONCOL, V29, P3825, DOI 10.1200/JCO.2010.34.2774; Costa C, 2014, CLIN CANCER RES, V20, P2001, DOI 10.1158/1078-0432.CCR-13-2233; Rosell R, 2011, CLIN CANCER RES, V17, P1160, DOI 10.1158/1078-0432.CCR-10-2158; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Oxnard GR, 2014, CLIN CANCER RES, V20, P1698, DOI 10.1158/1078-0432.CCR-13-2482; Ettinger DS, 2010, J NATL COMPR CANC NE, V8, P740; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Walter AO, 2013, CANCER DISCOV, V3, P1404, DOI 10.1158/2159-8290.CD-13-0314; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Fujita Y, 2012, J THORAC ONCOL, V7, P1640, DOI 10.1097/JTO.0b013e3182653d7f; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Yano S, 2011, J THORAC ONCOL, V6, P2011, DOI 10.1097/JTO.0b013e31823ab0dd; Chmielecki J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002356; Cross DAE, 2014, CANCER DISCOV, V4, P1046, DOI 10.1158/2159-8290.CD-14-0337; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003	28	2	2	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	1109-6535	1790-6245		CANCER GENOM PROTEOM	Cancer Genomics Proteomics	JAN-FEB	2015	12	1					31	37				7	Oncology; Genetics & Heredity	Oncology; Genetics & Heredity	AY0RW	WOS:000347305400004		
J	Kimura, H; Matsui, Y; Ishikawa, A; Nakajima, T; Yoshino, M; Sakairi, Y				Kimura, Hideki; Matsui, Yukiko; Ishikawa, Aki; Nakajima, Takahiro; Yoshino, Mitsuru; Sakairi, Yuichi			Randomized controlled phase III trial of adjuvant chemo-immunotherapy with activated killer T cells and dendritic cells in patients with resected primary lung cancer	CANCER IMMUNOLOGY IMMUNOTHERAPY			English	Article						Phase III study; Lung cancer; Adjuvant therapy; Immunotherapy; Lymph node; Dendritic cell	DRAINING LYMPH-NODES; CIRCULATING TUMOR-CELLS; GROWTH-FACTOR; CHEMOTHERAPY; IMMUNOTHERAPY; HETEROGENEITY; DORMANCY; THERAPY; MICROENVIRONMENT; METAANALYSIS	We conducted a phase III randomized controlled trial (RCT) to investigate the efficacy of postsurgical adjuvant immunotherapy combined with chemotherapy. The immunotherapy targets were residual micrometastases and clones resistant to chemotherapy. Between April 2007 and July 2012, 103 postsurgical non-small cell lung cancer patients were randomly assigned to receive either chemo-immunotherapy (group A) or chemotherapy (group B). The immunotherapy consisted of the adoptive transfer of autologous activated killer T cells and dendritic cells obtained from the lung cancer patients' own regional lymph nodes. The 2-year overall survival rates in groups A and B were 93.4 and 66.0 %, and the 5-year rates were 81.4 and 48.3 %, respectively. The differences were statistically significantly better in group A. The hazard ratio (HR) was 0.229 (p = 0.0013). The 2- and 5-year recurrence-free survival rates were 68.5, 41.4 and 56.8, 26.2 % in groups A and B, respectively. Those differences were also statistically significant (log-rank test p = 0.0020). The HR was 0.423 (p = 0.0027) in favor of group A. As for adverse reactions to immunotherapy, of a total of 762 courses, 52 (6.8 %) were accompanied with chills and shivering, and 47 (6.2 %), with fever (> 38 A degrees C). Immunotherapy has the potential to improve the postsurgical prognosis of lung cancer patients, but a large-scale multi-institutional RCT is awaited for further confirmation of this study.	[Kimura, Hideki; Matsui, Yukiko] Chiba Canc Ctr, Div Thorac Dis, Chiba 2608717, Japan; [Ishikawa, Aki; Nakajima, Takahiro; Yoshino, Mitsuru; Sakairi, Yuichi] Chiba Univ, Grad Sch Med, Dept Gen Thorac Surg, Chiba, Japan	Kimura, H (reprint author), Saiseikai Narashino Hosp, Izumi Cho 1-1-1, Narashino, Chiba 2758580, Japan.	h.kimura@chiba-saiseikai.com					Adema GJ, 1997, NATURE, V387, P713, DOI 10.1038/42716; Kimura H, 2007, LUNG CANCER, V56, P349, DOI 10.1016/j.lungcan.2007.01.018; Kim R, 2007, IMMUNOLOGY, V121, P1, DOI 10.1111/j.1365-2567.2007.02587.x; Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Kimura H, 1997, CANCER, V80, P42, DOI 10.1002/(SICI)1097-0142(19970701)80:1<42::AID-CNCR6>3.0.CO;2-H; Pardoll D, 2003, ANNU REV IMMUNOL, V21, P807, DOI 10.1146/annurev.immunol.21.120601.141135; O'Flaherty JD, 2012, LUNG CANCER, V76, P19, DOI 10.1016/j.lungcan.2011.10.018; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Gattinoni L, 2006, NAT REV IMMUNOL, V6, P383, DOI 10.1038/nri1842; Kuwai T, 2008, AM J PATHOL, V172, P358, DOI 10.2353/ajpath.2008.070625; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; MAASS G, 1995, P NATL ACAD SCI USA, V92, P5540, DOI 10.1073/pnas.92.12.5540; Strauss GM, 2008, J CLIN ONCOL, V26, P5043, DOI 10.1200/JCO.2008.16.4855; Almog N, 2010, CANCER LETT, V294, P139, DOI 10.1016/j.canlet.2010.03.004; Gorges TM, 2013, CANCER IMMUNOL IMMUN, V62, P931, DOI 10.1007/s00262-012-1387-1; Chen G, 2013, CANCER IMMUNOL IMMUN, V62, P203, DOI 10.1007/s00262-012-1388-0; Gajewski TF, 2006, IMMUNOL REV, V213, P131, DOI 10.1111/j.1600-065X.2006.00442.x; Burdett S, 2006, J THORAC ONCOL, V1, P611; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Becker JC, 2013, CANCER IMMUNOL IMMUN, V62, P1137, DOI 10.1007/s00262-013-1434-6; Berghmans T, 2005, LUNG CANCER-J IASLC, V49, P13, DOI 10.1016/j.lungcan.2005.01.002; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Bennouna J, 2011, LUNG CANCER, V74, P30, DOI 10.1016/j.lungcan.2011.02.004; Le Chevalier T, 2004, NEW ENGL J MED, V350, P351; Enderling H, 2012, CANCER RES, V72, P2172, DOI 10.1158/0008-5472.CAN-11-3269; Felip E, 2013, CURR OPIN ONCOL, V25, P115, DOI 10.1097/CCO.0b013e32835ca1b0; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gutkin DW, 2014, CANCER IMMUNOL IMMUN, V63, P45, DOI 10.1007/s00262-013-1480-0; KADOYAMA C, 1987, JPN J CLIN ONCOL, V17, P29; Kimura H, 2008, ANTICANCER RES, V28, P1229; KIMURA H, 1989, JPN J CLIN ONCOL, V19, P222; KIMURA H, 1983, JPN J CLIN ONCOL, V13, P3; Kimura H, 2005, ANTICANCER RES, V25, P85; Schweighoffer T, 1996, GENE THER, V3, P819; Tango T, 2003, MED STAT SERIES, V5, P59	37	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-7004	1432-0851		CANCER IMMUNOL IMMUN	Cancer Immunol. Immunother.	JAN	2015	64	1					51	59		10.1007/s00262-014-1613-0		9	Oncology; Immunology	Oncology; Immunology	AX9UY	WOS:000347248600005		
J	Matsushita, H; Hosoi, A; Ueha, S; Abe, J; Fujieda, N; Tomura, M; Maekawa, R; Matsushima, K; Ohara, O; Kakimi, K				Matsushita, Hirokazu; Hosoi, Akihiro; Ueha, Satoshi; Abe, Jun; Fujieda, Nao; Tomura, Michio; Maekawa, Ryuji; Matsushima, Kouji; Ohara, Osamu; Kakimi, Kazuhiro			Cytotoxic T Lymphocytes Block Tumor Growth Both by Lytic Activity and IFN gamma-Dependent Cell-Cycle Arrest	CANCER IMMUNOLOGY RESEARCH			English	Article							ANTIGEN-LOSS VARIANTS; IN-VIVO; INTERFERON-GAMMA; ADOPTIVE IMMUNOTHERAPY; ESTABLISHED TUMORS; CANCER; STAT1; ERADICATION; INDUCTION; P27(KIP1)	To understand global effector mechanisms of CTL therapy, we performed microarray gene expression analysis in a murine model using pmel-1 T-cell receptor (TCR) transgenic T cells as effectors and B16 melanoma cells as targets. In addition to upregulation of genes related to antigen presentation and the MHC class I pathway, and cytotoxic effector molecules, cell-cycle-promoting genes were downregulated in the tumor on days 3 and 5 after CTL transfer. To investigate the impact of CTL therapy on the cell cycle of tumor cells in situ, we generated B16 cells expressing a fluorescent ubiquitination-based cell-cycle indicator (B16-fucci) and performed CTL therapy in mice bearing B16-fucci tumors. Three days after CTL transfer, we observed diffuse infiltration of CTLs into the tumor with a large number of tumor cells arrested at the G(1) phase of the cell cycle, and the presence of spotty apoptotic or necrotic areas. Thus, tumor growth suppression was largely dependent on G(1) cell-cycle arrest rather than killing by CTLs. Neutralizing antibody to IFN gamma prevented both tumor growth inhibition and G(1) arrest. The mechanism of G(1) arrest involved the downregulation of S-phase kinase-associated protein 2 (Skp2) and the accumulation of its target cyclin-dependent kinase inhibitor p27 in the B16-fucci tumor cells. Because tumor-infiltrating CTLs are far fewer in number than the tumor cells, we propose that CTLs predominantly regulate tumor growth via IFN gamma-mediated profound cytostatic effects rather than via cytotoxicity. This dominance of G(1) arrest over other mechanisms may be widespread but not universal because IFN gamma sensitivity varied among tumors. (C) 2014 AACR.	[Matsushita, Hirokazu; Hosoi, Akihiro; Fujieda, Nao; Kakimi, Kazuhiro] Tokyo Univ Hosp, Dept Immunotherapeut, Tokyo 1138655, Japan; [Hosoi, Akihiro; Fujieda, Nao; Maekawa, Ryuji] Medinet Co Ltd, Yokohama, Kanagawa, Japan; [Ueha, Satoshi; Abe, Jun; Matsushima, Kouji] Univ Tokyo, Grad Sch Med, Dept Mol Prevent Med, Tokyo, Japan; [Tomura, Michio] Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Kyoto, Japan; [Ohara, Osamu] Kazusa DNA Res Inst, Dept Human Genome Res, Chiba, Japan	Kakimi, K (reprint author), Tokyo Univ Hosp, Dept Immunotherapeut, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kakimi@m.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	This study was supported in part by a Grant-in-Aid for Scientific Research of the Ministry of Education, Culture, Sports, Science and Technology of Japan (K. Kakimi).	Spiotto MT, 2004, NAT MED, V10, P294, DOI 10.1038/nm999; KAGI D, 1994, SCIENCE, V265, P528, DOI 10.1126/science.7518614; Brenner MK, 2010, CURR OPIN IMMUNOL, V22, P251, DOI 10.1016/j.coi.2010.01.020; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Dimco G, 2010, CELL CYCLE, V9, P4638, DOI 10.4161/cc.9.23.13955; LUSTER AD, 1993, J EXP MED, V178, P1057, DOI 10.1084/jem.178.3.1057; Lin HK, 2010, NATURE, V464, P374, DOI 10.1038/nature08815; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Lee SH, 2005, FEBS LETT, V579, P1027, DOI 10.1016/j.febslet.2005.01.005; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Delia D, 2003, ONCOGENE, V22, P7866, DOI 10.1038/sj.onc.1207086; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; Bromberg JF, 1996, P NATL ACAD SCI USA, V93, P7673, DOI 10.1073/pnas.93.15.7673; Imai N, 2009, EUR J IMMUNOL, V39, P241, DOI 10.1002/eji.200838824; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Kitagawa R, 2005, COLD SH Q B, V70, P99, DOI 10.1101/sqb.2005.70.002; MEURS E, 1990, CELL, V62, P379, DOI 10.1016/0092-8674(90)90374-N; Muller-Hermelink N, 2008, CANCER CELL, V13, P507, DOI 10.1016/j.ccr.2008.04.001; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; LIAO F, 1995, J EXP MED, V182, P1301, DOI 10.1084/jem.182.5.1301; Vierboom MPM, 1997, J EXP MED, V186, P695, DOI 10.1084/jem.186.5.695; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; DIGHE AS, 1994, IMMUNITY, V1, P447, DOI 10.1016/1074-7613(94)90087-6; Melnikova VO, 2004, ONCOGENE, V23, P2347, DOI 10.1038/sj.onc.1207405; Braumuller H, 2013, NATURE, V494, P361, DOI 10.1038/nature11824; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Hanson HL, 2000, IMMUNITY, V13, P265, DOI 10.1016/S1074-7613(00)00026-1; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; Breart B, 2008, J CLIN INVEST, V118, P1390, DOI 10.1172/JCI34388; Harvat BL, 1997, ONCOGENE, V14, P2111, DOI 10.1038/sj.onc.1201055; DEISS LP, 1995, GENE DEV, V9, P15, DOI 10.1101/gad.9.1.15; Gooch JL, 2000, CELL GROWTH DIFFER, V11, P335; Hobeika AC, 1999, J INTERF CYTOK RES, V19, P1351, DOI 10.1089/107999099312812; Hosoi A, 2014, INT J CANCER, V134, P1810, DOI 10.1002/ijc.28506; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Mukherjee P, 2001, CLIN CANCER RES, V7, p848S; Noji S, 2012, J IMMUNOTHER, V35, P460, DOI 10.1097/CJI.0b013e31826092db; Perret R, 2008, EUR J IMMUNOL, V38, P2886, DOI 10.1002/eji.200838483; Ranganath S, 1998, J IMMUNOL, V161, P3822; Wang S, 2010, MOL CANCER RES, V8, P798, DOI 10.1158/1541-7786.MCR-10-0027; Winter H, 2001, J IMMUNOL, V166, P7370; Zhang B, 2008, J CLIN INVEST, V118, P1398, DOI 10.1172/JCI33522	44	4	4	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	2326-6066	2326-6074		CANCER IMMUNOL RES	Cancer Immunol. Res.	JAN	2015	3	1					26	36		10.1158/2326-6066.CIR-14-0098		11	Oncology; Immunology	Oncology; Immunology	AY3AX	WOS:000347458000005		
J	Imada, Y; Osaki, M; Noguchi, M; Maeda, T; Fujiki, M; Kawamorita, S; Komiya, N; Naota, T				Imada, Yasushi; Osaki, Motonari; Noguchi, Mikiko; Maeda, Takatoshi; Fujiki, Misa; Kawamorita, Soichiro; Komiya, Naruyoshi; Naota, Takeshi			Flavin-Functionalized Gold Nanoparticles as an Efficient Catalyst for Aerobic Organic Transformations	CHEMCATCHEM			English	Article						flavins; gold; nanoparticles; oxidation; reduction	HYDROGEN-PEROXIDE; AU NANOPARTICLES; MOLECULAR-OXYGEN; VISIBLE-LIGHT; OXIDATION; SULFIDES; AMINES; DIIMIDE; MONOOXYGENASES; BIOCATALYSTS	Monolayer-protected gold clusters functionalized with synthetic flavins were synthesized and their catalytic activity in aerobic organic transformations investigated. Gold nanoparticles with 5-ethyl-3-(8-thiooctyl)lumiflavinium perchlorate acts as an efficient catalyst for the aerobic oxidation of organic sulfides to the corresponding sulfoxides upon treatment with hydrazine at room temperature and under atmospheric pressure in oxygen. With a catalytic amount of gold nanoparticles with 3-(8-thiooctyl)lumiflavin, diimide reduction of various olefins can be performed with hydrazine at room temperature under atmospheric pressure in air with greater yields of product alkanes than with non-supported 3-methyllumiflavin catalyst under the same conditions. Kinetic studies revealed that the monolayer-protected gold cluster-catalyzed reactions proceeded faster than those with non-supported catalysts over the full substrate concentration range for the hydrogenation of olefins and at lower substrate concentrations for sulfoxidation. This positive effect was rationalized by assuming a Michaelis-Menten-type mechanism in which the specific inclusion of substrates into the enzyme-like reaction cavities was a key factor in the high efficiency of the supported flavin catalysts.	[Imada, Yasushi; Osaki, Motonari; Noguchi, Mikiko; Maeda, Takatoshi; Fujiki, Misa; Kawamorita, Soichiro; Komiya, Naruyoshi; Naota, Takeshi] Osaka Univ, Grad Sch Engn Sci, Dept Chem, Toyonaka, Osaka 5608531, Japan	Naota, T (reprint author), Osaka Univ, Grad Sch Engn Sci, Dept Chem, Toyonaka, Osaka 5608531, Japan.	naota@chem.es.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Alexander B. E., 2001, CHEM-EUR J, V7, P297; Weare WW, 2000, J AM CHEM SOC, V122, P12890, DOI 10.1021/ja002673n; Kotoucova H, 2014, ORG BIOMOL CHEM, V12, P2137, DOI 10.1039/c3ob42081g; MURAHASHI SI, 1989, J AM CHEM SOC, V111, P5002, DOI 10.1021/ja00195a076; Hanes CS, 1932, BIOCHEM J, V26, P1406; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; Schatz A, 2010, CHEM-EUR J, V16, P8950, DOI 10.1002/chem.200903462; Pasquato L, 2004, J MATER CHEM, V14, P3481, DOI 10.1039/b410476e; Imada Y, 2013, SYNTHETIC COMMUN, V43, P3064, DOI 10.1080/00397911.2013.767912; Murahashi S, 2014, CHEM COMMUN, V50, P10295, DOI 10.1039/c4cc05216a; Imada Y, 2005, ANGEW CHEM INT EDIT, V44, P1704, DOI 10.1002/anie.200462429; Imada Y, 2010, ORG LETT, V12, P32, DOI 10.1021/ol902393p; Alvarez MM, 1997, J PHYS CHEM B, V101, P3706, DOI 10.1021/jp962922n; Svoboda J, 2008, CHEM-EUR J, V14, P1854, DOI 10.1002/chem.200701319; Imada Y, 2003, J AM CHEM SOC, V125, P2868, DOI 10.1021/ja028276p; Imada Y, 2006, CHEM-ASIAN J, V1, P136, DOI 10.1002/asia.200600080; KEMAL C, 1977, J AM CHEM SOC, V99, P7272, DOI 10.1021/ja00464a030; FUKUZUMI S, 1985, J AM CHEM SOC, V107, P3020, DOI 10.1021/ja00297a005; Imada Y, 2011, CHEM-EUR J, V17, P5908, DOI 10.1002/chem.201003278; Bergstad K, 1998, J ORG CHEM, V63, P6650, DOI 10.1021/jo980926d; Gelalcha FG, 2007, CHEM REV, V107, P3338, DOI 10.1021/cr0505223; Imada Y, 2013, TETRAHEDRON LETT, V54, P621, DOI 10.1016/j.tetlet.2012.11.133; Imada Y, 2013, SYNLETT, V24, P1679, DOI 10.1055/s-0033-1339276; Marsh BJ, 2011, CHEM COMMUN, V47, P280, DOI 10.1039/c0cc02272a; Imada Y, 2014, TETRAHEDRON, V70, P495, DOI 10.1016/j.tet.2013.11.024; Smit C, 2008, J ORG CHEM, V73, P9482, DOI 10.1021/jo801588d; Backvall J.-E., 2004, MODERN OXIDATION MET, P193, DOI 10.1002/3527603689.ch7; Fitzpatrick PF, 2001, ACCOUNTS CHEM RES, V34, P299, DOI 10.1021/ar0000511; Hoegy SE, 1997, TETRAHEDRON, V53, P5027, DOI 10.1016/S0040-4020(97)00206-8; Imada Y, 2007, TETRAHEDRON LETT, V48, P937, DOI 10.1016/j.tetlet.2006.12.017; Imada Y, 2005, J AM CHEM SOC, V127, P14544, DOI 10.1021/ja053976q; Imada Y, 2013, TETRAHEDRON, V69, P8572, DOI 10.1016/j.tet.2013.07.082; Imada Y, 2007, CHEM REC, V7, P354, DOI 10.1002/tcr.20135; Imada Y., 2005, ANGEW CHEM, V117, P1732, DOI 10.1002/ange.200462429; Ionita P, 2004, LANGMUIR, V20, P11536, DOI 10.1021/la048121q; Kamerbeek NM, 2003, ADV SYNTH CATAL, V345, P667, DOI 10.1002/adsc.200303014; KEMAL C, 1976, P NATL ACAD SCI USA, V73, P995, DOI 10.1073/pnas.73.4.995; Moonen MJH, 2002, ADV SYNTH CATAL, V344, P1023, DOI 10.1002/1615-4169(200212)344:10<1023::AID-ADSC1023>3.0.CO;2-T; Lechner R, 2010, SYNTHESIS-STUTTGART, P1712, DOI 10.1055/s-0029-1218709; Mazzini C, 1996, J ORG CHEM, V61, P8, DOI 10.1021/jo951905b; Pasto D. J., 1991, ORG REACTIONS, V40, P91; SHINKAI S, 1985, J AM CHEM SOC, V107, P6286, DOI 10.1021/ja00308a021; SHINKAI S, 1982, CHEM LETT, P809, DOI 10.1246/cl.1982.809; Tam-Chang SW, 1999, CHEM COMMUN, P65, DOI 10.1039/a806315j; Wellsted H, 2004, ANAL CHEM, V76, P2010, DOI 10.1021/ac035465x; YANO Y, 1985, J CHEM SOC PERK T 2, P753, DOI 10.1039/p29850000753; Zincke T., 1910, CHEM BER, V43, P837	47	4	4	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1867-3880	1867-3899		CHEMCATCHEM	ChemCatChem	JAN	2015	7	1					99	106		10.1002/cctc.201402619		8	Chemistry, Physical	Chemistry	AY4GN	WOS:000347536400016		
J	Mukaiyama, T; Ogata, K; Ono, T; Hayashi, Y				Mukaiyama, Takasuke; Ogata, Kento; Ono, Tsuyoshi; Hayashi, Yujiro			Asymmetric Organocatalyzed Epoxidation of 2-Oxoindoline-3-ylidene Acetaldehydes	CHEMCATCHEM			English	Article						asymmetric reaction; epoxide; organocatalysis; oxindole	ENANTIOSELECTIVE EPOXIDATION; ALPHA,BETA-UNSATURATED ALDEHYDES; MICHAEL ADDITION; ISATYLIDENE-3-ACETALDEHYDES APPLICATION; BIFUNCTIONAL ORGANOCATALYST; UNFUNCTIONALIZED OLEFINS; HYDROGEN-PEROXIDE; KETONES; CATALYSIS; ENALS	The asymmetric epoxidation of 2-oxoindoline-3-ylidene acetaldehydes, catalyzed by diarylprolinol silyl ether, has been developed. The reaction provides oxindole derivatives possessing chiral epoxides in good yield with good diastereoselectivity and excellent enantioselectivity.	[Mukaiyama, Takasuke; Ogata, Kento; Ono, Tsuyoshi; Hayashi, Yujiro] Tohoku Univ, Grad Sch Sci, Dept Chem, Aoba Ku, Sendai, Miyagi 9808578, Japan	Hayashi, Y (reprint author), Tohoku Univ, Grad Sch Sci, Dept Chem, Aoba Ku, 6-3 Aramaki Aza Aoba, Sendai, Miyagi 9808578, Japan.	yhayashi@m.tohoku.ac.jp			Mitsubishi Foundation; Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was supported by Mitsubishi Foundation and a Grant-in-Aid for Scientific Research on Innovative Areas "Advanced Molecular Transformations by Organocatalysts" from The Ministry of Education, Culture, Sports, Science and Technology, Japan.	Adamo MFA, 2000, J AM CHEM SOC, V122, P8317, DOI 10.1021/ja0004433; Dondoni A, 2008, ANGEW CHEM INT EDIT, V47, P4638, DOI 10.1002/anie.200704684; JACOBSEN EN, 1991, J AM CHEM SOC, V113, P7063, DOI 10.1021/ja00018a068; Lu XJ, 2008, J AM CHEM SOC, V130, P8134, DOI 10.1021/ja802982h; Hayashi Y, 2005, ANGEW CHEM INT EDIT, V44, P4212, DOI 10.1002/anie.200500599; Wang X, 2008, ANGEW CHEM INT EDIT, V47, P1119, DOI 10.1002/anie.200704185; Bertelsen S, 2009, CHEM SOC REV, V38, P2178, DOI 10.1039/b903816g; Inoue M, 2003, ANGEW CHEM INT EDIT, V42, P2654, DOI 10.1002/anie.200351130; Reisinger CM, 2008, ANGEW CHEM INT EDIT, V47, P8112, DOI 10.1002/anie.200803238; Liu RR, 2013, ORG LETT, V15, P2266, DOI 10.1021/ol400845c; Zhao GL, 2007, ADV SYNTH CATAL, V349, P1210, DOI 10.1002/adsc.200600529; Wang ZX, 1997, J AM CHEM SOC, V119, P11224, DOI 10.1021/ja972272g; Lu J, 2008, TETRAHEDRON LETT, V49, P6007, DOI 10.1016/j.tetlet.2008.07.175; IRIE R, 1990, TETRAHEDRON LETT, V31, P7345, DOI 10.1016/S0040-4039(00)88562-7; Marigo M, 2005, J AM CHEM SOC, V127, P6964, DOI 10.1021/ja051808s; Lattanzi A, 2005, ORG LETT, V7, P2579, DOI 10.1021/ol050694m; Nemoto T, 2001, J AM CHEM SOC, V123, P2725, DOI 10.1021/ja004201e; Lee S, 2006, TETRAHEDRON, V62, P11413, DOI 10.1016/j.tet.2006.07.055; Peris G, 2007, J AM CHEM SOC, V129, P8710, DOI 10.1021/ja073055a; Tanzer EM, 2012, CHEM-EUR J, V18, P11334, DOI 10.1002/chem.201201316; Lifchits O, 2010, J AM CHEM SOC, V132, P10227, DOI 10.1021/ja1037935; Liu RR, 2013, CHEM-EUR J, V19, P7319, DOI 10.1002/chem.201300977; Marigo M, 2005, ANGEW CHEM INT EDIT, V44, P794, DOI 10.1002/anie.200462101; Melchiorre P, 2008, ANGEW CHEM INT EDIT, V47, P6138, DOI 10.1002/anie.200705523; Mukaiyama T, 2014, CHEM-EUR J, V20, P13583, DOI 10.1002/chem.201403932; Mukherjee S, 2007, CHEM REV, V107, P5471, DOI 10.1021/cr0684016; MacMillan DWC, 2008, NATURE, V455, P304, DOI 10.1038/nature07367; Marques-Lopez E, 2010, NAT PROD REP, V27, P1138, DOI 10.1039/b924964h; Nemoto T, 2001, J AM CHEM SOC, V123, P9474, DOI 10.1021/ja0164879; Meninno S, 2013, CHEM COMMUN, V49, P3821, DOI 10.1039/c3cc36928e; ZHANG W, 1990, J AM CHEM SOC, V112, P2801, DOI 10.1021/ja00163a052; Bougauchi M, 1997, J AM CHEM SOC, V119, P2329, DOI 10.1021/ja964037o; Barbas CF, 2008, ANGEW CHEM INT EDIT, V47, P42, DOI 10.1002/anie.200702210; Barbas III C. F., 2008, ANGEW CHEM, V120, P44; Bondzic BP, 2010, ORG LETT, V12, P5434, DOI 10.1021/ol102269s; Page PCB, 2009, EUR J ORG CHEM, P3413, DOI 10.1002/ejoc.200900252; Dalko P. I., 2013, COMPREHENSIVE ENANTI; Dalko P. I., 2007, ENANTIOSELECTIVE ORG; Dondoni A., 2008, ANGEW CHEM, V120, P4716, DOI DOI 10.1002/ANGE.200704684; Frohn M, 2000, SYNTHESIS-STUTTGART, P1979; Gotoh H., 2013, ANGEW CHEM, P287; Hanson R. M., 1986, J ORG CHEM, V51, P1992; Hayashi Y., 2005, ANGEW CHEM, V117, P4284, DOI 10.1002/ange.200500599; Inoue M., 2003, ANGEW CHEM, V115, P2758, DOI 10.1002/ange.200351130; Jacobsen E. N., 1993, CATALYTIC ASYMMETRIC, P159; Jiang H, 2011, CHEM-EUR J, V17, P3842, DOI 10.1002/chem.201003477; Katsuki K., 1980, J AM CHEM SOC, V102, P5974; Lattanzi A, 2009, CHEM COMMUN, P1452, DOI 10.1039/b900098d; List B., 2012, SCI SYNTHESIS ASYMME, P392; List B., 2012, SCI SYNTHESIS ASYMME; Marigo M., 2005, ANGEW CHEM, V117, P804, DOI 10.1002/ange.200462101; Maruoka K., 2012, SCI SYNTHESIS ASYMME; Melchiorre P., 2008, ANGEW CHEM, V120, P6232, DOI DOI 10.1002/ANGE.200705523; Page PCB, 2004, ORG LETT, V6, P1543, DOI 10.1021/ol049782h; Palumbo C, 2011, ORG LETT, V13, P6248, DOI 10.1021/ol202646w; Reisinger C. M., 2008, ANGEW CHEM, V120, P8232, DOI 10.1002/ange.200803238; Russo A, 2009, SYNTHESIS-STUTTGART, P1551, DOI 10.1055/s-0029-1216638; Shi Y, 2004, ACCOUNTS CHEM RES, V37, P488, DOI 10.1021/ar030063x; Sparr C., 2009, ANGEW CHEM, V121, P3111; Sparr C, 2009, ANGEW CHEM INT EDIT, V48, P3065, DOI 10.1002/anie.200900405; Sunden H, 2006, TETRAHEDRON LETT, V47, P99, DOI 10.1016/j.tetlet.2005.10.128; Tanaka S, 2009, SYNLETT, P667, DOI 10.1055/s-0028-1087811; Walji AM, 2007, SYNLETT, P1477, DOI 10.1055/s-2007-980382; Wang X.-W., 2008, ANGEW CHEM, V120, P1135, DOI 10.1002/ange.200704185; Yu B, 2015, EUR J MED CHEM, V96, P673, DOI 10.1016/j.ejmech.2014.06.056; Zhuang W, 2005, ORG BIOMOL CHEM, V3, P3883, DOI 10.1039/b512542a	66	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1867-3880	1867-3899		CHEMCATCHEM	ChemCatChem	JAN	2015	7	1					155	159		10.1002/cctc.201402811		5	Chemistry, Physical	Chemistry	AY4GN	WOS:000347536400024		
J	Praveen, VK; Yamamoto, Y; Fukushima, T; Tsunobuchi, Y; Nakabayashi, K; Ohkoshi, S; Kato, K; Takata, M; Aida, T				Praveen, Vakayil K.; Yamamoto, Yohei; Fukushima, Takanori; Tsunobuchi, Yoshihide; Nakabayashi, Koji; Ohkoshi, Shin-ichi; Kato, Kenichi; Takata, Masaki; Aida, Takuzo			Translation of the assembling trajectory by preorganisation: a study of the magnetic properties of 1D polymeric unpaired electrons immobilised on a discrete nanoscopic scaffold	CHEMICAL COMMUNICATIONS			English	Article							HEXABENZOCORONENE GRAPHITIC NANOTUBE; CO-II; COAXIAL NANOTUBES; TRANSITION-METAL; COMPLEXES; NITRONYL; HETEROJUNCTION; SYSTEMS; CHAINS; PHOTOCONDUCTIVITY	A nitronyl nitroxide (NN)-appended hexabenzocoronene (HBCNN), when allowed to coassemble with bis(hexafluoroacetylacetonato)-cobalt( II), forms a coaxial nanotubular architecture featuring NN-Co(II) coordinated copolymer chains immobilised on the outer and inner nanotube surfaces. Upon lowering the temperature, this nanotube has enhanced magnetic susceptibility below 10 K.	[Praveen, Vakayil K.; Aida, Takuzo] Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; [Yamamoto, Yohei] Univ Tsukuba, Fac Pure & Appl Sci, Div Mat Sci, Tsukuba, Ibaraki 3058573, Japan; [Yamamoto, Yohei] Univ Tsukuba, Fac Pure & Appl Sci, TIMS, Tsukuba, Ibaraki 3058573, Japan; [Fukushima, Takanori] Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Tsunobuchi, Yoshihide; Nakabayashi, Koji; Ohkoshi, Shin-ichi] Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Kato, Kenichi; Takata, Masaki] RIKEN, SPring Ctr 8, Sayo, Hyogo 6795148, Japan; [Aida, Takuzo] RIKEN, Ctr Emergent Matter Sci, Wako, Saitama 3510198, Japan	Yamamoto, Y (reprint author), Univ Tsukuba, Fac Pure & Appl Sci, Div Mat Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058573, Japan.	yamamoto@ims.tsukuba.ac.jp; aida@macro.t.u-tokyo.ac.jp	洋平, 山本/C-8919-2011; Vakayil Karthikeyan, Praveen /A-6560-2010; Aida, Takuzo/I-9117-2012; Fukushima, Takanori/D-2474-2015	洋平, 山本/0000-0002-2166-3730; Vakayil Karthikeyan, Praveen /0000-0002-5407-9901; Fukushima, Takanori/0000-0001-5586-9238	Japan Society for the Promotion of Science (JSPS); MEXT, Japan [25708020]; Cooperative Research Program of "Network Joint Research Center for Materials and Devices"; Asahi Glass Foundation	V.K.P thanks the Japan Society for the Promotion of Science (JSPS) postdoctoral fellowship for foreign researchers. The synchrotron radiation experiments were performed at BL44B2 in SPring-8 with the approval of RIKEN (Proposal No. 20090021). This work was partially supported by a Grant-in-Aid for Young Scientist A (25708020) from MEXT, Japan, Cooperative Research Program of "Network Joint Research Center for Materials and Devices", and Asahi Glass Foundation.	Rybtchinski B, 2011, ACS NANO, V5, P6791, DOI 10.1021/nn2025397; Lei YL, 2010, J AM CHEM SOC, V132, P1742, DOI 10.1021/ja9084435; Korevaar PA, 2014, CHEM MATER, V26, P576, DOI 10.1021/cm4021172; Zhang W, 2009, ANGEW CHEM INT EDIT, V48, P4747, DOI 10.1002/anie.200900756; Nakabayashi K, 2007, CHEM-ASIAN J, V2, P164, DOI 10.1002/asia.200600293; Yamamoto Y, 2006, SCIENCE, V314, P1761, DOI 10.1126/science.1134441; Aida T, 2012, SCIENCE, V335, P813, DOI 10.1126/science.1205962; Nakanishi T, 2008, ADV MATER, V20, P443, DOI 10.1002/adma.200701537; Yamamoto Y, 2011, B CHEM SOC JPN, V84, P17, DOI 10.1246/bcsj.20100272; Ortony JH, 2014, NAT MATER, V13, P812, DOI [10.1038/nmat3979, 10.1038/NMAT3979]; Caneschi A, 2001, ANGEW CHEM INT EDIT, V40, P1760, DOI 10.1002/1521-3773(20010504)40:9<1760::AID-ANIE17600>3.0.CO;2-U; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; Ishii N, 2008, J AM CHEM SOC, V130, P24, DOI 10.1021/ja077666e; Nishihara H, 2014, CHEM LETT, V43, P388, DOI 10.1246/cl.140010; Lutz JF, 2013, SCIENCE, V341, P628, DOI 10.1126/science.1238149; Fukino T, 2014, SCIENCE, V344, P499, DOI 10.1126/science.1252120; Yamamoto Y, 2009, P NATL ACAD SCI USA, V106, P21051, DOI 10.1073/pnas.0905655106; Malicka JM, 2013, CHEM-EUR J, V19, P12991, DOI 10.1002/chem.201301539; Zhang W, 2013, J AM CHEM SOC, V135, P114, DOI 10.1021/ja311738m; NAKASHIMA N, 1986, J PHYS CHEM-US, V90, P3374, DOI 10.1021/j100406a014; Yamamoto Y, 2007, J AM CHEM SOC, V129, P9276, DOI 10.1021/ja073577q; Numata Y, 2007, J AM CHEM SOC, V129, P9902, DOI 10.1021/ja064828i; Zhang W, 2011, SCIENCE, V334, P340, DOI 10.1126/science.1210369; Rupar PA, 2012, SCIENCE, V337, P559, DOI 10.1126/science.1221206; Hill JP, 2004, SCIENCE, V304, P1481, DOI 10.1126/science.1097789; Chen ZJ, 2009, CHEM SOC REV, V38, P564, DOI 10.1039/b809359h; Jin W, 2008, J AM CHEM SOC, V130, P9434, DOI 10.1021/ja801179e; Bogani L, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.064406; Bussiere G, 2004, TOP CURR CHEM, V241, P97; Caneschi A, 2002, CHEM-EUR J, V8, P286, DOI 10.1002/1521-3765(20020104)8:1<286::AID-CHEM286>3.0.CO;2-D; CANESCHI A, 1988, INORG CHEM, V27, P1553, DOI 10.1021/ic00282a009; He YN, 2010, ADV MATER, V22, P829, DOI 10.1002/adma.200902601; Jia HP, 2008, CHEM COMMUN, P371, DOI 10.1039/b714678g; Kaizaki S, 2006, COORDIN CHEM REV, V250, P1804, DOI 10.1016/j.ccr.2006.02.029; Laget V, 1998, ADV MATER, V10, P1024, DOI 10.1002/(SICI)1521-4095(199809)10:13<1024::AID-ADMA1024>3.3.CO;2-3; Li JR, 2007, CHEM COMMUN, P2290, DOI 10.1039/b700569e; Chen J, 2005, INORG CHEM COMMUN, V8, P792, DOI 10.1016/j.inoche.2005.05.020; Munoz MJM, 2012, CHEM SCI, V3, P1395, DOI 10.1039/c2sc01101h; Ogita M, 2002, EUR J INORG CHEM, P886; Okamura Y, 2010, B CHEM SOC JPN, V83, P716, DOI 10.1246/bcsj.20090316; Saeki A, 2011, J PHYS CHEM LETT, V2, P2549, DOI 10.1021/jz201223e; Vaz MGF, 2012, INORG CHEM, V51, P3138, DOI 10.1021/ic202623p; Yamamoto T, 2008, ADV POLYM SCI, V220, P1, DOI 10.1007/12_2008_171; Yamamoto Y, 2009, CHEM LETT, V38, P888, DOI 10.1246/cl.2009.888; Yamamoto Y, 2006, ADV MATER, V18, P1297, DOI 10.1002/adma.200502116	45	0	0	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1359-7345	1364-548X		CHEM COMMUN	Chem. Commun.		2015	51	7					1206	1209		10.1039/c4cc08942a		4	Chemistry, Multidisciplinary	Chemistry	AX4IT	WOS:000346897300005		
J	Kimura, T; Shintate, M; Miyamoto, N				Kimura, Tatsuo; Shintate, Morio; Miyamoto, Nobuyoshi			In situ observation of the evaporation-induced self-assembling process of PS-b-PEO diblock copolymers for the fabrication of titania films by confocal laser scanning microscopy	CHEMICAL COMMUNICATIONS			English	Article							MESOPOROUS SILICA; THIN-FILMS; POROUS MATERIALS; TEMPLATES; ORGANIZATION; SURFACTANT; MECHANISM; DESIGN; PHASES	The drying process of clear precursor solutions for fabricating highly porous titania films was observed by CLSM. Further, we succeeded in detecting the formation of micelles in the precursor solution containing high-molecular-weight PS-b-PEO diblock copolymers at the initial stage of the drying process as the direct evidence that this synthesis consisted of the EISA process.	[Kimura, Tatsuo] Natl Inst Adv Ind Sci & Technol, Adv Mfg Res Inst, Moriyama Ku, Nagoya, Aichi 4638560, Japan; [Shintate, Morio; Miyamoto, Nobuyoshi] Fukuoka Inst Technol, Dept Life Environm & Mat Sci, Higashi Ku, Fukuoka 8110295, Japan; [Miyamoto, Nobuyoshi] Kyushu Univ, Inst Mat Chem & Engn, Kasuga, Fukuoka 8168560, Japan	Kimura, T (reprint author), Natl Inst Adv Ind Sci & Technol, Adv Mfg Res Inst, Moriyama Ku, Nagoya, Aichi 4638560, Japan.	t-kimura@aist.go.jp	Kimura, Tatsuo/F-9382-2014		Ministry of Economy, Trade and Industry (METI), Japan; Canon Foundation; JSPS KAKENHI [26288110]; MEXT KAKENHI [24104005]	The authors acknowledge the financial support as follows. T.K. is grateful to "the Environmentally Friendly Sensor Project" granted by the Ministry of Economy, Trade and Industry (METI), Japan. N.M. acknowledges the financial support by the Canon Foundation. A part of this work was also supported by JSPS KAKENHI Grant Number 26288110 (T.K.) and MEXT KAKENHI Grant Number 24104005 (N.M.).	Innocenzi P, 2011, CHEM MATER, V23, P2501, DOI 10.1021/cm200050r; Grosso D, 2004, ADV FUNCT MATER, V14, P309, DOI 10.1002/adfm.200305036; Kimura T, 2013, MACROMOL RAPID COMM, V34, P423, DOI 10.1002/marc.201200765; Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785; Crepaldi EL, 2003, J AM CHEM SOC, V125, P9770, DOI 10.1021/ja030070g; Huo QS, 1996, CHEM MATER, V8, P1147, DOI 10.1021/cm960137h; Sanchez C, 2008, CHEM MATER, V20, P682, DOI 10.1021/cm702100t; Higashiguchi K, 2008, J AM CHEM SOC, V130, P6326, DOI 10.1021/ja801553g; Stein A, 2014, CHEM MATER, V26, P259, DOI 10.1021/cm402184h; Kimura T, 2011, CHEM-ASIAN J, V6, P3236, DOI 10.1002/asia.201100173; Kimura T, 2014, J MATER CHEM A, V2, P10688, DOI 10.1039/c4ta01448k; Deng YH, 2013, CHEM SOC REV, V42, P4054, DOI 10.1039/c2cs35426h; Chandra D, 2011, PHYS CHEM CHEM PHYS, V13, P12529, DOI 10.1039/c1cp21060b; Wan Y, 2007, CHEM REV, V107, P2821, DOI 10.1021/cr068020s; Chandra D, 2011, J MATER CHEM, V21, P5738, DOI 10.1039/c0jm04347h; Bastakoti BP, 2014, LANGMUIR, V30, P651, DOI 10.1021/la403901x; Yang H, 1996, NATURE, V379, P703, DOI 10.1038/379703a0; KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0; FIROUZI A, 1995, SCIENCE, V267, P1138, DOI 10.1126/science.7855591; HUO QS, 1994, CHEM MATER, V6, P1176, DOI 10.1021/cm00044a016; Kimura T, 2012, LANGMUIR, V28, P12901, DOI 10.1021/la302695q; Edler KJ, 2013, CHEM SOC REV, V42, P3765, DOI 10.1039/c2cs35300h; ATTARD GS, 1995, NATURE, V378, P366, DOI 10.1038/378366a0; HUO QS, 1995, SCIENCE, V268, P1324, DOI 10.1126/science.268.5215.1324; Sanchez C, 2014, CHEM MATER, V26, P221, DOI 10.1021/cm402528b; Bastakoti B. P., SMALL, DOI [10.1002/smll.201402573, DOI 10.1002/SMLL.201402573]; Beck JS, 1992, AM CHEM SOC, V114, P10834, DOI DOI 10.1021/JA00053A020; Lu YF, 1997, NATURE, V389, P364; Kimura T, 2014, APL MATER, V2, DOI 10.1063/1.4897202; Kjellman T, 2013, CHEM SOC REV, V42, P3777, DOI 10.1039/c2cs35298b	30	2	2	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1359-7345	1364-548X		CHEM COMMUN	Chem. Commun.		2015	51	7					1230	1233		10.1039/c4cc08497g		4	Chemistry, Multidisciplinary	Chemistry	AX4IT	WOS:000346897300011		
J	Inami, T; Kurahashi, T; Matsubara, S				Inami, Tasuku; Kurahashi, Takuya; Matsubara, Seijiro			Nickel-catalysed synthesis of tetrasubstituted vinyl sulfides from thiocarbamates and internal alkynes	CHEMICAL COMMUNICATIONS			English	Article							C-S BOND; TERMINAL ALKYNES; STEREOSELECTIVE-SYNTHESIS; AROMATIC THIOLS; REGIOSELECTIVE ADDITION; CONVENIENT SYNTHESIS; COUPLING REACTION; ALIPHATIC THIOLS; PHENYL SULFIDES; CARBON-MONOXIDE	The thiocarbamoylation of internal alkynes to produce tetrasubstituted beta-aminocarbonyl vinyl sulfides was demonstrated using a nickel catalyst. This reaction was successful with a wide variety of substituents, and gave the syn-adducts exclusively.	[Inami, Tasuku; Kurahashi, Takuya; Matsubara, Seijiro] Kyoto Univ, Grad Sch Engn, Dept Chem Mat, Nishikyo Ku, Kyoto 6158510, Japan; [Kurahashi, Takuya] JST, ACT C, Kawaguchi, Saitama 3320012, Japan	Kurahashi, T (reprint author), Kyoto Univ, Grad Sch Engn, Dept Chem Mat, Nishikyo Ku, Kyoto 6158510, Japan.	kurahashi.taskuya.2c@kyoto-u.ac.jp; seijiro.2e@kyoto-u.ac.jp			JST, ACT-C; Ministry of Education, Culture, Sports, Science and Technology, Japan; Asahi Glass Foundation; Japan Society for the Promotion of Science for Young Scientists	This work was supported by JST, ACT-C, and Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan. T.K. acknowledges the Asahi Glass Foundation. T.I. also acknowledges the Japan Society for the Promotion of Science for Young Scientists for fellowship support.	Ananikov VP, 2008, ORGANOMETALLICS, V27, P4056, DOI 10.1021/om800282h; MURAHASHI SI, 1979, J ORG CHEM, V44, P2408, DOI 10.1021/jo01328a016; Kondo T, 2000, CHEM REV, V100, P3205, DOI 10.1021/cr9902749; Li GY, 2002, J ORG CHEM, V67, P3643, DOI 10.1021/jo010983y; Riduan SN, 2012, ORG LETT, V14, P1780, DOI 10.1021/ol3003699; Sugoh K, 2001, J AM CHEM SOC, V123, P5108, DOI 10.1021/ja010261o; BACKVALL JE, 1994, J ORG CHEM, V59, P5850; Nakamura I, 2006, ANGEW CHEM INT EDIT, V45, P4473, DOI 10.1002/anie.200601178; Ananikov VP, 2012, J AM CHEM SOC, V134, P6637, DOI 10.1021/ja210596w; Kundu S, 2011, ORGANOMETALLICS, V30, P5147, DOI 10.1021/om200452z; You W, 2010, ORG LETT, V12, P3930, DOI 10.1021/ol101619s; Ranjit S, 2010, ORG LETT, V12, P4134, DOI 10.1021/ol101729k; Malyshev DA, 2006, ORGANOMETALLICS, V25, P4462, DOI 10.1021/om060302v; Cao CS, 2005, J AM CHEM SOC, V127, P17614, DOI 10.1021/ja055096h; Yang Y, 2011, CHEM COMMUN, V47, P6557, DOI 10.1039/c1cc11605c; Kondoh A, 2007, ORG LETT, V9, P1383, DOI 10.1021/ol0702876; KUNIYASU H, 1991, J AM CHEM SOC, V113, P9796, DOI 10.1021/ja00026a013; Gerber R, 2012, CHEM-EUR J, V18, P8901, DOI 10.1002/chem.201200388; Kuniyasu H, 2006, TETRAHEDRON LETT, V47, P1141, DOI 10.1016/j.tetlet.2005.12.016; Han LB, 2004, J AM CHEM SOC, V126, P5080, DOI 10.1021/ja0494297; Ananikov VP, 2006, ORGANOMETALLICS, V25, P1970, DOI 10.1021/om051105j; Knapton DJ, 2005, J ORG CHEM, V70, P785, DOI 10.1021/jo0484068; Ananikov VP, 2010, CHEM-EUR J, V16, P2063, DOI 10.1002/chem.200902928; Lin CH, 2013, CHEM-EUR J, V19, P2578, DOI 10.1002/chem.201202704; Sarma R, 2012, CHEM COMMUN, V48, P4014, DOI 10.1039/c2cc30350g; Shoai S, 2007, ORGANOMETALLICS, V26, P5778, DOI 10.1021/om700811e; ISHIYAMA T, 1993, J AM CHEM SOC, V115, P7219, DOI 10.1021/ja00069a020; Arambasic M, 2013, ORG LETT, V15, P5162, DOI 10.1021/ol402650q; Di Giuseppe A, 2012, J AM CHEM SOC, V134, P8171, DOI 10.1021/ja300396h; Hooper JF, 2012, J AM CHEM SOC, V134, P2906, DOI 10.1021/ja2108992; Lee JY, 2008, J ORG CHEM, V73, P7413, DOI 10.1021/jo801169h; Ananikov VP, 2007, J AM CHEM SOC, V129, P7252, DOI 10.1021/ja071727r; Yang J, 2009, J ORG CHEM, V74, P182, DOI 10.1021/jo801644s; KUNIYASU H, 1992, J AM CHEM SOC, V114, P5902, DOI 10.1021/ja00040a087; Fraser LR, 2007, ORGANOMETALLICS, V26, P5602, DOI 10.1021/om700564t; Toyofuku M, 2005, J AM CHEM SOC, V127, P9706, DOI 10.1021/ja052175k; Nakamura I, 2008, ORG LETT, V10, P2649, DOI 10.1021/ol8007556; Ogawa A, 1999, J AM CHEM SOC, V121, P5108, DOI 10.1021/ja983949i; Weiss CJ, 2009, J AM CHEM SOC, V131, P2062, DOI 10.1021/ja808764q; Zhao QW, 2009, J ORG CHEM, V74, P459, DOI 10.1021/jo802235e; Ananikov VP, 2005, ADV SYNTH CATAL, V347, P1993, DOI 10.1002/adsc.200505168; Nishi M, 2012, ORG LETT, V14, P6116, DOI 10.1021/ol302810u; Hua R, 2001, J AM CHEM SOC, V123, P2899, DOI 10.1021/ja004063t; Yamamoto T, 2012, B CHEM SOC JPN, V85, P613, DOI 10.1246/bcsj.20100345; Sabarre A, 2008, ORG LETT, V10, P3941, DOI 10.1021/ol8012843; Weiss CJ, 2010, ORGANOMETALLICS, V29, P6308, DOI 10.1021/om100697h; Bates CG, 2004, ORG LETT, V6, P5005, DOI 10.1021/ol0477935; Tobisu M, 2008, ORG LETT, V10, P5223, DOI 10.1021/ol802223a; Arisawa M, 2011, TETRAHEDRON LETT, V52, P920, DOI 10.1016/j.tetlet.2010.12.065; Arisawa M, 2001, ORG LETT, V3, P763, DOI 10.1021/ol015521l; Arnould JC, 1996, TETRAHEDRON LETT, V37, P4523, DOI 10.1016/0040-4039(96)00873-8; Cremlyn R. J., 1996, INTRO ORGANOSULFUR C; CRISTAU HJ, 1986, J ORG CHEM, V51, P875, DOI 10.1021/jo00356a024; Guo SR, 2008, SYNTHETIC COMMUN, V38, P2722, DOI 10.1080/00397910802222746; Han LB, 1999, CHEM LETT, P863; Hirai T, 2004, CHEM LETT, V33, P1148, DOI 10.1246/cl.2004.1148; Hirai T, 2005, TETRAHEDRON LETT, V46, P117, DOI 10.1016/j.tetlet.2004.11.023; Hua R, 2007, ORG LETT, V9, P263, DOI 10.1021/ol062686r; Inami T, 2014, ORG LETT, V16, P5660, DOI 10.1021/ol5026102; Inami T., 2011, ORG LETT, V13, P1912; Ishiyama T, 1996, J ORGANOMET CHEM, V525, P225, DOI 10.1016/S0022-328X(96)06495-9; Iwasaki M, 2011, CHEM-ASIAN J, V6, P3190, DOI 10.1002/asia.201100643; Kamiya I, 2006, ORGANOMETALLICS, V25, P3562, DOI 10.1021/om0600442; Kuniyasu H, 2008, ORGANOMETALLICS, V27, P4788, DOI 10.1021/om800464y; Minami Y, 2010, ORG LETT, V12, P3744, DOI 10.1021/ol101289k; Minami Y, 2009, CHEM COMMUN, P3080, DOI 10.1039/b900492k; Nakamura I, 2010, HETEROCYCLES, V82, P689, DOI 10.3987/COM-10-S(E)44; Namyslo JC, 2006, SYNTHESIS-STUTTGART, P3367, DOI 10.1055/s-2006-950216; Nguyen VH, 1998, TETRAHEDRON, V54, P11445, DOI 10.1016/S0040-4020(98)00707-8; Oae S., 1991, ORGANIC SULFUR CHEM; OGAWA A, 1995, J AM CHEM SOC, V117, P7564, DOI 10.1021/ja00133a038; Ozaki T, 2011, B CHEM SOC JPN, V84, P155, DOI 10.1246/bcsj.20100187; RANE AM, 1994, TETRAHEDRON LETT, V35, P3225, DOI 10.1016/S0040-4039(00)76870-5; Reddy VP, 2009, SYNLETT, P2783, DOI 10.1055/s-0029-1217990; Toyofuku M, 2008, J AM CHEM SOC, V130, P10504, DOI 10.1021/ja804121j; Trostyanskaya G., 2001, RUSS CHEM B, V50, P2095; Trostyanskaya IG, 2012, SYNLETT, P535, DOI 10.1055/s-0031-1290345; Woodland CA, 2004, TETRAHEDRON LETT, V45, P1227, DOI 10.1016/j.tetlet.2003.11.132; Yang F, 2012, TETRAHEDRON LETT, V53, P5231, DOI 10.1016/j.tetlet.2012.07.059; Zhou J., 2011, EUR J ORG CHEM, P3411; Zyk N. V., 2003, RUSS CHEM REV, V72, P769, DOI 10.1070/RC2003v072n09ABEH000794	81	2	2	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1359-7345	1364-548X		CHEM COMMUN	Chem. Commun.		2015	51	7					1285	1288		10.1039/c4cc09123j		4	Chemistry, Multidisciplinary	Chemistry	AX4IT	WOS:000346897300026		
J	Yamaguchi, T; Hilbers, MF; Reinders, PP; Kobayashi, Y; Brouwer, AM; Abe, J				Yamaguchi, Tetsuo; Hilbers, Michiel F.; Reinders, Paul P.; Kobayashi, Yoichi; Brouwer, Albert M.; Abe, Jiro			Nanosecond photochromic molecular switching of a biphenyl-bridged imidazole dimer revealed by wide range transient absorption spectroscopy	CHEMICAL COMMUNICATIONS			English	Article							PHOTODISSOCIATION DYNAMICS; LIGHT	We demonstrate that a biphenyl-bridged imidazole dimer exhibits fast photochromism with a thermal recovery time constant of similar to 100 ns, which is the fastest thermal back reaction in all reported imidazole dimers. Sub-ps transient absorption spectroscopy reveals that the generation process of the colored species occurs within 1 ps.	[Yamaguchi, Tetsuo; Kobayashi, Yoichi; Abe, Jiro] Aoyama Gakuin Univ, Sch Sci & Engn, Dept Chem, Chuo Ku, Sagamihara, Kanagawa 2525258, Japan; [Hilbers, Michiel F.; Reinders, Paul P.; Brouwer, Albert M.] Univ Amsterdam, Vant Hoff Inst Mol Sci, NL-1090 GD Amsterdam, Netherlands; [Abe, Jiro] CREST, Japan Sci & Technol Agcy, Chiyoda Ku, Tokyo 1020076, Japan	Abe, J (reprint author), Aoyama Gakuin Univ, Sch Sci & Engn, Dept Chem, Chuo Ku, 5-10-1 Fuchinobe, Sagamihara, Kanagawa 2525258, Japan.	jiro_abe@chem.aoyama.ac.jp	Brouwer, Albert/A-2366-2010	Brouwer, Albert/0000-0002-1731-3869	Core Research for Evolutionary Science and Technology (CREST) program of the Japan Science and Technology Agency (JST); MEXT, Japan [26107010]; JSPS	This work was supported partly by the Core Research for Evolutionary Science and Technology (CREST) program of the Japan Science and Technology Agency (JST) and a Grant-in-Aid for Scientific Research on Innovative Areas "Photosynergetics" (No. 26107010) from MEXT, Japan. T. Yamaguchi appreciates the Research Fellowships of JSPS for Young Scientists.	Andreasson J, 2011, J AM CHEM SOC, V133, P11641, DOI 10.1021/ja203456h; Castellanos S, 2013, ANGEW CHEM INT EDIT, V52, P13985, DOI 10.1002/anie.201306183; Snellenburg JJ, 2012, J STAT SOFTW, V49, P1; Matsuda K, 2008, J PHYS CHEM C, V112, P17005, DOI 10.1021/jp807479g; Jacquart A, 2012, CHEM-EUR J, V18, P3706, DOI 10.1002/chem.201103411; Serak S, 2010, SOFT MATTER, V6, P779, DOI 10.1039/b916831a; Yagai S, 2005, J AM CHEM SOC, V127, P11134, DOI 10.1021/ja052645a; Raymo FM, 2002, ADV MATER, V14, P401, DOI 10.1002/1521-4095(20020318)14:6<401::AID-ADMA401>3.0.CO;2-F; Szacilowski K, 2008, CHEM REV, V108, P3481, DOI 10.1021/cr068403q; Kitagawa D, 2013, ANGEW CHEM INT EDIT, V52, P9320, DOI 10.1002/anie.201304670; Hatano S, 2013, J AM CHEM SOC, V135, P3164, DOI 10.1021/ja311344u; Kishimoto Y, 2009, J AM CHEM SOC, V131, P4227, DOI 10.1021/ja810032t; Kobatake S, 2007, NATURE, V446, P778, DOI 10.1038/nature05669; White TJ, 2008, SOFT MATTER, V4, P1796, DOI 10.1039/b805434g; Eelkema R, 2006, J AM CHEM SOC, V128, P14397, DOI 10.1021/ja065334o; GILAT SL, 1995, CHEM-EUR J, V1, P275, DOI 10.1002/chem.19950010504; Iwasaki T, 2014, CHEM COMMUN, V50, P7481, DOI 10.1039/c4cc02710h; Garcia-Amoros J, 2014, J MATER CHEM C, V2, P474, DOI 10.1039/c3tc31803f; Denekamp C, 1998, ADV MATER, V10, P1080, DOI 10.1002/(SICI)1521-4095(199810)10:14<1080::AID-ADMA1080>3.0.CO;2-T; Edkins RM, 2014, RSC ADV, V4, P5351, DOI 10.1039/c3ra43892a; Frisch M.J., GAUSSIAN09 REVISION; Harada Y, 2010, J PHYS CHEM LETT, V1, P1112, DOI 10.1021/jz100228w; Hashim PK, 2011, ANGEW CHEM INT EDIT, V50, P11729, DOI 10.1002/anie.201104614; Kumpulainen T, 2015, J PHYS CHEM B, V119, P2515, DOI 10.1021/jp508334s; MAEDA K, 1970, B CHEM SOC JPN, V43, P429, DOI 10.1246/bcsj.43.429; Miyasaka H, 2009, J AM CHEM SOC, V131, P7256, DOI 10.1021/ja809195s; Mutoh K, 2013, ORG LETT, V15, P2938, DOI 10.1021/ol401012u; Satoh Y, 2007, CHEM PHYS LETT, V448, P228, DOI 10.1016/j.cplett.2007.09.081; Shima K, 2014, J AM CHEM SOC, V136, P3796, DOI 10.1021/ja501028v; Tomasulo M, 2005, ORG LETT, V7, P1109, DOI 10.1021/ol050045a; Yagai S, 2012, ANGEW CHEM INT EDIT, V51, P9679, DOI 10.1002/anie.201205504; YAMAGUCHI T, 2013, JOURNAL PHYS CHEM A, V0118; Yamashita H, 2014, CHEM COMMUN, V50, P8468, DOI 10.1039/c4cc03137g	33	1	1	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1359-7345	1364-548X		CHEM COMMUN	Chem. Commun.		2015	51	7					1375	1378		10.1039/c4cc06001f		4	Chemistry, Multidisciplinary	Chemistry	AX4IT	WOS:000346897300050		
J	Sato, T; Sato, Y; Iwai, K; Kuge, S; Nishizawa, S; Teramae, N				Sato, Takaya; Sato, Yusuke; Iwai, Kenta; Kuge, Shusuke; Nishizawa, Seiichi; Teramae, Norio			Synthetic fluorescent probes capable of selective recognition of 3 '-overhanging nucleotides for siRNA delivery imaging	CHEMICAL COMMUNICATIONS			English	Article							PEPTIDE NUCLEIC-ACID; LIGHT-UP PROBES; RNA INTERFERENCE; MAMMALIAN-CELLS; THIAZOLE ORANGE; LIVE CELLS; DNA; BINDING; INTERCALATION; DUPLEXES	Peptide nucleic acid (PNA)-thiazole orange (TO) conjugates are developed as fluorescent probes capable of selective recognition of 3'-overhanging nucleotides of siRNAs for an accurate analysis of the siRNA delivery process.	[Sato, Takaya; Sato, Yusuke; Nishizawa, Seiichi; Teramae, Norio] Tohoku Univ, Grad Sch Sci, Dept Chem, Sendai, Miyagi 9808578, Japan; [Iwai, Kenta; Kuge, Shusuke] Tohoku Pharmaceut Univ, Dept Microbiol, Sendai, Miyagi 9818558, Japan	Sato, Y (reprint author), Tohoku Univ, Grad Sch Sci, Dept Chem, Sendai, Miyagi 9808578, Japan.	satoyuu@m.tohoku.ac.jp; teramae@m.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [24750064, 22225003, 24350033, 25620102]; Takeda Science Foundation	This work was supported by the Grants-in-Aid for Young Scientists (B) (No. 24750064), for Scientific Research (S) (No. 22225003), (B) (No. 24350033), and for Challenging Exploratory Research (No. 25620102) from the Ministry of Education, Culture, Sports, Science and Technology and by a grant from the Takeda Science Foundation.	Zhang SB, 2007, J CONTROL RELEASE, V123, P1, DOI 10.1016/j.jconrel.2007.07.016; Nygren J, 1998, BIOPOLYMERS, V46, P39, DOI 10.1002/(SICI)1097-0282(199807)46:1<39::AID-BIP4>3.0.CO;2-Z; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Chiu YL, 2004, CHEM BIOL, V11, P1165, DOI 10.1016/j.chembiol.2004.06.006; Jiang S, 2010, LANGMUIR, V26, P6689, DOI 10.1021/la904011q; Burnett JC, 2012, CHEM BIOL, V19, P60, DOI 10.1016/j.chembiol.2011.12.008; Svanvik N, 2000, ANAL BIOCHEM, V281, P26, DOI 10.1006/abio.2000.4534; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Resnier P, 2013, BIOMATERIALS, V34, P6429, DOI 10.1016/j.biomaterials.2013.04.060; Arambula JF, 2009, P NATL ACAD SCI USA, V106, P16068, DOI 10.1073/pnas.0901824106; Nielsen PE, 1999, ACCOUNTS CHEM RES, V32, P624, DOI 10.1021/ar980010t; Svanvik N, 2001, J AM CHEM SOC, V123, P803, DOI 10.1021/ja002294u; FKYERAT A, 1993, J AM CHEM SOC, V115, P9952, DOI 10.1021/ja00075a011; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688; Pecot CV, 2011, NAT REV CANCER, V11, P59, DOI 10.1038/nrc2966; Kamiya Y, 2013, CHEM SCI, V4, P4016, DOI 10.1039/c3sc51197a; Alabi CA, 2012, ACS NANO, V6, P6133, DOI 10.1021/nn3013838; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Shakeel S, 2006, J CHEM TECHNOL BIOT, V81, P892, DOI 10.1002/jctb.1505; Chen AA, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni188; Jung JJ, 2010, ANGEW CHEM INT EDIT, V49, P103, DOI 10.1002/anie.200905126; Printz M, 2009, CHEM-EUR J, V15, P3390, DOI 10.1002/chem.200801587; Ihmels H, 2005, TOP CURR CHEM, V258, P161, DOI 10.1007/b135804; Shin S, 2011, MOL BIOSYST, V7, P2110, DOI 10.1039/c1mb05054k; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; WALTER AE, 1994, P NATL ACAD SCI USA, V91, P9218, DOI 10.1073/pnas.91.20.9218; Armitage BA, 2008, TOP HETEROCYCL CHEM, V14, P11, DOI 10.1007/7081_2007_109; Armitage BA, 2005, TOP CURR CHEM, V253, P55, DOI 10.1007/b100442; Chiu YL, 2002, MOL CELL, V10, P549, DOI 10.1016/S1097-2765(02)00652-4; Holzhauser C, 2013, ACS CHEM BIOL, V8, P890, DOI 10.1021/cb3006616; ur Rehman Zia, 2013, ACS Nano, V7, P3767, DOI 10.1021/nn3049494; van der Wiel IM, 2009, J AM CHEM SOC, V131, P9872, DOI 10.1021/ja902636m; Wahba AS, 2011, ACS CHEM BIOL, V6, P912, DOI 10.1021/cb200070k; Yamada K, 2013, BIOORG MED CHEM LETT, V23, P3448, DOI 10.1016/j.bmcl.2013.03.054	34	1	1	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1359-7345	1364-548X		CHEM COMMUN	Chem. Commun.		2015	51	8					1421	1424		10.1039/c4cc08800j		4	Chemistry, Multidisciplinary	Chemistry	AX9OQ	WOS:000347232200005		
J	Ji, HW; Guan, YJ; Wu, L; Ren, JS; Miyoshi, D; Sugimoto, N; Qu, XG				Ji, Haiwei; Guan, Yijia; Wu, Li; Ren, Jinsong; Miyoshi, Daisuke; Sugimoto, Naoki; Qu, Xiaogang			A fluorescent probe for detection of an intracellular prognostic indicator in early-stage cancer	CHEMICAL COMMUNICATIONS			English	Article							MESOPOROUS SILICA NANOCONTAINERS; CYCLIN-DEPENDENT KINASES; GRAPHENE OXIDE; CONTROLLED-RELEASE; PEPTIDE; CELLS; NANOPARTICLES; EXPRESSION; PROTEINS; DELIVERY	Cyclin A(2) is a promising cancer prognostic indicator, but its intracellular in situ imaging is still a challenging task. This work designs an "off-on" fluorescent probe, which can fluorescently detect intracellular cyclin A(2) and distinguish cancer cells. In addition, this work sheds light on the development of future protein biosensors.	[Ji, Haiwei; Guan, Yijia; Wu, Li; Ren, Jinsong; Qu, Xiaogang] Chinese Acad Sci, Univ Chinese Acad Sci, Changchun Inst Appl Chem, Biol Chem Lab, Changchun, Jilin 130022, Peoples R China; [Ji, Haiwei; Guan, Yijia; Wu, Li; Ren, Jinsong; Qu, Xiaogang] Univ Chinese Acad Sci, Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Rare Earth Resource Utilizat, Changchun, Jilin 130022, Peoples R China; [Miyoshi, Daisuke; Sugimoto, Naoki] Konan Univ, FIBER, Kobe, Hyogo, Japan	Qu, XG (reprint author), Chinese Acad Sci, Univ Chinese Acad Sci, Changchun Inst Appl Chem, Biol Chem Lab, Changchun, Jilin 130022, Peoples R China.	xqu@ciac.ac.cn			973 Project [2011CB936004, 2012CB720602]; NSFC [21210002, 91213302, 21431007, 91413111]	This work was supported by 973 Project (2011CB936004, 2012CB720602) and NSFC (21210002, 91213302, 21431007, 91413111).	Kong HK, 2011, CHEM COMMUN, V47, P8052, DOI 10.1039/c1cc12811f; Mendoza N, 2003, CANCER RES, V63, P1020; Liao C, 2004, INT J CANCER, V108, P654, DOI 10.1002/ijc.11573; Wang XH, 2011, BIOSENS BIOELECTRON, V26, P4804, DOI 10.1016/j.bios.2011.06.012; Lee J, 2014, J AM CHEM SOC, V136, P12880, DOI 10.1021/ja507767h; Wang XH, 2010, ADV FUNCT MATER, V20, P3967, DOI 10.1002/adfm.201001118; Wu SS, 2013, ANGEW CHEM INT EDIT, V52, P5580, DOI 10.1002/anie.201300958; Wang Y, 2013, J AM CHEM SOC, V135, P4799, DOI 10.1021/ja312221g; Climent E, 2009, ANGEW CHEM INT EDIT, V48, P8519, DOI 10.1002/anie.200904243; Arooz T, 2000, BIOCHEMISTRY-US, V39, P9494, DOI 10.1021/bi0009643; Yang SB, 2011, ADV MATER, V23, P3575, DOI 10.1002/adma.201101599; Liu Z, 2008, J AM CHEM SOC, V130, P10876, DOI 10.1021/ja803688x; Li JL, 2012, ANGEW CHEM INT EDIT, V51, P1830, DOI 10.1002/anie.201106102; Coll C, 2011, ANGEW CHEM INT EDIT, V50, P2138, DOI 10.1002/anie.201004133; Wang HB, 2011, ANGEW CHEM INT EDIT, V50, P7065, DOI 10.1002/anie.201101351; Xie LM, 2009, J AM CHEM SOC, V131, P9890, DOI 10.1021/ja9037593; Campbell AS, 2014, ACS APPL MATER INTER, V6, P5393, DOI 10.1021/am500773g; Fernandez-Suarez M, 2008, NAT REV MOL CELL BIO, V9, P929, DOI 10.1038/nrm2531; Hucknall A, 2009, ADV MATER, V21, P2441, DOI 10.1002/adma.200900383; Wischerhoff E, 2008, ANGEW CHEM INT EDIT, V47, P5666, DOI 10.1002/anie.200801202; Feng LY, 2012, ADV MATER, V24, P125, DOI 10.1002/adma.201103205; Wu ZS, 2012, J AM CHEM SOC, V134, P19532, DOI 10.1021/ja308676h; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Zhang CL, 2011, ANGEW CHEM INT EDIT, V50, P6851, DOI 10.1002/anie.201100769; Qian RC, 2013, J AM CHEM SOC, V135, P13282, DOI 10.1021/ja406532e; Zhang YF, 2012, ANAL CHEM, V84, P1956, DOI 10.1021/ac202993p; Gao HL, 2014, CURR PHARM BIOTECHNO, V15, P210; Pazos E, 2008, J AM CHEM SOC, V130, P9652, DOI 10.1021/ja803520q; Lu CH, 2009, ANGEW CHEM INT EDIT, V48, P4785, DOI 10.1002/anie.200901479; Mrena J, 2006, INT J CANCER, V119, P1897, DOI 10.1002/ijc.21944; Blegen H, 2000, INT J GYNECOL CANCER, V10, P477, DOI 10.1046/j.1525-1438.2000.00077.x; Climent E, 2013, ANGEW CHEM INT EDIT, V52, P8938, DOI 10.1002/anie.201302954; Li HG, 2013, DALTON T, V42, P13495, DOI 10.1039/c3dt51053k; McInnes Campbell, 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P57, DOI 10.2174/1568011033353506; PATERLINI P, 1993, CANCER RES, V53, P235; Thornton PD, 2010, J AM CHEM SOC, V132, P2024, DOI 10.1021/ja9094439; Wu L, 2014, SMALL, V10, P330, DOI 10.1002/smll.201301273; Yu Z. Q., 2014, NANO LIFE, V4	38	2	2	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1359-7345	1364-548X		CHEM COMMUN	Chem. Commun.		2015	51	8					1479	1482		10.1039/c4cc08789e		4	Chemistry, Multidisciplinary	Chemistry	AX9OQ	WOS:000347232200021		
J	Hatanaka, Y				Hatanaka, Yasumaru			Development and Leading-Edge Application of Innovative Photoaffinity Labeling	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Review						photoaffinity labeling; chemical probe; diazirine; functional proteomics; biological ligand	PHOTO-CROSS-LINKING; ELECTROPLAX SODIUM-CHANNEL; LIGAND-BINDING SITES; CLICK CHEMISTRY; DIAZIRINE; PROTEINS; PROBES; IDENTIFICATION; SUBSTRATE; BIOLOGY	Photoaffinity labeling has become increasingly important with the development of powerful specific probes that are synthesized by installing a photo-activatable functional group (photophore) on the framework of biological ligands. The present review summarizes the development of diazirine-based photoaffinity labeling by focusing on its application to the structural elucidation of ligand-accepting sites within proteins.	Toyama Univ, Toyama 9300194, Japan	Hatanaka, Y (reprint author), Toyama Univ, 2360 Sugitani, Toyama 9300194, Japan.	yasu@pha.u-toyama.ac.jp			Japan Society for the Promotion of Sciences (JSPS)	The author is grateful to Emeritus Professor Yuichi Kanaoka for his pioneering work of sodium channel photoaffinity labeling. His frontier spirit in the field of life science strongly inspired me to keep challenging to the difficulties concealed in the photoaffinity research. I would like to express my sincere appreciation to all the collaborators contributing to our research, many of whom are cited in this review. I also express my cordial thanks to all of members in my group. This work was supported financially by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Sciences (JSPS).	Albertoni B, 2012, CHEM COMMUN, V48, P1272, DOI 10.1039/c2cc16477a; Kitamura N, 2005, P NATL ACAD SCI USA, V102, P2796, DOI 10.1073/pnas.0409344102; Hatanaka Y, 1994, Bioorg Med Chem, V2, P1367, DOI 10.1016/S0968-0896(00)82088-X; Hatanaka Y, 2000, J ORG CHEM, V65, P5639, DOI 10.1021/jo000414a; Li ZQ, 2014, J AM CHEM SOC, V136, P9990, DOI 10.1021/ja502780z; Dubinsky L, 2012, BIOORGAN MED CHEM, V20, P554, DOI 10.1016/j.bmc.2011.06.066; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Sato C, 2001, NATURE, V409, P1047, DOI 10.1038/35059098; SINGH A, 1962, J BIOL CHEM, V237, P3006; Sletten EM, 2009, ANGEW CHEM INT EDIT, V48, P6974, DOI 10.1002/anie.200900942; Saghatelian A, 2004, P NATL ACAD SCI USA, V101, P10000, DOI 10.1073/pnas.0402784101; Hashimoto M, 2008, EUR J ORG CHEM, P2513, DOI 10.1002/ejoc.200701069; Shaya D, 2014, J MOL BIOL, V426, P467, DOI 10.1016/j.jmb.2013.10.010; Aswad M, 2013, CHEM COMMUN, V49, P10242, DOI 10.1039/c3cc46055j; BRUNNER J, 1993, ANNU REV BIOCHEM, V62, P483, DOI 10.1146/annurev.bi.62.070193.002411; Das J, 2011, CHEM REV, V111, P4405, DOI 10.1021/cr1002722; Chiu DT, 2009, ACCOUNTS CHEM RES, V42, P649, DOI 10.1021/ar8002464; Hatanaka Y, 1998, HETEROCYCLES, V47, P625; Gubbens J, 2009, CHEM BIOL, V16, P3, DOI 10.1016/j.chembiol.2008.11.009; Backes BJ, 1999, J ORG CHEM, V64, P2322, DOI 10.1021/jo981990y; Frye SV, 2010, NAT CHEM BIOL, V6, P159; Schreiber SL, 2005, NAT CHEM BIOL, V1, P64, DOI 10.1038/nchembio0705-64; Shigdel UK, 2008, ANGEW CHEM INT EDIT, V47, P90, DOI 10.1002/anie.200703625; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; Kashiwayama Y, 2010, J BIOL CHEM, V285, P26315, DOI 10.1074/jbc.M110.104547; Prescher JA, 2005, NAT CHEM BIOL, V1, P13, DOI 10.1038/nchembio0605-13; FLEMING SA, 1995, TETRAHEDRON, V51, P12479; Maruyama N, 2006, PLANT CELL, V18, P1253, DOI 10.1105/tpc.105.036376; Thirumurugan P, 2013, CHEM REV, V113, P4905, DOI 10.1021/cr200409f; Blencowe A, 2005, SOFT MATTER, V1, P178, DOI 10.1039/b501989c; Kawaguchi Y, 2013, BIOORG MED CHEM LETT, V23, P3738, DOI 10.1016/j.bmcl.2013.05.008; Tanaka G, 2012, CHEM BIOL, V19, P1437, DOI 10.1016/j.chembiol.2012.09.011; Chee GL, 2010, BIOORGAN MED CHEM, V18, P830, DOI 10.1016/j.bmc.2009.11.048; Basle E, 2010, CHEM BIOL, V17, P213, DOI 10.1016/j.chembiol.2010.02.008; Lomenick B, 2011, ACS CHEM BIOL, V6, P34, DOI 10.1021/cb100294v; BAKER BR, 1961, J AM CHEM SOC, V83, P3713, DOI 10.1021/ja01478a034; Bayley H., 1983, PHOTOGENERATED REAGE; Bongo NB, 2010, BIOORG MED CHEM LETT, V20, P1834, DOI 10.1016/j.bmcl.2010.01.164; Bongo NB, 2009, BIOORG MED CHEM LETT, V19, P80, DOI 10.1016/j.bmcl.2008.11.013; BRUNNER J, 1980, J BIOL CHEM, V255, P3319; BRUNNER J, 1980, J BIOL CHEM, V255, P3313; Catterall W.A., 2001, NATURE, V409, P991; Catterall WA, 2001, NATURE, V409, P988, DOI 10.1038/35059188; Chan EWS, 2004, J AM CHEM SOC, V126, P14435, DOI 10.1021/ja047044i; Fillion D, 2006, J MED CHEM, V49, P2200, DOI 10.1021/jm050958a; Gastinel LN, 1999, EMBO J, V18, P3546, DOI 10.1093/emboj/18.13.3546; Hashimoto M, 2004, BIOORG MED CHEM LETT, V14, P2447, DOI 10.1016/j.bmcl.2004.03.011; Hashimoto M, 2005, CHEM PHARM BULL, V53, P1510, DOI 10.1248/cpb.53.1510; Hashimoto M, 2001, CARBOHYD RES, V331, P119, DOI 10.1016/S0008-6215(01)00025-8; Hashimoto M, 1997, HETEROCYCLES, V46, P119; Hashimoto M, 2005, HETEROCYCLES, V66, P531; Hashimoto M, 1999, CHEM PHARM BULL, V47, P667; Hatanaka Y, 1996, REV HETEROATOM CHEM, V14, P213; Hatanaka Y, 1996, CARBOHYD RES, V294, P95; Hatanaka Y, 2001, BIOORG MED CHEM LETT, V11, P411, DOI 10.1016/S0960-894X(00)00676-4; Hatanaka Y, 1996, HETEROCYCLES, V43, P519; Hatanaka Y, 1998, J AM CHEM SOC, V120, P453, DOI 10.1021/ja973056a; Hatanaka Yasumaru, 2002, Current Topics in Medicinal Chemistry, V2, P271, DOI 10.2174/1568026023394182; HATANAKA Y, 1994, J ORG CHEM, V59, P383, DOI 10.1021/jo00081a017; HATANAKA Y, 1995, BIOORG MED CHEM LETT, V5, P2859, DOI 10.1016/0960-894X(95)00514-T; Jahng WJ, 2003, BIOCHEMISTRY-US, V42, P6159, DOI 10.1021/bi034002i; Kaneda M, 2007, CHEMBIOCHEM, V8, P595, DOI 10.1002/cbic.200600527; Kaneda M, 2003, BIOCONJUGATE CHEM, V14, P849, DOI 10.1021/bc0340520; Kempin U, 1998, HETEROCYCLES, V49, P465; KOTZYBAHIBERT F, 1995, ANGEW CHEM INT EDIT, V34, P1296, DOI 10.1002/anie.199512961; Koumanov F, 1998, BIOCHEM J, V330, P1209; Lapinsky DJ, 2012, BIOORGAN MED CHEM, V20, P6237, DOI 10.1016/j.bmc.2012.09.010; Li HY, 1999, CHEM COMMUN, P365, DOI 10.1039/a809507h; Masuda S, 2011, BIOORG MED CHEM LETT, V21, P2252, DOI 10.1016/j.bmcl.2011.02.113; Morimoto S, 2013, CHEM COMMUN, V49, P1811, DOI 10.1039/c3cc38594a; Nakashima H, 2006, J AM CHEM SOC, V128, P15092, DOI 10.1021/ja066479y; NAKAYAMA H, 1993, ANN NY ACAD SCI, V707, P349, DOI 10.1111/j.1749-6632.1993.tb38067.x; NAKAYAMA H, 1992, BIOCHEM BIOPH RES CO, V184, P900, DOI 10.1016/0006-291X(92)90676-C; Nassal M., 1983, LIEBIGS ANN CHEM, V1983, P1510, DOI 10.1002/jlac.198319830907; Park JJ, 2005, CHEMBIOCHEM, V6, P814, DOI 10.1002/cbic.200400342; Ramakrishnan B, 2006, J MOL BIOL, V357, P1619, DOI 10.1016/j.jmb.2006.01.088; Ruhl T, 2002, CHEM COMMUN, P1630, DOI 10.1039/b204007g; Thuring JW, 2002, BIOCHEMISTRY-US, V41, P2002, DOI 10.1021/bi0106078; Tomohiro T, 2013, CHEM COMMUN, V49, P11551, DOI 10.1039/c3cc45780j; Tomohiro T, 2013, BIOORG MED CHEM LETT, V23, P5605, DOI 10.1016/j.bmcl.2013.08.041; Tomohiro T, 2011, BIOCONJUGATE CHEM, V22, P315, DOI 10.1021/bc100598r; Tomohiro T, 2009, HETEROCYCLES, V79, P897, DOI 10.3987/COM-08-S(D)60; Ueda H, 2004, BIOCHEM J, V382, P821; Yang J, 2002, BIOCHEM J, V367, P533, DOI 10.1042/BJ20020843; YOSHIDA E, 1990, CHEM PHARM BULL, V38, P982; Zhang HM, 2014, CHEM COMMUN, V50, P4891, DOI 10.1039/c4cc01528b	86	1	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	JAN	2015	63	1					1	12				12	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	AX5FH	WOS:000346951700001		
J	Hayashi, A; Kubota, M; Okamura, M; Nakayama, H				Hayashi, Aki; Kubota, Mai; Okamura, Miki; Nakayama, Hirokazu			Complex Formation with Layered Double Hydroxides for the Remediation of Hygroscopicity	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						layered double hydroxide; hygroscopicity; drug	HYDROTALCITE-LIKE COMPOUNDS; PHYSICOCHEMICAL PROPERTIES; CARBONATE IONS; MIXED-SOLUTION; INTERCALATION; DEINTERCALATION; DECARBONATION	Layered double hydroxides (LDHs) have been used commercially as antacids, to stabilize drugs, to allow the controlled release of incorporated drugs, and to act as drug carriers to reduce drug accumulation within the body. Several types of LDH were investigated: nitrate type (LDH-NO3); chloride type (LDH-Cl); and carbonate type (LDH-CO3). Each type was added to an aqueous or methanol (MeOH) solution containing a drug (pravastatin or nateglinide). With pravastatin sodium, the interlayer distance expanded after reaction with LDH-NO3 and LDH-Cl in aqueous solution. In contrast, the interlayer distance of LDH-CO3 increased in methanol with nateglinide. Each drug was intercalated into the interlayer space of LDH by ion exchange. The hygroscopicity of the drug substances, complexes, and physical mixtures were determined at 70% relative humidity. Increases in weight (%) of the complexes were less than those of the physical mixtures, which demonstrates that hygroscopicity was reduced upon complexation with LDH due to the layer of LDH over the drugs.	[Hayashi, Aki; Kubota, Mai; Okamura, Miki; Nakayama, Hirokazu] Kobe Pharmaceut Univ, Dept Funct Mol Chem, Higashinada Ku, Kobe, Hyogo 6588558, Japan	Hayashi, A (reprint author), Kobe Pharmaceut Univ, Dept Funct Mol Chem, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.	ahayashi@kobepharma-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [22590047]	This work was supported by a Grant-in-Aid for Scientific Research (No. 22590047) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Iyi N, 2010, CHEM LETT, V39, P591, DOI 10.1246/cl.2010.591; Gasser MS, 2009, COLLOID SURFACE B, V73, P103, DOI 10.1016/j.colsurfb.2009.05.005; MIYATA S, 1975, CLAY CLAY MINER, V23, P369, DOI 10.1346/CCMN.1975.0230508; Iyi N, 2011, APPL CLAY SCI, V54, P132, DOI 10.1016/j.clay.2011.07.017; Trikeriotis M, 2007, INT J PHARM, V332, P176, DOI 10.1016/j.ijpharm.2006.09.031; Hayashi A, 2011, CHEM LETT, V40, P276, DOI 10.1246/cl.2011.276; Iyi N, 2004, CHEM MATER, V16, P2926, DOI 10.1021/cm049579g; CHIBWE K, 1989, J CHEM SOC CHEM COMM, P926, DOI 10.1039/c39890000926; Gastuche M.C., 1967, CLAY MINER, V7, P177, DOI 10.1180/claymin.1967.007.2.05; Hayashi A, 2013, B CHEM SOC JPN, V86, P1256, DOI 10.1246/bcsj.20130130; Iyi N, 2008, J COLLOID INTERF SCI, V322, P237, DOI 10.1016/j.jcis.2008.02.047; Iyi N, 2005, CHEM LETT, V34, P932, DOI 10.1246/cl.2005.932; Kobo B., 1969, YAKUZAIGAKU, V29, P215; Nakayama H, 2003, J PHARM SCI-US, V92, P2419, DOI 10.1002/jps.10498; Nakayama H, 2009, J PHARM SCI-US, V98, P46, DOI 10.1002/jps.21414; Narita E., 1995, CLAY SCI, V9, P187; Oh JM, 2006, BIOCONJUGATE CHEM, V17, P1411, DOI 10.1021/bc0601323; REICHLE WT, 1986, SOLID STATE IONICS, V22, P135, DOI 10.1016/0167-2738(86)90067-6; Suzuki E., 1994, KAGAKU SOSETSU, V21, P49; ULIBARRI MA, 1995, APPL CLAY SCI, V10, P131, DOI 10.1016/0169-1317(95)00020-5; Yasutake A., 2008, CLAY SCI, V14, P49	21	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	JAN	2015	63	1					13	17				5	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	AX5FH	WOS:000346951700002		
J	Mukaida, M; Sugano, K; Terada, K				Mukaida, Makoto; Sugano, Kiyohiko; Terada, Katsuhide			Stability Order of Caffeine Co-crystals Determined by Co-crystal Former Exchange Reaction and Its Application for the Validation of in Silico Models	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						co-crystal; co-crystal former; exchange reaction; caffeine; hydrogen bond energy	PHARMACEUTICAL COCRYSTALS; HYDROXYBENZOIC ACIDS; PHASES; CARBAMAZEPINE; THROUGHPUT; PREDICTION; SCIENCE	The purpose of the present study was to determine the thermodynamic stability orders of co-crystals by co-crystal former (CCF) exchange reactions. Caffeine (CA) was employed as a model drug. The CCF exchange reaction was performed by liquid-assisted grinding using ethanol. When oxalic acid (OX) was added to CA-citric acid co-crystal (CA-CI), CA-CI converted to CA-OX, suggesting that CA-OX is more stable than CA-CI. The stability orders of other co-crystals were determined in the same manner. The stability order of CA co-crystals was determined as CA-OX,approximate to CA-p-hydroxybenzoic acid (HY)>CA-CI>CA-malonic acid>CA-maleic acid. The stability order correlated with the difference in hydrogen bond energy estimated in silico, except for CA-HY. The pi-pi stacking in CA-HY was suggested as a reason for this discrepancy. The CCF exchange reaction was demonstrated as a useful method to determine the stability order of co-crystals, which can be used for the validation of in silico parameters to predict co-crystal formation.	[Mukaida, Makoto; Sugano, Kiyohiko] Asahi Kasei Pharma Corp, Shizuoka 4102321, Japan; [Mukaida, Makoto; Sugano, Kiyohiko; Terada, Katsuhide] Toho Univ, Fac Pharmaceut Sci, Dept Pharmaceut, Chiba 2748510, Japan	Mukaida, M (reprint author), Asahi Kasei Pharma Corp, 632-1 Mifuku Izunokuni, Shizuoka 4102321, Japan.	mukaida.mb@om.asahi-kasei.co.jp					Almarsson O, 2004, CHEM COMMUN, P1889, DOI 10.1039/b402150a; Qiao N, 2011, INT J PHARMACEUT, V419, P1, DOI 10.1016/j.ijpharm.2011.07.037; Grecu T, 2014, CRYST GROWTH DES, V14, P165, DOI 10.1021/cg401339v; Abramov YA, 2012, J PHARM SCI-US, V101, P3687, DOI 10.1002/jps.23227; Mohammad MA, 2011, INT J PHARMACEUT, V407, P63, DOI 10.1016/j.ijpharm.2011.01.030; Blagden N, 2007, ADV DRUG DELIVER REV, V59, P617, DOI 10.1016/j.addr.2007.05.011; Bucar DK, 2009, CRYST GROWTH DES, V9, P1932, DOI 10.1021/cg801178m; Trask AV, 2005, CRYST GROWTH DES, V5, P1013, DOI 10.1021/cg0496540; Bucar DK, 2007, CHEM COMMUN, P525, DOI 10.1039/b611749j; Shan N, 2008, DRUG DISCOV TODAY, V13, P440, DOI 10.1016/j.drudis.2008.03.004; Guo K, 2010, CRYST GROWTH DES, V10, P268, DOI 10.1021/cg900885n; Fleischman SG, 2003, CRYST GROWTH DES, V3, P909, DOI 10.1021/cg034035x; Kojima T, 2010, INT J PHARMACEUT, V399, P52, DOI 10.1016/j.ijpharm.2010.07.055; Vishweshwar P, 2006, J PHARM SCI-US, V95, P499, DOI 10.1002/jps.20578; Yamamoto K, 2012, INT J PHARMACEUT, V437, P162, DOI 10.1016/j.ijpharm.2012.07.038; Issa N, 2009, CRYST GROWTH DES, V9, P442, DOI 10.1021/cg800685z; Karki S, 2007, MOL PHARM, V4, P347, DOI 10.1021/mp0700054; Schultheiss N, 2009, CRYST GROWTH DES, V9, P2950, DOI 10.1021/cg900129f; Karamertzanis PG, 2009, J CHEM THEORY COMPUT, V5, P1432, DOI 10.1021/ct8004326; Gelbrich T, 2006, CRYSTENGCOMM, V8, P448, DOI 10.1039/b600753h; Yamashita H, 2013, PHARM RES-DORDR, V30, P70, DOI 10.1007/s11095-012-0850-1; Friscic T, 2010, J PHARM PHARMACOL, V62, P1547, DOI 10.1111/j.2042-7158.2010.01133.x; Leung DH, 2012, CRYST GROWTH DES, V12, P1254, DOI 10.1021/cg201270s; Remenar JF, 2003, J AM CHEM SOC, V125, P8456, DOI 10.1021/ja035776p; Musumeci D, 2011, CHEM SCI, V2, P883, DOI 10.1039/c0sc00555j; Bysouth SR, 2011, INT J PHARMACEUT, V411, P169, DOI 10.1016/j.ijpharm.2011.03.037; Caira M. R., 1995, J CHEM SOC P2, V1995, P2213; Grecu T, 2014, CRYST GROWTH DES, V14, P1749, DOI 10.1021/cg401889h; Habgood M, 2010, CRYST GROWTH DES, V10, P3263, DOI 10.1021/cg100405s; Moribe Kunikazu, 2012, Journal of the Society of Powder Technology, Japan, V49, DOI 10.4164/sptj.49.184; Stahl P.H., 2002, HDB PHARM SALTS PROP; Walsh RDB, 2003, CHEM COMMUN, P186, DOI 10.1039/b208574g	32	1	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	JAN	2015	63	1					18	24				7	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	AX5FH	WOS:000346951700003		
J	Chen, LM; Kotani, A; Kusu, F; Wang, ZM; Zhu, JJ; Hakamata, H				Chen, Liangmian; Kotani, Akira; Kusu, Fumiyo; Wang, Zhimin; Zhu, Jingjing; Hakamata, Hideki			Quantitative Comparison of Caffeoylquinic Acids and Flavonoids in Chrysanthemum morifolium Flowers and Their Sulfur-Fumigated Products by Three-Channel Liquid Chromatography with Electrochemical Detection	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						Chrysanthemum morifolium flower; caffeoylquinic acid; flavonoid; sulfur-fumigation; electrochemical detection	FINGERPRINT ANALYSIS; FLOS CHRYSANTHEMI; MAJOR FLAVONOIDS; IDENTIFICATION; COMPONENTS; GLYCOSIDES; OXIDATION; MEDICINE; CELLS; LC	For the determination of seven caffeoylquinic acids [neochlorogenic acid (NcA), cryptochlorogenic acid (CcA), chlorogenic acid (CA), caffeic acid (CfA), isochlorogenic acid A (le A), isochlorogenic acid B (IcB), isochlorogenic acid C (IcC)] and two flavonoids [luteolin 7-O-glucoside (LtG) and luteolin (Lt)], a three-channel liquid chromatography with electrochemical detection (LC-3ECD) method was established. Chromatographic peak heights were proportional to each concentration, ranging from 2.5 to 100 ng/mL for NcA, CA, CcA, and CfA, and ranging from 2.5 to 250 ng/mL for LtG, Ic B, Ic A, Ic C, and Lt, respectively. The present LC-3ECD method was applied to the quantitative analysis of caffeoylquinic acids and flavonoids in four cultivars of Chrysanthemum morifolium flowers and their sulfur-fumigated products. It was found that 60% of LtG and more than 47% of caffeoylquinic acids were lost during the sulfur fumigation processing. Sulfur fumigation showed a destructive effect on the C. morifolium flowers. In addition, principle component analyses (PCA) were performed using the results of the quantitative analysis of caffeoylquinic acids and flavonoids to compare the "sameness" and "differences" of these analytes in C. morifolium flowers and the sulfur-fumigated products. PCA score plots showed that the four cultivars of C. morifolium flowers were clearly classified into four groups, and that significant differences were also found between the non-fumigated C. morifolium flowers and the sulfur-fumigated products. Therefore, it was demonstrated that the present LC-3ECD method coupled with PCA is applicable to the variation analysis of different C. morifolium flower samples.	[Chen, Liangmian; Kotani, Akira; Kusu, Fumiyo; Hakamata, Hideki] Tokyo Univ Pharm & Life Sci, Sch Pharm, Hachioji, Tokyo 19270392, Japan; [Chen, Liangmian; Wang, Zhimin; Zhu, Jingjing] China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing 100700, Peoples R China; [Chen, Liangmian; Wang, Zhimin; Zhu, Jingjing] Natl Engn Lab Qual Control Technol Chinese Herbal, Beijing 100700, Peoples R China	Kotani, A (reprint author), Tokyo Univ Pharm & Life Sci, Sch Pharm, 1432-1 Horinouchi, Hachioji, Tokyo 19270392, Japan.	kotani@toyaku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [26410161]; Special Project for Traditional Chinese Medicine Industry [201307008-04]; National Natural Science Foundation of China [81373960]	This research is supported in part by the Grants-in-Aid for Scientific Research C (No. 26410161 to AK) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Special Project for Traditional Chinese Medicine Industry (No. 201307008-04), and the National Natural Science Foundation of China (No. 81373960). Liangmian Chen, one of the authors, would also like to express his gratitude to the international exchange program between the China Academy of Chinese Medical Science and the School of Pharmacy, Tokyo University of Pharmacy and Life Sciences.	Lai JP, 2007, J CHROMATOGR B, V848, P215, DOI 10.1016/j.jchromb.2006.10.028; Matsumoto D, 2010, J CHROMATOGR A, V1217, P2986, DOI 10.1016/j.chroma.2010.02.050; Hotta H, 2001, BBA-GEN SUBJECTS, V1526, P159, DOI 10.1016/S0304-4165(01)00123-4; Kim HJ, 2005, PLANTA MED, V71, P871, DOI 10.1055/s-2005-873115; Xie YY, 2009, J ASIAN NAT PROD RES, V11, P771, DOI 10.1080/10286020903128470; Sun JH, 2012, J PHARMACEUT BIOMED, V61, P142, DOI 10.1016/j.jpba.2011.11.013; Sun QL, 2010, AFR J BIOTECHNOL, V9, P3817; Chu QC, 2004, J AGR FOOD CHEM, V52, P7828, DOI 10.1021/jf048933s; Liang XR, 2014, FOOD ANAL METHOD, V7, P197, DOI 10.1007/s12161-013-9618-4; Lin LZ, 2010, FOOD CHEM, V120, P319, DOI 10.1016/j.foodchem.2009.09.083; He DX, 2012, J ETHNOPHARMACOL, V139, P68, DOI 10.1016/j.jep.2011.10.043; Jiang X, 2013, PHYTOMEDICINE, V20, P97, DOI 10.1016/j.phymed.2012.09.030; Miyazawa M, 2003, BIOSCI BIOTECH BIOCH, V67, P2091, DOI 10.1271/bbb.67.2091; Avula B, 2014, J PHARMACEUT BIOMED, V88, P278, DOI 10.1016/j.jpba.2013.08.037; Clifford MN, 2007, J AGR FOOD CHEM, V55, P929, DOI 10.1021/jf062314x; Janeiro P, 2004, ANAL CHIM ACTA, V518, P109, DOI 10.1016/j.aca.2004.05.038; Cao G, 2012, ANALYST, V137, P3828, DOI 10.1039/c2an35543d; Chen LM, 2014, J PHARMACEUT BIOMED, V95, P93, DOI 10.1016/j.jpba.2014.02.015; Chinese Pharmacopoeia Committee, 2010, PHARM PEOPL REP CHIN, V1, P292; Hua B., 2006, QINGDAO MED J, V38, P282; Jolliffe T., 1986, PRINCIPAL COMPONENT; Kan W. L. T., 2011, FRONT PHARM, V2, P1; Lee JS, 2003, PLANTA MED, V69, P859, DOI 10.1055/s-2003-43207; Peng YR, 2006, LISHIZHEN MED MAT ME, V17, P1131; Wang S, 2014, PHYTOMEDICINE, V21, P773, DOI 10.1016/j.phymed.2013.10.019; Wang T, 2013, BIOCHEM SYST ECOL, V47, P74, DOI 10.1016/j.bse.2012.11.004; Wang YJ, 2009, CHROMATOGRAPHIA, V70, P109, DOI 10.1365/s10337-009-1121-0	27	1	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	JAN	2015	63	1					25	32				8	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	AX5FH	WOS:000346951700004		
J	Yamada, M; Nakamura, K; Kameda, T; Kobayashi, F; Matsuki, A; Tsuiki, H; Higaki, S; Iwasaka, Y; Hayakawa, K				Yamada, Maromu; Nakamura, Kaya; Kameda, Takayuki; Kobayashi, Fumihisa; Matsuki, Atsushi; Tsuiki, Hisanaga; Higaki, Seigo; Iwasaka, Yasunobu; Hayakawa, Kazuichi			Function of Rayon Fibers with Metallophthalocyanine Derivatives: Potential of Low-Molecular Weight Polycyclic Aromatic Hydrocarbon Removal and Bacillus sp Removal	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						phthalocyanine; polycyclic aromatic hydrocarbon; Bacillus sp.; adsorbent; antibacterial effect; fiber	BLUE-CHITIN COLUMN; COPPER-PHTHALOCYANINE; ASIAN DUST; MUTAGENS; RESIN	Polycyclic aromatic hydrocarbons (PAHs) are known as carcinogenic and/or mutagenic substances, and are present at high concentration in polluted environments. It has recently been reported that spore-forming bacteria (e.g., Bacillus spp.) can be transported long distances alive in the atmosphere, which raises the possibility that some of the transported bacteria could have adverse effects on human health. There is thus a need for filters that can remove gaseous PAHs from the air that people breathe and that can inhibit bacterial growth on the filters. We focused on metallophthalocyanine derivatives (M-Pc) which are known to adsorb PAHs as well as to inhibit the growth of bacteria as a potential filtering agent. In this study, we developed different types of M-Pc-supported rayon fibers by changing central metals, functional groups, concentrations of M-Pc and rayon types, and evaluated their removal effects by measuring adsorption rates of 3- and 4-ring PAHs with a HPLC and growth curves of Bacillus sp. with a spectrophotometer. The results showed that both the effects depended on functional groups and concentrations of M-Pc, and rayon types. The most effective combination was observed in Fe-Pc with sulfo group supported on cationized rayon fiber at the concentration of 2 to 3.3 wt%. Central metal species of M-Pc were influenced only on the antibacterial properties. This fiber would be applicable to filtering agents and textiles.	[Yamada, Maromu] Natl Inst Occupat Safety & Hlth, Tama Ku, Kawasaki, Kanagawa 2148585, Japan; [Yamada, Maromu] Kanazawa Univ, Ctr Innovat, Kanazawa, Ishikawa 9201192, Japan; [Nakamura, Kaya; Kameda, Takayuki; Hayakawa, Kazuichi] Kanazawa Univ, Grad Sch Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 9201192, Japan; [Kobayashi, Fumihisa] Kanazawa Univ, Coll Sci & Engn, Kanazawa, Ishikawa 9201192, Japan; [Matsuki, Atsushi; Iwasaka, Yasunobu] Kanazawa Univ, Inst Nat & Environm Technol, Kanazawa, Ishikawa 9201192, Japan; [Tsuiki, Hisanaga; Higaki, Seigo] Daiwabo Neu Co Ltd, Chuo Ku, Tokyo 1030006, Japan	Yamada, M (reprint author), Natl Inst Occupat Safety & Hlth, Tama Ku, 6-21-1 Nagao, Kawasaki, Kanagawa 2148585, Japan.	yamadam@h.jniosh.go.jp			Environment Research and Technology Development Fund, Ministry of the Environment, Japan [C-1155]	This research was partly funded by the Environment Research and Technology Development Fund (C-1155), Ministry of the Environment, Japan. We would like to thank Mr. Syota Yoshida and Mr. Shinji Morosawa for their assistance in experiments.	AKAIKE T, 1992, ARCH BIOCHEM BIOPHYS, V294, P55, DOI 10.1016/0003-9861(92)90136-K; Hua NP, 2007, AEROBIOLOGIA, V23, P291, DOI 10.1007/s10453-007-9076-9; ATKINSON R, 1994, ENVIRON HEALTH PERSP, V102, P117, DOI 10.2307/3431940; Maki T, 2010, SCI TOTAL ENVIRON, V408, P4556, DOI 10.1016/j.scitotenv.2010.04.002; Fang GC, 2004, CHEMOSPHERE, V55, P787, DOI 10.1016/j.chemosphere.2003.12.012; SHIRAI H, 1991, J PHYS CHEM-US, V95, P417, DOI 10.1021/j100154a073; Araki Y, 2009, J HEALTH SCI, V55, P77; Barbosa JMD, 2006, ENVIRON RES, V101, P304, DOI 10.1016/j.envres.2006.01.005; Echigo Akinobu, 2005, Saline Systems, V1, P8, DOI 10.1186/1746-1448-1-8; HAYATSU H, 1992, J CHROMATOGR, V597, P37, DOI 10.1016/0021-9673(92)80095-C; HAYATSU H, 1983, MUTAT RES, V119, P233, DOI 10.1016/0165-7992(83)90166-5; International Agency for Research on Cancer (IARC), 2012, IARC MON EV CARC R F, V100 F; Kimura M., 2003, PORPHYRIN HDB, P151; Kobayashi Fumihisa, 2010, Earozoru Kenkyu, V25; Nagai A, 1999, J HEALTH SCI, V45, P111; Sakamoto H, 1996, MUTAT RES-GENET TOX, V371, P79, DOI 10.1016/S0165-1218(96)90097-X; SHABAD LM, 1972, CANCER RES, V32, P617; Shirai H, 2010, JINKO KOSO NO YUME W; THRANE KE, 1981, ATMOS ENVIRON, V15, P909, DOI 10.1016/0004-6981(81)90090-1; Yamaguchi N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00525	20	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	JAN	2015	63	1					38	42				5	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	AX5FH	WOS:000346951700006		
J	Kitagawa, S; Fujiwara, M; Okinaka, Y; Yutani, R; Teraoka, R				Kitagawa, Shuji; Fujiwara, Megumi; Okinaka, Yuta; Yutani, Reiko; Teraoka, Reiko			Effects of Mixing Procedure Itself on the Structure, Viscosity, and Spreadability of White Petrolatum and Salicylic Acid Ointment and the Skin Permeation of Salicylic Acid	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						ointment; petrolatum; mixing procedure; viscosity; skin accumulation; salicylic acid	DEXAMETHASONE DIPROPIONATE; HEPARINOID OINTMENTS; ADMIXTURES; DELIVERY; MODEL	White petrolatum is a mixture of solid and liquid hydrocarbons and its structure can be affected by shear stress. Thus, it might also induce changes in its rheological properties. In this study, we used polarization microscopy to investigate how different mixing methods affect the structure of white petrolatum. We used two different mixing methods, mixing using a rotation/revolution mixer and mixing using an ointment slab and an ointment spatula. The extent of the fragmentation and dispersal of the solid portion of white petrolatum depended on the mixing conditions. Next, we examined the changes in the structure of a salicylic acid ointment, in which white petrolatum was used as a base, induced by mixing and found that the salicylic acid solids within the ointment were also dispersed. In addition to these structural changes, the viscosity and thixotropic behavior of both test substances also decreased in a mixing condition-dependent manner. The reductions in these parameters were most marked after mixing with a rotation/revolution mixer, and similar results were obtained for spreadability. We also investigated the effects of mixing procedure on the skin accumulation and permeation of salicylic acid. They were increased by approximately three-fold after mixing. Little difference in skin accumulation or permeation was detected between the two mixing methods. These findings indicate that mixing procedures themselves affect the utility and physiological effects of white petrolatum-based ointments. Therefore, these effects should be considered when mixing is required for the clinical use of petrolatum-based ointments.	[Kitagawa, Shuji; Fujiwara, Megumi; Okinaka, Yuta; Yutani, Reiko; Teraoka, Reiko] Kobe Pharmaceut Univ, Higashinada Ku, Kobe, Hyogo 6588558, Japan	Kitagawa, S (reprint author), Kobe Pharmaceut Univ, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.	shuji@kobepharma-u.ac.jp					Fujii M, 1997, BIOL PHARM BULL, V20, P249; KLIGMAN AM, 1963, ARCH DERMATOL, V88, P702; Kitagawa S, 2006, CHEM PHARM BULL, V54, P242, DOI 10.1248/cpb.54.242; Noda Y, 2011, INT J PHARMACEUT, V419, P131, DOI 10.1016/j.ijpharm.2011.07.034; Barry B. W., 1971, Journal of Texture Studies, V2, P259, DOI 10.1111/j.1745-4603.1971.tb01004.x; Fukami T., 2006, JPN J PHARM HLTH CAR, V32, P964; Marty JP, 2005, J EUR ACAD DERMATOL, V19, P7, DOI 10.1111/j.1468-3083.2005.01330.x; Ohtani M, 2002, YAKUGAKU ZASSHI, V122, P107, DOI 10.1248/yakushi.122.107; Ohzeki K., 2005, JPN J PHARM HLTH CAR, V31, P659; Pandey P, 2008, DRUG DEV IND PHARM, V34, P157, DOI 10.1080/03639040701484569; Park EK, 2010, ARCH PHARM RES, V33, P141, DOI 10.1007/s12272-010-2236-4; PENA LE, 1994, PHARMACEUT RES, V11, P875, DOI 10.1023/A:1018990010686; Suzuki T, 2012, CHEM PHARM BULL, V60, P260; Suzuki T, 2014, PHARMAZIE, V69, P104, DOI 10.1691/ph.2014.3145; Yamamoto Y, 2014, INT J PHARMACEUT, V463, P62, DOI 10.1016/j.ijpharm.2013.12.054; Yamamoto Y., 2012, J PHARM PHARM SCI, V4, P54; Yutani R, 2012, CHEM PHARM BULL, V60, P989	17	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	JAN	2015	63	1					43	48				6	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	AX5FH	WOS:000346951700007		
J	Yamashita-Higuchi, Y; Sugimoto, S; Matsunami, K; Inagaki, M; Otsuka, H; Takeda, Y				Yamashita-Higuchi, Yukiko; Sugimoto, Sachiko; Matsunami, Katsuyoshi; Inagaki, Masanori; Otsuka, Hideaki; Takeda, Yoshio			Nitrile-Containing Phenolic Glucosides from the Leaves of Glochidion acuminatum	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						Glochidion acuminatum; Euphorbiaceae; 2-(2,4-dihydroxyphenyl)acetonitrile; gallate; sulfate	MUELL	From the EtOAc-soluble fraction of a MeOH extract of the leaves of Glochidion acuminatum, six new compounds along with five known ones were isolated. The structures of the new compounds were elucidated to be two gallates, a p-hydroxybenzoate and an (S)-2-(4-hydroxycyclohex-1-en-1-yl)acetate of a nitrile-containing phenolic glucoside, methyl 2-(2-hydroxyphenyl)acetate beta-D-glucopyranoside, and (S)-methyl 2-[4-sulfooxycyclohex-1-en-1-yl]acetate on the basis of spectroscopic evidence.	[Yamashita-Higuchi, Yukiko; Sugimoto, Sachiko; Matsunami, Katsuyoshi; Otsuka, Hideaki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Minami Ku, Hiroshima 7348553, Japan; [Inagaki, Masanori; Otsuka, Hideaki; Takeda, Yoshio] Yasuda Womens Univ, Fac Pharm, Asaminami Ku, Hiroshima 7310153, Japan	Otsuka, H (reprint author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	hotsuka@hiroshima-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [22590006, 23590130, 25860078]; Japan Society for the Promotion of Science; Ministry of Health, Labour and Welfare; Research Foundation for Pharmaceutical Sciences; Takeda Science Foundation	The authors are grateful for access to the superconducting NMR instrument (JEOL JNM alpha-400) and an Applied Biosystem QSTAR XL system ESI (Nano Spray)MS at the Analysis Center of Life Science of the Graduate School of Biomedical Sciences, Hiroshima University. This work was supported in part by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Nos. 22590006, 23590130, and 25860078), the Japan Society for the Promotion of Science, and the Ministry of Health, Labour and Welfare. Thanks are also due to the Research Foundation for Pharmaceutical Sciences and the Takeda Science Foundation for the financial support.	Zhang YJ, 2001, J NAT PROD, V64, P870, DOI 10.1021/np010059z; Kawakita A, 2004, EVOLUTION, V58, P2201; Manga SSE, 2001, FITOTERAPIA, V72, P706; Eldahshan O. A., 2011, Current Research Journal of Biological Sciences, V3, P52; KUBO I, 1985, CHEM PHARM BULL, V33, P3817; Otsuka H, 2004, CHEM PHARM BULL, V52, P591, DOI 10.1248/cpb.52.591; Otsuka H, 1998, CHEM PHARM BULL, V46, P1180; SIMPOL LR, 1994, PHYTOCHEMISTRY, V36, P91, DOI 10.1016/S0031-9422(00)97019-5; Su Y.-F., 2005, J ASIAN NAT PROD RES, V2, P171; VALDES LJ, 1986, J NAT PROD, V49, P171, DOI 10.1021/np50043a031	10	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	JAN	2015	63	1					49	53				5	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	AX5FH	WOS:000346951700008		
J	Sato, H; Ogawa, K; Kojo, Y; Suzuki, H; Mizumoto, T; Onoue, S				Sato, Hideyuki; Ogawa, Kumiko; Kojo, Yoshiki; Suzuki, Hiroki; Mizumoto, Takahiro; Onoue, Satomi			Physicochemical Stability Study on Cyclosporine A Loaded Dry-Emulsion Formulation with Enhanced Solubility	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						cyclosporine A; dry emulsion; physicochemical stability	CLASSIFICATION-SYSTEM; SOLID DISPERSIONS; ABSORPTION; RATS	The main purpose of the present study was to evaluate the physicochemical stability of cyclosporine A (CsA)-loaded glycerol monooleate-based dry emulsion (DE). DE formulations containing 5-25% CsA (DE5-25) were stored at 25 degrees C/60% relative humidity for 4 weeks, and freeze-dried solid dispersion formulations containing 5-30% CsA (FD5-30) were also prepared as reference formulations. Even after the storage, no significant changes were observed in the appearance of any formulations. In the dissolution study, both DE and FD exhibited marked enhancement of solubility and there was at least 2.0-fold improvement in the initial dissolution rate of DE formulations compared with that of FD formulations. After storage, DE5, DE15 and FD5 maintained relatively high solubility, with 10% reduction compared with the initial state. However, the solubility of DE25 gradually decreased during storage, as evidenced by 76% reduction of the dissolution amount. No significant changes were seen in DE5-25 using powder X-ray diffraction, although thermal analysis revealed moderate changes in crystallinity in DE25 after storage, possibly leading to the decreased dissolution. Furthermore, particle size distributions of micelles in DE5 and DE15 were almost unchanged after storage for 4 weeks. From these findings, it appears that the physicochemical stability of CsA-loaded DE might vary depending on the manufacturing method and that further optimization could improve physical properties and stability.	[Sato, Hideyuki; Ogawa, Kumiko; Kojo, Yoshiki; Suzuki, Hiroki; Onoue, Satomi] Univ Shizuoka, Sch Pharmaceut Sci, Dept Pharmacokinet & Pharmacodynam, Suruga Ku, Shizuoka 4228526, Japan; [Sato, Hideyuki] Osaka Univ Pharmaceut Sci, Takatsuki, Osaka 5691094, Japan; [Mizumoto, Takahiro] ILS Inc, Dept Prod Dev, Moriya, Ibaraki 3020104, Japan; [Mizumoto, Takahiro] Amer Peptide Co, Sunnyvale, CA 94086 USA	Onoue, S (reprint author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Pharmacokinet & Pharmacodynam, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	onoue@u-shizuoka-ken.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24590200]; Takeda Science Foundation	This work was supported in part by a Grant-in-Aid for Scientific Research (C) (No. 24590200; S. Onoue) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and a Grant from Takeda Science Foundation.	Wu CY, 2005, PHARM RES, V22, P11, DOI 10.1007/s11095-004-9004-4; Onoue S, 2012, EUR J PHARM BIOPHARM, V80, P54, DOI 10.1016/j.ejpb.2011.10.003; Lobenberg R, 2000, EUR J PHARM BIOPHARM, V50, P3, DOI 10.1016/S0939-6411(00)00091-6; KOVARIK JM, 1994, J PHARM SCI, V83, P444, DOI 10.1002/jps.2600830336; Bertacche V, 2006, J PHARM SCI-US, V95, P159, DOI 10.1002/jps.20523; Dai J., 2004, ACTA PHARMACOL SIN, V39, P1023; Dubey R. R., 2004, PHARM TECH EUR, V16, P23; JOHNSTON A, 1986, BRIT J CLIN PHARMACO, V21, P331; Lechuga-Ballesteros D, 2003, J PHARM SCI-US, V92, P1821, DOI 10.1002/jps.10444; Miyake K, 1999, BIOL PHARM BULL, V22, P66; Onoue S, 2010, INT J PHARMACEUT, V399, P94, DOI 10.1016/j.ijpharm.2010.08.007; Sato H, 2013, INT J PHARMACEUT, V448, P282, DOI 10.1016/j.ijpharm.2013.03.026; Sato H, 2012, INT J PHARMACEUT, V426, P302, DOI 10.1016/j.ijpharm.2012.01.022; Sharma Pradeep, 2005, Farmaco (Lausanne), V60, P884, DOI 10.1016/j.farmac.2005.08.008; Van den Mooter G, 2006, INT J PHARM, V316, P1, DOI 10.1016/j.ijpharm.2006.02.025	15	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	JAN	2015	63	1					54	58				5	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	AX5FH	WOS:000346951700009		
J	Kawashima, Y; Ohkubo, K; Fukuzumi, S				Kawashima, Yuki; Ohkubo, Kei; Fukuzumi, Shunichi			Efficient Charge Separation in Li+@C-60 Supramolecular Complexes with Electron Donors	CHEMISTRY-AN ASIAN JOURNAL			English	Review						fullerenes; electron transfer; lithium; photochemistry; supramolecular chemistry	SMALL REORGANIZATION ENERGIES; CYCLIC PORPHYRIN DIMERS; ZINC CHLORIN-C-60 DYAD; PI-PI INTERACTIONS; DISTANCE DEPENDENCE; INCLUSION COMPLEXES; PHOTOVOLTAIC CELLS; ENDOHEDRAL METALLOFULLERENES; STRUCTURAL-CHARACTERIZATION; PHOTOPHYSICAL PROPERTIES	Lithium-ion-encapsulated fullerene (Li+@C-60) exhibits greatly enhanced reactivity in photoinduced electron-transfer reduction with electron donors compared with pristine C-60. The enhanced reactivity of Li+@C-60 results from the more positive one-electron reduction potential of Li+@C-60 (+0.14V versus a standard calomel electrode (SCE)) than that of C-60 (-0.43V versus SCE), whereas the reorganization energy of electron transfer of Li+@C-60 (1.01eV) becomes larger than that of C-60 (0.73eV) because of the change in electrostatic interactions of encapsulated Li+ upon electron transfer. Li+@C-60 can form strong supramolecular complexes with various anionic electron donors through electrostatic interactions. Li+@C-60 can also form strong supramolecular complexes with various electron donors, such as cyclic porphyrin dimers, corannulene, and crown ether fused monopyrrolotetrathiafulvalenes. Photoinduced electron transfer from electron donors to Li+@C-60 afforded long-lived charge-separated states of supramolecular complexes between electron donors and Li+@C-60. A photoelectrochemical solar cell composed of supramolecular nanoclusters of Li+@C-60 and zinc sulfonated meso-tetraphenylporphyrin exhibits significant enhancement in the photoelectrochemical performance than that of the reference system containing only a single component.	[Kawashima, Yuki; Ohkubo, Kei; Fukuzumi, Shunichi] Osaka Univ, Grad Sch Engn, Dept Mat & Life Sci, Suita, Osaka 5650871, Japan	Fukuzumi, S (reprint author), Osaka Univ, Grad Sch Engn, Dept Mat & Life Sci, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	fukuzumi@chem.eng.osaka-u.ac.jp	Fukuzumi, Shunichi /E-4728-2010; Ohkubo, Kei/E-5127-2012	Ohkubo, Kei/0000-0001-8328-9249			Nobukuni H, 2012, B CHEM SOC JPN, V85, P862, DOI 10.1246/bcsj.20120073; Takai A, 2010, J AM CHEM SOC, V132, P4477, DOI 10.1021/ja100192x; Fukuzumi S, 2012, COORDIN CHEM REV, V256, P2488, DOI 10.1016/j.ccr.2012.01.011; Balzani V, 2001, COORDIN CHEM REV, V219, P545, DOI 10.1016/S0010-8545(01)00351-4; Fukuzumi S, 2008, J MATER CHEM, V18, P1427, DOI 10.1039/b717958h; Natali M, 2014, CHEM SOC REV, V43, P4005, DOI 10.1039/c3cs60463b; Wang CR, 2001, ANGEW CHEM INT EDIT, V40, P397, DOI 10.1002/1521-3773(20010119)40:2<397::AID-ANIE397>3.0.CO;2-3; PEDERSEN CJ, 1967, J AM CHEM SOC, V89, P7017, DOI 10.1021/ja01002a035; Cong HL, 2013, COORDIN CHEM REV, V257, P2880, DOI 10.1016/j.ccr.2013.05.020; MARCUS RA, 1964, ANNU REV PHYS CHEM, V15, P155, DOI 10.1146/annurev.pc.15.100164.001103; Wijesinghe CA, 2011, CHEM-EUR J, V17, P3147, DOI 10.1002/chem.201002446; Kawashima Y, 2014, CHEMPHYSCHEM, V15, P3782, DOI 10.1002/cphc.201402512; Fukuzumi S, 2001, J AM CHEM SOC, V123, P10676, DOI 10.1021/ja015738a; Ohkubo K, 2002, J PHYS CHEM A, V106, P10991, DOI 10.1021/jp026603+; Chitta R, 2008, J MATER CHEM, V18, P1440, DOI 10.1039/b717502g; Fukuzumi S, 2006, B CHEM SOC JPN, V79, P177, DOI 10.1246/bcsj.79.177; Ohkubo K, 2004, ANGEW CHEM INT EDIT, V43, P853, DOI 10.1002/anie.200352870; Diederich F, 1999, CHEM SOC REV, V28, P263, DOI 10.1039/a804248i; Kawashima Y, 2013, J PHYS CHEM A, V117, P6737, DOI 10.1021/jp4047165; Ohkubo K, 2006, CHEM PHYS, V326, P3, DOI 10.1016/j.chemphys.2006.01.034; Walter MG, 2010, J PORPHYR PHTHALOCYA, V14, P759, DOI 10.1142/S1088424610002689; EBBESEN TW, 1991, CHEM PHYS LETT, V181, P501, DOI 10.1016/0009-2614(91)80302-E; Imahori H, 2001, J AM CHEM SOC, V123, P2607, DOI 10.1021/ja003346i; Ricks AB, 2012, J AM CHEM SOC, V134, P4581, DOI 10.1021/ja205913q; ARBOGAST JW, 1992, J AM CHEM SOC, V114, P2277, DOI 10.1021/ja00032a063; Ueno H, 2014, J AM CHEM SOC, V136, P11162, DOI 10.1021/ja505952y; Poddutoori PK, 2010, J PHYS CHEM B, V114, P14348, DOI 10.1021/jp911937d; Matsuo Y, 2012, ORG LETT, V14, P3784, DOI 10.1021/ol301671n; Bill NL, 2013, J AM CHEM SOC, V135, P10852, DOI 10.1021/ja404830y; Kawashima Y, 2012, J PHYS CHEM A, V116, P8942, DOI 10.1021/jp3059036; Grimm B, 2010, J AM CHEM SOC, V132, P17387, DOI 10.1021/ja108744a; Subbaiyan NK, 2009, J AM CHEM SOC, V131, P14646, DOI 10.1021/ja9067113; ARBOGAST JW, 1991, J AM CHEM SOC, V113, P8886, DOI 10.1021/ja00023a041; Butterfield AM, 2012, ORG PROCESS RES DEV, V16, P664, DOI 10.1021/op200387s; Faiz JA, 2009, CHEM SOC REV, V38, P422, DOI 10.1039/b710908n; Rudolf M, 2012, CHEM-EUR J, V18, P5136, DOI 10.1002/chem.201102844; Kamimura T, 2013, CHEM SCI, V4, P1451, DOI 10.1039/c3sc22065f; El-Khouly ME, 2014, CHEMPHYSCHEM, V15, P30, DOI 10.1002/cphc.201300715; Jin P, 2014, COORDIN CHEM REV, V270, P89, DOI 10.1016/j.ccr.2013.10.020; Gust D, 2009, ACCOUNTS CHEM RES, V42, P1890, DOI 10.1021/ar900209b; Zhang JY, 2013, ACCOUNTS CHEM RES, V46, P1548, DOI 10.1021/ar300301v; Fukuzumi S, 2008, PHYS CHEM CHEM PHYS, V10, P2283, DOI 10.1039/b801198m; Okada H, 2012, RSC ADV, V2, P10624, DOI 10.1039/c2ra21244g; AKASAKA T, 1995, NATURE, V374, P600, DOI 10.1038/374600a0; ARBOGAST JW, 1991, J PHYS CHEM-US, V95, P11, DOI 10.1021/j100154a006; Fukuzumi S, 2012, CHEM COMMUN, V48, P9801, DOI 10.1039/c2cc32848h; Fukuzumi S, 2013, DALTON T, V42, P15846, DOI 10.1039/c3dt51883c; Ohkubo K, 2013, CHEM COMMUN, V49, P4474, DOI 10.1039/c3cc41187g; Fukuzumi S, 1998, J AM CHEM SOC, V120, P8060, DOI 10.1021/ja9813459; Yamada M, 2014, J AM CHEM SOC, V136, P13240, DOI 10.1021/ja505391x; Murakami M, 2010, CHEM-EUR J, V16, P7820, DOI 10.1002/chem.200903236; Fukuzumi S, 2014, ACCOUNTS CHEM RES, V47, P1455, DOI 10.1021/ar400200u; Nobukuni H, 2010, CHEM-EUR J, V16, P11611, DOI 10.1002/chem.201001815; Kirner S, 2014, ADV MATER, V26, P1482, DOI 10.1002/adma.201304928; Aoyagi S, 2012, ANGEW CHEM INT EDIT, V51, P3377, DOI 10.1002/anie.201108551; Martin-Gomis L, 2008, J PHYS CHEM C, V112, P17694, DOI 10.1021/jp804983k; Krause M, 2007, CHEMPHYSCHEM, V8, P537, DOI 10.1002/cphc.200600363; D'Souza F, 1999, INORG CHEM, V38, P2157, DOI 10.1021/ic981358n; Popov AA, 2013, CHEM REV, V113, P5989, DOI 10.1021/cr300297r; Dunsch L, 2010, J AM CHEM SOC, V132, P5413, DOI 10.1021/ja909580j; Nobukuni H, 2009, J PHYS CHEM C, V113, P19694, DOI 10.1021/jp9076849; Chen N, 2010, CHEM COMMUN, V46, P4818, DOI 10.1039/c0cc00835d; Park JS, 2010, SCIENCE, V329, P1324, DOI 10.1126/science.1192044; Matsuo Y, 2008, CHEM REV, V108, P3016, DOI 10.1021/cr0684218; Wang TS, 2010, J AM CHEM SOC, V132, P16362, DOI 10.1021/ja107843b; GUST D, 1993, ACCOUNTS CHEM RES, V26, P198, DOI 10.1021/ar00028a010; Stevenson S, 2008, J AM CHEM SOC, V130, P11844, DOI 10.1021/ja803679u; Aoyagi S, 2010, NAT CHEM, V2, P678, DOI [10.1038/nchem.698, 10.1038/NCHEM.698]; Gust D, 2001, ACCOUNTS CHEM RES, V34, P40, DOI 10.1021/ar9801301; Fukuzumi S, 2011, J AM CHEM SOC, V133, P15938, DOI 10.1021/ja207588c; Kawashima Y, 2013, J PHYS CHEM C, V117, P21166, DOI 10.1021/jp407976b; Watanabe T, 2014, ORGANOMETALLICS, V33, P608, DOI 10.1021/om4008899; Ohkubo K, 2012, CHEM COMMUN, V48, P4314, DOI 10.1039/c2cc31186k; Kawase T, 2006, CHEM REV, V106, P5250, DOI 10.1021/cr0509657; BARTH WE, 1966, J AM CHEM SOC, V88, P380, DOI 10.1021/ja00954a049; Lee SH, 2012, CHEM SCI, V3, P257, DOI 10.1039/c1sc00614b; Lu X, 2013, ACCOUNTS CHEM RES, V46, P1627, DOI 10.1021/ar4000086; Guldi DM, 2000, J PHYS CHEM A, V104, P8601, DOI 10.1021/jp0016838; Aoyagi S., 2012, ANGEW CHEM, V124, P3433; Bhattacharya S, 2003, J PHYS CHEM B, V107, P4213, DOI 10.1021/jp022157e; Boyle MM, 2011, CHEM COMMUN, V47, P11870, DOI 10.1039/c1cc15333a; CAVE RJ, 1995, J PHYS CHEM-US, V99, P17501, DOI 10.1021/j100049a006; Fernando SRL, 1998, INORG CHEM, V37, P1900, DOI 10.1021/ic970369y; Fukuzumi S, 1998, J AM CHEM SOC, V120, P9220, DOI 10.1021/ja9815430; Guldi D. M., 2003, FULLERENES SYNTHESIS, P237; Guldi DM, 2007, PHYS CHEM CHEM PHYS, V9, P1400, DOI 10.1039/b617684b; Gust D., 2001, ELECT TRANSFER CHEM, V3, P272; Hasobe T, 2004, ADV MATER, V16, P975, DOI 10.1002/adma.200306519; ISIED SS, 1988, J AM CHEM SOC, V110, P635, DOI 10.1021/ja00210a074; KAJII Y, 1991, CHEM PHYS LETT, V181, P100, DOI 10.1016/0009-2614(91)90339-B; Kawakami H, 2013, ORG LETT, V15, P4466, DOI 10.1021/ol4020046; LAWSON DR, 1992, J ELECTROCHEM SOC, V139, pL68, DOI 10.1149/1.2221179; BARTH WE, 1971, J AM CHEM SOC, V93, P1730; Marcus R. A., 1993, ANGEW CHEM, V105, DOI DOI 10.1002/ANGE.19931050804; MARCUS RA, 1993, ANGEW CHEM INT EDIT, V32, P1111, DOI 10.1002/anie.199311113; MIKAMI K, 1995, J AM CHEM SOC, V117, P11134, DOI 10.1021/ja00150a013; Nielsen K., 2006, ANGEW CHEM, V118, P7002, DOI 10.1002/ange.200602724; Nielsen KA, 2006, ANGEW CHEM INT EDIT, V45, P6848, DOI 10.1002/anie.200602724; Nielsen KA, 2004, J AM CHEM SOC, V126, P16296, DOI 10.1021/ja044664a; Ohkubo K., 2004, ANGEW CHEM, V116, P871, DOI 10.1002/ange.200352870; SCOTT JR, 1993, J AM CHEM SOC, V115, P6820, DOI 10.1021/ja00068a045; Sugiyama Y, 1997, J AM CHEM SOC, V119, P9582, DOI 10.1021/ja971138t; Supur M, 2014, CHEM-EUR J, V20, P13976, DOI 10.1002/chem.201402449; Wang C. R., 2001, ANGEW CHEM, V113, P411, DOI 10.1002/1521-3757(20010119)113:2<411::AID-ANGE411>3.3.CO;2-Y; Wasielewski MR, 2009, ACCOUNTS CHEM RES, V42, P1910, DOI 10.1021/ar9001735	105	10	10	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	JAN	2015	10	1			SI		44	54		10.1002/asia.201403075		11	Chemistry, Multidisciplinary	Chemistry	AX1XD	WOS:000346736100003		
J	MacLean, MWA; Reid, LM; Wu, XW; Crudden, CM				MacLean, Michael W. A.; Reid, Lacey M.; Wu, Xiaowei; Crudden, Cathleen M.			Chirality in Ordered Porous Organosilica Hybrid Materials	CHEMISTRY-AN ASIAN JOURNAL			English	Review						asymmetric catalysis; chirality; enantioselectivity; heterogeneous catalysis; mesoporous materials	PERIODIC MESOPOROUS ORGANOSILICA; PERFORMANCE LIQUID-CHROMATOGRAPHY; CRYSTAL REACTION FIELD; ASYMMETRIC CATALYSIS; ENANTIOSELECTIVE REDUCTION; MOLECULAR RECOGNITION; PORE STRUCTURE; SOLID-STATE; ONE-STEP; SILICA	The ever-growing demand for chiral small molecules on a global scale has set a precedent for the proliferation of cost-effective and reliable methods for their synthesis and separation. Of these methods, those based on heterogeneous platforms present an unparalleled opportunity as they allow for the source of the chirality to be recycled. Chiral hybrid organosilica materials are one particularly interesting class of chiral heterogeneous platforms that creates a synergy between well-understood individual chiral molecules and the structural stability and inertness of the inorganic silicon scaffolds. This Focus Review summarizes the recent advances towards the incorporation of chirality into organosilica scaffolds, the synthesis of the chiral building blocks, and their promising applications towards facilitating asymmetric heterogeneous catalysis as well as chiral chromatography.	[MacLean, Michael W. A.; Reid, Lacey M.; Wu, Xiaowei; Crudden, Cathleen M.] Queens Univ, Dept Chem, Kingston, ON K7L 3N6, Canada; [Crudden, Cathleen M.] Nagoya Univ, Inst Transformat Biomol WPI ITbM, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Crudden, CM (reprint author), Queens Univ, Dept Chem, 90 Bader Lane, Kingston, ON K7L 3N6, Canada.	cathleen.crudden@chem.queensu.ca					Abramson S, 2002, TETRAHEDRON-ASYMMETR, V13, P357, DOI 10.1016/S0957-4166(02)00103-9; Alvaro M, 2004, CHEM MATER, V16, P2222, DOI 10.1021/cm0311630; Fan QH, 2002, CHEM REV, V102, P3385, DOI 10.1021/cr010341a; Garcia RA, 2012, J MATER CHEM, V22, P2607, DOI 10.1039/c2jm15381e; Jiang DM, 2006, J CATAL, V239, P65, DOI 10.1016/j.jcat.2006.01.018; Baleizao C, 2004, J CATAL, V223, P106, DOI 10.1016/j.jcat.2004.01.016; Pu L, 1998, CHEM REV, V98, P2405, DOI 10.1021/cr970463w; Jin RH, 2012, ADV SYNTH CATAL, V354, P3265, DOI 10.1002/adsc.201200222; [Anonymous], 2014, GENET ENG BIOTECHNOL; Corma A, 1997, CHEM REV, V97, P2373, DOI 10.1021/cr960406n; Polarz S, 2006, ADV MATER, V18, P1206, DOI 10.1002/adma.200502647; Mallat T, 2007, CHEM REV, V107, P4863, DOI 10.1021/cr0683663; Ramon DJ, 2006, CHEM REV, V106, P2126, DOI 10.1021/cr040698p; Bennani YL, 1997, CHEM REV, V97, P3161, DOI 10.1021/cr9407577; Thomas JM, 1999, J MOL CATAL A-CHEM, V141, P139, DOI 10.1016/S1381-1169(98)00257-X; Qiu HD, 2011, ANAL BIOANAL CHEM, V399, P3307, DOI 10.1007/s00216-010-4611-x; Zhuang TY, 2010, J MATER CHEM, V20, P6026, DOI 10.1039/c0jm01678k; Ma LQ, 2010, NAT CHEM, V2, P838, DOI [10.1038/nchem.738, 10.1038/NCHEM.738]; Hoffmann F, 2006, ANGEW CHEM INT EDIT, V45, P3216, DOI 10.1002/anie.200503075; Hao TT, 2012, RSC ADV, V2, P2010, DOI 10.1039/c2ra00805j; Beretta M, 2010, CHEM COMMUN, V46, P2495, DOI 10.1039/b923485c; NOYORI R, 1990, ACCOUNTS CHEM RES, V23, P345, DOI 10.1021/ar00178a005; Zhu GR, 2008, MICROPOR MESOPOR MAT, V116, P36, DOI 10.1016/j.micromeso.2008.03.012; Moreau JJE, 2001, J AM CHEM SOC, V123, P1509, DOI 10.1021/ja003843z; Diaz U, 2013, CHEM SOC REV, V42, P4083, DOI 10.1039/c2cs35385g; Jayalakshmi V, 2012, J MATER CHEM, V22, P15255, DOI 10.1039/c2jm33089j; Brethon A, 2004, TETRAHEDRON-ASYMMETR, V15, P495, DOI 10.1016/j.tetasy.2003.11.005; Zhang L, 2008, CHEM-ASIAN J, V3, P1842, DOI 10.1002/asia.200800160; Stein A, 2000, ADV MATER, V12, P1403, DOI 10.1002/1521-4095(200010)12:19<1403::AID-ADMA1403>3.0.CO;2-X; Song CE, 2002, CHEM REV, V102, P3495, DOI 10.1021/cr0103625; Morales V, 2013, J MATER SCI, V48, P5990, DOI 10.1007/s10853-013-7395-5; Meemken F, 2012, ANGEW CHEM INT EDIT, V51, P8212, DOI 10.1002/anie.201203007; Goh M, 2007, J AM CHEM SOC, V129, P8519, DOI 10.1021/ja070701x; Seki T, 2012, CHEM COMMUN, V48, P6369, DOI 10.1039/c2cc31247f; Brunel JM, 2005, CHEM REV, V105, P857, DOI 10.1021/cr040079g; Humblot V, 2002, J AM CHEM SOC, V124, P503, DOI 10.1021/ja012021e; MacQuarrie S, 2008, J AM CHEM SOC, V130, P14099, DOI 10.1021/ja804866e; Kuschel A, 2010, J AM CHEM SOC, V132, P6558, DOI 10.1021/ja1017706; Morell J, 2008, CHEM-EUR J, V14, P5935, DOI 10.1002/chem.200800239; Baleizao C, 2003, CHEM COMMUN, P1860, DOI 10.1039/b304814d; Benitez M, 2005, J ORG CHEM, V70, P2315, DOI 10.1021/jo047878j; Bergin E, 2012, ANNU REP PROG CHEM B, V108, P353, DOI 10.1039/c2oc90003c; Brethon A, 2001, J ORGANOMET CHEM, V627, P239, DOI 10.1016/S0022-328X(01)00758-6; Demers-Carpentier V, 2011, SCIENCE, V334, P776, DOI 10.1126/science.1208710; Fischer E, 1891, BER DTSCH CHEM GES, V24, P1836, DOI 10.1002/cber.189102401311; Garcia RA, 2008, CHEM MATER, V20, P2964, DOI 10.1021/cm703050u; Garcia RA, 2010, J CATAL, V274, P221, DOI 10.1016/j.jcat.2010.07.003; Gasparrini F, 2001, J CHROMATOGR A, V906, P35, DOI 10.1016/S0021-9673(00)00953-5; Gawley R. E., 2012, PRINCIPLES ASYMMETRI; HARADA T, 1977, CHEM LETT, P1131, DOI 10.1246/cl.1977.1131; Herault D, 2011, DALTON T, V40, P446, DOI 10.1039/c0dt01162b; Hoffmann F., 2006, ANGEW CHEM, V118, P3290, DOI 10.1002/ange.200503075; Ide A, 2007, CHEM MATER, V19, P2649, DOI 10.1021/cm063026j; Inagaki S, 2008, CHEM COMMUN, P202, DOI 10.1039/b714163g; Johnson BFG, 1999, CHEM COMMUN, P1167, DOI 10.1039/a902441g; Kuroda R, 2000, CHIRALITY, V12, P269, DOI 10.1002/(SICI)1520-636X(2000)12:4<269::AID-CHIR13>3.0.CO;2-P; Kuschel A, 2008, ANGEW CHEM INT EDIT, V47, P9513, DOI 10.1002/anie.200803405; Kuschel A., 2008, ANGEW CHEM, V120, P9655, DOI 10.1002/ange.200803405; Li C, 2004, CATAL REV, V46, P419, DOI 10.1081/CR-200036734; Liu KT, 2012, CHEM-EUR J, V18, P15546, DOI 10.1002/chem.201202407; Liu X, 2010, CHEM-ASIAN J, V5, P1232, DOI 10.1002/asia.200900737; Liu XA, 2010, CHEM-EUR J, V16, P12727, DOI 10.1002/chem.201000931; MacLean M. W. A., 2014, CHEM MAT IN PRESS; Meemken F., 2012, ANGEW CHEM, V124, P8336; Mori T, 2008, MACROMOLECULES, V41, P607, DOI 10.1021/ma702470t; Morioka K, 2005, POLYM J, V37, P299, DOI 10.1295/polymj.37.299; Nguyen Lien Ai, 2006, Int J Biomed Sci, V2, P85; Noyori R, 2002, ANGEW CHEM INT EDIT, V41, P2008, DOI 10.1002/1521-3773(20020617)41:12<2008::AID-ANIE2008>3.0.CO;2-4; Noyori R., 2002, ANGEW CHEM, V114, P2108, DOI DOI 10.1016/J.MOLCATA.2004.03.014; Pieraccini S, 2008, CHIRALITY, V20, P749, DOI 10.1002/chir.20482; Ran RX, 2012, J SEP SCI, V35, P1854, DOI 10.1002/jssc.201200047; Raynor SA, 2000, CHEM COMMUN, P1925, DOI 10.1039/b005689h; Seyden-Penne J., 1995, CHIRAL AUXILIARIES L; Shibasaki M., 2005, CATALYSTS FINE CHEM, V3, P201; van't Hoff J. H., 1874, ARCH NEERL SCI EXACT, V9, P445; Wang PY, 2009, J MATER CHEM, V19, P8009, DOI 10.1039/b913808k; Wang PY, 2009, MICROPOR MESOPOR MAT, V117, P91, DOI 10.1016/j.micromeso.2008.06.015; Webb J. D., 2014, UNPUB; Wu X. W., 2011, ANGEW CHEM, V123, P8245; Wu XB, 2013, J CHROMATOGR A, V1299, P78, DOI 10.1016/j.chroma.2013.05.051; Wu XW, 2011, ANGEW CHEM INT EDIT, V50, P8095, DOI 10.1002/anie.201101909; Xiang S, 2002, ANGEW CHEM INT EDIT, V41, P821, DOI 10.1002/1521-3773(20020301)41:5<821::AID-ANIE821>3.0.CO;2-A; Xiang S., 2002, ANGEW CHEM, V114, P849, DOI 10.1002/1521-3757(20020301)114:5<849::AID-ANGE849>3.3.CO;2-F; Yang QH, 2008, CHEM-ASIAN J, V3, P1214, DOI 10.1002/asia.200800110; GLADYSZ JA, 1992, CHEM REV, V92, P739, DOI 10.1021/cr00013a600	85	2	2	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	JAN	2015	10	1			SI		70	82		10.1002/asia.201402682		13	Chemistry, Multidisciplinary	Chemistry	AX1XD	WOS:000346736100005		
J	Matsuoka, A; Sandoval, CA; Uchiyama, M; Noyori, R; Naka, H				Matsuoka, Aki; Sandoval, Christian A.; Uchiyama, Masanobu; Noyori, Ryoji; Naka, Hiroshi			Why p-Cymene? Conformational Effect in Asymmetric Hydrogenation of Aromatic Ketones with a eta(6)-Arene/Ruthenium(II) Catalyst	CHEMISTRY-AN ASIAN JOURNAL			English	Article						asymmetric catalysis; CH; interaction; density functional calculations; hydrogenation; ruthenium	HYPERSPHERE SEARCH METHOD; LIGAND BIFUNCTIONAL CATALYSIS; POTENTIAL-ENERGY SURFACES; CARBONYL-COMPOUNDS; RUTHENIUM(II) CATALYST; TRANSITION-STATE; FORMIC-ACID; COMPLEXES; ENANTIOSELECTIVITY; MECHANISM	The global reaction route mapping (GRRM) methods conveniently define transition states in asymmetric hydrogenation and transfer hydrogenation of aromatic ketones via the [RuH{(S,S)-TsNCH(C6H5)CH(C6H5)NH2}((6)-p-cymene)] intermediate. Multiple electrostatic CH/ interactions are the common motif in the preferred diastereometric structures.	[Matsuoka, Aki; Noyori, Ryoji; Naka, Hiroshi] Nagoya Univ, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Matsuoka, Aki; Noyori, Ryoji; Naka, Hiroshi] Nagoya Univ, Res Ctr Mat Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Sandoval, Christian A.] Enantiotech Co Ltd, Zhongshan 528437, Guangdong, Peoples R China; [Uchiyama, Masanobu] RIKEN Ctr Sustainable Resource Sci, Wako, Saitama 3510198, Japan; [Uchiyama, Masanobu] RIKEN, Elements Chem Lab, Wako, Saitama 3510198, Japan; [Uchiyama, Masanobu] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Naka, H (reprint author), Nagoya Univ, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	h_naka@nagoya-u.jp	Uchiyama, Masanobu/B-7181-2015				Ohkuma T, 2006, J AM CHEM SOC, V128, P8724, DOI 10.1021/ja0620989; [Anonymous], 1969, ANGEW CHEM, DOI 10.1002/ange.19690812102; Maeda S, 2005, J PHYS CHEM A, V109, P5742, DOI 10.1021/jp0513162; MUETTERTIES EL, 1982, CHEM REV, V82, P499, DOI 10.1021/cr00051a002; Hayes AM, 2005, J AM CHEM SOC, V127, P7318, DOI 10.1021/ja051486s; Haack KJ, 1997, ANGEW CHEM INT EDIT, V36, P285, DOI 10.1002/anie.199702851; Zhou HF, 2008, ANGEW CHEM INT EDIT, V47, P8464, DOI 10.1002/anie.200802237; Martins JED, 2009, ORG LETT, V11, P847, DOI 10.1021/ol802801p; Yang H, 2013, J AM CHEM SOC, V135, P5808, DOI 10.1021/ja4005893; Petra DGI, 2000, CHEM-EUR J, V6, P2818, DOI 10.1002/1521-3765(20000804)6:15<2818::AID-CHEM2818>3.3.CO;2-H; Ohno K, 2004, CHEM PHYS LETT, V384, P277, DOI 10.1016/j.cplett.2003.12.030; Nishio M, 2011, PHYS CHEM CHEM PHYS, V13, P13873, DOI 10.1039/c1cp20404a; Takahashi O, 2010, CHEM REV, V110, P6049, DOI 10.1021/cr100072x; Hannedouche J, 2004, J AM CHEM SOC, V126, P986, DOI 10.1021/ja0392768; Vaclavik J, 2011, ORGANOMETALLICS, V30, P4822, DOI 10.1021/om200263d; Sandoval CA, 2006, CHEM-ASIAN J, V1, P102, DOI 10.1002/asia.200600098; Fujii A, 1996, J AM CHEM SOC, V118, P2521, DOI 10.1021/ja954126l; Gladiali S, 2006, CHEM SOC REV, V35, P226, DOI 10.1039/b513396c; Ran J, 2006, J PHYS CHEM A, V110, P9702, DOI 10.1021/jp0555403; Ikariya T, 2011, B CHEM SOC JPN, V84, P1, DOI 10.1246/bcsj.20100249; Ohno K, 2006, J PHYS CHEM A, V110, P8933, DOI 10.1021/jp0611491; Sortais JB, 2005, ORG LETT, V7, P1247, DOI 10.1021/ol047353d; WOODWARD RB, 1969, ANGEW CHEM INT EDIT, V8, P781, DOI 10.1002/anie.196907811; Palmer MJ, 1999, TETRAHEDRON-ASYMMETR, V10, P2045, DOI 10.1016/S0957-4166(99)00216-5; Houk KN, 2008, NATURE, V455, P309, DOI 10.1038/nature07368; Ikariya T, 2007, ACCOUNTS CHEM RES, V40, P1300, DOI 10.1021/ar700134q; HASHIGUCHI S, 1995, J AM CHEM SOC, V117, P7562, DOI 10.1021/ja00133a037; Yamakawa M, 2001, ANGEW CHEM INT EDIT, V40, P2818, DOI 10.1002/1521-3773(20010803)40:15<2818::AID-ANIE2818>3.0.CO;2-Y; Dub PA, 2013, J AM CHEM SOC, V135, P2604, DOI 10.1021/ja3097674; Yamakawa M, 2000, J AM CHEM SOC, V122, P1466, DOI 10.1021/ja991638h; Balcells D, 2007, NEW J CHEM, V31, P333, DOI 10.1039/b615528f; Arai N, 2013, ORG LETT, V15, P3030, DOI 10.1021/ol4012184; Sandoval CA, 2010, CHEM-ASIAN J, V5, P806, DOI 10.1002/asia.200900461; Ohkuma T, 2007, ORG LETT, V9, P255, DOI 10.1021/ol062661s; REED AE, 1985, J CHEM PHYS, V83, P735, DOI 10.1063/1.449486; Gridnev ID, 2008, J AM CHEM SOC, V130, P2560, DOI 10.1021/ja076542z; Wang C, 2008, CHEM-ASIAN J, V3, P1750, DOI 10.1002/asia.200800196; Noyori R, 2001, J ORG CHEM, V66, P7931, DOI 10.1021/jo010721w; Touge T, 2011, J AM CHEM SOC, V133, P14960, DOI 10.1021/ja207283t; Alonso DA, 1999, J AM CHEM SOC, V121, P9580, DOI 10.1021/ja9906610; Brown J. M., 2009, ANGEW CHEM, V121, P4544; Brown JM, 2009, ANGEW CHEM INT EDIT, V48, P4476, DOI 10.1002/anie.200900697; Canivet J, 2005, EUR J INORG CHEM, P4493, DOI 10.1002/ejic.200500498; Clapham SE, 2004, COORDIN CHEM REV, V248, P2201, DOI 10.1016/j.ccr.2004.04.007; Donoghue PJ, 2009, J AM CHEM SOC, V131, P410, DOI 10.1021/ja806246h; Frisch M. J., 2004, GAUSSIAN 03; Frisch M. J., 2010, GAUSSIAN 09; Haack K. J., 1997, ANGEW CHEM, V109, P297, DOI 10.1002/ange.19971090333; Hartwig J. F., 2011, ORGANOTRANSITION MET; Ito M, 2008, ORGANOMETALLICS, V27, P6053, DOI 10.1021/om800735z; Khaledy MM, 2003, J ORG CHEM, V68, P572, DOI 10.1021/jo020595b; Kobayashi Y, 2005, J AM CHEM SOC, V127, P15054, DOI 10.1021/ja0434580; Lennon IC, 2005, ORG PROCESS RES DEV, V9, P110, DOI 10.1021/op049838n; Maeda S, 2007, J PHYS CHEM A, V111, P13168, DOI 10.1021/jp709874f; Maeda S, 2008, J AM CHEM SOC, V130, P17228, DOI 10.1021/ja8065732; Matsubara T, 1996, INT J QUANTUM CHEM, V60, P1101, DOI 10.1002/(SICI)1097-461X(1996)60:6<1101::AID-QUA1>3.0.CO;2-3; Miyagi M, 2000, ORG PROCESS RES DEV, V4, P346, DOI 10.1021/op000019m; Mori S, 2006, CHEM-ASIAN J, V1, P391, DOI 10.1002/asia.200600014; Nishio M., 1998, CH PI INTERACTION EV; Noyori R, 1997, ACCOUNTS CHEM RES, V30, P97, DOI 10.1021/ar9502341; Ohkuma T., 2007, HDB HOMOGENEOUS HYDR, V3; Ohno K, 2010, J MOL CATAL A-CHEM, V324, P133, DOI 10.1016/j.molcata.2010.03.004; POMEROY RK, 1980, J CHEM SOC CHEM COMM, P661, DOI 10.1039/c39800000661; Rangelov MA, 2010, J MOL GRAPH MODEL, V29, P246, DOI 10.1016/j.jmgm.2010.07.006; Sozzani P, 2004, CHEM COMMUN, P768, DOI 10.1039/b316855g; Truhlar D. G., 1999, ACS S SER, V721; Yamakawa M., 2001, ANGEW CHEM, V113, P2900, DOI 10.1002/1521-3757(20010803)113:15<2900::AID-ANGE2900>3.0.CO;2-8; Zhou H. F., 2008, ANGEW CHEM, V120, P8592, DOI 10.1002/ange.200802237	68	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	JAN	2015	10	1			SI		112	115		10.1002/asia.201402979		4	Chemistry, Multidisciplinary	Chemistry	AX1XD	WOS:000346736100011		
J	Wang, CY; Hu, BL; Wang, JX; Gao, JK; Li, G; Xiong, WW; Zou, BH; Suzuki, M; Aratani, N; Yamada, H; Huo, FW; Lee, PS; Zhang, QC				Wang, Chengyuan; Hu, Benlin; Wang, Jiangxin; Gao, Junkuo; Li, Gang; Xiong, Wei-Wei; Zou, Binghua; Suzuki, Mitsuharu; Aratani, Naoki; Yamada, Hiroko; Huo, Fengwei; Lee, Pooi See; Zhang, Qichun			Rewritable Multilevel Memory Performance of a Tetraazatetracene Donor-Acceptor Derivative with Good Endurance	CHEMISTRY-AN ASIAN JOURNAL			English	Article						charge transfer; donor-acceptor systems; electrochemistry; heteroacenes; multilevel memory	FIELD-EFFECT TRANSISTORS; NONVOLATILE MEMORY; PHYSICAL-PROPERTIES; FUNCTIONAL POLYIMIDE; N-HETEROACENES; DATA-STORAGE; THIN-FILMS; BEHAVIOR; DEVICE; AMBIPOLAR	A new tetraazatetracene derivative, 2,3-[4,4-bis(N,N-diphenylamino)benzyl]-5,12-bis[(triisopropylsilyl)ethynyl]-1,4,6,11-tetraazatetracene (TPAs-BTTT), displays rewritable multilevel memory behavior, which is probably induced by multielectron intramolecular charge transfer (CT).	[Wang, Chengyuan; Hu, Benlin; Wang, Jiangxin; Li, Gang; Xiong, Wei-Wei; Zou, Binghua; Huo, Fengwei; Lee, Pooi See; Zhang, Qichun] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore; [Gao, Junkuo] Zhejiang Sci Tech Univ, Coll Mat & Text, Hangzhou 310018, Peoples R China; [Suzuki, Mitsuharu; Aratani, Naoki; Yamada, Hiroko] Nara Inst Sci & Technol, Grad Sch Mat Sci, Ikoma 6300192, Japan	Zhang, QC (reprint author), Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore.	qczhang@ntu.edu.sg	zhang, qichun/A-2253-2011; LEE, Pooi See/D-4551-2009; Huo, Fengwei/A-2243-2011; Gao, Junkuo/J-5866-2014; Aratani, Naoki/D-1626-2011	LEE, Pooi See/0000-0003-1383-1623; Huo, Fengwei/0000-0001-8990-6973; Gao, Junkuo/0000-0001-9778-4312; Aratani, Naoki/0000-0002-3181-6526			Chu CW, 2005, ADV MATER, V17, P1440, DOI 10.1002/adma.200500225; Li G, 2012, J AM CHEM SOC, V134, P20298, DOI 10.1021/ja310131k; Liu YY, 2010, J AM CHEM SOC, V132, P16349, DOI 10.1021/ja107046s; Xu H, 2014, ADV FUNCT MATER, V24, P2907, DOI 10.1002/adfm.201302855; Ye CQ, 2012, J AM CHEM SOC, V134, P20053, DOI 10.1021/ja305354y; Waser R, 2007, NAT MATER, V6, P833, DOI 10.1038/nmat2023; Tang ML, 2011, CHEM MATER, V23, P446, DOI 10.1021/cm102182x; Chau R, 2007, NAT MATER, V6, P810, DOI 10.1038/nmat2014; Schlutter F, 2013, J AM CHEM SOC, V135, P4550, DOI 10.1021/ja400857g; Li YJ, 2014, ACCOUNTS CHEM RES, V47, P1186, DOI 10.1021/ar400264e; Simao C, 2011, J AM CHEM SOC, V133, P13256, DOI 10.1021/ja204898u; [Anonymous], 2013, ANGEW CHEM, V125, P3898; Lee WY, 2011, CHEM MATER, V23, P4487, DOI 10.1021/cm201665g; Lei T, 2014, CHEM MATER, V26, P594, DOI 10.1021/cm4018776; Li JB, 2014, J ORG CHEM, V79, P4438, DOI 10.1021/jo500400d; Bunz UHF, 2013, ANGEW CHEM INT EDIT, V52, P3810, DOI 10.1002/anie.201209479; Ouyang JY, 2004, NAT MATER, V3, P918, DOI 10.1038/nmat1269; Zhang QC, 2011, CHEM-ASIAN J, V6, P856, DOI 10.1002/asia.201000659; Lundstrom M, 2003, SCIENCE, V299, P210, DOI 10.1126/science.1079567; Wang CL, 2012, CHEM REV, V112, P2208, DOI 10.1021/cr100380z; Ling QD, 2006, J AM CHEM SOC, V128, P8732, DOI 10.1021/ja062489n; Lindner BD, 2011, ANGEW CHEM INT EDIT, V50, P8588, DOI 10.1002/anie.201103676; Li G, 2013, ACS APPL MATER INTER, V5, P6458, DOI 10.1021/am4023434; Hu BL, 2014, CHEM SCI, V5, P3404, DOI 10.1039/c4sc00823e; Yang Y, 2006, ADV FUNCT MATER, V16, P1001, DOI 10.1002/adfm.200500429; Shang YL, 2007, J AM CHEM SOC, V129, P11674, DOI 10.1021/ja074226e; Xu JL, 2013, ADV MATER, V25, P2084, DOI 10.1002/adma.201204237; Li G, 2012, ASIAN J ORG CHEM, V1, P346, DOI 10.1002/ajoc.201200120; Scott JC, 2007, ADV MATER, V19, P1452, DOI 10.1002/adma.200602564; Song CL, 2011, ORG LETT, V13, P2880, DOI 10.1021/ol2008999; Tseng RJ, 2005, NANO LETT, V5, P1077, DOI 10.1021/nl050587l; Li G, 2013, CHEM-ASIAN J, V8, P1574, DOI 10.1002/asia.201300208; Wu YC, 2012, ACS APPL MATER INTER, V4, P1883, DOI 10.1021/am3003389; Li G, 2014, CHEM COMMUN, V50, P7656, DOI 10.1039/c4cc02908a; Liang ZX, 2011, ADV MATER, V23, P1535, DOI 10.1002/adma.201004325; Sokolov AN, 2012, ACCOUNTS CHEM RES, V45, P361, DOI 10.1021/ar2001233; Miao SF, 2012, ADV MATER, V24, P6210, DOI 10.1002/adma.201202319; Zhao JF, 2013, CHEM-ASIAN J, V8, P665, DOI 10.1002/asia.201201152; Hu BL, 2012, J AM CHEM SOC, V134, P17408, DOI 10.1021/ja307933t; Wen YG, 2011, CHEM REV, V111, P3358, DOI 10.1021/cr1001904; Wang CY, 2014, CHEM-ASIAN J, V9, P779, DOI 10.1002/asia.201301547; Li H, 2010, J AM CHEM SOC, V132, P5542, DOI 10.1021/ja910243f; Gu PY, 2013, J AM CHEM SOC, V135, P14086, DOI 10.1021/ja408208c; [Anonymous], 2011, ANGEW CHEM, V123, P8747; Bunz UHF, 2009, CHEM-EUR J, V15, P6780, DOI 10.1002/chem.200900990; Liu YL, 2009, CHEM MATER, V21, P3391, DOI 10.1021/cm9010508; Jiang GY, 2008, ADV MATER, V20, P2888, DOI 10.1002/adma.200800666; FREILICH SC, 1987, MACROMOLECULES, V20, P973, DOI 10.1021/ma00171a015	48	12	12	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	JAN	2015	10	1			SI		116	119		10.1002/asia.201402899		4	Chemistry, Multidisciplinary	Chemistry	AX1XD	WOS:000346736100012		
J	Nagatomo, M; Yoshioka, S; Inoue, M				Nagatomo, Masanori; Yoshioka, Shun; Inoue, Masayuki			Enantioselective Radical Alkynylation of C(sp(3))-H Bonds Using Sulfoximine as a Traceless Chiral Auxiliary	CHEMISTRY-AN ASIAN JOURNAL			English	Article						alkynes; amines; enantioselectiveity; photochemistry; radical reactions	C-H BONDS; LIGHT PHOTOREDOX CATALYSIS; CARBON-HYDROGEN BONDS; ORGANIC-SYNTHESIS; ACETYLENIC TRIFLONES; ASYMMETRIC-SYNTHESIS; VISIBLE-LIGHT; TETRAHYDROISOQUINOLINE DERIVATIVES; ORGANOMETALLIC REAGENTS; SYNTHETIC APPLICATIONS	Enantioselective alkynylation of C(sp(3))H bonds adjacent to a nitrogen atom has been achieved using only chiral p-tolyl tert-butyldimethylsilylethynyl sulfoximine and benzophenone under photo-irradiation conditions. A two-carbon alkyne unit was chemo- and enantioselectively transferred at the nitrogen-substituted methylene to produce the optically active propargylic amines of various structures. Remarkably, the NH-unprotected sulfoximine group efficiently transmits its stereochemical information to the product and functions as a traceless chiral auxiliary.	[Nagatomo, Masanori; Yoshioka, Shun; Inoue, Masayuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Inoue, M (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan.	inoue@mol.f.u-tokyo.ac.jp					Amaoka Y., 2014, CHEM SCI, DOI [10.1039/C4S01631A, DOI 10.1039/C4S01631A]; Kamijo S, 2011, ORG LETT, V13, P5928, DOI 10.1021/ol202659e; Hoffmann N, 2008, CHEM REV, V108, P1052, DOI 10.1021/cr0680336; Wu H, 2014, ANGEW CHEM INT EDIT, V53, P3466, DOI 10.1002/anie.201309967; Rowlands GJ, 2010, TETRAHEDRON, V66, P1593, DOI 10.1016/j.tet.2009.12.023; Rohlmann R, 2013, SYNLETT, V24, P6, DOI 10.1055/s-0032-1317673; Klussmann M, 2011, SYNTHESIS-STUTTGART, P353, DOI 10.1055/s-0030-1258303; Davies HML, 2008, NATURE, V451, P417, DOI 10.1038/nature06485; Xie J, 2014, TETRAHEDRON LETT, V55, P36, DOI 10.1016/j.tetlet.2013.10.090; Daugulis O, 2009, ACCOUNTS CHEM RES, V42, P1074, DOI 10.1021/ar9000058; Hoshikawa T, 2013, ORG BIOMOL CHEM, V11, P164, DOI 10.1039/c2ob26785c; KOSUGI H, 1987, J ORG CHEM, V52, P1078, DOI 10.1021/jo00382a019; Fagnoni M, 2007, CHEM REV, V107, P2725, DOI 10.1021/cr068352X; Trost BM, 2009, ADV SYNTH CATAL, V351, P963, DOI 10.1002/adsc.200800776; Okamura H, 2004, ORG LETT, V6, P1305, DOI 10.1021/ol049715n; Enders D, 1997, TETRAHEDRON-ASYMMETR, V8, P1895, DOI 10.1016/S0957-4166(97)00208-5; Xi YM, 2013, ORG BIOMOL CHEM, V11, P2387, DOI 10.1039/c3ob40137e; Girard SA, 2014, ANGEW CHEM INT EDIT, V53, P74, DOI 10.1002/anie.201304268; Yeung CS, 2011, CHEM REV, V111, P1215, DOI 10.1021/cr100280d; Hoshikawa T, 2013, CHEM SCI, V4, P3118, DOI 10.1039/c3sc51080h; Kamijo S, 2011, TETRAHEDRON LETT, V52, P2885, DOI 10.1016/j.tetlet.2011.03.128; Sibi MP, 2003, CHEM REV, V103, P3263, DOI 10.1021/cr020044l; Kim S, 2007, B CHEM SOC JPN, V80, P809, DOI 10.1246/bcsj.80.809; Li ZP, 2004, ORG LETT, V6, P4997, DOI 10.1021/ol047814v; Davies HML, 2003, CHEM REV, V103, P2861, DOI 10.1021/cr0200217; Liu C, 2011, CHEM REV, V111, P1780, DOI 10.1021/cr100379j; Reckenthaler M, 2013, ADV SYNTH CATAL, V355, P2727, DOI 10.1002/adsc.201300751; Kang YK, 2010, J AM CHEM SOC, V132, P11847, DOI 10.1021/ja103786c; Yu JB, 2013, TETRAHEDRON LETT, V54, P2006, DOI 10.1016/j.tetlet.2013.02.007; Sklute G, 2007, ORG LETT, V9, P1259, DOI 10.1021/ol070070b; Bloch R, 1998, CHEM REV, V98, P1407, DOI 10.1021/cr940474e; Bar G, 2003, CHEM SOC REV, V32, P251, DOI 10.1039/b111414j; Akindele T, 2009, ACCOUNTS CHEM RES, V42, P345, DOI 10.1021/ar800166q; Qin Y, 2014, TETRAHEDRON LETT, V55, P551, DOI 10.1016/j.tetlet.2013.11.051; Zhang B, 2011, ORG LETT, V13, P5212, DOI 10.1021/ol202090a; Ravelli D, 2013, CHEM SOC REV, V42, P97, DOI 10.1039/c2cs35250h; Li ZP, 2006, TETRAHEDRON-ASYMMETR, V17, P590, DOI 10.1016/j.tetasy.2006.02.007; Giri R, 2009, CHEM SOC REV, V38, P3242, DOI 10.1039/b816707a; Sun CL, 2011, CHEM REV, V111, P1293, DOI 10.1021/cr100198w; Chen X, 2009, ANGEW CHEM INT EDIT, V48, P5094, DOI 10.1002/anie.200806273; Rowlands GJ, 2009, TETRAHEDRON, V65, P8603, DOI 10.1016/j.tet.2009.07.001; He YP, 2011, TETRAHEDRON LETT, V52, P7064, DOI 10.1016/j.tetlet.2011.10.062; Prier CK, 2013, CHEM REV, V113, P5322, DOI 10.1021/cr300503r; Shi L, 2012, CHEM SOC REV, V41, P7687, DOI 10.1039/c2cs35203f; Bauer A, 2005, NATURE, V436, P1139, DOI 10.1038/nature03955; Rouquet G, 2013, ANGEW CHEM INT EDIT, V52, P11726, DOI 10.1002/anie.201301451; Yamaguchi J, 2012, ANGEW CHEM INT EDIT, V51, P8960, DOI 10.1002/anie.201201666; Mori K, 2011, J AM CHEM SOC, V133, P6166, DOI 10.1021/ja2014955; Benfatti F, 2009, CHEM COMMUN, P5919, DOI 10.1039/b910185c; Chen X., 2009, ANGEW CHEM, V121, P5196; Cinquini M., 1976, J CHEM SOC PERK T, P2061; Cozzi PG, 2004, EUR J ORG CHEM, P4095, DOI 10.1002/ejoc.200400246; El-Hachach N, 2009, TETRAHEDRON, V65, P1040, DOI 10.1016/j.tet.2008.11.066; Gais HJ, 2000, EUR J ORG CHEM, P3973; Girard S. A., 2014, ANGEW CHEM, V126, P76; Gong JC, 1996, J AM CHEM SOC, V118, P4486, DOI 10.1021/ja953518p; Gong JC, 1997, TETRAHEDRON LETT, V38, P787, DOI 10.1016/S0040-4039(96)02413-6; GREHN L, 1987, ACTA CHEM SCAND B, V41, P18, DOI 10.3891/acta.chem.scand.41b-0018; JOHNSON CR, 1973, ACCOUNTS CHEM RES, V6, P341, DOI 10.1021/ar50070a003; Johnson C. R., 1985, ALDRICHIM ACTA, V18, P3; Kakiuchi F, 2008, SYNTHESIS-STUTTGART, P3013, DOI 10.1055/s-2008-1067256; Leca D, 2002, ORG LETT, V4, P4093, DOI 10.1021/ol026837b; Licking U., 2013, ANGEW CHEM, V125, P9570; Lucking U, 2013, ANGEW CHEM INT EDIT, V52, P9399, DOI 10.1002/anie.201302209; Muller JFK, 1997, HELV CHIM ACTA, V80, P2182, DOI 10.1002/hlca.19970800717; Okamura H, 2004, CHEM LETT, V33, P482, DOI 10.1246/cl.2004.482; Paquette LA, 2003, J ORG CHEM, V68, P8625, DOI 10.1021/jo030196w; PAQUETTE LA, 1993, J ORG CHEM, V58, P4262, DOI 10.1021/jo00068a021; Reggelin M, 2000, SYNTHESIS-STUTTGART, P1; Rodriguez R, 2009, TETRAHEDRON, V65, P7001, DOI 10.1016/j.tet.2009.06.052; Rouquet G., 2013, ANGEW CHEM, V125, P11942; Wei CM, 2004, SYNLETT, P1472, DOI 10.1055/s-2004-829531; Worch C., 2008, ORGANOSULFUR CHEM AS, P209, DOI DOI 10.1002/9783527623235.CH6; Wu H., 2014, ANGEW CHEM, V126, P3534; Xiang J, 1997, TETRAHEDRON LETT, V38, P6635, DOI 10.1016/S0040-4039(97)01577-3; Xiang JS, 1996, TETRAHEDRON LETT, V37, P5269, DOI 10.1016/0040-4039(96)01117-3; Yamaguchi J., 2012, ANGEW CHEM, V124, P9092, DOI DOI 10.1002/ANIE.201201666; Zani L, 2006, CHEM COMMUN, P4263, DOI 10.1039/b607986p	78	3	3	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	JAN	2015	10	1			SI		120	123		10.1002/asia.201402983		4	Chemistry, Multidisciplinary	Chemistry	AX1XD	WOS:000346736100013		
J	Kitanosono, T; Kobayashi, S				Kitanosono, Taku; Kobayashi, Shu			Toward Chemistry-Based Design of the Simplest Metalloenzyme-Like Catalyst That Works Efficiently in Water	CHEMISTRY-AN ASIAN JOURNAL			English	Article						aldol reaction; asymmetric catalysis; enzyme models; metalloenzymes; supramolecular chemistry	ASYMMETRIC ALDOL REACTIONS; ENANTIOSELECTIVE HYDROXYMETHYLATION; ARTIFICIAL ALDOLASE; CHIRAL CATALYSTS; AQUEOUS-MEDIA; AMINO-ACID; COMPLEXES; ENZYME; KINETICS; KETONES	Enzymes exhibit overwhelmingly superior catalysis compared with artificial catalysts. Current strategies to rival enzymatic catalysis require unmodified or minimally modified structures of active sites, gigantic molecular weight, and sometimes the use of harsh conditions such as extremely low temperatures in organic solvents. Herein, we describe a design of small molecules that act as the simplest metalloenzyme-like catalysts that can function in water, without mimicking enzyme structures. These artificial catalysts efficiently promoted enantioselective direct-type aldol reactions using aqueous formaldehyde. The reactions followed Michaelis-Menten kinetics, and heat-resistant asymmetric environments were constructed in water.	[Kitanosono, Taku; Kobayashi, Shu] Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan	Kobayashi, S (reprint author), Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan.	shu_kobayashi@chem.s.u-tokyo.ac.jp	Kobayashi, Shu/E-9214-2012				Aehle W, 2007, ENZYMES IND; Agrawal YK, 2004, BIOINORG CHEM APPL, V2, P237, DOI 10.1155/S1565363304000159; Clapes P, 2010, CURR OPIN CHEM BIOL, V14, P154, DOI 10.1016/j.cbpa.2009.11.029; Trost BM, 2001, ORG LETT, V3, P2497, DOI 10.1021/ol0161211; Henseler AH, 2014, ADV SYNTH CATAL, V356, P1795, DOI 10.1002/adsc.201400033; Mase N, 2010, ORG BIOMOL CHEM, V8, P4043, DOI 10.1039/c004970k; Font D, 2008, ORG LETT, V10, P337, DOI 10.1021/ol702901z; WINTER G, 1982, NATURE, V299, P756, DOI 10.1038/299756a0; POLLACK SJ, 1986, SCIENCE, V234, P1570, DOI 10.1126/science.3787262; Hayashi Y, 2006, ANGEW CHEM INT EDIT, V45, P958, DOI 10.1002/anie.200502488; KLIBANOV AM, 1983, SCIENCE, V219, P722, DOI 10.1126/science.219.4585.722; Bertelsen S, 2009, CHEM SOC REV, V38, P2178, DOI 10.1039/b903816g; TRAMONTANO A, 1986, SCIENCE, V234, P1566, DOI 10.1126/science.3787261; Breslow R, 1998, CHEM REV, V98, P1997, DOI 10.1021/cr970011j; Khersonsky O, 2010, J MOL BIOL, V396, P1025, DOI 10.1016/j.jmb.2009.12.031; Matsuzawa A, 2014, CHEM-EUR J, V20, P68, DOI 10.1002/chem.201304297; Yoshikawa N, 1999, J AM CHEM SOC, V121, P4168, DOI 10.1021/ja990031y; Itoh S, 2009, CHEM-EUR J, V15, P10570, DOI 10.1002/chem.200900733; Chimni SS, 2006, TETRAHEDRON-ASYMMETR, V17, P2108, DOI 10.1016/j.tetasy.2006.07.016; Gijsen HJM, 1996, CHEM REV, V96, P443, DOI 10.1021/cr950031q; Paradowska J, 2009, ANGEW CHEM INT EDIT, V48, P4288, DOI 10.1002/anie.200802038; Trost BM, 2001, J AM CHEM SOC, V123, P3367, DOI 10.1021/ja003871h; List B, 2000, J AM CHEM SOC, V122, P2395, DOI 10.1021/ja994280y; Collot J, 2003, J AM CHEM SOC, V125, P9030, DOI 10.1021/ja035545i; Yamada YMA, 1997, ANGEW CHEM INT EDIT, V36, P1871, DOI 10.1002/anie.199718711; Torii H, 2004, ANGEW CHEM INT EDIT, V43, P1983, DOI 10.1002/anie.200352724; Matsui J, 1996, J ORG CHEM, V61, P5414, DOI 10.1021/jo9516805; Kobayashi S, 1998, J AM CHEM SOC, V120, P8287, DOI 10.1021/ja980715q; Motherwell WB, 2001, TETRAHEDRON, V57, P4663, DOI 10.1016/S0040-4020(01)00288-5; Kobayashi S, 2005, ORG LETT, V7, P4729, DOI 10.1021/ol051965w; Trost BM, 2000, J AM CHEM SOC, V122, P12003, DOI 10.1021/ja003033n; Trost BM, 2010, CHEM SOC REV, V39, P1600, DOI 10.1039/b923537j; Liu YL, 2009, CHEM-EUR J, V15, P2055, DOI 10.1002/chem.200802210; Bjerre J, 2008, APPL MICROBIOL BIOT, V81, P1, DOI 10.1007/s00253-008-1653-5; Breslow R, 1999, TETRAHEDRON LETT, V40, P3335, DOI 10.1016/S0040-4039(99)00460-8; Breslow R, 1970, J Am Chem Soc, V92, P1075, DOI 10.1021/ja00707a062; Darbre T, 2002, EUR J INORG CHEM, P3284; Drauz K., 2002, ENZYME CATALYSIS ORG; Hayashi Y., 2006, ANGEW CHEM, V118, P972, DOI 10.1002/ange.200502488; Imamoto T., 1994, LANTHANIDES ORGANIC; Itoh S, 2013, CHEM-ASIAN J, V8, P2125, DOI 10.1002/asia.201300308; Itoh S, 2013, TETRAHEDRON-ASYMMETR, V24, P1583, DOI 10.1016/j.tetasy.2013.10.009; Kitanosono T, 2012, ORG BIOMOL CHEM, V10, P7134, DOI 10.1039/c2ob26264a; Kitanosono T, 2014, CHEM REC, V14, P130, DOI 10.1002/tcr.201300040; Kobayashi S, 2007, PURE APPL CHEM, V79, P235, DOI 10.1351/pac200779020235; Kobayashi S, 2010, CHEM-ASIAN J, V5, P490, DOI 10.1002/asia.200900442; Kofoed J, 2006, ORG BIOMOL CHEM, V4, P3268, DOI 10.1039/b607342e; Mase N, 2006, J AM CHEM SOC, V128, P734, DOI 10.1021/ja0573312; Mukherjee C, 2011, CHEM-ASIAN J, V6, P2308, DOI 10.1002/asia.201100353; ONEIL IA, 1995, SYNLETT, P617; Paradowska J., 2009, ANGEW CHEM, V121, P4352; Putz MV, 2007, J OPTOELECTRON ADV M, V9, P2910; Reetz M. T., 2001, ANGEW CHEM, V113, P292, DOI 10.1002/1521-3757(20010119)113:2<292::AID-ANGE292>3.0.CO;2-F; Reetz MT, 2001, ANGEW CHEM INT EDIT, V40, P284, DOI 10.1002/1521-3773(20010119)40:2<284::AID-ANIE284>3.3.CO;2-E; REYMOND JL, 1995, J ORG CHEM, V60, P6970, DOI 10.1021/jo00126a057; RUTTER WJ, 1968, ANN NY ACAD SCI, V151, P102, DOI 10.1111/j.1749-6632.1968.tb11881.x; SASAKI S, 1989, CHEM PHARM BULL, V37, P912; Schmidt J, 2013, ORG BIOMOL CHEM, V11, P8419, DOI 10.1039/c3ob41898g; Tastan P, 2000, J MOL CATAL A-CHEM, V157, P261, DOI 10.1016/S1381-1169(00)00159-X; Torii H., 2004, ANGEW CHEM, V116, P2017, DOI 10.1002/ange.200352724; Toscano M. D., 2007, ANGEW CHEM, V119, P4552, DOI 10.1002/ange.200700710; Toscano MD, 2007, ANGEW CHEM INT EDIT, V46, P4468, DOI 10.1002/anie.200700710; Voet D., 1999, BIOCHEMISTRY; Yamada Y. M. A., 1997, ANGEW CHEM, V109, P1942	64	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	JAN	2015	10	1			SI		133	138		10.1002/asia.201403004		6	Chemistry, Multidisciplinary	Chemistry	AX1XD	WOS:000346736100016		
J	Suzuki, K; Jeong, J; Yamaguchi, K; Mizuno, N				Suzuki, Kosuke; Jeong, Jinu; Yamaguchi, Kazuya; Mizuno, Noritaka			Visible-Light-Responsive Multielectron Redox Catalysis of Lacunary Polyoxometalates Induced by Substrate Coordination to Their Lacuna	CHEMISTRY-AN ASIAN JOURNAL			English	Article						charge transfer; imines; nitroarenes; photoredox catalysis; polyoxometalates	COUPLING REACTIONS; CHEMOSELECTIVE HYDROGENATION; PHOTOCATALYTIC REDUCTION; PHOTOREDOX CATALYSIS; HIGHLY EFFICIENT; C-N; SILICOTUNGSTATE; NANOPARTICLES; OXIDATION; TIO2	We describe herein the efficient visible-light-responsive polyoxometalate-based multielectron photoredox catalysis induced by in situ coordination of alcohols to the lacuna of TBA(4)H(4)[-SiW10O36] (I, TBA=tetra-n-butylammonium). The coordination of alcohols to the lacuna of I generated a new highest occupied molecular orbital as the electron donor level and enabled the visible-light-responsive multielectron transfer from alcohols to I, which could be utilized for aerobic alcohol oxidation and one-pot synthesis of N-arylimines starting from nitroarenes and primary alcohols.	[Suzuki, Kosuke; Jeong, Jinu; Yamaguchi, Kazuya; Mizuno, Noritaka] Univ Tokyo, Sch Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan	Mizuno, N (reprint author), Univ Tokyo, Sch Engn, Dept Appl Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	tmizuno@mail.ecc.u-tokyo.ac.jp					Weinberg DR, 2012, CHEM REV, V112, P4016, DOI 10.1021/cr200177j; Suzuki K, 2014, ANGEW CHEM INT EDIT, V53, P5356, DOI 10.1002/anie.201403215; Liang SJ, 2014, ANGEW CHEM INT EDIT, V53, P2951, DOI 10.1002/anie.201311280; Esposti S, 2007, ANGEW CHEM INT EDIT, V46, P2531, DOI 10.1002/anie.200604820; Zhu HY, 2010, ANGEW CHEM INT EDIT, V49, P9657, DOI 10.1002/anie.201003908; Zhao CC, 2011, J AM CHEM SOC, V133, P20134, DOI 10.1021/ja209360x; Yang XJ, 2014, GREEN CHEM, V16, P1082, DOI 10.1039/c3gc42042f; Marrot J, 2012, J AM CHEM SOC, V134, P1724, DOI 10.1021/ja2090383; Mitsudome T, 2012, ANGEW CHEM INT EDIT, V51, P136, DOI 10.1002/anie.201106244; Tzirakis MD, 2009, CHEM SOC REV, V38, P2609, DOI 10.1039/b812100c; Habisreutinger SN, 2013, ANGEW CHEM INT EDIT, V52, P7372, DOI 10.1002/anie.201207199; Suzuki K, 2012, ANGEW CHEM INT EDIT, V51, P1597, DOI 10.1002/anie.201107041; Sorribes I, 2012, ANGEW CHEM INT EDIT, V51, P7794, DOI 10.1002/anie.201202584; Bassil BS, 2011, ANGEW CHEM INT EDIT, V50, P5961, DOI 10.1002/anie.201007617; Neumann R, 1998, PROG INORG CHEM, V47, P317; Evano G, 2008, CHEM REV, V108, P3054, DOI 10.1021/cr8002505; Hirano T, 2012, J AM CHEM SOC, V134, P6425, DOI 10.1021/ja3006012; Ryu I, 2011, ANGEW CHEM INT EDIT, V50, P1869, DOI 10.1002/anie.201004854; Kuhn A, 2012, J PHYS ORG CHEM, V25, P58, DOI 10.1002/poc.1868; Suzuki K, 2012, INORG CHEM, V51, P6953, DOI 10.1021/ic3008365; Valeur E, 2009, CHEM SOC REV, V38, P606, DOI 10.1039/b701677h; Furukawa S, 2014, CHEMPHYSCHEM, V15, P2665, DOI 10.1002/cphc.201402343; Li SJ, 2012, J AM CHEM SOC, V134, P19716, DOI 10.1021/ja307484a; Halperin SD, 2014, ANGEW CHEM INT EDIT, V53, P4690, DOI 10.1002/anie.201400420; Corma A, 2006, SCIENCE, V313, P332, DOI 10.1126/science.1128383; Fuldner S, 2010, GREEN CHEM, V12, P400, DOI 10.1039/b918140g; Long DL, 2010, ANGEW CHEM INT EDIT, V49, P1736, DOI 10.1002/anie.200902483; Shafir A, 2006, J AM CHEM SOC, V128, P8742, DOI 10.1021/ja063063b; Narayanam JMR, 2011, CHEM SOC REV, V40, P102, DOI 10.1039/b913880n; Monnier F, 2009, ANGEW CHEM INT EDIT, V48, P6954, DOI 10.1002/anie.200804497; Mizuno N, 1998, CHEM REV, V98, P199, DOI 10.1021/cr960401q; Kikukawa Y, 2012, ANGEW CHEM INT EDIT, V51, P3686, DOI 10.1002/anie.201200486; Naya S, 2014, ANGEW CHEM INT EDIT, V53, P7305, DOI 10.1002/anie.201402939; MURAHASHI SI, 1995, ANGEW CHEM INT EDIT, V34, P2443, DOI 10.1002/anie.199524431; Prier CK, 2013, CHEM REV, V113, P5322, DOI 10.1021/cr300503r; Bartberger MD, 2002, P NATL ACAD SCI USA, V99, P10958, DOI 10.1073/pnas.162095599; Suzuki K, 2013, CHEM SCI, V4, P596, DOI 10.1039/c2sc21619a; Morris AJ, 2009, ACCOUNTS CHEM RES, V42, P1983, DOI 10.1021/ar9001679; Kamata K, 2003, SCIENCE, V300, P964, DOI 10.1126/science.1083176; Bassil B. S., 2011, ANGEW CHEM, V123, P6083; Esposti S., 2007, ANGEW CHEM, V119, P2583, DOI 10.1002/ange.200604820; Habisreutinger S. N., 2013, ANGEW CHEM, V125, P7516; Halperin S. D., 2014, ANGEW CHEM, V126, P4778; Hill C. L., 2004, COMPREHENSIVE COORDI, V4, P679, DOI 10.1016/B0-08-043748-6/03036-X; Khenkin AM, 2010, CHEM-EUR J, V16, P1356, DOI 10.1002/chem.200901673; Kikukawa Y., 2012, ANGEW CHEM, V124, P3746; Liang S, 2014, ANGEW CHEM, V126, P2995; Long D.-L., 2010, ANGEW CHEM, V122, P1780; Mialane P., 2004, ANGEW CHEM, V116, P2324, DOI 10.1002/ange.200353433; Mialane P, 2004, ANGEW CHEM INT EDIT, V43, P2274, DOI 10.1002/anie.200353433; Minato T, 2014, CHEM-EUR J, V20, P5946, DOI 10.1002/chem.201400390; Mitsudome T., 2012, ANGEW CHEM, V124, P140; Monnier F., 2009, ANGEW CHEM, V121, P7088, DOI DOI 10.1002/ANGE.200804497; Murahashi S.-I., 1995, ANGEW CHEM, V107, P2670, DOI 10.1002/ange.19951072205; Naya S., 2014, ANGEW CHEM, V126, P7433; Pope M. T., 1983, HETEROPOLY ISOPOLY O; Rios-Berny O, 2010, TETRAHEDRON LETT, V51, P2730, DOI 10.1016/j.tetlet.2010.03.054; Ryu I., 2011, ANGEW CHEM, V123, P1909; Shiraishi Y, 2013, ACS CATAL, V3, P2318, DOI 10.1021/cs400532p; Sorribes I., 2012, ANGEW CHEM, V124, P7914; Suzuki K., 2014, ANGEW CHEM, V126, P5460; Suzuki K., 2012, ANGEW CHEM, V124, P1629; Zhu H., 2010, ANGEW CHEM, V122, P9851, DOI 10.1002/ange.201003908	63	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	JAN	2015	10	1			SI		144	148		10.1002/asia.201403072		5	Chemistry, Multidisciplinary	Chemistry	AX1XD	WOS:000346736100018		
J	Chechetka, SA; Pichon, B; Zhang, MF; Yudasaka, M; Begin-Colin, S; Bianco, A; Miyako, E				Chechetka, Svetlana A.; Pichon, Benoit; Zhang, Minfang; Yudasaka, Masako; Begin-Colin, Sylvie; Bianco, Alberto; Miyako, Eijiro			Multifunctional Carbon Nanohorn Complexes for Cancer Treatment	CHEMISTRY-AN ASIAN JOURNAL			English	Article						cancer; nanoparticles; nanomaterials; nanotubes; near infrared	IN-VIVO; MAGNETITE NANOPARTICLES; NANOTUBES; DELIVERY; CELLS; POLYETHYLENIMINE; ASSEMBLIES; TOXICITY; RELEASE; DRUG	Multifunctional carbon nanohorn (CNH) complexes were synthesized using oxidized CNH, magnetite (MAG) nanoparticles, and polyethyleneimine (PEI). The ferromagnetic MAG nanoparticles were loaded onto CNH (MAG-CNH) using iron(II) acetate and subsequent heat treatment. Chemical functionalization of the MAG-CNH complexes with PEI improved their water-dispersibility and allowed further conjugation with a fluorophore. The application of an external magnetic field significantly intensified the targeted vectorization of CNH complexes into human cervical cancer (HeLa) cells. Following cell uptake, laser irradiation of the cells showed a significant enhancement in the photothermal effects of CNHs leading to cell death. We have confirmed that the photothermal properties and ferromagnetic characteristics of CNH complexes show efficient cell elimination. The present study is an essential step toward the development of an innovative cancer therapy and a highly sensitive detection of cancer cells at the single-cell level.	[Chechetka, Svetlana A.; Zhang, Minfang; Yudasaka, Masako; Miyako, Eijiro] Natl Inst Adv Ind Sci & Technol, Nanotube Res Ctr NTRC, Tsukuba, Ibaraki 3058565, Japan; [Pichon, Benoit; Begin-Colin, Sylvie] CNRS UdS ECPM, UMR 7504, Inst Phys & Chim Mat Strasbourg, F-67034 Strasbourg 2, France; [Bianco, Alberto] CNRS, Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France	Miyako, E (reprint author), Natl Inst Adv Ind Sci & Technol, Nanotube Res Ctr NTRC, Cent 5,1-1-1 Higashi, Tsukuba, Ibaraki 3058565, Japan.	e-miyako@aist.go.jp					Andreoli E, 2014, J MATER CHEM B, V2, P4740, DOI 10.1039/c4tb00778f; Wang ST, 2010, ANGEW CHEM INT EDIT, V49, P3777, DOI 10.1002/anie.201000062; Fisher JW, 2010, CANCER RES, V70, P9855, DOI 10.1158/0008-5472.CAN-10-0250; Miyawaki J, 2008, ACS NANO, V2, P213, DOI 10.1021/nn700185t; Redl FX, 2004, J AM CHEM SOC, V126, P14583, DOI 10.1021/ja046808r; Yang D, 2009, CHEM COMMUN, P4447, DOI 10.1039/b908012k; Pagona G, 2006, CHEM MATER, V18, P3918, DOI 10.1021/cm0604864; Miyako E, 2012, P NATL ACAD SCI USA, V109, P7523, DOI 10.1073/pnas.1204391109; Zhang M, 2008, P NATL ACAD SCI USA, V105, P14773, DOI 10.1073/pnas.0801349105; Gao C, 2006, J PHYS CHEM B, V110, P7213, DOI 10.1021/jp0602474; Wan JQ, 2007, J MATER CHEM, V17, P1188, DOI 10.1039/b615527h; Yoo H, 2013, LANGMUIR, V29, P5962, DOI 10.1021/la3051302; Ghobril C, 2013, CHEM COMMUN, V49, P9158, DOI 10.1039/c3cc43161d; Forbes ZG, 2003, IEEE T MAGN, V39, P3372, DOI 10.1109/TMAG.2003.816260; Fleutot S, 2013, NANOSCALE, V5, P1507, DOI 10.1039/c2nr32117c; Kam NWS, 2005, P NATL ACAD SCI USA, V102, P11600, DOI 10.1073/pnas.0502680102; Scherer F, 2002, GENE THER, V9, P102, DOI 10.1038/sj/gt/3301624; Volodkin DV, 2009, ANGEW CHEM INT EDIT, V48, P1807, DOI 10.1002/anie.200805572; Zhang MF, 2007, ACS NANO, V1, P265, DOI 10.1021/nn700130f; Iijima S, 1999, CHEM PHYS LETT, V309, P165, DOI 10.1016/S0009-2614(99)00642-9; Baaziz W, 2014, J PHYS CHEM C, V118, P3795, DOI 10.1021/jp411481p; Nakanishi W, 2014, NANO TODAY, V9, P378, DOI 10.1016/j.nantod.2014.05.002; Wu GH, 2008, J AM CHEM SOC, V130, P8175, DOI 10.1021/ja802656d; Zhang Q, 2009, COMPOS SCI TECHNOL, V69, P633, DOI 10.1016/j.compscitech.2008.12.011; Hong GS, 2012, NAT MED, V18, P1841, DOI 10.1038/nm.2995; Au L, 2008, ACS NANO, V2, P1645, DOI 10.1021/nn800370j; Demortiere A, 2011, NANOSCALE, V3, P225, DOI 10.1039/c0nr00521e; Weissleder R, 2001, NAT BIOTECHNOL, V19, P316, DOI 10.1038/86684; Wagstaff AJ, 2012, INORG CHIM ACTA, V393, P328, DOI 10.1016/j.ica.2012.05.012; Lee SM, 2010, ADV MATER, V22, P4049, DOI 10.1002/adma.201001040; Masotti A, 2013, INT J MOL SCI, V14, P24619, DOI 10.3390/ijms141224619; Lamanna G, 2012, NANOTECHNOL REV, V1, P17, DOI 10.1515/ntrev-2011-0002; Miyawaki J, 2006, ADV MATER, V18, P1010, DOI 10.1002/adma.200502174; Dames P, 2007, NAT NANOTECHNOL, V2, P495, DOI 10.1038/nnano.2007.217; Lamanna G, 2013, NANOSCALE, V5, P4412, DOI 10.1039/c3nr00636k; Iverson NM, 2013, NAT NANOTECHNOL, V8, P873, DOI [10.1038/nnano.2013.222, 10.1038/NNANO.2013.222]; Gupta R. B., 2006, NANOPARTICLE TECHNOL, P416; Huang YP, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-267; Hui H., 2005, Journal of Physical Chemistry B, V109, DOI 10.1021/jp0441137; Isobe H, 2006, ANGEW CHEM, V118, P6828, DOI 10.1002/ange.200601718; Isobe H, 2006, ANGEW CHEM INT EDIT, V45, P6676, DOI 10.1002/anie.200601718; Miyako E, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/7/075106; Miyako E, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/47/475103; Pelengaris S., 2013, MOL BIOL CANC BRIDGE; Tahara Y, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/26/265106; Volodkin D. V., 2009, ANGEW CHEM, V121, P1839; Wang J, 2014, NPG ASIA MATER, V6, DOI 10.1038/am.2013.79; Wang S., 2010, ANGEW CHEM, V122, P3865; Zhou ZG, 2014, SCI REP-UK, V4, DOI 10.1038/srep03653	49	5	5	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	JAN	2015	10	1			SI		160	165		10.1002/asia.201403059		6	Chemistry, Multidisciplinary	Chemistry	AX1XD	WOS:000346736100021		
J	Harano, K; Yamada, J; Mizuno, S; Nakamura, E				Harano, Koji; Yamada, Junya; Mizuno, Shinichiro; Nakamura, Eiichi			High-Density Display of Protein Ligands on Self-Assembled Capsules via Noncovalent Fluorous Interactions	CHEMISTRY-AN ASIAN JOURNAL			English	Article						fluorous chemistry; fullerenes; protein display; self-assembly; vesicles	CATIONIC TETRAAMINO FULLERENE; VIVO GENE DELIVERY; MAGNETIC-RESONANCE; CHEMICAL BIOLOGY; BILAYER VESICLES; WATER; BINDING; NANOPARTICLES; MICROARRAYS; CHEMISTRY	Ligand display on self-assembled nanostructures is an important tool in generating bioactive materials. Here, we demonstrate the display of sugar and biotin molecules on sub-100nm-sized capsules with a high surface coverage, which was achieved by the use of noncovalent fluorous interactions between a fluorous-tagged ligand molecule and a fullerene vesicle covered with fluorous chains. Even after the high-density ligand display and protein binding, the vesicle stably maintains its spherical structure because the fluorous binding of the sugar does not affect the structural integrity of the vesicle that originates from strong fullerene-fullerene interactions.	[Harano, Koji; Yamada, Junya; Mizuno, Shinichiro; Nakamura, Eiichi] Univ Tokyo, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Nakamura, Eiichi] Japan Sci & Technol Agcy, CREST, Bunkyo Ku, Tokyo 1130033, Japan	Harano, K (reprint author), Univ Tokyo, Dept Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	harano@chem.s.u-tokyo.ac.jp; nakamura@chem.s.u-tokyo.ac.jp	NAKAMURA, EIICHI/G-5041-2014; Harano, Koji/E-9443-2010				Petkau-Milroy K, 2013, ORG BIOMOL CHEM, V11, P219, DOI 10.1039/c2ob26790j; Harano K, 2013, CHEM COMMUN, V49, P3525, DOI 10.1039/c3cc40752g; Versluis F, 2010, CHEM SOC REV, V39, P3434, DOI 10.1039/b919446k; Chen ZF, 2013, CHINESE J CHEM, V31, P695, DOI 10.1002/cjoc.201300274; [Anonymous], 2010, ANGEW CHEM, V122, P1709; AOI K, 1995, MACROMOLECULES, V28, P5391, DOI 10.1021/ma00119a037; Maeda R, 2008, HYPERTENS RES, V31, P141, DOI 10.1291/hypres.31.141; Montellano A, 2011, NANOSCALE, V3, P4035, DOI 10.1039/c1nr10783f; Minami K, 2014, SCI REP-UK, V4, DOI 10.1038/srep04916; Voskuhl J, 2009, CHEM SOC REV, V38, P495, DOI 10.1039/b803782p; De Cock LJ, 2010, ANGEW CHEM INT EDIT, V49, P6954, DOI 10.1002/anie.200906266; Cametti M, 2012, CHEM SOC REV, V41, P31, DOI 10.1039/c1cs15084g; [Anonymous], 2014, ANGEW CHEM, V126, P1026; Huang J, 2012, J AM CHEM SOC, V134, P119, DOI 10.1021/ja209676p; Kamiya N, 2007, J AM CHEM SOC, V129, P3816, DOI 10.1021/ja0693082; Matsushita H, 2014, ANGEW CHEM INT EDIT, V53, P1008, DOI 10.1002/anie.201308500; Homma T, 2011, J AM CHEM SOC, V133, P6364, DOI 10.1021/ja200498g; [Anonymous], 2007, ANGEW CHEM, V119, P8106; Ariga K, 2008, MACROMOL BIOSCI, V8, P981, DOI 10.1002/mabi.200800102; Harano K, 2014, J POLYM SCI POL PHYS, V52, P833, DOI 10.1002/polb.23493; Yabu H, 2013, ACS APPL MATER INTER, V5, P3262, DOI 10.1021/am4003149; Santos CM, 2009, CHEM COMMUN, P2854, DOI 10.1039/b821148e; Vincent JM, 2012, CHEM COMMUN, V48, P11382, DOI 10.1039/c2cc34750d; Kim K, 2007, CHEM SOC REV, V36, P267, DOI 10.1039/b603088m; Zhou SQ, 2001, SCIENCE, V291, P1944, DOI 10.1126/science.291.5510.1944; [Anonymous], 2010, ANGEW CHEM, V122, P7108; BREWER CF, 1979, BIOCHEMISTRY-US, V18, P2555, DOI 10.1021/bi00579a019; Curran DP, 2008, SCIENCE, V321, P1645, DOI 10.1126/science.1158721; Engel A, 2003, PHARMACEUT RES, V20, P51, DOI 10.1023/A:1022294624256; Hazel J. F., 1957, J COLLOID SCI, V12, P529, DOI 10.1016/0095-8522(57)90058-2; Homma T, 2010, ANGEW CHEM INT EDIT, V49, P1665, DOI 10.1002/anie.200904659; Isobe H, 2007, P NATL ACAD SCI USA, V104, P14895, DOI 10.1073/pnas.0705010104; Ko KS, 2005, J AM CHEM SOC, V127, P13162, DOI 10.1021/ja054811k; Lu ZQ, 2010, J PHYS CHEM C, V114, P13546, DOI 10.1021/jp104043r; Maeda-Mamiya R, 2010, P NATL ACAD SCI USA, V107, P5339, DOI 10.1073/pnas.0909223107; Matsuo Y, 2006, ORG SYNTH, V83, P80; Nakamura E, 2010, CHEM REC, V10, P260, DOI 10.1002/tcr.201000021; NEUROHR KJ, 1981, BIOCHEMISTRY-US, V20, P3499, DOI 10.1021/bi00515a030; Sawamura M, 2000, CHEM LETT, P1098, DOI 10.1246/cl.2000.1098; Thomas GB, 2009, J AM CHEM SOC, V131, P5471, DOI 10.1021/ja8076439; Uhlenheuer DA, 2012, CHEM-EUR J, V18, P6788, DOI 10.1002/chem.201200238; Vegas AJ, 2007, ANGEW CHEM INT EDIT, V46, P7960, DOI 10.1002/anie.200703198; Vico RV, 2011, LANGMUIR, V27, P1391, DOI 10.1021/la1038975	43	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	JAN	2015	10	1			SI		172	176		10.1002/asia.201403144		5	Chemistry, Multidisciplinary	Chemistry	AX1XD	WOS:000346736100023		
J	Li, YQ; Bastakoti, BP; Imura, M; Suzuki, N; Jiang, XF; Ohki, S; Deguchi, K; Suzuki, M; Arai, S; Yamauchi, Y				Li, Yunqi; Bastakoti, Bishnu Prasad; Imura, Masataka; Suzuki, Norihiro; Jiang, Xiangfen; Ohki, Shinobu; Deguchi, Kenzo; Suzuki, Madoka; Arai, Satoshi; Yamauchi, Yusuke			Synthesis of a Large-Sized Mesoporous Phosphosilicate Thin Film through Evaporation-Induced Polymeric Micelle Assembly	CHEMISTRY-AN ASIAN JOURNAL			English	Article						block copolymers; mesoporous materials; micelles; phosphosilicates; self-assembly	SILOXANE-OXIDE COATINGS; PHOSPHORIC-ACID; GLASSES; NANOPARTICLES; COMPOSITES; ADSORPTION; BEHAVIOR	A triblock copolymer, poly(styrene-b-2-vinyl pyridine-b-ethylene oxide) (PS-b-P2VP-b-PEO) was used as a soft template to synthesize large-sized mesoporous phosphosilicate thin films. The kinetically frozen PS core stabilizes the micelles. The strong interaction of the inorganic precursors with the P2VP shell enables the fabrication of highly robust walls of phosphosilicate and the PEO helps orderly packing of the micelles during solvent evaporation. The molar ratio of phosphoric acid and tetraethyl orthosilicate is crucial to achieve the final mesostructure. The insertion of phosphorus species into the siloxane network is studied by Si-29 and (31)PMASNMR spectra. The mesoporous phosphosilicate films exhibit steady cell adhesion properties and show great promise as excellent materials in bone-growth engineering applications.	[Li, Yunqi; Bastakoti, Bishnu Prasad; Jiang, Xiangfen; Yamauchi, Yusuke] Natl Inst Mat Sci, World Premier Int WPI Res Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki 3050044, Japan; [Li, Yunqi; Yamauchi, Yusuke] Waseda Univ, Fac Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Imura, Masataka] Natl Inst Mat Sci, Environm & Energy Mat Div, Opt & Elect Mat Unit, Tsukuba, Ibaraki 3050044, Japan; [Suzuki, Norihiro] Natl Inst Mat Sci, ICYS, Tsukuba, Ibaraki 3050047, Japan; [Ohki, Shinobu; Deguchi, Kenzo] Natl Inst Mat Sci, High Magnet Field Stn, Tsukuba, Ibaraki 3050003, Japan; [Suzuki, Norihiro; Arai, Satoshi] Waseda Biosci Res Inst Singapore WABIOS, Singapore 138667, Singapore; [Suzuki, Madoka] Waseda Univ, Org Univ Res Initiat, Shinjuku Ku, Tokyo 1620041, Japan	Bastakoti, BP (reprint author), Natl Inst Mat Sci, World Premier Int WPI Res Ctr Mat Nanoarchitecton, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.	Bastakoti.Bishnuprasad@nims.go.jp; Yamauchi.Yusuke@nims.go.jp	Yamauchi, Yusuke/D-2780-2015				Yamauchi Y, 2013, J CERAM SOC JPN, V121, P831, DOI 10.2109/jcersj2.121.831; Zhang WH, 2006, MICROPOR MESOPOR MAT, V89, P179, DOI 10.1016/j.micromeso.2005.09.031; Lusvardi G, 2009, ACTA BIOMATER, V5, P419, DOI 10.1016/j.actbio.2008.07.007; Bastakoti BP, 2014, LANGMUIR, V30, P651, DOI 10.1021/la403901x; Wu SH, 2013, CHEM SOC REV, V42, P3862, DOI 10.1039/c3cs35405a; Katiyar A, 2006, J CHROMATOGR A, V1122, P13, DOI 10.1016/j.chroma.2006.04.055; Li YQ, 2014, CHEM-EUR J, V20, P6027, DOI 10.1002/chem.201304689; Bastakoti BP, 2014, CHEM COMMUN, V50, P9101, DOI 10.1039/c4cc02556c; Kirby BJ, 2004, ELECTROPHORESIS, V25, P203, DOI 10.1002/elps.200305755; Bastakoti BP, 2014, PHYS CHEM CHEM PHYS, V16, P10425, DOI 10.1039/c4cp01118j; Dong WY, 2007, J AM CHEM SOC, V129, P13894, DOI 10.1021/ja073804o; Xiong LM, 2007, J AM CHEM SOC, V129, P11878, DOI 10.1021/ja070466i; Matsuda A, 2001, SOLID STATE IONICS, V139, P113, DOI 10.1016/S0167-2738(00)00819-5; Wu KCW, 2011, J MATER CHEM, V21, P8934, DOI 10.1039/c1jm10548e; O'Donnell MD, 2008, J NON-CRYST SOLIDS, V354, P3561, DOI 10.1016/j.jnoncrysol.2008.03.035; Bastakoti BP, 2014, ACS APPL MATER INTER, V6, P854, DOI 10.1021/am4039954; Long DH, 2009, J COLLOID INTERF SCI, V331, P40, DOI 10.1016/j.jcis.2008.11.026; Das SK, 2012, CHEM COMMUN, V48, P2891, DOI 10.1039/c2cc17181c; Bastakoti BP, 2012, NEW J CHEM, V36, P125, DOI 10.1039/c1nj20671k; Aronne A, 2005, CHEM MATER, V17, P2081, DOI 10.1021/cm047768t; Barth M., 2011, ACS NANO, V5, P5325; Cao ZC, 1998, J MATER RES, V13, P1553, DOI 10.1557/JMR.1998.0216; Guragain S, 2010, J COLLOID INTERF SCI, V350, P63, DOI 10.1016/j.jcis.2010.06.007; Jhone J. R., 2013, ACTA BIOMATER, V9, P4457; Kayaba Y, 2010, THIN SOLID FILMS, V519, P674, DOI 10.1016/j.tsf.2010.08.109; KOSLOVA NI, 1993, J MATER CHEM, V3, P111, DOI 10.1039/jm9930300111; Krawietz TR, 1998, J AM CHEM SOC, V120, P8502, DOI 10.1021/ja9813461; VIANA B, 1995, J MATER CHEM, V5, P719, DOI 10.1039/jm9950500719; Zakaria MB, 2013, EUR J INORG CHEM, P2330, DOI 10.1002/ejic.201201305	29	4	4	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	JAN	2015	10	1			SI		183	187		10.1002/asia.201402636		5	Chemistry, Multidisciplinary	Chemistry	AX1XD	WOS:000346736100025		
J	Yamamoto, Y; Matsubara, H; Murakami, K; Yorimitsu, H; Osuka, A				Yamamoto, Yutaro; Matsubara, Hiroshi; Murakami, Kei; Yorimitsu, Hideki; Osuka, Atsuhiro			Activator-Free Palladium-Catalyzed Silylation of Aryl Chlorides with Silylsilatranes	CHEMISTRY-AN ASIAN JOURNAL			English	Article						aryl chlorides; palladium; silylation; silylsilatranes; transmetalation	C-H SILYLATION; CROSS-COUPLING REACTIONS; ORGANIC HALIDES; PALLADIUM(0)-CATALYZED SILYLATION; FUNCTIONAL MONOSILANES; EFFICIENT SYNTHESIS; GRIGNARD-REAGENTS; SYNTHETIC ROUTE; DISILANES; SILICON	The palladium-catalyzed silylation of aryl chlorides with silylsilatranes proceeds under activator-free conditions; hence, wide functional group compatibility is displayed and boryl and siloxy groups are able to survive. Experimental and computational studies revealed that smooth transmetalation from the silylsilatrane to the arylpalladium chloride is facilitated by strong interaction between the Lewis acidic silicon and the chloride.	[Yamamoto, Yutaro; Murakami, Kei; Yorimitsu, Hideki; Osuka, Atsuhiro] Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan; [Matsubara, Hiroshi] Osaka Prefecture Univ, Grad Sch Sci, Dept Chem, Naka Ku, Sakai, Osaka 5998531, Japan; [Murakami, Kei] Kyoto Univ, Hakubi Ctr Adv Res, Sakyo Ku, Kyoto 6068502, Japan; [Yorimitsu, Hideki] JST, ACT C, Sakyo Ku, Kyoto 6068502, Japan	Matsubara, H (reprint author), Osaka Prefecture Univ, Grad Sch Sci, Dept Chem, Naka Ku, Sakai, Osaka 5998531, Japan.	matsu@c.s.osakafu-u.ac.jp; yori@kuchem.kyoto-u.ac.jp	Murakami, Kei /E-6804-2014				Iwasawa T, 2006, ORGANOMETALLICS, V25, P4665, DOI 10.1021/om060615q; Casado AL, 1998, J AM CHEM SOC, V120, P8978, DOI 10.1021/ja9742388; OTSUKA S, 1976, J AM CHEM SOC, V98, P5850, DOI 10.1021/ja00435a017; Surry DS, 2008, ANGEW CHEM INT EDIT, V47, P6338, DOI 10.1002/anie.200800497; Kurihara Y, 2013, CHEM COMMUN, V49, P11275, DOI 10.1039/c3cc46294c; Murata M, 2007, CHEM LETT, V36, P910, DOI 10.1246/cl.2007.910; Yamanoi Y, 2006, TETRAHEDRON LETT, V47, P7157, DOI 10.1016/j.tetlet.2006.08.001; Zarate C, 2014, J AM CHEM SOC, V136, P2236, DOI 10.1021/ja412107b; Jensen MS, 2000, ORG LETT, V2, P1081, DOI 10.1021/ol005641d; Tobisu M, 2008, CHEM-ASIAN J, V3, P1585, DOI 10.1002/asia.200800090; GUSTAVSON WA, 1982, ORGANOMETALLICS, V1, P884, DOI 10.1021/om00066a028; Tobisu M, 2008, J AM CHEM SOC, V130, P15982, DOI 10.1021/ja804992n; Murata M, 1997, J ORG CHEM, V62, P8569, DOI 10.1021/jo971143f; VEDEJS E, 1992, J AM CHEM SOC, V114, P6556, DOI 10.1021/ja00042a044; Puri JK, 2011, CHEM SOC REV, V40, P1791, DOI 10.1039/b925899j; Ishiyama T, 2003, ANGEW CHEM INT EDIT, V42, P5346, DOI 10.1002/anie.200352399; Stambuli JP, 2002, J AM CHEM SOC, V124, P9346, DOI 10.1021/ja0264394; [Anonymous], SHELXL 97 SHELXS 97; Denmark SE, 2003, ORG LETT, V5, P3483, DOI 10.1021/ol035288m; Tobisu M, 2006, J AM CHEM SOC, V128, P8152, DOI 10.1021/ja062745w; Xue LQ, 2010, CHEM SOC REV, V39, P1692, DOI 10.1039/b814973a; Li L, 2013, CHINA AGR ECON REV, V5, P5, DOI 10.1108/17561371311294739; Littke AF, 2002, J AM CHEM SOC, V124, P6343, DOI 10.1021/ja020012f; Ariafard A, 2006, ORGANOMETALLICS, V25, P5788, DOI 10.1021/om0607705; Lu B, 2008, ANGEW CHEM INT EDIT, V47, P7508, DOI 10.1002/anie.200802456; Pidaparthi RR, 2007, ORG LETT, V9, P1623, DOI 10.1021/ol070089e; Ishiyama T, 2013, ORG BIOMOL CHEM, V11, P8162, DOI 10.1039/c3ob41623b; Hamze A, 2006, ORG LETT, V8, P931, DOI 10.1021/ol052996u; Karshtedt D, 2006, ORGANOMETALLICS, V25, P4471, DOI 10.1021/om060492+; Grant DJ, 2009, J PHYS CHEM A, V113, P3656, DOI 10.1021/jp811386v; EABORN C, 1982, J ORGANOMET CHEM, V225, P331, DOI 10.1016/S0022-328X(00)86833-3; Manoso AS, 2001, J ORG CHEM, V66, P7449, DOI 10.1021/jo010621q; Murata M, 2002, ORG LETT, V4, P1843, DOI 10.1021/ol025770p; Yamanoi Y, 2005, J ORG CHEM, V70, P9607, DOI 10.1021/jo051131r; Garcia-Melchor M, 2013, ACCOUNTS CHEM RES, V46, P2626, DOI 10.1021/ar400080r; Auner N., 1994, ORGANOSILICON CHEM S; AZARIAN D, 1976, J ORGANOMET CHEM, V117, pC55, DOI 10.1016/S0022-328X(00)91902-8; Azarian H., 1981, ORGANOMET CHEM, V215, P49; Azuma H, 2011, CHEM LETT, V40, P959, DOI 10.1246/cl.2011.959; BABIN P, 1993, J ORGANOMET CHEM, V446, P135, DOI 10.1016/0022-328X(93)80045-D; Becerra R, 1998, CHEM FUNCT, V2, P153, DOI 10.1002/0470857250.ch4; Brook M. A., 2000, SILICON ORGANIC ORGA; Faller JW, 2002, ORGANOMETALLICS, V21, P5911, DOI 10.1021/om020578c; Fleming I., 2002, SCI SYNTHESIS CATEGO, V4; Frisch M J, 2010, GAUSSIAN 09 REVISION; Goossen LJ, 2000, SYNLETT, P1801; Han XJ, 2012, ORG LETT, V14, P2906, DOI 10.1021/ol301194e; Hartwig JF, 2012, ACCOUNTS CHEM RES, V45, P864, DOI 10.1021/ar200206a; HATANAKA Y, 1987, TETRAHEDRON LETT, V28, P4715, DOI 10.1016/S0040-4039(00)96607-3; Hiyama T., 2013, ORGANOMETALLICS SYNT; Iizuka M, 2008, EUR J ORG CHEM, P1161, DOI 10.1002/ejoc.200701141; Iovel I., 1999, CHEM HETEROCYCL COMP, V35, P1059, DOI 10.1007/BF02251797; Ishii Y, 1998, CHEM LETT, P157; Ishiyama T., 2003, ANGEW CHEM, V115, P5504, DOI 10.1002/ange.200352399; Kakiuchi F, 2002, CHEM LETT, P396, DOI 10.1246/cl.2002.396; Kosugi M, 1996, J ORGANOMET CHEM, V508, P255, DOI 10.1016/0022-328X(95)05840-L; KRAFFT TE, 1990, J ORG CHEM, V55, P5430, DOI 10.1021/jo00307a005; Lu B, 2008, ANGEW CHEM, P120, DOI 10.1002/ange.200802456; Marciniec B., 2009, HYDROSILYLATION; Martin R, 2008, ACCOUNTS CHEM RES, V41, P1461, DOI 10.1021/ar800036s; MATSUMOTO H, 1977, J ORGANOMET CHEM, V128, P409, DOI 10.1016/S0022-328X(00)92215-0; MATSUMOTO H, 1983, J ORGANOMET CHEM, V250, P99, DOI 10.1016/0022-328X(83)85042-6; MATSUMOTO H, 1981, J ORGANOMET CHEM, V208, P145, DOI 10.1016/S0022-328X(00)82669-8; MATSUMOTO H, 1975, J ORGANOMET CHEM, V85, pC1, DOI 10.1016/S0022-328X(00)89496-6; McNeill E, 2007, ORG LETT, V9, P3785, DOI 10.1021/ol701518f; Minami Y, 2014, CHEM LETT, V43, P201, DOI 10.1246/cl.130919; MORI M, 1991, J ORG CHEM, V56, P3486, DOI 10.1021/jo00011a009; Morita E, 2009, B CHEM SOC JPN, V82, P1012, DOI 10.1246/bcsj.82.1012; Murakami K, 2008, ANGEW CHEM INT EDIT, V47, P5833, DOI 10.1002/anie.200801949; Murakami K., 2008, ANGEW CHEM, V120, P5917; Murata M, 2010, J SYN ORG CHEM JPN, V68, P845; Naito S, 2002, J ORG CHEM, V67, P4200, DOI 10.1021/jo011157s; Penafiel I., 2011, J ORG CHEM, P7174; RICH JD, 1989, J AM CHEM SOC, V111, P5886, DOI 10.1021/ja00197a058; Riggleman S, 2003, J ORG CHEM, V68, P8106, DOI 10.1021/jo034809g; SAKAKURA T, 1987, CHEM LETT, P2211, DOI 10.1246/cl.1987.2211; Sebahar HL, 2002, J ORG CHEM, V67, P3788, DOI 10.1021/jo0200318; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Shirakawa E, 2000, CHEM COMMUN, P1895, DOI 10.1039/b006165o; Surry D. S., 2008, ANGEW CHEM, V120, P6438, DOI 10.1002/ange.200800497; TROST BM, 1983, TETRAHEDRON LETT, V24, P4895, DOI 10.1016/S0040-4039(01)99804-1; Uchiyama M, 2008, J AM CHEM SOC, V130, P472, DOI 10.1021/ja071268u; VERKADE JG, 1994, COORDIN CHEM REV, V137, P233, DOI 10.1016/0010-8545(94)03007-D; VERKADE JG, 1993, ACCOUNTS CHEM RES, V26, P483, DOI 10.1021/ar00033a005; WANNAGAT U, 1988, J ORGANOMET CHEM, V341, P95, DOI 10.1016/0022-328X(88)89066-1; YAMAMOTO K, 1980, TETRAHEDRON LETT, V21, P1653, DOI 10.1016/S0040-4039(00)77777-X; Yamanoi Y, 2009, J SYN ORG CHEM JPN, V67, P778; Zhang Y., 2002, ORGANOMETALLICS, V21, P5859, DOI 10.1021/om020644a	88	2	2	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	JAN	2015	10	1			SI		219	224		10.1002/asia.201402595		6	Chemistry, Multidisciplinary	Chemistry	AX1XD	WOS:000346736100029		
J	Soya, T; Naoda, K; Osuka, A				Soya, Takanori; Naoda, Koji; Osuka, Atsuhiro			Ni-II Metalations of [40]- and [42]Nonaphyrins(1.1.1.1.1.1.1.1.1): The Largest Doubly Twisted Huckel Antiaromatic Molecule	CHEMISTRY-AN ASIAN JOURNAL			English	Article						antiaromaticity; aromaticity; conformer; nickel metalation; nonaphyrin	SUBSTITUTED EXPANDED PORPHYRINS; INDEPENDENT CHEMICAL-SHIFTS; MOBIUS AROMATICITY; METAL-COMPLEXES; CARBON BONDS; MESO; HEXAPHYRINS; HEXAPHYRIN(1.1.1.1.1.1); SOLVENT	Ni-II metalation of [42]nonaphyrin gave two Huckel aromatic [42]nonaphyrin Ni-II complexes that possess different doubly twisted figure-eight conformations. While these complexes are conformers, the activation barriers for conformational interconversion were found to be exceptionally high. However, one-way isomerization from the higher-energy conformer to the lower-energy conformer can be induced upon treatment with trifluoroacetic acid (TFA). This conformational isomerization has been suggested to proceed via a protonation-induced caterpillar-like conformational rotation of the metal-free hexaphyrin-like segment by examining the similar isomerization of an A(3)B(6)-type [42]nonaphyrin Ni-II complex. Rh-I metalation of the lower-energy [42]nonaphyrin Ni-II complex afforded a [42]nonaphyrin Ni-II-Rh-I hybrid complex, which was oxidized with p-chloranil to produce a [40]nonaphyrin Ni-II-Rh-I hybrid complex as the largest doubly twisted Huckel antiaromatic molecule to date.	[Soya, Takanori; Naoda, Koji; Osuka, Atsuhiro] Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan	Osuka, A (reprint author), Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan.	osuka@kuchem.kyoto-u.ac.jp					Higashino T, 2010, ANGEW CHEM INT EDIT, V49, P4950, DOI 10.1002/anie.201001765; [Anonymous], 2008, ANGEW CHEM, V120, P9807; Osuka A, 2011, CHEM COMMUN, V47, P4330, DOI 10.1039/c1cc10534e; Higashino T, 2012, ANGEW CHEM INT EDIT, V51, P13105, DOI 10.1002/anie.201208147; Moriya K, 2010, ANGEW CHEM INT EDIT, V49, P4297, DOI 10.1002/anie.201001052; Tanaka Y, 2011, ANGEW CHEM INT EDIT, V50, P11460, DOI 10.1002/anie.201105809; [Anonymous], 2008, ANGEW CHEM, V120, P693; Reddy JS, 2006, ORG LETT, V8, P5541, DOI 10.1021/ol062359j; Vogel E, 2003, ANGEW CHEM INT EDIT, V42, P2857, DOI 10.1002/anie.200250690; Koide T, 2008, ANGEW CHEM INT EDIT, V47, P9661, DOI 10.1002/anie.200804570; Yoon MC, 2011, J PHYS CHEM B, V115, P14928, DOI 10.1021/jp207731k; Rzepa HS, 2008, ORG LETT, V10, P949, DOI 10.1021/ol703129z; Chandrashekar TK, 2003, ACCOUNTS CHEM RES, V36, P676, DOI 10.1021/ar020284n; Alonso M, 2012, CHEM-EUR J, V18, P10916, DOI 10.1002/chem.201200511; Chen ZF, 2005, CHEM REV, V105, P3842, DOI 10.1021/cr030088+; Fliegl H, 2010, J PHYS CHEM A, V114, P7153, DOI 10.1021/jp1021517; [Anonymous], 2010, ANGEW CHEM, V122, P5070; [Anonymous], 2010, ANGEW CHEM, V122, P4393; Mori S, 2007, J AM CHEM SOC, V129, P11344, DOI 10.1021/ja0744908; Tanaka Y, 2008, ANGEW CHEM INT EDIT, V47, P681, DOI 10.1002/anie.200704407; Shimizu S, 2006, CHEM-EUR J, V12, P4909, DOI 10.1002/chem.200600158; [Anonymous], 2011, ANGEW CHEM, V123, P11662; [Anonymous], 2012, ANGEW CHEM, V124, P13282; Mori S, 2005, INORG CHEM, V44, P4127, DOI 10.1021/ic050447e; Mori S, 2005, J AM CHEM SOC, V127, P8030, DOI 10.1021/ja051662x; Sessler JL, 2003, ANGEW CHEM INT EDIT, V42, P5134, DOI 10.1002/anie.200200561; [Anonymous], 2003, ANGEW CHEM, V115, P2964; [Anonymous], 2011, ANGEW CHEM, V123, P4432; Alonso M, 2013, CHEM-EUR J, V19, P1617, DOI 10.1002/chem.201203295; [Anonymous], 2011, ANGEW CHEM, V123, P4376; Stepien M, 2011, ANGEW CHEM INT EDIT, V50, P4288, DOI 10.1002/anie.201003353; Schleyer PV, 1996, J AM CHEM SOC, V118, P6317, DOI 10.1021/ja960582d; Sankar J, 2008, J AM CHEM SOC, V130, P13568, DOI 10.1021/ja801983d; Shin JY, 2001, J AM CHEM SOC, V123, P7190, DOI 10.1021/ja0106624; Zhang Z, 2014, J AM CHEM SOC, V136, P7591, DOI 10.1021/ja503451m; [Anonymous], 2003, ANGEW CHEM, V115, P5292; Kamimura Y, 2007, CHEM-EUR J, V13, P1620, DOI 10.1002/chem.200601304; Rath H, 2010, ANGEW CHEM INT EDIT, V49, P1489, DOI 10.1002/anie.200906017; Saito S, 2006, CHEM-EUR J, V12, P9095, DOI 10.1002/chem.200600671; Suzuki M, 2007, J AM CHEM SOC, V129, P464, DOI 10.1021/ja067102v; Suzuki M, 2005, CHEM COMMUN, P3685, DOI 10.1039/b506586k; Tanaka T, 2012, CHEM-ASIAN J, V7, P889, DOI 10.1002/asia.201101039; Tanaka Y, 2008, EUR J ORG CHEM, P1341, DOI 10.1002/ejoc.200701132; Taniguchi R, 2003, TETRAHEDRON LETT, V44, P2505, DOI 10.1016/S0040-4039(03)00328-9	44	2	2	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	JAN	2015	10	1			SI		231	238		10.1002/asia.201402933		8	Chemistry, Multidisciplinary	Chemistry	AX1XD	WOS:000346736100031		
J	Ohta, C; Haraguchi, K; Kato, Y; Endo, T; Kimura, O; Koga, N				Ohta, Chiho; Haraguchi, Koichi; Kato, Yoshihisa; Endo, Tetsuya; Kimura, Osamu; Koga, Nobuyuki			Distribution and excretion of 2,2 ',3,4 ',5,5 ',6-heptachlorobiphenyl (CB187) and its metabolites in rats and guinea pigs	CHEMOSPHERE			English	Article						CB187; Liver; Serum; Feces; Metabolism; Distribution	POLYCHLORINATED BIPHENYL METABOLITES; HYDROXYLATED PCB METABOLITES; WHOLE-BLOOD; ESTROGENIC ACTIVITY; LIVER-MICROSOMES; PBDE CONGENERS; ADIPOSE-TISSUE; YUSHO PATIENTS; OH-PCBS; CELLS	4-Hydroxy (OH)-2,2',3,4',5,5',6-heptachlorobiphenyl (CB187) is a polychlorinated biphenyl (PCB) metabolite present in human serum at the highest concentration of the PCB metabolites. Our previous study demonstrated that CB187 was metabolized by rat and guinea pig liver microsomes to the major metabolite 4'-OH-2,2',3,3',5,5',6-heptachlorobiphenyl (CB178), and the two minor metabolites 4-OH-CB187 and 4'-OH-2,2',3,5,5',6-hexachlorobiphenyl (CB151). In this study, the distribution of these metabolites in serum, liver and kidney, and their fecal excretion, were examined in rats and guinea pigs intraperitoneally dosed with CB187. Similarly to the in vitro study, 4'-OH-CB178 was a major metabolite in the liver, serum and feces of both animal species on day 4 after CB187 injection, and the level in the liver was about 20 times higher in untreated guinea pigs than in untreated rats. In addition, 4-OH-CB187, a minor metabolite, was detected in the serum and kidneys, but not in the feces, of both guinea pigs and rats. Another minor metabolite, 4'-OH-CB151, was detected at a lower level only in guinea pig feces; little was found in the serum or liver of either animals. Over the 30 d following CB187 injection into guinea pigs, 4'-OH-CB178 and 4-OH-CB187 in the serum was observed at higher level on day 4 and day 16 after injection, respectively. The majority of the 4'-OH-CB178 was rapidly excreted to the feces following unmetabolized CB187, whereas 4-OH-CB187 was not found in guinea pig feces and liver during 30 d. These results support previous reports that 4-OH-CB187 is retained persistently in animal blood. (C) 2014 Elsevier Ltd. All rights reserved.	[Ohta, Chiho; Koga, Nobuyuki] Nakamura Gakuen Univ, Fac Nutr Sci, Jonan Ku, Fukuoka 8140198, Japan; [Haraguchi, Koichi] Daiichi Coll Pharmaceut Sci, Minami Ku, Fukuoka 8158511, Japan; [Kato, Yoshihisa] Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Sanuki, Kagawa 7692193, Japan; [Endo, Tetsuya; Kimura, Osamu] Hlth Sci Univ Hokkaido, Fac Pharmaceut Sci, Tobetsu, Hokkaido 0610293, Japan	Koga, N (reprint author), Nakamura Gakuen Univ, Fac Nutr Sci, Jonan Ku, 5-7-1 Befu, Fukuoka 8140198, Japan.	chiho@nakamura-u.ac.jp; k-haraguti@daiichi-cps.ac.jp; kato@kph.bunri-u.ac.jp; endotty@hoku-iryo-u.ac.jp; o_kimura@hoku-iryo-u.ac.jp; nobuyuld@nakamura-u.ac.jp			Ministry of Health, Labour and Welfare of Japan; japan Society for the Promotion of Science [24310049, 25350115, 23510083, 24614012]	This work was supported in part by a Health and Labour Scientific Research Grant (H24-food-designated-014 N.K.) from the Ministry of Health, Labour and Welfare of Japan, and a Grant-in-Aid for Scientific Research (B) (No. 24310049 K.H.) and a Grant-in-Aid for Scientific Research (C) (No. 25350115 C. O, No. 23510083 Y.K., No. 24614012 O.K) from the Japan Society for the Promotion of Science.	Ohta C, 2005, XENOBIOTICA, V35, P319, DOI 10.1080/00498250500087507; Machala M, 2004, CHEM RES TOXICOL, V17, P340, DOI 10.1021/tx030034v; Pacyniak E, 2010, TOXICOL SCI, V115, P344, DOI 10.1093/toxsci/kfq059; PARKINSON A, 1983, J BIOL CHEM, V258, P5967; Park JS, 2007, ENVIRON HEALTH PERSP, V115, P20, DOI 10.1289/ehp.8913; Sandau CD, 2000, ENVIRON HEALTH PERSP, V108, P611, DOI 10.2307/3434880; Brouwer A, 1998, TOXICOL IND HEALTH, V14, P59; Guvenius DM, 2003, ENVIRON HEALTH PERSP, V111, P1235, DOI 10.1289/ehp.5946; Sjodin A, 2000, ENVIRON HEALTH PERSP, V108, P1035, DOI 10.2307/3434955; Sandala GM, 2004, SCI TOTAL ENVIRON, V331, P125, DOI 10.1016/j.scitotenv.2003.03.001; Connor K, 1997, TOXICOL APPL PHARM, V145, P111, DOI 10.1006/taap.1997.8169; BERGMAN A, 1994, ENVIRON HEALTH PERSP, V102, P464, DOI 10.2307/3432042; Kester MHA, 2000, ENDOCRINOLOGY, V141, P1897, DOI 10.1210/en.141.5.1897; JANSEN HT, 1993, REPROD TOXICOL, V7, P237, DOI 10.1016/0890-6238(93)90230-5; ARIYOSHI N, 1995, BIOCHEM BIOPH RES CO, V212, P455, DOI 10.1006/bbrc.1995.1991; Ariyoshi N, 1997, XENOBIOTICA, V27, P973, DOI 10.1080/004982597240136; BROUWER A, 1991, BIOCHEM SOC T, V19, P731; CADOGAN JIG, 1962, J CHEM SOC, P4257; Fangstrom B, 2002, ENVIRON HEALTH PERSP, V110, P895; Guvenius DM, 2002, ENVIRON TOXICOL CHEM, V21, P2264, DOI 10.1897/1551-5028(2002)021<2264:MOPBIH>2.0.CO;2; HARAGUCHI K, 1992, AMBIO, V21, P546; Humphrey HEB, 2000, ENVIRON HEALTH PERSP, V108, P167, DOI 10.2307/3454516; KANNAN N, 1994, ARCH ENVIRON HEALTH, V49, P375; Kato Y, 2009, DRUG METAB DISPOS, V37, P2095, DOI 10.1124/dmd.109.028621; Kimura-Kuroda J, 2005, DEV BRAIN RES, V154, P259, DOI 10.1016/j.devbrainres.2004.11.004; Kimura-Kuroda J, 2007, CHEMOSPHERE, V67, pS412, DOI 10.1016/j.chemosphere.2006.05.137; Kitamura S, 2005, TOXICOLOGY, V208, P377, DOI 10.1016/j.tox.2004.11.037; Koga N., 1996, YUSHO HUMAN DISASTER, P105; KOGA N, 1985, Fukuoka Acta Medica, V76, P160; Koga Nobuyuki, 2001, Fukuoka Acta Medica, V92, P167; KORACH KS, 1988, MOL PHARMACOL, V33, P120; Kramer VJ, 1997, TOXICOL APPL PHARM, V144, P363, DOI 10.1006/taap.1997.8163; Malmberg T, 2004, XENOBIOTICA, V34, P581, DOI 10.1080/00498250410001713078; Mimura Keisuke, 1999, Fukuoka Acta Medica, V90, P192; Ohta Chiho, 2005, Fukuoka Acta Medica, V96, P232; Pacyniak E, 2011, TOXICOL APPL PHARM, V257, P23, DOI 10.1016/j.taap.2011.08.014; Sandau CD, 2002, ENVIRON HEALTH PERSP, V110, P411; Schnellmann R.G., 1985, BIOCH TOXICOL, V7, P247; SONZOGNI W, 1991, ARCH ENVIRON CON TOX, V20, P56; Tabata K., 1999, XENOBIO METABOL DISP, V14, P286; Todaka T, 2009, CHEMOSPHERE, V74, P902, DOI 10.1016/j.chemosphere.2008.10.042; YOSHIHARA S, 1979, CHEMOSPHERE, V8, P531, DOI 10.1016/0045-6535(79)90100-0; Yoshimura H, 1979, Ann N Y Acad Sci, V320, P179, DOI 10.1111/j.1749-6632.1979.tb13143.x; You SH, 2006, MOL CELL ENDOCRINOL, V257-8, P26, DOI 10.1016/j.mce.2006.06.009	44	1	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0045-6535	1879-1298		CHEMOSPHERE	Chemosphere	JAN	2015	118						5	11		10.1016/j.chemosphere.2014.05.019		7	Environmental Sciences	Environmental Sciences & Ecology	AX5GC	WOS:000346953700002		
J	Kobayashi, J; Imuta, Y; Komorita, T; Yamada, K; Ishibashi, H; Ishihara, F; Nakashima, N; Sakai, J; Arizono, K; Koga, M				Kobayashi, Jun; Imuta, Yuki; Komorita, Tomohiro; Yamada, Katsumasa; Ishibashi, Hiroshi; Ishihara, Fumitaka; Nakashima, Naoya; Sakai, Jun; Arizono, Koji; Koga, Minoru			Trophic magnification of polychlorinated biphenyls and polybrominated diphenyl ethers in an estuarine food web of the Ariake Sea, Japan	CHEMOSPHERE			English	Article						Persistent organic pollutants; Estuary; Biomagnification; Stable isotope; Trophic level	PERSISTENT ORGANIC POLLUTANTS; WATER PARTITION-COEFFICIENTS; BIOMAGNIFICATION; PBDES; BIOACCUMULATION; DEBROMINATION; CONGENERS; POSITION; CHAINS; TROUT	To evaluate trophic biomagnification of polychlorinated biphenyls (PCBs) and polybrominated diphenyl ethers (PBDEs) in an estuary of the Ariake Sea, Japan, we measured concentrations of 209 PCB congeners and 28 PBDE congeners, and nitrogen stable isotope (delta N-15) levels in living aquatic organisms. The trophic magnification factor (TMF) for Sigma PCBs (all 209 congeners) was 1.52, and TMFs for 58 PCB congeners ranged from 0.90 to 3.28. In contrast, TMF for Sigma PBDEs was 1.17, and TMFs for 7 PBDE congeners ranged from 0.46 to 1.66. TMFs of PCB and PBDE congeners in this study were lower than those in marine food webs, and were similar to those in a lake food web. However, although negative relationships were observed between TMF and log octanol water partition coefficient (K-OW) values among PCB congeners in this study (log K-OW up to 7), positive relationships have been reported in several other studies. In the present estuary, PCB concentrations in sea bass may not reach a steady state because sea bass are migratory species. Therefore, TMFs of highly chlorinated congeners with high log K-OW values take longer to reach the steady state and may not increase with increasing log K-OW. (c) 2014 Elsevier Ltd. All rights reserved.	[Kobayashi, Jun; Komorita, Tomohiro; Sakai, Jun; Arizono, Koji; Koga, Minoru] Prefectural Univ Kumamoto, Fac Environm & Symbiot Sci, Kumamoto 8628502, Japan; [Imuta, Yuki; Ishihara, Fumitaka; Nakashima, Naoya] Prefectural Univ Kumamoto, Grad Sch Environm & Symbiot Sci, Kumamoto 8628502, Japan; [Yamada, Katsumasa] Seikai Natl Fisheries Res Inst, Nagasaki 8512213, Japan; [Ishibashi, Hiroshi] Shokei Univ, Jr Coll, Kumamoto 8628678, Japan	Kobayashi, J (reprint author), Prefectural Univ Kumamoto, Fac Environm & Symbiot Sci, 3-1400 Tsukide, Kumamoto 8628502, Japan.	jkobayashi@pu-kumamoto.ac.jp	Kobayashi, Junjiro/J-8547-2015		Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [5RFb-1203]	This research was supported by the Environment Research and Technology Development Fund (5RFb-1203) of the Ministry of the Environment, Japan. The authors are grateful to Dr. Noriyuki Suzuki of National Institute for Environmental Studies, and Associate Professor Dr. Akihide Kasai of Kyoto University for their critical advice. The authors thank Assistant Professor Dr. Kaoruko Mizukawa of Tokyo University of Agriculture and Technology for her helpful comments.	Law K, 2006, ENVIRON TOXICOL CHEM, V25, P2177, DOI 10.1897/05-500R.1; BALLSCHMITER K, 1980, FRESEN Z ANAL CHEM, V302, P20, DOI 10.1007/BF00469758; Mizukawa K, 2013, SCI TOTAL ENVIRON, V449, P401, DOI 10.1016/j.scitotenv.2013.01.092; Mizukawa K, 2009, MAR POLLUT BULL, V58, P1217, DOI 10.1016/j.marpolbul.2009.03.008; Hop H, 2002, ENVIRON SCI TECHNOL, V36, P2589, DOI 10.1021/es010231l; Stapleton HM, 2004, ENVIRON TOXICOL CHEM, V23, P1939, DOI 10.1897/03-462; Roberts SC, 2011, ENVIRON SCI TECHNOL, V45, P1999, DOI 10.1021/es103934x; HAWKER DW, 1988, ENVIRON SCI TECHNOL, V22, P382, DOI 10.1021/es00169a004; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Nfon E, 2008, SCI TOTAL ENVIRON, V397, P190, DOI 10.1016/j.scitotenv.2008.02.029; Stapleton HM, 2006, ENVIRON SCI TECHNOL, V40, P4653, DOI 10.1021/es060573x; Wu JP, 2009, ENVIRON POLLUT, V157, P904, DOI 10.1016/j.envpol.2008.11.001; Fisk AT, 2001, ENVIRON SCI TECHNOL, V35, P732, DOI 10.1021/es001459w; Wan Y, 2008, ENVIRON SCI TECHNOL, V42, P1078, DOI 10.1021/es0720560; Houde M, 2008, ENVIRON TOXICOL CHEM, V27, P2169, DOI 10.1897/08-071.1; Walters DM, 2011, ENVIRON SCI TECHNOL, V45, P3917, DOI 10.1021/es103158s; Kelly BC, 2008, SCI TOTAL ENVIRON, V401, P60, DOI 10.1016/j.scitotenv.2008.03.045; Braekevelt E, 2003, CHEMOSPHERE, V51, P563, DOI 10.1016/S0045-6535(02)00841-X; Burkhard LP, 2013, ENVIRON SCI TECHNOL, V47, P1186, DOI 10.1021/es305253r; Iwamura M., 2009, J ENV CHEM, V19, P527; Kobayashi J, 2010, J ENVIRON MONITOR, V12, P647, DOI 10.1039/b918327b; Luo XJ, 2013, ENVIRON POLLUT, V176, P36, DOI 10.1016/j.envpol.2013.01.025; Matsuo J., 2009, MAR POLLUT B, V58, P1615; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Nakata H., 2002, J ENV CHEM, V12, P127; Takao Yuji, 2010, P191; Walters DM, 2008, ENVIRON SCI TECHNOL, V42, P2316, DOI 10.1021/es0715849	28	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0045-6535	1879-1298		CHEMOSPHERE	Chemosphere	JAN	2015	118						201	206		10.1016/j.chemosphere.2014.08.066		6	Environmental Sciences	Environmental Sciences & Ecology	AX5GC	WOS:000346953700028		
J	Hasei, T; Sakaguchi, M; Yoneda, M; Wada, M; Miyagawa, S; Kobayashi, K; Fukuda, T; Arita, S; Ikemori, F; Watanabe, T				Hasei, Tomohiro; Sakaguchi, Masumi; Yoneda, Maki; Wada, Mitsuhiro; Miyagawa, Shuhei; Kobayashi, Kana; Fukuda, Takashi; Arita, Saori; Ikemori, Fumikazu; Watanabe, Tetsushi			Development of an Analytical Method for Strong Mutagens/Carcinogens, 3,9-Dinitrofluoranthene and Dinitropyrene Isomers, in the Environment and Their Particle-Size Distribution in Airborne Particles	CHROMATOGRAPHIA			English	Article						Two-dimensional HPLC; Separation; 3,9-Dinitrofluoranthene; Dinitropyrene isomers; Environmental sample; Particle-size distribution	PERFORMANCE LIQUID-CHROMATOGRAPHY; PARTICULATE AIR-POLLUTION; GASOLINE-ENGINE VEHICLES; LONG-TERM EXPOSURE; SURFACE SOIL; FLUORESCENCE DETECTION; ONLINE REDUCTION; LUNG-CANCER; MORTALITY; DIESEL	3,9-Dinitrofluoranthene (DNF) and 1,3-, 1,6-, and 1,8-dinitropyrene (DNP) isomers are classified as "possible human carcinogens (Group 2B)" by the International Agency for Research on Cancer (IARC). In the present study, we developed an analytical method for DNF and DNP isomers, which is composed of efficient purification of nitroarenes from impurities and separation of nitroarenes from each other using high-performance liquid chromatography (HPLC) and two-dimensional HPLC analysis. These nitroarenes are reduced to corresponding aminoarenes online and sensitively quantified by their fluorescence. We adopted this analytical method for surface soil and airborne particle samples. In the chromatograms of HPLC analysis, DNF and DNP isomers were sufficiently separated from each other and no interfering peaks were observed around DNF and DNP isomers. DNF and 1,3-, 1,6-, and 1,8-DNP isomers were detected in the ranges of 47-579, 27-165, 30-238, and 34-228 pg g(-1) of soil, respectively, from all analyzed samples (n = 6). The contribution ratios of DNF to the mutagenicity toward Salmonella typhimurium TA98 without a metabolic system (S9) were high in the range of 11.6-36.6 %. When classified airborne particles, namely, < 1.1, 1.1-2.0, 2.0-3.3, 3.3-7.0, and > 7.0 mu m in size, were analyzed, amounts of DNF were 64, 14, 13, 6, and 5 fg m(-3), respectively, and DNF tended to be detected in smaller airborne particles. This is the first report on an analytical method for DNF in the environment and the particle-size distribution of DNF in airborne particles.	[Hasei, Tomohiro; Sakaguchi, Masumi; Yoneda, Maki; Wada, Mitsuhiro; Miyagawa, Shuhei; Kobayashi, Kana; Fukuda, Takashi; Arita, Saori; Watanabe, Tetsushi] Kyoto Pharmaceut Univ, Kyoto 607, Japan; [Ikemori, Fumikazu] Nagoya City Inst Environm Sci, Nagoya, Aichi, Japan	Hasei, T (reprint author), Kyoto Pharmaceut Univ, Kyoto 607, Japan.	hasei@mb.kyoto-phu.ac.jp			Japanese Ministry of the Environment [C-1154]; Ministry of Health, Labour, and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan	This study was supported by the Environment Research and Technology Development Fund (C-1154) of the Japanese Ministry of the Environment, Grants-in-Aid for Cancer Research from the Ministry of Health, Labour, and Welfare of Japan, and Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	HANDA T, 1984, ENVIRON SCI TECHNOL, V18, P895, DOI 10.1021/es00130a002; HAYAKAWA K, 1992, ANAL CHIM ACTA, V266, P251, DOI 10.1016/0003-2670(92)85050-G; YAHAGI T, 1977, MUTAT RES, V48, P121, DOI 10.1016/0027-5107(77)90151-8; BARBONE F, 1995, AM J EPIDEMIOL, V141, P1161; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; [Anonymous], 2013, IARC MONOGRAPHS EVAL, V109; POPE CA, 1995, AM J RESP CRIT CARE, V151, P669; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; ARCHER VE, 1990, ARCH ENVIRON HEALTH, V45, P325; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Hasei T, 2012, J CHROMATOGR A, V1253, P52, DOI 10.1016/j.chroma.2012.06.091; Hasei T, 2006, J CHROMATOGR A, V1135, P65, DOI 10.1016/j.chroma.2006.09.044; HENDERSON TR, 1983, ENVIRON SCI TECHNOL, V17, P443, DOI 10.1021/es00114a002; HORIKAWA K, 1991, CARCINOGENESIS, V12, P1003, DOI 10.1093/carcin/12.6.1003; IARC, 2013, IARC MONOGRAPHS EVAL, V105; KAMIYA A, 1988, SCI TOTAL ENVIRON, V72, P1, DOI 10.1016/0048-9697(88)90002-2; MATSUOKA A, 1993, MUTAT RES, V298, P255, DOI 10.1016/0165-1218(93)90004-W; Murahashi T, 2003, J CHROMATOGR A, V992, P101, DOI 10.1016/S0021-9673(03)00279-6; Tokiwa H, 1990, GENETIC TOXICOLOGY C; Watanabe T, 2003, MUTAT RES-GEN TOX EN, V538, P121, DOI 10.1016/S1383-5718(03)00109-8; Watanabe T, 2008, MUTAT RES-GEN TOX EN, V649, P201, DOI 10.1016/j.mrgentox.2007.09.002; Watanabe T, 1999, J CHROMATOGR A, V839, P41, DOI 10.1016/S0021-9673(99)00174-0	22	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0009-5893	1612-1112		CHROMATOGRAPHIA	Chromatographia	JAN	2015	78	1-2					55	63		10.1007/s10337-014-2817-3		9	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	AX8LE	WOS:000347160200007		
J	Hasegawa, H; Nakagawa, K; Rahman, MA; Takemura, M; Maki, T; Naito, K; Rahman, MM				Hasegawa, H.; Nakagawa, K.; Rahman, M. Azizur; Takemura, M.; Maki, T.; Naito, K.; Rahman, M. Mamunur			A Fluorescent-Based HPLC Assay Using 4-Chloro-7-nitrobenzo-2-oxa-1, 3-diazole as Derivatization Agent for the Determination of Iron Bioavailability to Red Tide Phytoplankton	CHROMATOGRAPHIA			English	Article						Fluorescent-based HPLC assay; Marine phytoplankton; Red tide; Iron bioavailability; NBD; C1	POSTCOLUMN DERIVATIZATION; LIQUID-CHROMATOGRAPHY; MARINE-PHYTOPLANKTON; SURFACE WATERS; SOUTHERN-OCEAN; LIMITATION; PROTEINS; NITRATE; GROWTH; FERREDOXIN	A new fluorescent-based high-performance liquid chromatography (HPLC) assay using 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole (NBD-C1) was employed to determine iron (Fe) bioavailability to red tide phytoplankton in seawater. After growing four red tide species (Prymnesium parvum, Heterosigma akashiwo, Eutreptiella gymnastica, and Oltmannsiellopsis viridis) in f/2 artificial seawater under different Fe conditions, soluble extracts of the phytoplankton were derivatized using different fluorescent reagents (NBD-C1, 4-fluoro-7-nitrobenzo-2-oxa-1,3-diazole; NBD-F, fluorescamine, and ortho-phthalaldehyde; OPA) followed by HPLC assay. Among the four fluorescent reagents, NBD-C1 was most effective for derivatizing the phytoplankton extracts which would consist of proteins and peptides. HPLC chromatograms of the NBD-derivatized extracts showed gradual changes (decrease/increase) of six peaks for different Fe conditions. Four of the peaks decreased, while two peaks increased with the increase of Fe concentrations in the culture medium. Considering the consistency and sensitivity of chromatogram peaks E and A to different Fe, phosphate and nitrate conditions for all phytoplankton studied, the ratio of these two peaks (I (E/A) ) has been proposed as the indicator of Fe bioavailability to red tide phytoplankton.	[Hasegawa, H.; Maki, T.] Kanazawa Univ, Inst Sci & Technol, Kanazawa, Ishikawa 9201161, Japan; [Nakagawa, K.; Takemura, M.; Rahman, M. Mamunur] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Rahman, M. Azizur] Univ Technol Sydney, Sch Environm, Ctr Environm Sustainabil, Sydney, NSW 2007, Australia; [Naito, K.] Prefectural Univ Hiroshima, Fac Life & Environm Sci, Shobara, Hiroshima 7270023, Japan; [Rahman, M. Mamunur] BRRI, Dhaka 1701, Bangladesh	Hasegawa, H (reprint author), Kanazawa Univ, Inst Sci & Technol, Kanazawa, Ishikawa 9201161, Japan.	hhiroshi@se.kanazawa-u.ac.jp; rahmanmazizur@gmail.com	Hasegawa, Hiroshi/C-4261-2015	Hasegawa, Hiroshi/0000-0001-8210-4775	Japan Society for the Promotion of Science [24310056]	We sincerely thank Dr. Ichiro Imai, Hokkaido University, Japan, for supplying the algal cultures. This research was partially supported by a 'Grants-in-Aid' for Scientific Research (24310056) from the Japan Society for the Promotion of Science. We would like to extend our acknowledgment to Dr Richard Lim, School of the Environment, University of Technology Sydney, Australia for reviewing the manuscript prior to submission.	Blain S, 2007, NATURE, V446, P1070, DOI 10.1038/nature05700; Lyman J, 1940, J MAR RES, V3, P134; Timmermans KR, 2005, J SEA RES, V53, P109, DOI 10.1016/j.seares.2004.05.003; Morrissey J, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00043; James KJ, 1998, J CHROMATOGR A, V798, P147, DOI 10.1016/S0021-9673(97)01207-7; Moore JK, 2002, DEEP-SEA RES PT II, V49, P463; Kawakami SK, 2006, TRAC-TREND ANAL CHEM, V25, P133, DOI 10.1016/j.trac.2005.06.005; Kanazawa H, 1997, J CHROMATOGR A, V763, P23, DOI 10.1016/S0021-9673(96)00873-4; Hutchins DA, 1998, NATURE, V393, P561, DOI 10.1038/31203; Michaelsen JT, 2009, J CHROMATOGR B, V877, P3405, DOI 10.1016/j.jchromb.2009.06.043; Maroulis M, 2008, J CHROMATOGR B, V876, P245, DOI 10.1016/j.jchromb.2008.10.053; WELLS ML, 1995, MAR CHEM, V48, P157, DOI 10.1016/0304-4203(94)00055-I; Wright SW, 2010, DEEP-SEA RES PT II, V57, P758, DOI 10.1016/j.dsr2.2009.06.015; Peers G, 2005, LIMNOL OCEANOGR, V50, P1149; MIYANO H, 1985, ANAL CHIM ACTA, V170, P81, DOI 10.1016/S0003-2670(00)81728-6; GEIDER RJ, 1994, PHOTOSYNTH RES, V39, P275, DOI 10.1007/BF00014588; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229; Beardall J, 2001, AQUAT SCI, V63, P107, DOI 10.1007/PL00001342; Doucette GJ, 1996, MAR ECOL PROG SER, V130, P269, DOI 10.3354/meps130269; Eijk HMHV, 1993, J CHROMATOGR, V620, P143; Erdner DL, 1999, LIMNOL OCEANOGR, V44, P1609; Guo XF, 2011, J CHROMATOGR B, V879, P3932, DOI 10.1016/j.jchromb.2011.10.042; Hasegawa H, 2013, ADV BIOL CHEM, V3, P338; Hashimoto S, 2009, DEEP-SEA RES PT II, V56, P2928, DOI 10.1016/j.dsr2.2009.07.003; Hernandez MT, 2008, ORG GEOCHEM, V39, P1051, DOI 10.1016/j.orggeochem.2008.04.015; Latasa M, 2014, LIMNOL OCEANOGR-METH, V12, P46, DOI 10.4319/lom.2014.12.46; Maldonado MT, 2000, LIMNOL OCEANOGR, V45, P814; Maucher JM, 2003, BIOGEOCHEMISTRY ROSS, P209; Naito K, 2008, PHYCOL RES, V56, P58, DOI 10.1111/j.1440-1835.2008.00485.x; Needoba JA, 2004, J PHYCOL, V40, P517, DOI 10.1111/j.1529-8817.2004.03172.x; Okaichi T, 2003, RED TIDES; Ozturk M, 2002, ESTUAR COAST SHELF S, V55, P197, DOI 10.1006/ECSS.2001.0897; Rahman MM, 2014, CHEMOSPHERE, V95, P213, DOI 10.1016/j.chemosphere.2013.09.001; Soriano BD, 2012, J CHROMATOGR B, V880, P27, DOI 10.1016/j.jchromb.2011.11.011; TIMMERMANS KR, 1994, MAR BIOL, V121, P389, DOI 10.1007/BF00346749; WATANABE Y, 1983, ANAL CHEM, V55, P1786, DOI 10.1021/ac00261a032; Yoshida E, 2003, ANAL SCI, V19, P1001, DOI 10.2116/analsci.19.1001	37	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0009-5893	1612-1112		CHROMATOGRAPHIA	Chromatographia	JAN	2015	78	1-2					65	72		10.1007/s10337-014-2792-8		8	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	AX8LE	WOS:000347160200008		
J	Naya, M; Tamaki, N; Tsutsui, H				Naya, Masanao; Tamaki, Nagara; Tsutsui, Hiroyuki			Coronary Flow Reserve Estimated by Positron Emission Tomography to Diagnose Significant Coronary Artery Disease and Predict Cardiac Events	CIRCULATION JOURNAL			English	Review						Coronary artery disease; Coronary circulation; Positron emission tomography	MYOCARDIAL BLOOD-FLOW; INTIMA-MEDIA THICKNESS; VENTRICULAR EJECTION FRACTION; CHRONIC KIDNEY-DISEASE; INCREMENTAL PROGNOSTIC VALUE; TRANSIENT ISCHEMIC DILATION; TYPE-2 DIABETES-MELLITUS; HEALTHY-YOUNG SMOKERS; COMPUTED-TOMOGRAPHY; MICROVASCULAR DYSFUNCTION	Coronary artery disease (CAD) is a major cause of death in Japan. Coronary angiography is useful to assess the atherosclerotic burden in CAD patients, but its ability to predict whether patients will respond favorably to optimal medical therapy and revascularization is limited. The measurement of the fractional flow reserve with angiography is a well-validated method for identifying ischemic vessels. However, neither an anatomical assessment nor a functional assessment can delineate microvasculature or estimate its function. The quantitative coronary flow reserve (CFR) estimated from sequential myocardial perfusion images obtained by positron emission tomography (PET) during stress provides an accurate index of hyperemic reactivity to vasodilatory agents in the myocardium. In fact, there is growing evidence that the CFR reflects disease activity in the entire coronary circulation, including epicardial coronary artery stenosis, diffuse atherosclerosis, and microvascular dilatory function. Importantly, reduced CFR is observed even in patients without flow-limiting coronary stenosis, and its evaluation can improve the risk stratification of patients at any stage of CAD. This review focuses on the application of CFR estimated by cardiac PET for the diagnosis and risk stratification of patients with CAD.	[Naya, Masanao; Tsutsui, Hiroyuki] Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Med, Sapporo, Hokkaido 0608638, Japan; [Tamaki, Nagara] Hokkaido Univ, Grad Sch Med, Dept Nucl Med, Sapporo, Hokkaido 0608638, Japan	Naya, M (reprint author), Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Med, Kita Ku, N-15,W-7, Sapporo, Hokkaido 0608638, Japan.	naya@med.hokudai.ac.jp					Akinboboye OO, 2002, J AM COLL CARDIOL, V40, P703, DOI 10.1016/S0735-1097(02)02033-8; Anagnostopoulos C, 2008, EUR J NUCL MED MOL I, V35, P1593, DOI 10.1007/s00259-008-0793-2; McLaughlin MG, 2002, J NUCL CARDIOL, V9, P663, DOI 10.1067/mnc.2002.124949; Gullu H, 2006, ECHOCARDIOGR-J CARD, V23, P835, DOI 10.1111/j.1540-8175.2006.00342.x; WEISS AT, 1987, J AM COLL CARDIOL, V9, P752; Laine H, 1998, J AM COLL CARDIOL, V32, P147, DOI 10.1016/S0735-1097(98)00222-8; Di Carli MF, 2003, J AM COLL CARDIOL, V41, P1387, DOI 10.1016/S0735-1097(03)00166-9; Dorbala S, 2007, J NUCL MED, V48, P349; Sampson UK, 2007, J AM COLL CARDIOL, V49, P1052, DOI 10.1016/j.jacc.2006.12.015; Murthy VL, 2014, CIRCULATION, V129, P2518, DOI 10.1161/CIRCULATIONAHA.113.008507; Campisi R, 1998, CIRCULATION, V98, P119; PRYOR DB, 1993, ANN INTERN MED, V118, P81; Yokoyama I, 1996, CIRCULATION, V94, P3232; Rochitte CE, 2014, EUR HEART J, V35, P1120, DOI 10.1093/eurheartj/eht488; Greenwood JP, 2012, LANCET, V379, P453, DOI 10.1016/S0140-6736(11)61335-4; El Fakhri G, 2009, J NUCL MED, V50, P1062, DOI 10.2967/jnumed.104.007831; Ziadi MC, 2012, J NUCL CARDIOL, V19, P670, DOI 10.1007/s12350-011-9506-5; Danad I, 2013, J NUCL MED, V54, P55, DOI 10.2967/jnumed.112.104687; Di Carli MF, 2011, J NUCL MED, V52, P1369, DOI 10.2967/jnumed.110.082883; Murthy VL, 2011, CIRCULATION, V124, P2215, DOI 10.1161/CIRCULATIONAHA.111.050427; Naya M, 2011, J AM COLL CARDIOL, V58, P1807, DOI 10.1016/j.jacc.2011.06.051; Pellegrino T, 2005, J NUCL MED, V46, P1997; Hsiao E, 2013, J NUCL MED, V54, P1748, DOI 10.2967/jnumed.113.120063; Fukushima K, 2011, J NUCL MED, V52, P726, DOI 10.2967/jnumed.110.081828; Recio-Mayoral A, 2013, JACC-CARDIOVASC IMAG, V6, P660, DOI 10.1016/j.jcmg.2012.12.011; Fukuda D, 2006, HEART, V92, P759, DOI 10.1136/hrt.2005.067934; Charytan DM, 2010, CIRC-CARDIOVASC IMAG, V3, P663, DOI 10.1161/CIRCIMAGING.110.957761; Dorbala S, 2009, JACC-CARDIOVASC IMAG, V2, P846, DOI 10.1016/j.jcmg.2009.04.009; Miller JM, 2008, NEW ENGL J MED, V359, P2324, DOI 10.1056/NEJMoa0806576; Naya M, 2013, J AM COLL CARDIOL, V61, P2098, DOI 10.1016/j.jacc.2013.02.029; Parkash R, 2004, J NUCL CARDIOL, V11, P440, DOI 10.1016/j.nuclcard.2004.04.005; DICARLI M, 1995, CIRCULATION, V91, P1944; Naya M, 2014, J NUCL MED, V55, P248, DOI 10.2967/jnumed.113.121442; Yoshida K, 1996, J NUCL MED, V37, P1701; Yoshinaga K, 2006, J AM COLL CARDIOL, V48, P1029, DOI 10.1016/j.jacc.2006.06.025; Ziadi MC, 2011, J AM COLL CARDIOL, V58, P740, DOI 10.1016/j.jacc.2011.01.065; Prior JO, 2012, EUR J NUCL MED MOL I, V39, P1037, DOI 10.1007/s00259-012-2082-3; Murthy VL, 2012, CIRCULATION, V126, P1858, DOI 10.1161/CIRCULATIONAHA.112.120402; Yokoyama I, 1997, J AM COLL CARDIOL, V30, P1472, DOI 10.1016/S0735-1097(97)00327-6; Schwitter J, 2013, EUR HEART J, V34, P775, DOI 10.1093/eurheartj/ehs022; Fukushima K, 2012, J NUCL MED, V53, P887, DOI 10.2967/jnumed.111.099325; Tio RA, 2009, J NUCL MED, V50, P214, DOI 10.2967/jnumed.108.054395; Dorbala S, 2013, J AM COLL CARDIOL, V61, P176, DOI 10.1016/j.jacc.2012.09.043; Pepine CJ, 2010, J AM COLL CARDIOL, V55, P2825, DOI 10.1016/j.jacc.2010.01.054; Manabe O, 2009, J NUCL MED, V50, P68, DOI 10.2967/jnumed.108.055673; DIAMOND GA, 1979, NEW ENGL J MED, V300, P1350, DOI 10.1056/NEJM197906143002402; Lertsburapa K, 2008, J NUCL CARDIOL, V15, P745, DOI 10.1007/BF03007355; Morton G, 2012, J AM COLL CARDIOL, V60, P1546, DOI 10.1016/j.jacc.2012.05.052; Kajander S, 2010, CIRCULATION, V122, P603, DOI 10.1161/CIRCULATIONAHA.109.915009; Jaarsma C, 2012, J AM COLL CARDIOL, V59, P1719, DOI 10.1016/j.jacc.2011.12.040; Schindler TH, 2009, EUR HEART J, V30, P3064, DOI 10.1093/eurheartj/ehp482; Prior JO, 2005, CIRCULATION, V111, P2291, DOI 10.1161/01.CIR.0000164232.62768.51; Baller D, 1999, CIRCULATION, V99, P2871; BEANLANDS RSB, 1995, J AM COLL CARDIOL, V26, P1465, DOI 10.1016/0735-1097(95)00359-2; Brown TLY, 2008, EUR J NUCL MED MOL I, V35, P336, DOI 10.1007/s00259-007-0603-2; Campisi R, 1999, CIRCULATION, V99, P491; Campuzano R, 2006, J HYPERTENS, V24, P1581, DOI 10.1097/01.hjh.0000239294.17636.27; Curillova Z, 2009, EUR J NUCL MED MOL I, V36, P1603, DOI 10.1007/s00259-009-1121-1; Danad I, 2012, EUR HEART J-CARD IMG, V13, P317, DOI 10.1093/ehjci/jes038; Dunet V, 2012, CIRC J, V76, P160, DOI 10.1253/circj.CJ-11-0587; El Fakhri G, 2005, J NUCL MED, V46, P1264; Fujimoto K, 2004, AM J CARDIOL, V93, P1419, DOI 10.1016/j.amjcard.2004.02.046; Herzog BA, 2009, J AM COLL CARDIOL, V54, P150, DOI 10.1016/j.jacc.2009.02.069; Higuchi T, 2007, MICROCIRCULATION, V14, P805, DOI 10.1080/10739680701410827; Iwado Y, 2002, EUR J NUCL MED MOL I, V29, P984, DOI 10.1007/s00259-002-0818-1; Kamiya K, 2014, CIRC J, V78, P2468, DOI 10.1253/circj.CJ-13-1454; Katoh C, 2012, J NUCL CARDIOL, V19, P763, DOI 10.1007/s12350-012-9558-1; Katoh C, 2004, J NUCL MED, V45, P1908; Kaufmann PA, 2000, J AM COLL CARDIOL, V36, P103, DOI 10.1016/S0735-1097(00)00697-5; Lortie M, 2007, EUR J NUCL MED MOL I, V34, P1765, DOI 10.1007/s00259-007-0478-2; Marwick TH, 1997, AM J CARDIOL, V80, P865, DOI 10.1016/S0002-9149(97)00537-7; Masuda D, 2000, ANN NUCL MED, V14, P353, DOI 10.1007/BF02988695; Morita K, 2006, J NUCL MED, V47, P1914; Murthy VL, 2012, JACC-CARDIOVASC IMAG, V5, P1025, DOI 10.1016/j.jcmg.2012.06.007; Naya M, 2007, CIRC J, V71, P348, DOI 10.1253/circj.71.348; Naya M, 2011, EUR J NUCL MED MOL I, V38, P491, DOI 10.1007/s00259-010-1647-2; Naya M, 2013, J AM COLL CARDIOL, V62, P1129, DOI 10.1016/j.jacc.2013.05.037; Naya M, 2007, HYPERTENS RES, V30, P541, DOI 10.1291/hypres.30.541; Naya M, 2010, Q J NUCL MED MOL IM, V54, P145; Naya M, 2013, HEART VIEW, V17, P40; Ohira H, 2013, CIRC J, V77, P836, DOI 10.1253/circj.CJ-13-0213; Park CS, 2006, INT J CARDIOL, V113, P118, DOI 10.1016/j.ijcard.2005.08.018; Piek JJ, 2001, EUR HEART J, V22, P1725, DOI 10.1053/euhj.2000.2587; Schindler TH, 2004, CIRCULATION, V110, P1069, DOI 10.1161/01.CIR.0000140264.56496.76; Schneider CA, 1999, J AM COLL CARDIOL, V34, P1005, DOI 10.1016/S0735-1097(99)00316-2; Takagi A, 2006, HEART VESSELS, V21, P298, DOI 10.1007/s00380-006-0905-5; Takiuchi S, 2003, HYPERTENS RES, V26, P945, DOI 10.1291/hypres.26.945; Teragawa H, 2010, EUR J NUCL MED MOL I, V37, P368, DOI 10.1007/s00259-009-1307-6; Tsukamoto T, 2006, EUR J NUCL MED MOL I, V33, P1150, DOI 10.1007/s00259-006-0082-x; Tzortzis S, 2010, HYPERTENS RES, V33, P367, DOI 10.1038/hr.2010.2; UREN NG, 1994, NEW ENGL J MED, V330, P1782, DOI 10.1056/NEJM199406233302503; Yokoyama I, 1998, DIABETES, V47, P119, DOI 10.2337/diabetes.47.1.119; Yokoyama I, 1996, J NUCL MED, V37, P1937; Yoshinaga K, 2013, CIRC J, V77, P1662, DOI 10.1253/circj.CJ-13-0235; ZEIHER AM, 1989, EUR HEART J, V10, P66; ZEIHER AM, 1991, CIRCULATION, V84, P1984	96	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JAN	2015	79	1					15	23		10.1253/circj.CJ-14-1060		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX4KD	WOS:000346900700003		
J	Hibi, K; Kimura, K; Umemura, S				Hibi, Kiyoshi; Kimura, Kazuo; Umemura, Satoshi			Clinical Utility and Significance of Intravascular Ultrasound and Optical Coherence Tomography in Guiding Percutaneous Coronary Interventions	CIRCULATION JOURNAL			English	Review						Intravascular ultrasound; Optical coherence tomography; Percutaneous coronary intervention	ST-SEGMENT ELEVATION; ELUTING STENT IMPLANTATION; ACUTE MYOCARDIAL-INFARCTION; NO-REFLOW PHENOMENON; RANDOMIZED CONTROLLED-TRIAL; FOLLOW-UP; ANGIOGRAPHIC GUIDANCE; BIFURCATION LESIONS; DISTAL PROTECTION; ARTERY-DISEASE	Both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) can provide critical information that facilitates pre-interventional lesion assessment and post-interventional stent assessment and both have the potential to influence treatment strategy. Meta-analyses of randomized trials and observational studies comparing IVUS-guided percutaneous coronary intervention (PCI) with angiography-guided PCI revealed that IVUS-guided procedures reduce the incidence of target vessel revascularization, stent thrombosis, and myocardial infarction. Several IVUS criteria have been proposed to optimize stent implantation. Whether these criteria can be directly used to facilitate OCT-guided stent implantation needs to be clarified. Recent studies revealed several IVUS- and OCT-derived predictors of adverse events during PCI. Attenuated coronary plaque on IVUS might be related to deterioration of coronary flow after PCI, whereas tissue characterization on IVUS radiofrequency signal analysis can also detect coronary plaques at high risk for distal embolization. Thin-cap fibroatheroma on OCT has been proposed as a useful characteristic for predicting the no-reflow phenomenon. Furthermore, ostial plaque distribution as assessed by IVUS is reported to be a useful predictor of side-branch occlusion after PCI, whereas the severity of calcified lesions may be better assessed by OCT. Although IVUS and OCT each have inherent strengths and weaknesses, these techniques can complement each other, and selective utilization in appropriate patient subgroups or combined usage is expected to be beneficial during PCI procedures.	[Hibi, Kiyoshi; Kimura, Kazuo] Yokohama City Univ, Med Ctr, Div Cardiol, Yokohama, Kanagawa 2320024, Japan; [Umemura, Satoshi] Yokohama City Univ, Grad Sch Med, Dept Med Sci & Cardiorenal Med, Yokohama, Kanagawa 2320024, Japan	Hibi, K (reprint author), Yokohama City Univ, Med Ctr, Div Cardiol, Minami Ku, 4-57 Urafune Cho, Yokohama, Kanagawa 2320024, Japan.	hibikiyo@yokohama-cu.ac.jp			St. Jude Medical	Dr Hibi reports receiving unrestricted scholarship from St. Jude Medical; Dr Kimura, receiving unrestricted scholarship from Terumo.	Yamaguchi T, 2008, AM J CARDIOL, V101, P562, DOI 10.1016/j.amjcard.2007.09.116; Song HG, 2014, CATHETER CARDIO INTE, V83, P873, DOI 10.1002/ccd.24560; Zhang YJ, 2012, EUROINTERVENTION, V8, P855, DOI 10.4244/EIJV8I7A129; Witzenbichler B, 2014, CIRCULATION, V129, P463, DOI 10.1161/CIRCULATIONAHA.113.003942; Kawamori H, 2013, EUR HEART J-CARD IMG, V14, P865, DOI 10.1093/ehjci/jes299; Roy P, 2008, EUR HEART J, V29, P1851, DOI 10.1093/eurheartj/ehn249; Kubo T, 2013, JACC-CARDIOVASC IMAG, V6, P1095, DOI 10.1016/j.jcmg.2013.04.014; Ndrepepa G, 2010, J AM COLL CARDIOL, V55, P2383, DOI 10.1016/j.jacc.2009.12.054; Tanaka A, 2009, EUR HEART J, V30, P1348, DOI 10.1093/eurheartj/ehp122; Kaltoft A, 2010, J AM COLL CARDIOL, V55, P867, DOI 10.1016/j.jacc.2009.09.052; Kobayashi Y, 2014, CIRC J, V78, P2209, DOI 10.1253/circj.CJ-14-0108; Niccoli G, 2009, J AM COLL CARDIOL, V54, P281, DOI 10.1016/j.jacc.2009.03.054; Mudra H, 2001, CIRCULATION, V104, P1343, DOI 10.1161/hc3701.096064; Nakayama N, 2013, CIRC J, V77, P424, DOI 10.1253/circj.CJ-12-0630; Hong YJ, 2011, EUR HEART J, V32, P2059, DOI 10.1093/eurheartj/ehp034; Kume T, 2011, EUROINTERVENTION, V6, P768, DOI 10.4244/EIJV6I6A130; Li BH, 2013, CATHETER CARDIO INTE, V81, P494, DOI 10.1002/ccd.24295; Doi H, 2009, JACC-CARDIOVASC INTE, V2, P1269, DOI 10.1016/j.jcin.2009.10.005; Fujii K, 2005, J AM COLL CARDIOL, V45, P995, DOI 10.1016/j.jacc.2004.12.066; Abdel-Wahab M, 2013, JACC-CARDIOVASC INTE, V6, P10, DOI 10.1016/j.jcin.2012.07.017; Shiono Y, 2013, JACC-CARDIOVASC INTE, V6, P847, DOI 10.1016/j.jcin.2013.01.142; Stone GW, 2005, JAMA-J AM MED ASSOC, V293, P1063, DOI 10.1001/jama.293.9.1063; Furukawa E, 2005, CIRC J, V69, P325, DOI 10.1253/circj.69.325; Habara M, 2012, CIRC-CARDIOVASC INTE, V5, P193, DOI 10.1161/CIRCINTERVENTIONS.111.965111; Muramatsu T, 2007, CATHETER CARDIO INTE, V70, P677, DOI 10.1002/ccd.21190; Kume T, 2012, CIRC J, V76, P698, DOI 10.1253/circj.CJ-11-0845; Alfonso F, 2014, CIRC J, V78, P2099, DOI 10.1253/circj.CJ-14-0773; de Jaegere P, 1998, EUR HEART J, V19, P1214, DOI 10.1053/euhj.1998.1012; Okamura T, 2011, EUROINTERVENTION, V6, P1037, DOI 10.4244/EIJV6I9A182; Prati F, 2012, EUROINTERVENTION, V8, P823, DOI 10.4244/EIJV8I7A125; Parise H, 2011, AM J CARDIOL, V107, P374, DOI 10.1016/j.amjcard.2010.09.030; FISCHMAN DL, 1993, J AM COLL CARDIOL, V22, P1641; NAKAMURA S, 1994, CIRCULATION, V89, P2026; Mehanna E, 2013, CIRC J, V77, P2334, DOI 10.1253/circj.CJ-12-1458; Endo M, 2010, JACC-CARDIOVASC INTE, V3, P540, DOI 10.1016/j.jcin.2010.01.015; Gil RJ, 2009, J INTERV CARDIOL, V22, pE1, DOI 10.1111/j.1540-8183.2009.00492.x; Jeremias A, 2004, CIRCULATION, V109, P1930, DOI 10.1161/01.CIR.0000127105.99982.21; Maehara A, 2014, INT J CARDIOVAS IMAG, V30, P849, DOI 10.1007/s10554-014-0413-0; Maehara A, 2002, CIRCULATION, V105, P2037, DOI 10.1161/01.CIR.0000015503.04751.BD; Morino Y, 2010, CIRC J, V74, P1609, DOI 10.1253/circj.CJ-10-0025; Ogata Nobuhiko, 2011, Cardiovasc Interv Ther, V26, P83, DOI 10.1007/s12928-010-0037-9; Ogata Nobuhiko, 2014, Cardiovasc Interv Ther, V29, P209, DOI 10.1007/s12928-014-0245-9; Okura H, 2011, J INVASIVE CARDIOL, V23, P297; Ozaki Y, 2012, CIRC J, V76, P922, DOI 10.1253/circj.CJ-11-1122; Sakurai R, 2005, AM J CARDIOL, V96, P1251, DOI 10.1016/j.amjcard.2005.06.066; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Utsunomiya M, 2011, EUROINTERVENTION, V7, P340, DOI 10.4244/EIJV7I3A58; Yamada R, 2013, J CARDIOL, V61, P201, DOI 10.1016/j.jjcc.2012.10.007	48	2	2	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JAN	2015	79	1					24	33		10.1253/circj.CJ-14-1044		10	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX4KD	WOS:000346900700004		
J	Kohno, T				Kohno, Takashi			Report of the American Heart Association (AHA) Scientific Sessions 2014, Chicago	CIRCULATION JOURNAL			English	Article						American Heart Association; Japanese Circulation Society; Late-breaking clinical trials; Scientific Sessions	THERAPY; FAILURE; IMPACT	The American Heart Association (AHA) Scientific Sessions were held in Chicago on November 15-19, 2014. The meeting attracted more than 17,000 participants, including physicians, research scientists, students, and paramedical personnel, from more than 100 countries. Sessions over the 5 days included comprehensive and unparalleled education delivered via more than 5,000 presentations, with 1,000 invited faculty members and 4,000 abstract presentations from world leaders in cardiovascular (CV) disease. There were 16 trials scheduled in 4 late-breaking clinical trial sessions. The Dual Antiplatelet Therapy study revealed that aspirin plus a thienopyridine beyond 1 year subsequent to placement of a drug-eluting stent, as compared with aspirin therapy alone, significantly reduced stent thrombosis and major CV and cerebrovascular events but was associated with increased risk of bleeding. The IMPROVE-IT research showed that, relative to simvastatin with placebo, simvastatin with 10 mg of ezetimibe daily led to a significantly lower primary combined endpoint in moderate-to high-risk patients, who stabilized following acute coronary syndrome. This was the first trial to demonstrate incremental clinical benefit by adding a nonstatin agent to statin therapy and reaffirmed the low-density lipoprotein (LDL) hypothesis stating that reducing LDL-cholesterol prevents CV events. Summaries and overviews of both the late-breaking trials and the sessions to which members of the Japanese Circulation Society contributed are presented.	[Kohno, Takashi] Keio Univ, Sch Med, Dept Med, Div Cardiol, Tokyo 1608582, Japan	Kohno, T (reprint author), Keio Univ, Sch Med, Dept Med, Div Cardiol,Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	kohno@a2.keio.jp					Muhlestein JB, 2014, JAMA-J AM MED ASSOC, V312, P2234, DOI 10.1001/jama.2014.15825; Takeda N, 2010, J CLIN INVEST, V120, P254, DOI 10.1172/JCI40295; Kimura T, 2012, CIRCULATION, V125, P584, DOI 10.1161/CIRCULATIONAHA.111.046599; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Yoshihisa A, 2013, EUR J HEART FAIL, V15, P543, DOI 10.1093/eurjhf/hfs197; Butt M, 2012, CIRC-HEART FAIL, V5, P226, DOI 10.1161/CIRCHEARTFAILURE.111.964106; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; Garratt KN, 2015, CIRCULATION, V131, P62, DOI 10.1161/CIRCULATIONAHA.114.013570; Hemmi N, 2014, STEM CELL TRANSL MED, V3, P1473, DOI 10.5966/sctm.2014-0072; Ikeda Y, 2014, JAMA-J AM MED ASSOC, V312, P2510, DOI 10.1001/jama.2014.15690; Ishimori N, 2014, CIRC J, V78, P51, DOI 10.1253/circj.CJ-13-1466; Kaiser C, 2015, CIRCULATION, V131, P74, DOI 10.1161/CIRCULATIONAHA.114.013520; Kusunose K, 2014, CIRC J, V78, P1311, DOI 10.1253/circj.CJ-14-0411; Lacro RV, 2014, NEW ENGL J MED, V371, P2061, DOI 10.1056/NEJMoa1404731; Mauri L, 2014, NEW ENGL J MED, V371, P2155, DOI 10.1056/NEJMoa1409312; Muramatsu T, 2014, CIRC J, V78, P2610, DOI 10.1253/circj.CJ-14-1088; Smith PK, 2014, NEW ENGL J MED, V371, P2178, DOI 10.1056/NEJMoa1410490	17	11	14	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JAN	2015	79	1					34	40		10.1253/circj.CJ-14-1329		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX4KD	WOS:000346900700005		
J	Shimohama, T; Ako, J				Shimohama, Takao; Ako, Junya			Intrastent Thrombus - What You See Is What You Get? -	CIRCULATION JOURNAL			English	Editorial Material							OPTICAL COHERENCE TOMOGRAPHY; DRUG-ELUTING STENTS; NEOINTIMAL COVERAGE; IMPLANTATION; CLOPIDOGREL		[Shimohama, Takao; Ako, Junya] Kitasato Univ, Sagamihara, Kanagawa 2520374, Japan	Ako, J (reprint author), Kitasato Univ, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	jako@kitasato-u.ac.jp					Choi HH, 2012, INT J CARDIOVAS IMAG, V28, P491, DOI 10.1007/s10554-011-9849-7; Mitsutake Y, 2012, JACC-CARDIOVASC INTE, V5, P966, DOI 10.1016/j.jcin.2012.06.010; Honda Y, 2003, CIRCULATION, V108, P2, DOI 10.1161/01.CIR.0000075929.79964.D8; Saito S, 2014, CIRC J, V78, P1684, DOI 10.1253/circj.CJ-13-1482; Yamamoto M, 2009, AM HEART J, V158, P99, DOI 10.1016/j.ahj.2009.04.016; Sawada T, 2011, CIRC J, V75, P99, DOI 10.1253/circj.CJ-10-0525; Awata M, 2011, CIRC J, V75, P1113, DOI 10.1253/circj.CJ-10-0776; Ichikawa M, 2015, CIRC J, V79, P85, DOI 10.1253/circj.CJ-14-0639; Inoue T, 2011, HEART, V97, P1379, DOI 10.1136/hrt.2010.204339; Kim JS, 2009, HEART, V95, P1907, DOI 10.1136/hrt.2009.167759; Kubo T, 2014, CIRC J, V78, P2408, DOI 10.1253/circj.CJ-14-0337; Mauri L, 2014, NEW ENGL J MED, V371, P2155, DOI 10.1056/NEJMoa1409312; Nishinari M, 2013, CATHETER CARDIO INTE, V82, pE871, DOI 10.1002/ccd.25136; Otsuka F, 2014, CIRCULATION, V129, P211, DOI 10.1161/CIRCULATIONAHA.113.001790; Xie Y, 2008, AM J CARDIOL, V102, P27, DOI 10.1016/j.amjcard.2008.02.091	15	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JAN	2015	79	1					41	42		10.1253/circj.CJ-14-1271		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX4KD	WOS:000346900700006		
J	Akashi, H				Akashi, Hirokazu			Left Ventricular Assist Device-Acquired Aortic Insufficiency	CIRCULATION JOURNAL			English	Editorial Material							VALVE; SUPPORT		[Akashi, Hirokazu] Jinseisya Edogawa Hosp, Dept Cardiovasc Surg, Tokyo 1330052, Japan; [Akashi, Hirokazu] Juntendo Univ Hosp, Dept Cardiovasc Surg, Tokyo, Japan	Akashi, H (reprint author), Jinseisya Edogawa Hosp, Dept Cardiovasc Surg, Edogawa Ku, 2-24-18 Higashi Koiwa, Tokyo 1330052, Japan.	akashi@juntendo.ac.jp					Pak SW, 2010, J HEART LUNG TRANSPL, V29, P1172, DOI 10.1016/j.healun.2010.05.018; Jorde UP, 2014, CIRC-HEART FAIL, V7, P310, DOI 10.1161/CIRCHEARTFAILURE.113.000878; Toda K, 2011, ANN THORAC SURG, V92, P929, DOI 10.1016/j.athoracsur.2011.04.115; John R, 2010, J HEART LUNG TRANSPL, V29, P1321, DOI 10.1016/j.healun.2010.06.006; Hatano M, 2011, CIRC J, V75, P1147, DOI 10.1253/circj.CJ-10-1106; Adamson RM, 2011, J HEART LUNG TRANSPL, V30, P576, DOI 10.1016/j.healun.2010.11.007; Feldman D, 2013, J HEART LUNG TRANSPL, V32, P157, DOI 10.1016/j.healun.2012.09.013; D'Ancona G, 2012, ANN THORAC SURG, V93, pE89, DOI 10.1016/j.athoracsur.2011.11.019; Rajagopal K, 2013, J THORAC CARDIOV SUR, V145, P1373, DOI 10.1016/j.jtcvs.2012.11.066; Cowger J, 2010, CIRC-HEART FAIL, V3, P668, DOI 10.1161/CIRCHEARTFAILURE.109.917765; Otto CM, 2008, NEW ENGL J MED, V359, P1395, DOI 10.1056/NEJMe0807001; Imamura T, 2014, CIRC J, V78, P625, DOI 10.1253/circj.CJ-13-1201; Butler J, 2006, ANN THORAC SURG, V81, P1745, DOI 10.1016/j.athoracsur.2005.11.061; Holtz Jonathan, 2014, Curr Heart Fail Rep, V11, P103, DOI 10.1007/s11897-013-0172-6; Imamura T, 2015, CIRC J, V79, P104, DOI 10.1253/circj.CJ-14-0944	15	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JAN	2015	79	1					43	44		10.1253/circj.CJ-14-1302		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX4KD	WOS:000346900700007		
J	Chishaki, A; Chishaki, H				Chishaki, Akiko; Chishaki, Hiroaki			Postoperative High Blood Glucose - A Potentially Treatable Marker Related to Atrial Fibrillation After Coronary Artery Bypass Grafting -	CIRCULATION JOURNAL			English	Editorial Material							DIABETES-MELLITUS; INDEPENDENT RISK; PREVALENCE; COHORT		[Chishaki, Akiko] Kyushu Univ, Fac Med, Dept Hlth Sci, Fukuoka 812, Japan; [Chishaki, Hiroaki] Coll Healthcare Management, Dept Healthcare Management, Miyama, Japan	Chishaki, A (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Hlth Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	chishaki@hs.med.kyushu-u.ac.jp					Chen PS, 2014, CIRC RES, V114, P1500, DOI 10.1161/CIRCRESAHA.114.303772; Wiener RS, 2008, JAMA-J AM MED ASSOC, V300, P933, DOI 10.1001/jama.300.8.933; Movahed MR, 2005, INT J CARDIOL, V105, P315, DOI 10.1016/j.ijcard.2005.02.050; Zhang YQ, 2003, J BIOL CHEM, V278, P10417, DOI 10.1074/jbc.M211044200; Fujiwara M, 2014, CIRC J, V78, P345, DOI 10.1253/circj.CJ-13-0900; Watanabe H, 2008, CIRCULATION, V117, P1255, DOI 10.1161/CIRCULATIONAHA.107.744466; Iguchi Y, 2008, CIRC J, V72, P909, DOI 10.1253/circj.72.909; Yazici M, 2007, CIRC J, V71, P880, DOI 10.1253/circj.71.880; Lazar HL, 2004, CIRCULATION, V109, P1497, DOI 10.1161/01.CIR.0000121747.71054.79; Murphy NF, 2007, HEART, V93, P606, DOI 10.1136/hrt.2006.107573; Schoen T, 2012, J AM COLL CARDIOL, V60, P1421, DOI 10.1016/j.jacc.2012.06.030; Schnabel RB, 2009, LANCET, V373, P739, DOI 10.1016/S0140-6736(09)60443-8; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Tatsuishi W, 2015, CIRC J, V79, P112, DOI 10.1253/circj.CJ-14-0989; Viskin S, 1999, EUR HEART J, V20, P1429, DOI 10.1053/euhj.1999.1632	15	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JAN	2015	79	1					45	46		10.1253/circj.CJ-14-1277		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX4KD	WOS:000346900700008		
J	Sato, A				Sato, Akira			Predicting Cardiac and All-Cause Death in Asymptomatic Patients on Hemodialysis - Importance of Training in Interpretation of beta-Methyl Iodophenyl-Pentadecanoic Acid Single-Photon Emission Computed Tomography (BMIPP SPECT) Imaging -	CIRCULATION JOURNAL			English	Editorial Material							CORONARY-ARTERY-DISEASE		Univ Tsukuba, Fac Med, Div Cardiovasc, Tsukuba, Ibaraki 3058575, Japan	Sato, A (reprint author), Univ Tsukuba, Fac Med, Div Cardiovasc, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	asato@md.tsukuba.ac.jp					Kumada Y, 2014, CIRC J, V78, P986, DOI 10.1253/circj.CJ-13-1357; Moroi M, 2013, AM J KIDNEY DIS, V61, P466, DOI 10.1053/j.ajkd.2012.09.017; Kiriyama T, 2015, CIRC J, V79, P153, DOI 10.1253/circj.CJ-14-0646; Nishimura M, 2008, J AM COLL CARDIOL, V51, P139, DOI 10.1016/j.jacc.2007.08.057; Nishimura M, 2004, KIDNEY INT, V66, P811, DOI 10.1111/j.1523-1755.2004.00808.x; Suleiman K, 1997, NUCL MED COMMUN, V18, P922, DOI 10.1097/00006231-199710000-00005; WACKERS FJT, 1993, J AM COLL CARDIOL, V21, P1064; Yamagata K, 2015, CLIN EXP NEPHROL, V19, P54, DOI 10.1007/s10157-014-0978-x	8	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JAN	2015	79	1					47	48		10.1253/circj.CJ-14-1238		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX4KD	WOS:000346900700009		
J	Dohi, T				Dohi, Tomotaka			Do Statins Have a Specific Drug Effect Beyond Low-Density Lipoprotein-Cholesterol-Lowering in the Secondary Prevention of Coronary Artery Disease?	CIRCULATION JOURNAL			English	Editorial Material							ACUTE MYOCARDIAL-INFARCTION; REGRESSION TREATMENT JART; INTIMA-MEDIA THICKNESS; JAPANESE PATIENTS; ROSUVASTATIN; THERAPY; JUSTIFICATION; PROGRESSION; AMI		[Dohi, Tomotaka] Juntendo Univ, Sch Med, Dept Cardiovasc Med, Tokyo 1130033, Japan	Dohi, T (reprint author), Juntendo Univ, Sch Med, Dept Cardiovasc Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1130033, Japan.	tdohi@juntendo.ac.jp					Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Dohi T, 2010, ATHEROSCLEROSIS, V210, P497, DOI 10.1016/j.atherosclerosis.2009.12.001; Natsuaki M, 2012, CIRC J, V76, P1369, DOI 10.1253/circj.CJ-11-1356; Nohara R, 2013, CIRC J, V77, P1526, DOI 10.1253/circj.CJ-12-1149; Schachter M, 2005, FUND CLIN PHARMACOL, V19, P117, DOI 10.1111/j.1472-8206.2004.00299.x; Nezasa K, 2003, XENOBIOTICA, V33, P379, DOI 10.1080/0049825031000066259; Nohara R, 2012, CIRC J, V76, P221, DOI 10.1253/circj.CJ-11-0887; Chitose T, 2014, ATHEROSCLEROSIS, V237, P251, DOI 10.1016/j.atherosclerosis.2014.08.053; Davidson MH, 2002, EXPERT OPIN INV DRUG, V11, P125, DOI 10.1517/13543784.11.1.125; Fujita M, 2008, INT J CARDIOL, V129, P294, DOI 10.1016/j.ijcard.2007.06.054; Izawa A, 2015, CIRC J, V79, P161, DOI 10.1253/circj.CJ-14-0877; de Lemos JA, 2004, JAMA-J AM MED ASSOC, V292, P1307, DOI 10.1001/jama.292.11.1307; McTaggart F, 2001, AM J CARDIOL, V87, p28B; Sakamoto T, 2007, CIRC J, V71, P1348, DOI 10.1253/circj.71.1348	16	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JAN	2015	79	1					49	50		10.1253/circj.CJ-14-1283		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX4KD	WOS:000346900700010		
J	Shiba, Y				Shiba, Yuji			New Strategy for the Treatment of Myocarditis by Cell-Sheet Technology	CIRCULATION JOURNAL			English	Editorial Material							DILATED CARDIOMYOPATHY; HEART; TRANSPLANTATION; CARDIOMYOCYTES; TISSUES		Shinshu Univ, Inst Biomed Sci, Dept Cardiovasc Med, Matsumoto, Nagano 3908621, Japan	Shiba, Y (reprint author), Shinshu Univ, Inst Biomed Sci, Dept Cardiovasc Med, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	yshiba@shinshu-u.ac.jp					Kindermann I, 2008, CIRCULATION, V118, P639, DOI 10.1161/CIRCULATIONAHA.108.769489; Muller J, 2000, CIRCULATION, V101, P385; McNamara DM, 2001, CIRCULATION, V103, P2254; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Shiba Y, 2012, NATURE, V489, P322, DOI 10.1038/nature11317; Frustaci A, 2003, CIRCULATION, V107, P857, DOI 10.1161/01.CIR.0000048147.1596231; Eckart RE, 2011, J AM COLL CARDIOL, V58, P1254, DOI 10.1016/j.jacc.2011.01.049; Anzini M, 2013, CIRCULATION, V128, P2384, DOI 10.1161/CIRCULATIONAHA.113.003092; Bobbert P, 2011, EUR HEART J, V32, P1134, DOI 10.1093/eurheartj/ehq498; Caforio ALP, 2001, AUTOIMMUNITY, V34, P199, DOI 10.3109/08916930109007385; Dowell JD, 2003, CARDIOVASC RES, V58, P336, DOI 10.1016/S0008-6363(03)00254-2; Imanishi T, 2000, CARDIOVASC RES, V48, P101, DOI 10.1016/S0008-6363(00)00154-1; Kamata S, 2015, CIRC J, V79, P169, DOI 10.1253/circj.CJ-14-0840; Shimizu T, 2014, CIRC J, V78, P2594, DOI 10.1253/circj.CJ-14-0973; Shintani Y, 2009, J MOL CELL CARDIOL, V47, P288, DOI 10.1016/j.yjmcc.2009.05.009	15	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JAN	2015	79	1					51	52		10.1253/circj.CJ-14-1270		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX4KD	WOS:000346900700011		
J	Hirose, M; Matsushita, N				Hirose, Masamichi; Matsushita, Naoko			Mechanical Stretch and Endothelial to Mesenchymal Transition - Importance of Integrin beta 1-	CIRCULATION JOURNAL			English	Editorial Material							CARDIAC FIBROSIS; DYSSYNCHRONY		[Hirose, Masamichi] Iwate Med Univ, Sch Pharmaceut Sci, Dept Mol & Cellular Pharmacol, Morioka, Iwate 0283694, Japan; [Matsushita, Naoko] Iwate Med Univ, Sch Med, Dept Internal Med, Div Cardiol, Morioka, Iwate 0283694, Japan	Hirose, M (reprint author), Iwate Med Univ, Sch Pharmaceut Sci, Dept Mol & Cellular Pharmacol, Morioka, Iwate 0283694, Japan.	mhirose@iwate-med.ac.jp					Bhowmick NA, 2001, J BIOL CHEM, V276, P46707, DOI 10.1074/jbc.M106176200; Widyantoro B, 2010, CIRCULATION, V121, P2407, DOI 10.1161/CIRCULATIONAHA.110.938217; Kirk JA, 2013, CIRC RES, V113, P765, DOI 10.1161/CIRCRESAHA.113.300270; Kuwahara F, 2002, CIRCULATION, V106, P130, DOI 10.1161/01.CIR.0000020689.12472.E0; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Aisagbonhi O, 2011, DIS MODEL MECH, V4, P469, DOI 10.1242/dmm.006510; Koitabashi N, 2011, J CLIN INVEST, V121, P2301, DOI 10.1172/JCI44824; Basaran Y, 2011, ECHOCARDIOGR-J CARD, V28, P62, DOI 10.1111/j.1540-8175.2010.01242.x; Birnie D, 2009, HEART RHYTHM, V6, P1721, DOI 10.1016/j.hrthm.2009.08.014; Caracciolo G, 2013, CIRC J, V77, P2526, DOI 10.1253/circj.CJ-12-1230; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Mai JT, 2015, CIRC J, V79, P201, DOI 10.1253/circj.CJ-14-0721; Okayama K, 2012, HYPERTENSION, V59, P958, DOI 10.1161/HYPERTENSIONAHA.111.183905; Wu M, 2014, INT J CARDIOL, V171, pE65, DOI 10.1016/j.ijcard.2013.11.105; Wylie-Sears J, 2014, BIOCHEM BIOPH RES CO, V446, P870, DOI 10.1016/j.bbrc.2014.03.014	15	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JAN	2015	79	1					53	54		10.1253/circj.CJ-14-1237		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX4KD	WOS:000346900700012		
J	Tagami, T; Matsui, H; Horiguchi, H; Fushimi, K; Yasunaga, H				Tagami, Takashi; Matsui, Hiroki; Horiguchi, Hiromasa; Fushimi, Kiyohide; Yasunaga, Hideo			Thoracic Aortic Injury in Japan - Nationwide Retrospective Cohort Study -	CIRCULATION JOURNAL			English	Article						Aorta; Endovascular therapy; Japan; Trauma	ENDOVASCULAR STENT-GRAFT; OPEN SURGICAL REPAIR; MANAGEMENT; ANEURYSM; METAANALYSIS; MORTALITY; DISSECTION; OUTCOMES; SURGERY; RUPTURE	Background: The epidemiology of traumatic thoracic aortic injury has not been reported in many countries, so we investigated the current trends in Japan. Methods and Results: Patients with traumatic thoracic aortic injury from July 2007 to March 2013 were identified using a Japanese nationwide administrative database, the Diagnosis Procedure Combination inpatient database. The trends in crude in-hospital mortality and proportion of endovascular repair use among patients with repair were evaluated over time. A total of 617 incident cases of thoracic aortic injury were identified at 234 hospitals, and categorized into endovascular repair (n=126), open repair (n=76), and non-repair (n=415) groups. The in-hospital mortality rate for each of these groups was 5.6%, 15.8%, and 45.3%, respectively. The in-hospital survival rate was higher in the endovascular repair group than in the open repair group (log-rank chi(2)=4.9; P=0.03). Although the crude in-hospital mortality did not change significantly during the study period (Mantel-Haenszel trend test, P=0.10), the proportion of endovascular repair use among all repair cases increased significantly (P<0.001). Conclusions: The results of the present nationwide study suggest that the endovascular approach to treatment of thoracic aortic injury in Japan gained in popularity from 2007 to 2012.	[Tagami, Takashi; Matsui, Hiroki; Yasunaga, Hideo] Univ Tokyo, Sch Publ Hlth, Grad Sch Med, Dept Clin Epidemiol & Hlth Econ, Tokyo 1138555, Japan; [Tagami, Takashi] Nippon Med Sch, Dept Emergency & Crit Care Med, Tokyo 113, Japan; [Horiguchi, Hiromasa] Natl Hosp Org Headquarters, Clin Res Ctr, Dept Clin Data Management & Res, Tokyo, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Grad Sch Med, Dept Hlth Informat & Policy, Tokyo, Japan	Tagami, T (reprint author), Univ Tokyo, Sch Publ Hlth, Grad Sch Med, Dept Clin Epidemiol & Hlth Econ,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138555, Japan.	t-tagami@nms.ac.jp		Yasunaga, Hideo/0000-0002-6017-469X	Ministry of Health, Labour and Welfare of Japan [H26Policy-011]	Dr Horiguchi, Professor Fushimi, and Professor Yasunaga received grant support from the Ministry of Health, Labour and Welfare of Japan (Research on Policy Planning and Evaluation, Grant No. H26Policy-011). The funders had no role in the execution of this study or interpretation of the results.	Kurosawa K, 2013, CIRC J, V77, P2860, DOI 10.1253/circj.CJ-13-1252; Murad MH, 2011, J VASC SURG, V53, P193, DOI 10.1016/j.jvs.2010.08.028; Demetriades D, 2008, J TRAUMA, V64, P561, DOI 10.1097/TA.0b013e3181641bb3; Zipfel B, 2014, ANN THORAC SURG, V97, P774, DOI 10.1016/j.athoracsur.2013.09.034; Tagami T, 2015, EUR RESPIR J, V45, P463, DOI 10.1183/09031936.00081514; Azizzadeh A, 2014, J TRAUMA ACUTE CARE, V76, P510, DOI 10.1097/TA.0b013e3182aafe8c; Xenos ES, 2008, J VASC SURG, V48, P1343, DOI 10.1016/j.jvs.2008.04.060; Tang GL, 2008, J VASC SURG, V47, P671, DOI 10.1016/j.jvs.2007.08.031; Neschis DG, 2008, NEW ENGL J MED, V359, P1708, DOI 10.1056/NEJMra0706159; Watanabe K, 2013, SURG TODAY, V43, P1339, DOI 10.1007/s00595-012-0471-7; Kato N, 1997, RADIOLOGY, V205, P657; Hoffer EK, 2008, J VASC INTERV RADIOL, V19, P1153, DOI 10.1016/j.jvir.2008.05.012; Schulman CI, 2007, J TRAUMA, V62, P664, DOI 10.1097/TA.0b013e318031b58c; Takagi H, 2008, J THORAC CARDIOV SUR, V135, P1392, DOI 10.1016/j.jtcvs.2008.01.033; Chung J, 2008, J VASC INTERV RADIOL, V19, P479, DOI 10.1016/j.jvir.2007.10.022; de Mestral C, 2013, J AM COLL SURGEONS, V216, P1110, DOI 10.1016/j.jamcollsurg.2013.01.005; Handa N, 2014, CIRC J, V78, P1104, DOI 10.1253/circj.CJ-14-0131; Hirose H, 2006, J TRAUMA, V60, P597, DOI 10.1097/01.ta.0000205044.99771.44; Hoshina K, 2013, CIRC J, V77, P1996, DOI 10.1253/circj.CJ-13-0204; Ishimaru S, 2013, CIRC J, V77, P789, DOI 10.1253/circj.CJ-66-0057; Kurimoto Y, 2006, CIRC J, V70, P198, DOI 10.1253/circj.70.198; Murashita T, 2012, CIRC J, V76, P650, DOI 10.1253/circj.CJ-11-0982; Parodi J C, 1991, Ann Vasc Surg, V5, P491, DOI 10.1007/BF02015271; Tagami T, 2014, J THROMB HAEMOST, V12, P1470, DOI 10.1111/jth.12643	24	2	2	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JAN	2015	79	1					55	60		10.1253/circj.CJ-14-0916		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX4KD	WOS:000346900700013		
J	Yashiro, Y; Arimoto, T; Hashimoto, N; Tamura, H; Iwayama, T; Ishigaki, D; Kumagai, Y; Nishiyama, S; Takahashi, H; Shishido, T; Miyamoto, T; Watanabe, T; Kubota, I				Yashiro, Yoshinori; Arimoto, Takanori; Hashimoto, Naoaki; Tamura, Harutoshi; Iwayama, Tadateru; Ishigaki, Daisuke; Kumagai, Yu; Nishiyama, Satoshi; Takahashi, Hiroki; Shishido, Tetsuro; Miyamoto, Takuya; Watanabe, Tetsu; Kubota, Isao			Predictors of Left Atrial Coagulation Activity Among Paroxysmal Atrial Fibrillation Patients	CIRCULATION JOURNAL			English	Article						CHADS(2) score; D-dimer; Left atrial volume index; Paroxysmal atrial fibrillation; Warfarin	D-DIMER LEVELS; CATHETER ABLATION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; BLEEDING COMPLICATIONS; SPONTANEOUS CONVERSION; PERIPROCEDURAL STROKE; THROMBOEMBOLIC RISK; SINUS RHYTHM; CARDIOVERSION; MANAGEMENT	Background: The difference between left atrial (LA) and systemic coagulation activity in paroxysmal atrial fibrillation (PAF) is unclear. Methods and Results: We enrolled 100 patients with PAF who underwent AF ablation. Warfarin was stopped 1 day before the procedure. LA volume index and LA emptying fraction were measured by 64-slice multidetector computed tomography. Immediately after transseptal puncture, blood samples were simultaneously collected from the LA and systemic circulation (SC). In addition, to evaluate the effect of warfarin on D-dimer levels we recruited an additional 27 PAF patients on continuous warfarin. Even in patients with low CHADS(2) scores (mean 0.59 +/- 0.68) and during sinus rhythm, the prevalence of positive LA-D-dimer (>= 0.5 mu g/ml) was greater than that of SC-D-dimer (23% vs. 10%, P<0.01). The LA-D-dimer-positive patients had a larger mean LA volume index and reduced LA emptying fraction than the LA-D-dimer-negative patients. Multiple logistic regression analysis revealed that LA volume index was independently correlated with positive LA-D-dimer (odds ratio 2.245, 95% confidence interval 1.194-4.626, P=0.0112). The prevalence of positive LA-D-dimer was significantly lower in patients taking continuous warfarin, than in those on discontinuous warfarin (3.7% vs. 23%, P=0.025). Conclusions: An enlarged LA volume index was associated with high LA coagulation status in patients with paroxysmal AF. Adequate warfarin control during AF catheter ablation may reduce the prevalence of positive LA-D-dimer.	[Yashiro, Yoshinori; Arimoto, Takanori; Hashimoto, Naoaki; Tamura, Harutoshi; Iwayama, Tadateru; Ishigaki, Daisuke; Kumagai, Yu; Nishiyama, Satoshi; Takahashi, Hiroki; Shishido, Tetsuro; Miyamoto, Takuya; Watanabe, Tetsu; Kubota, Isao] Yamagata Univ, Sch Med, Dept Cardiol Pulmonol & Nephrol, Yamagata 9909585, Japan	Arimoto, T (reprint author), Yamagata Univ, Sch Med, Dept Cardiol Pulmonol & Nephrol, 2-2-2 Iida Nishi, Yamagata 9909585, Japan.	t-arimoto@med.id.yamagata-u.ac.jp			Ministry of Education Culture, Sport, Science and Technology, Japan [25461039]	This work was supported, in part, by a grant-in-aid for Scientific Research (No. 25461039) from the Ministry of Education Culture, Sport, Science and Technology, Japan.	Hof I, 2009, J CARDIOVASC ELECTR, V20, P159, DOI 10.1111/j.1540-8167.2008.01310.x; Okuyama Y, 2014, CIRC J, V78, P1342, DOI 10.1253/circj.CJ-13-1256; FATKIN D, 1994, J AM COLL CARDIOL, V23, P307; GRIMM RA, 1993, J AM COLL CARDIOL, V22, P1359; Di Biase L, 2014, CIRCULATION, V129, P2638, DOI 10.1161/CIRCULATIONAHA.113.006426; Motoki H, 2009, CIRC J, V73, P1403; Numa S, 2014, CIRC J, V78, P1600, DOI 10.1253/circj.CJ-13-1385; Parikh SS, 2010, PACE, V33, P532, DOI [10.1111/j.1540-8159.2010.02693.x, 10.1111/j.1540-8159.2010.02693..x]; Danesh J, 2001, CIRCULATION, V103, P2323; Alehagen U, 2004, THROMB HAEMOSTASIS, V92, P1250, DOI 10.1160/TH04-05-0278; Di Biase L, 2010, CIRCULATION, V121, P2550, DOI 10.1161/CIRCULATIONAHA.109.921320; FATKIN D, 1994, J AM COLL CARDIOL, V23, P961; Arimoto T, 2011, J CARDIOVASC ELECTR, V22, P1297, DOI 10.1111/j.1540-8167.2011.02123.x; STODDARD MF, 1995, J AM COLL CARDIOL, V25, P452, DOI 10.1016/0735-1097(94)00396-8; Tamura H, 2012, J CARDIOL, V60, P126, DOI 10.1016/j.jjcc.2012.02.010; Lester SJ, 1999, AM J CARDIOL, V84, P829, DOI 10.1016/S0002-9149(99)00446-4; Sherman DG, 2005, ARCH INTERN MED, V165, P1185, DOI 10.1001/archinte.165.10.1185; Vene N, 2003, THROMB HAEMOSTASIS, V90, P1163, DOI 10.1160/TH03-06-0363; Tamura H, 2011, J CARD FAIL, V17, P210, DOI 10.1016/j.cardfail.2010.10.006; MANNING WJ, 1994, J AM COLL CARDIOL, V23, P1535; Lim HS, 2013, J AM COLL CARDIOL, V61, P852, DOI 10.1016/j.jacc.2012.11.046; Nakatani Y, 2012, CIRC J, V76, P317, DOI 10.1253/circj.CJ-11-0885; Wen D, 2013, HEART, V99, P1192, DOI 10.1136/heartjnl-2013-304158; Calvo N, 2011, EUROPACE, V13, P486, DOI 10.1093/europace/euq456; de Isla LP, 2014, EUR HEART J-CARD IMG, V15, P793, DOI 10.1093/ehjci/jeu001; GRIMM RA, 1995, AM HEART J, V130, P174, DOI 10.1016/0002-8703(95)90253-8; Iwayama T, 2013, J CARDIOL, V63, P344; Ogawa S, 2010, CIRC J, V74, P2479, DOI 10.1253/circj.CJ-88-0001; Louie EK, 1998, J AM COLL CARDIOL, V32, P2081, DOI 10.1016/S0735-1097(98)00508-7; Masuda M, 2012, CIRC J, V76, P1430, DOI 10.1253/circj.CJ-12-0010; Sadanaga Tsuneaki, 2010, J Am Coll Cardiol, V55, P2225, DOI 10.1016/j.jacc.2009.12.049; YAMAMOTO K, 1995, J AM COLL CARDIOL, V25, P107, DOI 10.1016/0735-1097(94)00322-H	32	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JAN	2015	79	1					61	69		10.1253/circj.CJ-14-0630		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX4KD	WOS:000346900700014		
J	Mizukami, K; Yokoshiki, H; Mitsuyama, H; Watanabe, M; Tenma, T; Matsui, Y; Tsutsui, H				Mizukami, Kazuya; Yokoshiki, Hisashi; Mitsuyama, Hirofumi; Watanabe, Masaya; Tenma, Taro; Matsui, Yoshiro; Tsutsui, Hiroyuki			Predictors of High Defibrillation Threshold in Patients With Implantable Cardioverter-Defibillator Using a Transvenous Dual-Coil Lead	CIRCULATION JOURNAL			English	Article						Defibrillation testing; Defibrillation threshold; Dual-coil lead; Implantable cardioverter-defibrillator	VENTRICULAR OUTFLOW TRACT; SUDDEN CARDIAC DEATH; HYPERTROPHIC CARDIOMYOPATHY; CLINICAL PREDICTORS; ENERGY-REQUIREMENTS; PRIMARY PREVENTION; HEART-FAILURE; SCD-HEFT; THERAPY; TRIAL	Background: Defibrillation testing (DT) is considered a standard procedure during implantable cardioverter-defibrillator (ICD) implantation. However, little is known about the factors that are significantly related to patients with high defibrillation threshold (DFT) using the present triad system. Methods and Results: We examined 286 consecutive patients who underwent ICD implantation with a transvenous dual-coil lead and DT from December 2000 to December 2011. We defined patients who required 25 J or more by the implanted device as the high DFT group, and those who required less than 25 J as the normal DFT group. For each patient, assessment parameters included underlying disease, comorbidities, NYHA functional class, drugs, and echocardiographic measures. The high DFT group consisted of 12 patients (4.2%). Multivariate analysis identified 3 independent predictors for high DFT: atrial fibrillation (odds ratio (OR) 4.85, 95% confidence interval (CI) 1.24-22.33, P=0.023), hypertension (OR 4.01, 95% CI 1.08-15.96, P=0.039), thickness of interventricular septum (IVS)>12 mm (OR 4.82, 95% CI 1.17-20.31, P=0.030). Conclusions: Atrial fibrillation, hypertension and IVS hypertrophy were significantly associated with high DFT. Identification of such patients could help to lower the risk of complications with DT.	[Mizukami, Kazuya; Yokoshiki, Hisashi; Mitsuyama, Hirofumi; Watanabe, Masaya; Tenma, Taro; Tsutsui, Hiroyuki] Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Med, Sapporo, Hokkaido 0608638, Japan; [Matsui, Yoshiro] Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Surg, Sapporo, Hokkaido 0608638, Japan	Yokoshiki, H (reprint author), Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Med, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.	yokoshh@med.hokudai.ac.jp					Almquist AK, 2005, HEART RHYTHM, V2, P814, DOI 10.1016/j.hrthm.2005.05.008; Healey JS, 2010, J CARDIOVASC ELECTR, V21, P177, DOI 10.1111/j.1540-8167.2009.01616.x; Ishizu T, 2014, HYPERTENSION, V63, P500, DOI 10.1161/HYPERTENSIONAHA.113.02149; Russo AM, 2005, HEART RHYTHM, V2, P456, DOI 10.1016/j.hrthm.2005.01.015; Shukla HH, 2003, PACE, V26, P44; Lee DS, 2003, J AM COLL CARDIOL, V41, P1573, DOI 10.1016/S0735-1097(03)00253-5; PINSKI SL, 1991, AM HEART J, V122, P89, DOI 10.1016/0002-8703(91)90763-8; Vischer AS, 2013, J CARDIOVASC ELECTR, V24, P437, DOI 10.1111/jce.12042; Lin EF, 2013, PACE, V36, P231, DOI 10.1111/pace.12039; Brignole M, 2007, EUROPACE, V9, P540, DOI 10.1093/europace/eum083; Healey JS, 2012, J CARDIOVASC ELECTR, V23, P1313, DOI 10.1111/j.1540-8167.2012.02393.x; Mainigi SK, 2006, HEART RHYTHM, V3, P1010, DOI 10.1016/j.hrthm.2006.05.028; Birnie D, 2008, HEART RHYTHM, V5, P387, DOI 10.1016/j.hrthm.2007.11.018; Healey JS, 2012, AM HEART J, V164, P146, DOI 10.1016/j.ahj.2012.05.007; Murakoshi N, 2013, CIRC J, V77, P2419, DOI 10.1253/circj.CJ-13-1129; Brignole M, 2012, J AM COLL CARDIOL, V60, P981, DOI 10.1016/j.jacc.2012.05.014; Nanthakumar K, 2004, J AM COLL CARDIOL, V44, P2166, DOI 10.1016/j.jacc.2004.08.054; Blatt JA, 2008, J AM COLL CARDIOL, V52, P551, DOI 10.1016/j.jacc.2008.04.051; Codner P, 2012, ISR MED ASSOC J, V14, P343; Constantino J, 2010, HEART RHYTHM, V7, P953, DOI 10.1016/j.hrthm.2010.03.026; Crossley GH, 2009, PACE, V32, P166, DOI 10.1111/j.1540-8159.2008.02198.x; Day John D, 2008, Europace, V10, P347, DOI 10.1093/europace/eun027; EPSTEIN AE, 1992, CIRCULATION, V86, P1206; Gold MR, 2002, CIRCULATION, V105, P2043, DOI 10.1161/01.CIR.0000015508.59749.F5; Jacob Sony, 2010, Indian Pacing Electrophysiol J, V10, P21; Khalighi K, 1997, AM J CARDIOL, V79, P150; Klein H, 1999, AM J CARDIOL, V83, p91D; Kroll MW, 2010, FUND CLIN PHARMACOL, V24, P561, DOI 10.1111/j.1472-8206.2010.00848.x; Lubinski A, 2000, PACE, V23, P1996; Mainigi SK, 2006, HEART RHYTHM, V3, P492, DOI 10.1016/j.hrthm.2005.12.023; MARCHLINSKI FE, 1988, AM J CARDIOL, V62, P393, DOI 10.1016/0002-9149(88)90965-4; Mollerus M, 2008, J INTERV CARD ELECTR, V22, P221, DOI 10.1007/s10840-008-9254-x; Nagai T, 2009, CIRC J, V73, P1028; Przybylski A, 2010, KARDIOL POL, V68, P512; Quin EM, 2011, J CARDIOVASC ELECTR, V22, P569, DOI 10.1111/j.1540-8167.2010.01943.x; RAITT MH, 1995, J AM COLL CARDIOL, V25, P1576, DOI 10.1016/0735-1097(95)00093-J; Roberts BD, 2010, PACE, V33, P1342, DOI 10.1111/j.1540-8159.2010.02843.x; Schuger C, 2006, J CARDIOVASC ELECTR, V17, P247, DOI 10.1111/j.1540-8167.2006.00345.x; Shah P, 2013, J CARDIOVASC ELECTR, V24, P94, DOI 10.1111/j.1540-8167.2012.02361.x; Shantsila E, 2013, AM J CARDIOL, V111, P996, DOI 10.1016/j.amjcard.2012.12.005; Strickberger SA, 2004, J AM COLL CARDIOL, V44, P88, DOI 10.1016/j.jacc.2003.11.068; Tang ASL, 1996, PACE, V19, P960, DOI 10.1111/j.1540-8159.1996.tb03393.x; McAnulty J, 1997, NEW ENGL J MED, V337, P1576; Watanabe H, 2005, J CARDIOVASC ELECTR, V16, P262, DOI 10.1046/j.1540-8167.2005.40579.x; Yokoshiki H, 2013, CIRC J, V77, P2003, DOI 10.1253/circj.CJ-12-1507	45	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JAN	2015	79	1					77	84		10.1253/circj.CJ-14-0860		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX4KD	WOS:000346900700016		
J	Ichikawa, M; Takei, Y; Hamasaki, T; Kijima, Y				Ichikawa, Minoru; Takei, Yoshizumi; Hamasaki, Toshimitsu; Kijima, Yoshiyuki			Characterization of Patients With Angioscopically-Detected In-Stent Mural Thrombi - Genetics of Clopidogrel Responsiveness and Generations of Drug-Eluting Stents -	CIRCULATION JOURNAL			English	Article						Clopidogrel responsiveness; Coronary angioscopy; Drug-eluting stents; Stent thrombosis	PERCUTANEOUS CORONARY INTERVENTION; BARE-METAL STENTS; INCOMPLETE NEOINTIMAL COVERAGE; JAPANESE PATIENTS; DOSE CLOPIDOGREL; IMPLANTATION; POLYMORPHISM; CYP2C19; RESTENOSIS; OMEPRAZOLE	Background: The loss-of-function genotype of cytochrome P450 2C19 (CYP2C19) has been proposed as a risk factor for stent thrombosis in patients with drug-eluting stent implantation. The aim of this study was to clarify the clinical features of patients with angioscopically-detected in-stent mural thrombi (ISMT). Methods and Results: Enrolled were 100 stented segments in 55 patients with stable angina (20 bare-metal stents; 39 Cypher sirolimus-eluting stents [SES]; 26 Endeavor zotarolimus-eluting stents [ZES]; 13 Xience V everolimuseluting stents; and 2 Nobori biolimus-eluting stents). Dual antiplatelet therapy (100 mg aspirin+75 mg clopidogrel once daily) had been continued since stenting. A poor metabolizer (PM) of clopidogrel was defined as a homozygote of CYP2C19 loss-of-function alleles. Coronary angioscopy revealed ISMT in 6 patients (5 SES, 1 ZES). Between the ISMT group and control group (n=49), there were no significant differences with regards to the VerifyNow P2Y(12) platelet function assay or in-stent endothelial coverage grade. Exact logistic regression analyses with stepwise forward selection at a significance level of 0.10 were performed to reveal predictive variables for ISMT (respectively: odds ratio, 95% confidence interval, P value: CYP2C19 PM genotype (3.28, 0.88-24.80, 0.09), SES implantation (3.37, 0.90-28.09, 0.08), and presence of yellow plaque (3.69, 1.14-25.70, 0.02). Conclusions: Patients with ISMT were characterized by SES implantation, poor clopidogrel metabolism, and instent yellow plaque.	[Ichikawa, Minoru; Takei, Yoshizumi; Kijima, Yoshiyuki] Higashi Osaka City Gen Hosp, Dept Cardiol, Higashiosaka, Osaka 5788588, Japan; [Hamasaki, Toshimitsu] Osaka Univ, Grad Sch Med, Dept Biomed Stat, Suita, Osaka, Japan	Kijima, Y (reprint author), Higashi Osaka City Gen Hosp, Dept Cardiol, 3-4-5 Nishi Iwata, Higashiosaka, Osaka 5788588, Japan.	ykijima@ichou.med.osaka-u.ac.jp			Higashi-osaka City General Hospital	We thank Drs Tsuyoshi Nakata, Kenji Kawai, and Takashi Takagi, and Shohei Yoshima for their encouragement to pursue this study. This work was supported by a research grant from Higashi-osaka City General Hospital to Drs Kijima and Ichikawa.	Ali ZA, 2013, CIRC-CARDIOVASC INTE, V6, P507, DOI 10.1161/CIRCINTERVENTIONS.112.000248; Gilard M, 2008, J AM COLL CARDIOL, V51, P256, DOI 10.1016/j.jacc.2007.06.064; Palmerini T, 2013, J AM COLL CARDIOL, V62, P1915, DOI 10.1016/j.jacc.2013.08.725; Kotani J, 2006, J AM COLL CARDIOL, V47, P2108, DOI 10.1016/j.jacc.2005.11.092; Asakura M, 1998, CIRCULATION, V97, P2003; Yamamoto M, 2011, AM HEART J, V161, P1200, DOI 10.1016/j.ahj.2011.03.006; Trenk D, 2008, J AM COLL CARDIOL, V51, P1925, DOI 10.1016/j.jacc.2007.12.056; Nakata T, 2013, CIRC J, V77, P1436, DOI 10.1253/circj.CJ-12-1095; Desta Z, 2002, CLIN PHARMACOKINET, V41, P913, DOI 10.2165/00003088-200241120-00002; Ono T, 2011, THROMB RES, V128, pE130, DOI 10.1016/j.thromres.2011.07.028; Sawada T, 2011, CIRC J, V75, P99, DOI 10.1253/circj.CJ-10-0525; Bhatt DL, 2010, NEW ENGL J MED, V363, P1909, DOI 10.1056/NEJMoa1007964; McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9; Price MJ, 2012, J AM COLL CARDIOL, V59, P1928, DOI 10.1016/j.jacc.2011.11.068; Awata M, 2007, CIRCULATION, V116, P910, DOI 10.1161/CIRCULATIONAHA.105.609057; Dai K, 2013, J CARDIOL, V61, P22, DOI 10.1016/j.jjcc.2012.08.011; de Arruda Monika, 2002, Expert Rev Mol Diagn, V2, P487; Ichikawa Minoru, 2012, Cardiovasc Interv Ther, V27, P201; Inoue T, 2013, CIRC J, V78, P92; Kawakami H, 2009, J CARDIOL, V54, P153, DOI 10.1016/j.jjcc.2008.10.010; Lagerqvist B, 2007, NEW ENGL J MED, V356, P1009, DOI 10.1056/NEJMoa067722; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Miyazaki S, 2012, CIRC J, V76, P390, DOI 10.1253/circj.CJ-11-0961; Nakazawa G, 2011, J AM COLL CARDIOL, V57, P1314, DOI 10.1016/j.jacc.2011.01.011; NAVARESE EP, 2013, BMJ-BRIT MED J, V347, DOI DOI 10.1136/BMJ.F6530; Nishio R, 2012, CIRC J, V76, P2348, DOI 10.1253/circj.CJ-12-0476; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290; Takano M, 2008, CIRC-CARDIOVASC INTE, V1, P20, DOI 10.1161/CIRCINTERVENTIONS.108.769448; Waksman R, 2012, AM J CARDIOL, V109, P1288, DOI 10.1016/j.amjcard.2011.12.019; Xie HG, 1999, PHARMACOGENETICS, V9, P539, DOI 10.1097/01213011-199910000-00001	30	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JAN	2015	79	1					85	90		10.1253/circj.CJ-14-0639		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX4KD	WOS:000346900700017		
J	Shiono, Y; Kubo, T; Tanaka, A; Ino, Y; Yamaguchi, T; Tanimoto, T; Yamano, T; Matsuo, Y; Nishiguchi, T; Teraguchi, I; Ota, S; Ozaki, Y; Orii, M; Shimamura, K; Kitabata, H; Hirata, K; Imanishi, T; Akasaka, T				Shiono, Yasutsugu; Kubo, Takashi; Tanaka, Atsushi; Ino, Yasushi; Yamaguchi, Tomoyuki; Tanimoto, Takashi; Yamano, Takashi; Matsuo, Yoshiki; Nishiguchi, Tsuyoshi; Teraguchi, Ikuko; Ota, Shingo; Ozaki, Yuichi; Orii, Makoto; Shimamura, Kunihiro; Kitabata, Hironori; Hirata, Kumiko; Imanishi, Toshio; Akasaka, Takashi			Long-Term Outcome After Deferral of Revascularization in Patients With Intermediate Coronary Stenosis and Gray-Zone Fractional Flow Reserve	CIRCULATION JOURNAL			English	Article						Deferred revascularization; Fractional flow reserve; Gray zone; Intermediate coronary stenosis	FUNCTIONAL SEVERITY; ADENOSINE 5'-TRIPHOSPHATE; MYOCARDIAL-INFARCTION; ARTERY STENOSES; INTERVENTION; DISEASE; CATHETERIZATION; INTRACORONARY; ANGIOGRAPHY; CARDIOLOGY	Background: A strategy of deferred percutaneous coronary intervention for coronary stenosis with fractional flow reserve (FFR) 0.75-0.80, termed the gray zone, remains a matter of debate. The aim of this study was to assess the safety of deferring revascularization for patients with FFR 0.75-0.80 compared with those with FFR >0.80. Methods and Results: We assessed 3-year clinical outcome in 150 patients with angiographically intermediate stenosis who had revascularization deferred on the basis of FFR =0.75 (FFR 0.75-0.80, n=56; FFR >0.80, n=94). Target vessel failure (TVF), defined as a composite of cardiac death, target vessel-related myocardial infarction (MI), and ischemia-driven target vessel revascularization (TVR) was evaluated during follow-up. Cardiac death was observed in 1 patient with FFR 0.75-0.80. There was no target vessel-related MI in either group. The incidence of ischemiadriven TVR was higher in patients with FFR 0.75-0.80 than in those with FFR >0.80 (14% vs. 3%, P=0.020). TVF-free survival was significantly worse for the patients with FFR 0.75-0.80 than those with FFR >0.80 (hazard ratio, 5.2; 95% confidence intervals: 1.4-19.5; P=0.015). Conclusions: Patients with FFR 0.75-0.80 were at higher risk of TVF mainly due to TVR than those with FFR >0.80.	[Shiono, Yasutsugu; Kubo, Takashi; Tanaka, Atsushi; Ino, Yasushi; Yamaguchi, Tomoyuki; Tanimoto, Takashi; Yamano, Takashi; Matsuo, Yoshiki; Nishiguchi, Tsuyoshi; Teraguchi, Ikuko; Ota, Shingo; Ozaki, Yuichi; Orii, Makoto; Shimamura, Kunihiro; Kitabata, Hironori; Hirata, Kumiko; Imanishi, Toshio; Akasaka, Takashi] Wakayama Med Univ, Dept Cardiovasc Med, Wakayama 6418510, Japan	Kubo, T (reprint author), Wakayama Med Univ, Dept Cardiovasc Med, 811-1 Kimiidera, Wakayama 6418510, Japan.	takakubo@wakayama-med.ac.jp					De Bruyne B, 2003, CIRCULATION, V107, P1877, DOI 10.1161/01.CIR.0000061950.24940.88; Bech GJW, 2001, CIRCULATION, V103, P2928; De Bruyne B, 2012, NEW ENGL J MED, V367, P991, DOI 10.1056/NEJMoa1205361; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; Pijls NHJ, 2007, J AM COLL CARDIOL, V49, P2105, DOI 10.1016/j.jacc.2007.01.087; Pijls NHJ, 1996, NEW ENGL J MED, V334, P1703, DOI 10.1056/NEJM199606273342604; Courtis J, 2008, CATHETER CARDIO INTE, V71, P541, DOI 10.1002/ccd.21406; Berger A, 2005, J AM COLL CARDIOL, V46, P438, DOI 10.1016/j.jacc.2005.04.041; Kern MJ, 2006, CIRCULATION, V114, P1321, DOI 10.1161/CIRCULATIONAHA.106.177276; De Bruyne B, 2001, CIRCULATION, V104, P157; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Seo MK, 2012, CIRC-CARDIOVASC INTE, V5, P401, DOI 10.1161/CIRCINTERVENTIONS.111.965392; Pijls NHJ, 2013, CIRC J, V77, P561, DOI 10.1253/circj.CJ-13-0161; Lindstaedt M, 2010, CLIN CARDIOL, V33, P77, DOI 10.1002/clc.20693; Jeremias A, 2000, CIRCULATION, V101, P318; PIJLS NHJ, 1995, CIRCULATION, V92, P3183; Kern MJ, 2010, J AM COLL CARDIOL, V55, P173, DOI 10.1016/j.jacc.2009.06.062; Abe M, 2000, CIRCULATION, V102, P2365; Samady H, 2006, J AM COLL CARDIOL, V47, P2187, DOI 10.1016/j.jacc.2006.01.065; Pijls NHJ, 2012, J AM COLL CARDIOL, V59, P1045, DOI 10.1016/j.jacc.2011.09.077; Koo BK, 2014, CIRC J, V78, P1048, DOI 10.1253/circj.CJ-14-0249; Levine GN, 2011, CIRCULATION, V124, pE574, DOI 10.1161/CIR.0b013e31823ba622; Petraco R, 2013, JACC-CARDIOVASC INTE, V6, P222, DOI 10.1016/j.jcin.2012.10.014; Shiono Y, 2012, CIRC J, V76, P2218, DOI 10.1253/circj.CJ-12-0195; Usui Yasuhiro, 2003, Am J Cardiol, V92, P699, DOI 10.1016/S0002-9149(03)00829-4; Yanagisawa H, 2002, CIRC J, V66, P1105, DOI 10.1253/circj.66.1105	26	2	2	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JAN	2015	79	1					91	95		10.1253/circj.CJ-14-0671		5	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX4KD	WOS:000346900700018		
J	Saito, S; Maehara, A; Vlachojannis, GJ; Parise, H; Mehran, R				Saito, Shigeru; Maehara, Akiko; Vlachojannis, Georgios J.; Parise, Helen; Mehran, Roxana		RESOLUTE Japan Investigators	Clinical and Angiographic Evaluation of the Resolute Zotarolimus-Eluting Coronary Stent in Japanese Patients - Long-Term Outcome in the RESOLUTE Japan and RESOLUTE Japan Small Vessel Study -	CIRCULATION JOURNAL			English	Article						Coronary restenosis; Drug-eluting stent; Interventional ultrasonography; Percutaneous coronary intervention; Zotarolimus	INTRACORONARY ULTRASOUND; BALLOON ANGIOPLASTY; ARTERY DISEASE; IMPLANTATION; TRIAL; SYSTEM; DEPLOYMENT; REGISTRY	Background: This study evaluated the safety and efficacy of the RESOLUTE (TM) zotarolimus-eluting stent (R-ZES; Medtronic, Inc, Santa Rosa, CA, USA) in Japanese patients for the treatment of de novo native coronary lesions. Methods and Results: Both RESOLUTE Japan (R-Japan) and RESOLUTE Japan Small Vessel Study (R-Japan SVS) were prospective, multicenter, single-arm observational studies. R-Japan enrolled 100 patients (reference vessel diameter, 2.5-3.5 mm) and R-Japan SVS enrolled 65 patients (at least 1 lesion suitable for 2.25-mm stent) treated with R-ZES. In R-Japan, in-stent late lumen loss (LLL; the primary endpoint) at 8 months was 0.12 +/- 0.22 mm and volume obstruction on intravascular ultrasound was 2.33 +/- 3.51%. At 4 years, there were no cases of clinically driven target lesion revascularization (TLR); the target lesion failure (TLF; composite of cardiac death, target vessel myocardial infarction, and clinically driven TLR) was 5.6% (5/90). In R-Japan SVS, in-stent LLL at 9 months was 0.27 +/- 0.33 mm, TLF (primary endpoint) was 4.6% (3/65), without incidence of TLR. At 3 years, TLF was 7.9% (5/63) and clinically driven TLR, 3.2% (2/63). Conclusions: R-Japan and R-Japan SVS demonstrate substantial suppression of neointimal hyperplasia, low LLL, and excellent and sustained long-term clinical outcome with R-ZES in Japanese patients.	[Saito, Shigeru] Shonan Kamakura Gen Hosp, Cardiol & Catheterizat Labs, Kamakura, Kanagawa 2478533, Japan; [Maehara, Akiko] Columbia Univ Coll Phys & Surg, Imaging Core Lab, New York, NY 10032 USA; [Vlachojannis, Georgios J.; Mehran, Roxana] Mt Sinai Med Ctr, New York, NY 10029 USA; [Maehara, Akiko; Parise, Helen] Data Coordinating Ctr Cardiovasc Res Fdn, New York, NY USA	Saito, S (reprint author), Shonan Kamakura Gen Hosp, Cardiol & Catheterizat Labs, 1202-1 Yamazaki, Kamakura, Kanagawa 2478533, Japan.	saito@shonankamakura.or.jp			Medtronic, Inc	Both RESOLUTE Japan (ClinicalTrials.gov, NCT00927940) and the RESOLUTE Japan Small Vessel Study (NCT01150500) were funded by Medtronic, Inc.	Xu B, 2013, JACC-CARDIOVASC INTE, V6, P664, DOI 10.1016/j.jcin.2013.03.001; GOLDBERG SL, 1994, J AM COLL CARDIOL, V24, P996; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801; Shimohama T, 2010, AM J CARDIOL, V106, P13, DOI 10.1016/j.amjcard.2010.02.008; Neumann FJ, 2012, EUROINTERVENTION, V7, P1181, DOI 10.4244/EIJV7I10A189; Ikari Y, 2009, CIRC J, V73, P1038; Meredith IT, 2009, JACC-CARDIOVASC INTE, V2, P977, DOI 10.1016/j.jcin.2009.07.007; Kohsaka S, 2010, AM J CARDIOL, V105, P1698, DOI 10.1016/j.amjcard.2010.01.349; Muraoka Y, 2013, CIRC J, V77, P363, DOI 10.1253/circj.CJ-12-0575; Yeung AC, 2011, J AM COLL CARDIOL, V57, P1778, DOI 10.1016/j.jacc.2011.03.005; NAKAMURA S, 1994, CIRCULATION, V89, P2026; Brodie BR, 2003, CATHETER CARDIO INTE, V59, P184, DOI 10.1002/ccd.10474; Cannon LA, 2012, CATHETER CARDIO INTE, V80, P546, DOI 10.1002/ccd.23397; Caputo RP, 2003, CATHETER CARDIO INTE, V59, P455, DOI 10.1002/ccd.10581; FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802; Honda Y, 2009, CIRC J, V73, P1371; Ishihara T, 2013, CIRC J, V77, P1186, DOI 10.1253/circj.CJ-12-1369; Ishikawa T, 2009, J CARDIOL, V54, P238, DOI 10.1016/j.jjcc.2009.05.013; Lee M, 2013, AM J CARDIOL, V112, P1335, DOI 10.1016/j.amjcard.2013.06.012; Mori F, 2007, HEART VESSELS, V22, P152, DOI 10.1007/s00380-006-0952-y; Muraoka Y, 2011, HEART VESSELS, V26, P565, DOI 10.1007/s00380-010-0094-0; Qiao SB, 2014, AM J CARDIOL, V113, P613, DOI 10.1016/j.amjcard.2013.10.042; Saito Shigeru, 2011, Cardiovasc Revasc Med, V12, P273, DOI 10.1016/j.carrev.2010.12.007; Saito S, 2014, J CARDIOL, V64, P105, DOI 10.1016/j.jjcc.2013.12.003; Serruys PW, 2010, NEW ENGL J MED, V363, P136, DOI 10.1056/NEJMoa1004130	26	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JAN	2015	79	1					96	U353		10.1253/circj.CJ-14-0836		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX4KD	WOS:000346900700019		
J	Imamura, T; Kinugawa, K; Fujino, T; Inaba, T; Maki, H; Hatano, M; Kinoshita, O; Nawata, K; Kyo, S; Ono, M				Imamura, Teruhiko; Kinugawa, Koichiro; Fujino, Takeo; Inaba, Toshiro; Maki, Hisataka; Hatano, Masaru; Kinoshita, Osamu; Nawata, Kan; Kyo, Shunei; Ono, Minoru			Aortic Insufficiency in Patients With Sustained Left Ventricular Systolic Dysfunction After Axial Flow Assist Device Implantation	CIRCULATION JOURNAL			English	Article						Centrifugal; EVAHEART; HeartMate II; Ventricular assist device	COMMISSURAL FUSION; POOR-PROGNOSIS; HEART-FAILURE; SUPPORT; VALVE; MANAGEMENT; RECOVERY; BRIDGE	Background: Predicting the occurrence of aortic insufficiency (AI) during left ventricular assist device (LVAD) support has remained unsolved. Methods and Results: We enrolled 52 patients who had received continuous flow LVAD (14 axial and 38 centrifugal pumps) and who been followed for >= 6 months between Jun 2006 and Dec 2013. Native aortic valve (AV) opening was observed in 18 patients (35%) with improved LV systolic function, and none of them had AI. On multivariate logistic regression analysis preoperative shorter heart failure duration was the only independent predictor of postoperative native AV opening (P=0.042; odds ratio [OR], 0.999). Of the remaining 34 patients (65%) with closed AV, 11 had AI with enlargement of the aortic root and narrow pulse pressure. Among those with closed AV, axial pump use (n=13) was the only significant predictor of the development of AI (P=0.042; OR, 4.950). Patients with AI had lower exercise capacity and a higher readmission rate than those without AI during 2-year LVAD support (55% vs. 8%; P<0.001). Conclusions: Native AV opening during LVAD support is profoundly associated with reversal of LV systolic function, especially in patients with preoperative shorter heart failure duration. Among those in whom the native AV remains closed, low pulsatility of axial flow pump may facilitate aortic root remodeling and post-LVAD AI development that results in worse clinical outcome.	[Imamura, Teruhiko; Kinugawa, Koichiro; Kyo, Shunei] Univ Tokyo, Grad Sch Med, Dept Therapeut Strategy Heart Failure, Tokyo 1138655, Japan; [Fujino, Takeo; Inaba, Toshiro; Maki, Hisataka; Hatano, Masaru] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo 1138655, Japan; [Kinoshita, Osamu; Nawata, Kan; Ono, Minoru] Univ Tokyo, Grad Sch Med, Dept Thorac Surg, Tokyo 1138655, Japan	Kinugawa, K (reprint author), Univ Tokyo, Grad Sch Med, Dept Therapeut Strategy Heart Failure, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kinugawa-tky@umin.ac.jp			Secom Science and Technology Foundation	Grant-in-Aid from Secom Science and Technology Foundation to K. K. K. K. has conflicts of interest as follows. Employment: Daiichi-Sankyo, Otsuka, Terumo, Hitachi-Aloka, CSL Behring, Medix Japan, KCI, Nishimura Kikai, GlaxoSmithKline, Century Medical, Nippon Shinyaku, Edwards, Bayer, Senko Medical Instrument; Research grant: Terumo, Otsuka, ONO, Novartis, Sun Medical; Honoraria: Daiichi-Sankyo, ONO, Otsuka.	Pak SW, 2010, J HEART LUNG TRANSPL, V29, P1172, DOI 10.1016/j.healun.2010.05.018; Jorde UP, 2014, CIRC-HEART FAIL, V7, P310, DOI 10.1161/CIRCHEARTFAILURE.113.000878; Toda K, 2011, ANN THORAC SURG, V92, P929, DOI 10.1016/j.athoracsur.2011.04.115; Shiga T, 2012, CIRC J, V76, P2785, DOI 10.1253/circj.CJ-12-0231; John R, 2010, J HEART LUNG TRANSPL, V29, P1321, DOI 10.1016/j.healun.2010.06.006; Imamura T, 2014, J ARTIF ORGANS, V17, P23, DOI 10.1007/s10047-013-0748-7; Hatano M, 2011, CIRC J, V75, P1147, DOI 10.1253/circj.CJ-10-1106; Moazami N, 2013, J HEART LUNG TRANSPL, V32, P1, DOI 10.1016/j.healun.2012.10.001; Matsumiya G, 2005, J THORAC CARDIOV SUR, V130, P699, DOI 10.1016/j.jtcvs.2005.05.016; Imamura T, 2014, CIRC J, V78, P2259, DOI 10.1253/circj.CJ-14-0368; Rajagopal K, 2013, J THORAC CARDIOV SUR, V145, P1373, DOI 10.1016/j.jtcvs.2012.11.066; Imamura T, 2013, CIRC J, V77, P96, DOI 10.1253/circj.CJ-12-0686; Imamura T, 2012, CIRC J, V76, P1895, DOI 10.1253/circj.CJ-12-0182; Kirklin JK, 2014, J HEART LUNG TRANSPL, V33, P555, DOI 10.1016/j.healun.2014.04.010; Aggarwal A, 2013, ANN THORAC SURG, V95, P493, DOI 10.1016/j.athoracsur.2012.09.020; Westaby S, 2007, J THORAC CARDIOV SUR, V133, P575, DOI 10.1016/j.jtcvs.2006.10.014; Connelly JH, 2003, J HEART LUNG TRANSPL, V22, P1291, DOI 10.1016/S1053-2498(03)00028-7; Deo SV, 2014, ASAIO J, V60, P183, DOI 10.1097/MAT.0000000000000042; Gregory SD, 2013, ARTIF ORGANS, V37, P802, DOI 10.1111/aor.12143; Hata H, 2014, EUR J CARDIO-THORAC, V46, P193, DOI 10.1093/ejcts/ezt559; Holtz Jonathan, 2014, Curr Heart Fail Rep, V11, P103, DOI 10.1007/s11897-013-0172-6; Karmonik C, 2014, J THORAC CARDIOV SUR, V147, P1326, DOI 10.1016/j.jtcvs.2013.09.069; Martina JR, 2013, INTERACT CARDIOV TH, V17, P616, DOI 10.1093/icvts/ivt263; Simon MA, 2010, J CARD FAIL, V16, P99, DOI 10.1016/j.cardfail.2009.10.018; Simon MA, 2005, CIRCULATION S, V112, pI32; Slaughter MS, 2010, J HEART LUNG TRANSPL, V29, pS1, DOI 10.1016/j.healun.2010.01.011; Soucy KG, 2013, J HEART LUNG TRANSPL, V32, P581, DOI 10.1016/j.healun.2013.02.010; Stanfield JR, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4023525	28	5	5	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JAN	2015	79	1					104	U363		10.1253/circj.CJ-14-0944		10	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX4KD	WOS:000346900700020		
J	Shirakabe, A; Hata, N; Kobayashi, N; Okazaki, H; Shinada, T; Tomita, K; Yamamoto, M; Tsurumi, M; Matsushita, M; Yamamoto, Y; Yokoyama, S; Asai, K; Shimizu, W				Shirakabe, Akihiro; Hata, Noritake; Kobayashi, Nobuaki; Okazaki, Hirotake; Shinada, Takuro; Tomita, Kazunori; Yamamoto, Masanori; Tsurumi, Masafumi; Matsushita, Masato; Yamamoto, Yoshiya; Yokoyama, Shinya; Asai, Kuniya; Shimizu, Wataru			Serum Heart-Type Fatty Acid-Binding Protein Level Can Be Used to Detect Acute Kidney Injury on Admission and Predict an Adverse Outcome in Patients With Acute Heart Failure	CIRCULATION JOURNAL			English	Article						Acute decompensated heart failure; Liver fatty acid-binding protein; Mortality; Neutrophil gelatinase-associated lipocalin; Renal function	GELATINASE-ASSOCIATED LIPOCALIN; GLOMERULAR-FILTRATION-RATE; WORSENING RENAL-FUNCTION; RIFLE CRITERIA; URINARY BIOMARKERS; PROGNOSTIC IMPACT; CONSENSUS; SEVERITY; DISEASE; DAMAGE	Background: Different mechanisms of acute kidney injury (AKI) may exist for acute heart failure (AHF) patients compared with other patients. Methods and Results: We analyzed data from 282 patients with AHF. The biomarkers were measured within 30 min of admission. Patients were assigned to a no-AKI (n=213) or AKI group (Class R (n=49), Class I (n=15) or Class F (n=5)) using the RIFLE classifications on admission. We evaluated the relationships between the biomarkers and AKI, in-hospital mortality, all-cause death and HF events (HF re-admission, all-cause death) within 90 days. The serum heart-type fatty acid-binding protein (s-HFABP) levels were significantly higher in the AKI than in the no-AKI group, and the predictive biomarker for AKI was s-HFABP (odds ratio: 6.709; 95% confidence interval: 3.362-13.391). s-HFABP demonstrated an optimal balance between sensitivity and specificity (71.0%, 79.3%; area under the receiver-operating characteristic curve [AUC]=0.790) at 22.8 ng/ml for AKI, at 22.8 ng/ml for Class I/F (90.0%, 71.4%; AUC=0.836) and at 21.0 ng/ml for in-hospital mortality (74.3%, 70.0%; AUC=0.726). The Kaplan-Meier survival curves showed a significantly poorer prognosis in the high s-HFABP group (>= 22.9 ng/ml) than in other groups. Conclusions: The s-HFABP level can indicate AKI on admission, and a high s-HFABP level is associated with a poorer prognosis for AHF patients.	[Shirakabe, Akihiro; Hata, Noritake; Kobayashi, Nobuaki; Okazaki, Hirotake; Shinada, Takuro; Tomita, Kazunori; Yamamoto, Masanori; Tsurumi, Masafumi; Matsushita, Masato; Yamamoto, Yoshiya; Yokoyama, Shinya] Chiba Hokusoh Hosp, Nippon Med Sch, Div Intens Care Unit, Chiba 2701694, Japan; [Asai, Kuniya; Shimizu, Wataru] Nippon Med Sch, Dept Cardiovasc Med, Tokyo 113, Japan	Shirakabe, A (reprint author), Chiba Hokusoh Hosp, Nippon Med Sch, Div Intens Care Unit, 1715 Kamagari, Chiba 2701694, Japan.	s6042@nms.ac.jp		Kobayashi, Nobuaki/0000-0001-6757-4779			Matsui K, 2012, CIRC J, V76, P213, DOI 10.1253/circj.CJ-11-0342; Maisel AS, 2011, EUR J HEART FAIL, V13, P846, DOI 10.1093/eurjhf/hfr087; Hsieh MJ, 2013, CIRC J, V77, P217, DOI 10.1253/circj.CJ-12-0539; Shrestha K, 2012, AM J CARDIOL, V110, P1329, DOI 10.1016/j.amjcard.2012.06.035; Mullens W, 2009, J AM COLL CARDIOL, V53, P589, DOI 10.1016/j.jacc.2008.05.068; Hata N, 2010, EUR J HEART FAIL, V12, P32, DOI 10.1093/eurjhf/hfp169; Collins SP, 2012, EUR J HEART FAIL, V14, P1020, DOI 10.1093/eurjhf/hfs087; Endre ZH, 2011, KIDNEY INT, V79, P1119, DOI 10.1038/ki.2010.555; Bellomo R, 2007, INTENS CARE MED, V33, P409, DOI 10.1007/s00134-006-0478-x; Gheorghiade M, 2005, CIRCULATION, V112, P3958, DOI 10.1161/CIRCULATIONAHA.105.590091; Mori K, 2005, J CLIN INVEST, V115, P610, DOI 10.1172/JCI200523056; Shirakabe A, 2013, CIRC J, V77, P687, DOI 10.1253/circj.CJ-12-0994; Levey AS, 1999, ANN INTERN MED, V130, P461; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; LJUNGMAN S, 1990, DRUGS, V39, P10, DOI 10.2165/00003495-199000394-00004; Iseki K, 2008, INTERNAL MED, V47, P681, DOI 10.2169/internalmedicine.47.0906; Goto T, 2003, HEART, V89, P1303, DOI 10.1136/heart.89.11.1303; Dupont M, 2012, EUR J HEART FAIL, V14, P597, DOI 10.1093/eurjhf/hfs039; Doi K, 2011, CRIT CARE MED, V39, P2464, DOI 10.1097/CCM.0b013e318225761a; Ronco C, 2008, J AM COLL CARDIOL, V52, P1527, DOI 10.1016/j.jacc.2008.07.051; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Mathew TH, 2007, MED J AUSTRALIA, V187, P459; Sato N, 2008, J AM COLL CARDIOL, V51, pA338; Setsuta K, 2008, CIRC J, V72, P569; Shirakabe A, 2012, INT HEART J, V53, P313	25	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JAN	2015	79	1					119	128		10.1253/circj.CJ-14-0653		10	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX4KD	WOS:000346900700022		
J	Hirai, M; Kato, M; Kinugasa, Y; Sugihara, S; Yanagihara, K; Yamada, K; Watanabe, T; Yamamoto, K				Hirai, Masayuki; Kato, Masahiko; Kinugasa, Yoshiharu; Sugihara, Shinobu; Yanagihara, Kiyotaka; Yamada, Kensaku; Watanabe, Tomomi; Yamamoto, Kazuhiro			Clinical Scenario 1 Is Associated With Winter Onset of Acute Heart Failure	CIRCULATION JOURNAL			English	Article						Acute decompensated heart failure; Blood pressure; Diuretics; Seasonal variation	PRESERVED EJECTION FRACTION; ACUTE MYOCARDIAL-INFARCTION; SEASONAL-VARIATION; BLOOD-PRESSURE; MORTALITY; HOSPITALIZATION; TEMPERATURE; REGISTRY; JAPAN; POPULATION	Background: Several reports have evaluated the association between seasonal variation and acute heart failure (AHF) onset. Cold weather may induce AHF, but the clinical characteristics of patients susceptible to AHF during winter have not been established. Clinical Scenario (CS) is used in the early clinical management of AHF, so we investigated the relationship between CS classification and winter onset of AHF in Japan. Methods and Results: We enrolled 582 patients hospitalized for AHF and compared the frequency of AHF among the 4 seasons in each CS group to clarify the clinical characteristics of the winter onset group. Significant increase of AHF during winter was seen in CS1 (systolic blood pressure [SBP] (>140 mmHg) (P=0.01) but not in CS2 (SBP >= 100 and <= 140 mmHg) or CS3 (SBP <100 mmHg). CS1 patients were divided into winter and other season admission groups. In multivariate analysis, only lack of loop diuretic use was associated with winter admission of CS1 patients (odds ratio 0.562, 95% confidence interval: 0.256-0.798, P=0.006). Conclusions: Winter predominance of AHF was seen only in CS1, and lack of loop diuretic use was a risk factor for winter onset. Future studies are necessary to confirm whether loop diuretics are useful in preventing AHF with CS1 in winter.	[Hirai, Masayuki; Kato, Masahiko; Kinugasa, Yoshiharu; Sugihara, Shinobu; Yanagihara, Kiyotaka; Yamada, Kensaku; Watanabe, Tomomi; Yamamoto, Kazuhiro] Tottori Univ, Fac Med, Dept Mol Med & Therapeut, Div Cardiovasc Med, Yonago, Tottori 6838504, Japan	Kato, M (reprint author), Tottori Univ, Fac Med, Dept Mol Med & Therapeut, Div Cardiovasc Med, 36-1 Nishimachi, Yonago, Tottori 6838504, Japan.	mkato@med.tottori-u.ac.jp					Ulmer H, 2004, WIEN KLIN WOCHENSCHR, V116, P662, DOI 10.1007/s00508-004-0222-x; Sung KC, 2006, INT J CARDIOL, V107, P338, DOI 10.1016/j.ijcard.2005.03.045; Gallerani M, 2011, CLIN CARDIOL, V34, P389, DOI 10.1002/clc.20895; Gheorghiade M, 2006, JAMA-J AM MED ASSOC, V296, P2217, DOI 10.1001/jama.296.18.2217; Stewart S, 2002, J AM COLL CARDIOL, V39, P760, DOI 10.1016/S0735-1097(02)01685-6; Sato N, 2013, CIRC J, V77, P944, DOI 10.1253/circj.CJ-13-0187; IZZO JL, 1990, AM J HYPERTENS, V3, P405; Arntz HR, 2000, EUR HEART J, V21, P315, DOI 10.1053/euhj.1999.1739; Mehta RH, 2002, CIRCULATION, V106, P1110, DOI 10.1161/01.CIR.0000027568.39540.4B; Spencer FA, 1998, J AM COLL CARDIOL, V31, P1226, DOI 10.1016/S0735-1097(98)00098-9; Inglis SC, 2008, EUR J HEART FAIL, V10, P540, DOI 10.1016/j.ejheart.2008.03.008; Tu YK, 2013, J AM SOC HYPERTENS, V7, P216, DOI 10.1016/j.jash.2013.01.008; Boulay F, 1999, CIRCULATION, V100, P280; Kinugasa Y, 2013, CIRC J, V77, P705, DOI 10.1253/circj.CJ-12-1091; Gallerani M, 2007, CHRONOBIOL INT, V24, P143, DOI 10.1080/07420520601139755; Dohi K, 2014, CIRC J, V78, P1816, DOI 10.1253/circj.CJ-14-0592; MARCHANT B, 1993, BRIT HEART J, V69, P385; Kawaguchi M, 2003, CIRCULATION, V107, P714, DOI 10.1161/01.CIR.0000048123.22359.A0; Tsutsui H, 2007, CIRC J, V71, P449, DOI 10.1253/circj.71.449; Díaz Alejandro, 2007, Congest Heart Fail, V13, P263, DOI 10.1111/j.1527-5299.2007.07124.x; Kaneko H, 2014, J CARDIOL, V64, P470, DOI 10.1016/j.jjcc.2014.03.004; KUPARI M, 1990, AM J CARDIOL, V66, P1519, DOI 10.1016/0002-9149(90)90549-G; Martinez-Selles M, 2002, EUR J HEART FAIL, V4, P779, DOI 10.1016/S1388-9842(02)00116-2; Masuyama T, 2012, CIRC J, V76, P833, DOI 10.1253/circj.CJ-11-1500; Mebazaa Alexandre, 2008, Crit Care Med, V36, pS129, DOI 10.1097/01.CCM.0000296274.51933.4C; Milo-Cotter O, 2006, J CARD FAIL, V12, P114, DOI 10.1016/j.cardfail.2005.09.006; Ogawa M, 2007, CIRC J, V71, P455, DOI 10.1253/circj.71.455; Sandoval C, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-59; Walma EP, 1997, BRIT MED J, V315, P464	29	4	4	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JAN	2015	79	1					129	135		10.1253/circj.CJ-14-0710		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX4KD	WOS:000346900700023		
J	Nomura, A; Konno, T; Fujita, T; Tanaka, Y; Nagata, Y; Tsuda, T; Hodatsu, A; Sakata, K; Nakamura, H; Kawashiri, MA; Fujino, N; Yamagishi, M; Hayashi, K				Nomura, Akihiro; Konno, Tetsuo; Fujita, Takashi; Tanaka, Yoshihiro; Nagata, Yoji; Tsuda, Toyonobu; Hodatsu, Akihiko; Sakata, Kenji; Nakamura, Hiroyuki; Kawashiri, Masa-Aki; Fujino, Noboru; Yamagishi, Masakazu; Hayashi, Kenshi			Fragmented QRS Predicts Heart Failure Progression in Patients With Hypertrophic Cardiomyopathy	CIRCULATION JOURNAL			English	Article						Clinical outcome; Fragmented QRS complex; Hypertrophic cardiomyopathy	CARDIOVASCULAR MAGNETIC-RESONANCE; MOLECULAR-GENETIC DIAGNOSIS; CORONARY-ARTERY-DISEASE; SUDDEN-DEATH; PROGNOSTIC-SIGNIFICANCE; MYOCARDIAL SCAR; OF-CARDIOLOGY; MARKER; ASSOCIATION; MUTATIONS	Background: Although fragmented QRS complex (frag-QRS) reflecting intra-ventricular conduction delay has been shown to be a prognostic marker for cardiac events, few data exist regarding the impact of frag-QRS on cardiac events in hypertrophic cardiomyopathy (HCM). Methods and Results: Ninety-four HCM patients (56 male; mean age, 58 +/- 17 years) were retrospectively investigated. Frag-QRS was defined as the presence of various RsR' patterns in at least 2 contiguous ECG leads. Major arrhythmic events (MAE) were defined as sudden cardiac death, and combined sustained ventricular tachycardia/ ventricular fibrillation. New-onset atrial fibrillation (AF) was diagnosed based on ECG during provisional or routine medical examination. Heart failure (HF) with hospitalization was defined as hospital admission due to subjective or objective symptoms. Frag-QRS was detected in 31 patients (33%). TNNI3 was the most frequent disease-causing gene. Median follow-up was 4.6 years. The 4-year cumulative survival rates of cardiac death, MAE, new-onset AF and HF with hospitalization were 97.6%, 94.6%, 87.5% and 89.3%, respectively. On multivariate analysis, frag-QRS was significantly associated with HF with hospitalization (adjusted hazard ratios [95% confidence intervals]: 5.4 [1.2-36], P=0.03). Moreover, HF-free survival was significantly lower in the frag-QRS (+) group compared to the frag-QRS (-) group (79.0% vs. 95.1%, P=0.03). Conclusions: Frag-QRS is associated with HF with hospitalization in HCM patients who had a unique distribution of gene mutations.	[Nomura, Akihiro; Konno, Tetsuo; Fujita, Takashi; Tanaka, Yoshihiro; Nagata, Yoji; Tsuda, Toyonobu; Hodatsu, Akihiko; Sakata, Kenji; Kawashiri, Masa-Aki; Fujino, Noboru; Yamagishi, Masakazu; Hayashi, Kenshi] Kanazawa Univ, Grad Sch Med, Div Cardiovasc Med, Kanazawa, Ishikawa 9208641, Japan; [Konno, Tetsuo; Nakamura, Hiroyuki; Yamagishi, Masakazu] Kanazawa Univ, Res & Educ Ctr Innovat & Prevent Med, Kanazawa, Ishikawa 9208641, Japan; [Nakamura, Hiroyuki] Kanazawa Univ, Grad Sch Med Sci, Dept Publ Hlth, Kanazawa, Ishikawa 9208641, Japan	Konno, T (reprint author), Kanazawa Univ, Res & Educ Ctr Innovat & Prevent Med, 13-1 Takaramachi, Kanazawa, Ishikawa 9208641, Japan.	konnokontetsuo@staff.kanazawa-u.ac.jp			Ministry of Health, Welfare and Labor of Japan; Yoshida Scholarship Foundation	Masakazu Yamagishi was funded by a research grant for cardiovascular diseases (20C-4) from the Ministry of Health, Welfare and Labor of Japan. Akihiro Nomura was funded by the Yoshida Scholarship Foundation.	Adabag AS, 2008, J AM COLL CARDIOL, V51, P1369, DOI 10.1016/j.jacc.2007.11.071; Fujino N, 2013, CLIN CARDIOL, V36, P160, DOI 10.1002/clc.22082; Mogensen J, 2004, J AM COLL CARDIOL, V44, P2315, DOI 10.1016/j.jacc.2004.05.088; Konno T, 2004, EUR HEART J, V25, P246, DOI 10.1016/j.ehj.2003.10.031; Choudhury L, 2002, J AM COLL CARDIOL, V40, P2156, DOI 10.1016/S0735-1097(02)02602-5; Peters S, 2008, HEART RHYTHM, V5, P1417, DOI 10.1016/j.hrthm.2008.07.012; Maron BJ, 2000, NEW ENGL J MED, V342, P365, DOI 10.1056/NEJM200002103420601; Kang KW, 2014, HEART RHYTHM, V11, P1433, DOI 10.1016/j.hrthm.2014.05.002; Maron BJ, 2010, CIRCULATION, V121, P445, DOI 10.1161/CIRCULATIONAHA.109.878579; Bruder O, 2010, J AM COLL CARDIOL, V56, P875, DOI 10.1016/j.jacc.2010.05.007; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Marine JE, 2013, J AM COLL CARDIOL, V62, P595, DOI 10.1016/j.jacc.2013.05.026; Das MK, 2006, CIRCULATION, V113, P2495, DOI 10.1161/CIRCULATIONHA.105.595892; Hayashi T, 2013, CIRC J, V77, P2889, DOI 10.1253/circj.CJ-13-0335; O'Hanlon R, 2010, J AM COLL CARDIOL, V56, P867, DOI 10.1016/j.jacc.2010.05.010; Maron BJ, 2013, LANCET, V381, P242, DOI 10.1016/S0140-6736(12)60397-3; Das MK, 2008, CIRC-ARRHYTHMIA ELEC, V1, P258, DOI 10.1161/CIRCEP.107.763284; Morita H, 2008, CIRCULATION, V118, P1697, DOI 10.1161/CIRCULATIONAHA.108.770917; Elliott PM, 2006, HEART, V92, P785, DOI 10.1136/hrt.2005.068577; Gersh BJ, 2011, J AM COLL CARDIOL, V58, pE212, DOI 10.1016/j.jacc.2011.06.011; Femenia F, 2013, J INTERV CARD ELECTR, V38, P159, DOI 10.1007/s10840-013-9829-z; Van Driest SL, 2003, CIRCULATION, V108, P445, DOI 10.1161/01.CIR.0000080896.52003.DF; van den Wijngaard A, 2011, NETH HEART J, V19, P344, DOI 10.1007/s12471-011-0135-z; Baranchuk A, 2012, INT J CARDIOL, V160, P151, DOI 10.1016/j.ijcard.2012.05.072; Basso C, 2009, EUR HEART J, V30, P1627, DOI 10.1093/eurheartj/ehp121; Das MK, 2009, HEART RHYTHM, V6, pS8, DOI 10.1016/j.hrthm.2008.10.019; Fujita T, 2013, JACC-HEART FAIL, V1, P459, DOI 10.1016/j.jchf.2013.08.007; Haraoka K, 2010, HEART RHYTHM, V7, P1808, DOI 10.1016/j.hrthm.2010.09.008; Kawashiri M, 2014, HEART VESSELS, V29, P129, DOI 10.1007/s00380-013-0391-5; Konno T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101465; Konno T, 2007, CLIN SCI, V112, P577, DOI 10.1042/CS20060293; KULAKOWSKI P, 1993, EUR HEART J, V14, P941; Kusano KF, 2013, CIRC J, V77, P2873, DOI 10.1253/circj.CJ-13-1311; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; McLeod CJ, 2009, J AM COLL CARDIOL, V54, P229, DOI 10.1016/j.jacc.2009.02.071; Ozawa K, 2013, INT J CARDIOL, V168, P5015, DOI 10.1016/j.ijcard.2013.07.155; Puntmann VO, 2010, CIRC J, V74, P1197, DOI 10.1253/circj.CJ-09-1003; TEARE D, 1958, BRIT HEART J, V20, P1	38	2	2	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JAN	2015	79	1					136	143		10.1253/circj.CJ-14-0822		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX4KD	WOS:000346900700024		
J	Suwa, K; Saitoh, T; Takehara, Y; Sano, M; Nobuhara, M; Saotome, M; Urushida, T; Katoh, H; Satoh, H; Sugiyama, M; Wakayama, T; Alley, M; Sakahara, H; Hayashi, H				Suwa, Kenichiro; Saitoh, Takeji; Takehara, Yasuo; Sano, Makoto; Nobuhara, Mamoru; Saotome, Masao; Urushida, Tsuyoshi; Katoh, Hideki; Satoh, Hiroshi; Sugiyama, Masataka; Wakayama, Tetsuya; Alley, Marcus; Sakahara, Harumi; Hayashi, Hideharu			Characteristics of Intra-Left Atrial Flow Dynamics and Factors Affecting Formation of the Vortex Flow - Analysis With Phase-Resolved 3-Dimensional Cine Phase Contrast Magnetic Resonance Imaging	CIRCULATION JOURNAL			English	Article						Flow dynamics; Left atrium; Magnetic resonance imaging; Pulmonary vein; Vortex	BLOOD-FLOW; MRI; ECHOCARDIOGRAPHY; HEMODYNAMICS; PATTERNS; HEART; CARDIOMYOPATHY; VISUALIZATION; FIBRILLATION; ASSOCIATION	Background: The intra-left atrial (LA) blood flow from pulmonary veins (PVs) to the left ventricle (LV) changes under various conditions and might affect global cardiac function. By using phase-resolved 3-dimensional cine phase contrast magnetic resonance imaging (4D-Flow), the intra-LA vortex formation was visualized and the factors affecting the intra-LA flow dynamics were examined. Methods and Results: Thirty-two patients with or without organic heart diseases underwent 4D-Flow and transthoracic echocardiography. The intra-LA velocity vectors from each PV were post-processed to delineate streamline and pathline images. The vector images revealed intra-LA vortex formation in 20 of 32 patients. All the vortices developed during the late systolic and early diastolic phases and were directed counter-clockwise when viewed from the subjects' cranial side. The flow vectors from the right PVs lengthened predominantly toward the mitral valves and partly toward the LA appendage, whereas those from the left PVs directed rightward along the posterior wall and joined the vortex. Patients with vortex had less organic heart diseases, smaller LV and LA volume, and greater peak flow velocity and volume mainly in the left PVs, although the flow directions from each PV or PV areas did not differ. Conclusions: 4D-Flow can clearly visualize the intra-LA vortex formation and analyze its characteristic features. The vortex formation might depend on LV and LA volume and on flow velocity and volume from PVs.	[Suwa, Kenichiro; Sano, Makoto; Nobuhara, Mamoru; Saotome, Masao; Urushida, Tsuyoshi; Katoh, Hideki; Satoh, Hiroshi; Hayashi, Hideharu] Hamamatsu Univ Hosp, Div Cardiol, Hamamatsu, Shizuoka, Japan; [Saitoh, Takeji] Hamamatsu Univ Hosp, Dept Emergency Med, Hamamatsu, Shizuoka, Japan; [Takehara, Yasuo] Hamamatsu Univ Hosp, Dept Radiol, Hamamatsu, Shizuoka, Japan; [Sugiyama, Masataka; Sakahara, Harumi] Hamamatsu Univ Sch Med, Dept Radiol, Hamamatsu, Shizuoka 4313129, Japan; [Wakayama, Tetsuya] GE Healthcare Japan, Appl Sci Lab Asia Pacific, Hino, Tokyo, Japan; [Alley, Marcus] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA USA	Satoh, H (reprint author), Hamamatsu Univ Sch Med, Div Cardiol, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313129, Japan.	satoh36@hama-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [25461050]	The authors thank the sonographers in the clinical laboratory of Hamamatsu University Hospital for their help with the data collection in terms of TTE. This study was supported by the Ministry of Education, Culture, Sports, Science and Technology, Grants-in-Aid for Scientific Research (Grant Number 25461050).	Frydrychowicz A, 2008, J THORAC CARDIOV SUR, V136, P400, DOI 10.1016/j.jtcvs.2008.02.062; Frydrychowicz A, 2007, J COMPUT ASSIST TOMO, V31, P9, DOI 10.1097/01.rct.0000232918.45158.c9; Mano Y, 2013, EUR J VASC ENDOVASC, V46, P321, DOI 10.1016/j.ejvs.2013.06.011; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Isoda H, 2010, NEURORADIOLOGY, V52, P921, DOI 10.1007/s00234-009-0635-3; Matoh F, 2007, J CARD FAIL, V13, P372, DOI 10.1016/j.cardfail.2007.02.001; KILNER PJ, 1993, CIRCULATION, V88, P2235; Kilner PJ, 2000, NATURE, V404, P759, DOI 10.1038/35008075; Markl M, 2003, J MAGN RESON IMAGING, V17, P499, DOI 10.1002/jmri.10272; Fyrenius A, 2001, HEART, V86, P448, DOI 10.1136/heart.86.4.448; Yamashita S, 2007, J MAGN RESON IMAGING, V25, P473, DOI 10.1002/jmri.20828; Thomas L, 2002, J AM COLL CARDIOL, V40, P1630, DOI 10.1016/S0735-1097(02)02371-9; Bammer R, 2007, MAGN RESON MED, V57, P127, DOI 10.1002/mrm.21109; Bachler P, 2013, MAGN RESON IMAGING, V31, P178, DOI 10.1016/j.mri.2012.06.036; Eitel I, 2011, JAMA-J AM MED ASSOC, V306, P277, DOI 10.1001/jama.2011.992; Fluckiger JU, 2013, J MAGN RESON IMAGING, V38, P580, DOI 10.1002/jmri.23994; Foll D, 2013, EUR HEART J-CARD IMG, V14, P366, DOI 10.1093/ehjci/jes196; Inaba T, 2013, CIRC J, V77, P198, DOI 10.1253/circj.CJ-12-0203; Liu ZP, 2006, IEEE T VIS COMPUT GR, V12, P965, DOI 10.1109/TVCG.2006.116; Lorensen W. E., 1987, COMPUT GRAPH, V21, P163, DOI DOI 10.1145/37402.37422; Markl M, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-7; Nogami Y, 2013, EUR HEART J-CARD IMG, V14, P253, DOI 10.1093/ehjci/jes149; Park SJ, 2013, CIRC J, V77, P2390, DOI 10.1253/circj.CJ-13-0109; Richardson C, 1996, CIRCULATION, V93, P41; Son JW, 2012, CIRC J, V76, P2640, DOI 10.1253/circj.CJ-12-0360; Tanaka M, 2008, J CARDIOL, V52, P86, DOI 10.1016/j.jjcc.2008.05.005; Tayyareci Y, 2010, CIRC J, V74, P2109, DOI 10.1253/circj.CJ-10-0197; Thomas L, 2003, Eur J Echocardiogr, V4, P92, DOI 10.1053/euje.2002.0622; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1583	29	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JAN	2015	79	1					144	152		10.1253/circj.CJ-14-0562		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX4KD	WOS:000346900700025		
J	Kiriyama, T; Kumita, S; Moroi, M; Nishimura, T; Tamaki, N; Hasebe, N; Kikuchi, K				Kiriyama, Tomonari; Kumita, Shin-ichiro; Moroi, Masao; Nishimura, Tsunehiko; Tamaki, Nagara; Hasebe, Naoyuki; Kikuchi, Kenjiro			Interpretative Variability and Its Impact on the Prognostic Value of Myocardial Fatty Acid Imaging in Asymptomatic Hemodialysis Patients in a Multicenter Trial in Japan	CIRCULATION JOURNAL			English	Article						beta-methyl iodophenyl-pentadecanoic acid; Hemodialysis; Interpretive variability; Prognostic value; Single-photon emission computed tomography	EMISSION COMPUTED-TOMOGRAPHY; CHRONIC KIDNEY-DISEASE; NUCLEAR CARDIOLOGY; PERFUSION; RISK; ASSOCIATION; VALIDATION; METABOLISM; INFARCTION; STATEMENT	Background: The severity of impaired fatty acid utilization in the myocardium can predict cardiac death in asymptomatic patients on hemodialysis. However, interpretive variability and its impact on the prognostic value of myocardial fatty acid imaging are unknown. Methods and Results: A total of 677 patients who received hemodialysis for >= 20 years and had one or more cardiovascular risk factors underwent I-123-labeled beta-methyl iodophenyl-pentadecanoic acid (BMIPP) single-photon emission computed tomography (SPECT) at 48 hospitals across Japan. SPECT images were interpreted by experts at the nuclear core laboratory and by readers with varying skill levels at clinical centers, based on the standard 17-segment model and 5-point scoring systems, independently. The. values only reached fair agreement both for overall impression (kappa=0.298, normal vs. abnormal) and for categorical impression (kappa=0.244, normal vs. mildly abnormal vs. severely abnormal). The normalcy rate was lower in readers at the clinical centers (60.9%) than in experts (69.9%). In contrast to the results assessed by experts, a Kaplan-Meier analysis based on the interpretation by readers at the clinical centers failed to distinguish the risk of events in patients with normal scans from that of patients with mildly abnormal scans. Conclusions: Considerable variability and its impact on prognostic value were observed in the visual interpretation of BMIPP SPECT images between experts and readers at the clinical centers.	[Kiriyama, Tomonari; Kumita, Shin-ichiro] Nippon Med Sch, Dept Radiol, Tokyo 1130022, Japan; [Moroi, Masao] Toho Univ, Ohashi Med Ctr, Dept Cardiovasc Med, Tokyo, Japan; [Nishimura, Tsunehiko] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Kyoto, Japan; [Tamaki, Nagara] Hokkaido Univ, Grad Sch Med, Dept Nucl Med, Sapporo, Hokkaido, Japan; [Hasebe, Naoyuki; Kikuchi, Kenjiro] Asahikawa Med Univ, Dept Internal Med, Cardiovasc Resp & Neurol Div, Asahikawa, Hokkaido, Japan	Kiriyama, T (reprint author), Nippon Med Sch, Dept Radiol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1130022, Japan.	s7026@nms.ac.jp			Foundation for Biomedical Research and Innovation (Kobe, Japan); Nihon Mediphysics (Kobe, Japan)	This study was supported by the Foundation for Biomedical Research and Innovation (Kobe, Japan).; Dr Moroi has received speaker fees from Nihon Mediphysics (Kobe, Japan). The other authors declare that they have no relevant financial interests.	Fukuoka R, 2013, CIRC J, V77, P137, DOI 10.1253/circj.CJ-12-0011; Golub RJ, 1999, J NUCL CARDIOL, V6, P257, DOI 10.1016/S1071-3581(99)90037-5; Yoda S, 2012, J CARDIOL, V60, P377, DOI 10.1016/j.jjcc.2012.06.011; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Moroi M, 2013, AM J KIDNEY DIS, V61, P466, DOI 10.1053/j.ajkd.2012.09.017; Momose M, 2012, CIRC J, V76, P2633, DOI 10.1253/circj.CJ-12-0435; Douglas PS, 2009, J AM COLL CARDIOL, V53, P76, DOI 10.1016/j.jacc.2008.09.005; Hasebe N, 2008, THER APHER DIAL, V12, P526, DOI 10.1111/j.1744-9987.2008.00643.x; Golub RJ, 1996, J NUCL CARDIOL, V3, P114, DOI 10.1016/S1071-3581(96)90003-3; Foley R N, 1998, J Am Soc Nephrol, V9, pS16; Hwang EH, 1998, J NUCL MED, V39, P1681; Nakajima K, 2012, CIRC J, V76, P168, DOI 10.1253/circj.CJ-11-0857; Nakata T, 2000, NUCL MED COMMUN, V21, P897, DOI 10.1097/00006231-200010000-00003; RITCHIE JL, 1995, J AM COLL CARDIOL, V25, P19, DOI 10.1016/0735-1097(95)96219-O; Suleiman K, 1997, NUCL MED COMMUN, V18, P922, DOI 10.1097/00006231-199710000-00005; Tani S, 2014, CIRC J, V78, P841, DOI 10.1253/circj.CJ-14-0128; WACKERS FJT, 1993, J AM COLL CARDIOL, V21, P1064; Yoda S, 2014, J CARDIOL, V63, P350, DOI 10.1016/j.jjcc.2013.10.004; Yoda S, 2014, J CARDIOL, V64, P395, DOI 10.1016/j.jjcc.2014.02.025; Yoshinaga K, 2011, CIRC J, V75, P2187, DOI 10.1253/circj.CJ-10-1272	20	2	2	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JAN	2015	79	1					153	160		10.1253/circj.CJ-14-0646		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX4KD	WOS:000346900700026		
J	Izawa, A; Kashima, Y; Miura, T; Ebisawa, S; Kitabayashi, H; Yamamoto, H; Sakurai, S; Kagoshima, M; Tomita, T; Miyashita, Y; Koyama, J; Ikeda, U				Izawa, Atsushi; Kashima, Yuichiro; Miura, Takashi; Ebisawa, Soichiro; Kitabayashi, Hiroshi; Yamamoto, Hiroaki; Sakurai, Shunpei; Kagoshima, Mitsuru; Tomita, Takeshi; Miyashita, Yusuke; Koyama, Jun; Ikeda, Uichi		ALPS-AMI Investigators	Assessment of Lipophilic vs. Hydrophilic Statin Therapy in Acute Myocardial Infarction - ALPS-AMI Study -	CIRCULATION JOURNAL			English	Article						Acute myocardial infarction; Secondary prevention; Statin	DENSITY-LIPOPROTEIN CHOLESTEROL; ACUTE CORONARY SYNDROME; COA REDUCTASE INHIBITORS; HEART-FAILURE; CARDIOVASCULAR-DISEASE; SECONDARY PREVENTION; CLINICAL-OUTCOMES; JAPANESE PATIENTS; ARTERY-DISEASE; TARGETS TNT	Background: Statins reduce the incidence of cardiovascular events, but no randomized trial has investigated the best statins for secondary prevention. We compared the efficacy of hydrophilic pravastatin with that of lipophilic atorvastatin in patients with acute myocardial infarction (AMI). Methods and Results: A prospective, multicenter study enrolled 508 patients (410 men; mean age, 66.0 +/- 11.6 years) with AMI who were randomly assigned to atorvastatin (n=255) or pravastatin (n=253). The target control level of low-density lipoprotein cholesterol (LDL-C) was <100 mg/dl, and patients were followed for 2 years. The primary endpoint was the composite of death due to any cause, non-fatal myocardial infarction, non-fatal stroke, unstable angina or congestive heart failure requiring hospital admission, or any type of coronary revascularization. The primary endpoint occurred in 77 patients (30.4%) and in 80 patients (31.4%) in the pravastatin and atorvastatin groups, respectively (hazard ratio, 1.181; 95% confidence interval: 0.862-1.619; P=0.299), whereas greater reductions in serum total cholesterol and LDL-C were achieved in the atorvastatin group (P<0.001 for each). Changes in hemoglobin A1c, brain natriuretic peptide, and creatinine were not significant between the 2 regimens, and safety and treatment adherence were similar. Conclusions: On 2-year comparison of hydrophilic and lipophilic statins there was no significant difference in prevention of secondary cardiovascular outcome.	[Izawa, Atsushi; Kashima, Yuichiro; Miura, Takashi; Ebisawa, Soichiro; Tomita, Takeshi; Miyashita, Yusuke; Koyama, Jun; Ikeda, Uichi] Shinshu Univ, Sch Med, Dept Cardiovasc Med, Matsumoto, Nagano 3908621, Japan; [Kitabayashi, Hiroshi] Ina Gen Hosp, Ina, Saitama, Japan; [Yamamoto, Hiroaki] Nagano Chuo Hosp, Nagano, Japan; [Sakurai, Shunpei] Aizawa Hosp, Matsumoto, Nagano, Japan; [Kagoshima, Mitsuru] Joetsu Gen Hosp, Joetsu, Japan	Izawa, A (reprint author), Shinshu Univ, Sch Med, Dept Cardiovasc Med, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	izawa611@shinshu-u.ac.jp					Okada K, 2012, ATHEROSCLEROSIS, V224, P454, DOI 10.1016/j.atherosclerosis.2012.07.036; Nakamura H, 2009, ATHEROSCLEROSIS, V206, P512, DOI 10.1016/j.atherosclerosis.2009.03.031; Karthikeyan G, 2009, J AM COLL CARDIOL, V53, P244, DOI 10.1016/j.jacc.2008.09.041; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Lee KH, 2011, J AM COLL CARDIOL, V58, P1664, DOI 10.1016/j.jacc.2011.05.057; Kashima Y, 2009, J CARDIOL, V54, P76, DOI 10.1016/j.jjcc.2009.04.008; Taylor AJ, 2009, NEW ENGL J MED, V361, P2113, DOI 10.1056/NEJMoa0907569; Schachter M, 2005, FUND CLIN PHARMACOL, V19, P117, DOI 10.1111/j.1472-8206.2004.00299.x; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Okazaki S, 2004, CIRCULATION, V110, P1061, DOI 10.1161/01.CIR.0000140261.58966.A4; Lee HY, 2014, CIRC J, V78, P281, DOI 10.1253/circj.CJ-13-1494; Lin CF, 2011, CLIN THER, V33, P1120, DOI 10.1016/j.clinthera.2011.08.002; Takano H, 2013, CIRC J, V77, P917, DOI 10.1253/circj.CJ-12-1062; Khush KK, 2007, CIRCULATION, V115, P576, DOI 10.1161/CIRCULATIONAHA.106.625574; Hiro T, 2009, J AM COLL CARDIOL, V54, P293, DOI 10.1016/j.jacc.2009.04.033; Ho JE, 2012, AM J CARDIOL, V109, P1761, DOI 10.1016/j.amjcard.2012.02.019; Kastelein JJP, 2008, NEW ENGL J MED, V358, P1431, DOI 10.1056/NEJMoa0800742; Nakamura H, 2006, LANCET, V368, P1155, DOI 10.1016/S0140-6736(06)69472-5; Smith SC, 2011, J AM COLL CARDIOL, V58, P2432, DOI 10.1016/j.jacc.2011.10.824; Wang KL, 2012, J AM COLL CARDIOL, V60, P1231, DOI 10.1016/j.jacc.2012.05.019; Jukema JW, 2012, J AM COLL CARDIOL, V60, P875, DOI 10.1016/j.jacc.2012.07.007; Kouvelos GN, 2013, J CARDIOVASC PHARM T, V18, P5, DOI 10.1177/1074248412445506; Toyohara T, 2009, J AM SOC NEPHROL, V20, P2546, DOI 10.1681/ASN.2009070696; Mehra MR, 2002, J AM COLL CARDIOL, V40, P1609, DOI 10.1016/S0735-1097(02)02340-9; Ray KK, 2005, J AM COLL CARDIOL, V46, P1425, DOI 10.1016/j.jacc.2005.05.086; Arnaboldi L, 2010, CURR OPIN LIPIDOL, V21, P298, DOI 10.1097/MOL.0b013e32833b776c; Hirayama S, 2013, ATHEROSCLEROSIS, V230, P48, DOI 10.1016/j.atherosclerosis.2013.06.016; ICHIHARA K, 1993, J CARDIOVASC PHARM, V22, P852; Ijioma Nkechinyere, 2011, Expert Rev Cardiovasc Ther, V9, P131, DOI 10.1586/erc.10.179; Jones K, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6544; Kim Min Chul, 2011, Korean Journal of Internal Medicine, V26, P294, DOI 10.3904/kjim.2011.26.3.294; Makris GC, 2010, ATHEROSCLEROSIS, V213, P8, DOI 10.1016/j.atherosclerosis.2010.04.032; Miyauchi K, 2012, CIRC J, V76, P825, DOI 10.1253/circj.CJ-12-0135; Oh J, 2014, CIRC J, V78, P2447, DOI 10.1253/circj.CJ-14-0670; Okada K, 2012, CIRC J, V76, P1197, DOI 10.1253/circj.CJ-11-0966; Sakamoto T, 2007, CIRC J, V71, P1348, DOI 10.1253/circj.71.1348; Sakamoto T, 2006, AM J CARDIOL, V97, P1165, DOI 10.1016/j.amjcard.2005.11.031; Sakuma I, 2012, CIRC J, V76, P1324, DOI 10.1253/circj.CJ-12-0503; Satoh K, 2000, J CARDIOVASC PHARM, V35, P256, DOI 10.1097/00005344-200002000-00012; Steffens S, 2006, NAT CLIN PRACT NEPHR, V2, P378, DOI 10.1038/ncpneph0217	42	4	4	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JAN	2015	79	1					161	168		10.1253/circj.CJ-14-0877		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX4KD	WOS:000346900700027		
J	Kamata, S; Miyagawa, S; Fukushima, S; Imanishi, Y; Saito, A; Maeda, N; Shimomura, I; Sawa, Y				Kamata, Sokichi; Miyagawa, Shigeru; Fukushima, Satsuki; Imanishi, Yukiko; Saito, Atsuhiro; Maeda, Norikazu; Shimomura, Iichiro; Sawa, Yoshiki			Targeted Delivery of Adipocytokines Into the Heart by Induced Adipocyte Cell-Sheet Transplantation Yields Immune Tolerance and Functional Recovery in Autoimmune-Associated Myocarditis in Rats	CIRCULATION JOURNAL			English	Article						Adiponectin; Inflammation; Myocarditis; Transplantation	FULMINANT MYOCARDITIS; DIASTOLIC FUNCTION; MYOBLAST SHEET; ADIPONECTIN; FAILURE; CARDIOMYOPATHY; INFLAMMATION; INFARCTION; IMPROVES	Background: Clinical prognosis is critically poor in fulminant myocarditis, while it's initiation or progression is fated, in part, by T cell-mediated autoimmunity. Adiponectin (APN) and associated adipokines were shown to be immune tolerance inducers, although the clinically relevant delivery method into target pathologies is under debate. Whether the cell sheet-based delivery system of adipokines might induce immune tolerance and functional recovery in experimental autoimmune myocarditis (EAM) was tested. Methods and Results: Scaffold-free-induced adipocyte cell-sheet (iACS) was generated by differentiating adipose tissue-derived syngeneic stromal vascular-fraction cells into adipocytes on temperature-responsive dishes. Rats with EAM underwent iACS implantation or sham operation. Supernatants of iACS contained a high level of APN and hepatocyte growth factor (HGF), and reduced proliferation of CD4-positive T cells in vitro. Immunohistolabelling showed that the iACS implantation elevated the levels of APN and HGF in the myocardium compared to the sham operation, which attenuated the immunological response by inhibiting CD68-positive macropharges and CD4-positive T-cells and activating Foxp3-positive regulatory T cells. Consequently, left ventricular ejection fraction was significantly greater after the iACS implantation than after the sham operation, in association with less collagen accumulation. Conclusions: The targeted delivery of adipokines using tissue-engineered iACS ameliorated cardiac performance of the EAM rat model via effector T cell suppression and induction of immune tolerance. These findings might suggest a potential of this tissue-engineered drug delivery system in treating fulminant myocarditis in the clinical setting.	[Kamata, Sokichi; Miyagawa, Shigeru; Fukushima, Satsuki; Imanishi, Yukiko; Saito, Atsuhiro; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka 5650871, Japan; [Maeda, Norikazu; Shimomura, Iichiro] Osaka Univ, Grad Sch Med, Dept Metab Med, Suita, Osaka 5650871, Japan	Sawa, Y (reprint author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	sawa-p@surg1.med.osaka-u.ac.jp			Japan Society for the Promotion of Science [A22659251]	We thank Ms Masako Yokoyama and Mr Akima Harada for their technical assistance. We also thank Mr Norikazu Maeda and Mr Iichiro Shimomura for helpful discussions. This study was financially supported by a Grant-in-Aid from the Japan Society for the Promotion of Science (A22659251).	Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Hoashi T, 2009, J THORAC CARDIOV SUR, V138, P460, DOI 10.1016/j.jtcvs.2009.02.018; Shimizu T, 2009, CURR PHARM DESIGN, V15, P2807; Cihakova D, 2008, ADV IMMUNOL, V99, P95, DOI 10.1016/S0065-2776(08)00604-4; HECHT TT, 1983, J IMMUNOL, V131, P1049; Shibata R, 2009, CIRC J, V73, P608; Baldeviano GC, 2010, CIRC RES, V106, P1646, DOI 10.1161/CIRCRESAHA.109.213157; Okamoto Y, 2009, TRANSPLANTATION, V88, P879, DOI 10.1097/TP.0b013e3181b6efbf; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Kunita E, 2012, CIRC J, V76, P1687, DOI 10.1253/circj.CJ-11-1442; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Ishikane S, 2010, J MOL CELL CARDIOL, V49, P753, DOI 10.1016/j.yjmcc.2010.07.019; Gupta S, 2008, NAT CLIN PRACT CARD, V5, P693, DOI 10.1038/ncpcardio1331; Yu F, 2008, INT J CARDIOL, V129, P414, DOI 10.1016/j.ijcard.2007.07.130; Eriksson U, 2003, NAT MED, V9, P1484, DOI 10.1038/nm960; Takehara N, 2008, J AM COLL CARDIOL, V52, P1858, DOI 10.1016/j.jacc.2008.06.052; Aoto T, 2011, TRANSGENIC RES, V20, P1245, DOI 10.1007/s11248-011-9492-z; Bobbert P, 2011, EUR HEART J, V32, P1134, DOI 10.1093/eurheartj/ehq498; Choi JO, 2011, HEART, V97, P1067, DOI 10.1136/hrt.2010.219568; Futamatsu H, 2005, CIRC RES, V96, P823, DOI 10.1161/01.RES.0000163016.52653.2e; Imanishi Y, 2011, CIRCULATION, V124, pS10, DOI 10.1161/CIRCULATIONAHA.110.009993; Miyagawa S, 2002, CIRCULATION, V105, P2556, DOI 10.1161/01.CIR.0000016722.37138.F2; Robinson K, 2011, CRIT CARE, V15, DOI 10.1186/cc10021; Saito S, 2012, TRANSPLANTATION, V93, P1108, DOI 10.1097/TP.0b013e31824fd803; Takeuchi K, 2003, ANAT REC PART A, V274A, P883, DOI 10.1002/ar.a.10111; Yin WH, 2012, CIRC J, V76, P2139, DOI 10.1253/circj.CJ-11-1549	26	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JAN	2015	79	1					169	U437		10.1253/circj.CJ-14-0840		17	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX4KD	WOS:000346900700028		
J	Ando, M; Takahashi, Y; Park, IS; Tomoike, H				Ando, Makoto; Takahashi, Yukihiro; Park, In-Sam; Tomoike, Hitonobu			Aircraft Transfer of Pediatric Patients With Intractable Cardiac or Airway Problems - Single-Institutional Experience of a Specialty Hospital -	CIRCULATION JOURNAL			English	Article						Congenital heart defects; Japan; Pediatrics	INTERHOSPITAL TRANSPORT; HELICOPTER; SERVICE	Background: There is currently a well-established network for the allocation of donor organs for transplantation in Japan, and emergency patients are often transported by the "Doctor Helicopter". However, interhospital transfer of patients, which can require aircraft with specialized equipment, depends on arrangement by each responsible hospital. Methods and Results: Since 2009 there were 41 interhospital aviation transfers of pediatric patients with intractable cardiac or airway diseases seeking surgical treatment at Sakakibara Heart Institute. Of these, 22 were newborns, 21 were on continuous drip infusion and 14 on mechanical ventilator support. In 15 cases (36.6%), a commercial airliner was used, with the remaining using chartered emergency aircraft (eg, local fire department helicopter, Self-Defense-Forces of Japan and the Doctor Helicopter). The median transfer time was 239 min for commercial airliners, 51 min for chartered aircraft departing directly from the referring hospital and 120.5 min for chartered aircraft departing from a nearby location. The efficiency of the transfer exemplified by the percentage of the time on board the aircraft was significantly lower for commercial airliners compared with chartered emergency aircraft. Conclusions: Further efforts and cooperation with government are required to obtain geographically uniform availability of carriers with optimal medical equipment to improve pediatric patient outcomes.	[Ando, Makoto; Takahashi, Yukihiro] Sakakibara Heart Inst, Dept Pediat Cardiac Surg, Tokyo 1830003, Japan; [Park, In-Sam] Sakakibara Heart Inst, Dept Pediat Cardiol, Tokyo 1830003, Japan; [Tomoike, Hitonobu] Sakakibara Heart Inst, Tokyo 1830003, Japan	Ando, M (reprint author), Sakakibara Heart Inst, Dept Pediat Cardiac Surg, 3-16-1 Asahi Cho, Tokyo 1830003, Japan.	maando@shi.heart.or.jp					Okamoto Y, 2013, CIRC J, V77, P2596, DOI 10.1253/circj.CJ-12-1604; Eliason SHY, 2013, AM J PERINAT, V30, P377, DOI 10.1055/s-0032-1324706; Arora P, 2014, AM J PERINAT, V31, P237, DOI 10.1055/s-0033-1345259; Clement KC, 2010, PEDIATR CRIT CARE ME, V11, P509, DOI 10.1097/PCC.0b013e3181c515ca; EDGE WE, 1994, CRIT CARE MED, V22, P1186, DOI 10.1097/00003246-199407000-00023; Hata N, 2006, INTERNAL MED, V45, P45, DOI 10.2169/internalmedicine.45.1399; Imaizumi T, 2004, J NIPPON MED SCH, V7, P352; ISHIDA T, 1984, Journal of Emergency Medicine, V2, P45, DOI 10.1016/0736-4679(84)90048-9; KANTER RK, 1989, PEDIATRICS, V84, P43; Matsumoto Hisashi, 2013, Air Med J, V32, P84, DOI 10.1016/j.amj.2012.06.011; Ohara M, 2008, J OBSTET GYNAECOL RE, V34, P189, DOI 10.1111/j.1447-0756.2008.00756.x; Philpot C, 2008, PEDIATR CRIT CARE ME, V9, P15, DOI 10.1097/01.PCC.0000298658.02753.C1; Tanigawa K, 2006, RESUSCITATION, V69, P365, DOI 10.1016/j.resuscitation.2006.04.001; Tase Choichiro, 2010, Fukushima J Med Sci, V56, P71, DOI 10.5387/fms.56.71; Ummenhofer W, 1996, SCHWEIZ MED WSCHR, V126, P1785; Vos GD, 2003, EUR J EMERG MED, V10, P195, DOI 10.1097/01.mej.0000089163.61827.be	16	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JAN	2015	79	1					180	184		10.1253/circj.CJ-14-0597		5	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX4KD	WOS:000346900700029		
J	Enomoto, J; Nakazawa, M				Enomoto, Junko; Nakazawa, Makoto			Negative Effect of Aging on Psychosocial Functioning of Adults With Congenital Heart Disease	CIRCULATION JOURNAL			English	Article						Adult congenital heart disease; Aging; Anxiety; Depression; Psychosocial functioning	QUALITY-OF-LIFE; MENTAL-HEALTH; DEPRESSION; ANXIETY; PREVALENCE; ADOLESCENTS; PREDICTORS; DISORDERS; SYMPTOMS; COHORT	Background: Improvements in life expectancy among adults with congenital heart disease (ACHD) provide them with unique challenges throughout their lives and age-related psychosocial tasks in this group might differ from those of healthy counterparts. This study aimed to clarify age-related differences in psychosocial functioning in ACHD patients and determine the factors influencing anxiety and depression. Methods and Results: A total of 133 ACHD patients (aged 20-46) and 117 reference participants (aged 20-43) were divided in 2 age groups (20s and 30s/40s) and completed the Hospital Anxiety and Depression Scale, Independent-Consciousness Scale, and Problem-Solving Inventory. Only ACHD patients completed an illness perception inventory. ACHD patients over 30showed a significantly greater percentage of probable anxiety cases than those in their 20s and the reference group. Moreover, ACHD patients over 30 who had lower dependence on parents and friends, registered higher independence and problem-solving ability than those in their 20s, whereas this element did not vary with age in the reference participants. Furthermore, ACHD patients may develop an increasingly negative perception of their illness as they age. The factors influencing anxiety and depression in patients were aging, independence, problem-solving ability, and NYHA functional class. Conclusions: Although healthy people are psychosocially stable after their 20s, ACHD patients experience major differences and face unique challenges even after entering adulthood.	[Enomoto, Junko] Toyo Univ, Fac Letters, Tokyo 1128606, Japan; [Nakazawa, Makoto] Southern Tohoku Gen Hosp, Pediat & Lifelong Congenital Cardiol Inst, Koriyama, Fukushima, Japan	Enomoto, J (reprint author), Toyo Univ, Fac Letters, Bunkyo Ku, 5-28-20 Hakusan, Tokyo 1128606, Japan.	enomoto@toyo.jp			JSPS [22730556]	Name of Grant: JSPS Grants-in-Aid for Scientific Research KAKENHI (No. 22730556) to J.E.	Moons P, 2005, HEART, V91, P1193, DOI 10.1136/hrt.2004.042234; HEPPNER PP, 1982, J COUNS PSYCHOL, V29, P66, DOI 10.1037/0022-0167.29.1.66; Eslami B, 2013, J PSYCHOSOM RES, V74, P49, DOI 10.1016/j.jpsychores.2012.10.006; Moons P, 2005, EUR HEART J, V26, P298, DOI 10.1093/eurheartj/ehi054; Pike NA, 2012, J CARDIOVASC NURS, V27, P539, DOI 10.1097/JCN.0b013e31822ce5f6; Marelli AJ, 2007, CIRCULATION, V115, P163, DOI 10.1161/CIRCULATIONAHA.106.627224; van Rijen EHM, 2005, INT J CARDIOL, V99, P315, DOI 10.1016/j.ijcard.2004.09.004; Scott KM, 2008, PSYCHOL MED, V38, P1659, DOI 10.1017/S0033291708003413; Muller J, 2013, INT J CARDIOL, V165, P142, DOI 10.1016/j.ijcard.2011.08.005; van Rijen EHM, 2003, EUR HEART J, V24, P673, DOI 10.1016/S0195-668X(02)00749-2; Horner T, 2000, MAYO CLIN PROC, V75, P31; Shiina Y, 2011, INT J CARDIOL, V146, P13, DOI 10.1016/j.ijcard.2009.05.032; Popelova J, 2001, CARDIOL YOUNG, V11, P379, DOI 10.1017/S1047951101000488; Kovacs AH, 2009, INT J CARDIOL, V137, P158, DOI 10.1016/j.ijcard.2008.06.042; Scott KM, 2007, J AFFECT DISORDERS, V103, P113, DOI 10.1016/j.jad.2007.01.015; Bromberg JI, 2003, HEART LUNG, V32, P105, DOI 10.1067/mhl.2003.26; Warnes CA, 2008, CIRCULATION, V118, pE714, DOI 10.1161/CIRCULATIONAHA.108.190690; Delmas C, 2013, CIRC J, V77, P175, DOI 10.1253/circj.CJ-12-0759; Enomoto J, 2013, CIRC J, V77, P749, DOI 10.1253/circj.CJ-12-0716; Hayashi K, 1985, JAPANESE J COUNSELIN, V17, P73; Katou T, 1980, JAPANESE J ED PSYCHO, V28, P336; Loup O, 2009, EUR J CARDIO-THORAC, V36, P105, DOI 10.1016/j.ejcts.2009.03.023; Muller J, 2012, INT J CARDIOL, V154, P265, DOI 10.1016/j.ijcard.2010.09.029; Nio K, 2008, J JPN SOC CHILD HLTH, V17, P1; Pauliks Linda B, 2013, World J Cardiol, V5, P186, DOI 10.4330/wjc.v5.i6.186; Riley JP, 2012, J ADV NURS, V68, P1050, DOI 10.1111/j.1365-2648.2011.05809.x; Suzuki T, 2011, CIRC J, V75, P2465, DOI 10.1253/circj.CJ-11-0140; van Rijen EHM, 2005, CARDIOL YOUNG, V15, P168, DOI 10.1017/S1047951105000351; Wang QF, 2012, J PEDIATR-US, V161, P943, DOI 10.1016/j.jpeds.2012.04.010; Zigmond AS, 1993, ARCH PSYCHIAT DIAGNO, V4, P371; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	31	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JAN	2015	79	1					185	192		10.1253/circj.CJ-14-0682		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX4KD	WOS:000346900700030		
J	Shikata, T; Sasaki, N; Ueda, M; Kimura, T; Itohara, K; Sugahara, M; Fukui, M; Manabe, E; Masuyama, T; Tsujino, T				Shikata, Toshiyuki; Sasaki, Naoko; Ueda, Masahiro; Kimura, Takeshi; Itohara, Kanako; Sugahara, Masataka; Fukui, Miho; Manabe, Eri; Masuyama, Tohru; Tsujino, Takeshi			Use of Proton Pump Inhibitors Is Associated With Anemia in Cardiovascular Outpatients	CIRCULATION JOURNAL			English	Article						Anemia; Cardiovascular disease; Hemoglobin; Proton pump inhibitor	HEART-FAILURE PATIENTS; ATRIAL-FIBRILLATION; CLINICAL-OUTCOMES; HEMOGLOBIN LEVELS; IRON-DEFICIENCY; CLOPIDOGREL; METABOLISM; ABSORPTION; OMEPRAZOLE; THERAPY	Background: Proton pump inhibitors (PPI) are frequently prescribed in combination with aspirin for preventing peptic ulcer in patients with atherosclerotic diseases. In contrast, long-term use of PPI has been suggested to be associated with iron or vitamin B-12 deficiency. The effect of PPI on hemoglobin (Hb) concentration, however, has not been clarified in cardiovascular outpatients. Methods and Results: We retrospectively investigated the clinical characteristics of 278 continuous outpatients who received blood test including complete blood count and serum creatinine concentration (mean age, 69.9 +/- 10.8 years; male, 68.7%). The frequency of anemia was 51% in patients receiving PPI and 19% in those not receiving PPI (chi-squared test, P<0.001). On multivariate analysis female sex (P<0.001), peripheral artery disease (P=0.003), PPI (P=0.003), low white blood cell count (P=0.004), old age (P=0.007), and low estimated glomerular filtration rate (P=0.010) were independently associated with low Hb. Among these patients, we investigated the change in Hb after the initiation of PPI in 36 patients for whom data on Hb level within 1 year before and within 1 year after the initiation of PPI were available. Mean decrease in Hb after the initiation of PPI was 0.38 +/- 0.87 g/dl (95% confidence interval: -0.67 to -0.09 g/dl). Conclusions: Use of PPI was associated with anemia in Japanese cardiovascular outpatients.	[Shikata, Toshiyuki; Ueda, Masahiro; Kimura, Takeshi] Hyogo Coll Med Hosp, Dept Pharm, Nishinomiya, Hyogo, Japan; [Shikata, Toshiyuki; Tsujino, Takeshi] Hyogo Univ Hlth Sci, Grad Sch Pharm, Kobe, Hyogo 6508530, Japan; [Sasaki, Naoko; Tsujino, Takeshi] Hyogo Univ Hlth Sci, Sch Pharm, Dept Pharm, Kobe, Hyogo 6508530, Japan; [Itohara, Kanako; Sugahara, Masataka; Fukui, Miho; Manabe, Eri; Masuyama, Tohru; Tsujino, Takeshi] Hyogo Coll Med, Dept Internal Med, Cardiovasc Div, Nishinomiya, Hyogo 6638501, Japan	Tsujino, T (reprint author), Hyogo Univ Hlth Sci, Sch Pharm, Dept Pharm, Chuo Ku, 1-3-6 Minatojima, Kobe, Hyogo 6508530, Japan.	ttsujino@huhs.ac.jp					Ajmal Adnan, 2013, BMC Res Notes, V6, P443, DOI 10.1186/1756-0500-6-443; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Hamaguchi S, 2009, CIRC J, V73, P1901; Groenveld HF, 2008, J AM COLL CARDIOL, V52, P818, DOI 10.1016/j.jacc.2008.04.061; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; Yamada M, 2003, EUR J HAEMATOL, V70, P129, DOI 10.1034/j.1600-0609.2003.00031.x; Zacharski LR, 2008, J NATL CANCER I, V100, P996, DOI 10.1093/jnci/djn209; Ali T, 2009, AM J MED, V122, P896, DOI 10.1016/j.amjmed.2009.04.014; Andrews NC, 2000, ANNU REV GENOM HUM G, V1, P75, DOI 10.1146/annurev.genom.1.1.75; McColl KEL, 2009, AM J GASTROENTEROL, V104, pS5, DOI 10.1038/ajg.2009.45; Hutchinson C, 2007, GUT, V56, P1291, DOI 10.1136/gut.2006.108613; Anderson GJ, 2009, CURR OPIN GASTROEN, V25, P129, DOI 10.1097/MOG.0b013e32831ef1f7; Ng FH, 2008, AM J GASTROENTEROL, V103, P865, DOI 10.1111/j.1572-0241.2007.01715.x; Munoz M, 2011, J CLIN PATHOL, V64, P281, DOI 10.1136/jcp.2010.079046; Miura M, 2014, CIRC J, V78, P2276, DOI 10.1253/circj.CJ-14-0387; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Krieg L, 2011, BLOOD, V118, P6418, DOI 10.1182/blood-2011-04-350082; Stewart CA, 1998, ALIMENT PHARM THERAP, V12, P83; Bhatt DL, 2008, CIRCULATION, V118, P1894, DOI 10.1161/CIRCULATIONAHA.108.191087; Komori M, 2014, CIRC J, V78, P1335, DOI 10.1253/circj.CJ-13-1534; Lanas A, 2000, NEW ENGL J MED, V343, P834, DOI 10.1056/NEJM200009213431202; Anderson GJ, 2009, CELL MOL LIFE SCI, V66, P3241, DOI 10.1007/s00018-009-0051-1; Bhatt DL, 2010, NEW ENGL J MED, V363, P1909, DOI 10.1056/NEJMoa1007964; MARCUARD SP, 1994, ANN INTERN MED, V120, P211; SULLIVAN JL, 1981, LANCET, V1, P1293; Chitose T, 2012, CIRC J, V76, P71, DOI 10.1253/circj.CJ-11-0699; Kaneko H, 2013, J CARDIOL, V62, P102, DOI 10.1016/j.jjcc.2013.03.013; Kosiuk J, 2014, CIRC J, V78, P2402, DOI 10.1253/circj.CJ-14-0665; Matsumoto M, 2008, INT HEART J, V49, P577, DOI 10.1536/ihj.49.577; Tanaka S, 2012, CIRC J, V76, P328, DOI 10.1253/circj.CJ-11-0398; Yano H, 2012, CIRC J, V76, P2673, DOI 10.1253/circj.CJ-12-0511; Yasaka M, 2014, CIRC J, V78, P2367, DOI 10.1253/circj.CJ-14-0720; Zhang AS, 2009, HEMATOL-AM SOC HEMAT, V1, P207, DOI DOI 10.1182/ASHEDUCATION-2009.1.207	33	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JAN	2015	79	1					193	200		10.1253/circj.CJ-14-0582		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX4KD	WOS:000346900700031		
J	Asaumi, Y; Noguchi, T; Morita, Y; Matsuyama, TA; Otsuka, F; Fujiwara, R; Kanaya, T; Nagai, T; Higashi, M; Kusano, K; Anzai, T; Ishibashi-Ueda, H; Ogawa, H; Yasuda, S				Asaumi, Yasuhide; Noguchi, Teruo; Morita, Yoshiaki; Matsuyama, Taka-Aki; Otsuka, Fumiyuki; Fujiwara, Reiko; Kanaya, Tomoaki; Nagai, Toshiyuki; Higashi, Masahiro; Kusano, Kengo; Anzai, Toshihisa; Ishibashi-Ueda, Hatsue; Ogawa, Hisao; Yasuda, Satoshi			Non-Contrast T1-Weighted Magnetic Resonance Imaging at 3.0 Tesla in a Patient Undergoing Elective Percutaneous Coronary Intervention - Clinical and Pathological Significance of High-Intensity Plaque -	CIRCULATION JOURNAL			English	Editorial Material							CEREBRAL-ISCHEMIA; CAROTID PLAQUE		[Asaumi, Yasuhide; Noguchi, Teruo; Otsuka, Fumiyuki; Fujiwara, Reiko; Kanaya, Tomoaki; Nagai, Toshiyuki; Kusano, Kengo; Anzai, Toshihisa; Ogawa, Hisao; Yasuda, Satoshi] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Suita, Osaka 5658565, Japan; [Morita, Yoshiaki; Higashi, Masahiro] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Radiol, Suita, Osaka 5658565, Japan; [Matsuyama, Taka-Aki; Ishibashi-Ueda, Hatsue] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Pathol, Suita, Osaka 5658565, Japan	Asaumi, Y (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	asaumi.yasuhide.hp@ncvc.go.jp	Anzai, Toshihisa/J-2179-2015	Anzai, Toshihisa/0000-0003-3319-4967			Kawasaki T, 2009, JACC-CARDIOVASC IMAG, V2, P720, DOI 10.1016/j.jcmg.2009.01.016; Noguchi T, 2014, J AM COLL CARDIOL, V63, P989, DOI 10.1016/j.jacc.2013.11.034; Noguchi T, 2013, CIRC J, V77, P1975, DOI 10.1253/circj.CJ-13-0651; Murphy RE, 2003, CIRCULATION, V107, P3053, DOI 10.1161/01.CIR.0000074204.92443.37; Underhill HR, 2008, RADIOLOGY, V248, P550, DOI 10.1148/radiol.2482071114; Moody AR, 2003, CIRCULATION, V107, P3047, DOI 10.1161/01.CIR.0000074222.61572.44; Asaumi Y, 2014, JACC-CARDIOVASC IMAG, DOI [10.1016/j.jcmg.2014.07.020, DOI 10.1016/J.JCMG.2014.07.020]; Nakashima T, 2013, CIRC J, V77, P2844, DOI 10.1253/circj.CJ-13-0539	8	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	JAN	2015	79	1					218	220		10.1253/circj.CJ-14-0897		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX4KD	WOS:000346900700035		
J	Takasu, T; Hayashizaki, Y; Tahara, A; Kurosaki, E; Takakura, S				Takasu, Toshiyuki; Hayashizaki, Yuka; Tahara, Atsuo; Kurosaki, Eiji; Takakura, Shoji			Antihyperglycemic effect of ipragliflozin, a sodium-glucose co-transporter 2 inhibitor, in combination with oral antidiabetic drugs in mice	CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY			English	Article						antidiabetic drugs; blood glucose; ipragliflozin; sodium-glucose transporter 2; type 2 diabetes mellitus	TYPE-2 DIABETES-MELLITUS; SELECTIVE SGLT2 INHIBITOR; GLUCAGON-LIKE PEPTIDE-1; GLYCEMIC CONTROL; INSULIN THERAPY; DOUBLE-BLIND; METFORMIN; DAPAGLIFLOZIN; PIOGLITAZONE; HYPERGLYCEMIA	Inhibition of sodium-glucose cotransporter2 is a novel strategy for glycemic control in type2 diabetes mellitus patients. As the mechanism of action of sodium-glucose cotransporter2 inhibitors on plasma glucose levels is distinct from that of existing oral antidiabetic drugs, a combination of the two might provide a therapeutic benefit. Here, we investigated the antihyperglycemic effect of ipragliflozin, a selective sodium-glucose cotransporter2 inhibitor, alone or in combination with oral antidiabetic drugs in a range of relevant mouse models to analyse the blood glucose-lowering properties of different drug types based on their mechanism of action. Oral glucose tolerance tests in ICR mice were used to evaluate the effect of ipragliflozin in combination with the insulin secretagogues, glibenclamide or nateglinide. Liquid meal tests in ICR mice and diabetic KK-A(y) mice were used to investigate the combined effect of ipragliflozin with the dipeptidyl peptidase-4 inhibitor, sitagliptin, and -glucosidase inhibitor, voglibose, respectively. Four-week repeated administration tests in KK-A(y) mice were used to examine the combined effect of ipragliflozin with the insulin sensitizers, pioglitazone and metformin. In all mouse models tested, the combination of ipragliflozin and existing oral antidiabetic drugs lowered blood glucose or glycated hemoglobin levels more than either monotherapy. In conclusion, inhibition of sodium-glucose cotransporter2 by ipragliflozin, alone or in combination with existing oral antidiabetic drugs, has a robust effect on blood glucose levels in a range of mouse models of hyperglycemia.	[Takasu, Toshiyuki; Hayashizaki, Yuka; Tahara, Atsuo; Kurosaki, Eiji; Takakura, Shoji] Astellas Pharma Inc, Tsukuba Res Ctr, Drug Discovery Res, Tsukuba, Ibaraki 3058585, Japan	Takakura, S (reprint author), Astellas Pharma Inc, Tsukuba Res Ctr, Drug Discovery Res, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan.	shoji.takakura@astellas.com					Vallon V, 2011, J AM SOC NEPHROL, V22, P104, DOI 10.1681/ASN.2010030246; Rosenstock J, 2012, DIABETES CARE, V35, P1232, DOI 10.2337/dc11-1926; Tahara A, 2012, J PHARMACOL SCI, V120, P36, DOI 10.1254/jphs.12089FP; OHKUBO Y, 1995, DIABETES RES CLIN PR, V28, P103, DOI 10.1016/0168-8227(95)01064-K; Bailey CJ, 2010, LANCET, V375, P2223, DOI 10.1016/S0140-6736(10)60407-2; Luna B, 2001, AM FAM PHYSICIAN, V63, P1747; Han SP, 2008, DIABETES, V57, P1723, DOI 10.2337/db07-1472; Kurosaki E, 2013, PHARMACOL THERAPEUT, V139, P51, DOI 10.1016/j.pharmthera.2013.04.003; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Rosenstock J, 2012, DIABETES CARE, V35, P1473, DOI 10.2337/dc11-1693; Wilding JPH, 2013, DIABETES OBES METAB, V15, P403, DOI 10.1111/dom.12038; [Anonymous], 1995, DIABETES CARE, V18, P1510; Turner RC, 1999, JAMA-J AM MED ASSOC, V281, P2005, DOI 10.1001/jama.281.21.2005; Tahara A, 2012, N-S ARCH PHARMACOL, V385, P423, DOI 10.1007/s00210-011-0713-z; Tolhurst G, 2009, J PHYSIOL-LONDON, V587, P27, DOI 10.1113/jphysiol.2008.164012; Oku A, 1999, DIABETES, V48, P1794, DOI 10.2337/diabetes.48.9.1794; IWATSUKA H, 1970, ENDOCRINOL JAPON, V17, P23; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Imamura M, 2012, BIOORGAN MED CHEM, V20, P3263, DOI 10.1016/j.bmc.2012.03.051; Smulders RA, 2012, DIABETES OBES METAB, V14, P937, DOI 10.1111/j.1463-1326.2012.01624.x; HERRMANN C, 1995, DIGESTION, V56, P117; Tahara A, 2013, EUR J PHARMACOL, V715, P246, DOI 10.1016/j.ejphar.2013.05.014; Bennett WL, 2012, J MANAG CARE PHAR SA, V1, ps3; HOFMANN CA, 1992, ENDOCRINOLOGY, V130, P735, DOI 10.1210/en.130.2.735; Lee YJ, 2007, KIDNEY INT, V72, pS27, DOI 10.1038/sj.ki.5002383; Miura T, 1998, BIOMED RES-TOKYO, V19, P335; Pouwer F, 2009, DIABETES-METAB RES, V25, pS4, DOI 10.1002/dmrr.981; Saydah SH, 2004, JAMA-J AM MED ASSOC, V291, P335, DOI 10.1001/jama.291.3.335; Shinozaki K, 1996, METABOLISM, V45, P731, DOI 10.1016/S0026-0495(96)90139-0; UK Prospective Diabetes Study (UKPDS) Group, 1998, LANCET, V352, P837, DOI DOI 10.1016/S0140-6736(98)07019-6; Veltkamp SA, 2012, CLIN THER, V34, P1761, DOI 10.1016/j.clinthera.2012.06.027	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1440-1681			CLIN EXP PHARMACOL P	Clin. Exp. Pharmacol. Physiol.	JAN	2015	42	1					87	93		10.1111/1440-1681.12317		7	Pharmacology & Pharmacy; Physiology	Pharmacology & Pharmacy; Physiology	AX1SU	WOS:000346727200011		
J	Zuhlsdorf, A; Park, JH; Wada, Y; Rust, S; Reunert, J; DuChesne, I; Gruneberg, M; Marquardt, T				Zuhlsdorf, Andrea; Park, Julien Heinrich; Wada, Yoshinao; Rust, Stephan; Reunert, Janine; DuChesne, Ingrid; Gruneberg, Marianne; Marquardt, Thorsten			Transferrin variants: Pitfalls in the diagnostics of Congenital disorders of glycosylation	CLINICAL BIOCHEMISTRY			English	Article						Congenital disorders of glycosylation; Transferrin; Mutation; Isoelectric focusing; Neuraminidase; Mass spectrometry; Carbohydrate deficient transferrin; Biomarker; High-performance liquid chromatography; Glycosylation	CARBOHYDRATE-DEFICIENT TRANSFERRIN; CAPILLARY-ZONE-ELECTROPHORESIS	Objectives: Transferrin variants can hinder the diagnostic process in cases of suspected Congenital disorders of glycosylation which affect N-Glycosylation. In addition they can impair the use of Carbohydrate deficient Transferrin as a biomarker for chronic alcohol abuse, in which Asialo-Transferrin and Disialo-Transferrin are increased. We present a novel transferrin variant as well as an overview of transferrin mutations found at our laboratory. Design and methods: Blood samples from patients with suspected CDG were analyzed using the standard diagnostic procedures of Isoelectric focusing and High-performance liquid chromatography as well as the additional procedures of neuraminidase digestion of glycans and Electrospray ionization time-of-flight mass spectrometry (ESI-TOF MS). Results: Four known and one previously unreported transferrin variants were identified. Neuraminidase digestion and ESI-TOF MS revealed changes in charge of the transferrin molecules while the glycosylation status was found to be normal. Conclusion: Transferrin variants are pitfalls in the diagnostics of CDG. The found variants change the charge of the transferrin molecule, thus affecting the standard diagnostic procedures. Neuraminidase digestion as well as ESI-TOF MS can identify variants and mutations in a laboratory context. (C) 2014 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.	[Zuhlsdorf, Andrea; Park, Julien Heinrich; Rust, Stephan; Reunert, Janine; DuChesne, Ingrid; Gruneberg, Marianne; Marquardt, Thorsten] Univ Klinikum Munster, Klin & Poliklin Kinder & Jugendmed Allgemeine Pad, D-48149 Munster, Germany; [Wada, Yoshinao] Osaka Univ, Osaka Med Ctr, Izumi, Osaka 5941101, Japan; [Wada, Yoshinao] Osaka Univ, Res Inst Maternal & Child Hlth, Izumi, Osaka 5941101, Japan	Marquardt, T (reprint author), Univ Klinikum Munster, Klin & Poliklin Kinder & Jugendmed Allgemeine Pad, Albert Schweitzer Campus 1,Gebaude A1, D-48149 Munster, Germany.	marquat@uni-muenster.de					Marklova E, 2007, CLIN CHIM ACTA, V385, P6, DOI 10.1016/j.cca.2007.07.002; Guillard M, 2011, J INHERIT METAB DIS, V34, P901, DOI 10.1007/s10545-011-9311-y; Jaeken J, 2013, HAND CLINIC, V113, P1737, DOI 10.1016/B978-0-444-59565-2.00044-7; de Wolf HK, 2011, CLIN CHIM ACTA, V412, P1683, DOI 10.1016/j.cca.2011.05.008; Cylwik B, 2013, ACTA BIOCHIM POL, V60, P361; Helander A, 2001, CLIN CHEM, V47, P1225; Kutalik Z, 2011, HUM MOL GENET, V20, P3710, DOI 10.1093/hmg/ddr272; Parente F, 2010, CLIN CHIM ACTA, V411, P64, DOI 10.1016/j.cca.2009.10.004; Park JH, 2014, CLIN CHIM ACTA, V436, P135, DOI 10.1016/j.cca.2014.05.011; Quintana E, 2009, J CHROMATOGR B, V877, P2513, DOI 10.1016/j.jchromb.2009.06.031; Solomons Hilary Denis, 2012, Germs, V2, P75, DOI 10.11599/germs.2012.1015; Tegtmeyer LC, 2014, NEW ENGL J MED, V370, P533, DOI 10.1056/NEJMoa1206605; WANG AC, 1966, AM J HUM GENET, V18, P454	13	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0009-9120	1873-2933		CLIN BIOCHEM	Clin. Biochem.	JAN	2015	48	1-2					11	13		10.1016/j.clinbiochem.2014.09.022		3	Medical Laboratory Technology	Medical Laboratory Technology	AX3QC	WOS:000346852900004		
J	Taniguchi, N; Matsuda, S; Kawaguchi, T; Tabara, Y; Ikezoe, T; Tsuboyama, T; Ichihashi, N; Nakayama, T; Matsuda, F; Ito, H				Taniguchi, Naoya; Matsuda, Shuichi; Kawaguchi, Takahisa; Tabara, Yasuharu; Ikezoe, Tome; Tsuboyama, Tadao; Ichihashi, Noriaki; Nakayama, Takeo; Matsuda, Fumihiko; Ito, Hiromu			The KSS 2011 Reflects Symptoms, Physical Activities, and Radiographic Grades in a Japanese Population	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article; Proceedings Paper	Open Scientific Meeting of the Knee-Society	MAR, 2014	New Orleand, LA	Knee Soc			TOTAL KNEE ARTHROPLASTY; PATIENT EXPECTATIONS; OSTEOARTHRITIS; PAIN; REPLACEMENT; JOINT; SATISFACTION; DISABILITY; SYSTEM	Cultural and ethnic differences are present both in subjective and objective measures of patient health, but scoring systems do not always reflect these differences, and so validation of outcomes tools in different cultural settings is important. Recently, a revised version of The Knee Society Score(A (R)) (KSS 2011) was developed, but to our knowledge, the degree that this tool evaluates clinical symptoms, physical activities, and radiographic grades in the general Japanese population is not known. We therefore asked: (1) how KSS 2011 reflects knee conditions and function in the general Japanese population, in particular evaluating changes with increasing patient age; (2) can objective measures of physical function be correlated with KSS 2011; and (3) does radiographic osteoarthritis (OA) grade correlate with KSS 2011? Two hundred twenty-six people in the general Japanese population, aged 35 to 92 years, with and without knee arthritis, voluntarily participated in this cross-sectional study. Residents who had no serious disease or symptoms based on a self-assessment were recruited. This study consisted of a questionnaire including self-administered KSS 2011, physical examination, and weightbearing radiographs of the knee. Leg muscle strength, Timed Up and Go test, and body mass index (BMI) were examined in all the participants. Radiographs were graded according to the Kellgren and Lawrence scale (KL grade). Multivariable linear regression analysis showed that KSS 2011 correlated with age (coefficient: -0.30 +/- A 0.12, p = 0.011), BMI (coefficient: -1.47 +/- A 0.42, p < 0.001), leg muscle strength (coefficient: 0.41 +/- A 0.13, p = 0.002), and Timed Up and Go Test (coefficient: -1.96 +/- A 0.92, p = 0.034), but not sex, as independent variables by a stepwise method. KSS 2011 was also correlated with radiographic OA evaluated by KL grade (coefficient: -12.2 +/- A 2.9, p < 0.001). KSS 2011 reflects symptoms, physical activities, and radiographic OA grades of the knee in an age-dependent manner in the general Japanese population. Level IV, diagnostic study. See Guidelines for Authors for a complete description of levels of evidence.	[Taniguchi, Naoya; Matsuda, Shuichi; Ito, Hiromu] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Sakyo Ku, Shogoin, Kyoto 6068507, Japan; [Kawaguchi, Takahisa; Tabara, Yasuharu; Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan; [Ikezoe, Tome; Tsuboyama, Tadao; Ichihashi, Noriaki] Kyoto Univ, Grad Sch Med, Kyoto, Japan; [Nakayama, Takeo] Kyoto Univ, Sch Publ Hlth, Dept Hlth Informat, Kyoto, Japan	Matsuda, S (reprint author), Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Sakyo Ku, 54 Kawahara Cho, Shogoin, Kyoto 6068507, Japan.	smat522@kuhp.kyoto-u.ac.jp					Yoshimura N, 2009, J BONE MINER METAB, V27, P620, DOI 10.1007/s00774-009-0080-8; Odding E, 1998, ANN RHEUM DIS, V57, P203, DOI 10.1136/ard.57.4.203; INSALL JN, 1989, CLIN ORTHOP RELAT R, P13; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; ANDERSON JJ, 1988, AM J EPIDEMIOL, V128, P179; Imoto AM, 2012, ACTA ORTOP BRAS, V20, P174, DOI 10.1590/S1413-78522012000300008; Bach CM, 2002, CLIN ORTHOP RELAT R, P184; Matsuda S, 2013, CLIN ORTHOP RELAT R, V471, P127, DOI 10.1007/s11999-012-2533-y; Kurtz SM, 2011, INT ORTHOP, V35, P1783, DOI 10.1007/s00264-011-1235-5; Zhai GJ, 2006, ARTHRIT RHEUM-ARTHR, V55, P264, DOI 10.1002/art.21835; Scuderi GR, 2012, CLIN ORTHOP RELAT R, V470, P3, DOI 10.1007/s11999-011-2135-0; Bourne RB, 2010, CLIN ORTHOP RELAT R, V468, P57, DOI 10.1007/s11999-009-1119-9; O'Reilly SC, 1999, ANN RHEUM DIS, V58, P15, DOI 10.1136/ard.58.1.15; Koh IJ, 2013, CLIN ORTHOP RELAT R, V471, P1441, DOI 10.1007/s11999-012-2622-y; Kreibich DN, 1996, CLIN ORTHOP RELAT R, P221; Weinstein AM, 2013, J BONE JOINT SURG AM, V95A, P385, DOI 10.2106/JBJS.L.00206; [Anonymous], 2005, CLIN ORTHOPS REL RES; MCALINDON TE, 1992, ANN RHEUM DIS, V51, P844, DOI 10.1136/ard.51.7.844; Mahomed NN, 2002, J RHEUMATOL, V29, P1273; Richmond J, 2010, J BONE JOINT SURG AM, V92A, P990, DOI 10.2106/JBJS.I.00982; Dickstein R, 1998, GERONTOLOGY, V44, P204, DOI 10.1159/000022011; Noble PC, 2006, CLIN ORTHOP RELAT R, P35, DOI 10.1097/011.blo.0000238825.63648.1e; BADLEY EM, 1992, ANN RHEUM DIS, V51, P366, DOI 10.1136/ard.51.3.366; BAYLEY KB, 1995, MED CARE, V33, pAS226; Nakayama T, 2010, JAP J GENET COUNSEL, V31, P117; Noble PC, 2011, CLIN ORTHOP RELAT R, V470, P1; OReilly SC, 1996, ANN RHEUM DIS, V55, P931, DOI 10.1136/ard.55.12.931; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142; Van Der Straeten C, 2013, CLIN ORTHOP RELAT R, V471, P1	29	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0009-921X	1528-1132		CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	JAN	2015	473	1					70	75		10.1007/s11999-014-3650-6		6	Orthopedics; Surgery	Orthopedics; Surgery	AX4LA	WOS:000346902900015		
J	Kubo, T; Shimose, S; Fujimori, J; Furuta, T; Arihiro, K; Ochi, M				Kubo, Tadahiko; Shimose, Shoji; Fujimori, Jun; Furuta, Taisuke; Arihiro, Koji; Ochi, Mitsuo			Does Expression of Glucose Transporter Protein-1 Relate to Prognosis and Angiogenesis in Osteosarcoma?	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article							ENDOTHELIAL GROWTH-FACTOR; POSITRON-EMISSION-TOMOGRAPHY; HIGH-GRADE OSTEOSARCOMA; SOFT-TISSUE SARCOMAS; NEOADJUVANT CHEMOTHERAPY; GLUT-1 EXPRESSION; THERAPEUTIC TARGET; CARCINOMA; RECEPTOR; SURVIVAL	The survival of patients who present with nonmetastatic extremity osteosarcoma has dramatically improved, but there are some patients who do not respond to chemotherapy. The ability to identify patients with a poorer prognosis might allow us to target different therapy for these patients. Glucose transporter protein-1 (Glut-1), one of the key factors in glucose metabolism, has been reported to be an independent prognostic factor in various tumors. However, little is known about the role of the Glut-1 pathway in osteosarcoma. We asked (1) if Glut-1 expression is a prognostic marker for survival in patients with osteosarcoma, and (2) if there is a relationship between Glut-1 expression and tumor angiogenesis. Thirty-seven patients with resectable high-grade osteosarcomas treated between 1982 and 2007 were reviewed retrospectively. Patients were excluded if representative biopsy material and followup data were not available. The expression of Glut-1 and the number of CD34-positive microvessels for angiogenic activity were measured immunohistochemically. The median followup was 6 years 6 months (range, 11-211 months). Survival analyses were evaluated using the Kaplan-Meier method and the Cox proportional hazards model. The association between Glut-1 expression and microvessel density was analyzed using Student's t-test and chi-square test. For 12 (32.4%) of 37 patients with osteosarcoma, the expression of Glut-1 was positive, with four patients (10.8%) showing strong expression of Glut-1 protein. The expression of Glut-1 correlated with a shorter disease-free survival period (relative risk, 20.13; 95% CI, 1.77-229.3; p = 0.0016). The microvessel density mean value of positive Glut-1 expression (mean +/- A SD, 26.5 +/- A 19.4) was lower than that of negative expression (mean +/- A SD, 46.4 +/- A 35.3; Student's t-test, p = 0.038). When more than 50 was defined as a high microvessel density, positive expression of Glut-1 was significantly associated with low microvessel density (chi-square test, p = 0.049). These findings indicate that Glut-1 is a potential predictor of survival in patients with osteosarcoma and that glucose metabolism may be negatively associated with angiogenesis. If substantiated in larger numbers of patients, these findings might stimulate the development of novel treatments for patients with a poorer prognosis. Level III, prognostic study. See the Instructions for Authors for a complete description of levels of evidence.	[Kubo, Tadahiko; Shimose, Shoji; Fujimori, Jun; Furuta, Taisuke; Ochi, Mitsuo] Hiroshima Univ, Grad Sch Biomed Sci, Dept Orthopaed Surg, Minami Ku, Hiroshima 7348551, Japan; [Arihiro, Koji] Hiroshima Univ Hosp, Dept Anat Pathol, Hiroshima, Japan	Kubo, T (reprint author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Orthopaed Surg, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	kubot@hiroshima-u.ac.jp					Airley RE, 2005, INT J ONCOL, V26, P1477; Bacci G, 2001, EUR J CANCER, V37, P2030, DOI 10.1016/S0959-8049(01)00229-5; KASAHARA M, 1977, J BIOL CHEM, V252, P7384; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Fan JA, 2010, CANCER BIOTHER RADIO, V25, P521, DOI 10.1089/cbr.2010.0784; Luo XM, 2010, J INT MED RES, V38, P1885; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Cantuaria G, 2001, CANCER, V92, P1144, DOI 10.1002/1097-0142(20010901)92:5<1144::AID-CNCR1432>3.0.CO;2-T; Bramer JAM, 2009, EJSO-EUR J SURG ONC, V35, P1030, DOI 10.1016/j.ejso.2009.01.011; Kimura H, 2009, J ORTHOP SCI, V14, P556, DOI 10.1007/s00776-009-1372-5; Ahrens WA, 2008, HUM PATHOL, V39, P1519, DOI 10.1016/j.humpath.2008.03.002; Kitamura K, 2011, J HEPATOL, V55, P846, DOI 10.1016/j.jhep.2011.01.038; Bielack SS, 2002, J CLIN ONCOL, V20, P776, DOI 10.1200/JCO.20.3.776; Hoang BH, 2004, INT J CANCER, V109, P106, DOI 10.1002/ijc.11677; Eselgrim M, 2006, PEDIATR BLOOD CANCER, V47, P42, DOI 10.1002/pbc.20608; Meyers PA, 1998, J CLIN ONCOL, V16, P2452; Wenger RH, 2000, J EXP BIOL, V203, P1253; Tateishi U, 2006, EUR J NUCL MED MOL I, V33, P683, DOI 10.1007/s00259-005-0044-8; Amann T, 2009, EXPERT OPIN THER TAR, V13, P1411, DOI 10.1517/14728220903307509; Yang QC, 2007, JPN J CLIN ONCOL, V37, P127, DOI 10.1093/jjco/hyl137; Kubo T, 2008, CANCER, V112, P2119, DOI 10.1002/cncr.23437; TAKAHASHI Y, 1995, CANCER RES, V55, P3964; Cifuentes M, 2011, J CELL PHYSIOL, V226, P1425, DOI 10.1002/jcp.22668; HOLM S, 1979, SCAND J STAT, V6, P65; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Szablewski L, 2013, BBA-REV CANCER, V1835, P164, DOI 10.1016/j.bbcan.2012.12.004; Iwamoto Y, 2009, J ORTHOP SCI, V14, P397, DOI 10.1007/s00776-009-1347-6; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Haber RS, 1998, CANCER, V83, P34, DOI 10.1002/(SICI)1097-0142(19980701)83:1<34::AID-CNCR5>3.0.CO;2-E; Kubo T, 2011, J BONE JOINT SURG AM, V93A, P519, DOI 10.2106/JBJS.J.00198; Calvo MB, 2010, INT J ENDOCRINOL, DOI 10.1155/2010/205357; Chen J, 2014, J CANCER RES CLIN, V140, P1205, DOI 10.1007/s00432-014-1644-0; Dutour A, 2009, J NUCL MED, V50, P1533, DOI 10.2967/jnumed.109.062356; Eary JF, 1998, CLIN CANCER RES, V4, P1215; Endo M, 2007, JPN J CLIN ONCOL, V37, P955, DOI 10.1093/jjco/hym125; ENNEKING WF, 1980, CLIN ORTHOP RELAT R, P106; Huvos AG, 1991, BONE TUMORS DIAGNOSI, P122; Kim M, 2009, J ORTHOP SCI, V14, P292, DOI 10.1007/s00776-009-1334-y; Kleespies A, 2004, J SURG ONCOL, V87, P95, DOI 10.1002/jso.20070; Kreuter M, 2004, CLIN CANCER RES, V10, P8531, DOI 10.1158/1078-0432.CCR-04-0969; Lewis IJ, 2007, JNCI-J NATL CANCER I, V99, P98; Nieweg OE, 1996, J NUCL MED, V37, P257; Shan XH, 2013, J COMPUT ASSIST TOMO, V37, P22, DOI 10.1097/RCT.0b013e318279abd1; Yang R, 2007, INT J CANCER, V121, P943, DOI 10.1002/ijc.22749; Younes M, 2001, ANTICANCER RES, V21, P575; Zhuang YF, 2014, TUMOR BIOL, V35, P1745, DOI 10.1007/s13277-014-1692-8	47	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0009-921X	1528-1132		CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	JAN	2015	473	1					305	310		10.1007/s11999-014-3910-5		6	Orthopedics; Surgery	Orthopedics; Surgery	AX4LA	WOS:000346902900056		
J	Yamanaka, Y; Nakamura, T; Sato, K; Toyama, Y				Yamanaka, Yoshiaki; Nakamura, Toshiyasu; Sato, Kazuki; Toyama, Yoshiaki			Reply to the Letter to the Editor: How Does Ulnar Shortening Osteotomy Influence Morphologic Changes in the Triangular Fibrocartilage Complex?	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Letter									[Yamanaka, Yoshiaki] Univ Occupat & Environm Hlth, Sch Med, Dept Orthopaed Surg, Fukuoka, Japan; [Nakamura, Toshiyasu; Sato, Kazuki; Toyama, Yoshiaki] Keio Univ, Sch Med, Dept Orthopaed Surg, Shinjuku Ku, Tokyo 1608582, Japan	Nakamura, T (reprint author), Keio Univ, Sch Med, Dept Orthopaed Surg, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	tosiyasu@sc.itc.keio.ac.jp					Tatebe M, 2007, J HAND SURG-AM, V32A, P445, DOI 10.1016/j.jhsa.2007.01.013; Yamanaka Y, 2014, CLIN ORTHOP RELAT R, V472, P3489, DOI 10.1007/s11999-014-3854-9	2	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0009-921X	1528-1132		CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	JAN	2015	473	1					399	400		10.1007/s11999-014-4042-7		2	Orthopedics; Surgery	Orthopedics; Surgery	AX4LA	WOS:000346902900074		
J	Yasuda, T; Loenneke, JP; Ogasawara, R; Abe, T				Yasuda, Tomohiro; Loenneke, Jeremy P.; Ogasawara, Riki; Abe, Takashi			Effects of short-term detraining following blood flow restricted low-intensity training on muscle size and strength	CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING			English	Article						cessation; magnetic resonance imaging; maximum strength; muscle hypertrophy; vascular occlusion	VASCULAR OCCLUSION; TIME-COURSE; MYOSTATIN; ACTIVATION; EXPRESSION; TENDON; MEN	We investigated the effects of 3weeks of detraining on muscle cross-sectional area (CSA) and one-repetition maximum strength (1-RM) in young men who had previously participated in 6weeks (3daysweek(-1)) of bench press training [blood flow restricted low-intensity (LI-BFR; n=10, 20% 1-RM) or high-intensity (HI; n=7, 75% 1-RM)]. Bench press 1-RM and muscle CSA of triceps brachii (TB) and pectoralis major (PM) were evaluated before (pre) and after training period (post) as well as after detraining period (detraining). Bench press 1-RM was higher at both post and detraining than at pre for LI-BFR (P<001) and the HI (P<001). TB and PM muscle CSA were higher at both post and detraining than at pre for the HI group (P<001), while the LI-BFR group only increased (P<001) at post. Relative dynamic strength (1-RM divided by TB muscle CSA) was higher at both post and detraining than at pre for the HI group (P<001), while the LI-BFR group only increased (P<001) at detraining. In conclusion, increased muscle strength following 6weeks of training with LI-BFR as well as HI was well preserved at 3weeks of detraining. HI-induced muscle strength appears to be dependent upon both neural adaptations and muscle hypertrophy with training and detraining. On the other hand, LI-BFR-induced muscle strength appears to be related primarily to muscle hypertrophy with training and to neural adaptations with detraining.	[Yasuda, Tomohiro] Univ Tokyo, Dept Ischem Circulatory Physiol, Grad Sch Med, Tokyo 1138655, Japan; [Loenneke, Jeremy P.] Univ Oklahoma, Dept Hlth & Exercise Sci, Norman, OK 73019 USA; [Ogasawara, Riki] Ritsumeikan Univ, Fac Sport & Hlth Sci, Kyoto, Japan; [Abe, Takashi] Indiana Univ, Dept Kinesiol, Bloomington, IN 47405 USA	Yasuda, T (reprint author), Univ Tokyo, Dept Ischem Circulatory Physiol, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yasuda-tomohiro@umin.ac.jp					American College of Sports Medicine, 2009, MED SCI SPORTS EXERC, V41, P687, DOI DOI 10.1249/MSS.0B013E3181915670; Yasuda T, 2011, EUR J APPL PHYSIOL, V111, P2525, DOI 10.1007/s00421-011-1873-8; Takarada Y, 2000, J APPL PHYSIOL, V88, P2097; Tokmakidis SP, 2009, CLIN PHYSIOL FUNCT I, V29, P316, DOI 10.1111/j.1475-097X.2009.00866.x; Yasuda T, 2008, J SPORT SCI MED, V7, P467; Karabulut M, 2010, EUR J APPL PHYSIOL, V108, P147, DOI 10.1007/s00421-009-1204-5; Kubo K, 2010, J STRENGTH COND RES, V24, P322, DOI 10.1519/JSC.0b013e3181c865e2; Jespersen JG, 2011, SCAND J MED SCI SPOR, V21, P215, DOI 10.1111/j.1600-0838.2009.01044.x; Rhea MR, 2004, J STRENGTH COND RES, V18, P918, DOI 10.1519/00124278-200411000-00040; Fatouros IG, 2005, BRIT J SPORT MED, V39, P776, DOI 10.1136/bjsm.2005.019117; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Trendelenburg AU, 2009, AM J PHYSIOL-CELL PH, V296, pC1258, DOI 10.1152/ajpcell.00105.2009; Loenneke JP, 2012, EUR J APPL PHYSIOL, V112, P1849, DOI 10.1007/s00421-011-2167-x; Mujika I, 2000, SPORTS MED, V30, P79, DOI 10.2165/00007256-200030020-00002; Hakkinen K, 2000, EUR J APPL PHYSIOL, V83, P51, DOI 10.1007/s004210000248; Ivey FM, 2000, J GERONTOL A-BIOL, V55, pB152; Fujita S, 2007, J APPL PHYSIOL, V103, P903, DOI 10.1152/japplphysiol.00195.2007; Laurentino GC, 2012, MED SCI SPORT EXER, V44, P406, DOI 10.1249/MSS.0b013e318233b4bc; Abe T, 2000, EUR J APPL PHYSIOL O, V81, P174, DOI 10.1007/s004210050027; Kubo K, 2006, J APPL BIOMECH, V22, P112; Guillet C, 2005, DIABETES METAB, V2, p5S20; NARICI MV, 1989, EUR J APPL PHYSIOL O, V59, P310, DOI 10.1007/BF02388334; Thiebaud Robert S, 2013, Interv Med Appl Sci, V5, P53, DOI 10.1556/IMAS.5.2013.2.1; Yasuda T, SCAND J MED IN PRESS	24	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1475-0961	1475-097X		CLIN PHYSIOL FUNCT I	Clin. Physiol. Funct. Imaging	JAN	2015	35	1					71	75		10.1111/cpf.12165		5	Physiology	Physiology	AX1JK	WOS:000346703300010		
J	Ogasawara, K; Kobayashi, G				Ogasawara, Kota; Kobayashi, Genya			The impact of social workers on infant mortality in inter-war Tokyo: Bayesian dynamic panel quantile regression with endogenous variables	CLIOMETRICA			English	Article						Dynamic panel data; Endogenous variable; Infant mortality; Quantile regression; Social worker	INSURANCE PROGRAMS; MODELS; INFERENCE	Although no comprehensive sickness insurance system existed in Japan until the mid-twentieth century, the infant mortality rate in Japan started to decline from the early twentieth century onwards, specifically owing to health improvements in low-income areas. This paper focuses on the impact of social workers called Homen iin on reducing the infant mortality rate in inter-war Tokyo. These social workers were in charge of the medical casework and provided access to medical treatment for low-income households under the District Committees System. To examine how the activities of these social workers influenced infant mortality, this paper analyses panel data for Tokyo between 1926 and 1937. By employing the dynamic panel quantile regression approach, it is found that the activities of social workers played a vital role in mitigating the risk of infant mortality, especially in areas that had a higher infant mortality rate.	[Ogasawara, Kota] Tokyo Inst Technol, Grad Sch Decis Sci & Technol, Dept Social Engn, Meguro Ku, Tokyo 1528552, Japan; [Kobayashi, Genya] Chiba Univ, Fac Law Polit & Econ, Chiba, Japan	Ogasawara, K (reprint author), Tokyo Inst Technol, Grad Sch Decis Sci & Technol, Dept Social Engn, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528552, Japan.	ogasawara.k.ab@m.titech.ac.jp					Wooldridge JM, 2005, J APPL ECONOM, V20, P39, DOI 10.1002/jae.770; Chernozhukov V, 2005, ECONOMETRICA, V73, P245, DOI 10.1111/j.1468-0262.2005.00570.x; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; Lee S, 2007, J ECONOMETRICS, V141, P1131, DOI 10.1016/j.jeconom.2007.01.014; Deb P, 2006, J APPL ECONOM, V21, P1081, DOI 10.1002/jae.891; Hatton TJ, 2011, ECON HIST REV, V64, P951, DOI 10.1111/j.1468-0289.2010.00572.x; Mishra P, 2009, J HEALTH ECON, V28, P855, DOI 10.1016/j.jhealeco.2009.05.004; Cutler D, 2005, DEMOGRAPHY, V42, P1, DOI 10.1353/dem.2005.0002; Geweke J, 2003, ECONOMETRICA, V71, P1215, DOI 10.1111/1468-0262.00444; FOSTER J, 1984, ECONOMETRICA, V52, P761, DOI 10.2307/1913475; Galvao AF, 2011, J ECONOMETRICS, V164, P142, DOI 10.1016/j.jeconom.2011.02.016; Barnum H, 1988, POLICY PLANNING RES, V65; Bowblis JR, 2010, J ECON HIST, V70, P221; Brown JC, 1989, J ECON HIST, V49, P450; Cabinet Bureau of Statistics, NIH TEIK JINK DOT TO; Chernozhukov V, 2006, J ECONOMETRICS, V132, P491, DOI 10.1016/j.jeconom.2005.02.009; Doornik J.A., 2007, OBJECT ORIENTED MATR; Endo K, 1974, MEIJI GAKUIN RONSHU, V40, P35; Evans RD, 1987, DEATH HAMBURG; FILDES V, 1992, J BIOSOC SCI, V24, P53; Fogel R. W., 1997, HDB POPULATION FAM A, V1A; Fogel Robert William, 2004, ESCAPE HUNGER PREMAT; Gamper-Rabindran S, 2010, J DEV ECON, V92, P180; Hijikata S, 2002, TOKYO NO KINDAI SHOG; Iga M, 1983, NIIGATA DAIGAKU KYOI, V25, P133; Iga M, 1984, SHAKAI HOSHO KENKYU, V20, P295; Ikeda Y., 1986, NIHON SHAKAIFUKUSHI; Ikemoto M, 1999, NIHON NIOKERU SHAKAI; Ito S, 1998, SHAKAI KEIZAISHIGAKU, V63, P725; Ito S, 1990, SANGYOKA NO JIDAI, P225; Iwamoto H, 2008, SHAKAI MONDAI KENKYU, V57, P41; Iwamoto H, 2007, SHAKAI MONDAI KENKYU, V57, P91; Japan Medical Association, 1938, DAIN ZENK BYOS HOK, V2; Kawamura S, 1934, HAREYUKU SHAKAI; Kawamura S, 1930, SHAKAIKU NO KENKYU; Kobayashi G, 2012, COMPUTATION STAT, V27, P359, DOI 10.1007/s00180-011-0263-3; Koenker R, 2005, QUANTILE REGRESSION; McKeown T, 1976, MODERN RISE POPULATI; Minami R, 1996, NIHON NO KEIZAIHATTE; Ministry of Welfare, 1976, IS HYAK SHI; Mitchell B. R., 1988, BRIT HIST STAT; Miwa O, 1976, MEIJIGAKUIN RONSOU, V45, P1; Mouri T, 1972, GENDAINIHON SHONIHOK; Municipal Office of Tokyo, TOK TOK; Municipal Office of Tokyo, 1930, TOK SUID TOK; Nakagawa K, 1985, NIHON NO TOSHIKASO; Nakano M, 2003, SHAKAI FUKUSHIGAKU, V44, P87; National Congress of Social Worker and Child Committee, 1988, MIN NAN SHI; Ninomiya K, 2009, KINDAI NO OKAYAMA NI; Ogasawara K, 2012, OHARA SHAKAI MONDAI, V649, P47; Ono S, 1994, KOSHIKYODO NO HOTTAN; Reid A, 2002, POP STUD-J DEMOG, V56, P151, DOI 10.1080/00324720215926; Research Institute of Social Work, 1943, KIND IR HATT SHI; Saguchi T, 1991, WASEDA SHOGAKU, V344, P891; Saito O, 1992, KEIZAI KENKYU, V43, P248; Saito O, 2008, SHAKAI KEIZAISHIGAKU, V73, P611; Saito Osamu, 2008, SENKANKINIHON NO SHA, P359; Social Welfare Bureau, SHAK TOK YOR; Social Welfare Bureau, 1928, NIH TOK NENK, V42; Statistics Bureau of the Cabinet, 1924, ZENK HOM GAIK; Szreter S., 1988, SOC HIST MED, V1, P1, DOI [10.1093/shm/1.1.1., DOI 10.1093/SHM/1.1.1]; Tokyo City, 1925, TOKYOSHI NIOKERU NYU; Tokyo City Social Welfare Bureau, 1933, TOK YOH CHOS; Tokyo City Social Welfare Bureau, 1939, YOH RIB NO CHOS; Tokyo City Social Welfare Bureau, TOK SHAK OK U NENP; Tokyo City Social Welfare Bureau, 1934, YOH NIOK NYUYOJ NO S; Tokyo City Social Welfare Bureau, 1938, TOK NIOK MUR RIYOJ N; Tokyo City Social Welfare Bureau, 1926, NYUJ NIK CHOS; Tokyo City Social Welfare Bureau, 1932, TOK SHIB NAR SHIS CH; Tokyo City Social Welfare Bureau, 1924, TOK HOM; Tokyo City Social Welfare Bureau, 1934, TOK YOH CHOS; Tokyo Institute for Municipal Research, 1928, TOSH NIOK NINS NIK C; United Nations, 1985, SOC DIFF CHILD MORT; Van den Doel IT, 1995, STAT NEERL, V49, P343; VICTORA CG, 1988, INT J EPIDEMIOL, V17, P651, DOI 10.1093/ije/17.3.651; Winegarden CR, 1998, EXPLOR ECON HIST, V35, P431, DOI 10.1006/exeh.1998.0707; World Health Organization (first), 2013, WORLD HLTH STAT 2013; Yamada S, 1939, HINKU NO HITOBITO WO; Yoshida K., 2004, SHIN NIHON SHAKAIJIG	79	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-2505	1863-2513		CLIOMETRICA	Cliometrica	JAN	2015	9	1					97	130		10.1007/s11698-014-0110-1		34	Economics; History; History Of Social Sciences	Business & Economics; History; Social Sciences - Other Topics	AX8GI	WOS:000347147700005		
J	Okazaki, R; Yanagawa, K				Okazaki, Ryota; Yanagawa, Kohji			On CW complexes supporting Eliahou-Kervaire type resolutions of Borel fixed ideals	COLLECTANEA MATHEMATICA			English	Article							CELLULAR RESOLUTIONS; MORSE-THEORY	We prove that the Eliahou-Kervaire resolution of a Cohen-Macaulay stable monomial is supported by a regular CW complex whose underlying space is a closed ball. We also show that the modified Eliahou-Kervaire resolutions of variants of a Borel fixed ideal (e.g., a squarefree strongly stable ideal) are supported by regular CW complexes, and their underlying spaces are closed balls in the Cohen-Macaulay case.	[Okazaki, Ryota] Fukuoka Univ Educ, Fac Educ, Fukuoka 8114192, Japan; [Yanagawa, Kohji] Kansai Univ, Dept Math, Suita, Osaka 5648680, Japan	Yanagawa, K (reprint author), Kansai Univ, Dept Math, Suita, Osaka 5648680, Japan.	rokazaki@fukuoka-edu.ac.jp; yanagawa@kansai-u.ac.jp			JSPS KAKENHI [24740013, 25400057]	The first author is supported by JSPS KAKENHI Grant Number 24740013. The second author is supported by JSPS KAKENHI Grant Number 25400057.	BJORNER A, 1983, T AM MATH SOC, V277, P323, DOI 10.2307/1999359; Bayer D, 1998, MATH RES LETT, V5, P31; Bayer D, 1998, J REINE ANGEW MATH, V502, P123; DANARAJ G, 1974, DUKE MATH J, V41, P443, DOI 10.1215/S0012-7094-74-04150-7; BJORNER A, 1980, T AM MATH SOC, V260, P159, DOI 10.2307/1999881; Aramova A, 2000, J ALGEBR COMB, V12, P207, DOI 10.1023/A:1011238406374; Batzies E, 2002, J REINE ANGEW MATH, V543, P147; Bjorner A., 1984, EUROPEAN J COMBIN, V5, P7; Bjorner A., 1995, HDB COMBINATORICS, V1, P1819; Bruns W., 1998, COHEN MACAULAY RINGS; Clark T., 2012, PROGR COMMUTATIVE AL, P143; ELIAHOU S, 1990, J ALGEBRA, V129, P1, DOI 10.1016/0021-8693(90)90237-I; Forman R, 1998, ADV MATH, V134, P90, DOI 10.1006/aima.1997.1650; HERZOG J., 2002, HOMOL HOMOTOPY APPL, V4, P277; Lundell A. T., 1969, TOPOLOGY CW COMPLEXE; Mermin J, 2010, J COMMUT ALGEBR, V2, P55, DOI 10.1216/JCA-2010-2-1-55; Nagel Uwe, 2009, ELECTRON J COMB, V16, P59; Okazaki R, 2013, J ALGEBR COMB, V38, P407, DOI 10.1007/s10801-012-0409-6; Sinefakopoulos A, 2008, J ALGEBRA, V319, P2739, DOI 10.1016/j.jalgebra.2008.01.017; Stanley R., 2004, COMBINATORICS COMMUT; Velasco M, 2008, J ALGEBRA, V319, P102, DOI 10.1016/j.jalgebra.2007.10.011; Yanagawa K, 2012, NAGOYA MATH J, V207, P79, DOI 10.1215/00277630-1630032	22	0	0	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	0010-0757	2038-4815		COLLECT MATH	Collect. Math.	JAN	2015	66	1					125	147		10.1007/s13348-014-0104-0		23	Mathematics, Applied; Mathematics	Mathematics	AX9UC	WOS:000347246500007		
J	Deng, SK; Yoshiyama, K; Mitsubuchi, T; Sakurai, A				Deng, Shangkun; Yoshiyama, Kazuki; Mitsubuchi, Takashi; Sakurai, Akito			Hybrid Method of Multiple Kernel Learning and Genetic Algorithm for Forecasting Short-Term Foreign Exchange Rates	COMPUTATIONAL ECONOMICS			English	Article						FX trading; Financial prediction; Multiple kernel learning; Genetic algorithm; MKL-GA hybrid method; Technical indicators	SUPPORT VECTOR MACHINES; NEURAL-NETWORK; STOCK-MARKET; TIME-SERIES; MODELS; RETURNS	Our proposed prediction and learning method is a hybrid referred to as MKL-GA, which combines multiple kernel learning (MKL) for regression (MKR) and a genetic algorithm (GA) to construct the trading rules. In this study, we demonstrate that the evaluation criteria used to examine the effectiveness of a financial market price forecasting method should be the profit and profit-risk ratio, rather than errors in prediction. Thus, it is necessary to use a price prediction method and a trading rules learning method. We tested the proposed method on the foreign exchange market for the USD/JPY currency pair, where the features used for prediction were extracted from the trading history of the three main currency pairs with three different short-term horizons. MKR is essential for utilizing the information contained in many of the features derived from different information sources and for various representations of the same information source. The GA is essential for generating trading rules, which are described using a mixture of discrete structures and continuous parameters. First, the MKR predicts the change in the exchange rate based on technical indicators such as the moving average convergence and divergence of the three currency pairs. Next, the GA generates a trading rule by combining the results of the MKR with several commonly used overbought/oversold technical indicators. The experimental results show that the proposed hybrid method outperforms other baseline methods in terms of the returns and return-risk ratio. In addition, the kernel weights employed for different currency pairs and the different time horizons used in the MKR step, as well as the trading strategy generated in the GA step, should be beneficial during actual trading.	[Deng, Shangkun; Yoshiyama, Kazuki; Mitsubuchi, Takashi; Sakurai, Akito] Keio Univ, Grad Sch Sci & Technol, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	Sakurai, A (reprint author), Keio Univ, Grad Sch Sci & Technol, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	dsk8672@gmail.com; cloud-cluster@z8.keio.jp; mitsubuchi@ae.keio.ac.jp; sakurai@ae.keio.ac.jp			fund "Keio Leading-edge Laboratory of Science & Technology Research Grant"; Global-COE program (Symbiotic, Safe and Secure System Design) of Keio University, Japan	This research was partially supported by the fund "Keio Leading-edge Laboratory of Science & Technology Research Grant" and by the Global-COE program (Symbiotic, Safe and Secure System Design) of Keio University, Japan. The authors would like to thank ICAP and Forexite for making their foreign exchange data available for this research.	Yeh CY, 2011, EXPERT SYST APPL, V38, P2177, DOI 10.1016/j.eswa.2010.08.004; Gehrig T, 2006, INT J FINANC ECON, V11, P327, DOI 10.1002/ijfe.301; Kodogiannis V, 2002, NEURAL COMPUT APPL, V11, P90, DOI 10.1007/s005210200021; Chen AS, 2004, COMPUT OPER RES, V31, P1049, DOI 10.1016/S0305-0548(03)00064-9; Wu MC, 2007, PHYSICA A, V375, P633, DOI 10.1016/j.physa.2006.09.018; Wong BK, 1998, INFORM MANAGE, V34, P129, DOI 10.1016/S0378-7206(98)00050-0; Mizuno T, 2006, PHYSICA A, V364, P336, DOI 10.1016/j.physa.2005.08.079; Sermpinis G, 2012, EXPERT SYST APPL, V39, P8865, DOI 10.1016/j.eswa.2012.02.022; Joutou T, 2009, 2009 16TH IEEE INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, VOLS 1-6, P285; Neely CJ, 2003, J INT MONEY FINANC, V22, P223, DOI 10.1016/S0261-5606(02)00101-8; Allen F, 1999, J FINANC ECON, V51, P245, DOI 10.1016/S0304-405X(98)00052-X; Cao LJ, 2003, NEUROCOMPUTING, V51, P321, DOI 10.1016/S0925-2312(02)00577-5; de Faria EL, 2009, EXPERT SYST APPL, V36, P12506, DOI 10.1016/j.eswa.2009.04.032; Sonnenburg S, 2006, J MACH LEARN RES, V7, P1531; Pai PF, 2005, OMEGA-INT J MANAGE S, V33, P497, DOI 10.1016/j.omega.2004.07.024; Gencay R, 2003, J ECON DYN CONTROL, V27, P909, DOI 10.1016/S0165-1889(02)00049-0; PESARAN MH, 1995, J FINANC, V50, P1201, DOI 10.2307/2329349; Azoff E. M., 1994, NEURAL NETWORKS TIME, DOI John Wiley & Sons, Inc; Bach F.R., 2004, P 21 INT C MACH LEAR, P6; Badawy F.A., 2005, P ITI 3 INT C INF CO, P109; Banzhaf W., 1998, GENETIC PROGRAMMING; Barnett W. A., 1997, J ECONOMETRICS, V82, P157, DOI 10.1016/S0304-4076(97)00081-X; BOLLERSLEV T, 1986, J ECONOMETRICS, V31, P307, DOI 10.1016/0304-4076(86)90063-1; Bonilla CA, 2011, MACROECON DYN, V15, P713, DOI 10.1017/S130100510000295; Box G.E.P., 1994, TIME SERIES ANAL FOR; Broock W, 1996, ECONOMET REV, V15, P197, DOI 10.1080/07474939608800353; CHAMPERNOWNE DG, 1948, J ROY STAT SOC B, V10, P204; Chu S. C. W., 2000, P 2000 IEEE INT C MA, V1, P53, DOI 10.1109/ICMIT.2000.917270; Dempster M. A. H., 2002, EUR J FINANC, V8, P275, DOI 10.1080/13518470110052831; Deng S., 2011, P AIA 2011, DOI [10.2316/P.2011.717-111, DOI 10.2316/P.2011.717-111]; Drozdz S, 2007, EUR PHYS J B, V58, P499, DOI 10.1140/epjb/e2007-00246-8; Fletcher T., 2010, JMLR P, V11, P167; Foresti L, 2009, LECT NOTES COMPUT SC, V5769, P933, DOI 10.1007/978-3-642-04277-5_94; Frick A., 1996, P 6 INT AFIR C NURNB, V1/2, P997; Fuente D., 2006, GECCO 2006 C P, V2, P1857; Goldberg D. E., 1989, GENETIC ALGORITHMS S; Hann TH, 1996, NEUROCOMPUTING, V10, P323, DOI 10.1016/0925-2312(95)00137-9; Hirabayashi A., 2009, GECCO 2009, P1529; Joachims T., 1998, P ECML 98 10 EUR C M, V1398, P137; Koskela T., 1998, INT J KNOWLEDGE BASE, V2, P60; Kwapien J, 2009, J ECON INTERACT COOR, V4, P55, DOI 10.1007/s11403-009-0047-9; Kwok JTY, 2000, IEEE T NEURAL NETWOR, V11, P1162, DOI 10.1109/72.870047; Lee M., 2003, INT J BUSINESS EC, V2, P155; Luss R, 2015, QUANT FINANC, V15, P999, DOI 10.1080/14697688.2012.672762; MEESE RA, 1983, J INT ECON, V14, P3, DOI 10.1016/0022-1996(83)90017-X; Mehdi K, 2011, APPL SOFT COMPUT, V11, P2664; Olson D, 2004, J BANK FINANC, V28, P85, DOI 10.1016/S0378-4266(02)00399-0; Park C.-H., 2004, 200404 AGMAS PROJ; Ravindran R., 2008, ANN LOND C MON EC MA; Riccardo C., 1997, INT J FINANC ECON, V2, P267; Schulmeister S., 2007, WIFO WORKING PAPERS; SHARPE WF, 1994, J PORTFOLIO MANAGE, V21, P49, DOI 10.3905/jpm.1994.409501; Stawicki S. P., 2007, SCIENTIST, V1, P14; Vapnik V. N., 1995, NATURE STAT LEARNING; Wilder J.W., 1978, NEW CONCEPTS TECHNIC; Williams L., 2005, TRADE STOCKS COMMODI; Zhao QY, 2009, ICIC 2009: SECOND INTERNATIONAL CONFERENCE ON INFORMATION AND COMPUTING SCIENCE, VOL 3, PROCEEDINGS, P189, DOI 10.1109/ICIC.2009.253	57	3	3	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0927-7099	1572-9974		COMPUT ECON	Comput. Econ.	JAN	2015	45	1					49	89		10.1007/s10614-013-9407-6		41	Economics; Management; Mathematics, Interdisciplinary Applications	Business & Economics; Mathematics	AX9WL	WOS:000347249900003		
J	Xiong, J; Kubo, K; Noro, S; Akutagawa, T; Nakamura, T				Xiong, J.; Kubo, K.; Noro, S.; Akutagawa, T.; Nakamura, T.			Supramolecular cations of (m-halogenated-anilinium)(dibenzo[18]crown-6) in Keggin[SMo12O402] polyoxometallates	CRYSTENGCOMM			English	Article							CRYSTALLINE MOLECULAR GYROTOP; PHENYLENE ROTOR; ROTATION; HYDROGEN; DYNAMICS; FERROELECTRICITY; TRANSITION; GYROSCOPES; COMPLEXES; COMPASSES	Four supramolecular cations (m-XAni(+))(DB[18]crown-6) (X = F, Cl, Br or I; Ani(+) = anilinium ion; DB[18]crown-6 = dibenzo[18]crown-6) were introduced into crystals of a Keggin [SMo12O402-] polyanion to form [(m-XAni(+))(DB[18]crown-6)](2)[SMo12O402-]center dot 4CH(3)CN (1, 2, 3 or 4 for X = F, Cl, Br or I) through a hydrogen-bonding interaction. Crystals 1, 2, 3 and 4, which were isomorphous to each other, crystallized in the monoclinic space group P2(1)/(n). Supramolecular cations (m-XAni(+))(DB[18]crown-6) were constructed by a N-H+center dot center dot center dot O hydrogen-bonding interaction. [SMo12O402-] polyoxoanions were infinitely extended in three dimensions through a weak C-H center dot center dot center dot O hydrogen-bonding interaction with DB[18] crown-6. Disorder of the halogen atoms at the meta-position was observed in crystals 1, 2 and 3. The rotational freedom of the (m-XAni(+)) cations was suppressed because of weak interactions with surrounding molecules.	[Xiong, J.; Kubo, K.; Noro, S.; Nakamura, T.] Hokkaido Univ, Grad Sch Environm Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Kubo, K.; Noro, S.; Nakamura, T.] Hokkaido Univ, Res Inst Elect Sci, Kita Ku, Sapporo, Hokkaido 0010020, Japan; [Akutagawa, T.] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan	Xiong, J (reprint author), Hokkaido Univ, Grad Sch Environm Sci, Kita Ku, N10W5, Sapporo, Hokkaido 0600810, Japan.	xiongjun@ees.hokudai.ac.jp; kkubo@es.hokudai.ac.jp; noro@es.hokudai.ac.jp; akuta@tagen.tohoku.ac.jp; tnaka@es.hokudai.ac.jp	Noro, Shin-ichiro/E-1322-2012; Nakamura, Takayoshi/A-5251-2012		JSPS	This work was supported by JSPS Core-to-Core Program, A. Advanced Research Networks.	Dominguez Z, 2002, J AM CHEM SOC, V124, P7719, DOI 10.1021/ja025753v; Akutagawa T, 2005, J AM CHEM SOC, V127, P4397, DOI 10.1021/ja043527a; FUNATSU T, 1995, NATURE, V374, P555, DOI 10.1038/374555a0; Nishihara S, 2002, CHEM COMMUN, P408, DOI 10.1039/b110368g; Long DL, 2007, CHEM SOC REV, V36, P105, DOI 10.1039/b502666k; Xu HS, 2009, INORG CHEM, V48, P10275, DOI 10.1021/ic901416m; Coronado E, 1998, CHEM REV, V98, P273, DOI 10.1021/cr970471c; Setaka W, 2012, P NATL ACAD SCI USA, V109, P9271, DOI 10.1073/pnas.1114733109; Zhang Y, 2012, J AM CHEM SOC, V134, P11044, DOI 10.1021/ja3047427; Akutagawa T, 2009, NAT MATER, V8, P342, DOI [10.1038/nmat2377, 10.1038/NMAT2377]; Bai Y, 2011, CRYSTENGCOMM, V13, P4181, DOI 10.1039/c1ce05192j; Dominguez Z, 2002, J AM CHEM SOC, V124, P2398, DOI 10.1021/ja0119447; Champin B, 2007, CHEM SOC REV, V36, P358, DOI 10.1039/b604484k; Li LL, 2009, CRYST GROWTH DES, V9, P5206, DOI 10.1021/cg9006718; Setaka W, 2013, J AM CHEM SOC, V135, P14560, DOI 10.1021/ja408405f; Song YF, 2010, CRYSTENGCOMM, V12, P109, DOI 10.1039/b910434h; Clemente-Juan JM, 2012, CHEM SOC REV, V41, P7464, DOI 10.1039/c2cs35205b; Lemouchi C, 2012, J AM CHEM SOC, V134, P7880, DOI 10.1021/ja301484b; Durot S, 2010, DALTON T, V39, P10557, DOI 10.1039/c0dt00457j; Shi ZY, 2013, CRYSTENGCOMM, V15, P7583, DOI 10.1039/c3ce41312h; Yamase T, 1998, CHEM REV, V98, P307, DOI 10.1021/cr9604043; Leigh DA, 2003, NATURE, V424, P174, DOI 10.1038/nature01758; Astumian RD, 1997, SCIENCE, V276, P917, DOI 10.1126/science.276.5314.917; Kelly TR, 1999, NATURE, V401, P150, DOI 10.1038/43639; Setaka W, 2013, ORG LETT, V15, P5092, DOI 10.1021/ol402464d; Setaka W, 2012, J AM CHEM SOC, V134, P12458, DOI 10.1021/ja305822e; Sadakane M, 1998, CHEM REV, V98, P219, DOI 10.1021/cr960403a; Kay ER, 2007, ANGEW CHEM INT EDIT, V46, P72, DOI 10.1002/anie.200504313; KELLY TR, 1994, J AM CHEM SOC, V116, P3657, DOI 10.1021/ja00087a085; Kumagai H, 2002, INORG CHEM, V41, P1989, DOI 10.1021/ic010599j; Koumura N, 1999, NATURE, V401, P152; Akutagawa T, 2011, INORG CHEM, V50, P6711, DOI 10.1021/ic200683e; Fu DW, 2011, J AM CHEM SOC, V133, P12780, DOI 10.1021/ja204540g; Casarini D, 2001, ANGEW CHEM INT EDIT, V40, P2536, DOI 10.1002/1521-3773(20010702)40:13<2536::AID-ANIE2536>3.0.CO;2-R; Endo D, 2012, B CHEM SOC JPN, V85, P305, DOI 10.1246/bcsj.20110371; Endo T, 2011, DALTON T, V40, P1491, DOI 10.1039/c0dt01140a; Godinez G. E., 2002, J AM CHEM SOC, V124, P4701; Khan NS, 2011, J ORG CHEM, V76, P1418, DOI 10.1021/jo102480s; Nishihara S, 2007, CHEM-ASIAN J, V2, P1083, DOI 10.1002/asia.200700010; Steiner T., 2002, ANGEW CHEM INT EDIT, V41, P4; Stryer L, 1995, BIOCHEMISTRY; Vu T, 2001, INORG CHEM, V40, P65, DOI 10.1021/ic991310p; Wendeler M, 1997, J AM CHEM SOC, V119, P9793, DOI 10.1021/ja9640657; Xue GL, 2012, ELECTROCHIM ACTA, V69, P315, DOI 10.1016/j.electacta.2012.03.003	44	0	0	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1466-8033			CRYSTENGCOMM	Crystengcomm		2015	17	4					856	861		10.1039/c4ce01988a		6	Chemistry, Multidisciplinary; Crystallography	Chemistry; Crystallography	AX4IW	WOS:000346897500018		
J	Shi, YR; Zhu, G; Mikami, M; Shimomura, Y; Wang, YH				Shi, Yurong; Zhu, Ge; Mikami, Masayoshi; Shimomura, Yasuo; Wang, Yuhua			A novel Ce3+ activated Lu3MgAl3SiO12 garnet phosphor for blue chip light-emitting diodes with excellent performance	DALTON TRANSACTIONS			English	Article							YAG-CE; PHOTOLUMINESCENCE PROPERTIES; OPTICAL-PROPERTIES; WHITE-LIGHT; LUMINESCENT PROPERTIES; EMISSION; COLOR; CAALSIN3; LEDS; SUBSTITUTION	A novel Ce3+ activated Lu3MgAl3SiO12:Ce phosphor was synthesized and found to crystallize in the garnet structure. The crystal structure of the synthesized phosphor has been characterised by X-ray diffraction and Rietveld refinement. Both room and high temperature photoluminescence spectra are utilized to investigate the luminescence properties and crystal field splitting. The high temperature quenching of these phosphors and their quantum efficiency (QE) are also studied using both the prepared YAG: Ce and the commercial YAG: Ce phosphor named P46-y3 as the reference. Upon excitation with blue light, the composition-optimized Lu3MgAl3SiO12:Ce phosphor exhibited strong yellow light with a high QE of 81.2% and better thermal stability than that of the commercial phosphor. The results indicate that the Lu3MgAl3SiO12:Ce phosphor can serve as a candidate for blue chip LEDs.	[Shi, Yurong; Zhu, Ge; Wang, Yuhua] Lanzhou Univ, Sch Phys Sci & Technol, Key Lab Special Funct Mat & Struct Design, Minist Educ, Lanzhou 730000, Peoples R China; [Shi, Yurong] Zhoukou Normal Univ, Key Lab Rare Earth Funct Mat & Applicat, Zhoukou 466001, Peoples R China; [Mikami, Masayoshi] Sci & Technol Res Ctr, Mitsubishi Chem Grp, Yokohama, Kanagawa 2278502, Japan	Wang, YH (reprint author), Lanzhou Univ, Sch Phys Sci & Technol, Key Lab Special Funct Mat & Struct Design, Minist Educ, Lanzhou 730000, Peoples R China.	wyh@lzu.edu.cn			Specialized Research Fund for the Doctoral Program of Higher Education [20120211130003]; National Natural Science Funds of China [51372105]	This work was supported by the Specialized Research Fund for the Doctoral Program of Higher Education (No. 20120211130003) and the National Natural Science Funds of China (Grant No. 51372105).	Liu YF, 2011, J MATER CHEM, V21, P6354, DOI 10.1039/c0jm04404k; Zhang ZJ, 2012, J MATER CHEM, V22, P23871, DOI 10.1039/c2jm35170f; Shang MM, 2012, J PHYS CHEM C, V116, P10222, DOI 10.1021/jp302252k; Lin YS, 2007, J LUMIN, V122, P580, DOI 10.1016/j.jlumin.2006.01.230; Shang MM, 2014, INORG CHEM, V53, P7748, DOI 10.1021/ic501063j; Setlur AA, 2006, CHEM MATER, V18, P3314, DOI 10.1021/cm060898c; Xie RJ, 2006, CHEM MATER, V18, P5578, DOI 10.1021/cm061010n; Liu TC, 2011, CHEM MATER, V23, P3698, DOI 10.1021/cm201289s; Setlur AA, 2008, CHEM MATER, V20, P6277, DOI 10.1021/cm801732d; Chen WT, 2012, J AM CHEM SOC, V134, P8022, DOI 10.1021/ja301593z; Tao ZX, 2013, DALTON T, V42, P2121, DOI 10.1039/c2dt32117c; Milanese C, 2004, CHEM MATER, V16, P1232, DOI 10.1021/cm031138u; Chung HY, 2010, J AM CERAM SOC, V93, P1838, DOI 10.1111/j.1551-2916.2010.03626.x; Zhang ZJ, 2012, J MATER CHEM, V22, P9813, DOI 10.1039/c2jm30220a; Yang H, 2008, J LUMIN, V128, P1570, DOI 10.1016/j.jlumin.2008.03.003; Gong XH, 2014, INORG CHEM, V53, P6607, DOI 10.1021/ic500153u; Suehiro T, 2011, ACS APPL MATER INTER, V3, P811, DOI 10.1021/am101160e; Jia YC, 2012, RSC ADV, V2, P2678, DOI 10.1039/c2ra00894g; Bachmann V, 2009, CHEM MATER, V21, P2077, DOI 10.1021/cm8030768; Mao ZY, 2010, INORG CHEM, V49, P4922, DOI 10.1021/ic902538a; Li JW, 2007, CHEM MATER, V19, P3592, DOI 10.1021/cm070994t; Liu YF, 2011, CHEM COMMUN, V47, P10677, DOI 10.1039/c1cc14324g; Shi YR, 2012, OPT EXPRESS, V20, P21656, DOI 10.1364/OE.20.021656; Kalaji A, 2013, CHEM PHYS LETT, V586, P91, DOI 10.1016/j.cplett.2013.09.007; Pan YX, 2004, J PHYS CHEM SOLIDS, V65, P845, DOI 10.1016/j.jpcs.2003.08.018; Im WB, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2976138; Katelnikovas A, 2013, J LUMIN, V136, P17, DOI 10.1016/j.jlumin.2012.11.012; Katelnikovas A, 2009, J LUMIN, V129, P1356, DOI 10.1016/j.jlumin.2009.07.006; Katelnikovas A, 2011, OPT MATER, V33, P992, DOI 10.1016/j.optmat.2010.11.023; Kim SK, 2010, OPT EXPRESS, V18, P11025, DOI 10.1364/OE.18.011025; Lin YS, 2005, J ELECTROCHEM SOC, V152, pJ41, DOI 10.1149/1.1896307; MINISCALCO WJ, 1978, J APPL PHYS, V49, P6109, DOI 10.1063/1.324531; Ogieglo JM, 2013, J PHYS CHEM A, V117, P2479, DOI 10.1021/jp309572p; Praveena R, 2011, J ALLOY COMPD, V509, P859, DOI 10.1016/j.jallcom.2010.09.113; Ronda Cees, 2008, LUMINESCENCE THEORY; Shigeo S., 1998, PHOSPHOR HDB; Wang L, 2010, OPT EXPRESS, V18, P25177, DOI 10.1364/OE.18.025177; Wang LX, 2010, J RARE EARTH, V28, P16, DOI 10.1016/S1002-0721(09)60041-7	38	3	3	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1477-9226	1477-9234		DALTON T	Dalton Trans.		2015	44	4					1775	1781		10.1039/c4dt03144j		7	Chemistry, Inorganic & Nuclear	Chemistry	AX4MZ	WOS:000346907800032		
J	Kim, M; Kobayashi, M; Kato, H; Yamane, H; Sato, Y; Kakihana, M				Kim, Minsung; Kobayashi, Makoto; Kato, Hideki; Yamane, Hisanori; Sato, Yasushi; Kakihana, Masato			Crystal structures and luminescence properties of Eu2+-activated new NaBa0.5Ca0.5PO4 and Na3Ba2Ca(PO4)(3)	DALTON TRANSACTIONS			English	Article							LIGHT-EMITTING-DIODES; PHOSPHO-OLIVINES; OXIDES	NaBa1-xCaxPO4:Eu2+ were synthesized using polymerizable complex method. New phases were observed at x = 1/3 and 0.5, which were identified by single-crystal XRD analysis as Na3Ba2Ca(PO4)(3) and NaBa0.5-Ca0.5PO4 with a trigonal system. Though both phases pretend to be solid solutions between NaBaPO4 and NaCaPO4, they have different coordination environments and PO4 orderings. 1 mol% Eu2+-activated NaBaPO4, Na3Ba2Ca(PO4)(3), and NaBa0.5Ca0.5PO4 exhibited an emission maximum at 435 nm, 458 nm, and 460 nm, respectively. The shift of the emission maximum might be due to a change in the Eu-O bond length.	[Kim, Minsung; Kobayashi, Makoto; Kato, Hideki; Yamane, Hisanori; Kakihana, Masato] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan; [Sato, Yasushi] Okayama Univ Sci, Fac Sci, Dept Chem, Okayama 7000005, Japan	Kakihana, M (reprint author), Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan.	kakihana@tagen.tohoku.ac.jp	Kobayashi, Makoto/C-2748-2015; Sato, Yasushi/C-3694-2011		Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [22107002, 2206]; Japan Society for the Promotion of Science (JSPS) [24-9285]	The authors thank HORIBA for helping us to measure emission lifetime. This work was partially supported by a Grant-in-Aid for Scientific Research (no. 22107002) on Innovative Areas of "Fusion Materials: Creative Development of Materials and Exploration of Their Function through Molecular Control" (no. 2206) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) and a Grant-in-Aid for JSPS Fellows (24-9285) from Japan Society for the Promotion of Science (JSPS).	Momma K, 2011, J APPL CRYSTALLOGR, V44, P1272, DOI 10.1107/S0021889811038970; [Anonymous], 2005, RAPID AUTO; Pust P, 2014, NAT MATER, V13, P891, DOI [10.1038/nmat4012, 10.1038/NMAT4012]; Chung SY, 2002, NAT MATER, V1, P123, DOI 10.1038/nmat732; Zukauskas A, 2001, MRS BULL, V26, P764; Zhang SY, 2011, J AM CERAM SOC, V94, P2987, DOI 10.1111/j.1551-2916.2011.04481.x; Fujii K, 2014, CHEM MATER, V26, P2488, DOI 10.1021/cm500776x; HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x; Tang YS, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2721846; Burla MC, 2005, J APPL CRYSTALLOGR, V38, P381, DOI 10.1107/S002188980403225X; Chang MH, 2012, MICROELECTRON RELIAB, V52, P762, DOI 10.1016/j.microrel.2011.07.063; Pust P, 2014, CHEM MATER, V26, P3544, DOI 10.1021/cm501162n; Han JK, 2013, J AM CERAM SOC, V96, P1526, DOI 10.1111/jace.12212; Schubert EF, 2005, SCIENCE, V308, P1274, DOI 10.1126/science.1108712; Qin CX, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/18/185105; Padhi AK, 1997, J ELECTROCHEM SOC, V144, P1188, DOI 10.1149/1.1837571; Dai PP, 2013, J MATER CHEM C, V1, P4570, DOI 10.1039/c3tc30128a; Choi S, 2012, MATER LETT, V75, P186, DOI 10.1016/j.matlet.2012.02.019; Poort SHM, 1997, J ALLOY COMPD, V260, P93, DOI 10.1016/S0925-8388(97)00140-0; Bachmann V., 2009, CHEM MATER, V126, P2077; Farrugia L. J., 1999, J APPL CRYSTALLOGR, V32, P837, DOI DOI 10.1107/S0021889899006020; Hasegawa T., 2013, ECS J SOLID STATE SC, V2, P3107; Higashi T., 1999, NUMABS NUMERICAL ABS; Horosaki N., 2014, CHEM MATER, V26, P4280; Kakihana M, 1996, J SOL-GEL SCI TECHN, V6, P7, DOI 10.1007/BF00402588; Kakihana M, 1999, B CHEM SOC JPN, V72, P1427, DOI 10.1246/bcsj.72.1427; Kim M., 2013, OPT PHOTONICS J, V3, P13; Kim M, 2014, J CERAM SOC JPN, V122, P626, DOI 10.2109/jcersj2.122.626; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Zhang SY, 2011, INORG CHEM, V50, P2897, DOI 10.1021/ic102504x	30	0	0	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1477-9226	1477-9234		DALTON T	Dalton Trans.		2015	44	4					1900	1904		10.1039/c4dt03024a		5	Chemistry, Inorganic & Nuclear	Chemistry	AX4MZ	WOS:000346907800047		
J	Escalona, Z; Alvarez, B; Uenishi, H; Toki, D; Yuste, M; Revilla, C; del Moral, MG; Alonso, F; Ezquerra, A; Dominguez, J				Escalona, Z.; Alvarez, B.; Uenishi, H.; Toki, D.; Yuste, M.; Revilla, C.; Gomez del Moral, M.; Alonso, F.; Ezquerra, A.; Dominguez, J.			Molecular characterization of porcine Siglec-10 and analysis of its expression in blood and tissues	DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY			English	Article						Siglec-10; B cells; Monoclonal antibody; Swine	SWINE FEVER VIRUS; SIALIC-ACID; DENDRITIC CELLS; ALVEOLAR MACROPHAGES; CD33-RELATED SIGLECS; IMMUNE-SYSTEM; RESPONSES; RESOLUTION; CLONING; FAMILY	Siglecs are sialic acid binding Ig-like proteins involved in the control of leukocyte responses. In this study we describe the characterization of a porcine orthologue of Siglec-10. A cDNA clone was obtained from a porcine library which encodes a protein with sequence homology to human Siglec-10. This cDNA codes for a type I transmembrane protein containing four Ig-like domains, a transmembrane region, and a cytoplasmic tail with three tyrosine-based motifs, including a membrane-proximal Grb2-binding motif, and two ITIM motifs. When expressed on transfected cells, porcine Siglec-10 was able to bind red blood cells in a sialic acid-dependent manner. Monoclonal antibodies were developed against this protein and used to examine its cell and tissue distribution in the pig. Siglec-10 was found to be expressed on blood B cells and B cell areas of the spleen and lymph nodes. A weak expression was also detected on monocytes. (C) 2014 Elsevier Ltd. All rights reserved.	[Escalona, Z.; Alvarez, B.; Yuste, M.; Revilla, C.; Alonso, F.; Ezquerra, A.; Dominguez, J.] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotecnol, Madrid 28040, Spain; [Uenishi, H.] Inst Japan Assoc Technoinnovat Agr Forestry & Fis, Tsukuba, Ibaraki 3050854, Japan; [Gomez del Moral, M.] Univ Complutense Madrid, Fac Med, Dept Biol Celular & Inmunol, Madrid 28040, Spain	Dominguez, J (reprint author), INIA, Dept Biotecnol, Ctra Coruna Km 7-5, Madrid 28040, Spain.	juncal@inia.es	Ezquerra, Angel/I-3440-2012; Dominguez, Javier/I-1210-2015		Spanish Ministry of Science and Innovation (MICINN) [AGL2009-09729, AGL2012-31556]; Spanish Ministry of Economy and Competitiveness; MICINN	We thank Paloma Martinez de la Riva and Elena Ramos for technical assistance. Funding for this work was provided by grants AGL2009-09729 and AGL2012-31556 from the Spanish Ministry of Science and Innovation (MICINN) and the Spanish Ministry of Economy and Competitiveness. Zoraida Escalona was supported by a doctoral fellowship from MICINN.	Alvarez B, 2008, VET RES, V39, DOI 10.1051/vetres:2007051; Ackermann JA, 2011, EMBO J, V30, P1621, DOI 10.1038/emboj.2011.74; Whitney G, 2001, EUR J BIOCHEM, V268, P6083, DOI 10.1046/j.0014-2956.2001.02543.x; Lock K, 2004, IMMUNOBIOLOGY, V209, P199, DOI 10.1016/j.imbio.2004.04.007; Delputte PL, 2004, J VIROL, V78, P8094, DOI 10.1128/JVI.78.15.8094-8101.2004; Uenishi H, 2007, NUCLEIC ACIDS RES, V35, pD650, DOI 10.1093/nar/gkl954; Alphey MS, 2003, J BIOL CHEM, V278, P3372, DOI 10.1074/jbc.M210602200; Crocker PR, 2012, ANN NY ACAD SCI, V1253, P102, DOI 10.1111/j.1749-6632.2011.06449.x; Munday J, 2001, BIOCHEM J, V355, P489, DOI 10.1042/0264-6021:3550489; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Pillai S, 2012, ANNU REV IMMUNOL, V30, P357, DOI 10.1146/annurev-immunol-020711-075018; CARRASCOSA AL, 1982, J VIROL METHODS, V3, P303, DOI 10.1016/0166-0934(82)90034-9; May AP, 1998, MOL CELL, V1, P719, DOI 10.1016/S1097-2765(00)80071-4; Li N, 2001, J BIOL CHEM, V276, P28106, DOI 10.1074/jbc.M100467200; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Chamorro S, 2004, IMMUNOBIOLOGY, V209, P57, DOI 10.1016/j.imbio.2004.02.002; Cornish AL, 1998, BLOOD, V92, P2123; Ding C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000997; GONZALEZ S, 1990, VET IMMUNOL IMMUNOP, V26, P71, DOI 10.1016/0165-2427(90)90133-D; Kantonen S, 2011, MOL CELL BIOL, V31, P4524, DOI 10.1128/MCB.05684-11; Kitzig F, 2002, BIOCHEM BIOPH RES CO, V296, P355, DOI 10.1016/S0006-291X(02)00885-9; Martinez-Moliner V, 2012, MICROBIOL-SGM, V158, P2117, DOI 10.1099/mic.0.056994-0; Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008	23	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0145-305X	1879-0089		DEV COMP IMMUNOL	Dev. Comp. Immunol.	JAN	2015	48	1					116	123		10.1016/j.dci.2014.09.011		8	Immunology; Zoology	Immunology; Zoology	AY0BR	WOS:000347263500012		
J	Ng, TH; Wu, MH; Chang, SH; Aoki, T; Wang, HC				Ng, Tze Hann; Wu, Miao-Hsien; Chang, Sheng-Hsiung; Aoki, Takashi; Wang, Han-Ching			The DNA fibers of shrimp hemocyte extracellular traps are essential for the clearance of Escherichia coli	DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY			English	Article						Shrimp; Hemocytes; Extracellular traps; Bacteria killing	CELL-DEATH; BOVINE NEUTROPHILS; MAST-CELLS; RELEASE; CHALLENGE; INFECTION; BACTERIA; HISTONE; DEFENSE; INDUCE	Extracellular traps (ETs) are a part of the vertebrate immune response that was only recently discovered. These structures are formed in response to pathogenic invasion and they act to kill the invader. Vertebrate ETs are composed of chromosomal DNA, histone proteins and other antimicrobial cytoplasmic proteins. Pathogenic stimulation was also recently shown to trigger a similar ET response in shrimp hemocytes, and in the present study, we evaluate the role of the DNA fibers in the bactericidal properties of these invertebrate ETs. When the formation of shrimp ETs was disrupted by DNase I, the ETs antibacterial activity was also reduced, indicating that the DNA fibers are important for ET-mediated bacterial clearance. We also found that at high bacterial densities, shrimp ETs were a more effective antibacterial response than phagocytosis. (C) 2014 Elsevier Ltd. All rights reserved.	[Ng, Tze Hann; Chang, Sheng-Hsiung; Aoki, Takashi; Wang, Han-Ching] Natl Cheng Kung Univ, Inst Biotechnol, Coll Biosci & Biotechnol, Tainan 701, Taiwan; [Wu, Miao-Hsien] Natl Cheng Kung Univ, Dept Life Sci, Coll Biosci & Biotechnol, Tainan 701, Taiwan; [Aoki, Takashi] Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Coll Biosci & Biotechnol, Tainan 701, Taiwan; [Aoki, Takashi] Waseda Univ, Consolidated Res Inst Adv Sci & Med Care, Shinjuku Ku, Tokyo, Japan	Wang, HC (reprint author), Natl Cheng Kung Univ, Inst Biotechnol, Tainan 701, Taiwan.	wanghc@mail.ncku.edu.tw			Ministry of Science and Technology [NSC 101-2628-B-006 -001 -MY4, NSC 103-2811-B-006-001]	This investigation was supported financially by the Ministry of Science and Technology (NSC 101-2628-B-006 -001 -MY4 and NSC 103-2811-B-006-001). We are indebted to Paul Barlow for his helpful criticism.	Brinkmann V, 2012, J CELL BIOL, V198, P773, DOI 10.1083/jcb.201203170; Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x; Papayannopoulos V, 2009, TRENDS IMMUNOL, V30, P513, DOI 10.1016/j.it.2009.07.011; Lin AM, 2011, J IMMUNOL, V187, P490, DOI 10.4049/jimmunol.1100123; Farrera C, 2013, J IMMUNOL, V191, P2647, DOI 10.4049/jimmunol.1300436; Hellenbrand KM, 2013, MICROB PATHOGENESIS, V54, P67, DOI 10.1016/j.micpath.2012.09.007; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Rosa RD, 2010, ISJ-INVERT SURVIV J, V7, P262; Dorrington T, 2011, FISH SHELLFISH IMMUN, V30, P94, DOI 10.1016/j.fsi.2010.09.006; Gupta AK, 2010, FEBS LETT, V584, P3193, DOI 10.1016/j.febslet.2010.06.006; Aulik NA, 2010, INFECT IMMUN, V78, P4454, DOI 10.1128/IAI.00840-10; Chow OA, 2010, CELL HOST MICROBE, V8, P445, DOI 10.1016/j.chom.2010.10.005; Behrendt JH, 2010, VET IMMUNOL IMMUNOP, V133, P1, DOI 10.1016/j.vetimm.2009.06.012; HIRSCH JG, 1958, J EXP MED, V108, P925, DOI 10.1084/jem.108.6.925; Yousefi S, 2008, NAT MED, V14, P949, DOI 10.1038/nm.1855; Palic D, 2007, DEV COMP IMMUNOL, V31, P805, DOI 10.1016/j.dci.2006.11.010; Chuammitri P, 2009, VET IMMUNOL IMMUNOP, V129, P126, DOI 10.1016/j.vetimm.2008.12.013; Jenne CN, 2013, CELL HOST MICROBE, V13, P169, DOI 10.1016/j.chom.2013.01.005; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Webster SJ, 2010, J IMMUNOL, V185, P2968, DOI 10.4049/jimmunol.1000805; Guimaraes-Costa AB, 2009, P NATL ACAD SCI USA, V106, P6748, DOI 10.1073/pnas.0900226106; Ng TH, 2013, DEV COMP IMMUNOL, V41, P644, DOI 10.1016/j.dci.2013.06.014; Wardini AB, 2010, J GEN VIROL, V91, P259, DOI 10.1099/vir.0.014613-0; Liu P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090042; Lu T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00365; Nama B.H., 2012, FISH SHELLFISH IMMUN, V33, P92; Saffarzadeh M., 2012, PLOS ONE, V27; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; von Kockritz-Blickwede M, 2008, BLOOD, V111, P3070, DOI 10.1182/blood-2007-07-104018	30	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0145-305X	1879-0089		DEV COMP IMMUNOL	Dev. Comp. Immunol.	JAN	2015	48	1					229	233		10.1016/j.dci.2014.10.011		5	Immunology; Zoology	Immunology; Zoology	AY0BR	WOS:000347263500025		
J	Takeuchi, M; Matsuda, K; Yamaguchi, S; Asakawa, K; Miyasaka, N; Lal, P; Yoshihara, Y; Koga, A; Kawakami, K; Shimizu, T; Hibi, M				Takeuchi, Miki; Matsuda, Koji; Yamaguchi, Shingo; Asakawa, Kazuhide; Miyasaka, Nobuhiko; Lal, Pradeep; Yoshihara, Yoshihiro; Koga, Akihiko; Kawakami, Koichi; Shimizu, Takashi; Hibi, Masahiko			Establishment of Gal4 transgenic zebrafish lines for analysis of development of cerebellar neural circuitry	DEVELOPMENTAL BIOLOGY			English	Article						Zebrafish; Cerebellum; Gal4; Neural circuits; Cell migration	CLIMBING FIBER PROJECTION; FISH GNATHONEMUS-PETERSI; ALDOLASE-C COMPARTMENTS; GENE TRAP APPROACH; ZEBRIN-II; EFFERENT CONNECTIONS; TRANSPOSABLE ELEMENT; RHOMBIC LIP; IN-VIVO; GLUTAMATE TRANSPORTERS	The cerebellum is involved in some forms of motor coordination and motor learning. Here we isolated transgenic (Tg) zebrafish lines that express a modified version of Gal4-VP16 (GFF) in the cerebellar neural circuits: granule, Purkinje, or eurydendroid cells, Bergmann glia, or the neurons in the inferior olive nuclei (10) which send climbing fibers to Purkinje cells, with the transposon ToI2 system. By combining GFF lines with Tg lines carrying a reporter gene located downstream of Gal4 binding sequences (upstream activating sequence: UAS), we investigated the anatomy and developmental processes of the cerebellar neural circuitry. Combining an IO-specific Gal4 line with a UAS reporter line expressing the photoconvertible fluorescent protein Kaede demonstrated the contralateral projections of climbing fibers. Combining a granule cell-specific Gal4 line with a UAS reporter line expressing wheat germ agglutinin (WGA) confirmed direct and/or indirect connections of granule cells with Purkinje cells, eurydendroid cells, and IO neurons in zebrafish. Time-lapse analysis of a granule cell-specific Gal4 line revealed initial random movements and ventral migration of granule cell nuclei. Transgenesis of a reporter gene with another transposon Toll system visualized neuronal structure at a single cell resolution. Our findings indicate the usefulness of these zebrafish Gal4 Tg lines for studying the development and function of cerebellar neural circuits. (C) 2014 Elsevier Inc. All rights reserved.	[Takeuchi, Miki; Shimizu, Takashi; Hibi, Masahiko] Nagoya Univ, Biosci & Biotechnol Ctr, Lab Organogenesis & Organ Funct, Nagoya, Aichi 4648601, Japan; [Matsuda, Koji; Yamaguchi, Shingo; Shimizu, Takashi; Hibi, Masahiko] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648602, Japan; [Asakawa, Kazuhide; Lal, Pradeep; Kawakami, Koichi] Natl Inst Genet, Div Mol & Dev Biol, Mishima, Shizuoka 4118540, Japan; [Miyasaka, Nobuhiko; Yoshihara, Yoshihiro] RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan; [Koga, Akihiko] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 4648506, Japan	Hibi, M (reprint author), Nagoya Univ, Biosci & Biotechnol Ctr, Lab Organogenesis & Organ Funct, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	hibi@bio.nagoya-u.ac.jp			Ministry of Education, Science, Sports and Technology (MEXT), Japan [23241063, 24370088, 25440104]; MEXT [25111709, 26115512]; Uehara Memorial Foundation; Takeda Science Foundation; Naito Foundation Natural Science Scholarship	We thank B. Appel for the olig2:EGFP line, K Hatta for UAS:Kaede line, Y. Ohashi and Y. Miyashita for AcGFP-P2A-WGA plasmid, K Kondoh and S. Tsukazaki for fish care, the National BioResource Project (NBRP) for zebrafish maintenance, G. Abe and H. Kikuta for gene and enhancer trap constructs, and the members of the Hibi laboratory for helpful discussions. This work was supported by Grants-in-Aid for Scientific Research (A, B, and C) from the Ministry of Education, Science, Sports and Technology (MEXT), Japan (23241063 to K.K., 24370088 to M.H., 25440104 to T.S.); Grants-in-Aid for Scientific Research on Innovative Areas from MEXT (25111709, 26115512 to M.H.); the Uehara Memorial Foundation (to M.H.); Takeda Science Foundation (to M.H.); the Naito Foundation Natural Science Scholarship (to M.H.).	AHN AH, 1994, DEVELOPMENT, V120, P2081; Aigaki T, 2001, J NEUROGENET, V15, P169; Altman J., 1997, DEVELOPMENTOF CEREBE; WULLIMANN MF, 1989, J COMP NEUROL, V289, P554, DOI 10.1002/cne.902890403; Miyazaki T, 2003, EUR J NEUROSCI, V17, P2563, DOI 10.1046/j.1460-9568.2003.02698.x; Douglass AD, 2008, CURR BIOL, V18, P1133, DOI 10.1016/j.cub.2008.06.077; Urasaki A, 2008, P NATL ACAD SCI USA, V105, P19827, DOI 10.1073/pnas.0810380105; Han VZ, 2003, J NEUROSCI, V23, P11147; Mueller T, 2002, MECH DEVELOP, V117, P123, DOI 10.1016/S0925-4773(02)00194-6; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; Kani S, 2010, DEV BIOL, V343, P1, DOI 10.1016/j.ydbio.2010.03.024; Pisharath H, 2007, MECH DEVELOP, V124, P218, DOI 10.1016/j.mod.2006.11.005; Higashijima S, 2004, J COMP NEUROL, V480, P19, DOI 10.1002/cne.20279; Braz JM, 2002, P NATL ACAD SCI USA, V99, P15148, DOI 10.1073/pnas.222546999; Tanabe K, 2010, J NEUROSCI, V30, P16983, DOI 10.1523/JNEUROSCI.3352-10.2010; Buffo A, 2013, PROG NEUROBIOL, V109, P42, DOI 10.1016/j.pneurobio.2013.08.001; Sugihara I, 2004, J NEUROSCI, V24, P8771, DOI 10.1523/JNEUROSCI.1961-04.2004; Hatta K, 2006, NAT PROTOC, V1, P960, DOI 10.1038/nprot.2006.96; Punnamoottil B, 2008, DEV DYNAM, V237, P2195, DOI 10.1002/dvdy.21618; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Hisano S, 2002, MOL BRAIN RES, V107, P23, DOI 10.1016/S0169-328X(02)00442-4; Volkmann K, 2010, J COMP NEUROL, V518, P2794, DOI 10.1002/cne.22364; Scott EK, 2007, NAT METHODS, V4, P323, DOI 10.1038/NMETH1033; Muto A, 2011, P NATL ACAD SCI USA, V108, P5425, DOI 10.1073/pnas.1000887108; Hibi M, 2012, DEV NEUROBIOL, V72, P282, DOI 10.1002/dneu.20875; Ahrens MB, 2012, NATURE, V485, P471, DOI 10.1038/nature11057; Ito M, 2005, PROG BRAIN RES, V148, P95, DOI 10.1016/S0079-6123(04)48009-1; Volkmann K, 2008, DEV BIOL, V313, P167, DOI 10.1016/j.ydbio.2007.10.024; Mueller T, 2003, DEV BRAIN RES, V140, P137, DOI 10.1016/S0165-3806(02)00583-7; Ito M, 2006, PROG NEUROBIOL, V78, P272, DOI 10.1016/j.pneurobio.2006.02.006; Obholzer N, 2008, J NEUROSCI, V28, P2110, DOI 10.1523/JNEUROSCI.5230-07.2008; Kimura Y, 2013, CURR BIOL, V23, P843, DOI 10.1016/j.cub.2013.03.066; Arrenberg AB, 2009, P NATL ACAD SCI USA, V106, P17968, DOI 10.1073/pnas.0906252106; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Yoshihara Y, 1999, NEURON, V22, P33, DOI 10.1016/S0896-6273(00)80676-5; Yoshihara Y, 2002, NEUROSCI RES, V44, P133, DOI 10.1016/S0168-0102(02)00130-X; Perrimon N, 1998, INT J DEV BIOL, V42, P243; Bernardos RL, 2006, GENE EXPR PATTERNS, V6, P1007, DOI 10.1016/j.modgep.2006.04.006; Pan YA, 2013, DEVELOPMENT, V140, P2835, DOI 10.1242/dev.094631; Koga A, 2008, DEV DYNAM, V237, P2466, DOI 10.1002/dvdy.21688; Hashimoto M, 2012, DEV GROWTH DIFFER, V54, P373, DOI 10.1111/j.1440-169X.2012.01348.x; Apps R, 2009, NAT REV NEUROSCI, V10, P670, DOI 10.1038/nrn2698; Ohashi Y, 2011, MOL CELL NEUROSCI, V46, P136, DOI 10.1016/j.mcn.2010.08.013; Sugihara I, 2006, CEREBELLUM, V5, P15, DOI 10.1080/14734220500527385; Distel M, 2010, J CELL BIOL, V191, P875, DOI 10.1083/jcb.201004154; Ito M, 2008, NAT REV NEUROSCI, V9, P304, DOI 10.1038/nrn2332; Akitake CM, 2011, DEV BIOL, V352, P191, DOI 10.1016/j.ydbio.2011.01.002; Asakawa K, 2009, METHODS, V49, P275, DOI 10.1016/j.ymeth.2009.01.004; Matsui H, 2014, P NATL ACAD SCI USA, V111, P11846, DOI 10.1073/pnas.1403105111; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; Halpern ME, 2008, ZEBRAFISH, V5, P97, DOI 10.1089/zeb.2008.0530; Koster RW, 2006, J NEUROSCI, V26, P7293, DOI 10.1523/JNEUROSCI.0095-06.2006; Bae YK, 2009, DEV BIOL, V330, P406, DOI 10.1016/j.ydbio.2009.04.013; BROCHU G, 1990, J COMP NEUROL, V291, P538, DOI 10.1002/cne.902910405; Asakawa K, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00100; Butler A. B., 1996, COMP VERTEBRATE NEUR; Distel Martin, 2011, Commun Integr Biol, V4, P336, DOI 10.4151/cib.4.3.15037; FINGER TE, 1978, BRAIN RES, V153, P608, DOI 10.1016/0006-8993(78)90346-3; Folgueira M, 2006, J COMP NEUROL, V497, P542, DOI 10.1002/cne.20979; Fujita H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086679; Heap LA, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00053; Hibi M, 2014, NEW PRINCIPLES DEV P, P161; Higashijima S, 2004, J COMP NEUROL, V480, P1, DOI 10.1002/cne.20278; Hirsch N, 2002, DEV DYNAM, V225, P422, DOI 10.1002/dvdy.10178; Ikenaga T, 2005, J COMP NEUROL, V487, P300, DOI 10.1002/cne.20553; Ikenaga T, 2006, CEREBELLUM, V5, P268, DOI 10.1080/14734220600930588; ITO H, 1990, J COMP NEUROL, V298, P385, DOI 10.1002/cne.902980402; Kawakami K, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-105; Ke M.T., 2014, CURRENT PROTOCOLS NE, V66, P22221; Koga A, 1995, MOL GEN GENET, V249, P400; Koga A, 2007, J HUM GENET, V52, P628, DOI 10.1007/s10038-007-0161-2; Koide T, 2009, P NATL ACAD SCI USA, V106, P9884, DOI 10.1073/pnas.0900470106; LANNOO MJ, 1991, PROG NEUROBIOL, V37, P329, DOI 10.1016/0301-0082(91)90022-S; LANNOO MJ, 1991, J COMP NEUROL, V310, P215, DOI 10.1002/cne.903100207; McFarland KA, 2008, DEV BIOL, V318, P162, DOI 10.1016/j.ydbio.2008.03.016; MEEK J, 1992, J COMP NEUROL, V316, P17, DOI 10.1002/cne.903160103; MEEK J, 1986, J COMP NEUROL, V245, P319, DOI 10.1002/cne.902450304; MEEK J, 1986, J COMP NEUROL, V245, P342, DOI 10.1002/cne.902450305; MEEK J, 1992, EUR J MORPHOL, V30, P37; Miyasaka N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4639; Miyasaka N, 2009, J NEUROSCI, V29, P4756, DOI 10.1523/JNEUROSCI.0118-09.2009; MURAKAMI T, 1987, J COMP NEUROL, V256, P607, DOI 10.1002/cne.902560413; Muto A, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00110; NIEUWENH.R, 1974, Z ANAT ENTWICKLUNGS, V144, P315, DOI 10.1007/BF00522813; Ogura E, 2009, DEV DYNAM, V238, P641, DOI 10.1002/dvdy.21863; POUWELS E, 1978, ANAT EMBRYOL, V153, P55, DOI 10.1007/BF00569849; Rieger S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000240; Sasamura K, 2013, J COMP NEUROL, V521, P3321, DOI 10.1002/cne.23352; Scott EK, 2009, J NEUROCHEM, V110, P441, DOI 10.1111/j.1471-4159.2009.06161.x; Shin Jimann, 2003, Methods in Cell Science, V25, P7, DOI 10.1023/B:MICS.0000006847.09037.3a; Sugihara I, 2007, J COMP NEUROL, V500, P1076, DOI 10.1002/cne.21219; Sugihara I, 2007, J COMP NEUROL, V501, P13, DOI 10.1002/cne.21223; Toro S, 2009, GENE EXPR PATTERNS, V9, P200, DOI 10.1016/j.gep.2008.12.007; TORRES B, 1992, J COMP NEUROL, V324, P449, DOI 10.1002/cne.903240311; Umeda K, 2013, NEUROSCI RES, V75, P69, DOI 10.1016/j.neures.2012.08.010; Urasaki Akihiro, 2009, V546, P85, DOI 10.1007/978-1-60327-977-2_6; Wullimann M, 2014, LATERAL LINE SYSTEM, P195; Wullimann MF, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00027; WULLIMANN MF, 1988, BRAIN BEHAV EVOLUT, V32, P293, DOI 10.1159/000116558; Yang CY, 2004, J COMP NEUROL, V474, P209, DOI 10.1002/cne.20150	101	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0012-1606	1095-564X		DEV BIOL	Dev. Biol.	JAN 1	2015	397	1					1	17		10.1016/j.ydbio.2014.09.030		17	Developmental Biology	Developmental Biology	AX5CR	WOS:000346945200001		
J	de Mochel, NSR; Luong, M; Chiang, M; Javier, AL; Luu, E; Fujimori, T; MacGregor, GR; Cinquin, O; Cho, KWY				de Mochel, Nabora Soledad Reyes; Luong, Mui; Chiang, Michael; Javier, Anna L.; Luu, Elizabeth; Fujimori, Toshihiko; MacGregor, Grant R.; Cinquin, Olivier; Cho, Ken W. Y.			BMP signaling is required for cell cleavage in preimplantation-mouse embryos	DEVELOPMENTAL BIOLOGY			English	Article						BMP; Smad1; Morula; Preimplantation; Cell cleavage; Cell division	LOOP-HELIX PROTEINS; TGF-BETA; STEM-CELLS; MUTANT MICE; ID GENES; BLASTOCYST; TROPHECTODERM; FAMILY; DIFFERENTIATION; RECEPTOR	The mechanisms regulating cell division during development of the mouse pre-implantation embryo are poorly understood. We have investigated whether bone morphogenetic protein (BMP) signaling is involved in controlling cell cycle during mouse pre-implantation development. We mapped and quantitated the dynamic activities of BMP signaling through high-resolution immunofluorescence imaging combined with a 3D segmentation method. Immunostaining for phosphorylated Smad1/5/8 shows that BMP signaling is activated in mouse embryos as early as the 4-cell stage, and becomes spatially restricted by late blastocyst stage. Perturbation of BMP signaling in preimplantation mouse embryos, whether by treatment with a small molecule inhibitor, with Noggin protein, or by overexpression of a dominant-negative BMP receptor, indicates that BMPs regulate cell cleavage up to the morula stage. These results indicate that BMP signaling is active during mouse pre-implantation development and is required for cell cleavage in preimplantation mouse embryos. (C) 2014 Elsevier Inc. All rights reserved.	[de Mochel, Nabora Soledad Reyes; Luong, Mui; Chiang, Michael; Javier, Anna L.; Luu, Elizabeth; MacGregor, Grant R.; Cinquin, Olivier; Cho, Ken W. Y.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; [Fujimori, Toshihiko] Natl Inst Basic Biol, Div Embryol, Okazaki, Japan	Cho, KWY (reprint author), Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA.				NIH [R01-HD056219, R01-GM102635, F31-HD074409, R25GM055246, T32-HD060555, T15-LM007443]; National Cancer Institute of the National Institutes of Health [P30CA062203]	We thank the Transgenic Mouse Facility at University of California, Irvine for blastomere injections, Dr. Amanda Cinquin for advice on confocal microscopy and immunostaining, Dr. Magdalena Zemicka-Goetz for sharing unpublished data, and Dr. Ed Monuki for p-Smad1 antibody and pCIG-DNBR. We thank Dr. Ira Blitz for his intellectual and editorial input, Dr. Hiroshi Sasaki for discussion, and Ms. Krishna Patel for immunohistology and genotyping. This work was funded by NIH (R01-HD056219 to KC and R01-GM102635 to OC, F31-HD074409 and R25GM055246 for NM, and T32-HD060555 and T15-LM007443 for MC). Additionally, research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award Number P30CA062203. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexander C, 2011, DEVELOPMENT, V138, P5135, DOI 10.1242/dev.067801; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; Yao LC, 2006, DEVELOPMENT, V133, P4025, DOI 10.1242/dev.02561; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; Vogt J, 2011, CELL SIGNAL, V23, P1831, DOI 10.1016/j.cellsig.2011.06.019; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Eom DS, 2011, DEVELOPMENT, V138, P3179, DOI 10.1242/dev.058602; Komatsu Y, 2011, DEVELOPMENT, V138, P3915, DOI 10.1242/dev.068833; Lim Y, 2005, MECH DEVELOP, V122, P603, DOI 10.1016/j.mod.2004.12.001; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; ZIOMEK CA, 1982, J EXP ZOOL, V221, P345, DOI 10.1002/jez.1402210310; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Beppu H, 2000, DEV BIOL, V221, P249, DOI 10.1006/dbio.2000.9670; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Natale DR, 2004, DEV BIOL, V268, P76, DOI 10.1016/j.ydbio.2003.12.011; Martin RM, 2005, CYTOM PART A, V67A, P45, DOI 10.1002/cyto.a.20172; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Zernicka-Goetz M, 2009, NAT REV GENET, V10, P467, DOI 10.1038/nrg2564; Yamaguchi K, 1999, EMBO J, V18, P179, DOI 10.1093/emboj/18.1.179; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; Takaku K, 1998, CELL, V92, P645, DOI 10.1016/S0092-8674(00)81132-0; Ciemerych MA, 2005, ONCOGENE, V24, P2877, DOI 10.1038/sj.onc.1208608; Kretzschmar M, 1997, NATURE, V389, P618; Cuny GD, 2008, BIOORG MED CHEM LETT, V18, P4388, DOI 10.1016/j.bmcl.2008.06.052; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Gardner RL, 1997, DEVELOPMENT, V124, P289; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Yi SE, 2000, DEVELOPMENT, V127, P621; Yagi R, 2007, DEVELOPMENT, V134, P3827, DOI 10.1242/dev.010223; Hogg K, 2010, ENDOCRINOLOGY, V151, P1247, DOI 10.1210/en.2009-0914; Chu GC, 2004, DEVELOPMENT, V131, P3501, DOI 10.1242/dev.01248; De Solorzano CO, 2001, J MICROSC-OXFORD, V201, P404; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Coucouvanis E, 1999, DEVELOPMENT, V126, P535; Arnold SJ, 2006, DEV BIOL, V296, P104, DOI 10.1016/j.ydbio.04.442; COPP AJ, 1978, J EMBRYOL EXP MORPH, V48, P109; Doan LT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044009; Gardner RL, 2002, HUM REPROD, V17, P1839, DOI 10.1093/humrep/17.7.1839; Javier AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042566; Kurotaki Y, 2007, SCIENCE, V316, P719, DOI 10.1126/science.1138591; MACGREGOR GR, 1989, NUCLEIC ACIDS RES, V17, P2365, DOI 10.1093/nar/17.6.2365; Macias-Silva M, 1998, J BIOL CHEM, V273, P25628, DOI 10.1074/jbc.273.40.25628; Maserbourg S., 2005, J BIOL CHEM, V280, P32122; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; Nagy A., 2003, MANIPULATING MOUSE E; Nichols J., 1998, CELL, V95, P37; Nishioka N, 2008, MECH DEVELOP, V125, P270, DOI 10.1016/j.mod.2007.11.002; Roelen BAJ, 1997, INT J DEV BIOL, V41, P541; SMITH R, 1977, J EMBRYOL EXP MORPH, V41, P79; Solloway MJ, 1999, DEVELOPMENT, V126, P1753; von Bubnoff A, 2005, DEV BIOL, V281, P210, DOI 10.1016/j.ydbio.2005.02.014; Westermarck S.P., 2001, MOL CELL BIOL, V21, P2373; White E, 1996, GENE DEV, V10, P1, DOI 10.1101/gad.10.1.1; Yu Y.B., 2008, NAT CHEM BIOL, V4, P33	62	4	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0012-1606	1095-564X		DEV BIOL	Dev. Biol.	JAN 1	2015	397	1					45	55		10.1016/j.ydbio.2014.10.001		11	Developmental Biology	Developmental Biology	AX5CR	WOS:000346945200004		
J	Hasan, MZ; Ikawati, M; Tocharus, J; Kawaichi, M; Oka, C				Hasan, Md Zobaer; Ikawati, Muthi; Tocharus, Jiraporn; Kawaichi, Masashi; Oka, Chio			Abnormal development of placenta in HtrA1-deficient mice	DEVELOPMENTAL BIOLOGY			English	Article						HtrA1; Placenta; Preeclampsia; Trophoblast; Maternal artery remodeling	SERINE-PROTEASE HTRA1; RETINAL-PIGMENT EPITHELIUM; TROPHOBLAST GIANT-CELLS; SMALL-VESSEL DISEASE; MOUSE PLACENTA; UP-REGULATION; MACULAR DEGENERATION; GROWTH RESTRICTION; OXIDATIVE STRESS; STEM-CELLS	Abnormal levels of High temperature requirement A1 (HtrA1) protein have been repeatedly observed in sera and placentas of preeclampsia patients. To understand the functions of HtrA1 in placentation and in the etiology of preeclampsia, we established HtrA1(-/-) mice. HtrA1(-/-) mice show intrauterine growth retardation, and their placentas are small due to a reduced size of the junctional zone and aberrant vascularization in the labyrinth at the mid-gestation stage. HtrA1 is expressed by Tpbpa-positive trophoblast precursors in the outer ectoplacental cone and junctional zone from embryonic day 7.5 to 10.5. In the HtrA1(-/-) placenta, Tpbpa-positive cell precursors are decreased in the early stage. Spongiotrophoblasts and glycogen trophoblast cells, both of which differentiate from Tpbpa-positive precursors, are consequently decreased in the junctional zone. Fewer spiral artery-associated trophoblast giant cells, another cell type derived from Tpbpa-positive precursors, invade the decidua and associate with maternal arteries in the HtrA1(-/-) placenta than in the wild type placenta. Maternal arteries in the HtrA1(-/-) decidua have narrower lumens, thicker arterial walls, and more vascular smooth muscle cells remaining in the walls than those in the wild type decidua, indicating impaired remodeling of maternal arteries. These results indicate that HtrA1 plays important roles in the differentiation of trophoblasts from Tpbpa-positive precursors in the ectoplacental cone. Insufficient levels of HtrA1 cause poor placental development and intrauterine growth retardation, due to aberrant trophoblast differentiation and consequent defects in maternal artery remodeling, and may contribute to the onset of preeclampsia. (C) 2014 Elsevier Inc. All rights reserved.	[Hasan, Md Zobaer; Ikawati, Muthi; Kawaichi, Masashi; Oka, Chio] Nara Inst Sci & Technol, Lab Gene Funct Anim, Nara 6300192, Japan; [Ikawati, Muthi] Gadjah Mada Univ, Fac Pharm, Yogyakarta 55281, Indonesia; [Tocharus, Jiraporn] Chiang Mai Univ, Fac Med, Dept Anat, Chiang Mai 50200, Thailand	Oka, C (reprint author), Nara Inst Sci & Technol, Lab Gene Funct Anim, 8916-5 Takayama, Nara 6300192, Japan.	coka@bs.naist.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	We thank Dr. James Cross and Dr. David Simmons for providing plasmid DNAs for RNA probes. Md. Zobaer Hasan was supported by a scholarship from Ministry of Education, Culture, Sports, Science and Technology of Japan.	Shiga A, 2011, HUM MOL GENET, V20, P1800, DOI 10.1093/hmg/ddr063; Inagaki A, 2012, PLACENTA, V33, P919, DOI 10.1016/j.placenta.2012.08.003; Mould A, 2012, GENE DEV, V26, P2063, DOI 10.1101/gad.199828.112; Tsuchiya A, 2005, BONE, V37, P323, DOI 10.1016/j.bone.2005.03.015; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Mullany SA, 2011, CLIN CANCER RES, V17, P427, DOI 10.1158/1078-0432.CCR-09-3069; Chien J, 2004, ONCOGENE, V23, P1636, DOI 10.1038/sj.onc.1207271; Simmons DG, 2005, DEV BIOL, V284, P12, DOI 10.1016/j.ydbio.2005.05.010; Launay S, 2008, CELL DEATH DIFFER, V15, P1408, DOI 10.1038/cdd.2008.82; Hu D, 2010, INT J DEV BIOL, V54, P341, DOI 10.1387/ijdb.082768dh; Hara K, 2009, NEW ENGL J MED, V360, P1729, DOI 10.1056/NEJMoa0801560; GUILLEMOT F, 1994, NATURE, V371, P333, DOI 10.1038/371333a0; Austin BA, 2009, INVEST OPHTH VIS SCI, V50, P2896, DOI 10.1167/iovs.08-2495; Jones A, 2011, P NATL ACAD SCI USA, V108, P14578, DOI 10.1073/pnas.1102853108; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Baldi A, 2002, ONCOGENE, V21, P6684, DOI 10.1038/sj.onc.1205911; Simmons DG, 2007, DEV BIOL, V304, P567, DOI 10.1016/j.ydbio.2007.01.009; Erlebacher A, 2004, DEV BIOL, V275, P158, DOI 10.1016/j.ydbio.2004.07.032; Arima T, 2006, DEV BIOL, V297, P361, DOI 10.1016/j.ydbio.2006.05.003; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Plaks V, 2013, P NATL ACAD SCI USA, V110, P11109, DOI 10.1073/pnas.1309561110; Yan JL, 2001, DEV BIOL, V235, P422, DOI 10.1006/dbio.2001.0300; Grau S, 2006, J BIOL CHEM, V281, P6124, DOI 10.1074/jbc.M500361200; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Hou S, 2007, DEV CELL, V13, P226, DOI 10.1016/j.devcel.2007.07.001; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Adamson SL, 2002, DEV BIOL, V250, P358, DOI [10.1006/dbio.2002.0773, 10.1016/S0012-1606(02)90773-6]; Tanaka M, 1997, DEV BIOL, V190, P55, DOI 10.1006/dbio.1997.8685; Meiner VL, 1996, P NATL ACAD SCI USA, V93, P14041, DOI 10.1073/pnas.93.24.14041; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Tiaden AN, 2012, STEM CELLS, V30, P2271, DOI 10.1002/stem.1190; Strauss KM, 2005, HUM MOL GENET, V14, P2099, DOI 10.1093/hmg/ddi215; Zhao H, 2009, PLACENTA, V30, P861, DOI 10.1016/j.placenta.2009.07.012; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Harris LK, 2010, AM J PATHOL, V177, P2103, DOI 10.2353/ajpath.2010.100182; Hu SI, 1998, J BIOL CHEM, V273, P34406, DOI 10.1074/jbc.273.51.34406; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Alba BM, 2004, MOL MICROBIOL, V52, P613, DOI 10.1111/j.1365-2958.2003.03982.x; McCarthy FP, 2011, PLACENTA, V32, P413, DOI 10.1016/j.placenta.2011.03.010; Oka C, 2004, DEVELOPMENT, V131, P1041, DOI 10.1242/dev.00999; CARNEY EW, 1993, MOL REPROD DEV, V34, P357, DOI 10.1002/mrd.1080340403; Chen YY, 2014, J BIOL CHEM, V289, P22958, DOI 10.1074/jbc.M114.576744; Dokras A, 2006, BIOL REPROD, V75, P899, DOI 10.1095/biolreprod.106.053603; El-Hashash AHK, 2005, DIFFERENTIATION, V73, P154, DOI 10.1111/j.1432-0436.2005.00013.x; Ferrer-Vaquer A, 2008, DEV DYNAM, V237, P1893, DOI 10.1002/dvdy.21597; Fontana V, 2012, J MOL HISTOL, V43, P487, DOI 10.1007/s10735-012-9429-8; Graham JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074094; GUILLEMOT F, 1993, MECH DEVELOP, V42, P171, DOI 10.1016/0925-4773(93)90006-J; GUILLEMOT F, 1995, NAT GENET, V9, P235, DOI 10.1038/ng0395-235; Harris Lynda K, 2007, Reprod Sci, V14, P28, DOI 10.1177/1933719107309588; Hu D, 2011, DEV BIOL, V358, P231, DOI 10.1016/j.ydbio.2011.07.036; Li Y, 2011, J CLIN ENDOCR METAB, V96, P403, DOI 10.1210/jc.2010-1405; Lorenzi T, 2009, PLACENTA, V30, P35, DOI 10.1016/j.placenta.2008.10.016; Marzioni D, 2009, HISTOL HISTOPATHOL, V24, P1213; Marzioni D, 2012, PLACENTA, V33, P1036, DOI 10.1016/j.placenta.2012.09.011; Nakayama H, 1997, DEV GENET, V21, P21, DOI 10.1002/(SICI)1520-6408(1997)21:1<21::AID-DVG3>3.0.CO;2-A; Ng TK, 2011, INVEST OPHTH VIS SCI, V52, P3706, DOI 10.1167/iovs.10-6773; Nie G, 2006, PLACENTA, V27, P491, DOI 10.1016/j.placenta.2005.03.009; Nie GY, 2005, DEV DYNAM, V233, P1102, DOI 10.1002/dvdy.20399; Nie GY, 2006, DEV DYNAM, V235, P3448, DOI 10.1002/dvdy.20999; Nie GY, 2003, BIOCHEM J, V371, P39, DOI 10.1042/BJ20021569; Nowak RA, 1999, BIOL REPROD, V60, P85, DOI 10.1095/biolreprod60.1.85; Palei ACT, 2013, CURR DRUG TARGETS, V14, P325; Rodriguez TA, 2004, MOL CELL BIOL, V24, P228, DOI 10.1128/MCB.24.1.228-244.2004; Salbaum JM, 2011, DIABETOLOGIA, V54, P1909, DOI 10.1007/s00125-011-2132-6; Simmons D.G., 2008, BMC GENOMICS, V9; Skorko-Glonek J, 1999, MOL GEN GENET, V262, P342; Supanji, 2013, EXP EYE RES, V112, P79, DOI 10.1016/j.exer.2013.04.013; Tocharus J, 2004, DEV GROWTH DIFFER, V46, P257; Vierkotten S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022959; Zong L, 2013, ARCH MED SCI, V9, P690, DOI 10.5114/aoms.2013.34989; Zurawa-Janicka D, 2008, ACTA BIOCHIM POL, V55, P9	74	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0012-1606	1095-564X		DEV BIOL	Dev. Biol.	JAN 1	2015	397	1					89	102		10.1016/j.ydbio.2014.10.015		14	Developmental Biology	Developmental Biology	AX5CR	WOS:000346945200008		
J	Tashiro, M; Izumikawa, K; Ashizawa, N; Narukawa, M; Yamamoto, Y				Tashiro, Masato; Izumikawa, Koichi; Ashizawa, Nobuyuki; Narukawa, Munetoshi; Yamamoto, Yoshihiro			Clinical significance of methicillin-resistant coagulase-negative staphylococci obtained from sterile specimens	DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE			English	Article						Methicillin-resistant coagulase-negative staphylococci; Methicillin-resistant Staphylococcus aureus; Contamination; Sterile specimen	INTENSIVE-CARE UNITS; BLOOD CULTURES; NOSOCOMIAL INFECTIONS; BACTEREMIA; EPIDERMIDIS; STATES; EPIDEMIOLOGY; SURVEILLANCE; CRITERIA; UPDATE	Distinguishing true coagulase-negative staphylococci bacteremia from contamination remains a challenge. We conducted a retrospective analysis of 183 patients with methicillin-resistant coagulase-negative staphylococci (MR-CoNS)-positive and methicillin-resistant Staphylococcus aureus-positive cultures obtained from sterile sites such as blood, synovial fluid, ascitic fluid, and cerebrospinal fluid. Of the 209 MR-CoNS isolates, 83 (39.7%) were considered infection associated, and 126 (60.3%) were considered contamination. MR-CoNS isolates cultured from synovial fluid were more likely to be infection associated (P= 0.009). The median interval from insertion of a central venous catheter to onset of infection tended to be longer in MR-CoNS infection cases than in methicillin-resistant S. aureus infection cases (41 days versus 14 days, P= 0.055). In conclusion, our results suggest that the proportion of cases of true MR-CoNS infection may be higher than previously reported. (C) 2015 Elsevier Inc. All rights reserved.	[Tashiro, Masato; Ashizawa, Nobuyuki; Narukawa, Munetoshi; Yamamoto, Yoshihiro] Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Dept Clin Infect Dis, Toyama 9300194, Japan; [Tashiro, Masato; Izumikawa, Koichi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Infect Dis, Unit Mol Microbiol & Immunol, Nagasaki 8528501, Japan	Yamamoto, Y (reprint author), Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Dept Clin Infect Dis, 2630 Sugitani, Toyama 9300194, Japan.	mtashiro@nagasaki-u.ac.jp; koizumik@nagasaki-u.ac.jp; ashizawa@med.u-toyama.ac.jp; narukawa@med.u-toyama.ac.jp; yamamoto@med.u-toyama.ac.jp			Pfizer Inc.	Yoshihiro Yamamoto has received lecture fees from Pfizer Inc. Koichi Izumikawa has received honoraria from Pfizer Japan, Inc.; Astellas Pharma, Inc.; and Merck & Co., Inc. No other authors declare any conflicts of interest.	KLOOS WE, 1994, CLIN MICROBIOL REV, V7, P117; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Huang H, 2006, J CLIN MICROBIOL, V44, P2423, DOI 10.1128/JCM.00254-06; Chu VH, 2008, CLIN INFECT DIS, V46, P232, DOI 10.1086/524666; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Cherifi S, 2013, J CLIN MICROBIOL, V51, P1541, DOI 10.1128/JCM.03378-12; Richards MJ, 1999, PEDIATRICS, V103, part. no., DOI 10.1542/peds.103.4.e39; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Weinstein MP, 1997, CLIN INFECT DIS, V24, P584; Richards MJ, 1999, CRIT CARE MED, V27, P887, DOI 10.1097/00003246-199905000-00020; Hall KK, 2006, CLIN MICROBIOL REV, V19, P788, DOI 10.1128/CMR.00062-05; Souvenir D, 1998, J CLIN MICROBIOL, V36, P1923; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3; Mirrett S, 2001, J CLIN MICROBIOL, V39, P3279, DOI 10.1128/JCM.39.9.3279-3281.2001; Beekmann SE, 2005, INFECT CONT HOSP EP, V26, P559, DOI 10.1086/502584; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; ROTH RR, 1988, ANNU REV MICROBIOL, V42, P441; Finkelstein R, 2002, AM J INFECT CONTROL, V30, P21, DOI 10.1067/mic.2002.118406; Gaynes RP, 1996, PEDIATRICS, V98, P357; Glickman SW, 2010, AM J EMERG MED, V28, P208, DOI 10.1016/j.ajem.2008.10.016; Herwaldt LA, 1996, CLIN INFECT DIS, V22, P14; Natoli S, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-83; Olendzki AN, 2014, EUR J CLIN MICROBIOL, V33, P29, DOI 10.1007/s10096-013-1923-8; PFALLER M A, 1988, Clinical Microbiology Reviews, V1, P281; Seo SK, 2000, AM J MED, V109, P697, DOI 10.1016/S0002-9343(00)00596-9; Seybold U, 2009, INFECTION, V37, P256, DOI 10.1007/s15010-008-8020-4	27	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0732-8893	1879-0070		DIAGN MICR INFEC DIS	Diagn. Microbiol. Infect. Dis.	JAN	2015	81	1					71	75		10.1016/j.diagmicrobio.2014.09.019		5	Infectious Diseases; Microbiology	Infectious Diseases; Microbiology	AX4EX	WOS:000346887600017		
J	Hikosaka, M; Yazawa, M; Sakuma, H; Uchikawa, Y; Takayama, M; Kishi, K				Hikosaka, Makoto; Yazawa, Masaki; Sakuma, Hisashi; Uchikawa, Yumiko; Takayama, Masayoshi; Kishi, Kazuo			Anatomic Basis of Anorectal Reconstruction by Dynamic Graciloplasty With Pudendal Nerve Anastomosis	DISEASES OF THE COLON & RECTUM			English	Article						Anorectal reconstruction; Dynamic graciloplasty; Pudendal nerve; Nerve anastomosis	SEVERE FECAL INCONTINENCE; ANAL-SPHINCTER; MUSCLE	BACKGROUND: Dynamic graciloplasty has been proposed for anal reconstruction, but this method has 2 major drawbacks. First, an electrical device is required for control of the gracilis. The anastomosis with the pudendal nerve will provide more physiological control. Second, the limitation in the mobility of the muscle flap results in wrapping the anal canal with the muscle's distal portion, which is tendonlike and inelastic. Enhancing the mobility of the muscle flap will enable wrapping with the proximal, muscle-like, and extensible portion, possibly providing better sphincteric function. However, the basis for such an operative method is lacking. OBJECTIVE: The aim of this study is to provide the basis for the refined method of anal sphincter reconstruction by dynamic graciloplasty with pudendal nerve anastomosis and to verify the feasibility of lengthening the nerve to the gracilis muscle flap by dissecting into the muscle belly, detaching the gracilis muscle from its origin, and enhancing the mobility of the muscle flap. STUDY DESIGN: This is a retrospective, descriptive study. METHODS: The results from the anatomical study on 9 cadavers are reported. RESULTS: Tension-free anastomosis of the pudendal nerve and nerve to the gracilis was successfully performed in all the 9 cases: in 2 cases, by lengthening the nerve. The detachment of the muscle origin improved the mobility of the muscle flap, and the more proximal portion could be used for wrapping the anal canal, as confirmed in 4 cases. LIMITATIONS: The limited number of cases was a shortcoming of this study. CONCLUSIONS: By lengthening the nerve to the muscle, the gracilis can be used for anal sphincter reconstruction with pudendal nerve anastomosis, negating the need for an electrical device. By detaching the origin of the gracilis muscle, its proximal portion can be used to wrap the anal canal, possibly enabling a longer functional canal with stronger constricting force and better vascularity. These modifications to past methods may improve fecal continence after the operation.	[Hikosaka, Makoto] Natl Ctr Child Hlth & Dev, Dept Plast & Reconstruct Surg, Tokyo, Japan; [Yazawa, Masaki; Kishi, Kazuo] Keio Univ, Dept Plast & Reconstruct Surg, Sch Med, Tokyo 1608582, Japan; [Sakuma, Hisashi] Yokohama Municipal Hosp, Dept Plast & Reconstruct Surg, Yokohama, Kanagawa, Japan; [Uchikawa, Yumiko] Tachikawa Hosp, Dept Plast & Reconstruct Surg, Tokyo, Japan; [Takayama, Masayoshi] Hiratsuka City Hosp, Dept Plast & Reconstruct Surg, Hiratsuka, Kanagawa, Japan	Yazawa, M (reprint author), Keio Univ, Dept Plast & Reconstruct Surg, Sch Med, Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan.	yazawa@a7.keio.jp			Japan Society for Promotion of Science [JSPS KAKENHI 24791923]	Dr Uchikawa was funded by a grant (JSPS KAKENHI 24791923) from the Japan Society for Promotion of Science.	Engel J, 2003, ANN SURG, V238, P203, DOI 10.1097/01.sla.0000080823.38569.b0; Darnis B, 2013, DIS COLON RECTUM, V56, P505, DOI 10.1097/DCR.0b013e3182809490; Guelinckx PJ, 1996, MICROSURG, V17, P391, DOI 10.1002/(SICI)1098-2752(1996)17:7<391::AID-MICR9>3.0.CO;2-J; PICKRELL KL, 1952, ANN SURG, V135, P853, DOI 10.1097/00000658-195206000-00010; Mantoo S, 2012, EXPERT REV MED DEVIC, V9, P483, DOI [10.1586/erd.12.38, 10.1586/ERD.12.38]; Cavina E, 1998, DIS COLON RECTUM, V41, P1010, DOI 10.1007/BF02237392; Congilosi SM, 1997, BRIT J SURG, V84, P1269; Pirro N, 2005, DIS COLON RECTUM, V48, P2085, DOI 10.1007/s10350-005-0129-2; Sato T, 1999, DIS COLON RECTUM, V42, P505, DOI 10.1007/BF02234177; Sato T, 2005, SURGERY, V137, P8, DOI 10.1016/j.surg.2004.05.046; Thornton M J, 2004, Colorectal Dis, V6, P470, DOI 10.1111/j.1463-1318.2004.00714.x	11	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0012-3706	1530-0358		DIS COLON RECTUM	Dis. Colon Rectum	JAN	2015	58	1					104	108		10.1097/DCR.0000000000000268		5	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AX7KB	WOS:000347093800017		
J	Sato, I; Shimbo, T; Kawasaki, Y; Masaki, N				Sato, Izumi; Shimbo, Takuro; Kawasaki, Yohei; Masaki, Naohiko			Comparison of peginterferon alfa-2a and alfa-2b for treatment of patients with chronic hepatitis C: a retrospective study using the Japanese Interferon Database	DRUG DESIGN DEVELOPMENT AND THERAPY			English	Article						sustained virologic response; HCV genotype; sustained virologic response; adverse events	VIRUS-INFECTION; PLUS RIBAVIRIN; RANDOMIZED-TRIAL; NAIVE PATIENTS; EFFICACY; HCV; METAANALYSIS; SIMEPREVIR	Purpose: We aimed to compare the rates of sustained virologic response (SVR) achieved with peginterferon (PFG-IFN) alla-2a and alfa-2b in combination with ribavinin (RBV) for chronic hepatitis C. using a large database of hepatitis cases to improve the generalizability of these results. Methods: We identified patients with chronic hepatitis C who were treated with PEG-IFN alth-2a or alfa-211 and RBV, from the Japanese Interferon Database, between December 2009 and April 2013. This database contains the medical records of IFN treatment collected from 36 prefectures in Japan. Multivariable logistic regression analysis was used to compare SVR rates obtained with PEG-IFN alfa-2a and alfa-2b, in combination with RBV. Results: A total of 16,349 patients were recorded in the Japanese Interferon Database. After application of the exclusion criteria, 12,706 patients (3,578 [1,710 males, 1,868 females] on PIG-IFN alfa-2a; and 9,128 [4,652 males, 4,476 females] on PEG-IFN alfa-2b) were included in this analysis. The SVR rate in the PEG-IFN alfa-2b group was 62.0%, as compared with a rate of 55.1% in the PEG-IFN alfa-2a group (crude odds ratio =1.31; 95% confidence interval [Cl]: 1.23 to 1.44). There was no significant difference in the adjusted SVR rates between the two groups (adjusted odds ratio =0.96; 95% CI: 0.88 to 1.05) Similar proportions of adverse events were observed in the two groups, with the exception of thrombocytopenia, retinopathy, and anemia. Conclusion: There was no significant difference in the SVR rates and safety profile between chronic hepatitis C patients treated with the PEG-IFN alfa-2a and alfa-2b.	[Sato, Izumi] Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Clin Study & Informat, Tokyo, Japan; [Shimbo, Takuro] Ohta Nishinouchi Hosp, Fukushima, Japan; [Kawasaki, Yohei] Tokyo Univ Sci, Dept Math, Tokyo 162, Japan; [Masaki, Naohiko] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Chiba, Japan	Sato, I (reprint author), 1-21-1 Toyama,Shinjuku Ku, Tokyo 1628655, Japan.	isato@hosp.ncgm.go.jp			Ministry of Health, Labour and Welfare of Japan	Acknowledgments Financial support was provided by a Grant-In-Aid from the Ministry of Health, Labour and Welfare of Japan (Research on Hepatitis: 2009-2014) to NM.	Silva M, 2006, J HEPATOL, V45, P204, DOI 10.1016/j.jhep.2006.03.008; Hayashi N, 2014, J HEPATOL, V61, P219, DOI 10.1016/j.jhep.2014.04.004; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Izumi N, 2014, J GASTROENTEROL, V49, P941, DOI 10.1007/s00535-014-0949-8; Miyase S, 2012, J GASTROENTEROL, V47, P1014, DOI 10.1007/s00535-012-0560-9; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; Rumi MG, 2010, GASTROENTEROLOGY, V138, P108, DOI 10.1053/j.gastro.2009.08.071; Laguno M, 2009, HEPATOLOGY, V49, P22, DOI 10.1002/hep.22598; Brochot E, 2013, ANTIVIR RES, V98, P1, DOI 10.1016/j.antiviral.2013.02.006; Awad T, 2010, HEPATOLOGY, V51, P1176, DOI 10.1002/hep.23504; Tsubota A, 2011, WORLD J GASTROENTERO, V17, P419, DOI 10.3748/wjg.v17.i4.419; Singal AK, 2011, DIGEST DIS SCI, V56, P2221, DOI 10.1007/s10620-011-1765-0; Editors of the Drafting Committee for Hepatitis Management Guidelines: the Japan Society of Hepatology, 2013, HEPATOL RES, V43, P1; Mach TH, 2011, POL ARCH MED WEWN, V121, P434; Ministry of Health Labour and Welfare, 2010, MEAS HEP; Scotto G, 2008, J INTERF CYTOK RES, V28, P623, DOI 10.1089/jir.2007.0116; Shiffman M L, 2001, Curr Gastroenterol Rep, V3, P30; Witthoeft T, 2010, J VIRAL HEPATITIS, V17, P459, DOI 10.1111/j.1365-2893.2009.01255.x; World Health Organization (WHO), 2014, HEP C; Yenice N, 2006, TURK J GASTROENTEROL, V17, P97; Zhao SH, 2010, CLIN THER, V32, P1565, DOI 10.1016/j.clinthera.2010.08.009	21	0	0	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1177-8881			DRUG DES DEV THER	Drug Des. Dev. Ther.		2015	9						283	289		10.2147/DDDT.S72245		7	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX6TL	WOS:000347053900001		
J	Bortey-Sam, N; Nakayama, SMM; Ikenaka, Y; Akoto, O; Baidoo, E; Yohannes, YB; Mizukawa, H; Ishizuka, M				Bortey-Sam, Nesta; Nakayama, Shouta M. M.; Ikenaka, Yoshinori; Akoto, Osei; Baidoo, Elvis; Yohannes, Yared Beyene; Mizukawa, Hazuki; Ishizuka, Mayumi			Human health risks from metals and metalloid via consumption of food animals near gold mines in Tarkwa, Ghana: Estimation of the daily intakes and target hazard quotients (THQs)	ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY			English	Article						OffaI; Muscle; Estimated daily intake; Target hazard quotient; Ghana	HEAVY-METALS; DAIRY-PRODUCTS; DIETARY-INTAKE; CADMIUM; MEAT; LEAD; EXPOSURE; TISSUES; ZINC; CHINA	Heavy metal and metalloid contamination in food resulting from mining is of major concern due to the potential risk involved. Food consumption is the most likely route of human exposure to metals. This study was therefore to assess metals in different organs and different animal species near gold mines used for human consumption (free-range chicken, goat and sheep) in Tarkwa, Ghana, and to estimate the daily intake and health risk. The concentrations of Cr, Mn, Fe, Co, Ni, Cu, Zn, As, Cd, and Pb were measured with an inductively coupled plasma-mass spectrometer and Hg analysis was done using the mercury analyzer. Principal component analysis of the results showed a clear separation between chicken, grouped on one side, and the ruminants clustered on another side in both offal and muscle. Interestingly, As, Cd, Hg, Mn and Pb made one cluster in the offal of chicken. Chicken muscle also showed similar distribution with As, Hg and Pb clustered together. The daily intake of metals (mu g/kg body weight/day) were in the following ranges; As [0.002 (kidneys of goat and sheep)-0.19 (chicken gizzard)], Cd [0.003 (chicken muscle)-0.55 (chicken liver)], Hg [0.002 (goat muscle)-0.29 (chicken liver)], Pb [0.01 (muscles and kidneys of goat and sheep)-0.96 (chicken gizzard)] and Mn [0.13 (goat kidney)-8.92 (sheep liver)]. From the results, daily intakes of As, Cd, Hg, Pb and Mn in these food animals were low compared to the provisional tolerable daily intake guidelines. The THQs although less than one, indicated that contributions of chicken gizzard and liver to toxic metal exposure in adults and especially children could be significant. (C) 2014 Published by Elsevier Inc.	[Bortey-Sam, Nesta; Nakayama, Shouta M. M.; Ikenaka, Yoshinori; Yohannes, Yared Beyene; Mizukawa, Hazuki; Ishizuka, Mayumi] Hokkaido Univ, Grad Sch Vet Med, Kita Ku, Sapporo, Hokkaido 0600818, Japan; [Akoto, Osei; Baidoo, Elvis] Kwame Nkrumah Univ Sci & Technol, Dept Chem, Kumasi, Ghana	Ishizuka, M (reprint author), Hokkaido Univ, Grad Sch Vet Med, Dept Environm Vet Sci, Lab Toxicol,Kita Ku, N18,W9, Sapporo, Hokkaido 0600818, Japan.	ishizum@vetmed.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [24248056, 24405004, 26304043]; foundation of JSPS Core to Core Program; Mitsui Co., Ltd.; Environment Fund; Akiyama Life Science Foundation; Nihon Seimei Foundation	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan awarded to M. Ishizuka (24248056, 24405004) and Y. Ikenaka (26304043) and the foundation of JSPS Core to Core Program (AA Science Platforms). We would like to acknowledge the financial support by the Mitsui & Co., Ltd. Environment Fund, The Akiyama Life Science Foundation and The Nihon Seimei Foundation. We also express our sincere gratitude and thanks to Mr. Joseph Prah, Mr. Joseph Addae and Mr. Takahiro Ichise who in various ways assisted to carry out this research.	Akabzaa T., 2001, HLTH IMPACTS, V6, P60; AmonooNeizer EH, 1996, WATER AIR SOIL POLL, V91, P363, DOI 10.1007/BF00666270; Crossgrove J, 2004, NMR BIOMED, V17, P544, DOI 10.1002/nbm.931; Lai HY, 2010, INT J ENV RES PUB HE, V7, P3595, DOI 10.3390/ijerph7103596; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Wang XL, 2005, SCI TOTAL ENVIRON, V350, P28, DOI 10.1016/j.scitotenv.2004.09.044; Zheng N, 2007, SCI TOTAL ENVIRON, V383, P81, DOI 10.1016/j.scitotenv.2007.05.002; Abou-Arab AAK, 2001, FOOD CHEM TOXICOL, V39, P593, DOI 10.1016/S0278-6915(00)00176-9; Navarro MC, 2008, J GEOCHEM EXPLOR, V96, P183, DOI 10.1016/j.gexplo.2007.04.011; Ihedioha JN, 2013, ECOTOX ENVIRON SAFE, V93, P101, DOI 10.1016/j.ecoenv.2013.04.010; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; Kapaj S, 2006, J ENVIRON SCI HEAL A, V41, P2399, DOI 10.1080/10934520600873571; Lin HJ, 2013, J HAZARD MATER, V262, P1132, DOI 10.1016/j.jhazmat.2012.12.049; MARGOSHES M, 1957, J AM CHEM SOC, V79, P4813, DOI 10.1021/ja01574a064; Cui YJ, 2005, ENVIRON INT, V31, P784, DOI 10.1016/j.envint.2005.05.025; Bowler RM, 2006, NEUROTOXICOLOGY, V27, P315, DOI 10.1016/j.neuro.2005.10.007; Loutfy N, 2006, SCI TOTAL ENVIRON, V370, P1, DOI 10.1016/j.scitotenv.2006.05.012; Demirbas A, 1999, FOOD CHEM, V67, P27, DOI 10.1016/S0308-8146(99)00103-X; Uluozlu OD, 2009, J HAZARD MATER, V163, P982, DOI 10.1016/j.jhazmat.2008.07.050; Caggiano R, 2005, ENVIRON RES, V99, P48, DOI 10.1016/j.envres.2004.11.002; KAGI JHR, 1960, J BIOL CHEM, V235, P3460; EC, 2006, OFF J EUR UNION; European Environment and Health Information System (ENHIS), 2007, EXP CHILDR CHEM HAZ; FAO/WHO, 2010, 73 M JECFA; FSA (Food Standard Agency), 2006, MET OTH EL PROC FISH; Ghana Statistical Service, 2010, POP HOUS CENS; Hayford E.K., 2008, W AFR J APPL ECOL, V14, P1; HENRY RB, 1994, TOXICOL LETT, V74, P23, DOI 10.1016/0378-4274(94)90071-X; Hiroaki I., 2013, INT J HYG ENVIR HEAL, V217, P70; Husain A, 1996, B ENVIRON CONTAM TOX, V57, P549; John GF, 2011, SCI TOTAL ENVIRON, V409, P4958; Kendall RJ, 1996, ENVIRON TOXICOL CHEM, V15, P4, DOI 10.1897/1551-5028(1996)015<0004:AERAOL>2.3.CO;2; Klos KJ, 2006, EUR J NEUROL, V13, P1139, DOI 10.1111/j.1468-1331.2006.01407.x; Okoye COB, 2010, B CHEM SOC ETHIOPIA, V24, P133; Peter F., 2012, ENVIRON INT, V49, P9; Pompe-Gotal Jelena, 2002, Veterinarski Arhiv, V72, P303; Rubio MR, 1998, B ENVIRON CONTAM TOX, V60, P164; SAC/MOHC (The Standardization Administration China/Ministry of Health China), 2005, MAX LEV CONT FOOD GB; Saha N., 2012, ENVIRON MONIT ASSESS, V185, P3867; Salisbury R.M., 1958, NZ VET J, V6, P2, DOI 10.1080/00480169.1958.33279; Singh AN, 2005, J ENVIRON SCI-CHINA, V17, P168; Tubaro A., 2007, VET TOXICOLOGY BASIC, P663; USDA, 2006, FOR AGR SERV GAIN RE; USEPA, 2007, INT RISK INF SYST DA; USEPA (United States Environmental Protection Agency), 2000, RISK BAS CONC TABL; Villar T. d C., 2005, Journal of Applied Sciences, V5, P1250; Wang CL, 2013, ENVIRON TOXICOL PHAR, V35, P419, DOI 10.1016/j.etap.2013.02.004; WHO, 2000, TECHN REP SER, V896; WHO, 1996, TRAC EL HUM NUTR HLT; Yabe J, 2013, ENVIRON TOXICOL CHEM, V32, P189, DOI 10.1002/etc.2029; Yabe J, 2010, J VET MED SCI, V72, P1257, DOI 10.1292/jvms.10-0058	51	3	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0147-6513	1090-2414		ECOTOX ENVIRON SAFE	Ecotox. Environ. Safe.	JAN	2015	111						160	167		10.1016/j.ecoenv.2014.09.008		8	Environmental Sciences; Toxicology	Environmental Sciences & Ecology; Toxicology	AY0DK	WOS:000347267800022		
J	Nakata, H; Hinosaka, M; Yanagimoto, H				Nakata, Haruhiko; Hinosaka, Mari; Yanagimoto, Hayato			Macrocyclic-, polycyclic-, and nitro musks in cosmetics, household commodities and indoor dusts collected from Japan: Implications for their human exposure	ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY			English	Article						Macrocyclic musks; Musk-T; Cosmetics; Household commodities; Indoor dusts; Human exposure	SYNTHETIC MUSKS; FRAGRANCE MATERIALS; PERSONAL CARE; UNITED-STATES; PRODUCTS; PBDES; CHINA; AIR; US	This paper reported the occurrence and concentrations of macrocyclic-, polycyclic- and nitro musks in cosmetics and household commodities collected from Japan. The high concentrations and detection frequencies of Musk T, habanolide, and exaltolides were found in commercial products, suggesting their large amounts of production and usage in Japan. Polycyclic musks, HHCB and OTNE, also showed high concentrations in cosmetics and products. The estimated dairy intakes of Musk T and HHCB by the dermal exposure to commercial products were 7.8 and 7.9 mu g/kg/day in human, respectively, and perfume and body lotion are dominant exposure sources. We also analyzed synthetic musks in house dusts. Polycyclic musks, HHCB and OTNE, showed high concentrations in samples, but macrocyclic musks were detected only in a few samples, although these types of musks were highly detected in commercial products. This is probably due to easy-degradation of macrocyclic musks in indoor environment. The dairy intakes of HHCB by dust ingestions were 0.22 ng/kg/day in human, which were approximately five orders of magnitudes lower than those of dermal absorption from commercial household commodities. (C) 2014 Elsevier Inc. All rights reserved.	[Nakata, Haruhiko; Hinosaka, Mari; Yanagimoto, Hayato] Kumamoto Univ, Grad Sch Sci & Technol, Chuo Ku, Kumamoto 8608555, Japan	Nakata, H (reprint author), Kumamoto Univ, Grad Sch Sci & Technol, Chuo Ku, 2-39-1 Kurokami, Kumamoto 8608555, Japan.	nakata@sci.kumamoto-u.ac.jp					Jones-Otazo HA, 2005, ENVIRON SCI TECHNOL, V39, P5121, DOI 10.1021/es048267b; Simonich SL, 2002, ENVIRON SCI TECHNOL, V36, P2839, DOI 10.1021/es025503e; Reiner JL, 2006, CHEMOSPHERE, V62, P867, DOI 10.1016/j.chemosphere.2005.10.006; Sanchez-Prado L, 2011, TALANTA, V85, P370, DOI 10.1016/j.talanta.2011.03.079; Guo Y, 2011, ENVIRON SCI TECHNOL, V45, P3788, DOI 10.1021/es2002106; Bester K, 2009, J CHROMATOGR A, V1216, P470, DOI 10.1016/j.chroma.2008.08.093; Nakata H, 2012, MAR POLLUT BULL, V64, P2211, DOI 10.1016/j.marpolbul.2012.07.049; Schreurs RHMM, 2004, ENVIRON SCI TECHNOL, V38, P997, DOI 10.1021/es034648y; Lu Y, 2011, ENVIRON POLLUT, V159, P3522, DOI 10.1016/j.envpol.2011.08.015; Kraft P, 2001, CHIRALITY, V13, P388, DOI 10.1002/chir.1050; Roosens L, 2007, CHEMOSPHERE, V69, P1540, DOI 10.1016/j.chemosphere.2007.05.072; Rudel RA, 2009, ATMOS ENVIRON, V43, P170, DOI 10.1016/j.atmosenv.2008.09.025; Wu N, 2007, ENVIRON SCI TECHNOL, V41, P1584, DOI 10.1021/es0620282; Fromme H, 2004, INDOOR AIR, V14, P188, DOI 10.1046/j.1600-0668.2003.00223.x; Bester K, 2008, CHEMOSPHERE, V71, P2003, DOI 10.1016/j.chemosphere.2008.02.004; Brunn H., 2004, SYNTHETIC MUSK FRAGR, P259; Butte W, 2004, HANDB ENVIRON CHEM, V3, P105; Gautschi M, 2001, CHIMIA, V55, P379; HERA Polycyclic musks AHTN (CAS 1506-02-1) and HHCB (CAS 1222-05-05), 2004, HUM ENV RISK ASS ING, P1; Kubwabo C, 2012, ANAL BIOANAL CHEM, V404, P467, DOI 10.1007/s00216-012-6124-2; Liu NN, 2013, CHEMOSPHERE, V93, P1804, DOI 10.1016/j.chemosphere.2013.06.027; Lu Y, 2011, ARCH ENVIRON CON TOX, V60, P182, DOI 10.1007/s00244-010-9595-1; McGinty D, 2011, FOOD CHEM TOXICOL, V49, pS174, DOI 10.1016/j.fct.2011.07.023; NHK Broadcasting Culture Research Institute, 2011, REP LIF JAP 2010; Salvito D, 2011, ECOTOX ENVIRON SAFE, V74, P1619, DOI 10.1016/j.ecoenv.2011.05.002; Seinen W, 1999, TOXICOL LETT, V111, P161, DOI 10.1016/S0378-4274(99)00177-0; Slania R, 2004, SYNTHETIC MUSK FRAGR, P281; Sommer C., 2004, SYNTHETIC MUSK FRAGR, P1; Sommer C, 2004, DEUT LEBENSM-RUNDSCH, V100, P224; SPENCER PS, 1984, TOXICOL APPL PHARM, V75, P571, DOI 10.1016/0041-008X(84)90194-7; Suehiro A., 1999, J SOC BIOSCI BIOENG, V77, P444; USEPA, 2003, HIGH PROD VOL HPV CH	32	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0147-6513	1090-2414		ECOTOX ENVIRON SAFE	Ecotox. Environ. Safe.	JAN	2015	111						248	255		10.1016/j.ecoenv.2014.09.032		8	Environmental Sciences; Toxicology	Environmental Sciences & Ecology; Toxicology	AY0DK	WOS:000347267800034		
J	Wang, B; Qiu, JH; Feng, HX; Sakai, E				Wang, Bin; Qiu, Jianhui; Feng, Huixia; Sakai, Eiichi			Preparation of graphene oxide/polypyrrole/multi-walled carbon nanotube composite and its application in supercapacitors	ELECTROCHIMICA ACTA			English	Article						Supercapacitors; polypyrrole; chlorinated-multiwalled carbon nanotube; graphene oxide	HIGH-ENERGY DENSITY; ELECTROCHEMICAL CAPACITANCE; ASYMMETRIC SUPERCAPACITORS; REDOX SUPERCAPACITORS; ELECTRODE MATERIALS; GRAPHITE OXIDE; PERFORMANCE; POLYANILINE; NANOCOMPOSITES; SURFACE	We report a novel method for preparing graphene oxide/polypyrrole/multi-walled carbon nanotubes (MWCNTs) composites (PCMG). The MWCNTs are treated by sulfuric acid, nitric acid and thionyl chloride, and then composite with graphene oxide and PPy by in suit polymerization. Transition electron microscopy (TEM), scanning electron microscopy (SEM), X-ray photoelectron spectroscopy (XPS) and X-ray diffraction (XRD) results show that in 3-D structure of PCMG composites, PPy chains act as the "bridge" between graphene oxide and chlorinated-MWCNTs. Electrochemical tests reveal that the PCMG1-1 composite has high capacitance of 406.7 F g(-1) at current density of 0.5 A g(-1), and the capacitance retention of PCMG1-1 composite is 92% after 1000 cycles. (C) 2014 Elsevier Ltd. All rights reserved.	[Wang, Bin; Qiu, Jianhui; Sakai, Eiichi] Akita Prefectural Univ, Dept Machine Intelligence & Syst Engn, Fac Syst Engn, Akita 0150055, Japan; [Feng, Huixia] Lanzhou Univ Technol, Coll Petrochem Technol, Lanzhou 730050, Peoples R China	Qiu, JH (reprint author), Akita Prefectural Univ, Dept Machine Intelligence & Syst Engn, Fac Syst Engn, Akita 0150055, Japan.	qiu@akita-pu.ac.jp					Sun YQ, 2011, ENERG ENVIRON SCI, V4, P1113, DOI 10.1039/c0ee00683a; Hulicova D, 2005, CHEM MATER, V17, P1241, DOI 10.1021/cm049337g; Roberts ME, 2009, J MATER CHEM, V19, P6977, DOI 10.1039/b916666a; Beidaghi M, 2011, ELECTROCHIM ACTA, V56, P9508, DOI 10.1016/j.electacta.2011.08.054; Cheng Q, 2013, J POWER SOURCES, V241, P423, DOI 10.1016/j.jpowsour.2013.04.105; Hung CJ, 2014, J POWER SOURCES, V259, P145, DOI 10.1016/j.jpowsour.2014.02.094; Fan LZ, 2006, ELECTROCHEM COMMUN, V8, P937, DOI 10.1016/j.elecom.2006.03.035; Yuan CZ, 2011, NANOSCALE, V3, P529, DOI 10.1039/c0nr00423e; Zhu ZZ, 2011, ELECTROCHIM ACTA, V56, P1366, DOI 10.1016/j.electacta.2010.10.070; Wang HL, 2010, ACS APPL MATER INTER, V2, P821, DOI 10.1021/am900815k; Deng SX, 2013, ELECTROCHIM ACTA, V111, P707, DOI 10.1016/j.electacta.2013.08.055; Bose S, 2012, J MATER CHEM, V22, P767, DOI 10.1039/c1jm14468e; Zhu J, 2013, CHEMCATCHEM, V5, P378, DOI 10.1002/cctc.201200471; Liang BL, 2014, J MATER CHEM A, V2, P2129, DOI 10.1039/c3ta14460g; Rose M, 2011, SMALL, V7, P1108, DOI 10.1002/smll.201001898; Peng YJ, 2014, J POWER SOURCES, V272, P970, DOI 10.1016/j.jpowsour.2014.09.022; Tan L, 2013, RSC ADV, V3, P2561, DOI 10.1039/c2ra22516f; Hu H, 2014, J POWER SOURCES, V268, P451, DOI 10.1016/j.jpowsour.2014.06.074; Zheng C, 2014, J POWER SOURCES, V258, P290, DOI 10.1016/j.jpowsour.2014.01.056; Liu JH, 2012, ACS APPL MATER INTER, V4, P2870, DOI 10.1021/am300640y; Hu J, 2014, CARBON, V67, P221, DOI 10.1016/j.carbon.2013.09.085; Jiang H, 2013, ENERG ENVIRON SCI, V6, P41, DOI 10.1039/c2ee23284g; Paek SM, 2009, NANO LETT, V9, P72, DOI 10.1021/nl802484w; [Anonymous], 2010, PROG POLYM SCI, DOI DOI 10.1016/J.PROGPOLYMSCI.2009.09.003; Wang YG, 2006, ADV MATER, V18, P2619, DOI 10.1002/adma.200600445; Feng HX, 2014, J POWER SOURCES, V246, P621, DOI 10.1016/j.jpowsour.2013.08.002; Luo YS, 2013, RSC ADV, V3, P5851, DOI 10.1039/c3ra00151b; Yan J, 2010, J POWER SOURCES, V195, P3041, DOI 10.1016/j.jpowsour.2009.11.028; Arbizzani C, 1996, ELECTROCHIM ACTA, V41, P21, DOI 10.1016/0013-4686(95)00289-Q; Baibarac M, 2004, CARBON, V42, P3143, DOI 10.1016/j.carbon.2004.07.030; Gupta V, 2006, ELECTROCHIM ACTA, V52, P1721, DOI 10.1016/j.electacta.2006.01.074; Zhang LL, 2009, CHEM SOC REV, V38, P2520, DOI 10.1039/b813846j; Lai LF, 2012, ACS NANO, V6, P5941, DOI 10.1021/nn3008096; Byon HR, 2011, CARBON, V49, P457, DOI 10.1016/j.carbon.2010.09.042; Zhu CZ, 2012, J MATER CHEM, V22, P6300, DOI 10.1039/c2jm16699b; Lu AH, 2012, MACROMOL CHEM PHYS, V213, P1107, DOI 10.1002/macp.201100606; Wang GP, 2012, CHEM SOC REV, V41, P797, DOI 10.1039/c1cs15060j; Fan XB, 2008, ADV MATER, V20, P4490, DOI 10.1002/adma.200801306; Lu XJ, 2012, ELECTROCHIM ACTA, V69, P160, DOI 10.1016/j.electacta.2012.02.107; Zhang JT, 2012, CHEMSUSCHEM, V5, P818, DOI 10.1002/cssc.201100571; Jaidev, 2011, J MATER CHEM, V21, P17601; Liu J, 2001, J MATER CHEM, V11, P404, DOI 10.1039/b008026h; Zhou SP, 2013, RSC ADV, V3, P1797, DOI 10.1039/c2ra22323f	43	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0013-4686	1873-3859		ELECTROCHIM ACTA	Electrochim. Acta	JAN 1	2015	151						230	239		10.1016/j.electacta.2014.10.153		10	Electrochemistry	Electrochemistry	AX3IH	WOS:000346832700029		
J	Shahzad, K; Tsuji, E; Aoki, Y; Nagata, S; Habazaki, H				Shahzad, Khurram; Tsuji, Etsushi; Aoki, Yoshitaka; Nagata, Shinji; Habazaki, Hiroki			Formation and field-assisted dissolution of anodic films on iron in fluoride-containing organic electrolyte	ELECTROCHIMICA ACTA			English	Article						Anodizing; iron; porous anodic film; organic electrolyte; fluoride	ALPHA-FE2O3 NANOTUBE ARRAYS; VOLUME EXPANSION FACTOR; HIGH-ASPECT-RATIO; OXIDE-FILMS; TIO2 NANOTUBES; SULFURIC-ACID; ALUMINA; GROWTH; ANODIZATION; FABRICATION	Magnetron-sputtered iron films were potentiodynamically anodized at two different sweep rates to 50 V in an ethylene glycol electrolyte containing ammonium fluoride and water. At a high sweep rate of 1.0 V s(-1), a barrier-type anodic film was formed even though the current efficiency was as low as similar to 50%. In contrast, a nanoporous anodic film developed at a low sweep rate of 0.05 V s(-1), and the film-formation efficiency reduced to 37%. The main part of the anodic films consists of iron (III) hydroxyfluoride with a thin inner layer composed of FeF3. The inner fluoride layer is formed owing to the faster inward migration of fluoride ions compared to that of the oxygen species. During immersion or re-anodizing of the iron specimen with an approximately 100-nm-thick, barrier-type anodic film at and below 15 V, thinning of the anodic film proceeded uniformly and film dissolution was enhanced by applying an electric field. The impact of the electric field on film formation and dissolution is discussed. (C) 2014 Elsevier Ltd. All rights reserved.	[Shahzad, Khurram; Tsuji, Etsushi; Aoki, Yoshitaka; Habazaki, Hiroki] Hokkaido Univ, Grad Sch Chem Sci & Engn, Sapporo, Hokkaido 0608628, Japan; [Tsuji, Etsushi; Aoki, Yoshitaka; Habazaki, Hiroki] Hokkaido Univ, Div Mat Chem, Fac Engn, Sapporo, Hokkaido 0608628, Japan; [Tsuji, Etsushi; Aoki, Yoshitaka; Habazaki, Hiroki] Hokkaido Univ, Frontier Chem Ctr, Fac Engn, Sapporo, Hokkaido 0608628, Japan; [Nagata, Shinji] Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan	Habazaki, H (reprint author), Hokkaido Univ, Grad Sch Chem Sci & Engn, Sapporo, Hokkaido 0608628, Japan.	habazaki@eng.hokudai.ac.jp	Nagata, Shinji/A-1796-2015		Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	This work was supported in part by the "Nanotechnology Platform" program of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Roy P, 2011, ANGEW CHEM INT EDIT, V50, P2904, DOI 10.1002/anie.201001374; KYOTANI T, 1995, CHEM MATER, V7, P1427, DOI 10.1021/cm00056a001; Mohapatra SK, 2009, CHEM MATER, V21, P3048, DOI 10.1021/cm8030208; Hebert KR, 2012, NAT MATER, V11, P162, DOI [10.1038/nmat3185, 10.1038/NMAT3185]; Garcia-Vergara SJ, 2006, ELECTROCHIM ACTA, V52, P681, DOI 10.1016/j.electacta.2006.05.054; Zhang ZH, 2010, APPL CATAL B-ENVIRON, V95, P423, DOI 10.1016/j.apcatb.2010.01.022; THOMPSON GE, 1978, NATURE, V272, P433, DOI 10.1038/272433a0; Habazaki H, 2010, J PHYS CHEM C, V114, P18853, DOI 10.1021/jp1078136; Curioni M, 2009, J ELECTROCHEM SOC, V156, pC407, DOI 10.1149/1.3230642; Berger S, 2008, PHYS STATUS SOLIDI-R, V2, P102, DOI 10.1002/pssr.200802019; Prakasam HE, 2006, NANOTECHNOLOGY, V17, P4285, DOI 10.1088/0957-4484/17/17/001; Habazaki H, 2007, ELECTROCHEM COMMUN, V9, P1222, DOI 10.1016/j.elecom.2006.12.023; Houser JE, 2008, PHYS STATUS SOLIDI A, V205, P2396, DOI 10.1002/pssa.200779407; Xie KY, 2011, ELECTROCHEM COMMUN, V13, P657, DOI 10.1016/j.elecom.2011.03.040; Santamaria M, 2011, ELECTROCHIM ACTA, V56, P10533, DOI 10.1016/j.electacta.2011.05.027; Thompson GE, 1997, THIN SOLID FILMS, V297, P192, DOI 10.1016/S0040-6090(96)09440-0; LOHRENGEL MM, 1993, MAT SCI ENG R, V11, P243, DOI 10.1016/0927-796X(93)90005-N; Zhou F, 2011, J ELECTROCHEM SOC, V158, pC202, DOI 10.1149/1.3578028; Blawert C, 2006, ADV ENG MATER, V8, P511, DOI 10.1002/adem.200500257; Macak JM, 2006, ELECTROCHIM ACTA, V52, P1258, DOI 10.1016/j.electacta.2006.07.021; Zhou F, 2012, ELECTROCHIM ACTA, V59, P186, DOI 10.1016/j.electacta.2011.10.052; Santamaria M, 2013, J SOLID STATE ELECTR, V17, P3005, DOI 10.1007/s10008-013-2131-2; Shimizu K, 1997, J ELECTROCHEM SOC, V144, P418, DOI 10.1149/1.1837425; Albu SP, 2009, PHYS STATUS SOLIDI-R, V3, P64, DOI 10.1002/pssr.200802285; HOAR TP, 1959, J PHYS CHEM SOLIDS, V9, P97, DOI 10.1016/0022-3697(59)90199-4; Oh J, 2011, ELECTROCHIM ACTA, V56, P4044, DOI 10.1016/j.electacta.2011.02.002; Rangaraju RR, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/13/135303; Houser JE, 2009, NAT MATER, V8, P415, DOI [10.1038/nmat2423, 10.1038/NMAT2423]; Cheng H, 2012, J MATER CHEM, V22, P22692, DOI 10.1039/c2jm34373h; Curioni M, 2013, SURF INTERFACE ANAL, V45, P1485, DOI 10.1002/sia.5222; Di Franco F, 2012, J ELECTROCHEM SOC, V159, pC33, DOI 10.1149/2.031201jes; DOOLITTLE LR, 1985, NUCL INSTRUM METH B, V9, P344, DOI 10.1016/0168-583X(85)90762-1; Garcia-Vergarai SJ, 2006, P R SOC A, V462, P2345, DOI 10.1098/rspa.2006.1686; Garcia-Vergara SJ, 2007, THIN SOLID FILMS, V515, P5418, DOI 10.1016/j.tsf.2007.01.013; Garcia-Vergara SJ, 2009, ELECTROCHIM ACTA, V54, P6403, DOI 10.1016/j.electacta.2009.06.018; Garcia-Vergara SJ, 2007, CORROS SCI, V49, P3696, DOI 10.1016/j.corsci.2007.03.033; Jagminas A, 2011, APPL SURF SCI, V257, P3893, DOI 10.1016/j.apsusc.2010.11.113; Jagminas A, 2011, ELECTROCHIM ACTA, V56, P5452, DOI 10.1016/j.electacta.2011.03.011; Konno Y, 2013, ECS TRANSACTIONS, V50, P183, DOI 10.1149/05037.0183ecst; MASUDA H, 1995, SCIENCE, V268, P1466, DOI 10.1126/science.268.5216.1466; O'Sullivan J.P., 1970, R P L SOC LONDON A, V317, P511; Wei W, 2012, CHEM COMMUN, V48, P4244, DOI 10.1039/c2cc31007d; Young L., 1979, Journal of the Electrochemical Society, V126, DOI 10.1149/1.2129134	43	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0013-4686	1873-3859		ELECTROCHIM ACTA	Electrochim. Acta	JAN 1	2015	151						363	369		10.1016/j.electacta.2014.10.132		7	Electrochemistry	Electrochemistry	AX3IH	WOS:000346832700047		
J	Ozawa, H; YukiTawaraya; Arakawa, H				Ozawa, Hironobu; YukiTawaraya; Arakawa, Hironori			Effects of the Alkyl Chain Length of Imidazolium Iodide in the Electrolyte Solution on the Performance of Black-Dye-Based Dye-Sensitized Solar Cells	ELECTROCHIMICA ACTA			English	Article						Dye-sensitize solar cells; Imidazolium iodide; Alkyl chain length; Ion conductivity	NANOCRYSTALLINE TIO2; PHOTOVOLTAIC PERFORMANCE; EFFICIENCY IMPROVEMENT; LIQUID ELECTROLYTES; CATIONS; RECOMBINATION; 4-TERT-BUTYLPYRIDINE; SPECTROSCOPY; CONVERSION; ADDITIVES	Five kinds of electrolyte solutions containing the imidazolium iodide with a different alkyl chain length (DMImI, EMImI, MPImI, DMPImI and HMImI; DMImI = 1,3-dimethylimidazolium iodide, EMImI = 1-ethyl-3- methylimidazolium iodide, MPImI = 1-methyl-3-n-propylimidazolium iodide, DMPImI = 1,2-dimethyl-3- n-propylimidazolium iodide, HMImI = 1-n-hexyl-3-methylimidazolium iodide) have been prepared to investigate the effects of the alkyl chain length of the imidazolium iodide on the performance of dyesensitized solar cells (DSCs) with Black dye and D131. The photocurrent density (Jsc) increased and the fill factor (FF) decreased with increasing the alkyl chain length of the imidazolium iodide. Electrochemical impedance spectroscopic measurements of the DSCs revealed that the conduction band energy of TiO2 shifted to the positive direction and the diffusion resistance of the redox couple in the electrolyte solution increased with increasing the alkyl chain length of the imidazolium iodide. Therefore, the observed increment of the Jsc value seems to be attributed mainly to the conduction band energy shift of TiO2, and the observed decrement of the FF value would be caused by increasing the diffusion resistance of the redox couple in the electrolyte solution. The conversion efficiency of the DSCs was found to depend on the ion conductivity of the electrolyte solution, which is closely related to the alkyl chain length of the imidazolium iodide. This study demonstrated that the conversion efficiency could be improved by using EMImI instead of the conventional imidazolium iodide (DMPImI) due to the larger ion conductivity with a slightly higher conduction band energy of TiO2. (C) 2014 Elsevier Ltd. All rights reserved.	[Ozawa, Hironobu; YukiTawaraya; Arakawa, Hironori] Tokyo Univ Sci, Fac Engn, Dept Ind Chem, Shinjuku Ku, Tokyo 1620826, Japan	Arakawa, H (reprint author), Tokyo Univ Sci, Fac Engn, Dept Ind Chem, Shinjuku Ku, 12-1 Ichigaya Funagawara, Tokyo 1620826, Japan.	arakawa@ci.kagu.tus.ac.jp			New Energy and Industrial Technology Development Organization (NEDO) of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan [25810043]	This work was supported by the < GS1 > New Energy and Industrial Technology Development Organization (NEDO) of Japan. H.O. acknowledges a Grant-in-Aid for young scientist (B) (No. 25810043) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Ozawa H, 2014, CHEMPHYSCHEM, V15, P1201, DOI 10.1002/cphc.201301025; Hagfeldt A, 2010, CHEM REV, V110, P6595, DOI 10.1021/cr900356p; Altobello S, 2005, J AM CHEM SOC, V127, P15342, DOI 10.1021/ja053438d; Nazeeruddin MK, 2001, J AM CHEM SOC, V123, P1613, DOI 10.1021/ja003299u; NAZEERUDDIN MK, 1993, J AM CHEM SOC, V115, P6382, DOI 10.1021/ja00067a063; Wyss P, 2012, J MATER CHEM, V22, P24424, DOI 10.1039/c2jm34706g; Kambe S, 2002, J PHYS CHEM B, V106, P2967, DOI 10.1021/jp013397h; Yella A, 2011, SCIENCE, V334, P629, DOI 10.1126/science.1209688; Qu SY, 2010, J PHYS CHEM C, V114, P1343, DOI 10.1021/jp909786k; Kusama H, 2004, J PHOTOCH PHOTOBIO A, V162, P441, DOI 10.1016/s1010-6030(03)00414-3; Schlichthorl G, 1997, J PHYS CHEM B, V101, P8141, DOI 10.1021/jp9714126; Zaban A, 2003, CHEMPHYSCHEM, V4, P859, DOI 10.1002/cphc.200200615; Yum JH, 2011, ENERG ENVIRON SCI, V4, P842, DOI 10.1039/c0ee00536c; Yu Z, 2011, DALTON T, V40, P10289, DOI 10.1039/c1dt11023c; Wang ZS, 2005, J PHYS CHEM B, V109, P3907, DOI 10.1021/jp044851v; Katoh R, 2009, J PHYS CHEM C, V113, P20738, DOI 10.1021/jp906190a; Mathew S, 2014, NAT CHEM, V6, P242, DOI [10.1038/nchem.1861, 10.1038/NCHEM.1861]; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; Kelly CA, 1999, LANGMUIR, V15, P7047, DOI 10.1021/la990617y; Hara K, 2004, LANGMUIR, V20, P4205, DOI 10.1021/la0357615; Kelly CA, 2001, COORDIN CHEM REV, V211, P295, DOI 10.1016/S0010-8545(00)00285-X; Boschloo G, 2006, J PHYS CHEM B, V110, P13144, DOI 10.1021/jp0619641; Kubo W, 2003, J PHYS CHEM B, V107, P4374, DOI 10.1021/jp034248x; Gratzel M, 2009, ACCOUNTS CHEM RES, V42, P1788, DOI 10.1021/ar900141y; Marinado T, 2009, PHYS CHEM CHEM PHYS, V11, P133, DOI 10.1039/b812154k; Ozawa H, 2012, RSC ADV, V2, P3198, DOI 10.1039/c2ra01257j; Ozawa H, 2013, RSC ADV, V3, P9175, DOI 10.1039/c3ra23495a; Balraju P, 2009, J PHOTOCH PHOTOBIO A, V206, P53, DOI 10.1016/j.jphotochem.2009.05.014; Jeon SH, 2010, ELECTROCHIM ACTA, V55, P5652, DOI 10.1016/j.electacta.2010.04.103; Kanzaki T, 2006, PHOTOCH PHOTOBIO SCI, V5, P389, DOI 10.1039/b517588g; Kou DX, 2013, ELECTROCHIM ACTA, V100, P197, DOI 10.1016/j.electacta.2013.03.105; Kubo W, 2002, CHEM COMMUN, P374, DOI 10.1039/b110019j; Long HJ, 2011, J PHYS CHEM C, V115, P14408, DOI 10.1021/jp202826m; Ozawa H, 2012, CHEM-ASIAN J, V7, P156, DOI 10.1002/asia.201100484; Son KM, 2008, J APPL ELECTROCHEM, V38, P1647, DOI 10.1007/s10800-008-9611-6; Yanagida M, 2003, INORG CHEM, V42, P7921, DOI 10.1021/ic034674x; Yang HT, 2011, ELECTROCHIM ACTA, V56, P6271, DOI 10.1016/j.electacta.2011.05.054; Yella A, 2014, ANGEW CHEM INT EDIT, V53, P2973, DOI 10.1002/anie.201309343; Yu Z, 2010, J PHYS CHEM C, V114, P22330, DOI 10.1021/jp1073686	39	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0013-4686	1873-3859		ELECTROCHIM ACTA	Electrochim. Acta	JAN 1	2015	151						447	452		10.1016/j.electacta.2014.11.067		6	Electrochemistry	Electrochemistry	AX3IH	WOS:000346832700058		
J	Satake, H; Yano, T; Muto, M; Minashi, K; Yoda, Y; Kojima, T; Oono, Y; Ikematsu, H; Aoyama, I; Morita, S; Miyamoto, S; Fujii, S; Yoshizawa, A; Ochiai, A; Hayashi, R; Kaneko, K				Satake, Hironaga; Yano, Tomonori; Muto, Manabu; Minashi, Keiko; Yoda, Yusuke; Kojima, Takashi; Oono, Yasuhiro; Ikematsu, Hiroaki; Aoyama, Ikuo; Morita, Shuko; Miyamoto, Shinichi; Fujii, Satoshi; Yoshizawa, Akihiko; Ochiai, Atsushi; Hayashi, Ryuichi; Kaneko, Kazuhiro			Clinical outcome after endoscopic resection for superficial pharyngeal squamous cell carcinoma invading the subepithelial layer	ENDOSCOPY			English	Article							MUCOSAL RESECTION; SUBMUCOSAL DISSECTION; HYPOPHARYNGEAL CARCINOMA; MUSCULARIS MUCOSAE; SURGICAL-TREATMENT; CANCER; ESOPHAGUS; HEAD; MESOPHARYNGEAL; FEASIBILITY	Background and study aims: The curability of endoscopic resection for superficial pharyngeal squamous cell carcinoma (SPSCC) has not been fully elucidated, particularly for lesions invading the subepithelial layer, which carry the risk of metastasis. The aim of this study was to evaluate the curative potential of endoscopic resection for SPSCC invading the subepithelial layer. Patients and methods: From June 2002 to July 2010, 198 SPSCCs in 176 consecutive patients were treated by endoscopic resection at two tertiary referral centers. Selection criteria were initial endoscopic resection, histologically proven squamous cell carcinoma invading the subepithelial layer, no lymph node or distant metastasis before endoscopic resection, and no prior treatment for pharyngeal squamous cell carcinoma. Endoscopic resection was performed under general anesthesia. Long-term survival and clinical outcomes were retrospectively evaluated. Results: Among 176 consecutive patients, 50 lesions in 47 patients (all male; median age 64 years) were histologically diagnosed from endoscopic resection specimens as having subepithelial invasion. Median tumor thickness was 1000 mu m (range 200-10000 mu m). Six patients developed local recurrence (13 %; 95% confidence interval [CI] 3.1%-22.4 %), and all were cured with organ-preserving intervention. After a median follow-up period of 71 months (range 27-116 months), one patient (2 %; 95% CI 0-6.3 %) developed neck lymph node metastasis. A total of 14 patients (30 %) were followed for 5 years or more, and 5-year overall survival and disease-specific survival rates were 84.5% (95 % CI 73%-96%) and 100%, respectively. Conclusions: Endoscopic resection has curative potential as a minimally invasive treatment option for SPSCC that invades the subepithelial layer.	[Satake, Hironaga; Yano, Tomonori; Minashi, Keiko; Yoda, Yusuke; Kojima, Takashi; Oono, Yasuhiro; Ikematsu, Hiroaki; Kaneko, Kazuhiro] Natl Canc Ctr Hosp East, Endoscopy Div, Dept Gastroenterol, Kashiwa, Chiba 2778577, Japan; [Muto, Manabu] Kyoto Univ, Grad Sch Med, Dept Clin Oncol, Kyoto, Japan; [Aoyama, Ikuo; Morita, Shuko; Miyamoto, Shinichi] Kyoto Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Kyoto, Japan; [Fujii, Satoshi; Ochiai, Atsushi] Natl Canc Ctr, Res Ctr Innovat Oncol, Div Pathol, Kashiwa, Chiba, Japan; [Yoshizawa, Akihiko] Shinshu Univ Hosp, Dept Lab Med, Nagano, Japan; [Hayashi, Ryuichi] Natl Canc Ctr Hosp East, Dept Head & Neck Surg, Kashiwa, Chiba 2778577, Japan	Yano, T (reprint author), Natl Canc Ctr Hosp East, Endoscopy Div, Dept Gastroenterol, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	toyano@east.ncc.go.jp					Iizuka T, 2009, ENDOSCOPY, V41, P113, DOI 10.1055/s-0028-1119453; Okada K, 2012, ENDOSCOPY, V44, P556, DOI 10.1055/s-0032-1309720; Eckel HE, 2001, OTOLARYNG HEAD NECK, V124, P561, DOI 10.1067/mhn.2991.115060; Muto M, 2002, GASTROINTEST ENDOSC, V56, P517, DOI 10.1067/mge.2002.128104; Muto M, 2010, J CLIN ONCOL, V28, P1566, DOI 10.1200/JCO.2009.25.4680; NAGAWA H, 1995, CANCER, V75, P1061, DOI 10.1002/1097-0142(19950301)75:5<1061::AID-CNCR2820750502>3.0.CO;2-1; Nakamura K, 2006, INT J RADIAT ONCOL, V65, P1045, DOI 10.1016/j.ijrobp.2006.02.001; Pesko P, 2006, DIS ESOPHAGUS, V19, P248, DOI 10.1111/j.1442-2050.2006.00585.x; Kodama M, 1998, SURGERY, V123, P432, DOI 10.1016/S0039-6060(98)70165-5; Kraus DH, 1997, OTOLARYNG HEAD NECK, V116, P637, DOI 10.1016/S0194-5998(97)70240-7; Muto M, 2011, GASTROINTEST ENDOSC, V74, P477, DOI 10.1016/j.gie.2011.04.027; Johansen LV, 2000, ACTA ONCOL, V39, P529; Triboulet JP, 2001, ARCH SURG-CHICAGO, V136, P1164, DOI 10.1001/archsurg.136.10.1164; Shimizu Y, 2002, GASTROINTEST ENDOSC, V56, P387, DOI 10.1067/mge.2002.127100; Suzuki H, 2010, ENDOSCOPY, V42, P1, DOI 10.1055/s-0029-1243807; Gono K, 2004, J BIOMED OPT, V9, P568, DOI 10.1117/1.1695563; Katada C, 2007, ENDOSCOPY, V39, P779, DOI 10.1055/s-2007-966761; Wahlberg PCG, 1998, HEAD NECK-J SCI SPEC, V20, P714, DOI 10.1002/(SICI)1097-0347(199812)20:8<714::AID-HED9>3.0.CO;2-2; Barnes D, 2005, WHO CLASSIFICATION T; Erkal HS, 2001, J CLIN ONCOL, V19, P1358; Fujii S, 2010, HISTOPATHOLOGY, V56, P510, DOI 10.1111/j.1365-2559.2010.03512.x; Holsinger FC, 2006, HEAD NECK-J SCI SPEC, V28, P705, DOI 10.1002/hed.20375; Iizuka T, 2011, ENDOSCOPY, V43, P839, DOI 10.1055/s-0031-1271112; Muto M, 2004, CANCER, V101, P1375, DOI 10.1002/cncr.20482; Muto M, 2005, DIGEST ENDOSC, V17, P23; Shimizu Y, 2009, ENDOSCOPY, V41, P374, DOI 10.1055/s-0029-1214488; Shimizu Y, 2006, GASTROINTEST ENDOSC, V64, P255, DOI 10.1016/j.gie.2006.01.049; Tani M, 2003, ENDOSCOPY, V35, P348, DOI 10.1055/s-2003-38153; The Japan Esophageal Society, 2008, JAP CLASS ES CANC	29	2	2	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0013-726X	1438-8812		ENDOSCOPY	Endoscopy	JAN	2015	47	1					11	18		10.1055/s-0034-1378107		8	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AW9TM	WOS:000346600200005		
J	Kaise, M; Ohkura, Y; Iizuka, T; Kimura, R; Nomura, K; Kuribayashi, Y; Yamada, A; Yamashita, S; Furuhata, T; Kikuchi, D; Ogawa, O; Matsui, A; Mitani, T; Hoteya, S				Kaise, Mitsuru; Ohkura, Yasuo; Iizuka, Toshiro; Kimura, Ryusuke; Nomura, Kosuke; Kuribayashi, Yasutaka; Yamada, Akihiro; Yamashita, Satoshi; Furuhata, Tsukasa; Kikuchi, Daisuke; Ogawa, Osamu; Matsui, Akira; Mitani, Toshifumi; Hoteya, Shu			Endocytoscopy is a promising modality with high diagnostic accuracy for gastric cancer	ENDOSCOPY			English	Article							SQUAMOUS-CELL CARCINOMA; IN-VIVO; SYSTEM; ESOPHAGUS; LESIONS	Background and study aim: Endocytoscopy (ECS) enables in vivo microscopic imaging, which allows analysis of mucosal structures at the cellular level; however, limited data are available on the validity of ECS in the stomach. The aim of this study was to evaluate the feasibility of ECS in the diagnosis of early gastric cancer. Patients and methods: Gastric lesions that were the targets of histopathological diagnosis by endoscopic submucosal dissection or biopsy specimen were prospectively enrolled and evaluated using a single charge-coupled device-integrated endocytoscope, following double staining with crystal violet and methylene blue. High grade ECS atypia was defined according to specific irregularities in gland structure and cell nuclei. The primary end point was the accuracy of ECS diagnosis for gastric cancer, using histopathological diagnosis as the gold standard. Results: A total of 82 lesions were investigated, including 23 early gastric cancers, 10 gastric adenomas, and 49 non-neoplastic lesions. Ten lesions could not be clearly observed by ECS because of poor staining due to viscous mucus or plaque; thus, assessability rates with ECS were 88% in total and 91% for gastric cancer. High grade ECS atypia was observed in 86% of assessable gastric cancers, but not in any cases of gastric adenomas or non-neoplastic lesions. The sensitivity, specificity, positive and negative predictive values of high grade ECS atypia as the criterion for the diagnosis of gastric cancer were 86%, 100%, 100%, and 94%, respectively. No serious complications occurred during or after the examinations. Conclusion: ECS is a clinically feasible modality to obtain in vivo histology, with high diagnostic accuracy in gastric cancer.	[Kaise, Mitsuru; Iizuka, Toshiro; Kimura, Ryusuke; Nomura, Kosuke; Kuribayashi, Yasutaka; Yamada, Akihiro; Yamashita, Satoshi; Furuhata, Tsukasa; Kikuchi, Daisuke; Ogawa, Osamu; Matsui, Akira; Mitani, Toshifumi; Hoteya, Shu] Toranomon Gen Hosp, Dept Gastroenterol, Tokyo 1058470, Japan; [Ohkura, Yasuo] Kyorin Univ, Sch Med, Dept Pathol, Tokyo, Japan	Kaise, M (reprint author), Toranomon Gen Hosp, Dept Gastroenterol, Minato Ku, 2-2-2 Toranomon, Tokyo 1058470, Japan.	kaise@toranomon.gr.jp					Neumann H, 2013, INFLAMM BOWEL DIS, V19, P356, DOI 10.1002/ibd.23025; Neumann H, 2011, ALIMENT PHARM THER, V33, P1183, DOI 10.1111/j.1365-2036.2011.04647.x; Inoue H, 2006, ENDOSCOPY, V38, P891, DOI 10.1055/s-2006-944667; Kudo SE, 2011, ENDOSCOPY, V43, P869, DOI 10.1055/s-0030-1256663; Kumagai Y, 2004, ENDOSCOPY, V36, P590, DOI 10.1055/s-2004-814533; Dixon MF, 2002, GUT, V51, P130, DOI 10.1136/gut.51.1.130; Kaise M, 2010, GASTROENTEROL CLIN N, V39, P771, DOI 10.1016/j.gtc.2010.08.028; Ezoe Y, 2011, GASTROENTEROLOGY, V141, P2017, DOI 10.1053/j.gastro.2011.08.007; Goetz M, 2014, NAT REV GASTRO HEPAT, V11, P11, DOI 10.1038/nrgastro.2013.134; Shimizu Y, 2013, GASTROINTEST ENDOSC, V78, P351, DOI 10.1016/j.gie.2013.03.1336; Kumagai Y, 2010, DIGEST ENDOSC, V22, P10, DOI 10.1111/j.1443-1661.2009.00931.x; Cipolletta L, 2009, ENDOSCOPY, V41, P129, DOI 10.1055/s-0028-1103452; Kato M, 2010, GASTROINTEST ENDOSC, V72, P523, DOI 10.1016/j.gie.2010.04.041; Chiu PWY, 2014, DIGEST ENDOSC, V26, P52, DOI 10.1111/den.12050; Eberl T, 2007, ENDOSCOPY, V39, P497, DOI 10.1055/s-2007-966446	15	1	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0013-726X	1438-8812		ENDOSCOPY	Endoscopy	JAN	2015	47	1					19	25		10.1055/s-0034-1377965		7	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AW9TM	WOS:000346600200006		
J	Mukai, S; Itoi, T; Baron, TH; Sofuni, A; Itokawa, F; Kurihara, T; Tsuchiya, T; Ishii, K; Tsuji, S; Ikeuchi, N; Tanaka, R; Umeda, J; Tonozuka, R; Honjo, M; Gotoda, T; Moriyasu, F; Yasuda, I				Mukai, Shuntaro; Itoi, Takao; Baron, Todd H.; Sofuni, Atsushi; Itokawa, Fumihide; Kurihara, Toshio; Tsuchiya, Takayoshi; Ishii, Kentaro; Tsuji, Shujiro; Ikeuchi, Nobuhito; Tanaka, Reina; Umeda, Junko; Tonozuka, Ryosuke; Honjo, Mitsuyoshi; Gotoda, Takuji; Moriyasu, Fuminori; Yasuda, Ichiro			Endoscopic ultrasound-guided placement of plastic vs. biflanged metal stents for therapy of walled-off necrosis: a retrospective single-center series	ENDOSCOPY			English	Article							PANCREATIC-FLUID COLLECTIONS; TRANSMURAL DRAINAGE; EUS; PSEUDOCYSTS; VIDEOS; NECROSECTOMY; DEBRIDEMENT; OUTCOMES; TRIAL	Background and study aims: Recently, a novel fully covered and biflanged metal stent (BFMS) dedicated to the drainage of walled-off necrosis (WON) was developed. The aim of this study was to retrospectively evaluate the safety, efficacy, and cost performance of drainage of WON using the novel BFMS compared with a traditional plastic stent. Patients and methods: A total of 70 patients with symptomatic WON were treated under endoscopic ultrasound (EUS) guidance. Initial drainage was conducted using the single gateway technique with placement of one or more plastic stents or a single BFMS. If drainage was unsuccessful, direct endoscopic necrosectomy (DEN) was performed. Results: There were no statistically significant differences in rates of technical success, clinical success, and adverse events between plastics stents and BFMS, despite the size of WON in the BFMS group being significantly larger than that in the plastic stent group (105.6 vs. 77.1 mm; P=0.003). The mean procedure times for the first EUS-guided drainage and for re-intervention were significantly shorter in the BFMS group than in the plastic stent group (28.8 +/- 7.1 vs. 42.6 +/- 14.2, respectively, for drainage, P<0.001; and 34.9 +/- 8.5 vs. 41.8 +/- 7.6, respectively, for re-intervention, P<0.001). There was no statistically significant difference in the total cost between plastic stent and BFMS use in the treatment of WON ($5352 vs. $6274; P=0.25). Conclusions: Plastic stents and BFMS were safe and effective for the treatment of WON. In particular, BFMS placement appeared to be preferable for initial EUS-guided drainage and additional reintervention (e.g. DEN) as it reduced the procedure time. Prospective randomized controlled trials are warranted.	[Mukai, Shuntaro; Itoi, Takao; Sofuni, Atsushi; Itokawa, Fumihide; Kurihara, Toshio; Tsuchiya, Takayoshi; Ishii, Kentaro; Tsuji, Shujiro; Ikeuchi, Nobuhito; Tanaka, Reina; Umeda, Junko; Tonozuka, Ryosuke; Honjo, Mitsuyoshi; Gotoda, Takuji; Moriyasu, Fuminori] Tokyo Med Univ, Dept Gastroenterol & Hepatol, Tokyo 1600023, Japan; [Baron, Todd H.] Univ N Carolina, Chapel Hill, NC USA; [Yasuda, Ichiro] Gifu Univ Hosp, Dept Internal Med 1, Gifu, Japan	Itoi, T (reprint author), Tokyo Med Univ, Dept Gastroenterol & Hepatol, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	itoi@tokyo-med.ac.jp			Research Committee of Intractable Pancreatic Diseases	The authors are indebted to Maya Vardaman and Associate Professor Edward Barroga, Senior Medical Editor of the Department of International Medical Communications of Tokyo Medical University, for their editorial review of the English manuscript. This work was financially supported in part by the Research Committee of Intractable Pancreatic Diseases (Principal investigator: Tooru Shimosegawa) as provided by the Ministry of Health, Labour, and Welfare of Japan.	Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; Siddiqui AA, 2013, GASTROINTEST ENDOSC, V78, P589, DOI 10.1016/j.gie.2013.03.1337; Varadarajulu S, 2011, GASTROINTEST ENDOSC, V74, P74, DOI 10.1016/j.gie.2011.03.1122; Gardner TB, 2009, GASTROINTEST ENDOSC, V69, P1085, DOI 10.1016/j.gie.2008.06.061; Itoi T, 2012, GASTROINTEST ENDOSC, V75, P870, DOI 10.1016/j.gie.2011.10.020; Varadarajulu S, 2011, J GASTROINTEST SURG, V15, P2080, DOI 10.1007/s11605-011-1621-8; Varadarajulu S, 2008, GASTROINTEST ENDOSC, V68, P1102, DOI 10.1016/j.gie.2008.04.028; Fabbri C, 2012, ENDOSCOPY, V44, P429, DOI 10.1055/s-0031-1291624; Seewald S, 2012, DIGEST ENDOSC, V24, P36, DOI 10.1111/j.1443-1661.2011.01162.x; Seifert H, 2000, LANCET, V356, P653, DOI 10.1016/S0140-6736(00)02611-8; Arvanitakis M, 2007, GASTROINTEST ENDOSC, V65, P609, DOI 10.1016/j.gie.2006.06.083; Yasuda I, 2013, ENDOSCOPY, V45, P627, DOI 10.1055/s-0033-1344027; Voermans RP, 2007, GASTROINTEST ENDOSC, V66, P909, DOI 10.1016/j.gie.2007.05.043; BINMOELLER KF, 1995, GASTROINTEST ENDOSC, V42, P219, DOI 10.1016/S0016-5107(95)70095-1; Bang JY, 2013, J GASTROEN HEPATOL, V28, P1725, DOI 10.1111/jgh.12328; Itoi T, 2013, J HEPATO-BIL-PAN SCI, V20, P403, DOI 10.1007/s00534-012-0551-5; Yamamoto N, 2013, GASTROINTEST ENDOSC, V77, P809, DOI 10.1016/j.gie.2013.01.009; Cotton PB, 2010, GASTROINTEST ENDOSC, V71, P446, DOI 10.1016/j.gie.2009.10.027; Baron TH, 2012, CLIN GASTROENTEROL H, V10, P1202, DOI 10.1016/j.cgh.2012.07.009; Penn DE, 2012, GASTROINTEST ENDOSC, V76, P679, DOI 10.1016/j.gie.2012.04.457; Weilert F, 2012, ENDOSCOPY, V44, P780, DOI 10.1055/s-0032-1309839; Baron TH, 2002, GASTROINTEST ENDOSC, V56, P7, DOI 10.1067/mge.2002.125106; Talreja JP, 2008, GASTROINTEST ENDOSC, V68, P1199, DOI 10.1016/j.gie.2008.06.015; Gardner TB, 2011, GASTROINTEST ENDOSC, V73, P718, DOI 10.1016/j.gie.2010.10.053; Fogel EL, 2011, J GASTROINTEST SURG, V15, P1098, DOI 10.1007/s11605-011-1505-y; Itoi T, 2009, DIGEST ENDOSC, V21, pS53, DOI 10.1111/j.1443-1661.2009.00851.x; Mukai S, 2014, GASTROINTEST ENDOSC, V79, P531, DOI 10.1016/j.gie.2013.10.004	27	7	7	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0013-726X	1438-8812		ENDOSCOPY	Endoscopy	JAN	2015	47	1					47	55		10.1055/s-0034-1377966		9	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AW9TM	WOS:000346600200010		
J	Ogura, T; Sano, T; Onda, S; Imoto, A; Masuda, D; Yamamoto, K; Kitano, M; Takeuchi, T; Inoue, T; Higuchi, K				Ogura, Takeshi; Sano, Tatsushi; Onda, Saori; Imoto, Akira; Masuda, Daisuke; Yamamoto, Kazuhiro; Kitano, Masayuki; Takeuchi, Toshihisa; Inoue, Takuya; Higuchi, Kazuhide			Endoscopic ultrasound-guided biliary drainage for right hepatic bile duct obstruction: novel technical tips	ENDOSCOPY			English	Article								Endoscopic ultrasound (EUS)-guided biliary drainage (EUS-BD) is not normally indicated for an obstructed right intrahepatic bile duct (IHBD). The technical feasibility and clinical efficacy of a novel technique of EUS-BD for right IHBD obstruction were evaluated. A total of 11 patients underwent drainage using either a left or a right biliary access route. The causes of obstructive jaundice were cholangiocarcinoma (n=6), pancreatic can-cer (n=3), gastric cancer (n=1), and colon cancer (n=1). After placement of an uncovered metal stent to bridge the obstruction, a hepaticogastrostomy was completed using a covered stent. Mean procedure time was 33.9 +/- 10.0 minutes. Technical and functional success were achieved in all patients, and no adverse events occurred. This novel method appears to be safe and effective for right IHBD obstruction.	[Ogura, Takeshi; Sano, Tatsushi; Onda, Saori; Imoto, Akira; Masuda, Daisuke; Takeuchi, Toshihisa; Inoue, Takuya; Higuchi, Kazuhide] Osaka Med Coll, Dept Internal Med 2, Osaka 4648681, Japan; [Yamamoto, Kazuhiro] Osaka Med Coll, Dept Radiol, Osaka 4648681, Japan; [Kitano, Masayuki] Kinki Univ, Fac Med, Dept Gastroenterol & Hepatol, Osaka, Japan	Ogura, T (reprint author), Osaka Med Coll, Dept Internal Med 2, 1-1 Daigakuchou, Osaka 4648681, Japan.	oguratakeshi0411@yahoo.co.jp					Itoi T, 2011, J HEPATO-BIL-PAN SCI, V18, P664, DOI 10.1007/s00534-011-0410-9; Park DH, 2009, AM J GASTROENTEROL, V104, P2168, DOI 10.1038/ajg.2009.254; Park SJ, 2013, GASTROINTEST ENDOSC, V78, P374, DOI 10.1016/j.gie.2013.04.183; Kawakubo K, 2014, J HEPATO-BIL-PAN SCI, V21, P328, DOI 10.1002/jhbp.27; Fogel EL, 2001, ENDOSCOPY, V33, P31, DOI 10.1055/s-2001-11186; Ogura T, 2014, J GASTROEN HEPATOL, V29, P1815, DOI 10.1111/jgh.12598; Sarkaria Savreet, 2013, Gastrointest Endosc Clin N Am, V23, P435, DOI 10.1016/j.giec.2012.12.013	7	6	6	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0013-726X	1438-8812		ENDOSCOPY	Endoscopy	JAN	2015	47	1					72	75		10.1055/s-0034-1378111		4	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AW9TM	WOS:000346600200014		
J	Eleftheriadis, N; Inoue, H; Ikeda, H; Onimaru, M; Maselli, R; Kudo, S				Eleftheriadis, Nikolas; Inoue, Haruhiro; Ikeda, Haruo; Onimaru, Manabu; Maselli, Roberta; Kudo, Shin-ei			Polyps in Lynch syndrome. Differences in quality of colonoscopy between Western and Eastern endoscopists	ENDOSCOPY			English	Letter							COLORECTAL-CANCER; PIT PATTERN		[Eleftheriadis, Nikolas] Showa Univ, Ctr Digest Dis, Northern Yokohama Hosp, Tsuzuki Ku, Yokohama, Kanagawa 2248503, Japan	Eleftheriadis, N (reprint author), Showa Univ, Ctr Digest Dis, Northern Yokohama Hosp, Tsuzuki Ku, 35-1 Chigasakichuo, Yokohama, Kanagawa 2248503, Japan.	nikoseleftheriadis@yahoo.com					KUDO S, 1994, J CLIN PATHOL, V47, P880, DOI 10.1136/jcp.47.10.880; Kudo S, 2001, ENDOSCOPY, V33, P367; Kudo S, 2000, WORLD J SURG, V24, P1081; Wada Y, 2011, DIGEST ENDOSC, V23, P106, DOI 10.1111/j.1443-1661.2011.01109.x; [Anonymous], 2003, GASTROINTEST ENDOSC, V58, P063; KUDO S, 1995, ENDOSCOPY, V27, P54, DOI 10.1055/s-2007-1005633; KUDO S, 1995, EUR J CANCER, V31A, P1118, DOI 10.1016/0959-8049(95)00251-D; Kudo SE, 2013, ISRN GASTROENTEROL, V2013; Rondagh EJA, 2013, ENDOSCOPY, V45, P257, DOI 10.1055/s-0032-1326195	9	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0013-726X	1438-8812		ENDOSCOPY	Endoscopy	JAN	2015	47	1					89	89				1	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AW9TM	WOS:000346600200019		
J	Huang, M; Sakiyama, T; Matsuda, H; Morita, C				Huang, M.; Sakiyama, T.; Matsuda, H.; Morita, C.			Free vibration analysis of stepped rectangular plates resting on non-homogeneous elastic foundations	ENGINEERING ANALYSIS WITH BOUNDARY ELEMENTS			English	Article						Half boundary method; Plate; Free vibration; Elastic foundations	FINITE-ELEMENT FORMULATION; SHEAR DEFORMATION-THEORY; TRANSVERSE VIBRATIONS; INHOMOGENEOUS FOUNDATIONS; GALERKIN METHOD; MINDLIN PLATES; THICK PLATES; SUPPORTS	A Half Boundary Method (HBM) is proposed for analyzing the free vibration problem of rectangular plates with stepped thickness resting on non-homogeneous elastic foundations. The unknown quantities of the method exist only on half of the boundary. The non-homogeneous elastic foundation discussed here consists of two-segment elastic Winkler foundation. The fundamental differential equations are established for the bending problem of the plate on elastic foundations. The Green function, which is obtained by transforming these differential equations into integral equations and using numerical integration, is used to establish the characteristic equation of the free vibration. The effects of the modulus of the foundation, the stepped thickness and aspect ratio on the frequency parameters are considered. By comparing the present numerical results with those previously published, the efficiency and accuracy of the present method are investigated. (C) 2014 Elsevier Ltd. All rights reserved.	[Huang, M.] North China Elect Power Univ, Sch Nucl Sci & Engn, Beijing, Peoples R China; [Sakiyama, T.; Matsuda, H.; Morita, C.] Nagasaki Univ, Dept Struct Engn, Nagasaki 85, Japan	Huang, M (reprint author), North China Elect Power Univ, Sch Nucl Sci & Engn, Beijing, Peoples R China.	huangmei@ncepu.edu.cn			Japan Society for the Promotion [20560433]; State key laboratory of intense pulsed radiation simulation and effect (Northwest institute of nuclear technology, China)	The present study was sponsored by the Japan Society for the Promotion (No. 20560433) and State key laboratory of intense pulsed radiation simulation and effect (Northwest institute of nuclear technology, China).	Omurtag MH, 1998, COMPUT STRUCT, V67, P253, DOI 10.1016/S0045-7949(97)00128-4; Omurtag MH, 1997, INT J NUMER METH ENG, V40, P295, DOI 10.1002/(SICI)1097-0207(19970130)40:2<295::AID-NME66>3.0.CO;2-2; Canelas A, 2010, ENG ANAL BOUND ELEM, V34, P845, DOI 10.1016/j.enganabound.2010.05.010; Akavci SS, 2014, COMPOS STRUCT, V108, P667, DOI 10.1016/j.compstruct.2013.10.019; Bahmyari E, 2013, ENG ANAL BOUND ELEM, V37, P1212, DOI 10.1016/j.enganabound.2013.05.003; Huang MH, 2001, COMPUT STRUCT, V79, P2547, DOI 10.1016/S0045-7949(01)00134-1; Liew KM, 2001, INT J SOLIDS STRUCT, V38, P4937, DOI 10.1016/S0020-7683(00)00329-2; Xiang Y, 2002, J SOUND VIB, V250, P503, DOI 10.1006/jsvi.2001.3922; Xiang Y, 1996, J ENG MECH-ASCE, V122, P54, DOI 10.1061/(ASCE)0733-9399(1996)122:1(54); Wang DD, 2011, COMPUT MECH, V48, P47, DOI 10.1007/s00466-011-0580-y; Guo SJ, 1997, J SOUND VIB, V204, P645, DOI 10.1006/jsvi.1997.0955; Hank IE, 1992, J SOUND VIB, V153, P51; HORENBERG JAG, 1985, J SOUND VIB, V101, P317, DOI 10.1016/S0022-460X(85)80132-2; Huang M, 2009, J SOUND VIB, V322, P227, DOI 10.1016/j.jsv.2008.11.006; Huang M, 2010, J SOUND VIB, V329, P485, DOI 10.1016/j.jsv.2009.08.036; Jahromi HN, 2013, INT J MECH SCI, V57, P1; JU F, 1995, J SOUND VIB, V183, P533, DOI 10.1006/jsvi.1995.0269; Lal R, 1997, J SOUND VIB, V207, P1, DOI 10.1006/jsvi.1996.1138; Lam KY, 2000, ENG STRUCT, V22, P364, DOI 10.1016/S0141-0296(98)00116-3; LAURA PAA, 1984, J SOUND VIB, V95, P531, DOI 10.1016/0022-460X(84)90235-9; LAURA PAA, 1985, J SOUND VIB, V101, P307, DOI 10.1016/S0022-460X(85)80131-0; Lee WM, 2010, ENG ANAL BOUND ELEM, V34, P1064, DOI 10.1016/j.enganabound.2010.06.018; LIU WH, 1994, J SOUND VIB, V169, P601, DOI 10.1006/jsvi.1994.1036; Matsunaga H, 2000, J ENG MECH-ASCE, V126, P27, DOI 10.1061/(ASCE)0733-9399(2000)126:1(27); Peng LX, 2014, INT J MECH SCI, V78, P8, DOI 10.1016/j.ijmecsci.2013.10.009; Shen HS, 2001, J SOUND VIB, V244, P299, DOI 10.1006/jsvi.2000.3501; Thai HT, 2013, INT J MECH SCI, V73, P40, DOI 10.1016/j.ijmecsci.2013.03.017; Xiang Y, 2003, INT J MECH SCI, V45, P1229, DOI 10.1016/S0020-7403(03)00141-3; Yajuvindra Kumar, 2012, MECCANICA, V47, P893	29	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0955-7997	1873-197X		ENG ANAL BOUND ELEM	Eng. Anal. Bound. Elem.	JAN	2015	50						180	187		10.1016/j.enganabound.2014.07.008		8	Engineering, Multidisciplinary; Mathematics, Interdisciplinary Applications	Engineering; Mathematics	AX6FI	WOS:000347018200019		
J	Yamamoto, S; Hayashi, S; Furusaki, S; Shioya, S				Yamamoto, Shinjiro; Hayashi, Shuhei; Furusaki, Shintaro; Shioya, Suteaki			5-Aminolevulinic acid promotes callus growth and paclitaxel production in light-grown Taxus cuspidata suspension cultures	ENGINEERING IN LIFE SCIENCES			English	Article						5-Aminolevulinic acid; Callus culture; Paclitaxel; Photosynthetically active radiation; Taxus cuspidata	PLANT-CELL CULTURE; IN-SITU EXTRACTION; METHYL JASMONATE; TAXOL PRODUCTION; ORGANIC-SOLVENTS; BACCATIN III; ENHANCEMENT; ELICITATION; INDUCTION; RECOVERY	Cultured plant cells generally produce low levels of secondary metabolites, and elicitors of secondary metabolites usually inhibit callus growth. The aim of this study was to determine the effect of 5-aminolevulinic acid (ALA), a chlorophyll precursor that promotes plant growth, on callus induction from leaves of Taxus cuspidata, and on callus growth on solid medium. ALA at 0.76, 7.6, and 76 M had similar effects on callus induction and growth, while ALA at 760 M had negative effects. Next, the effects of ALA concentrations on callus growth and paclitaxel production in suspension cultures in the dark were evaluated. The results showed that 0.76 and 7.6 M ALA stimulated growth and paclitaxel production, while 76 M ALA had negative effects. ALA is thought to promote cellular activity under light conditions. Therefore, the effects of light intensity on callus growth and paclitaxel production in the presence of ALA were evaluated. Our results showed that the best conditions for callus growth and paclitaxel production were 7.6 M ALA under photosynthetically active radiation of 12 mol photons m(-2) s(-1). Callus growth and paclitaxel production were inhibited under stronger light (24 mol photons m(-2) s(-1)). Together, these results show that ALA promoted callus growth and the production of paclitaxel by light-grown cultured T. cuspidata cells.	[Yamamoto, Shinjiro; Hayashi, Shuhei; Shioya, Suteaki] Sojo Univ, Dept Appl Life Sci, Nishi Ku, Kumamoto 8600082, Japan; [Furusaki, Shintaro] Kanto Gakuin Univ, Inst Sci & Technol, Kanazawa Ku, Yokohama, Kanagawa, Japan	Yamamoto, S (reprint author), Sojo Univ, Dept Appl Life Sci, Nishi Ku, 4-22-1 Ikeda, Kumamoto 8600082, Japan.	syamamot@life.sojo-u.ac.jp					Seki M, 1997, BIOTECHNOL BIOENG, V53, P214, DOI 10.1002/(SICI)1097-0290(19970120)53:2<214::AID-BIT12>3.0.CO;2-K; Wang CG, 2001, APPL MICROBIOL BIOT, V55, P404, DOI 10.1007/s002530000567; LAANE C, 1987, BIOTECHNOL BIOENG, V30, P81, DOI 10.1002/bit.260300112; STIERLE A, 1993, SCIENCE, V260, P214, DOI 10.1126/science.8097061; Exposito O, 2010, BIOTECHNOL PROGR, V26, P1145, DOI 10.1002/btpr.424; Hotta Y, 1997, PLANT GROWTH REGUL, V22, P109, DOI 10.1023/A:1005883930727; Wang CG, 2001, BIOTECHNOL PROGR, V17, P89, DOI 10.1021/bp0001359; Ketchum REB, 1999, BIOTECHNOL BIOENG, V62, P97, DOI 10.1002/(SICI)1097-0290(19990105)62:1<97::AID-BIT11>3.0.CO;2-C; Malik S, 2011, PROCESS BIOCHEM, V46, P23, DOI 10.1016/j.procbio.2010.09.004; Yukimune Y, 1996, NAT BIOTECHNOL, V14, P1129, DOI 10.1038/nbt0996-1129; Onrubia M, 2013, J PLANT PHYSIOL, V170, P211, DOI 10.1016/j.jplph.2012.09.004; Wilson SA, 2012, PLANT BIOTECHNOL J, V10, P249, DOI 10.1111/j.1467-7652.2011.00664.x; McPartland TJ, 2012, BIOTECHNOL PROGR, V28, P990, DOI 10.1002/btpr.1562; Zhang B, 2005, P NATL ACAD SCI USA, V102, P227, DOI 10.1073/pnas.0406361102; Naeem MS, 2012, PLANT PHYSIOL BIOCH, V57, P84, DOI 10.1016/j.plaphy.2012.05.018; Kwon IC, 1998, PROCESS BIOCHEM, V33, P701, DOI 10.1016/S0032-9592(98)00037-5; Bindu RC, 1998, PLANT GROWTH REGUL, V26, P15, DOI 10.1023/A:1006098005335; BRODELIUS P, 1988, APPL MICROBIOL BIOT, V27, P561; Choi HK, 2000, BIOTECHNOL LETT, V22, P1793, DOI 10.1023/A:1005658405449; Collins-Pavao M., 1996, Journal of Biotechnology, V49, P95, DOI 10.1016/0168-1656(96)01525-8; Cusido RM, 2014, BIOTECHNOL ADV, V32, P1157, DOI 10.1016/j.biotechadv.2014.03.002; DAVIES ME, 1972, PLANTA, V104, P50, DOI 10.1007/BF00387683; GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; Kingdston G. D., 1995, TAXOL SCI APPL, P287; Mirjalili N, 1996, BIOTECHNOL PROGR, V12, P110, DOI 10.1021/bp9500831; Patil RA, 2013, PLANT CELL TISS ORG, V112, P303, DOI 10.1007/s11240-012-0237-3; Roberts SG, 1997, CURR OPIN BIOTECH, V8, P154, DOI 10.1016/S0958-1669(97)80094-8; SEKI M, 1995, J CHEM ENG JPN, V28, P488, DOI 10.1252/jcej.28.488; SUFFNESS M, 1993, ANNU REP MED CHEM, V28, P305; Taura K, 2013, SOLVENT EXTR RES DEV, V20, P65; Wang LJ, 2005, J INTEGR PLANT BIOL, V47, P1084, DOI 10.1111/j.1744-7909.2005.00150.x; Yamamoto S, 2006, SOLVENT EXTR RES DEV, V13, P131; Yamamoto S., 2005, SOLVENT EXTR RES DEV, V12, P149; Yamamoto S, 2009, SOLVENT EXTR RES DEV, V16, P93; Yukimune Y, 2000, PHYTOCHEMISTRY, V54, P13, DOI 10.1016/S0031-9422(00)00006-6	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1618-0240	1618-2863		ENG LIFE SCI	Eng. Life Sci.	JAN	2015	15	1					116	121		10.1002/elsc.201300171		6	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	AX9QF	WOS:000347236300013		
J	Teramage, MT; Onda, Y; Wakiyama, Y; Kato, H; Kanda, T; Tamura, K				Teramage, Mengistu T.; Onda, Yuichi; Wakiyama, Yoshifumi; Kato, Hiroaki; Kanda, Takashi; Tamura, Kenji			Atmospheric Pb-210 as a tracer for soil organic carbon transport in a coniferous forest	ENVIRONMENTAL SCIENCE-PROCESSES & IMPACTS			English	Article							JAPANESE CEDAR; EROSION; CS-137; DEPOSITION; INVENTORIES; ENVIRONMENT; PO-210; IMPACT; BE-7; LEAD	Core soils and falling litter samples were collected in a Japanese cypress forest (Chamaecyparis obtusa) to determine the litter-fed Pb-210(ex) and organic carbon transfer from the forest canopy to soil and their subsequent distribution. Of the canopy residing Pb-210(ex) pool, litterfall annually transports 53% to the forest floor while it adds 117 g m(-2) per year of organic carbon to the forest soil, implying that litterfall dynamics can influence the distribution of Pb-210(ex) and soil organic carbon (SOC). Pb-210(ex) and SOC showed identical profile shapes and strong correlation in spatial as well as along the soil depth, indicating that both are affected by a similar process. Given the ubiquitous natural source of Pb-210(ex), it is plausible to infer that radiolead can be a possible tracer to study the SOC redistribution at regional and global scales.	[Teramage, Mengistu T.; Onda, Yuichi; Kato, Hiroaki] Univ Tsukuba, Dept Integrat Environm Sci, Grad Sch Life & Environm Sci, Ibaraki 3058572, Japan; [Teramage, Mengistu T.] Hawassa Univ, Coll Agr, Hawassa, Ethiopia; [Wakiyama, Yoshifumi] Univ Tsukuba, Terrestrial Environm Res Ctr, Ibaraki 3058577, Japan; [Kanda, Takashi; Tamura, Kenji] Univ Tsukuba, Dept Environm Soil Chem, Grad Sch Life & Environm Sci, Ibaraki 3058577, Japan	Teramage, MT (reprint author), Univ Tsukuba, Dept Integrat Environm Sci, Grad Sch Life & Environm Sci, Ibaraki 3058572, Japan.	teramaget@yahoo.com	Onda, Yuichi/N-6527-2014; Wakiyama, Yoshifumi/E-3576-2015	Onda, Yuichi/0000-0001-8753-0378; Wakiyama, Yoshifumi/0000-0001-6085-7063	Core Research for Evolutional Science and Technology (CREST) research project	This study is supported by the Core Research for Evolutional Science and Technology (CREST) research project. We are grateful to Mrs Tebeyien Negashe for her support in reading and correcting the manuscript.	Van Oost K, 2007, SCIENCE, V318, P626, DOI 10.1126/science.1145724; Lal R, 1998, CRIT REV PLANT SCI, V17, P319, DOI 10.1016/S0735-2689(98)00363-3; Lal R, 2003, ENVIRON INT, V29, P437, DOI 10.1016/S0160-4120(02)00192-7; Branford D, 2004, WATER AIR SOIL POLL, V157, P107, DOI 10.1023/B:WATE.0000038879.99600.69; Wakiyama Y, 2010, GEODERMA, V159, P39, DOI 10.1016/j.geoderma.2010.06.012; Teramage MT, 2013, GEODERMA, V192, P59, DOI 10.1016/j.geoderma.2012.08.030; Berhe AA, 2007, BIOSCIENCE, V57, P337, DOI 10.1641/B570408; Stankwitz C, 2012, ENVIRON SCI TECHNOL, V46, P8061, DOI 10.1021/es204208w; Onda Y, 2010, HYDROL PROCESS, V24, P527, DOI 10.1002/hyp.7548; Daushy F. EI-, 1988, ENVIRON INT, V14, P305; Dorr H., 1995, PALEOLIMNOLOGY, V13, P157; DORR H, 1989, RADIOCARBON, V31, P655; DORR H, 1991, WATER AIR SOIL POLL, V57-8, P809, DOI 10.1007/BF00282944; Fowler D, 1995, WATER AIR SOIL POLL, V85, P2113, DOI 10.1007/BF01186146; Fukuyama T, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2006JF000657; IPCC, 2003, GOOD PRACT GUID LAND; Kaste JM, 2011, GEOCHIM COSMOCHIM AC, V75, P1642, DOI 10.1016/j.gca.2011.01.011; Kato H, 2010, GEOMORPHOLOGY, V114, P508, DOI 10.1016/j.geomorph.2009.08.009; LEWIS DM, 1977, GEOCHIM COSMOCHIM AC, V41, P1557, DOI 10.1016/0016-7037(77)90167-3; Likuku A. S., 2009, WATER AIR SOIL POLL, V9, P179; Mol P. J., 2012, ENV DEV, V1, P10; Nagakura J, 2004, TREE PHYSIOL, V24, P1203; Osaki S, 2003, J RADIOANAL NUCL CH, V255, P449, DOI 10.1023/A:1022555626377; Osaki S, 2007, J RADIOANAL NUCL CH, V272, P147, DOI 10.1007/s10967-006-6820-5; Pricope N. G., 2009, J SPAT HYDROL, V9, P21; Ritchie C., 2007, GEOMORPHOLOGY, V89, P163; Vaaramaa K, 2010, SCI TOTAL ENVIRON, V408, P6165, DOI 10.1016/j.scitotenv.2010.09.004	27	0	0	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2050-7887	2050-7895		ENVIRON SCI-PROC IMP	Environ. Sci.-Process Impacts		2015	17	1					110	119		10.1039/c4em00402g		10	Chemistry, Analytical; Environmental Sciences	Chemistry; Environmental Sciences & Ecology	AX4JG	WOS:000346898500010		
J	Suriadi, MM; Usui, K; Tottori, T; Terada, K; Fujitani, S; Umeoka, S; Usui, N; Baba, K; Matsuda, K; Inoue, Y				Suriadi, Meilia M.; Usui, Keiko; Tottori, Takayasu; Terada, Kiyohito; Fujitani, Shigeru; Umeoka, Shuichi; Usui, Naotaka; Baba, Kouichi; Matsuda, Kazumi; Inoue, Yushi			Preservation of absolute pitch after right amygdalohippocampectomy for a pianist with TLE	EPILEPSY & BEHAVIOR			English	Article						Absolute pitch; Mesial temporal lobe epilepsy; Amygdalohippocampectomy; Memory	TEMPORAL-LOBE EPILEPSY; SELECTIVE AMYGDALOHIPPOCAMPECTOMY; FUNCTIONAL-ANATOMY; MUSICIANS; MEMORY; COMPONENTS; PERCEPTION; RESECTION; ABILITY	Absolute pitch (AP) ability is a raremusical phenomenon. In the literature, it has been suggested that the relative specialization for pitch processing is in the right temporal lobe in the non-AP population. Since the anatomic basis for absolute pitch is not fully understood and cases of temporal lobe epilepsy of AP possessors are extremely rare, applicability of resection as a treatment of epilepsy in this particular area should be evaluated with caution. In the present study, we examined an AP possessor who suffered from medically refractory temporal lobe epilepsy and underwent right selective amygdalohippocampectomy (SAH). The SAH procedure clearly avoided disturbing important structures for AP, inasmuch as postsurgically she preserved her AP ability and was seizure-free. She did well post-operatively in the test of pure sine wave tones with short reaction time, which could be identified as "true" absolute pitch. (C) 2014 Elsevier Inc. All rights reserved.	[Suriadi, Meilia M.; Usui, Keiko; Tottori, Takayasu; Terada, Kiyohito; Fujitani, Shigeru; Umeoka, Shuichi; Usui, Naotaka; Baba, Kouichi; Matsuda, Kazumi; Inoue, Yushi] Shizuoka Inst Epilepsy & Neurol Disorders, Natl Epilepsy Ctr, Shizuoka 4208688, Japan	Suriadi, MM (reprint author), Shizuoka Inst Epilepsy & Neurol Disorders, Natl Epilepsy Ctr, 886 Urushiyama, Shizuoka 4208688, Japan.	meiliasuriadi@gmail.com			Japan Epilepsy Research Foundation	This study was funded by grants from the Japan Epilepsy Research Foundation.	SCHLAUG G, 1995, SCIENCE, V267, P699, DOI 10.1126/science.7839149; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908; Morino M, 2009, J NEUROSURG, V110, P1164, DOI 10.3171/2008.9.JNS08247; TAKEUCHI AH, 1993, PSYCHOL BULL, V113, P345, DOI 10.1037//0033-2909.113.2.345; Ross DA, 2005, EPILEPSY BEHAV, V7, P578, DOI 10.1016/j.yebeh.2005.05.019; Ohnishi T, 2001, CEREB CORTEX, V11, P754, DOI 10.1093/cercor/11.8.754; Johnsrude IS, 2000, BRAIN, V123, P155, DOI 10.1093/brain/123.1.155; Zatorre RJ, 1998, P NATL ACAD SCI USA, V95, P3172, DOI 10.1073/pnas.95.6.3172; Clusmann H, 2002, J NEUROSURG, V97, P1131, DOI 10.3171/jns.2002.97.5.1131; Helmstaedter C, 2003, ANN NEUROL, V54, P425, DOI 10.1002/ana.10692; Helmstaedter C, 2008, EPILEPSIA, V49, P88, DOI 10.1111/j.1528-1167.2007.01386.x; Baharloo S, 1998, AM J HUM GENET, V62, P224, DOI 10.1086/301704; Luders E, 2004, NEUROIMAGE, V22, P656, DOI 10.1016/j.neuroimage.2004.01.032; Bermudez P, 2009, J BIOL, V8; Bermudez P, 2009, MUSIC PERCEPT, V27, P89, DOI 10.1525/MP.2009.27.2.89; Critchley M., 1970, APHASIOLOGY OTHER AS, P256; Gregersen PK, 1999, AM J HUM GENET, V65, P911, DOI 10.1086/302541; Liegeois-Chauvel Catherine, 1998, Brain, V121, P1853, DOI 10.1093/brain/121.10.1853; Limb Charles J, 2006, Anat Rec A Discov Mol Cell Evol Biol, V288, P435, DOI 10.1002/ar.a.20316; LOCKHEAD GR, 1981, J ACOUST SOC AM, V70, P387, DOI 10.1121/1.386773; Loui P, 2012, NEUROIMAGE, V63, P632, DOI 10.1016/j.neuroimage.2012.07.030; Loui P, 2011, J COGNITIVE NEUROSCI, V23, P1015, DOI 10.1162/jocn.2010.21500; Luria A R, 1965, J Neurol Sci, V2, P288, DOI 10.1016/0022-510X(65)90113-9; Trujillo-Pozo I, 2013, FRONT HUM NEUROSCI, V7, P1; Wilson SJ, 2009, CEREB CORTEX, V19, P724, DOI 10.1093/cercor/bhn121; ZATORRE RJ, 1989, CORTEX, V25, P567	26	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	JAN	2015	42						14	17		10.1016/j.yebeh.2014.10.025		4	Behavioral Sciences; Clinical Neurology; Psychiatry	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	AX6RC	WOS:000347048000006		
J	Nakamura, I; Yamaguchi, T; Tsukimori, A; Sato, A; Fukushima, S; Matsumoto, T				Nakamura, I.; Yamaguchi, T.; Tsukimori, A.; Sato, A.; Fukushima, S.; Matsumoto, T.			New options of antibiotic combination therapy for multidrug-resistant Pseudomonas aeruginosa	EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES			English	Article							POINT CHECKERBOARD PLATE; METALLO-BETA-LACTAMASE; AMINOGLYCOSIDE; COLISTIN	Several antibiotic combinations have demonstrated increased activity against multidrug-resistant Pseudomonas aeruginosa (MDRP) in vitro compared with a single antibiotic. The aim of this study was to investigate the activity against MDRP of some aminoglycosides in combination with monobactam, piperacillin (PIPC), and carbapenem. Clinical isolates of MDRP were collected between November 2010 and October 2012 from patients in Tokyo Medical University Hospital, Tokyo (1,015 beds). Our new method was designed to evaluate three concentrations around the breakpoint of each drug using the Checkerboard method. The aminoglycosides tested were amikacin (AMK), tobramycin (TOB), and arbekacin (ABK). Ciprofloxacin, PIPC, and biapenem (BIPM), which have been reported to demonstrate combination effects, were also tested. Sixty-six MDRP strains were identified from the 2,417 P. aeruginosa strains. Of the 66, 27 tested positive for metallo-beta-lactamase (MBL). Aztreonam (AZT) with AMK or ABK was the most effective against MDRP. PIPC with AMK or ABK were somewhat effective. AZT with AMK or ABK were more effective against MBL-positive strains than MBL-negative strains. However, PIPC with AMK or ABK were more effective against MBL-negative strains than MBL-positive strains. Combination activities showed differences between MBL-positive and MBL-negative strains.	[Nakamura, I.; Yamaguchi, T.; Tsukimori, A.; Sato, A.; Fukushima, S.] Tokyo Med Univ Hosp, Dept Infect Control & Prevent, Tokyo, Japan; [Yamaguchi, T.] Toho Univ, Fac Med, Dept Microbiol & Infect Dis, Ota Ku, Tokyo 1438540, Japan; [Tsukimori, A.; Sato, A.; Matsumoto, T.] Tokyo Med Univ, Dept Microbiol, Tokyo 1608402, Japan	Yamaguchi, T (reprint author), Toho Univ, Fac Med, Dept Microbiol & Infect Dis, Ota Ku, 5-21-16 Omorinishi, Tokyo 1438540, Japan.	tetsuo.yamaguchi@med.toho-u.ac.jp					Tateda K, 2006, SCAND J INFECT DIS, V38, P268, DOI 10.1080/00365540500440353; HALL MJ, 1983, J ANTIMICROB CHEMOTH, V11, P427, DOI 10.1093/jac/11.5.427; Laraki N, 1999, ANTIMICROB AGENTS CH, V43, P902; Montero M, 2009, INFECTION, V37, P461, DOI 10.1007/s15010-009-8342-x; Falagas ME, 2005, CLIN INFECT DIS, V40, P1333, DOI 10.1086/429323; Docquier JD, 2003, ANTIMICROB AGENTS CH, V47, P1522, DOI 10.1128/AAC.47.5.1522-1528.2003; Araoka H, 2010, SCAND J INFECT DIS, V42, P231, DOI 10.3109/00365540903443157; Araoka H, 2012, JPN J INFECT DIS, V65, P84; Linden PK, 2003, CLIN INFECT DIS, V37, pE154, DOI 10.1086/379611; Nakamura I, 2014, J INFECT CHEMOTHER, V20, P266, DOI 10.1016/j.jiac.2013.12.005; Oie S, 2003, J ANTIMICROB CHEMOTH, V52, P911, DOI 10.1093/jac/dkg478; Watanabe T, 1997, J ANTIMICROB CHEMOTH, V39, P471, DOI 10.1093/jac/39.4.471	12	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0934-9723	1435-4373		EUR J CLIN MICROBIOL	Eur. J. Clin. Microbiol. Infect. Dis.	JAN	2015	34	1					83	87		10.1007/s10096-014-2192-x		5	Infectious Diseases; Microbiology	Infectious Diseases; Microbiology	AX8LJ	WOS:000347160700010		
J	Hashi, S; Yano, I; Shibata, M; Masuda, S; Kinoshita, M; Matsumoto, R; Ikeda, A; Takahashi, R; Matsubara, K				Hashi, Sachiyo; Yano, Ikuko; Shibata, Mai; Masuda, Satohiro; Kinoshita, Masako; Matsumoto, Riki; Ikeda, Akio; Takahashi, Ryosuke; Matsubara, Kazuo			Effect of CYP2C19 polymorphisms on the clinical outcome of low-dose clobazam therapy in Japanese patients with epilepsy	EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY			English	Article						Clobazam; N-Desmethylclobazam; CYP2C19 poor metabolizer; Low-dose therapy; Therapeutic drug monitoring	ANTIEPILEPTIC DRUGS; N-DESMETHYLCLOBAZAM; REFRACTORY EPILEPSY; ILAE-COMMISSION; METABOLISM; CLASSIFICATION; GENOTYPES; EFFICACY; SEIZURES; IMPACT	Clobazam (CLB) is metabolized by cytochrome P450 (CYP) 3A4 to yield N-desmethylclobazam (N-CLB), which is further inactivated by CYP2C19. The aim of this study was to retrospectively evaluate the relationship between CYP2C19 polymorphisms and the efficacy of low-dose, add-on CLB therapy in Japanese patients with epilepsy. Fifty patients were divided into three groups according to their CYP2C19 polymorphism. CLB and N-CLB serum concentrations and seizure frequency before and after starting CLB were analyzed. Extensive metabolizers (EMs, n = 11), intermediate metabolizers (IMs, n = 22), and poor metabolizers (PMs, n = 17) were included. Although the dose-normalized CLB serum concentrations were not significantly different, the dose-normalized N-CLB serum concentrations were significantly higher in PMs than in EMs or IMs. Seizure frequency was significantly decreased by the CLB therapy in PMs (p < 0.01), but not in EMs or IMs. CLB serum concentrations did not correlate with seizure reduction rate, but median N-CLB serum concentrations were significantly higher in patients with excellent seizure control (a parts per thousand 90 % seizure reduction) compared to those with a parts per thousand 50 % seizure reduction or with < 50 % seizure reduction (1103, 341, and 570 ng/mL, respectively). The efficacy of low-dose CLB therapy was significantly influenced by CYP2C19 polymorphisms. Ideally, CLB therapy should be started with a low dose (2.5 mg/day) and dosage increased until N-CLB serum concentration reaches 1100 ng/mL or until the desired effect is acquired, a recommendation that is particularly important for PMs.	[Hashi, Sachiyo; Yano, Ikuko; Shibata, Mai; Masuda, Satohiro; Matsubara, Kazuo] Kyoto Univ Hosp, Dept Clin Pharmacol & Therapeut, Sakyo Ku, Kyoto 6068507, Japan; [Yano, Ikuko; Shibata, Mai] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharm & Educ, Sakyo Ku, Kyoto 6068501, Japan; [Kinoshita, Masako] Natl Utano Hosp, Natl Hosp Org, Dept Neurol, Ukyo Ku, Kyoto 6168255, Japan; [Matsumoto, Riki; Ikeda, Akio; Takahashi, Ryosuke] Kyoto Univ, Grad Sch Med, Dept Neurol, Sakyo Ku, Kyoto 6068507, Japan	Yano, I (reprint author), Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharm & Educ, Sakyo Ku, Kyoto 6068501, Japan.	iyano@kuhp.kyoto-u.ac.jp	Masuda, Satohiro/E-6691-2010; 	Masuda, Satohiro/0000-0002-3589-5989; Matsumoto, Riki/0000-0003-3985-9210; Ikeda, Akio/0000-0002-0790-2598	Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was partially supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	ALLEN JW, 1983, BRIT MED J, V286, P1246; Anderson GD, 1998, ANN PHARMACOTHER, V32, P554, DOI 10.1345/aph.17332; STEWART JA, 1991, EPILEPSIA, V32, P407; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Van Schaik RHN, 2002, CLIN CHEM, V48, P1668; Beal SL, 2001, J PHARMACOKINET PHAR, V28, P481, DOI 10.1023/A:1012299115260; Patsalos PN, 2008, EPILEPSIA, V49, P1239, DOI 10.1111/j.1528-1167.2008.01561.x; Neels HM, 2004, CLIN CHEM LAB MED, V42, P1228, DOI 10.1515/CCLM.2004.245; Benedetti MS, 2000, FUNDAM CLIN PHARM, V14, P301; Commission on Classification and Terminology of the International League Against Epilepsy, 1989, EPILEPSIA, V30, P389; Contin M, 2002, THER DRUG MONIT, V24, P737, DOI 10.1097/00007691-200212000-00009; DEMORAIS SMF, 1994, MOL PHARMACOL, V46, P594; de Leon J, 2013, THER DRUG MONIT, V35, P30, DOI 10.1097/FTD.0b013e31827ada88; Dichter MA, 1996, NEW ENGL J MED, V334, P1583; Fielding S, 1979, BR J CLIN PHARM S, V7, P7; Giraud C, 2004, DRUG METAB DISPOS, V32, P1279; GOLDSTEIN JA, 1994, BIOCHEMISTRY-US, V33, P1743, DOI 10.1021/bi00173a017; Hachad H, 2002, THER DRUG MONIT, V24, P91, DOI 10.1097/00007691-200202000-00016; Hosohata K, 2009, DRUG METAB DISPOS, V37, P821, DOI 10.1124/dmd.108.025833; Inoue K, 1997, PHARMACOGENETICS, V7, P103, DOI 10.1097/00008571-199704000-00003; BANCAUD J, 1981, EPILEPSIA, V22, P489; JAWAD S, 1984, BRIT J CLIN PHARMACO, V18, P873; Kinoshita M, 2007, J NEUROL SCI, V263, P44, DOI 10.1016/j.jns.2007.05.025; Kosaki K, 2004, BRAIN DEV-JPN, V26, P530, DOI 10.1016/j.braindev.2004.02.010; LEVY RH, 1983, DRUG METAB DISPOS, V11, P286; Ng YT, 2007, NEUROTHERAPEUTICS, V4, P138, DOI 10.1016/j.nurt.2006.11.002; Odani A, 1996, BIOL PHARM BULL, V19, P444; Robertson MM, 1986, EPILEPSIA S1, V27, P27; SCHMIDT D, 1986, ARCH NEUROL-CHICAGO, V43, P824; SENNOUNE S, 1992, THER DRUG MONIT, V14, P269, DOI 10.1097/00007691-199208000-00002; Seo T, 2008, PHARMACOGENOMICS, V9, P527, DOI 10.2217/14622416.9.5.527; Shorvon Simon D., 1995, P763; Theis JGW, 1997, J CHILD NEUROL, V12, P208	33	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0031-6970	1432-1041		EUR J CLIN PHARMACOL	Eur. J. Clin. Pharmacol.	JAN	2015	71	1					51	58		10.1007/s00228-014-1773-z		8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX8JX	WOS:000347156900006		
J	Noguchi, K; Hirota, M; Miyoshi, T; Tani, Y; Noda, Y; Ito, H; Nanba, S				Noguchi, Kaoru; Hirota, Minoru; Miyoshi, Toru; Tani, Yoshinori; Noda, Yoko; Ito, Hiroshi; Nanba, Seiji			Single administration of vildagliptin attenuates postprandial hypertriglyceridemia and endothelial dysfunction in normoglycemic individuals	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						endothelial function; postprandial lipemia; dipeptidyl peptidase 4	GLUCAGON-LIKE PEPTIDE-1; DIPEPTIDYL PEPTIDASE-4 INHIBITOR; CORONARY-ARTERY-DISEASE; NONFASTING TRIGLYCERIDES; GLYCEMIC CONTROL; HEART-DISEASE; ALOGLIPTIN; GLP-1; SECRETION; THERAPY	Postprandial hypertriglyceridemia impairs endothelial function and plays an important role in the development of atherosclerosis. The aim of the present study was to examine the postprandial effects of the dipeptidyl peptidase-4 inhibitor vildagliptin and the -glucosidase inhibitor voglibose on endothelial dysfunction and lipid profiles following a single administration. A randomized cross-over trial using 11 normoglycemic individuals was performed. The postprandial effects of a single administration of vildagliptin (50 mg) or voglibose (0.3 mg) on endothelial function were analyzed using brachial artery flow-mediated dilation (FMD) and lipid profiles during fasting and 1.5 and 3 h after an oral cookie-loading test. Compared with voglibose, vildagliptin significantly suppressed postprandial endothelial dysfunction, (%FMD, -1.6 +/- 0.9 vildagliptin vs. -4.0 +/- 0.7 voglibose; P=0.01) and the postprandial incremental increase in the triglyceride level (28 +/- 18 vildagliptin vs. 51 +/- 26 mg/dl voglibose; P=0.01) 3 h after a cookie-loading test. In addition, vildagliptin significantly increased the levels of glucagon-like peptide-1 compared with voglibose 3 h after a loading cookie test (4.4 +/- 0.6 vs. 2.9 +/- 0.7 pmol/l, respectively; P=0.04). No significant differences in the levels of glucose, apolipoprotein B-48, glucagon or insulin were observed between vildagliptin and voglibose treatments. In conclusion, a single administration of vildagliptin attenuated postprandial endothelial dysfunction and postprandial hypertriglyceridemia, suggesting that vildagliptin may be a promising antiatherogenic agent.	[Noguchi, Kaoru; Hirota, Minoru; Tani, Yoshinori; Nanba, Seiji] Okayama Rosai Hosp, Dept Cardiol, Okayama 7028055, Japan; [Miyoshi, Toru; Noda, Yoko; Ito, Hiroshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Med, Okayama 7008558, Japan	Miyoshi, T (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Med, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	miyoshit@cc.okayama-u.ac.jp					Feng J, 2007, J MED CHEM, V50, P2297, DOI 10.1021/jm0701041; Basu A, 2007, AM J PHYSIOL-ENDOC M, V293, pE1289, DOI 10.1152/ajpendo.00373.2007; Tremblay AJ, 2011, DIABETES OBES METAB, V13, P366, DOI 10.1111/j.1463-1326.2011.01362.x; Hsieh J, 2010, DIABETOLOGIA, V53, P552, DOI 10.1007/s00125-009-1611-5; Hiki M, 2010, CIRC J, V74, P1471, DOI 10.1253/circj.CJ-10-0013; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Matikainen N, 2006, DIABETOLOGIA, V49, P2049, DOI 10.1007/s00125-006-0340-2; Wojdemann M, 1998, DIGEST DIS SCI, V43, P799, DOI 10.1023/A:1018874300026; Hattori Y, 2010, DIABETOLOGIA, V53, P2256, DOI 10.1007/s00125-010-1831-8; Veniant MM, 1997, J CLIN INVEST, V100, P180, DOI 10.1172/JCI119511; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Ceriello A, 2011, DIABETES CARE, V34, P697, DOI 10.2337/dc10-1949; Bae JH, 2001, ATHEROSCLEROSIS, V155, P517, DOI 10.1016/S0021-9150(00)00601-8; Masuda D, 2009, EUR J CLIN INVEST, V39, P689, DOI 10.1111/j.1365-2362.2009.02163.x; DeFronzo RA, 2008, DIABETES CARE, V31, P2315, DOI 10.2337/dc08-1035; Ayaori M, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.003277; Kato T, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-12; Kitano D, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-92; Moritoh Y, 2008, EUR J PHARMACOL, V588, P325, DOI 10.1016/j.ejphar.2008.04.018; Nakamura K, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0110-2; Noda Y, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-8; Nystrom T, 2004, AM J PHYSIOL-ENDOC M, V287, pE1209, DOI 10.1152/ajpendo.00237.2004; Qin XF, 2005, AM J PHYSIOL-GASTR L, V288, pG943, DOI 10.1152/ajpgi.00303.2004; van Oostrom AJHHM, 2003, J LIPID RES, V44, P576, DOI 10.1194/jlr.M200419-JLR200	24	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	JAN	2015	9	1					84	88		10.3892/etm.2014.2051		5	Medicine, Research & Experimental	Research & Experimental Medicine	AX1HS	WOS:000346699000013		
J	Nowak, D; Liem, NLM; Mossner, M; Klaumunzer, M; Papa, RA; Nowak, V; Jann, JC; Akagi, T; Kawamata, N; Okamoto, R; Thoennissen, NH; Kato, M; Sanada, M; Hofmann, WK; Ogawa, S; Marshall, GM; Lock, RB; Koeffler, HP				Nowak, Daniel; Liem, Natalia L. M.; Mossner, Maximilian; Klaumuenzer, Marion; Papa, Rachael A.; Nowak, Verena; Jann, Johann C.; Akagi, Tadayuki; Kawamata, Norihiko; Okamoto, Ryoko; Thoennissen, Nils H.; Kato, Motohiro; Sanada, Masashi; Hofmann, Wolf-Karsten; Ogawa, Seishi; Marshall, Glenn M.; Lock, Richard B.; Koeffler, H. Phillip			Variegated clonality and rapid emergence of new molecular lesions in xenografts of acute lymphoblastic leukemia are associated with drug resistance	EXPERIMENTAL HEMATOLOGY			English	Article							ACUTE MYELOID-LEUKEMIA; DEOXYCYTIDINE KINASE; IN-VITRO; FOLYLPOLYGLUTAMATE SYNTHETASE; GLUCOCORTICOID RESISTANCE; PRECLINICAL EVALUATION; ARA-C; CELLS; GENE; MODELS	The use of genome-wide copy-number analysis and massive parallel sequencing has revolutionized the understanding of the clonal architecture of pediatric acute lymphoblastic leukemia (ALL) by demonstrating that this disease is composed of highly variable clonal ancestries following the rules of Darwinian selection. The current study aimed to analyze the molecular composition of childhood ALL biopsies and patient-derived xenografts with particular emphasis on mechanisms associated with acquired chemoresistance. Genomic DNA from seven primary pediatric ALL patient samples, 29 serially passaged xenografts, and six in vivo selected chemoresistant xenografts were analyzed with 250K single-nucleotide polymorphism arrays. Copy-number analysis of non drug-selected xenografts confirmed a highly variable molecular pattern of variegated subclones. Whereas primary patient samples from initial diagnosis displayed a mean of 5.7 copy-number alterations per sample, serially passaged xenografts contained a mean of 8.2 and chemoresistant xenografts a mean of 10.5 copy-number alterations per sample, respectively. Resistance to cytarabine was explained by a new homozygous deletion of the DCK gene, whereas methotrexate resistance was associated with monoallelic deletion of FPGS and mutation of the remaining allele. This study demonstrates that selecting for chemoresistance in xenografted human ALL cells can reveal novel mechanisms associated with drug resistance. Copyright (C) 2015 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc.	[Nowak, Daniel; Nowak, Verena; Kawamata, Norihiko; Okamoto, Ryoko; Thoennissen, Nils H.; Koeffler, H. Phillip] Univ Calif Los Angeles, Sch Med, Cedars Sinai Med Ctr, Div Hematol & Oncol, Los Angeles, CA USA; [Nowak, Daniel; Mossner, Maximilian; Klaumuenzer, Marion; Nowak, Verena; Jann, Johann C.; Hofmann, Wolf-Karsten] Heidelberg Univ, Med Fac Mannheim, Dept Hematol & Oncol, D-68169 Mannheim, Germany; [Liem, Natalia L. M.; Papa, Rachael A.; Lock, Richard B.] Univ New S Wales, Lowy Canc Res Ctr, Childrens Canc Inst Australia Med Res, Sydney, NSW, Australia; [Akagi, Tadayuki] Kanazawa Univ, Grad Sch Med Sci, Dept Stem Cell Biol, Kanazawa, Ishikawa 9201192, Japan; [Kato, Motohiro; Sanada, Masashi; Ogawa, Seishi] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto, Japan; [Marshall, Glenn M.] Sydney Childrens Hosp, Kids Canc Ctr, Randwick, NSW, Australia; [Koeffler, H. Phillip] Natl Univ Singapore, Singapore 117548, Singapore	Nowak, D (reprint author), Heidelberg Univ, Med Fac Mannheim, Dept Hematol & Oncol, Pettenkofer Str 22, D-68169 Mannheim, Germany.	daniel.nowak@medma.uni-heidelberg.de	Akagi, Tadayuki/E-1078-2011; Lock, Richard/G-4253-2013		Deutsche Forschungsgemeinschaft [817/1-1]; National Health and Medical Research Council (Australia); StaR Award (Singapore); National Institutes of Health [5R01CA026038-35]	Dr D. Nowak has received a research grant from the Deutsche Forschungsgemeinschaft (no. 817/1-1). Prof RB Lock received a Research Fellowship from the National Health and Medical Research Council (Australia). Prof HP Koeffler was supported by the StaR Award (Singapore) and by a National Institutes of Health grant (no. 5R01CA026038-35).	Kawamata N, 2008, BLOOD, V111, P776, DOI 10.1182/blood-2007-05-088310; Clappier E, 2011, J EXP MED, V208, P653, DOI 10.1084/jem.20110105; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; CARSON DA, 1980, P NATL ACAD SCI-BIOL, V77, P6865, DOI 10.1073/pnas.77.11.6865; Stark M, 2009, BLOOD, V113, P4362, DOI 10.1182/blood-2008-08-173799; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Piovan E, 2013, CANCER CELL, V24, P766, DOI 10.1016/j.ccr.2013.10.022; Yang JJ, 2008, BLOOD, V112, P4178, DOI 10.1182/blood-2008-06-165027; Yamamoto G, 2007, AM J HUM GENET, V81, P114, DOI 10.1086/518809; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Schlossmacher G, 2011, J ENDOCRINOL, V211, P17, DOI 10.1530/JOE-11-0135; Liani E, 2003, INT J CANCER, V103, P587, DOI 10.1002/ijc.10829; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Bachmann PS, 2007, CANCER RES, V67, P4482, DOI 10.1158/0008-5472.CAN-06-4244; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; High LM, 2010, MOL PHARMACOL, V77, P483, DOI 10.1124/mol.109.060780; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Grant S, 1998, ADV CANCER RES, V72, P197; Gidding CEM, 1999, CRIT REV ONCOL HEMAT, V29, P267, DOI 10.1016/S1040-8428(98)00023-7; Okamoto R, 2010, HAEMATOL-HEMATOL J, V95, P1481, DOI 10.3324/haematol.2009.011114; Hunger SP, 2012, J CLIN ONCOL, V30, P1663, DOI 10.1200/JCO.2011.37.8018; Martin SA, 2009, EMBO MOL MED, V1, P323, DOI 10.1002/emmm.200900040; Inaba H, 2013, LANCET, V381, P1943, DOI 10.1016/S0140-6736(12)62187-4; Tzoneva G, 2013, NAT MED, V19, P368, DOI 10.1038/nm.3078; Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Liem NLM, 2004, BLOOD, V103, P3905, DOI 10.1182/blood-2003-08-2911; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; BOUFFARD DY, 1993, BIOCHEM PHARMACOL, V45, P1857, DOI 10.1016/0006-2952(93)90444-2; Lock RB, 2002, BLOOD, V99, P4100, DOI 10.1182/blood.V99.11.4100; Bachmann PS, 2007, CURR DRUG TARGETS, V8, P773, DOI 10.2174/138945007780830809; Fernandez-Calotti Paula, 2005, Leuk Lymphoma, V46, P335, DOI 10.1080/10428190400015683; Jansson J, 2011, LEUKEMIA RES, V35, P800, DOI 10.1016/j.leukres.2010.10.018; Jiang W, 2008, TOXICOLOGY, V252, P113, DOI 10.1016/j.tox.2008.07.057; Kanno SI, 2007, CLIN CHIM ACTA, V377, P144, DOI 10.1016/j.cca.2006.09.014; Leclerc GJ, 2007, LEUKEMIA RES, V31, P293, DOI 10.1016/j.leukres.2006.06.016; Lee EM, 2007, LEUKEMIA LYMPHOMA, V48, P659, DOI 10.1080/10428190601113584; Leil TA, 2007, CANCER RES, V67, P8772, DOI 10.1158/0008-5472.CAN-07-0156; MCGUIRE JJ, 1980, J BIOL CHEM, V255, P5776; POSER RG, 1981, CANCER RES, V41, P4441; Sarkar M, 2005, BIOCHEM PHARMACOL, V70, P426, DOI 10.1016/j.bcp.2005.05.014; Song JH, 2009, INT J ONCOL, V34, P1165, DOI 10.3892/ijo_00000245; Synold TW, 1996, LEUKEMIA LYMPHOMA, V21, P9, DOI 10.3109/10428199609067573; Szymanska B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033894; Zhao RB, 2000, J BIOL CHEM, V275, P26599, DOI 10.1074/jbc.M002580200; Zunino SJ, 2010, CANCER LETT, V296, P49, DOI 10.1016/j.canlet.2010.03.017	48	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	JAN	2015	43	1					32	43		10.1016/j.exphem.2014.09.007		12	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	AX4GS	WOS:000346892200004		
J	Kubo, K; Nemoto, K; Kobayashi, H; Kuriyama, Y; Harada, H; Matsunami, H; Eguchi, T; Kihou, N; Ota, T; Keitoku, S; Kimura, T; Shinano, T				Kubo, Katashi; Nemoto, Kazutoshi; Kobayashi, Hiroyuki; Kuriyama, Yasushi; Harada, Hirohide; Matsunami, Hisaya; Eguchi, Tetsuya; Kihou, Nobuharu; Ota, Takeshi; Keitoku, Shoji; Kimura, Takeshi; Shinano, Takuro			Analyses and countermeasures for decreasing radioactive cesium in buckwheat in areas affected by the nuclear accident in 2011	FIELD CROPS RESEARCH			English	Article						Buckwheat; Fagopyrum esculentum Moench; Great East Japan Earthquake; Nuclear power plant accident; Potassium application; Radioactive cesium	PADDY-FIELD; FUKUSHIMA PREFECTURE; RADIOCESIUM; SOILS; ZEOLITE; ACCUMULATION; MECHANISMS; RETENTION; PLANTS; CS-137	Tokyo Electric Power Company's Fukushima Dai-ichi nuclear power plant released radioactive cesium (Cs) into the environment after the Great East Japan Earthquake of March 11, 2011. After radioactive Cs fell onto agricultural fields, radioactive nuclide levels in some buckwheat (Fagopyrum esculentum Wench) grain subsequently exceeded new standard limits for radioactive materials, including that for radioactive Cs (100 Bq kg(-1)) established by the Japanese government in 2012. A survey of soils and buckwheat grain from 68 farmers' fields in 2012 revealed that soil exchangeable potassium (K) concentration was significantly and negatively correlated with radioactive Cs concentration in the grain. The effect of K application on the reduction of radioactive Cs concentration in the grain was confirmed by pot and field experiments conducted respectively in 2012 and 2013. This effect might result from the similarity of ion forms of K and Cs and/or the lower exchangeable Cs concentrations at higher exchangeable K concentrations in soil. Based on these results, farmers were recommended to establish a soil exchangeable K concentration of 250 mg kg(-1) (300 mg kg(-1) in K2O) before applying basal fertilizer. After this recommendation, the soil K concentrations of farmers' fields increased, causing an overall decrease in radioactive Cs concentrations of buckwheat grain produced in 2013. Consequently, no grain sample from this year exceeded the standard limits for radioactive Cs level across the affected area in Japan. These efforts contributed greatly to the rehabilitation and reconstruction of agriculture in the area contaminated with radioactive Cs. (C) 2014 Elsevier B.V. All rights reserved.	[Kubo, Katashi; Kobayashi, Hiroyuki; Matsunami, Hisaya; Eguchi, Tetsuya; Ota, Takeshi; Shinano, Takuro] Natl Agr & Food Res Org, Tohoku Agr Res Ctr, Agr Radiat Res Ctr, Arai, Fukushima 9602156, Japan; [Nemoto, Kazutoshi; Keitoku, Shoji] Fukushima Agr Technol Ctr, Dept Field Crops & Hort, Koriyama, Fukushima 9630531, Japan; [Kuriyama, Yasushi; Harada, Hirohide] Minist Agr Forestry & Fisheries MAFF Japan, Chiyoda Ku, Tokyo 1008950, Japan; [Kihou, Nobuharu] Natl Inst Agroenvironm Sci, Soil Environm Div, Tsukuba, Ibaraki 3058604, Japan; [Kimura, Takeshi] NARO Headquarters, Tsukuba, Ibaraki 3058517, Japan	Kobayashi, H (reprint author), NARO, Agr Res Ctr, 3-1-1 Kannondai, Tsukuba, Ibaraki 3058666, Japan.	kobah@affrc.go.jp			MAFF of Japan	We are grateful to Dr. Nobuhisa Koga, Ms. Megumi Kaji, Mr. Yasuhiro Ichihashi, and Mr. Sumito Yasuoka of MAFF for their kind advice through the experiments. We also thank Dr. Ichiro Taniyama of the National Institute for Agro-Environmental Sciences, Mr. Nobuyuki Hoshi of the Miyagi Prefectural Furukawa Agricultural Experiment Station, and Mr. Terunobu Kumekawa of the Tochigi Prefectural Agricultural Experiment Station for their helpful advice and collaboration in conducting the experiments. Dr. Toshifumi Murakami, Mr. Masakatsu Ito, Mr. Takao Sakurai, Mr. Masanori Yoshida, Mr. Junji Tanji, Mr. Rikio Shishido, Mr. Noriyuki Izawa, and Mr. Tadashi Kan of the Agricultural Radiation Research Center, NARO Tohoku Agricultural Research Center provided field management support. Ms. Yuki Sato, Ms. Tomoko Saito, Ms. Yukari Watanabe, and Ms. Yurie Yoshida of the Agricultural Radiation Research Center, NARO Tohoku Agricultural Research Center, supported sample preparation for the analyses. This study was conducted as part of the "Emergency Research for the Establishment of Measures to Reduce Transition of Radioactive Substances to Agricultural Products According to Field Environment, and Development of Decontamination Technologies for Radioactive Substances in Agricultural Land" project funded by MAFF of Japan.	White PJ, 2000, NEW PHYTOL, V147, P241, DOI 10.1046/j.1469-8137.2000.00704.x; Zhu YG, 2000, J EXP BOT, V51, P1635, DOI 10.1093/jexbot/51.351.1635; Ohmori Y, 2014, J PLANT RES, V127, P57, DOI 10.1007/s10265-013-0616-9; Delvaux B, 2000, ENVIRON SCI TECHNOL, V34, P1489, DOI 10.1021/es990658g; Clemens S, 2013, TRENDS PLANT SCI, V18, P92, DOI 10.1016/j.tplants.2012.08.003; Bosch P, 2004, J NUCL MATER, V324, P183, DOI 10.1016/j.jnucmat.2003.10.001; CREMERS A, 1988, NATURE, V335, P247, DOI 10.1038/335247a0; Dakora FD, 2002, PLANT SOIL, V245, P35, DOI 10.1023/A:1020809400075; Endo S, 2013, J ENVIRON RADIOACTIV, V116, P59, DOI 10.1016/j.jenvrad.2012.08.018; Atun G, 2002, J RADIOANAL NUCL CH, V253, P275, DOI 10.1023/A:1019658011221; Boettinger J.L., 2002, SOIL MINERALOGY ENV, V7, P585; Fujimura S, 2013, PLANT PROD SCI, V16, P166; Fujimura S., 2012, P INT S ENV MON DOS; Kubo K, 2011, PLANT PROD SCI, V14, P148, DOI 10.1626/pps.14.148; Kubo K., 2013, 12 INT WHEAT GEN S, P98; MAFF, 2013, STAT YB MIN AGR FOR; MHLW, 2012, RAD MAT FOODS CURR S; MHLW, 2012, RES RAD FOODS SAMPL; Ohmori Y, 2014, J PLANT RES, V127, P67, DOI 10.1007/s10265-013-0618-7; Saito T., 2012, P INT S ENV MON DOS; Sawhney BL, 1964, P SOIL SCI SOC AM, V28, P183, DOI 10.2136/sssaj1964.03615995002800020017x; Smolders E, 1996, PLANT SOIL, V181, P205, DOI 10.1007/BF00012054; Sparks D.L., 1996, METHODS SOIL ANAL CH; Valke E., 1997, ZEOLITES, V18, P225; Waegeneers N, 1999, J ENVIRON QUAL, V28, P1005; Xiong ZQ, 2010, PEDOSPHERE, V20, P209, DOI 10.1016/S1002-0160(10)60008-2; Yamaguchi Noriko, 2012, Bulletin of the National Institute of Agro-Environmental Sciences, V31, P75; Yudintseva E.V., 1980, AGROKHIMIYA, V6, P93	28	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-4290	1872-6852		FIELD CROP RES	Field Crop. Res.	JAN	2015	170						40	46		10.1016/j.fcr.2014.10.001		7	Agronomy	Agriculture	AX8AE	WOS:000347132000005		
J	Kashiwagi, J; Krishnamurthy, L; Purushothaman, R; Upadhyaya, HD; Gaur, PM; Gowda, CLL; Ito, O; Varshney, RK				Kashiwagi, J.; Krishnamurthy, L.; Purushothaman, R.; Upadhyaya, H. D.; Gaur, P. M.; Gowda, C. L. L.; Ito, O.; Varshney, R. K.			Scope for improvement of yield under drought through the root traits in chickpea (Cicer arietinum L.)	FIELD CROPS RESEARCH			English	Review						Chickpea (Cicer arietinum L.); Deep root systems; Drought avoidance; South Asia; Terminal drought	CARBON-ISOTOPE DISCRIMINATION; WATER-USE; GROWTH ANGLE; GRAIN-YIELD; VERTICAL-DISTRIBUTION; STOMATAL CONDUCTANCE; GENOTYPIC VARIATION; LEAF TEMPERATURE; WHEAT CULTIVARS; HARVEST INDEX	Chickpea (Cicer arietinum L.) is a major grain legume crop in South Asia, and terminal drought severely constrains its productivity. In this review, we describe how root systems can improve the productivity of chickpea under the terminal drought that occurs in a receding stored soil water conditions in central and south India and propose possible breeding and screening methods. In chickpea, total root biomass in early growth stages has been shown to significantly contribute to seed yield under terminal drought in central and south India. Maximising acquisition of water stored in 15-30 cm soil layer by roots had greater implications as the timing of absorption, available soil water and root size matches well for the complete use of water from this zone. However, deeper root systems and a greater exploitation of subsoil water offers potential for further productivity improvements under terminal drought. As proof of this concept, contrasting chickpea accessions for important root traits, such as root biomass and rooting depth, have been screened in a chickpea germplasm collection which comprises rich diversity for root traits. Through analysing mapping populations derived from crosses between these accessions, a 'QTL hotspot' that explained a large part of the phenotypic variation for the major drought tolerance traits including root traits was identified and introgressed into a leading Indian chickpea cultivar. Yield advantages of the introgression lines were demonstrated in multi-location evaluations under terminal drought. As an alternative screening method, that would indirectly asses the root system strength, to identify further promising chickpea genotypes with multiple drought tolerance traits, the leaf canopy temperature and carbon isotope discrimination measurements can be proposed. (C) 2014 Elsevier B.V. All rights reserved.	[Kashiwagi, J.] Hokkaido Univ, Crop Sci Lab, Grad Sch Agr, Kita Ku, Sapporo, Hokkaido 0608589, Japan; [Krishnamurthy, L.; Purushothaman, R.; Upadhyaya, H. D.; Gaur, P. M.; Gowda, C. L. L.; Varshney, R. K.] Int Crops Res Inst Semi Arid Trop, Patancheru 502324, Andhra Pradesh, India; [Ito, O.] United Nations Univ, Shibuya Ku, Tokyo 1508925, Japan	Kashiwagi, J (reprint author), Hokkaido Univ, Crop Sci Lab, Grad Sch Agr, Kita Ku, Kita 9,Nishi 9, Sapporo, Hokkaido 0608589, Japan.	jkashi@res.agr.hokudai.ac.jp	Updhayaya, Hari/C-4858-2014; Varshney, Rajeev/C-5295-2014; Junichi, Kashiwagi/H-9326-2013	Updhayaya, Hari/0000-0002-5166-6844; Varshney, Rajeev/0000-0002-4562-9131; 			Aguirrezabal LAN, 1996, J EXP BOT, V47, P411, DOI 10.1093/jxb/47.3.411; Upadhyaya HD, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-106; PASSIOURA JB, 1977, J AUST I AGR SCI, V43, P117; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121; SUBBARAO GV, 1995, CRIT REV PLANT SCI, V14, P469, DOI 10.1080/713608125; Li YY, 2009, ENVIRON EXP BOT, V66, P341, DOI 10.1016/j.envexpbot.2009.02.001; Benjamin JG, 2006, FIELD CROP RES, V97, P248, DOI 10.1016/j.fcr.2005.10.005; Kashiwagi J, 2013, FIELD CROP RES, V145, P88, DOI 10.1016/j.fcr.2013.02.011; Turner NC, 2001, ADV AGRON, V71, P193, DOI 10.1016/S0065-2113(01)71015-2; Berger JD, 2011, EUPHYTICA, V180, P1, DOI 10.1007/s10681-011-0391-4; Price AH, 2002, J EXP BOT, V53, P989, DOI 10.1093/jexbot/53.371.989; Uga Y, 2013, NAT GENET, V45, P1097, DOI 10.1038/ng.2725; Berger JD, 2004, AUST J AGR RES, V55, P1071, DOI 10.1071/AR04104; Ali MY, 2005, J AGRON CROP SCI, V191, P464; Lynch JP, 2007, AUST J BOT, V55, P493, DOI 10.1071/BT06118; Kato Y, 2006, PLANT SOIL, V287, P117, DOI 10.1007/s11104-006-9008-4; Tuberosa R, 2002, PLANT MOL BIOL, V48, P697, DOI 10.1023/A:1014897607670; Takai T, 2010, FIELD CROP RES, V115, P165, DOI 10.1016/j.fcr.2009.10.019; Varshney RK, 2014, THEOR APPL GENET, V127, P445, DOI 10.1007/s00122-013-2230-6; Condon AG, 2002, CROP SCI, V42, P122; Francois C, 2002, REMOTE SENS ENVIRON, V80, P122, DOI 10.1016/S0034-4257(01)00293-0; Rebetzke GJ, 2002, CROP SCI, V42, P739; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.arplant.40.1.503; Zaman-Allah M, 2011, FUNCT PLANT BIOL, V38, P270, DOI 10.1071/FP10244; Kashiwagi J, 2006, FIELD CROP RES, V95, P171, DOI 10.1016/j.fcr.2005.02.012; Krishnamurthy L, 2013, FUNCT PLANT BIOL, V40, P1350, DOI 10.1071/FP13088; Kumar J, 2001, CROP SCI, V41, P605; Liang QA, 2010, ANN BOT-LONDON, V106, P223, DOI 10.1093/aob/mcq097; Purushothaman R, 2014, FIELD CROP RES, V163, P24, DOI 10.1016/j.fcr.2014.04.006; Horie T, 2006, PLANT CELL ENVIRON, V29, P653, DOI 10.1111/j.1365-3040.2005.01445.x; Wasson AP, 2012, J EXP BOT, V63, P3485, DOI 10.1093/jxb/ers111; Kamoshita A, 2002, CROP SCI, V42, P255; Inagaki MN, 2009, CEREAL RES COMMUN, V37, P513, DOI 10.1556/CRC.37.2009.4.4; SAXENA NP, 1993, CROP SCI, V33, P1424; Upadhyaya HD, 2001, THEOR APPL GENET, V102, P1292, DOI 10.1007/s00122-001-0556-y; Steele KA, 2006, THEOR APPL GENET, V112, P208, DOI 10.1007/s00122-005-0110-4; Ali MY, 2002, PLANT SOIL, V245, P123, DOI 10.1023/A:1021115809702; GATES DM, 1968, ANN REV PLANT PHYSIO, V19, P211, DOI 10.1146/annurev.pp.19.060168.001235; Kashiwagi J, 2005, EUPHYTICA, V146, P213, DOI 10.1007/s10681-005-9007-1; Jones HG, 1999, PLANT CELL ENVIRON, V22, P1043, DOI 10.1046/j.1365-3040.1999.00468.x; Varshney RK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-523; Tardieu F, 2012, J EXP BOT, V63, P25, DOI 10.1093/jxb/err269; Berger JD, 2007, CHICKPEA BREEDING AND MANAGEMENT, P47, DOI 10.1079/9781845932138.003; Bidinger F. R., 1982, Drought resistance in crops with emphasis on rice, P357; Blum, 2009, FIELD CROPS RES, V112, P119; BLUM A, 1983, PLANT CELL ENVIRON, V6, P219, DOI 10.1111/1365-3040.ep11587630; Chloupek O, 2006, THEOR APPL GENET, V112, P779, DOI 10.1007/s00122-005-0147-4; Foulkes MJ, 2001, J AGR SCI, V137, P1; Gaur P.M., 2006, INT CHICKPEA PIGEONP, V13, P5; Gregory P.J., 1988, WORLD CROPS COOL SEA, P857; GREGORY PJ, 1994, RESOURCE CAPTURE BY CROPS, P77; Huang BR, 2000, BOOK SOIL P, P39; Hussain Ashok Aftab, 1999, AUSTR J PLANT PHYSL, V26, P503; Ingram K. T., 1995, Rainfed lowland rice: agricultural research for high-risk environments., P55; Jodha N.S., 1987, CHICKPEA, P1; Kashiwagi J., 2008, Journal of SAT Agricultural Research, V6, P1; Keig B., 1974, 744 CSRIO DIV LAND U, P45; KRAUSS U, 1994, PLANT SOIL, V166, P259, DOI 10.1007/BF00008339; Krishnamurthy L., 1996, ROOT NITROGEN CROPPI, P234; Levitt J., 1980, WATER RAD SALT OTHER, V2, P93; LUDLOW MM, 1990, ADV AGRON, V43, P107, DOI 10.1016/S0065-2113(08)60477-0; LUNGLEY DR, 1973, PLANT SOIL, V38, P145, DOI 10.1007/BF00011223; MAMBANI B, 1983, PLANT SOIL, V73, P59, DOI 10.1007/BF02197757; OYANAGI A, 1994, PLANT SOIL, V165, P323, DOI 10.1007/BF00008076; OYANAGI A, 1993, JPN J CROP SCI, V62, P565; PASSIOURA JB, 1983, AGR WATER MANAGE, V7, P265, DOI 10.1016/0378-3774(83)90089-6; Purushothaman R, 2013, PLANT PROD SCI, V16, P1, DOI 10.1626/pps.16.1; Saxena N.P., 1990, P 5 AUSTR AGR C 24 2, P657; Saxena N.P., 1984, PHYSL TROPICAL FIELD, P419; Singh K.B., 1995, J AGRON CROP SCI, V36, P472; Summerfield R.J., 1990, CHICKPEA 90S, P61; VANDERWERF A, 1988, PHYSIOL PLANTARUM, V72, P483; Varshney RK, 2013, PLANT GEN, V6, P1, DOI [DOI 10.3835/PLANTGENOME2013.07.0022, 10.3835/plantgenome2013.07.0022, DOI 10.3835/PLANTGEN0ME2013.07.0022]; York LM, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00355	74	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-4290	1872-6852		FIELD CROP RES	Field Crop. Res.	JAN	2015	170						47	54		10.1016/j.fcr.2014.10.003		8	Agronomy	Agriculture	AX8AE	WOS:000347132000006		
J	Zhang, TS; Yamashita, Y; Yasuda, M; Yamamoto, N; Ashida, H				Zhang, Tianshun; Yamashita, Yoko; Yasuda, Michiko; Yamamoto, Norio; Ashida, Hitoshi			Ashitaba (Angelica keiskei) extract prevents adiposity in high-fat diet-fed C57BL/6 mice	FOOD & FUNCTION			English	Article							ACTIVATED PROTEIN-KINASE; METABOLIC SYNDROME; LIVER-DISEASE; VISCERAL FAT; OBESITY; CHALCONES; TISSUE; ALPHA; 4-HYDROXYDERRICIN; XANTHOANGELOL	Two main chalcones, 4-hydroxyderricin and xanthoangelol, from Ashitaba, which is a food ingredient and a folk medicine in Asia, have been demonstrated to modulate lipid metabolism in 3T3-L1 and HepG2 cells. In this study, we investigated the effects of Ashitaba extract on adiposity in mice fed a high-fat (HF) diet and its underlying mechanisms based on adipose tissue and hepatic lipid metabolism. C57BL/6 mice were fed a normal or HF diet supplemented with Ashitaba extract (0.01% and 0.1%, w/w) for 16 weeks. Ashitaba extract suppressed the HF diet-induced body weight gain and fat deposition in white adipose tissue, reduced plasma cholesterol, glucose, and insulin levels, increased the adiponectin level, lowered triglyceride and the liver cholesterol content, increased phosphorylation of AMP-activated protein kinase (AMPK) in adipose tissue and liver, inhibited lipogenesis in adipose tissue by down-expression of peroxisome proliferator-activated receptor (PPAR) gamma, CCAAT/enhancer-binding protein alpha and sterol regulatory element-binding protein 1 (SREBP1), inhibited lipogenesis in the liver by down-expression of SREBP1 and its target enzyme fatty acid synthase, and promoted fatty acid oxidation by up-expression of carnitine palmitoyltransferase-1A and PPAR alpha. In conclusion, Ashitaba extract can possibly prevent adiposity through modulating lipid metabolism through phosphorylation of AMPK in adipose tissue and liver.	[Zhang, Tianshun; Yamashita, Yoko; Ashida, Hitoshi] Kobe Univ, Grad Sch Agr Sci, Dept Agrobiosci, Kobe, Hyogo 6578501, Japan; [Yasuda, Michiko] Kobe Univ, Org Adv Sci & Technol, Kobe, Hyogo 6578501, Japan; [Yamamoto, Norio] House Wellness Foods Corp, Food Sci Res Ctr, Itami, Hyogo 6640011, Japan	Zhang, TS (reprint author), Kobe Univ, Grad Sch Agr Sci, Dept Agrobiosci, Kobe, Hyogo 6578501, Japan.	ashida@kobe-u.ac.jp			Special Coordination Funds for Promoting Science and Technology, Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovative Bioproduction Kobe), MEXT, Japan	Part of this study was supported by Special Coordination Funds for Promoting Science and Technology, Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovative Bioproduction Kobe), MEXT, Japan. The authors thank Japan Bio Science Laboratory Co., Ltd for providing the Ashitaba Chalcone Powder. The authors thank Ms Yuki Kimura for her assistance during animal treatment.	Akihisa T, 2003, CANCER LETT, V201, P133, DOI 10.1016/S0304-3835(03)00466-X; Enoki T, 2007, J AGR FOOD CHEM, V55, P6013, DOI 10.1021/jf070720q; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505; Tilg H, 2008, MOL MED, V14, P222, DOI 10.2119/2007-00119.Tilg; Wanders RJA, 2001, BIOCHEM SOC T, V29, P250, DOI 10.1042/0300-5127:0290250; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Goldstein JL, 2008, J CLIN INVEST, V118, P1220, DOI 10.1172/JCI34973; Ohkura N, 2011, BIOFACTORS, V37, P455, DOI 10.1002/biof.187; Lois K, 2008, INT J CLIN PRACT, V62, P932, DOI 10.1111/j.1742-1241.2008.01773.x; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Trout KK, 2007, BIOL RES NURS, V8, P305, DOI 10.1177/1099800406298775; Akihisa T, 2006, J NAT PROD, V69, P38, DOI 10.1021/np058080d; Kim SJ, 2008, BIOL PHARM BULL, V31, P1415, DOI 10.1248/bpb.31.1415; Ejaz A, 2009, J NUTR, V139, P919, DOI 10.3945/jn.108.100966; Despres JP, 2008, ARTERIOSCL THROM VAS, V28, P1039, DOI 10.1161/ATVBAHA.107.159228; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Gastaldelli A, 2002, J CLIN ENDOCR METAB, V87, P5098, DOI 10.1210/jc.2002-020696; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Korenblat KM, 2008, GASTROENTEROLOGY, V134, P1369, DOI [10.1053/j.gastro.2008.01.075, 10.1053/j.gastro.:2008.01.075]; FREYTAG SO, 1994, GENE DEV, V8, P1654, DOI 10.1101/gad.8.14.1654; Nishikawa S, 2007, EXP ANIM TOKYO, V56, P263, DOI 10.1538/expanim.56.263; Fabbrini E, 2009, P NATL ACAD SCI USA, V106, P15430, DOI 10.1073/pnas.0904944106; Braissant O, 1998, ENDOCRINOLOGY, V139, P2748, DOI 10.1210/en.139.6.2748; Kimura Y, 2004, PLANTA MED, V70, P211, DOI 10.1055/s-2004-815537; Pang J, 2008, ARCH BIOCHEM BIOPHYS, V476, P178, DOI 10.1016/j.abb.2008.02.019; Sanyal AJ, 2005, NAT CLIN PRACT GASTR, V2, P46, DOI 10.1038/ncpgasthep0084; Ricquier D, 2000, BIOCHEM J, V345, P161, DOI 10.1042/0264-6021:3450161; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; O'Neill HM, 2013, MOL CELL ENDOCRINOL, V366, P135, DOI 10.1016/j.mce.2012.06.019; Ruderman NB, 2003, ACTA PHYSIOL SCAND, V178, P435, DOI 10.1046/j.1365-201X.2003.01164.x; Zhang TS, 2013, MOL NUTR FOOD RES, V57, P1729, DOI 10.1002/mnfr.201300020; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Friedman JM, 2000, NATURE, V404, P632; Bonnefont Jean-Paul, 2004, Molecular Aspects of Medicine, V25, P495, DOI 10.1016/j.mam.2004.06.004; Boss O, 1998, EUR J ENDOCRINOL, V139, P1, DOI 10.1530/eje.0.1390001; Hwang JH, 2007, AM J PHYSIOL-ENDOC M, V293, P1663; Kawabata K, 2011, MOL NUTR FOOD RES, V55, P467, DOI 10.1002/mnfr.201000267; KOZAWA M, 1977, CHEM PHARM BULL, V25, P515; Lee W.J., 2006, BIOCHEM BIOPH RES CO, V340, P281; MIYAZAWA S, 1987, J BIOL CHEM, V262, P8131; Nakamura T, 2012, ARCH BIOCHEM BIOPHYS, V521, P71, DOI 10.1016/j.abb.2012.03.013; Nishiumi S, 2008, ARCH BIOCHEM BIOPHYS, V470, P187, DOI 10.1016/j.abb.2007.11.021; Nugara RN, 2014, NUTRITION, V30, P1177, DOI 10.1016/j.nut.2014.01.015; Takahashi M, 1999, J NUTR SCI VITAMINOL, V45, P583; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Ye J. M., 2003, AM J PHYSIOL-ENDOC M, V284, P531; You T., 2005, AM J PHYSIOL-ENDOC M, V288, P741; Zhang TS, 2014, FOOD FUNCT, V5, P1134, DOI 10.1039/c3fo60694e	52	1	1	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2042-6496	2042-650X		FOOD FUNCT	Food Funct.		2015	6	1					135	145		10.1039/c4fo00525b		11	Biochemistry & Molecular Biology; Food Science & Technology	Biochemistry & Molecular Biology; Food Science & Technology	AX9QB	WOS:000347235900012		
J	Morina, F; Takahama, U; Yamauchi, R; Hirota, S; Veljovic-Jovanovic, S				Morina, Filis; Takahama, Umeo; Yamauchi, Ryo; Hirota, Sachiko; Veljovic-Jovanovic, Sonja			Quercetin 7-O-glucoside suppresses nitrite-induced formation of dinitrosocatechins and their quinones in catechin/nitrite systems under stomach simulating conditions	FOOD & FUNCTION			English	Article							N-NITROSO COMPOUNDS; MUCOSAL BLOOD-FLOW; ELECTROCHEMICAL OXIDATION; GREEN TEA; DIETARY NITRATE; HUMAN SALIVA; THIOCYANATE CONJUGATE; DEPENDENT REDUCTION; ACIDIC CONDITIONS; ASCORBIC-ACID	Foods of plant origin contain flavonoids. In the adzuki bean, (+)-catechin, quercetin 3-O-rutinoside (rutin), and quercetin 7-O-beta-D-glucopyranoside (Q7G) are the major flavonoids. During mastication of foods prepared from the adzuki bean, the flavonoids are mixed with saliva and swallowed into the stomach. Here we investigated the interactions between Q7G and (+)-catechin at pH 2, which may proceed in the stomach after the ingestion of foods prepared from the adzuki bean. Q7G reacted with nitrous acid producing nitric oxide ((NO)-N-center dot) and a glucoside of 2-(3,4-dihydroxybenzoyl)-2,4,6-trihydroxy-3(2H)-benzofuranone. (+)-Catechin reacted with nitrous acid producing (NO)-N-center dot and 6,8-dinitrosocatechin. The production of the dinitrosocatechin was partly suppressed by Q7G, and the suppression resulted in the enhancement of Q7G oxidation. 6,8-Dinitrosocatechin reacted further with nitrous acid generating the o-quinone, and the quinone formation was effectively suppressed by Q7G. In the flavonoids investigated, the suppressive effect decreased in the order Q7G approximate to quercetin > kaempferol > quercetin 4'-O-glucoside > rutin. Essentially the same results were obtained when (-)-epicatechin was used instead of (+)-catechin. The results indicate that nitrous acid-induced formation of 6,8-dinitrosocatechins and the o-quinones can be suppressed by flavonols in the stomach, and that both a hydroxyl group at C3 and ortho-hydroxyl groups in the B-ring are required for efficient suppression.	[Morina, Filis; Veljovic-Jovanovic, Sonja] Univ Belgrade, Inst Multidisciplinary Res, Belgrade 11030, Serbia; [Takahama, Umeo] Kyushu Dent Univ, Dept Biosci, Kitakyushu, Fukuoka 8038580, Japan; [Yamauchi, Ryo] Gifu Univ, Fac Appl Biol Sci, Dept Appl Life Sci, Gifu 5011193, Japan; [Hirota, Sachiko] Univ E Asia, Fac Appl Hlth Sci, Shimonoseki, Yamaguchi 7518503, Japan	Morina, F (reprint author), Univ Belgrade, Inst Multidisciplinary Res, Belgrade 11030, Serbia.	takahama@kyu-dent.ac.jp			Ministry of Education and Science in Japan [22500790, 23500986]; Ministry of Education, Science and Technological Development of Republic Serbia [III43010]	Part of this study was supported by Grants-in-Aid for Scientific Research (22500790 and 23500986) from the Ministry of Education and Science in Japan. S. Veljovic-Jovanovic and F. Morina acknowledge the partial support from Ministry of Education, Science and Technological Development of Republic Serbia (III43010).	Jorgensen LV, 1998, FREE RADICAL RES, V29, P339, DOI 10.1080/10715769800300381; Schonthal AH, 2011, MOL NUTR FOOD RES, V55, P874, DOI 10.1002/mnfr.201000644; Timbola AK, 2006, J BRAZIL CHEM SOC, V17, P139, DOI 10.1590/S0103-50532006000100020; Lu YR, 1997, FOOD CHEM, V59, P187, DOI 10.1016/S0308-8146(96)00287-7; Ly TN, 2005, J AGR FOOD CHEM, V53, P8183, DOI 10.1021/jf051264d; Rocha BS, 2014, FOOD FUNCT, V5, P1646, DOI [10.1039/c4fo00124a, 10.1039/C4FO00124A]; Lee SYH, 2006, FREE RADICAL BIO MED, V40, P323, DOI 10.1016/j.freeadbiomed.2005.08.031; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, P156, DOI 10.1038/nrd2466; Takahama U, 2014, FREE RADICAL RES, V48, P956, DOI 10.3109/10715762.2014.929121; Brett AMO, 2003, ELECTROANAL, V15, P1745, DOI 10.1002/elan.200302800; Miyoshi M, 2003, FREE RADICAL RES, V37, P85, DOI 10.1080/1071576021000086632; Danila AM, 2007, J AGR FOOD CHEM, V55, P1139, DOI 10.1021/jf062815i; Gago B, 2007, FREE RADICAL BIO MED, V43, P1233, DOI 10.1016/j.freeradbiomed.2007.06.007; Hirota S, 2014, FOOD SCI TECHNOL RES, V20, P439, DOI 10.3136/fstr.20.439; Schultz CP, 1996, ANAL BIOCHEM, V240, P7, DOI 10.1006/abio.1996.0323; Siraki AG, 2004, TOXICOL SCI, V81, P148, DOI 10.1093/toxsci/kfh182; Olschlager C, 2008, PHYTOCHEMISTRY, V69, P1389, DOI 10.1016/j.phytochem.2008.01.001; Bjorne H, 2004, J CLIN INVEST, V113, P106, DOI 10.1172/JCI200419019; Ohsawa K, 2003, MUTAT RES-GEN TOX EN, V539, P65, DOI 10.1016/S1383-5718(03)00156-6; Manach C, 2004, AM J CLIN NUTR, V79, P727; Zenkevich IG, 2007, MOLECULES, V12, P654, DOI 10.3390/12030654; Peri L, 2005, FREE RADICAL BIO MED, V39, P668, DOI 10.1016/j.freeradbiomed.2005.04.021; Panzella L, 2005, CHEM RES TOXICOL, V18, P722, DOI 10.1021/tx0496486; Doel JJ, 2005, EUR J ORAL SCI, V113, P14, DOI 10.1111/j.1600-0722.2004.00184.x; Rocha BS, 2011, CURR DRUG TARGETS, V12, P1351; Frank J, 2009, J NUTR, V139, P58, DOI 10.3945/jn.108.096412; Bondonno CP, 2014, FOOD FUNCT, V5, P849, DOI 10.1039/c3fo60590f; Egert S, 2011, ADV NUTR, V2, P8, DOI [10.3945/an.110.000026., 10.3945/an.110.000026]; Pannala AS, 2003, FREE RADICAL BIO MED, V34, P576, DOI 10.1016/S0891-5849(02)01353-9; Takahama U, 2010, FREE RADICAL RES, V44, P293, DOI 10.3109/10715760903486057; Takahama U, 2007, J AGR FOOD CHEM, V55, P4169, DOI 10.1021/jf0634606; Lambert JD, 2007, MOL PHARM, V4, P819, DOI 10.1021/mp700075m; Bolton JL, 2000, CHEM RES TOXICOL, V13, P135, DOI 10.1021/tx9902082; BENJAMIN N, 1994, NATURE, V368, P502, DOI 10.1038/368502a0; Eichholzer M, 1998, NUTR REV, V56, P95; Janeiro P, 2004, ANAL CHIM ACTA, V518, P109, DOI 10.1016/j.aca.2004.05.038; Bhagwat S., 2013, USDA DATA BASE FLAVO; Bondzic AM, 2013, NEW J CHEM, V37, P901, DOI 10.1039/c2nj40742f; Cavalieri EL, 2002, CARCINOGENESIS, V23, P1071, DOI 10.1093/carcin/23.6.1071; De Lucia M, 2008, CHEM RES TOXICOL, V21, P2407, DOI 10.1021/tx800283d; Fahlman B. M., 2009, J PHOTOCH PHOTOBIO B, V97, P7123; Hirota S, 1998, J AGR FOOD CHEM, V46, P3497, DOI 10.1021/jf980294w; Hirota S, 2005, J AGR FOOD CHEM, V53, P3265, DOI 10.1021/jf0404389; Jurd L., 1962, CHEM FLAVONOID COMPO, P107; Masuda S, 2006, J HEALTH SCI, V52, P211, DOI 10.1248/jhs.52.211; Veljovic-Jovanovic S, 2014, J AGR FOOD CHEM, V62, P4951, DOI 10.1021/jf500860s; OBRIEN PJ, 1991, CHEM-BIOL INTERACT, V80, P1, DOI 10.1016/0009-2797(91)90029-7; Ohashi H, 1999, J WOOD SCI, V45, P53, DOI 10.1007/BF00579524; Petersson J, 2007, AM J PHYSIOL-GASTR L, V292, pG718, DOI 10.1152/ajpgi.00435.2006; Rocha BS, 2009, TOXICOLOGY, V265, P41, DOI 10.1016/j.tox.2009.09.008; SOBALA GM, 1989, GASTROENTEROLOGY, V97, P357; Takahama U, 2012, CHEM RES TOXICOL, V25, P207, DOI 10.1021/tx200438q; Takahama U, 2002, J AGR FOOD CHEM, V50, P4317, DOI 10.1021/jf011697q; Takahama U, 2013, FOOD CHEM, V141, P2600, DOI 10.1016/j.foodchem.2013.04.065; Tanaka K, 1998, MUTAT RES-GEN TOX EN, V412, P91, DOI 10.1016/S1383-5718(97)00178-2; TEBAYASHI SI, 1995, J PESTIC SCI, V20, P299; Terao J., 1998, FLAVONOIDS HLTH DIS, P277; Volk J, 2009, FREE RADICAL BIO MED, V47, P496, DOI 10.1016/j.freeradbiomed.2009.04.012; Xiao JS, 2008, J AGR FOOD CHEM, V56, P2096, DOI 10.1021/jf072679x; Xu J, 2001, J APPL MICROBIOL, V90, P523, DOI 10.1046/j.1365-2672.2001.01278.x; Yoshida K., 2005, ITE LETT BATTER NEW, V6, pC1	61	2	2	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2042-6496	2042-650X		FOOD FUNCT	Food Funct.		2015	6	1					219	229		10.1039/c4fo00695j		11	Biochemistry & Molecular Biology; Food Science & Technology	Biochemistry & Molecular Biology; Food Science & Technology	AX9QB	WOS:000347235900021		
J	Kitajima, Y				Kitajima, Yuichiro			Imperfect Cloning Operations in Algebraic Quantum Theory	FOUNDATIONS OF PHYSICS			English	Article						No-cloning theorem; Fidelity; Completely positive map; Algebraic quantum field theory	TRANSITION-PROBABILITY; FIELD THEORY	No-cloning theorem says that there is no unitary operation that makes perfect clones of non-orthogonal quantum states. The objective of the present paper is to examine whether an imperfect cloning operation exists or not in a C*-algebraic framework. We define a universal -imperfect cloning operation which tolerates a finite loss of fidelity in the cloned state, and show that an individual system's algebra of observables is abelian if and only if there is a universal -imperfect cloning operation in the case where the loss of fidelity is less than . Therefore in this case no universal -imperfect cloning operation is possible in algebraic quantum theory.	Nihon Univ, Coll Ind Technol, Narashino, Chiba 2758576, Japan	Kitajima, Y (reprint author), Nihon Univ, Coll Ind Technol, 2-11-1 Shin Ei, Narashino, Chiba 2758576, Japan.	kitajima.yuichirou@nihon-u.ac.jp			JSPS KAKENHI [23701009]; John Templeton Foundation [35771]	The author wishes to thank Izumi Ojima and Yutaka Shikano for helpful comments on an earlier draft. The author is supported by the JSPS KAKENHI, No. 23701009 and the John Templeton Foundation Grant ID 35771.	ALBERTI PM, 1983, LETT MATH PHYS, V7, P107, DOI 10.1007/BF00419927; ALBERTI PM, 1983, LETT MATH PHYS, V7, P25, DOI 10.1007/BF00398708; Clifton R, 2003, FOUND PHYS, V33, P1561, DOI 10.1023/A:1026056716397; Buzek V, 1996, PHYS REV A, V54, P1844, DOI 10.1103/PhysRevA.54.1844; WOOTTERS WK, 1982, NATURE, V299, P802, DOI 10.1038/299802a0; DIEKS D, 1982, PHYS LETT A, V92, P271, DOI 10.1016/0375-9601(82)90084-6; BURES D, 1969, T AM MATH SOC, V135, P199, DOI 10.2307/1995012; ARAKI H, 1982, LETT MATH PHYS, V6, P237, DOI 10.1007/BF00403278; HAAG R, 1964, J MATH PHYS, V5, P848, DOI 10.1063/1.1704187; Horuzhy S. S., 1990, INTRO ALGEBRAIC QUAN; KADISON R., 1983, FUNDAMENTALS THEORY, VI; Kadison R. V, 1983, FUNDAMENTALS THEORY; Nielsen M, 2000, QUANTUM COMPUTATION; PAULSEN V., 2002, COMPLETELY BOUNDED M; PROMISLO.D, 1971, PAC J MATH, V36, P507; RAGGIO GA, 1982, LETT MATH PHYS, V6, P233, DOI 10.1007/BF00403277; Roberts J. E., 1969, Communications in Mathematical Physics, V11, DOI 10.1007/BF01645853; ROOS H, 1970, COMMUN MATH PHYS, V16, P238, DOI 10.1007/BF01646790; Takesaki M, 2002, THEORY OPERATOR ALGE; Uhlmann A., 1976, Reports on Mathematical Physics, V9, DOI 10.1016/0034-4877(76)90060-4; Uhlmann A., 1985, ANN PHYS, V497, P524, DOI 10.1002/andp.19854970419	21	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0015-9018	1572-9516		FOUND PHYS	Found. Phys.	JAN	2015	45	1					62	74		10.1007/s10701-014-9843-8		13	Physics, Multidisciplinary	Physics	AY0IJ	WOS:000347280200005		
J	Murakami, K; Sato, M; Tsubouchi, N; Ohtsuka, Y; Sugawara, K				Murakami, Kenji; Sato, Masahiko; Tsubouchi, Naoto; Ohtsuka, Yasuo; Sugawara, Katsuyasu			Steam gasification of Indonesian subbituminous coal with calcium carbonate as a catalyst raw material	FUEL PROCESSING TECHNOLOGY			English	Article						Subbituminous coal; Steam gasification; Calcium carbonate; Catalyst; Ion exchange	WATER-VAPOR GASIFICATION; BROWN-COAL; HYDROGEN-PRODUCTION; CATION-EXCHANGE; CARBOXYL GROUPS; RANK COALS; DECOMPOSITION; PYROLYSIS; IRON; REACTOR	The effect of Ca catalysts prepared from CaCO3 on the steam gasification of Indonesian subbituminous coal at 700-800 degrees C is examined: The char obtained by pyrolyzing the coal with 0.59 wt.% of Ca (dry basis) showed conversions in steam gasification at 750 and 800 degrees C of around 70 and 90 wt.% (dry ash and catalyst free basis), which were 2 and 1.5 times larger than those of the coal without the Ca catalyst, respectively. The activity of this Ca catalyst was as high as that prepared using an aqueous solution of Ca(OH)(2). The TPD and XRD measurements demonstrated that the Ca catalyst from CaCO3 was initially present in the ion-exchanged form, and as a finely dispersed calcium species after pyrolysis. These results confirm that CaCO3 is effective as a catalyst raw material in the steam gasification of subbituminous coal, even at low catalyst loadings. (C) 2014 Elsevier B.V. All rights reserved.	[Murakami, Kenji; Sato, Masahiko; Sugawara, Katsuyasu] Akita Univ, Fac Engn & Resource Sci, Dept Engn Appl Chem, Akita 0108502, Japan; [Tsubouchi, Naoto] Hokkaido Univ, Ctr Adv Res Energy & Mat, Kita Ku, Sapporo, Hokkaido 0608628, Japan; [Ohtsuka, Yasuo] Tohoku Univ, Inst Multidisciplinaty Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan	Murakami, K (reprint author), Akita Univ, Fac Engn & Resource Sci, Dept Engn Appl Chem, 1-1 Tegata Gakuen Machi, Akita 0108502, Japan.	murakami@gipc.akita-u.ac.jp	Tsubouchi, Naoto/D-8112-2012	Tsubouchi, Naoto/0000-0001-8236-8252	Energy Innovation Program: Strategic Technical Platform for Clean Coal Technology (STEP-CCT) [P07021]; New Energy and Industrial Technology Development Organization (NEDO); Japan Coal Energy Center (JCOAL)	This work was carried out as a part of the Energy Innovation Program: Strategic Technical Platform for Clean Coal Technology (STEP-CCT, P07021). The authors thank the New Energy and Industrial Technology Development Organization (NEDO) and the Japan Coal Energy Center (JCOAL) for the financial support.	OHTSUKA Y, 1986, FUEL, V65, P1653, DOI 10.1016/0016-2361(86)90264-4; LAFFERTY C, 1990, FUEL, V69, P78, DOI 10.1016/0016-2361(90)90261-N; Wu YQ, 2011, FUEL PROCESS TECHNOL, V92, P523, DOI 10.1016/j.fuproc.2010.11.007; Kim J, 2013, INT J HYDROGEN ENERG, V38, P6014, DOI 10.1016/j.ijhydene.2012.12.058; Murakami K, 2012, FUEL PROCESS TECHNOL, V95, P78, DOI 10.1016/j.fuproc.2011.11.020; Sugano M, 1999, FUEL, V78, P945, DOI 10.1016/S0016-2361(98)00214-2; Karimi A, 2011, FUEL, V90, P1285, DOI 10.1016/j.fuel.2010.12.006; Yu JL, 2006, FUEL, V85, P127, DOI 10.1016/j.fuel.2005.05.026; Lee JM, 1998, APPL THERM ENG, V18, P1013; Wang J, 2009, FUEL, V88, P1572, DOI 10.1016/j.fuel.2008.12.017; Popa T, 2013, APPL CATAL A-GEN, V464, P207, DOI 10.1016/j.apcata.2013.05.038; MURAKAMI K, 1995, FUEL PROCESS TECHNOL, V43, P95, DOI 10.1016/0378-3820(95)00009-V; Popa T, 2013, FUEL, V103, P161, DOI 10.1016/j.fuel.2012.08.049; Kopyscinski J, 2014, FUEL, V128, P210, DOI 10.1016/j.fuel.2014.03.014; Ohtsuka Y, 1996, ENERG FUEL, V10, P431, DOI 10.1021/ef950174f; SCHAFER HNS, 1979, FUEL, V58, P673, DOI 10.1016/0016-2361(79)90222-9; HERMANN G, 1986, FUEL, V65, P1410, DOI 10.1016/0016-2361(86)90115-8; HUTTINGER KJ, 1984, FUEL, V63, P9, DOI 10.1016/0016-2361(84)90246-1; JOHNSON JL, 1976, CATAL REV, V14, P131, DOI 10.1080/03602457608073409; Murakami K, 1996, FUEL PROCESS TECHNOL, V46, P183, DOI 10.1016/0378-3820(95)00056-9; Murakami K, 2003, J COLLOID INTERF SCI, V260, P176, DOI 10.1016/S0021-9797(02)00172-8; Nabatame T., 1986, J FUEL SOC JPN, V65, P53; Ohtsuka Y, 1997, CATAL TODAY, V39, P111, DOI 10.1016/S0920-5861(97)00093-X; Ohtsuka Y., 1990, CALCIUM MAGNESIUM AC, P253; OHTSUKA Y, 1995, ENERG FUEL, V9, P1038, DOI 10.1021/ef00054a016; SCHAFER HNS, 1979, FUEL, V58, P667, DOI 10.1016/0016-2361(79)90221-7; SCHAFER HNS, 1980, FUEL, V59, P295, DOI 10.1016/0016-2361(80)90212-4; Takarada T. Y., 1988, J FUEL SOC JAPAN, V67, P683	28	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-3820	1873-7188		FUEL PROCESS TECHNOL	Fuel Process. Technol.	JAN	2015	129						91	97		10.1016/j.fuproc.2014.08.023		7	Chemistry, Applied; Energy & Fuels; Engineering, Chemical	Chemistry; Energy & Fuels; Engineering	AX6HG	WOS:000347023000012		
J	Hanaoka, T; Miyazawa, T; Shimura, K; Hirata, S				Hanaoka, Toshiaki; Miyazawa, Tomohisa; Shimura, Katsuya; Hirata, Satoshi			Jet fuel synthesis in hydrocracking of Fischer-Tropsch product over Pt-loaded zeolite catalysts prepared using microemulsions	FUEL PROCESSING TECHNOLOGY			English	Article						Pt; Microemulsion; Jet fuel; Hydrocracking; BTL	MIDDLE DISTILLATE; TRANSPORTATION FUELS; BETA-CATALYSTS; N-DECANE; CRACKING; WAXES; HYDROISOMERIZATION; BIOMASS; CONVERSION; PARTICLES	In order to design an economical biomass-to-liquid (BTL) process, effective jet fuel production from Fischer Tropsch (FT) product was investigated under the following conditions: temperature 250 degrees C, initial H-2 pressure 1 MPa, and reaction time 1 h, using Pt-loaded zeolite catalysts with a low Pt content (0.1 wt.%). First, a screening study was performed to determine the hydrocracking performance on n-C28H58 and n-C38H74 of various Pt-loaded zeolite catalysts prepared using an impregnation method. Pt-loaded beta-type zeolite catalysts with Pt particle sizes of 2.3-13.1 nm and higher acid amounts led to high jet fuel yields. Pt-loaded beta-type zeolite catalysts with the different loaded Pt particle sizes were prepared using microemulsions. The effect of Pt particle size on hydrocracking behaviors of the FT product was investigated using Pt-loaded beta-type zeolite catalysts with Pt particle sizes of 2.3-14.8 nm with constant Pt content, acid amount, and pore parameters. Under the experimental conditions employed for the present study, the maximum jet fuel yield was 29.1 C-mol% with Pt particle size 7.6 nm. (C) 2014 Elsevier B.V. All rights reserved.	[Hanaoka, Toshiaki; Miyazawa, Tomohisa; Shimura, Katsuya; Hirata, Satoshi] Natl Inst Adv Ind Sci & Technol, Biomass Refinery Res Ctr, Higashihiroshima, Hiroshima 7390046, Japan	Hanaoka, T (reprint author), Natl Inst Adv Ind Sci & Technol, Biomass Refinery Res Ctr, 3-11-32 Kagamiyama, Higashihiroshima, Hiroshima 7390046, Japan.	t.hanaoka@aist.go.jp					Aboul-Gheit AK, 2012, J TAIWAN INST CHEM E, V43, P711, DOI 10.1016/j.jtice.2012.03.007; Calemma V, 2010, CATAL TODAY, V149, P40, DOI 10.1016/j.cattod.2009.03.018; Dancuart LP, 2004, STUD SURF SCI CATAL, V152, P482; LIPPENS BC, 1965, J CATAL, V4, P319, DOI 10.1016/0021-9517(65)90307-6; Liu YY, 2009, TOP CATAL, V52, P597, DOI 10.1007/s11244-009-9239-8; Chica A, 1999, J CATAL, V187, P167, DOI 10.1006/jcat.1999.2601; LUISI PL, 1988, BIOCHIM BIOPHYS ACTA, V947, P209, DOI 10.1016/0304-4157(88)90025-1; Francis J, 2011, APPL CATAL A-GEN, V409, P140, DOI 10.1016/j.apcata.2011.09.040; Yan QG, 2013, BIORESOURCE TECHNOL, V127, P281, DOI 10.1016/j.biortech.2012.09.069; COONRADT HL, 1964, IND ENG CHEM PROC DD, V3, P38, DOI 10.1021/i260009a010; Hanaoka T, 2010, FUEL PROCESS TECHNOL, V91, P859, DOI 10.1016/j.fuproc.2009.09.012; Alvarez F, 1996, J CATAL, V162, P179, DOI 10.1006/jcat.1996.0275; Dupain X, 2006, APPL CATAL B-ENVIRON, V63, P277, DOI 10.1016/j.apcatb.2005.10.012; Baliban RC, 2012, COMPUT CHEM ENG, V47, P29, DOI 10.1016/j.compchemeng.2012.06.032; Liu GR, 2013, RENEW SUST ENERG REV, V25, P59, DOI 10.1016/j.rser.2013.03.025; Corma A, 1997, APPL CATAL A-GEN, V152, P107, DOI 10.1016/S0926-860X(96)00338-9; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Dupain X, 2005, CATAL TODAY, V106, P288, DOI 10.1016/j.cattod.2005.07.148; ARCHIBALD RC, 1960, IND ENG CHEM, V52, P745, DOI 10.1021/ie50609a021; Baliban B.C., 2013, ENERG FUEL, V27, P4302; BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126; BOUTONNET M, 1987, J CATAL, V103, P95, DOI 10.1016/0021-9517(87)90096-0; Calemma V, 2005, CATAL TODAY, V106, P282, DOI 10.1016/j.cattod.2005.07.185; Calemma V., 2001, STUD SURF SCI CATAL, V136, P307; Chao KJ, 1996, APPL CATAL A-GEN, V143, P223, DOI 10.1016/0926-860X(96)00096-8; Cho KM, 2009, CHEM ENG J, V146, P307, DOI 10.1016/j.cej.2008.10.008; Cho KM, 2008, APPL CATAL B-ENVIRON, V83, P195, DOI 10.1016/j.apcatb.2008.02.022; Folkedahl BC, 2011, FUEL PROCESS TECHNOL, V92, P1939, DOI 10.1016/j.fuproc.2011.05.013; Fujimoto S., 2008, INT ENERGY J, V9, P73; Hanaoka T, 2000, APPL CATAL A-GEN, V190, P291, DOI 10.1016/S0926-860X(99)00323-3; Hanaoka Toshiaki, 2011, Journal of the Japan Institute of Energy, V90, DOI 10.3775/jie.90.1072; Hanaoka T, 2001, J COLLOID INTERF SCI, V235, P235, DOI 10.1006/jcis.2000.7353; Hanaoka T, 2012, CATALYSTS, V2, P281, DOI 10.3390/catal2020281; VANHARDE.R, 1969, SURF SCI, V15, P189, DOI 10.1016/0039-6028(69)90148-4; Ikeda M, 1999, CATAL LETT, V58, P195, DOI 10.1023/A:1019010908170; Ikeda M., 2001, CATAL COMMUN, V2, P261, DOI 10.1016/S1566-7367(01)00045-0; Iliopoulou EF, 2014, APPL CATAL B-ENVIRON, V145, P177, DOI 10.1016/j.apcatb.2013.03.026; Kang J, 2012, CATAL LETT, V142, P1295, DOI 10.1007/s10562-012-0910-5; Kim MY, 2012, CATAL COMMUN, V26, P78, DOI 10.1016/j.catcom.2012.05.006; Komvokis VG, 2012, CATAL TODAY, V196, P42, DOI 10.1016/j.cattod.2012.06.029; Lappas AA, 2011, IND ENG CHEM RES, V50, P531, DOI 10.1021/ie100200u; Lee J, 2010, KOREAN J CHEM ENG, V27, P807, DOI 10.1007/s11814-010-0127-5; Lee J, 2010, KOREAN J CHEM ENG, V27, P1755, DOI 10.1007/s11814-010-0279-3; MASON MG, 1977, PHYS REV LETT, V39, P288, DOI 10.1103/PhysRevLett.39.288; Ohashi Y., 2004, KAGAKUBINRAN, pII; Rao TVM, 2012, MICROPOR MESOPOR MAT, V164, P148, DOI 10.1016/j.micromeso.2012.07.016; Schalitzky H.W., 2011, BIOMASS CONV BIOREFI, V1, P29, DOI 10.1007/s13399-010-0003-x; Tijmensen MJA, 2002, BIOMASS BIOENERG, V23, P129, DOI 10.1016/S0961-9534(02)00037-5; Triantafyllidis KS, 2007, STUD SURF SCI CATAL, V170, P1344; Wang ZB, 1997, APPL CATAL A-GEN, V159, P119, DOI 10.1016/S0926-860X(97)00059-8	50	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-3820	1873-7188		FUEL PROCESS TECHNOL	Fuel Process. Technol.	JAN	2015	129						139	146		10.1016/j.fuproc.2014.09.011		8	Chemistry, Applied; Energy & Fuels; Engineering, Chemical	Chemistry; Energy & Fuels; Engineering	AX6HG	WOS:000347023000017		
J	Nonaka, M; Gotoda, T; Kusano, C; Fukuzawa, M; Itoi, T; Moriyasu, F				Nonaka, Masaya; Gotoda, Takuji; Kusano, Chika; Fukuzawa, Masakatsu; Itoi, Takao; Moriyasu, Fuminori			Safety of Gastroenterologist-Guided Sedation with Propofol for Upper Gastrointestinal Therapeutic Endoscopy in Elderly Patients Compared with Younger Patients	GUT AND LIVER			English	Article						Elderly patient; Propofol; Safety; Sedation; Upper gastrointestinal therapeutic endoscopy	LOW-DOSE PROPOFOL; ADMINISTERED PROPOFOL; SUBMUCOSAL DISSECTION; MODERATE SEDATION; MIDAZOLAM; NURSES; METAANALYSIS; MEPERIDINE	Background/Aims: Propofol sedation for elderly patients during time-consuming endoscopic procedures is controversial. Therefore, we investigated the safety of using propofol in elderly patients during upper gastrointestinal therapeutic endoscopy. Methods: The medical records of 160 patients who underwent therapeutic endoscopic procedures under gastroenterologist-guided propofol sedation at a single institution were retrospectively reviewed. The subjects were divided into two groups: a younger group; patients <75 years old; and an elderly group, patients >= 75 years old. The two groups were compared with respect to the therapeutic regimen, circulatory dynamics, and presence/absence of discontinuation of propofol treatment. Results: Although the number of patients with liver dysfunction was higher in the elderly group, there were no other significant differences in the baseline characteristics, including the American Society of Anesthesiologists classification, between the elderly and younger groups. The average maintenance rate of continuous propofol infusion was lower in the elderly patients. No statistically significant differences were found in the occurrence of adverse events between the elderly and younger groups. None of the patients returned to a resedated state after the initial recovery from sedation. Conclusions: Gastroenterologist-guided propofol sedation in elderly patients can be safely achieved in the same manner as that in younger patients, even for time-consuming upper gastrointestinal therapeutic endoscopic procedures.	[Nonaka, Masaya; Gotoda, Takuji; Kusano, Chika; Fukuzawa, Masakatsu; Itoi, Takao; Moriyasu, Fuminori] Tokyo Med Univ, Dept Gastroenterol & Hepatol, Tokyo 1600023, Japan; [Nonaka, Masaya] Yuri Kumiai Gen Hosp, Dept Gastroenterol, Akita, Japan	Gotoda, T (reprint author), Tokyo Med Univ, Dept Gastroenterol & Hepatol, Shinjuku Ku, 6-7-1 Nishi Shinjuku, Tokyo 1600023, Japan.	takujigotoda@yahoo.co.jp					Rex DK, 2009, GASTROENTEROLOGY, V137, P1229, DOI 10.1053/j.gastro.2009.06.042; Gasparovic S, 2006, WORLD J GASTROENTERO, V12, P327; Schilling D, 2009, ENDOSCOPY, V41, P295, DOI 10.1055/s-0028-1119671; Kongkam P, 2008, J GASTROINTEST LIVER, V17, P291; Horiuchi A, 2008, DIGESTION, V78, P190, DOI 10.1159/000187118; Cohen LB, 2004, GASTROINTEST ENDOSC, V59, P795, DOI 10.1016/S0016-5107(04)00349-9; Rex DK, 2005, GASTROENTEROLOGY, V129, P1384, DOI 10.1053/j.gastro.2005.08.014; Lee CK, 2011, GASTROINTEST ENDOSC, V73, P206, DOI 10.1016/j.gie.2010.09.035; Vargo JJ, 2002, GASTROENTEROLOGY, V123, P8, DOI 10.1053/gast.2002.34232; Sipe BW, 2002, GASTROINTEST ENDOSC, V55, P815, DOI 10.1067/mge.2002.124636; Heuss LT, 2012, ENDOSCOPY, V44, P504, DOI 10.1055/s-0031-1291668; Qadeer MA, 2005, CLIN GASTROENTEROL H, V3, P1049, DOI 10.1053/S1542-3565(05)00742-1; McQuaid KR, 2008, GASTROINTEST ENDOSC, V67, P910, DOI 10.1016/j.gie.2007.12.046; Tohda G, 2006, ENDOSCOPY, V38, P360, DOI 10.1055/s-2005-921192; Cohen LB, 2006, AM J GASTROENTEROL, V101, P967, DOI 10.1111/j.1572-0241.2006.00500.x; Yamagata T, 2011, INTERNAL MED, V50, P1455, DOI 10.2169/internalmedicine.50.4627; Agostoni M, 2011, GASTROINTEST ENDOSC, V74, P266, DOI 10.1016/j.gie.2011.04.028; Cohen LB, 2003, GASTROINTEST ENDOSC, V58, P725, DOI 10.1016/S0016-5107(03)02010-8; Paspatis GA, 2002, AM J GASTROENTEROL, V97, P1963; Horiuchi A, 2009, AM J GASTROENTEROL, V104, P1650, DOI 10.1038/ajg.2009.250; Klotz U, 2009, DRUG METAB REV, V41, P67, DOI 10.1080/03602530902722679; Heuss LT, 2003, GASTROINTEST ENDOSC, V57, P664, DOI 10.1067/mge.2003.191; Kiriyama S, 2010, J GASTROENTEROL, V45, P831; Manolaraki MM, 2009, ANN GASTROENTEROL, V22, P90; Park CH, 2013, DIGEST DIS SCI, V58, P540, DOI 10.1007/s10620-012-2376-0; Qadeer MA, 2011, DIGESTION, V84, P37, DOI 10.1159/000321621	26	2	2	EDITORIAL OFFICE GUT & LIVER	SEOUL	305 LOTTE GOLD ROSE II, 890-59, DAECHI 4-DONG, GANGNAM-GU, SEOUL, 135-839, SOUTH KOREA	1976-2283	2005-1212		GUT LIVER	Gut Liver	JAN	2015	9	1					38	42		10.5009/gnl13368		5	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AX8EC	WOS:000347142100006		
J	Iwasaki, S; Kamisawa, T; Koizumi, S; Chiba, K; Tabata, T; Kuruma, S; Kuwata, G; Fujiwara, T; Koizumi, K; Arakawa, T; Momma, K; Hara, S; Igarashi, Y				Iwasaki, Susumu; Kamisawa, Terumi; Koizumi, Satomi; Chiba, Kazuro; Tabata, Taku; Kuruma, Sawako; Kuwata, Go; Fujiwara, Takashi; Koizumi, Koichi; Arakawa, Takeo; Momma, Kumiko; Hara, Seiichi; Igarashi, Yoshinori			Characteristic Findings of Endoscopic Retrograde Cholangiopancreatography in Autoimmune Pancreatitis	GUT AND LIVER			English	Article						Pancreatitis, chronic; Cholangitis, sclerosing	MAJOR DUODENAL PAPILLA; INTERNATIONAL CONSENSUS; DIAGNOSTIC-CRITERIA; JUNCTION; ANATOMY	Background/Aims: Diffuse or segmental irregular narrowing of the main pancreatic duct (MPD), as observed by endoscopic retrograde cholangiopancreatography (ERCP), is a characteristic feature of autoimmune pancreatitis (AIP). Methods: ERCP findings were retrospectively examined in 40 patients with AIP in whom irregular narrowing of the MPD was detected near the orifice. The MPD opening sign was defined as the MPD within 1.5 cm from the orifice being maintained. The distal common bile duct (CBD) sign was defined as the distal CBD within 1.5 cm from the orifice being maintained. Endoscopic findings of a swollen major papilla and histological findings of specimens obtained from the major papilla were examined in 26 and 21 patients, respectively. Results: The MPD opening sign was detected in 26 of the 40 patients (65%). The distal CBD sign was detected in 25 of the 32 patients (78%), which showed stenosis of the lower bile duct. The patients who showed the MPD opening sign frequently showed the distal CBD sign (p=0.018). Lymphoplasmacytic infiltration, but not dense fibrosis, was histologically detected in biopsy specimens obtained from the major papilla. Conclusions: On ERCP, the MPD and CBD adjacent to the major papilla are frequently maintained in patients with AIP involving the pancreatic head. These signs are useful for diagnosing AIP on ERCP.	[Iwasaki, Susumu; Kamisawa, Terumi; Koizumi, Satomi; Chiba, Kazuro; Tabata, Taku; Kuruma, Sawako; Kuwata, Go; Fujiwara, Takashi; Koizumi, Koichi; Arakawa, Takeo; Momma, Kumiko; Hara, Seiichi] Tokyo Metropolitan Komagome Hosp, Dept Internal Med, Tokyo 1138677, Japan; [Hara, Seiichi; Igarashi, Yoshinori] Toho Univ, Sch Med, Omori Med Ctr, Div Gastroenterol & Hepatol, Tokyo, Japan	Kamisawa, T (reprint author), Tokyo Metropolitan Komagome Hosp, Dept Internal Med, Bunkyo Ku, 3-18-22 Honkomagome, Tokyo 1138677, Japan.	kamisawa@cick.jp					Kamisawa T, 2003, GUT, V52, P683, DOI 10.1136/gut.52.5.683; Kamisawa T, 2013, GUT, V62, P1373, DOI 10.1136/gutjnl-2012-304224; Kamisawa T, 2010, NAT REV GASTRO HEPAT, V7, P401, DOI 10.1038/nrgastro.2010.81; Kamisawa T, 2008, GASTROINTEST ENDOSC, V68, P358, DOI 10.1016/j.gie.2008.02.018; Kamisawa T, 2008, PANCREAS, V37, pE62, DOI 10.1097/MPA.0b013e318175e3a0; Unno H, 2002, GASTROINTEST ENDOSC, V56, P880, DOI 10.1067/mge.2002.129605; Kamisawa T, 2006, WORLD J GASTROENTERO, V12, P2031; Sugumar A, 2011, GUT, V60, P666, DOI 10.1136/gut.2010.207951; Shimosegawa T, 2011, PANCREAS, V40, P352, DOI 10.1097/MPA.0b013e3182142fd2; BOYDEN EA, 1957, SURG GYNECOL OBSTET, V104, P641; FLATI G, 1994, AM SURGEON, V60, P712; Kim MH, 2010, DIGEST SURG, V27, P110, DOI 10.1159/000286573; Kubota Kensuke, 2007, Pancreas, V35, pe51; Nishino T, 2010, J GASTROENTEROL, V45, P988, DOI 10.1007/s00535-010-0250-4; Okazaki K, 2012, PANCREAS, V41, P1341; SUDA K, 1980, ACTA PATHOL JAPON, V30, P187; Takuma K, 2011, WORLD J GASTROENTERO, V17, P2332, DOI 10.3748/wjg.v17.i18.2332	17	0	0	EDITORIAL OFFICE GUT & LIVER	SEOUL	305 LOTTE GOLD ROSE II, 890-59, DAECHI 4-DONG, GANGNAM-GU, SEOUL, 135-839, SOUTH KOREA	1976-2283	2005-1212		GUT LIVER	Gut Liver	JAN	2015	9	1					113	117		10.5009/gnl13473		5	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AX8EC	WOS:000347142100017		
J	Ogiwara, K; Nogami, K; Hosokawa, K; Ohnishi, T; Matsumoto, T; Shima, M				Ogiwara, K.; Nogami, K.; Hosokawa, K.; Ohnishi, T.; Matsumoto, T.; Shima, M.			Comprehensive evaluation of haemostatic function in von Willebrand disease patients using a microchip-based flow chamber system	HAEMOPHILIA			English	Article						clinical phenotype; desmopressin; factor VIII; flow chamber system; von Willebrand disease; von Willebrand factor	FACTOR-VIII BINDING; THROMBUS FORMATION; DIAGNOSIS; PATHOPHYSIOLOGY; MULTIMERIZATION; DOMAIN; BLOOD	The diagnosis of von Willebrand disease (VWD) is difficult due to the wide spectrum of clinical phenotypes associated with this disorder. We have analysed and characterized haemostatic function in VWD patients using a microchip-based flow chamber system. Microchips coated with either collagen [platelet (PL)-chip] or collagen/thromboplastin [atherome (AR)-chip] were used to evaluate platelet thrombus formation at 1000 s(-1) and fibrin-rich platelet thrombus formation at 240 s(-1) respectively. Blood samples from an asymptomatic patient with VWD type 1 [von Willebrand factor (VWF): RCo 3.2%; bleeding score (BS 2] displayed normal thrombus formation in both PL- and AR-chips, whereas blood from a symptomatic type 1 patient (VWF: RCo 14%, BS 9) had significantly delayed capillary occlusion. Nearly complete suppression of the flow pressure increase was observed in symptomatic patients with VWD type 2A (BS 13) and 2N (BS 27), whereas no flow pressure was found for the type 3 patient (BS 6). Fibrin-rich platelet thrombus formation was only weakly increased by the in vitro addition of factor VIII (FVIII) to blood samples from the type 3 patient, but was normalized by the addition of VWF/FVIII. The in vivo effects of treatment with desmopressin or VWF/FVIII for the symptomatic patients were analysed using two types of microchips. The PL-chip was highly sensitive for patients' VWF-mediated platelet functions, whereas the AR-chip allowed assessment of overall haemostatic ability, including sensitivity to both VWF and FVIII. The combined analysis with PL- and AR-chips may be potentially useful for the diagnosis of VWD based on clinical phenotypes, and for monitoring drug effects.	[Ogiwara, K.; Nogami, K.; Matsumoto, T.; Shima, M.] Nara Med Univ, Dept Pediat, Kashihara, Nara 6348522, Japan; [Hosokawa, K.; Ohnishi, T.] Fujimori Kogyo Co, Res Inst, Yokohama, Kanagawa, Japan	Nogami, K (reprint author), Nara Med Univ, Dept Pediat, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	roc-noga@naramed-u.ac.jp			 [24591558]	We thank Dr. Koji Yada, Hiroaki Minami, Shoko Furukawa, for helpful suggestion on flow chamber systems, and thank Drs. Masaki Hayakawa and Masanori Matsumoto for help with the VWF multimer analysis. This work was partly supported by grants for MEXT KAKENHI 24591558.	Allen S, 2000, BLOOD, V95, P2000; Hosokawa K, 2013, THROMB HAEMOSTASIS, V109, P102, DOI 10.1160/TH12-06-0441; Mazurier C, 2001, BEST PRACT RES CL HA, V14, P337, DOI 10.1053/beha.2001.0138; Sadler JE, 2006, J THROMB HAEMOST, V4, P2103, DOI 10.1111/j.1538-7836.2006.02146.x; Shima M, 2008, HAEMOPHILIA, V14, P83, DOI 10.1111/j.1365-2516.2008.01737.x; Tosetto A, 2011, J THROMB HAEMOST, V9, P1143, DOI 10.1111/j.1538-7836.2011.04265.x; Castaman G, 2013, HAEMATOLOGICA, V98, P667, DOI 10.3324/haematol.2012.077263; Ogawa S, 2012, HAEMOPHILIA, V18, P926, DOI 10.1111/j.1365-2516.2012.02867.x; Hosokawa K, 2011, J THROMB HAEMOST, V9, P2029, DOI 10.1111/j.1538-7836.2011.04464.x; Sugimoto M, 2003, BLOOD, V101, P915, DOI 10.1182/blood-2002-03-0944; Tosetto A, 2006, J THROMB HAEMOST, V4, P766, DOI 10.1111/j.1538-7836.2006.01847.x; Jorieux S, 1998, BLOOD, V92, P4663; Tsuji S, 1999, BLOOD, V94, P968; Schneider SW, 2007, P NATL ACAD SCI USA, V104, P7899, DOI 10.1073/pnas.0608422104; KUNDU SK, 1995, SEMIN THROMB HEMOST, V21, P106; Rodeghiero F, 2009, BLOOD, V114, P1158, DOI 10.1182/blood-2009-01-153296; Castaman G, 2010, BRIT J HAEMATOL, V151, P245, DOI 10.1111/j.1365-2141.2010.08333.x; Nishino M, 1996, INT J HEMATOL, V64, P127; Rydz N, 2012, J THROMB HAEMOST, V10, P2223, DOI 10.1111/j.1538-7836.2012.04923.x; Schneider MF, 2008, CHEMPHYSCHEM, V9, P641, DOI 10.1002/cphc.200700566; Shibata M, 1999, THROMB HAEMOSTASIS, V81, P793; Stegner D, 2011, J MOL MED, V89, P109, DOI 10.1007/s00109-010-0691-5; SWARTZ MJ, 1977, J BIOL CHEM, V252, P8105	23	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-8216	1365-2516		HAEMOPHILIA	Haemophilia	JAN	2015	21	1					71	80		10.1111/hae.12610		10	Hematology	Hematology	AX5RU	WOS:000346985600038		
J	Abe, K; Akamatsu, R				Abe, Keina; Akamatsu, Rie			Japanese children and plate waste: contexts of low self-efficacy	HEALTH EDUCATION JOURNAL			English	Article						Children; self-efficacy; nutrition education; Japan; plate waste	LUNCH; CONSUMPTION; STUDENTS; FRUIT	Objective: Leaving a portion of meals uneaten, known as plate waste, is a serious problem among children in Japan. Although children's confidence that they can completely finish meals is related to plate waste, the circumstances that influence this confidence are not known. This study examined situations in which low self-efficacy for finishing their meal occurs among elementary school children in Tokyo, Japan. Design: A survey using a cross-sectional self-reporting questionnaire was conducted in December 2009. This questionnaire included items about plate waste behaviour, self-efficacy for completely finishing meals in specific situations, sex, height and weight. Methods: A total of 2659 Japanese 5(th)-grade students completed the questionnaire. Univariate logistic regression and multivariate logistic regression analyses were performed with the plate waste behaviour item, the not-completely-eaten group and the completely-eaten group as dependent variables, and with the self-efficacy items as independent variables. Results: Significant correlations were found between plate waste and low self-efficacy for completely finishing meals when portion size is too large' (boys: Odds ratio (OR) = 3.94; 95% Confidence interval (CI) = 2.83, 5.49 and girls: OR = 2.68; 95% CI = 2.03, 3.54), when food one dislikes is served' (boys: OR = 3.74; 95% CI = 2.77, 5.04 and girls: OR = 2.89; 95% CI = 2.21, 3.76), and when the time allowed to eat is too short' (boys: OR = 1.57; 95% CI = 1.16, 2.14 and girls: OR = 1.49; 95% CI = 1.13, 1.97). Low self-efficacy when a meal is not delicious' (OR = 1.79; 95% CI = 1.32, 2.43) was a predictor of plate waste only among boys. Conclusions: The results suggest that in Japan environmental improvement and nutritional education are related to children's plate waste.	[Abe, Keina; Akamatsu, Rie] Ochanomizu Univ, Grad Sch Humanities & Sci, Tokyo 1128610, Japan	Akamatsu, R (reprint author), Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, 2-1-1 Otsuka, Tokyo 1128610, Japan.	akamatsu.rie@ocha.ac.jp					Abe K, 2013, J CHILD NUTR MANAGEM, V37; Baik JY, 2009, NUTR RES, V29, P831, DOI 10.1016/j.nutres.2009.10.009; Baxter SD, 2002, J NUTR EDUC BEHAV, V34, P166, DOI 10.1016/S1499-4046(06)60086-9; Thompson VJ, 2007, J NUTR EDUC BEHAV, V39, P2, DOI 10.1016/j.jneb.2006.06.006; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037//0033-295X.84.2.191; Cohen JFW, 2013, AM J PREV MED, V44, P114, DOI 10.1016/j.amepre.2012.09.060; Bergman EA, 2004, J CHILD NUTR MANAGEM, V28; Getlinger MJ, 1996, J AM DIET ASSOC, V96, P906, DOI 10.1016/S0002-8223(96)00245-3; Gustavsson J., 2011, GLOBAL FOOD LOSSES F; Lee HS, 2001, J AM DIET ASSOC, V101, P1060, DOI 10.1016/S0002-8223(01)00261-9; McCaffree J, 2009, J AM DIET ASSOC, V109, P205, DOI 10.1016/j.jada.2008.11.038; Ministry of Education Culture Sports Science and Technology of Japan, 2009, SCH HLTH EX SURV HEI; Ministry of Education Culture Sports Science and Technology of Japan, 2008, GUID COURS STUD EL S; Ministry of Education Culture Sports Science and Technology of Japan, 2009, ENF SCH LUNCH IMPL S; Nozue M, 2010, NUTR RES PRACT, V4, P400, DOI 10.4162/nrp.2010.4.5.400; Safety Division of the National Agency for the Advancement of Sports and Health in Japan, 2007, REP SURV ACT COND DI	16	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0017-8969	1748-8176		HEALTH EDUC J	Health Educ. J.	JAN	2015	74	1					74	83		10.1177/0017896913519429		10	Education & Educational Research; Public, Environmental & Occupational Health	Education & Educational Research; Public, Environmental & Occupational Health	AX4MU	WOS:000346907400007		
J	Sasaki, N; Okumura, Y; Watanabe, I; Sonoda, K; Kogawa, R; Takahashi, K; Iso, K; Nakahara, S; Maruyama, A; Takemura, S; Hirayama, A				Sasaki, Naoko; Okumura, Yasuo; Watanabe, Ichiro; Sonoda, Kazumasa; Kogawa, Rikitake; Takahashi, Keiko; Iso, Kazuki; Nakahara, Shiro; Maruyama, Ayako; Takemura, Saya; Hirayama, Atsushi			Relations between contact force, bipolar voltage amplitude, and mapping point distance from the left atrial surfaces of 3D ultrasound- and merged 3D CT-derived images: Implication for atrial fibrillation mapping and ablation	HEART RHYTHM			English	Article						Contact force; 3D ultrasound image; 3D CT image; Bipolar voltage amplitude	CATHETER ABLATION; RADIOFREQUENCY ABLATION; IMPEDANCE; INTERVENTION; INTEGRATION; RESPIRATION; ARRHYTHMIAS; SYSTEM; IMPACT	BACKGROUND Catheter tip-derived contact force (CF) and 3-dimensional (3D) maps are key to mapping and ablation of atrial fibrillation. OBJECTIVE This study sought to determine the relation between CF and 3D map surfaces. METHODS We conducted a validation study of CARTo-based 3D ultrasound (3D-US) and 3D-US merged with computed tomography (3D-Merge-CT) left atrium/pulmonary vein images. Under fluoroscopic guidance, 1361 mapping points (20 patients) with CFs and electrogram information were randomly acquired around the PVs. RESULTS CF correlated weakly with the distance of mapping points from the 3D-Merge-CT (r = 0.27; P < .001) and 3D-US (r = 0.22; P < .001) surfaces but not with bipolar voltage (r = 0.01; P=.2400). Low CF (0-4 g) yielded points close to the 3D-US surface; moderate (5-9 g) and high CFs (10-20 g) generated points beyond the surface (0.1 +/- 3.9, 1.4 +/- 3.4, and 2.3 +/- 3.4 mm; P < .05 for each). Low, moderate, and high CFs yielded points below, close to, and beyond the 3D-Merge-CT surface (-1.2 +/- 3.7, 0.4 +/- 3.0, and 1.0 (0 2.9 mm; P < .05 for each). CONCLUSION Poor correlation between CF and the distance of mapping points from the 3D map surfaces and electrogram information shows the limitation of 3D mapping and electrogram information for predicting good contact. In addition, mapping seems to require far less CF than ablation requires.	[Sasaki, Naoko; Okumura, Yasuo; Watanabe, Ichiro; Sonoda, Kazumasa; Kogawa, Rikitake; Takahashi, Keiko; Iso, Kazuki; Hirayama, Atsushi] Nihon Univ, Sch Med, Div Cardiol, Dept Med, Tokyo 1738610, Japan; [Nakahara, Shiro] Dokkyo Med Univ Koshigaya Hosp, Dept Cardiol, Saitama, Japan; [Maruyama, Ayako; Takemura, Saya] Biosense Webster Inc, Johnson & Johnson, Diamond Bar, CA USA	Okumura, Y (reprint author), Nihon Univ, Sch Med, Div Cardiol, Dept Med,Itabashi Ku, 30-1 Ohyaguchi Kamicho, Tokyo 1738610, Japan.	yasuwo128@yahoo.co.jp					Kumar S, 2013, HEART RHYTHM, V10, P962, DOI 10.1016/j.hrthm.2013.03.022; Dong J, 2006, CIRCULATION, V113, P186, DOI 10.1161/CIRCULATIONAHA.105.565200; De Bortoli A, 2013, J CARDIOVASC ELECTR, V24, P1210, DOI 10.1111/jce.12215; Nakagawa H, 2013, CIRC-ARRHYTHMIA ELEC, V6, P746, DOI 10.1161/CIRCEP.113.978320; Okumura Y, 2008, J CARDIOVASC ELECTR, V19, P632, DOI 10.1111/j.1540-8167.2008.01135.x; Makimoto H, 2014, CIRC-ARRHYTHMIA ELEC, V7, P46, DOI 10.1161/CIRCEP.113.000556; Kumar S, 2012, HEART RHYTHM, V9, P1041, DOI 10.1016/j.hrthm.2012.02.015; Hong C, 2001, RADIOLOGY, V220, P712, DOI 10.1148/radiol.2203010055; STRICKBERGER SA, 1995, AM HEART J, V130, P1026, DOI 10.1016/0002-8703(95)90204-X; Kuck KH, 2012, HEART RHYTHM, V9, P18, DOI 10.1016/j.hrthm.2011.08.021; Singh SM, 2008, HEART RHYTHM, V5, P1548, DOI 10.1016/j.hrthm.2008.08.027; Okumura Y, 2008, CIRC-ARRHYTHMIA ELEC, V1, P110, DOI 10.1161/CIRCEP.108.769935; den Uijl DW, 2008, HEART RHYTHM, V5, P1403, DOI 10.1016/j.hrthm.2008.07.020; Kistler PM, 2006, J CARDIOVASC ELECTR, V17, P1093, DOI 10.1111/j.1540-8167.2006.00594.x; Kumar S, 2013, J CARDIOVASC ELECTRO; Noseworthy PA, 2005, HEART RHYTHM, V2, P1173, DOI 10.1016/j.hrthm.2005.08.008; Okumura Y, 2013, J CARDIOVASC ELECTR, V24, P259, DOI 10.1111/jce.12062; Reichlin T, 2014, HEART RHYTHM, V11, P194, DOI 10.1016/j.hrthm.2013.10.048; Sigfridsson A, 2007, J MAGN RESON IMAGING, V25, P113, DOI 10.1002/jmri.20820	19	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1547-5271	1556-3871		HEART RHYTHM	Heart Rhythm	JAN	2015	12	1					36	43		10.1016/j.hrthm.2014.09.007		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX3RR	WOS:000346857100012		
J	Lee, KK; Imaizumi, N; Chamberland, SR; Alder, NN; Boelsterli, UA				Lee, Kang Kwang; Imaizumi, Naoki; Chamberland, Sally R.; Alder, Nathan N.; Boelsterli, Urs A.			Targeting Mitochondria With Methylene Blue Protects Mice Against Acetaminophen-Induced Liver Injury	HEPATOLOGY			English	Article							MOUSE-LIVER; NONHEPATOTOXIC REGIOISOMER; REACTIVE METABOLITES; ALZHEIMERS-DISEASE; OXIDANT STRESS; CELL-DEATH; IN-VIVO; INHIBITION; HEPATOTOXICITY; MECHANISMS	Acetaminophen (APAP) overdose is a frequent cause of drug-induced liver injury and the most frequent cause of acute liver failure in the Western world. Previous studies with mouse models have revealed that impairment of mitochondrial respiration is an early event in the pathogenesis, but the exact mechanisms have remained unclear, and therapeutic approaches to specifically target mitochondria have been insufficiently explored. Here, we found that the reactive oxidative metabolite of APAP, N-acetyl-p-benzoquinoneimine (NAPQI), caused the selective inhibition of mitochondrial complex II activity by >90% in both mouse hepatic mitochondria and yeast-derived complexes reconstituted into nanoscale model membranes, as well as the decrease of succinate-driven adenosine triphosphate (ATP) biosynthesis rates. Based on these findings, we hypothesized that methylene blue (MB), a mitochondria-permeant redox-active compound that can act as an alternative electron carrier, protects against APAP-induced hepatocyte injury. We found that MB (<3 mu M) readily accepted electrons from NAPQI-altered, succinate-energized complex II and transferred them to cytochrome c, restoring ATP biosynthesis rates. In cultured mouse hepatocytes, MB prevented the mitochondrial permeability transition and loss of intracellular ATP without interfering with APAP bioactivation. In male C57BL/6J mice treated with APAP (450 mg/kg, intraperitoneally [IP]), MB (10 mg/kg, IP, administered 90 minutes post-APAP) protected against hepatotoxicity, whereas mice treated with APAP alone developed massive centrilobular necrosis and increased serum alanine aminotransferase activity. APAP treatment inhibited complex II activity ex vivo, but did not alter the protein expression levels of subunits SdhA or SdhC after 4 hours. Conclusion: MB can effectively protect mice against APAP-induced liver injury by bypassing the NAPQI-altered mitochondrial complex II, thus alleviating the cellular energy crisis. Because MB is a clinically used drug, its potential application after APAP overdose in patients should be further explored. (Hepatology 2015;61:326-336)	[Lee, Kang Kwang; Imaizumi, Naoki; Boelsterli, Urs A.] Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT 06269 USA; [Imaizumi, Naoki] Univ Ryukyus, Mol Genet Lab, Nishihara, Okinawa 90301, Japan; [Chamberland, Sally R.; Alder, Nathan N.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA	Boelsterli, UA (reprint author), Univ Connecticut, Sch Pharm, Dept Pharmaceut Sci, 69 North Eagleville Rd,Unit 3092, Storrs, CT 06269 USA.	urs.boelsterli@uconn.edu					Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594; BURCHAM PC, 1991, J BIOL CHEM, V266, P5049; DONNELLY PJ, 1994, ARCH TOXICOL, V68, P110, DOI 10.1007/s002040050043; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; Gunawan BK, 2006, GASTROENTEROLOGY, V131, P165, DOI 10.1053/j.gastro.2006.03.045; Atamna H, 2010, J ALZHEIMERS DIS, V20, pS439, DOI 10.3233/JAD-2010-100414; McGill MR, 2013, TOXICOL APPL PHARM, V269, P240, DOI 10.1016/j.taap.2013.03.026; Davey GP, 1998, J BIOL CHEM, V273, P12753, DOI 10.1074/jbc.273.21.12753; Abdelmegeed MA, 2013, FREE RADICAL BIO MED, V60, P211, DOI 10.1016/j.freeradbiomed.2013.02.018; Tian ZG, 2013, INT IMMUNOPHARMACOL, V17, P309, DOI 10.1016/j.intimp.2013.06.022; Gabrielli D, 2004, PHOTOCHEM PHOTOBIOL, V79, P227, DOI 10.1562/BE-03-27.1; Qiu YC, 1998, J BIOL CHEM, V273, P17940, DOI 10.1074/jbc.273.28.17940; Zielonka J, 2012, CHEM RES TOXICOL, V25, P1793, DOI 10.1021/tx300164j; Dougherty PP, 2012, J EMERG MED, V43, P58, DOI 10.1016/j.jemermed.2011.05.023; Lee KK, 2014, REDOX BIOL, V2, P599, DOI 10.1016/j.redox.2014.03.003; TIRMENSTEIN MA, 1989, J BIOL CHEM, V264, P9814; Landin JS, 1996, TOXICOL APPL PHARM, V141, P299; RAMSAY RR, 1989, ARCH BIOCHEM BIOPHYS, V273, P449, DOI 10.1016/0003-9861(89)90504-3; Cover C, 2005, J PHARMACOL EXP THER, V315, P879, DOI 10.1124/jpet.105.088898; Schwall CT, 2012, BBA-BIOENERGETICS, V1817, P1588, DOI 10.1016/j.bbabio.2012.04.015; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Burke AS, 2010, CHEM RES TOXICOL, V23, P1286, DOI 10.1021/tx1001755; Han D, 2013, TRENDS PHARMACOL SCI, V34, P243, DOI 10.1016/j.tips.2013.01.009; Wu HM, 2014, BRIT J PHARMACOL, V171, P2790, DOI 10.1111/bph.12637; Williams CD, 2014, TOXICOL APPL PHARM, V274, P417, DOI 10.1016/j.taap.2013.12.003; MYERS TG, 1995, CHEM RES TOXICOL, V8, P403, DOI 10.1021/tx00045a012; Saito C, 2010, TOXICOL APPL PHARM, V246, P8, DOI 10.1016/j.taap.2010.04.015; Hinson JA, 2013, DRUG-INDUCED LIVER DISEASE, 3RD EDITION, P305, DOI 10.1016/B978-0-12-387817-5.00019-4; Hanawa N, 2008, J BIOL CHEM, V283, P13565, DOI 10.1074/jbc.M708916200; Lee KK, 2013, FREE RADICAL BIO MED, V65, P584, DOI 10.1016/j.freeradbiomed.2013.07.038; Jaeschke H, 2012, DRUG METAB REV, V44, P88, DOI 10.3109/03602532.2011.602688; Bajt ML, 2004, TOXICOL SCI, V80, P343, DOI 10.1093/toxsci/kfh151; Atamna H, 2008, FASEB J, V22, P703, DOI 10.1096/fj.07-9610com; Stamper BD, 2011, CHEM RES TOXICOL, V24, P549, DOI 10.1021/tx1004198; LoGuidice A, 2011, HEPATOLOGY, V54, P969, DOI 10.1002/hep.24464; Atamna H, 2012, BIOFACTORS, V38, P158, DOI 10.1002/biof.197; BIRGE RB, 1990, TOXICOL APPL PHARM, V105, P472, DOI 10.1016/0041-008X(90)90150-S; ESTERLINE RL, 1989, BIOCHEM PHARMACOL, V38, P2387, DOI 10.1016/0006-2952(89)90481-4; GILLETTE J, 1973, DRUG METAB DISPOS, V1, P164; Gonzalez FJ, 2001, TOXICOL LETT, V120, P199, DOI 10.1016/S0378-4274(01)00296-X; HRUSHESKY WJM, 1985, LANCET, V1, P565; James LP, 2013, DRUG-INDUCED LIVER DISEASE, 3RD EDITION, P331, DOI 10.1016/B978-0-12-387817-5.00020-0; KELNER MJ, 1988, ARCH BIOCHEM BIOPHYS, V262, P422, DOI 10.1016/0003-9861(88)90393-1; Latchoumycandane C, 2007, HEPATOLOGY, V45, P412, DOI 10.1002/hep.21475; Marks BD, 2002, ASSAY DRUG DEV TECHN, V1, P73, DOI 10.1089/154065802761001329; MCCORD JM, 1970, J BIOL CHEM, V245, P1374; Muratsubaki H, 2008, CELL BIOCHEM FUNCT, V26, P275, DOI 10.1002/cbf.1429; NELSON SD, 1991, ADV EXP MED BIOL, V283, P579; Paban V, 2014, NEUROPHARMACOLOGY, V76, P68, DOI 10.1016/j.neuropharm.2013.06.033; Poteet E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048279	50	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0270-9139	1527-3350		HEPATOLOGY	Hepatology	JAN	2015	61	1					326	336		10.1002/hep.27385		11	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AX6AF	WOS:000347005100039		
J	Fujii, Y; Uchida, Y; Mochida, S				Fujii, Yohei; Uchida, Yoshihito; Mochida, Satoshi			Drug-Induced Immunoallergic Hepatitis During Combination Therapy With Daclatasvir and Asunaprevir	HEPATOLOGY			English	Article									[Fujii, Yohei; Uchida, Yoshihito; Mochida, Satoshi] Saitama Med Univ, Dept Gastroenterol & Hepatol, Moroyama, Saitama 3500495, Japan	Mochida, S (reprint author), Saitama Med Univ, Dept Gastroenterol & Hepatol, Fac Med, 38 Morohongo, Moroyama, Saitama 3500495, Japan.	smochida@saitama-med.ac.jp					Lok AS, 2014, J HEPATOL, V60, P490, DOI 10.1016/j.jhep.2013.10.019; Kumada H, 2014, HEPATOLOGY, V59, P2083, DOI 10.1002/hep.27113; Manns M, 2014, LANCET; Shiohara Tetsuo, 2006, Allergol Int, V55, P1, DOI 10.2332/allergolint.55.1	4	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0270-9139	1527-3350		HEPATOLOGY	Hepatology	JAN	2015	61	1					400	401		10.1002/hep.27559		2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AX6AF	WOS:000347005100047		
J	Tamaki, R; Shoji, Y; Okada, Y; Miyano, K				Tamaki, Ryo; Shoji, Yasushi; Okada, Yoshitaka; Miyano, Kenjiro			Spectrally Resolved Interband and Intraband Transitions by Two-Step Photon Absorption in InGaAs/GaAs Quantum Dot Solar Cells	IEEE JOURNAL OF PHOTOVOLTAICS			English	Article						Gallium arsenide; indium gallium arsenide; photovoltaic cells; quantum dots; spectroscopy; III-V semiconductor materials	EFFICIENCY	Two-step photon absorption processes in a self-organized In0.4Ga0.6As/GaAs quantum dot solar cell have been investigated by means of infrared (IR) light-biased change in external quantum efficiency (Delta EQE) spectroscopy at 9 K. In this paper, not only interband transitions but intraband transitions were both spectrally resolved by utilizing wavelength tunable intense mid-IR pulsed laser as the IR bias light source. The obtained EQE enhancement was attributed from reexcitation of photocarriers captured by quantum dots. The bound-to-continuum intraband transition probability was estimated to be about 8% by irradiating 100-suns-equivalent IR bias light.	[Tamaki, Ryo; Shoji, Yasushi; Okada, Yoshitaka; Miyano, Kenjiro] Univ Tokyo, Adv Sci & Technol Res Ctr, Tokyo 1538904, Japan	Tamaki, R (reprint author), Univ Tokyo, Adv Sci & Technol Res Ctr, Tokyo 1538904, Japan.	tamaki@mbe.rcast.u-tokyo.ac.jp; shoji@mbe.rcast.u-tokyo.ac.jp; okada@mbe.rcast.u-tokyo.ac.jp; umiyano@mail.ecc.u-tokyo.ac.jp	Miyano, Kenjiro/G-7534-2014		New Generation Concentration Photovoltaics program by the Incorporated Administrative Agency New Energy and Industrial Technology Development Organization; Ministry of Economy, Trade, and Industry, Japan	This work was supported under the New Generation Concentration Photovoltaics program supported by the Incorporated Administrative Agency New Energy and Industrial Technology Development Organization, and the Ministry of Economy, Trade, and Industry, Japan.	Tomic S, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.195321; Luque A, 2012, NAT PHOTONICS, V6, P146, DOI [10.1038/nphoton.2012.1, 10.1038/NPHOTON.2012.1]; SHOCKLEY W, 1961, J APPL PHYS, V32, P510, DOI 10.1063/1.1736034; Fujii H, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.10ND04; Harada Y., 2013, J APPL PHYS, V113; Hu W. G., 2010, APPL PHYS LETT, V97; Jolley G, 2013, PROG PHOTOVOLTAICS, V21, P736, DOI 10.1002/pip.2161; Kita T, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.195312; Kita T, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.035301; Luque A, 1997, PHYS REV LETT, V78, P5014, DOI 10.1103/PhysRevLett.78.5014; Luque A, 2013, PROG PHOTOVOLTAICS, V21, P658, DOI 10.1002/pip.1250; Marti A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.247701; Murayama M, 1998, JPN J APPL PHYS 1, V37, P4109, DOI 10.1143/JJAP.37.4109; Nishikawa K., 2012, APPL PHYS LETT, V100; Okada Y., 2011, J APPL PHYS, V109; Popescu V., 2009, APPL PHYS LETT, V95; Sato D., 2012, J APPL PHYS, V112; Shoji Y., 2012, J APPL PHYS, V112; Shoji Y., 2013, J PHYS D, V46; Shoji Y., 2012, J APPL PHYS, V111; Sogabe T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04792; Strandberg R., 2009, J APPL PHYS, V105; Tamaki R., 2014, APPL PHYS LETT, V105; Tomic S., 2008, APPL PHYS LETT, V93; Tomic S, 2015, PROG PHOTOVOLTAICS, V23, P546, DOI 10.1002/pip.2455; Yoshida K., 2012, J APPL PHYS, V112	26	3	3	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-3381			IEEE J PHOTOVOLT	IEEE J. Photovolt.	JAN	2015	5	1					229	233		10.1109/JPHOTOV.2014.2368712		5	Energy & Fuels; Materials Science, Multidisciplinary; Physics, Applied	Energy & Fuels; Materials Science; Physics	AX1WA	WOS:000346732700033		
J	Yamada, Y; Nakamura, T; Endo, M; Wakamiya, A; Kanemitsu, Y				Yamada, Yasuhiro; Nakamura, Toru; Endo, Masaru; Wakamiya, Atsushi; Kanemitsu, Yoshihiko			Photoelectronic Responses in Solution-Processed Perovskite CH3NH3PbI3 Solar Cells Studied by Photoluminescence and Photoabsorption Spectroscopy	IEEE JOURNAL OF PHOTOVOLTAICS			English	Article						Photoluminescence; semiconductor devices; solar energy	ORGANOMETAL HALIDE PEROVSKITES; OPTICAL ABSORPTION; EXCITONS; DEPOSITION; COMPOUND; LENGTHS	Photoelectronic responses of organic-inorganic hybrid perovskite CH3NH3PbI3 on mesoporous TiO2 electrodes are investigated. On the basis of near-band-edge optical absorption and photoluminescence spectra, the bandgap energy and exciton binding energy as a function of temperature are obtained. The exciton binding energy is much smaller than thermal energy at room temperature, which means that most excitons are thermally dissociated, and optical processes are determined by the photoexcited electrons and holes. We determined the temperature dependence of exciton binding energy, which changes from similar to 30 meV at 13 K to 6 meV at 300 K. In addition, the bandgap energy and the exciton binding energy show abrupt changes at 150 K due to structural phase transition. Our fundamental optical studies provide essential information for improving the device performance of solar cells based on halide perovskite semiconductors.	[Yamada, Yasuhiro; Nakamura, Toru; Endo, Masaru; Wakamiya, Atsushi; Kanemitsu, Yoshihiko] Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan	Yamada, Y (reprint author), Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan.	yamada.yasuhiro.6c@kyoto-u.ac.jp; nakamura.tooru.25z@gmail.com; endo@hydrogen.kuicr.kyoto-u.ac.jp; wakamiya@scl.kyoto-u.ac.jp; kanemitu@scl.kyoto-u.ac.jp	Wakamiya, Atsushi/E-6773-2014; Kanemitsu, Yoshihiko/D-2006-2014		Sumitomo Electric Industries Group CSR foundation; JST-PRESTO; JST-CREST	This work was supported by The Sumitomo Electric Industries Group CSR foundation, JST-PRESTO, and JST-CREST.	Kojima A, 2009, J AM CHEM SOC, V131, P6050, DOI 10.1021/ja809598r; Burschka J, 2013, NATURE, V499, P316, DOI 10.1038/nature12340; MITZI DB, 1995, SCIENCE, V267, P1473, DOI 10.1126/science.267.5203.1473; Even J, 2014, J PHYS CHEM C, V118, P11566, DOI 10.1021/jp503337a; Im JH, 2011, NANOSCALE, V3, P4088, DOI 10.1039/c1nr10867k; ISHIHARA T, 1994, J LUMIN, V60-1, P269, DOI 10.1016/0022-2313(94)90145-7; Zhou HP, 2014, SCIENCE, V345, P542, DOI 10.1126/science.1254050; Eperon GE, 2014, ADV FUNCT MATER, V24, P151, DOI 10.1002/adfm.201302090; ONODAYAMAMURO N, 1990, J PHYS CHEM SOLIDS, V51, P1383, DOI 10.1016/0022-3697(90)90021-7; STURGE MD, 1962, PHYS REV, V127, P768, DOI 10.1103/PhysRev.127.768; HIRASAWA M, 1994, PHYSICA B, V201, P427, DOI 10.1016/0921-4526(94)91130-4; Lee MM, 2012, SCIENCE, V338, P643, DOI 10.1126/science.1228604; POGLITSCH A, 1987, J CHEM PHYS, V87, P6373, DOI 10.1063/1.453467; Liu MZ, 2013, NATURE, V501, P395, DOI 10.1038/nature12509; ELLIOTT RJ, 1957, PHYS REV, V108, P1384, DOI 10.1103/PhysRev.108.1384; Tanaka K, 2003, SOLID STATE COMMUN, V127, P619, DOI 10.1016/S0038-1098(03)00566-0; Wakamiya A, 2014, CHEM LETT, V43, P711, DOI 10.1246/cl.140074; Yamada Y, 2014, J AM CHEM SOC, V136, P11610, DOI 10.1021/ja506624n; D'Innocenzo V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4586; Docampo P., 2014, NAT COMMUN, V4; Heo JH, 2013, NAT PHOTONICS, V7, P487, DOI 10.1038/NPHOTON.2013.80; Kim HS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00591; Ogawa T., 1995, OPTICAL PROPERTIES L; Phuong L. Q., 2013, APPL PHYS LETT, V103; Stranks SD, 2013, SCIENCE, V342, P341, DOI 10.1126/science.1243982; Xing GC, 2013, SCIENCE, V342, P344, DOI 10.1126/science.1243167; Yamada Y., 2014, APPL PHYS EXP, V7; Yamada Y., 2012, APPL PHYS LETT, V101; Yu P. Y., 2005, FUNDAMENTALS SEMICON	29	16	16	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-3381			IEEE J PHOTOVOLT	IEEE J. Photovolt.	JAN	2015	5	1					401	405		10.1109/JPHOTOV.2014.2364115		5	Energy & Fuels; Materials Science, Multidisciplinary; Physics, Applied	Energy & Fuels; Materials Science; Physics	AX1WA	WOS:000346732700060		
J	Kim, M; Wakabayashi, YK; Yokoyama, M; Nakane, R; Takenaka, M; Takagi, S				Kim, Minsoo; Wakabayashi, Yuki K.; Yokoyama, Masafumi; Nakane, Ryosho; Takenaka, Mitsuru; Takagi, Shinichi			Ge/Si Heterojunction Tunnel Field-Effect Transistors and Their Post Metallization Annealing Effect	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Article						Heterojunction; high-k gate-stack; interface state density; postmetallization annealing (PMA); subthreshold swing (SS); tunnel FET	SILICON; SURFACE; STATES; TFETS	Ge/Si heterojunction tunnel field-effect transistors (TFETs) with an Al2O3 gate-stack are demonstrated. The high performances of steep subthreshold swing (SS) of 58 mV/decade and large I-ON/I-OFF ratio over 10(7) are realized by a proper postmetallization annealing (PMA) process. We can obtain the high-quality Al2O3/Ge interface with D-it of as low as similar to 10(11) cm(-2)eV(-1) by electron cyclotron resonance oxygen plasma post oxidation. The electrical characteristics of the Ge/SOI TFETs are studied with changing PMA temperature from 200 degrees C to 400 degrees C. It is found that D-it between Al2O3 and the Si channel region is a critical factor for significantly reducing SS of Ge/Si heterojunction TFETs.	[Kim, Minsoo; Wakabayashi, Yuki K.; Yokoyama, Masafumi; Nakane, Ryosho; Takenaka, Mitsuru; Takagi, Shinichi] Univ Tokyo, Dept Elect Engn & Informat Syst, Tokyo 1138654, Japan; [Kim, Minsoo; Yokoyama, Masafumi; Takenaka, Mitsuru; Takagi, Shinichi] Japan Sci & Technol Agcy, Japan Core Res Evolut Sci & Technol, Tokyo 1138656, Japan	Kim, M (reprint author), Univ Tokyo, Dept Elect Engn & Informat Syst, Tokyo 1138654, Japan.	minsoo@mosfet.t.u-tokyo.ac.jp; wakabayashi@cryst.t.u-tokyo.ac.jp; yokoyama@mosfet.t.u-tokyo.ac.jp; nakane@cryst.t.u-tokyo.ac.jp; takenaka@mosfet.t.u-tokyo.ac.jp; takagi@ee.t.u-tokyo.ac.jp			Japan Society for the Promotion of Science	This work was supported by the Grants-in-Aid for Scientific Research through the Japan Society for the Promotion of Science. The review of this paper was arranged by Editor H. Jaouen.	Lee MH, 2013, IEEE T ELECTRON DEV, V60, P2423, DOI 10.1109/TED.2013.2264101; PEOPLE R, 1985, APPL PHYS LETT, V47, P322, DOI 10.1063/1.96206; Vandooren A, 2013, SOLID STATE ELECTRON, V83, P50, DOI 10.1016/j.sse.2013.01.026; Ionescu AM, 2011, NATURE, V479, P329, DOI 10.1038/nature10679; Vandooren A, 2012, SOLID STATE ELECTRON, V72, P82, DOI 10.1016/j.sse.2011.12.008; Wang LQ, 2010, IEEE ELECTR DEVICE L, V31, P431, DOI 10.1109/LED.2010.2044012; Kim SH, 2009, 2009 SYMPOSIUM ON VLSI TECHNOLOGY, DIGEST OF TECHNICAL PAPERS, P178; Seabaugh AC, 2010, P IEEE, V98, P2095, DOI 10.1109/JPROC.2010.2070470; Oh J, 2004, J ELECTRON MATER, V33, P364, DOI 10.1007/s11664-004-0144-4; Gandhi R, 2011, IEEE ELECTR DEVICE L, V32, P437, DOI 10.1109/LED.2011.2106757; Choi WY, 2007, IEEE ELECTR DEVICE L, V28, P743, DOI 10.1109/LED.2007.901273; Ganapathi K, 2011, IEEE ELECTR DEVICE L, V32, P689, DOI 10.1109/LED.2011.2112753; Li R, 2012, IEEE ELECTR DEVICE L, V33, P363, DOI 10.1109/LED.2011.2179915; Zhao QT, 2011, IEEE ELECTR DEVICE L, V32, P1480, DOI 10.1109/LED.2011.2163696; BERGLUND CN, 1966, IEEE T ELECTRON DEV, VED13, P701, DOI 10.1109/T-ED.1966.15827; Born M., 2006, P 25 INT C MICR, P124; Chen ZX, 2009, IEEE ELECTR DEVICE L, V30, P754, DOI 10.1109/LED.2009.2021079; GRAY PV, 1966, APPL PHYS LETT, V8, P31, DOI 10.1063/1.1754468; Han G., 2011, APPL PHYS LETT, V98; Huang Q., 2012, IEEE INT EL DEV M DE, P851; Knoch J, 2009, PROCEEDINGS OF TECHNICAL PROGRAM: 2009 INTERNATIONAL SYMPOSIUM ON VLSI TECHNOLOGY, SYSTEMS AND APPLICATIONS, P45; Mookerjea S., 2009, IEDM, P949; Morita Y, 2013, S VLSI, pT236; NICOLLIA.EH, 1967, BELL SYST TECH J, V46, P1055; Shih C.-H., 2013, J APPL PHYS, V113; Toh E.-H., 2007, APPL PHYS LETT, V91; Verhulst A. S., 2008, J APPL PHYS, V104; Zhang R., 2011, APPL PHYS LETT, V98	28	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9383	1557-9646		IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	JAN	2015	62	1					9	15		10.1109/TED.2014.2371038		7	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	AX5PR	WOS:000346979800002		
J	Shirota, R; Yang, BJ; Chiu, YY; Chen, HT; Ng, SF; Wang, PY; Chang, JH; Kurachi, I				Shirota, Riichiro; Yang, Bo-Jun; Chiu, Yung-Yueh; Chen, Hsuan-Tse; Ng, Seng-Fei; Wang, Pin-Yao; Chang, Jung-Ho; Kurachi, Ikuo			New Method to Analyze the Shift of Floating Gate Charge and Generated Tunnel Oxide Trapped Charge Profile in NAND Flash Memory by Program/Erase Endurance	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Article						Endurance; Flash memory; reliability; trap	SILICON DIOXIDE; CURRENT STRESS; INTERFACE; DEGRADATION; INJECTION; STATES; CELLS	A new test system was devised and used to separate the amount of floating gate (FG) charge (Q(FG)) from the oxide trapped charge (Q(OX)) generated by program-and-erase (P/E) cycles. We also extracted the pure V-mid shift caused by the generation of Q(OX), which is separated from the part of V-t shift coming from Q(FG) deviation. The identification of Q(FG) and Vmid shift makes it possible to analyze the detailed the oxide trapped charge profile. The Q(FG) shift generated by P/E cycles displays asymmetry between the programmed and erased states: the absolute value of Q(FG) exhibits a maximum at similar to 100 cycles in the programmed states, while Q(FG) monotonically decreases in the erased one. Considering that the Fowler-Nordheim tunneling current is sensitive to the oxide trap near the cathode, itself the source of electron tunneling current, our results indicate that the hole trap is dominant near to Si, whereas the electron trap is dominant near FG.	[Shirota, Riichiro; Yang, Bo-Jun; Chiu, Yung-Yueh; Chen, Hsuan-Tse; Ng, Seng-Fei] Natl Chiao Tung Univ, Hsinchu 30010, Taiwan; [Wang, Pin-Yao; Chang, Jung-Ho] Windond Elect Corp, Zhubei 30265, Taiwan; [Kurachi, Ikuo] High Energy Accelerator Res Org, Tsukuba, Ibaraki 3050801, Japan	Shirota, R (reprint author), Natl Chiao Tung Univ, Hsinchu 30010, Taiwan.	riichiro.shirota@gmail.com; ballgym.ece96@g2.nctu.edu.tw; yuppes@hotmail.com; tbr092811@gmail.com; ngsengfei@gmail.com; pywang1@winbond.com; jhchang0@winbond.com; i_kurachi@mtg.biglobe.ne.jp			National Science Council of Taiwan	This work was supported by the National Science Council of Taiwan. The review of this paper was arranged by Editor U. E. Avci.	Park YB, 1998, IEEE T ELECTRON DEV, V45, P1361, DOI 10.1109/16.678579; DEPAS M, 1995, SOLID STATE ELECTRON, V38, P1465, DOI 10.1016/0038-1101(94)00269-L; Mielke N, 2006, INT REL PHY, P29, DOI 10.1109/RELPHY.2006.251188; Arai F., 1998, P IRPS, P378; ARITOME S, 1993, P IEEE, V81, P776, DOI 10.1109/5.220908; Compagnoni CM, 2007, INT EL DEVICES MEET, P165, DOI 10.1109/IEDM.2007.4418892; Fayrushin A., 2009, IEDM, P1; FLEETWOOD DM, 1992, APPL PHYS LETT, V60, P2883, DOI 10.1063/1.106807; Kirisawa R., 1990, VLSI S, P129; Kurata H., 2006, VLSI S, P112; LAI SK, 1981, J APPL PHYS, V52, P6231, DOI 10.1063/1.328565; Lee JD, 2003, INT REL PHY, P497; LEE KH, 1993, J APPL PHYS, V73, P4434, DOI 10.1063/1.352781; Liang M.- S., 1981, IEDM, P396; Liu H., 2009, WORLD WIR MOB MULT N, P1; Shirota R., 2014, P IEEE IMW MAY, P1; ZIEGLER K, 1978, APPL PHYS LETT, V32, P249, DOI 10.1063/1.90008	17	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9383	1557-9646		IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	JAN	2015	62	1					114	120		10.1109/TED.2014.2366116		7	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	AX5PR	WOS:000346979800017		
J	Hu, W; Cheung, G; Ortega, A; Au, OC				Hu, Wei; Cheung, Gene; Ortega, Antonio; Au, Oscar C.			Multiresolution Graph Fourier Transform for Compression of Piecewise Smooth Images	IEEE TRANSACTIONS ON IMAGE PROCESSING			English	Article						Image compression; graph Fourier transform; piecewise smooth images	DEPTH VIDEO COMPRESSION; MOTION; QUANTIZATION; OPTIMALITY	Piecewise smooth (PWS) images (e.g., depth maps or animation images) contain unique signal characteristics such as sharp object boundaries and slowly varying interior surfaces. Leveraging on recent advances in graph signal processing, in this paper, we propose to compress the PWS images using suitable graph Fourier transforms (GFTs) to minimize the total signal representation cost of each pixel block, considering both the sparsity of the signal's transform coefficients and the compactness of transform description. Unlike fixed transforms, such as the discrete cosine transform, we can adapt GFT to a particular class of pixel blocks. In particular, we select one among a defined search space of GFTs to minimize total representation cost via our proposed algorithms, leveraging on graph optimization techniques, such as spectral clustering and minimum graph cuts. Furthermore, for practical implementation of GFT, we introduce two techniques to reduce computation complexity. First, at the encoder, we low-pass filter and downsample a high-resolution (HR) pixel block to obtain a low-resolution (LR) one, so that a LR-GFT can be employed. At the decoder, upsampling and interpolation are performed adaptively along HR boundaries coded using arithmetic edge coding, so that sharp object boundaries can be well preserved. Second, instead of computing GFT from a graph in real-time via eigen-decomposition, the most popular LR-GFTs are pre-computed and stored in a table for lookup during encoding and decoding. Using depth maps and computer-graphics images as examples of the PWS images, experimental results show that our proposed multiresolution-GFT scheme outperforms H.264 intra by 6.8 dB on average in peak signal-to-noise ratio at the same bit rate.	[Hu, Wei; Au, Oscar C.] Hong Kong Univ Sci & Technol, Dept Elect & Comp Engn, Hong Kong, Hong Kong, Peoples R China; [Cheung, Gene] Grad Univ Adv Studies, Natl Inst Informat, Tokyo 1130033, Japan; [Ortega, Antonio] Univ So Calif, Dept Elect Engn, Los Angeles, CA 90089 USA	Hu, W (reprint author), Hong Kong Univ Sci & Technol, Dept Elect & Comp Engn, Hong Kong, Hong Kong, Peoples R China.	huwei@ust.hk; cheung@nii.ac.jp; antonio.ortega@sipi.usc.edu; eeau@ust.hk					Maitre M, 2010, J VIS COMMUN IMAGE R, V21, P513, DOI 10.1016/j.jvcir.2010.03.005; Malvar HS, 2003, IEEE T CIRC SYST VID, V13, P598, DOI 10.1109/TCSVT.2003.814964; Wakin MB, 2006, IEEE T IMAGE PROCESS, V15, P1071, DOI 10.1109/TIP.2005.864175; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888; Gray RM, 1998, IEEE T INFORM THEORY, V44, P2325, DOI 10.1109/18.720541; Merkle P, 2009, SIGNAL PROCESS-IMAGE, V24, P73, DOI 10.1016/j.image.2008.10.010; GEMAN D, 1995, IEEE T IMAGE PROCESS, V4, P932, DOI 10.1109/83.392335; Effros M, 2004, IEEE T INFORM THEORY, V50, P1605, DOI 10.1109/TIT.2004.831787; Candes EJ, 2004, COMMUN PUR APPL MATH, V57, P219, DOI 10.1002/cpa.10116; Cheung G., 2010, PICT COD S PCS 2010, P298; Cheung G, 2011, IEEE IMAGE PROC, P129, DOI 10.1109/ICIP.2011.6115673; Cheung NM, 2012, IEEE IMAGE PROC, P3021; Daribo I, 2014, IEEE T IMAGE PROCESS, V23, P4696, DOI 10.1109/TIP.2014.2353817; Daribo I, 2012, IEEE IMAGE PROC, P1541, DOI 10.1109/ICIP.2012.6467166; Do MN, 2005, IEEE T IMAGE PROCESS, V14, P2091, DOI 10.1109/TIP.2005.859376; Goyal VK, 2001, IEEE SIGNAL PROC MAG, V18, P9, DOI 10.1109/79.952802; Goyal VK, 2000, IEEE T INFORM THEORY, V46, P1623, DOI 10.1109/18.850706; Graziosi D. B., 2013, P INT C TEL CAST BRA; Hammond D., 2010, APPL COMPUT HARMON A, V30, P129; Han SC, 2001, IEEE T IMAGE PROCESS, V10, P1605, DOI 10.1109/83.967388; Hochbaum D. S., 2011, P 3 INT C SCAL SPAC, V6667, P338; Hu W., 2013, P IEEE INT WORKSH MM, P001; Hu W, 2012, IEEE IMAGE PROC, P1297; Huang J.J.Y., 1963, IEEE Transactions on Communication Systems, VCS-11, DOI 10.1109/TCOM.1963.1088759; HUFFMAN DA, 1952, P IRE, V40, P1098, DOI 10.1109/JRPROC.1952.273898; Jain A., 1989, FUNDAMENTALS DIGITAL; Jana S, 2006, IEEE T INFORM THEORY, V52, P4049, DOI 10.1109/TIT.2006.880056; KIM WS, 2009, P IEEE INT C IM PROC, P721; KIM WS, 2012, P IEEE INT C AC SPEE, P813; Kim WS, 2010, PROC SPIE, V7543, DOI 10.1117/12.839030; Morvan Y, 2006, P SOC PHOTO-OPT INS, V6055, pK550, DOI 10.1117/12.642666; Papadimitriou K. S. C., 1998, COMBINATORIAL OPTIMI, P165; Shen G., 2010, PICT COD S PCS 2010, P566; Shen GW, 2010, IEEE IMAGE PROC, P3393, DOI 10.1109/ICIP.2010.5652792; Shukla R, 2005, IEEE T IMAGE PROCESS, V14, P343, DOI 10.1109/TIP.2004.840710; Tian D., 2009, P SOC PHOTO-OPT INS, V7443; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wan PF, 2013, INT CONF ACOUST SPEE, P1831; Wiegand T, 2003, CIRCUITS SYSTEMS VID, V13, P560, DOI DOI 10.1109/TCSVT.2003.815165; Yea S, 2009, SIGNAL PROCESS-IMAGE, V24, P89, DOI 10.1016/j.image.2008.10.007; Zhang C, 2013, IEEE SIGNAL PROC LET, V20, P106, DOI 10.1109/LSP.2012.2230165	41	3	3	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1057-7149	1941-0042		IEEE T IMAGE PROCESS	IEEE Trans. Image Process.	JAN	2015	24	1					419	433		10.1109/TIP.2014.2378055		15	Computer Science, Artificial Intelligence; Engineering, Electrical & Electronic	Computer Science; Engineering	AX5ZA	WOS:000347002000001		
J	Harada, M				Harada, Masaaki			Extremal Type I Z(k)-Codes and k-Frames of Odd Unimodular Lattices	IEEE TRANSACTIONS ON INFORMATION THEORY			English	Article						Self-dual code; unimodular lattice; frame	SELF-DUAL CODES; LEECH LATTICE; CLASSIFICATION; LENGTH; Z(4)-CODES	For some extremal (optimal) odd unimodular lattice L in dimensions 12, 16, 20, 28, 32, 36, 40, and 44, we determine all integers k such that L contains a k-frame. This result yields the existence of an extremal Type I Z(k)-code of lengths 12, 16, 20, 32, 36, 40, and 44, and a near-extremal Type I Z(k)-code of length 28 for positive integers k with only a few exceptions.	Tohoku Univ, Grad Sch Informat Sci, Res Ctr Pure & Appl Math, Sendai, Miyagi 9808577, Japan	Harada, M (reprint author), Tohoku Univ, Grad Sch Informat Sci, Res Ctr Pure & Appl Math, Sendai, Miyagi 9808577, Japan.	mharada@m.tohoku.ac.jp			JSPS KAKENHI [23340021]	This work was partially carried out at Yamagata University, Yamagata, Japan, and this work was supported in part by the JSPS KAKENHI under Grant 23340021.	Bannai E, 1999, IEEE T INFORM THEORY, V45, P1194, DOI 10.1109/18.761269; Rains EM, 1998, J NUMBER THEORY, V73, P359, DOI 10.1006/jnth.1998.2306; Bacher R., 2001, RESEAUX EUCLIDIENS D, P212; Betsumiya K., 2012, ELECT J COMBINAT, V19, P18; Bosma W, 1997, J SYMB COMPUT, V24, P235, DOI 10.1006/jsco.1996.0125; Bouyuklieva S, 2013, FINITE FIELDS TH APP, V21, P67, DOI 10.1016/j.ffa.2013.01.009; Chapman R, 2000, J AUST MATH SOC A, V69, P287; Chapman R., 1996, J TH NOMBRES BORDEAU, V8, P369; Conway J. H., 1999, SPHERE PACKINGS LATT; Conway JH, 1998, J NUMBER THEORY, V72, P357, DOI 10.1006/jnth.1998.2257; CONWAY JH, 1992, J COMB THEORY A, V60, P183, DOI 10.1016/0097-3165(92)90003-D; CONWAY JH, 1990, IEEE T INFORM THEORY, V36, P1319, DOI 10.1109/18.59931; Gaulter M, 2001, J NUMBER THEORY, V91, P81, DOI 10.1006/jnth.2001.2670; Gulliver TA, 2001, J COMB THEORY A, V95, P185, DOI 10.1006/jcta.2000.3159; Gulliver T.A., 2005, AKCE INT J GRAPHS CO, V2, P11; Harada M, 2002, DISCRETE MATH, V256, P471, DOI 10.1016/S0012-365X(02)00389-8; Harada M., INT J COMBI IN PRESS; Harada M, 2005, EUR J COMBIN, V26, P543, DOI 10.1016/j.ejc.2004.06.013; Harada M., 2003, HOKKAIDO MATH J, V32, P153; Harada M, 2009, MATH COMPUT, V78, P1787; Harada M, 2002, DISCRETE MATH, V245, P273, DOI 10.1016/S0012-365X(01)00310-7; Harada M, 2014, MATH COMPUT, V83, P1427; LEON JS, 1982, J COMB THEORY A, V32, P178, DOI 10.1016/0097-3165(82)90019-X; MALLOWS CL, 1976, SIAM J APPL MATH, V31, P649, DOI 10.1137/0131058; MALLOWS CL, 1973, INFORM CONTROL, V22, P188, DOI 10.1016/S0019-9958(73)90273-8; Harada M, 2012, FINITE FIELDS TH APP, V18, P529, DOI 10.1016/j.ffa.2011.11.004; Melchor CA, 2008, IEEE T INFORM THEORY, V54, P4743, DOI 10.1109/TIT.2008.928976; Miezaki T., 2013, COMMUNICATION; Miezaki T, 2012, J NUMBER THEORY, V132, P2773, DOI 10.1016/j.jnt.2012.05.030; PLESS V, 1980, IEEE T INFORM THEORY, V26, P305, DOI 10.1109/TIT.1980.1056195; Pless V., 1972, Discrete Mathematics, V3, DOI 10.1016/0012-365X(72)90034-9; Pless V., 1972, Journal of Combinatorial Theory, Series A, V12, DOI 10.1016/0097-3165(72)90088-X; Rains EM, 1998, IEEE T INFORM THEORY, V44, P134, DOI 10.1109/18.651000; Rains EM, 1998, HANDBOOK OF CODING THEORY, VOLS I & II, P177; Seberry Wallis J., 1979, LECT NOTES PURE APPL, V45; Siegel CL, 1969, NACHR AKAD WISS G MP, V1969, P87	36	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9448	1557-9654		IEEE T INFORM THEORY	IEEE Trans. Inf. Theory	JAN	2015	61	1					72	81		10.1109/TIT.2014.2368563		10	Computer Science, Information Systems; Engineering, Electrical & Electronic	Computer Science; Engineering	AX5PX	WOS:000346980400007		
J	Nock, R; Ali, WBH; D'Ambrosio, R; Nielsen, F; Barlaud, M				Nock, Richard; Ali, Wafa Bel Haj; D'Ambrosio, Roberto; Nielsen, Frank; Barlaud, Michel			Gentle Nearest Neighbors Boosting over Proper Scoring Rules	IEEE TRANSACTIONS ON PATTERN ANALYSIS AND MACHINE INTELLIGENCE			English	Article						Boosting; proper scoring rules; nearest neighbors	CLASSIFICATION; ALGORITHMS; REGRESSION	Tailoring nearest neighbors algorithms to boosting is an important problem. Recent papers study an approach, UNN, which provably minimizes particular convex surrogates under weak assumptions. However, numerical issues make it necessary to experimentally tweak parts of the UNN algorithm, at the possible expense of the algorithm's convergence and performance. In this paper, we propose a lightweight Newton-Raphson alternative optimizing proper scoring rules from a very broad set, and establish formal convergence rates under the boosting framework that compete with those known for UNN. To the best of our knowledge, no such boosting-compliant convergence rates were previously known in the popular Gentle Adaboost's lineage. We provide experiments on a dozen domains, including Caltech and SUN computer vision databases, comparing our approach to major families including support vector machines, (Ada)boosting and stochastic gradient descent. They support three major conclusions: (i) GNNB significantly outperforms UNN, in terms of convergence rate and quality of the outputs, (ii) GNNB performs on par with or better than computationally intensive large margin approaches, (iii) on large domains that rule out those latter approaches for computational reasons, GNNB provides a simple and competitive contender to stochastic gradient descent. Experiments include a divide-and-conquer improvement of GNNB exploiting the link with proper scoring rules optimization.	[Ali, Wafa Bel Haj; Barlaud, Michel] Univ Nice Sophia Antipolis, CNRS, F-06189 Nice, France; [D'Ambrosio, Roberto] Univ Campus Biomed Rome, Rome, Italy; [Nielsen, Frank] Sony Comp Sci Labs Inc, Fundamental Res Lab, Tokyo, Japan; [Barlaud, Michel] Univ Nice Sophia Antipolis, Inst Univ France, F-06189 Nice, France	Nock, R (reprint author), NICTA, Canberra, ACT, Australia.	richard.nock@nicta.com.au; belhajal@i3s.unice.fr; r.dambrosio@unicampus.it; nielsen@lix.polytechnique.fr; barlaud@i3s.unice.fr			Australian Government; Australian Research Council through the ICT Centre of Excellence program	The authors would like to thank the reviewers for insightful comments. Codes used (GNNB and manifold learning) available upon request to Richard Nock and Michel Barlaud NICTA is funded by the Australian Government as represented by the Department of Broadband, Communication and the Digital Economy and the Australian Research Council through the ICT Centre of Excellence program.	Banerjee A, 2005, J MACH LEARN RES, V6, P1705; Perronnin F, 2012, PROC CVPR IEEE, P3482, DOI 10.1109/CVPR.2012.6248090; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Xiao JX, 2010, PROC CVPR IEEE, P3485, DOI 10.1109/CVPR.2010.5539970; Bartlett PL, 2006, J AM STAT ASSOC, V101, P138, DOI 10.1198/016214505000000907; Schapire RE, 1999, MACH LEARN, V37, P297, DOI 10.1023/A:1007614523901; Nock R, 2012, INT J COMPUT VISION, V100, P294, DOI 10.1007/s11263-012-0539-2; Grunwald PD, 2004, ANN STAT, V32, P1367, DOI 10.1214/009053604000000553; Wang JJ, 2010, PROC CVPR IEEE, P3360, DOI 10.1109/CVPR.2010.5540018; Gneiting T, 2007, J AM STAT ASSOC, V102, P359, DOI 10.1198/016214506000001437; Barron AR, 2008, ANN STAT, V36, P64, DOI 10.1214/009053607000000631; Bache K., UCI MACHINE LEARNING; Blum A, 2006, LECT NOTES COMPUT SC, V3940, P52; Bottou L., 2010, P 19 INT C COMP STAT, V19, P177; Chatfield K., 2011, P BRIT MACH VIS C, P1; Cucala L, 2009, J AM STAT ASSOC, V104, P263, DOI 10.1198/jasa.2009.0125; D'Ambrosio R., 2012, P 23 EUR C MACH LE 1, P314; Devroye L., 1996, PROBABILISTIC THEORY; Garcia-Pedrajas N, 2009, EXPERT SYST APPL, V36, P10570, DOI 10.1016/j.eswa.2009.02.065; Griffin G., 2007, CNSTR2007001 CALTECH; Kakade S., 2009, ABS09100610 CORR; Nock R., 2013, P 6 ACM SIGGRAPH AS; Nock R., 2008, P ADV NEUR INF PROC, P1201; Nock R., 2013, P 13 ACM IEEE CS JOI, P313; Nock R, 2009, IEEE T PATTERN ANAL, V31, P2048, DOI 10.1109/TPAMI.2008.225; Quinlan J. R., 1993, C4 5 PROGRAMS MACHIN; Sebban M, 2003, J MACH LEARN RES, V3, P863, DOI 10.1162/jmlr.2003.3.4-5.863; Shalev-Shwartz S., 2007, P 24 INT C MACH LEAR, P807, DOI DOI 10.1145/1273496.1273598; STONE CJ, 1977, ANN STAT, V5, P595, DOI 10.1214/aos/1176343886; Vernet E., 2011, P ADV NEUR INF PROC, P1224	30	0	0	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	0162-8828	1939-3539		IEEE T PATTERN ANAL	IEEE Trans. Pattern Anal. Mach. Intell.	JAN	2015	37	1					80	93		10.1109/TPAMI.2014.2307877		14	Computer Science, Artificial Intelligence; Engineering, Electrical & Electronic	Computer Science; Engineering	AX5ML	WOS:000346970600008		
J	Houle, ME; Nett, M				Houle, Michael E.; Nett, Michael			Rank-Based Similarity Search: Reducing the Dimensional Dependence	IEEE TRANSACTIONS ON PATTERN ANALYSIS AND MACHINE INTELLIGENCE			English	Article						Nearest neighbor search; intrinsic dimensionality; rank-based search	CLUSTERING-ALGORITHM; METRIC-SPACES	This paper introduces a data structure for k-NN search, the Rank Cover Tree (RCT), whose pruning tests rely solely on the comparison of similarity values; other properties of the underlying space, such as the triangle inequality, are not employed. Objects are selected according to their ranks with respect to the query object, allowing much tighter control on the overall execution costs. A formal theoretical analysis shows that with very high probability, the RCT returns a correct query result in time that depends very competitively on a measure of the intrinsic dimensionality of the data set. The experimental results for the RCT show that non-metric pruning strategies for similarity search can be practical even when the representational dimension of the data is extremely high. They also show that the RCT is capable of meeting or exceeding the level of performance of state-of-the-art methods that make use of metric pruning or other selection tests involving numerical constraints on distance values.	[Houle, Michael E.] Res Org Informat & Syst, Natl Inst Informat, Chiyoda Ku, Tokyo 1018430, Japan; [Nett, Michael] Google Japan, Minato Ku, Tokyo 1066126, Japan	Houle, ME (reprint author), Res Org Informat & Syst, Natl Inst Informat, Chiyoda Ku, 2-1-2 Hitotsuba Shi, Tokyo 1018430, Japan.	meh@nii.ac.jp; mnett@google.com			JSPS Kakenhi Kiban (A) Research Grant [25240036]; JST ERATO Kawarabayashi Large Graph Project; JST ERATO Minato Discrete Structure Manipulation System Project	Michael Houle acknowledges the financial support of JSPS Kakenhi Kiban (A) Research Grant 25240036, the JST ERATO Kawarabayashi Large Graph Project, and the JST ERATO Minato Discrete Structure Manipulation System Project. We are also grateful to Ilia Zvedeniouk for providing us with patches that allowed us to include the ANN library in our experimental evaluation. Much of Nett's work on this paper was conducted while he was with the University of Tokyo, Japan, and the National Institute of Informatics, Japan.	Abraham I., 2004, P 15 ANN ACM SIAM S, P550; Andoni A., 2005, E2LSH 0 1 USER MANUA; Guha S, 2000, INFORM SYST, V25, P345, DOI 10.1016/S0306-4379(00)00022-3; Ankerst M, 1999, SIGMOD RECORD, VOL 28, NO 2 - JUNE 1999, P49; Houle ME, 2005, PROC INT CONF DATA, P619; Gupta A, 2003, ANN IEEE SYMP FOUND, P534, DOI 10.1109/SFCS.2003.1238226; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; PUGH W, 1990, COMMUN ACM, V33, P668, DOI 10.1145/78973.78977; Chan HTH, 2005, PROCEEDINGS OF THE SIXTEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P762; Muja M, 2009, VISAPP 2009: PROCEEDINGS OF THE FOURTH INTERNATIONAL CONFERENCE ON COMPUTER VISION THEORY AND APPLICATIONS, VOL 1, P331; Geusebroek JM, 2005, INT J COMPUT VISION, V61, P103, DOI 10.1023/B:VISI.0000042993.50813.60; Breunig MM, 2000, SIGMOD REC, V29, P93; Chavez E, 2001, ACM COMPUT SURV, V33, P273, DOI 10.1145/502807.502808; Asuncion Arthur, 2007, UCI MACHINE LEARNING; Beyer K, 1999, LECT NOTES COMPUT SC, V1540, P217; Beygelzimer A., 2006, P INT C MACH LEARN I, V1, P97; Bozkaya T, 1999, ACM T DATABASE SYST, V24, P361, DOI 10.1145/328939.328959; Brin S., 1995, P 21 INT C VER LARG, P574; Chandola V, 2009, ACM COMPUT SURV, V41, DOI 10.1145/1541880.1541882; Ciaccia P, 1997, PROCEEDINGS OF THE TWENTY-THIRD INTERNATIONAL CONFERENCE ON VERY LARGE DATABASES, P426; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; de Vries T, 2010, Proceedings 2010 10th IEEE International Conference on Data Mining (ICDM 2010), DOI 10.1109/ICDM.2010.151; Ertoz L, 2003, P DMSEC 2003, P1; Ester M, 1996, P 2 INT C KNOWL DISC, V96, P226; Gionis A., 1999, P INT C VER LARG DAT, V99, P518; Goodman J. E., 1997, HDB DISCRETE COMPUTA; Goyal N., 2008, P 1 ACM INT C WEB SE, P25, DOI 10.1145/1341531.1341538; Guttman A, 1984, P ACM SIGMOD INT C M, V14, P47, DOI [DOI 10.1145/602259.602266, 10.1145/971697.602266]; Houle ME, 2008, STAT ANAL DATA MIN, V1, P157, DOI 10.1002/sam.10013; Houle ME, 2013, LECT NOTES COMPUT SC, V8199, P16, DOI 10.1007/978-3-642-41062-8_3; Indyk P., 1998, Proceedings of the Thirtieth Annual ACM Symposium on Theory of Computing, DOI 10.1145/276698.276876; Kamber M, 2006, DATA MINING CONCEPTS; Karger D. R., 2002, P 34 ANN ACM S THEOR, P741; Katayama N, 1997, P ACM SIGMOD INT C M, V26, P369; Krauthgamer R., 2004, P 15 ANN ACM SIAM S, P798; Krauthgamer R, 2004, LECT NOTES COMPUT SC, V3142, P858; Lifshits Y, 2009, PROCEEDINGS OF THE TWENTIETH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P318; Motwani R, 1996, ACM COMPUT SURV, V28, P33, DOI 10.1145/234313.234327; Mount D., 2010, ANN LIB APPROXIMATE; Navarro G., 1999, P STRING PROC INF RE, P141; Pestov V, 2000, INFORM PROCESS LETT, V73, P47, DOI 10.1016/S0020-0190(99)00156-8; Reuters Ltd, 2005, REUT CORP; Samet H., 2006, FDN MULTIDIMENSIONAL; Sarwar B. M., 2000, PROC WEBKDD, P1; Slivkins A., 2005, P 24 ANN ACM S PRINC, P41, DOI 10.1145/1073814.1073823; STONE CJ, 1977, ANN STAT, V5, P595, DOI 10.1214/aos/1176343886; Guha S, 2001, INFORM SYST, V26, P35, DOI 10.1016/S0306-4379(01)00008-4; Tschopp D., 2011, P ADV NEUR INF PROC, V24, P2231; Weber R., 1998, P 24 INT C VER LARG, V98, P194; Ye N., 2003, HDB DATA MINING	50	0	0	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	0162-8828	1939-3539		IEEE T PATTERN ANAL	IEEE Trans. Pattern Anal. Mach. Intell.	JAN	2015	37	1					136	150		10.1109/TPAMI.2014.2343223		15	Computer Science, Artificial Intelligence; Engineering, Electrical & Electronic	Computer Science; Engineering	AX5ML	WOS:000346970600012		
J	Moriyama, S				Moriyama, Shin-ichi			Experiment of the Lorentz Force Law Using Twin Toy Motors	IEEJ TRANSACTIONS ON ELECTRICAL AND ELECTRONIC ENGINEERING			English	Article						DC motor; DC generator; Lorentz force law; electromagnetism; laboratory experiment		This paper proposes a torque measurement method with two toy motors. The aim is to study the basic principles of electric motors and generators, that is, the Lorentz force law, in a laboratory experiment. The two motors are directly coupled and used as a driver and a generator, respectively. The generator functions as an electric brake and as a rotational speed sensor. Since the experimental setup does not need any torque tester, its handling is very easy. It is confirmed from the demonstration tests that the twin characteristics of the motors on motional electromotive force lead to reasonable results of torque estimation. (c) 2014 Institute of Electrical Engineers of Japan. Published by John Wiley & Sons, Inc.	Kyushu Inst Technol, Iizuka, Fukuoka 8208502, Japan	Moriyama, S (reprint author), Kyushu Inst Technol, Kawazu 680-4, Iizuka, Fukuoka 8208502, Japan.	moriyama@ces.kyutech.ac.jp					Grant IS, 1990, ELECTROMAGNETISM; MOYSSIDES PG, 1986, J APPL PHYS, V59, P19, DOI 10.1063/1.336863; Schubert TF, 2009, IEEE T EDUC, V52, P57, DOI 10.1109/TE.2008.917195; Yeadon W, 2001, HDB SMALL ELECT MOTO	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1931-4973	1931-4981		IEEJ T ELECTR ELECTR	IEEJ Trans. Electr. Electron. Eng.	JAN	2015	10	1					12	17		10.1002/tee.22071		6	Engineering, Electrical & Electronic	Engineering	AX1KI	WOS:000346705700002		
J	Ding, M; She, JH; Yokoyama, R; Wu, M; Cao, WH				Ding, Min; She, Jinhua; Yokoyama, Ryuichi; Wu, Min; Cao, Weihua			Two-Loop Power-Flow Control of Grid-Connected Microgrid Based on Equivalent-Input-Disturbance Approach	IEEJ TRANSACTIONS ON ELECTRICAL AND ELECTRONIC ENGINEERING			English	Article						power-flow control; distributed generation; pq theory; equivalent input disturbance; grid-connected microgrid	STRATEGIES; INVERTERS; REJECTION; SYSTEMS	This study employed the equivalent-input-disturbance (EID) approach to devise a two-loop power-flow control system that controls the output current of an inverter so as to regulate the flow of active and reactive power between a distributed generation unit and a utility grid. It actively eliminates disturbances that degrade the power quality of a microgrid. The pq theory and an all-pass filter are employed to generate an instantaneous reference current for the control system based on the prescribed active and reactive power of a utility grid terminal. The inner loop consists of a disturbance compensator and a state observer. The disturbance compensator uses information acquired from the state observer to estimate disturbances, such as drops and harmonics in the grid voltage, and compensates for them by incorporating the equivalent input disturbance into the control law. The outer loop consists of a resonance-based internal model and a state-feedback controller, which enables the output current of inverter to track the instantaneous reference current. The small-gain theorem ensures the stability of the system. The system improves the power quality and guarantees that the flow of active and reactive power from the grid and inverter has low harmonic distortion. Simulations demonstrated the effectiveness of the system. (c) 2014 Institute of Electrical Engineers of Japan. Published by John Wiley & Sons, Inc.	[Ding, Min; Yokoyama, Ryuichi] Waseda Univ, Grad Sch Environm & Energy Engn, Tokyo 1698555, Japan; [Ding, Min; Wu, Min; Cao, Weihua] China Univ Geosci, Sch Automat, Wuhan 430074, Peoples R China; [She, Jinhua] Cent S Univ, Sch Informat Sci & Engn, Changsha 410083, Hunan, Peoples R China; [She, Jinhua] Tokyo Univ Technol, Sch Comp Sci, Hachioji, Tokyo 1920982, Japan	Cao, WH (reprint author), China Univ Geosci, Sch Automat, Wuhan 430074, Peoples R China.	weihuacao@cug.edu.cn			National Natural Science Foundation of China [61210011]	The authors wish to thank Dr. Jie Zhang and Mr. Luefeng Chen for helpful advice and discussions. This work was supported by the National Natural Science Foundation of China under Grant 61210011.	AKAGI H, 1984, IEEE T IND APPL, V20, P625, DOI 10.1109/TIA.1984.4504460; Itkonen T, 2009, IEEE T POWER ELECTR, V24, P2446, DOI 10.1109/TPEL.2009.2033064; Qian W, 2005, IEEE T ENERGY CONVER, V20, P53, DOI 10.1109/TEC.2004.841513; Zmood DN, 2003, IEEE T POWER ELECTR, V18, P814, DOI 10.1109/TPEL.2003.810852; Ho CNM, 2009, IEEE T POWER ELECTR, V24, P2484, DOI 10.1109/TPEL.2009.2031804; Jang SI, 2004, IEEE T POWER DELIVER, V19, P745, DOI 10.1109/TPWRD.2003.822964; Lopes JAP, 2006, IEEE T POWER SYST, V21, P916, DOI 10.1109/TPWRS.2006.873018; Saitou M, 2003, IEEE IND APPLIC SOC, P1222; Katiraei F, 2006, IEEE T POWER SYST, V21, P1821, DOI 10.1109/TPWRS.2006.879260; Lascu C, 2007, IEEE T POWER ELECTR, V22, P1826, DOI 10.1109/TPEL.2007.904060; Dasgupta S, 2011, IEEE T POWER ELECTR, V26, P732, DOI 10.1109/TPEL.2010.2096590; Blaabjerg F, 2006, IEEE T IND ELECTRON, V53, P1398, DOI 10.1109/TIE.2006.881997; Dasgupta S, 2011, IEEE T POWER ELECTR, V26, P717, DOI 10.1109/TPEL.2010.2096479; Khajehoddin SA, 2013, IEEE T POWER ELECTR, V28, P221, DOI 10.1109/TPEL.2012.2197866; Tang Y, 2010, IEEE T POWER ELECTR, V25, P2786, DOI 10.1109/TPEL.2010.2051337; Carastro F, 2006, 32 ANN C IEEE IND EL, P2546; Gonzalez M, 2004, 2004 IEEE 9TH INTERNATIONAL POWER ELECTRONICS CONGRESS, TECHNICAL PROCEEDINGS, P177; Dai M, 2008, IEEE T POWER ELECTR, V23, P343, DOI 10.1109/TPEL.2007.911815; She JH, 2008, IEEE T IND ELECTRON, V55, P380, DOI 10.1109/TIE.2007.905976; She JH, 2007, IEEE T VEH TECHNOL, V56, P3722, DOI [10.1109/TVT.2007.904543, 10.1109/TVT2007.904543]; She JH, 2011, IEEE-ASME T MECH, V16, P330, DOI 10.1109/TMECH.2010.2043258; Tang X, 2012, IEEE T ENERGY CONVER, V27, P213, DOI 10.1109/TEC.2012.2183874; Tarafdar Haque M., 1941, IEEE REG 10 C COMP C, V3, P1941	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1931-4973	1931-4981		IEEJ T ELECTR ELECTR	IEEJ Trans. Electr. Electron. Eng.	JAN	2015	10	1					36	43		10.1002/tee.22076		8	Engineering, Electrical & Electronic	Engineering	AX1KI	WOS:000346705700005		
J	Kitajima, T; Yasuno, T				Kitajima, Takahiro; Yasuno, Takashi			Maximum Power Control System for Small Wind Turbine using Predicted Wind Speed	IEEJ TRANSACTIONS ON ELECTRICAL AND ELECTRONIC ENGINEERING			English	Article						maximum power; variable speed; wind generator; wind speed prediction	ENERGY-CONVERSION; POINT TRACKING; GENERATION; DIFFUSER; DESIGN	This paper describes a novel approach of maximum power control for small wind turbines by using predicted wind speed data. Because of the moment of inertia of the wind turbine, when using conventional control method, the time lag of control will occur due to turbulence in the environment. Our proposed control system uses future information, which is the predicted wind speed, for wind turbine control. The control algorithm creates a reference trajectory of the rotational speed of the wind turbine. The advantage of using the predicted data is that the controller can operate the wind turbine efficiently so that the rotational speed of the wind turbine catches up with the reference speed at the maximum power point. Simulation results show improvement of generation efficiency compared to the conventional control method. Then we discuss the influence of the prediction error of wind speed on control performance. (c) 2014 Institute of Electrical Engineers of Japan. Published by John Wiley & Sons, Inc.	[Kitajima, Takahiro; Yasuno, Takashi] Univ Tokushima, Fac Engn, Dept Elect & Elect Engn, Tokushima 7708506, Japan	Kitajima, T (reprint author), Univ Tokushima, Fac Engn, Dept Elect & Elect Engn, 2-1 Minami Josanjima, Tokushima 7708506, Japan.	kitaji-t@ee.tokushima-u.ac.jp					Matsushima T, 2006, RENEW ENERG, V31, P1343, DOI 10.1016/j.renene.2005.07.008; Grant A, 2008, RENEW ENERG, V33, P1157, DOI 10.1016/j.renene.2007.08.005; Kazmi SMR, 2011, IEEE T IND ELECTRON, V58, P29, DOI 10.1109/TIE.2010.2044732; Kim KH, 2013, IEEE T IND ELECTRON, V60, P3207, DOI 10.1109/TIE.2012.2200210; Ohya Y, 2008, J WIND ENG IND AEROD, V96, P524, DOI 10.1016/j.jweia.2008.01.006; Ostergaard KZ, 2009, INT J ROBUST NONLIN, V19, P92, DOI 10.1002/rnc.1340; De Broe AM, 1999, IEEE T ENERGY CONVER, V14, P1630, DOI 10.1109/60.815116; Mirecki A, 2007, IEEE T IND ELECTRON, V54, P660, DOI 10.1109/TIE.2006.885456; Muljadi E, 2001, IEEE T IND APPL, V37, P240, DOI 10.1109/28.903156; Chen JW, 2013, IEEE T IND ELECTRON, V60, P2652, DOI 10.1109/TIE.2012.2196901; Chen J, 2013, IEEE T IND ELECTRON, V60, P5050, DOI 10.1109/TIE.2012.2225401; BOX GEP, 1958, ANN MATH STAT, V29, P610, DOI 10.1214/aoms/1177706645; Dayan E, 2006, REFOCUS, V7, P36; Dayan E, 2006, REFOCUS, V7, P33, DOI 10.1016/S1471-0846(06)70545-5; Fujimura N, IEEJ T POWER ENERGY, V129, P614; Hayasaki N, 2008, P 13 NAT S POW EN S; Kadokura S, 2009, V08065 CRIEPI; Kawahito T, 1994, IEEJ T POWER ENERGY, V114, P283; Kitajima T, 2013, IEEJ T ELECTR ELECTR, V8, P33, DOI 10.1002/tee.21788; Koutroulis E, 2006, IEEE T IND ELECTRON, V53, P486, DOI 10.1109/TIE.2006.870658; Putrus G, 2009, P CIRED 2009 PRAG CZ, P542; Sori H, 2008, J SIGNAL PROCESSING, V12, P507; Suzuki T., 1988, Transactions of the Society of Instrument and Control Engineers, V24; Tanaka T, 1997, RENEW ENERG, V12, P387, DOI 10.1016/S0960-1481(97)00055-4; Watson SJ, 2007, J PHYS CONF SER, V75, P12001, DOI 10.1088/1742-6596/75/1/012001; Yaoqin J, 2002, P IEEE INT C POW SYS, P144	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1931-4973	1931-4981		IEEJ T ELECTR ELECTR	IEEJ Trans. Electr. Electron. Eng.	JAN	2015	10	1					55	62		10.1002/tee.22065		8	Engineering, Electrical & Electronic	Engineering	AX1KI	WOS:000346705700008		
J	Imura, A; Takahashi, T; Fujitsuna, M; Zanma, T; Doki, S				Imura, Akihiro; Takahashi, Tomoya; Fujitsuna, Masami; Zanma, Tadanao; Doki, Shinji			Improved PMSM Model Considering Flux Characteristics for Model Predictive-Based Current Control	IEEJ TRANSACTIONS ON ELECTRICAL AND ELECTRONIC ENGINEERING			English	Article						permanent magnet synchronous motor (PMSM); model predictive control (MPC); motor model; magnetic saturation; current control	MAGNET SYNCHRONOUS MOTOR; SATURATION; TORQUE	Model predictive-based current control, which was proposed in our previous study, offers better current response performance by employing mathematical models of an inverter and a permanent magnet synchronous motor (PMSM). The performance of this kind of approach depends on the predictive model. From a more practical point of view, current behavior in the steady state should be improved. In our previous model predictive-based current control, the inverter model was refined by taking the dead-time into consideration. The use of the refined inverter model reduces the current offset in the control. However, the PMSM model was not investigated. This paper proposes a more appropriate PMSM model for model predictive-based current control in order to improve the current prediction in the steady state. For the purpose, we incorporate more detailed magnetic flux characteristics instead of average characteristics into the improved PMSM model. Specifically, in the improved PMSM model, the inductance of the PMSM is divided into transient and steady-state parts on the basis of magnetic saturation. The effectiveness of the improved model in the model predictive-based current control is demonstrated through simulations and experiments. (c) 2014 Institute of Electrical Engineers of Japan. Published by John Wiley & Sons, Inc.	[Imura, Akihiro; Takahashi, Tomoya; Fujitsuna, Masami] DENSO CORP, Engn Res & Dev Ctr, Kariya, Aichi 4488661, Japan; [Zanma, Tadanao] Chiba Univ, Grad Sch Engn, Div Artificial Syst Sci, Inage Ku, Chiba 2638522, Japan; [Imura, Akihiro; Doki, Shinji] Nagoya Univ, Grad Sch Engn, Dept Elect Engn & Comp Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Imura, A (reprint author), DENSO CORP, Engn Res & Dev Ctr, 1-1 Showa, Kariya, Aichi 4488661, Japan.	AKIHIRO_IMURA@denso.co.jp					Geyer T, 2009, IEEE T IND ELECTRON, V56, P1894, DOI 10.1109/TIE.2008.2007030; Mademlis C, 2001, IEEE T ENERGY CONVER, V16, P246, DOI 10.1109/60.937204; Pacas M, 2005, IEEE T IND ELECTRON, V52, P1350, DOI 10.1109/TIE.2005.855662; Stumberger B, 2003, IEEE T IND APPL, V39, P1264, DOI 10.1109/TIA.2003.816538; Hagino M., 2011, P 2011 14 EUR C POW; Imura A., 2011, PROC OF IEEE THE 37T, P3551; Imura A, 2014, IEEJ T ELECTR ELECTR, V9, P83, DOI 10.1002/tee.21939; Jebai AK, 2011, P IEEE EL MACH DRIV, P1316; Kano Y, 2004, P IEEJ TECHN M ROT M, P13; Maciejowski Jan M., 2001, PREDICTIVE CONTROL C; Maeda T, 2011, P 37 ANN IEEE IND EL, P1826; Matsutani S., 2009, P ICROS SICE INT JOI, P4847; Matsutani S, 2008, P IEEE 34 ANN C IND, P1305; Nakatsugawa J, 2010, IEEJ T IND APPL, V130, P1212; Yamazaki K, 2011, P IEEJ IND APPL SOC, P179; Yan Y, 2006, 37 IEEE POW EL SPEC, P1	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1931-4973	1931-4981		IEEJ T ELECTR ELECTR	IEEJ Trans. Electr. Electron. Eng.	JAN	2015	10	1					92	100		10.1002/tee.22070		9	Engineering, Electrical & Electronic	Engineering	AX1KI	WOS:000346705700013		
J	Imai, S; Adachi, K				Imai, Satomitsu; Adachi, Koji			Fundamental Characteristics of a MEMS-Diaphragm Actuator using a Thermal Expansion Drive Composed of a Conductive Polymer	IEEJ TRANSACTIONS ON ELECTRICAL AND ELECTRONIC ENGINEERING			English	Article						conductive polymer; thermal expansion drive; actuator; diaphragm; MEMS; polythiophene	POLYIMIDE MEMBRANE	Performance of a MEMS actuator using a thermal expansion drive of a conductive polymer (CP) is investigated by applying electricity to it. The actuator consists of a thin polymer diaphragm (5 mm diameter) and a thin CP (ion-doped polythiophene) layer coated on the diaphragm surface. Polyimide (10 m thickness) and PET (110 m thickness) sheets were chosen as the diaphragm materials. The diaphragm is deflected by the thermal expansion of the CP by applying electricity to it. Merits of using the CP instead of metal are realizing flexible actuators and the applicability to a low-heat-resistant material diaphragm. The relationship between thickness of the CP layer (10-50 m thickness) and electrical resistance (30-600 ) and the relationship between the input voltage (1-8 V) and the generated diaphragm displacement (several tens of micrometers) were investigated experimentally. These relationships were compared with those in the case of using the thermal expansion of a vapor-deposited aluminum layer (0.1 m thickness). The results of the investigation indicate that the diaphragm based on CP can produce the required displacement. In the case the CP-layer-based thermal expansion, however, larger input voltage than in the case of the aluminum-layer-based thermal expansion is needed to obtain the same displacement amplitudes. Therefore, the main problem concerning use of the CP-based diaphragm is considered to be enhancing the electrical conductance of the CP layer. (c) 2014 Institute of Electrical Engineers of Japan. Published by John Wiley & Sons, Inc.	[Imai, Satomitsu; Adachi, Koji] Nihon Univ, Coll Sci & Technol, Funabashi, Chiba 2748501, Japan	Imai, S (reprint author), Nihon Univ, Coll Sci & Technol, 7-24-1 Narashinodai, Funabashi, Chiba 2748501, Japan.	imai@eme.cst.nihon-u.ac.jp					Galineau J, 2013, SENSOR ACTUAT A-PHYS, V189, P117, DOI 10.1016/j.sna.2012.09.021; Chen Z, 2011, SENSOR ACTUAT A-PHYS, V168, P131, DOI 10.1016/j.sna.2011.02.034; Stanczyk T, 2000, J MICROELECTROMECH S, V9, P314, DOI 10.1109/84.870057; Svedberg M, 2006, SENSOR ACTUAT A-PHYS, V125, P534, DOI 10.1016/j.sna.2005.08.015; Imai S, 2013, PRECIS ENG, V37, P572, DOI 10.1016/j.precisioneng.2013.01.002; Aslam M, 2004, SENSOR ACTUAT B-CHEM, V103, P153, DOI 10.1016/j.snb.2004.04.102; Briand D, 2006, SENSOR ACTUAT A-PHYS, V132, P317, DOI 10.1016/j.sna.2006.06.003; Butler JT, 1999, SENSOR ACTUAT A-PHYS, V72, P88, DOI 10.1016/S0924-4247(98)00211-8; Carlen ET, 2002, J MICROELECTROMECH S, V11, P165, DOI 10.1109/JMEMS.2002.1007394; Dearing SS, 2010, SENSOR ACTUAT A-PHYS, V157, P210, DOI 10.1016/j.sna.2009.11.017; Enikov ET, 2012, SENSOR ACTUAT A-PHYS, V105, P16; Gerrati AP, 2011, INT C MICR SYST CANC, P332; Hitachi Chemical DuPont MicroSystems, 2003, HIGH HEAT RES FIN PO; Hoffmann M, 1999, SENSOR ACTUAT A-PHYS, V78, P28, DOI 10.1016/S0924-4247(99)00200-9; Imai S, 2012, J ADV MECH DES SYST, V6, P287, DOI 10.1299/jamdsm.6.287; Kato W, 1974, BASICS APPL ELASTICI, P270; Lin P-Y, 2011, J OPTICS, V13, P1; Meng E, 2009, IEEE ENG MED BIO, P1039, DOI 10.1109/IEMBS.2009.5334826; Naka Y, 2009, ICCAS SICE, P4761; Ouyang G, 2010, SENSOR ACTUAT A-PHYS, V158, P313, DOI 10.1016/j.sna.2010.02.006; R&D center of Shin-Etsu Polymer Co. Ltd, 2011, SEPLEGYDA OC AE401; Shearwood C, 1996, MICROELECTRONIC ENG, V30, P1; Wego A, 2001, SENSOR ACTUAT A-PHYS, V88, P220, DOI 10.1016/S0924-4247(00)00519-7; Yao Q, 2008, SENSOR ACTUAT A-PHYS, V144, P176, DOI 10.1016/j.sna.2008.01.005	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1931-4973	1931-4981		IEEJ T ELECTR ELECTR	IEEJ Trans. Electr. Electron. Eng.	JAN	2015	10	1					101	108		10.1002/tee.22075		8	Engineering, Electrical & Electronic	Engineering	AX1KI	WOS:000346705700014		
J	Noda, T; Nakamatsu, T; Mekaru, T				Noda, Taku; Nakamatsu, Toshihiro; Mekaru, Takehiro			Measurement of Cable Resistance at High Frequencies	IEEJ TRANSACTIONS ON ELECTRICAL AND ELECTRONIC ENGINEERING			English	Article						frequency response; measurement; power cables; resistance; skin effect		Because of the presence of large capacitance, measuring the series resistance of a cable as a voltage drop is not an easy task especially at high frequencies. Considering this fact, this letter proposes a method to extract series resistance values of a single-core cable at high frequencies from the measured frequency response of its open-ended input impedance. The proposed method has been applied to the measurement of the series resistance of an existing 66-kV underground cable, and the result is presented. (c) 2014 Institute of Electrical Engineers of Japan. Published by John Wiley & Sons, Inc.	[Noda, Taku] Cent Res Inst Elect Power Ind, Elect Power Engn Res Lab, Yokosuka, Kanagawa, Japan; [Nakamatsu, Toshihiro; Mekaru, Takehiro] Okinawa Elect Power Co, Power Syst Management Dept, Urasoe, Okinawa, Japan	Noda, T (reprint author), Cent Res Inst Elect Power Ind, Elect Power Engn Res Lab, Yokosuka, Kanagawa, Japan.	takunoda@ieee.org					WEDEPOHL LM, 1973, P I ELECTR ENG, V120, P253; Schelkunoff SA, 1934, BELL SYST TECH J, V13, P532; AMETANI A, 1980, IEEE T POWER AP SYST, V99, P902, DOI 10.1109/TPAS.1980.319718; Katsuta G, 1990, ANN M REC IEEJ; Noda T, 2008, IEEJ T ELECTR ELECTR, V3, P549, DOI 10.1002/tee.20312	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1931-4973	1931-4981		IEEJ T ELECTR ELECTR	IEEJ Trans. Electr. Electron. Eng.	JAN	2015	10	1					112	113		10.1002/tee.22069		2	Engineering, Electrical & Electronic	Engineering	AX1KI	WOS:000346705700016		
J	Tachioka, Y; Narita, T; Ishii, J				Tachioka, Yuuki; Narita, Tomohiro; Ishii, Jun			Semi-Blind Source Separation using Binary Masking and Independent Vector Analysis	IEEJ TRANSACTIONS ON ELECTRICAL AND ELECTRONIC ENGINEERING			English	Article						binary masking; independent vector analysis; automatic speech recognition		Recent prevalence of speech recognition system increases the opportunity of simultaneous recognition of multiple speakers' utterances. There are two types of source separation methods: physical and statistical. The former is based on the physical information such as a direction of arrival of sound sources. The latter only uses statistical independence. The advantage of the former is fast computation and effectiveness with precise information; and that of the latter is no need for physical information, which leads to the robustness of measurement errors. In this paper, we propose to combine these approaches effectively. Experiments on a speech recognition task show that the proposed method can achieve the upper limit performance of the two approaches. (c) 2014 Institute of Electrical Engineers of Japan. Published by John Wiley & Sons, Inc.	[Tachioka, Yuuki; Narita, Tomohiro; Ishii, Jun] Mitsubishi Electr Corp, Informat Technol R&D Ctr, Kamakura, Kanagawa 2478501, Japan	Tachioka, Y (reprint author), Mitsubishi Electr Corp, Informat Technol R&D Ctr, 5-1-1 Ofuna, Kamakura, Kanagawa 2478501, Japan.	Tachioka.Yuki@eb.MitsubishiElectric.co.jp					Murata N, 2001, NEUROCOMPUTING, V41, P1, DOI 10.1016/S0925-2312(00)00345-3; Ono N, 2011, 2011 IEEE WORKSHOP ON APPLICATIONS OF SIGNAL PROCESSING TO AUDIO AND ACOUSTICS (WASPAA), P189, DOI 10.1109/ASPAA.2011.6082320; Sawada H, 2011, IEEE T AUDIO SPEECH, V19, P516, DOI 10.1109/TASL.2010.2051355; Tachioka Yuuki, 2012, Acoustical Science and Technology, V33, DOI 10.1250/ast.33.68	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1931-4973	1931-4981		IEEJ T ELECTR ELECTR	IEEJ Trans. Electr. Electron. Eng.	JAN	2015	10	1					114	115		10.1002/tee.22072		2	Engineering, Electrical & Electronic	Engineering	AX1KI	WOS:000346705700017		
J	Akiyama, S; Thuswaldner, JM; Zaimi, T				Akiyama, Shigeki; Thuswaldner, Joerg M.; Zaimi, Toufik			Characterisation of the numbers which satisfy the height reducing property	INDAGATIONES MATHEMATICAE-NEW SERIES			English	Article						Height of polynomials; Special algebraic numbers; Representations of algebraic numbers		Let a be a complex number. We show that there is a finite subset F of the ring of the rational integers Z, such that F [alpha] = Z [alpha], if and only if a is an algebraic number whose conjugates, over the field of the rationals, are all of modulus one, or all of modulus greater than one. This completes the answer to a question, on the numbers satisfying the height reducing property, posed in Akiyama and Zemi (2013). (C) 2014 Royal Dutch Mathematical Society (KWG). Published by Elsevier B.V. All rights reserved.	[Akiyama, Shigeki] Univ Tsukuba, Inst Math, Tsukuba, Ibaraki 3500006, Japan; [Thuswaldner, Joerg M.] Leoben Univ, Dept Math & Stat, A-8700 Leoben, Austria; [Zaimi, Toufik] Larbi Ben Mhidi Univ, Dept Math & Informat, Oum El Bouaghi 04000, Algeria	Zaimi, T (reprint author), Larbi Ben Mhidi Univ, Dept Math & Informat, Oum El Bouaghi 04000, Algeria.	akiyama@math.tsukuba.ac.jp; joerg.thuswaldner@unileoben.ac.at; toufikzaimi@yahoo.com			project "Fractals and Numeration" - Austrian Science Fund [11136]; project "Discrete Mathematics" - Austrian Science Fund [W1230]	We thank the referee for careful reading of this paper. The second author was supported by projects "Fractals and Numeration" (11136) and "Discrete Mathematics" (W1230) funded by the Austrian Science Fund.	Akiyama S., COMMENTS HEIGH UNPUB; Akiyama S, 2013, CENT EUR J MATH, V11, P1616, DOI 10.2478/s11533-013-0262-4; Akiyama S, 2012, FUNCT APPROX COMM MA, V47, P105, DOI 10.7169/facm/2012.47.1.9; Lagarias JC, 1997, J FOURIER ANAL APPL, V3, P83, DOI 10.1007/BF02647948; Petho A., 2004, P 2003 NAG C FUR TOT, P115; Steiner W., 2015, T AM MATH S IN PRESS	6	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0019-3577	1872-6100		INDAGAT MATH NEW SER	Indag. Math.-New Ser.	JAN	2015	26	1					24	27				4	Mathematics	Mathematics	AY0CK	WOS:000347265300003		
J	Akiyama, S; Thuswaldner, JM; Zaimi, T				Akiyama, Shigeki; Thuswaldner, Joerg M.; Zaimi, Toufik			Comments on the height reducing property II	INDAGATIONES MATHEMATICAE-NEW SERIES			English	Article						Height of polynomials; Special algebraic numbers; Number systems	GENERALIZED RADIX REPRESENTATIONS; CANONICAL NUMBER-SYSTEMS; DYNAMICAL-SYSTEMS; QUADRATIC FIELDS; INTEGERS	A complex number a is said to satisfy the height reducing property if there is a finite set F subset of Z such that Z[alpha] = F[alpha], where Z is the ring of the rational integers. It is easy to see that a is an algebraic number when it satisfies the height reducing property. We prove the relation Card(F) >= max {2, vertical bar M-alpha (0)vertical bar}, where M-alpha is the minimal polynomial of a over the field of the rational numbers, and discuss the related optimal cases, for some classes of algebraic numbers a. In addition, we show that there is an algorithm to determine the minimal height polynomial of a given algebraic number, provided it has no conjugate of modulus one. (C) 2014 Royal Dutch Mathematical Society (KWG). Published by Elsevier B.V. All rights reserved.	[Akiyama, Shigeki] Univ Tsukuba, Inst Math, Tsukuba, Ibaraki 3500006, Japan; [Thuswaldner, Joerg M.] Leoben Univ, Dept Math & Stat, A-8700 Leoben, Austria; [Zaimi, Toufik] Larbi Ben Mhidi Univ, Dept Math & Informat, Oum El Bouaghi 04000, Algeria	Zaimi, T (reprint author), Larbi Ben Mhidi Univ, Dept Math & Informat, Oum El Bouaghi 04000, Algeria.	akiyama@math.tsulcuba.ac.jp; joerg.thuswaldner@unileoben.ac.at; toufikzahni@yahoo.com			Austrian Science Fund [11136, W1230]	The second author was supported by projects 11136 and W1230 funded by the Austrian Science Fund.	Akiyama S, 2008, ISR J MATH, V168, P53, DOI 10.1007/s11856-008-1056-4; Akiyama S, 2013, CENT EUR J MATH, V11, P1616, DOI 10.2478/s11533-013-0262-4; Akiyama S, 2013, J NUMBER THEORY, V133, P375, DOI 10.1016/j.jnt.2012.07.015; Akiyama S, 2012, FUNCT APPROX COMM MA, V47, P105, DOI 10.7169/facm/2012.47.1.9; Akiyama S, 2015, INDAGAT MATH NEW SER, V26, P24; Akiyama S, 2005, ACTA MATH HUNG, V108, P207, DOI 10.1007/s10474-005-0221-z; GILBERT WJ, 1981, J MATH ANAL APPL, V83, P264, DOI 10.1016/0022-247X(81)90262-6; Akiyama S, 2006, ACTA ARITH, V121, P21, DOI 10.4064/aa121-1-2; KATAI I, 1981, ACTA MATH ACAD SCI H, V37, P159, DOI 10.1007/BF01904880; KOVACS B, 1981, ACTA MATH ACAD SCI H, V37, P405, DOI 10.1007/BF01895142; Berthe Valerie, 2005, INTEGERS, V5, pA2; Eilenberg S., 1974, PURE APPL MATH, V58; Farkas G., 1999, ANN U SCI BUDAP C, V18, P47; Fuchs C, 2006, ANN I FOURIER, V56, P2345; German L, 2007, ACTA MATH HUNG, V115, P155, DOI 10.1007/s10474-007-5224-5; GRUNWALD V., 1885, GIORNALE MATEMATICHE, V23; Katai I., 1999, ANN U SCI BUDAPEST S, V18, P103; Katai I., 1994, ANN U SCI BUDAPEST S, V14, P91; Lagarias JC, 1997, J FOURIER ANAL APPL, V3, P83, DOI 10.1007/BF02647948; Petho A., 2004, P 2003 NAG C YOK CHO, P115; Siegel A., 2009, MEM SOC MATH FR, V118, P140; STEIDL G, 1989, BIT, V29, P563, DOI 10.1007/BF02219240; van de Woestijne C, 2008, J NUMBER THEORY, V128, P2914, DOI 10.1016/j.jnt.2008.02.012; Zaimi T, 2007, J NUMBER THEORY, V127, P103, DOI 10.1016/j.jnt.2007.01.014; Zaimi T., 2010, J THEOR NOMBR BORDX, V22, P513	25	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0019-3577	1872-6100		INDAGAT MATH NEW SER	Indag. Math.-New Ser.	JAN	2015	26	1					28	39				12	Mathematics	Mathematics	AY0CK	WOS:000347265300004		
J	Sato, C; Goglio, L				Sato, Chiaki; Goglio, Luca			Special Issue: Special Issue On Impact Phenomena Of Adhesively Bonded Joints	INTERNATIONAL JOURNAL OF ADHESION AND ADHESIVES			English	Editorial Material									[Sato, Chiaki] Tokyo Inst Technol, Precis & Intelligence Lab, Tokyo 152, Japan; [Goglio, Luca] Politecn Torino, Dept Mech & Aerosp Engn, Turin, Italy	Sato, C (reprint author), Tokyo Inst Technol, Precis & Intelligence Lab, Tokyo 152, Japan.	csato@pi.titech.ac.jp						0	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0143-7496	1879-0127		INT J ADHES ADHES	Int. J. Adhes. Adhes.	JAN	2015	56				SI		1	2		10.1016/j.ijadhadh.2014.09.006		2	Engineering, Chemical; Materials Science, Multidisciplinary	Engineering; Materials Science	AX8BI	WOS:000347135200001		
J	Yokoyama, T; Nakai, K				Yokoyama, Takashi; Nakai, Kenji			Determination of the impact tensile strength of structural adhesive butt joints with a modified split Hopkinson pressure bar	INTERNATIONAL JOURNAL OF ADHESION AND ADHESIVES			English	Article						Epoxy; Al alloy, pure titanium; Butt joint, finite element stress analysis; Impact	SINGLE LAP JOINTS; FINITE-ELEMENT-ANALYSIS; FEM STRESS-ANALYSIS; STRAIN-RATE; DYNAMIC STRENGTH; SHEAR-STRENGTH; HOLLOW CYLINDERS; LOADS; COMPRESSION; DEFORMATION	The impact tensile strength of structural adhesive butt joints was determined with a modified split Hopkinson pressure bar using hat-shaped specimens. A typical two-part structural epoxy adhesive (Scotch weld (R) DP-460) and two different adherend materials (Al alloy 7075-T6 and commercially pure titanium) were used in the adhesion tests. The impact tensile strength of adhesive butt joints with similar adherends was evaluated from the peak value of the applied tensile stress history. The corresponding static tensile strengths were measured on an Instron testing machine using joint specimens of the same geometry as those used in the impact tests. An axisymmetric finite element analysis was performed to investigate the static elastic stress distributions in the adhesive layer of the joint specimens. The effects of loading rate, adherend material and adhesive thickness on the joint tensile strength were examined. The joint tensile strength was clearly observed to increase with the loading rate up to an order of 10(6) MPa/s, and decrease gradually with the adhesive thickness up to nearly 180 mu m, depending on the adherend materials used. The loading rate dependence of the tensile strength was herein discussed in terms of the dominant failure modes in the joint specimens after static and impact testing. (C) 2014 Elsevier Ltd. All rights reserved.	[Yokoyama, Takashi; Nakai, Kenji] Okayama Univ Sci, Dept Mech Engn, Okayama 7000005, Japan	Yokoyama, T (reprint author), Okayama Univ Sci, Dept Mech Engn, Okayama 7000005, Japan.	yokoyama@mech.ous.ac.jp			Light Metal Educational Foundation, Inc., Osaka, Japan [44]	The authors wish to acknowledge Professor Chiaki Sato from Tokyo Institute of Technology for his helpful comments on this work. Special thanks are also due to Tomoya Ikeda, a former graduate student, for his technical assistance in the experimental work. Financial support from the Light Metal Educational Foundation, Inc., Osaka, Japan (Educational Research Fund 44), is greatly appreciated.	Challita G, 2011, INT J ADHES ADHES, V31, P146, DOI 10.1016/j.ijadhadh.2010.11.014; Yokoyama T, 2012, J ADHESION, V88, P471, DOI 10.1080/00218464.2012.660813; Yokoyama T, 1998, JSME INT J A-SOLID M, V41, P503; Challita G, 2010, INT J ADHES ADHES, V30, P236, DOI 10.1016/j.ijadhadh.2010.02.004; Goglio L, 2008, INT J ADHES ADHES, V28, P329, DOI 10.1016/j.ijadhadh.2007.08.004; Adams RD, 1996, INT J ADHES ADHES, V16, P61, DOI 10.1016/0143-7496(95)00050-X; Sen O, 2011, INT J ADHES ADHES, V31, P541, DOI 10.1016/j.ijadhadh.2011.04.006; Iwamoto T, 2010, INT J SOLIDS STRUCT, V47, P175, DOI 10.1016/j.ijsolstr.2009.09.026; Galliot C, 2012, INT J ADHES ADHES, V35, P68, DOI 10.1016/j.ijadhadh.2012.02.002; Al-Zubaidy HA, 2012, COMPOS STRUCT, V94, P3258, DOI 10.1016/j.compstruct.2012.04.025; Kim JG, 2013, J ADHES SCI TECHNOL, V27, P794, DOI 10.1080/01694243.2012.727154; REEDY ED, 1993, INT J SOLIDS STRUCT, V30, P2929, DOI 10.1016/0020-7683(93)90204-K; Yokoyama T, 2003, J STRAIN ANAL ENG, V38, P233, DOI 10.1243/030932403765310563; [Anonymous], 1998, T76142 NF; Fancello E, 2008, J ADHES SCI TECHNOL, V22, P1523, DOI 10.1163/156856108X309495; Adamvalli M, 2008, INT J ADHES ADHES, V28, P321, DOI 10.1016/j.ijadhadh.2007.10.005; Kihara K, 2003, INT J ADHES ADHES, V23, P253, DOI 10.1016/S0143-7496(03)00004-6; Chen X, 2010, J ADHES SCI TECHNOL, V24, P291, DOI 10.1163/016942409X12529160192106; Sawa T, 2002, J ADHES SCI TECHNOL, V16, P1449, DOI 10.1163/156856102320252895; Goda Y, 2011, J ADHESION, V87, P766, DOI 10.1080/00218464.2011.597308; Sawa T, 2003, J ADHES SCI TECHNOL, V17, P2157, DOI 10.1163/156856103772150760; LINDHOLM US, 1968, EXP MECH, V8, P1, DOI 10.1007/BF02326244; Frew DJ, 2002, EXP MECH, V42, P93, DOI 10.1177/0018512002042001794; [Anonymous], 1995, ANN BOOK ASTM STAND; ADAMS RD, 1978, J STRAIN ANAL ENG, V13, P1, DOI 10.1243/03093247V131001; Raykhere SL, 2010, MATER DESIGN, V31, P2102, DOI 10.1016/j.matdes.2009.10.043; He XC, 2011, INT J ADHES ADHES, V31, P248, DOI 10.1016/j.ijadhadh.2011.01.006; Bezemer AA, 1998, INT J ADHES ADHES, V18, P255, DOI 10.1016/S0143-7496(97)00032-8; Graff KF, 1975, WAVE MOTION ELASTIC, P130; Higuchi I, 2002, J ADHES SCI TECHNOL, V16-12, P1585, DOI 10.1163/15685610260255233; Higuchi I, 1999, J ADHESION, V69, P59, DOI 10.1080/00218469908015919; Kishida K, 1984, I PHYC C SER, V70, P221; Kolsky H., 1949, Proceedings of the Physical Society. Section B, V62, DOI 10.1088/0370-1301/62/11/302; Liao LJ, 2011, INT J ADHES ADHES, V31, P612, DOI 10.1016/j.ijadhadh.2011.06.008; Martinez MA, 1998, INT J ADHES ADHES, V18, P375, DOI 10.1016/S0143-7496(98)00023-2; Riley WF, 1999, MECH MATER, P620; Sancaktar E, 2008, MODELING ADHESIVELY, P95, DOI 10.1007/978-3-540-79056-3_4; Sato C, 2000, INT J ADHES ADHES, V20, P17, DOI 10.1016/S0143-7496(99)00010-X; Sato C, 2005, ADHESIVE BONDING SCI, P164; Sato C, 1999, J ADHESION, V70, P57, DOI 10.1080/00218469908010487; Sato C, 2009, INT J ADHES ADHES, V29, P670, DOI 10.1016/j.ijadhadh.2009.02.005; Sawa T, 2003, J ADHES SCI TECHNOL, V17, P943, DOI 10.1163/156856103322112860; Srivastava V, 2000, J TEST EVAL, V28, P438; Sugaya Toru, 2011, Journal of Solid Mechanics and Materials Engineering, V5, DOI 10.1299/jmmp.5.921; Wang P, 2006, MECH MATER, V38, P1001, DOI 10.1016/j.mechmat.2005.10.002; Yokoyama Takashi, 2012, Journal of Solid Mechanics and Materials Engineering, V6, DOI 10.1299/jmmp.6.131; Yokoyama T, 2003, WELDING INT, V17-7, P514, DOI 10.1533/weli.17.7.514.24258; Zhao H, 2011, SCI TECHNOL WELD JOI, V16, P405, DOI 10.1179/1362171810Y.0000000011	48	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0143-7496	1879-0127		INT J ADHES ADHES	Int. J. Adhes. Adhes.	JAN	2015	56				SI		13	23		10.1016/j.ijadhadh.2014.07.011		11	Engineering, Chemical; Materials Science, Multidisciplinary	Engineering; Materials Science	AX8BI	WOS:000347135200003		
J	Adachi, T; Kataoka, T; Higuchi, M				Adachi, Tadaharu; Kataoka, Takao; Higuchi, Masahiro			Predicting impact shear strength of phenolic resin adhesive blended with nitrile rubber	INTERNATIONAL JOURNAL OF ADHESION AND ADHESIVES			English	Article						Impact; Phenolic; Strain rate-temperature dependence; Shear strength	TIME-TEMPERATURE DEPENDENCE; II FRACTURE-TOUGHNESS; SINGLE LAP JOINTS; BUTT JOINTS; VISCOELASTIC MATERIALS; TENSILE PROPERTIES; PEELING PROPERTIES; DYNAMIC STRENGTH; MODEL ADHESIVES; EPOXY-RESIN	The impact shear strength of phenolic resin adhesive blended with nitrile rubber in a double-lap steel joint was measured to discuss the applicability of the strain rate-temperature equivalent principle. This strain rate-temperature equivalent principle was confirmed to be applicable to the quasi-static shear strengths of the adhesive. Because phenolic resin adhesive blended with nitrite rubber was in the glass transition state under a quasi-static deformation at room temperature and its adhesive strength was sensitive to the strain rate, the impact strength of the adhesive could not be predicted without the strain rate-temperature equivalent principle. Instead, the impact strength of the adhesive measured by using a manufactured impact testing machine could be predicted approximately with quasi-static results at low temperature by using the principle. The strain rate-temperature equivalent principle was clarified to be sufficient for predicting impact strengths without the need for impact testing. (C) 2014 Elsevier Ltd. All rights reserved.	[Adachi, Tadaharu] Toyohashi Univ Technol, Dept Mech Engn, Toyohashi, Aichi 4418580, Japan; [Kataoka, Takao] Tokyo Inst Technol, Dept Mech Sci & Engn, Tokyo 152, Japan; [Higuchi, Masahiro] Kanazawa Univ, Fac Mech Engn, Kanazawa, Ishikawa, Japan	Adachi, T (reprint author), Toyohashi Univ Technol, Dept Mech Engn, Tempaku Ku, 1-1 Hibarigaoka, Toyohashi, Aichi 4418580, Japan.	adachi@me.tut.ac.jp					Adachi T, 2003, P I MECH ENG L-J MAT, V217, P29, DOI 10.1243/14644200360539418; GSELL C, 1981, J MATER SCI, V16, P1956, DOI 10.1007/BF00540644; Challita G, 2010, INT J ADHES ADHES, V30, P236, DOI 10.1016/j.ijadhadh.2010.02.004; Adams RD, 1996, INT J ADHES ADHES, V16, P61, DOI 10.1016/0143-7496(95)00050-X; Yokoyama T, 2003, J STRAIN ANAL ENG, V38, P233, DOI 10.1243/030932403765310563; Adamvalli M, 2008, INT J ADHES ADHES, V28, P321, DOI 10.1016/j.ijadhadh.2007.10.005; Kihara K, 2003, INT J ADHES ADHES, V23, P253, DOI 10.1016/S0143-7496(03)00004-6; SMITH TL, 1958, J POLYM SCI, V32, P99, DOI 10.1002/pol.1958.1203212409; AUBREY DW, 1980, J POLYM SCI POL CHEM, V18, P2597, DOI 10.1002/pol.1980.170180818; [Anonymous], 1984, INT J ADHES ADHES, DOI 10.1016/0143-7496(84)90055-1; Chen X, 2010, J ADHES SCI TECHNOL, V24, P291, DOI 10.1163/016942409X12529160192106; GENT AN, 1969, PROC R SOC LON SER-A, V310, P433, DOI 10.1098/rspa.1969.0085; Baldan A, 2004, J MATER SCI, V39, P4729, DOI 10.1023/B:JMSC.0000035317.87118.ab; Araki W, 2002, P I MECH ENG L-J MAT, V216, P79, DOI 10.1243/146442002320139289; Araki W, 2005, J APPL POLYM SCI, V96, P51, DOI 10.1002/app.21358; ATKINS AG, 1975, J MATER SCI, V10, P1381, DOI 10.1007/BF00540829; Banea MD, 2019, J ADHES SCI TECH, V24, P2011; Bezemer AA, 1998, INT J ADHES ADHES, V18, P255, DOI 10.1016/S0143-7496(97)00032-8; Buche F, 1955, J APPL PHYS, V26, P1133; Challita C, 2011, INT J ADHES ADHES, V31, P146; Derail C, 1997, J ADHESION, V61, P123, DOI 10.1080/00218469708010519; Derail C, 1998, J ADHESION, V68, P203, DOI 10.1080/00218469808029255; Ferry J. D, 1970, VISCOELASTIC PROPERT, P292; GENT AN, 1971, J POLYM SCI A2, V9, P659, DOI 10.1002/pol.1971.160090408; Goglio Rossetto L, 2008, INT J IMPACT ENG, V35, P635; GREENSMITH HW, 1960, T SOC RHEOL, V4, P179; Guiu A, 2002, INT J ADHES ADHES, V22, P415, DOI 10.1016/S0143-7496(02)00025-8; JORDAN M, 1988, INT J ADHES ADHES, V8, P39, DOI 10.1016/0143-7496(88)90056-5; Kasamori M., 1992, Journal of the Society of Materials Science, Japan, V41; Lim WW, 1997, J APPL POLYM SCI, V63, P835; LIM WW, 1995, J APPL POLYM SCI, V57, P55, DOI 10.1002/app.1995.070570106; MIYANO Y, 1995, COMPOSITES, V26, P713, DOI 10.1016/0010-4361(95)91138-U; North WPT, 1966, EXP MECH, V6, P337, DOI 10.1007/BF02327209; Sato C, 1999, J ADHESION, V70, P57, DOI 10.1080/00218469908010487; Srivastava V, 2000, J TEST EVAL, V28, P438; Ward IM, 1985, MECH PROPERTIES SOLI, P133; Wu J, 1994, J MATER SCI, V28, P3373; Yokoyama T, 1997, T JSME A, V63, P2604; Yokoyama T, 2006, J PHYS IV, V134, P789, DOI 10.1051/jp4:2006134122	39	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0143-7496	1879-0127		INT J ADHES ADHES	Int. J. Adhes. Adhes.	JAN	2015	56				SI		53	60		10.1016/j.ijadhadh.2014.07.010		8	Engineering, Chemical; Materials Science, Multidisciplinary	Engineering; Materials Science	AX8BI	WOS:000347135200008		
J	Hayashida, S; Sugaya, T; Kuramoto, S; Sato, C; Mihara, A; Onuma, T				Hayashida, Shota; Sugaya, Toru; Kuramoto, Satoshi; Sato, Chiaki; Mihara, Arata; Onuma, Takashi			Impact strength of joints bonded with high-strength pressure-sensitive adhesive	INTERNATIONAL JOURNAL OF ADHESION AND ADHESIVES			English	Article						Pressure-sensitive; Plastics; Fracture toughness; Impact; Double cantilever beam	FINITE-ELEMENT-ANALYSIS; COHESIVE ZONE MODEL; SPLIT HOPKINSON BAR; BUTT JOINTS; STRESS-RESPONSE; ENVIRONMENTAL DEGRADATION; MECHANICAL-BEHAVIOR; BENDING MOMENTS; SOFT ADHESIVES; SHEAR-STRENGTH	The impact strength of joints bonded with a double-coated high-strength pressure-sensitive adhesive (PSA) was experimentally investigated. PSA has recently been used to join parts of mobile devices such as smart-phones, which are often subjected to drop impacts. Consequently, the impact strength of PSA bonded joints has become important. Two types of specimens, butt joint specimens and double cantilever beam (DCB) specimens bonded with adhesives were utilized for the experiments. Quasi-static tests and impact tests of the specimens were carried out using a mechanical testing machine and an impact testing machine. The PSA layers in the specimens were observed using a high-speed digital camera. The deformation and strain distribution in the adherends of the DCB specimens were also measured using a novel high-speed digital camera with photoelastic imaging capability. Though the strength of the butt joints increased as the loading rate increased, the critical fracture energy of the DCB specimens decreased at high loading rates. This may be attributed to the transition to the brittle nature of the PSA in the loading range in which no cavitation occurred. To verify the critical fracture energy obtained with the DCB tests, finite element analyses (FEA) based on the cohesive zone model (CZM) were carried out, and the load-displacement curves of the DCB tests were simulated. The predicted results showed good agreements with the experimental results. (C) 2014 Elsevier Ltd. All rights reserved.	[Hayashida, Shota; Sugaya, Toru; Kuramoto, Satoshi] Tokyo Inst Technol, Midori Ku, Grad Sch, Yokohama, Kanagawa 2268503, Japan; [Sato, Chiaki] Tokyo Inst Technol, Precis & Intelligence Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Mihara, Arata; Onuma, Takashi] Photron Ltd, Chiyoda Ku, Tokyo 1020071, Japan	Sato, C (reprint author), Tokyo Inst Technol, Precis & Intelligence Lab, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268503, Japan.	csato@pi.titech.ac.jp					Loh WK, 2003, J ADHESION, V79, P1135, DOI 10.1080/00218460390268164; Yokoyama T, 1998, JSME INT J A-SOLID M, V41, P503; Josse G, 2004, J ADHESION, V80, P87, DOI 10.1080/00218460490276821; Zhang L, 2009, INT J ADHES ADHES, V29, P217, DOI 10.1016/j.ijadhadh.2008.05.002; Goglio L, 2008, INT J ADHES ADHES, V28, P329, DOI 10.1016/j.ijadhadh.2007.08.004; Adams RD, 1996, INT J ADHES ADHES, V16, P61, DOI 10.1016/0143-7496(95)00050-X; Christensen SF, 1998, INT J ADHES ADHES, V18, P333, DOI 10.1016/S0143-7496(98)00015-3; Loureiro AL, 2010, J ADHESION, V86, P765, DOI 10.1080/00218464.2010.482440; Yamaguchi T, 2006, EUR PHYS J E, V20, P7, DOI 10.1140/epje/i2005-10078-6; Yokoyama T, 2003, J STRAIN ANAL ENG, V38, P233, DOI 10.1243/030932403765310563; Georgiou I, 2003, J ADHESION, V79, P239, DOI 10.1080/00218460390148121; Rahul-Kumar P, 1999, ACTA MATER, V47, P4161, DOI 10.1016/S1359-6454(99)00276-1; Liljedahl CDM, 2006, J ADHESION, V82, P1061, DOI 10.1080/00218460600948495; Sawa T, 2003, J ADHES SCI TECHNOL, V17, P2157, DOI 10.1163/156856103772150760; Marzi S, 2009, J ADHES SCI TECHNOL, V23, P881, DOI 10.1163/156856109X411238; Diehl T, 2008, INT J ADHES ADHES, V28, P237, DOI 10.1016/j.ijadhadh.2007.06.003; Peykova Y, 2010, INT J ADHES ADHES, V30, P245, DOI 10.1016/j.ijadhadh.2010.02.005; Blackman BRK, 2003, INT J FRACTURE, V119, P25, DOI 10.1023/A:1023998013255; Higuchi I, 2003, J ADHESION, V79, P1017, DOI 10.1080/00218460390252422; Belingardi G, 2005, INT J ADHES ADHES, V25, P173, DOI 10.1016/j.ijadhadh.2004.06.004; Bezemer AA, 1998, INT J ADHES ADHES, V18, P255, DOI 10.1016/S0143-7496(97)00032-8; Blackman BRK, 2009, ENG FRACT MECH, V76, P2868, DOI 10.1016/j.engfracmech.2009.07.013; Blackman BRK, 2000, J MATER SCI, V35, P1867, DOI 10.1023/A:1004793730352; Brockmann W, 1996, INT J ADHES ADHES, V16, P81, DOI 10.1016/0143-7496(96)89797-1; Cayssials F, 1996, J ADHESION, V58, P281, DOI 10.1080/00218469608015206; Creton C, 1996, J POLYM SCI POL PHYS, V34, P545, DOI 10.1002/(SICI)1099-0488(199602)34:3<545::AID-POLB13>3.0.CO;2-I; Doi M, 2007, J NON-NEWTON FLUID, V145, P52, DOI 10.1016/j.jnnfm.2006.12.006; Gay C, 1999, PHYS REV LETT, V82, P936, DOI 10.1103/PhysRevLett.82.936; Goglio L, 2008, INT J IMPACT ENG, V35, P635, DOI 10.1016/j.ijimpeng.2007.02.006; HARRIS JA, 1985, P I MECH ENG C-J MEC, V199, P121; Higuchi I, 2002, J ADHES SCI TECHNOL, V16-12, P1585, DOI 10.1163/15685610260255233; Higuchi I, 1999, J ADHESION, V69, P59, DOI 10.1080/00218469908015919; Higuchi I, 2002, J ADHES SCI TECHNOL, V16, P1327, DOI 10.1163/156856102320252831; Horgnies M, 2007, INT J ADHES ADHES, V27, P661, DOI 10.1016/j.ijadhadh.2006.12.002; Hua Y, 2006, J ADHESION, V82, P135, DOI 10.1080/00218460600559557; KINLOCH AJ, 1987, J ADHESION, V24, P109, DOI 10.1080/00218468708075421; Creton C, 2000, J POLYM SCI POL PHYS, V38, P965, DOI 10.1002/(SICI)1099-0488(20000401)38:7<965::AID-POLB7>3.3.CO;2-#; Lakrout H, 1999, J ADHESION, V69, P307, DOI 10.1080/00218469908017233; Liljedahl CDM, 2007, INT J ADHES ADHES, V27, P505, DOI 10.1016/j.ijadhadh.2006.09.015; Muralidharan V, 2006, INT J ADHES ADHES, V26, P117, DOI 10.1016/j.ijadhadh.2005.03.001; Poh BT, 2007, J APPL POLYM SCI, V105, P680, DOI 10.1002/app.26072; Sato C, 1999, J ADHESION, V70, P57, DOI 10.1080/00218469908010487; Sawa T, 2003, J ADHES SCI TECHNOL, V17, P943, DOI 10.1163/156856103322112860; Sawa T, 1996, J ADHESION, V59, P1, DOI 10.1080/00218469608011072; Williams JA, 2008, INT J ADHES ADHES, V28, P192, DOI 10.1016/j.ijadhadh.2007.06.007; Yamaguchi T, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/64002; Yang HL, 2007, INT J ADHES ADHES, V27, P536, DOI 10.1016/j.ijadhadh.2006.09.014; Zosel A, 1998, INT J ADHES ADHES, V18, P265, DOI 10.1016/S0143-7496(98)80060-2	48	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0143-7496	1879-0127		INT J ADHES ADHES	Int. J. Adhes. Adhes.	JAN	2015	56				SI		61	72		10.1016/j.ijadhadh.2014.09.005		12	Engineering, Chemical; Materials Science, Multidisciplinary	Engineering; Materials Science	AX8BI	WOS:000347135200009		
J	Naz, I; Saifullah; Palomares-Rius, JE; Blok, V; Khan, SM; Ali, S; Baig, A				Naz, Ishrat; Saifullah; Emilio Palomares-Rius, Juan; Blok, Vivian; Khan, Shah Masaud; Ali, Sardar; Baig, Ayesha			Sustainable Management of the Southern Root-knot Nematode, Meloidogyne incognita (Kofoid and White) Chitwood, by Means of Amendments of Fumaria parviflora	INTERNATIONAL JOURNAL OF AGRICULTURE AND BIOLOGY			English	Article						Fumaria parviflora; Meloidogyne; Tomato; Dry amendments; Eco-friendly management	NEMATOCIDAL ACTIVITY; ORGANIC AMENDMENTS; IN-VITRO; RESISTANT; JAVANICA; TOMATOES; CROP	Greenhouse and field studies were conducted in the spring and autumn of 2010 to test the efficacy of dry amendments of Fumaria parviflora as a form of eco-friendly management of Meloidogyne incognita in tomato. Various preparations of F. parviflora (in the form of dry root, stem, leaf and whole plant powder) at different dose rates (10, 20 and 30 g per kg of soil) significantly reduced levels of M. incognita in the roots of tomato cv. Rio Grande, and promoted plant growth. The root amendments of F. parviflora at the highest application dose (30 g per kg of soil) were the most effective, significantly reducing the number of galls, the galling index, the egg masses per g of the root, and the adult females per g of the root. Shoot and root lengths, the fresh and the dry shoot weight, and the number of branches and flowers per plant were improved in greenhouse trials that were conducted in the spring and autumn. Under naturally infested field conditions, the root's amendment of F. parviflora at the highest application dose was the most effective, and reduced the number of galls, the GI, the number of egg masses per g of root, the adult females per g of root, and the reproduction factor (Rf). It also promoted plant, health and increased the number of fruits per plant and the fruit weight per plant in the spring and autumn experiment. Dry amendments of F. parviflora have remarkable nematicidal potential and could be used as an effective and environment-friendly management tool against M. incognita as an alternative to chemical control. (C) 2015 Friends Science Publishers	[Naz, Ishrat; Saifullah] Univ Agr, Dept Plant Pathol, Peshawar, Khyber Pakhtunk, Pakistan; [Emilio Palomares-Rius, Juan] Miyazaki Univ, Fac Med, Dept Parasitol, Kiyotake, Miyazaki 8891692, Japan; [Emilio Palomares-Rius, Juan] IAS, CSIC, Cordoba 14080, Spain; [Blok, Vivian] Univ Haripur, Dept Agr, Khyber Pakthunkhwa, Pakistan; [Khan, Shah Masaud; Ali, Sardar] James Hutton Inst, Cell & Mol Sci, Dundee DD2 5DA, Scotland; [Baig, Ayesha] Univ Agr, Inst Biotechnol & Genet Engn, Peshawar, Khyber Pakhtunk, Pakistan	Naz, I (reprint author), Univ Agr, Dept Plant Pathol, POB 25130, Peshawar, Khyber Pakhtunk, Pakistan.	ishratro@hotmail.com			Higher Education Commission (HEC) of Pakistan	This research, which forms part of the PhD study by Ishrat Naz, was supported by the Higher Education Commission (HEC) of Pakistan, under the indigenous scholarship programme.	Verdejo-Lucas S, 2009, PLANT PATHOL, V58, P990, DOI 10.1111/j.1365-3059.2009.02089.x; McSorley R, 2011, J NEMATOL, V43, P69; Thoden TC, 2011, NEMATOLOGY, V13, P133, DOI 10.1163/138855410X541834; SASSER JN, 1980, PLANT DIS, V64, P36; Hooks CRR, 2010, APPL SOIL ECOL, V46, P307, DOI 10.1016/j.apsoil.2010.09.005; Chitwood DJ, 2002, ANNU REV PHYTOPATHOL, V40, P221, DOI 10.1146/annurev.phyto.40.032602.130045; HUSSEY RS, 1973, PLANT DIS REP, V57, P1025; Wang KH, 2002, NEMATROPICA, V32, P35, DOI 10.1111/1467-9310.00237; DROPKIN VH, 1969, PHYTOPATHOLOGY, V59, P1632; Sorribas FJ, 2005, EUR J PLANT PATHOL, V111, P29, DOI 10.1007/s10658-004-1982-x; Oka Y, 2010, APPL SOIL ECOL, V44, P101, DOI 10.1016/j.apsoil.2009.11.003; DRINKWATER LE, 1995, ECOL APPL, V5, P1098, DOI 10.2307/2269357; Campbell C. L., 1990, INTRO PLANT DIS EPID; Conway G., 1995, DEPLETION NATURAL RE; D'Addabbo T., 2009, EUR J PLANT PATHOL, V125, P29; Devi N. R., 2011, Journal of Experimental Sciences, V2, P7; Faruk M. I., 2011, Bangladesh Journal of Agricultural Research, V36, P477; Gomez K.A., 1984, STAT PROCEDURES AGR; Hawa Z.E.J., 2012, MOLECULES, V17, P7305; Isakeit T, 2005, PLANT DIS, V89, P529, DOI 10.1094/PD-89-0529A; Khan S. A., 2011, Pakistan Journal of Phytopathology, V23, P9; Medina-Filho H.P., 1980, ACTA HORTIC, V100, P383; Moens Maurice, 2009, P1, DOI 10.1079/9781845934927.0001; Naz I, 2013, J AGR FOOD CHEM, V61, P5689, DOI 10.1021/jf401309r; Naz I., 2012, AFR J BIOTECHNOL, V11, P16546; Naz I, 2013, PLANT PATHOL, V62, P943, DOI 10.1111/j.1365-3059.2012.02682.x; Oka Y, 2013, PEST MANAG SCI, V69, P1225, DOI 10.1002/ps.3487; Pakeerathan K., 2009, American-Eurasian Journal of Agricultural and Environmental Science, V6, P494; Pariha K., 2012, BIOSCI INT, V1, P102; Perez MP, 2003, PLANT PATHOL, V52, P395, DOI 10.1046/j.1365-3059.2003.00859.x; Powers LE, 2000, ECOLOGICAL PRINCIPLE; Rahmatullah M., 2010, ADV NAT APPL SCI, V4, P105; Randhawa N., 2002, IND J NEMATOL, V32, P2; Sasser J. N., 1987, Vistas on Nematology: A Commemoration of the Twenty-fifth Anniversary of the Society of Nematologists, P7; Sasser J. N., 1990, ROOT KNOT NEWS MELOI, P477; Southey J.F., 1986, TECHNICAL B MAFF ADA, P202; Tandon V., 2011, EMERG TRENDS ZOOL, V11, P351; Tariq Marium, 2007, Turkish Journal of Biology, V31, P225; Taylor A. L., 1978, IDENTIFICATION CONTR; Vahabi S, 2011, J MED PLANTS RES, V5, P4870; Whitehead AG, 1998, PLANT NEMATODE CONTR	41	0	0	FRIENDS SCIENCE PUBL	FAISALABAD	399-B, PEOPLES COLONY NO 1, FAISALABAD, 38090, PAKISTAN	1560-8530	1814-9596		INT J AGRIC BIOL	Int. J. Agric. Biol.		2015	17	2					289	296				8	Agriculture, Multidisciplinary; Biology	Agriculture; Life Sciences & Biomedicine - Other Topics	AY0TI	WOS:000347309400008		
J	Matsumura, Y; Tanaka, M; Yamamoto, M; Nagao, M; Machida, K; Ito, Y; Takakura, S; Ogawa, K; Yoshizawa, A; Fujimoto, Y; Okamoto, S; Uemoto, S; Ichiyama, S				Matsumura, Yasufumi; Tanaka, Michio; Yamamoto, Masaki; Nagao, Miki; Machida, Kiyomasa; Ito, Yutaka; Takakura, Shunji; Ogawa, Kohei; Yoshizawa, Atsushi; Fujimoto, Yasuhiro; Okamoto, Shinya; Uemoto, Shinji; Ichiyama, Satoshi			High prevalence of carbapenem resistance among plasmid-mediated AmpC beta-lactamase-producing Klebsiella pneumoniae during outbreaks in liver transplantation units	INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS			English	Article						Molecular epidemiology; Am pC; Carbapenems; Outer membrane protein	EXTENDED-SPECTRUM; ESCHERICHIA-COLI; ENTEROBACTERIACEAE; GENES; STRAIN; SPREAD; SALMONELLA; EMERGENCE; THERAPY; VARIANT	During a prospective surveillance using PCR for the detection of plasmid-mediated AmpC p-lactamase (pAmpC)-producing Enterobacteriaceae, outbreaks due to pAmpC-producing Klebsiella pneumoniae (pAmpC-Kp) occurred in an adult liver transplantation unit (aLTU) and a paediatric liver transplantation unit (pLTU), with carbapenem-resistant (CR) variants. Between April 2010 and March 2012, a total of 32 patients infected with pAmpC-Kp were found by prospective surveillance using PCR detection at a Japanese university hospital. Multilocus sequence typing, analysis of outer membrane proteins, and detection of carbapenemases were performed. Clinical courses of patients with bloodstream infection (BSI) were reviewed. Of 32 pAmpC-Kp isolates from each patient, 20 (18 from aLTU patients) were DHA-1-producing sequence type 11 (DHA-1-ST11), 9 were CMY-2-ST451778 (all from pLTU patients) and the other 3 isolates had different sequence types. CR variants were isolated from 8 aLTU patients with DHA-1-ST11 and from 1 pLTU patient with CMY-2-ST45. All of the pAmpC-Kp isolates, including CR variants, were negative for carbapenemases. All of the DHA-1-ST11 and CMY-2-ST45 isolates lacked OmpK35, and seven CR variants also lacked OmpK36. BSIs due to DHA-1-ST11 isolates, including CR variants, occurred in six aLTU patients, four of whom died. The outbreaks were controlled after application of intensified infection control measures. During pAmpC-Kp outbreaks involving 27 liver transplants, CR variants with porin loss developed in nine patients, and DHA-1-ST11 K. pneumoniae caused BSIs with high mortality. (C) 2014 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.	[Matsumura, Yasufumi; Yamamoto, Masaki; Nagao, Miki; Takakura, Shunji; Ichiyama, Satoshi] Kyoto Univ Hosp, Dept Infect Control & Prevent, Sakyo Ku, Kyoto 6068507, Japan; [Matsumura, Yasufumi; Tanaka, Michio; Yamamoto, Masaki; Nagao, Miki; Machida, Kiyomasa; Ito, Yutaka; Takakura, Shunji; Ichiyama, Satoshi] Kyoto Univ, Grad Sch Med, Dept Clin Lab Med, Sakyo Ku, Kyoto 6068507, Japan; [Ito, Yutaka] Kyoto Univ, Grad Sch Med, Dept Resp Med, Sakyo Ku, Kyoto 6068507, Japan; [Ogawa, Kohei; Yoshizawa, Atsushi; Fujimoto, Yasuhiro; Okamoto, Shinya; Uemoto, Shinji] Kyoto Univ Hosp, Dept Hepatopancreatobiliary Transplant & Pediat, Sakyo Ku, Kyoto 6068507, Japan	Matsumura, Y (reprint author), Kyoto Univ, Grad Sch Med, Dept Clin Lab Med, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	yazblood@kuhp.kyoto-u.ac.jp		Matsumura, Yasufumi/0000-0001-8595-8944			Tacconelli E, 2014, CLIN MICROBIOL INFEC, V20, P1, DOI 10.1111/1469-0691.12427; Matsumura Y, 2012, J ANTIMICROB CHEMOTH, V67, P2612, DOI 10.1093/jac/dks278; Tsai YK, 2011, ANTIMICROB AGENTS CH, V55, P1485, DOI 10.1128/AAC.01275-10; Baraniak A, 2013, ANTIMICROB AGENTS CH, V57, P1992, DOI 10.1128/AAC.02571-12; Tzouvelekis LS, 2012, CLIN MICROBIOL REV, V25, P682, DOI 10.1128/CMR.05035-11; Nordmann P, 2012, EMERG INFECT DIS, V18, P1503, DOI 10.3201/eid1809.120355; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Doi Y, 2007, INT J INFECT DIS, V11, P191, DOI 10.1016/j.ijid.2006.07.008; Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x; Findlay J, 2012, CLIN MICROBIOL INFEC, V18, P140, DOI 10.1111/j.1469-0691.2011.03515.x; Harris PNA, 2012, INT J ANTIMICROB AG, V40, P297, DOI 10.1016/j.ijantimicag.2012.06.004; Hernandez-Alles S, 1999, MICROBIOL-UK, V145, P673; Ruiz E, 2012, J ANTIMICROB CHEMOTH, V67, P886, DOI 10.1093/jac/dkr548; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233; Lopez-Camacho E, 2014, J ANTIMICROB CHEMOTH, V69, P632, DOI 10.1093/jac/dkt419; Novais A, 2012, EUR J CLIN MICROBIOL, V31, P3057, DOI 10.1007/s10096-012-1665-z; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Mata C, 2012, J ANTIMICROB CHEMOTH, V67, P115, DOI 10.1093/jac/dkr412; Garcia-Fernandez A, 2009, J ANTIMICROB CHEMOTH, V63, P274, DOI 10.1093/jac/dkn470; Chiu SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069428; Clinical and Laboratory Standards Institute, 2012, M100S22 CLSI; Garcia-Fernandez A, 2010, ANTIMICROB AGENTS CH, V54, P4178, DOI 10.1128/AAC.01301-09; Giles WP, 2004, ANTIMICROB AGENTS CH, V48, P2845, DOI 10.1128/AAC.48.8.2845-2852.2004; Li B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075805; Mata C, 2011, CLIN MICROBIOL INFEC, V17, P1514, DOI 10.1111/j.1469-0691.2011.03539.x; Ohana S, 2005, ANTIMICROB AGENTS CH, V49, P2095, DOI 10.1128/AAC.49.5.2095-2097.2005; Seo MR, 2010, CHEMOTHERAPY, V56, P46, DOI 10.1159/000290972; Sidjabat HE, 2009, ANTIMICROB AGENTS CH, V53, P4733, DOI 10.1128/AAC.00533-09; Yamasaki K, 2010, J CLIN MICROBIOL, V48, P3267, DOI 10.1128/JCM.02111-09; Yu FY, 2012, J MED MICROBIOL, V61, P984, DOI 10.1099/jmm.0.043000-0	30	1	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0924-8579	1872-7913		INT J ANTIMICROB AG	Int. J. Antimicrob. Agents	JAN	2015	45	1					33	40		10.1016/j.ijantimicag.2014.08.015		8	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	AX7OU	WOS:000347105800005		
J	Hiraki, Y; Yasumori, N; Nagano, M; Inoue, D; Tsuji, Y; Kamimura, H; Karube, Y				Hiraki, Yoichi; Yasumori, Naoko; Nagano, Masahisa; Inoue, Daisuke; Tsuji, Yasuhiro; Kamimura, Hidetoshi; Karube, Yoshiharu			Optimal loading regimen and achievement of trough concentrations for teicoplanin using Japanese population parameters	INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS			English	Letter									[Hiraki, Yoichi; Yasumori, Naoko; Nagano, Masahisa; Inoue, Daisuke] Natl Hosp Org Kumamoto Med Ctr, Dept Pharm, Kumamoto 8600008, Japan; [Tsuji, Yasuhiro] Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Toyama 9300194, Japan; [Kamimura, Hidetoshi; Karube, Yoshiharu] Fukuoka Univ, Fac Pharmaceut Sci, Johnan Ku, Fukuoka 8140180, Japan	Hiraki, Y (reprint author), Natl Hosp Org Kumamoto Med Ctr, Dept Pharm, 1-5 Ninomaru, Kumamoto 8600008, Japan.	hiraki@kumamed.jp					Gould FK, 2009, J ANTIMICROB CHEMOTH, V63, P849, DOI 10.1093/jac/dkp065; Pea F, 2004, CLIN PHARMACOKINET, V43, P405, DOI 10.2165/00003088-200443060-00004; Brink AJ, 2008, INT J ANTIMICROB AG, V32, P455, DOI 10.1016/j.ijantimicag.2008.05.012; Nakayama K, 2006, JPN J CHEMOTHER, V54, P1; Ueda T, 2012, J INFECT CHEMOTHER, V18, P296, DOI 10.1007/s10156-011-0325-z	5	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0924-8579	1872-7913		INT J ANTIMICROB AG	Int. J. Antimicrob. Agents	JAN	2015	45	1					87	88				3	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	AX7OU	WOS:000347105800016		
J	Moore, JE; Alcorn, M; Ara, W; Millar, BC; McCaughan, J; Rendall, JC; McNeilly, J; Kuribayashi, T; Yamamoto, S; Matsuda, M; Goldsmith, CE; Elborn, JS; Downey, DG				Moore, John E.; Alcorn, Michael; Ara, Wakana; Millar, B. Cherie; McCaughan, John; Rendall, Jacqueline C.; McNeilly, Joanne; Kuribayashi, Takashi; Yamamoto, Shizuo; Matsuda, Motoo; Goldsmith, Colin E.; Elborn, J. Stuart; Downey, Damian G.			Do veterinary antibiotics have efficacy against highly resistant Gram-negative pathogens from patients with cystic fibrosis?	INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS			English	Letter									[Moore, John E.; Millar, B. Cherie; Goldsmith, Colin E.] BHSCT, Belfast City Hosp, Northern Ireland Publ Hlth Lab, Dept Bacteriol, Belfast BT9 7AD, Antrim, North Ireland; [Moore, John E.] Univ Ulster, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland; [Moore, John E.; Elborn, J. Stuart] Queens Univ, Sch Med Dent & Biomed Sci, CII, Belfast BT9 7BL, Antrim, North Ireland; [Moore, John E.; Rendall, Jacqueline C.; McNeilly, Joanne; Elborn, J. Stuart; Downey, Damian G.] BHSCT, Belfast City Hosp, Northern Ireland Reg Adult Cyst Fibrosis Ctr, Belfast BT9 7AB, Antrim, North Ireland; [Alcorn, Michael] St Davids Poultry Team Ltd, Lympstone EX8 5AN, Exmouth, England; [Ara, Wakana; Kuribayashi, Takashi; Yamamoto, Shizuo] Azabu Univ, Sch Life & Environm Sci, Immunol Lab, Sagamihara, Kanagawa 229, Japan; [McCaughan, John] BHSCT, Royal Grp Hosp, Dept Med Microbiol, Belfast BT9 7AD, Antrim, North Ireland; [Matsuda, Motoo] Azabu Univ, Sch Environm Hlth Sci, Mol Biol Lab, Sagamihara, Kanagawa 229, Japan	Moore, JE (reprint author), Belfast City Hosp, Dept Bacteriol, Northern Ireland Publ Hlth Lab, Belfast BT9 7AD, Antrim, North Ireland.	jemoore@niphl.dnet.co.uk					FERREIRA MOS, 1985, J INT MED RES, V13, P270	1	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0924-8579	1872-7913		INT J ANTIMICROB AG	Int. J. Antimicrob. Agents	JAN	2015	45	1					93	95				4	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	AX7OU	WOS:000347105800020		
J	Davis, KJ; Landis, SH; Oh, YM; Mannino, DM; Han, MK; van der Molen, T; Aisanov, Z; Menezes, AM; Ichinose, M; Muellerova, H				Davis, Kourtney J.; Landis, Sarah H.; Oh, Yeon-Mok; Mannino, David M.; Han, MeiLan K.; van der Molen, Thys; Aisanov, Zaurbek; Menezes, Ana M.; Ichinose, Masakazu; Muellerova, Hana			Continuing to Confront COPD International Physician Survey: physician knowledge and application of COPD management guidelines in 12 countries	INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE			English	Article						chronic obstructive pulmonary disease; physician beliefs; adherence to guidelines	OBSTRUCTIVE PULMONARY-DISEASE; PRIMARY-CARE; ADHERENCE; DIAGNOSIS; BARRIERS	Aim: Utilizing data from the Continuing to Confront COPD (chronic obstructive pulmonary disease) International Physician Survey, this study aimed to describe physicians' knowledge and application of the GOLD (Global initiative for chronic Obstructive Lung Disease) Global Strategy for the Diagnosis, Management and Prevention of COPD diagnosis and treatment recommendations and compare performance between primary care physicians (PCPs) and respiratory specialists. Materials and methods: Physicians from 12 countries were sampled from in-country professional databases; 1,307 physicians (PCP to respiratory specialist ratio three to one) who regularly consult with COPD, emphysema, or chronic bronchitis patients were interviewed online, by telephone or face to face. Physicians were questioned about COPD risk factors, prognosis, diagnosis, and treatment, including knowledge and application of the GOLD global strategy using patient scenarios. Results: Physicians reported using spirometry routinely (PCPs 82%, respiratory specialists 100%; P<0.001) to diagnose COPD and frequently included validated patient-reported outcome measures (PCPs 67%, respiratory specialists 81%; P<0.001). Respiratory specialists were more likely than PCPs to report awareness of the GOLD global strategy (93% versus 58%, P<0.001); however, when presented with patient scenarios, they did not always perform better than PCPs with regard to recommending GOLD-concordant treatment options. The proportion of PCPs and respiratory specialists providing first-or second-choice treatment options concordant with GOLD strategy for a GOLD B-type patient was 38% versus 67%, respectively. For GOLD C and D-type patients, the concordant proportions for PCPs and respiratory specialists were 40% versus 38%, and 57% versus 58%, respectively. Conclusion: This survey of physicians in 12 countries practicing in the primary care and respiratory specialty settings showed high awareness of COPD-management guidelines. Frequent use of guideline-recommended COPD diagnostic practices was reported; however, gaps in the application of COPD-treatment recommendations were observed, warranting further evaluation to understand potential barriers to adopt guideline recommendations.	[Davis, Kourtney J.; Muellerova, Hana] GlaxoSmithKline, Worldwide Epidemiol, Wavre, Belgium; [Landis, Sarah H.] GlaxoSmithKline, Worldwide Epidemiol, Uxbridge UB11 1BT, Middx, England; [Oh, Yeon-Mok] Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea; [Mannino, David M.] Univ Kentucky, Coll Publ Hlth, Lexington, KY USA; [Han, MeiLan K.] Univ Michigan, Div Pulm & Crit Care, Ann Arbor, MI 48109 USA; [van der Molen, Thys] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Aisanov, Zaurbek] Pulmonol Res Inst, Moscow, Russia; [Menezes, Ana M.] Univ Fed Pelotas, Pelotas, Brazil; [Ichinose, Masakazu] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan	Landis, SH (reprint author), GlaxoSmithKline, Worldwide Epidemiol, Stockley Pk West, Uxbridge UB11 1BT, Middx, England.	sarah.h.landis@gsk.com	Menezes, Ana/G-7266-2012		GlaxoSmithKline (GSK)	The survey was conducted by Abt SRBI, a global survey research firm that specializes in health surveys. The authors would like to acknowledge editorial support in the form of draft manuscript development, assembling tables and figures, collating author comments, and copyediting, which was provided by Kate Hollingworth of Continuous Improvement Ltd. The authors would like to further acknowledge the analytical support provided by Joe Maskell. This support was funded by GlaxoSmithKline (GSK).	Aisanov Z, 2012, INT J CHRONIC OBSTR, V7, P271, DOI 10.2147/COPD.S28059; Corrado A, 2012, RESP MED, V106, P989, DOI 10.1016/j.rmed.2012.03.008; Perez X, 2012, RESP MED, V106, P374, DOI 10.1016/j.rmed.2011.09.010; Salinas GD, 2011, INT J CHRONIC OBSTR, V6, P171, DOI 10.2147/COPD.S16396; Glaab T, 2012, INT J CHRONIC OBSTR, V7, P101, DOI 10.2147/COPD.S27887; Rennard S, 2002, EUR RESPIR J, V20, P799, DOI 10.1183/09031936.02.03242002; Miravitlles M, 2013, PRIM CARE RESP J, V22, P117, DOI 10.4104/pcrj.2013.00016; Barr R Graham, 2005, Am J Med, V118, P1415; Bellamy David, 2006, Prim Care Respir J, V15, P48, DOI 10.1016/j.pcrj.2005.11.003; Fukuhara S, 2005, RESPIROLOGY, V10, P341, DOI 10.1111/j.1440-1843.2005.00717.x; Glaab Thomas, 2006, COPD, V3, P141, DOI 10.1080/15412550600829299; Global Initiative for Chronic Obstructive Lung Disease, 2014, GLOB STRAT DIAGN MAN; Halpin DMG, 2007, RESP MED, V101, P2378, DOI 10.1016/j.rmed.2007.06.010; Hernandez P, 2013, CAN RESPIR J, V20, P97; Jones R, 2013, LANCET RESP MED, V1, pE17, DOI 10.1016/S2213-2600(13)70015-8; Jones RCM, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-62; Laniado-Laborín Rafael, 2013, J Prim Care Community Health, V4, P172, DOI 10.1177/2150131913475817; Mullerova H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085540; National Institute for Health and Care Excellence (NICE), 2010, CHRON OBSTR PULM DIS; NCQA, 2013, IMPR QUAL PAT EXP ST; Sobradillo Pena Victor, 2000, Chest, V118, P981; Takeda, 2010, DAX SUMM PROD CHAR; Wurst KE, 2014, INT J CHRONIC OBSTR, V9, P1021, DOI 10.2147/COPD.S58258; Yawn Barbara P, 2008, Int J Chron Obstruct Pulmon Dis, V3, P311	24	1	1	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-2005			INT J CHRONIC OBSTR	Int. J. Chronic Obstr. Pulm. Dis.		2015	10						39	55		10.2147/COPD.S70162		17	Respiratory System	Respiratory System	AX6TQ	WOS:000347054400001		
J	Kim, JH; Kinugasa, Y; Yu, HC; Murakami, G; Abe, S; Cho, BH				Kim, Ji Hyun; Kinugasa, Yusuke; Yu, Hee Chul; Murakami, Gen; Abe, Shinichi; Cho, Baik Hwan			Lack of striated muscle fibers in the longitudinal anal muscle of elderly Japanese: a histological study using cadaveric specimens	INTERNATIONAL JOURNAL OF COLORECTAL DISEASE			English	Article						Longitudinal anal muscle; Conjoint longitudinal muscle coat; Smooth muscle; Striated muscle; Levator ani; Integral pelvic floor theory	ANATOMY; RELEVANCE	Purpose and methods The aim of this study is to investigate variations in the longitudinal anal muscle (LAM), especially in the meeting pattern between the levator ani and rectum at the origin of the LAM. We examined the histology of the anal canal and the lower rectum of 50 cadavers (25 males, 25 females) of elderly Japanese individuals with the aid of immunohistochemistry. Results We observed two patterns in the meeting site between the levator ani and the rectum. In type 1, observed in 26 specimens, the smooth muscle-rich fascia lining the internal or medial aspect of the levator ani (i.e., the fascia pelvis parietalis or endopelvic fascia) was connected to the external muscle layer. In type 2, observed in 24 specimens, multiple intramuscular septa of the levator ani were attached to a smooth muscle mass, with the latter joining the external smooth muscle layer of the rectum. However, 21 specimens (6 type 1 and 15 type 2) carried few smooth muscles at the meeting site. We did not find any striated muscle in the LAM, although this might have been the result of age-associated degeneration. Thus, active traction of the pelvic viscera by the LAM seemed unlikely in elderly Japanese. Conclusions Rather than playing an active role, as suggested by the integral pelvic floor theory, the LAM seemed to be an elastic skeleton that maintains the shape of the anal canal.	[Kim, Ji Hyun] Chonbuk Natl Univ, Sch Med, Dept Anat, Jeonju, South Korea; [Kinugasa, Yusuke] Shizuoka Canc Ctr Hosp, Div Colon & Rectal Surg, Shizuoka, Japan; [Yu, Hee Chul; Cho, Baik Hwan] Chonbuk Natl Univ, Sch Med, Dept Surg, Jeonju, South Korea; [Yu, Hee Chul; Cho, Baik Hwan] Chonbuk Natl Univ, Sch Med, Biomed Res Inst, Jeonju, South Korea; [Murakami, Gen] Iwamizawa Asuka Hosp, Div Internal Med, Iwamizawa, Hokkaido, Japan; [Abe, Shinichi] Tokyo Dent Coll, Dept Anat, Tokyo, Japan; [Yu, Hee Chul] Chonbuk Natl Univ Hosp, Dept Surg, Jeonju, South Korea	Yu, HC (reprint author), Chonbuk Natl Univ Hosp, Dept Surg, Jeonju, South Korea.	hcyu@jbnu.ac.kr			National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea [0620220-1]	We thank the people who donated their bodies after death to Tokyo Dental College for research and education on human anatomy without any socioeconomic benefit. We also thank their families for agreeing to these donations and for their patience in awaiting the return of bones after the end of this study. This study was supported by a grant (0620220-1) from the National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea.	Aigner F, 2004, DIS COLON RECTUM, V47, P131, DOI 10.1007/s10350-003-0031-8; MOTOHASHI O, 1995, ACTA NEUROCHIR, V136, P88, DOI 10.1007/BF01411441; Shafik A, 1999, WORLD J UROL, V17, P266, DOI 10.1007/s003450050144; Myers RP, 1998, J UROLOGY, V159, P2148, DOI 10.1016/S0022-5347(01)63297-X; Kinugasa Y, 2011, DIS COLON RECTUM, V54, P232, DOI 10.1007/DCR.0b013e318202388f; Kinugasa Y, 2012, YONSEI MED J, V53, P849, DOI 10.3349/ymj.2012.53.4.849; COURTNEY H, 1950, AM J SURG, V79, P155, DOI 10.1016/0002-9610(50)90208-X; Arakawa Takashi, 2004, Anatomical Science International, V79, P72, DOI 10.1111/j.1447-073x.2004.00069.x; Arakawa T, 2004, BIOMED RES-TOKYO, V25, P45, DOI 10.2220/biomedres.25.45; GORSCH R V, 1960, Clin Symp, V12, P35; Hieda K, 2013, CLIN ANAT, V26, P843, DOI 10.1002/ca.22227; Hinata Nobuyuki, 2014, Anat Cell Biol, V47, P44, DOI 10.5115/acb.2014.47.1.44; Hirata E, 2011, CLIN ANAT, V24, P469, DOI 10.1002/ca.21042; Kalyani RR, 2014, LANCET DIABETES ENDO, V2, P819, DOI 10.1016/S2213-8587(14)70034-8; LAWSON JON, 1974, ANN ROY COLL SURG, V54, P288; LEVY EDWARD, 1936, AMER JOUR SURG, V34, P141; LUNNISS PJ, 1992, BRIT J SURG, V79, P882, DOI 10.1002/bjs.1800790908; Macchi V, 2008, CLIN ANAT, V21, P447, DOI 10.1002/ca.20633; Miyake N, 2010, ANAT REC, V293, P438, DOI 10.1002/ar.21089; Murakami G, 2002, CLIN ANAT, V15, P241, DOI 10.1002/ca.10015; Petros PE, 1999, INT UROGYNECOL J PEL, V10, P356, DOI DOI 10.1007/S001920050059; Petros P E, 1997, Int Urogynecol J Pelvic Floor Dysfunct, V8, P74; SHAFIK A, 1984, UROLOGY, V23, P611; Smith G E, 1908, J Anat Physiol, V42, P198; Soga H, 2007, INT UROGYNECOL J, V18, P1423, DOI 10.1007/s00192-007-0380-2; Standring S, 2005, GRAYS ANATOMY, P1208; Williams PL, 1995, GRAYS ANATOMY, P1780; Zhai LD, 2011, EUR UROL, V59, P415, DOI 10.1016/j.eururo.2010.11.030	28	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-1958	1432-1262		INT J COLORECTAL DIS	Int. J. Colorectal Dis.	JAN	2015	30	1					43	49		10.1007/s00384-014-2038-0		7	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AX8IC	WOS:000347152300005		
J	Yamamoto, T; Hirano, M; Momiyama, M; Ueda, K				Yamamoto, Toshiyuki; Hirano, Maki; Momiyama, Masanori; Ueda, Kazuki			Basaloid follicular hyperplasia of the overlying epidermis of pilomatricoma	INTERNATIONAL JOURNAL OF DERMATOLOGY			English	Letter							DERMATOFIBROMA		[Yamamoto, Toshiyuki] Fukushima Med Univ, Dept Dermatol, Fukushima 9601295, Japan; [Hirano, Maki; Momiyama, Masanori; Ueda, Kazuki] Fukushima Med Univ, Dept Plast Surg, Fukushima 9601295, Japan	Yamamoto, T (reprint author), Fukushima Med Univ, Dept Dermatol, Hikarigaoka 1, Fukushima 9601295, Japan.	toyamade@fmu.ac.jp					Yamamoto T, 2009, J EUR ACAD DERMATOL, V23, P371, DOI 10.1111/j.1468-3083.2009.03089.x; Nomura E, 2013, INT J DERMATOL, V52, P735, DOI 10.1111/j.1365-4632.2011.05285.x; Yamamoto T, 2003, EUR J DERMATOL, V13, P419	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0011-9059	1365-4632		INT J DERMATOL	Int. J. Dermatol.	JAN	2015	54	1					E41	E43		10.1111/ijd.12595		4	Dermatology	Dermatology	AX1TL	WOS:000346728800009		
J	Guennec, B; Ueno, A; Sakai, T; Takanashi, M; Itabashi, Y; Ota, M				Guennec, Benjamin; Ueno, Akira; Sakai, Tatsuo; Takanashi, Masahiro; Itabashi, Yu; Ota, Mie			Dislocation-based interpretation on the effect of the loading frequency on the fatigue properties of JIS S15C low carbon steel	INTERNATIONAL JOURNAL OF FATIGUE			English	Article						Frequency effect; Low carbon steel; Ultrasonic test; Dislocation structure; Seeger theory	GRAIN-BOUNDARY SEGREGATION; IRON SINGLE-CRYSTALS; HIGH-CYCLE FATIGUE; ALPHA-IRON; STRAIN-RATE; ULTRASONIC FATIGUE; MECHANICAL-PROPERTIES; LOW-TEMPERATURES; RATE SENSITIVITY; IN-SITU	Fatigue properties of low carbon steels are known to be particularly sensitive to the loading frequency. Indeed, literatures related to this field usually point out an increasing fatigue life with an increase of the loading frequency. The authors of the present paper have already reconfirmed such a general phenomenon in the case of JIS S15C (0.15%C) low carbon steel. In that paper, S-N properties under usual frequencies of 0.2-140 Hz can be successfully normalized by the lower yield stress at the individual frequency. Nevertheless, some irregularities have been detected on the fatigue property at 20 kHz. In order to clarify the physical meaning of such irregularities, we will compare fatigue properties at usual frequencies and ultrasonic frequency. In this work, the former experimental results were reintroduced and new discussions were developed by performing additional experiments and analyses paying an attention to microstructure and dislocation structure. Thus, it was found that the loading frequency effect at ultrasonic frequency is due to a particular behavior of B.C.C. ferrite under high strain rate. Such a behavior causes strain inhomogeneities at grain boundaries, and then facilitates the intergranular crack initiation mode rather than the usual intragranular one often reported at lower loading frequencies. Longer ultrasonic fatigue lives at ultrasonic frequency are directly related to this transition of the crack initiation mode. In addition, effects of the pearlitic volume fraction on the fatigue behavior have been also discussed in the present work. (C) 2014 Elsevier Ltd. All rights reserved.	[Guennec, Benjamin] Ritsumeikan Univ, Grad Sch Sci & Engn, Kusatsu, Shiga 5258577, Japan; [Ueno, Akira; Sakai, Tatsuo] Ritsumeikan Univ, Coll Sci & Engn, Kusatsu, Shiga 5258577, Japan; [Takanashi, Masahiro; Itabashi, Yu] IHI Corp, Struct Strength Dept, Res Lab, Isogo Ku, Yokohama, Kanagawa 2358501, Japan; [Ota, Mie] Ritsumeikan Univ, Res Org Sci & Technol, Kusatsu, Shiga 5258577, Japan	Guennec, B (reprint author), Ritsumeikan Univ, Grad Sch Sci & Engn, 1-1-1 Nojihigashi, Kusatsu, Shiga 5258577, Japan.	gr0081rh@ed.ritsumei.ac.jp; sakai@se.ritsumei.ac.jp					Kamaya M, 2012, MATER CHARACT, V66, P56, DOI 10.1016/j.matchar.2012.02.001; Caillard D, 2011, ACTA MATER, V59, P4974, DOI 10.1016/j.actamat.2011.04.048; MAGNIN T, 1979, MATER SCI ENG, V39, P175, DOI 10.1016/0025-5416(79)90057-0; Guennec B, 2014, INT J FATIGUE, V66, P29, DOI 10.1016/j.ijfatigue.2014.03.005; Sommer C, 1998, ACTA MATER, V46, P1537, DOI 10.1016/S1359-6454(97)00363-7; Caillard D, 2010, ACTA MATER, V58, P3504, DOI 10.1016/j.actamat.2010.02.024; Wang C, 2012, INT J FATIGUE, V45, P91, DOI 10.1016/j.ijfatigue.2012.06.005; Zhu X, 2006, INT J FATIGUE, V28, P1566, DOI 10.1016/j.ijfatigue.2005.04.016; WEISSE M, 1993, ACTA METALL MATER, V41, P2227, DOI 10.1016/0956-7151(93)90392-6; SEEGER A, 1954, PHILOS MAG, V45, P771; SATO A, 1973, ACTA METALL MATER, V21, P753, DOI 10.1016/0001-6160(73)90040-0; SUZUKI S, 1983, SCRIPTA METALL MATER, V17, P1325, DOI 10.1016/0036-9748(83)90225-9; Caillard D, 2010, ACTA MATER, V58, P3493, DOI 10.1016/j.actamat.2010.02.023; Stainier L, 2002, J MECH PHYS SOLIDS, V50, P1511, DOI 10.1016/S0022-5096(01)00114-4; MUGHRABI H, 1976, ACTA METALL MATER, V24, P659, DOI 10.1016/0001-6160(76)90086-9; Kamaya M, 2009, MATER CHARACT, V60, P125, DOI 10.1016/j.matchar.2008.07.010; Papakyriacou M, 2001, MAT SCI ENG A-STRUCT, V308, P143, DOI 10.1016/S0921-5093(00)01978-X; Zettl B, 2006, INT J FATIGUE, V28, P1583, DOI 10.1016/j.ijfatigue.2005.05.016; Marines I, 2003, INT J FATIGUE, V25, P1037, DOI 10.1016/S0142-1123(03)00161-0; Rittel D, 2006, MAT SCI ENG A-STRUCT, V432, P191, DOI 10.1016/j.msea.2006.05.154; Sommer C, 1998, ACTA MATER, V46, P1527, DOI 10.1016/S1359-6454(97)00362-5; Caillard D, 2013, ACTA MATER, V61, P2793, DOI 10.1016/j.actamat.2013.01.048; CHAI HF, 1987, MATER SCI ENG, V93, P159, DOI 10.1016/0025-5416(87)90421-6; Ebara R, 2006, INT J FATIGUE, V28, P1465, DOI 10.1016/j.ijfatigue.2005.04.019; Engler-Pinto Jr CC, 2007, P VHCF 4 ANN ARB, P421; GUIU F, 1982, FATIGUE ENG MATER, V5, P311, DOI 10.1111/j.1460-2695.1982.tb01240.x; Heo NH, 2004, SCRIPTA MATER, V51, P339, DOI 10.1016/j.scriptamat.2004.03.037; Heo NH, 2013, ACTA MATER, V61, P4022, DOI 10.1016/j.actamat.2013.03.016; INMAN MC, 1958, ACTA METALL MATER, V6, P73, DOI 10.1016/0001-6160(58)90116-0; Kamaya M, 2010, MATER TRANS, V51, P1516, DOI 10.2320/matertrans.MAW201005; KIKUKAWA M, 1965, J BASIC ENG-T ASME, V87, P857; KURAMOTO E, 1979, SCRIPTA METALL MATER, V13, P1039, DOI 10.1016/0036-9748(79)90199-6; LEEMANS D, 1974, METALL TRANS, V5, P1331, DOI 10.1007/BF02646616; LOW JR, 1962, ACTA METALL MATER, V10, P215; MIN ZH, 1985, ACTA METALL MATER, V33, P563, DOI 10.1016/0001-6160(85)90020-3; MUGHRABI H, 1975, Z METALLKD, V66, P719; PUSKAR A, 1978, ENG FRACT MECH, V10, P187, DOI 10.1016/0013-7944(78)90002-4; QUESNEL DJ, 1975, MATER SCI ENG, V18, P199, DOI 10.1016/0025-5416(75)90170-6; SAKA H, 1973, T IRON STEEL I JPN, V13, P318; Sakai T, 2007, SOC MAT SCI JPN; SASAKI S, 1979, ENG FRACT MECH, V12, P531; Setowaki S., 2011, P 5 INT C VER HIGH C, P153; SOLOMON HD, 1971, ACTA METALL MATER, V19, P291, DOI 10.1016/0001-6160(71)90095-2; Taira S, 1963, JSMS JPN, V12, P536; Tang M, 1998, ACTA MATER, V46, P3221, DOI 10.1016/S1359-6454(98)00006-8; Vaynman S, 2006, SCRIPTA MATER, V55, P351, DOI 10.1016/j.scriptamat.2006.04.029; Yamane Y, 1964, T JPN SOC MACH ENG, V30, P772; YOKOBORI T, 1979, SCRIPTA METALL MATER, V13, P515, DOI 10.1016/0036-9748(79)90097-8; Zhang M, 1999, INT J FATIGUE, V21, P823, DOI 10.1016/S0142-1123(99)00031-6	49	3	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-1123	1879-3452		INT J FATIGUE	Int. J. Fatigue	JAN	2015	70						328	341		10.1016/j.ijfatigue.2014.10.006		14	Engineering, Mechanical; Materials Science, Multidisciplinary	Engineering; Materials Science	AX6FA	WOS:000347017400034		
J	Wu, H; Hamada, S; Oda, Y; Noguchi, H				Wu, Hao; Hamada, Shigeru; Oda, Yasuji; Noguchi, Hiroshi			Effect of internal hydrogen on very high cycle fatigue of precipitation-strengthened steel SUH660	INTERNATIONAL JOURNAL OF FATIGUE			English	Article						Hydrogen; Very high cycle fatigue; Fatigue life; Fatigue crack initiation; Vickers hardness	AUSTENITIC STAINLESS-STEELS; CRACK GROWTH-BEHAVIOR; GASEOUS-HYDROGEN; TENSILE PROPERTIES; IRON-BASE; DISLOCATION; TEMPERATURE; ENVIRONMENT; MECHANISM; MOBILITY	The fatigue life of SUH660 steel is dominated by crack initiation in the region of very high cycle fatigue owing to the new crack initiation behavior near the tip of temporarily arrested crack. The effect of internal hydrogen on very high cycle fatigue life is investigated focused on crack initiation life via fatigue and Vickers hardness tests. Hydrogen inhibits cracks initiation, and accelerates the increase in crack initiation lives with decreasing stress in low and medium hardness zones. Hydrogen increases the hardness in low and medium hardness zones. Hydrogen extends new crack initiation lives and causes longer very high cycle fatigue life. (C) 2014 Elsevier Ltd. All rights reserved.	[Wu, Hao] Kyushu Univ, Grad Sch Engn, Dept Mech Engn, Nishi Ku, Fukuoka 8190395, Japan; [Hamada, Shigeru; Oda, Yasuji; Noguchi, Hiroshi] Kyushu Univ, Fac Engn, Dept Mech Engn, Nishi Ku, Fukuoka 8190395, Japan; [Hamada, Shigeru] Res Ctr Hydrogen Ind Use & Storage HYDROGENIUS, Nishi Ku, Fukuoka 8190395, Japan	Noguchi, H (reprint author), Res Ctr Hydrogen Ind Use & Storage HYDROGENIUS, Nishi Ku, 744 Moto Oka, Fukuoka 8190395, Japan.	nogu@mech.kyushu-u.ac.jp		Noguchi, Hiroshi/0000-0002-9439-7226	New Energy and Industrial Technology Development Organization (NEDO)	This study was conducted as a part of the "Fundamental Research Project on Advanced Hydrogen Science (2006-2012)" funded by the New Energy and Industrial Technology Development Organization (NEDO).	Takakuwa O, 2012, INT J HYDROGEN ENERG, V37, P5268, DOI 10.1016/j.ijhydene.2011.12.035; HICKS PD, 1990, METALL TRANS A, V21, P365, DOI 10.1007/BF02782416; Mine Y, 2011, CORROS SCI, V53, P2619, DOI 10.1016/j.corsci.2011.04.022; THOMPSON AW, 1975, METALL TRANS A, V6, P1431, DOI 10.1007/BF02641935; Kanezaki T, 2008, INT J HYDROGEN ENERG, V33, P2604, DOI 10.1016/j.ijhydene.2008.02.067; Kobayashi K, 2008, INT J FATIGUE, V30, P1978, DOI 10.1016/j.ijfatigue.2008.01.004; Macadre A, 2011, INT J FATIGUE, V33, P1608, DOI 10.1016/j.ijfatigue.2011.07.007; Kubota M, 2009, TRIBOL INT, V42, P1352, DOI 10.1016/j.triboint.2009.04.006; Murakami Y, 2010, ENG FRACT MECH, V77, P1926, DOI 10.1016/j.engfracmech.2010.04.012; Murakami Y, 2008, METALL MATER TRANS A, V39A, P1327, DOI 10.1007/s11661-008-9506-5; Brass AM, 2006, CORROS SCI, V48, P3222, DOI 10.1016/j.corsci.2005.11.004; Barnoush A, 2012, SCRIPTA MATER, V66, P414, DOI 10.1016/j.scriptamat.2011.12.004; BIRNBAUM HK, 1994, MAT SCI ENG A-STRUCT, V176, P191, DOI 10.1016/0921-5093(94)90975-X; DEMAREZ A, 1954, ACTA METALL MATER, V2, P214, DOI 10.1016/0001-6160(54)90162-5; Gaddam R, 2014, CORROS SCI, V78, P378, DOI 10.1016/j.corsci.2013.08.009; HEADLEY TJ, 1982, METALL TRANS A, V13, P345, DOI 10.1007/BF02643343; Jia GW, 2007, J MATER PROCESS TECH, V187, P562, DOI 10.1016/j.jmatprotec.2006.11.093; Lei Z, 2013, 13 INT C FRACT; Mine Y, 2012, MAT SCI ENG A-STRUCT, V548, P118, DOI 10.1016/j.msea.2012.03.101; Miyamoto T, 2012, T JPN SOC MECH ENG A, V78, P531; MORIYA S, 1979, MATER SCI ENG, V40, P217, DOI 10.1016/0025-5416(79)90192-7; Murakami Y, 2010, METALL MATER TRANS A, V41A, P2548, DOI 10.1007/s11661-010-0275-6; Nakamura J, 2010, PROCEDIA ENGINEER, V2, P1235, DOI 10.1016/j.proeng.2010.03.134; Nakatani M, 2009, 12 INT C FRACT; Shishime K, 2013, MATER SCI FORUM, V567-568, P409; SOLOMON HD, 1973, METALL TRANS, V4, P341, DOI 10.1007/BF02649635; Suzuki Yuichi, 2012, Journal of Solid Mechanics and Materials Engineering, V6, DOI 10.1299/jmmp.6.265; Takakuwa O, 2014, INT J HYDROGEN ENERG, V39, P6095, DOI 10.1016/j.ijhydene.2014.01.190; Taketomi S, 2008, J MATER SCI, V43, P1166, DOI 10.1007/s10853-007-2364-5; WILSON FG, 1968, ACTA METALL MATER, V16, P115, DOI 10.1016/0001-6160(68)90080-1; Wong YK, 2003, THESIS U W AUSTR; Wu H, 2013, INT J FATIGUE, V48, P48, DOI 10.1016/j.ijfatigue.2012.09.021; Wu H, 2014, INT J FATIGUE, V63, P1, DOI 10.1016/j.ijfatigue.2013.12.011; Wu H, 2013, INT J FATIGUE, V55, P291, DOI 10.1016/j.ijfatigue.2013.06.021	34	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-1123	1879-3452		INT J FATIGUE	Int. J. Fatigue	JAN	2015	70						406	416		10.1016/j.ijfatigue.2014.07.006		11	Engineering, Mechanical; Materials Science, Multidisciplinary	Engineering; Materials Science	AX6FA	WOS:000347017400041		
J	Nakanishi, H; Shojo, H; Ohmori, T; Hara, M; Takada, A; Adachi, N; Saito, K				Nakanishi, Hiroaki; Shojo, Hideki; Ohmori, Takeshi; Hara, Masaaki; Takada, Aya; Adachi, Noboru; Saito, Kazuyuki			A novel method for sex determination by detecting the number of X chromosomes	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						X chromosome; Amelogenin gene; Copy number variation; Real-time polymerase chain reaction; Sex determination	POLYMERASE-CHAIN-REACTION; Y HOMOLOGOUS GENE; REAL-TIME PCR; COPY-NUMBER; HUMAN GENOME; DNA; IDENTIFICATION; AMPLIFICATION; AMELOGENIN; REGIONS	A novel method for sex determination, based on the detection of the number of X chromosomes, was established. Current methods, based on the detection of the Y chromosome, can directly identify an unknown sample as male, but female gender is determined indirectly, by not detecting the Y chromosome. Thus, a direct determination of female gender is important because the quality (e.g., fragmentation and amelogenin-Y null allele) of the Y chromosome DNA may lead to a false result. Thus, we developed a novel sex determination method by analyzing the number of X chromosomes using a copy number variation (CNV) detection technique (the comparative Ct method). In this study, we designed a primer set using the amelogenin-X gene without the CNV region as the target to determine the X chromosome copy number, to exclude the influence of the CNV region from the comparative Ct value. The number of X chromosomes was determined statistically using the CopyCaller software with real-time PCR. All DNA samples from participants (20 males, 20 females) were evaluated correctly using this method with 1-ng template DNA. A minimum of 0.2-ng template DNA was found to be necessary for accurate sex determination with this method. When using ultraviolet-irradiated template DNA, as mock forensic samples, the sex of the samples could not be determined by short tandem repeat (STR) analysis but was correctly determined using our method. Thus, we successfully developed a method of sex determination based on the number of X chromosomes. Our novel method will be useful in forensic practice for sex determination.	[Nakanishi, Hiroaki; Saito, Kazuyuki] Juntendo Univ, Sch Med, Dept Forens Med, Bunkyo Ku, Tokyo 1138421, Japan; [Shojo, Hideki; Adachi, Noboru] Univ Yamanashi, Dept Legal Med, Fac Med, Chuo Ku, Chuo, Yamanashi 4093898, Japan; [Ohmori, Takeshi] Natl Res Inst Police Sci, Kashiwa, Chiba 2770882, Japan; [Hara, Masaaki; Takada, Aya] Saitama Med Univ, Dept Forens Med, Moroyama, Saitama 3500495, Japan	Nakanishi, H (reprint author), Juntendo Univ, Sch Med, Dept Forens Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	hnakani@juntendo.ac.jp			JSPS KAKENHI [24790462]	This work was supported by JSPS KAKENHI Grant Number 24790462. Part of this study was presented at the 11th Indo Pacific Association of Law, Medicine and Science Congress 2013 in Malaysia, and won the Best Poster award. We thank the Laboratory of Molecular and Biochemical Research, Research Support Center, Juntendo University Graduate School of Medicine for technical assistance.	Adachi N, 2014, LEGAL MED-TOKYO, V16, P52, DOI 10.1016/j.legalmed.2013.10.001; AKANE A, 1992, FORENSIC SCI INT, V52, P143, DOI 10.1016/0379-0738(92)90102-3; Rose-Zerilli MJ, 2009, CLIN CHEM, V55, P1680, DOI 10.1373/clinchem.2008.120105; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Abe S, 2013, J HUM GENET, V58, P250, DOI 10.1038/jhg.2013.7; Almal SH, 2012, J HUM GENET, V57, P6, DOI 10.1038/jhg.2011.108; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; SULLIVAN KM, 1993, BIOTECHNIQUES, V15, P636; Santos FR, 1998, NAT GENET, V18, P103, DOI 10.1038/ng0298-103; Choi SK, 1999, EXP MOL MED, V31, P36; Codina AE, 2009, INT J LEGAL MED, V123, P459, DOI 10.1007/s00414-008-0301-z; Gamazon ER, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r46; Hosono H, 2009, CLIN CHEM, V55, P1546; Ma Y, 2012, INT J LEGAL MED, V126, P713, DOI 10.1007/s00414-012-0720-8; Morikawa T, 2011, ACTA MED OKAYAMA, V65, P113; Mukerjee S, 2013, INT J LEGAL MED, V127, P1, DOI 10.1007/s00414-011-0646-6; NAKAHORI Y, 1991, AM J MED GENET, V39, P472, DOI 10.1002/ajmg.1320390420; Nakanishi H, LEGAL MED IN PRESS; Nogami H, 2008, FORENSIC SCI INT-GEN, V2, P349, DOI 10.1016/j.fsigen.2008.05.001; Ou XL, 2012, INT J LEGAL MED, V126, P513, DOI 10.1007/s00414-011-0594-1; Qin J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn518; Repnikova EA, 2013, FORENSIC SCI INT-GEN, V7, P475, DOI 10.1016/j.fsigen.2013.05.008; Roccazzello AM, 2004, FORENSIC SCI INT, V146, pS165, DOI 10.1016/j.forsiint.2004.09.050; Soejima M, 2011, TRANSFUSION, V51, P762, DOI 10.1111/j.1537-2995.2010.02895.x; Thangaraj K, 2002, INT J LEGAL MED, V116, P121, DOI 10.1007/s00414-001-0262-y; Whale AS, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks203	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	JAN	2015	129	1					23	29		10.1007/s00414-014-1065-2		7	Medicine, Legal	Legal Medicine	AX8IS	WOS:000347153900003		
J	Torimitsu, S; Makino, Y; Saitoh, H; Sakuma, A; Ishii, N; Hayakawa, M; Inokuchi, G; Motomura, A; Chiba, F; Hoshioka, Y; Iwase, H				Torimitsu, Suguru; Makino, Yohsuke; Saitoh, Hisako; Sakuma, Ayaka; Ishii, Namiko; Hayakawa, Mutsumi; Inokuchi, Go; Motomura, Ayumi; Chiba, Fumiko; Hoshioka, Yumi; Iwase, Hirotaro			Stature estimation in Japanese cadavers based on scapular measurements using multidetector computed tomography	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						Forensic anthropology; Anthropometry; Multidetector computed tomography; Scapula; Regression analysis; Stature estimation	HEIGHT; LENGTH; POPULATION; DIMENSIONS; HAND; RECONSTRUCTION; IMAGES; NORTH; FEMUR; SPINE	This study assessed the correlation between stature and scapular measurements in a Japanese population, using three-dimensional (3D) computed tomographic (CT) images, and derived regression equations for predicting stature. A total of 194 cadavers (100 males 94 females) underwent postmortem CT (PMCT) and subsequent forensic autopsy in our department between May 2011 and April 2014. Left and right longitudinal scapular lengths (LLSL and RLSL, respectively) and left and right transverse scapular lengths (LTSL and RTSL, respectively) were measured on 3D CT reconstructed images that extracted only scapular data. The correlation between stature and each of the scapular measurements were analyzed using Pearson product-moment correlation coefficients. The four variables correlated significantly with stature, regardless of sex. The LLSL measurement had the lowest standard error of estimation value among all subjects (4.22 cm) and among all females (4.37 cm), whereas the RLSL measurement had the lowest standard error of estimation value among all males (3.75 cm). The results of this study indicate that scapular measurements may be useful for the forensic estimation of the stature of Japanese individuals, particularly in cases where better predictors, such as long bone lengths, are unavailable.	[Torimitsu, Suguru; Makino, Yohsuke; Saitoh, Hisako; Sakuma, Ayaka; Ishii, Namiko; Hayakawa, Mutsumi; Inokuchi, Go; Motomura, Ayumi; Chiba, Fumiko; Hoshioka, Yumi; Iwase, Hirotaro] Chiba Univ, Grad Sch Med, Dept Legal Med, Chuo Ku, Chiba 2608670, Japan	Torimitsu, S (reprint author), Chiba Univ, Grad Sch Med, Dept Legal Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	number60188@chiba-u.jp; ymakino-tky@umin.ac.jp; hms1466@faculty.chiba-u.jp; a.sakuma@chiba-u.jp; acua2807@chiba-u.jp; moo600@faculty.chiba-u.jp; goinokuchi@chiba-u.jp; aama0171@chiba-u.jp; chibafumico@chiba-u.jp; yhoshioka@chiba-u.jp; iwase@faculty.chiba-u.jp					Ahmed AA, 2013, FORENSIC SCI INT, V228, p[178, e1]; JASON DR, 1995, J FORENSIC SCI, V40, P59; ABDELMALEK AK, 1990, FORENSIC SCI INT, V46, P181, DOI 10.1016/0379-0738(90)90304-H; Rastogi Prateek, 2008, Legal Medicine, V10, P185, DOI 10.1016/j.legalmed.2008.01.001; TERAZAWA K, 1990, MED SCI LAW, V30, P354; Karakas HM, 2011, SKELETAL RADIOL, V40, P623, DOI 10.1007/s00256-010-0937-x; Giroux CL, 2008, J FORENSIC SCI, V53, P65, DOI 10.1111/j.1556-4029.2007.00598.x; Pelin C, 2005, J FORENSIC SCI, V50, P294; Arroyo M, 2010, NUTR HOSP, V25, P1053, DOI 10.3305/nh.2010.25.6.4854; Bidmos MA, 2008, J FORENSIC SCI, V53, P1044, DOI 10.1111/j.1556-4029.2008.00808.x; Campobasso C P, 1998, Boll Soc Ital Biol Sper, V74, P75; Chiba F, 2013, INT J LEGAL MED, V127, P1005, DOI 10.1007/s00414-013-0883-y; De Mendonca MC, 2000, AM J PHYS ANTHROPOL, V112, P39, DOI 10.1002/(SICI)1096-8644(200005)112:1<39::AID-AJPA5>3.0.CO;2-#; Giurazza F, 2013, LEGAL MED-TOKYO, V15, P202, DOI 10.1016/j.legalmed.2013.01.002; Giurazza F, 2012, FORENSIC SCI INT, V222, p[398, e1]; Gocha TP, 2013, J FORENSIC SCI, V58, P1279, DOI 10.1111/1556-4029.12231; Hasegawa Iwao, 2009, Legal Medicine, V11, P260, DOI 10.1016/j.legalmed.2009.07.004; Hauser R, 2005, FORENSIC SCI INT, V147, P185, DOI 10.1016/j.forsciint.2004.09.070; Jamaiyah H, 2010, Med J Malaysia, V65 Suppl A, P131; Krishan K, 2012, J FORENSIC LEG MED, V19, P211, DOI 10.1016/j.jflm.2011.12.024; Krishan K, 2012, J FORENSIC LEG MED, V19, P285, DOI 10.1016/j.jflm.2011.12.036; Lopez-Alcaraz M, 2014, INT J LEGAL MED; Lorkiewicz-Muszynska D, 2013, INT J LEGAL MED, V127, P653, DOI 10.1007/s00414-012-0805-4; MacalusoJr PJ, 2014, INT J LEGAL MED; Mahakkanukrauh P., 2011, FORENSIC SCI INT, V210, p279e1; Marinho L, 2012, FORENSIC SCI INT, V220, p[292, e1]; Nicholson G P, 1996, J Shoulder Elbow Surg, V5, P1, DOI 10.1016/S1058-2746(96)80024-3; OUSLEY S, 1995, J FORENSIC SCI, V40, P768; Sakuma A, 2010, J FORENSIC SCI, V55, P1624, DOI 10.1111/j.1556-4029.2010.01526.x; Terazawa K, 1985, NIHON HOIGAKU ZASSHI, V30, P35; Torimitsu S, 2014, INT J LEGAL MED; Torimitsu S, 2014, LEGAL MED-TOKYO, V16, P181, DOI 10.1016/j.legalmed.2014.03.001; Torimitsu S, 2014, LEGAL MED-TOKYO, V16, P14, DOI 10.1016/j.legalmed.2013.10.003; WILLEY P, 1991, J FORENSIC SCI, V36, P813	34	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	JAN	2015	129	1					211	218		10.1007/s00414-014-1054-5		8	Medicine, Legal	Legal Medicine	AX8IS	WOS:000347153900028		
J	Li, C; Cui, SP; Nie, ZR; Gong, XZ; Wang, ZH; Itsubo, N				Li, Chen; Cui, Suping; Nie, Zuoren; Gong, Xianzheng; Wang, Zhihong; Itsubo, Norihiro			The LCA of portland cement production in China	INTERNATIONAL JOURNAL OF LIFE CYCLE ASSESSMENT			English	Article						Air pollution; Alternative fuels and raw materials (AFRs); Best available techniques (BATs); Denitration (deNOx); Energy saving; NSP (new suspension preheater); Waste heat recovery	LIFE-CYCLE ASSESSMENT; OZONE CREATION POTENTIALS; ORGANIC-COMPOUNDS; INDUSTRY; INVENTORIES; MANUFACTURE; TECHNOLOGY; IMPACT; MODEL; EU	Cement production is associated with a considerable environmental load, which needs to be fully understood before effective measures can be taken. The existing literature did not give detailed life cycle assessment (LCA) study of China and had limited potential for investigating how best available techniques (BATs) would provide a maximum benefit when they are applied in China. Japan was selected as a good example to achieve better environmental performance of cement production. We identified potentials for reducing emissions and saving energy and natural resources in Chinese cement industry through the comparative analysis. This paper follows the principal of Life Cycle Assessment and International Reference Life Cycle Data System (ILCD). The functional units are "1 t of portland cement" and with 42.5 MPa of strength grade. The input (limestone, sandstone, ferrous tailings, coal, and electricity) and output (CO2 from limestone decomposition and coal combustion, NOx, PM, and SO2) of cement manufacturing were calculated by use of on-site measurements, calculation by estimated coefficients, and derivation by mass and heat balance principle. The direct (cement manufacturing) and indirect (electricity production) LCI are added to be total LCI results (cement production). The impact categories of global warming potential (GWP), acidification potential (AP), eutrophication potential (EP), photochemical oxidant formation potential (POCP), and human toxicity potential (HTP) are used to calculate environmental impact. Only in GWP of cement manufacturing China has advantage. Japanese cement industry shows remarkable superiorities in the environmental impacts of AP, POCP, HTP, and EP due to advanced technologies. SO2 emissions make the corresponding AP and HTP. PM emissions result in part of HTP. The NOx emissions are the major contributors of POCP, AP, EP, and HTP in China. China emits fewer CO2 emissions (2.09 %) in cement manufacturing than Japan but finally makes higher total GWP than Japan due to more GWP of electricity generation in power stations. The waste heat recovery technology can save electricity but bring more coal use and CO2 emissions. The alternative fuel and raw materials usage and denitration and de-dust technologies can relieve the environmental load. Using the functional unit with the strength grade, the life cycle impact assessment (LCIA) results are affected. LCA study allows a clear understanding from the view of total environmental impact rather than by the gross domestic product (GDP) unit from an economic development perspective. In an LCA study, the power generation should be considered in the life cycle of cement production.	[Li, Chen; Cui, Suping; Nie, Zuoren; Gong, Xianzheng; Wang, Zhihong] Beijing Univ Technol BJUT, China Ctr Natl Mat Life Cycle Assessment CNMLCA, Sch Mat Sci & Engn, Beijing 100124, Peoples R China; [Itsubo, Norihiro] Tokyo City Univ, Dept Environm & Informat Studies, Yokohama, Kanagawa 2248551, Japan; [Li, Chen] China Cement Assoc, Beijing, Peoples R China	Li, C (reprint author), Beijing Univ Technol BJUT, China Ctr Natl Mat Life Cycle Assessment CNMLCA, Sch Mat Sci & Engn, Beijing 100124, Peoples R China.	lichen1102@emails.bjut.edu.cn; cuisuping@bjut.edu.cn			National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2011BAE29B00]; China National "863" Program [2013AA031602]; Beijing Natural Science Foundation [2141001]	This work is financially supported by the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (No. 2011BAE29B00). China National "863" Program (No. 2013AA031602), Beijing Natural Science Foundation (No. 2141001). Thanks to JCA (Japanese Cement Association) for providing data.	Huijbregts MAJ, 2000, CHEMOSPHERE, V41, P541, DOI 10.1016/S0045-6535(00)00030-8; [Anonymous], 2006, 14040 ISO; Derwent RG, 1998, ATMOS ENVIRON, V32, P2429, DOI 10.1016/S1352-2310(98)00053-3; Li C, 2014, J CLEAN PROD, V72, P204, DOI 10.1016/j.jclepro.2014.02.048; Van den Heede P, 2012, CEMENT CONCRETE COMP, V34, P431, DOI 10.1016/j.cemconcomp.2012.01.004; Seyler C, 2005, INT J LIFE CYCLE ASS, V10, P120, DOI 10.1065/lca2004.08.173; Jenkin ME, 1999, ATMOS ENVIRON, V33, P1275, DOI 10.1016/S1352-2310(98)00261-1; Josa A, 2007, CEMENT CONCRETE RES, V37, P781, DOI 10.1016/j.cemconres.2007.02.004; Josa A, 2004, CEMENT CONCRETE RES, V34, P1313, DOI 10.1016/j.cemconres.2003.12.020; BREF, 2013, BEST AV TECHN BAT RE; CCA, 2006, CHIN CEM ALM 2001 20; CCA, 2013, REP CHIN CEM PROD 20; Cembureau, 2013, ENV PROD DECL EPD CE; Cembureau, 2012, MAIN CHAR CEM; Cembureau, 1997, BEST AV TECHN CEM IN; China Cement Association (CCA), 2009, CHIN CEM ALM 2008; China Cement Association (CCA), 2012, CHIN CEM ALM 2011; China Cement Association (CCA), 2010, CHIN CEM ALM 2009; China Cement Association (CCA), 2011, CHIN CEM ALM 2010; China Electric Power Yearbook editorial committee, 2012, CHIN EL POW YB 2010; CNMLCA, 2012, MAT LIF CYCL ASS DAT; CNMLCA, 2010, MAT LIF CYCL ASS DAT; CNMLCA, 2010, THERM POW STAT DAT; CNMLCA and EBML, 2011, RES PROGR REP PM NOX; CNMLCA and EBML, 2013, RES PROGR REP EC BUI; Cui SP, 2013, Patent, Patent No. [201310110236.6, 201210560857, 201210560857.X]; Cui SP, 2013, Patent, Patent No. [201310110314.2, 20121014161909, 2012101416190.9]; Cui SP, 2012, Patent, Patent No. [201210452172.3, 2013101988324, 201310198832.4]; Cui SP, 2013, Patent, Patent No. [201310199222.6, 2013101102366, 201310110236.6]; Ecoinvent, 2010, EC DAT V2 2; ELCD, 2013, EUR REF LIF CYCL DAT; EPD, 2008, SUPP ANN ENV PROD DE; GaBi, 2013, GaBi database, Patent No. [2013101103142, 201310110314.2]; Geng Y, 2012, ENVIRON SCI TECHNOL, V46, P107, DOI 10.1021/es204293x; GOVCN, 2012, DECL CHIN CENTR GOV; Heijungs R., 1992, ENV LIFE CYCLE ASSES; Huang QF, 2012, ENVIRON SCI TECHNOL, V46, P13031, DOI 10.1021/es3042274; Huijbregts M. A. J., 2000, J IND ECOL, V4, P75, DOI 10.1162/108819800300106393; International Organization for Standardization (ISO), 2006, 14044 ISO; IPCC/OECD, 2007, IPCC GUID NAT GREENH; ISO, 2006, 14025 ISO; JCA, 2013, [No title captured], Patent No. [2013101992226, 201310199222.6]; JCA, 2010, [No title captured], Patent No. [2012104521723, 201210452172.3]; JEMAI, 2005, POW STAT DAT; JEMAI, 2012, CEM MAN DAT; Li C, 2013, MATER SCI FORUM, V743-744, P802, DOI 10.4028/www.scientific.net/MSF.743-744.802; Li Chen, 2012, Journal of Shanghai Jiaotong University (Science), V17, DOI 10.1007/s12204-012-1283-z; Li C, 2013, MATER SCI FORUM, V743-744, P252, DOI 10.4028/www.scientific.net/MSF.743-744.252; Li C, 2014, MATER SCI FORUM, V787, P117; Li C, 2011, MATER SCI FORUM, V685, P181, DOI 10.4028/www.scientific.net/MSF.685.181; NDRC, 2006, EN CONS EM RED WORK; Nie ZR, 2013, INT J LIFE CYCLE ASS, V18, P1435, DOI 10.1007/s11367-013-0591-3; Nisbet MA, 2003, PCA R D SERIAL; PCA, 1998, PEA R D SERIAL; PCR, 2006, PROD CAT RUL PREG EN; Pennington DW, 2010, INT J LIFE CYCLE ASS, V15, P231, DOI 10.1007/s11367-009-0149-6; SAC, 2007, GB167802007 SAC; SAC (Standardization Administration of the People's Republic of China), 2007, GB1752007 SAC; UNFCCC, 2008, CLEAN DEV MECH CDM P; von Bahr B, 2003, J CLEAN PROD, V11, P713, DOI 10.1016/S0959-6526(02)00126-9; WBCSD, 2011, CEM CO2 EN PROT VERS; Wolf MA, 2012, INT REFERENCE LIFE C, DOI [10.2788/85670, DOI 10.2788/85670]; Wolf MA, 2006, P 7 INT C ECOBALANCE, P845; World Nuclear Association, 2013, NUCL POW JAP	64	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0948-3349	1614-7502		INT J LIFE CYCLE ASS	Int. J. Life Cycle Assess.	JAN	2015	20	1					117	127		10.1007/s11367-014-0804-4		11	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	AX8IQ	WOS:000347153700010		
J	Boulay, AM; Motoshita, M; Pfister, S; Bulle, C; Munoz, I; Franceschini, H; Margni, M				Boulay, Anne-Marie; Motoshita, Masaharu; Pfister, Stephan; Bulle, Cecile; Munoz, Ivan; Franceschini, Helen; Margni, Manuele			Analysis of water use impact assessment methods (part A): evaluation of modeling choices based on a quantitative comparison of scarcity and human health indicators	INTERNATIONAL JOURNAL OF LIFE CYCLE ASSESSMENT			English	Article						Impact modeling; Life cycle assessment; Model comparison; Water deprivation; Water footprint	LCA; AVAILABILITY	In the past decade, several methods have emerged to quantify water scarcity, water availability and the human health impacts of water use. It was recommended that a quantitative comparison of methods should be performed to describe similar impact pathways, namely water scarcity and human health impacts from water deprivation. This is precisely the goal of this paper, which aims to (1) identify the key relevant modeling choices that explain the main differences between characterization models leading to the same impact indicators; (2) quantify the significance of the differences between methods, and (3) discuss the main methodological choices in order to guide method development and harmonization efforts. The modeling choices are analysed for similarity of results (using mean relative difference) and model response consistency (through rank correlation coefficient). Uncertainty data associated with the choice of model are provided for each of the models analysed, and an average value is provided as a tool for sensitivity analyses. The results determined the modeling choices that significantly influence the indicators and should be further analysed and harmonised, such as the regional scale at which the scarcity indicator is calculated, the sources of underlying input data and the function adopted to describe the relationship between modeled scarcity indicators and the original withdrawal-to-availability or consumption-to-availability ratios. The inclusion or exclusion of impacts from domestic user deprivation and the inclusion or exclusion of trade effects both strongly influence human health impacts. At both midpoint and endpoint, the comparison showed that considering reduced water availability due to degradation in water quality, in addition to a reduction in water quantity, greatly influences results. Other choices are less significant in most regions of the world. Maps are provided to identify the regions in which such choices are relevant. This paper provides useful insights to better understand scarcity, availability and human health impact models for water use and identifies the key relevant modeling choices and differences, making it possible to quantify model uncertainty and the significance of these choices in a specific regional context. Maps of regions where these specific choices are of importance were generated to guide practitioners in identifying locations for sensitivity analyses in water footprint studies. Finally, deconstructing the existing models and highlighting the differences and similarities has helped to determine building blocks to support the development of a consensual method.	[Boulay, Anne-Marie; Bulle, Cecile; Margni, Manuele] Ecole Polytech, CIRAIG, Montreal, PQ H3C 3A7, Canada; [Motoshita, Masaharu] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058569, Japan; [Pfister, Stephan] ETH, Inst Environm Engn, CH-8093 Zurich, Switzerland; [Munoz, Ivan; Franceschini, Helen] Unilever, Safety & Environm Assurance Ctr, Colworth, England; [Motoshita, Masaharu] Tech Univ Berlin, Dept Environm Technol, D-10623 Berlin, Germany	Boulay, AM (reprint author), Ecole Polytech, CIRAIG, Montreal, PQ H3C 3A7, Canada.	anne-marie.boulay@polymtl.ca	Pfister, Stephan/B-1317-2011	Pfister, Stephan/0000-0001-8984-2041	ArcelorMittal; Bombardier; le Mouvement Desjardins; Hydro-Quebec; LVMH; Michelin; Nestle; RECYC-QUEBEC; RONA; SAQ; Solvay; Total; Umicore; Veolia Environnement	The authors would like to acknowledge the contribution of Francis Gassert from the World Resource Institute (WRI) for providing data and understanding into the Aquaduct model. We acknowledge the financial support of the industrial partners in the International Chair in Life Cycle Assessment (a research unit of CIRAIG): ArcelorMittal, Bombardier, le Mouvement Desjardins, Hydro-Quebec, LVMH, Michelin, Nestle, RECYC-QUEBEC, RONA, SAQ, Solvay, Total, Umicore, Veolia Environnement.	Aguilar-Manjarrez J, 2006, WRI MAJOR WATERSHEDS; Alcamo J, 2000, KASSEL WORLD WATER S, V2; Brent AC, 2004, INT J LIFE CYCLE ASS, V9, P172, DOI 10.1065/lca2004.03.149; Ridoutt BG, 2010, GLOBAL ENVIRON CHANG, V20, P113, DOI 10.1016/j.gloenvcha.2009.08.003; Perry C, 2007, IRRIG DRAIN, V56, P367, DOI 10.1002/rid; [Anonymous], 2009, DROP; Bayart JB, 2010, INT J LIFE CYCLE ASS, V15, P439, DOI 10.1007/s11367-010-0172-7; [Anonymous], 2014, 14046 ISO; Pfister S, 2009, ENVIRON SCI TECHNOL, V43, P4098, DOI 10.1021/es802423e; Berger M, 2013, J IND ECOL, V17, P79, DOI 10.1111/j.1530-9290.2012.00495.x; Alcamo J, 2003, HYDROLOG SCI J, V48, P339, DOI 10.1623/hysj.48.3.339.45278; Boulay AM, 2011, ENVIRON SCI TECHNOL, V45, P8948, DOI 10.1021/es1030883; Vorosmarty CJ, 2000, SCIENCE, V289, P284, DOI 10.1126/science.289.5477.284; Kounina A, 2013, INT J LIFE CYCLE ASS, V18, P707, DOI 10.1007/s11367-012-0519-3; Rosenbaum RK, 2008, INT J LIFE CYCLE ASS, V13, P532, DOI 10.1007/s11367-008-0038-4; Boulay AM, 2011, INT J LIFE CYCLE ASS, V16, P639, DOI 10.1007/s11367-011-0300-z; Alcamo J, 2003, HYDROLOG SCI J, V48, P317, DOI 10.1623/hysj.48.3.317.45290; Ridoutt BG, 2013, INT J LIFE CYCLE ASS, V18, P204, DOI 10.1007/s11367-012-0458-z; Bauer C, 2005, LIFE CYCLE ASSESSMEN; Bayart JB, 2014, INT J LIFE CYCLE ASS, V19, P1336, DOI 10.1007/s11367-014-0732-3; Bourgault G, 2012, SETAC EUR 22 ANN M 6; Bulle C, 2012, LCA 12 US WASH TAC; Fekete BM, 2002, GLOBAL BIOGEOCHEM CY, V16, p[15, 15]; Fenner K, 2005, ENVIRON SCI TECHNOL, V39, P1932, DOI 10.1021/es048917b; Food and Agriculture Organization of the United Nations, AQUASTAT FAOS INF SY; Frischknecht R, 2008, SWISS ECOLOGICAL SCA; Hertwich EG, 1999, RISK ANAL, V19, P1193, DOI 10.1023/A:1007094930671; Hoekstra AY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032688; Mekonnen M.M., 2011, NATL WATER FOOTPRINT; Motoshita M., 2010, INT J LIFE CYCLE ASS, V16, P65; Motoshita M, 2010, P 9 INT C ECOBALANCE, P3; Owens J. W., 2002, J IND ECOL, V5, P37; Pfister S, 2011, SURFACE WATER USE HU; Pfister S, 2013, J CLEAN PROD; Rodda JC, 2003, WORLD WATER RESOURCE	35	4	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0948-3349	1614-7502		INT J LIFE CYCLE ASS	Int. J. Life Cycle Assess.	JAN	2015	20	1					139	160		10.1007/s11367-014-0814-2		22	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	AX8IQ	WOS:000347153700012		
J	Matsuzaki, K; Ryu, T; Sueoka, A; Tsukamoto, K				Matsuzaki, Kenichiro; Ryu, Takahiro; Sueoka, Atsuo; Tsukamoto, Keizo			Theoretical and experimental study on rifling mark generating phenomena in BTA deep hole drilling process (generating mechanism and countermeasure)	INTERNATIONAL JOURNAL OF MACHINE TOOLS & MANUFACTURE			English	Article						Self-excited vibration; BTA; Drilling; Rifling mark; Chatter vibration	CHATTER VIBRATION; SUPPRESSION; ROUNDNESS; SHAFT	Boring and Trepanning Association (BTA) deep hole drilling is used for producing holes with high aspect ratios. In this process, chatter vibration sometimes occurs, and a rifling mark is formed on the bore surface. The rifling mark generating phenomenon is considered to be a result of self-excited vibration caused by time delay. An analytical model is proposed considering the supporting condition of the boring bar in detail. In a real machine for BTA drilling, the boring bar is supported at the oil pressure head and the supporting pad, as well as at the base. The stability of the self-excited vibration is analyzed numerically, and the result is compared with the experiment. The theoretical and experimental results agree well with each other. Furthermore, the effect of an additional guide pad proposed by the authors as a countermeasure is evaluated theoretically and experimentally. (C) 2014 Elsevier Ltd. All rights reserved.	[Matsuzaki, Kenichiro] Kagoshima Univ, Dept Mech Engn, Kagoshima 890, Japan; [Ryu, Takahiro] Oita Univ, Dept Mech & Energy Syst Engn, Oita 87011, Japan; [Sueoka, Atsuo] Kyushu Polytech Coll, Kitakyushu, Fukuoka, Japan; [Tsukamoto, Keizo] Ayabo Corp, Anjo, Aichi, Japan	Matsuzaki, K (reprint author), Kagoshima Univ, Dept Mech Engn, 1-21-40 Korimoto, Kagoshima 890, Japan.	matsuzaki@mech.kagoshima-u.ac.jp			JSPS KAKENHI [23560262, 26420179]; Strategic Core Technology Advancement Program	This work was supported by JSPS KAKENHI Grant Numbers 23560262 and 26420179 and partially supported by the 2010 Strategic Core Technology Advancement Program. The authors thank everyone from the Kyushu Bureau of Economy, Trade and Industry and the Kyushu Industrial Technology Center for their cooperation.	Al-Wedyan HM, 2007, J MANUF SCI E-T ASME, V129, P48, DOI 10.1115/1.2280610; Ema S, 2000, INT J MACH TOOL MANU, V40, P1141, DOI 10.1016/S0890-6955(99)00119-4; Chin DH, 2005, PRECIS ENG, V29, P176, DOI 10.1016/j.precisioneng.2004.06.003; CHIN JH, 1995, INT J MACH TOOL MANU, V35, P29, DOI 10.1016/0890-6955(95)80007-7; Deng CS, 2001, INT J MACH TOOL MANU, V41, P1165, DOI 10.1016/S0890-6955(01)00007-4; Deng CS, 2004, J MANUF SCI E-T ASME, V126, P524, DOI 10.1115/1.1765142; Kong LF, 2014, J MATER PROCESS TECH, V214, P2617, DOI 10.1016/j.jmatprotec.2014.05.029; Kong LF, 2013, INT J NONLIN MECH, V55, P170, DOI 10.1016/j.ijnonlinmec.2013.06.004; Matsuzaki K., 2010, T JAPAN SOC MECH E C, V76, P1684; Matsuzaki K., 2009, T JAPAN SOC MECH E C, V75, P1918; Messaoud A, 2009, J SOUND VIB, V321, P620, DOI 10.1016/j.jsv.2008.10.028; Weinert K, 2005, CIRP ANN-MANUF TECHN, V54, P363, DOI 10.1016/S0007-8506(07)60123-1	12	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0890-6955	1879-2170		INT J MACH TOOL MANU	Int. J. Mach. Tools Manuf.	JAN	2015	88						194	205		10.1016/j.ijmachtools.2014.10.003		12	Engineering, Manufacturing; Engineering, Mechanical	Engineering	AX6GG	WOS:000347020500017		
J	Zhang, H; Mizutani, H; Nakagawa, H; Kawaike, K				Zhang, Hao; Mizutani, Hideaki; Nakagawa, Hajime; Kawaike, Kenji			Euler-Lagrange model for local scour and grain size variation around a spur dyke	INTERNATIONAL JOURNAL OF MULTIPHASE FLOW			English	Article						Spur dyke; Euler-Lagrange coupling; Stochastic model; Local scour; Grain sorting	BED-LOAD TRANSPORT; NUMERICAL-SIMULATION; HYDRAULIC STRUCTURES; COHERENT STRUCTURES; FLOW; DYNAMICS; DIKES; PIERS; RIVER	This paper presents a three-dimensional Euler-Lagrange two-phase flow model. The fluid phase is simulated by solving the unsteady Reynolds-averaged Navier-Stokes equations with a k-epsilon turbulence closure on an unstructured Eulerian grid, and a Lagrangian model integrating the grain trajectory and momentum equations is employed to predict the granular phase in motion. Considering the deterministic nature of the movement of individual grains and the stochastic nature of the behavior of grain groups, the grain-bed exchanges in terms of the grain entrainment and deposition are modeled with a stochastic approach. The vertical bed sorting and armouring processes are simulated by introducing a layering scheme for static grains in the bed. The numerical model is applied to predict the bed deformation around a spur dyke in a uniform and a non-uniform sediment beds. It is found that both the predicted local scour geometry and the grain size distribution are reasonably consistent with those of the experiments. According to the results, local scour in a non-uniform bed is smaller than that in a uniform one. The non-uniform bed around the spur dyke is coarsened, but sand ribbons occur in the upper part of the scour hole and at the downstream of the spur dyke. (C) 2014 Elsevier Ltd. All rights reserved.	[Zhang, Hao] Kochi Univ, Res & Educ Fac, Nat Sci Cluster, Agr Unit, Nankoku, Kochi 7838502, Japan; [Mizutani, Hideaki] Kyoto Univ, Disaster Prevent Res Inst, Shirahama Oceanog Observ, Wakayama 6492201, Japan; [Nakagawa, Hajime; Kawaike, Kenji] Kyoto Univ, Disaster Prevent Res Inst, Ujigawa Open Lab, Fushimi Ku, Kyoto 6128235, Japan	Zhang, H (reprint author), Kochi Univ, Res & Educ Fac, Nat Sci Cluster, Agr Unit, Monobe B200, Nankoku, Kochi 7838502, Japan.	zhang@kochi-u.ac.jp			MEXT, Japan [22760369]; JST/JICA SATREPS Program on Disaster Prevention/Mitigation Measures against Floods and Storm Surges in Bangladesh	This study was funded by the Grant-in-Aid for Young Scientist (B), MEXT, Japan (PI: Dr. H. Zhang, Grant No. 22760369) and the JST/JICA SATREPS Program on Disaster Prevention/Mitigation Measures against Floods and Storm Surges in Bangladesh (PI: Dr. H. Nakagawa).	Khosronejad A, 2012, ADV WATER RESOUR, V37, P73, DOI 10.1016/j.advwatres.2011.09.013; Nagata N, 2005, J HYDRAUL ENG-ASCE, V131, P1074, DOI 10.1061/(ASCE)0733-9429(2005)131:12(1074); Escauriaza C, 2011, J FLUID MECH, V666, P36, DOI 10.1017/S0022112010004192; Paik J, 2010, J HYDRAUL ENG-ASCE, V136, P981, DOI 10.1061/(ASCE)HY.1943-7900.0000089; Ashida K., 1972, T JAPAN SOC CIVIL EN, V206, P59, DOI DOI 10.2208/JSCEJ1969.1972.206_59; Bihs H, 2011, J HYDRAUL ENG-ASCE, V137, P1287, DOI 10.1061/(ASCE)HY.1943-7900.0000401; Chang Y. S., 2003, J TURBUL; Chrisohoides A, 2003, J HYDRAUL ENG-ASCE, V129, P177, DOI 10.1061/(ASCE)0733-0733-9429(2003)129:3(177); Einstein H.A., 1942, T ASCE, V107, P561; Fukuoka S., 2013, ADV RIVER SEDIMENT R; Karami H, 2014, WATER ENVIRON J, V28, P124, DOI 10.1111/wej.12019; Koken M, 2011, J HYDRAUL RES, V49, P736, DOI 10.1080/00221686.2011.616316; Koken M, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006491; Liu B.Y., 1991, THESIS KYOTO U; Meyer-Peter E., 1948, 2 M INT ASS HYDR STR, P39; Mizutani H., 2010, 29 ANN C JAP SOC NAT, P145; Mizutani H., 2011, THESIS KYOTO U JAPAN; Nakagawa H., 1986, P 3 INT S RIV SED U, P885; Nakagawa H, 2013, J FLOOD RISK MANAG, V6, P345, DOI 10.1111/jfr3.12021; Onda S., 2007, ANN J HYDRAULIC ENG, V51, P943; Salaheldin TM, 2004, J HYDRAUL ENG-ASCE, V130, P91, DOI 10.1061/(ASCE)0733-9429(2004)130:2(91); VANRIJN LC, 1984, J HYDRAUL ENG-ASCE, V110, P1431; Yeganeh-Bakhtiary A, 2009, J HYDRAUL RES, V47, P203, DOI 10.3826/jhr.2009.3168; Yeganeh-Bakhtiary A., 2013, J OFFSHORE MECH ARCT, P135; Zamankhan P, 2009, J OFFSHORE MECH ARCT, V131, DOI 10.1115/1.3058705; Zhang H, 2006, PROC MONOGR ENG WATE, P1683; Zhang H., 2011, ANN DISAS PREV RES B, V54B, P511; Zhang H., 2009, ANN J HYDRAUL ENG JS, V53, P145; Zhang H, 2009, INT J SEDIMENT RES, V24, P33, DOI 10.1016/S1001-6279(09)60014-7; Zhang H, 2012, INT J SEDIMENT RES, V27, P141, DOI 10.1016/S1001-6279(12)60023-7; Zhang H, 2005, THESIS KYOTO U JAPAN	31	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0301-9322	1879-3533		INT J MULTIPHAS FLOW	Int. J. Multiph. Flow	JAN	2015	68						59	70		10.1016/j.ijmultiphaseflow.2014.10.003		12	Mechanics	Mechanics	AX8CA	WOS:000347136900006		
J	Yamaguchi, K; Thomas, AG; Busfield, JJC				Yamaguchi, Ken; Thomas, Alan G.; Busfield, James J. C.			Stress relaxation, creep and set recovery of elastomers	INTERNATIONAL JOURNAL OF NON-LINEAR MECHANICS			English	Article						Elastomer; Creep; Set recovery; Stress relaxation; Viscoelastic; Boltzmann superposition	RUBBER	The stress relaxation, creep and recovery behaviour of a cross-linked unfilled natural rubber has been investigated at moderate stresses in tension. The aim being to extend the idea, initially developed by Alan Gent in his seminal 1962 paper on the relaxation behaviour of rubber, in order to understand and examine the time dependent mechanisms that are present in elastomers under strain. A method based upon the Boltzmann superposition principle was used to compare the creep compliance with a measurement of its recovery after release from a range of constant loads held for different times. The creep behaviour was seen to exhibit the usual linear dependence on the logarithm of time. The recovery data was also seen to reduce onto a single recovery curve for any given applied tensile stress for a range of loading times using the Boltzmann superposition principle. The differences between the relative rates of the creep and the recovery behaviour can in part be attributed to the non-linearity in the stress-strain behaviour exhibited in tension of the elastomer. (C) 2014 Elsevier Ltd. All rights reserved.	[Yamaguchi, Ken] Bridgestone Corp, Tire Mat Dev, Kodaira, Tokyo 1878531, Japan; [Thomas, Alan G.; Busfield, James J. C.] Queen Mary Univ London, Mat Res Inst, London E1 4NS, England	Busfield, JJC (reprint author), Queen Mary Univ London, Mat Res Inst, Mile End Rd, London E1 4NS, England.	j.busfield@qmul.ac.uk					CHAI CK, 1981, POLYMER, V22, P399, DOI 10.1016/0032-3861(81)90055-0; DERHAM CJ, 1973, J MATER SCI, V8, P1023, DOI 10.1007/BF00756634; Gent A.N., 1962, J APPL POLYM SCI, V6, P433, DOI 10.1002/app.1962.070062207; GENT AN, 1958, J POLYM SCI, V28, P625, DOI 10.1002/pol.1958.1202811814; THOMAS AG, 1955, T FARADAY SOC, V51, P569, DOI 10.1039/tf9555100569	5	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0020-7462	1878-5638		INT J NONLIN MECH	Int. J. Non-Linear Mech.	JAN	2015	68				SI		66	70		10.1016/j.ijnonlinmec.2014.07.004		5	Mechanics	Mechanics	AX8AH	WOS:000347132300010		
J	Kitada, S; Yoshimura, K; Miki, K; Miki, M; Hashimoto, H; Matsui, H; Kuroyama, M; Ageshio, F; Kagawa, H; Mori, M; Maekura, R; Kobayashi, K				Kitada, S.; Yoshimura, K.; Miki, K.; Miki, M.; Hashimoto, H.; Matsui, H.; Kuroyama, M.; Ageshio, F.; Kagawa, H.; Mori, M.; Maekura, R.; Kobayashi, K.			Validation of a commercial serodiagnostic kit for diagnosing pulmonary Mycobacterium avium complex disease	INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE			English	Article						non-tuberculous mycobacteria; enzyme immunoassay; diagnostic tool	GLYCOPEPTIDOLIPID CORE ANTIGEN; ENZYME-IMMUNOASSAY; LUNG-DISEASE; RISK-FACTORS	SETTING: A commercial serodiagnostic kit for diagnosing pulmonary disease due to Mycobacterium avium complex (MAC-PD) was developed and launched in Japan in 2011. OBJECTIVE: To evaluate the performance of this kit in routine clinical settings. METHODS: In this retrospective single-centre study, data on serum levels of anti-glycopeptidolipid (GPL) core IgA antibody (U/ml) measured using the kit were analysed in patients diagnosed with MAC-PD according to American Thoracic Society criteria, in those with pulmonary tuberculosis (PTB) or pulmonary M. kansasii disease and in healthy volunteers. RESULTS: The anti-GPL-core IgA antibody levels of serum were significantly higher (P < 0.0001) in patients with MAC-PD (n = 485) than in those with PTB (n = 133) or pulmonary M. kansasii disease (n = 23) or in healthy subjects (n = 265). When the cut-off level was set at 0.7 U/ml, the sensitivity and specificity were respectively 78.6% and 96.9%. Higher antibody levels were observed in patients with greater extent of disease on chest computed tomography (P < 0.0001). CONCLUSIONS: The serodiagnostic kit revealed good sensitivity and specificity. The antibody levels may reflect disease activity. Additional work is needed to determine whether the diagnostic assay could be used in conjunction with current diagnostic criteria to improve the diagnosis of MAC-PD.	[Kitada, S.; Yoshimura, K.; Miki, K.; Miki, M.; Hashimoto, H.; Matsui, H.; Kuroyama, M.; Ageshio, F.; Kagawa, H.; Mori, M.; Maekura, R.] Natl Hosp Org, Natl Toneyama Hosp, Dept Resp Med, Toyonaka, Osaka 5608552, Japan; [Kobayashi, K.] Sakai City Inst Publ Hlth, Osaka, Japan	Kitada, S (reprint author), Natl Hosp Org, Natl Toneyama Hosp, Dept Resp Med, 5-1-1 Toneyama, Toyonaka, Osaka 5608552, Japan.	kitadase@toneyama.go.jp			Ministry of Health, Labour and Welfare, Tokyo, Japan	The authors would like to thank Y Yamamoto (laboratory technician, NHO National Toneyama Hospital) for performing the serodiagnostic tests, and all the health care workers of NHO National Toneyama hospital who volunteered for this study. The study was supported by a grant (Research on Emerging and Reemerging Infectious Diseases) from the Ministry of Health, Labour and Welfare, Tokyo, Japan.	American Thoracic Society, 1997, AM J RESP CRIT CARE, V156, pS1; Kitada S, 2008, AM J RESP CRIT CARE, V177, P793, DOI 10.1164/rccm.200705-771OC; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Maekawa K, 2011, CHEST, V140, P723, DOI 10.1378/chest.10-2315; Kobashi Y, 2013, SCAND J INFECT DIS, V45, P241, DOI 10.3109/00365548.2012.714904; Dirac MA, 2012, AM J RESP CRIT CARE, V186, P684, DOI 10.1164/rccm.201205-0825OC; Nishiuchi Y, 2007, CLIN INFECT DIS, V45, P347, DOI 10.1086/519383; Khan K, 2007, AM J RESP CRIT CARE, V176, P306, DOI 10.1164/rccm.200702-2010C; Kitada S, 2007, EUR RESPIR J, V29, P1217, DOI 10.1183/09031936.00061806; Kitada S, 2005, CLIN DIAGN LAB IMMUN, V12, P44, DOI 10.1128/CDLI.12.1.44-51.2005; Chatterjee D, 2001, CELL MOL LIFE SCI, V58, P2018, DOI 10.1007/PL00000834; Jeong BH, 2013, J CLIN MICROBIOL, V51, P2747, DOI 10.1128/JCM.00702-13; Kitada S, 2010, CHEST, V138, P236, DOI 10.1378/chest.10-0248; Kitada S, 2002, CLIN INFECT DIS, V35, P1328, DOI 10.1086/344277; Kitada S, 2013, EUR RESPIR J, V42, P454, DOI 10.1183/09031936.00098212; Shu CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080473; WALLACE RJ, 1990, AM REV RESPIR DIS, V142, P940; Watanabe M, 2011, MOD RHEUMATOL, V21, P144, DOI 10.1007/s10165-010-0368-5	18	0	0	INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)	PARIS	68 BOULEVARD SAINT-MICHEL,, 75006 PARIS, FRANCE	1027-3719	1815-7920		INT J TUBERC LUNG D	Int. J. Tuberc. Lung Dis.	JAN	2015	19	1					97	103		10.5588/ijtld.14.0564		7	Infectious Diseases; Respiratory System	Infectious Diseases; Respiratory System	AX4HG	WOS:000346893500018		
J	Yamana, H; Matsui, H; Fushimi, K; Yasunaga, H				Yamana, H.; Matsui, H.; Fushimi, K.; Yasunaga, H.			Treatment options and outcomes of hospitalised tuberculosis patients: a nationwide study	INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE			English	Article						tuberculosis; mortality; risk factor	RISK-FACTORS; PULMONARY TUBERCULOSIS; MORTALITY; PREVALENCE; DRUGS	SETTING: Although standardised multidrug treatments exist, mortality among hospitalised tuberculosis (TB) patients is high. OBJECTIVE: To characterise TB patients requiring acute hospital care and identify factors associated with in-hospital mortality. DESIGN: Using a Japanese national database of acute-care hospitals, we identified patients with sputum smear-positive pulmonary TB who were discharged (both deceased and alive) between July 2010 and March 2013. Demographic characteristics, comorbidity, procedures and treatments were examined. We performed a multivariable logistic regression analysis to identify risk factors for in-hospital mortality. RESULTS: Of 877 treated patients (566 males, mean age 74.5 years) identified, 152 (17.3%) died. A standard four-drug regimen of isoniazid (INH), rifampicin (RMP), ethambutol (EMB) and pyrazinamide was given to 279 (31.8%) patients, and INH, RMP and EMB to 335 (38.2%) patients. Multivariable analysis showed that the three-drug regimen was significantly associated with higher rates of in-hospital mortality (OR 1.87, 95%CI 1.07-3.27, P = 0.028). Other factors associated with in-hospital death were age, male sex, smoking habit, emergency admission, dementia and severe respiratory condition. CONCLUSION: The risk factors for in-hospital death identified include the use of the three-drug regimen. Treatment choice could influence the outcome of hospitalised TB patients.	[Yamana, H.; Matsui, H.; Yasunaga, H.] Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo 1130033, Japan; [Yamana, H.] Bunkyo City Publ Hlth Ctr, Tokyo, Japan; [Fushimi, K.] Tokyo Med & Dent Univ, Grad Sch Med, Dept Hlth Policy & Informat, Tokyo, Japan	Yasunaga, H (reprint author), Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	yasunagah-tky@umin.ac.jp		Yasunaga, Hideo/0000-0002-6017-469X	Ministry of Health, Labour and Welfare, Tokyo, Japan [H25-Policy-010]; Council for Science and Technology Policy, Tokyo, Japan [0301002001001]	This study was supported by grants from the Ministry of Health, Labour and Welfare, Tokyo, Japan (Research on Policy Planning and Evaluation grant number: H25-Policy-010), and the Council for Science and Technology Policy, Tokyo, Japan (Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST program grant number: 0301002001001).	COMBS DL, 1990, ANN INTERN MED, V112, P397; Abos-Hernandez R, 2002, INT J TUBERC LUNG D, V6, P470; Sako A, 2014, GASTROINTEST ENDOSC, V80, P88, DOI 10.1016/j.gie.2013.12.006; Waitt CJ, 2011, INT J TUBERC LUNG D, V15, P871, DOI 10.5588/ijtld.10.0352; von Reyn CF, 2011, INT J TUBERC LUNG D, V15, P1087, DOI 10.5588/ijtld.10.0517; Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; Erbes R, 2006, EUR RESPIR J, V27, P1223, DOI 10.1183/09031936.06.00088105; Hansel NN, 2004, CHEST, V126, P1079, DOI 10.1378/chest.126.4.1079; Wu CY, 2011, INT J TUBERC LUNG D, V15, P125; Ferrara G, 2012, CURR OPIN PULM MED, V18, P233, DOI 10.1097/MCP.0b013e328351f9d6; Kim HJ, 2010, INT J TUBERC LUNG D, V14, P79; [Anonymous], 2004, LANCET, V363, P157; British Thoracic Association, 1981, BR J DIS CHEST, V75, P141; East African/British Medical Research Council, 1974, LANCET, V2, P1100; Ito K, 2012, KEKKAKU, V87, P51; Japanese Society for Tuberculosis Therapeutic Committee, 2008, KEKKAKU, V83, P529; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Langendam MW, 2012, EUR RESPIR J, V39, P1012, DOI 10.1183/09031936.00125511; Matos ED, 2006, INT J TUBERC LUNG D, V10, P1360; Ministry of Health Labour and Welfare., 2014, STAT DES MED I TYP 2; Ministry of Health Labour and Welfare Japanese Government, 2013, ANN HLTH LAB WELF RE; Mtei L, 2005, CLIN INFECT DIS, V40, P1500, DOI 10.1086/429825; Sterling TR, 2006, INT J TUBERC LUNG D, V10, P542; TB CARE I, 2014, INT STAND TUB CAR; Wada M, 2001, Kekkaku, V76, P33; World Health Organization, 2013, WHOHTMTB201311; World Health Organization, 2011, WHOHTMTB20116; World Health Organization (WHO), 2009, WHOHTMTB2009420	28	0	0	INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)	PARIS	68 BOULEVARD SAINT-MICHEL,, 75006 PARIS, FRANCE	1027-3719	1815-7920		INT J TUBERC LUNG D	Int. J. Tuberc. Lung Dis.	JAN	2015	19	1					120	126		10.5588/ijtld.14.0333		7	Infectious Diseases; Respiratory System	Infectious Diseases; Respiratory System	AX4HG	WOS:000346893500021		
J	Ito, T; Mochizuki, K; Oka, T; Hanada, K; Tanabe, K				Ito, Takafumi; Mochizuki, Kaori; Oka, Tomohiro; Hanada, Ken; Tanabe, Kazuaki			Study of mizoribine therapy in elderly patients with membranous nephropathy: comparison with patients not receiving mizoribine	INTERNATIONAL UROLOGY AND NEPHROLOGY			English	Article						Elderly patients; Membranous nephropathy; Mizoribine; Steroid	REGISTRY J-RBR; PROTEINURIA; DISEASE	We have previously reported the results of mizoribine (MZR) treatment for elderly patients with membranous nephropathy (MN). Here, we retrospectively compared these patients with those who had been initially treated with prednisolone (PSL) alone. The subjects were patients with MN aged a parts per thousand yen65 years who were examined between April 2007 and September 2010 and followed for at least 1 year. The median period until the start of treatment in the MZR group (MZR-G) was 60 days. The urinary protein level at the start of MZR treatment was 3.89 +/- A 2.3 g/gCr. Urinary protein in the group not treated with MZR (N-MZR-G) was 1.0 +/- A 1.1 g/gCr, showing a tendency to improve in patients with nephrotic syndrome relative to the MZR-G (p = 0.055). The PSL dose in the MZR-G versus N-MZR-G at 1 year was 5.7 +/- A 3.0 versus 6.25 +/- A 2.5 mg/day, the urinary protein level was 0.19 +/- A 0.2 versus 0.13 +/- A 0.1 g/gCr, and the remission rate was 80 versus 75 %. In the MZR-G, the total PSL dose at 1 year after the start of MZR treatment was 5,058 +/- A 1,904 versus 6,649 +/- A 875 mg in the N-MZR-G. Adverse events occurred in 3/5 patients (60 %) in the MZR-G and in 3/4 patients (75 %) in the N-MZR-G. Elderly patients with MN who respond poorly to PSL treatment may be treated successfully with MZR.	[Ito, Takafumi; Mochizuki, Kaori; Oka, Tomohiro; Hanada, Ken; Tanabe, Kazuaki] Shimane Univ, Fac Med, Izumo, Shimane, Japan	Ito, T (reprint author), Shimane Univ, Fac Med, Izumo, Shimane, Japan.	tito@med.shimane-u.ac.jp					Alexopoulos E, 2006, NEPHROL DIAL TRANSPL, V21, P2127; Cattran DC, 2001, KIDNEY INT, V59, P1484, DOI 10.1046/j.1523-1755.2001.0590041484.x; Irie F, 2006, KIDNEY INT, V69, P1264, DOI 10.1038/sj.ki.5000284; Kikuchi Y, 2005, NEPHROL DIAL TRANSPL, V20, P1573, DOI 10.1093/ndt/gfh888; Barrett CMF, 2014, INT UROL NEPHROL, V46, P963, DOI 10.1007/s11255-013-0593-x; Haase M, 2012, INT UROL NEPHROL, V44, P635, DOI 10.1007/s11255-011-0099-3; Ito T, 2012, J NEW REM CLIN, V61, P480; Koshikawa S, 1993, KIDNEY DIAL, V4, P631; Matsumoto Y, 2013, RENAL FAILURE, V35, P936, DOI 10.3109/0886022X.2013.808133; Matsuo S, 2011, JPN J NEPHROL, V53, P78; Saito T, 2014, CLIN EXP NEPHROL, V18, P784, DOI 10.1007/s10157-013-0925-2; Wen M, 2014, INT UROL NEPHROL, V46, P847, DOI 10.1007/s11255-014-0673-6; Yokoyama H, 2012, CLIN EXP NEPHROL, V16, P903, DOI 10.1007/s10157-012-0673-8; Yokoyama H, 2012, CLIN EXP NEPHROL, V16, P557, DOI 10.1007/s10157-012-0593-7	14	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0301-1623	1573-2584		INT UROL NEPHROL	Int. Urol. Nephrol.	JAN	2015	47	1					131	135		10.1007/s11255-014-0850-7		5	Urology & Nephrology	Urology & Nephrology	AX9UE	WOS:000347246700020		
J	Oshima, Y; Moriyama, T; Itabashi, M; Takei, T; Nitta, K				Oshima, Yasuko; Moriyama, Takahito; Itabashi, Mitsuyo; Takei, Takashi; Nitta, Kosaku			Characteristics of IgA nephropathy in advanced-age patients	INTERNATIONAL UROLOGY AND NEPHROLOGY			English	Article						IgA nephropathy; Advanced-age; Hypertension; Dyslipidemia; Hyperuricemia	ISOLATED MICROSCOPIC HEMATURIA; IMMUNOGLOBULIN-A NEPHROPATHY; NATURAL-HISTORY; OXFORD CLASSIFICATION; RENAL BIOPSY; CLINICOPATHOLOGICAL CORRELATIONS; PROSPECTIVE COHORT; PROGNOSTIC-FACTORS; PATHOLOGY; JAPAN	The susceptible age for IgA nephropathy (IgAN) is < 30 years. However, IgAN sometimes develops in people aged > 60 years, and its characteristics remain unknown. We divided 600 IgAN patients into three groups: advanced-age group (AAG, n = 31, a parts per thousand yen60 years); middle-aged group (MAG, n = 162, 40-59 years); and young-aged group (YAG, n = 407, 20-39 years). We analyzed clinical and histological background, renal outcome, and risk of progression. In the AAG, mean arterial pressure (MAP) and the number of hypertensive patients were significantly higher than in the YAG. Total protein, serum albumin, and estimated glomerular filtration rate were significantly lower, and blood urea nitrogen, proteinuria, and N-acetyl-beta-d-glucosaminidase were significantly higher in the AAG than in MAG and YAG. In histological findings, interstitial fibrosis/tubular atrophy by Oxford classification and arteriosclerosis were more severe in the AAG than the in YAG. Renal survival rate analyzed by Kaplan-Meier method was significantly lower in the AAG (22.9 %/19 years in the AAG vs. 69.2 and 84.9 %/20 years in the MAG and YAG, p < 0.0001). The patients who progressed to end-stage renal disease (ESRD) in the AAG had higher MAP and more severe proteinuria compared with the patients who did not progress to ESRD in the AAG. The characteristics of IgAN in advanced-age were lower renal function, high levels of proteinuria, severe interstitial change, and arteriolosclerosis caused by glomerulopathy and concomitant diseases, such as hypertension, dyslipidemia, and hyperuricemia. Prognosis was poor, and > 70 % developed ESRD within 20 years.	[Oshima, Yasuko; Moriyama, Takahito; Itabashi, Mitsuyo; Takei, Takashi; Nitta, Kosaku] Tokyo Womens Med Univ, Dept Med, Kidney Ctr, Shinjuku Ku, Tokyo 1628666, Japan	Moriyama, T (reprint author), Tokyo Womens Med Univ, Dept Med, Kidney Ctr, Shinjuku Ku, Kawada Cho 8-1, Tokyo 1628666, Japan.	takamori@kc.twmu.ac.jp					Suzuki Y, 2014, CLIN EXP NEPHROL, V18, P481, DOI 10.1007/s10157-013-0849-x; Shen P, 2008, NETH J MED, V66, P242; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Kim Byung Soo, 2009, Korean Journal of Internal Medicine, V24, P356, DOI 10.3904/kjim.2009.24.4.356; Moutzouris DA, 2009, CLIN J AM SOC NEPHRO, V4, P1073, DOI 10.2215/CJN.00990209; Ochi A, 2013, INT UROL NEPHROL, V45, P469, DOI 10.1007/s11255-012-0251-8; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Gutierrez E, 2012, J AM SOC NEPHROL, V23, P1753, DOI 10.1681/ASN.2012010063; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Liu YY, 2014, INT UROL NEPHROL, V46, P1153, DOI 10.1007/s11255-013-0606-9; Goto M, 2009, NEPHROL DIAL TRANSPL, V24, P3068, DOI 10.1093/ndt/gfp273; Miura N, 2009, CLIN EXP NEPHROL, V13, P460, DOI 10.1007/s10157-009-0179-1; Koyama A, 1997, AM J KIDNEY DIS, V29, P526, DOI 10.1016/S0272-6386(97)90333-4; Moriyama T, 2012, INT UROL NEPHROL, V44, P1177, DOI 10.1007/s11255-011-0109-5; Rivera F, 2004, KIDNEY INT, V66, P898, DOI 10.1111/j.1523-1755.2004.00833.x; Szeto CC, 2001, AM J MED, V110, P434, DOI 10.1016/S0002-9343(01)00659-3; Frimat L, 1996, NEPHROL DIAL TRANSPL, V11, P1043; Shen PC, 2007, NEPHRON CLIN PRACT, V106, P157, DOI 10.1159/000104426; Duan ZY, 2013, AM J NEPHROL, V38, P241, DOI 10.1159/000354646; Fang J, 2014, INT UROL NEPHROL, V46, P49, DOI 10.1007/s11255-013-0480-5; Matsuzaki K, 2013, CLIN EXP NEPHROL, V17, P823; Moriyama T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091756; Moriyama T, 2010, NEPHRON CLIN PRACT, V115, pC227, DOI 10.1159/000313040; Nair R, 2004, AM J KIDNEY DIS, V44, P618, DOI 10.1053/j.ajkd.2004.05.044; Yokoyama H, 2012, CLIN EXP NEPHROL, V16, P903, DOI 10.1007/s10157-012-0673-8	25	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0301-1623	1573-2584		INT UROL NEPHROL	Int. Urol. Nephrol.	JAN	2015	47	1					137	145		10.1007/s11255-014-0872-1		9	Urology & Nephrology	Urology & Nephrology	AX9UE	WOS:000347246700021		
J	Heishi, M; Shinmei, K; Sanjiwa, DAR; Uno, T; Kubo, M; Itoh, T				Heishi, Masaru; Shinmei, Kenichi; Sanjiwa, Dasanarayake Althge Rasika; Uno, Takahiro; Kubo, Masataka; Itoh, Takahito			Polymer electrolyte based on lithium oxalate	IONICS			English	Article						Polymer electrolyte; Lithium oxalate salt; Ionic conductivity	COPOLYMER ELECTROLYTES; SALTS; CONDUCTIVITY	Polymer electrolytes composed of poly(ethylene oxide) (PEO), lithium oxalate (LiOX), and borontrifluoride diethyl ether (BF3I double dagger OEt2) were prepared, and their ionic conductivities, lithium ion transference number, thermal properties, and infrared spectra were investigated. The polymer electrolyte for the PEO/LiOX in the absence of BF3I double dagger OEt2 showed the ionic conductivity of 10(-6) S cm(-1) at 130 A degrees C. The addition of BF3I double dagger OEt2 into the polymer electrolyte for the PEO/LiOX system induced an increase of the ionic conductivities by three orders of magnitude. IR spectra showed that in the polymer electrolyte for the PEO/LiOX system in the presence of BF3I double dagger OEt2, new interactions between LiOX and BF3I double dagger OEt2 and also between LiOX and PEO were observed. The polymer electrolyte for the PEO/LiOX system in the presence of BF3I double dagger OEt2 showed the lithium ion transference number of 0.55, which is higher than that (0.19) of PEO/LiTFSI polymer electrolyte. It was found that usage of the carboxyl discrete lithium salt for the polymer electrolyte is a promising method to improve lithium transference number.	[Heishi, Masaru; Uno, Takahiro; Itoh, Takahito] Mie Univ, Grad Sch Engn, Div Chem Mat, Tsu, Mie 5148507, Japan; [Kubo, Masataka] Mie Univ, Grad Sch Reg Innovat Studies, Tsu, Mie 5148507, Japan; [Heishi, Masaru; Shinmei, Kenichi; Sanjiwa, Dasanarayake Althge Rasika] Sekisui Chem Co Ltd, Corp R&D Ctr, Clean Technol & Adv Mat Inst, Tsukuba, Ibaraki 3004292, Japan	Itoh, T (reprint author), Mie Univ, Grad Sch Engn, Div Chem Mat, 1577 Kurimamachiya Cho, Tsu, Mie 5148507, Japan.	itoh@chem.mie-u.ac.jp					Fujinami T, 1997, CHEM MATER, V9, P2236, DOI 10.1021/cm970399z; BRUCE PG, 1987, J ELECTROANAL CHEM, V225, P1, DOI 10.1016/0022-0728(87)80001-3; Manoratne CH, 2006, INT J ELECTROCHEM SC, V1, P32; Patel M, 2010, J PHYS CHEM B, V114, P5233, DOI 10.1021/jp1009077; Nguyen CA, 2011, CHEM MATER, V23, P2142, DOI 10.1021/cm103572q; Itoh T, 2009, IONICS, V15, P27, DOI 10.1007/s11581-008-0285-1; Croce F, 1998, NATURE, V394, P456; Heishi M, 2013, ELECTROCHIM ACTA, V114, P54, DOI 10.1016/j.electacta.2013.09.151; Tominaga Y, 2000, ELECTROCHIM ACTA, V45, P3081, DOI 10.1016/S0013-4686(00)00402-3; Bruce P. G., 1995, SOLID STATE ELECTROC; EVANS J, 1987, POLYMER, V28, P2324, DOI 10.1016/0032-3861(87)90394-6; Florjanczyk Z, 2000, ELECTROCHIM ACTA, V45, P3563, DOI 10.1016/S0013-4686(00)00475-8; Geiculescu OE, 2004, J ELECTROCHEM SOC, V151, pA1363, DOI 10.1149/1.1773581; Gray F. M., 1997, POLYM ELECTROLYTES; Gray F. M., 1991, SOLID POLYM ELECTROL; Itoh T, 2008, J POWER SOURCES, V189, P531; MacCallum J. R., 1987, POLYM ELECTROLYTE RE, V1; MacCallum J. R., 1989, POLYM ELECTROLYTE RE, V2; Ollivrin X, 2003, ELECTROCHIM ACTA, V48, P1961, DOI 10.1016/S0013-4686(03)00173-7; Ryu SW, 2005, J ELECTROCHEM SOC, V152, pA158, DOI 10.1149/1.1828244; Scrosati B., 1993, APPL ELECTROACTIVE P; Trapa PE, 2005, J ELECTROCHEM SOC, V152, pA2281, DOI 10.1149/1.2073089; Vincent CA, 1997, MODERN BATTERIES INT; Vito VD, 2011, ELECTROCHIM ACTA, V57, P4; Xu W, 2002, SOLID STATE IONICS, V147, P295, DOI 10.1016/S0167-2738(02)00032-2	25	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0947-7047	1862-0760		IONICS	Ionics	JAN	2015	21	1					89	94		10.1007/s11581-014-1167-3		6	Chemistry, Physical; Electrochemistry; Physics, Condensed Matter	Chemistry; Electrochemistry; Physics	AX8GY	WOS:000347149200010		
J	Matsunaga, S				Matsunaga, Shigeki			Anomalous electrical properties in superionic (Ag (x) Cu1-x )Br (x=0.5): ab initio study	IONICS			English	Article						(AgxCux-1)Br; Ab initio calculation; Band structure; Density of states; Charge transfer; Occupation probability; Dynamic properties; Phonon propagation; Electrical properties	CUI	The electrical properties of superionic (Ag (x) Cu1-x )Br (x = 0.5), band structure and density of states, have been examined by ab initio calculation based on the density functional theory in comparison with solid CuBr in zinc blend structure. The charge transfer between ions has been discussed in relation with the occupation probability of Cu ion in superionic (Ag (x) Cu1-x )Br (x = 0.5).	Nagaoka Natl Coll Technol, Nagaoka, Niigata 9408532, Japan	Matsunaga, S (reprint author), Nagaoka Natl Coll Technol, Nishikatakai 888, Nagaoka, Niigata 9408532, Japan.	matsu@nagaoka-ct.ac.jp			Ministry of Education and Culture	The author thanks Professor S. Tamaki for his helpful comments and encouragement on this study. This study was supported by the Grant-in-Aid for Scientific Research of the Ministry of Education and Culture. Part of the results in this study was obtained using the supercomputing resources in the Cybermedia Centre, Osaka University.	Gonze X, 2009, COMPUT PHYS COMMUN, V180, P2582, DOI 10.1016/j.cpc.2009.07.007; MEISTER J, 1994, J PHYS CHEM-US, V98, P8245, DOI 10.1021/j100084a048; Shimojo F, 2003, J PHYS SOC JPN, V72, P2702, DOI 10.1143/JPSJ.72.2702; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.13.5188; Verstraete M, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.195123; TROULLIER N, 1991, PHYS REV B, V43, P1993, DOI 10.1103/PhysRevB.43.1993; Galamba N, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2768968; Amrani B, 2006, PHYSICA B, V381, P179, DOI 10.1016/j.physb.2006.01.447; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRev.136.B864; HIRSHFELD FL, 1977, THEOR CHIM ACTA, V44, P129, DOI 10.1007/BF00549096; Benmessabih T, 2007, PHYSICA B, V392, P309, DOI 10.1016/j.physb.2006.11.046; Chandra S., 1981, SUPERIONIC SOLIDS PR; Endo K, 1999, CHEM PHYS LETT, V308, P390, DOI 10.1016/S0009-2614(99)00631-4; HOSHINO S, 1983, J PHYS SOC JPN, V52, P1261, DOI 10.1143/JPSJ.52.1261; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; LAWN BR, 1964, ACTA CRYSTALLOGR, V17, P1341, DOI 10.1107/S0365110X64003401; Matsunaga S, 2012, P 13 AS C SOL STAT I, P730; Matsunaga S, 2009, J PHYS CONF SER, V144, DOI 10.1088/1742-6596/144/1/012011; Matsunaga S, 2012, MOL SIMULAT, V38, P384, DOI 10.1080/08927022.2010.544305; Matsunaga S, 2013, PHYS CHEM LIQ, V51, P414, DOI 10.1080/00319104.2013.777959; Matsunaga S, 2013, T MAT RES SOC JPN, V38, P113; Matsunaga S, 2013, MOL SIMULAT, V39, P119, DOI 10.1080/08927022.2012.706711; Teltow J, 1958, Z PHYS CHEM, V18, P134; Victora RH, 1997, PHYS REV B, V56, P4417, DOI 10.1103/PhysRevB.56.4417	24	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0947-7047	1862-0760		IONICS	Ionics	JAN	2015	21	1					161	166		10.1007/s11581-014-1144-x		6	Chemistry, Physical; Electrochemistry; Physics, Condensed Matter	Chemistry; Electrochemistry; Physics	AX8GY	WOS:000347149200017		
J	Bolouki, N; Tomita, K; Hassaballa, S; Yamagata, Y; Uchino, K				Bolouki, Nima; Tomita, Kentaro; Hassaballa, Safwat; Yamagata, Yukihiko; Uchino, Kiichiro			Temporal evolution of electron density and electron temperature profiles in a non-thermal atmospheric-pressure plasma measured by laser Thomson scattering	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							DIELECTRIC-BARRIER DISCHARGES; ION RECOMBINATION; ARGON; MODEL; NE	The laser Thomson scattering technique has been applied for measuring the spatiotemporal changes in the electron density (n(e)) and electron temperature (T-e) of a capacity-coupled micro-discharge generated in neon gas at near-atmospheric pressure. A significant difference has been observed in temporal behavior between n(e) and T-e after the discharge generation. The value of n(e) decreases monotonically from t = 25 ns when the electrical input is truncated. On the other hand, T-e is approximately 1.7 eV at 15 ns and, after this point, T-e rapidly decreases to about 0.8 eV. Subsequently, T-e decreases gradually. These features are discussed on the basis of the recombination processes. (C) 2015 The Japan Society of Applied Physics	[Bolouki, Nima; Tomita, Kentaro; Yamagata, Yukihiko; Uchino, Kiichiro] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 8168580, Japan; [Hassaballa, Safwat] Al Azhar Univ, Dept Phys, Fac Sci, Cairo, Egypt	Bolouki, N (reprint author), Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 8168580, Japan.	bolouki.nima.721@m.kyushu-u.ac.jp		Hassaballa, Safwat/0000-0002-1244-2039			Hassaballa S, 2004, IEEE T PLASMA SCI, V32, P127, DOI 10.1109/TPS.2004.823980; HINNOV E, 1962, PHYS REV, V125, P795, DOI 10.1103/PhysRev.125.795; Chirokov A, 2005, PURE APPL CHEM, V77, P487, DOI 10.1351/pac200577020487; Belmonte T, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/36/363001; VANDESANDEN MCM, 1993, PHYS REV E, V47, P2792, DOI 10.1103/PhysRevE.47.2792; MEUNIER J, 1995, J APPL PHYS, V78, P731, DOI 10.1063/1.360684; BATES DR, 1961, NATURE, V189, P652, DOI 10.1038/189652a0; DANGELO N, 1965, PHYS REV, V140, P1488; DESAI SV, 1969, J QUANT SPECTROSC RA, V9, P1371, DOI 10.1016/0022-4073(69)90122-8; Eliasson B., 1994, PURE APPL CHEM, V66, P1275, DOI DOI 10.1351/PAC199466061275); FLANNERY MR, 1994, ADV ATOM MOL OPT PHY, V32, P117; FUNAHASH.A, 1968, J PHYS SOC JPN, V25, P298, DOI 10.1143/JPSJ.25.298; Hassaballa S, 2005, JPN J APPL PHYS 2, V44, pL442, DOI 10.1143/JJAP.44.L442; Hassaballa S, 2005, J SOC INF DISPLAY, V13, P639, DOI 10.1889/1.2039292; Kogelschatz U, 2003, PLASMA CHEM PLASMA P, V23, P1, DOI 10.1023/A:1022470901385; Koike S, 2004, JPN J APPL PHYS 1, V43, P5550, DOI 10.1143/JJAP.43.5550; LEVIN LA, 1981, IEEE J QUANTUM ELECT, V17, P2282, DOI 10.1109/JQE.1981.1070708; MAKIN B, 1963, PHYS REV LETT, V11, P281, DOI 10.1103/PhysRevLett.11.281; MANSBACH P, 1969, PHYS REV, V181, P275, DOI 10.1103/PhysRev.181.275; Mase H, 2004, IEEE T PLASMA SCI, V32, P380, DOI 10.1109/TPS.2004.828116; Mase H, 2003, APPL PHYS LETT, V83, P5392, DOI 10.1063/1.1636825; Selezneva SE, 2003, PLASMA SOURCES SCI T, V12, P107, DOI 10.1088/0963-0252/12/1/314; Siemens W, 1857, ANN PHYS CHEM, V102, P66; Sonoda Y., 2009, J PLASMA FUSION RES, V8, P696; Tomita K, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.066101; Tomita K, 2009, J PLASMA FUSION RES, V8, P488; Tomita K., 2010, DENKI GAKKAI RONBU A, V130, P1099; Tomita K, 2012, J INSTRUM, V7, DOI 10.1088/1748-0221/7/02/C02057; Vicek J., 1989, J PHYS D, V22, P623; VITOLS AP, 1972, PHYS REV A, V5, P2618, DOI 10.1103/PhysRevA.5.2618	30	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	JAN	2015	54	1							016101	10.7567/JJAP.54.016101		4	Physics, Applied	Physics	AX5HT	WOS:000346957900031		
J	Hiraga, T; Ueno, I; Ohta, K; Shiga, N; Watanabe, H; Kubo, M; Takarada, S; Tanaka, N				Hiraga, Takashi; Ueno, Ichiro; Ohta, Kazuya; Shiga, Noriyasu; Watanabe, Hirofumi; Kubo, Masaki; Takarada, Shigeru; Tanaka, Norio			Switching mechanism of an all-optical switch using pulsed gating	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							MACH-ZEHNDER INTERFEROMETER; MULTIMODE INTERFERENCE; INTERSUBBAND; TRANSITIONS; RESONATOR	A versatile optically gated optical switch using an organic dye is suitable for light-path switching in an optical communication device for various wavelengths of the signal light. We have developed two types of all-optical switch, i.e., a coaxial configuration and a different-axis configuration. The coaxial configuration exhibits a faster response (similar to 80 mu s) than the different-axis configuration (similar to 3 ms). Here, the response time of the signal light (1310 nm) is analyzed as a function of both the gating power (pulse height) and pulse width of the gating light (980 nm). The heating and propagation processes in a tiny area around the focal point of both the signal light and the gating light are discussed. (C) 2015 The Japan Society of Applied Physics	[Hiraga, Takashi; Ueno, Ichiro] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan; [Hiraga, Takashi; Ohta, Kazuya; Shiga, Noriyasu] Trimatiz Ltd, Ichikawa, Chiba 2720023, Japan; [Watanabe, Hirofumi] Inter Energy Co Ltd, Yokohama, Kanagawa 2220033, Japan; [Kubo, Masaki] Himeji Rika Co Ltd, Himeji, Hyogo 6712111, Japan; [Takarada, Shigeru; Tanaka, Norio] Dainichiseika Color & Chem Mfg Co Ltd, Chuo Ku, Tokyo 1038383, Japan	Hiraga, T (reprint author), Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan.						Al-hetar AM, 2011, OPT COMMUN, V284, P1181, DOI 10.1016/j.optcom.2010.10.025; Yang X, 2004, OPT COMMUN, V236, P329, DOI 10.1016/j.optcom.2004.03.050; Shen TZ, 2014, NAT MATER, V13, P394, DOI [10.1038/nmat3888, 10.1038/NMAT3888]; Janner D, 2008, J OPT A-PURE APPL OP, V10, DOI 10.1088/1464-4258/10/10/104003; Bahrami A, 2011, OPT APPL, V41, P165; Tsiokos D, 2004, IEEE PHOTONIC TECH L, V16, P284, DOI 10.1109/LPT.2003.819394; Li Y, 2006, SEMICOND SCI TECH, V21, P1105, DOI 10.1088/0268-1242/21/8/022; Bahrami A, 2011, OPTIK, V122, P1787, DOI 10.1016/j.ijleo.2010.11.005; Ju H, 2005, OPT EXPRESS, V13, P942, DOI 10.1364/OPEX.13.000942; Bahuguna R, 2006, IEEE T MAGN, V42, P3099, DOI 10.1109/TMAG.2006.878870; Bananej A, 2004, IRAN J SCI TECHNOL, V28, P205; Das Barman A, 2009, OPT FIBER TECHNOL, V15, P39, DOI 10.1016/j.yofte.2008.04.002; Dawlaty J. M., 2004, MRS P, V831, pE73; De Dobbelaere P, 2002, IEEE COMMUN MAG, V40, P88, DOI 10.1109/35.989763; Deng J.-S., 2006, INT J MICROWAVE OPTI, V1, P570; Fedoryshyn Y, 2012, IEEE J QUANTUM ELECT, V48, P885, DOI 10.1109/JQE.2012.2193558; Guan Y., 2013, INT C ART INT SOFTW, P239; Hiraga T., 2012, OPTICAL COMMUNICATIO, P147; Hiraga T, 2011, PROC SPIE, V7935, DOI 10.1117/12.874405; Hiraga T., 2008, P SOC PHOTO-OPT INS, V6891; Keller HM, 1999, OPT COMMUN, V170, P35, DOI 10.1016/S0030-4018(99)00448-4; Le TT, 2013, PHOTONIC NANOSTRUCT, V11, P261, DOI 10.1016/j.photonics.2013.05.003; Li JQ, 2006, OPT COMMUN, V260, P318, DOI 10.1016/j.optcom.2005.10.054; Li Y, 2007, OPT EXPRESS, V15, P17922, DOI 10.1364/OE.15.017922; Lovkesh, 2011, OPTIK, V122, P978, DOI 10.1016/j.ijleo.2010.06.033; Malhotra Y, 2011, OPTIK, V122, P435, DOI 10.1016/j.ijleo.2010.02.027; Manning RJ, 2007, ICTON 2007: Proceedings of the 9th International Conference on Transparent Optical Networks, Vol 2, P239, DOI 10.1109/ICTON.2007.4296193; Merlin J, 2005, OPT EXPRESS, V13, P5024, DOI 10.1364/OPEX.13.005024; Naruse M, 2005, IEEE PHOTONIC TECH L, V17, P1701, DOI 10.1109/LPT.2005.851879; Ohtomo Y., 2010, OFC NFOEC, P1; Rostami A, 2006, MICROELECTRON J, V37, P976, DOI 10.1016/j.mejo.2006.01.021; Sun G, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2132084; Taraphdar C, 2010, OPT LASER TECHNOL, V42, P249, DOI 10.1016/j.optlastec.2009.06.017; Ueno I, 2003, JPN J APPL PHYS 1, V42, P1272, DOI 10.1143/JJAP.42.1272; Wu YD, 2013, PR ELECTROMAGN RES S, P452; Yin R, 2008, OPT COMMUN, V281, P4616, DOI 10.1016/j.optcom.2008.05.042; Yue P, 2013, OPTIK, V124, P2623, DOI 10.1016/j.ijleo.2012.07.039; Zhuang L, 2013, OPTIK, V124, P5611, DOI 10.1016/j.ijleo.2013.04.041	38	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	JAN	2015	54	1							012201	10.7567/JJAP.54.012201		7	Physics, Applied	Physics	AX5HT	WOS:000346957900013		
J	Kamada, K; Taue, S; Kobayashi, T				Kamada, Keigo; Taue, Shuji; Kobayashi, Tetsuo			Optimization of Bandwidth and Signal Responses of Optically Pumped Atomic Magnetometers for Biomagnetic Applications (vol 50, 056602, 2011)	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Correction									[Kamada, Keigo; Taue, Shuji; Kobayashi, Tetsuo] Kyoto Univ, Grad Sch Engn, Kyoto 6158510, Japan	Kamada, K (reprint author), Kyoto Univ, Grad Sch Engn, Kyoto 6158510, Japan.	kamada@bfe.kuee.kyoto-u.ac.jp					Kamada K, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.056602	1	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	JAN	2015	54	1							019201	10.7567/JJAP.54.019201		1	Physics, Applied	Physics	AX5HT	WOS:000346957900037		
J	Kozawa, T				Kozawa, Takahiro			Relationships between quencher diffusion constant and exposure dose dependences of line width, line edge roughness, and stochastic defect generation in extreme ultraviolet lithography	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							CHEMICALLY AMPLIFIED RESIST; NM HALF PITCH; EUV RESIST; ACID DIFFUSION; AMPLIFICATION RESISTS; SIMULATION; DESIGN; BASE	Control of the acid catalytic chain reaction is essential in the pattern formation of chemically amplified resists used for the high-volume production of semiconductor devices. In this study, the relationships between the quencher diffusion constant and the exposure dose dependences of the line width, line edge roughness (LER), and stochastic defect generation were investigated assuming extreme ultraviolet (EUV) lithography. The dependence of the latent images of line-and-space patterns with 16 nm half-pitch on the quencher diffusion constant was calculated on the basis of sensitization and reaction mechanisms of chemically amplified EUV resists. The exposure latitude of the line width increased with the quencher diffusion constant. The dependences of LER and stochastic defect (bridges and pinching) generation on the deviation of the exposure dose became weak by increasing the quencher diffusion constant, similarly to the case for the dependence of the line width. (C) 2015 The Japan Society of Applied Physics	Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan	Kozawa, T (reprint author), Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan.	kozawa@sanken.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [25246036]	This work was supported in part by a Grant-in-Aid for Scientific Research (Project No. 25246036) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT).	Yamamoto H, 2005, JPN J APPL PHYS 1, V44, P5836, DOI 10.1143/JJAP.44.5836; Kozawa T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.066504; SCHLEGEL L, 1991, J VAC SCI TECHNOL B, V9, P278, DOI 10.1116/1.585607; USHIROGOUCHI T, 1995, P SOC PHOTO-OPT INS, V2438, P609, DOI 10.1117/12.210384; Kozawa T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.126501; Natsuda K, 2007, JPN J APPL PHYS 1, V46, P7285, DOI 10.1143/JJAP.46.7285; Kozawa T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.076503; NAKAMURA J, 1991, JPN J APPL PHYS 1, V30, P2619, DOI 10.1143/JJAP.30.2619; Kozawa T, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.026502; Fukuyama T, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.065004; Ito H, 2005, ADV POLYM SCI, V172, P37, DOI 10.1007/b97574; Kozawa T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.116505; Kozawa T, 2013, J PHOTOPOLYM SCI TEC, V26, P643; Yamamoto H, 2004, JPN J APPL PHYS 2, V43, pL848, DOI 10.1143/JJAP.43.L848; Hinsberg WD, 2001, IBM J RES DEV, V45, P667; Kozawa T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.030209; Kozawa T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.076505; Itani T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.010002; Hirose R, 2007, JPN J APPL PHYS 2, V46, pL979, DOI 10.1143/JJAP.46.L979; ASAKAWA K, 1995, P SOC PHOTO-OPT INS, V2438, P563, DOI 10.1117/12.210361; Wurm S, 2007, JPN J APPL PHYS 1, V46, P6105, DOI 10.1143/JJAP.46.6105; Natsuda K, 2006, JPN J APPL PHYS 2, V45, pL1256, DOI 10.1143/JJAP.45.L1256; Kozawa T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.030001; ITO H, 1983, POLYM ENG SCI, V23, P1012, DOI 10.1002/pen.760231807; KAWAI Y, 1994, JPN J APPL PHYS 1, V33, P7023, DOI 10.1143/JJAP.33.7023; Fukuda H, 2001, P SOC PHOTO-OPT INS, V4346, P319, DOI 10.1117/12.435732; Hattori K., 2000, Journal of Photopolymer Science and Technology, V13, DOI 10.2494/photopolymer.13.477; Hattori K, 2002, P SOC PHOTO-OPT INS, V4691, P1243, DOI 10.1117/12.474505; Hendrickx E, 2013, J PHOTOPOLYM SCI TEC, V26, P587; Hinsberg W, 2000, P SOC PHOTO-OPT INS, V3999, P148, DOI 10.1117/12.388294; Inukai K, 2013, J PHOTOPOLYM SCI TEC, V26, P691; Itani T, 2011, J PHOTOPOLYM SCI TEC, V24, P111, DOI 10.2494/photopolymer.24.111; Itani T., 1998, ACS SYM SER, V706, P110; Kozawa T, 2008, JPN J APPL PHYS, V47, P5404, DOI 10.1143/JJAP.47.5404; Kozawa T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.076504; Kozawa T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.086504; Kozawa T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.06JC02; Kozawa T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.066502; Kozawa T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.016501; Kozawa T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.076502; Richter E, 2000, MICROELECTRON ENG, V53, P479, DOI 10.1016/S0167-9317(00)00360-9; Sugi R, 2012, J PHOTOPOLYM SCI TEC, V25, P603, DOI 10.2494/photopolymer.25.603; Tanaka Y, 2007, J VAC SCI TECHNOL B, V25, P2114, DOI 10.1116/1.2787867; Tsubaki H, 2013, J PHOTOPOLYM SCI TEC, V26, P649; Utsumi Y, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.06FC07; Van Steenwinckel D, 2007, P SOC PHOTO-OPT INS, V6519, pV5190, DOI 10.1117/12.712861	46	3	3	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	JAN	2015	54	1							016502	10.7567/JJAP.54.016502		7	Physics, Applied	Physics	AX5HT	WOS:000346957900034		
J	Kozawa, T				Kozawa, Takahiro			Effects of dose shift on line width, line edge roughness, and stochastic defect generation in chemically amplified extreme ultraviolet resist with photodecomposable quencher	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							NM HALF PITCH; ELECTRON-BEAM; LITHOGRAPHY	In chemically amplified resists used for high-volume production of semiconductor devices, the control of acid catalytic reaction is essential for fine patterning. A basic compound, called a quencher, plays an important role in the control of acid catalytic reaction. In particular, the photodecomposable quencher is effective for the enhancement of the chemical gradient. In this study, the effects of photodecomposable quenchers on the dose shift (the deviation from the sizing dose) dependences of line width, line edge roughness (LER), and stochastic defect generation were investigated, assuming line-and-space patterns with 11 nm half-pitch. The exposure latitude of line width in a chemically amplified resist with photodecomposable quenchers was larger than that in a chemically amplified resist with conventional non-photodecomposable quenchers at sizing doses > 20 mJcm(-2). By using photodecomposable quenchers, LER and the probability of stochastic defect generation were decreased, while the dose shift dependences of LER and stochastic defect generation did not significantly differ, compared with those observed using conventional non-photodecomposable quenchers. (C) 2015 The Japan Society of Applied Physics	Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan	Kozawa, T (reprint author), Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan.	kozawa@sanken.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [25246036]	This work was supported in part by a Grant-in-Aid for Scientific Research (Project No. 25246036) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT).	Yamamoto H, 2005, JPN J APPL PHYS 1, V44, P5836, DOI 10.1143/JJAP.44.5836; Kozawa T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.066504; Kozawa T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.126501; Natsuda K, 2007, JPN J APPL PHYS 1, V46, P7285, DOI 10.1143/JJAP.46.7285; Kozawa T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.076503; Kozawa T, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.026502; Fukuyama T, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.065004; KOZAWA T, 1992, JPN J APPL PHYS 1, V31, P4301, DOI 10.1143/JJAP.31.4301; KINOSHITA H, 1989, J VAC SCI TECHNOL B, V7, P1648, DOI 10.1116/1.584507; Natsuda K, 2008, JPN J APPL PHYS, V47, P4932, DOI 10.1143/JJAP.47.4932; Kozawa T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.116505; Yamamoto H, 2004, JPN J APPL PHYS 2, V43, pL848, DOI 10.1143/JJAP.43.L848; Vogt BD, 2007, J VAC SCI TECHNOL B, V25, P175, DOI 10.1116/1.2429675; Thackeray J, 2013, J PHOTOPOLYM SCI TEC, V26, P605; Kozawa T, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.036501; Kozawa T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.030209; Kozawa T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.076505; Kozawa T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.066504; Itani T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.010002; Kozawa T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.066508; Nalamasu O, 1998, J VAC SCI TECHNOL B, V16, P3716, DOI 10.1116/1.590396; Hirose R, 2007, JPN J APPL PHYS 2, V46, pL979, DOI 10.1143/JJAP.46.L979; Wurm S, 2007, JPN J APPL PHYS 1, V46, P6105, DOI 10.1143/JJAP.46.6105; Natsuda K, 2006, JPN J APPL PHYS 2, V45, pL1256, DOI 10.1143/JJAP.45.L1256; Kozawa T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.030001; Van Steenwinckel D, 2008, J MICRO-NANOLITH MEM, V7, DOI 10.1117/1.2909204; Chen S. F., 2012, P SOC PHOTO-OPT INS, V8325; Funato S., 1995, J PHOTOPOLYM SCI TEC, V8, P543, DOI 10.2494/photopolymer.8.543; Gallatin GM, 2012, PROC SPIE, V8322, DOI 10.1117/12.917006; Gallatin GM, 2005, P SOC PHOTO-OPT INS, V5754, P38, DOI 10.1117/12.607233; Gao WM, 2012, PROC SPIE, V8322, DOI 10.1117/12.917804; Hendrickx E, 2013, J PHOTOPOLYM SCI TEC, V26, P587; Hinsberg W, 2000, P SOC PHOTO-OPT INS, V3999, P148, DOI 10.1117/12.388294; Inukai K, 2013, J PHOTOPOLYM SCI TEC, V26, P691; Itani T, 2011, J PHOTOPOLYM SCI TEC, V24, P111, DOI 10.2494/photopolymer.24.111; Kozawa T., 2014, JPN J APPL PHYS, V54; Kozawa T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.036503; Kozawa T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.086504; Kozawa T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.076502; Mack CA, 2012, PROC SPIE, V8325, DOI 10.1117/12.916195; Smith MD, 2013, PROC SPIE, V8682, DOI 10.1117/12.2011701; Tsubaki H, 2013, J PHOTOPOLYM SCI TEC, V26, P649; Wu WL, 2007, P SOC PHOTO-OPT INS, V6519, P51902, DOI 10.1117/12.720424	43	2	2	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	JAN	2015	54	1							016503	10.7567/JJAP.54.016503		6	Physics, Applied	Physics	AX5HT	WOS:000346957900035		
J	Kyoden, T; Yasue, Y; Ishida, H; Akiguchi, S; Andoh, T; Takada, Y; Teranishi, T; Hachiga, T				Kyoden, Tomoaki; Yasue, Youichi; Ishida, Hiroki; Akiguchi, Shunsuke; Andoh, Tsugunobu; Takada, Yogo; Teranishi, Tsunenobu; Hachiga, Tadashi			Multi-channel laser Doppler velocimetry using a two-dimensional optical fiber array for obtaining instantaneous velocity distribution characteristics	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							CORONARY-ARTERY-DISEASE; CAROTID-ENDARTERECTOMY; MULTIPOINT LDV; FACING STEP; FLOWS; ANGIOGRAPHY; MEMS	A laser Doppler velocimeter (LDV) has been developed that is capable of performing two-dimensional (2D) cross-sectional measurements. It employs two horizontal laser light sheets that intersect at an angle of 13.3 degrees. Since the intersection region is thin, it can be used to approximately determine the 2D flow field. An 8 x 8 array of optical fibers is used to simultaneously measure Doppler frequencies at 64 points. Experiments were conducted to assess the performance of the LDV, and it was found to be capable of obtaining spatial and temporal velocity information at multiple points in a flow field. The technique is fast, noninvasive, and accurate over long sampling periods. Furthermore, its applicability to an actual flow field was confirmed by measuring the temporal velocity distribution of a pulsatile flow in a rectangular flow channel with an obstruction. The proposed device is thus a useful, compact optical instrument for conducting simultaneous 2D cross-sectional multipoint measurements. (C) 2015 The Japan Society of Applied Physics	[Kyoden, Tomoaki; Ishida, Hiroki; Akiguchi, Shunsuke; Teranishi, Tsunenobu; Hachiga, Tadashi] Toyama Coll, Natl Inst Technol, Imizu, Toyama 9330293, Japan; [Yasue, Youichi] Nippon Marine Enterprises Ltd, Yokosuka, Kanagawa 2380004, Japan; [Andoh, Tsugunobu] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Toyama 9300194, Japan; [Takada, Yogo] Osaka City Univ, Grad Sch Engn, Osaka 5588585, Japan	Kyoden, T (reprint author), Toyama Coll, Natl Inst Technol, Imizu, Toyama 9330293, Japan.				Mazda Foundation [26350555, 26350523]	This work was financially supported by Grants-in-Aid for Scientific Research (26350555 and 26350523) and the Mazda Foundation. The authors would like to thank Mr. R. Sakai and Mr. K. Tanino of the National Institute of Technology, Toyama College for technical support.	Ahmed SA, 1998, EXP THERM FLUID SCI, V17, P309, DOI 10.1016/S0894-1777(98)00009-0; FRIEDMAN AH, 1984, J NEUROSURG, V60, P325, DOI 10.3171/jns.1984.60.2.0325; ADRIAN RJ, 1991, ANNU REV FLUID MECH, V23, P261, DOI 10.1146/annurev.fluid.23.1.261; Dziubak T, 2012, COMPUT PHYS COMMUN, V183, P800, DOI 10.1016/j.cpc.2011.11.026; HERTZER NR, 1985, ARCH INTERN MED, V145, P849, DOI 10.1001/archinte.145.5.849; Wereley ST, 2010, ANNU REV FLUID MECH, V42, P557, DOI 10.1146/annurev-fluid-121108-145427; Stuer H, 1999, EUR J MECH B-FLUID, V18, P675, DOI 10.1016/S0997-7546(99)00104-1; Thorn R, 2013, MEAS SCI TECHNOL, V24, DOI 10.1088/0957-0233/24/1/012003; Ho CM, 1996, J FLUID ENG-T ASME, V118, P437, DOI 10.1115/1.2817778; Ho CM, 1998, ANNU REV FLUID MECH, V30, P579, DOI 10.1146/annurev.fluid.30.1.579; Kume T, 2008, ATHEROSCLEROSIS, V197, P799, DOI 10.1016/j.atherosclerosis.2007.07.028; Durst F., 1976, PRINCIPLES LASER DOP; Enrico B, 2009, EUR RADIOL, V19, P837, DOI 10.1007/s00330-008-1223-3; Furuichi N, 2004, EXP FLUIDS, V36, P274, DOI 10.1007/S00348-003-0718-6; Furuichi N., 2003, KEISOKU JIDO SEIGYO, V39, P218; Grigoriadis DGE, 2009, INT J HEAT FLUID FL, V30, P462, DOI 10.1016/j.ijheatfluidflow.2009.01.010; Hachiga T, 1998, EXP FLUIDS, V24, P70, DOI 10.1007/s003480050152; Haruta M, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.04EL05; Hosokawa S, 2013, NUCL ENG DES, V263, P342, DOI 10.1016/j.nucengdes.2013.06.009; Ishida H, 2012, J APPL PHYS, V112, DOI 10.1063/1.4766815; Ishida H, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.032701; Lee SJ, 2005, J APPL PHYS, V97, DOI 10.1063/1.1851596; Lima R, 2007, J BIOMECH, V40, P2752, DOI 10.1016/j.jbiomech.2007.01.012; Lowe KT, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/4/045402; MACKEY WC, 1990, J VASC SURG, V11, P226, DOI 10.1067/mva.1990.17574; Peng XX, 2008, J HYDRODYN, V20, P770; Shi SX, 2013, FLOW MEAS INSTRUM, V29, P67, DOI 10.1016/j.flowmeasinst.2012.10.011; Shimada T, 2005, J NEUROSURG, V103, P593, DOI 10.3171/jns.2005.103.4.0593; Takahashi H, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.07KF08; Takei M, 2004, POWDER TECHNOL, V142, P70, DOI 10.1016/j.powtec.2004.04.002; Taninaka S., 2008, J ENV ENG, V3, P326, DOI 10.1299/jee.3.326	31	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	JAN	2015	54	1							012501	10.7567/JJAP.54.012501		6	Physics, Applied	Physics	AX5HT	WOS:000346957900016		
J	Matsuura, H; Morine, T; Nagamachi, S				Matsuura, Hideharu; Morine, Tatsuya; Nagamachi, Shinji			Density and energy level of a deep-level Mg acceptor in 4H-SiC	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							HALL SCATTERING FACTOR; MAJORITY-CARRIER CONCENTRATION; MOBILITY; EPILAYERS; DONOR; 6H; TEMPERATURE; DEPENDENCE; SILICON; GAN	Reliably determining the densities and energy levels of deep-level dominant acceptors in heavily doped wide-band-gap semiconductors has been a topic of recent discussion. In these discussions, the focus is on both Hall scattering factors for holes and distribution functions for acceptors. Mg acceptor levels in 4H-SiC seem to be deep, and so here the electrical properties of Mg-implanted 4H-SiC layers are studied by measuring Hall effects. The obtained Hall scattering factors are not reliable because they drop to less than 0.5 at high measurement temperatures. Moreover, the Fermi-Dirac distribution function is unsuitable for examining Mg acceptors because the obtained acceptor density is much higher than the concentration of implanted Mg atoms. However, by using a distribution function that includes the influence of the excited states of a deep-level acceptor, the density and energy level of Mg acceptors can be reliably determined. (C) 2015 The Japan Society of Applied Physics	[Matsuura, Hideharu; Morine, Tatsuya] Osaka Electrocommun Univ, Dept Elect & Elect Engn, Neyagawa, Osaka 5728530, Japan; [Nagamachi, Shinji] Nagamachi Sci Lab Co Ltd, Amagasaki, Hyogo 6610976, Japan	Matsuura, H (reprint author), Osaka Electrocommun Univ, Dept Elect & Elect Engn, Neyagawa, Osaka 5728530, Japan.	matsuura@isc.osakac.ac.jp					Kagamihara S, 2004, J APPL PHYS, V96, P5601, DOI 10.1063/1.1798399; Matsuura H, 2004, J APPL PHYS, V96, P2708, DOI 10.1063/1.1775298; Matsunami H, 1997, MAT SCI ENG R, V20, P125, DOI 10.1016/S0927-796X(97)00005-3; Rutsch G, 1998, J APPL PHYS, V84, P2062, DOI 10.1063/1.368266; BIERSACK JP, 1980, NUCL INSTRUM METHODS, V174, P257, DOI 10.1016/0029-554X(80)90440-1; IKEDA M, 1980, PHYS REV B, V22, P2842, DOI 10.1103/PhysRevB.22.2842; Ng G, 2009, J APPL PHYS, V106, DOI 10.1063/1.3212532; Ashcroft N. W., 1976, SOLID STATE PHYS, P586; DELALAMO JA, 1985, J APPL PHYS, V57, P2314, DOI 10.1063/1.334333; Heer C. V., 1972, STAT MECH KINETIC TH, P224; Iwata H, 2001, J APPL PHYS, V89, P6228, DOI 10.1063/1.1366660; LIN JF, 1981, SOLID STATE ELECTRON, V24, P827, DOI 10.1016/0038-1101(81)90098-8; Look DC, 1996, J APPL PHYS, V80, P1913, DOI 10.1063/1.363007; Madelung O., 2004, SEMICONDUCTORS DATA, P68; Maslakovets Y. P., 1968, FIZ TVERD TELA+, V10, P634; Matsuura H, 2004, J APPL PHYS, V95, P4213, DOI 10.1063/1.1655683; Matsuura H, 2003, J APPL PHYS, V94, P2234, DOI 10.1063/1.1589176; Matsuura H, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.245216; Matsuura H., 2011, ADV CONDENSED MATTER, V10; Matsuura H, 2005, J APPL PHYS, V97, DOI 10.1063/1.1887832; Matsuura H, 2002, NEW J PHYS, V4, DOI 10.1088/1367-2630/4/1/312; Matsuura H, 2004, J APPL PHYS, V96, P7346, DOI 10.1063/1.1814805; Matsuura H, 2008, J MATER SCI-MATER EL, V19, P720, DOI 10.1007/s10854-007-9390-6; Matsuura H, 2002, JPN J APPL PHYS 1, V41, P496, DOI 10.1143/JJAP.41.496; Matsuura H, 2000, JPN J APPL PHYS 1, V39, P5069, DOI 10.1143/JJAP.39.5069; Nashiyama I., 1995, PROPERTIES SILICON C, P87; Pensl G., 2003, Materials Science Forum, V433-436; Pernot J, 2000, APPL PHYS LETT, V77, P4359, DOI 10.1063/1.1332102; RODE DL, 1995, APPL PHYS LETT, V66, P1972, DOI 10.1063/1.113294; Sapoval B., 1993, PHYSICS SEMICONDUCTO, P112; Sapoval B., 1993, PHYS SEMICONDUCTORS, P73; SCHAFFER WJ, 1994, MATER RES SOC SYMP P, V339, P595; Schmidt F., 2004, SILICON CARBIDE RECE, P517; Singh J., 1994, SEMICONDUCTOR DEVICE, P110; Smith R. A., 1978, SEMICONDUCTORS+, P92; Sze S. M., 2007, PHYS SEMICONDUCTOR D, P35; Sze S. M., 2007, PHYS SEMICONDUCTOR D, P22; Sze S. M., 2007, PHYS SEMICONDUCTOR D, VThird, P23; Yu P. Y., 1999, FUNDAMENTALS SEMICON, P156	39	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	JAN	2015	54	1							011301	10.7567/JJAP.54.011301		7	Physics, Applied	Physics	AX5HT	WOS:000346957900006		
J	Naito, T; Yamaura, S; Yamamoto, K; Tanaka, T; Chiba, H; Ogino, H; Takahagi, K; Kitagawa, S; Taniguchi, D				Naito, Teruki; Yamaura, Shingo; Yamamoto, Kazuo; Tanaka, Tai; Chiba, Hidetoshi; Ogino, Hayato; Takahagi, Kazuhiro; Kitagawa, Shinya; Taniguchi, Daiki			Theoretical and experimental investigation of plasma antenna characteristics on the basis of gaseous collisionality and electron density	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							DIFFERENCE TIME-DOMAIN; EQUATIONS	This paper reports plasma antenna characteristics investigated theoretically and experimentally, on the basis of the plasma parameters: gaseous collisionality and electron density. The antenna structure is a basic quarter-wavelength monopole antenna in the UHF band. The dependence of the antenna gain on the plasma parameters is obtained by analytical equations from plasma and antenna theory, and by numerical simulations. In the plasma antenna, the ratio of the electron elastic collision frequency to the total number of electrons at the plasma cross section determines the antenna's internal loss and the electrical equivalent antenna length, whereas the ratio of the radio wave frequency to the total number of electrons at the plasma cross section determines the antenna's resonant frequency. These results are confirmed by experimental results of the antenna's impedance and radiation patterns. (C) 2015 The Japan Society of Applied Physics	[Naito, Teruki; Yamamoto, Kazuo] Mitsubishi Electr Corp, Adv Technol R&D Ctr, Amagasaki, Hyogo 6618661, Japan; [Yamaura, Shingo; Tanaka, Tai; Chiba, Hidetoshi] Mitsubishi Electr Corp, Informat Technol R&D Ctr, Kamakura, Kanagawa 2478501, Japan; [Ogino, Hayato] Mitsubishi Electr Corp, Commun Syst Ctr, Amagasaki, Hyogo 6618661, Japan; [Takahagi, Kazuhiro; Kitagawa, Shinya; Taniguchi, Daiki] Minist Def, Elect Syst Res Ctr, Setagaya Ku, Tokyo 1548511, Japan	Naito, T (reprint author), Mitsubishi Electr Corp, Adv Technol R&D Ctr, Amagasaki, Hyogo 6618661, Japan.	naito.teruki@bc.mitsubishielectric.co.jp					Anderson T., 2004, IEEE Conference Record - Abstracts. 31st IEEE International Conference On Plasma Science (IEEE Cat. No.04CH37537); Mitola J, 1999, IEEE PERS COMMUN, V6, P13, DOI 10.1109/98.788210; Cummer SA, 1997, IEEE T ANTENN PROPAG, V45, P392, DOI 10.1109/8.558654; Kumar R, 2011, J APPL PHYS, V109, DOI 10.1063/1.3564937; LUEBBERS RJ, 1991, IEEE T ANTENN PROPAG, V39, P429, DOI 10.1109/8.81453; Winters JH, 1998, IEEE PERS COMMUN, V5, P23, DOI 10.1109/98.656155; Russo P, 2011, IEEE T ANTENN PROPAG, V59, P425, DOI 10.1109/TAP.2010.2096387; TAFLOVE A, 1980, IEEE T ELECTROMAGN C, V22, P191, DOI 10.1109/TEMC.1980.303879; Alexeff Igor, 2008, Physics of Plasmas, V15, DOI 10.1063/1.2919157; Rayner JP, 2004, IEEE T PLASMA SCI, V32, P269, DOI 10.1109/TPS.2004.826019; Alexeff I, 2006, IEEE T PLASMA SCI, V34, P166, DOI 10.1109/TPS.2006.872180; Chen YC, 1996, IEEE T MICROW THEORY, V44, P832, DOI 10.1109/22.506441; Balanis C., 2005, ANTENNA THEORY; Chen Q., 1994, P 2 INT C COMP EL, P323; Dib N, 1999, IEEE T MICROW THEORY, V47, P509, DOI 10.1109/22.754886; DONAHUE T, 1951, PHYS REV, V81, P248, DOI 10.1103/PhysRev.81.248; Engel A. V., 1994, IONIZED GASES, P230; Fukawasa T., 2013, IEICE TECH REP, P25; GHOSE RN, 1967, IEEE T ANTENN PROPAG, VAP15, P713, DOI 10.1109/TAP.1967.1139019; HANSEN RC, 1975, IEEE T COMMUN, VCO23, P430, DOI 10.1109/TCOM.1975.1092825; Hettinger J., 1919, US Patent, Patent No. 1309031; Knappmiller S, 2006, IEEE T PLASMA SCI, V34, P786, DOI 10.1109/TPS.2006.874849; Lally J. F., 1970, IEEE Transactions on Antennas and Propagation, VAP-18, DOI 10.1109/TAP.1970.1139798; Lieberman M. A., 2005, PRINCIPLES PLASMA DI, P540; Lieberman M.A., 2005, PRINCIPLES PLASMA DI, P96; Malik HK, 2010, J APPL PHYS, V108, DOI 10.1063/1.3452335; Metz C., 2006, U.S. Patent, Patent No. 7145512; Misono K., 1999, REP GRAD SCH ELECT S, V20, P49; MUR G, 1981, IEEE T ELECTROMAGN C, V23, P377, DOI 10.1109/TEMC.1981.303970; Naito T, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.066003; Ovsyanikov V. V., 2008, P 4 INT C UWBUSIS, P77; Raizer Y. P., 1991, GAS DISCHARGE PHYS, P55; Takeda Y., 2007, SHOMEI GAKKAISHI, V91, P700; Zheng L., 2008, P INT S ANT PROP EM, P222	34	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	JAN	2015	54	1							016001	10.7567/JJAP.54.016001		7	Physics, Applied	Physics	AX5HT	WOS:000346957900030		
J	Nakai, E; Chen, MY; Yoshimura, M; Tomioka, K; Fukui, T				Nakai, Eiji; Chen, Muyi; Yoshimura, Masatoshi; Tomioka, Katsuhiro; Fukui, Takashi			InGaAs axial-junction nanowire-array solar cells	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							MOCVD GAAS; EFFICIENCY; SILICON; LIMIT; MOVPE	Axial p-i-n junction nanowire (NW) solar cells (SCs) with a position-controlled GaAs-based NW array were fabricated by selective-area metal organic vapor phase epitaxy (SA-MOVPE). The measured electron-beam-induced current (EBIC) signals showed the formation of an axial p-i-n junction, which confirms power generation under sunlight illumination. The series resistance of the NW SCs is much higher than that of conventional planar SCs based on Si or other III-V compound semiconductors. The main difficulty concerning the fabrication of these NW SCs is the degradation of series resistance between the GaAs-based NWs and the indium-tin oxide (ITO) deposited as a transparent electrode. The series resistance of the fabricated GaAs-based NW SCs was reduced by introducing a tin doping contact layer between the ITO and the NW array, which is formed by pulse doping. As a result of this improved structure, the fabricated SCs exhibited an open-circuit voltage of 0.544V, a short-circuit current of 18.2 mA/cm(2), and a fill factor of 0.721 for an overall conversion efficiency of 7.14% under AM1.5G illumination. The series resistance of the SCs could be decreased to 0.132 ohm.cm(2), which is one order of magnitude lower than that of the SC without a highly doped contact layer. This reduced series resistance indicates that nanostructure SCs with transparent electrodes and multijunction NW SCs with high efficiencies can be fabricated on a commercial basis in the near future. (C) 2015 The Japan Society of Applied Physics	[Nakai, Eiji; Chen, Muyi; Yoshimura, Masatoshi; Tomioka, Katsuhiro; Fukui, Takashi] Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido 0608628, Japan; [Nakai, Eiji; Chen, Muyi; Yoshimura, Masatoshi; Tomioka, Katsuhiro; Fukui, Takashi] Hokkaido Univ, Res Ctr Integrated Quantum Elect, Sapporo, Hokkaido 0608628, Japan; [Tomioka, Katsuhiro] JST PRESTO, Kawaguchi, Saitama 3320012, Japan	Nakai, E (reprint author), Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido 0608628, Japan.	nakai@rciqe.hokudai.ac.jp	Fukui, Takashi/A-5261-2012; Tomioka, Katsuhiro/N-9611-2015	Tomioka, Katsuhiro/0000-0002-5780-7783	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [23221007]	We would like to thank Professors J. Motohisa and S. Hara for helpful discussions. We would also like to thank Mr. H. Goto and Dr. T. Maebashi for helping us with the measurements, and Dr. K. Ikejiri and Mr. F. Ishizaka for supporting the MOVPE experiments. This work was financially supported by a Grant-in-Aid for Scientific Research (Grant Number 23221007) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT).	Bremner SP, 2008, PROG PHOTOVOLTAICS, V16, P225, DOI 10.1002/pip.799; Goto H, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.035004; Cui YC, 2013, NANO LETT, V13, P4113, DOI 10.1021/nl4016182; Tomioka K, 2013, NANO LETT, V13, P5822, DOI 10.1021/nl402447h; Wang JF, 2001, SCIENCE, V293, P1455, DOI 10.1126/science.1062340; Tomioka K, 2010, NANO LETT, V10, P1639, DOI 10.1021/nl9041774; Regolin I, 2011, J CRYST GROWTH, V315, P143, DOI 10.1016/j.jcrysgro.2010.08.028; Li C, 2003, APPL PHYS LETT, V83, P4014, DOI 10.1063/1.1625421; Wallentin J, 2013, SCIENCE, V339, P1057, DOI 10.1126/science.1230969; Heurlin M, 2011, NANO LETT, V11, P2028, DOI 10.1021/nl2004219; Meillaud F, 2006, SOL ENERG MAT SOL C, V90, P2952, DOI 10.1016/j.solmat.2006.06.002; Glas F, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.121302; Krogstrup P, 2013, NAT PHOTONICS, V7, P306, DOI [10.1038/nphoton.2013.32, 10.1038/NPHOTON.2013.32]; Nishioka K, 2006, SOL ENERG MAT SOL C, V90, P1308, DOI 10.1016/j.solmat.2005.08.003; Mariani G, 2011, NANO LETT, V11, P2490, DOI 10.1021/nl200965j; Yoshimura M, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.052301; Heurlin M, 2014, NANO LETT, V14, P749, DOI 10.1021/nl404039d; Yao MQ, 2014, NANO LETT, V14, P3293, DOI 10.1021/nl500704r; Green MA, 2014, PROG PHOTOVOLTAICS, V22, P1, DOI 10.1002/pip.2452; Tomioka K, 2012, NATURE, V488, P189, DOI 10.1038/nature11293; Fukui T, 2012, AMBIO, V41, P119, DOI 10.1007/s13280-012-0266-5; GLEW RW, 1984, J CRYST GROWTH, V68, P44, DOI 10.1016/0022-0248(84)90395-6; Mariani G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2509; Nakai E, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.055002; PARSONS JD, 1984, J CRYST GROWTH, V68, P60, DOI 10.1016/0022-0248(84)90398-1; Sato T, 2008, J CRYST GROWTH, V310, P5111, DOI 10.1016/j.jcrysgro.2008.07.123; Sinharoy S., 2000, P 28 IEEE PHOT SPEC, P1285; TANG X, 1989, J CRYST GROWTH, V98, P827, DOI 10.1016/0022-0248(89)90323-0; VEUHOFF E, 1985, J ELECTROCHEM SOC, V132, P1958, DOI 10.1149/1.2114261; Yamaguchi M, 1999, SEMICONDUCTORS+, V33, P961, DOI 10.1134/1.1187812; Yoshimura M, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4847355; Yoshimura M, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.04DH08; Zhao JH, 1999, IEEE T ELECTRON DEV, V46, P1978, DOI 10.1109/16.791985	33	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	JAN	2015	54	1							015201	10.7567/JJAP.54.015201		4	Physics, Applied	Physics	AX5HT	WOS:000346957900023		
J	Nakajima, K; Murai, R; Ono, S; Morishita, K; Kivambe, MM; Powell, DM; Buonassisi, T				Nakajima, Kazuo; Murai, Ryota; Ono, Satoshi; Morishita, Kohei; Kivambe, Maulid M.; Powell, Douglas M.; Buonassisi, Tonio			Shape and quality of Si single bulk crystals grown inside Si melts using the noncontact crucible method	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							SILICA CRUCIBLES; CZOCHRALSKI; TRANSPORT; SURFACE; SPEED	The noncontact crucible method enables production of Si bulk single crystals without crucible contact by intentionally establishing a distinct low-temperature region in the Si melt. In this contribution, we correlate crystal growth conditions to crystal material properties. The shape of the growing interface was generally convex in the growth direction. The quality of the Si ingots was determined by the spatial distributions of dislocations, resistivity, oxygen concentration, and minority-carrier lifetime. In an ingot with a convex bottom, swirl patterns with higher resistivity are present in the top, middle, and bottom of the ingot. The dislocation density decreased from the top (first to solidify) to the bottom of the ingot because dislocations in the ingot moved to the periphery from the center of the ingot during crystal growth owing to the convex growing interface. The oxygen concentration was concentrically distributed on the seed axis owing to the convex growing interface. The lifetime was as high as 1.8ms after phosphorus diffusion gettering (PDG) and 205 mu s before PDG at an injection level of 1 x 10(15)cm(-3). The lifetime was not strongly affected by the dislocation density, which was as low as 10(2) -10(3)cm(-2). (C) 2015 The Japan Society of Applied Physics Large depth Small depth	[Nakajima, Kazuo; Murai, Ryota; Ono, Satoshi] FUTURE PV Innovat, Koriyama, Fukushima 9630215, Japan; [Morishita, Kohei] Kyoto Univ, Grad Sch Engn, Kyoto 6068501, Japan; [Kivambe, Maulid M.; Powell, Douglas M.; Buonassisi, Tonio] MIT, Cambridge, MA 02139 USA	Nakajima, K (reprint author), FUTURE PV Innovat, Koriyama, Fukushima 9630215, Japan.		Nakajima, Kazuo/B-8616-2009; Morishita, Kohei/C-1904-2009		Japan Science and Technology Agency (JST) under the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); U. S. Department of Energy (DOE) [DE-EE0005314]; National Science Foundation (NSF); DOE under NSF CA [EEC-1041895]; Department of Defense; NSF [ECS-0335765]	This study was supported by the Japan Science and Technology Agency (JST) under the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT). We thank S. Ochi of Kyoto University, N. Usami of Nagoya University, and K. Kutsukake of Tohoku University for their support. This work was also supported by the U. S. Department of Energy (DOE) under Contract No. DE-EE0005314 and by the National Science Foundation (NSF) and the DOE under NSF CA No. EEC-1041895. D.M.P. acknowledges the support of the Department of Defense through the National Defense Science and Engineering Graduate (NDSEG) Fellowship Program. This work was performed in part at the Center for Nanoscale Systems, a member of the National Nanotechnology Infrastructure Network, which is supported by the NSF under No. ECS-0335765.	TOGAWA S, 1995, J CRYST GROWTH, V148, P70, DOI 10.1016/0022-0248(94)00655-5; Nakajima K, 2012, J CRYST GROWTH, V344, P6, DOI 10.1016/j.jcrysgro.2012.01.051; RAVISHANKAR PS, 1985, SOL ENERG MATER, V12, P361, DOI 10.1016/0165-1633(85)90006-1; DASH WC, 1959, J APPL PHYS, V30, P459, DOI 10.1063/1.1702390; Nakajima K, 2013, J CRYST GROWTH, V372, P121, DOI 10.1016/j.jcrysgro.2013.03.024; Nakajima K, 2014, J CRYST GROWTH, V389, P112, DOI [10.1016/j.jcrysgro.2013.12.006, 10.1016/j.jcrysgro.2013.12.000]; Nakajima K, 2012, J CRYST GROWTH, V355, P38, DOI 10.1016/j.jcrysgro.2012.06.034; Nakajima K, 2014, J CRYST GROWTH, V405, P44, DOI 10.1016/j.jcrysgro.2014.07.024; Castellanos S, 2014, J APPL PHYS, V115, DOI 10.1063/1.4876445; REA SN, 1981, J CRYST GROWTH, V54, P267, DOI 10.1016/0022-0248(81)90471-1; IZUNOME K, 1995, J CRYST GROWTH, V151, P291, DOI 10.1016/0022-0248(95)00097-6; Nakajima K, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.025501; Demina SE, 2007, OPT MATER, V30, P62, DOI 10.1016/j.optmat.2006.11.012; Kalaev VV, 2003, J CRYST GROWTH, V249, P87, DOI 10.1016/S0022-0248(02)02109-7; Richter A, 2012, ENRGY PROCED, V27, P88, DOI 10.1016/j.egypro.2012.07.034; Bliss D. F., 2004, EVOLUTION APPL KYROP, P29; Czochralski J, 1917, Z PHYS CHEM-STOCH VE, V92, P219; Kivambe M, 2014, J CRYST GROWTH, V407, P31, DOI 10.1016/j.jcrysgro.2014.08.021; Kivambe M., 2014, 40 IEEE PHOT SPEC C; Rudolph P., 2012, J JPN ASS CRYST GROW, V39, P8; Rudolph P, 2011, J CRYST GROWTH, V318, P249, DOI 10.1016/j.jcrysgro.2010.10.070; D'Aragona F. S., 1972, Journal of the Electrochemical Society, V119; Sinton R. A., 1996, P 25 IEEE PHOT SPEC, P457; Voronkov VV, 2005, J CRYST GROWTH, V273, P412, DOI 10.1016/j.jcrysgro.2004.10.036; ZULEHNER W, 1983, J CRYST GROWTH, V65, P189, DOI 10.1016/0022-0248(83)90051-9	25	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	JAN	2015	54	1							015504	10.7567/JJAP.54.015504		7	Physics, Applied	Physics	AX5HT	WOS:000346957900027		
J	Nishida, Y; Yoshida, T; Aiga, F; Yamazaki, Y; Miyazaki, H; Kajita, A; Sakai, T				Nishida, Yasutaka; Yoshida, Takashi; Aiga, Fumihiko; Yamazaki, Yuichi; Miyazaki, Hisao; Kajita, Akihiro; Sakai, Tadashi			First-principles study of chemical-edge-doping effect on transport properties of armchair-edge graphene nanoribbons	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							ELECTRON-GAS; MOBILITY; RIBBONS; STATE; BORON	We have investigated the electronic transport of graphene nanoribbons (GNRs) with armchair edges containing boron, nitrogen, or oxygen, using the first-principles density functional theory. We found that such dopants at edge sites provided the n-or p-type doping effect for armchair graphene nanoribbons (AGNRs). As a result, even under an applied bias potential lower than the band gap energy of pristine AGNR, the nitrogen edgedoped GNRs show a large conductance that is almost the same as that of the ideal zigzag GNRs. (C) 2015 The Japan Society of Applied Physics	[Nishida, Yasutaka; Yoshida, Takashi; Aiga, Fumihiko; Yamazaki, Yuichi; Miyazaki, Hisao; Kajita, Akihiro; Sakai, Tadashi] Low Power Elect Assoc & Project LEAP, Tsukuba, Ibaraki 3058569, Japan	Nishida, Y (reprint author), Low Power Elect Assoc & Project LEAP, Tsukuba, Ibaraki 3058569, Japan.	yasutaka.nishida@toshiba.co.jp			METI; NEDO	This work was performed as part of the "Ultra-Low Voltage Device Project" funded and supported by METI and NEDO.	Huang B, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2826547; Nakada K, 1996, PHYS REV B, V54, P17954, DOI 10.1103/PhysRevB.54.17954; Li YF, 2009, ACS NANO, V3, P1952, DOI 10.1021/nn9003428; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; LOUIE SG, 1982, PHYS REV B, V26, P1738, DOI 10.1103/PhysRevB.26.1738; Ozaki T, 2005, PHYS REV B, V72, DOI [10.1103/PhysRevB.72.045121, 10.1109/PhysRevB.72.045121]; Bolotin KI, 2008, SOLID STATE COMMUN, V146, P351, DOI 10.1016/j.ssc.2008.02.024; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Ozaki T, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.035116; Dutta S, 2008, J PHYS CHEM B, V112, P1333, DOI 10.1021/jp710637c; Geim AK, 2009, SCIENCE, V324, P1530, DOI 10.1126/science.1158877; Yu SS, 2010, IEEE T NANOTECHNOL, V9, P78, DOI 10.1109/TNANO.2009.2020797; Novoselov KS, 2012, NATURE, V490, P192, DOI 10.1038/nature11458; Yan QM, 2007, NANO LETT, V7, P1469, DOI 10.1021/nl070133j; Wang G, 2012, CHEM PHYS LETT, V533, P74, DOI 10.1016/j.cplett.2012.03.029; CEPERLEY DM, 1980, PHYS REV LETT, V45, P566, DOI 10.1103/PhysRevLett.45.566; Miwa RH, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/15/155708; LANDAUER R, 1957, IBM J RES DEV, V1, P223; Ozaki T, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.155108; MORRISON I, 1993, PHYS REV B, V47, P6728, DOI 10.1103/PhysRevB.47.6728; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRev.136.B864; Chauhan S., 2014, APPL NANOSCI, V4, P461; Datta S., 2005, QUANTUM TRANSPORT AT; Katagiri M., 2013, P IEEE IITC, P113; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Martins TB, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.196803; Miyazaki H., 2013, SOL STAT DEV MAT, P678; Ouyang YJ, 2011, SURF SCI, V605, P1643, DOI 10.1016/j.susc.2010.10.030; Padilha JE, 2011, INT J QUANTUM CHEM, V111, P1379, DOI 10.1002/qua.22690; Wada M., 2013, P IEEE IITC, P187; Wakabayashi K, 1999, PHYS REV B, V59, P8271, DOI 10.1103/PhysRevB.59.8271; Yamazaki Y, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.025101; Zeng H, 2012, COMP MATER SCI, V60, P234, DOI 10.1016/j.commatsci.2012.03.040; Zhao P, 2012, CHEM PHYS LETT, V554, P172, DOI 10.1016/j.cplett.2012.10.045; Zheng XH, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.235426	35	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	JAN	2015	54	1							015101	10.7567/JJAP.54.015101		5	Physics, Applied	Physics	AX5HT	WOS:000346957900022		
J	Ogawa, T; Ikegaya, T				Ogawa, Toshio; Ikegaya, Taiki			Elastic constants measured from acoustic wave velocities in barium titanate piezoelectric ceramics	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							DIELECTRIC-PROPERTIES; GRAIN-SIZE; COARSE	The longitudinal and transverse wave velocities in barium titanate (BT) ceramics sintered at different firing temperatures were measured using an ultrasonic precision thickness gauge with high-frequency pulse generation to evaluate elastic constants, such as Young's modulus and Poisson's ratio. With increasing firing temperature, the longitudinal and transverse wave velocities increased; as a result, Young's modulus increased because of BT ceramics being mechanically hard. Poisson's ratio after DC poling, however, was almost independent of the firing temperature. It was confirmed that there was an important factor for generating piezoelectricity regarding changes in Young's modulus and Poisson's ratio after DC poling compared with those before DC poling, that is, lowering Young's modulus and increasing Poisson's ratio. Furthermore, the modulus of rigidity and bulk modulus increased with the firing temperature because of the increase in ceramic bulk density. The modulus of rigidity decreased and the bulk modulus increased during DC poling because of domain alignment. (C) 2015 The Japan Society of Applied Physics	[Ogawa, Toshio; Ikegaya, Taiki] Shizuoka Inst Sci & Technol, Dept Elect & Elect Engn, Shizuoka 4378555, Japan	Ogawa, T (reprint author), Shizuoka Inst Sci & Technol, Dept Elect & Elect Engn, Shizuoka 4378555, Japan.				Strategic Research Foundation from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [S1001032]; Cooperation Research Foundation;  [21560340];  [26420282]	This work was partially supported by two Grants-in-Aid for Scientific Research C (Nos. 21560340 and 26420282), a Grant from the Strategic Research Foundation Grant-Aided Project for Private Universities 2010-2014 (No. S1001032) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT), and a Cooperation Research Foundation 2014 between Academy and Industry of Fukuroi City, Shizuoka, Japan.	Alfrey Jr T., 1948, MECH BEHAV HIGH POLY, P15; Wada S, 2005, J APPL PHYS, V98, DOI 10.1063/1.1957130; Demartin M, 1996, APPL PHYS LETT, V68, P3046, DOI 10.1063/1.115572; KITTEL C, 1946, PHYS REV, V70, P281, DOI 10.1103/PhysRev.70.281; Randall CA, 1998, J AM CERAM SOC, V81, P677; Ogawa T, 1999, JPN J APPL PHYS 1, V38, P5465, DOI 10.1143/JJAP.38.5465; [Anonymous], ULTR PREC THICKN GAG; [Anonymous], 1988, 1761987 IEEE; ARLT G, 1985, J APPL PHYS, V58, P1619, DOI 10.1063/1.336051; ARLT G, 1983, FERROELECTRICS, V48, P213; Cao WW, 1996, J PHYS CHEM SOLIDS, V57, P1499, DOI 10.1016/0022-3697(96)00019-4; ARLT G, 1990, FERROELECTRICS, V104, P217, DOI 10.1080/00150199008223825; MITSUI T, 1953, PHYS REV, V90, P193, DOI 10.1103/PhysRev.90.193; KINOSHITA K, 1976, J APPL PHYS, V47, P371, DOI 10.1063/1.322330; BUESSEM WR, 1966, J AM CERAM SOC, V49, P33, DOI 10.1111/j.1151-2916.1966.tb13144.x; Chenskii E. V., 1973, Soviet Physics - Solid State, V14; Choi YK, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3508947; Hoshina T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.09MC02; Hoshina T, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.09KC01; Jaffe B., 1971, PIEZOELECTRIC CERAMI, P53; Khachaturyan A.G., 1983, THEORY STRUCTURAL TR, P198; Mason W. P., 1950, PIEZOELECTRIC CRYSTA, P390; Mason W. P., 1964, PHYS ACOUSTICS, P182; Ogawa T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.09LD03; Ogawa T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.09MD07; Ogawa T., 2011, CERAMIC T, V226, P49; Ogawa T., 2012, CERAMIC TRANSACTIONS, V235, P105; Ogawa T., 2013, PIEZOELECTRIC MAT DE, P35; Ogawa T, 2013, CERAM TRANS, V240, P267; Ogawa T, 2002, JPN J APPL PHYS 1, V41, P7108, DOI 10.1143/JJAP.41.7108; Ogawa T., 2011, FERROELECTRICS APPL, P3; PHILIPPOFF W, 1955, J APPL PHYS, V26, P846, DOI 10.1063/1.1722106; Salje E., 1990, PHASE TRANSITIONS FE, P76	33	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	JAN	2015	54	1							011501	10.7567/JJAP.54.011501		6	Physics, Applied	Physics	AX5HT	WOS:000346957900008		
J	Oshima, R; Yamanaka, M; Kawanami, H; Sakata, I; Matsubara, K; Sugaya, T				Oshima, Ryuji; Yamanaka, Mitsuyuki; Kawanami, Hitoshi; Sakata, Isao; Matsubara, Koji; Sugaya, Takeyoshi			Fabrication of hydrogenated amorphous Si/crystalline Si1-xGex (x <= 0.84) heterojunction solar cells grown by solid source molecular beam epitaxy	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							CHEMICAL-VAPOR-DEPOSITION; RELAXED-SIGE; INTERNAL PHOTOEMISSION; LAYERS; SILICON; GE; HETEROSTRUCTURES; DISLOCATIONS; TECHNOLOGY	We characterized hydrogenated amorphous Si/single-crystalline Si1-xGex heterojunction solar cells grown on Si substrates with Ge content (x) between 0.49 and 0.84 in an effort to develop materials with a bandgap range of 0.9-1.0 eV for solar applications. We showed that 3-mu m-thick Si0.16Ge0.84 films grown by molecular-beam epitaxy on a virtual substrate composed of buffer layers with stepwise gradation of their composition have an almost fully strain-relaxed condition and a low dislocation density, less than 10(5) cm(-2). An absorption edge extending up to 1300 nm and an increased quantum efficiency were observed in Si1-xGex cells with x = 0.49, 0.70, and 0.84. Consequently, the short-circuit current density increased non-linearly with Ge content, being 14.0 and 24.0 mA/cm(2) for 3-mu m-thick Si and Si0.16Ge0.84 cells, respectively. (C) 2015 The Japan Society of Applied Physics	[Oshima, Ryuji; Yamanaka, Mitsuyuki; Kawanami, Hitoshi; Sakata, Isao; Matsubara, Koji; Sugaya, Takeyoshi] Natl Inst Adv Ind Sci & Technol, Res Ctr Photovolta Technol, Tsukuba, Ibaraki 3058568, Japan	Oshima, R (reprint author), Natl Inst Adv Ind Sci & Technol, Res Ctr Photovolta Technol, Tsukuba, Ibaraki 3058568, Japan.	r.oshima@aist.go.jp			New Energy and Industrial Technology Development Organization (NEDO)	This study was supported by the New Energy and Industrial Technology Development Organization (NEDO).	Said K, 1999, THIN SOLID FILMS, V337, P85, DOI 10.1016/S0040-6090(98)01390-X; Friedman DJ, 1998, J CRYST GROWTH, V195, P409, DOI 10.1016/S0022-0248(98)00561-2; Oshima R, 2013, J CRYST GROWTH, V378, P226, DOI 10.1016/j.jcrysgro.2012.12.154; Yoon TS, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.1988986; Larsen AN, 2006, MAT SCI SEMICON PROC, V9, P454, DOI 10.1016/j.mssp.2006.08.039; Mizuno H, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4766339; Hadi SA, 2014, SOL ENERGY, V103, P154, DOI 10.1016/j.solener.2014.01.039; LUTZ MA, 1995, APPL PHYS LETT, V66, P724, DOI 10.1063/1.114112; HULL R, 1989, THIN SOLID FILMS, V183, P117, DOI 10.1016/0040-6090(89)90437-9; Gaiduk PI, 2000, THIN SOLID FILMS, V367, P120, DOI 10.1016/S0040-6090(00)00660-X; Philipps SP, 2010, SOL ENERG MAT SOL C, V94, P869, DOI 10.1016/j.solmat.2010.01.010; Law DC, 2010, SOL ENERG MAT SOL C, V94, P1314, DOI 10.1016/j.solmat.2008.07.014; Hoshi Y, 2009, J CRYST GROWTH, V311, P825, DOI 10.1016/j.jcrysgro.2008.09.100; BREMOND G, 1992, THIN SOLID FILMS, V222, P60, DOI 10.1016/0040-6090(92)90039-E; Chakraborty S, 2006, THIN SOLID FILMS, V504, P73, DOI 10.1016/j.tsf.2005.09.044; Daami A, 2001, MAT SCI SEMICON PROC, V4, P331, DOI 10.1016/S1369-8001(00)00101-3; DASH WC, 1956, J APPL PHYS, V27, P1193, DOI 10.1063/1.1722229; Egawa T, 2004, APPL SURF SCI, V224, P104, DOI 10.1016/j.apsusc.2003.08.072; Furlan J, 1998, SOL ENERG MAT SOL C, V53, P15, DOI 10.1016/S0927-0248(98)00002-6; Kaneko T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.120204; Kuznetsov VI, 1995, J VAC SCI TECHNOL B, V13, P2892, DOI 10.1116/1.588312; Lin CH, 2013, APPL SURF SCI, V275, P269, DOI 10.1016/j.apsusc.2012.12.113; MIMURA H, 1987, APPL PHYS LETT, V50, P326, DOI 10.1063/1.98189; Nakano S, 2012, J NON-CRYST SOLIDS, V358, P2249, DOI 10.1016/j.jnoncrysol.2011.12.045; Park JS, 2007, J APPL PHYS, V101, DOI 10.1063/1.2710356; Sakata I, 2009, SOL ENERG MAT SOL C, V93, P737, DOI 10.1016/j.solmat.2008.09.017; SCHWARTZ PV, 1990, APPL PHYS LETT, V57, P2004, DOI 10.1063/1.103991; Shiraki Y, 2005, SURF SCI REP, V59, P153, DOI 10.1016/j.surfrep.2005.08.001; TANAKA M, 1992, JPN J APPL PHYS 1, V31, P3518, DOI 10.1143/JJAP.31.3518; Usami N, 2008, THIN SOLID FILMS, V517, P14, DOI 10.1016/j.tsf.2008.08.044; WANG KL, 1993, J VAC SCI TECHNOL B, V11, P1159, DOI 10.1116/1.586832	31	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	JAN	2015	54	1							012301	10.7567/JJAP.54.012301		5	Physics, Applied	Physics	AX5HT	WOS:000346957900014		
J	Sakai, M; Takao, H; Matsunaga, T; Tanaka, Y; Arai, T; Haruyama, S; Otomo, T; Hirama, H; Sakuraba, T; Honda, Z; Higuchi, K; Kitajima, A; Oshima, A; Hasegawa, S; Awano, H				Sakai, Masamichi; Takao, Hiraku; Matsunaga, Tomoyoshi; Tanaka, Yusuke; Arai, Tatsuya; Haruyama, Shota; Otomo, Takashi; Hirama, Hiroaki; Sakuraba, Takahito; Honda, Zentaro; Higuchi, Koji; Kitajima, Akira; Oshima, Akihiro; Hasegawa, Shigehiko; Awano, Hiroyuki			Hall resistivity and transverse magnetoresistivity generated in simultaneous presence of spin-polarized current and external magnetic field in a nonmagnetic bipolar conductor YH2	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							METAL; INJECTION	We have carried out magnetotransport measurements of the bipolar conductor YHx (x similar or equal to 2) employing the ferromagnetic conductor Co as the source and drain electrodes, from which the spin-polarized currents are injected. Both the Hall resistivity (HR) and transverse magnetoresistivity (TMR) ratio are enhanced by a factor of similar to 3 and similar to 6, respectively, when Co electrodes are used instead of Au electrodes. We derived two types of closed formulae of HR and TMR, the first (second) type of which was derived by simultaneously (independently) considering the external magnetic field and spin-orbit interaction, but both types of which were derived by considering spin-dependent electrochemical potential caused by the presence of the ferromagnetic electrodes. Carrier parameter assessments based on the two types of formulae as well as the two types of electrode samples enable us to infer that coupling mechanisms between the external magnetic field and spin-orbit interaction are required for the precise interpretation of HR and TMR measured in the simultaneous presence of magnetic field and spin splitting in a diffusion force field, especially for conductors with strong spin-orbit interaction. (C) 2015 The Japan Society of Applied Physics	[Sakai, Masamichi; Takao, Hiraku; Matsunaga, Tomoyoshi; Tanaka, Yusuke; Arai, Tatsuya; Haruyama, Shota; Otomo, Takashi; Hirama, Hiroaki; Sakuraba, Takahito; Honda, Zentaro] Saitama Univ, Grad Sch Sci & Engn, Div Mat Sci, Saitama 3388570, Japan; [Higuchi, Koji; Kitajima, Akira; Oshima, Akihiro; Hasegawa, Shigehiko] Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan; [Awano, Hiroyuki] Toyota Technol Inst, Informat Storage Mat Lab, Nagoya, Aichi 4888511, Japan	Sakai, M (reprint author), Saitama Univ, Grad Sch Sci & Engn, Div Mat Sci, Saitama 3388570, Japan.	sakai@fms.saitama-u.ac.jp	Oshima, Akihiro/E-7641-2012		Japan Society for the Promotion of Science [24656007]; Nanotechnology Platform Project [S-13-OS-0011, F-13-OS-0016, F-14-OS-0019, F-14-OS-0027]; Toyota Technological Institute [F-13-TT- 0030, F-14-TT-0030]; Network Joint Research Center for Materials and Devices [2013360, 2014349]; Ministry of Education, Culture, Sports, Science and Technology, Japan	This study was supported in part by a Grant-in-Aid for Challenging Exploratory Research (24656007) from the Japan Society for the Promotion of Science. A part of this study was supported by the Nanotechnology Platform Project (Nanotechnology Open Facilities in Osaka University, Nos. S-13-OS-0011, F-13-OS-0016, F-14-OS-0019, and F-14-OS-0027, and Toyota Technological Institute, Nos. F-13-TT- 0030 and F-14-TT-0030) and the Network Joint Research Center for Materials and Devices (Nos. 2013360 and 2014349) of the Ministry of Education, Culture, Sports, Science and Technology, Japan.	TEDROW PM, 1973, PHYS REV B, V7, P318, DOI 10.1103/PhysRevB.7.318; Wunderlich J, 2009, NAT PHYS, V5, P675, DOI 10.1038/NPHYS1359; Takahashi S, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.031009; Fert A, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.184420; VALET T, 1993, PHYS REV B, V48, P7099, DOI 10.1103/PhysRevB.48.7099; Jedema FJ, 2001, NATURE, V410, P345, DOI 10.1038/35066533; VANSON PC, 1987, PHYS REV LETT, V58, P2271, DOI 10.1103/PhysRevLett.58.2271; Fert A, 1999, J MAGN MAGN MATER, V200, P338, DOI 10.1016/S0304-8853(99)00375-3; Gradhand M, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.245109; Arsenault LF, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.214408; BERGER L, 1969, PHYS REV, V177, P790, DOI 10.1103/PhysRev.177.790; Look D. C., 1989, ELECT CHARACTERIZATI, P11; MOVAGHAR B, 1991, PHYS STATUS SOLIDI B, V166, P311, DOI 10.1002/pssb.2221660202; PETERMAN DJ, 1979, PHYS REV B, V19, P4867, DOI 10.1103/PhysRevB.19.4867; Saito E., 2014, SPIN CURRENT TOPOLOG, P36; Sakai M, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.093001; Sakai M, 2010, J APPL PHYS, V108, DOI 10.1063/1.3500443	17	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	JAN	2015	54	1							013001	10.7567/JJAP.54.013001		11	Physics, Applied	Physics	AX5HT	WOS:000346957900018		
J	Shimamura, K; Ofosu, JA; Komurasaki, K; Koizumi, H				Shimamura, Kohei; Ofosu, Joseph A.; Komurasaki, Kimiya; Koizumi, Hiroyuki			Predicting propagation limits of laser-supported detonation by Hugoniot analysis	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							REGIME TRANSITION; ABSORPTION WAVE; SHOCK-WAVE; IONIZATION; PROPULSION	Termination conditions of a laser-supported detonation (LSD) wave were investigated using control volume analysis with a Shimada-Hugoniot curve and a Rayleigh line. Because the geometric configurations strongly affect the termination condition, a rectangular tube was used to create the quasi-one-dimensional configuration. The LSD wave propagation velocity and the pressure behind LSD were measured. Results reveal that the detonation states during detonation and at the propagation limit are overdriven detonation and Chapman-Jouguet detonation, respectively. The termination condition is the minimum velocity criterion for the possible detonation solution. Results were verified using pressure measurements of the stagnation pressure behind the LSD wave. (C) 2015 The Japan Society of Applied Physics	[Shimamura, Kohei] Univ Tsukuba, Dept Engn Mech & Energy, Tsukuba, Ibaraki 3058573, Japan; [Ofosu, Joseph A.; Komurasaki, Kimiya] Univ Tokyo, Grad Sch Frontier Sci, Dept Adv Energy, Kashiwa, Chiba 2778561, Japan; [Koizumi, Hiroyuki] Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo 1538904, Japan	Shimamura, K (reprint author), Univ Tsukuba, Dept Engn Mech & Energy, Tsukuba, Ibaraki 3058573, Japan.				Ministry of Education, Culture, Sports, Science and Technology (MEXT) [23246145]; Japan Society for the Promotion of Science (JSPS) [25203]; University of Tsukuba	This work was supported by a Grant-in-Aid for Scientific Research (A), No. 23246145 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), by a Grant-in-Aid for JSPS Fellows, No. 25203, from the Japan Society for the Promotion of Science (JSPS), and by the University of Tsukuba Basic Research Support Program Type A.	Sasoh A, 2010, AIAA J, V48, P2811, DOI 10.2514/1.J050174; Hidaka Y, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3083218; Boiko V. A., 1976, Soviet Journal of Quantum Electronics, V6, DOI 10.1070/QE1976v006n09ABEH011840; Bose T. K., 2003, HIGH TEMPERATURE GAS; BOURNOT P, 1979, ACTA ASTRONAUT, V6, P257, DOI 10.1016/0094-5765(79)90097-3; Endo T, 2004, AIAA J, V42, P1921, DOI 10.2514/1.976; FICKETT W., 2011, DETONATION THEORY EX; FISHER VI, 1980, ZH EKSP TEOR FIZ+, V79, P2142; Gan L., 2014, AIP ADV, V4; Gautschi G, 2002, PIEZOELECTRIC SENSOR; Gupta R. N., 1989, 101528 NASA TM; Katsurayama H, 2009, ACTA ASTRONAUT, V65, P1032, DOI 10.1016/j.actaastro.2009.03.028; Kozlov G. I., 1979, Soviet Physics - Technical Physics, V24; Landau L., 1987, FLUID MECH, V6; MAHER WE, 1974, J APPL PHYS, V45, P2138, DOI 10.1063/1.1663559; Mori K, 2002, J APPL PHYS, V92, P5663, DOI 10.1063/1.1513869; Mori K, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2183812; Mori K, 2004, J SPACECRAFT ROCKETS, V41, P887, DOI 10.2514/1.5677; Myrabo LN, 2011, AIP CONF PROC, V1402, DOI 10.1063/1.3657026; Nemtsev I. Z., 1977, SOV J PLASMA PHYS, V3, P649; Oda Y, 2011, J INFRARED MILLIM TE, V32, P877, DOI 10.1007/s10762-011-9798-1; Oda Y, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.116001; Phipps C, 2010, J PROPUL POWER, V26, P609, DOI 10.2514/1.43733; Raizer Y. P., 1978, LASER INDUCED DISCHA; Shimada Y, 2010, AIP CONF PROC, V1230, P366, DOI 10.1063/1.3435453; Shimamura K, 2014, IEEE T PLASMA SCI, V42, P3121, DOI 10.1109/TPS.2014.2304960; Shimamura K, 2011, J APPL PHYS, V109, DOI 10.1063/1.3574922; Toyoda K, 2002, VACUUM, V65, P383, DOI 10.1016/S0042-207X(01)00446-8; Ushio M, 2008, SHOCK WAVES, V18, P35, DOI 10.1007/s00193-008-0137-y; Vikharev A. L., 1988, SOV PHYS JETP, V94, P136	30	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	JAN	2015	54	1							016201	10.7567/JJAP.54.016201		5	Physics, Applied	Physics	AX5HT	WOS:000346957900032		
J	Sorimachi, M; Miyamoto, T				Sorimachi, Mikio; Miyamoto, Tomoyuki			Control of carrier reserving and injection for high-speed semiconductor optical amplifier by using a tunnel injection structure	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							CROSS-GAIN MODULATION; WAVELENGTH CONVERSION; RECOVERY; TRANSPARENCY; ACCELERATION; SWITCHES; DYNAMICS	In this study, we explore a new way of controlling the carrier dynamics of semiconductor optical amplifiers (SOAs) by using a tunneling injection structure, which allows for high-speed operation. The proposed SOA uses carrier reserving to compensate for the decreased carriers caused by signal amplification. We can control the SOA operation properties for high-speed signals by adjusting its characteristics of carrier injection from the reservoir layer to the active layer. Numerical simulations showed that this structure has the potential to suppress signal distortion at a high operation speed of 100 Gbps. (C) 2015 The Japan Society of Applied Physics	[Sorimachi, Mikio; Miyamoto, Tomoyuki] Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 2268503, Japan	Sorimachi, M (reprint author), Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 2268503, Japan.	mikio.sorimachi@ms.pi.titech.ac.jp; tmiyamot@pi.titech.ac.jp					Akiyama T, 2007, P IEEE, V95, P1757, DOI 10.1109/JPROC.2007.900899; ANDO Y, 1987, J APPL PHYS, V61, P1497, DOI 10.1063/1.338082; Diez S, 1997, IEEE J SEL TOP QUANT, V3, P1131, DOI 10.1109/2944.658587; EISENSTEIN G, 1991, APPL PHYS LETT, V58, P158, DOI 10.1063/1.105237; Geraghty DF, 1997, IEEE J SEL TOP QUANT, V3, P1146, DOI 10.1109/2944.658588; Pleumeekers JL, 2002, IEEE PHOTONIC TECH L, V14, P12, DOI 10.1109/68.974145; Durhuus T, 1996, J LIGHTWAVE TECHNOL, V14, P942, DOI 10.1109/50.511594; Sugawara M, 2001, JPN J APPL PHYS 2, V40, pL488, DOI 10.1143/JJAP.40.L488; KALMAN RF, 1992, IEEE PHOTONIC TECH L, V4, P1048, DOI 10.1109/68.157145; Dupertuis MA, 2000, IEEE PHOTONIC TECH L, V12, P1453, DOI 10.1109/68.887655; EISENSTEIN G, 1989, APPL PHYS LETT, V54, P454, DOI 10.1063/1.100950; GILLNER L, 1993, IEE PROC-J, V140, P309; Higa Y, 2008, PHYS STATUS SOLIDI C, V5, P2838, DOI 10.1002/pssc.200779218; Higa Y, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.080209; MANNING RJ, 1994, ELECTRON LETT, V30, P787, DOI 10.1049/el:19940536; MARCENAC DD, 1995, ELECTRON LETT, V31, P1442, DOI 10.1049/el:19951014; Obermann K, 1998, J LIGHTWAVE TECHNOL, V16, P78, DOI 10.1109/50.654987; RATOVELOMANANA F, 1995, IEEE PHOTONIC TECH L, V7, P992, DOI 10.1109/68.414679; Sugawara M, 2002, MEAS SCI TECHNOL, V13, P1683, DOI 10.1088/0957-0233/13/11/304; Sun H, 2006, IEEE PHOTONIC TECH L, V18, P196, DOI 10.1109/LPT.2005.860040; Talli G, 2005, OPT COMMUN, V245, P363, DOI 10.1016/j.optcom.2004.10.029	21	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	JAN	2015	54	1							010303	10.7567/JJAP.54.010303		4	Physics, Applied	Physics	AX5HT	WOS:000346957900003		
J	Takagi, K; Nagase, T; Kobayashi, T; Kushida, T; Naito, H				Takagi, Kenichiro; Nagase, Takashi; Kobayashi, Takashi; Kushida, Takashi; Naito, Hiroyoshi			High-performance and electrically stable solution-processed polymer field-effect transistors with a top-gate configuration	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							THIN-FILM TRANSISTORS; PI-INTERACTION; BIAS-STRESS; INTERFACES; STABILITY; INJECTION; TRANSPORT; MOBILITY; SURFACE; TFTS	The electrical performance of organic field-effect transistors (organic FETs or OFETs) based on the soluble semiconductor regioregular poly(3-hexylthiophene) (P3HT) with a top-gate configuration is investigated. P3HT FETs with the top-gate configuration show that field-effect mobility is independent of substrate surface energy and are comparable to bottom-gate P3HT FETs with hydrophobic surface passivations on SiO2 gate insulators. Gate bias stress experiments reveal a high electrical stability with negligible hysteresis and small threshold voltage shifts in top-gate devices with different polymer gate insulators, which is comparable or superior to that of hydrogenated amorphous silicon thin film transistors. (C) 2015 The Japan Society of Applied Physics	[Takagi, Kenichiro; Nagase, Takashi; Kobayashi, Takashi; Naito, Hiroyoshi] Osaka Prefecture Univ, Dept Phys & Elect, Sakai, Osaka 5998531, Japan; [Nagase, Takashi; Kobayashi, Takashi; Naito, Hiroyoshi] Osaka Prefecture Univ, Res Inst Mol Elect Devices, Sakai, Osaka 5998531, Japan; [Kushida, Takashi] Teijin Ltd, Integrat Technol Res Inst, Hino, Tokyo 1918512, Japan	Takagi, K (reprint author), Osaka Prefecture Univ, Dept Phys & Elect, Sakai, Osaka 5998531, Japan.	naito@pe.osakafu-u.ac.jp			Japan Society for the Promotion of Science (JSPS); Council for Science and Technology Policy; JSPS [23360140]; Ministry of Education, Culture, Sports, Science, and Technology, Japan [2401, 24102011]	This research was supported by a grant from the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)", initiated by the Council for Science and Technology Policy. It was also partly supported by a Grant-in-Aid for Scientific Research (B) (No. 23360140) from the JSPS and by a Grant-in-Aid for Scientific Research on Innovative Areas "New Polymeric Materials Based on Element-Blocks (No. 2401)" (No. 24102011) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Hwang DK, 2011, ADV MATER, V23, P1293, DOI 10.1002/adma.201004278; Salleo A, 2002, APPL PHYS LETT, V81, P4383, DOI 10.1063/1.1527691; Hwang DK, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2830329; Hao XT, 2007, J PHYS CHEM B, V111, P10365, DOI 10.1021/jp0732209; Kline RJ, 2006, NAT MATER, V5, P222, DOI 10.1038/nmat1590; LIBSCH FR, 1993, APPL PHYS LETT, V62, P1286, DOI 10.1063/1.108709; Hamadani BH, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2824845; Street RA, 2002, APPL PHYS LETT, V81, P2887, DOI 10.1063/1.1512950; Sirringhaus H, 1999, NATURE, V401, P685, DOI 10.1038/44359; Hill IG, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2112189; Richards TJ, 2007, J APPL PHYS, V102, DOI 10.1063/1.2804288; Goldmann C, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2171479; Ho PKH, 2007, ADV MATER, V19, P215, DOI 10.1002/adma.200601285; Sirringhaus H, 2005, ADV MATER, V17, P2411, DOI 10.1002/adma.200501152; Lee CH, 2007, IEEE T ELECTRON DEV, V54, P45, DOI 10.1109/TED.2006.887220; Umeda T, 2009, J APPL PHYS, V105, DOI 10.1063/1.3072669; Wei QS, 2009, ACS APPL MATER INTER, V1, P2660, DOI 10.1021/am9005572; Burgi L, 2003, J APPL PHYS, V94, P6129, DOI 10.1063/1.1613369; Endo T, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.121601; Grecu S, 2006, ORG ELECTRON, V7, P276, DOI 10.1016/j.orgel.2006.03.005; Gu G, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2146059; Hwang DK, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2345243; Jiang L, 2010, ORG ELECTRON, V11, P344, DOI 10.1016/j.orgel.2009.10.015; Kushida T, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3553481; Nagase T, 2010, ADV MATER, V22, P4706, DOI 10.1002/adma.201001871; Suemori K, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2812573; Umeda T, 2008, ORG ELECTRON, V9, P545, DOI 10.1016/j.orgel.2008.02.015; Wang SD, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2844857; Wei QS, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3454242; Yamazaki S, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.091602	30	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	JAN	2015	54	1							011601	10.7567/JJAP.54.011601		5	Physics, Applied	Physics	AX5HT	WOS:000346957900010		
J	Teranishi, T; Sogabe, T; Hayashi, H; Kishimoto, A; Iokibe, K; Toyota, Y				Teranishi, Takashi; Sogabe, Tsuyoshi; Hayashi, Hidetaka; Kishimoto, Akira; Iokibe, Kengo; Toyota, Yoshitaka			Effect of Mg loading on the high-frequency tunability of Ba0.8Sr0.2TiO3 ceramics	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							DIELECTRIC-PROPERTIES; THIN-FILMS; DOPED BATIO3; RELAXOR FERROELECTRICS; TITANATE CERAMICS; MICROWAVE DEVICES; PHASE-TRANSITION; MICROSTRUCTURE; BA1-XSRXTIO3; TEMPERATURE	The effect of Mg loading on the high-frequency tunable properties and dielectric loss of Ba0.8Sr0.2Ti1-xMgxO3 (BSTM) ceramics was investigated. Variation in the lattice parameters and the 90 degrees domain configuration with Mg loading indicated a decrease in the tetragonal distortion. Additionally, the 90 degrees domain size decreased slightly with a low Mg loading, up to 0.1 mol %, resulting in a higher domain-wall density compared with the non-doped specimen. The 0.075 mol% Mg-loaded BSTM ceramic exhibited the highest tunability; this was attributed to the domain-size effect. The loss tangent (tan delta) roughly decreased with Mg loading, due to loaded oxygen vacancies. The maximum figure of merit value (FOM = tunability/tan delta) at 10 MHz was achieved for the 0.075 mol% Mg specimen, twice that of the non-doped specimen, due to an increase in the tunability and a decrease in the loss tangent with Mg loading. (C) 2015 The Japan Society of Applied Physics	[Teranishi, Takashi; Sogabe, Tsuyoshi; Hayashi, Hidetaka; Kishimoto, Akira; Iokibe, Kengo; Toyota, Yoshitaka] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan	Teranishi, T (reprint author), Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan.	terani-t@cc.okayama-u.ac.jp					Ang C, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.174109; HAGEMANN HJ, 1978, J PHYS C SOLID STATE, V11, P3333, DOI 10.1088/0022-3719/11/15/031; Carlson CM, 2000, APPL PHYS LETT, V76, P1920, DOI 10.1063/1.126212; Tinte S, 2004, J PHYS-CONDENS MAT, V16, P3495, DOI 10.1088/0953-8984/16/20/019; Yoon SH, 2007, J APPL PHYS, V102, DOI 10.1063/1.2777119; Duran P, 2002, ADV MATER, V14, P137, DOI 10.1002/1521-4095(20020116)14:2<137::AID-ADMA137>3.0.CO;2-7; Tagantsev AK, 2003, J ELECTROCERAM, V11, P5, DOI 10.1023/B:JECR.0000015661.81386.e6; Zhou LQ, 2001, J EUR CERAM SOC, V21, P531, DOI 10.1016/S0955-2219(00)00239-9; Teranishi T, 2009, MATER SCI ENG B-ADV, V161, P55, DOI 10.1016/j.mseb.2008.11.039; ARLT G, 1985, J APPL PHYS, V58, P1619, DOI 10.1063/1.336051; Chen IW, 2000, NATURE, V404, P168, DOI 10.1038/35004548; CROSS LE, 1987, FERROELECTRICS, V76, P241; Jeon JH, 2004, J EUR CERAM SOC, V24, P1045, DOI 10.1016/S0955-2219(03)00385-6; Bhardwaj C, 2013, J PHYS CHEM SOLIDS, V74, P94, DOI 10.1016/j.jpcs.2012.08.005; BURN I, 1979, J MATER SCI, V14, P2453, DOI 10.1007/BF00737036; Su B, 2004, J APPL PHYS, V95, P1382, DOI 10.1063/1.1636263; Gevorgian SS, 2001, IEEE T MICROW THEORY, V49, P2117, DOI 10.1109/22.963146; Zhang LX, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3006327; Cha SH, 2006, JPN J APPL PHYS 1, V45, P7797, DOI 10.1143/JJAP.45.7797; Cross L. E., 1994, Ferroelectrics, V151, DOI 10.1080/00150199408244755; Glazounov AE, 2000, PHYS REV LETT, V85, P2192, DOI 10.1103/PhysRevLett.85.2192; Ha JY, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.011402; Hansen P, 1998, J ELECTROCERAM, V2, P85; Hoshina T, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.09KC01; Jeon YA, 2001, JPN J APPL PHYS 1, V40, P6496, DOI 10.1143/JJAP.40.6496; Jeong J, 2004, JPN J APPL PHYS 1, V43, P5373, DOI 10.1143/JJAP.43.5373; Lee SJ, 2004, JPN J APPL PHYS 1, V43, P6750, DOI 10.1143/JJAP.43.6750; Li JY, 2006, J APPL PHYS, V100, DOI 10.1063/1.2216884; Liang RH, 2004, JPN J APPL PHYS 1, V43, P201, DOI 10.1143/JJAP.43.201; Liang RH, 2007, CERAM INT, V33, P957, DOI 10.1016/j.ceramint.2006.02.009; Moriwake H, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.09MC01; Nagai T, 2000, J AM CERAM SOC, V83, P107, DOI 10.1111/j.1151-2916.2000.tb01156.x; Ostapchuk T, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/47/474215; Park BH, 2002, JPN J APPL PHYS 1, V41, P7222, DOI 10.1143/JJAP.41.7222; Teranishi T, 2009, J APPL PHYS, V105, DOI 10.1063/1.3089250; Teranishi T, 2009, J APPL PHYS, V105, DOI 10.1063/1.3131624; Teranishi T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09KF06; Tsurumi T, 2005, JPN J APPL PHYS 1, V44, P6989, DOI 10.1143/JJAP.44.6989; TSURUMI T, 1994, JPN J APPL PHYS 1, V33, P1959, DOI 10.1143/JJAP.33.1959; Hahn DW, 2008, JPN J APPL PHYS, V47, P5526, DOI 10.1143/JJAP.47.5526; Yoon SH, 2011, J APPL PHYS, V109, DOI 10.1063/1.3582146	41	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	JAN	2015	54	1							011502	10.7567/JJAP.54.011502		6	Physics, Applied	Physics	AX5HT	WOS:000346957900009		
J	Toyama, T; Konishi, T; Seo, Y; Tsuji, R; Terai, K; Nakashima, Y; Maenishi, R; Arata, A; Yudate, S; Tsutsumi, Y; Shirakata, S				Toyama, Toshihiko; Konishi, Takafumi; Seo, Yuichi; Tsuji, Ryotaro; Terai, Kengo; Nakashima, Yuto; Maenishi, Ryuichiro; Arata, Akiko; Yudate, Shinji; Tsutsumi, Yasuo; Shirakata, Sho			Annealing-induced optical-bandgap widening of Cu2ZnSnS4 thin films with observation of simultaneous increase in local-structure ordering	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							RAMAN-SCATTERING; SOLAR-CELLS; SPECTROSCOPY; IFEFFIT; GROWTH; EDGE	We achieved annealing-induced optical-bandgap widening in Cu2ZnSnS4 (CZTS), which is a promising material for use in high-efficiency thin-film solar cells, and we performed synchrotron-radiation X-ray absorption fine structure (XAFS) measurements to study the reasons underlying the widening. CZTS thin-film samples were fabricated at a low temperature of 230 degrees C via sputtering with a CZTS ceramic target followed by annealing at up to 550 degrees C. Optical absorption spectroscopy revealed optical bandgap widening when the annealing temperature was >= 350 degrees C. Compositional changes, phase separations, and lattice strains were excluded as possible reasons. XAFS measurements revealed that the radial distribution functions (RDFs) around the Zn K-absorption edge almost completely corresponded to those of a kesterite structure. In addition, the RDFs indicated that the disorder of atomic positions within 1 nm from zinc atoms tended to decrease with increasing annealing temperature, which we conclude is the primary reason for the optical-bandgap widening. (C) 2015 The Japan Society of Applied Physics	[Toyama, Toshihiko; Konishi, Takafumi; Seo, Yuichi; Tsuji, Ryotaro] Osaka Univ, Grad Sch Engn, Kaneka Fundamental Technol Alliance Res Labs, Suita, Osaka 5650871, Japan; [Terai, Kengo; Nakashima, Yuto; Tsutsumi, Yasuo] Akashi Coll, Natl Inst Technol, Dept Elect & Comp Engn, Akashi, Hyogo 6748501, Japan; [Maenishi, Ryuichiro; Arata, Akiko; Yudate, Shinji; Shirakata, Sho] Ehime Univ, Fac Engn, Dept Elect & Elect Engn, Matsuyama, Ehime 7900826, Japan	Toyama, T (reprint author), Osaka Univ, Grad Sch Engn, Kaneka Fundamental Technol Alliance Res Labs, Suita, Osaka 5650871, Japan.	toyama@arl.eng.osaka-u.ac.jp					Leitao JP, 2011, THIN SOLID FILMS, V519, P7390, DOI 10.1016/j.tsf.2010.12.105; Scragg JJ, 2011, CHEM MATER, V23, P4625, DOI 10.1021/cm202379s; Walsh A, 2012, ADV ENERGY MATER, V2, P400, DOI 10.1002/aenm.201100630; Li CR, 2013, PHYS LETT A, V377, P2398, DOI 10.1016/j.physleta.2013.06.046; Todorov T, 2009, THIN SOLID FILMS, V517, P2541, DOI 10.1016/j.tsf.2008.11.035; Mitzi DB, 2011, SOL ENERG MAT SOL C, V95, P1421, DOI 10.1016/j.solmat.2010.11.028; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; Nozaki H, 2012, J ALLOY COMPD, V524, P22, DOI 10.1016/j.jallcom.2012.01.134; Paier J, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.115126; Siebentritt S, 2012, PROG PHOTOVOLTAICS, V20, P512, DOI 10.1002/pip.2156; Tanaka T, 2005, J PHYS CHEM SOLIDS, V66, P1978, DOI 10.1016/j.jpcs.2005.09.037; Rehr JJ, 2000, REV MOD PHYS, V72, P621, DOI 10.1103/RevModPhys.72.621; Schorr S, 2011, SOL ENERG MAT SOL C, V95, P1482, DOI 10.1016/j.solmat.2011.01.002; Fernandes PA, 2009, THIN SOLID FILMS, V517, P2519, DOI 10.1016/j.tsf.2008.11.031; Moriya K, 2007, JPN J APPL PHYS 1, V46, P5780, DOI 10.1143/JJAP.46.5780; Scragg JJS, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4863685; Katagiri H, 1997, SOL ENERG MAT SOL C, V49, P407, DOI 10.1016/S0927-0248(97)00119-0; Ankudinov AL, 1998, PHYS REV B, V58, P7565, DOI 10.1103/PhysRevB.58.7565; Sun L, 2011, SOL ENERG MAT SOL C, V95, P2907, DOI 10.1016/j.solmat.2011.06.026; SHOCKLEY W, 1961, J APPL PHYS, V32, P510, DOI 10.1063/1.1736034; Barkhouse DAR, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4714737; Toyama T, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.075503; Valakh MY, 2013, PHYS STATUS SOLIDI-R, V7, P258, DOI 10.1002/pssr.201307073; CODY GD, 1984, SEMICONDUCT SEMIMET, V21, P11; ENDO S, 1986, SOL CELLS, V16, P1, DOI 10.1016/0379-6787(86)90071-2; Just J., 2011, HASY LAB ANN REP; Just J, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3671994; Katagiri H., 2011, P 37 IEEE PHOT SPEC; Katou T., 2012, P 27 EUR PHOT SOL EN; Kumar YBK, 2009, SOL ENERG MAT SOL C, V93, P1230, DOI 10.1016/j.solmat.2009.01.011; Kodigala SR, 2010, THIN FILM NANOSTRUCT, V35, P21, DOI 10.1016/S1543-5016(10)35002-9; Kodigala SR, 2010, THIN FILM NANOSTRUCT, V35, P195, DOI 10.1016/S1543-5016(10)35005-4; Kondow M, 2004, J PHYS-CONDENS MAT, V16, pS3229, DOI 10.1088/0953-8984/16/31/017; ITO K, 1988, JPN J APPL PHYS 1, V27, P2094, DOI 10.1143/JJAP.27.2094; Newville M, 2001, J SYNCHROTRON RADIAT, V8, P322, DOI 10.1107/S0909049500016964; Rech B, 2013, TRANSITION TO RENEWABLE ENERGY SYSTEMS, P283; Sze S M, 2007, PHYS SEMICONDUCTOR D, P7; Torquato S., 2001, RANDOM HETEROGENEOUS, P210; Toyama T, 2005, J APPL PHYS, V98, DOI 10.1063/1.1953865; Toyama T., 2013, 23 INT PHOT SOL EN C, P1123; Toyama T., PHYS STATUS SOLIDI C; Toyama T, 2014, THIN SOLID FILMS, V555, P148, DOI 10.1016/j.tsf.2013.05.141; Valentini Matteo, 2011, Proceedings of the 26th European International Conference on Photovoltaic Solar Energy; Wakisaka Y., UNPUB; Yu P. Y., 1996, FUNDAMENTALS SEMICON, P234; Zhang YB, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.075127	46	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	JAN	2015	54	1							015503	10.7567/JJAP.54.015503		7	Physics, Applied	Physics	AX5HT	WOS:000346957900026		
J	Umehara, T; Iinuma, S; Sadono, A; Kurokawa, Y; Yamada, A				Umehara, Takeshi; Iinuma, Shohei; Sadono, Adiyudha; Kurokawa, Yasuyoshi; Yamada, Akira			Electrical characterization of Cu(In, Ga)Se-2 thin films peeled off from Mo-coated soda-lime glass substrate by AC Hall measurement	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							CU(IN,GA)SE-2 SOLAR-CELLS; PERFORMANCE; SODIUM; MOSE2	We have developed a new evaluation method for electrical properties of Cu(In, Ga)Se-2 (CIGS) grown on a Mo-coated soda-lime glass (SLG). The method consists of the peel-off process and the AC Hall measurement, which enables us to evaluate CIGS films grown on the Mo electrode. It was found, from the measurement, that the hole concentration of CIGS grown on a Mo-coated SLG was approximately two orders of magnitude higher than that on a SLG, suggesting the Na-doping effect. Furthermore, the hole mobility of 0.47cm(2)/(V.s) was simultaneously measured, even though the film was deposited on the Mo electrode. (C) 2015 The Japan Society of Applied Physics	[Umehara, Takeshi; Iinuma, Shohei; Sadono, Adiyudha; Kurokawa, Yasuyoshi; Yamada, Akira] Tokyo Inst Technol, Dept Phys Elect, Meguro Ku, Tokyo 1528552, Japan; [Yamada, Akira] Tokyo Inst Technol, Photovolta Res Ctr PVREC, Meguro Ku, Tokyo 1528552, Japan	Umehara, T (reprint author), Tokyo Inst Technol, Dept Phys Elect, Meguro Ku, Tokyo 1528552, Japan.	umehara.t.aa@m.titech.ac.jp; yamada.a.ac@m.titech.ac.jp	Kurokawa, Yasuyoshi/P-1057-2014		New Energy and Industrial Technology Development Organization (NEDO) under the Ministry of Economy, Trade and Industry of Japan	This work was supported by the New Energy and Industrial Technology Development Organization (NEDO) under the Ministry of Economy, Trade and Industry of Japan. The authors wish to thank Dr. T. Minemoto of Ritsumeikan University for his advice on CIGS peel-off techniques.	Wang XG, 2005, SOL ENERG MAT SOL C, V88, P65, DOI 10.1016/j.solmat.2004.06.020; Oonishi S, 2011, THIN SOLID FILMS, V519, P7347, DOI 10.1016/j.tsf.2010.12.223; Zhang L, 2009, SOL ENERG MAT SOL C, V93, P114, DOI 10.1016/j.solmat.2008.09.002; Dinca SA, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.235201; NOUFI R, 1984, APPL PHYS LETT, V45, P668, DOI 10.1063/1.95350; Nakada T, 1997, JPN J APPL PHYS 1, V36, P732, DOI 10.1143/JJAP.36.732; Bodegard M, 1999, SOL ENERG MAT SOL C, V58, P199, DOI 10.1016/S0927-0248(98)00203-7; Lee J, 2005, THIN SOLID FILMS, V480, P336, DOI 10.1016/j.tsf.2004.11.087; Kronik L, 1998, ADV MATER, V10, P31, DOI 10.1002/(SICI)1521-4095(199801)10:1<31::AID-ADMA31>3.0.CO;2-3; Cho DH, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4733679; Zhu XL, 2012, SOL ENERG MAT SOL C, V101, P57, DOI 10.1016/j.solmat.2012.02.015; Schroeder DJ, 1998, J APPL PHYS, V83, P1519, DOI 10.1063/1.366860; Niles DW, 1997, J VAC SCI TECHNOL A, V15, P3044, DOI 10.1116/1.580902; Islam MM, 2009, J CRYST GROWTH, V311, P2212, DOI 10.1016/j.jcrysgro.2008.12.005; Abou-Ras D, 2005, THIN SOLID FILMS, V480, P433, DOI 10.1016/j.tsf.2004.11.098; Lindemuth J, 2011, PROC SPIE, V8110, DOI 10.1117/12.893100; Contreras M. A., 1997, P 26 IEEE PHOT SPEC, P359; Marron DF, 2005, J APPL PHYS, V97, DOI 10.1063/1.1891274; Kawamura M, 2009, J CRYST GROWTH, V311, P753, DOI 10.1016/j.jcrysgro.2008.09.091; Mesa F, 2010, THIN SOLID FILMS, V518, P1764, DOI 10.1016/j.tsf.2009.09.028; Minemoto T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.04DP06; Osada S, 2011, SOL ENERG MAT SOL C, V95, P223, DOI 10.1016/j.solmat.2010.03.033; Rusu M, 2001, SOL ENERG MAT SOL C, V70, P175, DOI 10.1016/S0927-0248(01)00023-X; Weinhardt L, 2007, THIN SOLID FILMS, V515, P6119, DOI 10.1016/j.tsf.2006.12.109; Yoon J. - H., 2010, P 2010 35 IEEE PHOT	25	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	JAN	2015	54	1							018001	10.7567/JJAP.54.018001		3	Physics, Applied	Physics	AX5HT	WOS:000346957900036		
J	Yasuda, Y; Tokoo, N; Morita, T; Suzuki, K				Yasuda, Yusuke; Tokoo, Naoya; Morita, Toshiaki; Suzuki, Kazuhiro			Reliability of sintered silver layer obtained using silver-oxide paste in power cycling test	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							NANOPARTICLES; ELECTRONICS; PARTICLES	To investigate the reliability of a sintered silver bonding layer obtained using silver-oxide paste, a power cycling test was performed. The module obtained using silver-oxide paste achieved 73,400 power cycles in a test with T-jmax = 150 degrees C (Delta T-j = 120 degrees C), while a soldered (Pb3.5Sn1.5Ag) power module failed at 24,600 cycles. After the cycling test, a crack was observed in the Pb3.5Sn1.5Ag solder layer but not in the sintered silver layer. These results reveal that the sintered silver layer obtained using silver-oxide paste can treble the lifetime of a power module. (C) 2015 The Japan Society of Applied Physics	[Yasuda, Yusuke; Tokoo, Naoya; Morita, Toshiaki; Suzuki, Kazuhiro] Hitachi Ltd, Hitachi Res Lab, Hitachi, Ibaraki 3191292, Japan	Yasuda, Y (reprint author), Hitachi Ltd, Hitachi Res Lab, Hitachi, Ibaraki 3191292, Japan.	yusuke.yasuda.jf@hitachi.com					Neudeck PG, 2002, P IEEE, V90, P1065, DOI 10.1109/JPROC.2002.1021571; Scheuermann U, 2009, MICROELECTRON RELIAB, V49, P1319, DOI 10.1016/j.microrel.2009.06.045; Hu A, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3502604; Ide E, 2005, ACTA MATER, V53, P2385, DOI 10.1016/j.actamat.2005.01.047; Cooper JA, 2002, P IEEE, V90, P956, DOI 10.1109/JPROC.2002.1021561; Bai JGF, 2006, IEEE T DEVICE MAT RE, V6, P436, DOI 10.1109/TDMR.2006.882196; Held M, 1997, P IEEE POW EL DRIV S, P425, DOI DOI 10.1109/PEDS.1997.618742; Hunger T., P 13 EUR C POW EL AP, P1; Lide D. R., 2007, HDB CHEM PHYS, P215; Morita T, 2008, MATER TRANS, V49, P2875, DOI 10.2320/matertrans.MRA2008269; Scheuermann U., 2008, P INT S POW SEM DEV, P12; Siow KS, 2014, J ELECTRON MATER, V43, P947, DOI 10.1007/s11664-013-2967-3; U. Scheuermann, 2012, P C INT POW EL SYST, P132; Yasuda Y, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.025001; Yasuda Y, 2014, J THERM ANAL CALORIM, V115, P1583, DOI 10.1007/s10973-013-3420-9	15	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	JAN	2015	54	1							010302	10.7567/JJAP.54.010302		3	Physics, Applied	Physics	AX5HT	WOS:000346957900002		
J	Yokoyama, H; Hoshi, T				Yokoyama, Haruki; Hoshi, Takuya			P-type conductivity control of Si-doped GaAsSb layers grown by metalorganic chemical vapor deposition	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							MOLECULAR-BEAM EPITAXY; HETEROJUNCTION BIPOLAR-TRANSISTORS; CARBON-TETRACHLORIDE; TUNNEL-JUNCTION; PHASE EPITAXY; INP; DIFFUSION; MOCVD; PHOTOLUMINESCENCE; HETEROSTRUCTURES	The electrical characteristics of Si-doped GaAsSb layers grown at various growth temperatures from 530 to 630 degrees C by metalorganic chemical vapor deposition (MOCVD), are investigated. When the substrate temperature is 530 degrees C, the conductivity of Si-doped GaAsSb layers is n-type. In contrast, Si-doped GaAsSb layers grown at higher temperature (580 degrees C) show p-type conductivity. Moreover, the p-type carrier concentration in these layers increases proportionally to the increase of the disilane (Si2H6) flow rate. This is the first time that p-type doping into GaAsSb layers has been achieved by MOCVD using Si as a dopant. (C) 2015 The Japan Society of Applied Physics	[Yokoyama, Haruki; Hoshi, Takuya] NTT Device Technol Labs, Atsugi, Kanagawa 2430198, Japan	Yokoyama, H (reprint author), NTT Device Technol Labs, Atsugi, Kanagawa 2430198, Japan.	yokoyama.haruki@lab.ntt.co.jp					Agert C, 2002, SEMICOND SCI TECH, V17, P39, DOI 10.1088/0268-1242/17/1/307; Ulloa JM, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2741608; Yu T, 2013, IEEE ELECTR DEVICE L, V34, P1503, DOI 10.1109/LED.2013.2287237; Hu J, 1998, APPL PHYS LETT, V73, P2799, DOI 10.1063/1.122594; SCHUBERT EF, 1990, J APPL PHYS, V67, P1969, DOI 10.1063/1.345576; CHERNG MJ, 1986, J ELECTRON MATER, V15, P79, DOI 10.1007/BF02649907; Watkins SP, 2000, J CRYST GROWTH, V221, P59, DOI 10.1016/S0022-0248(00)00649-7; Oh JH, 1997, JPN J APPL PHYS 1, V36, P6300, DOI 10.1143/JJAP.36.6300; Schimper HJ, 2006, J CRYST GROWTH, V287, P642, DOI 10.1016/j.jcrysgro.2005.10.121; MOISON JM, 1989, PHYS REV B, V40, P6149, DOI 10.1103/PhysRevB.40.6149; Verreck D, 2014, J APPL PHYS, V115, DOI 10.1063/1.4864128; Hakala M, 2002, J APPL PHYS, V91, P4988, DOI 10.1063/1.1462844; Bolognesi CR, 2001, IEEE T ELECTRON DEV, V48, P2631, DOI 10.1109/16.960389; Bolognesi CR, 1999, IEEE ELECTR DEVICE L, V20, P155, DOI 10.1109/55.753751; CHEN CY, 1995, APPL PHYS LETT, V67, P1402, DOI 10.1063/1.114507; CUNNINGHAM BT, 1989, APPL PHYS LETT, V54, P1905, DOI 10.1063/1.101237; CUNNINGHAM BT, 1990, APPL PHYS LETT, V56, P836, DOI 10.1063/1.103321; Detz H, 2011, J CRYST GROWTH, V323, P42, DOI 10.1016/j.jcrysgro.2010.10.014; Dvorak N. W., 2000, J VAC SCI TECHNOL A, V18, P761; ELLIOTT KR, 1982, APPL PHYS LETT, V40, P898, DOI 10.1063/1.92940; Hoshi T, 2013, J CRYST GROWTH, V380, P197, DOI 10.1016/j.jcrysgro.2013.06.014; KLEM JF, 1991, J CRYST GROWTH, V111, P628, DOI 10.1016/0022-0248(91)91053-D; KOBAYASHI N, 1987, APPL PHYS LETT, V50, P1435, DOI 10.1063/1.97846; McDermott BT, 1996, APPL PHYS LETT, V68, P1386, DOI 10.1063/1.116088; Mohata D, 2012, IEEE ELECTR DEVICE L, V33, P1568, DOI 10.1109/LED.2012.2213333; NORDELL N, 1990, J APPL PHYS, V67, P778, DOI 10.1063/1.345731; Oda Y, 2003, APPL SURF SCI, V216, P532, DOI 10.1016/S0169-4332(03)00490-2; Oda Y, 2004, J CRYST GROWTH, V261, P393, DOI 10.1016/j.jcrysgro.2003.11.033; ONUMA T, 1982, J ELECTROCHEM SOC, V129, P837, DOI 10.1149/1.2123983; SANDHU A, 1988, ELECTRON LETT, V24, P451, DOI 10.1049/el:19880305; Seidel U, 2007, J CRYST GROWTH, V298, P777, DOI 10.1016/j.jcrysgro.2006.10.132; SEKI Y, 1978, J APPL PHYS, V49, P822, DOI 10.1063/1.324610; VANHOVE JM, 1994, J VAC SCI TECHNOL B, V12, P1200, DOI 10.1116/1.587043; VEUHOFF E, 1985, J ELECTROCHEM SOC, V132, P1958, DOI 10.1149/1.2114261; Zolper J. C., 1994, 24 IEEE PHOT SPEC C	35	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	JAN	2015	54	1							015506	10.7567/JJAP.54.015506		4	Physics, Applied	Physics	AX5HT	WOS:000346957900029		
J	Yoshida, T				Yoshida, Toshiyuki			Effects of natural and anneal-induced oxides on atomic-layer-deposition Al2O3/In0.53Ga0.47As interfaces	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							AL2O3; MOS; PERFORMANCE; SYSTEM; IMPACT; CMOS	To investigate the effects of the surface residual oxide on the interface properties of atomic-layer-deposition (ALD) Al2O3/In0.53Ga0.47As structures, we prepared various types of pre-ALD surfaces with different ratios and amounts of oxide components. All of the surfaces showed high mid-gap state densities, and the existence of the As5+ component lent a small advantage to the capacitance-voltage (C-V) behavior. By interrupting the ALD process and applying the annealing process in N-2 or O-2 atmosphere, additional oxide components were introduced extrinsically, which increased the mid-gap state density. The post-metallization annealing process was effective for removing the mid-gap states originating from both the native and extrinsic oxide components. (C) 2015 The Japan Society of Applied Physics	Shimane Univ, Interdisciplinary Grad Sch Sci & Engn, Matsue, Shimane 6908504, Japan	Yoshida, T (reprint author), Shimane Univ, Interdisciplinary Grad Sch Sci & Engn, Matsue, Shimane 6908504, Japan.	yosisi@ecs.shimane-u.ac.jp					Ahn J, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4850520; Alian A, 2012, IEEE ELECTR DEVICE L, V33, P1544, DOI 10.1109/LED.2012.2212692; Chen HP, 2012, IEEE T ELECTRON DEV, V59, P2383, DOI 10.1109/TED.2012.2205255; Hinkle CL, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2883956; Takagi S, 2008, IEEE T ELECTRON DEV, V55, P21, DOI 10.1109/TED.2007.911034; Krylov I, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4704925; Ye PD, 2008, J VAC SCI TECHNOL A, V26, P697, DOI 10.1116/1.2905246; Takagi S, 2013, SOLID STATE ELECTRON, V88, P2, DOI 10.1016/j.sse.2013.04.020; Yuan Y, 2012, IEEE T ELECTRON DEV, V59, P2100, DOI 10.1109/TED.2012.2197000; Djara V, 2013, MICROELECTRON ENG, V109, P182, DOI 10.1016/j.mee.2013.03.026; Djara V, 2012, IEEE T ELECTRON DEV, V59, P1084, DOI 10.1109/TED.2012.2185242; Mukherjee C, 2014, ACS APPL MATER INTER, V6, P3263, DOI 10.1021/am405019d; Chagarov EA, 2009, SURF SCI, V603, P3191, DOI 10.1016/j.susc.2009.08.009; Yoshida T, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4753927; Ahn J, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4818330; Hinkle CL, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2801512; Jevasuwan W, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.065701; Jevasuwan W, 2012, MATERIALS, V5, P404, DOI 10.3390/ma5030404; Kim EJ, 2009, J APPL PHYS, V106, DOI 10.1063/1.3266006; Klejna S, 2011, J NANOSCI NANOTECHNO, V11, P8246, DOI 10.1166/jnn.2011.5044; Krylov I, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4816588; Lamagna L, 2011, MICROELECTRON ENG, V88, P431, DOI 10.1016/j.mee.2010.10.035; SAKAI T, 1993, JPN J APPL PHYS 1, V32, P4005, DOI 10.1143/JJAP.32.4005; Shekhter P, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3664778; Trinh HD, 2013, J ELECTRON MATER, V42, P2439, DOI 10.1007/s11664-013-2616-x; Yoshida T, 1999, JPN J APPL PHYS 1, V38, P2349, DOI 10.1143/JJAP.38.2349; Zhou XJ, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.104201	27	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	JAN	2015	54	1							010301	10.7567/JJAP.54.010301		4	Physics, Applied	Physics	AX5HT	WOS:000346957900001		
J	Kimura, Y; Chai, YW				Kimura, Yoshisato; Chai, Yaw-Wang			Ordered Structures and Thermoelectric Properties of MNiSn (M = Ti, Zr, Hf)-Based Half-Heusler Compounds Affected by Close Relationship with Heusler Compounds	JOM			English	Article							THERMAL-CONDUCTIVITY; TRANSPORT-PROPERTIES; HIGH-PERFORMANCE; TINISN ALLOYS; N-TYPE; P-TYPE; M-A; M-B; ZRNISN; FIGURE	Half-Heusler compounds are excellent thermoelectric materials. A characteristic of the half-Heusler-type ordered structure is the vacancy site that occupies one-fourth of all the lattice points. Therefore, a half-Heusler ABX phase (where A and B are typically transition metal elements, such as Ti, Zr, and Hf, and X represents a half-metal element such as Sn or Sb) has a crystallographically close relationship with a Heusler AB(2)X phase in the sense that the vacancy site in the half-Heusler phase is filled with B atoms in the Heusler phase. The thermoelectric properties are improved or affected by point lattice defects related to the vacancy site and the B site, such as the antisite atom B in the vacancy site, vacancies in the B site, and vacancy-site occupancy by quaternary C atoms. A modulated-like nanostructure due to point defects regarding vacancies and Ni atoms is formed for an instance in ZrNiSn alloys even close to the stoichiometric composition. Ni-rich nanoclusters are locally formed by excessive Ni antisite atoms in the vacancy site, which work as precursors of Heusler precipitates (TiNi2Sn, ZrNi2Sn, and so forth). The vacancy-site occupation in ZrNiSn with Co and Ir results in the drastic conversion of thermoelectric properties from n type to p type, and the effective reduction of the lattice thermal conductivity.	[Kimura, Yoshisato; Chai, Yaw-Wang] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Mat Sci & Engn, Yokohama, Kanagawa 2268502, Japan	Kimura, Y (reprint author), Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Mat Sci & Engn, Yokohama, Kanagawa 2268502, Japan.	kimura.y.ac@m.titech.ac.jp			Japan Society for Promotion of Science (JSPS) [23246120]; Advanced Low Carbon Technology Research and Development Program-Japan Science and Technology Agency (JST-ALCA)	A series of research works related to the present article was partially supported by Grants-in-Aid for Scientific Research No. 23246120-Japan Society for Promotion of Science (JSPS), and Advanced Low Carbon Technology Research and Development Program-Japan Science and Technology Agency (JST-ALCA). The authors are deeply grateful to the group members.	Abeles B., 1963, PHYS REV B, V29, P1906; Anderson D.J., 2005, 3 INT EN CONV ENG C, V3, P1681; SLACK GA, 1957, PHYS REV, V105, P829, DOI 10.1103/PhysRev.105.829; Kimura Y, 2010, ACTA MATER, V58, P4354, DOI 10.1016/j.actamat.2010.04.028; Sharp JW, 2001, PHYS STATUS SOLIDI A, V187, P507, DOI 10.1002/1521-396X(200110)187:2<507::AID-PSSA507>3.3.CO;2-D; OGUT S, 1995, PHYS REV B, V51, P10443, DOI 10.1103/PhysRevB.51.10443; Kirievsky K, 2013, J SOLID STATE CHEM, V203, P247, DOI 10.1016/j.jssc.2013.04.032; Hohl H, 1999, J PHYS-CONDENS MAT, V11, P1697, DOI 10.1088/0953-8984/11/7/004; Yu C, 2009, ACTA MATER, V57, P2757, DOI 10.1016/j.actamat.2009.02.026; ALIEV FG, 1989, Z PHYS B CON MAT, V75, P167, DOI 10.1007/BF01307996; Katayama T, 2003, J ELECTRON MATER, V32, P1160, DOI 10.1007/s11664-003-0006-5; Makongo JPA, 2011, J AM CHEM SOC, V133, P18843, DOI 10.1021/ja206491j; Kimura Y, 2006, MATER RES SOC SYMP P, V886, P331; Chai YW, 2013, ACTA MATER, V61, P6684, DOI 10.1016/j.actamat.2013.07.030; Xie WJ, 2010, ACTA MATER, V58, P4705, DOI 10.1016/j.actamat.2010.05.005; Uher C, 1999, PHYS REV B, V59, P8615, DOI 10.1103/PhysRevB.59.8615; Joshi G, 2011, ADV ENERGY MATER, V1, P643, DOI 10.1002/aenm.201100126; Kimura Y, 2009, J ELECTRON MATER, V38, P934, DOI 10.1007/s11664-009-0710-x; Makongo JPA, 2011, J SOLID STATE CHEM, V184, P2948, DOI 10.1016/j.jssc.2011.08.036; Stadnyk Y, 2005, J ALLOY COMPD, V387, P251, DOI 10.1016/j.jallcom.2004.06.052; Bhattacharya S, 2002, APPL PHYS LETT, V81, P43, DOI 10.1063/1.1488698; Preston GD, 1938, NATURE, V142, P570, DOI 10.1038/142570a0; Muta H, 2006, MATER TRANS, V47, P1453, DOI 10.2320/matertrans.47.1453; Katsuyama S, 2004, J ALLOY COMPD, V385, P232, DOI 10.1016/j.jallcom.2004.02.061; Culp SR, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2168019; Yan XA, 2011, NANO LETT, V11, P556, DOI 10.1021/nl104138t; Graf T, 2011, PROG SOLID STATE CH, V39, P1, DOI 10.1016/j.progsolidstchem.2011.02.001; Guinier A, 1938, NATURE, V142, P569, DOI 10.1038/142569b0; Hohl H, 1998, J PHYS-CONDENS MAT, V10, P7843, DOI 10.1088/0953-8984/10/35/016; Qiu PF, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3396981; Larson P, 2000, PHYS REV B, V62, P12754, DOI 10.1103/PhysRevB.62.12754; Kimura Y, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2828713; Poon SJ, 2011, J MATER RES, V26, P2795, DOI 10.1557/jmr.2011.329; Sakurada S, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1868063; Bhattacharya S, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.184203; Kimura Y, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2364721; Chai YW, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3679377; Romaka VV, 2013, INTERMETALLICS, V35, P45, DOI 10.1016/j.intermet.2012.11.022; Xia Y, 2001, J PHYS-CONDENS MAT, V13, P77, DOI 10.1088/0953-8984/13/1/308; Yang JH, 2006, MRS BULL, V31, P224, DOI 10.1557/mrs2006.49; Yu C, 2012, J MATER RES, V27, P2457, DOI 10.1557/jmr.2012.171; Asami C, 2009, MATER RES SOC SYMP P, V1128, P179; Bennett GL, 1996, PROCEEDINGS ICT '96 - FIFTEENTH INTERNATIONAL CONFERENCE ON THERMOELECTRICS, P357; Chai YW, 2014, SCRIPTA MATER, V83, P13, DOI 10.1016/j.scriptamat.2014.03.025; Chen L.D., 2006, J APPL PHYS, V99; Culp SR, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2959103; Goldsmid H. J., 2001, Proceedings ICT2001. 20 International Conference on Thermoelectrics (Cat. No.01TH8589), DOI 10.1109/ICT.2001.979602; Guinier A, 1938, CR HEBD ACAD SCI, V206, P1641; Hayashi Y., 2004, ADV MAT ENERGY CONVE, VII, P367; Hazama H, 2011, J APPL PHYS, V110, DOI 10.1063/1.3633518; Kawano K, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2769398; Kawano K, 2008, J APPL PHYS, V104, DOI 10.1063/1.2956699; Kenjo T., 2010, MRS S P, V1218; Kim S.W., 2008, INTERMETALLICS, V15, P349; Kim S.W., 2004, ADV MAT ENERGY CONVE, VII, P377; Kimura Y., 2006, THESIS TOKYO I TECHN; Kimura Y, 2010, MATER SCI FORUM, V654-656, P2795, DOI 10.4028/www.scientific.net/MSF.654-656.2795; Kimura Y., 2014, 23246120 JAP SOC PRO; Kimura Y, 2009, MATER RES SOC SYMP P, V1128, P15; Kimura Y, 2011, MRS P, V1295, P335; Kimura Y., 2006, P 25 INT C THER, P115; Miyamoto K, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.081901; Miyazaki H, 2014, MATER TRANS, V55, P1209, DOI 10.2320/matertrans.E-M2014803; Muta H., 2006, P 25 INT C THERM VIE, P120; Muta H., 2005, P 24 INT C THERM ICT, P339; Ponnambalam V, 2008, J APPL PHYS, V103, DOI 10.1063/1.2896591; Preston G.D., 1938, P ROY SOC LOND A MAT, V167, P534; Rowe D.M., 1995, CRC HDB THERMOELECTR; Sekimoto T, 2006, J ALLOY COMPD, V407, P326, DOI 10.1016/j.jallcom.2005.06.036; Stadnyk Y.V., 1991, NEORGAN MAT, V27, P2209; Villars P., 1997, PEARSONS HDB DESK ED; Westbrook J. H., 1995, INTERMETALLIC COMPOU, V1; Westbrook J.H., 1995, INTERMETALLIC COMPOU, V2; Wu T, 2007, J APPL PHYS, V102, DOI 10.1063/1.2809377; Zhu ZY, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.113201	75	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1047-4838	1543-1851		JOM-US	JOM	JAN	2015	67	1					233	245		10.1007/s11837-014-1233-3		13	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering; Mineralogy; Mining & Mineral Processing	Materials Science; Metallurgy & Metallurgical Engineering; Mineralogy; Mining & Mineral Processing	AX8JE	WOS:000347155100031		
J	Honda, N				Honda, Nobuhiro			Double solid twistor spaces II: General case	JOURNAL FUR DIE REINE UND ANGEWANDTE MATHEMATIK			English	Article							PROJECTIVE-PLANES; CONNECTED SUM	In this paper we investigate Moishezon twistor spaces which have a structure of double covering over a very simple rational threefold. These spaces can be regarded as a direct generalization of the twistor spaces studied in [J. Differential Geom. 36 (1992), 451-491] and [Compos. Math. 82 (1992), 25-55] to the case of arbitrary signature. In particular, the branch divisor of the double covering is a cut of the rational threefold by a single quartic hypersurface. We determine a defining equation of the hypersurface in an explicit form. We also show that these twistor spaces interpolate LeBrun twistor spaces and the twistor spaces constructed in [J. Differential Geom. 82 (2009), 411-444].	Tohoku Univ, Inst Math, Sendai, Miyagi 980, Japan	Honda, N (reprint author), Tohoku Univ, Inst Math, Sendai, Miyagi 980, Japan.	honda@math.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan	The author was partially supported by the Grant-in-Aid for Young Scientists (B), The Ministry of Education, Culture, Sports, Science and Technology, Japan.	HITCHIN NJ, 1981, P LOND MATH SOC, V43, P133; LEBRUN C, 1991, J DIFFER GEOM, V34, P223; Campana F, 1998, MATH Z, V229, P137, DOI 10.1007/PL00004646; HITCHIN NJ, 1980, P ROY SOC LOND A MAT, V370, P173, DOI 10.1098/rspa.1980.0028; Honda N, 2008, INVENT MATH, V174, P463, DOI 10.1007/s00222-008-0139-5; Honda N., J ALGEBRAIC IN PRESS; Honda N, 2009, J DIFFER GEOM, V82, P411; KREUSSLER B, 1992, COMPOS MATH, V82, P25; PEDERSEN H, 1994, P AM MATH SOC, V121, P859, DOI 10.2307/2160286; POON YS, 1986, J DIFFER GEOM, V24, P97; POON YS, 1992, J DIFFER GEOM, V36, P451	11	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0075-4102	1435-5345		J REINE ANGEW MATH	J. Reine Angew. Math.	JAN	2015	698						181	220		10.1515/crelle-2013-0003		40	Mathematics	Mathematics	AX8UY	WOS:000347185000007		
J	Gallego-Jutgla, E; Sole-Casals, J; Vialatte, FB; Dauwels, J; Cichocki, A				Gallego-Jutgla, Esteve; Sole-Casals, Jordi; Vialatte, Francois-Benoit; Dauwels, Justin; Cichocki, Andrzej			A Theta-Band EEG Based Index for Early Diagnosis of Alzheimer's Disease	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Alzheimer's disease; data interpretation; electroencephalography; mild cognitive impairment; phase synchronization	MILD COGNITIVE IMPAIRMENT; SYNCHRONIZATION; COHERENCE; RHYTHMS	Despite recent advances, early diagnosis of Alzheimer's disease (AD) from electroencephalography (EEG) remains a difficult task. In this paper, we offer an added measure through which such early diagnoses can potentially be improved. One feature that has been used for discriminative classification is changes in EEG synchrony. So far, only the decrease of synchrony in the higher frequencies has been deeply analyzed. In this paper, we investigate the increase of synchrony found in narrow frequency ranges within the. band. This particular increase of synchrony is used with the well-known decrease of synchrony in the alpha band to enhance detectable differences between AD patients and healthy subjects. We propose a new synchrony ratio that maximizes the differences between two populations. The ratio is tested using two different data sets, one of them containing mild cognitive impairment patients and healthy subjects, and another one, containing mild AD patients and healthy subjects. The results presented in this paper show that classification rate is improved, and the statistical difference between AD patients and healthy subjects is increased using the proposed ratio.	[Gallego-Jutgla, Esteve; Sole-Casals, Jordi] Univ Vic, Cent Univ Catalonia, Data & Signal Proc Grp, Vic 08500, Catalonia, Spain; [Vialatte, Francois-Benoit] ESPCI ParisTech, Lab SIGMA, Paris, France; [Dauwels, Justin] Nanyang Technol Univ, Singapore 639798, Singapore; [Cichocki, Andrzej] BSI RIKEN ABSP Lab, Wako, Saitama, Japan; [Cichocki, Andrzej] Polish Acad Sci, Syst Res Inst, PL-01447 Warsaw, Poland	Sole-Casals, J (reprint author), Univ Vic, Cent Univ Catalonia, Data & Signal Proc Grp, Vic 08500, Catalonia, Spain.	jordi.sole@uvic.cat	Sole-Casals, Jordi/B-7754-2008	Sole-Casals, Jordi/0000-0002-6534-1979	Esteve Gallego-Jutgla thanks the University of Vic - Central University of Catalonia (UVic-UCC); University of Vic - Central University of Catalonia [R0947]	Esteve Gallego-Jutgla thanks the University of Vic - Central University of Catalonia (UVic-UCC) for partially supporting this project under a PhD grant ("Amb el suport de l'ajut predoctoral de la Universitat de Vic - Universitat Central de Catalunya"). Jordi Sole-Casals and Esteve Gallego-Jutgla acknowledge support from the University of Vic - Central University of Catalonia (grant R0947). The authors would like to acknowledge anonymous reviewers for their detailed and helpful comments to the manuscript and to V. Zaiats for his help in reviewing the final version of the manuscript.	Alzheimer's Association, 2014, ALZHEIMERS DEMENT, V10, pe47, DOI DOI 10.1016/J.JALZ.2014.02.001; Dauwels J, 2010, NEUROIMAGE, V49, P668, DOI 10.1016/j.neuroimage.2009.06.056; Koenig T, 2005, NEUROBIOL AGING, V26, P165, DOI 10.1016/j.neurobiolaging.2004.03.008; Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P708, DOI 10.1016/j.clinph.2004.09.022; Knyazeva MG, 2010, NEUROBIOL AGING, V31, P1132, DOI 10.1016/j.neurobiolaging.2008.07.019; Jeong JS, 2004, CLIN NEUROPHYSIOL, V115, P1490, DOI 10.1016/j.clinph.2004.01.001; Dauwels J, 2010, CURR ALZHEIMER RES, V7, P487; Locatelli T, 1998, ELECTROEN CLIN NEURO, V106, P229, DOI 10.1016/S0013-4694(97)00129-6; Toth B, 2014, INT J PSYCHOPHYSIOL, V92, P1, DOI 10.1016/j.ijpsycho.2014.02.001; Babiloni C, 2011, J ALZHEIMERS DIS, V26, P201, DOI 10.3233/JAD-2011-0051; Vialatte FB, 2009, LECT NOTES COMPUT SC, V5507, P979, DOI 10.1007/978-3-642-03040-6_119; Stam CJ, 2006, NEUROIMAGE, V32, P1335, DOI 10.1016/j.neuroimage.2006.05.033; Kramer MA, 2007, INT J NEURAL SYST, V17, P61, DOI 10.1142/S0129065707000932; Adler G, 2003, J NEURAL TRANSM, V110, P1051, DOI 10.1007/s00702-003-0024-8; Babiloni C, 2006, BRAIN RES BULL, V69, P63, DOI 10.1016/j.brainresbull.2005.10.013; Dauweis J., 2011, INT J ALZHEIMERS DIS, V2011, DOI [10.4061/2011/539621, DOI 10.4061/2011/539621]; Dauwels J, 2009, IEEE ENG MED BIO, P2224, DOI 10.1109/IEMBS.2009.5334862; GALLEGOJUTGLA E, 2012, ENG MED BIOL SOC EMB, P4266; Gallego-Jutgla E, 2013, FRONT ARTIF INTEL AP, V256, P167, DOI 10.3233/978-1-61499-320-9-167; Hsiao FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068792; Knyazeva MG, 2013, NEUROBIOL AGING, V34, P694, DOI 10.1016/j.neurobiolaging.2012.07.012; Nunez PL, 2006, ELECT FIELDS BRAIN N; van der Hiele K, 2007, CLIN NEUROPHYSIOL, V118, P1931, DOI 10.1016/j.clinph.2007.05.070; Vecchio F., 2013, CLIN NEUROPHYSIOL, V62, P223, DOI [10.1016/B978-0-7020-5307-8.00015-6, DOI 10.1016/B978-0-7020-5307-8.00015-6]; Yi R, 2014, CLIN EEG NEUROSCI, DOI 10.1177-1550059413502779	25	1	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2015	43	4					1175	1184		10.3233/JAD-140468		10	Neurosciences	Neurosciences & Neurology	AX3RU	WOS:000346857400008		
J	Jung, CG; Uhm, KO; Horike, H; Kim, MJ; Misumi, S; Ishida, A; Ueda, Y; Choi, EK; Kim, YS; Michikawa, M; Hida, H				Jung, Cha-Gyun; Uhm, Kyung-Ok; Horike, Hirofumi; Kim, Mi-Jeong; Misumi, Sachiyo; Ishida, Akimasa; Ueda, Yoshimoto; Choi, Eun-Kyoung; Kim, Yong-Sun; Michikawa, Makoto; Hida, Hideki			Auraptene Increases the Production of Amyloid-beta via c-Jun N-Terminal Kinase-Dependent Activation of gamma-Secretase	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Alzheimer's disease; amyloid-beta production; auraptene; c-Jun N-terminal kinase; gamma-secretase	FAMILIAL ALZHEIMERS-DISEASE; NECROSIS-FACTOR-ALPHA; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PRECURSOR PROTEIN; IN-VIVO; CITRUS COUMARIN; TRANSGENIC MICE; APP CLEAVAGE; EXPRESSION; PHOSPHORYLATION	Amyloid-beta (A beta) peptide plays a major role in the pathogenesis of Alzheimer's disease (AD), and is generated by beta- and gamma-secretase-mediated proteolytic processing of amyloid-beta protein precursor (A beta PP). In the present study, we investigated the effect of 118 natural compounds on A beta production in the medium of HEK293 cells stably expressing human A beta PP695 (HEK293-A beta PP) using A beta 42 sandwich ELISA to find natural compounds that can modulate A beta production. We found that a coumarin derivative of citrus fruits, auraptene, increased A beta production. Treatment of HEK293-A beta PP cells and rat primary cortical neurons with auraptene significantly increased the secretion of A beta 40, A beta 42, and the A beta 42/40 ratio. However, auraptene did not change the protein levels of the A beta PP processing enzymes, a disintegrin and metalloproteinases 10 (ADAM10, alpha-secretase), beta-site A beta PP cleaving enzyme-1 (BACE-1, beta-secretase), and presenilin 1 (PS1, gamma-secretase component). Auraptene increased the activity of gamma-secretase but not that of alpha- and beta-secretase. Furthermore, auraptene enhanced gamma-secretase-mediated production of A beta from A beta PP or A beta PP-C99, but not through alpha- and beta-secretase. Auraptene also phosphorylated c-Jun N-terminal kinase (JNK), and pretreatment with the JNK inhibitor, SP600125, reduced auraptene-induced gamma-secretase activity. Overall, our results suggest that auraptene-mediated activation of JNK may contribute to the production of A beta by promoting gamma-secretase activity.	[Jung, Cha-Gyun; Misumi, Sachiyo; Ishida, Akimasa; Ueda, Yoshimoto; Hida, Hideki] Nagoya City Univ, Grad Sch Med Sci, Dept Neurophysiol & Brain Sci, Nagoya, Aichi 4678601, Japan; [Jung, Cha-Gyun; Uhm, Kyung-Ok; Horike, Hirofumi; Kim, Mi-Jeong] NCGG, Res Inst, Dept Alzheimers Dis Res, Obu, Aichi, Japan; [Choi, Eun-Kyoung] Hallym Univ, Ilsong Inst Life Sci, Lab Cellular Aging & Neurodegenerat, Anyang, Gyeonggi Do, South Korea; [Kim, Yong-Sun] Hallym Univ, Coll Med, Dept Microbiol, Chunchon, Gangwon Do, South Korea; [Michikawa, Makoto] Nagoya City Univ, Grad Sch Med Sci, Dept Biochem, Nagoya, Aichi 4678601, Japan	Jung, CG (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Neurophysiol & Brain Sci, Mizuho Ku, 1 Kawasumi, Nagoya, Aichi 4678601, Japan.	jung@med.nagoya-cu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan [H23-005]; Ono medical research foundation	This work was supported by a Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to CGJ), by a grant from the Ministry of Health, Labor and Welfare of Japan (Research on Dementia, Health and Labor Sciences Research Grants H23-005) (M. M.), and by Ono medical research foundation (M. M.).	Akiyama H, 2000, ALZ DIS ASSOC DIS, V14, pS47, DOI 10.1097/00002093-200000001-00008; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759; Colombo A, 2009, NEUROBIOL DIS, V33, P518, DOI 10.1016/j.nbd.2008.12.014; Tamagno E, 2008, J NEUROCHEM, V104, P683, DOI 10.1111/j.1471-4159.2007.05072.x; Kim J, 2007, J NEUROSCI, V27, P627, DOI 10.1523/JNEUROSCI.4849-06.2007; Curini M, 2006, CURR MED CHEM, V13, P199, DOI 10.2174/092986706775197890; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Vingtdeux V, 2005, NEUROBIOL DIS, V20, P625, DOI 10.1016/j.nbd.2005.05.004; Kumar-Singh S, 2006, HUM MUTAT, V27, P686, DOI 10.1002/humu.20336; Walker ES, 2005, J NEUROCHEM, V92, P294, DOI 10.1111/j.1471-4159.2004.02858.x; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Selkoe DJ, 2001, PHYSIOL REV, V81, P741; Tomita S, 1998, J BIOL CHEM, V273, P6277, DOI 10.1074/jbc.273.11.6277; Murakami A, 2003, CANCER LETT, V195, P17, DOI 10.1016/S0304-3835(03)00058-2; Tanaka T, 2008, NUTR CANCER, V60, P70, DOI 10.1080/01635580802381253; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Liao YF, 2004, J BIOL CHEM, V279, P49523, DOI 10.1074/jbc.M402034200; Zhu XW, 2001, J NEUROCHEM, V76, P435, DOI 10.1046/j.1471-4159.2001.00046.x; Koike H, 1999, BIOCHEM J, V343, P371, DOI 10.1042/0264-6021:3430371; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Okuyama S, 2013, EUR J PHARMACOL, V699, P118, DOI 10.1016/j.ejphar.2012.11.043; de Medina P, 2010, MOL PHARMACOL, V78, P827, DOI 10.1124/mol.110.065250; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Lim GP, 2000, J NEUROSCI, V20, P5709; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Lim GP, 2001, NEUROBIOL AGING, V22, P983, DOI 10.1016/S0197-4580(01)00299-8; Paola D, 2000, BIOCHEM BIOPH RES CO, V268, P642, DOI 10.1006/bbrc.2000.2164; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; Deng Y, 2006, J NEUROSCI, V26, P3845, DOI 10.1523/JNEURSCI.5384-05.2006; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Kukar T, 2005, NAT MED, V11, P545, DOI 10.1038/nm1235; Shen CY, 2008, J BIOL CHEM, V283, P17721, DOI 10.1074/jbc.M800013200; Matsui T, 2007, BRAIN RES, V1161, P116, DOI 10.1016/j.brainres.2007.05.050; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; Okuyama S, 2014, EVID-BASED COMPL ALT, DOI 10.1155/2014/408503; Jun DY, 2007, CARCINOGENESIS, V28, P1303, DOI 10.1093/carcin/bgm028; Zhou Y, 2003, SCIENCE, V302, P1215, DOI 10.1126/science.1090154; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Murakami A, 1997, JPN J CANCER RES, V88, P443; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Kuo LH, 2008, MOL BIOL CELL, V19, P4201, DOI 10.1091/mbc.E07-09-0987; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; McGeer PL, 1996, NEUROLOGY, V47, P425; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Jantzen PT, 2002, J NEUROSCI, V22, P2246; Tong Y, 2005, J NEURAL TRANSM, V112, P455, DOI 10.1007/s00702-004-0255-3; Sastre M, 2006, P NATL ACAD SCI USA, V103, P443, DOI 10.1073/pnas.0503839103; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Ramelot TA, 2001, J MOL BIOL, V307, P871, DOI 10.1006/jmbi.2001.4535; Tamagno E, 2005, J NEUROCHEM, V92, P628, DOI 10.1111/j.1471-4159.2004.02895.x; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Jung CG, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-47; Kang IJ, 2013, NEUROTOXICOLOGY, V34, P16, DOI 10.1016/j.neuro.2012.09.013; Kawabata K, 2006, FEBS LETT, V580, P5288, DOI 10.1016/j.febslet.2006.08.072; Mazzitelli S, 2011, J NEUROSCI, V31, P16969, DOI 10.1523/JNEUROSCI.4491-11.2011; McGeer EG, 1999, CURR PHARM DESIGN, V5, P821; Sano Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000051; Tomita S, 1999, J BIOL CHEM, V274, P2243, DOI 10.1074/jbc.274.4.2243; Zheng Q, 2002, J CANCER RES CLIN, V128, P539, DOI 10.1007/s00432-002-0373-y	71	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2015	43	4					1215	1228		10.3233/JAD-141692		14	Neurosciences	Neurosciences & Neurology	AX3RU	WOS:000346857400011		
J	Iwayama, K; Kawabuchi, R; Park, I; Kurihara, R; Kobayashi, M; Hibi, M; Oishi, S; Yasunaga, K; Ogata, H; Nabekura, Y; Tokuyama, K				Iwayama, Kaito; Kawabuchi, Ryosuke; Park, Insung; Kurihara, Reiko; Kobayashi, Masashi; Hibi, Masanobu; Oishi, Sachiko; Yasunaga, Koichi; Ogata, Hitomi; Nabekura, Yoshiharu; Tokuyama, Kumpei			Transient energy deficit induced by exercise increases 24-h fat oxidation in young trained men	JOURNAL OF APPLIED PHYSIOLOGY			English	Article						energy balance; energy flux; epoc; metabolic chamber	DIFFERENT TIME INTERVALS; BODY-WEIGHT REGULATION; SKELETAL-MUSCLE; CARBOHYDRATE INGESTION; POSTEXERCISE RECOVERY; GLYCOGEN RESYNTHESIS; PROTEIN-KINASE; FASTED STATE; METABOLISM; BALANCE	Whole body fat oxidation increases during exercise. However, 24-h fat oxidation on a day with exercise often remains similar to that of sedentary day, when energy intake is increased to achieve an energy-balanced condition. The present study aimed to examine a possibility that time of the day when exercise is performed makes differences in 24-h fat oxidation. As a potential mechanism of exercise affecting 24-h fat oxidation, its relation to exercise-induced transient energy deficit was examined. Nine young male endurance athletes underwent three trials of indirect calorimetry using a metabolic chamber, in which they performed a session of 100 min of exercise before breakfast (AM), after lunch (PM), or two sessions of 50 min of exercise before breakfast and after lunch (AM/PM) at 65% of maximal oxygen uptake. Experimental meals were designed to achieve individual energy balance. Twentyfour- hour energy expenditure was similar among the trials, but 24-h fat oxidation was 1,142 +/- 97, 809 +/- 88, and 608 +/- 46 kcal/24 h in descending order of its magnitude for AM, AM/PM, and PM, respectively (P < 0.05). Twenty-four-hour carbohydrate oxidation was 2,558 +/- 110, 2,374 +/- 114, and 2,062 +/- 96 kcal/24 h for PM, AM/PM, and AM, respectively. In spite of energy-balanced condition over 24 h, exercise induced a transient energy deficit, the magnitude of which was negatively correlated with 24-h fat oxidation (r = -0.72, P < 0.01). Similarly, transient carbohydrate deficit after exercise was negatively correlated with 24-h fat oxidation (r = -0.40, P < 0.05). The time of the day when exercise is performed affects 24-h fat oxidation, and the transient energy/carbohydrate deficit after exercise is implied as a factor affecting 24-h fat oxidation.	[Iwayama, Kaito; Kawabuchi, Ryosuke; Park, Insung; Kurihara, Reiko; Kobayashi, Masashi; Ogata, Hitomi; Nabekura, Yoshiharu; Tokuyama, Kumpei] Univ Tsukuba, Grad Sch Comprehens Human Sci, Doctoral Program Sports Med, Tsukuba, Ibaraki 3058574, Japan; [Hibi, Masanobu; Oishi, Sachiko; Yasunaga, Koichi] Kao Corp, Hlth Care Food Res Labs, Tokyo, Japan	Tokuyama, K (reprint author), Univ Tsukuba, Grad Sch Comprehens Human Sci, Doctoral Program Sports Med, Tennodai 1-1-1, Tsukuba, Ibaraki 3058574, Japan.	tokuyama@taiiku.tsukuba.ac.jp			Japan Society for the Promotion of Science [B 25282215]; Ministry of Education, Culture, Sports, Science and Technology, Japan	This study was supported, in part, by the Japan Society for the Promotion of Science (Grants-in-aid for Scientific Research B 25282215) and the Ministry of Education, Culture, Sports, Science and Technology, Japan (Body and Mind Integrated Sports Sciences Project 2010-2013).	Akerstrom TCA, 2006, BIOCHEM BIOPH RES CO, V342, P949, DOI 10.1016/j.bbrc.2006.02.057; Flatt JP, 1996, P NUTR SOC, V55, P449, DOI 10.1079/PNS19960041; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Philp A, 2012, AM J PHYSIOL-ENDOC M, V302, pE1343, DOI 10.1152/ajpendo.00004.2012; FLATT JP, 1987, AM J CLIN NUTR, V45, P296; De Bock K, 2008, J APPL PHYSIOL, V104, P1045, DOI 10.1152/japplphysiol.01195.2007; Sato M, 2011, OBES RES CLIN PRACT, V5, pE220, DOI 10.1016/j.orcp.2011.02.001; Bennard P, 2006, APPL PHYSIOL NUTR ME, V31, P502, DOI 10.1139/H06-027; Schutz Y, 2004, INT J OBESITY, V28, pS3, DOI 10.1038/sj.ijo.0802852; Pannacciulli N, 2007, AM J CLIN NUTR, V86, P625; Tokuyama K, 2009, J APPL PHYSIOL, V106, P640, DOI 10.1152/japplphysiol.90718.2008; Janssen I, 2000, J APPL PHYSIOL, V89, P81; Casey A, 2000, AM J PHYSIOL-ENDOC M, V278, pE65; Henderson GC, 2007, J PHYSIOL-LONDON, V584, P963, DOI 10.1113/physiol.2007.137331; Melanson EL, 2009, EXERC SPORT SCI REV, V37, P93, DOI 10.1097/JES.0b013e31819c2f0b; Bell C, 2004, J CLIN ENDOCR METAB, V89, P3573, DOI 10.1210/jc.2003-032146; Horowitz JF, 1997, AM J PHYSIOL-ENDOC M, V273, pE768; Sriwijitkamol A, 2007, DIABETES, V56, P836, DOI 10.2337/db06-1119; COYLE EF, 1985, J APPL PHYSIOL, V59, P429; Wong AKF, 2009, CLIN SCI, V116, P607, DOI 10.1042/CS20080066; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; BIELINSKI R, 1985, AM J CLIN NUTR, V42, P69; Burton FL, 2010, BRIT J NUTR, V104, P1249, DOI 10.1017/S0007114510002023; De Bock K, 2005, J PHYSIOL-LONDON, V564, P649, DOI 10.1113/jphysiol.2005.083170; FERRANNINI E, 1988, METABOLISM, V37, P287, DOI 10.1016/0026-0495(88)90110-2; FLATT JP, 1988, DIABETES METAB REV, V4, P571; Gaesser CA, 1984, MED SCI SPORTS EXERC, V16, P29; Hargreaves M, 2000, EXERCISE SPORT SCI, P3; Izumida Y, 2013, NAT COMMUN, V4, P1; JEQUIER E, 1992, ENERGY METABOLISM, P123; Melanson EL, 2007, J APPL PHYSIOL, V103, P1576, DOI 10.1152/japplphysiol.01455.2006; Melanson EL, 2009, J APPL PHYSIOL, V107, P1847, DOI 10.1152/japplphysiol.00958.2009; Melanson EL, 2002, J APPL PHYSIOL, V92, P1045, DOI 10.1152/japplphysiol.00706.2001; Ministry of Health Labour and Welfare of Japan, 2005, DIET REF INT JAP; MONTAIN SJ, 1991, J APPL PHYSIOL, V70, P882; MOUGIOS V, 1995, METABOLISM, V44, P681, DOI 10.1016/0026-0495(95)90129-9; Mougios V, 2003, J APPL PHYSIOL, V94, P476, DOI 10.1152/japplphysiol.00624.2002; Shimada K, 2013, METABOLISM, V62, P793, DOI 10.1016/j.metabol.2012.12.008; WILLCUTTS KF, 1988, INT J SPORTS MED, V9, P240, DOI 10.1055/s-2007-1025013	39	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	8750-7587	1522-1601		J APPL PHYSIOL	J. Appl. Physiol.	JAN 1	2015	118	1					80	85		10.1152/japplphysiol.00697.2014		6	Physiology; Sport Sciences	Physiology; Sport Sciences	AX8OQ	WOS:000347169000011		
J	Khan, AA; Morrison, A; Hanley, DA; Felsenberg, D; McCauley, LK; O'Ryan, F; Reid, IR; Ruggiero, SL; Taguchi, A; Tetradis, S; Watts, NB; Brandi, ML; Peters, E; Guise, T; Eastell, R; Cheung, AM; Morin, SN; Masri, B; Cooper, C; Morgan, SL; Obermayer-Pietsch, B; Langdahl, BL; Al Dabagh, R; Davison, KS; Kendler, DL; Sandor, GK; Josse, RG; Bhandari, M; El Rabbany, M; Pierroz, DD; Sulimani, R; Saunders, DP; Brown, JP; Compston, J				Khan, Aliya A.; Morrison, Archie; Hanley, David A.; Felsenberg, Dieter; McCauley, Laurie K.; O'Ryan, Felice; Reid, Ian R.; Ruggiero, Salvatore L.; Taguchi, Akira; Tetradis, Sotirios; Watts, Nelson B.; Brandi, Maria Luisa; Peters, Edmund; Guise, Teresa; Eastell, Richard; Cheung, Angela M.; Morin, Suzanne N.; Masri, Basel; Cooper, Cyrus; Morgan, Sarah L.; Obermayer-Pietsch, Barbara; Langdahl, Bente L.; Al Dabagh, Rana; Davison, K. Shawn; Kendler, David L.; Sandor, George K.; Josse, Robert G.; Bhandari, Mohit; El Rabbany, Mohamed; Pierroz, Dominique D.; Sulimani, Riad; Saunders, Deborah P.; Brown, Jacques P.; Compston, Juliet		Int Task Force Osteonecrosis Jaw	Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus	JOURNAL OF BONE AND MINERAL RESEARCH			English	Article						OSTEONECROSIS OF THE JAW; BISPHOSPHONATES; DENOSUMAB; IMAGING; RISK FACTORS; DIAGNOSIS; TREATMENT; MANAGEMENT	BISPHOSPHONATE-RELATED OSTEONECROSIS; MULTIPLE-MYELOMA PATIENTS; BREAST-CANCER PATIENTS; BEAM COMPUTED-TOMOGRAPHY; BONE-MINERAL DENSITY; RANDOMIZED-CONTROLLED-TRIAL; CROSS-LINKING TELOPEPTIDE; RESISTANT PROSTATE-CANCER; SINGLE-CENTER EXPERIENCE; RENAL-CELL CARCINOMA	This work provides a systematic review of the literature from January 2003 to April 2014 pertaining to the incidence, pathophysiology, diagnosis, and treatment of osteonecrosis of the jaw (ONJ), and offers recommendations for its management based on multidisciplinary international consensus. ONJ is associated with oncology-dose parenteral antiresorptive therapy of bisphosphonates (BP) and denosumab (Dmab). The incidence of ONJ is greatest in the oncology patient population (1% to 15%), where high doses of these medications are used at frequent intervals. In the osteoporosis patient population, the incidence of ONJ is estimated at 0.001% to 0.01%, marginally higher than the incidence in the general population (<0.001%). New insights into the pathophysiology of ONJ include antiresorptive effects of BPs and Dmab, effects of BPs on gamma delta T-cells and on monocyte and macrophage function, as well as the role of local bacterial infection, inflammation, and necrosis. Advances in imaging include the use of cone beam computerized tomography assessing cortical and cancellous architecture with lower radiation exposure, magnetic resonance imaging, bone scanning, and positron emission tomography, although plain films often suffice. Other risk factors for ONJ include glucocorticoid use, maxillary or mandibular bone surgery, poor oral hygiene, chronic inflammation, diabetes mellitus, ill-fitting dentures, as well as other drugs, including antiangiogenic agents. Prevention strategies for ONJ include elimination or stabilization of oral disease prior to initiation of antiresorptive agents, as well as maintenance of good oral hygiene. In those patients at high risk for the development of ONJ, including cancer patients receiving high-dose BP or Dmab therapy, consideration should be given to withholding antiresorptive therapy following extensive oral surgery until the surgical site heals with mature mucosal coverage. Management of ONJ is based on the stage of the disease, size of the lesions, and the presence of contributing drug therapy and comorbidity. Conservative therapy includes topical antibiotic oral rinses and systemic antibiotic therapy. Localized surgical debridement is indicated in advanced nonresponsive disease and has been successful. Early data have suggested enhanced osseous wound healing with teriparatide in those without contraindications for its use. Experimental therapy includes bone marrow stem cell intralesional transplantation, low-level laser therapy, local platelet-derived growth factor application, hyperbaric oxygen, and tissue grafting. (c) 2014 American Society for Bone and Mineral Research (c) 2014 American Society for Bone and Mineral Research	[Khan, Aliya A.] McMaster Univ, Dept Med, Div Endocrinol & Metab, Hamilton, ON, Canada; [Khan, Aliya A.] McMaster Univ, Dept Med, Div Geriatr, Hamilton, ON, Canada; [Morrison, Archie] Dalhousie Univ, Div Oral & Maxillofacial Surg, Halifax, NS, Canada; [Hanley, David A.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Hanley, David A.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Hanley, David A.] Univ Calgary, Dept Oncol, Calgary, AB, Canada; [Felsenberg, Dieter] Charite, Ctr Muscle & Bone Res, D-13353 Berlin, Germany; [Felsenberg, Dieter] Free Univ Berlin, Berlin, Germany; [Felsenberg, Dieter] Humboldt Univ, D-10099 Berlin, Germany; [McCauley, Laurie K.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA; [O'Ryan, Felice] Kaiser Permanente Med Ctr, Oakland, CA USA; [Reid, Ian R.] Univ Auckland, Dept Med, Auckland, New Zealand; [Ruggiero, Salvatore L.] New York Ctr Orthognath & Maxillary Surg, Lake Success, NY USA; [Taguchi, Akira] Matsumoto Dent Univ, Sch Dent, Dept Oral & Maxillofacial Radiol, Shojiri, Japan; [Tetradis, Sotirios] Univ Calif Los Angeles, Sch Dent, Div Diagnost & Surg Sci, Los Angeles, CA 90024 USA; [Watts, Nelson B.] Mercy Hlth Osteoporosis & Bone Hlth Serv, Cincinnati, OH USA; [Brandi, Maria Luisa] Univ Florence, Dept Surg & Translat Med, Florence, Italy; [Peters, Edmund] Univ Alberta, Edmonton, AB, Canada; [Guise, Teresa] Indiana Univ, Dept Med, Div Endocrinol, Indianapolis, IN USA; [Eastell, Richard] Univ Sheffield, Dept Human Metab, Sheffield, S Yorkshire, England; [Cheung, Angela M.] Univ Toronto, Toronto, ON, Canada; [Morin, Suzanne N.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Masri, Basel] Jordan Hosp & Med Ctr, Jordan Osteoporosis Ctr, Amman, Jordan; [Cooper, Cyrus] Univ Southampton, MRC, Lifecourse Epidemiol Unit, Southampton, Hants, England; [Cooper, Cyrus] Univ Southampton, NIHR Nutr Biomed Res Ctr, Southampton, Hants, England; [Cooper, Cyrus] Univ Oxford, NIHR Musculoskeletal Biomed Res Unit, Oxford, England; [Morgan, Sarah L.] Univ Alabama Birmingham, Birmingham Osteoporosis Prevent & Treatment Clin, Div Clin Immunol & Rheumatol, Birmingham, AL USA; [Obermayer-Pietsch, Barbara] Med Univ Graz, Div Endocrinol & Metab, Dept Internal Med, Graz, Austria; [Langdahl, Bente L.] Aarhus Univ Hosp, Dept Endocrinol & Internal Med, DK-8000 Aarhus, Denmark; [Al Dabagh, Rana; El Rabbany, Mohamed] Univ Toronto, Fac Dent, Toronto, ON, Canada; [Davison, K. Shawn] Univ Victoria, Dept Grad Studies, Victoria, BC, Canada; [Kendler, David L.] Univ British Columbia, Dept Med, Div Endocrinol, Vancouver, BC, Canada; [Sandor, George K.] Univ Oulu, Oulu Univ Hosp, Dept Oral & Maxillofacial Surg, Oulu, Finland; [Josse, Robert G.] Univ Toronto, Div Endocrinol & Metab, Toronto, ON, Canada; [Bhandari, Mohit] McMaster Univ, Dept Surg, Div Orthopaed Surg, Hamilton, ON L8S 4L8, Canada; [Bhandari, Mohit] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Pierroz, Dominique D.] IOF, Nyon, Switzerland; [Sulimani, Riad] King Saud Univ, Coll Med, Riyadh 11461, Saudi Arabia; [Saunders, Deborah P.] Northeast Canc Ctr Hlth Sci North, Dept Dent Oncol, Sudbury, ON, Canada; [Brown, Jacques P.] Univ Laval, Quebec City, PQ, Canada; [Compston, Juliet] Cambridge Biomed Campus, Cambridge, England	Khan, AA (reprint author), 209-331 Sheddon Ave, Oakville, ON, Canada.	aliya@mcmaster.ca			Smith and Nephew; Stryker; Amgen; Zimmer; Moximed; Bioventus; Merck; Eli Lilly; Sanofi; De Puy; Servier; NPS; Alexion; Shire; SPA; Bruno Farmaceutici; MSD; Novartis; Actavis; GSK; Alliance for Better Bone Health; Pfizer; Medtronic; Roche; Warner Chilcott; AstraZeneca; IDS; Otsuka; IBMS; Exelixis; Dentsply; Astellas; Axellus; Takeda; Asahi Kasei; Teijin; AbbVie; Amarin; Bristol-Meyers Squibb; Corcept; Endo; Imagepace; Janssen; Noven; Pfizer/Wyeth; Radius; Sanofi-Aventis	M Bhandari received funding from Smith and Nephew, Stryker, Amgen, Zimmer, Moximed, Bioventus, Merck, Eli Lilly, Sanofi, De Puy; ML Brandi has served on the board for Alexion, Servier, Eli Lilly, and Amgen, and received funding from Servier, NPS, Eli Lilly, Amgen, Alexion, Shire, SPA, Bruno Farmaceutici, and MSD; J Brown has served on the board for Amgen, Eli Lilly, and Merck, and received funding for grant, lectures, and development of educational presentations from Amgen, Eli Lilly, Merck, Novartis, and Actavis; A Cheung received grants and consultancy fee from Amgen, Eli Lilly, and Merck, and honoraria from Amgen and Eli Lilly; C Cooper received consultancy, lecture fees, and honoraria from Amgen, GSK, Alliance for Better Bone Health, MSD, Eli Lilly, Pfizer, Novartis, Servier, Merck, Medtronic, and Roche; D Hanley received fees for consultancy, lectures, development of educational presentations from Amgen, Eli Lilly, Merck, Novartis, and Warner Chilcott; R Eastell received grants, lecture fees, and travel expenses from Amgen, AstraZeneca, IDS, Novartis, Roche, Alexion, Otsuka, IBMS, and Merck; K Davison has served on the board for Amgen Merck and Novartis and received consultancy, lecture fees, funding for development of educational presentations, and manuscript preparation and travel expenses from Amgen, Merck, and Novartis; T Guise has received consultancy, expert testimony lecture fees from Novartis, AstraZeneca, Amgen, and Exelixis; L McCauley received consultancy fees from Dentsply and owns Amgen stock; B Josse has served on the board for Merck, Eli Lilly, and Amgen, and received funding for grants, lectures, and travels from Amgen and Eli Lilly; D Kendler received consultancy, grants, and lecture fees from Amgen, Pfizer, Eli Lilly, Merck, and Astellas; A Khan has served on the board for Amgen and Eli Lilly and has received grants and lecture fees from Amgen, Eli Lilly, NPS, and Merck; B Langdhal has served on the board for Amgen, Merck, and Eli Lilly, and received consultancy fees and grants from Eli Lilly, Axellus, Amgen, Merck, and Eli Lilly; S Morin has served on the board for Amgen, Merck, and Eli Lilly, and received consultancy fees and grants from Merck; B Obermayer-Pietsch received consultancy and lecture fees from MSD, IDS, and Eli Lilly; F O'Ryan received support for travel from AAOMS; E Peters no conflict to disclose. I Ried has served on the board for Merck, and received consultancy, testimony, and lecture fees from Novartis, Merck, Amgen, Sanofi, and Eli Lilly; S Ruggerio received consultancy fees from Amgen; D Saunders received consultancy fees from Takeda; A Taguchi received consultancy and lectures fees and grants from Asahi Kasei and Teijin; S Tetradis has received consultancy fees and grants from Amgen; N Watts is the co-founder, director, and stockholder of OsteoDynamics, and has received consultancy and lecture fees from Amgen, AbbVie, Amarin, Bristol-Meyers Squibb, Corcept, Endo, Imagepace, Janssen, Eli Lilly, Merck, Novartis, Noven, NPS, Pfizer/Wyeth, Radius, and Sanofi-Aventis; J Compston, B Masri, A Morrison, D Pierroz, E Rabbany, and G Sandor state that they have no conflicts of interest.	Abtahi J, 2012, J ORAL PATHOL MED, V41, P494, DOI 10.1111/j.1600-0714.2011.01125.x; Aguiar BD, 2007, ANN ONCOL, V18, P556; Akinmoladun V I, 2008, Afr J Med Med Sci, V37, P395; Ali-Erdem Mehmet, 2011, Med Oral Patol Oral Cir Bucal, V16, pe879; Allam E, 2011, ORAL DIS, V17, P291, DOI 10.1111/j.1601-0825.2010.01739.x; American Association of Endodontists;American Academy of Oral and Maxillofacial Radiography, 2011, PA DENT J HARRISB, V78, P37; American Dental Association Council on Scientific Affairs, 2006, J AM DENT ASSOC, V137, P1304; American Dental Association U.S. Department of Health andHuman Services, DENT RAD EX REC PAT; Smith MR, 2009, NEW ENGL J MED, V361, P745, DOI 10.1056/NEJMoa0809003; Lodi G, 2010, J ORAL MAXIL SURG, V68, P107, DOI 10.1016/j.joms.2009.07.068; Mauri D, 2009, BREAST CANCER RES TR, V116, P433, DOI 10.1007/s10549-009-0432-z; Corso A, 2007, LEUKEMIA, V21, P1545, DOI 10.1038/sj.leu.2404682; Dimopoulos MA, 2006, HAEMATOL-HEMATOL J, V91, P968; Taylor KH, 2010, BRIT J ORAL MAX SURG, V48, P221, DOI 10.1016/j.bjoms.2009.08.030; Ziebart T, 2011, ORAL ONCOL, V47, P195, DOI 10.1016/j.oraloncology.2010.12.003; Vincenzi B, 2005, J INTERF CYTOK RES, V25, P144, DOI 10.1089/jir.2005.25.144; Marx RE, 2005, J ORAL MAXIL SURG, V63, P1567, DOI 10.1016/j.joms.2005.07.010; Dimopoulos MA, 2009, ANN ONCOL, V20, P117, DOI 10.1093/annonc/mdn554; Atalay B, 2011, LASER MED SCI, V26, P815, DOI 10.1007/s10103-011-0974-2; Grbic JT, 2010, J AM DENT ASSOC, V141, P1365; Orita Y, 2011, THYROID, V21, P31, DOI 10.1089/thy.2010.0169; Chiandussi S, 2006, DENTOMAXILLOFAC RAD, V35, P236, DOI 10.1259/dmfr/27458726; Khan AA, 2008, J RHEUMATOL, V35, P1391; Smith MR, 2012, LANCET, V379, P39, DOI 10.1016/S0140-6736(11)61226-9; Tsao C, 2013, J ORAL MAXIL SURG, V71, P1360, DOI 10.1016/j.joms.2013.02.016; Hikita H, 2009, J BONE MINER METAB, V27, P663, DOI 10.1007/s00774-009-0090-6; Barrett-Lee P, 2014, LANCET ONCOL, V15, P114, DOI 10.1016/S1470-2045(13)70539-4; Freiberger JJ, 2012, J ORAL MAXIL SURG, V70, P1573, DOI 10.1016/j.joms.2012.04.001; Vescovi P, 2010, LASER MED SCI, V25, P101, DOI 10.1007/s10103-009-0687-y; Badros A, 2006, J CLIN ONCOL, V24, P945, DOI 10.1200/JCO.2005.04.2465; Bagan JV, 2008, ORAL ONCOL, V44, P1088, DOI 10.1016/j.oraloncology.2008.01.012; Lyles KW, 2007, NEW ENGL J MED, V357, P1799, DOI 10.1056/NEJMoa074941; Etminan M, 2008, J RHEUMATOL, V35, P691; Marx RE, 2007, J ORAL MAXIL SURG, V65, P2397, DOI 10.1016/j.joms.2007.08.003; Garcia-Ferrer L, 2008, AM J ROENTGENOL, V190, P949, DOI 10.2214/AJR.07.3045; Popovic KS, 2010, RADIOL ONCOL, V44, P215, DOI 10.2478/v10019-010-0032-x; [Anonymous], 2007, J ORAL MAXILLOFAC SU, V65, P369; Lehrer S, 2008, ORAL SURG ORAL MED O, V106, P389, DOI 10.1016/j.tripleo.2008.01.033; Coleman RE, 2011, NEW ENGL J MED, V365, P1396, DOI 10.1056/NEJMoa1105195; Wilde F, 2012, OR SURG OR MED OR PA, V114, P804, DOI 10.1016/j.oooo.2012.08.458; Christodoulou C, 2009, ONCOLOGY-BASEL, V76, P209, DOI 10.1159/000201931; Fizazi K, 2009, J CLIN ONCOL, V27, P1564, DOI 10.1200/JCO.2008.19.2146; Assaf AT, 2013, ANTICANCER RES, V33, P3917; Scagliotti GV, 2012, J THORAC ONCOL, V7, P1823, DOI 10.1097/JTO.0b013e31826aec2b; Ripamonti CI, 2009, ANN ONCOL, V20, P137, DOI 10.1093/annonc/mdn526; Junquera L, 2008, J ORAL MAXIL SURG, V66, P1516, DOI 10.1016/j.joms.2008.02.012; Amadori D, 2013, LANCET ONCOL, V14, P663, DOI 10.1016/S1470-2045(13)70174-8; Kunchur R, 2009, J ORAL MAXIL SURG, V67, P1167, DOI 10.1016/j.joms.2009.02.004; Sambrook PN, 2012, BONE, V50, P289, DOI 10.1016/j.bone.2011.10.024; MYERS DT, 1994, CLIN NUCL MED, V19, P644, DOI 10.1097/00003072-199407000-00020; Henry DH, 2011, J CLIN ONCOL, V29, P1125, DOI 10.1200/JCO.2010.31.3304; Harper RP, 2007, J ORAL MAXIL SURG, V65, P573, DOI 10.1016/j.joms.2006.10.076; Scagliotti GV, 2012, ANN ONCOL, V23, P2082, DOI 10.1093/annonc/mds128; Zavras AI, 2006, J ORAL MAXIL SURG, V64, P917, DOI 10.1016/j.joms.2006.02.011; Papapoulos S, 2012, J BONE MINER RES, V27, P694, DOI 10.1002/jbmr.1479; Gimsing P, 2010, LANCET ONCOL, V11, P973, DOI 10.1016/S1470-2045(10)70198-4; Brunello A, 2009, BONE, V44, P173, DOI 10.1016/j.bone.2008.08.132; Zervas K, 2006, BRIT J HAEMATOL, V134, P620, DOI 10.1111/j.1365-2141.2006.06230.x; Scoletta M, 2013, J ORAL MAXIL SURG, V71, P994, DOI 10.1016/j.joms.2013.01.006; Sedghizadeh PP, 2009, J AM DENT ASSOC, V140, P1259; Smidt-Hansen T, 2013, J ORAL MAXIL SURG, V71, P1532, DOI 10.1016/j.joms.2013.03.019; Bedogni A, 2008, ORAL SURG ORAL MED O, V105, P358, DOI 10.1016/j.tripleo.2007.08.040; Wilde F, 2009, ORAL SURG ORAL MED O, V107, P412, DOI 10.1016/j.tripleo.2008.09.019; Chaturvedi P, 2010, EJSO-EUR J SURG ONC, V36, P541, DOI 10.1016/j.ejso.2009.12.003; Bi YM, 2010, AM J PATHOL, V177, P280, DOI 10.2353/ajpath.2010.090592; McClung M, 2009, OBSTET GYNECOL, V114, P999, DOI 10.1097/AOG.0b013e3181bdce0a; Krishnan A, 2009, J COMPUT ASSIST TOMO, V33, P298, DOI 10.1097/RCT.0b013e31817e4986; Lewiecki EM, 2007, J BONE MINER RES, V22, P1832, DOI 10.1359/JBMR.070809; Hutchinson M, 2010, J ORAL MAXIL SURG, V68, P2232, DOI 10.1016/j.joms.2010.05.003; Lo JC, 2010, J ORAL MAXIL SURG, V68, P243, DOI 10.1016/j.joms.2009.03.050; GOTCHER JE, 1981, J PERIODONTAL RES, V16, P441, DOI 10.1111/j.1600-0765.1981.tb00995.x; Fehm T, 2009, GYNECOL ONCOL, V112, P605, DOI 10.1016/j.ygyno.2008.11.029; Aghaloo TL, 2010, J ORAL MAXIL SURG, V68, P959, DOI 10.1016/j.joms.2009.10.010; Gnant M, 2011, LANCET ONCOL, V12, P631, DOI 10.1016/S1470-2045(11)70122-X; Ruggiero SL, 2004, J ORAL MAXIL SURG, V62, P527, DOI 10.1016/j.joms.2004.02.004; Raje N, 2008, CLIN CANCER RES, V14, P2387, DOI 10.1158/1078-0432.CCR-07-1430; Abrahamsen B, 2010, CURR OPIN RHEUMATOL, V22, P404, DOI 10.1097/BOR.0b013e32833ad677; Hoff AO, 2011, ANN NY ACAD SCI, V1218, P47, DOI 10.1111/j.1749-6632.2010.05771.x; Yamashita J, 2011, CLIN CANCER RES, V17, P1405, DOI 10.1158/1078-0432.CCR-10-1614; Fournier P, 2002, CANCER RES, V62, P6538; Nicoletti P, 2012, ONCOLOGIST, V17, P279, DOI 10.1634/theoncologist.2011-0202; Devogelaer JP, 2007, OSTEOPOROSIS INT, V18, P1211, DOI 10.1007/s00198-007-0367-3; Miyazaki H, 2012, BJU INT, V110, pE520, DOI 10.1111/j.1464-410X.2012.11205.x; Montefusco V, 2008, LEUKEMIA LYMPHOMA, V49, P2156, DOI 10.1080/10428190802483778; Martins MAT, 2012, ORAL ONCOL, V48, P79, DOI 10.1016/j.oraloncology.2011.08.010; Aghaloo TL, 2011, J BONE MINER RES, V26, P1871, DOI 10.1002/jbmr.379; Ngamphaiboon N, 2011, CLIN BREAST CANCER, V11, P252, DOI 10.1016/j.clbc.2011.02.001; Wilde F, 2011, ORAL SURG ORAL MED O, V111, P153, DOI 10.1016/j.tripleo.2010.04.015; Guarneri V, 2010, BREAST CANCER RES TR, V122, P181, DOI 10.1007/s10549-010-0866-3; Kikuiri T, 2010, J BONE MINER RES, V25, P1668, DOI 10.1002/jbmr.37; Kendler DL, 2010, J BONE MINER RES, V25, P72, DOI 10.1359/jbmr.090716; Sieber P, 2013, CLIN DRUG INVEST, V33, P117, DOI 10.1007/s40261-012-0041-1; Schubert M, 2012, ORAL ONCOL, V48, P349, DOI 10.1016/j.oraloncology.2011.11.004; Tennis P, 2012, PHARMACOEPIDEM DR S, V21, P810, DOI 10.1002/pds.3292; Taguchi A, 2013, ORAL RADIOL, V29, P98, DOI 10.1007/s11282-012-0114-0; Nair SP, 1996, INFECT IMMUN, V64, P2371; Fedele S, 2010, AM J MED, V123, P1060, DOI 10.1016/j.amjmed.2010.04.033; Hoff AO, 2008, J BONE MINER RES, V23, P826, DOI [10.1359/jbmr.080205, 10.1359/JBMR.080205]; Yamazaki T, 2012, INT J ORAL MAX SURG, V41, P1397, DOI 10.1016/j.ijom.2012.06.020; Bone HG, 2013, J CLIN ENDOCR METAB, V98, P4483, DOI 10.1210/jc.2013-1597; Mavrokokki T, 2007, J ORAL MAXIL SURG, V65, P415, DOI 10.1016/j.joms.2006.10.061; Lopez-Jornet P, 2010, J ORAL PATHOL MED, V39, P697, DOI 10.1111/j.1600-0714.2010.00927.x; Musto P, 2008, CANCER, V113, P1588, DOI 10.1002/cncr.23783; Tetradis Sotirios, 2010, J Calif Dent Assoc, V38, P27; Miller PD, 2008, BONE, V43, P222, DOI 10.1016/j.bone.2008.04.007; Bedogni A, 2011, ORAL ONCOL, V47, P420, DOI 10.1016/j.oraloncology.2011.02.024; Arce K, 2009, J ORAL MAXIL SURG, V67, P75, DOI 10.1016/j.joms.2008.12.002; Stopeck AT, 2010, J CLIN ONCOL, V28, P5132, DOI 10.1200/JCO.2010.29.7101; Fatterpekar GM, 2011, J COMPUT ASSIST TOMO, V35, P553, DOI 10.1097/RCT.0b013e318227a81d; Ariji Y, 2013, ORAL RADIOL, V29, P111, DOI 10.1007/s11282-013-0124-6; Elad S, 2010, CLIN ORAL INVEST, V14, P43, DOI 10.1007/s00784-009-0311-3; Boonen S, 2012, NEW ENGL J MED, V367, P1714, DOI 10.1056/NEJMoa1204061; Bisdas S, 2008, CLIN RADIOL, V63, P71, DOI 10.1016/j.crad.2007.04.023; Mucke T, 2011, J CANCER RES CLIN, V137, P907, DOI 10.1007/s00432-010-0953-1; Wessel JH, 2008, J ORAL MAXIL SURG, V66, P625, DOI 10.1016/j.joms.2007.11.032; Farah CS, 2003, AUST DENT J, V48, P61, DOI 10.1111/j.1834-7819.2003.tb00011.x; Sonis ST, 2009, ORAL ONCOL, V45, P164, DOI 10.1016/j.oraloncology.2008.04.013; Cheung A, 2010, NEW ENGL J MED, V363, P2473, DOI 10.1056/NEJMc1002684; Aragon-Ching JB, 2009, CANCER INVEST, V27, P221, DOI 10.1080/07357900802208608; Moretti F, 2011, ORAL SURG ORAL MED O, V112, P777, DOI 10.1016/j.tripleo.2011.07.004; Barasch A, 2011, J DENT RES, V90, P439, DOI 10.1177/0022034510397196; Estilo CL, 2008, ONCOLOGIST, V13, P911, DOI 10.1634/theoncologist.2008-0091; Kunchur R, 2008, AUST DENT J, V53, P354, DOI 10.1111/j.1834-7819.2008.00078.x; Wang EP, 2007, J ORAL MAXIL SURG, V65, P1328, DOI 10.1016/j.joms.2007.03.006; Beuselinck B, 2012, BRIT J CANCER, V107, P1665, DOI 10.1038/bjc.2012.385; Hansen T, 2006, J ORAL PATHOL MED, V35, P155, DOI 10.1111/j.1600-0714.2006.00391.x; Bashutski JD, 2010, NEW ENGL J MED, V363, P2396, DOI 10.1056/NEJMoa1005361; Lau AN, 2009, J RHEUMATOL, V36, P1835, DOI 10.3899/jrheum.081176; Hong JW, 2010, OSTEOPOROSIS INT, V21, P847, DOI 10.1007/s00198-009-1024-9; Pautke C, 2011, J ORAL MAXIL SURG, V69, P84, DOI 10.1016/j.joms.2010.07.014; Khan AA, 2009, J RHEUMATOL, V36, P478, DOI 10.3899/jrheum.080759; Marx RE, 2003, J ORAL MAXIL SURG, V61, P1115, DOI 10.1016/S0278-2391(03)00720-1; Khan AA, 2011, J RHEUMATOL, V38, P1396, DOI 10.3899/jrheum.100221; Diz P, 2012, J AM DENT ASSOC, V143, P981; Malden N, 2012, J BONE MINER METAB, V30, P171, DOI 10.1007/s00774-011-0299-z; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Hokugo A, 2010, J BONE MINER RES, V25, P1337, DOI 10.1002/jbmr.23; Bamias A, 2005, J CLIN ONCOL, V23, P8580, DOI 10.1200/JCO.2005.02.8670; Morag Y, 2009, RADIOGRAPHICS, V29, P1971, DOI 10.1148/rg.297095050; Sarasquete ME, 2008, BLOOD, V112, P2709, DOI 10.1182/blood-2008-04-147884; Cartsos VM, 2008, J AM DENT ASSOC, V139, P23; Aghaloo TL, 2014, J BONE MINER RES, V29, P843, DOI 10.1002/jbmr.2097; Jadu F, 2007, ANN ONCOL, V18, P2015, DOI 10.1093/annonc/mdm370; Kyrgidis A, 2008, J CLIN ONCOL, V26, P4634, DOI 10.1200/JCO.2008.16.2768; Boonyapakorn T, 2008, ORAL ONCOL, V44, P857, DOI 10.1016/j.oraloncology.2007.11.012; Tyndall DA, 2012, OR SURG OR MED OR PA, V113, P817, DOI 10.1016/j.oooo.2012.03.005; Chang ST, 2012, BONE, V51, P524, DOI 10.1016/j.bone.2012.05.010; Rathbone EJ, 2013, J CLIN ONCOL, V31, P2685, DOI 10.1200/JCO.2012.46.4792; Morris PG, 2012, J ORAL MAXIL SURG, V70, P2768, DOI 10.1016/j.joms.2011.12.028; Lipton A, 2012, EUR J CANCER, V48, P3082, DOI 10.1016/j.ejca.2012.08.002; Ruggiero SL, 2006, ORAL SURG ORAL MED O, V102, P433, DOI 10.1016/j.tripleo.2006.06.004; Allen M. R., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P358; Treister NS, 2010, ORAL SURG ORAL MED O, V109, P753, DOI 10.1016/j.tripleo.2009.12.005; Torres SR, 2011, DENTOMAXILLOFAC RAD, V40, P501, DOI 10.1259/dmfr/14636637; Aguirre JI, 2012, J BONE MINER RES, V27, P2130, DOI 10.1002/jbmr.1669; Allen MR, 2009, J ORAL MAXIL SURG, V67, P1373, DOI 10.1016/j.joms.2009.03.048; Cafro AM, 2008, CLIN LYMPHOMA MYELOM, V8, P111; Lee JJ, 2011, HEAD NECK-J SCI SPEC, V33, P1366, DOI 10.1002/hed.21380; Van den Wyngaert T, 2011, CLIN NUCL MED, V36, P17, DOI 10.1097/RLU.0b013e3181feeb72; Coleman R, 2011, BREAST CANCER RES TR, V127, P429, DOI 10.1007/s10549-011-1429-y; Allen MR, 2010, J ORAL MAXIL SURG, V68, P2730, DOI 10.1016/j.joms.2010.05.090; Iwamoto J, 2012, CLIN DRUG INVEST, V32, P547, DOI 10.2165/11634430-000000000-00000; Bedogni A, 2007, BONE, V41, P942, DOI 10.1016/j.bone.2007.08.025; O'Ryan FS, 2009, J ORAL MAXIL SURG, V67, P1363, DOI 10.1016/j.joms.2009.03.005; Subramanian G, 2011, ORAL SURG ORAL MED O, V112, P744, DOI 10.1016/j.tripleo.2011.04.020; Allen MR, 2008, J ORAL MAXIL SURG, V66, P987, DOI 10.1016/j.joms.2008.01.038; Tosi P, 2006, BLOOD, V108, P3951, DOI 10.1182/blood-2006-07-033571; Vandone AM, 2012, ANN ONCOL, V23, P193, DOI 10.1093/annonc/mdr039; Dore F, 2009, J NUCL MED, V50, P30, DOI 10.2967/jnumed.107.048785; Pozzi S, 2007, LEUKEMIA LYMPHOMA, V48, P56, DOI 10.1080/10428190600977690; Vahtsevanos K, 2009, J CLIN ONCOL, V27, P5356, DOI 10.1200/JCO.2009.21.9584; Yamazaki T, 2012, BONE, V51, P882, DOI 10.1016/j.bone.2012.08.115; Torres SR, 2012, OR SURG OR MED OR PA, V113, P695, DOI 10.1016/j.oooo.2011.11.011; Bone HG, 2008, J CLIN ENDOCR METAB, V93, P2149, DOI 10.1210/jc.2007-2814; Fizazi K, 2011, LANCET, V377, P813, DOI 10.1016/S0140-6736(10)62344-6; Catalano L, 2007, ANN HEMATOL, V86, P415, DOI 10.1007/s00277-007-0263-0; Allen MR, 2009, CELLS TISSUES ORGANS, V189, P289, DOI 10.1159/000151371; Katz J, 2011, INT J ORAL MAX SURG, V40, P605, DOI 10.1016/j.ijom.2011.02.002; Stockmann P, 2010, CLIN ORAL INVEST, V14, P311, DOI 10.1007/s00784-009-0293-1; Pautke C, 2012, BONE, V51, P592, DOI 10.1016/j.bone.2012.04.020; Santini D, 2003, CLIN CANCER RES, V9, P2893; Vescovi P, 2012, J ORAL PATHOL MED, V41, P214, DOI 10.1111/j.1600-0714.2011.01091.x; Orwoll E, 2012, J CLIN ENDOCR METAB, V97, P3161, DOI 10.1210/jc.2012-1569; Ripamonti CI, 2011, ORAL ONCOL, V47, P185, DOI 10.1016/j.oraloncology.2011.01.002; Saad F, 2012, ANN ONCOL, V23, P1341, DOI 10.1093/annonc/mdr435; Scarfe WC, 2012, AUST DENT J, V57, P46, DOI 10.1111/j.1834-7819.2011.01657.x; Fortuna G, 2012, J ORAL PATHOL MED, V41, P222, DOI 10.1111/j.1600-0714.2011.01095.x; Allen MR, 2011, OSTEOPOROSIS INT, V22, P693, DOI 10.1007/s00198-010-1268-4; Sedghizadeh PP, 2009, J AM DENT ASSOC, V140, P61; Hellstein JW, 2011, J AM DENT ASSOC, V142, P1243; Francini F, 2011, J AM DENT ASSOC, V142, P506; Abtahi J, 2013, INT J ORAL MAX SURG, V42, P632, DOI 10.1016/j.ijom.2013.02.007; Sonnier KE, 1997, J PERIODONTOL, V68, P758; Lipton A, 2008, CLIN CANCER RES, V14, P6690, DOI 10.1158/1078-0432.CCR-07-5234; Ulmner M, 2014, J ORAL MAXIL SURG, V72, P76, DOI 10.1016/j.joms.2013.06.221; PETERS E, 1993, ORAL SURG ORAL MED O, V75, P739, DOI 10.1016/0030-4220(93)90433-5; Ravosa MJ, 2011, ARCH ORAL BIOL, V56, P491, DOI 10.1016/j.archoralbio.2010.11.003; Morgan GJ, 2010, LANCET, V376, P1989, DOI 10.1016/S0140-6736(10)62051-X; Grant BT, 2008, J ORAL MAXIL SURG, V66, P223, DOI 10.1016/j.joms.2007.09.019; Kang B, 2013, J BONE MINER RES, V28, P1631, DOI 10.1002/jbmr.1894; Allen MR, 2013, J ORAL MAXIL SURG, V71, P1017, DOI 10.1016/j.joms.2012.11.016; English BC, 2010, THER CLIN RISK MANAG, V6, P579, DOI 10.2147/TCRM.S14303; Walter C, 2008, EUR UROL, V54, P1066, DOI 10.1016/j.eururo.2008.06.070; Lesclous P, 2009, BONE, V45, P843, DOI 10.1016/j.bone.2009.07.011; Epstein MS, 2010, ORAL SURG ORAL MED O, V110, P593, DOI 10.1016/j.tripleo.2010.05.067; Aviles A, 2013, CURR ONCOL, V20, pE13, DOI 10.3747/co.20.1055; Bantis A, 2011, TUMORI, V97, P479, DOI 10.1700/950.10401; Baqain ZH, 2010, ANN ROY COLL SURG, V92, P489, DOI 10.1308/003588410X12699663903395; Bast F, 2012, HNO, V60, P1127, DOI 10.1007/s00106-012-2554-6; Berenson JR, 2008, CLIN CANCER RES, V14, P6289, DOI 10.1158/1078-0432.CCR-08-0666; Berenson JR, 2011, AM J HEMATOL, V86, P25, DOI 10.1002/ajh.21912; Bianch SD, 2007, ORAL SURG ORAL MED O, V104, P249, DOI 10.1016/j.tripleo.2007.01.040; Bonacina R, 2011, J CAN DENT ASSOC, V77, P1; Bonomi M, 2010, MED ONCOL, V27, P224, DOI 10.1007/s12032-009-9195-y; Capalbo S, 2006, INT J HEMATOL, V83, P439, DOI 10.1532/IJH97.E0536; Cella L, 2011, HEAD FACE MED, V7, DOI 10.1186/1746-160X-7-16; Cetiner S, 2009, J BONE MINER METAB, V27, P435, DOI 10.1007/s00774-009-0047-9; Clarke BM, 2007, OTOLARYNG HEAD NECK, V136, P396, DOI 10.1016/j.otohns.2006.11.008; Conte Neto Nicolau, 2013, Int J Exp Pathol, V94, P65, DOI 10.1111/iep.12007; Crawford BS, 2009, CANCER INVEST, V27, P984, DOI 10.3109/07357900902783203; Dhanrajani P J, 2008, Dent Update, V35, P642; Dhanrajani PJ, 2007, DENT UPDATE, V34, P573; Ding XY, 2012, BREAST, V21, P544, DOI 10.1016/j.breast.2012.04.008; Ertas Umit, 2010, Eur J Dent, V4, P334; Fellows JL, 2011, J DENT RES, V90, P433, DOI 10.1177/0022034510387795; Felsenberg D, 2006, NAT CLIN PRACT ENDOC, V2, P662, DOI 10.1038/ncpendmet0348; Ferlito S, 2011, J ORAL MAXIL SURG, V69, pE1, DOI 10.1016/j.joms.2010.10.055; Fitzpatrick SG, 2012, J ORAL MAXIL SURG, V70, P325, DOI 10.1016/j.joms.2011.02.049; Flaitz C M, 2000, Tex Dent J, V117, P40; Flaitz CM, 2000, TEX DENT J, V117, P40; Froelich K, 2011, EUR ARCH OTO-RHINO-L, V268, P1219, DOI 10.1007/s00405-011-1496-z; Ganguly S, 2012, CLIN TRANSPLANT, V26, P447, DOI 10.1111/j.1399-0012.2011.01527.x; Grbic JT, 2008, J AM DENT ASSOC, V139, P32; Guarneri V, 2005, ONCOLOGIST, V10, P842, DOI 10.1634/theoncologist.10-10-842; Haidar A, 2009, SCAND J UROL NEPHROL, V43, P442, DOI 10.3109/00365590903295193; Hines SL, 2009, BREAST CANCER RES TR, V117, P603, DOI 10.1007/s10549-009-0332-2; Hoefert S, 2011, J ORAL MAXIL SURG, V69, P362, DOI 10.1016/j.joms.2010.06.200; Huang JS, 2005, BRIT J ORAL MAX SURG, V43, P532, DOI 10.1016/j.bjoms.2005.05.012; Ibrahim T, 2008, ONCOLOGIST, V13, P330, DOI 10.1634/theoncologist.2007-0159; Israeli RS, 2007, CLIN GENITOURIN CANC, V5, P271, DOI 10.3816/CGC.2007.n.003; Iwamoto J, 2011, DIABETES RES CLIN PR, V93, P166, DOI 10.1016/j.diabres.2011.03.033; Jackson Iain, 2007, Dent Update, V34, P573; Ji X, 2012, ORAL DIS, V18, P85, DOI 10.1111/j.1601-0825.2011.01848.x; Kessler HP, 2005, TEX DENT J, V122, P206; Kessler Harvey P, 2005, Tex Dent J, V122, P198; Kharazmi M, 2013, J CRANIOFAC SURG, V24, P2218, DOI 10.1097/SCS.0b013e3182a24846; Kharazmi M, 2013, BRIT J ORAL MAX SURG, V51, pE285, DOI 10.1016/j.bjoms.2013.02.013; Khosla S, 2007, J BONE MINER RES, V22, P1479, DOI 10.1359/JBMR.0707ONJ; Kucukzeybek Y, 2010, UHOD-ULUSLAR HEMATOL, V20, P135; Kwon YD, 2011, CLIN ORAL IMPLAN RES, V22, P100, DOI 10.1111/j.1600-0501.2010.01965.x; Kwon YD, 2009, J ORAL MAXIL SURG, V67, P2644, DOI 10.1016/j.joms.2009.04.067; La VN, 2008, SUPPORT CARE CANCER, V16, P1311; Landesberg R, 2011, ANN NY ACAD SCI, V1218, P62, DOI 10.1111/j.1749-6632.2010.05835.x; Lee CYS, 2010, IMPLANT DENT, V19, P29, DOI 10.1097/ID.0b013e3181cec8bc; Lehrer S, 2009, J ORAL MAXIL SURG, V67, P159, DOI 10.1016/j.joms.2008.09.015; Lipton A, 2006, CLIN CANCER RES, V12, p6209S, DOI 10.1158/1078-0432.CCR-06-1213; Lipton A, 2006, CLIN CANCER RES, V12, p6305S, DOI 10.1158/1078-0432.CCR-06-1157; Marini Francesca, 2011, Front Biosci (Elite Ed), V3, P364, DOI 10.2741/e251; Maurer P, 2011, INT J ORAL MAX SURG, V40, P285, DOI 10.1016/j.ijom.2010.11.006; Meghji S, 1998, BRIT J RHEUMATOL, V37, P1095; Mozzati M, 2012, ORAL ONCOL, V48, P469, DOI 10.1016/j.oraloncology.2011.12.004; Narongroeknawin Pongthorn, 2010, Spec Care Dentist, V30, P77, DOI 10.1111/j.1754-4505.2009.00128.x; Neville BW, 2009, ORAL MAXILLOFACIAL P; Nicolatou-Galitis O, 2011, ORAL SURG ORAL MED O, V112, P195, DOI 10.1016/j.tripleo.2011.02.037; O'Connell JE, 2012, IRISH J MED SCI, V181, P237, DOI 10.1007/s11845-011-0790-5; Ortega C, 2007, ACTA ONCOL, V46, P664, DOI 10.1080/02841860601185917; Otto S, 2009, J ORAL MAXIL SURG, V67, P589, DOI 10.1016/j.joms.2008.09.028; Pabst AM, 2012, CLIN ORAL INVEST, V16, P87, DOI 10.1007/s00784-010-0507-6; Pazianas M, 2008, OSTEOPOROSIS INT, V19, P773, DOI 10.1007/s00198-007-0502-1; Peddi P, 2013, CANCER TREAT REV, V39, P97, DOI 10.1016/j.ctrv.2012.07.002; Phal PM, 2007, AM J NEURORADIOL, V28, P1139, DOI 10.3174/ajnr.A0518; Polizzotto MN, 2006, BRIT J HAEMATOL, V132, P114, DOI 10.1111/j.1365-2141.2005.05833.x; Powell D, 2012, QJM-INT J MED, V105, P965, DOI 10.1093/qjmed/hcs112; Ria R, 2013, INT J CLIN EXP MED, V6, P30; Ruggiero SL, 2014, J ORAL MAXIL SURG, V72, P1938, DOI 10.1016/j.joms.2014.04.031; Ruggiero SL, 2009, AUST ENDOD J, V35, P119, DOI 10.1111/j.1747-4477.2009.00213.x; Safra T, 2011, ONCOLOGY-BASEL, V81, P298, DOI 10.1159/000334456; Salzman R, 2013, OTOL NEUROTOL, V34, P209, DOI 10.1097/MAO.0b013e31827ca34d; Sanna G, 2006, ANN ONCOL, V17, P1512, DOI 10.1093/annonc/mdl163; Schiodt M, 2014, OR SURG OR MED OR PA, V117, P204, DOI 10.1016/j.oooo.2013.10.010; Scoletta M, 2011, J ORAL MAXIL SURG, V69, P456, DOI 10.1016/j.joms.2010.07.026; Scully C, 2002, BRIT DENT J, V192, P139, DOI 10.1038/sj.bdj.4801315a; Sedghizadeh PP, 2012, OR SURG OR MED OR PA, V114, P764, DOI 10.1016/j.oooo.2012.08.444; Sharma Dileep, 2013, Vasc Cell, V5, P1, DOI 10.1186/2045-824X-5-1; Soki FN, 2013, J CELL BIOCHEM, V114, P67, DOI 10.1002/jcb.24301; Suei Y, 2013, ORAL RADIOL, V29, P121, DOI 10.1007/s11282-013-0135-3; Tassinari D, 2007, J PALLIAT MED, V10, P352, DOI 10.1089/jpm.2006.0122; Taylor T, 2013, BRIT DENT J, V214, DOI 10.1038/sj.bdj.2013.327; Thumbigere-Math V, 2012, AM J CLIN ONCOL-CANC, V35, P386, DOI 10.1097/COC.0b013e3182155fcb; Troeltzsch M, 2012, J CAN DENT ASSOC, V78; Van den Wyngaert T, 2011, SUPPORT CARE CANCER, V19, P2035, DOI 10.1007/s00520-010-1061-0; Vescovi P, 2011, ORAL ONCOL, V47, P191, DOI 10.1016/j.oraloncology.2010.11.007; Vestergaard P, 2012, J ORAL MAXIL SURG, V70, P821, DOI 10.1016/j.joms.2011.02.093; von Minckwitz G, 2010, EJC SUPPL, V8, P65, DOI 10.1016/S1359-6349(10)70055-0; Walter C, 2009, CANCER, V115, P1631, DOI 10.1002/cncr.24119; Walter C, 2010, HEAD FACE MED, V6, DOI 10.1186/1746-160X-6-11; White S, 2008, ORAL RADIOLOGY; Wickham N, 2013, J LARYNGOL OTOL, V127, pS51, DOI 10.1017/S002221511300100X; Wutzl A, 2012, HEAD NECK-J SCI SPEC, V34, P194, DOI 10.1002/hed.21708; Yamashita Junro, 2012, J Evid Based Dent Pract, V12, P233, DOI 10.1016/S1532-3382(12)70046-5; Young J, 2013, BREAST, V22, P495, DOI 10.1016/j.breast.2012.09.012; Zadik Y, 2012, QUINTESSENCE INT, V43, P97	302	21	25	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0884-0431	1523-4681		J BONE MINER RES	J. Bone Miner. Res.	JAN	2015	30	1					3	23		10.1002/jbmr.2405		21	Endocrinology & Metabolism	Endocrinology & Metabolism	AX4PR	WOS:000346914600002		
J	Kawakami, Y; Ii, M; Matsumoto, T; Kuroda, R; Kuroda, T; Kwon, SM; Kawamoto, A; Akimaru, H; Mifune, Y; Shoji, T; Fukui, T; Kurosaka, M; Asahara, T				Kawakami, Yohei; Ii, Masaaki; Matsumoto, Tomoyuki; Kuroda, Ryosuke; Kuroda, Tomoya; Kwon, Sang-Mo; Kawamoto, Atsuhiko; Akimaru, Hiroshi; Mifune, Yutaka; Shoji, Taro; Fukui, Tomoaki; Kurosaka, Masahiro; Asahara, Takayuki			SDF-1/CXCR4 Axis in Tie2-Lineage Cells Including Endothelial Progenitor Cells Contributes to Bone Fracture Healing	JOURNAL OF BONE AND MINERAL RESEARCH			English	Article						FRACTURE HEALING; CX CHEMOKINE RECEPTOR 4 (CXCR4); STROMAL-DERIVED FACTOR-1 (SDF-1); KNOCKOUT MICE; ENDOTHELIAL PROGENITOR CELL (EPC)	MESENCHYMAL STEM-CELLS; CHEMOKINE RECEPTOR CXCR4; LOCAL TRANSPLANTATION; CD34-POSITIVE CELLS; STIMULATING FACTOR; MOLECULAR-CLONING; DELAYED UNION; MOUSE MODEL; MARROW; MICE	CXC chemokine receptor 4 (CXCR4) is a specific receptor for stromal-derived-factor 1 (SDF-1). SDF-1/CXCR4 interaction is reported to play an important role in vascular development. On the other hand, the therapeutic potential of endothelial progenitor cells (EPCs) in fracture healing has been demonstrated with mechanistic insight of vasculogenesis/angiogenesis and osteogenesis enhancement at sites of fracture. The purpose of this study was to investigate the influence of the SDF-1/CXCR4 pathway in Tie2-lineage cells (including EPCs) in bone formation. We created CXCR4 gene conditional knockout mice using the Cre/loxP system and set two groups of mice: Tie2-Cre(ER) CXCR4 knockout mice (CXCR4(-/-)) and wild-type mice (WT). We report here that in vitro, EPCs derived from of CXCR4(-/-) mouse bone marrow demonstrated severe reduction of migration activity and EPC colony-forming activity when compared with those derived from WT mouse bone marrow. In vivo, radiological and morphological examinations showed fracture healing delayed in the CXCR4(-/-) group and the relative callus area at weeks 2 and 3 was significantly smaller in CXCR4(-/-) group mice. Quantitative analysis of capillary density at perifracture sites also showed a significant decrease in the CXCR4(-/-) group. Especially, CXCR4(-/-)group mice demonstrated significant early reduction of blood flow recovery at fracture sites compared with the WT group in laser Doppler perfusion imaging analysis. Real-time RT-PCR analysis showed that the gene expressions of angiogenic markers (CD31, VE-cadherin, vascular endothelial growth factor [VEGF]) and osteogenic markers (osteocalcin, collagen 1A1, bone morphogenetic protein 2 [BMP2]) were lower in the CXCR4(-/-) group. In the gain-of-function study, the fracture in the SDF-1 intraperitoneally injected WT group healed significantly faster with enough callus formation compared with the SDF-1 injected CXCR4(-/-) group. We demonstrated that an EPC SDF-1/CXCR4 axis plays an important role in bone fracture healing using Tie2-Cre(ER) CXCR4 conditional knockout mice. (c) 2014 American Society for Bone and Mineral Research.	[Kawakami, Yohei; Matsumoto, Tomoyuki; Kuroda, Tomoya; Kawamoto, Atsuhiko; Akimaru, Hiroshi; Mifune, Yutaka; Shoji, Taro; Fukui, Tomoaki; Asahara, Takayuki] Inst Biomed Res & Innovat, Grp Vasc Regenerat, Kobe, Hyogo 6500047, Japan; [Kawakami, Yohei; Matsumoto, Tomoyuki; Kuroda, Ryosuke; Mifune, Yutaka; Shoji, Taro; Fukui, Tomoaki; Kurosaka, Masahiro] Kobe Univ, Grad Sch Med, Dept Orthopaed Surg, Kobe, Hyogo 657, Japan; [Ii, Masaaki] Osaka Med Coll, Fac Med, Dept Pharmacol, Takatsuki, Osaka 5968686, Japan; [Asahara, Takayuki] Tokai Univ, Sch Med, Dept Regenerat Med Sci, Isehara, Kanagawa 25911, Japan; [Kwon, Sang-Mo] Pusan Natl Univ, Sch Med, Dept Physiol, Yangsan, South Korea	Asahara, T (reprint author), Inst Biomed Res & Innovat, Grp Vasc Regenerat, Chuo Ku, 2-2 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	masaii@art.osaka-med.ac.jp; asa777@is.icc.u-tokai.ac.jp					Matsumoto T, 2008, J CELL PHYSIOL, V215, P234, DOI 10.1002/jcp.21309; WARDELL K, 1993, IEEE T BIO-MED ENG, V40, P309, DOI 10.1109/10.222322; Kucia M, 2004, J MOL HISTOL, V35, P233; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269; Grewal TS, 2000, FASEB J, V14, P523; Granero-Molto F, 2009, STEM CELLS, V27, P1887, DOI 10.1002/stem.103; De Falco E, 2004, BLOOD, V104, P3472, DOI 10.1182/blood-2003-12-4423; Kitaori T, 2009, ARTHRITIS RHEUM-US, V60, P813, DOI 10.1002/art.24330; Zhu W, 2007, J BIOL CHEM, V282, P18676, DOI 10.1074/jbc.M610232200; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Marsh D, 1998, CLIN ORTHOP RELAT R, pS22; Matsumoto T, 2006, AM J PATHOL, V169, P1440, DOI 10.2353/ajpath.2006.060064; Fukui T, 2012, J BONE MINER RES, V27, P1118, DOI 10.1002/jbmr.1558; Matsumoto T, 2008, BONE, V43, P434, DOI 10.1016/j.bone.2008.05.001; Laing AJ, 2007, J BONE JOINT SURG BR, V89B, P116, DOI 10.1302/0301-620X.89B1.18222; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Hodohara K, 2000, BLOOD, V95, P769; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annutev.med.57.121304.131306; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; ARAKI K, 1995, P NATL ACAD SCI USA, V92, P160, DOI 10.1073/pnas.92.1.160; Manigrasso MB, 2004, J ORTHOP TRAUMA, V18, P687, DOI 10.1097/00005131-200411000-00006; Otsuru S, 2008, STEM CELLS, V26, P223, DOI 10.1634/stemcells.2007-0515; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Chen T, 2007, STEM CELLS, V25, P392, DOI 10.1634/stemcells.2006-0145; Kawao N, 2013, J BONE MINER RES, V28, P1561, DOI 10.1002/jbmr.1921; Kawakami Y, 2012, CELL TRANSPLANT, V21, P2689, DOI 10.3727/096368912X654920; Otsuru S, 2007, BIOCHEM BIOPH RES CO, V354, P453, DOI 10.1016/j.bbrc.2006.12.226; Moutsatsos IK, 2001, MOL THER, V3, P449, DOI 10.1006/mthe.2001.0291; Lu CY, 2007, J ORTHOP RES, V25, P51, DOI 10.1002/jor.20264; Masuda H, 2011, CIRC RES, V109, P20, DOI 10.1161/CIRCRESAHA.110.231837; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Mifune Y, 2008, STEM CELLS, V26, P1395, DOI 10.1634/stemcells.2007-0820; Shoji T, 2010, LAB INVEST, V90, P637, DOI 10.1038/labinvest.2010.39; Gupta SK, 1999, J IMMUNOL, V163, P2368; NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22; Lee DY, 2008, BONE, V42, P932, DOI 10.1016/j.bone.2008.01.007; Bouvard C, 2012, CARDIOVASC RES, V95, P39, DOI 10.1093/cvr/cvs153; Cho SW, 2009, MOL THER, V17, P1979, DOI 10.1038/mt.2009.153; Chung SH, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3158; Colnot CI, 2001, MECH DEVELOP, V100, P245, DOI 10.1016/S0925-4773(00)00532-3; HAMMER RRR, 1985, CLIN ORTHOP RELAT R, P233; Ii M, 2010, METHODS MOL BIOL, V660, P9, DOI 10.1007/978-1-60761-705-1_2; Kwon SM, 2008, CIRCULATION, V118, P157, DOI 10.1161/CIRCULATIONAHA.107.754978; LINDEN M, 1995, AM J PHYSIOL-HEART C, V269, pH1496; Makino Y, 2013, BONE, V53, P248, DOI 10.1016/j.bone.2012.11.033; Onai N, 2000, BLOOD, V96, P2074; Rodriguez-Merchan EC, 2004, CLIN ORTHOP RELAT R, P4, DOI 10.1097/00003086-200402000-00003; Tsukada S, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt168	49	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0884-0431	1523-4681		J BONE MINER RES	J. Bone Miner. Res.	JAN	2015	30	1					95	105		10.1002/jbmr.2318		11	Endocrinology & Metabolism	Endocrinology & Metabolism	AX4PR	WOS:000346914600011		
J	Sakai, S; Suzuki, M; Tashiro, Y; Tanaka, K; Takeda, S; Aizawa, K; Hirata, M; Yogo, K; Endo, K				Sakai, Sadaoki; Suzuki, Miho; Tashiro, Yoshihito; Tanaka, Keisuke; Takeda, Satoshi; Aizawa, Ken; Hirata, Michinori; Yogo, Kenji; Endo, Koichi			Vitamin D Receptor Signaling Enhances Locomotive Ability in Mice	JOURNAL OF BONE AND MINERAL RESEARCH			English	Article						PRECLINICAL STUDIES; SARCOPENIA	RANDOMIZED CONTROLLED-TRIALS; OSTEOPOROTIC FRACTURES; PREDICT MORTALITY; GROWTH-HORMONE; SCHWANN-CELLS; D ANALOG; WOMEN; BONE; EXPRESSION; MUSCLE	Bone fractures markedly reduce quality of life and life expectancy in elderly people. Although osteoporosis increases bone fragility, fractures frequently occur in patients with normal bone mineral density. Because most fractures occur on falling, preventing falls is another focus for reducing bone fractures. In this study, we investigated the role of vitamin D receptor (VDR) signaling in locomotive ability. In the rotarod test, physical exercise enhanced locomotive ability of wild-type (WT) mice by 1.6-fold, whereas exercise did not enhance locomotive ability of VDR knockout (KO) mice. Compared with WT mice, VDR KO mice had smaller peripheral nerve axonal diameter and disordered AChR morphology on the extensor digitorum longus muscle. Eldecalcitol (ED-71, ELD), an analog of 1,25(OH)(2)D-3, administered to rotarod-trained C57BL/6 mice enhanced locomotor performance compared with vehicle-treated nontrained mice. The area of AChR cluster on the extensor digitorum longus was greater in ELD-treated mice than in vehicle-treated mice. ELD and 1,25(OH)(2)D-3 enhanced expression of IGF-1, myelin basic protein, and VDR in rat primary Schwann cells. VDR signaling regulates neuromuscular maintenance and enhances locomotive ability after physical exercise. Further investigation is required, but Schwann cells and the neuromuscular junction are targets of vitamin D-3 signaling in locomotive ability. (c) 2014 American Society for Bone and Mineral Research.	[Sakai, Sadaoki; Suzuki, Miho; Tashiro, Yoshihito; Tanaka, Keisuke; Takeda, Satoshi; Aizawa, Ken; Hirata, Michinori; Yogo, Kenji; Endo, Koichi] Chugai Pharmaceut Co Ltd, Prod Res Dept, Fuji Gotemba Res Labs, Gotemba, Japan	Endo, K (reprint author), Chugai Pharmaceut Co Ltd, Prod Res Dept, 1-135 Komakado, Shizuoka 4128513, Japan.	endokui@chugai-pharm.co.jp					Andersen NB, 2000, EUR J ENDOCRINOL, V143, P409, DOI 10.1530/eje.0.1430409; DOHERTY TJ, 1993, J APPL PHYSIOL, V74, P868; Bischoff-Ferrari HA, 2005, JAMA-J AM MED ASSOC, V293, P2257, DOI 10.1001/jama.293.18.2257; Bischoff-Ferrari HA, 2004, JAMA-J AM MED ASSOC, V291, P1999, DOI 10.1001/jama.291.16.1999; Garcia LA, 2011, ENDOCRINOLOGY, V152, P2976, DOI 10.1210/en.2011-0159; Dennison E, 2000, HORM RES, V54, P58, DOI 10.1159/000053299; Faulkner KA, 2006, OSTEOPOROSIS INT, V17, P1318, DOI 10.1007/s00198-006-0071-8; Nguyen ND, 2007, J BONE MINER RES, V22, P1147, DOI 10.1359/JBMR.070412; Sakai S, 2009, J BONE MINER METAB, V27, P643, DOI 10.1007/s00774-009-0084-4; Matsumoto T, 2011, BONE, V49, P605, DOI 10.1016/j.bone.2011.07.011; Takasu H, 2006, J CLIN INVEST, V116, P528, DOI 10.1172/JCI24742; Pellitteri R, 2006, BRAIN RES, V1069, P139, DOI 10.1016/j.brainres.2005.11.049; Nakamura K, 2008, J ORTHOP SCI, V13, P1, DOI 10.1007/s00776-007-1202-6; Apel PJ, 2009, J ORTHOP RES, V27, P385, DOI 10.1002/jor.20773; Harada S, 2012, J BONE MINER RES, V27, P461, DOI 10.1002/jbmr.555; Melcangi RC, 1998, NEUROSCIENCE, V85, P569, DOI 10.1016/S0306-4522(97)00628-3; Endo I, 2003, ENDOCRINOLOGY, V144, P5138, DOI 10.1210/en.2003-0502; Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391; Kikuta J, 2013, P NATL ACAD SCI USA, V110, P7009, DOI [10.1073/pnas.1218799110, 10.1073/1218799110]; Apel PJ, 2010, MUSCLE NERVE, V41, P335, DOI 10.1002/mus.21485; Nakamura K, 2011, J ORTHOP SCI, V16, P489, DOI 10.1007/s00776-011-0108-5; Carlberg C, 2006, ANTICANCER RES, V26, P2637; Cheng HL, 1996, J NEUROCHEM, V66, P525; Clark Brian C, 2011, Curr Aging Sci, V4, P192; Bischoff-Ferrari HA, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3692; Ensrud KE, 2000, J AM GERIATR SOC, V48, P241; Gao WQ, 1999, J NEUROBIOL, V39, P142, DOI 10.1002/(SICI)1097-4695(199904)39:1<142::AID-NEU11>3.0.CO;2-H; GARDSELL P, 1989, CALCIFIED TISSUE INT, V45, P327, DOI 10.1007/BF02556001; Payne AM, 2006, J PHYSIOL-LONDON, V570, P283, DOI 10.1113/jphysiol.2005.100032; PETERSON AC, 1984, J COMP NEUROL, V227, P348, DOI 10.1002/cne.902270305; Vega SR, 2010, HORM METAB RES, V42, P982, DOI 10.1055/s-0030-1267950; Toogood AA, 1998, BAILLIERE CLIN ENDOC, V12, P281, DOI 10.1016/S0950-351X(98)80023-2; Uchiyama Y, 2002, BONE, V30, P582, DOI 10.1016/S8756-3282(02)00682-8; WHO, 1994, WHO TECHNICAL REPORT, V843, P1; Zhu TS, 2008, BRAIN RES, V1206, P20, DOI 10.1016/j.brainres.2008.02.051	35	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0884-0431	1523-4681		J BONE MINER RES	J. Bone Miner. Res.	JAN	2015	30	1					128	136		10.1002/jbmr.2317		9	Endocrinology & Metabolism	Endocrinology & Metabolism	AX4PR	WOS:000346914600014		
J	Yamauchi, S; Obara, K; Uchibori, K; Kamimura, A; Azumi, K; Kihara, A				Yamauchi, Saori; Obara, Keisuke; Uchibori, Kenya; Kamimura, Akiko; Azumi, Kaoru; Kihara, Akio			Opt2 mediates the exposure of phospholipids during cellular adaptation to altered lipid asymmetry	JOURNAL OF CELL SCIENCE			English	Article						Lipid asymmetry; Plasma membrane; Phospholipid; Yeast	P-TYPE ATPASE; DIRECTING VACUOLAR MORPHOGENESIS; YEAST PLASMA-MEMBRANE; SACCHAROMYCES-CEREVISIAE; RIM101 PATHWAY; AMBIENT PH; GENE-EXPRESSION; PHOSPHATIDYLETHANOLAMINE; PROTEINS; MUTANTS	Plasma membrane lipid asymmetry is important for various membrane-associated functions and is regulated by membrane proteins termed flippases and floppases. The Rim101 pathway senses altered lipid asymmetry in the yeast plasma membrane. The mutant lem3 Delta cells, in which lipid asymmetry is disturbed owing to the inactivation of the plasma membrane flippases, showed a severe growth defect when the Rim101 pathway was impaired. To identify factors involved in the Rim101-pathway-dependent adaptation to altered lipid asymmetry, we performed DNA microarray analysis and found that Opt2 induced by the Rim101 pathway plays an important role in the adaptation to altered lipid asymmetry. Biochemical investigation of Opt2 revealed its localization to the plasma membrane and the Golgi, and provided several lines of evidence for the Opt2-mediated exposure of phospholipids. In addition, Opt2 was found to be required for the maintenance of vacuolar morphology and polarized cell growth. These results suggest that Opt2 is a novel factor involved in cell homeostasis by regulating lipid asymmetry.	[Yamauchi, Saori; Obara, Keisuke; Uchibori, Kenya; Kamimura, Akiko; Azumi, Kaoru; Kihara, Akio] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan	Obara, K (reprint author), Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan.	obarak@pharm.hokudai.ac.jp; kihara@pharm.hokudai.ac.jp	Obara, Keisuke/A-3824-2012; KIHARA, AKIO/A-3802-2012	KIHARA, AKIO/0000-0001-5889-0788	Japan Society for the Promotion of Science [25650059];  [25440038];  [23770135]	This work was supported by a Grant-in-Aid for Scientific Research (C) [grant number 25440038], a Grant-in-Aid for Young Scientists (B) [grant number 23770135] to K.O. and a Grant-in-Aid for Challenging Exploratory Research [grant number 25650059] to A.Kihara from the Japan Society for the Promotion of Science.	Baldridge RD, 2012, P NATL ACAD SCI USA, V109, pE290, DOI 10.1073/pnas.1115725109; DEVAUX PF, 1991, BIOCHEMISTRY-US, V30, P1163, DOI 10.1021/bi00219a001; WADA Y, 1992, J BIOL CHEM, V267, P18665; Zhao M, 2008, J NUCL MED, V49, P1345, DOI 10.2967/jnumed.107.048603; Ikeda M, 2006, BIOL PHARM BULL, V29, P1542, DOI 10.1248/bpb.29.1542; Saito K, 2007, DEV CELL, V13, P743, DOI 10.1016/j.devcel.2007.09.014; Causton HC, 2001, MOL BIOL CELL, V12, P323; RAYMOND CK, 1992, INT REV CYTOL, V139, P59, DOI 10.1016/S0074-7696(08)61410-2; Kihara A, 2002, J BIOL CHEM, V277, P30048, DOI 10.1074/jbc.M203385200; Ikeda M, 2008, MOL BIOL CELL, V19, P1922, DOI 10.1091/mbc.E07-08-0806; SIKORSKI RS, 1989, GENETICS, V122, P19; Emoto K, 2000, J CELL BIOL, V149, P1215, DOI 10.1083/jcb.149.6.1215; Penalva MA, 2004, ANNU REV MICROBIOL, V58, P425, DOI 10.1146/annurev.micro.58.030603.123715; Lubkowitz MA, 1998, MOL MICROBIOL, V28, P729, DOI 10.1046/j.1365-2958.1998.00827.x; Iwamoto K, 2004, GENES CELLS, V9, P891, DOI 10.1111/j.1365-2443.2004.00782.x; FADOK VA, 1992, J IMMUNOL, V148, P2207; Hua ZL, 2002, MOL BIOL CELL, V13, P3162, DOI 10.1091/mbc.E02-03-0172; Obara K, 2012, J BIOL CHEM, V287, P38473, DOI 10.1074/jbc.M112.394205; Furuta N, 2007, MOL BIOL CELL, V18, P295, DOI 10.1091/mbc.E06-05-0461; Ohya Y, 2005, P NATL ACAD SCI USA, V102, P19015, DOI 10.1073/pnas.0509436102; Toti F, 1996, BLOOD, V87, P1409; VALLS LA, 1987, CELL, V48, P887, DOI 10.1016/0092-8674(87)90085-7; Chen CY, 1999, J CELL BIOL, V147, P1223, DOI 10.1083/jcb.147.6.1223; Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; Gurtovenko AA, 2008, J PHYS CHEM B, V112, P4629, DOI 10.1021/jp8001993; Castrejon F, 2006, EUKARYOT CELL, V5, P507, DOI 10.1128/EC.5.3.507-517.2006; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Verkleij AJ, 2000, J MEMBRANE BIOL, V178, P1, DOI 10.1007/s002320010009; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Decottignies A, 1998, J BIOL CHEM, V273, P12612, DOI 10.1074/jbc.273.20.12612; Penalva MA, 2002, MICROBIOL MOL BIOL R, V66, P426, DOI 10.1128/MMBR.66.3.426-446.2002; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Lamb TM, 2003, MOL CELL BIOL, V23, P677, DOI 10.1128/MCB.23.2.677-686.2003; Kihara A, 2004, MOL BIOL CELL, V15, P4949, DOI 10.1091/mbc.E04-06-0458; Lamb TM, 2001, J BIOL CHEM, V276, P1850; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Obara K, 2014, MOL CELL BIOL, V34, P3525, DOI 10.1128/MCB.00408-14; Francois J, 2001, FEMS MICROBIOL REV, V25, P125, DOI 10.1016/S0168-6445(00)00059-0; SEIGNEURET M, 1984, P NATL ACAD SCI-BIOL, V81, P3751, DOI 10.1073/pnas.81.12.3751; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; WADA Y, 1992, J BIOL CHEM, V267, P18671; Aouida M, 2009, BIOCHEM CELL BIOL, V87, P653, DOI [10.1139/o09-045, 10.1139/O09-045]; KLIONSKY DJ, 1989, EMBO J, V8, P2241; Noji T, 2006, BIOCHEM BIOPH RES CO, V344, P323, DOI 10.1016/j.bbrc.2006.03.095; Serrano R, 2002, MOL MICROBIOL, V46, P1319, DOI 10.1046/j.1365-2958.2002.03246.x; Yamagata M, 2011, BIOCHEM BIOPH RES CO, V410, P786, DOI 10.1016/j.bbrc.2011.06.061	50	1	1	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0021-9533	1477-9137		J CELL SCI	J. Cell Sci.	JAN 1	2015	128	1					61	69		10.1242/jcs.153890		9	Cell Biology	Cell Biology	AX8NY	WOS:000347167200008		
J	Liu, CT; Shige, S; Takayabu, YN; Zipser, E				Liu, Chuntao; Shige, Shoichi; Takayabu, Yukari N.; Zipser, Edward			Latent Heating Contribution from Precipitation Systems with Different Sizes, Depths, and Intensities in the Tropics	JOURNAL OF CLIMATE			English	Article							TRMM PR DATA; LARGE-SCALE CIRCULATIONS; SPECTRAL RETRIEVAL; RAINFALL CHARACTERISTICS; PART I; TEMPORAL VARIATION; DIURNAL-VARIATION; MOISTURE BUDGETS; EASTERN PACIFIC; DEEP CONVECTION	Latent heating (LH) from precipitation systems with different sizes, depths, and convective intensities is quantified with 15 years of LH retrievals from version 7 Precipitation Radar (PR) products of the Tropical Rainfall Measuring Mission (TRMM). Organized precipitation systems, such as mesoscale convective systems (MCSs; precipitation area >2000 km(2)), contribute to 88% of the LH above 7 km over tropical land and 95% over tropical oceans. LH over tropical land is mainly from convective precipitation, and has one vertical mode with a peak from 4 to 7 km. There are two vertical modes of LH over tropical oceans. The shallow mode from about 1 to 4 km results from small, shallow, and weak precipitation systems, and partially from congestus clouds with radar echo top between 5 and 8 km. The deep mode from 5 to 9 km is mainly from stratiform precipitation in MCSs. MCSs of different regions and seasons have different LH vertical structure mainly due to the different proportion of stratiform precipitation. MCSs over ocean have a larger fraction of stratiform precipitation and a top-heavy LH structure. MCSs over land have a higher percentage of convective versus stratiform precipitation, which results in a relatively lower-level peak in LH compared to MCSs over the ocean. MCSs during monsoons have properties of LH in between those typical land and oceanic MCSs. Consistent with the diurnal variation of precipitation, tropical land has a stronger LH diurnal variation than tropical oceans with peak LH in the late afternoon. Over tropical oceans in the early morning, the shallow mode of LH peaks slightly earlier than the deep mode. There are almost no diurnal changes of MCSs LH over oceans. However, the small convective systems over land contribute a significant amount of LH at all vertical levels in the afternoon, when the contribution of MCSs is small.	[Liu, Chuntao] Texas A&M Univ, Dept Phys & Environm Sci, Corpus Christi, TX 78412 USA; [Shige, Shoichi] Kyoto Univ, Grad Sch Sci, Kyoto, Japan; [Takayabu, Yukari N.] Univ Tokyo, Atmosphere & Ocean Res Inst, Tokyo, Japan; [Zipser, Edward] Univ Utah, Dept Atmospher Sci, Salt Lake City, UT USA	Liu, CT (reprint author), Texas A&M Univ, Dept Phys & Environm Sci, 6300 Ocean Dr, Corpus Christi, TX 78412 USA.	chuntao.liu@tamucc.edu			NASA [NNX13AF73G, NNX11AG31G, NNX08AK28G]	The authors benefited from discussions with Dr. Robert Houze. The constructive comments of the three reviewers are appreciated and improved the clarity and readability of the manuscript. This research was supported by NASA Precipitation Measurement Mission Grants NNX13AF73G and NNX11AG31G under the direction of Dr. Ramesh Kakar and NASA Grant NNX08AK28G under the direction of Dr. Erich Stocker. Thanks also go to Drs. Erich Stocker and John Kwiatkowski and the rest of the Precipitation Processing System (PPS) team at NASA Goddard Space Flight Center, Greenbelt, MD, for data processing assistance.	Takayabu YN, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027531; Funk A, 2013, J METEOROL SOC JPN, V91, P257, DOI 10.2151/jmsj.2013-302; YANAI M, 1973, J ATMOS SCI, V30, P611, DOI 10.1175/1520-0469(1973)030<0611:DOBPOT>2.0.CO;2; Jakob C, 2008, J CLIMATE, V21, P4348, DOI 10.1175/2008JCLI2122.1; Schumacher C, 2007, J ATMOS SCI, V64, P2593, DOI 10.1175/JAS3938.1; Kummerow C, 1998, J ATMOS OCEAN TECH, V15, P809, DOI 10.1175/1520-0426(1998)015<0809:TTRMMT>2.0.CO;2; Tao WK, 2010, J CLIMATE, V23, P1874, DOI 10.1175/2009JCLI3278.1; Liu CT, 2009, J CLIMATE, V22, P767, DOI 10.1175/2008JCLI2641.1; HOUZE RA, 1989, Q J ROY METEOR SOC, V115, P425, DOI 10.1002/qj.49711548702; Liu CT, 2008, J APPL METEOROL CLIM, V47, P2712, DOI 10.1175/2008JAMC1890.1; Wall C, 2013, J GEOPHYS RES-ATMOS, V118, P6478, DOI 10.1002/jgrd.50455; Nesbitt SW, 2006, MON WEATHER REV, V134, P2702, DOI 10.1175/MWR3200.1; Awaka J, 2009, J METEOROL SOC JPN, V87A, P31, DOI 10.2151/jmsj.87A.31; Liu CT, 2011, J HYDROMETEOROL, V12, P394, DOI 10.1175/2010JHM1320.1; SIMPSON J, 1988, B AM METEOROL SOC, V69, P278, DOI 10.1175/1520-0477(1988)069<0278:APTRMM>2.0.CO;2; Lebsock MD, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016076; Shige S, 2009, J CLIMATE, V22, P5577, DOI 10.1175/2009JCLI2919.1; Shige S, 2007, J APPL METEOROL CLIM, V46, P1098, DOI 10.1175/JAM2510.1; Shige S, 2008, J APPL METEOROL CLIM, V47, P620, DOI 10.1175/2007JAMC1738.1; EMANUEL KA, 1994, Q J ROY METEOR SOC, V120, P1111, DOI 10.1002/qj.49712051902; Houze RA, 1997, B AM METEOROL SOC, V78, P2179, DOI 10.1175/1520-0477(1997)078<2179:SPIROC>2.0.CO;2; Nesbitt SW, 2003, J CLIMATE, V16, P1456, DOI 10.1175/1520-0442-16.10.1456; Zhang CD, 2004, J CLIMATE, V17, P133, DOI 10.1175/1520-0442(2004)017<0133:SMCITT>2.0.CO;2; Morita J, 2006, DYNAM ATMOS OCEANS, V42, P107, DOI 10.1016/j.dynatmoce.2006.02.002; THOMPSON RM, 1979, J ATMOS SCI, V36, P53, DOI 10.1175/1520-0469(1979)036<0053:SAPOSS>2.0.CO;2; Shige S, 2004, J APPL METEOROL, V43, P1095, DOI 10.1175/1520-0450(2004)043<1095:SROLHP>2.0.CO;2; Schumacher C, 2004, J ATMOS SCI, V61, P1341, DOI 10.1175/1520-0469(2004)061<1341:TTDRTL>2.0.CO;2; Liu CT, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017123; Johnson RH, 1999, J CLIMATE, V12, P2397, DOI 10.1175/1520-0442(1999)012<2397:TCOTC>2.0.CO;2; JOHNSON RH, 1976, J ATMOS SCI, V33, P1890, DOI 10.1175/1520-0469(1976)033<1890:TROCSP>2.0.CO;2; Cecil DJ, 2005, MON WEATHER REV, V133, P543, DOI 10.1175/MWR-2876.1; Zipser EJ, 2006, B AM METEOROL SOC, V87, P1057, DOI 10.1175/BAMS-87-8-1057; GRAY WM, 1977, MON WEATHER REV, V105, P1171, DOI 10.1175/1520-0493(1977)105<1171:DVODCC>2.0.CO;2; Takayabu YN, 2010, J CLIMATE, V23, P2030, DOI 10.1175/2009JCLI3110.1; Tao WK, 2006, B AM METEOROL SOC, V87, P1555, DOI 10.1175/BAMS-87-11-1555; Schumacher C, 2003, J CLIMATE, V16, P1739, DOI 10.1175/1520-0442(2003)016<1739:SRITTA>2.0.CO;2; NITTA T, 1974, MON WEATHER REV, V102, P17, DOI 10.1175/1520-0493(1974)102<0017:HAMBAU>2.0.CO;2; Arakawa A., 1975, GARP PUBL SER, V16, P183; AUGUSTINE JA, 1984, MON WEATHER REV, V112, P1745, DOI 10.1175/1520-0493(1984)112<1745:TDVOLS>2.0.CO;2; AWAKA J., 1998, P 8 URSI COMM F OP S, P143; Del Genio AD, 2012, SURV GEOPHYS, V33, P637, DOI 10.1007/s10712-011-9148-9; FRANK WM, 1989, J ATMOS SCI, V46, P3464, DOI 10.1175/1520-0469(1989)046<3464:TVDOHI>2.0.CO;2; Fu YF, 2007, J APPL METEOROL CLIM, V46, P667, DOI 10.1175/JAM2484.1; Hall TJ, 1999, J ATMOS SCI, V56, P3401, DOI 10.1175/1520-0469(1999)056<3401:TDCOWP>2.0.CO;2; Houze R. A.  Jr., 2004, Reviews of Geophysics, V42, DOI 10.1029/2004RG000150; Imaoka K, 2013, SOLA, V9, P51, DOI 10.2151/sola.2013-012; JOHNSON RH, 1984, MON WEATHER REV, V112, P1590, DOI 10.1175/1520-0493(1984)112<1590:PTHAMB>2.0.CO;2; Liu CT, 2013, J GEOPHYS RES-ATMOS, V118, P453, DOI 10.1029/2012JD018409; Mapes B, 2011, J ADV MODEL EARTH SY, V3, DOI 10.1029/2011MS000042; Mapes BE, 2003, J ATMOS SCI, V60, P2697, DOI 10.1175/1520-0469(2003)060<2697:SEIRB>2.0.CO;2; Riehl H., 1958, GEOPHYSICA, V6, P503; Dias MAFS, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000335; Xu WX, 2009, MON WEATHER REV, V137, P4261, DOI 10.1175/2009MWR2982.1; YANAI M, 1993, REPRESENTATION CUMUL, V46, P39; Yokoyama C, 2014, J CLIMATE, V27, P5575, DOI 10.1175/JCLI-D-13-00315.1; Zhang CD, 2010, J ATMOS SCI, V67, P3488, DOI 10.1175/2010JAS3398.1; Zipser E. J., 2003, METEOROL MONOGR, V51, P49	57	1	1	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0894-8755	1520-0442		J CLIMATE	J. Clim.	JAN	2015	28	1					186	203		10.1175/JCLI-D-14-00370.1		18	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	AX6XJ	WOS:000347061200011		
J	Takatama, K; Minobe, S; Inatsu, M; Small, RJ				Takatama, Kohei; Minobe, Shoshiro; Inatsu, Masaru; Small, R. Justin			Diagnostics for Near-Surface Wind Response to the Gulf Stream in a Regional Atmospheric Model	JOURNAL OF CLIMATE			English	Article							AIR-SEA INTERACTION; EASTERN EQUATORIAL PACIFIC; BOUNDARY-LAYER; SATELLITE-OBSERVATIONS; CLIMATE MODELS; SST VARIATIONS; IN-SITU; TEMPERATURE; OCEAN; EXTENSION	The mechanisms acting on near-surface winds over the Gulf Stream are diagnosed using 5-yr outputs of a regional atmospheric model. The diagnostics for the surface-layer momentum vector, its curl, and its convergence are developed with a clear separation of pressure adjustment from downward momentum inputs from aloft in the surface-layer system. The results suggest that the downward momentum mixing mechanism plays a dominant role in contributing to the annual-mean climatological momentum curl, whereas the pressure adjustment mechanism plays a minor role. In contrast, the wind convergence is mainly due to the pressure adjustment mechanism. This can be explained by the orientation of background wind to the sea surface temperature front. The diagnostics also explain the relatively strong seasonal variation in surface-layer momentum convergence and the small seasonal variation in curl. Finally, the surface-layer response to other western boundary currents is examined using a reanalysis dataset.	[Takatama, Kohei] Univ Hawaii Manoa, Int Pacific Res Ctr, Honolulu, HI 96822 USA; [Takatama, Kohei; Minobe, Shoshiro; Inatsu, Masaru] Hokkaido Univ, Grad Sch Sci, Sapporo, Hokkaido, Japan; [Small, R. Justin] Natl Ctr Atmospher Res, Climate & Global Dynam Div, Boulder, CO 80307 USA	Takatama, K (reprint author), Univ Hawaii Manoa, Int Pacific Res Ctr, POST Bldg,1680 East West Rd, Honolulu, HI 96822 USA.	takatama@hawaii.edu	Minobe, Shoshiro/E-2997-2010		Japan Agency for Marine-Earth Science and Technology (JAMSTEC); National Aeronautics and Space Administration (NASA) [NNX07AG53G]; National Oceanic and Atmospheric Administration (NOAA) [NA11NMF4320128]; Office of Science, U.S. Department of Energy [DE-SC0006766, DE-SC0005111]; National Science Foundation [NSF OCE05-50233]; Ministry of Education, Culture, Sports, Science and Technology of Japan [22106008, 22244057]; Research Program on Climate Change Adaptation - Ministry of Education, Culture, Sports, Science and Technology of Japan	We thank the three anonymous reviewers for providing useful comments and suggestions. This research was supported by the Japan Agency for Marine-Earth Science and Technology (JAMSTEC), by the National Aeronautics and Space Administration (NASA) through Grant NNX07AG53G, and by National Oceanic and Atmospheric Administration (NOAA) through Grant NA11NMF4320128, which funds research at the International Pacific Research Center. We gratefully acknowledge support from the Office of Science, U.S. Department of Energy Grants DE-SC0006766 and DE-SC0005111 and from the National Science Foundation through Grant NSF OCE05-50233. This research was also supported by a Grant-in-Aid for Scientific Research on Innovative Areas (22106008), a Grant-in-Aid for Scientific Research (A) (22244057), and the Research Program on Climate Change Adaptation, all of which are funded by the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Nonaka M, 2003, J CLIMATE, V16, P1404, DOI 10.1175/1520-0442(2003)16<1404:COSSTA>2.0.CO;2; Putrasahan DA, 2013, DYNAM ATMOS OCEANS, V63, P60, DOI 10.1016/j.dynatmoce.2013.04.001; Minobe S, 2010, J CLIMATE, V23, P3699, DOI 10.1175/2010JCLI3359.1; Small RJ, 2008, DYNAM ATMOS OCEANS, V45, P274, DOI 10.1016/j.dynatmoce.2008.01.001; Reynolds RW, 2007, J CLIMATE, V20, P5473, DOI 10.1175/2007JCLI1824.1; Liu WT, 2000, GEOPHYS RES LETT, V27, P2545; Wang YQ, 2003, J CLIMATE, V16, P1721, DOI 10.1175/1520-0442(2003)016<1721:AHRRCM>2.0.CO;2; LINDZEN RS, 1987, J ATMOS SCI, V44, P2418, DOI 10.1175/1520-0469(1987)044<2418:OTROSS>2.0.CO;2; WALLACE JM, 1989, J CLIMATE, V2, P1492, DOI 10.1175/1520-0442(1989)002<1492:TIOSST>2.0.CO;2; Song QT, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2006JC003680; O'Neill LW, 2005, J CLIMATE, V18, P2706, DOI 10.1175/JCLI3415.1; Xie SP, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015884; Minobe S, 2008, NATURE, V452, P206, DOI 10.1038/nature06690; Chelton DB, 2010, OCEANOGRAPHY, V23, P52; Brachet S, 2012, J CLIMATE, V25, P1847, DOI 10.1175/JCLI-D-11-00329.1; Saha S, 2010, B AM METEOROL SOC, V91, P1015, DOI 10.1175/2010BAMS3001.1; Chelton DB, 2007, J PHYS OCEANOGR, V37, P495, DOI 10.1175/JPO3025.1; Liu WT, 2008, J OCEANOGR, V64, P631, DOI 10.1007/s10872-008-0053-x; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Xie SP, 2004, B AM METEOROL SOC, V85, P195, DOI 10.1175/BAMS-85-2-195; Chelton DB, 2004, SCIENCE, V303, P978, DOI 10.1126/science.1091901; Liu WT, 2002, J OCEANOGR, V58, P121, DOI 10.1023/A:1015832919110; O'Neill LW, 2010, J CLIMATE, V23, P559, DOI 10.1175/2009JCLI2662.1; Kuwano-Yoshida A, 2010, J CLIMATE, V23, P3676, DOI 10.1175/2010JCLI3261.1; Bryan FO, 2010, J CLIMATE, V23, P6277, DOI 10.1175/2010JCLI3665.1; Small RJ, 2003, J CLIMATE, V16, P3723, DOI 10.1175/1520-0442(2003)016<3723:NSOART>2.0.CO;2; Chelton DB, 2001, J CLIMATE, V14, P1479, DOI 10.1175/1520-0442(2001)014<1479:OOCBSW>2.0.CO;2; O'Neill LW, 2012, J CLIMATE, V25, P1544, DOI 10.1175/JCLI-D-11-00121.1; Tokinaga H, 2005, J CLIMATE, V18, P3470, DOI 10.1175/JCLI3485.1; Liu WT, 2007, J CLIMATE, V20, P5784, DOI 10.1175/2007JCLI1732.1; Tokinaga H, 2009, J CLIMATE, V22, P4241, DOI 10.1175/2009JCLI2763.1; O'Neill LW, 2003, J CLIMATE, V16, P2340, DOI 10.1175/2780.1; Tanimoto Y, 2011, J CLIMATE, V24, P4419, DOI 10.1175/2011JCLI4062.1; HAYES SP, 1989, J CLIMATE, V2, P1500, DOI 10.1175/1520-0442(1989)002<1500:TIOSST>2.0.CO;2; BUSINGER JA, 1984, DYNAM ATMOS OCEANS, V8, P267, DOI 10.1016/0377-0265(84)90012-5; DEARDORF.JW, 1968, J GEOPHYS RES, V73, P2549, DOI 10.1029/JB073i008p02549; Gemmill W., 2007, 260 NCEPEMC; Hand R, 2014, CLIM DYNAM, V42, P715, DOI 10.1007/s00382-013-1715-y; Iizuka S, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012576; Maloney ED, 2006, J CLIMATE, V19, P2743, DOI 10.1175/JCLI3728.1; Miyama T, 2012, TELLUS A, V64, DOI 10.3402/tellusa.v64i0.18962; Shimada T, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046625; Skyllingstad ED, 2007, BOUND-LAY METEOROL, V123, P219, DOI 10.1007/s10546-006-9127-8; Spall MA, 2007, J CLIMATE, V20, P3785, DOI 10.1175/JCL14234.1; SWEET W, 1981, MON WEATHER REV, V109, P1042, DOI 10.1175/1520-0493(1981)109<1042:ASIEIT>2.0.CO;2; Takatama K, 2012, ATMOS SCI LETT, V13, P16, DOI 10.1002/asl.355; WAI MM, 1989, Q J ROY METEOR SOC, V115, P29, DOI 10.1002/qj.49711548503	47	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0894-8755	1520-0442		J CLIMATE	J. Clim.	JAN	2015	28	1					238	255		10.1175/JCLI-D-13-00668.1		18	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	AX6XJ	WOS:000347061200014		
J	Mishima, K; Nakano, A; Umeda, H; Shiraishi, R; Ueyama, Y				Mishima, Katsuaki; Nakano, Asuka; Umeda, Hirotsugu; Shiraishi, Ruriko; Ueyama, Yoshiya			Gender differences in posed smiles using principal component analysis	JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY			English	Article						Discriminate analysis; Gender difference; Motion analysis; Posed smile; Principal component analysis	LIP MOTION; IMAGES	Objectives: The purpose of this study was to clarify gender differences in posed smiles using principal component analysis (PCA). Materials and methods: Fourteen adult volunteers, 7 males and 7 females, were enrolled. Using the motion analyzing system we developed, range images and 5 x 5 virtual grids were produced across the whole sequence while the volunteers were asked to smile. Two sets of all intersections of the virtual grids captured while the subject was smiling were regarded as PCA variables. Discriminate analysis was then applied to compare the males and females. Results: The first and second principal component scores (PCSs) were plotted on the x-axis and y-axis, respectively. The center of gravity of the PCSs is shown by the plus on the x-axis and minus on the y-axis for the males and by the minus on the x-axis and the plus on the y-axis for the females. Discriminate analyses of the PCSs revealed a correct gender classification rate of 74.4% for posed smiles. Conclusions: While the sample size is too small to extrapolate from these results, we can conclude that PCA can be used to identify gender differences while smiling. (C) 2014 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.	[Mishima, Katsuaki; Nakano, Asuka; Umeda, Hirotsugu; Shiraishi, Ruriko; Ueyama, Yoshiya] Yamaguchi Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Ube, Yamaguchi 7558505, Japan	Mishima, K (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Minami Kogushi 1-1-1, Ube, Yamaguchi 7558505, Japan.	kmishima@yamaguchi-u.ac.jp					Ackerman J L, 1998, Clin Orthod Res, V1, P2; Popat H, 2012, J CRANIO MAXILL SURG, V40, P36, DOI 10.1016/j.jcms.2010.12.005; Mishima K, 2011, J CRANIO MAXILL SURG, V39, P232, DOI 10.1016/j.jcms.2010.04.006; Popat H, 2012, ORTHOD CRANIOFAC RES, V15, P92, DOI 10.1111/j.1601-6343.2011.01539.x; Meyer AH, 2014, AM J ORTHOD DENTOFAC, V145, P296, DOI 10.1016/j.ajodo.2013.10.019; Jolliffe I. T., 2002, PRINCIPAL COMPONENT, P1; Kawamura S, 2008, PERCEPTION, V37, P1637, DOI 10.1068/p5811; Kawamura S, 2006, PERCEPT MOTOR SKILL, V103, P210, DOI 10.2466/PMS.103.1.210-214; Liang LZ, 2013, INT J ORAL SCI, V5, P49, DOI 10.1038/ijos.2013.17; Lucas B., 1981, P 7 INT JOINT C ART, P674; Mishima K, 2014, J CRANIO MAXILL SURG, V42, P428, DOI 10.1016/j.jcms.2013.05.035; Mishima K, 2006, COMPUT MED IMAG GRAP, V30, P53, DOI 10.1016/j.compmedimag.2005.11.002; Okutomi M., 1991, Proceedings 1991 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (91CH2983-5), DOI 10.1109/CVPR.1991.139662; Popat H, 2010, OTOLARYNG HEAD NECK, V142, P867, DOI 10.1016/j.otohns.2010.03.003; Sharma N, 2012, J PROSTHET DENT, V107, P327, DOI 10.1016/S0022-3913(12)60085-7; Singh B, 2013, ANGLE ORTHOD, V83, P468, DOI 10.2319/061212-488.1; Tamura H, 2002, COMPUTER IMAGE PROCE, p[184, 252]; Valentin D, 1997, J MATH PSYCHOL, V41, P398, DOI 10.1006/jmps.1997.1186; Van der Geld PA, 2007, AM J ORTHOD DENTOFAC, V131	19	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1010-5182	1878-4119		J CRANIO MAXILL SURG	J. Cranio-MaxilloFac. Surg.	JAN	2015	43	1					144	148		10.1016/j.jcms.2014.10.026		5	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	AX3IO	WOS:000346833400025		
J	Kawasaki, I; Hiura, Y; Tamai, A; Yoshida, Y; Yakusiji, Y; Ikuno, Y; Okada, M; Ueno, H; Tanaka, N; Yamagami, K; Fukumoto, M; Hosoi, M				Kawasaki, Isao; Hiura, Yoshikazu; Tamai, Anna; Yoshida, Yoko; Yakusiji, Yosuke; Ikuno, Yoshiko; Okada, Megumi; Ueno, Hiroki; Tanaka, Nagaaki; Yamagami, Keiko; Fukumoto, Mariko; Hosoi, Masayuki			Sitagliptin reduces the urine albumin-to-creatinine ratio in type 2 diabetes through decreasing both blood pressure and estimated glomerular filtration rate	JOURNAL OF DIABETES			English	Article						albumin-to-creatinine ratio; diabetic nephropathy; sitagliptin	DIPEPTIDYL PEPTIDASE-4 INHIBITOR; NEPHROPATHY; MICROALBUMINURIA	BackgroundWe investigated the change in the urine albumin-to-creatinine ratio (ACR) to examine the effect of sitagliptin on diabetic nephropathy. MethodsSitagliptin at a dose of 50mg was administered to 247 outpatients with type 2 diabetes. Data were collected on the patients' laboratory results (including the ACR), blood pressure, and body weight. Clinical data were compared before and after 3 months' administration of sitagliptin. ResultsThe ACR changed from 150.0538.6mg/gCre to 148.3764.6mg/gCre over 3 months. In the patients with micro- and macro-albuminuria, the ACR after 3 months significantly decreased compared with the baseline (P=0.04 and P=0.02, respectively). The subjects whose ACR decreased experienced significantly larger decreases over the 3-month period in blood pressure and estimated glomerular filtration rate (eGFR) than the other subjects. There was no significant correlation between change in ACR (ACR) and change in hemoglobin A1c (HbA1c) during 3 months (r=0.04, P=0.59), but there was a significant correlation between change in ACR and change in systolic blood pressure (r=0.16, P=0.03). Multiple regression analysis revealed that the significant predictors for ACR were change in systolic blood pressure (=0.21, P=0.016) and change in eGFR (=0.20, P=0.024) over 3 months (r=0.35, P=0.04). ConclusionsSitagliptin reduces the ACR through decreasing both blood pressure and eGFR, with no correlation with a decrease in HbA1c over a 3-month period. These results may reflect the direct action of sitagliptin on the kidneys.	[Kawasaki, Isao; Tamai, Anna; Yoshida, Yoko; Yakusiji, Yosuke; Ikuno, Yoshiko; Okada, Megumi; Ueno, Hiroki; Yamagami, Keiko; Fukumoto, Mariko; Hosoi, Masayuki] Osaka City Gen Hosp, Dept Endocrinol & Metab, Osaka, Japan; [Hiura, Yoshikazu; Tanaka, Nagaaki] Jyuso Municipal Hosp, Osaka, Japan	Kawasaki, I (reprint author), 2-13-22 Miyakojima Hondoori,Miyakojima Ku, Osaka, Osaka 5340021, Japan.	i-kawasaki@hospital.city.osaka.jp					Araki S, 2007, DIABETES, V56, P1727, DOI 10.2337/db06-1646; Adler AI, 2003, KIDNEY INT, V63, P225, DOI 10.1046/j.1523-1755.2003.00712.x; Pala L, 2003, BIOCHEM BIOPH RES CO, V310, P28, DOI 10.1016/j.bbrc.2003.08.111; Mistry GC, 2008, J CLIN PHARMACOL, V48, P592, DOI 10.1177/0091270008316885; Schmieder RE, 2011, J AM SOC NEPHROL, V22, P1353, DOI 10.1681/ASN.2010091001; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; Gutzwiller JP, 2004, J CLIN ENDOCR METAB, V89, P3055, DOI 10.1210/jc.2003-031403; Hattori S, 2011, ENDOCR J, V58, P69, DOI 10.1507/endocrj.K10E-382; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Ogawa S, 2011, TOHOKU J EXP MED, V223, P133, DOI 10.1620/tjem.223.133; Augustyns K, 1999, CURR MED CHEM, V6, P311; Kirino Y, 2008, J ENDOCRINOL, V200, P53; Mega C, 2011, EXP DIABETES RES, V2011, P1; MOGENSEN CE, 1984, NEW ENGL J MED, V311, P89, DOI 10.1056/NEJM198407123110204; VIBERTI GC, 1982, LANCET, V1, P1430	15	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1753-0393	1753-0407		J DIABETES	J. Diabetes	JAN	2015	7	1					41	46		10.1111/1753-0407.12153		6	Endocrinology & Metabolism	Endocrinology & Metabolism	AX6ON	WOS:000347041500008		
J	Hotta, N				Hotta, Nigishi			Brave new world: Our journal has become an Open Access journal	JOURNAL OF DIABETES INVESTIGATION			English	Editorial Material									Chubu Rosai Hosp, Japan Labour Hlth & Welf Org, Nagoya, Aichi, Japan	Hotta, N (reprint author), Chubu Rosai Hosp, Japan Labour Hlth & Welf Org, Nagoya, Aichi, Japan.	hotta@chubuh.rofuku.go.jp					[Anonymous], 2013, SCIENCE, V342, P58; Van Noorden R, 2014, NATURE, V512, P17, DOI 10.1038/512017a; Arns M, 2014, NATURE, V515, P467, DOI 10.1038/515467a; Hotta N, 2010, J DIABETES INVEST, V1, P6, DOI 10.1111/j.2040-1124.2010.00007.x; Hotta N, 2014, J DIABETES INVEST, V5, P1, DOI 10.1111/jdi.12180	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2040-1116	2040-1124		J DIABETES INVEST	J. Diabetes Investig.	JAN	2015	6	1					1	2		10.1111/jdi.12306		2	Endocrinology & Metabolism	Endocrinology & Metabolism	AX9PR	WOS:000347234800001		
J	Maezawa, Y; Takemoto, M; Yokote, K				Maezawa, Yoshiro; Takemoto, Minoru; Yokote, Koutaro			Cell biology of diabetic nephropathy: Roles of endothelial cells, tubulointerstitial cells and podocytes	JOURNAL OF DIABETES INVESTIGATION			English	Review						Cell type specific; Conditional targeting; Diabetic nephropathy	GROWTH-FACTOR-BETA; GLOMERULOTUBULAR JUNCTION ABNORMALITIES; EPITHELIAL-MESENCHYMAL TRANSITION; SLIT-DIAPHRAGM PROTEIN; VEGF-A EXPRESSION; KIDNEY-DISEASE; NITRIC-OXIDE; GLOMERULAR BARRIER; TRANSFORMING GROWTH-FACTOR-BETA-1; NEPHRIN EXPRESSION	Diabetic nephropathy is the major cause of end-stage renal failure throughout the world in both developed and developing countries. Diabetes affects all cell types of the kidney, including endothelial cells, tubulointerstitial cells, podocytes and mesangial cells. During the past decade, the importance of podocyte injury in the formation and progression of diabetic nephropathy has been established and emphasized. However, recent findings provide additional perspectives on pathogenesis of diabetic nephropathy. Glomerular endothelial damage is already present in the normoalbuminuric stage of the disease when podocyte injury starts. Genetic targeting of mice that cause endothelial injury leads to accelerated diabetic nephropathy. Tubulointerstitial damage, previously considered to be a secondary effect of glomerular protein leakage, was shown to have a primary significance in the progression of diabetic nephropathy. Emerging evidence suggests that the glomerular filtration barrier and tubulointerstitial compartment is a composite, dynamic entity where any injury of one cell type spreads to other cell types, and leads to the dysfunction of the whole apparatus. Accumulation of novel knowledge would provide a better understanding of the pathogenesis of diabetic nephropathy, and might lead to a development of a new therapeutic strategy for the disease.	[Maezawa, Yoshiro; Takemoto, Minoru; Yokote, Koutaro] Chiba Univ Grad Sch Med, Dept Clin Cell Biol & Med, Chiba, Japan; [Maezawa, Yoshiro; Takemoto, Minoru; Yokote, Koutaro] Chiba Univ Hosp, Div Diabet Metab & Endocrinol, Chiba, Japan	Yokote, K (reprint author), Chiba Univ Grad Sch Med, Dept Clin Cell Biol & Med, Chiba, Japan.	kyokote@faculty.chiba-u.jp					Cohen MP, 2005, KIDNEY INT, V68, P1554, DOI 10.1111/j.1523-1755.2005.00567.x; Jin J, 2012, CELL, V151, P384, DOI 10.1016/j.cell.2012.08.037; Fujimoto M, 2003, BIOCHEM BIOPH RES CO, V305, P1002, DOI 10.1016/S0006-291X(03)00885-4; Pagtalunan ME, 1997, J CLIN INVEST, V99, P342, DOI 10.1172/JCI119163; Nakagawa T, 2011, NAT REV NEPHROL, V7, P36, DOI 10.1038/nrneph.2010.152; Coward RJM, 2005, DIABETES, V54, P3095, DOI 10.2337/diabetes.54.11.3095; White KE, 2002, DIABETES, V51, P3083, DOI 10.2337/diabetes.51.10.3083; Kolavennu V, 2008, DIABETES, V57, P714, DOI 10.2337/db07-1241; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; LAMBERTON RP, 1984, DIABETES, V33, P125, DOI 10.2337/diabetes.33.2.125; Zhao HJ, 2006, J AM SOC NEPHROL, V17, P2664, DOI 10.1681/ASN.2006070798; Satchell SC, 2012, KIDNEY INT, V82, P949, DOI 10.1038/ki.2012.258; Doublier S, 2003, DIABETES, V52, P1023, DOI 10.2337/diabetes.52.4.1023; Friden V, 2011, KIDNEY INT, V79, P1322, DOI 10.1038/ki.2011.58; Lee S, 2007, NEPHROL DIAL TRANSPL, V22, P396, DOI 10.1093/ndt/gfl598; Inoki K, 2011, J CLIN INVEST, V121, P2181, DOI 10.1172/JCI44771; SANDERSON N, 1995, P NATL ACAD SCI USA, V92, P2572, DOI 10.1073/pnas.92.7.2572; Niranjan T, 2008, NAT MED, V14, P290, DOI 10.1038/nm1731; Schiffer M, 2001, J CLIN INVEST, V108, P807, DOI 10.1172/JCI12367; Zhu L, 2011, J AM SOC NEPHROL, V22, P1621, DOI 10.1681/ASN.2010111146; Li JH, 2010, DIABETES, V59, P2612, DOI 10.2337/db09-1631; Kato H, 2011, J BIOL CHEM, V286, P26003, DOI 10.1074/jbc.M111.223164; Burns WC, 2006, J AM SOC NEPHROL, V17, P2484, DOI 10.1681/ASN.2006050525; Gilbert RE, 1999, KIDNEY INT, V56, P1627, DOI 10.1046/j.1523-1755.1999.00721.x; Verzola D, 2007, KIDNEY INT, V72, P1262, DOI 10.1038/sj.ki.5002531; TAFT JL, 1994, DIABETES, V43, P1046, DOI 10.2337/diabetes.43.8.1046; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; Rastaldi MP, 2002, KIDNEY INT, V62, P137, DOI 10.1046/j.1523-1755.2002.00430.x; Salmon AHJ, 2012, J PATHOL, V226, P562, DOI 10.1002/path.3964; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Nieuwdorp M, 2006, DIABETES, V55, P1127, DOI 10.2337/diabetes.55.04.06.db05-1619; Herman-Edelstein M, 2011, DIABETES, V60, P1779, DOI 10.2337/db10-1110; [Anonymous], 2012, COLD SPRING HARB PER, DOI DOI 10.1101/CSHPERSPECT.A011213; Kosugi T, 2009, AM J PATHOL, V174, P1221, DOI 10.2353/ajpath.2009.080605; Aaltonen P, 2001, LAB INVEST, V81, P1185, DOI 10.1038/labinvest.3780332; Jeansson M, 2006, AM J PHYSIOL-RENAL, V290, pF111, DOI 10.1152/ajprenal.00173.2005; Broekhuizen LN, 2010, DIABETOLOGIA, V53, P2646, DOI 10.1007/s00125-010-1910-x; Davis BJ, 2004, DIABETOLOGIA, V47, P89, DOI 10.1007/s00125-003-1256-8; Sugimoto H, 1998, DIABETOLOGIA, V41, P1426, DOI 10.1007/s001250051088; Cooper ME, 1999, DIABETES, V48, P2229, DOI 10.2337/diabetes.48.11.2229; Haraldsson B, 2008, PHYSIOL REV, V88, P451, DOI 10.1152/physrev.00055.2006; BADER R, 1980, PATHOL RES PRACT, V167, P204; Dai CS, 2009, J AM SOC NEPHROL, V20, P1997, DOI 10.1681/ASN.2009010019; Flyvbjerg A, 2002, DIABETES, V51, P3090, DOI 10.2337/diabetes.51.10.3090; Yuan HT, 2009, MOL CELL BIOL, V29, P2011, DOI 10.1128/MCB.01472-08; Sivaskandarajah GA, 2012, DIABETES, V61, P2958, DOI 10.2337/db11-1655; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Rask-Madsen C, 2013, CELL METAB, V17, P20, DOI 10.1016/j.cmet.2012.11.012; Canaud G, 2013, NAT MED, V19, P1288, DOI 10.1038/nm.3313; Gao F, 2013, J CELL BIOCHEM, V114, P1029, DOI 10.1002/jcb.24442; Nakagawa T, 2007, J AM SOC NEPHROL, V18, P539, DOI 10.1681/ASN.2006050459; Chuang PY, 2007, KIDNEY INT, V72, P965, DOI 10.1038/sj.ki.5002456; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513; Eremina V, 2003, J CLIN INVEST, V111, P707, DOI 10.1172/JCI200317423; Chen HY, 2011, DIABETES, V60, P590, DOI 10.2337/db10-0403; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Atkins RC, 2010, NEPHROL DIAL TRANSPL, V25, P331, DOI 10.1093/ndt/gfp757; Veron D, 2011, DIABETOLOGIA, V54, P1227, DOI 10.1007/s00125-010-2034-z; Cina DP, 2012, J AM SOC NEPHROL, V23, P412, DOI 10.1681/ASN.2011070690; Toyoda M, 2007, DIABETES, V56, P2155, DOI 10.2337/db07-0019; Satoh M, 2010, MICROCIRCULATION, V17, P103, DOI 10.1111/j.1549-8719.2009.00010.x; Najafian B, 2011, CONTRIB NEPHROL, V170, P36, DOI 10.1159/000324942; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Coward RJM, 2007, DIABETES, V56, P1127, DOI 10.2337/db06-0693; Lewko B, 2004, KIDNEY INT, V66, P1001, DOI 10.1111/j.1523-1755.2004.00848.x; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Langham RG, 2002, DIABETOLOGIA, V45, P1572, DOI 10.1007/s00125-002-0946-y; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; Ku CH, 2008, DIABETES, V57, P2824, DOI 10.2337/db08-0647; Koesters R, 2010, AM J PATHOL, V177, P632, DOI 10.2353/ajpath.2010.091012; Hong SW, 2001, AM J PATHOL, V158, P1653; Godel M, 2011, J CLIN INVEST, V121, P2197, DOI 10.1172/JCI44774; Kuwabara A, 2010, DIABETOLOGIA, V53, P2056, DOI 10.1007/s00125-010-1810-0; Baelde HJ, 2004, AM J KIDNEY DIS, V43, P636, DOI 10.1053/j.ajkd.2003.12.028; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Meyer TW, 1999, DIABETOLOGIA, V42, P1341, DOI 10.1007/s001250051447; Hasegawa K, 2013, NAT MED, V19, P1496, DOI 10.1038/nm.3363; Greka A, 2012, ANNU REV PHYSIOL, V74, P299, DOI 10.1146/annurev-physiol-020911-153238; Welsh GI, 2010, CELL METAB, V12, P329, DOI 10.1016/j.cmet.2010.08.015; Daehn I, 2014, J CLIN INVEST, V124, P1608, DOI 10.1172/JCI71195; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Lindenmeyer MT, 2007, J AM SOC NEPHROL, V18, P1765, DOI 10.1681/ASN.2006121304; Bonnet F, 2001, DIABETOLOGIA, V44, P874; Sung SH, 2006, J AM SOC NEPHROL, V17, P3093, DOI 10.1681/ASN.2006010064; Menini S, 2007, DIABETOLOGIA, V50, P2591, DOI 10.1007/s00125-007-0821-y; Weil EJ, 2012, KIDNEY INT, V82, P1010, DOI 10.1038/ki.2012.234; Jia JY, 2008, AM J NEPHROL, V28, P500, DOI 10.1159/000113538; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Koop K, 2003, J AM SOC NEPHROL, V14, P2063, DOI 10.1097/01.ASN.0000078803.53165.C9; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Jeansson M, 2011, J CLIN INVEST, V121, P2278, DOI 10.1172/JCI46322; Nakamura T, 2000, NEPHROL DIAL TRANSPL, V15, P1379, DOI 10.1093/ndt/15.9.1379; Bonventre JV, 2012, SEMIN NEPHROL, V32, P452, DOI 10.1016/j.semnephrol.2012.07.008; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Betsholtz C, 2004, CURR OPIN NEPHROL HY, V13, P45, DOI 10.1097/01.mnh.0000109582.66112.60; Blasutig IM, 2008, MOL CELL BIOL, V28, P2035, DOI 10.1128/MCB.01770-07; Bortoloso E, 2004, EUR J ENDOCRINOL, V150, P799, DOI 10.1530/eje.0.1500799; Brodsky SV, 2002, AM J PHYSIOL-HEART C, V283, pH2130, DOI 10.1152/ajpheart.00196.2002; Dessapt-Baradez C, 2014, J AM SOC NEPHROL, V25, P33, DOI 10.1681/ASN.2012121218; desVriese AS, 2001, J AM SOC NEPHROL, V12, P993; Eremina V, 2007, NEPHRON PHYSIOL, V106, P32, DOI 10.1159/000101798; FIORETTO P, 1995, KIDNEY INT, V48, P1929, DOI 10.1038/ki.1995.493; GIBB DM, 1989, ARCH DIS CHILD, V64, P129; Gojo A, 2007, EUR J PHARMACOL, V568, P242, DOI 10.1016/j.ejphar.2007.04.011; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Hakroush S, 2009, AM J PATHOL, V175, P1883, DOI 10.2353/ajpath.2009.080792; Hanamura K, 2014, CLIN EXP NEPHROL, V18, P95, DOI 10.1007/s10157-013-0814-8; Hohenstein B, 2006, KIDNEY INT, V69, P1654, DOI 10.1038/sj.ki.5000294; Hohenstein B, 2008, NEPHROL DIAL TRANSPL, V23, P1346, DOI 10.1093/ndt/gfm797; Holian J, 2008, AM J PHYSIOL-RENAL, V295, pF1388, DOI 10.1152/ajprenal.00055.2008; Jeansson M, 2003, J AM SOC NEPHROL, V14, P1756, DOI 10.1097/01.ASN.0000072741.02714.6E; Jeansson M, 2006, DIABETOLOGIA, V49, P2200, DOI 10.1007/s00125-006-0319-z; Jeansson M, 2009, J AM SOC NEPHROL, V20, P114, DOI 10.1681/ASN.2007111205; Kamba T, 2006, AM J PHYSIOL-HEART C, V290, pH560, DOI 10.1152/ajpheart.00133.2005; Kelly DJ, 2002, NEPHROL DIAL TRANSPL, V17, P1327, DOI 10.1093/ndt/17.7.1327; Kolset SO, 2012, J HISTOCHEM CYTOCHEM, V60, P976, DOI 10.1369/0022155412465073; Komers R, 2011, KIDNEY INT, V79, P432, DOI 10.1038/ki.2010.428; Kosugi T, 2010, AM J PHYSIOL-RENAL, V298, pF609, DOI 10.1152/ajprenal.00377.2009; LANE PH, 1993, KIDNEY INT, V43, P661, DOI 10.1038/ki.1993.95; Lim HS, 2004, DIABETES CARE, V27, P2918, DOI 10.2337/diacare.27.12.2918; Maezawa Y, 2012, GLOMERULAR CELL BIOL; Maezawa Y, 2006, DIABETES-METAB RES, V22, P313, DOI 10.1002/dmrr.612; Matoba K, 2013, KIDNEY INT, V84, P545, DOI 10.1038/ki.2013.130; Menne J, 2006, KIDNEY INT, V70, P1456, DOI 10.1038/sj.ki.5001830; Meuwese MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014262; Najafian B, 2006, J AM SOC NEPHROL, V17, pS53, DOI 10.1681/ASN.2005121342; Najafian B, 2003, J AM SOC NEPHROL, V14, P908, DOI 10.1097/01.ASN.0000057854.32413.81; Petermann AT, 2004, NEPHRON EXP NEPHROL, V98, pE114, DOI 10.1159/000081555; Schrijvers BF, 2006, NEPHROL DIAL TRANSPL, V21, P324, DOI 10.1093/ndt/gfi217; Scott RP, 2012, J AM SOC NEPHROL, V23, P1149, DOI 10.1681/ASN.2011121206; Sequeira-Lopez MLS, 2010, J AM SOC NEPHROL, V21, P460, DOI 10.1681/ASN.2009090964; Sharma K, 2000, CYTOKINE GROWTH F R, V11, P115, DOI 10.1016/S1359-6101(99)00035-0; Takemoto M, 2013, DIABETES RES CLIN PR, V100, pE26, DOI 10.1016/j.diabres.2012.12.018; Tsuchida K, 1999, DIABETOLOGIA, V42, P579, DOI 10.1007/s001250051198; Ueno M, 1997, Kidney Int Suppl, V63, pS191; VUKOVICH TC, 1989, J CLIN ENDOCR METAB, V69, P84; Wang SN, 2000, AM J PHYSIOL-RENAL, V278, pF554; Wang XM, 2014, AM J PHYSIOL-RENAL, V306, pF205, DOI 10.1152/ajprenal.90005.2013; WATTS GF, 1988, DIABETES METAB, V14, P653; White KE, 2008, NEPHROL DIAL TRANSPL, V23, P3539, DOI 10.1093/ndt/gfn351; YAMAMOTO T, 1993, P NATL ACAD SCI USA, V90, P1814, DOI 10.1073/pnas.90.5.1814	142	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2040-1116	2040-1124		J DIABETES INVEST	J. Diabetes Investig.	JAN	2015	6	1					3	15		10.1111/jdi.12255		13	Endocrinology & Metabolism	Endocrinology & Metabolism	AX9PR	WOS:000347234800002		
J	Yamamoto, Y; Yamamoto, H				Yamamoto, Yasuhiko; Yamamoto, Hiroshi			Enzymatic and non-enzymatic post-translational modifications linking diabetes and heart disease	JOURNAL OF DIABETES INVESTIGATION			English	Editorial Material							GLUCOSAMINE; SYSTEM		[Yamamoto, Yasuhiko; Yamamoto, Hiroshi] Kanazawa Univ Grad Sch Med Sci, Dept Biochem & Mol Vasc Biol, Kanazawa, Ishikawa, Japan	Yamamoto, Y (reprint author), Kanazawa Univ Grad Sch Med Sci, Dept Biochem & Mol Vasc Biol, Kanazawa, Ishikawa, Japan.	yasuyama@med.kanazawa-u.ac.jp					Yamazaki KG, 2012, J CARDIOVASC TRANSL, V5, P805, DOI 10.1007/s12265-012-9405-4; Nagy T, 2006, AM J PHYSIOL-CELL PH, V290, pC57, DOI 10.1152/ajpcell.00263.2005; Petrova R, 2002, J MOL CELL CARDIOL, V34, P1425, DOI 10.1006/jmcc.2002.2084; Dassanayaka S, 2014, PHARMACOL THERAPEUT, V142, P62, DOI 10.1016/j.pharmthera.2013.11.005; Erickson JR, 2013, NATURE, V502, P372, DOI 10.1038/nature12537; KANNEL WB, 1974, AM J CARDIOL, V34, P29, DOI 10.1016/0002-9149(74)90089-7; Bidasee KR, 2003, DIABETES, V52, P1825, DOI 10.2337/diabetes.52.7.1825; McLarty JL, 2013, LIFE SCI, V92, P621, DOI 10.1016/j.lfs.2012.08.006; VansLinthout S, 2008, BASIC RES CARDIOL, V103, P319	9	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2040-1116	2040-1124		J DIABETES INVEST	J. Diabetes Investig.	JAN	2015	6	1					16	17		10.1111/jdi.12248		2	Endocrinology & Metabolism	Endocrinology & Metabolism	AX9PR	WOS:000347234800003		
J	Kawamura, T; Umemura, T; Hotta, N				Kawamura, Takahiko; Umemura, Toshitaka; Hotta, Nigishi			Curious relationship between cognitive impairment and diabetic retinopathy	JOURNAL OF DIABETES INVESTIGATION			English	Editorial Material							ASSOCIATION; DECLINE; PEOPLE		[Kawamura, Takahiko; Hotta, Nigishi] Chubu Rosai Hosp, Dept Diabet & Endocrine Internal Med, Nagoya, Aichi, Japan; [Kawamura, Takahiko] Chubu Rosai Hosp, Ctr Prevent Med, Nagoya, Aichi, Japan; [Umemura, Toshitaka] Chubu Rosai Hosp, Dept Neurol, Nagoya, Aichi, Japan	Kawamura, T (reprint author), Chubu Rosai Hosp, Dept Diabet & Endocrine Internal Med, Nagoya, Aichi, Japan.	kawamura.hsc@chubuh.rofuku.go.jp					Kawamura T, 2012, J DIABETES INVEST, V3, P413, DOI 10.1111/j.2040-1124.2012.00234.x; Barzilay JI, 2013, CLIN J AM SOC NEPHRO, V8, P1907, DOI 10.2215/CJN.11321112; Crosby-Nwaobi R, 2012, DIABETES RES CLIN PR, V96, P101, DOI 10.1016/j.diabres.2011.11.010; Umemura T, 2011, J NEUROL NEUROSUR PS, V82, P1186, DOI 10.1136/jnnp.2010.217380; Hotta N, 2012, DIABETIC MED, V29, P1529, DOI 10.1111/j.1464-5491.2012.03684.x; Crosby-Nwaobi RR, 2013, DIABETES CARE, V36, P3177, DOI 10.2337/dc12-2141; Kawamura T, 2014, J DIABETES INVEST, V5, P597, DOI 10.1111/jdi.12190	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2040-1116	2040-1124		J DIABETES INVEST	J. Diabetes Investig.	JAN	2015	6	1					21	23		10.1111/jdi.12234		3	Endocrinology & Metabolism	Endocrinology & Metabolism	AX9PR	WOS:000347234800005		
J	Okada, H; Senmaru, T; Fukui, M; Kondo, Y; Ishigami, A; Maruyama, N; Obayashi, H; Yamazaki, M; Nakamura, N; Hasegawa, G				Okada, Hiroshi; Senmaru, Takafumi; Fukui, Michiaki; Kondo, Yoshitaka; Ishigami, Akihito; Maruyama, Naoki; Obayashi, Hiroshi; Yamazaki, Masahiro; Nakamura, Naoto; Hasegawa, Goji			Senescence marker protein-30/gluconolactonase deficiency exacerbates diabetic nephropathy through tubular injury in a mouse model of type 1 diabetes	JOURNAL OF DIABETES INVESTIGATION			English	Article						Diabetic nephropathy; Senescence marker protein-30; Tubular injury	PERMEABILITY TRANSITION PORE; SMP30 KNOCKOUT MICE; PROTEIN-30 SMP30; CELL-DEATH; OXIDATIVE STRESS; HYPOXIA; LIVER; PROGRESSION; FIBROSIS; DAMAGE	Aims/IntroductionSenescence marker protein-30 (SMP30) is abundantly expressed in renal proximal tubule cells, but its expression decreases with age. Previous studies have shown that reduced SMP30 expression could contribute to aging-associated deterioration of cellular function and tissue injury. In the present study, we investigated the effects of SMP30 deficiency on the pathogenesis of diabetic nephropathy. Materials and MethodsDiabetes was induced using streptozotocin in male SMP30 knockout mice (KO) and wild-type mice at 7weeks-of-age. VitaminC was added to the drinking water to prevent vitaminC deficiency in KO mice. The mice were killed 12weeks after the induction of diabetes. ResultsUrinary biomarkers for proximal tubule damage were significantly increased in non-diabetic KO mice compared with wild-type mice. Furthermore, diabetes-induced tubular damage was significantly exacerbated by SMP30 deletion. Morphological analysis showed a link between cortical tubulointerstitial fibrosis area and the degree of tubular damage. However, SMP30 deletion did not affect mesangial expansion. Tubular injury was associated with accumulation of hypoxia-inducible factor-1 and increased hypoxia-inducible factor-1 targeted gene expression. SMP30 deletion initiated oxidative stress; however, it did not exacerbate the oxidative stress seen in diabetic mice. In contrast, tubular inflammation was associated with SMP30 deletion only in diabetic mice. ConclusionsBased on this evidence, we concluded that SMP30 deficiency exacerbates proximal tubule injury in diabetic mice. Decreased SMP30 could contribute to the increased incidence of various chronic kidney diseases, including diabetic nephropathy, with age.	[Okada, Hiroshi; Senmaru, Takafumi; Fukui, Michiaki; Yamazaki, Masahiro; Nakamura, Naoto; Hasegawa, Goji] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Endocrinol & Metab, Kyoto, Japan; [Obayashi, Hiroshi] Inst Bioresponse Informat, Kyoto, Japan; [Kondo, Yoshitaka; Ishigami, Akihito; Maruyama, Naoki] Tokyo Metropolitan Inst Gerontol, Tokyo, Japan	Hasegawa, G (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Endocrinol & Metab, Kyoto, Japan.	goji@koto.kpu-m.ac.jp			Japan Society for the Promotion of Science [23591317]	The present study was supported by a Grant-in-Aid for Scientific Research (23591317 to GH) from the Japan Society for the Promotion of Science. We gratefully acknowledge Muneo Tsujikawa for his experimental assistance. VC powder was kindly provided by DSM Nutrition Japan (Tokyo, Japan). The authors declare no conflict of interest.	Shoag J, 2010, ARTERIOSCL THROM VAS, V30, P662, DOI 10.1161/ATVBAHA.108.181636; Halestrap AP, 2003, CURR MED CHEM, V10, P1507, DOI 10.2174/0929867033457278; Park H, 2010, J GASTROENTEROL, V45, P426, DOI 10.1007/s00535-009-0154-3; Wada T, 2000, KIDNEY INT, V58, P1492, DOI 10.1046/j.1523-1755.2000.00311.x; Fujita T, 1998, BIOCHEM BIOPH RES CO, V250, P374, DOI 10.1006/bbrc.1998.9327; Higgins DF, 2007, J CLIN INVEST, V117, P3810, DOI 10.1172/JCI30487; Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103; Sato T, 2006, AM J RESP CRIT CARE, V174, P530, DOI 10.1164/rccm.200511-1816OC; Anders HJ, 2011, KIDNEY INT, V80, P915, DOI 10.1038/ki.2011.217; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maruyama N, 2010, GERIATR GERONTOL INT, V10, pS88, DOI 10.1111/j.1447-0594.2010.00586.x; Hasegawa G, 2010, ENDOCRINOLOGY, V151, P529, DOI 10.1210/en.2009-1163; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Lin Y, 2013, ENDOCRINOLOGY, V154, P3855, DOI 10.1210/en.2013-1053; Ichas F, 1998, BBA-BIOENERGETICS, V1366, P33, DOI 10.1016/S0005-2728(98)00119-4; Son TG, 2006, MECH AGEING DEV, V127, P451, DOI 10.1016/j.mad.2006.01.005; Stroka DM, 2001, FASEB J, V15, P2445; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5; Najafian B, 2009, DIABETES RES CLIN PR, V83, P1, DOI 10.1016/j.diabres.2008.08.024; Yumura W, 2006, HISTOL HISTOPATHOL, V21, P1151; Nangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757; Dalla Vestra M, 2000, DIABETES METAB, V26, P8; FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7; Higgins DF, 2004, AM J PHYSIOL-RENAL, V287, P1223; Huang XX, 2001, MOL CELL BIOCHEM, V224, P1, DOI 10.1023/A:1011990300114; Ishigami A, 2004, BIOCHEM BIOPH RES CO, V315, P575, DOI 10.1016/j.bbrc.2004.01.091; Ishigarni A, 2007, GERIATR GERONTOL INT, V7, P316, DOI 10.1111/j.1447-0594.2007.00420.x; Ishii K, 2005, HISTOL HISTOPATHOL, V20, P761; Kaissling B, 2013, BBA-MOL BASIS DIS, V1832, P931, DOI 10.1016/j.bbadis.2013.02.010; Kimura K, 2008, AM J PHYSIOL-RENAL, V295, P1023; Kiss E, 2010, AM J PATHOL, V176, P2150, DOI 10.2353/ajpath.2010.090370; Kiss E, 2003, TRANSPLANTATION, V76, P480, DOI 10.1097/01.TP.0000066354.31050.5A; Vallon V, 2011, AM J PHYSIOL-REG I, V300, P1009; Wenz T, 2011, J AGING RES, V2011, DOI [10.4061/2011/810619, DOI 10.4061/2011/810619]	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2040-1116	2040-1124		J DIABETES INVEST	J. Diabetes Investig.	JAN	2015	6	1					35	43		10.1111/jdi.12252		9	Endocrinology & Metabolism	Endocrinology & Metabolism	AX9PR	WOS:000347234800007		
